<SEC-DOCUMENT>0000859737-21-000023.txt : 20211116
<SEC-HEADER>0000859737-21-000023.hdr.sgml : 20211116
<ACCEPTANCE-DATETIME>20211116083650
ACCESSION NUMBER:		0000859737-21-000023
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		137
CONFORMED PERIOD OF REPORT:	20210925
FILED AS OF DATE:		20211116
DATE AS OF CHANGE:		20211116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0928

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		211414202

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>holx-20210925.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:fe647887-7476-401d-8075-31ce3ecd561d,g:aafd6a0b-1c31-49b5-81b9-4feb5a12e92f,d:07bbd5e33a1f472e83c59d8668de41f8--><html xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:holx="http://www.hologic.com/20210925" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>holx-20210925</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl8yLTEtMS0xLTA_2699379d-0c53-4a35-9941-674166507e95">0000859737</ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl8zLTEtMS0xLTA_50730bf2-85bb-491d-9990-9182261784e8">false</ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl80LTEtMS0xLTA_c1c26683-16da-4f4d-9df2-85a98be0e5a2">2021</ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl81LTEtMS0xLTA_47e6f6b5-0623-4f44-9753-d8ffb7e47ff9">FY</ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl82LTEtMS0xLTA_757dc244-6085-4437-806b-c6fcbaeec872">September 25</ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:WarrantyTermForProducts" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM5NTc0_257c2dd2-2a08-4cdf-8688-8a506165be31">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="idd4c3415bf074cb794ce6b40d287d9c5_I20210925" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzItMi0xLTEtMA_02f16d49-6b43-4394-a621-52f2c15316bb">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ic46d5dcd82604bcbb61ee95e7645d76f_I20210925" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzMtMi0xLTEtMA_165f9ccd-d064-4133-aefd-27a56e4799b1">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i2e8a93ab7a16493487f16e6dd346050c_I20210925" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzQtMi0xLTEtMA_c22840a2-2884-4a0b-b279-ae99f79104b3">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i9f6243dcc94a4351be212ad078c329c8_I20210925" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzUtMi0xLTEtMA_52980acb-8f6c-45a9-a169-6a164b03698b">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="if08ab3a606434b90acdb237e36cd8380_I20210925" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzYtMi0xLTEtMA_be1b099e-d38b-4373-a790-d292079d6c2d"></ix:nonNumeric><ix:nonNumeric contextRef="i215e3aea9151448587579caf2488d39e_I20190929" name="us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156">us-gaap:LiabilitiesAbstract</ix:nonNumeric><ix:nonNumeric contextRef="i215e3aea9151448587579caf2488d39e_I20190929" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100">us-gaap:LiabilitiesAbstract</ix:nonNumeric><ix:nonNumeric contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f">us-gaap:OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da">us-gaap:AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7">us-gaap:OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ie9a15e5e0d5f4a248aab637516ec83a5_D20200927-20210925" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ3MTk_de8b43b0-f008-41d7-b826-9f3a463875ab">P4Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i92447176f15248e38b97d41aed3a3da5_D20131201-20131231" decimals="4" name="holx:PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjMvZnJhZzowYzJhZTc5OWI3ZjI0YzY1YTJlYWE0MzFlOWU5OTY4Yi90YWJsZTpkZTQwNmUzMTFiYmU0ODAwYTQ0MjRkODEyZTMwYmY1OC90YWJsZXJhbmdlOmRlNDA2ZTMxMWJiZTQ4MDBhNDQyNGQ4MTJlMzBiZjU4XzAtMS0xLTEtMA_8f944e65-0878-43d8-b950-b69bbfcf7efa">33.33</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925" decimals="4" name="holx:EmployerContributionsPercentVestedAnnually" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzIvZnJhZzpiZWU5ZmQ0MjEwM2U0ZGFjODMwZGMyM2I1MWE0ZWNkMS90ZXh0cmVnaW9uOmJlZTlmZDQyMTAzZTRkYWM4MzBkYzIzYjUxYTRlY2QxXzU4_c8684165-861b-4ef9-8163-7ae8e62edd25">33.33</ix:nonFraction><ix:nonNumeric contextRef="i7b8ac8388fb9456faa4239e3d9f5c6a3_D20210627-20210925" name="holx:TransitionServicesAgreementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzYyNg_91ec9144-43e9-4830-8cd0-3e6aa51ccfb1">P3M</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="holx-20210925.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i5ef8678e66ac489db5e4d0fa0f43053b_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i6af15f648ee54b4780a1d239d1bbda85_I20211111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5585ae25a954d67a9e131196d3a358a_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb9457cf546c4165b579b1ec171ac91f_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71201bb972ba45a28e50f67d16e6e9a6_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c0068fc5d5747a882ce9ccbd0123f38_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ee1f21a1904304a5934d3026a42b57_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf8b9b630f904fd0b483af12525ec51f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie676d127765b44e19633b016ca95774d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3278f0ce96b40519a22ae965c771b3f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1da2069ac20464e9013c24fe294ff2d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id753e6e364a144f8a4338bd5656f66cf_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia927c77ddd4b4c3f9e25433620cafd9a_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92f8eca055a24f3ba805ccce80af7729_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic258825922e845e48ae770d90cf914bf_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i684e08be393948ad91d177dd16acf8c5_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7511415f2519453297890d5928acc96d_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5428b64a6a64d48acae1ca5892619ff_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1169eac86c27452c96edd0243c74ad5d_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i330e64f51bae41568645cc62f16c3c3c_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4332687a95c44e4381175f1e41bb50d2_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide57006743114d5bbe3750f80d39e212_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2bc815063394f1c91be4496c525a478_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09031c9523ad42779d78b1cea5ecfffd_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i107888c74437440cbe2fd3eed3be8cb2_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifccad0744b37455da40b51a3e9af3cab_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7986c81bc3444e2bac570e31b4e5a5d_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8210852c21614405a339fbf5ee62cbc2_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb44d2cf92b48549d1472c325455031_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebdc63da66e44f02a09288f80627eb36_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba28c6f4ffe544f5845e9d09779a223b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7190f0470994899bbd92415a32894ec_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4afe6a62c1ae4038bd5fc9a1b0c45638_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7452f8bbde6a4dc0b0d39086f1ec6fb2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22b5647d92ba43c1addee91de2482e15_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52f80aa9ecc24057bc66c2e40b7eb278_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i349d16b63da54ca1a91efd54fc2025a2_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife279decce604602a60f3488e853f6ec_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i270a8009f56048a5aeb8b08ad88b3013_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib61d23ac15c4492d8dadef811af5939a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b95455d5e674ece8cf4c41a77810b2f_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4910978b239f42caab2d6ea6ebc0a8a4_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c0525997c5f435fb443ec3494b56714_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74767d9ffa3c4e68806179884dda54ac_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7c492a6bad949d8bbe9a19b9f847e6a_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41abe384e7ed44d0b93eb28da26c630d_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6fdf1c3d1c24fc2b1d849ed7b49afa5_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cc5988aecbc4312a8f722462e31ba5d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2bcf88f2cd249149361fc0e5b495fa2_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i284bf3087c864f18b52aa92132f5472a_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a56c91d1533454184368992ce4da0cb_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie460e7e6ecc64b75bae28b8d8803defd_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39e4f5900241494c9567649e19c96f03_D20211014-20211014"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-14</xbrli:startDate><xbrli:endDate>2021-10-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>holx:Customer</xbrli:measure></xbrli:unit><xbrli:context id="i5ab554f4731046f5a8db6df08f11e210_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i31b7d848d9294ea0bcafe1e9b98352e2_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i257fac080d6542d2b019c98a7b842cab_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20cf81a427114e06a602d55fd54d095a_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8d9c018e3364bb88f017d0ea722c968_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">holx:OneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1760e146b45f410688b3ff89a82a6684_D20190630-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ecce514a4df495b8d3d8479bdf9d0f2_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib977b0b83f104827aef9be1e2307b7e3_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9b633f8acdd4e20aa3c715419399907_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentAndSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a0e94b8d14543b8b882b82d9c97b4ca_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentAndSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d36b248dea543d9b31d755d693a800a_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentUnderCustomerUsageAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i240c4a4b528e48fcbae1ae3adac1be94_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentUnderCustomerUsageAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff4e30233d1a415382913c229d305f89_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a1a54208b5e468786e129cb05b9304d_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c6c435d399d423185f62c22c21c3f26_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id78ad9f144ef4c5f824abd84cc11f14d_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20c305b597ae44238fbe77067406d53b_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759a6a937e3f4b359b04123f53698e83_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f5a4fc2e0a249feb5e822c662f420e2_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7133ee75e2dd4ac999d32c90c55818c6_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5f33f2bd0484efea0b8ae4a94ebb11e_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6d30cd544794d8bad91533ff053e6f2_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22a8c525301944a9944a49cff920233b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ad6095503c64c51a121bfc7570d481c_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65a3feacdfc4f8db0941415413e890d_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ae31be4bb5c4a43a23c3e6238becfc2_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf8cbc783b5949dbb79a0305af7adb43_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6c3f788c0bb4582bfe4f3e18fdab22e_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i614f3db626964b0ba19f7be4c30f7447_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id938fd73f4344d9cbe5e4513a3d14cde_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1bf447986ca4495be7ba966e2186eea_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f935dfa1dfc42c1819964e91a6a8a64_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d5d0520adb34afba7a74726aaf4fd2e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i153284bf00784fb3b525b3a99606668e_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1075d2362f62458aa8909dd277c391b9_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba0c605799354665aaf32f5e35c613c0_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i397c8ef1ac694286900c772850590741_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a58be7c5d3a47b2a567894820bae0e7_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie735dea6c3194f28bea2b55697a00db1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i693d74165a33465a96c1b16aaf3362ee_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6e41df507bc48da9b9dbf2c59f4e28f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c123a5aa5c74f40857a7f1a499427f9_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib52deda671d64acda80d8851600a5b3f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ca56ec6117e459a933cdc1284e27c76_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3da811ec6224b7aaf2247ddbed15752_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24181a753fcf40f4955b32c1fa5f7f67_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cf9e1877cd24f22b338685574b8c19a_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1764f8386ed1463785aedd29aa1705e0_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044591b70cf04ae2890d5b307e363d47_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id726e42e341143488233910071609e4e_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b99fdca3c5843718c49fe1d11331a75_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c23227b249540639f90d63654aa0b54_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida01d42fd7b44dfcb8af2d9a4e61fe93_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e1fee5b3bff48a6968339ee9bea5f5d_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i710936347b24460c9bd5ba52032b894d_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbbed19de9d04478a40050d57d4eb672_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib512458f54004c1c91782978a54d120e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee6a5a2a7a4f4e3c92f42828d7360c4d_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98d0b62cc24e442bb94c648589df1886_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aac6887b6f64875a859a71ba2b4b94b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cc0b83aa93c48f48c108df5541f41ff_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i054b061ff3bb4c10a95c6b96ddc407f6_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6346aa91d524afe85aa61f0161caa3d_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i164438a7cadc4df1b56c4a64d8637889_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e559bc22d7d4793b38e4a328c0efdc2_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d3e4855ffd49b4a75816f598968a6b_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26606deeae75471ca65b268474556c52_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieee384db572047e4bc0a55fa16caac03_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51e026b96a0148719035aed371e20da8_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4497464c0da44052a7c519318511a239_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9411184d269b43d689c70581552a716e_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3b69d34963e43d5a345ff8d104b509c_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e61574a9b46411bb0ae2371322a832e_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifac209011a2246ed84b08c9d11d3ec13_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic32aed22715f404fa87eea8875fb1bed_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib54386ce9dbd4629889a414173ff052f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i767c4b13fb8b4298b5e3c88d7d4a412b_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6d9385d2791424fa11a988430cc65d1_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">holx:PensioninAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0deccf8630d14bf58974f26313ae1cf6_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02ce74e9dbd343d6a1cd77cfa6108906_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic351d3dbbd53499fba2fea622656b21d_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">holx:PensioninAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fa9316ea07a42e7bebfbfaa9b69e71a_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0e3770e763f4ddb888efca3f38034da_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ab0ba57c4c4db1ad33b536e3e7e589_D20171001-20171230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05d2321cba894df2b8040fb7171ae337_D20180930-20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2018-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6827d7fb33684f72ad15f7ec7825491c_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c63be7c32ce4ddd8e21e1134530b893_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a83c89446b8446ab0792c574b8e11bc_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i824c5596d87e486cbcedd0f0406ca67e_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0448f6218dcc4bb79af08c1f322d677c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42d6e39bab1d429394487dda896a9573_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ef043735b8b4239bd022e3c816a7d5e_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic89ac9c9ef5e4b44bc94c7ab3aadfbf0_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if412fa8d384c47b689b9c1cc6f70fb14_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e51833b6bb54770a5cad8d4c19d8fcc_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d6987883e2244438841300f24394299_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8608e05ef25e4918a0697a01f20908b8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c981e5c311541219a8ce678b8f5e556_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7021a097ba6b45e4b62b6e9a182526c0_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35128fa0cb9b4182a1faa4cc5d635680_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad3d88d570654a5eba0e1150c061cbc6_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0e58ad8c5574352954de0afd7c3c79e_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d9b9f86933044f9b736c54f4167a157_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i082d8e77f8fd4606afa5130d1718f9f4_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic627db3203ae4b219001b3708f0efa7f_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id50b2a3739074642949584da79fb2ae6_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec921088a39b409a82dd4e10a4ae0ccc_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i470023b769a94ad0b13e2609e2a72838_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35bd7f402edc440a8814d0fd91080075_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17dfc20b126b4985b7eda3cc4db3237f_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33cc4a6d3eea43fdb3367b91d64fe447_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeea03eaa2ce4eeaba648099e4e98f19_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44fec30a86bc4fdca0e8af8e653b41eb_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id679baf745974c8ba5972d62f85ff59a_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a4d3cf9145043e6a6e200011f21e141_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic93f6848c1c446b6a57343a9d7193209_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2899ef5f0e54bf481c6056474080ba9_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a41050bbd2f4b08bf819adc739c81b4_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3620d49142cd46a09f8dce2f449ad3a0_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6eee8b72e7d491c8f95b676990b140d_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77866d045d77495391adc42c2d578d4f_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1d584b446ba445593d7564671b578f3_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27464b40c6284a7ca171e8ecbf4473ed_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4444d39b093b4cc6818d013167b30698_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic727d8274f6049b8a3d7106820845e16_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdac9696c83845cbad8c3916522749af_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i271d00413b22420da0972fe262ee308e_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8631f56a67a14a0eaece9796d4d326c6_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad66804c34ae4b02af8b821d199b124c_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i071fdf8810d44be79afb0d4142823f1c_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f2294499fc4cbfbda896074c917f74_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84014ab98a4b42999ddae99b7c9f17d6_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i650a3c515fb14f28b27a2fc34755a9b6_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ce55741e08d45cfb3768da278fa78cd_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ff14eff3dae4e748c42b944b71e66c5_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cce2f2486644d48b444db7df588805c_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f414a4aae9647f39eb553c172b71177_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c62b7c793f4af4829020516aa6f08f_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17631bcf62d64f15a706d210ecad4fc5_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6465511e129b4f2b9244e3f15dc79aaf_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i880e7908395c466ea1496767a0761862_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12a3197c6b1443fca044a190d98cdcf6_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51cd7e31b542458f934ce2f21f3bbf77_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia873c88964a74ad8b51878c7599c0ee5_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fe5921de4e944419c03317f20e3cf76_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia66b3e8f28174bfc803903de805bdd71_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i464eee65cbc7418d983a6e014907ca29_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d9782966cd04624b4574f83bf76bd86_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51349d90e1e74711bc82d5c52b4c361a_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c5d7207e8a04d8f95ed445f4e2ca090_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba6b598c34a40368885f7a795edc3ed_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb689fd1c43b48ba823acc223d5dd95f_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fd4ffa7b1c745a1bb74880e80155088_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i233647819a5f40d194dce2a1a9997d5a_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i649c6b3f0c7c4dbaad7e0f14df3f9369_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b0f72609834981a2d8cce09ff40e97_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id55b5cbb5f9b4ffb9cdc329793b4ec2a_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d916bf7bc7c4a77b9a424ea474da6ee_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea5061f31944f2b9ce4b953e7acb45d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebf4abb2d7924525b0124ad8f4ac294d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf7514aec24c41be8928b4b1735c6c67_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7759fd469e4744c1aef40bd5673059f9_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2987070776a540ddace03c1f2bc15110_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fc551316da34c2e8fefb62c8a6c00b8_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dacb4bf98504ba0adc0104184a6b73e_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93dd5c0ed3164c9592d8fe3882f0a28d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i043f4d719f7b44348bdf12b5a66ef493_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd533908ee6c40dd84ac4f8768c5930c_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie54dd0f63ac74f119354986074fabb9f_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6f6c97bcbe64066a4c7b7de88fde26f_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e752284b89d41fcad2da9334eb55ced_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i756b9830819145cf947d010150d735da_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddfef9e089734fc49273fb759f37826d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac2499d2fe7f4e5299751553c9849768_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f774c3730dc47318167508519cccd16_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i595655c2121c42c4a0d63656cb7b4da9_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bd7c0bc86cd4fd797e73c8a52e9c016_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i135f102a0e3348f19dffba8a6b80c845_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic76f2583244f4da1b4d8e2ffba810bd4_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3c88c28c8d849709bac1efc12058749_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d2066aba8e543da9c51bbcd0eeec832_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97948eaa2bd440598a0350abca5c22c9_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafa45be8be374656afd2437b80f21836_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3ec9b2c72414e3986057885d7706597_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80fdffced13f49329a2ec191679666fc_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f2dd55044054b76a0d73fc9c9908555_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eb7c94b54a04e06b4612b1dc367c680_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6f02780b07b4af0a4ade42afb9a3277_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d68382b58894a7a8493d2c3c72f0bdb_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b27c44ab2c049dab1ada8ce3e2c9dde_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if613c1f13698495a8a9033eb60e30394_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i471641798bc6486890424f64b25cab0b_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a75be05e6974cdeabdb5101ca308496_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c981ade86904092ab44cdc3421e6c6c_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58c230109b9d48e3bb3cde0f8a0abd26_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80097451dd62453689464503df8df92f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cd1f66491984c7bb0dd1d0bc4fb2a69_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53fbadaaa41d47dd83cdd5d7dfa70cd8_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae08e83f10e40cfb00da11f047781ec_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2cf64befe504f17b267aaa43d3d20d6_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e66734d295a41f3bf8bc60c57b17a6f_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13c1a5da1ce942d2aae72b3f00d90f06_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c10cbf1ca23411a80e5d03d6ee6dccd_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13dbf383b09e471e8163112ba23934f4_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf97bcf6dbc8421a9a3716760bcb97e7_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00ab011f780a4f6f8ac17f56d74cdd4b_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3def95246ab34bf5acf9bbbfc8b7d08c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic55d68378e9b4082aba5a6b9d59fb043_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i611616cb655d4d7d9572751cfacacf64_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice08cc7189624f368d50df2bf2de0a54_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadf19b3b6d394dbd927075a441de11a2_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd4c3415bf074cb794ce6b40d287d9c5_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46d5dcd82604bcbb61ee95e7645d76f_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e8a93ab7a16493487f16e6dd346050c_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f6243dcc94a4351be212ad078c329c8_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if08ab3a606434b90acdb237e36cd8380_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i215e3aea9151448587579caf2488d39e_I20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide9bb99b7773447e866b67fabae6a11d_I20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id80e5c3b505e41f3ac02c7fd4f5a90f6_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd232192ed78407a974ddcf2b2257851_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63bca38bbb4548949606b34deb9181e6_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dc7bf647e314aef9275b300600f7660_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4cbe84c2c244569ac0c808b9c550275_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63a69ff36b674be191db12ceabcae07d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ea319a404a74e32a76dde8d8433c89d_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fefdb83fea04155bda0d8947d2e2c81_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c5787a7635445a6a57c55963ee616c2_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id55ff3c8d27c42eb867928b21b604ce3_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsLongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>holx:Segment</xbrli:measure></xbrli:unit><xbrli:context id="i474f42fec50e415899f9fcc327fc81f0_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i185383b2d2cf4d63b7121bb5d0c32d01_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fed62fa0ae548ef9551dac57b66c922_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b68378841c444ef93e2ed5a74fb5f45_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d1855a726e04afa80871b8a251ccd6f_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a385ec34dde4c0498c6601386e0ded1_I20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i209e37886ec24b4ca152f473bd170893_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1adc191bfb1944e6a9cbc20ef1487b58_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia55f2fdbeb5742f7b3342b8cee59d144_D20210627-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942be4914a6f424abf0ee50bc8e25578_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2e17b8f966541f782e6ed141bb9f99d_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i989b3c343b4149569fea2cd1610908f1_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i190577d230694c6db7092cbe00fd5262_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice6517c799d444b38d8fd28d773fafac_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aef7229f2fb43e2bf47467c959ff49f_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79d7a89a26634ea88d3359abf077c8ba_D20210222-20210222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-22</xbrli:startDate><xbrli:endDate>2021-02-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72e70f5d003f4a96987b3a7637d2c815_I20210222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36c42ab7aefa4f41aab159b7a5733d71_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if659372cd83b4bd4bc8116d8668b1a35_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f176b8a88dd4e52a616432565abdf82_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2946643ddc6a41b8bc328cd550813b7c_D20210104-20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2021-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dbe228069a44bdeab333d84de471731_I20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764422f35a5940fb9fd05f652236cf3a_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ee9425976bd4c5ea618b0d36430a7c8_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9077d45e6f24c7586761d31add141ac_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec517cd2e58d49acbb42aa527e1d9b85_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6087fbabae0944f982d1de9eb1a1ed44_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e4b2db5b6ae4c4ba84f02771907f7a4_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e988670f72849c99fb52b89dee92904_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id68fc41b2dac49ce95512717f490a715_D20191230-20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2019-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93bd6cff06a4e7f87214f6eb2cbfd4b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16b5a1f413384f9ca72737023db38188_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36618631bdde40eab7a2277b4c960865_I20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedf53a2286ab4650ab8d967009ff9c57_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6917f131714d4eaa8f02a7754033309b_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa9b0872e98f4d10ad0e93ab1bc740eb_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie280a98b55e94f6c8d1901932bc65953_D20190728-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-28</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i434021f3ec27448fbe1165597b733f5d_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76683b5c18404ee8b099355c544bc298_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic95991b5e000422fbe8ed48efcf4b896_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida7a175c50e343bc88edc64520ef9945_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88c8081745b4259b3951cbc18febc64_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b728effda394302a72ca98b3567ed57_I20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c8888b8e35a4df4a031e6fa6250444b_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d53a4eb8eac4b2c99a46ebf3435d28f_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b6dc772990a4dd08e146f2812715ff8_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b1421425b23449bb82f2089d54bfb94_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d2e8a19c496462f9cfc2bb84de929f2_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iead19d3763124535a6de6bd936833053_D20191001-20191001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d4407f36384a78ab3fd3c29df58e1a_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecc2544b7c7d4f2181bf059594fbb073_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a15ceda3194f6a95ab1a2052135e7b_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia45d1465e59545618e64088cd88eaf9a_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica09cd88fe9a4e17bb42730a0eb48197_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7936fd11ed2e4b85af34c8ff95ea99bb_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00310a9d53394da3824af468349e5507_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32aaf02b449b417fbbb6835a78a46b59_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fea61ca81bf4d459c97ba34e9961f73_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d4b7a8cc9a44411b8b72747d549afa1_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i589c665e90724c12916b1829bbe8611d_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i363a0363e6354e97b13c269c6820cf5a_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8f2a1f7b45b44309d99d3e69e91b1a6_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd04b96a2ff54f9fb515dc126ab745cf_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6820742ad8bf45d0b4eb5cacd1ed2d5b_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0d1533cac054998bd77025d6327d119_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie74335c4192849e4962d43b0b1fc20f4_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4bdf24b380d49bf82bd81fb2c06d677_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic611866316f1423b90b7f3d0aa696327_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72c37f79fbe241d9b526e41c78b64391_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9761cec969414f2dac8d0f65e729f1f5_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab1dbf3209e94bba8c72c6ae4d7bccc0_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibef98710ecdd4cd1aab89a2c225d4bb4_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6b1f0af679346b0bae0f56c6a024a23_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d06325cd28b4c4abb1d24a6b9f3b7e1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94ed1a363cfc4dcdbd9da0e0010b4605_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i237590b8c9a24937a685c8ff3cfc59a0_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b56d54de384d5e85d583af397a2df1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37821908786c4b708eab490638465e93_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bf618176c7846639223696bf6423a6b_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a345959c154a2d8df036461ee29971_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20c9c1045bba4ae987407ffe8c49f36c_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226927fc24ca401dbaa730834a36cc50_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2db2f22615e94b14baa99827dcd76f70_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c8b3bd2cb5743559dcb3f8b8dd002a9_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6661f7e6f8814fa0a6d62d9cf0f20dbf_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia255713509bd43e8bcf5ee357d39d247_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i052b6805906a4d2c89ee54aabd364d66_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aaac8bd6b554479a2fec5dc2c597d98_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">holx:TepnelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1bf8affe32c4e59ac455013cb5723b4_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">holx:CynosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d2e5c8508f041c0baa077405508f177_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe6803d94cea48cf812f89fc284feb20_D20180930-20181229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2018-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa3e68e1e5d546bfae26d63f7380f8b2_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ab4cd18b9a4591a4f3349bf628b8ea_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5ac9a1dd0c24e55b09475fe7b9368e8_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia15a38914d0c431881116c0c57a58aad_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i486e6244f19a4457ac36f56cf1470533_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3f1f73d7de842cb99735553e7abceab_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacf8cf06e1004995ae54b544e1d55f8a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1817a9609f14627a2d7989c9899505b_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i700525be08934f2c83c783a70ee542dc_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3a3dd46c67d43109e42cbca6545498c_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib071bc950aab4dea8b04dd63bb5fcf90_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87d92969a5ba412c8c5427576dc4c085_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a1525cddd894988b24e75e818155953_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff284685ee2f435ea04c0a1a5ca36df5_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70090c579bcd4961b00c27f03e26059b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id40664d5921a4796ba4b25ff9b2df421_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia81fd6cc362e4e8ba3a639e55937a919_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987fbf31a45c43e3bae95b8e5240af87_I20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55f8ef212efb4b25bf5f4170fbe2cf4e_I20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfe44565012b45bcaa3449fb3bb9f8e5_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd947cfb444742399b5c1ace77c408b1_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafd7f93a96974c4bb03d8ef2216bde64_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ff7dff07c19479d8d7294b3f41e4502_D20181217-20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-17</xbrli:startDate><xbrli:endDate>2018-12-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie832e870ba2c42c59c28352c2f958f69_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i652ebb0e49d2467fb5a2db3d5fb30206_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditFacility2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0cc2fe65c6840608feb94760bc0727f_D20220625-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditFacility2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-25</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie810eb40b7d8415ebbbf9fc97518f0ac_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="debt_instrument"><xbrli:measure>holx:debt_instrument</xbrli:measure></xbrli:unit><xbrli:context id="i08ae73b31aa74566b4be619e65396e03_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica7ec8355d2a4b94a212d956ffd6cb98_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37227dbc9a1b4b84b8f8518571a9c190_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2aae87d5ebc4b419aaf8b70fa7a9da0_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie74af5ae594d4d13ba8933a5998eadeb_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c788b804fa84fb88a30f3178cfe6010_I20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60bf2cb0eaf6478486595f6f3d4f3b1c_D20210927-20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-27</xbrli:startDate><xbrli:endDate>2021-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ef80047f7894c36ae90aa6a3c52242a_I20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08e28b6fbb1c4a4284c842f3cbf9792a_I20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf897b14244c423cbe46652e18311bcc_D20210927-20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">holx:EurocurrencyRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-27</xbrli:startDate><xbrli:endDate>2021-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ade552830964807a4049d7ee32b7074_D20210927-20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">holx:EurocurrencyRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-27</xbrli:startDate><xbrli:endDate>2021-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b582144f7fd4f718cb0fe6f6d00dc2a_D20210927-20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">holx:EurocurrencyRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-27</xbrli:startDate><xbrli:endDate>2021-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia77e5b12c3d44c7fb98f381230c562a4_D20180119-20180119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-19</xbrli:startDate><xbrli:endDate>2018-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62108c6a80cb45f69acbd92821a7917d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad19ce928cc147b4a6d313f0bee64c59_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id41609d12cf047148859a8228474e2bd_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b7aafeef10b4cb39da754e699f15172_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i608d5220bab04a068eb77c0863e0e36a_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e507642eb964db6860b69fb5f71596c_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie12d730be0c14e1f9f1c5feaed78db40_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02f6ad83b4ca4d948d52c4704f2e4326_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03accd3c4a404ba1becc118185a02608_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaa36a6d1efb41cb8948ae469d7b66a1_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3adbde1625f143509c7660ebf25386e1_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie51341073d8740bab85b03dc5cbb80c6_D20201015-20201015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-15</xbrli:startDate><xbrli:endDate>2020-10-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcae078f20ac485186d995bbd72b5c6c_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d531947d51410a8d540905838b6d9d_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ccbfebd983b455f947f37aab7a949b0_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd6b00bf571a45b79bec794d5b438566_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0b31f3326de4002a60eb9c0311715ac_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d4b04bc14144fa5b03735e07bd838a6_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfc1f74a5de948999cd82322770f0eba_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99b892bb7bdd405aa700578ed296fdde_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i580c0405f9b548989c3f94ad170c061b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8eae7b7b71e466b8c9e1876e7f31390_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79503f9eb2e64b5383905a0821499fdd_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90abd2f2507648759350a4c487e7133b_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i859a66c6b93d4b9887cc31492d39939f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i875c28ce0ee54237b5b3ae2cc86658a0_D20160425-20160425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-04-25</xbrli:startDate><xbrli:endDate>2016-04-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cfd402b776d44a0a41a299cca8f7ede_I20160425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-04-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4812438b158c4e59a58edb46ec6692b1_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id66308ea8ebc4fd4838c14af38426030_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d6eb9a53b2c48879a529442ab3b794a_D20210627-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i397a73cea4db4782a2daff7fe814251a_I20210611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife9157147e3b4536a9046a87f5a4d781_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c371851af5c4029b78c5f593a1a596f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia65923c3b6874551939bf4e2608b53bb_I20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f11d3ec54a14c5e9eb1e8a150c8bc11_I20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc96b1d6d081406abb844157f1ed6e5c_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1406035f87284cafbfec6b6f722dc49c_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc463bd6a5a1402f90b9512aff6a663a_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie913b1898868426c83630108b0931936_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d8ebd59017941e09e4b709e2c259721_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1e254ea6d6943bb8318cf1919f88ee6_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i125f4bfdd8b84928ab52d980197004dc_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc0150b9393b4c8b954b2e122c43851c_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dcaf65163dc4875a6d42ef1db4db39a_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i038a6263f66c4604975a68690f426831_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73170ab8f09241c6addd83b14085fb1d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd0a92c2fbda45e5a76e08e7693a71ee_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f31160d70448a4bc9dc1766821eb8d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15a2dcf988324496812e93ba7fe0dbfe_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e5c21e5481b48d39c7959cb8bc8c777_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie36b916fb59a49dd9387e30c28f5ec5b_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b282273a4c84a8caba87fd238f92b67_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id901e08a99744558bdb5e1f2583dcbbe_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c2fff5e4e74c19ad8880629979f011_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib332bb7657f04489b5fa9e02f29ad82b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a8c569fd753446ebfcdbe23ec063f7c_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia383a042e26d453ea66d7eaa8d23c21a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3a7bf1b1614469fb146d97f9eaddd6b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ca8c80f7c34ee4800d09f086e64eaf_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59b0c160a0424f80895466659951d8a5_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie43b4fa2b20c49fb8a55c4a741714682_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id66df1a2532a483f863906f0802057c7_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib91d7b55ffbe4550b988ae9a14a17fb7_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91dece30b943448ab8d1ec46e9bc104e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0b57f07560240bbb91b31af0add8433_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia11ee15324c14f1bb58ad7901a2e8f89_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d46afcc2f043149b8d49cfd5f03353_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if91afb4383874bc4926b10047930d0c4_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i382a342e009b41b7ba2429981f375e2f_D20181230-20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-30</xbrli:startDate><xbrli:endDate>2019-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i273f68028b9048b4bcb9cc44e3765361_D20181230-20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-30</xbrli:startDate><xbrli:endDate>2019-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6960dde2df794b28bb51b31c7a27d8d7_D20181230-20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-30</xbrli:startDate><xbrli:endDate>2019-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i461d1a7632c3438dbb6d29204125214d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia06d0a30712b4655924b65bdcb87307c_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc9edb45f9c24890a42f08ce96b5a3d5_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20b6f0eac2434262a3cac9fb4d6a84a8_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d960bac02334aadb2300cb9a53f0809_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i276f90f490c64954a3fcb6fce34ac50d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5ffdf58eb9f4baeb95351040e234393_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">holx:NetOperatingLossCarryforwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5daaef3be8904e43aea1b5d817ea7ea9_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">holx:TaxCreditCarryforwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd8d2cba4a8d4ac4869ea733f58a335d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d836e99e1744b98a12d054959a730e7_D20210627-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aa941ab35ec45b98ce91c612351ba23_D20210627-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaffd59eb8187474fb5a4d8af030af483_D20181230-20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-30</xbrli:startDate><xbrli:endDate>2019-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i814cfc79d9f948ac96c6d5e239cf1326_I20160613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2016-06-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88b3d268274c46d98f224f8c6c9816fb_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:June132019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12da8222241d4afe9a4fd7ee1a5a6030_I20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i945e50292f26455c9fb03af3ee5dc38d_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc5c3fa0816048caa2da1ed91c216daf_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie11a3dc3cc614addb28fd00bd0cf9a2c_I20201209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec92020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1a4a87513914de081e110fe2f694f1d_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec92020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e1998ffb6bc4561a84610ab181828cb_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i747e381970ad4c3992a6131bcbfc5461_D20210926-20211116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-11-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57712fb9ed674d6ebb6261cb65be3db3_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i748a99e2a6c74677886bd3b4e6b89ac2_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:TwoThousandEightEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i623fe63350cc4f4bbf60f09a3b45072a_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0202135faa1f4b469d6ecb622791638d_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i452f1577e5c942c4a2cebac00daff1d2_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb317bb99ad84ae3a58c21783556ecaa_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia34f9b5ebf6940d8862b1e4e259514e0_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacda269ea4f047c08ae1a3627ce6fcf9_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db32da71cc1455088030b8c7b621bf0_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic05d68681e5c4f9eacb730bfede1f07c_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b47832b29e04b3bb2ed3c90cfc6f1fa_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i920ca50d08084b8b97e8598c37fc6711_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i199364dd0aa84ab9b4bd4fb3a7b46bee_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i935c7d53d46d4c65944f086fdbf09aec_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c14b446dbbc4ed1ba4f1d985a7197ec_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88b1b0c9c5604d23ab52ca8f9713a3d9_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9133708dc8a4713aad750ae0f4663a0_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9a15e5e0d5f4a248aab637516ec83a5_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e32118662c4420ba5a02eec6689e797_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16882582e0204737b097e2891c7c65e4_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14ca5f4e78bb437a81cded9e6c66f121_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie582e31fa38344bea5db72aa1a9ab369_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74b0294ab860440d9476b34210f76f37_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b62684619cf449b9f9b6a4e0bef8642_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0bd21f9a30840228f9a47abe615910a_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ae9481304b4cbda64fdf0b97da2601_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia618e91ec0fc43d09d5b6352f024ece8_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia28511c78fc648ccac995a4d5840b7b8_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cc04f37c6b947d3b9bc3cda079ee134_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia51b0591bb904743909f38530873e249_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313b0dcd780d4e46bd994d7390ef9a63_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1f36b739b804d62873d875e6ab53e6e_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb7931cabae1458c905c13e1f1be44c6_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8e24c06b55c4c71852aa0419edcd4c1_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcf0307d722e405a9d4239a5969664a9_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00a4b6b947964d0c9cf7a620d260cdb8_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4dbd93a38124c16a4fcf7162433450f_D20120301-20120331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2012-03-01</xbrli:startDate><xbrli:endDate>2012-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3222582dc9e54de994fbc83070afcdca_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46abb586bf124b4085396c348e397ede_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59c4542075c04499bd7780fac311ed3c_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide2dd65f185944a7af648c12349053bf_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92447176f15248e38b97d41aed3a3da5_D20131201-20131231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2013-12-01</xbrli:startDate><xbrli:endDate>2013-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7174a6cf5674cc7a6e006b12d20074f_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">holx:OneThirdAnnuallyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09879e74afc8419ebec21bb3b905b88d_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf5f8f1317384761bd3f09365e030290_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i539c042130bf4c0ea0ca1aaf167a10a3_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2b78f80558e4fa2aa90758d4605b59c_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f565dc1ab5b4eb6aef305378185c37c_D20180727-20180727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">holx:CompanyVs.MinervaSurgicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-27</xbrli:startDate><xbrli:endDate>2018-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2f30513167641b4843c24f196c963b3_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i219e75a86551445f84f935b59c0a9995_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e21c713b33d4b199f4353e62c47d003_D20191120-20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-20</xbrli:startDate><xbrli:endDate>2019-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04f6b978d03c4001921c33d5129a2d94_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b8ac8388fb9456faa4239e3d9f5c6a3_D20210627-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31bd370f6c9d45cbb9bf2321aef87fe9_D20210627-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6a08f19521748068ae388682bbfb97b_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa33bf2f57be45678091ef0f4e3cb31e_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied23a24d717e4da1895598ce729fd2bf_D20210627-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i982ea739818b424cbe9228324e052c58_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a7761670014c0e89cd95059279c22a_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b63b6326364b86b8c1c35e06779d17_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a986aa268d54c1c9fed13658c3b20ec_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26018f332aa24e47a89ddb88990c5d5f_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i103c26400f644d6794e2701b7b92414f_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98caa293bf89418e947a8f295926a7d8_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb68d71446d14424bd72697ac3285509_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3b6afa22e0f493095f052e3a37c80f9_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0490b02597f34bb0a3d9b518df6ea31c_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb7a6e4fce84451a598a007a83c7c2e_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad80942a21184b6099e93a927140cccc_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8d7dce3b25048bebda69f0f9c683dc0_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbe9fe13010940de8718a210bf402a2d_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i680aa07110f848c0a9f91bc57d1d9d9d_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e0820fa934740988bc68c46b00eaa05_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74b686e1df1549aca26f39228fe341fa_D20200927-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c4ff82c84e041298fcbdf87e237dcf5_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5b4e0cf7b6d4802a7d62ddca53a82db_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe57ae2fbed04a638154dae73a66c811_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i355f32c131b14099b97cc874503e497f_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c83bdbf9ef94aa59101a9aea2be7873_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i548c9eddb08b4f14967120bc035c9ec8_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4b55414cc384a68b8e3567008300ae5_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib41f0019abbb463c9a8e10c2f96a5e29_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66522b5564db479e9fd59f735b53bcda_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e2c2ca6c4484232a21bb281c44dd840_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36c8c111abcf4b43a4042a7c166306fe_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecc61f191e354207a73d576c73bc8d42_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58fd21fdaa0f4e66ab9388859b3f172e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b547462cf5d4b5597648a8fe55a37e6_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1d488dc858b49ac92911c8316dc04c3_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8cb3192812b4442b0a3e479a2307bc0_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_1"></div><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTI0_7be1669d-f5af-448f-9623-53047bb63a3d">10-K</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6MDVmMmE1YWRmMDU1NGYxNGJhM2U5N2EzODM3ZWQ4ZmQvdGFibGVyYW5nZTowNWYyYTVhZGYwNTU0ZjE0YmEzZTk3YTM4MzdlZDhmZF8wLTAtMS0xLTA_180a94f7-ce87-425f-afd2-a8a261288edb">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the fiscal year ended: <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8xOTg_4077e848-9bfa-41ae-8b43-1ef9b10b956d">September&#160;25, 2021</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6OWY0ZDQyODgzNmNkNGUwZDlkMzAxMmIwNjZiZDI1ZDMvdGFibGVyYW5nZTo5ZjRkNDI4ODM2Y2Q0ZTBkOWQzMDEyYjA2NmJkMjVkM18wLTAtMS0xLTA_3ac90a4f-3dc2-4ae2-bc84-4dc22d245b33">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTI1_23ccaf40-371c-4d47-b07a-2967bcecc693">1-36214</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTI2_86bc7c12-c300-4f84-b03b-b171380b2ccb">HOLOGIC, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:252.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:241.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6YjQ1ZThjOWZlM2RkNDBkMGEzMjMwNDBkYTFhZTZjNzEvdGFibGVyYW5nZTpiNDVlOGM5ZmUzZGQ0MGQwYTMyMzA0MGRhMWFlNmM3MV8wLTAtMS0xLTA_d2f1d451-c4e3-4d2d-abe3-73c155aaa1e8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6YjQ1ZThjOWZlM2RkNDBkMGEzMjMwNDBkYTFhZTZjNzEvdGFibGVyYW5nZTpiNDVlOGM5ZmUzZGQ0MGQwYTMyMzA0MGRhMWFlNmM3MV8wLTItMS0xLTA_e6690573-003e-46c5-836f-86d8ac8ba63d">04-2902449</ix:nonNumeric></span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE5_a8986041-a225-4e88-8b7e-c990604d80cd">250 Campus Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTEz_78d8aad4-840e-4f0e-831e-680571e89a78">Marlborough</ix:nonNumeric>, <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTI3_e0a9c6d7-b5f6-475c-a7b5-3423fea1d949">Massachusetts</ix:nonNumeric> <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTIz_45406f89-cfdb-4f09-9018-9a849dc92f5c">01752</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code (<ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE3_1377a17c-d421-49a5-a6f8-d8911eb52fc3">508</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE0_1c9193b1-0761-4ed2-8c90-f3cf117d9518">263-2900</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:184.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:139.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:184.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Each Exchange on which Registered</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6ZDE2M2NhMjNiMWU3NGQzN2I1Yjc5YTgzZDIxNzQ2NmEvdGFibGVyYW5nZTpkMTYzY2EyM2IxZTc0ZDM3YjViNzlhODNkMjE3NDY2YV8yLTAtMS0xLTA_c7d9ac36-fcb2-41bb-83fc-5fcef6e707bf">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6ZDE2M2NhMjNiMWU3NGQzN2I1Yjc5YTgzZDIxNzQ2NmEvdGFibGVyYW5nZTpkMTYzY2EyM2IxZTc0ZDM3YjViNzlhODNkMjE3NDY2YV8yLTEtMS0xLTA_bc112b65-3fff-449e-affe-721948beef85">HOLX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6ZDE2M2NhMjNiMWU3NGQzN2I1Yjc5YTgzZDIxNzQ2NmEvdGFibGVyYW5nZTpkMTYzY2EyM2IxZTc0ZDM3YjViNzlhODNkMjE3NDY2YV8yLTItMS0xLTA_938fa241-c798-49c3-bd23-eb86a2c4e871">The NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:&#160;None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-top:5pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTIw_d4318fbd-6d28-4073-aec9-57c616a5823d">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d)&#160;of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE1_39a56c17-2771-4506-8bea-cf1c9674dde1">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE2_ff6b083c-dac2-4ba2-b0b5-5150ef55f27d">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTIx_52cfb0d6-a7be-41c9-a8db-807d1806a03e">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act (Check one).</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.715%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.572%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6Y2FhODY5ZjUwZTkxNDUyYmJmZGYwOWM3ZmIyZjBjOWUvdGFibGVyYW5nZTpjYWE4NjlmNTBlOTE0NTJiYmZkZjA5YzdmYjJmMGM5ZV8wLTAtMS0xLTA_a6d12ccf-e93b-4e2a-828a-099bb6bea128">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6Y2FhODY5ZjUwZTkxNDUyYmJmZGYwOWM3ZmIyZjBjOWUvdGFibGVyYW5nZTpjYWE4NjlmNTBlOTE0NTJiYmZkZjA5YzdmYjJmMGM5ZV8xLTctMS0xLTA_a2b3527d-74f7-4c8d-9503-6779561d1af1">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6Y2FhODY5ZjUwZTkxNDUyYmJmZGYwOWM3ZmIyZjBjOWUvdGFibGVyYW5nZTpjYWE4NjlmNTBlOTE0NTJiYmZkZjA5YzdmYjJmMGM5ZV8yLTctMS0xLTA_6ad842a2-732a-428d-b43a-ed81dfd63372">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. &#167;7262(b)) by the registered public accounting firm that prepared or issued its audit report. &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE4_f1149a79-b785-4e9a-a448-25afd0f6170b">&#9746;</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTEy_34362930-9dc3-4d4c-bb7b-0306bf8909f5">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant's Common Stock held by non-affiliates of the registrant as of March 27, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i5ef8678e66ac489db5e4d0fa0f43053b_I20210327" decimals="0" format="ixt:num-dot-decimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8yOTM4_07a43a84-4d54-41d3-84cd-6083ed771c62">18,639,078,720</ix:nonFraction> based on the price of the last reported sale on NASDAQ Global Select Market on that date.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;11, 2021, <ix:nonFraction unitRef="shares" contextRef="i6af15f648ee54b4780a1d239d1bbda85_I20211111" decimals="0" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zMDQx_4c0cc649-8cbc-4db9-a1ee-c80c7be8e09e">251,420,529</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $0.01 par value, were outstanding.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTIy_ad47956f-c1f0-4150-9a9b-e1d9059ed7b0" escape="true">Portions of the registrant&#8217;s Proxy Statement for the registrant&#8217;s annual meeting of stockholders to be filed within 120 days of the end of its fiscal year ended September&#160;25, 2021 are incorporated into Part III (Items 10, 11, 12, 13 and 14) of this Annual Report on Form&#160;10-K where indicated.</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT ON FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Fiscal Year Ended September&#160;25, 2021 </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_10">PART I</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_13">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_16">19</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_19">30</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_22">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_25">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_28">31</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_31">PART&#160;II</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_34">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_34">32</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_40">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_40">33</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_43">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_43">34</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_58">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_58">53</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_61">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_61">54</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_64">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_64">54</a></span></div></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_67">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_67">54</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_70">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_70">58</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_73">PART&#160;III</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_76">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_76">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_79">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_79">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_82">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_82">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_85">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_85">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_88">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_88">59</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_91">PART&#160;IV</a></span></div></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_94">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_94">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_97">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_97">66</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Some of the statements contained in this report and documents incorporated by reference herein are forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended (the "Securities Act") and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements involve known and unknown risks, uncertainties and other factors which may cause our or our industry&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements regarding:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;padding-left:7.75pt">the ongoing and possible future effects of the global COVID-19 pandemic and associated economic disruptions, including supply chain constraints and inflation, on our business, financial condition, results of operations and cash flows and our ability to further draw down our revolver;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ongoing and possible future effects of the global COVID-19 pandemic on our customers and suppliers;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">continued demand for our COVID-19 assays; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses, including emerging vaccine mandates, to the COVID-19 pandemic; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to manufacture, on a scale necessary to meet demand, our COVID-19 assays as well as the systems on which the assays run; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to predict accurately the demand for our products, and products under development and to develop strategies to address markets successfully;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of the continuing worldwide macroeconomic uncertainty, including the UK&#8217;s decision to leave the European Union (known as Brexit), on our business and results of operations; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of the worldwide political and social uncertainty and divisions throughout the world, including the impact on trade regulation and tariffs, that may adversely impact the cost and sale of our products in certain countries, or increase the costs we may incur to purchase materials, parts and equipment from our suppliers;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the development of new competitive technologies and products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the impact and anticipated benefits of completed acquisitions and acquisitions we may complete in the future;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to consolidate certain of our manufacturing and other operations on a timely basis and within budget, without disrupting our business and to achieve anticipated cost synergies related to such actions; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to successfully manage ongoing organizational and strategic changes, including our ability to attract, motivate and retain key employees and maintain engagement and efficiency in remote work environments; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to obtain regulatory approvals and clearances for our products, including the implementation of the new European Union Medical Device Regulations, and maintain compliance with complex and evolving regulations; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">potential cybersecurity threats and targeted computer crime;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the coverage and reimbursement decisions of third-party payors; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the guidelines, recommendations, and studies published by various organizations relating to the use of our products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of consolidation in the healthcare industry;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the possibility of interruptions or delays at our manufacturing facilities, or the failure to secure alternative suppliers if any of our sole source third-party manufacturers fail to supply us;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to meet production and delivery schedules for our products; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to protect our intellectual property rights; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the possibility that products may contain undetected errors or defects or otherwise not perform as anticipated;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the anticipated development of markets we sell our products into and the success of our products in these markets; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the anticipated performance and benefits of our products; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">business strategies; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">estimated asset and liability values; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the impact of future tax legislation;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">conducting business internationally;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the impact and costs and expenses of any litigation we may be subject to now or in the future; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our compliance with covenants contained in our debt agreements; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">anticipated trends relating to our financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations, including the potential impact of the phase out of LIBOR by June 30, 2023; and </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our liquidity, capital resources and the adequacy thereof. </span></div><div style="padding-left:31.5pt;text-align:justify"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; "intends," &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; "likely," "future," "strategy," &#8220;potential,&#8221; "seeks," "goal" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events, conditions or circumstances on which any of our forward-looking statements are based. Factors that could cause or contribute to differences in our future financial results include the cautionary statements set forth herein and in our other filings with the Securities and Exchange Commission, including those set forth under &#8220;Risk Factors&#8221; set forth in Part I, Item&#160;1A of this Annual Report on Form 10-K (this "Annual Report"). We qualify all of our forward-looking statements by these cautionary statements.</span></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRADEMARK NOTICE</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic is a trademark of Hologic, Inc. Other trademarks, logos, and slogans registered or used by Hologic and its divisions and subsidiaries in the United States and other countries include, but are not limited to, the following: 3Dimensions, 3D Mammography, 3D Performance, 3DQuorum, Acessa, Acessa Health, Acessa ProVu, AccuProbe, Aixplorer, Affirm, Affirm Prone, Alpha Imaging, Amplidiag, Aptima, ATEC, Biotheranostics, BioZorb, Brevera, Celero, Clarity HD, C-View, Definity, DirectRay, Emsor, Eviva, Faxitron, Faxitron Bioptics, Fluent, Fluoroscan, Focal, Focal Therapeutics, Genius 3D, Genius 3D Mammography, Genius AI, Health Beacons, Hitec-Imaging, Hologic, Horizon DXA, Insight, Intelligent 2D, ImageChecker CAD, LOCalizer, Medicor, Mobidiag, MyoSure, NovaSure, Novodiag, NXC Imaging, Panther, Panther Fusion, Progensa, Quantra, Rapid Ffn, SecurViewDX, Selenia, Selenia Dimensions, Sertera, SmartCurve, Smart-Depth, SmartSlices, SuperSonic Imagine, ThinPrep, Tigris, Tomcat, UltraFast, and Unify Workspace. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other brand names or trademarks appearing in this Annual Report on Form 10-K are the property of their respective owners. Hologic&#8217;s use or display of other parties&#8217; trademarks, trade dress or products in this Annual Report does not imply that Hologic has a relationship with, or endorsement or sponsorship of, the trademark or trade dress owners. </span></div><div style="margin-bottom:18pt;margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_13"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Business</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives. We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Until December 30, 2019, our product portfolio included aesthetic and medical treatment systems sold by our former Medical Aesthetic business. We completed the sale of our Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020).</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Through our Diagnostics segment, we offer a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther, Panther Fusion and Tigris), our ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Our Aptima family of molecular diagnostic assays is used to detect, among other things, the infectious microorganisms that cause common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, or CTGC, certain high-risk strains of human papillomavirus, or HPV; and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, the parasite that causes trichomoniasis; Mycoplasma genitalium; and Herpes Simplex viruses 1 and 2. We also offer viral load tests for HIV, Hepatitis C and Hepatitis B for use on our Panther instrument system. Our assay portfolio also includes diagnostic tests for a range of acute respiratory infections, including SARS-CoV-2, as well as a test for the detection of Group B Streptococcus, or GBS, that are run on the Panther Fusion system, a field upgradeable instrument addition to the base Panther system. In response to the COVID-19 pandemic, we developed and launched the Aptima SARS-CoV-2 assay (which runs on our standard Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system). The Panther Fusion SARS-CoV-2 assay and the Aptima SARS-CoV-2 assay were launched at the end of our second quarter and in the third quarter of fiscal 2020, respectively. The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. These solutions include 3D digital mammography systems, image analytics software utilizing artificial intelligence, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, connectivity solutions and breast conserving surgery products. Our most advanced breast imaging platforms, Selenia Dimensions and 3Dimensions, utilize tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our GYN Surgical products include our NovaSure endometrial ablation system, or NovaSure, our MyoSure hysteroscopic tissue removal system, or MyoSure, our Fluent fluid management system, or Fluent, as well as our Acessa ProVu laparoscopic radiofrequency ablation system, or Acessa. The NovaSure portfolio is comprised of the NovaSure CLASSIC and NovaSure ADVANCED devices and, most recently, the NovaSure V5 device for the treatment of abnormal uterine bleeding. The MyoSure suite of devices offers four options to provide incision-less removal of fibroids, polyps, and other pathology within the uterus. The Fluent system is a fluid management system that provides liquid distention during diagnostic and operative hysteroscopic procedures. The Acessa system is a fully integrated system that uses laparoscopic ultrasound, guidance mapping and radiofrequency ablation to treat nearly all types of fibroids.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Skeletal Health segment's products include the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm, which assists in performing minimally invasive orthopedic surgical procedures on a patient's extremities, such as the hand, wrist, knee, foot, and ankle.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to we, us, Hologic or our company refer to Hologic, Inc. and its consolidated subsidiaries. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our internet website address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.hologic.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Through our website, we make available, free of charge, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports, as well as proxy statements, and, from time to time, other documents as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (SEC). These SEC reports can be accessed through the investor relations section of our website. The information found on our website is not part of this or any other report we file with or furnish to the SEC. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors and others should note that we announce material financial information to our investors using our investor relations website (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">investors.hologic.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), SEC filings, press releases, public conference calls and webcasts. We use these channels as well as social media to communicate with our members and the public about our Company, our services and other issues. It is possible that the information we post on social media could be deemed to be material information. Therefore, we encourage investors, the media, and others interested in our Company to review the information we post on the social media channels listed on our investor relations website. We have used, and intend to continue to use, our investor relations website, as well as our Twitter account (@Hologic), as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Additional corporate governance information, including our certificate of incorporation, bylaws, governance guidelines, board committee charters, and code of business conduct and ethics, is also available on our investor relations website under the heading &#8220;Corporate Governance.&#8221; The contents of our websites are not intended to be incorporated by reference into this Annual Report or in any other report or document we file with the SEC, and any references to our websites are intended to be inactive textual references only.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC maintains an internet website that contains reports, proxy and information statements, and other information regarding Hologic and other issuers that file electronically with the SEC. The SEC&#8217;s internet website address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We view our operations and manage our current business in four principal reporting segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Financial information concerning these segments is provided in Note 16 to our audited consolidated financial statements contained in Item 15 of this Annual Report. The following describes our principal products in each of our segments.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostics Product Offerings</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Molecular Diagnostic Assay Portfolio</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aptima Family of Molecular Diagnostic Assays.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our Aptima molecular diagnostic assays are used to detect, among other things, the infectious microorganisms that cause common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, or GTGC; certain high-risk strains of human papillomavirus, or HPV; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parasite that causes trichomoniasis; Mycoplasma genitalium; and Herpes simplex viruses 1 and 2. In addition, we also offer viral load assays for the quantitation of Hepatitis B virus, or HBV, Hepatitis C virus, or HCV, and human immunodeficiency virus, or HIV-1, for use on our Panther instrument system. All three of these viral load assays are both CE-marked and FDA approved. Our fourth viral load assay for the quantitation of human cytomegalovirus, or CMV, was CE-marked in June 2021, and we have submitted an application to the FDA for approval of our Aptima CMV Quant assay in the U.S. We also offer our Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis, a common and complex ailment affecting millions of women a year. In response to the COVID-19 pandemic, we developed and launched our Aptima SARS-CoV-2 assay for the detection of SARS-CoV-2, the virus that causes COVID-19 disease, which runs on our standard Panther and Panther Fusion systems. The Aptima SARS-CoV-2 assay for our standard Panther system was granted Emergency Use Authorization by the FDA in May 2020 and is also CE-marked. Our Aptima products integrate a number of proprietary core technologies, including our target capture technology, our Transcription Mediated Amplification, or TMA, technology, and our hybridization protection assay, or HPA, and dual kinetic assay, or DKA, technologies, to produce highly sensitive amplification assays. Each of these technologies is described in greater detail below.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Target Capture/Nucleic Acid Extraction Technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The detection of target organisms that are present in small numbers in a large-volume clinical sample requires that target organisms be concentrated to a detectable level. One way to accomplish this is to isolate the particular nucleic acid of interest by binding it to a solid support. This support, with the target bound to it, can then be separated from the original sample. We refer to such techniques as &#8220;target capture.&#8221; We have developed target capture techniques to immobilize nucleic acids on magnetic beads by using a &#8220;capture probe&#8221; that binds to the bead and to the target nucleic acid. We use magnetic separation to concentrate the target by drawing the magnetic beads to the sides of a sample tube, while the remainder of the sample is removed from the tube. When used in conjunction with our amplification procedures, target capture techniques concentrate the nucleic acid target(s) and also remove materials in the sample that might otherwise </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interfere with amplification.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transcription-Mediated Amplification (TMA) Technology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The goal of amplification technologies is to increase the copy number of a target nucleic acid sequences that may be present in samples in small numbers. These copies can then be detected using nucleic acid probes. Amplification technologies can yield results in only a few hours versus the several days or weeks required for traditional culture methods. TMA is a transcription-based amplification system that uses two different enzymes to drive the process. The first enzyme is a reverse transcriptase that creates a double-stranded DNA copy from an RNA or DNA template. The second enzyme, an RNA polymerase, makes thousands of copies of the complementary RNA sequence, known as the &#8220;RNA amplicon,&#8221; from the double-stranded DNA template. Each RNA amplicon serves as a new target for the reverse transcriptase and the process repeats automatically, resulting in an exponential amplification of the original target that can produce over a billion copies of the RNA amplicon in less than thirty minutes.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hybridization Protection Assay (HPA) and Dual Kinetic Assay (DKA) Technologies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With our HPA technology, we have simplified testing, further increased test sensitivity and specificity, and increased convenience. In the HPA process, the acridinium ester, or AE, molecule is protected within the double-stranded helix that is formed when the probe binds to its specific target. Prior to activating the AE molecule, known as &#8220;lighting off,&#8221; a chemical is added that destroys the AE molecule on any unhybridized probes, leaving the label on the hybridized probes largely unaffected. When the &#8220;lighting off&#8221; or detection reagent is added to the specimen, only the label attached to the hybridized probe is left to produce a signal indicating that the target organism&#8217;s DNA or RNA is present. All of these steps occur in a single tube and without any wash steps, which were required as part of conventional probe tests. Our DKA technology uses two types of AE molecules that can be differentiated from each other &#8212; one that &#8220;flashes&#8221; and another one that &#8220;glows.&#8221; By using DKA technology, we have created nucleic acid test, or NAT, assays that can detect two separate targets simultaneously.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Panther Fusion Family of Molecular Diagnostic Assays</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Panther Fusion molecular diagnostic assays are performed on the Panther Fusion system and utilize polymerase chain reaction, or PCR, technology to amplify target nucleic acid sequences for easier detection. Our Panther Fusion assay portfolio includes diagnostic tests for a range of acute respiratory infections (influenza A virus, influenza B virus, respiratory syncytial virus, adenovirus, human metapneumovirus, rhinovirus and parainfluenza), as well as a test for the detection of Group B Streptococcus, or GBS. In addition, in response to the COVID-19 pandemic, in fiscal 2020 we developed and launched the Panther Fusion SARS-CoV-2 assay for the detection of SARS-CoV-2. The Panther Fusion SARS-CoV-2 assay was granted Emergency Use Authorization by the FDA in March 2020.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Molecular Diagnostic Instrumentation</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed and continue to develop instrumentation and software designed specifically for use with certain of our molecular diagnostic assays. We also provide technical support and service to maintain these instrument systems in the field. By placing our proprietary instrumentation in laboratories and hospitals, we can establish a platform for future sales of our assays.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our instrumentation includes the Tigris system, an integrated, fully-automated testing instrument for high-volume laboratories which is approved for use with a number of our Aptima assays; the Panther instrument system, an integrated, fully-automated testing instrument capable of serving high-, medium- and low-volume laboratories; and our semi-automated direct tube sampling, or DTS, instruments which are used to run a number of infectious disease assays. Our instrumentation also includes the Tomcat instrument, a fully automated general-purpose instrument designed to improve pre-analytical sample processing by eliminating the inefficient and error-prone activities associated with manually transferring samples from one tube to another. In addition, our Panther Fusion system, including the related Fusion assays for flu and respiratory testing, extends the capabilities of our Panther system by adding the flexibility of PCR, functionality to our existing TMA-based technology. The Panther Fusion systems is available as a modular in-lab upgrade to our base Panther system. We received CE-mark approval for the Panther Fusion system in the third quarter of fiscal 2017 and FDA clearance in October 2017.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">ThinPrep System</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The ThinPrep System is the most widely used method for cervical cancer screening in the U.S. The ThinPrep System has multiple configurations, including one or more of the following: the ThinPrep 2000 Processor, ThinPrep 5000 Processor, ThinPrep5000 Processor with Autoloader, ThinPrep Genesis Processor, ThinPrep Imaging System, ThinPrep Integrated Imager, and related reagents, filters and other supplies, such as the ThinPrep Pap Test and our ThinPrep PreservCyt Solution.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The ThinPrep Process.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ThinPrep process begins with the patient&#8217;s cervical sample being obtained by the physician using a cervical sampling device that, rather than being smeared on a microscope slide as in a conventional Pap smear, is inserted into a vial filled with our proprietary ThinPrep PreservCyt Solution. This enables most of the patient&#8217;s cell samples to be preserved before the cells can be damaged by air drying. The ThinPrep specimen vial is then labeled and sent to a laboratory equipped with a ThinPrep Processor for slide preparation. At the laboratory, the ThinPrep specimen vial is inserted into a ThinPrep Processor, a proprietary sample preparation device, which automates the process of preparing cervical slides for staining and microscopic examination. Additionally, an aliquot used for subsequent molecular testing can be produced using the ThinPrep Genesis Processor.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of manual screening, the cytotechnologist screens each Pap test slide with a microscope to first determine the adequacy of the slide and then to examine the entire slide to differentiate diseased or abnormal cells from normal cells. With the ThinPrep Imaging Systems, the screening process has been automated to combine the power of computer imaging technology with human interpretive skills. Prior to human review, the ThinPrep Imaging Systems rapidly scan, locate and highlight areas of interest for review. By directing the cytotechnologist to areas of interest on a slide, these systems may increase a cytology laboratory&#8217;s screening productivity and diagnostic accuracy. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Additional Applications.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;In addition to serving as a replacement for the conventional Pap smear, the ThinPrep System can also be used for non-gynecological cytology screening applications including fine-needle aspiration specimens (e.g., breast, thyroid, lung or liver), body fluids (e.g., urine, pleural fluid, ascitic fluid or pericardial fluid), respiratory specimens (e.g., sputum or brushing of respiratory tracts) and ancillary testing (e.g., cell blocks, immunocytochemistry or special stains).</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Rapid Fetal Fibronectin Test</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rapid Fetal Fibronectin Test is a single-use disposable test used to determine a woman&#8217;s risk of pre-term birth by detecting the presence of a specific protein, fetal fibronectin, in vaginal secretions during pregnancy. The test utilizes a single-use, disposable cassette and is analyzed on our instrument, the TLI IQ System.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Oncology Product Offerings</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we completed the acquisition of Biotheranostics, Inc., or Biotheranostics, and now offer two proprietary laboratory developed tests, or LDTs, that support physicians in the treatment of cancer: the Breast Cancer Index test and the CancerTYPE ID test. The Breast Cancer Index, or BCI, test is a PCR-based gene expression test used for determining which patients with early-stage, hormone-receptor positive, or HR+, breast cancer is likely to benefit from extended endocrine therapy. In January 2021, the National Comprehensive Cancer Network revised its clinical practice guidelines to include BCI as the only gene expression assay to predict benefit from extended endocrine therapy for patients with early-stage HR+ breast cancer. The CancerTYPE ID test is a PCR-based gene expression test that is designed to identify the source of metastatic cancer in order to improve diagnostic accuracy and inform treatment decisions. Both of these LDTs are offered as a service solely out of our Biotheranostics' licensed, CLIA-certified, CAP-accredited laboratory in San Diego, California. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mobidiag Product Offerings</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we completed the acquisition of Mobidiag Oy, or Mobidiag, a developer of innovative molecular diagnostic tests and instrumentation, headquartered in Espoo, Finland. Mobidiag develops and markets PCR-based tests for acute care conditions such as gastrointestinal and respiratory infections (including SARS-CoV-2), antimicrobial resistance management, and healthcare associated infections. The Amplidiag and Novodiag platforms are automated instruments that deliver rapid turnaround times ranging from 50 minutes to two hours. The Novodiag instrument combines real-time PCR and microarray capabilities to provide high level multiplexing, assisting clinicians in efficiently identifying which organism is responsible for an infection. Although Mobidiag currently does not offer any of its products in the U.S., we intend to invest in assay development to drive growth of the Novodiag instrument, including seeking clearance for the Novodiag instrument and related assays in the U.S.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Breast Health Products</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mammography Solutions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our Dimensions platform includes the Selenia Dimensions and 3Dimensions systems capable of performing both 2D and 3D tomosynthesis image acquisition and display. When operating in tomosynthesis mode, each system acquires a series of low dose x-ray images taken in a scanning motion at various angles. The images are mathematically processed into a series of small slices, allowing for visualization of the breast in multiple contiguous slices. Our clinical results for FDA approval demonstrated that conventional 2D digital mammography with the addition of our Genius 3D Mammography is superior to 2D digital mammography alone for both screening and diagnostics. Hologic Clarity HD technology provides our highest resolution </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">imaging, and our C-View and Intelligent 2D software products provide 2D images that are mathematically synthesized from the data within a tomosynthesis exam. Elimination of the 2D exposure reduces the breast compression time and patient dose compared to the current "combo" exam, which includes a tomosynthesis exam and a conventional digital 2D exam. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 3DQuorum technology, powered by Genius AI, is an artificial intelligence, or AI, powered algorithm that expedites mammography exam reading time without compromising image quality, sensitivity or accuracy. The 3DQuorum technology uses Genius AI-powered analytics to uniquely reconstruct high-resolution 3D data to produce 6 mm &#8220;SmartSlices.&#8221; By utilizing 3DQuorum technology the number of 3D images to review is reduced by two-thirds, saving an estimated average of one hour per eight hours of daily image interpretation time. The 3DQuorum technology also reduces the typical Hologic Clarity HD and Intelligent 2D study size by approximately 50%, bringing the storage space and network impact back down to that of standard resolution 3D imaging. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The images captured by digital mammography systems are typically transmitted electronically for review by a radiologist at a reading workstation. To address this process, we offer the SecurViewDX workstation approved for interpretation of mammograms from most vendors as well as images from other diagnostic breast modalities. We also offer image analytic products such as Genius AI Detection (Hologic's first artificial intelligence cancer detection algorithm utilizing deep-learning technology) and ImageChecker CAD to provide markings of suspicious areas of the breast that may be cancerous, as well as Quantra software to automate breast density measurement tools for our mammography systems. These technologies provide reviewers with the potential to focus on key patients that might otherwise be overlooked during the review process, thus potentially increasing cancer detection.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Stereotactic Breast Biopsy Systems</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We provide clinicians with the flexibility of choosing prone or upright systems for breast biopsy by offering two minimally invasive stereotactic breast biopsy guidance systems: the Affirm Prone breast biopsy table and the Affirm upright system. The Affirm upright attachment is used with our Dimensions systems. These breast biopsy systems provide an alternative to open surgical biopsy and can be performed as an outpatient procedure under local anesthesia, allowing shorter recovery times. The Affirm tomosynthesis option provides faster lesion targeting and reduced patient procedure time compared to traditional stereotactic biopsy procedures. The Affirm system is pre-programmed for use with our Brevera, Eviva and ATEC vacuum-assisted breast biopsy devices.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Ultrasound Solutions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultrasound is used extensively by clinicians across the breast health continuum including screening, diagnosis, interventions, and surgical treatments. Ultrasound is commonly used as a complement to 3D mammography screening for women with dense breast tissue, as a diagnostic tool to further characterize lesions prior to biopsy, and for interventional and surgical guidance. Our UltraFast technology enables innovative imaging modes and frame rates of up to 20,000 images per second resulting in high performance and image quality. Our portfolio consists of premium ultrasound carts including the Aixplorer, Mach 20, Mach 30, and Mach 40 ultrasound system. The Supersonic Mach 40 ultrasound systems offers integration benefits with our existing breast health portfolio.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Breast Biopsy and Surgery Products</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer a wide range of minimally invasive products for breast biopsy and breast surgery. Our breast biopsy portfolio includes three types of tethered vacuum-assisted breast biopsy products; the Brevera, ATEC, and Eviva devices. Each tethered device is powered by a console and utilizes our fluid management system. The ATEC device can be used under all standard imaging guidance modalities (stereotactic x-ray, ultrasound, MRI and molecular breast imaging) whereas our Brevera and Eviva devices are used exclusively under stereotactic x-ray guidance. We also offer the Celero and Sertera biopsy devices, both of which are non-tethered (no separate console), spring-loaded, disposable core biopsy devices, which are used exclusively under ultrasound-guidance. We also have products for marking, localizing and filling the void after surgery in addition to specimen imaging products for radiology, surgery and pathology.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GYN Surgical Products</span></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">NovaSure</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NovaSure CLASSIC endometrial ablation system allows physicians to treat women suffering from abnormal uterine bleeding. The system features Smart-Depth technology that continuously monitors and measures tissue impedance to provide a more customized, reliable and reproducible depth of ablation for every patient. The NovaSure system consists of a disposable device and a controller that delivers RF energy to ablate the endometrial lining of the uterus in order to eliminate or reduce the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patient&#8217;s abnormal bleeding. The NovaSure disposable device is a hand-held, single-use device that incorporates a flexible gold-plated mesh electrode used to deliver the RF energy to the endometrial tissue. The NovaSure RF Controller generates and delivers RF energy customized for each patient, monitors several critical treatment and safety parameters, and automatically controls the endpoint of the procedure. We also offer the NovaSure ADVANCED and NovaSure V5 device which have a slimmer diameter. These devices are designed to improve patient comfort and physician ease-of-use while maintaining the clinical efficacy of the NovaSure system.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">MyoSure</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The MyoSure system is designed to provide efficient and effective hysteroscopic removal of tissue within the uterus, including fibroids and polyps. Removal of fibroids can provide effective relief from heavy menstrual bleeding commonly attributed to such pathology. Unlike other methods of tissue removal, the excavated tissue samples remain intact, which allows them to be tested for abnormalities. The MyoSure system consists of a tissue removal device, control unit, and hysteroscope. The MyoSure tissue removal device is single-use and features simultaneous tissue cutting and removal. The device incorporates a rapidly rotating and reciprocating cutting blade. During the procedure, the tissue removal device is inserted through the MyoSure hysteroscope. This tissue removal device is powered by a control unit, which features a simple user interface and is foot pedal activated. We offer multiple handpiece devices that differ in size and are focused on addressing different pathology types.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fluent Fluid Management System</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Fluent Fluid Management System is utilized for diagnostic and operative hysteroscopic procedures. Fluent is designed for simplified setup and operation, and streamlined workflow for the operating room team.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Acessa ProVu System</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Acessa ProVu System is used by laparoscopic surgeons to treat fibroids using controlled radiofrequency energy (heat) to cause coagulative necrosis. The treated tissue softens and shrinks over time, allowing fibroid symptoms to resolve without more invasive treatment. The Acessa System includes an ultrasound probe to locate the fibroids, guidance mapping that provides visual cues, and a percutaneous handpiece that deploys radiofrequency energy.</span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skeletal Health Products</span></div><div style="margin-top:5pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Horizon DXA Systems</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bone densitometry is the measurement of bone density to assist in the diagnosis and monitoring of osteoporosis and other metabolic bone diseases that can lead to frailty and debilitating bone fractures. Osteoporosis is a disease that is most prevalent in post-menopausal women. Our Horizon line of x-ray bone densitometers incorporates advanced features designed for bone health screening and body composition assessment. Body composition assessment is the precise measurement of bone, lean mass, and fat mass within the body. These measurements are valued within the health and wellness and human performance categories, informing nutrition and exercise programming decisions. </span></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fluoroscan Insight FD</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Fluoroscan Insight FD is a mini C-arm imaging system that provides low intensity, real-time x-ray imaging, with high-resolution images at radiation levels and at a cost below those of conventional x-ray and standard sized fluoroscopic equipment. Mini C-arm systems are used primarily by orthopedic surgeons to assist in performing minimally invasive surgical procedures on a patient&#8217;s extremities, such as the hand, wrist, knee, foot and ankle.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketing, Sales and Service</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell and service our products through a combination of direct sales and service forces and a network of independent distributors and sales representatives. In fiscal 2021, 2020, and 2019, no customer accounted for more than 10% of our consolidated revenues. In fiscal 2020 revenues from two customers accounted for 12.5% and 10.9%, respectively, of our Diagnostics segment revenue, and in fiscal 2019 revenues from one customer accounted for 14.5% of our Diagnostics segment revenue. These customers were all large clinical laboratories reflecting the consolidation in that industry. No other customer accounted for more than 10% of our revenues in any other business segment in fiscal 2021, 2020, or 2019. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. sales force is structured to specifically target the customers in each of our business segments. We maintain distinct teams focused on the Diagnostics, Breast Health, GYN Surgical, and Skeletal Health markets. Our end customers include clinical laboratories, hospitals, healthcare providers and surgeons in both hospital and office settings, and we target various specialists at healthcare entities who use our products, such as ob-gyns, radiologists and breast surgeons. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A critical element of our strategy in the U.S. for our Diagnostics, Breast and Skeletal Health, and GYN Surgical divisions has been to utilize the results of our clinical trials and expanded FDA labeling to demonstrate safety, efficacy and productivity improvements to our target customers. Our U.S. sales efforts for these divisions also includes the use of national account managers focused on obtaining purchasing contracts from large purchasing entities, such as managed care organizations, integrated delivery networks and government healthcare facilities. In addition, in certain regions of the U.S., we use a limited number of independent dealers or distributors to sell and service certain of our products. Internationally, our products in all divisions are marketed and sold through a combination of a direct sales force and a network of distributors.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our service organization is responsible for installing our products and providing warranty and repair services, applications training and biomedical training. Products sold by our direct sales force typically carry limited warranties covering parts and labor for twelve months. Products sold through dealers also carry limited warranties that are typically for twelve months and cover only parts and components. We also offer service contracts that generally cover one to three years after the original warranty period. We provide both repair services and routine maintenance services under these arrangements, and also offer repair and maintenance services on a time and materials basis to customers that do not have service contracts. Our Breast Health business generates a majority of our service revenue, primarily relating to service contracts for our digital mammography and related products. Internationally, we primarily use distributors, sales representatives and third parties to provide maintenance service for our products, however we do provide direct service in countries where we have a subsidiary (Germany, UK, France, Spain, Japan, China, and Australia).</span></div><div style="margin-top:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is highly competitive and characterized by continual change and improvements in technology. This is particularly the case in the market segments in which we operate. A number of companies have developed or are expected to develop products that compete or will compete with our products. Many of these competitors offer a broader product portfolio and have greater brand recognition than we do, which may make these competitors more attractive to hospitals, radiology clients, group purchasing organizations, laboratories, physicians and other potential customers. Competitors may develop superior products or products of similar quality for sale at the same or lower prices. Moreover, our products could be rendered obsolete by changes to industry standards or guidelines or advances in technology. We can give no assurance that we will be able to compete successfully with existing or new competitors.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current environment of managed care, economically motivated buyers, consolidation among healthcare providers, increased competition and declining reimbursement rates, we have been increasingly required to compete on the basis of price, value, reliability and efficiency. We believe the current global economic conditions and healthcare reform measures are putting additional competitive pressure on us, including on our average selling prices, overall procedure rates and market sizes.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the success of our products depends on our ability to differentiate ourselves and to demonstrate that our products deliver the clinical and operational attributes that are most important and cost-effective to customers. These attributes include, but are not limited to, superiority in efficacy, ease of use, reliability, accuracy, quality and cost. We believe our continued success depends in large part upon our ability to invest in product enhancements and technologies that will help us distinguish ourselves from our competitors.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diagnostics.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ThinPrep liquid-based cytology product faces direct competition in the U.S. primarily from Becton, Dickinson and Company, or BD, which manufactures a competitive offering. We also compete with the conventional Pap smear and other alternative methods for detecting cervical cancer and/or its precursors. Internationally, our ThinPrep product competes with a variety of companies and other non-FDA approved tests, since fewer regulatory barriers exist in most international markets as compared to the U.S. Additionally, testing volume in this category is also under pressure due to clinical guideline changes, which lengthen the interval between screenings and increasingly afford the option of HPV testing as the primary means of detection.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our Rapid Fetal Fibronectin Test is currently the only available in vitro diagnostic test for predicting the risk of pre-term birth in the U.S. Internationally, our Rapid Fetal Fibronectin Test competes with Actim Partus manufactured by Medix Biochemical and PartoSure manufactured by Qiagen GmbH, or Qiagen. However, our Rapid Fetal Fibronectin Test could also experience competition from companies that manufacture and market pregnancy-related diagnostic products and services. In addition, healthcare providers use diagnostic techniques such as clinical examination and transvaginal ultrasound to help diagnose the likelihood of pre-term birth and may use these techniques together with the Rapid Fetal Fibronectin Test or instead of using the Rapid Fetal Fibronectin Test.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the molecular diagnostics market, our products compete with many companies in the U.S. and abroad engaged in the development, commercialization and distribution of similar products intended for clinical molecular diagnostic applications. Clinical laboratories also may offer testing services that are competitive with our products and may use reagents purchased </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">from us or others to develop their own lab developed tests. The market for our COVID-19 assays is new and rapidly evolving both in the United States and in the rest of the world. For example, in the United States over 400 assays have received Emergency Use Authorization from the FDA, and we compete with the providers of all of these tests, including manufacturers of molecular diagnostic tests (including so-called high throughput nucleic acid tests, rapid antigen tests and at-home testing solutions), and antibody tests, as well clinical laboratories making their own lab developed tests for the detection of SARS-CoV-2.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the global clinical diagnostics market, we compete with several companies offering alternative technologies to our diagnostic products. For example, in the U.S., our Aptima Combo 2 test competes against BD and Roche Diagnostics Corporation, or Roche, and our Aptima HPV test competes with tests marketed by BD, Qiagen and Roche.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breast Health.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mammography and related products and subsystems compete on a worldwide basis with products offered by a number of competitors, including General Electric Company, or GE, Siemens AG, or Siemens, Koninklijke Philips NV, or Philips, Planmed Oy, or Planmed, Carestream Health, Inc., or Carestream, FUJIFILM Holdings Corporation, or Fuji, Internazionale Medico Scientifica Srl, or I.M.S., and Toshiba Corporation. In the U.S., our digital mammography systems compete with digital mammography systems from GE, Siemens, Fuji, I.M.S., Philips and Planmed. Our digital mammography systems also compete with Fuji&#8217;s and Carestream's Computed Radiography, or CR mammography systems, and other lower-priced alternatives to 2D digital mammography and analog mammography systems. In the U.S., GE, Siemens and Fuji have received FDA approval for their breast tomosynthesis systems, and we believe that other competitors are developing tomosynthesis systems for commercial use in the U.S. Our Dimensions tomosynthesis systems also compete in certain countries outside of the U.S. with tomosynthesis systems developed by GE, Siemens, Fuji, and I.M.S.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary competitor for our breast biopsy product line is Devicor Medical Products, Inc., part of Danaher Corporation's Leica Biosystems division. In addition, other competitors include CareFusion, a BD company, Sanarus Technologies, LLC and Intact Medical Corporation.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GYN Surgical.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NovaSure system currently faces direct competition from The Cooper Companies, Inc., or CooperSurgical, and Minerva Surgical, Inc., or Minerva, each of which currently markets an FDA-approved endometrial ablation device for the treatment of abnormal uterine bleeding. In addition to these devices, we also compete with alternative treatments to our NovaSure system, such as drug therapy, intrauterine devices, hysterectomy, dilation and curettage and rollerball ablation. Because drug therapy is an alternative to our NovaSure procedure, NovaSure&#8217;s competitors also include many major pharmaceutical companies that manufacture hormonal drugs for women.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MyoSure product competes directly with hysteroscopic loop resection, as well as hysteroscopic tissue removal systems such as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic plc&#8217;s TruClear device and Minerva's (formerly Boston Scientific Corporations') Symphion device. The MyoSure product also competes with alternative therapeutic techniques such as hysteroscopic resection with a monopolar or bipolar loop, which is currently the most common technique for removing intrauterine fibroids and polyps.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Acessa ProVu System competes directly with Gynesonics, Inc., which currently markets a radiofrequency ablation device for treating uterine fibroids. The Acessa ProVu System also competes with alternative fibroid treatment options such as hysterectomy, laparoscopic myomectomy, and uterine artery embolization.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Skeletal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> Health.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">GE is our primary competitor in the bone densitometry market, and we also compete with Orthoscan Inc. in the mini-C arm market.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase many of the components, subassemblies, and raw materials used in our products from numerous suppliers worldwide. For reasons of quality assurance, scarcity and/or cost effectiveness, certain components, subassemblies, and raw materials used in our products are available only from one or a limited number of suppliers. We work closely with our suppliers to develop contingency plans to ensure continuity of quality and reliable supply. We established long-term supply contracts with many of our suppliers, and in other instances, we developed in-house capability to offset potential shortages caused by sole source suppliers. Due to the high standards and FDA requirements applicable to manufacturing our products, such as the FDA's Quality System Regulation and Good Manufacturing Practices, we may not be able to quickly establish additional or replacement sources for certain components or materials. In addition, the COVID-19 pandemic and associated economic disruptions have had an adverse impact on our supply chains. Moreover, we use certain components in our products, including semiconductor chips, that have been the subject of recent global supply chain shortages and disruptions. In the event that we are unable to obtain sufficient quantities of raw materials or components or subassemblies on commercially reasonable terms or in a timely manner, our ability to manufacture our products on a timely and cost-competitive basis may be compromised, which may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current supplier of certain key raw materials for certain of our amplified NAT diagnostic assays is Roche, a direct competitor of our Diagnostics business. Our Diagnostic business has two supply agreements with GE Healthcare Bio-Sciences Corp., an affiliate of GE, for membranes used in connection with our ThinPrep product line and for primers used in the manufacture of Aptima, Fusion, Progensa and AccuProbe product lines. GE is a direct competitor with our Breast Health and Skeletal Health businesses. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have sole source third-party contract manufacturers for each of our molecular diagnostics instrument product lines and for our Skeletal Health products. KMC Systems, Inc., or KMC Systems, is the only manufacturer of the Tigris instrument spare parts; Stratec Biomedical AG, or Stratec, is the only manufacturer of the Panther instrument, and Flextronics Medical Sales and Marketing, LTD, or Flextronics, is the only manufacturer of our Skeletal Health finished goods products. We are dependent on these sole source third-party manufacturers, and this dependence exposes us to increased risks associated with production delays, delivery schedules, manufacturing capability, quality control, quality assurance and costs. We have no firm long-term volume commitments with either KMC Systems, Stratec or Flextronics. If KMC Systems, Stratec, Flextronics or any of our other third-party manufacturers experiences delays, disruptions, capacity constraints or quality control problems in its development or manufacturing operations, curtails operations or otherwise fails to supply us with products in sufficient quantities, instrument and equipment shipments to our customers could be delayed or cancelled, which would decrease our revenues and may harm our competitive position and reputation. Further, because we place orders with our manufacturers based on forecasts of expected demand for our instruments and Skeletal Health products, if we inaccurately forecast demand, we may be unable to obtain adequate manufacturing capacity or adequate quantities of components to meet our customers' delivery requirements.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, and our contract manufacturers, manufacture our products at a limited number of different facilities located in the U.S. and throughout the world. In most cases, the manufacturing of each of our products is concentrated in one or a few locations. An interruption in manufacturing capabilities at any of these facilities, as a result of equipment failure or other reasons, could reduce, delay or prevent the production of our products. Some of our manufacturing operations are located outside of the U.S., including in Costa Rica and the United Kingdom. Those manufacturing operations are also subject to additional challenges and risks associated with international operations described under the caption &#8220;Risk Factors&#8221; set forth in Part I, Item 1A of this Annual Report.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time-to-time new regulations are enacted that can affect the content and manufacturing of our products. We evaluate the necessary steps for compliance with regulations as they are enacted. In August 2012, the SEC adopted a rule requiring disclosures of specified minerals, known as conflict minerals, that are necessary to the functionality or production of products manufactured or contracted to be manufactured by public companies. The conflict minerals rule requires companies annually to disclose and report whether or not such minerals originate from the Democratic Republic of Congo or an adjoining country. The conflict minerals rule could affect sourcing at competitive prices and availability in sufficient quantities of certain minerals used in the manufacture of our products, including tantalum, tin, gold and tungsten. The number of suppliers who provide conflict-free minerals may be limited. In addition, there may be material costs associated with complying with the disclosure requirements, such as costs related to determining the source of certain minerals used in our products, as well as costs of possible changes to products, processes, or sources of supply as a consequence of such verification activities. Since our supply chain is complex, we may not be able to sufficiently verify the origins of the relevant minerals used in our products through the due diligence procedures that we implement, which may harm our reputation. In addition, we may encounter challenges to satisfy those customers who require that all of the components of our products be certified as conflict-free, which could place us at a competitive disadvantage if we are unable to do so.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other regulations which affect the content and manufacturing of our products include, for example, the Registration, Evaluation, Authorization and Restriction of Chemical substances, or REACH, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, or RoHS, and the Waste Electrical and Electronic Equipment Directive, or WEEE, enacted in the European Union which require the registration of and regulate the use of certain hazardous substances and chemicals in, and require the collection, reuse and recycling of waste from, certain products we manufacture. Similar legislation that has been or is in the process of being enacted in Japan and China and various states of the U.S. may require us to re-design our products to ensure compliance with the applicable standards, for example by requiring the use of different types of materials. These redesigns or alternative materials may detrimentally impact the performance of our products, add greater testing lead-times for product introductions, result in additional costs or have other similar negative effects.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets in which we participate are characterized by rapid technological change, frequent product introductions and evolving customer requirements. Investment in research and development is critical to driving our future growth. Our research and development efforts are focused on the further development and improvement of our existing products, the design and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development of new innovative medical technologies and regulatory compliance across all our business segments. In fiscal 2020, in response to the COVID-19 pandemic, we developed and launched the Aptima SARS-CoV-2 assay (which runs on our Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to product development, our research and development personnel play an active role in the review of product specifications, clinical protocols and FDA submissions, as well as ensuring that certain of our products conform to European health, safety and environmental requirements, or CE-marking. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patents and Proprietary Rights</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely primarily on a combination of trade secrets, patents, copyrights, trademarks and confidentiality procedures to protect our products and technology. Due to the rapid technological changes that characterize the markets we operate in, we believe that trade secrets and other unpatented know-how relied upon in connection with the development of new products and the enhancement of existing products are generally as important as patent protection in establishing and maintaining a competitive advantage. Nevertheless, we have obtained patents and will continue to make efforts to obtain patents, when available, in connection with our product development programs. We do not consider our business to be materially dependent upon any individual patent.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own numerous U.S. patents and have applied for numerous additional U.S. patents relating to our technologies. We also own or have applied for corresponding patents in selected foreign countries. These patents relate to various aspects of most of our products. We do not know if current or future patent applications will be issued with the full scope of the claims sought, if at all, or whether any patents issued will be challenged or invalidated. There is a risk that our patent applications will not result in granted patents or that granted patents will not provide significant protection for our products and technology. Third parties may infringe, misappropriate or otherwise violate our intellectual property rights, or copy or reverse engineer portions of our technology. Our competitors may independently develop similar or superior technology that our patents do not cover. In addition, because patent applications in the U.S. are not generally publicly disclosed until eighteen months after the application is filed, unpublished applications may have been filed by third parties that relate to our technology. Moreover, there is a risk that foreign intellectual property laws will not protect our intellectual property rights to the same extent as intellectual property laws in the U.S. The rights provided by a patent are finite in time. Over the coming years, certain patents relating to current products will expire in the U.S. and abroad which may allow third parties to exploit those technologies. In the absence of significant patent protection, we may be vulnerable to competitors who attempt to copy our products, processes or technology.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the patents we have been issued or we have acquired, we license patents from others on a variety of terms and conditions.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged in intellectual property litigation as described in Note 14 to our consolidated financial statements entitled "Litigation and Related Matters," and as may also be described herein, and we may be notified in the future of claims that we may be infringing, misappropriating or otherwise violating the intellectual property rights of third parties. In connection with any such claims, we may seek to enter into settlement and/or licensing arrangements. There is a risk in these situations that no license will be available or that a license will not be available on reasonable terms. Alternatively, we may decide or be required to litigate such claims. A successful claim against us may require us to remove the alleged infringing product from the market or to design around the third party's patent, potentially resulting in less market demand for the product.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture, sale, lease and service of medical diagnostic and surgical devices intended for commercial use are subject to extensive governmental regulation by the FDA in the U.S. and by a variety of regulatory agencies in other countries. Under the Federal Food, Drug and Cosmetic Act, known as the FD&amp;C Act, manufacturers of medical products and devices must comply with certain regulations governing the design, testing, manufacturing, packaging, servicing and marketing of medical products. Some of our products are also subject to the Radiation Control for Health and Safety Act, administered by the FDA, which imposes performance standards and record keeping, reporting, product testing and product labeling requirements for devices that emit radiation, such as x-rays. FDA product approvals may be withdrawn or suspended if compliance with regulatory standards is not maintained or if problems occur following initial marketing. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA classifies medical devices into three classes based on risk. Regulatory control increases from Class I (lowest risk) to Class III (highest risk). The FDA generally must clear or approve the commercial sale of new medical devices in Classes II and III. Commercial sales of our Class II (except for Class II exempt devices) and Class III medical devices within the U.S. must be preceded by either a pre-market notification filing pursuant to Section 510(k) of the FD&amp;C Act (Class II) or the granting of a pre-market approval, or PMA (Class III). Our Class I and Class II exempt medical devices must follow Hologic&#8217;s internal Quality System processes prior to commercialization and throughout their product lifecycle. All classes of devices must meet FDA's quality system (QS), establishment registration, medical device listing, labeling and medical device </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting (MDR) regulations. The FDA can authorize the emergency use of an unapproved medical product or an unapproved use of an approved medical product, referred to as Emergency Use Authorization, or EUA, for certain emergency circumstances after the Health and Human Services Secretary has made a declaration of emergency justifying authorization of emergency use. An EUA allows use in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by emerging infectious disease threats when there are no adequate, approved, and available alternatives.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may also waive otherwise-applicable current good manufacturing practice (CGMP) requirements to accommodate emergency response needs. In March 2020, the FDA granted EUA for our Panther Fusion SARS-CoV-2 assay for testing for the COVID-19 virus. In May 2020, the FDA granted EUA for our Aptima SARS-CoV-2 assay for use on our standard Panther instrument.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A 510(k) pre-market notification filing must contain information establishing that the device to be sold is substantially equivalent to a device commercially distributed prior to May 28, 1976 or to a device that has been determined by the FDA to be substantially equivalent. The PMA procedure involves a complex and lengthy testing process that is subject to review by the FDA and may require several years to obtain. We may need to first obtain an investigational device exemption (for significant risk devices), known as an IDE, in order to conduct extensive clinical testing of the device to obtain the necessary clinical data for submission to the FDA. The FDA will approve a PMA only if after evaluating the supporting technical data it finds that the PMA contains sufficient, valid scientific evidence to assure that the device is safe and effective for its intended use(s). This approval may be granted with post-approval requirements including inspection of manufacturing facilities and/or additional patient follow-up for an indefinite period of time.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our Biotheranostics laboratory in San Diego, California and the laboratories that purchase certain of our products, including the Aptima SARS-CoV-2 EUA, Aptima Flu Multiplex EUA, Fusion SARS-CoV-2 EUA, ThinPrep System, ThinPrep Imaging System, Rapid Fetal Fibronectin Test, Aptima Combo 2, Aptima HPV tests and Aptima HIV-1 Quant, HCV Quant Dx, HBV Quant, Aptima Trichomonas Vaginalis (Trich), Aptima Mycoplasma Genitalium (MGen), Aptima HSV 1 &amp; 2, Aptima BV, Aptima CV/TV, and Panther Fusion Assays are subject to extensive regulation under the Clinical Laboratory Improvement Amendments of 1988, or CLIA, which requires laboratories to meet specified standards in the areas of personnel qualifications, administration, participation in proficiency testing, patient test management, quality control, quality assurance and inspections. Adverse interpretations of current CLIA regulations or future changes in CLIA regulations could have an adverse effect on sales of any affected products or services. These laboratories are also licensed by the appropriate state agencies in the states in which they operate, where such licensure is required. In addition, our laboratories hold state licenses or permits, as applicable, from various states to the extent that they accept specimens from one or more of these states, each of which requires out-of-state laboratories to obtain licensure. If a laboratory is out of compliance with CLIA or with state laws or regulations governing licensed laboratories, penalties may include suspension, limitation or revocation of the license or CLIA certificate, assessment of financial penalties or fines, or imprisonment. Loss of a laboratory's CLIA certificate or state license may also result in the inability to receive payments from state and federal health care programs as well as private third party payors. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain analyte specific reagents, referred to as ASR products, as with other Class I products, may be sold without 510(k) clearance or PMA approval. However, ASR products are subject to significant restrictions. The manufacturer may not make clinical or analytical performance claims for the ASR product, may not promote their use with specific laboratory equipment and may only sell the ASR product to clinical laboratories that are qualified to run high complexity tests under CLIA. Each laboratory must validate the ASR product for use in diagnostic procedures as a laboratory developed test. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to a variety of federal, state and foreign laws which broadly relate to our interactions with healthcare practitioners and other participants in the healthcare system, including, among others, the following:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">anti-kickback and anti-bribery laws, such as the Foreign Corrupt Practices Act, or the FCPA, the UK&#8217;s Bribery Act 2010, or the UK Anti-Bribery Act;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">laws regulating the confidentiality of sensitive personal information and the circumstances under which such information may be released and/or collected, such as the Health Insurance Portability and Accountability Act of 1996, or HIPAA, the Health Information Technology for Economic and Clinical Health Act, or HITECH Act, and the European Union General Data Protection Regulation, or GDPR; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">healthcare reform laws, such as the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act of 2010, which we refer to together as PPACA, which include new regulatory mandates and other measures designed to constrain medical costs, as well as stringent new reporting requirements of financial relationships between device manufacturers and physicians and teaching hospitals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are subject to numerous federal, state, foreign and local laws relating to safe working conditions, manufacturing practices, environmental protection, fire hazard control and disposal of hazardous or potentially hazardous </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substances, data privacy and protection among others. We may be required to incur significant costs to comply with these laws and regulations in the future and complying with these laws may result in a material adverse effect upon our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of medical devices outside of the U.S. are subject to foreign requirements that vary widely from country to country. For example, our ability to market our products outside of the U.S. is contingent upon maintaining our International Standards Organization, or ISO, Quality System certification, complying with European directives and in some cases receiving specific marketing authorization from the appropriate foreign regulatory authorities. Foreign registration is an ongoing process as we register additional products and/or product modifications.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The time required to obtain approval from a foreign country to market and sell our products may be longer or shorter than that required for FDA approval and the requirements may differ. In addition, we may be required to meet the FDA&#8217;s export requirements or receive FDA export approval for the export of our products to foreign countries.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are also subject to approval and regulation by foreign regulatory and safety agencies. For example, the EU has adopted the EU Medical Device Regulation (the "EU MDR") and the In Vitro Diagnostic Regulation (the "EU IVDR"), each of which impose stricter requirements for the marketing and sale of medical devices, including in the area of clinical evaluation requirements, quality systems and post-market surveillance. Manufacturers of currently approved medical devices had until May 2021 to meet the requirements of the EU MDR and will have until May 2022 to meet the EU IVDR. Complying with the requirements of these regulations may require us to incur significant expenditures. Failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to the EU requirements. The recently rebranded National Medical Products Administration (formerly CFDA), or the NMPA, has historically been conservative leading to extended review times. However, more recently, the NMPA has been more interactive, which we attribute to its response to the long delays in getting lifesaving medical devices into China. If this continues, this could favorably affect our ability to introduce new products in the Chinese market.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory environment in China continues to evolve, and officials in the Chinese government exercise broad discretion in deciding how to interpret and apply regulations. It is possible that the Chinese government's current or future interpretation and application of existing or new regulations will negatively impact our China operations, result in regulatory investigations or lead to fines or penalties.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that governmental authorities will continue to scrutinize the healthcare industry closely and that changes in laws, regulations or policies by governmental authorities may cause increases in uncertainties and compliance costs, exposure to litigation and other adverse effects to our business and operations. Delays in receipt of, or failure to obtain, clearances or approvals for future products could delay or preclude realization of product revenues from new products or result in substantial additional costs which could decrease our profitability.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information about the regulations to which our business is subject and the impact such regulations may have on our business, see the disclosures under the captions &#8220;Manufacturing&#8221; and &#8220;Reimbursement&#8221; in this Item 1, and &#8220;Risk Factors&#8221; in Item 1A below.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reimbursement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market acceptance of our medical products in the U.S. and other countries is dependent upon the purchasing and procurement practices of our customers and patient need for our products and procedures and, the coverage and reimbursement of patients&#8217; medical expenses by government healthcare programs, private insurers or other healthcare payors. In the U.S., the Centers for Medicare&#160;&amp; Medicaid Services, known as CMS, establishes coverage policies and payment rates for Medicare beneficiaries. CMS publishes payment rates for physician, hospital, laboratory and ambulatory surgical center services on an annual basis. Under current CMS policies and regulations, varying payment levels have been established for tests and procedures performed using our products. Coverage policies for Medicare patients may vary by regional Medicare contractor in the absence of a national coverage determination and payment rates for procedures will vary based on the geographic price index. Coverage policies and reimbursement rates for Medicaid patients are dependent on each state Medicaid plan and will vary. Coverage policies and reimbursement rates for patients with private insurance is dependent on the individual private payor&#8217;s decisions. Moreover, private insurance carriers may choose not to follow the CMS coverage policies or payment rates. The use of our products outside of the U.S. is similarly affected by reimbursement policies adopted by foreign regulatory authorities and insurance carriers.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare policy and payment reform proposals and medical cost containment measures are being adopted in the U.S. and in many foreign countries. The ability of our customers to obtain adequate reimbursement for our products and services </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from private and governmental third-party payors is critical to the success of medical technology companies because it may affect which products customers purchase and the prices they are willing to pay. Reimbursement and coverage vary by country and can significantly impact acceptance of new products and technologies. Even if we develop a promising new product, we may find limited demand for the product unless reimbursement approval and coverage is obtained from private and governmental third-party payors. Further, ongoing legislative or administrative reform to the reimbursement system in the U.S. and other countries may impact reimbursement for procedures using our medical products and/or limit coverage for those procedures facilitated by our products. This includes price regulation, competitive bidding and tendering, coverage and payment policies, comparative effectiveness of therapies, technology assessments and managed-care arrangements. These trends could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We view human capital management and the strength of our employees as integral to the long-term success of our business and the strengthening of our communities. We understand that we rely on our employees worldwide to propel our organization forward with great ideas, innovations and leadership. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;25, 2021, we had 6,705 full-time employees, including 1,965 in manufacturing operations, 1,666 in sales and marketing, 1,424 in support services, 913 in research and development, and 737 in general administration. Approximately 3,920 of these employees are in the U.S. and approximately 2,785 were outside the U.S. In various countries outside the U.S., certain of our employees are unionized and, where local law requires, participate in works councils. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Engagement</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to develop and maintain a talented, engaged and diverse workforce that has a positive impact on our performance, and on our customers and their patients. We have been conducting an annual engagement survey since 2015 in which most of employees regularly participate. We believe our foundation of employee engagement, our commitment to our employees, and their commitment to each other fortifies our leaders and teams and improves their business performance. We also offer a range of programs to develop our managers and enhance our leadership across the Company. Our professional development efforts are aimed at increasing organizational talent and capabilities and identifying and developing potential successors for key leadership positions. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Benefits</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in the physical, emotional and financial well-being of our employees through our robust compensation and benefit programs. These programs (which vary by country/region) include a variety of health plan options, tax-favorable savings accounts and other wellness offerings. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic Response</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting at the beginning of the COVID-19 pandemic, we took precautions to protect the health and safety of our employees by instituting robust hygiene practices, implementing temperature scanning stations, installing temporary safety structures, and increasing our cleaning protocols. For the front-line employees who came to work throughout the COVID-19 pandemic to develop and manufacture our COVID-19 tests, or who installed Panther instruments in locked-down hospitals during the most uncertain times of the COVID-19 pandemic, we were able to provide extraordinary financial awards. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to actively monitor the COVID-19 pandemic, and respond based on guidance from U.S. and global health organizations, relevant governmental guidance and evolving practices. In addition, in response to the continuing challenges stemming from the COVID-19 pandemic, we developed several employee-focused initiatives to support the physical, mental, and financial well-being of our employees. These initiatives include providing enhanced accident and critical illness insurance, increasing access to telehealth services, developing an employee assistance program that provides mental health therapy, wellness coaching, and medication management, and offering subscriptions to self-care mobile apps. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity Drives Performance</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to creating an inclusive and diverse work environment that promotes equal opportunity, dignity and respect, starting with our Board and our Leadership team. Of our eight directors, three are women, three were born outside of the U.S., and two were predominantly educated outside of the U.S. We believe that our focus on the lives of women has helped us to attract a diverse workforce and build an inclusive ethos where different perspectives are valued and respected. Building a diverse workforce begins with our hiring practices and extends to our access to opportunities, strategic development and promotion of internal talent. We seek to identify and develop high-potential women and other diverse individuals within the Company. In addition to women holding several key roles within the Company (Chief Financial Officer; Chief Human Resources Officer; Division President, Breast and Skeletal Health; Vice President of Tax; Treasurer; and Chief of Staff), African American leaders have assumed important leadership roles as Division President, GYN Surgical, Vice President of Sales, Breast and Skeletal Health, Corporate Secretary, and Chief Information Security Officer. Additionally, given that our commercial teams are an important pipeline for senior management, we are pleased that a significant number of our commercial </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">team members below the level of vice president are women and/or people of color. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to hire the most qualified person for the job and believe that, over time, this will lead to an increasingly diverse workforce. As a part of finding the most qualified people, we are committed to ensuring that diverse slates of candidates are identified and considered for all roles, from the boardroom and c-suite to all levels of the workforce. We believe our focus on talent identification, development, engagement and succession planning has been particularly successful in developing a deep and diverse talent pipeline. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health and Safety</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to comply in letter and in spirit with applicable health and safety laws and regulations and implement programs, policies and procedures to achieve compliance throughout the Company. We also establish our own environmental health and safety standards in addition to those that are legally required. We employ management systems and procedures designed to protect human safety, health, and the environment. We seek to reduce risk and protect our employees and communities by employing safe technologies and operating procedures, and by maintaining a business continuity program to stay prepared for emergencies. We have also developed safety rules and procedures to address behaviors and work practices that can lead to accidents and injuries. Safety performance is assessed throughout the year by management and during annual performance reviews. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Community Engagement and Volunteerism</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We take the role we play as leaders in the communities where we live and work seriously. Our philanthropic and charitable efforts are an important part of our culture. We center our giving efforts in three specific areas to maximize our impact in ways that align with the values of our employees and customers: (i) women's health, and other healthcare fields in which Hologic operates; (ii) science, technology, engineering, and math education (STEM), especially for underprivileged groups; and (iii) social and racial equality, especially in healthcare. We also support employees in giving back to community organizations through volunteering and matching donations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Worldwide sales, including U.S. sales, do not reflect any significant degree of seasonality; however, customer purchases of our GYN Surgical products have been historically lower in our second fiscal quarter compared to our other fiscal quarters. Our respiratory infectious disease product line within our Diagnostics segment is also subject to significant seasonal and year-over-year fluctuations. In addition, the summer months, which occur during our fourth fiscal quarter, typically have had lower order rates internationally for most of our products.</span></div><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_16"></div><div style="padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors </span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In evaluating our business, the risks described below, as well as other information contained in this Annual Report and in our other filings with the SEC should be considered carefully. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business. The occurrence of any of these events or circumstances could individually or in the aggregate have a material adverse effect on our business, financial condition, cash flow or results of operations. This report contains forward-looking statements; please refer to the cautionary statements made under the heading "Special Note Regarding Forward-Looking Statements" for more information on the qualifications and limitations on forward-looking statements.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">THE COVID-19 GLOBAL PANDEMIC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The extent to which the COVID-19 pandemic and associated economic disruptions could have a material adverse impact on our business and the demand for many of our products will depend on future developments that are highly uncertain and difficult to predict. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has created significant volatility, uncertainty and economic disruption in the markets we sell our products into and operate in, primarily the U.S., Europe, and Asia-Pacific and negatively impacted business and healthcare activity globally. We believe that the COVID-19 pandemic's impact on our operating results, cash flows and financial condition remains uncertain and will be primarily driven by the severity and duration of the COVID-19 pandemic (including the extent of future surges, variants and the efficacy of vaccination); the COVID-19 pandemic's impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; the timing, scope and effectiveness of U.S. and international governmental responses to the COVID-19 pandemic and associated economic disruptions; and the impact of the COVID-19 pandemic on the health, well-being and productivity of our employees. As healthcare systems continue to respond to the demands of managing COVID-19 and the resulting economic uncertainties, governments around the world have imposed measures designed to reduce the transmission of COVID-19 and individuals continue to respond to the fear of contracting COVID-19. In particular, elective procedures and exams were delayed or cancelled, there has been a significant reduction in physician office visits, and hospitals postponed or canceled capital purchases as well as limited or eliminated services. While </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">elective procedures and exams and capital purchases have increased from initially depressed levels, the reduction in elective procedures, exams and capital purchases has had, and we believe may continue to have, a negative impact on the sales of most of our products (other than our COVID-19 assays and related systems and ancillaries) which has adversely affected our operating results, cash flows and financial condition. Additionally, governments and other third-party payors around the world facing tightening budgets could move to further reduce the reimbursement rates or the scope of coverage offered, which could further adversely affect sales of our products. </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize anticipated revenue from our COVID-19 diagnostic assays</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed assays to detect COVID-19. While we have seen significant demand for our COVID-19 assays, other companies are working to produce or have produced tests for COVID-19 which may lead to the diversion of customers away from us and toward other companies. Moreover, considerable uncertainty remains as to the demand for ongoing COVID-19 testing, and thus, for our COVID-19 assays. There is no guarantee that current or anticipated demand will continue, or if demand does continue or increases, that we will be able to produce in quantities to meet the demand. A significant decline in demand for our COVID-19 assays without a corresponding increase in our other businesses could have a material, adverse effect on our results of operations, cash flow and financial position.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The COVID-19 pandemic and associated economic disruptions have had and may continue to have a material adverse effect on manufacturing, distribution and supply chain.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and associated economic disruptions have had an adverse impact on our manufacturing capacity, supply chains and distribution systems, including as a result of impacts associated with preventive and precautionary measures that we, other businesses and governments are taking. A number of our suppliers and manufacturers have been adversely affected by the COVID-19 pandemic. Delays or disruptions experienced by our suppliers and manufacturers caused by the COVID-19 pandemic and associated economic disruptions may prevent us from obtaining raw materials, components and subassemblies for our products in a timely manner. In addition, government and customer vaccine mandates may lead to employee attrition for us and our suppliers. Any resulting reduction or interruption in our manufacturing and distribution processes could result in a reduction in our revenues and harm our competitive position and reputation. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GLOBAL CHALLENGES</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continuing worldwide political and social uncertainty, as well as tariffs and social tensions, may adversely affect our business and prospects, both domestically and internationally.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Political and social uncertainty and divisions are rife in the U.S. and throughout the world, impairing political, trade and economic relations worldwide. This impacts how we are able to do business and expand our global footprint. Changes in policy in the U.S. and other countries regarding international trade, including import and export regulation and international trade agreements, could negatively impact our business. In recent years, the U.S. has imposed tariffs on goods imported from China and certain other countries, which has resulted in retaliatory tariffs by China and other countries. Changes or uncertainty in tariffs or further retaliatory trade measures taken by China or other countries in response, could affect the demand for our products and services, impact the competitive position of our products, prevent us from being able to sell products in certain countries or otherwise adversely impact our results of operations. The implementation of more restrictive trade policies, such as more detailed inspections, higher tariffs or new barriers to entry, could negatively impact our business, results of operations and financial condition. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our international operations and foreign acquisitions expose us to additional operational challenges that we might not otherwise face.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International expansion is a key component of our growth strategy. In fiscal 2021, 30.7% of our revenue came from outside of the U.S. As we grow internationally, our future and existing international operations may subject us to a number of additional risks and expenses, any of which could harm our operating results. These risks and expenses include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political and economic changes and disruptions, export/import controls and tariff regulations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in developing staffing and simultaneously managing operations in multiple locations as a result of, among other things, distance, language and cultural differences; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">governmental currency controls;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">multiple, conflicting and changing government laws and regulations (including, among other things, antitrust and tax requirements);</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">protectionist laws and business practices that favor local companies; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in the collection of trade accounts receivable; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties and expenses related to implementing internal controls over financial reporting and disclosure controls and procedures; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses associated with customizing products for clients in foreign countries; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">possible adverse tax consequences; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to obtain and maintain required regulatory approvals or favorable third-party reimbursement;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operation in parts of the world where strict compliance with anti-bribery laws may conflict with local customs and practices; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to effectively obtain, maintain, protect or enforce intellectual property rights, reduced protection for intellectual property rights in some countries, and the inability to otherwise protect against clone or &#8220;knock off&#8221; products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the lack of ability to enforce non-compete agreements with former owners of acquired businesses competing with us in China and other foreign countries; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lower margins on a number of our products sold outside of the U.S.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS DEVELOPMENT AND COMPETITION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our long-term success will depend upon our ability to integrate acquired businesses and execute on business development activities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, we made a number of tactical acquisitions which complemented our existing businesses. Any inability to successfully integrate new businesses, decreases in customer loyalty or product orders, failure to retain or develop the acquired workforce, failure to realize anticipated economic, operational and other benefits and synergies in a timely manner, failure to establish and maintain appropriate controls or unknown or contingent liabilities could adversely affect our ability to realize the anticipated benefits of any new product or acquisition. The integration of an acquired business, whether or not successful, requires significant efforts which may result in additional expenses and divert the attention of our management and technical personnel from other projects. Acquisitions, in particular, are inherently risky, and we cannot guarantee that any past or future transaction will be successful. As part of our long-term strategy, we are also engaged in business development activities including evaluating future acquisitions, joint development opportunities, technology licensing arrangements and other opportunities to further expand our presence in or diversify into priority growth areas by accessing new products and technologies. We may not be able to identify appropriate business development activities or acquisition candidates, consummate transactions or obtain agreements with favorable terms, if at all. We may also be subject to increasing regulatory scrutiny from competition and antitrust authorities in connection with acquisitions. If we are successful in pursuing future acquisitions, we may be required to expend significant funds, incur additional debt or other obligations, or issue additional securities, which may negatively affect our operating results and financial condition. If we spend significant funds or incur additional debt or obligations, our ability to obtain financing for working capital or other purposes could be adversely affected, and we may be more vulnerable to economic downturns and competitive pressures. If we fail to identify, acquire and integrate complementary businesses and products, our business, results of operations and/or financial condition could be adversely affected.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face intense competition from other companies and may not be able to compete successfully.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets in which we sell our products are intensely competitive, subject to rapid technological change and may be significantly affected by new product introductions and other market activities of industry participants, and these competitive pressures may reduce the demand and prices for our products. Other companies may develop products that are superior to and/or less expensive than our products. Improvements in existing competitive products or the introduction of new competitive products may reduce our ability to compete for sales, particularly if those competitive products demonstrate better safety or effectiveness, clinical results, ease of use or lower costs. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some companies may have significant competitive advantages over us, which may make them more attractive to hospitals, clinics, radiology clients, group purchasing organizations, laboratories, and physicians, including:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater brand recognition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger or more established distribution networks and customer bases;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a broader product portfolio, resulting in the ability to offer rebates or bundle products to offer discounts or incentives to gain a competitive advantage;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher levels of automation and greater installed bases of such equipment;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">more extensive research, development, sales, marketing, and manufacturing capabilities and greater financial resources; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater technical resources positioning them to continue to improve their technology in order to compete in an evolving industry. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Challenges in the development of our products could materially impact our long-term success. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth depends in large part on our ability to identify and develop new products or new indications for or enhancements of existing products. The development of new products and enhancement of existing products requires significant investment in research and development, clinical trials and regulatory approvals. The results of our product development efforts may be affected by a number of factors, including our ability to anticipate customer needs, innovate and develop new products, complete clinical trials, obtain regulatory clearances and approvals and reimbursement in the U.S. and abroad, manufacture products in a cost-effective manner, obtain, maintain, protect and enforce appropriate intellectual property protection for our products, gain and maintain market approval of our products and access capital. If we are not able to successfully enhance existing products or develop new products, our products may be rendered obsolete or uncompetitive by changing technology or new industry standards. We cannot assure that any products now in development or that we may seek to develop in the future will achieve technological feasibility, obtain regulatory approval or gain market acceptance, and we may be unable to recover all or a meaningful part of our investment in such products and technologies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The markets for our newly developed products and newly introduced enhancements to our existing products may not develop as expected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The successful commercialization of our newly developed products and newly introduced enhancements to our existing products are subject to numerous risks, both known and unknown, including:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty of the development of a market for such product;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trends relating to, or the introduction or existence of, competing products or technologies that may be more effective, safer or easier to use than our products or technologies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the perception of our products as compared to other products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recommendation and support for the use of our products by influential customers, such as highly regarded hospitals, physicians and treatment centers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability and extent of data demonstrating the clinical efficacy of our products or treatments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition, including the presence of competing products sold by companies with longer operating histories, more recognizable names and more established distribution networks; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other technological developments.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Often, the development of a significant market for a product will depend upon the establishment of a reimbursement code or an advantageous reimbursement level for use of the product. Moreover, even if addressed, such reimbursement codes or levels frequently are not established until after a product is developed and commercially introduced, which can delay the successful commercialization of a product. If we are unable to successfully commercialize and create a significant market for our newly developed products and newly introduced enhancements to our existing products our business and prospects could be harmed. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot maintain our current corporate collaborations and enter into new corporate collaborations, our product development could be delayed and our revenue could be adversely impacted. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relied and/or expect to rely on corporate collaborators for funding development, marketing, distribution, and the commercialization of certain products. If any of our corporate collaborators were to breach, terminate, fail to renew our agreements or otherwise fail to properly conduct its obligations in a timely manner, the development or commercialization and subsequent marketing of the products contemplated by the collaboration could be delayed or terminated. Further, we would be required to devote additional resources to product development or marketing, to terminate some development programs or to seek alternative corporate collaborations with certain partners or companies that could make it more difficult for us to enter into advantageous business transactions or relationships with others. Any of the foregoing risks could harm our business and prospects. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS CONTINUITY AND RELIANCE ON THIRD PARTIES</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Supply Chain and Manufacturing</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reliance on one third-party manufacturer for certain of our product lines and a limited number of suppliers for some key raw materials, components and subassemblies for our products exposes us to increased risks associated with production delays, delivery schedules, manufacturing capability, quality control, quality assurance and costs.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have sole source third-party manufacturers for each of our Panther and Tigris molecular diagnostics instruments and for our Skeletal Health products. Similarly, we rely on one or a limited number of suppliers for some key components or subassemblies for our products due to cost, quality, expertise or other considerations. We have no firm long-term volume commitments with certain of our sole source suppliers, including the manufacturers of our Panther or Tigris instruments. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Similarly, we rely on one or a limited number of suppliers for some key raw materials for our products due to cost, quality, expertise or other considerations, and some of these suppliers are competitors. For example, F. Hoffmann-LaRoche Ltd, a direct competitor of our Diagnostics business, is the parent company of Roche, our current supplier of certain key raw materials for certain of our amplified NAT diagnostic assays. GE Healthcare Bio-Sciences Corp., an affiliate of GE, supplies us with the membranes used in connection with our ThinPrep product line. GE is a direct competitor with our Breast Health and Skeletal Health businesses. Moreover, we use certain components in our products, including semiconductor chips, that have been the subject of recent global supply chain shortages and disruptions. If any of our sole source manufacturers or suppliers, or other third-party manufacturers or suppliers, experiences delays, disruptions, capacity constraints or quality control problems in its development or manufacturing operations or becomes insolvent or otherwise fails to supply us with goods in sufficient quantities, including as a result of disruptions caused by the COVID-19 pandemic (as described above) or otherwise, then shipments to our customers could be delayed, which would decrease our revenues and harm our competitive position and reputation. Moreover, the failure of a supplier to provide sufficient quantities, acceptable quality and timely delivery of goods at an acceptable price, or an interruption in the delivery of goods from such a supplier could adversely affect our business and results of operations. Obtaining alternative sources of supply of products, components, subassemblies or raw materials could involve significant delays and other costs and regulatory challenges and may not be available to us on reasonable terms, if at all.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future need to find new contract manufacturers or suppliers to replace existing manufacturers or suppliers, increase our volumes or reduce our costs. We may not be able to find contract manufacturers or suppliers that meet our needs, including regulatory requirements, and even if we do, the process of qualifying such alternative manufacturers and suppliers is often expensive and time consuming. As a result, we may lose revenues and our customer relationships may suffer.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interruptions, delays, shutdowns or damage at our manufacturing or laboratory facilities could harm our business.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In most cases, the manufacturing of each of our products is concentrated in one or a few locations. In addition, we rely on a single laboratory facility to process each of our Biotheranostics gene expression tests for breast cancer. An interruption in manufacturing or testing capabilities at any of these facilities, as a result of equipment failure, transportation interruptions, disruptions caused by the COVID-19 pandemic, other pandemics or other reasons, could reduce, delay or prevent the production of our products. Our facilities and those of our contract manufacturers or suppliers are subject to the risk of catastrophic loss due to unanticipated events, such as fires, earthquakes, explosions, floods or weather conditions. Our facilities may experience plant shutdowns, strikes or other labor disruptions, or periods of reduced production as a result of equipment failures, loss of power, gray outs, delays in deliveries or extensive damage, which could harm our business and prospects. Some of our manufacturing operations are located outside the U.S., including in Costa Rica and the United Kingdom. Those manufacturing operations are also subject to additional challenges and risks associated with international operations described herein.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Customer Concentration and Distributors</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Diagnostics segment depends on a small number of customers for a significant portion of its product sales, and the loss of any of these customers or any cancellation or delay of a large purchase by any of these customers could significantly reduce revenues in our Diagnostics segment.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we do not currently have any customers that represent more than 10% of our consolidated revenues, or more than 10% of a business segment's revenue in fiscal 2021, historically a material portion of product sales in our Diagnostics segment came from (and we anticipate will continue to come from) a limited number of customers, two of which accounted for 12.5% and 10.9%, respectively, of our Diagnostics segment revenue in fiscal 2020. The loss of any of these key customers, or a significant reduction in sales volume or pricing to these customers, could significantly reduce our Diagnostics segment revenues or profitability.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We utilize distributors for a portion of our sales, the loss of which could harm our revenues in the territory serviced by these distributors.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on strategic relationships with a number of key distributors for sales and service of our products. If any of our strategic relationships terminate without replacement or if our strategic partners fail to perform their contractual obligations, our revenues and/or ability to service our products in the territories serviced by these distributors could be adversely affected. We do not control our distributors, and these parties may not be successful in marketing our products. These parties may fail to commit the necessary resources to market and sell our products to the level of our expectations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we elect to distribute new products directly, we will have to invest in additional sales and marketing resources, including additional field sales personnel, which would significantly increase future selling, general and administrative expenses. If we fail to successfully market our products, our product sales will decrease. We may also be exposed to risks as a result of transitioning a territory from a distributor sales model to a direct sales model, such as difficulties maintaining relationships with specific customers, hiring appropriately trained personnel or ensuring compliance with local product </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">registration requirements, any of which could result in lower revenues than previously received from the distributor in that territory.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TALENT AND EMPLOYEE RETENTION</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends on our ability to attract, motivate and retain key personnel and plan for future executive transitions. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of any of our key personnel, particularly executive management or key research and development personnel, could harm our business and prospects and could impede the achievement of our research and development, operational or strategic objectives. We also continue to face the challenges of maintaining employee well-being, recognizing that the additional financial, family and health burdens that many employees may be experiencing due to the COVID-19 pandemic and related economic uncertainties may adversely impact job performance and employee retention. Government and customer vaccine mandates that apply to us may also lead to employee attrition, challenges securing future labor needs, inefficiencies connected to employee turnover and costs associated with implementation and on-going compliance, which could have a material adverse effect on our business, financial condition, and results of operations. Additionally, in our industry, there is substantial competition for key personnel in the regions in which we operate. We face intense competition for employees, particularly as employees are increasingly able to work remotely. Also, facilitating seamless leadership transitions for key positions is a critical factor in sustaining the success of our organization. If our succession planning efforts are not effective, it could adversely impact our business. We continue to assess the key personnel that we believe are essential to our long-term success. Future organizational changes could also cause our employee attrition rate to increase. If we fail to effectively manage any organizational and/or strategic changes, our financial condition, results of operations, and reputation, as well as our ability to successfully attract, motivate and retain key employees, could be harmed. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CYBERSECURITY AND DATA PRIVACY</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increased cybersecurity requirements, vulnerabilities, threats and more sophisticated and targeted computer crime could pose a risk to our systems, networks, products, solutions, services and data.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased global cybersecurity vulnerabilities, threats, computer viruses, ransomware and phishing attacks and more sophisticated and targeted cyber-related attacks, as well as cybersecurity failures resulting from human error and technological errors, pose a risk to the security of Hologic and its customers, business partners' and suppliers' products, systems and networks and the confidentiality, availability and integrity of data on these products, systems and networks. As the perpetrators of such attacks become more capable, as cybercrime becomes commoditized, and as critical infrastructure is increasingly becoming digitized, the risks in this area continue to grow. While we attempt to mitigate these risks by employing a number of measures, including employee training, monitoring and testing, and maintenance of protective systems and contingency plans, we remain potentially vulnerable to additional known or unknown threats, and we cannot assure that the impact from such threats will not be material. In addition to existing risks, the adoption of new technologies and acquisitions of new businesses may also increase our exposure to cybersecurity breaches and failures. We also have access to sensitive, confidential or personal data or information that is subject to privacy and security laws, regulations or customer-imposed controls. Despite our implementation of controls to protect our systems and sensitive, confidential or personal data or information, we may be vulnerable to material security breaches, theft, misplaced, lost or corrupted data, employee errors and/or malfeasance (including misappropriation by departing employees) that could potentially lead to the compromising of sensitive, confidential or personal data or information, improper use of our systems, software solutions or networks, unauthorized access, use, disclosure, modification or destruction of information, defective products, production downtimes and operational disruptions. In addition, a cyber-related attack could result in other negative consequences, including damage to our reputation or competitiveness, remediation or increased protection costs, litigation or regulatory action. Although we have experienced occasional actual or attempted breaches of our computer systems, to date we do not believe any of these breaches has had a material effect on our business, operations or reputation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with laws relating to the confidentiality of sensitive personal information or standards related to the transmission of electronic health data, may require us to make significant changes to our products, or incur penalties or other liabilities.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State, federal and foreign laws, such as the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, regulate the confidentiality of sensitive personal information and the circumstances under which such information may be released. These measures may govern the disclosure and use of personal and patient medical record information and may require users of such information to implement specified security measures, and to notify individuals in the event of privacy and security breaches. Evolving laws and regulations in this area could restrict the ability of our customers to obtain, use or disseminate patient information, or could require us to incur significant additional costs to re-design our products in a timely manner, either of which could have an adverse impact on our results of operations. Other health information standards, such as regulations under HIPAA, establish standards regarding electronic health data transmissions and transaction code set rules for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specified electronic transactions, for example transactions involving submission of claims to third-party payors. These standards also continue to evolve and are often unclear and difficult to apply. Outside the U.S., we are impacted by privacy and data security requirements at the international, national and regional level, and on an industry specific basis. More privacy and security laws and regulations are being adopted, and more are being enforced, with potential for significant financial penalties. In the EU, increasingly stringent data protection and privacy rules have been enacted. The EU General Data Protection Regulation (GDPR) applies uniformly across the EU and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances. The GDPR also requires companies processing personal data of individuals residing in the EU to comply with EU privacy and data protection rules. Failure to maintain the confidentiality of sensitive personal information in accordance with the applicable regulatory requirements, or to abide by electronic health data transmission standards, could expose us to breach of contract claims, fines and penalties, costs for remediation and harm to our reputation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THIRD-PARTY REIMBURSEMENT AND GUIDELINES</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare cost containment legislation and the failure of third-party payors to provide appropriate levels of coverage and reimbursement for the use of products and treatments facilitated by our products could harm our business and prospects.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and market acceptance of our diagnostics, breast and skeletal health and surgical products and the treatments facilitated by these products are dependent upon the coverage decisions and reimbursement policies established by government healthcare programs and private health insurers. These policies affect which products customers purchase and the prices they are willing to pay. Reimbursement varies by country and can significantly impact the acceptance of new products and technologies. Even if we develop a promising new product, we may find limited demand for the product unless appropriate reimbursement approval is obtained from private and governmental third-party payors. Further legislative or administrative reforms to the reimbursement systems in the U.S. and other countries in a manner that significantly reduces reimbursement for procedures using our diagnostics, breast and skeletal health and surgical products or denies coverage for those procedures facilitated by our products, including price regulation, competitive bidding and tendering, coverage and payment policies, comparative effectiveness of therapies, technology assessments and managed-care arrangements, could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guidelines, recommendations and studies published by various organizations may reduce the use of our products.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional societies, government agencies, practice management groups, private health/science foundations, and organizations involved in healthcare issues may publish guidelines, recommendations or studies to the healthcare and patient communities. Organizations like these have in the past made recommendations about our products and those of our competitors. If followed by healthcare providers and insurers, such publications could result in decreased use of our products. For example, in November 2012, the American Congress of Obstetrics and Gynecologists, known as the ACOG, released updates in which it recommended less frequent cervical cancer screening similar to guidelines released in March 2012 by the U.S. Preventative Services Task Force, or the USPSTF, and the American Cancer Society. We believe that these recommendations and guidelines may have contributed to increased screening intervals for cervical cancer, which we believe has and may continue to adversely affect our ThinPrep revenues. Our ThinPrep revenues may also be adversely affected by the July 2020 American Cancer Society cervical cancer screening recommendation for a primary human papillomavirus (HPV) test rather than a Pap test. In addition, on October 20, 2015, the American Cancer Society issued guidelines recommending that women start annual mammograms at age 45 instead of 40 and have a mammogram every two years instead of annually. This recommendation could result in a decrease in purchases of our mammography systems.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGULATORY AND LEGAL</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or exposures to additional tax liabilities could negatively impact the Company's operating results.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes, as well as taxes that are not income-based, in both the U.S. and jurisdictions outside of the U.S. Our future effective tax rate could be unfavorably affected by numerous factors including a change in, or the interpretation of, tax rules and regulations in the jurisdictions in which we operate (including changes in legislation currently being considered), a change in our geographic earnings mix, and/or to the jurisdictions in which we operate, or a change in the measurement of our deferred taxes. We are also subject to ongoing tax audits in various jurisdictions, and tax authorities may disagree with certain positions we have taken and assess additional taxes. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly regulated industry, and changes in healthcare laws and regulations or our inability to obtain in a timely manner or at all U.S. or foreign regulatory clearances or approvals for our current and newly developed products and services or product or service enhancements, could adversely affect our business and prospects.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a highly regulated industry. As a result, governmental actions may adversely affect our business, operations or financial condition, including</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new laws, regulations or judicial decisions, or new interpretations of existing laws, regulations or decisions, related to healthcare availability, method of delivery and payment for healthcare products and services; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the FDA and foreign regulatory approval processes that may delay or prevent the approval of new products and result in lost market opportunity; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in FDA and foreign regulations that may require additional safety monitoring, labeling changes, restrictions on product distribution or use, or other measures after the introduction of our products to market, which could increase our costs of doing business, adversely affect the future permitted uses of approved products, or otherwise adversely affect the market for our products; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new laws, regulations and judicial decisions affecting pricing or marketing practices.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the high level of regulatory oversight to which our products are subject, the process of obtaining clearances and approvals can be costly and time consuming. In addition, there is a risk that any approvals or clearances, once obtained, may be withdrawn. Most medical devices cannot be marketed in the U.S. without 510(k) clearance or pre-market approval by the FDA. Any modifications to a device that has received a pre-market approval that affect the safety or effectiveness of the device require a pre-market approval supplement or possibly a separate pre-market approval, either of which is likely to be time consuming, expensive and uncertain to obtain. If the FDA requires us to seek one or more pre-market approval supplements or new pre-market approvals for any modification to a previously approved device, we may be required to cease marketing or to recall the modified device until we obtain approval, and we may be subject to significant criminal and/or civil sanctions, including, but not limited to, regulatory fines or penalties. States may also regulate the manufacture, sale and use of medical devices, particularly those that employ x-ray technology. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are also subject to approval and regulation by foreign regulatory and safety agencies. For example, the EU has adopted the EU Medical Device Regulation (the &#8220;EU MDR&#8221;) and the In Vitro Diagnostic Regulation (the &#8220;EU IVDR&#8221;), each of which impose stricter requirements for the marketing and sale of medical devices, including in the area of clinical evaluation requirements, quality systems and post-market surveillance. Manufacturers of currently approved medical devices will have until May 2022 to meet the EU IVDR. Complying with the requirements of these regulations may require us to incur significant expenditures. Failure to meet these requirements could adversely impact our business in the EU and other regions that tie their product registrations to the EU requirements. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that governmental authorities will continue to scrutinize the healthcare industry closely and that changes in laws, regulations or policies by governmental authorities may cause increased uncertainties and compliance costs, exposure to litigation and other adverse effects to our business and operations. Delays in receipt of, or failure to obtain or maintain, clearances or approvals for future products could delay or preclude realization of product revenues from new or existing products or result in substantial additional costs which could decrease our profitability.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, maintaining compliance with multiple regulators, and multiple centers within the FDA, adds complexity and cost to our manufacturing processes. Our manufacturing facilities and those of our contract manufacturers are subject to periodic regulatory inspections by the FDA and other regulatory agencies, and these facilities are subject to the FDA's Quality System Regulation and Good Manufacturing Practices. We or our contractors may fail to satisfy these regulatory requirements in the future, and any failure to do so may prevent us from selling our products.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our activities may subject us to risks under federal and state laws prohibiting &#8220;kickbacks&#8221; and false or fraudulent claims.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the provisions of a federal law commonly known as the anti-kickback statute, and several similar state laws, which prohibit payments intended to induce physicians or others either to refer patients or to acquire or arrange for or recommend the acquisition of healthcare products or services. While the federal law applies only to products or services for which payment may be made by a federal healthcare program, state laws often apply regardless of whether federal funds may be involved. These laws constrain the sales, marketing and other promotional activities of manufacturers of medical devices by limiting the kinds of financial arrangements, including sales programs that may be used with hospitals, physicians, laboratories and other potential purchasers of medical devices. Other federal and state laws generally prohibit individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other third-party payors that are false or fraudulent, or are for items or services that were not provided as claimed. Similarly, the Patient Protection and Affordable Care Act also includes stringent reporting requirements of financial relationships between device manufacturers and physicians and teaching hospitals. Specifically, under one provision of the law, which is commonly referred to as the Physician Payment Sunshine Act, we are required to collect data on and annually report to CMS certain payments or other transfers of value to physicians and teaching hospitals and annually report certain ownership and investment interests held by physicians or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their immediate family members. Anti-kickback and false claims laws and the Physician Payment Sunshine Act prescribe civil and criminal penalties (including fines) for noncompliance that can be substantial.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, our international operations are subject to the provisions of the U.S. Foreign Corrupt Practices Act of 1977, as amended ("FCPA"), which prohibits U.S. companies and their representatives from offering or making improper payments to foreign officials for the purpose of obtaining or retaining business. In many countries, the healthcare professionals we regularly interact with may meet the definition of a foreign official for purposes of the FCPA. Our international operations are also subject to various other international anti-bribery laws such as the UK Anti-Bribery Act. Despite meaningful measures that we undertake to facilitate lawful conduct, which include training and compliance programs and internal policies and procedures, we may not always prevent unauthorized, reckless or criminal acts by our employees or agents, or employees or agents of businesses or operations we may acquire. Violations of these laws, or allegations of such violations, could disrupt our operations, involve significant management distraction and have a material adverse effect on our business, financial condition and results of operations. We also could be subject to adverse publicity, severe penalties, including criminal and civil penalties, disgorgement, further changes or enhancements to our procedures, policies and controls, personnel changes and other remedial actions. Moreover, our failure to comply with domestic or foreign laws could result in various adverse consequences, including possible delay in approval or refusal to approve a product, recalls, seizures, and withdrawal of an approved product from the market.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to the risk of product liability claims relating to our products for which we may not have adequate insurance.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business involves the risk of product liability and other claims inherent to the medical device business. If even one of our products is found to have caused or contributed to injuries or deaths, we could be held liable for substantial damages. We maintain product liability insurance subject to deductibles and exclusions. There is a risk that the insurance coverage will not be sufficient to protect us from product and other liability claims, or that product liability insurance will not be available to us at a reasonable cost, if at all. An under-insured or uninsured claim could harm our business and prospects. In addition, claims could adversely affect the reputation of the related product, which could damage that product&#8217;s competitive position in the market.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sale and use of our diagnostic products could also lead to product liability claims if someone were to allege that one of our products contained a design or manufacturing defect that resulted in inaccurate test results or the failure to detect a disorder for which it was being used to screen, or caused injuries to a patient. Any product liability claim brought against us, with or without merit, could result in an increase in our product liability insurance rates or the inability to secure additional coverage in the future. Also, even a meritless or unsuccessful product liability claim could be time consuming and expensive to defend. This could result in a diversion of management&#8217;s attention from our business and adversely affect the perceived safety and efficacy of our products, which could harm our business and prospects.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to environmental, health and safety laws and regulations, including related to our use and recycling of hazardous materials and the composition of our products.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development and manufacturing processes involve the controlled use of hazardous materials, such as toxic and carcinogenic chemicals and various radioactive compounds, and the risk of contamination or injury from these materials cannot be eliminated. In such event, we could be held liable for any resulting damages, and any such liability could be extensive. From time to time new regulations are enacted, and it is difficult to anticipate how such regulations will be implemented and enforced. We continue to evaluate the necessary steps for compliance with regulations as they are enacted. These regulations include, for example, regulations enacted in the EU such as the Registration, Evaluation, Authorization and Restriction of Chemical Substances, or REACH, which requires the registration of and regulates use of certain chemicals, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive, or RoHS, which regulates the use of certain hazardous substances in certain products we manufacture, and the Waste Electrical and Electronic Equipment Directive, or WEEE, which requires the collection, reuse and recycling of waste from certain products we manufacture. These and similar legislation that has been or is in the process of being enacted in Japan, China and various states of the U.S. may require us to re-design our products to ensure compliance with the applicable standards, for example by requiring the use of different types of materials. These redesigns or the use of alternative materials may detrimentally impact the performance of our products, add greater testing lead times for product introductions, result in additional costs or have other similar effects. We are also subject to other substantial regulation relating to environmental, health and safety matters, including occupational health and safety, environmental protection, hazardous substance control, and waste management and disposal. The failure to comply with such regulations could subject us to, among other things, fines and criminal liability. We may also be required to incur significant costs to comply with these and future regulations, which may result in a material adverse effect upon our business, financial condition and results of operation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is dependent on technologies we license, and if we fail to maintain these licenses or license new technologies and rights to particular nucleic acid sequences for targeted diseases in the future, we may be limited in our ability to develop new products.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is dependent on licenses from third parties for some of our key technologies. For example, our patented TMA technology is based on technology we licensed from Stanford University. We anticipate that we will enter into new licensing arrangements in the ordinary course of business to expand our product portfolio and access new technologies to enhance our products and develop new products. Many of these licenses will provide us with exclusive rights to the subject technology or disease marker. If our license with respect to any of these technologies or markers is terminated for any reason, we may not be able to sell products that incorporate that technology. Similarly, we may lose competitive advantages if we fail to maintain exclusivity under an exclusive license.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to develop additional diagnostic tests for diseases may depend on the ability of third parties to discover particular sequences or markers and correlate them with disease, as well as the rate at which such discoveries are made. Our ability to design products that target these diseases may depend on our ability to obtain the necessary rights from the third parties that make any of these discoveries. In addition, there are a finite number of diseases and conditions for which our NAT diagnostic assays may be economically viable. If we are unable to access new technologies or the rights to particular sequences or markers necessary for additional diagnostic products on commercially reasonable terms, we may be limited in our ability to develop new diagnostic products.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and manufacturing processes may require access to technologies and materials that may be subject to patents or other intellectual property rights held by third parties. Our business could be adversely affected if we are unable to obtain the additional intellectual property rights necessary to commercialize our products.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be harmed if we are unable to protect our proprietary technology.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relied primarily on a combination of trade secrets, patents, copyrights, trademarks and confidentiality procedures to protect our products and technology. Despite these precautions, unauthorized third parties may infringe, misappropriate or otherwise violate our intellectual property, or copy or reverse engineer portions of our technology. The pursuit and assertion of a patent right, particularly in areas like nucleic acid diagnostics and biotechnology, involve complex determinations and, therefore, are characterized by substantial uncertainty. We do not know if current or future patent applications will be issued with the full scope of the claims sought, if at all, or whether any patents that are issued will be challenged or invalidated. The patents that we own or license could also be subjected to invalidation proceedings or similar disputes, and an unfavorable outcome could require us to cease using the related technology or to attempt to license rights to the technology from the prevailing party. There is also a risk that intellectual property laws outside of the U.S. will not protect our intellectual property rights to the same extent as intellectual property laws in the U.S. Even if our proprietary information is protected by patents or otherwise, the initiation of actions to protect our proprietary information could be costly and divert the efforts and attention of our management and technical personnel, and the outcome of such litigation is often uncertain. As a result of these uncertainties, we could also elect to forego such litigation or settle such litigation without fully enforcing our proprietary rights. In the absence of significant patent protection, we may be vulnerable to competitors who attempt to copy our products, processes or technology. Additionally, rights provided by a patent are finite in time. Over the coming years, certain patents relating to current products will expire in the U.S. and abroad thus allowing third parties to utilize certain of our technologies.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be harmed if we infringe upon the intellectual property rights of others.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been substantial litigation regarding patent and other intellectual property rights in the medical device, diagnostic products and related industries. We are and have been involved in patent litigation and may in the future be subject to further claims of infringement of intellectual property rights possessed by third parties. In connection with claims of patent infringement, we may seek to enter into settlement and/or licensing arrangements. There is a risk in these situations that no license will be available or that a license will not be available on reasonable terms. Alternatively, we may decide to litigate such claims or to design around the technology. These actions could be costly and would divert the efforts and attention of our management and technical personnel. As a result, any infringement claims by third parties or claims for indemnification by customers resulting from infringement claims, whether or not proven to be true, may harm our business and prospects.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEBTEDNESS</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a significant amount of indebtedness outstanding, which limits our operating flexibility, and could adversely affect our operations and financial results and prevent us from fulfilling our obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 25, 2021, we had approximately $3.05 billion aggregate principal of indebtedness outstanding (exclusive of additional funds that would be available to draw under our revolver and any funds that we may draw under our accounts </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivable securitization program). We also have other contractual obligations and deferred tax liabilities, which as of September 25, 2021, are described under &#8220;Notes to Consolidated Financial Statements &#8212; Income Taxes, and Non-cancelable Purchase Commitments.&#8221; This significant level of indebtedness and our other obligations may:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make it more difficult for us to satisfy our obligations with respect to our outstanding indebtedness; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to general adverse economic and industry conditions, including increases in interest rates; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to dedicate a substantial portion of our cash flow from operations to interest and principal payments on our indebtedness, which would reduce the availability of our cash flow to fund working capital, capital expenditures, expansion efforts, strategic transactions and other general corporate purposes; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we participate; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our competitors that have less debt; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to borrow additional funds for working capital, capital expenditures, expansion efforts, strategic transactions or other general corporate purposes. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the terms of our financing obligations contain certain covenants that restrict our ability, and that of our subsidiaries, to engage in certain transactions and may impair our ability to respond to changing business and economic conditions, including, among other things, limitations on our ability to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur indebtedness or issue certain preferred equity; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay dividends, repurchase our common stock, or make other distributions or restricted payments; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make certain investments; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">agree to payment restrictions affecting the restricted subsidiaries; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell or otherwise transfer or dispose of assets, including equity interests of our subsidiaries; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enter into transactions with our affiliates; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create liens; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">designate our subsidiaries as unrestricted subsidiaries; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consolidate, merge or sell substantially all of our assets; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">use the proceeds of permitted sales of our assets. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated credit facilities also require us to satisfy certain financial covenants. Our ability to comply with these provisions may be affected by general economic conditions, political decisions, industry conditions and other events beyond our control. Our failure to comply with the covenants contained in our amended and restated credit facilities, including financial covenants, could result in an event of default, which could materially and adversely affect our results of operations and financial condition.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there were an event of default under one of our debt instruments or a change of control, the holders of the defaulted debt could cause all amounts outstanding with respect to that debt to be due and payable immediately and may be cross-defaulted to other debt, including our outstanding notes. Our assets or cash flow may not be sufficient to fully repay borrowings under our outstanding debt instruments if accelerated upon an event of default or a change of control, and there is no guarantee that we would be able to repay, refinance or restructure the payments on such debt. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations-Liquidity and Capital Resources.&#8221;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to generate sufficient cash flow to service all of our indebtedness and other obligations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make payments on and to refinance our indebtedness and to fund planned capital expenditures, strategic transactions and expansion efforts will depend on our ability to generate cash in the future. This, to a certain extent, is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control. Our business may not be able to generate sufficient cash flow from operations, and we cannot assure that future borrowings will be available to us in amounts sufficient to enable us to pay our indebtedness as such indebtedness matures and to fund our other liquidity needs. If this occurs, we will need to refinance all or a portion of our indebtedness on or before maturity, and there can be no assurance that we will be able to refinance any of our indebtedness on commercially reasonable terms, or at all. We may need to adopt one or more alternatives, such as reducing or delaying planned expenses and capital expenditures, selling assets, restructuring debt, or obtaining additional equity or debt financing. These alternative strategies may not be affected on satisfactory terms, if at all. Our ability to refinance our indebtedness or obtain additional financing, or to do so on commercially reasonable terms, will depend on, among other things, our financial condition at the time, restrictions in agreements governing our indebtedness, and other factors, including the condition of the financial markets and the markets in which we compete. If we do not generate sufficient cash flow from operations, and additional borrowings, refinancings or proceeds from asset sales are not available to us, we may not have sufficient cash to enable us to meet all of our obligations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A significant portion of our indebtedness is subject to floating interest rates, which may expose us to higher interest payments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our indebtedness is subject to floating interest rates, which makes us more vulnerable in the event of adverse economic conditions, increases in prevailing interest rates, or a downturn in our business. As of September 25, 2021, approximately $1.6 billion aggregate principal of our indebtedness, which represented the outstanding principal under our amended and restated credit facilities and asset securitization agreement, was subject to floating interest rates. We currently have limited hedging arrangements in place to mitigate the impact of higher interest rates, including an interest rate swap agreement, which expires on December 17, 2023. We cannot assure that we would be able to extend this hedge at an attractive price and terms.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The proposed discontinuation or replacement of LIBOR would require us to amend certain agreements and may otherwise adversely affect our business.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intends to phase out LIBOR. It is currently anticipated that LIBOR will be completely phased out by June 30, 2023. Changes in the method of calculating LIBOR, or the replacement of LIBOR with an alternative rate or benchmark, may adversely affect interest rates and result in higher borrowing costs. This could materially and adversely affect our results of operations, cash flows and liquidity. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, and we cannot predict what alternative rate or benchmark would be negotiated. This may result in an increase to our interest expense.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL RISK FACTORS</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in our charter, bylaws, and indebtedness may have the effect of discouraging advantageous offers for our business or common stock and limit the price that investors might be willing to pay in the future for shares of our common stock.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our charter, bylaws, and the provisions of the Delaware General Corporation Law include provisions that may have the effect of discouraging or preventing a change of control. Our indebtedness also contains provisions which either accelerate or require us to offer to repurchase the indebtedness at a premium upon a change of control. These provisions could limit the price that our stockholders might receive in the future for shares of our common stock.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is volatile.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock has been, and may continue to be, highly volatile. We believe that a variety of factors could cause the price of our common stock to fluctuate, perhaps substantially, including:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new, or changes in, recommendations, guidelines or studies that could affect the use of our products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements and rumors of developments related to our business, including changes in reimbursement rates or regulatory requirements, proposed and completed acquisitions, or the industry in which we compete; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">published studies and reports relating to the comparative efficacy of products and markets in which we participate; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quarterly fluctuations in our actual or anticipated operating results and order levels; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general conditions in the U.S. or worldwide economy; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our stock repurchase program; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements of technological innovations; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new products or product enhancements by us or our competitors; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments in patents or other intellectual property rights and litigation; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments in relationships with our customers and suppliers; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of healthcare reform legislation and the adoption of additional reform legislation in the future; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success or lack of success of integrating our acquisitions. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the stock market in general and the markets for shares of &#8220;high-tech&#8221; and life sciences companies, have historically experienced extreme price fluctuations which have often been unrelated to the operating performance of affected companies. Any such fluctuations in the future could adversely affect the market price of our common stock, and the market price of our common stock may decline.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_22"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own and lease real property to support our business, including manufacturing, marketing, research and development, logistical support and administration. The following lists those properties that we own or lease that we believe are material to our business. We believe that we have adequate space for our anticipated needs and that suitable additional space will be available at commercially reasonable prices as needed.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.847%"><tr><td style="width:1.0%"></td><td style="width:24.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.422%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Material Properties&#160;Owned:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Primary Use</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Newark, DE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DirectRay digital detector research and development and plate manufacturing operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manchester, UK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative and supply chain operations</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Londonderry, NH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego, CA </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics headquarters, including administrative and manufacturing operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego, CA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics research and development, administrative and manufacturing operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warstein, Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations, research and development and administrative functions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.502%"><tr><td style="width:1.0%"></td><td style="width:19.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Material&#160;Properties Leased:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Primary Use</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease<br/>Expiration<br/>(fiscal&#160;year)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Renewals</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danbury, CT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing facility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Danbury, CT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations and research and development</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marlborough, MA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Headquarters, including research and development, manufacturing and distribution operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,&#160;five-yr.&#160;periods</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marlborough, MA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,&#160;five-yr.&#160;period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alajuela, Costa Rica</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing facility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,&#160;five-yr.&#160;periods</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manchester, England</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations and research and development</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2035</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ougr&#233;e, Belgium</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing operations and research and development</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2032</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also lease various administrative and customer support centers throughout the world including in Brussels, Belgium, Kerpen, Germany, Madrid, Spain, Beijing, China, Wiesbaden, Germany, Aix-en-Provence, France, and Espoo, Finland, and also maintain specialized research and development and manufacturing operations at various additional locations.</span></div><div style="text-indent:31.5pt"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_25"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of legal matters as of September&#160;25, 2021, please see Note 14 to our consolidated financial statements entitled &#8220;Litigation and Related Matters,&#8221; which is incorporated by reference into this item.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_31"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Market Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;HOLX.&#8221; </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Number of Holders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of November&#160;11, 2021, there were approximately 881 holders of record of our common stock, including multiple beneficial holders at depositories, banks and brokers listed as a single holder in the street name of each respective depository, bank or broker.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Policy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have never declared or paid cash dividends on our capital stock, and we currently have no plans to do so. Our current policy is to retain all of our earnings to finance future growth (including acquisitions), pay down our existing indebtedness and repurchase our common stock. The existing covenants under certain of our credit facilities also place limits on our ability to issue dividends and repurchase stock.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Sales of Unregistered Securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We did not sell unregistered securities during the fourth quarter of fiscal 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer's Purchases of Equity Securities</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of Repurchase</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>(#)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share<br/>($)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased As Part of Publicly<br/>Announced Plans or<br/>Programs&#160;<br/>(#)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per<br/>Share As Part of Publicly<br/>Announced Plans or<br/>Programs&#160;<br/>($)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under Our<br/>Programs <br/>(in millions) <br/>($) (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 27, 2021 &#8211; July 24, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 25, 2021 &#8211; August 21, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 22, 2021 &#8211; September 25, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;___________________________________</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the majority of restricted stock units granted, the number of shares issued on the date that the restricted stock units vest is net of the minimum statutory tax withholding requirements that we pay in cash to the appropriate tax authorities on behalf of our employees. These repurchases of our common stock were to cover employee income tax withholding obligations in connection with the vesting of restricted stock units under our equity incentive plans.</span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On December 9, 2020, the Board of Directors authorized a new share repurchase plan to repurchase up to $1.0 billion of the Company's outstanding common stock, effective December 11, 2020. In connection with this authorization, the prior plan was terminated.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_37"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information shall not be deemed to be "filed" with the SEC nor shall the information be incorporated by reference into any future filings under the Securities Act, except to the extent that we specifically incorporate it by reference into a document filed under the Securities Act or the Exchange Act.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares cumulative total shareholder return on our common stock since September&#160;24, 2016 with the cumulative total return of the Standard&#160;&amp; Poor&#8217;s Health Care Supplies Index. This graph assumes the investment of $100 on September&#160;24, 2016 in our common stock, and the S&amp;P Health Care Supplies Index. Measurement points are the last trading day of each respective fiscal year.</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:24.75pt"><img src="holx-20210925_g1.jpg" alt="holx-20210925_g1.jpg" style="height:567px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Reserved</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Not applicable.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-indent:24.75pt"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with the Consolidated Financial Statements, the information described under the caption &#8220;Risk Factors&#8221; in Part I, Item&#160;1A of this Annual Report and our Special Note Regarding Forward-Looking Statements at the outset of this Annual Report.</span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_46"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products focused on women's health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives. We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Until December 30, 2019, our product portfolio included aesthetic and medical treatments systems sold by our former Medical Aesthetic business. We completed the sale of our Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Diagnostics segment, we offer a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther, Panther Fusion and Tigris), our ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Our Aptima family of molecular diagnostic assays is used to detect, among other things, the infectious microorganisms that cause common sexually transmitted diseases, or STDs, such as: chlamydia and gonorrhea, or GTGC; certain high-risk strains of human papillomavirus, or HPV; and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parasite that causes trichomoniasis; Mycoplasma genitalium; and Herpes simplex viruses 1 and 2. We also offer viral load tests for HIV, Hepatitis C and Hepatitis B for use on our Panther instrument system. Our assay portfolio also includes diagnostic tests for a range of acute respiratory infections, including SARS-CoV-2, as well as a test for the detection of Group B Streptococcus, or GBS, that are run on the Panther Fusion system, a field upgradeable instrument addition to the base Panther system. In response to the COVID-19 pandemic, we developed and launched the Aptima SARS-CoV-2 assay (which runs on our standard Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system). The Panther Fusion SARS-CoV-2 assay and the Aptima SARS-CoV-2 assay were launched at the end of our second quarter and in the third quarter of fiscal 2020, respectively. The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. These solutions include 3D digital mammography systems, image analytics software utilizing artificial intelligence, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, connectivity solutions and breast conserving surgery products. Our most advanced breast imaging platforms, Selenia Dimensions and 3Dimensions, utilize tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GYN Surgical products include our NovaSure Endometrial Ablation System, or NovaSure, and our MyoSure Hysteroscopic Tissue Removal System, or MyoSure, as well as our Fluent Fluid Management system, or Fluent. The NovaSure portfolio is comprised of the NovaSure CLASSIC and NovaSure ADVANCED devices and involves a trans-cervical procedure for the treatment of abnormal uterine bleeding. The MyoSure suite of devices offers four options to provide incision-less removal of fibroids, polyps, and other pathology within the uterus. The Fluent system is a fluid management system that provides liquid distention during diagnostic and operative hysteroscopic procedures.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Skeletal Health segment's products includes the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm, which assists in performing minimally invasive orthopedic surgical procedures on a patient's extremities, such as the hand, wrist, knee, foot, and ankle.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medical Aesthetics segment consisted of a portfolio of aesthetic treatment systems. We completed the sale of our Medical Aesthetics business on December 30, 2019.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to we, us, Hologic or our company refer to Hologic, Inc. and its consolidated subsidiaries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Considerations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption in the markets we sell our products into, primarily the U.S., Europe and Asia-Pacific. Starting in the second quarter of fiscal 2020, the spread of COVID-19 negatively impacted business and healthcare activity globally. In particular, due to government measures, elective </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">procedures and exams were delayed or cancelled, there were significant reductions in physician office visits, and hospitals postponed or canceled capital purchases as well as limited or eliminated services; however, in the second half of the third quarter of fiscal 2020, we started to see a recovery of elective procedures and exams as economies were opened back up and restrictions eased, which has continued through the fourth quarter of fiscal 2021. The reductions in testing and procedures had a negative impact on our operating results and cash flows in fiscal 2020, however, the impact of the commercial release of our COVID-19 assays more than offset those negative impacts as we generated significant revenue from the sales of these assays starting in the third quarter of fiscal 2020 through the fourth quarter of fiscal 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our results of operations and cash flows since the third quarter of fiscal 2020 have been positively impacted by the sale of our COVID-19 assays as well the continued recovery of our other primary product lines and businesses to pre-COVID levels, the COVID-19 pandemic could have an adverse impact on our operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: reduced demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products as well as the timing and effectiveness of distributing vaccines; the severity and duration of the COVID-19 pandemic; the resurgence of COVID-19 infections; the emergence of new COVID strain variants; the COVID-19 pandemic's impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic and associated economic disruptions. We expect that as the current COVID-19 pandemic subsides, there may be a significantly reduced demand for ongoing testing, and thus, for our COVID-19 assays. As expected in the third quarter of fiscal 2021, revenues generated from the sale of its COVID-19 assays decreased significantly in the U.S. compared to the prior year period and the first and second quarters of fiscal 2021 as the population of vaccinated people continues to grow in the U.S. In the fourth quarter of fiscal 2021, COVID-19 assay revenues increased compared to the preceding quarter primarily due to the impact of the delta strain of COVID-19 resulting in higher demand for testing. However, COVID-19 assay revenues decreased compared to the corresponding prior year period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the negative impact of COVID-19 on our business, in April 2020, we initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but we also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances, effected employee terminations. Further in April 2020, we shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of our products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased During fiscal 2021 the majority of the impacted manufacturing facilities were back to pre-COVID levels. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also taken and continue to take measures to ensure the safety of our employees and to comply with governmental orders. These measures could require that our employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in our commercial and marketing activities. In addition, complying with government and customer vaccine mandates that apply to us may lead to employee attrition, disrupt our workforce and result in additional costs associated with implementation and on-going compliance, which could have an adverse impact on our operating results, cash flows and financial condition.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions and Disposition</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth a description of certain of our acquisitions and dispositions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our last two fiscal years:</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mobidiag</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2021, we completed the acquisition of Mobidiag Oy, or Mobidiag, for a purchase price of $729.6&#160;million. Mobidiag, located in Finland, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. This acquisition expanded our molecular diagnostics portfolio into the near-patient testing market. Based on our preliminary valuation, we allocated $399.9 million of the purchase price to the value of intangible assets and $432.6 million to goodwill. The remaining $102.9 million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as we continue to gather information supporting the acquired assets and liabilities. Mobidiag's results of operations are reported in our Diagnostics segment.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biotheranostics</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, we completed the acquisition of Biotheranostics, Inc., or Biotheranostics, for a purchase price of $231.3&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs lab testing procedures at its facility. Based on our preliminary valuation, we allocated $162.4 million of the purchase price to the value of intangible assets and $80.9 million to goodwill. The remaining $12.0 million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preliminary as we continue to gather information supporting the acquired assets and liabilities. Biotheranostics' results of operations are included in our Diagnostic segment and its revenues are reported within service and other revenues in our consolidated statements of operations. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagenode</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the acquisition of Diagenode SA, or Diagenode, for a purchase price of $155.1&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR technology to detect infectious diseases of bacterial, viral or parasite origin. Based on our preliminary valuation, we allocated $79.0 million of the purchase price to the value of intangible assets and $83.5 million to goodwill. The remaining $7.4 million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as we continue to gather information supporting the acquired assets and liabilities. Diagenode's results of operations are included in our Diagnostics segment.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Somatex Medical Technologies</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2020, we completed the acquisition of Somatex Medical Technologies GmbH, or Somatex, for a purchase price of $62.9&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. Based on our preliminary valuation, we allocated $40.1 million of the purchase price to the value of intangible assets and $32.4 million to goodwill. The remaining $9.6 million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as we continue to gather information supporting the acquired assets and liabilities. Somatex' results of operations are included in our Breast Health segment. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, we completed the acquisition of assets from NXC Imaging, for a purchase price of $5.6&#160;million. NXC Imaging was a long-standing distributor of our Breast and Skeletal products in the U.S.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, we completed the acquisition of Acessa Health, Inc., or Acessa for a purchase price of $162.0&#160;million, which included contingent consideration and was estimated at $81.8 million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its Acessa ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are included in our GYN Surgical segment. The contingent consideration is based on annual incremental revenue growth over a three-year period ending annually in December. The contingent consideration is payable after each annual measurement period. We remeasure the contingent consideration liability on a quarterly basis, and for fiscal year 2021 we recorded a gain of $6.7 million to decrease the liability to its fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period, partially offset by lower discount rates and accretion of the liability. The liability was recorded at $75.1 million at September 25, 2021.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, we completed the acquisition of Health Beacons, Inc., or Health Beacons, for a purchase price of $19.7 million. Health Beacons manufactures the LOCalizer product. Health Beacon's results of operations are reported in our Breast Health segment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the acquisition of assets from Alpha Imaging, LLC, or Alpha Imaging, for a purchase price of $18.0 million. Alpha Imaging was a long-standing distributor of our Breast and Skeletal products in the U.S.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, we acquired approximately 46% of the outstanding shares of SuperSonic Imagine SA, or SSI, which is headquartered in France. SSI specializes in ultrasound imaging and designs, develops and markets an ultrasound platform used in the non-invasive care path for the characterization of breast, liver or prostate diseases. We initially accounted for this investment as an equity method investment.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, we acquired an additional 7.6 million common shares of SSI for $12.6 million. As a result, we owned approximately 78% of the outstanding shares of SSI at November 21, 2019 and controlled SSI's voting interest and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations. We performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within our consolidated financial statements within our Breast Health segment. We remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million in Other income (expense), net in the first quarter of fiscal 2020. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, we acquired the remaining 4.8 million shares outstanding of SSI for $8.5 million. As of September 25, 2021, we owned 100% of SSI. Accordingly we recorded an adjustment to our net income for the noncontrolling interest we did not own of $1.8 million and $4.7 million (both of which were losses) for the years ended September 25, 2021 and September 26, 2020, respectively.</span></div><div style="margin-top:4pt;text-align:justify;text-indent:29.25pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">Disposition - Medical Aesthetics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the sale of our Medical Aesthetics. At the closing, we received cash proceeds of $153.4 million. The sales price was finalized in the fourth quarter of fiscal 2020, and we repaid $3.4 million, resulting in a final sales price of $150.0 million. As a result of the sale, we recorded a $30.2 million impairment charge in the first quarter of fiscal 2020 to record the asset group at fair value less costs to dispose as it met the assets held-for-sale criteria. For additional information, see Note 15 to our consolidated financial statements included herein. Following the sale of our Medical Aesthetics business, we have not generated any further product revenue related to this business, although additional expenses have been and will be incurred primarily in connection with the indemnification of legal and tax matters that existed as of the date of disposition. In addition, we agreed to provide transition services for a period of up to 15 months, which ended in March 2021.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year Ended September&#160;25, 2021 Compared to Fiscal Year Ended September&#160;26, 2020 </span></div><div style="margin-top:5pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:28.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.032%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Product Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,596.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,967.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,227.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated a 53.9% increase in product revenues in fiscal 2021 compared to fiscal 2020 primarily due to the increase in the Diagnostics business from a full year of sales of our two COVID-19 assays, one of which was launched near the end of the second quarter of fiscal 2020 and the other in the third quarter of fiscal 2020. Excluding sales of our COVID-19 assays, product revenues in the prior year period were adversely impacted by the COVID-19 pandemic, and product revenues in the current year periods have increased across our divisions. We primarily attribute this increase to recovery of elective procedures and exams, including associated capital equipment spending, as economies were opened back up and restrictions eased, and to a lesser extent a portion of the increase was driven by our current year acquisitions. The increase in product revenues in fiscal 2021 compared to fiscal 2020 was partially offset by no revenues from the Medical Aesthetics business in the current fiscal year as we disposed of this business segment on December 30, 2019, the beginning of our second quarter of fiscal 2020.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics product revenues increased 73.4% in fiscal 2021 compared to fiscal 2020 primarily due to increases in Molecular Diagnostics of $1,457.7 million, Cytology and Perinatal of $58.3 million, and an increase in blood-screening of $6.3 million. While we divested our blood screening business in the second quarter of fiscal 2017, we continue to provide long-term access to Panther instrumentation and certain supplies to the purchaser of that business. Molecular Diagnostics product revenue was $3.1 billion in fiscal 2021 compared to $1.6 billion in fiscal 2020. The increase was primarily attributable to revenues of $2.16 billion in fiscal 2021 compared to $929.3 million in fiscal 2020 from our two SARS-CoV-2 assays (primarily the Aptima SARS-CoV-2 assay and to a lesser extent the Panther Fusion SARS-CoV-2 assay), an increase in Panther and Panther Fusion instrument sales due to demand for increased testing capacity for COVID-19, and an increase of $150.2 million in Aptima assays sales, which primarily consist of our CTGC, HPV and Trichomonas vaginalis assays, and related collection kits due to a return to pre-COVID testing levels. Prior fiscal year sales of these assays were adversely impacted by the COVID-19 pandemic and related lockdowns across the globe. In addition, we had an increase of $9.4 million in worldwide sales of our virology products in the current fiscal year. We expect that sales of our COVID-19 assays will decline significantly in fiscal 2022 compared to the current fiscal year primarily due to the continued distribution of vaccines. Cytology &amp; Perinatal product revenue increased $58.3 million in the current fiscal year primarily due to higher ThinPrep test volumes, which we primarily attribute to the recovery of wellness office visits that had previously been delayed or cancelled in the prior year in response to the COVID-19 pandemic, partially offset by lower average selling prices and lower Perinatal product volumes. The inclusion of Diagenode and Mobidiag contributed $29.9 million of product revenue in the current fiscal year. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies in current fiscal year.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health product revenues increased 21.3% in fiscal 2021 compared to fiscal 2020 as product revenues in the prior fiscal year were adversely impacted by the COVID-19 pandemic and related lockdowns across the globe. These increases were primarily due to an increase in sales volume of our digital mammography systems and related workflow products (primarily Intelligent 2D, Clarity HD and SmartCurve), Affirm Prone breast biopsy tables, and our interventional breast solutions products, primarily Eviva, ATEC, and Brevera disposables (relaunched in the fourth quarter of fiscal 2020). In addition, we had higher sales of our breast conserving surgery products and ultrasound imaging products. We primarily attribute the increase in revenues to hospitals and imaging centers purchasing capital equipment following a significant decline in such spending during fiscal 2020 and to the recovery of elective procedures and exams as elective procedures and wellness visits that had previously been delayed or cancelled in the prior year in response to the COVID-19 pandemic. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies in the current year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical product revenues increased 29.8% in fiscal 2021 compared to fiscal 2020, primarily due to the recovery of elective medical visits and procedures that had previously been delayed or cancelled in response to the COVID-19 pandemic and to a lesser extent healthcare providers increasing their inventory levels. These revenue increases were primarily due to increases in the sales volumes of MyoSure systems, NovaSure systems, Fluent Fluid Management systems and to a lesser extent sales of ProVu systems acquired in the Acessa acquisition in the fourth quarter of fiscal 2020. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies in the current year.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health product revenues increased 22.7% in fiscal 2021 compared to fiscal 2020 primarily due to an increase in sales volume of both our Insight FD mini C-arm and Horizon DXA systems. We primarily attribute this increase to the increase in wellness visits and healthcare screenings in 2021 as a result of the ongoing recovery from the COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020. We have generated no revenue from the segment since that date.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues by geography as a percentage of total revenues were as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:22.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:71.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.956%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.958%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our product revenue increased in all our geographic regions, our largest proportionate increase was in Europe, which we primarily attribute to strong sales of our SARS-CoV-2 assays in Europe, growth in our Aptima assays in Europe as we expanded our customer base, increased sales from the adoption of co-testing for cervical cancer screening in Germany and to a lesser extent in the UK, as well as the inclusion of revenue from Diagenode, Mobidiag and Somatex, which are predominantly in Europe. Asia-Pacific product revenue as a percentage of total product revenue increased primarily due to an increase in sales of our SARS-CoV-2 assays in the region, an increase in sales of our mammography systems and growth in ThinPrep and Molecular Diagnostics primarily due to the recovery of wellness office visits that had previously been delayed or cancelled in response to the COVID-19 pandemic.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Other Revenues</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Service and Other Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues are primarily comprised of revenue generated from our field service organization to provide ongoing service, installation and repair of our products. The majority of these revenues are generated within our Breast Health segment. Service and other revenues increased 21.0% in fiscal 2021 compared to fiscal 2020 primarily due to an increase in Breast Health service contract revenue as the Breast Health business continued to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period, as well as additions from our distributor acquisitions. We also experienced an increase in spare parts revenue in the current fiscal year for services that had previously been delayed or cancelled due to the COVID-19 pandemic. In our Diagnostics business, we had additional royalty revenue in the current fiscal year of $34.4 million from Grifols related to licensing our intellectual property to our COVID-19 assays for their sale in Spain. In addition, the inclusion of Biotheranostics added $33.7 million in the current fiscal year. These increases were partially offset by the sale of the Medical Aesthetics business which contributed $15.6 million of service revenue in the prior fiscal year.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:25.772%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.506%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Product<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Product<br/>Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cost of Product Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Amortization of Acquired Intangible Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Impairment of Intangible Assets and Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross margin was 70.2% in fiscal 2021 compared to 61.8% in fiscal 2020. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cost of product revenues as a percentage of product revenues was 24.3% in the current year compared to 29.6% in the prior year. Cost of product revenues as a percentage of revenue decreased in fiscal 2021 primarily due to sales of our SARS-CoV-2 assays, which have higher gross margins compared to our other Diagnostic products, and comprised 43.5% and 28.8% of total product revenue in fiscal 2021 and fiscal 2020, respectively. Also benefiting gross margin in the current year were higher sales volumes from our other businesses and product lines as they have continued to recover from the COVID-19 pandemic as economies opened back up and restrictions eased and the disposition of Medical Aesthetics, which had lower gross margins compared to our remaining businesses. Partially offsetting these decreases were higher field service costs for our expanded instrument installed base for the Diagnostics business and higher freight costs.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics' product costs as a percentage of revenue decreased in fiscal 2021 compared to fiscal 2020 primarily due to higher sales of our SARS-CoV-2 assays and higher overall production of our Aptima assays and ThinPrep Pap Test reducing fixed overhead on a unit basis. These increases were partially offset by increased international freight costs, increased inventory reserves, higher field service costs for our expanded instrument installed base, an increase in amortization of placed instruments, and a slight decline in average selling prices partially driven by geographic mix.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health&#8217;s product costs as a percentage of revenue decreased in fiscal 2021 compared to fiscal 2020 primarily due to the impact of the COVID-19 pandemic in the prior year, which resulted in decreased sales volume across the majority of our product lines, period costs for temporary facility shut-downs and reduced manufacturing utilization and higher inventory reserves. In the current fiscal year, sales volumes have increased for our higher margin 3Dimensions systems, higher-margin workflow products (primarily consisting of Intelligent 2D, Clarity HD and SmartCurve), and our breast biopsy and breast conserving surgery disposable products. Increased sales also improved manufacturing utilization.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical&#8217;s product costs as a percentage of revenue decreased in fiscal 2021 compared to fiscal 2020 primarily due to the impact of the COVID-19 pandemic in the prior year, which resulted in significant decreases in sales volume of our NovaSure and MyoSure devices, period costs for the temporary shutdown of our manufacturing facility and reduced manufacturing utilization. In the current fiscal year, the Surgical business has recovered to pre-COVID levels which significantly improved manufacturing utilization and margins, partially offset by the product mix of higher volumes of lower margin products, including our Fluent Fluid Management systems and Acessa ProVu systems.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health&#8217;s product costs as a percentage of revenue decreased in fiscal 2021 compared to fiscal 2020 due to higher sales volume of both our Insight FD mini C-arm and Horizon DXA systems and lower inventory reserves in the current year.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Acquired Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets included in cost of product revenues relates to acquired developed technology, which is generally amortized over its estimated useful life of between 5 and 15 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed. Amortization expense increased in fiscal 2021 compared to fiscal 2020 primarily due to intangible assets acquired in the Mobidiag, Acessa, Biotheranostics, Diagenode and Somatex acquisitions, partially offset by lower amortization of intangible assets acquired in the Cytyc acquisition which reduces over time.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets and Equipment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As discussed in Note 2 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets, of which $25.8 million was allocated to developed technology assets and written off to cost of revenues. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:26.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Service<br/>and Other<br/>Revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Service<br/>and Other<br/>Revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cost of Service and Other Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues gross margin was 46.7% in fiscal 2021 compared to 42.4% in fiscal 2020. The increase in gross margin was primarily due to additional royalty revenue from Grifols related to licensing our intellectual property related to our COVID-19 assays for their sale in Spain, which has a high margin, and laboratory testing services from Biotheranostics, which has a higher gross margin than our legacy service businesses. In addition, in the current year period the Breast Health business had an increase in service contract revenue which benefited gross margin as service contract revenue has higher margins compared to revenue from spare parts, installation and training. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:27.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration&#8212;fair value adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and divestiture charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Percentage not meaningful</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses increased 24.2% in fiscal 2021 compared to fiscal 2020 primarily due to higher R&amp;D project spend in Diagnostics, Breast Health and Surgical, the inclusion of expenses from the Mobidiag, Acessa, Biotheranostics, Diagenode and Somatex acquisitions aggregating $14.6 million, higher salary expense from increased headcount in Diagnostics, higher project and consulting spend and increased spending to implement the European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) requirements. In the current year, we also recorded a $7.0 million charge related to the purchase of intellectual property in Breast Health that has no future alternative use. Partially offsetting these increases in the current year was the reduction of expense due to the disposition of the Medical Aesthetics business which contributed $7.3 million of expense in the prior year. In addition, we recorded a credit to research and development expenses of $11.0 million and $7.1 million in fiscal 2021 and 2020, respectively, from the Biomedical Advanced Research and Development Authority (BARDA) in connection with a grant to expand manufacturing capacity, obtain FDA approval of our SARS-CoV-2 assays and develop sampling pooling capability and other enhancements to our SARS-CoV-2 assays. At any point in time, we have a number of different research projects and clinical trials being conducted and the timing of these projects and related costs can vary from period to period.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and Marketing Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling and marketing expenses increased 15.8% in fiscal 2021 compared to fiscal 2020 primarily due inclusion of expenses from the Mobidiag, Acessa, Biotheranostics, Diagenode and Somatex acquisitions aggregating $36.3 million, an increase in commissions in Breast Health, Surgical and Diagnostics from higher revenues, and an increase in marketing initiatives and consulting spend. Partially offsetting these increases in the current year was the disposition of the Medical Aesthetics business which contributed $23.7 million of expense in the prior year, lower travel and trade show expenses in response to the COVID-19 pandemic, decreases in meeting expenses primarily related to cancelling our national sales meeting and not having an in-person RSNA conference as a result of the COVID-19 pandemic, and lower bonus expense.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General and administrative expenses increased 21.8% in fiscal 2021 compared to fiscal 2020 primarily due to the inclusion of expenses from the Mobidiag, Acessa, Biotheranostics, Diagenode and Somatex acquisitions aggregating $16.4 million, increased acquisition transaction costs including $11.5 million for a transfer tax related to the Mobidiag acquisition, a $11.2 million non-income tax charge related to an ongoing non-income tax audit, higher expense from our deferred compensation plan, higher litigation and settlement costs, increased consulting spend for corporate initiatives and information system implementation projects, higher charitable donations, higher salary expenses due to an increase in headcount and the cessation of furloughs implemented in April 2020 due to the COVID-19 pandemic before the end of the prior year period, and lower credits in the current year of $3.5 million related to transition services provided to Cynosure. Partially offsetting these increases were lower stock-based compensation and bonuses, lower bad debt expense, the disposition of the Medical Aesthetics business, which contributed $5.5 million of expenses in the prior year, expenses incurred in the prior year to separate and dispose of that business, and a $3.3 million benefit due to reversal of a tax reserve.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Acquired Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets results from customer relationships, trade names, distributor relationships and business licenses related to our acquisitions. These intangible assets are generally amortized over their estimated useful lives of between 2 and 30 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed utilizing expected undiscounted future cash flows. Amortization expense increased 6.3% in fiscal 2021 compared to fiscal 2020 primarily due to increases from recent acquisitions, partially offset by assets from older acquisitions becoming fully amortized.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Fair Value Adjustments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Acessa, we are obligated to make contingent earn-out payments. The payments are based on achieving incremental revenue growth over a three-year period ending annually in December. As of the acquisition date for Acessa, we recorded a contingent consideration liability for the estimated fair value of the amount we expected to pay to the former shareholders of the acquired business. This liability is not contingent on future employment, and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable company revenue growth rates, implied volatility and applying a risk adjusted discount rate. Increases or decreases in the fair value of contingent consideration liabilities can result from the passage of time, changes in discount rates, and changes in the timing, probabilities and amount of revenue estimates. In the current year, we recorded a gain of $6.7 million to decrease the liability to its fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period, partially offset by a lower discount rate and accretion of the liability based on the passage of time.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets of which $4.4 million was written off to operating expenses. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and Divestiture Charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have implemented various cost reduction initiatives to align our cost structure with our operations and related to integration activities. These actions have primarily resulted in the termination of employees, As a result, we recorded charges of $9.3 million in fiscal 2021 and $15.3 million in fiscal 2020, primarily related to severance benefits. For additional information, please refer to Note 6 to our consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.591%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense in fiscal 2021 and 2020 consists primarily of the cash interest costs and the related amortization of the debt discount and deferred issuance costs on our outstanding debt. Interest expense in fiscal 2021 decreased compared to fiscal 2020 primarily due to a decrease in LIBOR year over year, the basis for determining interest expense under our 2018 Credit Agreement, lower interest rates on our Senior Notes due to issuing our 2029 Senior Notes and paying off our 2025 Senior Notes, and the pay-off of amounts outstanding under our accounts receivable asset securitization agreement in the prior year, partially offset by issuance costs expensed from the issuance of the 2029 Senior Notes and higher interest rate swap expenses.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Extinguishment Loss</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt Extinguishment Loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2021, we completed a private placement of $950 million aggregate principal amount of our 2029 Senior Notes, The proceeds under the 2029 Senior Notes offering, together with available cash, were used to redeem our 2025 Senior Notes in the same principal amount. In connection with this transaction, we recorded a debt extinguishment loss of $21.6 million in the first quarter of fiscal 2021. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), net</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Income (Expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, this account primarily consisted of a net foreign currency exchange loss of $17.1 million, partially driven by the mark-to-market and settling of outstanding forward foreign currency exchange and option contracts, and a charge of $1.8 million for the write-off of an equity investment, partially offset by a gain of $13.4 million on the cash surrender value of life insurance contracts related to our deferred compensation plan driven by current year stock market gains.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2020, this account primarily consisted of net foreign currency exchange gains of $3.2 million primarily due to hedging activities, a net gain of $3.2 million to reflect an adjustment to remeasure our initial investment in SSI in connection with purchase accounting and a gain of $2.3 million on the cash surrender value of life insurance contracts related to our deferred compensation plan. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision (Benefit) for Income Taxes.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Provision (Benefit) for Income Taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Percentage not meaningful</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for fiscal 2021 was a provision of 20.8%. The effective tax rate was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes and the global intangible low-taxed income inclusion.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for fiscal 2020 was a benefit of 10.8%. The effective tax rate differed from the U.S. statutory tax rate primarily due to a $313.4 million discrete net tax benefit related to the sale of the Medical Aesthetics business, the impact of the U.S. deduction for foreign derived intangible income, federal and state tax credits, and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes, reserves for uncertain tax positions net of releases resulting from statute of limitations expirations and favorable audit settlements, the global intangible low-taxed income inclusion, and unbenefited foreign losses.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Results of Operations</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Until December 30, 2019, our product portfolio included aesthetic and medical treatments systems sold by our former Medical Aesthetic business. We completed the disposition of the Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). The accounting policies of the segments are the same as those described in the footnotes to the accompanying consolidated financial statements contained in Item 15 of this Annual Report. We measure segment performance based on total revenues and operating income (loss). Revenues from product sales of each of these segments are described in further detail above. The discussion that follows is a summary analysis of total revenues and the primary changes in operating income or loss by segment. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diagnostics</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,695.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929.7&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210.4&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics revenues increased in fiscal 2021 compared to fiscal 2020 primarily due to the increase in product revenues from the recovery of our core product lines, current year acquisitions and sales of our SARS-CoV-2 assays discussed above, an increase in royalty revenue from Grifols related to licensing our intellectual property to our COVID-19 assays for their sale in Spain, and the inclusion of laboratory testing service revenue from Biotheranostics.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Operating income for this business segment increased in fiscal 2021 compared to fiscal 2020 primarily due to an increase in gross profit from higher revenues partially offset by an increase in operating expenses. Gross margin was 73.2% in the current year compared to 65.2% in the prior year. The increase in gross margin was primarily due to increased sales of our SARS-CoV-2 assays, higher overall production of our Aptima assays and ThinPrep Pap Test reducing fixed overhead on a unit basis and increased royalty revenue from Grifols, partially offset by an increase in freight costs to ship product internationally, an increase in inventory reserves, higher field service costs, an increase in amortization of placed Panther instruments as the installed base has increased significantly year over year, and higher intangible asset amortization expense from the Mobidiag, Diagenode and Biotheranostics acquisitions in the current year.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in fiscal 2021 compared to fiscal 2020 primarily due to higher compensation and benefits driven by salary, commissions and our deferred compensation plan, an increase in headcount in the operations, service and sales departments, an increase in R&amp;D project spend, higher acquisition transaction expenses, which included $11.5 million for a transfer tax related to the Mobidiag acquisition, higher bad debt expense, an increase in marketing initiatives, a lower BARDA credit of $3.9 million in the current year, and additional expenses from the Mobidiag, Biotheranostics and Diagenode acquisitions. These increases were partially offset by lower bonus expense.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breast Health</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:37.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.907%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.907%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.907%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.8&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.4&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health revenues increased in fiscal 2021 compared to fiscal 2020 primarily due to an increase of $143.0 million in product revenue as discussed above and an increase of $57.3 million in service and other revenue. The increase in service revenue is primarily due to an increase in service contract revenue as the Breast Health business continued to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period, the addition of service contracts from the NXC Imaging acquisition and an increase in spare parts revenue.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in fiscal 2021 compared to fiscal 2020 primarily due to an increase in gross profit from higher revenues with higher gross margin, partially offset by an increase in operating expenses. Gross margin was 56.4% in the current year compared to 52.8% in the prior year. The increase in gross profit was primarily due to the increase in product revenue and service revenue discussed above and lower costs related to the step-up in fair value of inventory of $2.3 million for the Somatex acquisition in the current year compared to $6.8 million for the SSI and Health Beacons acquisitions in the prior year. In addition, gross profit in the prior year was impacted by the COVID-19 pandemic, which resulted in decreased sales volume across the majority of our product lines, period costs for temporary facility shut-downs and reduced manufacturing utilization and higher inventory reserves.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in fiscal 2021 compared to fiscal 2020 due to due to higher compensation and benefits driven by higher commissions from increased sales and our deferred compensation plan, a $7.0 million charge related to the purchase of intellectual property, an increase in R&amp;D project spend, an increase in consulting spend, an increase in marketing initiatives and the prior year included a benefit from the reversal of acquisition related accruals and a holdback. These increases were partially offset by lower bonus expense, lower stock compensation expense, a decrease in trade show expenses and lower bad debt expense.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GYN Surgical</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.812%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical revenues increased in fiscal 2021 compared to fiscal 2020 due to the increase in product revenues discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in fiscal 2021 compared to fiscal 2020 primarily due to an increase in gross profit from higher revenues with higher gross margin, partially offset by an increase in operating expenses. Gross margin was 61.0% in the current year, compared to 59.1% in the prior year. The increase in gross margin was primarily due to the increased sales volume in the current year as the GYN Surgical business recovered to pre-COVID levels and the impact of the COVID-19 pandemic on the prior year, which resulted in decreased sales volume, period costs for temporary facility shut-downs and reduced manufacturing utilization. The increase in gross margin was partially offset by an unfavorable product mix of lower margin products, including our Fluent Fluid Management system and Acessa ProVu systems, higher intangible asset amortization expense from the Acessa acquisition, and an increase in inventory reserves.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in fiscal 2021 compared to fiscal 2020 primarily due to the inclusion of Acessa expenses of $15.0 million, higher compensation and benefits driven by our deferred compensation plan and commissions from the increase in sales, increased spending on research and development projects, higher travel, marketing initiative spend and consulting, and an increase in bad debt expense partially offset by a gain of $6.7 million related to the fair value adjustments for contingent consideration related to the Acessa acquisition.</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skeletal Health</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:37.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.091%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Loss as a % of Segment Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health revenues increased in fiscal 2021 compared to fiscal 2020 primarily due to the increase in product revenues discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss increased in fiscal 2021 compared to fiscal 2020 primarily due to an increase in operating expenses, partially offset by an increase in gross profit from higher revenues. Gross margin decreased to 31.4% in the current year compared to 33.2% in the prior year primarily due to higher service costs, partially offset by higher sales volume of our products and higher inventory reserves in the prior year.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in fiscal 2021 compared to fiscal 2020 primarily due to higher compensation and benefits and an increase in trade show expenses.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year Ended September&#160;26, 2020 Compared to Fiscal Year Ended September&#160;28, 2019</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Discussions of year-to-year comparisons between fiscal 2020 and 2019 that are not included in this Form 10-K can be found in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended September 26, 2020.</span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_52"></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;25, 2021, we had working capital of $1,841.9 million, and our cash and cash equivalents totaled $1,170.3 million. Our cash and cash equivalents balance increased by $469.3 million during fiscal 2021 principally due to cash generated from operating activities partially offset by cash used in financing and investing activities related to acquisitions of businesses, repurchases of common stock, net repayments of debt and capital expenditures.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, our operating activities provided us with $2,330.4 million of cash, primarily due to net income of $1,869.7 million, non-cash charges for depreciation and amortization aggregating $406.9 million, stock-based compensation expense of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$65.0 million and a debt extinguishment loss of $21.6 million. These adjustments to net income were partially offset by a decrease in net deferred tax liabilities of $70.1 million primarily due to the amortization of intangible assets. Cash provided by operations included a net cash inflow of $13.0 million from changes in our operating assets and liabilities. Changes in our operating assets and liabilities were driven primarily by a decrease in accounts receivable of $110.9 million primarily due to payments received from customers that had large balances from COVID-19 assay sales in our Diagnostics division and lower revenues in fourth quarter of fiscal 2021 compared to the fourth quarter of fiscal 2020, an increase in accounts payable of $20.4 million primarily due to the timing of these payments, and an increase in deferred revenue of $14.0 million primarily due to an increase in service contracts as the Breast Health business continues to convert a high percentage of its installed base of digital mammography systems to service contracts upon expiration of the warranty period, and a decrease in prepaid income taxes of $13.0 million. These cash inflows were partially offset by an increase in inventory of $84.1 million primarily due to the increase in raw materials and inventory to continue to support SARS-CoV-2 assay demand and production and an increase in prepaid expenses and other assets of $56.3 million due to an increase in technology implementation capitalized costs and licenses and the timing of value added tax receivables.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, our investing activities used cash of $1,329.6 million primarily related to net cash paid for our fiscal 2021 acquisitions of Biotheranostics, Diagenode, Somatex, and Mobidiag of $1,164.7 million and net capital expenditures of $156.2 million, which primarily consisted of purchases of manufacturing equipment primarily to expand the capacity of our molecular diagnostics manufacturing facilities and the placement of equipment under customer usage agreements. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, our financing activities used cash of $529.8 million, primarily related to $970.8 million for the repayment of our 2025 Senior Notes, $409.8 million for repurchases of our common stock, $250.0 million for the repayment of amounts borrowed under our revolving credit line, $75.0 million for scheduled principal payments under our 2018 Credit Agreement, $71.5 million for the net repayment of amounts borrowed under our accounts receivable securitization agreement and payments of $47.5 million for employee-related taxes withheld for the net share settlement of vested restricted stock units. Partially offsetting these uses of cash were net proceeds of $936.3 million under our 2029 Senior Notes, $320.0 million of proceeds under the accounts receivable securitization agreement that we restarted in the third quarter of 2021 to partially fund the Mobidiag acquisition, and $51.3 million from our equity plans, primarily from the exercise of stock options.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total recorded debt outstanding of $3.0 billion at September&#160;25, 2021, which was comprised of our term loan under our then existing Credit Agreement of $1.38 billion (principal of $1.39 billion), 2029 Senior Notes of $934.5&#160;million (principal of $950.0 million), and 2028 Senior Notes of $395.4 million (principal of $400.0 million), Securitization Program of $248.5&#160;million, and $64.5 million in debt acquired in the Mobidiag acquisition. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Credit Agreement (Subsequent Event)</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2021, we refinanced our existing term loan and revolving credit facility with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto (the "2018 Credit Agreement") by entering into Refinancing Amendment No. 2 dated as of September 27, 2021, to the Amended and Restated Credit and Guaranty Agreement, dated as of October 3, 2017, as amended(the "2021 Credit Agreement"). Substantially all of the proceeds under the 2021 Credit Agreement of $1.5 billion were used to repay the amounts outstanding under the term loan under the 2018 Credit Agreement. Borrowings under the 2021 Credit Agreement are secured by first-priority liens on, and a first priority security interest in (in each case subject to certain liens permitted under the 2021 Credit Agreement), substantially all of our U.S. assets and the assets of the Subsidiary Guarantors. These liens are subject to release during the term of the facilities if we are able to achieve certain corporate or corporate family ratings and other conditions are met. The credit facilities (the "2021 Credit Facilities") under the 2021 Credit Agreement consist of:</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $1.5 billion secured term loan ("2021 Term Loan") with a stated maturity date of September 25, 2026; and</span></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility (the "2021 Revolver") under which the Borrowers may borrow up to $2.0 billion, subject to certain sublimits, with a stated maturity date of September 25, 2026.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this Annual Report, there have been no borrowings under the 2021 Revolver. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2021 Credit Agreement, other than Swing Line Loans (as defined in the 2021 Credit Agreement), bear interest, at our option, at the Base Rate (as defined in the 2021 Credit Agreement), at the Eurocurrency Rate (as defined in the 2021 Credit Agreement), at the Alternative Currency Daily Rate (as defined in the 2021 Credit Agreement), or at the LIBOR Daily Floating Rate (as defined in the 2021 Credit Agreement), in each case plus the Applicable Rate (as defined in the 2021 Credit Agreement).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Applicable Rate in regards to the Base Rate, the Eurocurrency Rate, the Alternative Currency Daily Rate, the Alternative Currency Term Rate and the LIBOR Daily Floating Rate is subject to change depending on the Total Net Leverage Ratio (as defined in the 2021 Credit Agreement). The borrowings of the Term Loan under the 2021 Credit Facilities initially bear interest at an annual rate equal to the Eurocurrency Rate for a one month interest period plus an Applicable Rate equal to 1.00%.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to pay a quarterly commitment fee calculated on a daily basis equal to the Applicable Rate as of such day multiplied by the undrawn committed amount available under the Revolver (taking into account any outstanding amounts under the LS Sublimit). This commitment fee is initially 0.15% per annum for the Revolver.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to make scheduled principal payments under the 2021 Term Loan in increasing amounts ranging from $3.750 million per three-month period commencing with the three-month period ending on December 29, 2022 to $18.750 million per three-month period commencing with the three month period ending on December 26, 2025. The remaining scheduled balance of $1.335 billion (or such lesser aggregate principal amount of Term Loans then outstanding) on the 2021 Term Loan and any amounts outstanding under the 2021 Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2021 Credit Agreement, we may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). Certain of the mandatory prepayments are subject to reduction or elimination of certain financial covenants are met. These mandatory prepayments are required to be applied first to the 2021 Term Loan, second to any outstanding amount under any Swing Line Loans (as defined in the 2021 Credit Agreement), third to the 2021 Revolver, fourth to prepay any outstanding reimbursement obligations with respect to Letters of Credit (as defined in the 2021 Credit Agreement) and fifth to cash collateralize any Letters of Credit. Subject to certain limitations, we may voluntarily prepay any of the 2021 Credit Facilities without premium or penalty. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting our ability subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on our assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of our business. In additions, the 2021 Credit Agreement requires the Borrowers to maintain certain financial ratios. The 2021 Credit Agreement also contains customary representations and warranties and events of default, including payments defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the company. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 25, 2021, the total aggregate principal balance of the 2028 Senior Notes was $400.0 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries. The 2028 Senior Notes were issued pursuant to an indenture, dated as of January 19, 2018, among the Company, the guarantors and Wells Fargo Bank, National Association, as trustee. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. We may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. We also have the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, we completed a private placement of our 2029 Senior Notes. The total aggregate principal balance of the 2029 Senior Notes is $950.0 million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries. The 2029 Senior Notes were issued pursuant to an indenture, dated as of September 28, 2020, among the Company, the guarantors and Wells Fargo Bank, National Association, as trustee. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021. We may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. We may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We also have the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, we paid off the total amount outstanding of $250.0 million previously borrowed under our then existing accounts receivable securitization program. On April 13, 2020, we amended the Credit and Security agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. On June 11, 2021, we amended and restated the Credit and Security agreement to restart the Securitization Program (the "Securitization Program") and increase the maximum borrowing amount to $320.0 million. Under the terms of the Securitization Program, we and certain of our wholly-owned subsidiaries sell our customer receivables to a bankruptcy remote special purpose entity, which is wholly-owned by us. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay our other debts or liabilities. The Securitization Program provides for annual renewals.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Loans outstanding under the Securitization Program bear interest at LIBOR plus an applicable margin for defined tranches. As of September&#160;25, 2021, there was $248.5 million outstanding under this program. The weighted average interest rate under the Securitization Program was 0.8% as of September 25, 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal 2022 Acquisition</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 14, 2021,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we announced that we entered into an agreement to acquire Bolder Surgical, Inc., or Bolder, a privately held, U.S.-based company that provides advanced energy vessel sealing surgical devices, for approximately $160.0 million, subject to working capital and other customary closing adjustments. The closing is subject to certain regulatory approvals, but we expect the acquisition to close before the end of calendar 2021. The acquisition will add laparoscopic vessel sealing, dividing and dissecting devices to the GYN Surgical portfolio and also will enable Hologic to expand the use of Bolder&#8217;s devices to OB/GYN specialists. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration Earn-Out Payments</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain of our acquisitions, we have incurred the obligation to make contingent earnout payments tied to performance criteria, principally revenue growth of the acquired business over a specified period. In addition, contractual provisions relating to these contingent earn-out obligations may result in the risk of litigation relating to the calculation of the amount due or our operation of the acquired business. Such litigation could be expensive and divert management attention and resources. Our obligation to make contingent payments may also result in significant operating expenses.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contingent consideration arrangements are recorded as either additional purchase price or compensation expense if continuing employment is required to receive such payments. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, contingent consideration that is deemed to be part of the purchase price is recorded as a liability based on the estimated fair value of the consideration we expect to pay to the former shareholders of the acquired business as of the acquisition date. This liability is re-measured each reporting period with the change in fair value recorded through a separate line item within our Consolidated Statements of Operations. Increases or decreases in the fair value of contingent consideration liabilities can result from changes in discount rates, changes in the timing, probabilities and amount of revenue estimates, and accretion of the liability for the passage of time. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, our primary contingent consideration liability is from our acquisition of Acessa Health. We have an obligation to the former Acessa Health shareholders to make contingent payments based on a multiple of annual incremental revenue growth over a three year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, the contingent consideration was deemed to be part of the purchase price and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of the business, comparable company revenue growth rates, implied volatility and applying a risk adjusted discount rate. At September 25, 2021 this liability was recorded at $75.1 million and no contingent earnout payments have been earned or made.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Board of Directors authorized a new five-year share repurchase plan, to repurchase up to $1.0 billion of our outstanding common stock. The prior plan was terminated in connection with this new authorization. As of September 25, 2021, $691.6 million remained available under this authorization. Subsequent to September 25, 2021, we repurchased 2.3 million shares of our common stock for $167.0 million. </span></div><div style="margin-bottom:3pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Liquidity Considerations</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to review and evaluate potential strategic transactions (both acquisitions and dispositions) and alliances that we believe will complement or enhance our business and stockholder value. Subject to the Risk Factors set forth in Part I, Item&#160;1A of this Annual Report and the general disclaimers set forth in our Special Note Regarding Forward-Looking Statements at the outset of this Annual Report, we believe that our cash and cash equivalents, cash flows from operations, the cash available under our 2021 Revolver and our Securitization Program will provide us with sufficient funds in order to fund our expected normal operations and debt payments over the next twelve months. Our longer-term liquidity is contingent upon future operating performance. We may also require additional capital in the future to fund capital expenditures, repayment of debt, acquisitions including contingent consideration payments, strategic transactions or other investments. As described above, we have significant indebtedness outstanding under our 2021 Credit Agreement, 2028 Senior Notes, 2029 Senior Notes and Securitization Program. These capital requirements could be substantial. Our operating performance may also be affected by matters discussed under the above-referenced Risk Factors set forth elsewhere in this report. These risks, trends and uncertainties may also adversely affect our long-term liquidity.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently involved in certain legal proceedings and claims. In connection with these legal proceedings and claims, management periodically reviews estimates of potential costs to be incurred by us in connection with the adjudication or settlement, if any, of these proceedings. These estimates are based on an analysis of potential litigation outcomes and settlement strategies. In accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, loss contingencies are accrued if, in the opinion of management, an adverse outcome is probable and such outcome can be reasonably estimated. It is possible that future results for any particular quarter or annual period may be materially affected by changes in our assumptions or the effectiveness of our strategies relating to these proceedings.</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Off-Balance Sheet Arrangements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, of a magnitude that we believe could have a material impact on our financial condition or liquidity.</span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_55"></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition for multiple element arrangements, allowance for doubtful accounts, reserves for excess and obsolete inventories, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, stock-based compensation, contingent liabilities, tax reserves and recoverability of our net deferred tax assets and related valuation allowances. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates if past experience or other assumptions do not turn out to be substantially accurate. Any differences may have a material impact on our financial condition and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of what we believe to be the more significant critical accounting policies and estimates used in the preparation of our consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inventories include material, labor and overhead, and are stated at the lower of cost (first-in, first-out) or market. As a developer and manufacturer of high technology medical equipment and diagnostic test kits, we may be exposed to a number of economic and industry factors that could result in portions of our inventory becoming either obsolete or in excess of anticipated usage. Our policy is to establish inventory reserves when conditions exist that suggest that our inventory may be in excess of anticipated demand or is obsolete based upon our assumptions about future demand for our products and market conditions. Although considerable effort is made to ensure the accuracy of our forecasts of future product demand, any significant unanticipated changes in demand or expected usage could have a significant negative impact on the value of our inventory and our operating results.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record tangible and intangible assets acquired and liabilities assumed in business combinations under the purchase method of accounting. Amounts paid for each acquisition are allocated to the assets acquired and liabilities assumed based on their fair values at the dates of acquisition. Contingent consideration, which is not deemed to be linked to continuing employment, is recorded at fair value as measured on the date of acquisition using an appropriate valuation model, such as the Monte Carlo simulation model. The value recorded is based on estimates of future financial projections under various potential scenarios, in which the model runs many simulations based on comparable companies' growth rates and their implied volatility. These cash flow projections are discounted with a risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment, specifically projected revenues, and given the inherent uncertainties in making these estimates, actual results are likely to differ from the amounts originally recorded and could be materially different.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of identifiable intangible assets is based on detailed valuations that use information and assumptions provided by management, which consider management&#8217;s best estimate of inputs and assumptions that a market participant would use. We allocate any excess purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed to goodwill. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally use the income approach in which cash flow projections on an after-tax basis are discounted using a risk adjusted rate to determine the estimated fair value of certain identifiable intangible assets including developed technology, in-process research and development projects, customer relationships, and trade names. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results specifically revenue growth rates. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to property, plant and equipment, we estimate the fair value of these assets using a combination of the cost and market approaches, depending on the component. Generally, we apply the cost or income approach as the primary methods in estimating the fair value of land and buildings as the market approach is less reliable based on potential significant differences between the property being valued and the potentially comparable sales of similar properties.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We test goodwill at the reporting unit level for impairment on an annual basis and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying value. Events that could indicate impairment and trigger an interim impairment assessment include, but are not limited to current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate, operational performance of the business or key personnel, and an adverse action or assessment by a regulator. Our annual impairment test date is the first day of our fiscal fourth quarter.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the test, we either use the qualitative assessment permitted by ASC 350, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the single step quantitative approach prescribed under ASC 350 including amendments under ASU 2017-04. Under the qualitative approach we consider a number of factors, including the amount by which the previous quantitative test's fair value exceeded the carrying value of the reporting units, the forecasts in our then-current strategic plan compared to the forecasts in the previous quantitative test, an evaluation of discount rates, long-term growth rates including the terminal year rate, if tax rates would have significantly changed, an evaluation of current economic factors for both the worldwide economy and specifically the medical device industry, and any significant changes in customer and supplier relationships. We weigh these factors to determine if it is more likely than not that the fair value of the reporting unit exceeds its carrying value. If after </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performing a qualitative assessment, indicators are present, or we identify factors that cause us to believe it is appropriate to perform a more precise calculation of fair value, we would move beyond the qualitative assessment and perform a quantitative impairment test.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the quantitative impairment test, we perform a comparison of the reporting unit&#8217;s carrying value to its fair value. We consider a number of factors to determine the fair value of a reporting unit, including an independent valuation to conduct this test. The valuation is based upon expected future discounted operating cash flows of the reporting unit as well as analysis of recent sales and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ratio comparisons of similar companies. We base the discount rate on the weighted average cost of capital, or WACC, of market participants. If the carrying value of a reporting unit exceeds its estimated fair value, we apply the single step approach under ASU 2017-04. As a result of this simplified approach the goodwill impairment is calculated as the amount by which the carrying value of the reporting unit exceeds its fair value to the extent of the goodwill balance.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our fiscal 2021 annual impairment test on the first day of the fourth quarter and utilized the quantitative approach. We utilized discounted cash flows, or DCF, and market approaches to estimate the fair value of our reporting units as of June 27, 2021 and ultimately used the fair value determined by the DCF in making our impairment test conclusions. We believe we used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of our reporting units had fair values exceeding their carrying values.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;25, 2021, we believe that our reporting units, with goodwill aggregating $3.3 billion, were not at risk of failing the goodwill impairment test based on its current forecasts and qualitative assessment.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the fair value of our reporting units was determined by use of the DCF, and the key assumptions that drive the fair value in this model are the WACC, terminal values, growth rates, and the amount and timing of expected future cash flows, significant judgment is applied in determining fair value. If the current economic environment were to deteriorate, this would likely result in a higher WACC because market participants would require a higher rate of return. In the DCF as the WACC increases, the fair value decreases. The other significant factor in the DCF is our projected financial information (i.e., amount and timing of expected future cash flows and growth rates) and if these assumptions were to be adversely impacted, this could result in a reduction of the fair value of a reporting unit.</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are initially recorded at fair value and stated net of accumulated amortization and impairments. We amortize intangible assets that have finite lives using either the straight-line method, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be utilized. We evaluate the recoverability of our definite lived intangible assets whenever events or changes in circumstances or business conditions indicate that the carrying value of these assets may not be recoverable based on expectations of future undiscounted cash flows for each asset group. If the carrying value of an asset or asset group exceeds its undiscounted cash flows, the Company estimates the fair value of the assets, generally utilizing a discounted cash flow analysis based on the present value of estimated future cash flows to be generated by the assets using a risk-adjusted discount rate. To estimate the fair value of the assets, the Company uses market participant assumptions pursuant to ASC 820, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue from the sale of our products, primarily medical imaging systems and diagnostic and surgical disposable products, and related services, which are primarily support and maintenance services on our medical imaging systems. See Note 3 for further discussion of revenue recognition.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider revenue to be earned when all of the following criteria are met: we have a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount that we expect to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and we have transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration we expect to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for our products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefit of the product. As such, the performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts and extended warranties are recognized over time based on the contract term, which represents a faithful depiction of the transfer of goods and services </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">given the stand-ready nature of the performance obligations. Service revenue related to professional services for installation, training and repairs is recognized as the services are performed based on the specific nature of the service.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize receivables when we have an unconditional right to payment, which represents the amount we expect to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. We treat shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and record these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our contracts have multiple performance obligations. For contracts with multiple performance obligations, we are required to allocate the transaction price to each performance obligation using our best estimate of the standalone selling price of each distinct good or service in the contract. We determine the best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, we rely on prices set by our pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also place instruments (or equipment) at customer sites but retain title to the instrument (for example, the ThinPrep Processor, ThinPrep Imaging System, and the Panther system). The customer has the right to use the instrument for a period of time, and then we recover the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded operating lease for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. We recognize a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the asset and liability method for accounting for income taxes in accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under this method, we recognize deferred income tax assets and liabilities for the future tax consequences of differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases, and also for operating loss and tax credit carry-forwards at each reporting period. We measure deferred tax assets and liabilities using enacted tax rates and laws applicable to the period and jurisdiction in which we expect the differences to affect taxable income. We evaluate both the positive and negative evidence that affects the realizability of net deferred tax assets and assess the need for a valuation allowance. The future benefit to be derived from our deferred tax assets is dependent upon our ability to generate sufficient future taxable income in each jurisdiction of the right type to realize the assets. We establish a valuation allowance when necessary to reduce deferred tax assets to the amounts expected to be realized. To the extent we establish or release a valuation allowance, a tax charge or benefit will be recorded as a component of the income tax provision on the statement of operations in the reporting period that such determination is made.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recognized $228.6 million in net deferred tax liabilities at September&#160;25, 2021 and $186.3 million at September&#160;26, 2020. The increase was primarily due to purchase accounting related intangible additions to deferred liabilities in fiscal 2021. The liabilities primarily relate to deferred taxes associated with our acquisitions. The tax assets relate primarily to net operating loss carryforwards, accruals and reserves, stock-based compensation, and research credits. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting for income taxes requires a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if, based on the technical merits, it is more likely than not that the position will be sustained upon audit, including resolutions of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. We evaluate these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit and new audit activity. Any change in these factors could result in the recognition of a tax benefit or an additional charge to the tax provision.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;25, 2021, we had $212.8 million in gross unrecognized tax benefits excluding interest, of which $197.0 million, if recognized, would reduce our effective tax rate. As of September&#160;26, 2020, we had $197.1 million in gross unrecognized tax benefits excluding interest, of which $184.9 million, if recognized, would have reduced our effective tax rate. The Tax Cuts and Jobs Act subjects a U.S. shareholder to tax on global intangible low-taxed income (&#8220;GILTI&#8221;) earned by certain foreign subsidiaries. The FASB Staff Q&amp;A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed Income, states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. The Company accounts for GILTI in the year the tax is incurred as a period cost.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, there are many transactions and calculations where the ultimate tax outcome is uncertain. Judgment is required in determining our worldwide income tax provision. In our opinion, we have made adequate </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provisions for income taxes for all years subject to audit. While we consider our estimates reasonable, no assurance can be given that the final tax outcome will not be different than amounts reflected in our historical income tax provisions and accruals. If our assumptions are incorrect, the differences could have a material impact on our income tax provision and operating results in the period in which such determination is made.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2 to our consolidated financial statements contained in Item&#160;15 of this Annual Report.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_58"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments, Other Financial Instruments, and Derivative Commodity Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments consist of cash and cash equivalents, accounts receivable, equity investments, foreign currency derivative contracts, an interest rate swap agreement, insurance contracts, accounts payable and debt obligations. Except for our outstanding 2028 and 2029 Senior Notes, the fair value of these financial instruments approximate their carrying amount. The fair value of our 2028 and 2029 Senior Notes was approximately $424.5 million and $964.7 million, respectively, as of September 25, 2021. Amounts outstanding under our 2018 Credit Agreement of $1.4 billion aggregate principal and Securitization Program of $248.5 million as of September&#160;25, 2021 are subject to variable rates of interest based on current market rates, and as such, we believe the carrying amount of these obligations approximates fair value.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Primary Market Risk Exposures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our primary market risk exposure is in the areas of interest rate risk and foreign currency exchange rate risk. We incur interest expense on borrowings outstanding under our 2028 and 2029 Senior Notes, 2018 Credit Agreement and Securitization Program. The 2028 and 2029 Senior Notes have fixed interest rates. Borrowings under our 2018 Credit Agreement bore interest at the Eurocurrency Rate (i.e., LIBOR) plus the applicable margin of 1.00% per annum, and borrowings under our Securitization program currently bear interest at LIBOR plus the applicable margin of 0.7%.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;25, 2021, there was $1.6 billion of aggregate principal outstanding under the 2018 Credit Agreement and Securitization Program. Since these debt obligations are variable rate instruments, our interest expense associated with these instruments is subject to change. A hypothetical 10% adverse movement (increase in LIBOR rate) would increase annual interest expense by approximately $0.3 million. We entered into an interest rate swap agreement to help mitigate the interest rate volatility associated with the variable rate interest on the amounts outstanding under the 2018 Credit Agreement. The critical terms of the interest rate swap were designed to mirror the terms of our LIBOR-based borrowings under the 2018 Credit Agreement, and therefore the interest rate swap is highly effective at offsetting the cash flows being hedged. We designated this derivative instrument as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. The interest rate swap contract expires on December 17, 2023.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intends to phase out LIBOR by the end of 2021, which was extended to the end of 2023. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, including our interest rate swap agreement, and we cannot predict what alternative rate or benchmark would be negotiated or the extent to which this would adversely affect our interest rate and the effectiveness of our interest rate hedging activity.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The return from cash and cash equivalents will vary as short-term interest rates change. A hypothetical 10% increase or decrease in interest rates, however, would not have a material adverse effect on our financial condition.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our international business is subject to risks, including, but not limited to: unique economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility. Accordingly, our future results could be materially adversely impacted by changes in these or other factors.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business worldwide and maintain sales and service offices outside the U.S. as well as manufacturing facilities in Costa Rica and the United Kingdom. Our international sales are denominated in a number of currencies, primarily the Euro, U.S. dollar, UK Pound and Chinese Renminbi. The majority of our foreign subsidiaries functional currency is the local currency, although certain foreign subsidiaries functional currency is the U.S. dollar based on the nature of their operations or functions. Fluctuations in the foreign currency rates could affect our sales, cost of goods and operating margins and could result in exchange losses. In addition, currency devaluations can result in a loss if we hold deposits of that currency. We have executed forward foreign currency contracts to hedge a portion of results denominated in the Euro, UK Pound, Australian dollar, Japanese Yen, Canadian dollar and Chinese Renminbi. These contracts do not qualify for hedge accounting. As a result, we may experience volatility in our Consolidated Statements of Operations due to (i) the impact of unrealized gains and losses reported in other income, net on the mark-to-market of outstanding contracts and (ii) realized gains and losses </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized in other income, net, whereas the offsetting economic gains and losses are reported in the line item of the underlying cash flow, for example, revenue. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the operating expenses of our international subsidiaries that are incurred in local currencies will not have a material adverse effect on our business, results of operations or financial condition. Our operating results and certain assets and liabilities that are denominated in foreign currencies are affected by changes in the relative strength of the U.S. dollar against those currencies. Our expenses, denominated in foreign currencies, are positively affected when the U.S. dollar strengthens against those currencies and adversely affected when the U.S. dollar weakens. However, we believe that the foreign currency exchange risk is not significant. We believe a hypothetical 10% increase or decrease in foreign currencies that we transact in would not have a material adverse impact on our financial condition or results of operations. During fiscal 2021, we incurred net foreign exchange losses of $17.1 million and in 2020 and 2019, we incurred net foreign exchange gains of $3.4 million and $5.1 million, respectively.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Financial Statements and Supplementary Data</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Consolidated Financial Statements and Supplementary Data are set forth under Part IV, Item&#160;15, which is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9A. Controls and Procedures</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;25, 2021, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Management on Internal Control over Financial Reporting</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act, as amended, as a process designed by, or under the supervision of our principal executive and principal financial officers and effected by our board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles and includes those policies and procedures that:</span></div><div style="margin-top:5pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and disposition of our assets;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorization of our management and directors; and</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our internal control system was designed to provide reasonable assurance to our management and board of directors regarding the preparation and fair presentation of published financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has assessed the effectiveness of our internal control over financial reporting as of September&#160;25, 2021. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (COSO) in Internal Control-Integrated Framework.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has excluded from our assessment of and conclusion on the effectiveness of internal control over financial reporting the internal controls of Mobidiag Oy, Diagenode SA, Biotheranostics, Inc., and Somatex Medical Technologies GmbH, which are included in the consolidated financial statements of Hologic, Inc. as of and for the year ended September 25, 2021 and constituted $1.4 billion and $1.1 billion of our total assets and net assets, respectively, as of September 25, 2021 and $77.1 million and $40.3 million of revenues and pre-tax losses, respectively, for the year then ended.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the foregoing, based on management&#8217;s assessment, we believe that, as of September&#160;25, 2021, our internal control over financial reporting is effective at a reasonable assurance level based on these criteria.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst&#160;&amp; Young LLP, an independent registered public accounting firm, has issued an attestation report on the effectiveness of our internal control over financial reporting. This report in which they expressed an unqualified opinion is included below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of Hologic, Inc.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Hologic, Inc.&#8217;s internal control over financial reporting as of September 25, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Hologic, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of September 25, 2021, based on the COSO criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As indicated in the accompanying Report of Management on Internal Control over Financial Reporting, management&#8217;s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Mobidiag Oy, Diagenode SA, Biotheranostics, Inc., and Somatex Medical Technologies GmbH, which are included in the 2021 consolidated financial statements of the Company and constituted $1.4 billion and $1.1 billion of total and net assets, respectively, as of September 25, 2021 and $77.1 million and $40.3 million of revenues and pre-tax losses, respectively, for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Mobidiag Oy, Diagenode SA, Biotheranostics, Inc., and Somatex Medical Technologies GmbH.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2021 consolidated financial statements of the Company and our report dated November 16, 2021 expressed an unqualified opinion thereon.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Report of Management on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ernst&#160;&amp; Young LLP</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston, Massachusetts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended September&#160;25, 2021, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9B. Other Information</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_73"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section&#160;406 of the Sarbanes-Oxley Act of 2002, we have adopted a Code of Ethics for Senior Financial Officers that applies to our principal executive officer, principal financial officer, and principal accounting officer and controller, and other persons performing similar functions. Our Code of Ethics for Senior Financial Officers is publicly available on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">investors.hologic.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as Appendix A to our Code of Conduct. We intend to satisfy the disclosure requirement under Item&#160;5.05 of Current Report on Form 8-K regarding an amendment to, or waiver from, a provision of this code by posting such information on our website, at the address specified above.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;11. Executive Compensation</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a number of equity compensation plans for employees, officers, directors and others whose efforts contribute to our success. The table below sets forth certain information as of the end of our fiscal year ended September&#160;25, 2021 regarding the shares of our common stock available for grant or granted under stock option plans and equity incentives that (i)&#160;were approved by our stockholders, and (ii)&#160;were not approved by our stockholders.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:44.061%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>securities&#160;to&#160;be<br/>issued upon<br/>exercise&#160; of<br/>outstanding<br/>options,&#160;warrants<br/>and rights<br/>(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average<br/>exercise&#160; price&#160; of<br/>outstanding<br/>options,<br/>warrants&#160;and&#160; rights<br/>(b) (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160; securities<br/>remaining&#160;available&#160;for<br/>future&#160;issuance&#160;under<br/>equity&#160;compensation<br/>plans&#160;(excluding<br/>securities&#160;reflected&#160;in<br/>column (a))<br/>(c)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by security holders&#160;(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,127,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by security holders</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,127,161&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,588,412&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes 2,958,017 shares that are issuable upon restricted stock units (RSUs), performance stock units (PSUs) and market stock units (MSUs) vesting. The remaining balance consists of outstanding stock option grants.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The weighted average exercise price does not take into account the shares issuable upon vesting of outstanding RSUs, PSUs and MSUs, which have no exercise price.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additional information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;13. Certain Relationships and Related Transactions and Director Independence</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;14. Principal Accounting Fees and Services</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to our Definitive Proxy Statement for our annual meeting of stockholders to be filed with the SEC within 120 days after the close of our fiscal year.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_94"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15. Exhibits and Financial Statement Schedules</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) The following documents are filed as part of this report:</span></div><div style="margin-top:9pt;text-align:justify;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Financial Statements</span></div><div style="margin-top:5pt;padding-left:81pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firm on Consolidated Financial Statements</span></div><div style="margin-top:5pt;padding-left:81pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Operations for the years ended September&#160;25, 2021, September&#160;26, 2020 and September&#160;28, 2019 </span></div><div style="margin-top:5pt;padding-left:81pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Comprehensive Income (Loss) for the years ended September&#160;25, 2021,&#160;September&#160;26, 2020 and September&#160;28, 2019 </span></div><div style="margin-top:5pt;padding-left:81pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets as of September&#160;25, 2021 and September&#160;26, 2020 </span></div><div style="margin-top:5pt;padding-left:81pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity for the years ended September&#160;25, 2021, September&#160;26, 2020 and September&#160;28, 2019 </span></div><div style="margin-top:5pt;padding-left:81pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows for the years ended September&#160;25, 2021, September&#160;26, 2020 and September&#160;28, 2019 </span></div><div style="margin-top:5pt;text-align:justify;text-indent:81pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Financial Statement Schedules</span></div><div style="margin-top:5pt;padding-left:81pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All schedules have been omitted because they are not required or because the required information is given in the Consolidated Financial Statements or Notes thereto.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Listing of Exhibits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312516793341/d299707dex21.htm">Asset Purchase Agreement, dated December 14, 2016, by and among Hologic, Inc., Grifols Diagnostic Solutions Inc. and Grifols, S.A.</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/15/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/859737/000119312519296652/d820369d8k.htm">Securities Purchase Agreement, dated as of November 20, 2019, by and among Hologic, Inc., Hologic Holdings Limited and Lotus Buyer, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/20/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000859737/000119312521110358/d75473dex21.htm">Share Purchase Agreement, dated as of April 8, 2021, by and among Hologic, Inc. and certain sellers listed therein</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">04/08/2021</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973717000023/holx_q4-2017xex31.htm">Certificate of Incorporation of Hologic, with amendments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/30/2017</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000019/exhibit31-hologicseventham.htm">Seventh Amended and Restated Bylaws of Hologic, Inc.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">06/25/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specimen Certificate for Shares of Hologic&#8217;s Common Stock (filed in paper format)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-A</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/31/1990</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520256460/d942100dex41.htm">Indenture, dated September 28, 2020, by and among Hologic, Inc., the guarantors party thereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex43-holxx2029notesxfirsts.htm">First Supplemental Indenture dated as of May 18, 2021 among Hologic, Inc., The Subsidiary Guarantor Party Hereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Filed herewith</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520256460/d942100dex41.htm">Form of 3.250% Senior Note due 2029 (included in Exhibit 4.2)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2020</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex44.htm">Indenture dated January 19, 2018, by and among Hologic, the Guarantors party thereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/19/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex43.htm">First Supplemental Indenture dated January</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex43.htm"> 19, 2018, by and among Hologic, the Guarantors party thereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/19/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex44.htm">Form of 4.625% Senior Note due 2028 (included in Exhibit 4.5)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/19/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex48-holxxsecondsupplement.htm">Second Supplemental Indenture dated as of November 9, 2018 among Hologic, Inc., The Subsidiary Guarantor Parties Hereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Filed Herewith</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex49-holxxthirdsupplementa.htm">Third</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex49-holxxthirdsupplementa.htm"> </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex49-holxxthirdsupplementa.htm">Supplemental Indenture dated as of January 8, 2019 among Hologic, Inc., the Subsidiary Guarantors Party Hereto and Wells Fargo Bank, National Association, as Trustee </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed Herewith</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex410-holxxfourthsupplemen.htm">Fourth</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex410-holxxfourthsupplemen.htm"> </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex410-holxxfourthsupplemen.htm">Supplemental Indenture dated as of March 14, 2019 among Hologic, Inc., The Subsidiary Guarantor Party Hereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed Herewith</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex411-holxx2028notesxfifth.htm">Fifth</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex411-holxx2028notesxfifth.htm"> </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex411-holxx2028notesxfifth.htm">Supplemental Indenture dated as of May 18, 2021 among Hologic, Inc., the Subsidiary Guarantor Party Hereto and Wells Fargo Bank, National Association, as Trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed Herewith</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex47.htm">Description of Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312512331837/d385376dex101.htm">The 2003 Incentive Award Plan of Gen-Probe Incorporated as amended and restated.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">08/02/2012</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513101083/d499702dex102.htm">Hologic Amended and Restated 2008 Equity Incentive Plan.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/15/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000027/exhibit102-formofnonxquali.htm">Form of Stock Option Award Agreement Under 2008 Equity Incentive Plan (adopted fiscal 2016).</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/14/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000064/exhibit104-fy17nonxqualifi.htm">Form of Stock Option Award Agreement Under 2008 Equity Incentive Plan (adopted fiscal 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/09/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000064/exhibit101-fy17psuawardagr.htm">Form of Restricted Stock Unit Award Agreement Under 2008 Equity Incentive Plan (adopted fiscal 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/09/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312519288355/d830662dex102.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (relative TSR) (adopted fiscal 2020).</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/08/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312519288355/d830662dex101.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (ROIC) (adopted fiscal 2020).</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/08/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312519288355/d830662dex103.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (Free Cash Flow) (adopted fiscal 2020).</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/08/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex102.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (relative TSR) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex101.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (ROIC) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex103.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex103.htm">(Free Cash Flow) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex104.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (ROIC &#8211; Outside US) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex105.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (relative TSR &#8211; Outside US) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520287973/d36462dex106.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (Free Cash Flow &#8211; Outside US) (adopted fiscal 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/06/2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312521320117/d420566dex102.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (relative TSR) (adopted fiscal 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/04/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312521320117/d420566dex101.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (ROIC) (adopted fiscal 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/04/2021</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312521320117/d420566dex103.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (Free Cash Flow) (adopted fiscal 2022). </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/04/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312521320117/d420566dex104.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (ROIC &#8211; Outside US) (adopted fiscal 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/04/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312521320117/d420566dex105.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (relative TSR &#8211; Outside US) (adopted fiscal 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/04/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312521320117/d420566dex106.htm">Form of Performance Stock Unit Award Agreement Under 2008 Equity Incentive Plan (Free Cash Flow &#8211; Outside US) (adopted fiscal 2022).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/04/2021</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513453681/d592931dex1018.htm">Form of Independent Director Restricted Stock Unit Award Agreement Under 2008 Equity Incentive Plan (annual grant).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2013</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000049/exhibit101-esppasamended.htm">Hologic, Inc. 2012 Employee Stock Purchase Plan, as amended</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/04/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000029/exhibit102short-termincent.htm">Hologic Short-Term Incentive Plan, as amended and restated</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/07/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000036/exhibit101-deferredequityp.htm">Hologic Amended and Restated Deferred Equity Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/16/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513453681/d592931dex1031.htm">Rabbi Trust Agreement.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312509047232/dex101.htm">Form of Indemnification Agreement (as executed with each director of Hologic).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/06/2009</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513466750/d640972dex101.htm">Employment Agreement dated December 6, 2013 by and between Stephen P. MacMillan and Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/09/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000023/exhibit103-amendedandresta.htm">Amended and Restated Employment Agreement by and between the Company and Stephen P. MacMillan, dated September 18, 2015.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/21/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1033.htm">Amendment No. 1 to Amended and Restated Employment Agreement by and between the Company and Stephen P. MacMillan, dated September&#160;24, 2016.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/17/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312520264729/d25481dex101.htm">Amendment No. 2 to Amended and Restated Employment Agreement by and between the Company and Stephen P. MacMillan, dated October 5, 2020.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/06/2020</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513466750/d640972dex103.htm">Form of Matching Restricted Stock Unit Award Agreement</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/09/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312513466750/d640972dex104.htm">Change of Control Agreement dated December 6, 2013 by and between Stephen P. MacMillan and Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/09/2013</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518233148/d585850dex101.htm">Severance and Change of Control Agreement dated July 31, 2018 by and between Karleen M. Oberton and Hologic, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">07/31/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973721000019/ex102-bebotransitionagreem.htm">Transition</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973721000019/ex102-bebotransitionagreem.htm"> Agreement </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973721000019/ex102-bebotransitionagreem.htm">by and between Allison </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973721000019/ex102-bebotransitionagreem.htm">P. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973721000019/ex102-bebotransitionagreem.htm">Bebo and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973721000019/ex102-bebotransitionagreem.htm">Hologic, Inc. dated July 2, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">07/28/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973715000010/holx_q2-2015xex102.htm">Severance and Change of Control Agreement dated February 2, 2015 by and between John M. Griffin and Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/28/2015</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973720000032/a8-kxthornalex101xcica.htm">Severance and Change of Control Agreement dated September 15, 2020 by and between Kevin R. Thornal and Hologic, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/15/2020</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973720000039/holxq4-2020ex1039.htm">Severance and Change of Control Agreement by and between Hologic, Inc. and Sean S. Daugherty, dated August 31, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/17/2020</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973721000006/ex101verstreken-ukcontract.htm">Amended Contract of Employment between Jan Verstreken and Hologic dated December 11, 2020</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/27/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973721000019/ex101-hellmanncic.htm">Severance and Change of Control Agreement dated June 28, 2021 by and between Elisabeth (Lisa) Hellmann and Hologic, Inc.</a></span></div><div><span><br/></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">07/28/2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/849778/000104746904002696/a2127335zex-10_17.txt">Office Lease dated December&#160;31, 2003 between Cytyc and Marlborough Campus Limited Partnership.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytyc<br/>Corporation<br/>10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2003</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973717000023/holx_q4-2017xex1052.htm">First Amendment to that Office Lease dated December&#160;31, 2003 between Cytyc and Marlborough Campus Limited Partnership, entered into August 23, 2017, by and between Hines Global REIT Marlborough Campus LLC and Hologic, Inc. (1)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/30/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312507253993/dex1045.htm">Lease Agreement by and between Zona Franca Coyol S.A. and Cytyc Surgical Products Costa Rica S.A. dated April 23, 2007.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/29/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1057.htm">Addendum 1 to Lease Agreement by and between Zona Franca Coyol S.A. and Cytyc Surgical Products Costa Rica S.A. dated July 22, 2007. (2) (3)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1058.htm">Addendum 2 to Lease Agreement by and between Zona Franca Coyol S.A. and Cytyc Surgical Products Costa Rica S.A. dated September 22, 2008. (2) (3)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973718000002/holx_q1-2018xex105.htm">Addendum No. 3 to Current Lease by and Between BCR Fondo de Inversion Inmobiliario and Hologic Surgical Products Costa Rica S.R.L. (1)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/30/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312507253993/dex1046.htm">Lease Agreement by and between 445 Simarano Drive, Marlborough LLC and Cytyc dated July 11, 2006.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/29/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000026/holxq4-2019ex1061.htm">First Amendment to Lease by and between 445 Simarano Drive Marlborough LLC and Hologic, Inc. dated July 14, 2016. (2)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/28/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex1048-creweroadwythenshaw.htm">Lease</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex1048-creweroadwythenshaw.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex1048-creweroadwythenshaw.htm">of land situate at Crewe Road, Wythenshawe in the City of Manchester between the Council of the City of Manchester and V.G. Instruments Group Limited dated February 8, 1988 (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex1048-creweroadwythenshaw.htm">2)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Filed Herewith</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517302740/d417723dex101.htm">Amended and Restated Credit and Guaranty Agreement, originally dated May 29, 2015, and amended and restated as of October 3, 2017 among Hologic, Hologic GGO 4 Ltd, each Designated Borrower from time to time party thereto, the Guarantors from time to time party thereto, each Lender from time to time party thereto and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/04/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518351385/d677404dex101.htm">Refinancing Amendment No. 1 dated as of December 17, 2018 to the Amended and Restated Credit and Guaranty Agreement dated as of October 3, 2017.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/18/2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312521284205/d233719dex101.htm">Refinancing Amendment No. 2, dated as of September 27, 2021, to the Amended and Restated Credit and Guaranty Agreement dated as of October 3, 2017, as amended.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/27/2021</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/820237/000093639207000824/a35067exv10w101.htm">Supply Agreement for Panther Instrument System effective November&#160;22, 2006 between Gen-Probe Incorporated and STRATEC Biomedical Systems AG. (1)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gen-Probe<br/>10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/30/2007</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1062.htm">Amendment No. 1 dated June 1, 2011 to Supply Agreement for Panther Instrument System. (1)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/24/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973716000071/holx_q4x2016xex1063.htm">Amendment No. 2 dated February 28, 2013 to Supply Agreement for Panther Instrument System. (1)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/24/2016</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517028258/d339131dex101.htm">Intellectual Property License, dated as of January 31, 2017, by and among Hologic, Inc., Gen-Probe Incorporated and Grifols Diagnostics Solutions Inc.</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/02/2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/859737/000085973719000013/holx_q2-2019xex101.htm">First Amendment, dated as of April 9, 2019, to Intellectual Property License, dated as of January 31, 2017, by and among Hologic, Inc., Gen-Probe Incorporated and Grifols Diagnostic Solutions.</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">05/01/2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.583%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated&#160; by<br/>Reference</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period&#160;End<br/>Date</span></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2021ex211.htm">Subsidiaries of Hologic.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2021ex231.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2021ex311.htm">Certification of Hologic&#8217;s CEO pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2021ex312.htm">Certification of Hologic&#8217;s CFO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2021ex321.htm">Certification of Hologic&#8217;s CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holxq4-2021ex322.htm">Certification of Hologic&#8217;s CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indicates management contract or compensatory plan, contract or arrangement.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Confidential treatment has been granted with respect to certain portions of this exhibit. A complete version of this</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;exhibit has been filed separately with the SEC.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain portions of this exhibit are considered confidential and have been omitted as permitted under SEC rules and regulations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;16. Form 10-K Summary</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_100"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:14pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:243.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:213.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HOLOGIC, INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;STEPHEN P. MACMILLAN&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: November&#160;16, 2021 </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-bottom:5pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:213.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:166.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:16.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:91.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;         STEPHEN P. MACMILLAN</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer (Principal Executive Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STEPHEN P. MACMILLAN&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;           KARLEEN M. OBERTON</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">KARLEEN M. OBERTON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;                BENJAMIN J. COHN</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Corporate Controller (Principal Accounting Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BENJAMIN J. COHN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;            SALLY W. CRAWFORD</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lead Independent Director<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SALLY W. CRAWFORD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;         CHARLES DOCKENDORFF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CHARLES DOCKENDORFF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;              SCOTT T. GARRETT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SCOTT T. GARRETT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;             LUDWIG N. HANTSON</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LUDWIG N. HANTSON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;                 NAMAL NAWANA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NAMAL NAWANA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;         CHRISTIANA STAMOULIS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CHRISTIANA STAMOULIS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/S/&#160;&#160;&#160;&#160;                AMY M. WENDELL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AMY M. WENDELL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_106"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Financial Statements</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Years ended September&#160;25, 2021,&#160;September&#160;26, 2020 and September&#160;28, 2019 </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_109">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_109">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_112">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_112">6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_115">Consolidated Statements of Comprehensive Income (Loss</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_115">7</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_118">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_118">8</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_121">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_121">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_124">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_124">10</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_127">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0c0cff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_127">11</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_109"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of Hologic, Inc.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of Hologic, Inc. (the Company) as of September 25, 2021 and September 26, 2020, the related consolidated statements of operations, comprehensive income (loss), stockholders&#8217; equity and cash flows for each of the three years in the period ended September 25, 2021, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at September 25, 2021 and September 26, 2020, and the results of its operations and its cash flows for each of the three years in the period ended September 25, 2021, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of September 25, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated November 16, 2021 expressed an unqualified opinion thereon.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Critical Audit Matters</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Income Taxes - Uncertain Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 9 to the consolidated financial statements, at September 25, 2021 the Company had $212.8 million in gross unrecognized tax benefits excluding interest. The Company is a party to many transactions in the ordinary course of business where the ultimate tax outcome is uncertain. To account for this uncertainty, the Company must determine whether each tax position&#8217;s technical merits are more-likely-than-not to be sustained in an audit by a taxing authority and then measure the amount of tax benefit that qualifies for recognition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Auditing the recognition and measurement of uncertain tax positions requires significant auditor judgment because the Company&#8217;s determination of whether a tax position&#8217;s technical merits are more-likely-than-not to be sustained in an audit is judgmental and is based on interpretations of tax laws and legal rulings. In addition, measuring the amount of tax benefit that qualifies for recognition for each uncertain tax position requires judgment in assessing the potential outcomes that could occur if a tax position undergoes an audit by a taxing authority. These judgments are reassessed each reporting period and can be affected by, among other things, changes in tax law, recent tax rulings, and changes in the status of ongoing tax audits.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s processes to assess and measure uncertain tax positions, including management&#8217;s controls to determine if a tax position&#8217;s technical merits are more-likely-than-not to be sustained in an audit and, if so, measure the amount of tax benefit that qualifies for recognition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To test the Company&#8217;s assessment and measurement of uncertain tax positions, we involved our tax professionals to assess whether the uncertain tax positions identified by the Company are more-likely-than-not to be sustained upon audit and if so, to assist in testing the assumptions made by the Company in measuring the amount of tax benefit that qualifies for recognition. Our procedures included, among others, assessing the Company&#8217;s correspondence with the relevant tax authorities and evaluating income tax opinions or other third-party advice obtained by the Company. We also used our knowledge of, and experience with, the application of domestic and international income tax laws by the relevant income tax authorities to evaluate the Company&#8217;s assessments of whether the uncertain tax position is more-likely-than-not to be sustained and if so, the potential outcomes that could occur upon an audit by a taxing authority. We tested the completeness and accuracy of the data and calculations used to determine the amount of tax benefit to recognize. We also compared the Company&#8217;s income tax disclosures included in Note 9 to the consolidated financial statements to disclosures required by the relevant accounting guidance.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Product Revenue Recognition</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 3 to the consolidated financial statements, the Company generates product revenue from the sale of medical imaging systems, diagnostic and surgical disposable products. The Company&#8217;s contracts for capital equipment sales generally have multiple performance obligations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing the timing and amount of revenue recognized for product sales required significant auditor judgment because it involves several subjective management assumptions and estimates including the identification of performance obligations within the contracts, the estimation of the standalone selling price of each performance obligation, the determination of the transaction price and the allocation of the transaction price to each performance obligation, and a determination of the point in time at which those performance obligations were satisfied.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s processes to account for product revenue recognition, including management&#8217;s controls over determining the transaction price, the identification of performance obligations in revenue contracts, the estimation of the standalone selling price for each performance obligation, the allocation of the transaction price to each performance obligation, and the determination of the point in time at which the Company transferred control of the promised items to the customer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test product revenue, we evaluated whether management&#8217;s revenue recognition policies are appropriate and in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. We tested management&#8217;s determination of the transaction price by comparing the price to the customer contract for a sample of transactions. We tested management&#8217;s identification of the performance obligations and the allocation of transaction price to each performance obligation by performing an independent assessment, in comparison to the standard, on a sample of customer contracts. We tested management&#8217;s estimated standalone selling prices for its identified performance obligations based on actual prices charged for similar products and services sold on a standalone basis. We also tested management&#8217;s assertion that control was transferred to the customer by inspecting documentation supporting the transfer of control for a sample of contracts. In addition, we performed other procedures which included, among others, analytical procedures over product revenue and testing a sample of revenue transactions that occurred near the end of the fiscal year to evaluate accounting cut-off. We also compared the Company&#8217;s revenue recognition disclosures included in Note 3 to the consolidated financial statements to disclosures required by the relevant accounting guidance.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Business Combinations</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 5 to the consolidated financial statements, during 2021, the Company completed several business combinations for total consideration of $1,178.9 million. The most significant of these were the acquisition of all the outstanding equity of (1) Mobidiag Oy for total consideration of $729.6 million, (2) Biotheranostics, Inc. for total consideration of $231.3 million, and (3) Diagenode SA for total consideration of $155.1 million. These business combinations resulted in the recognition of intangible assets of $681.4 million. As of September 25, 2021, the Company also recorded within accrued expenses and other long-term liabilities a contingent consideration liability of $75.1 million related to an acquisition completed in 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing the Company&#8217;s accounting for business combinations was complex due to the significant estimation required by management to determine the fair value of identified intangible assets, which principally consisted of developed technology related to currently marketed products and an in process research and development (&#8220;IPR&amp;D&#8221;) asset, totaling $627.1 million and to determine the fair value of the contingent consideration liability. The Company used an income approach to measure the fair value of the acquired developed technology and IPR&amp;D related intangible assets, and a Monte Carlo simulation model to value the contingent consideration liability. The significant assumptions used to estimate the fair value of these intangible assets and the contingent consideration liability included discount rates and certain assumptions that form the basis of the forecasted results, specifically revenue growth rates. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We obtained an understanding, evaluated the design and tested the operating effectiveness of the controls over the Company&#8217;s accounting for business combinations. For example, we tested controls over the identification and valuation of intangible assets and measurement of the contingent consideration liability, including the valuation models and underlying assumptions used to develop such estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To test the estimated fair value of the developed technology and IPR&amp;D assets and the contingent consideration liability, we performed audit procedures that included, among others, evaluating the Company's use of the different valuation models for each estimate and testing the significant assumptions described above that were used in the models. We tested the completeness and accuracy of the underlying data used in each analysis. For example, to evaluate revenue growth rates, we compared the assumptions used to current industry, market and economic trends, to the historical results of the acquired businesses, and to other guideline companies within the same industry. We also performed sensitivity analyses over the significant assumptions used to evaluate the changes in the fair value of each estimate that would result from changes in the assumptions. We involved our valuation professionals to test the models and the significant assumptions noted above. We also compared the Company&#8217;s disclosures included in Note 5 to the consolidated financial statements to disclosures required by the relevant accounting guidance.</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ernst&#160;&amp; Young LLP</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2002.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston, Massachusetts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.134%"><tr><td style="width:1.0%"></td><td style="width:52.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.497%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.497%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5585ae25a954d67a9e131196d3a358a_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMtMi0xLTEtMA_f32c8848-713f-4d9a-a274-9abfc35f7316">4,967.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb9457cf546c4165b579b1ec171ac91f_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMtNC0xLTEtMA_32c9ddf7-51ff-46f0-b79c-4351753bad09">3,227.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71201bb972ba45a28e50f67d16e6e9a6_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMtNi0xLTEtMA_19ec8ad9-50ed-41f1-bcfc-b241fe4044b7">2,771.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0068fc5d5747a882ce9ccbd0123f38_D20200927-20210925" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQtMi0xLTEtMA_d57f38e8-3d05-4db2-b13b-6d2eb761693b">665.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88ee1f21a1904304a5934d3026a42b57_D20190929-20200926" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQtNC0xLTEtMA_b2947dc1-fb2b-4af5-ad05-c36ec76e19a8">549.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8b9b630f904fd0b483af12525ec51f_D20180930-20190928" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQtNi0xLTEtMA_c8dd914b-ecc8-4686-9923-27cb7e04c4bc">596.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzUtMi0xLTEtMA_55f1dfbc-7d60-49c8-9f17-4e3bc5f46d5c">5,632.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzUtNC0xLTEtMA_4c13d7e1-8ac0-4744-8f2a-5bb29ba924e7">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzUtNi0xLTEtMA_ca40360f-c7b7-42fd-b25e-11ad5ddb9c9a">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5585ae25a954d67a9e131196d3a358a_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzctMi0xLTEtMA_6d5d2df6-65e4-45ce-831c-b591f2d3e9f0">1,205.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb9457cf546c4165b579b1ec171ac91f_D20190929-20200926" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzctNC0xLTEtMA_5c040142-1a77-48fe-9919-e5cbb66be969">953.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71201bb972ba45a28e50f67d16e6e9a6_D20180930-20190928" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzctNi0xLTEtMA_286aa6f1-068b-4cf6-b358-218dedcd504a">948.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzgtMi0xLTEtMA_55c16596-7c06-41af-b5d2-b99397768a48">276.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzgtNC0xLTEtMA_2c34199b-ab03-4553-a737-936cf974af5c">253.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzgtNi0xLTEtMA_008ba73d-717e-465c-a85d-66dac3cb61f8">318.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzktMi0xLTEtMA_02efa159-f212-4a47-912c-1673c6c1dfad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzktNC0xLTEtMA_50d2c76c-33a5-40fd-911a-b41f906478b3">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzktNi0xLTEtMA_ff135347-fa70-4546-baca-f61c5659ef6b">578.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0068fc5d5747a882ce9ccbd0123f38_D20200927-20210925" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEwLTItMS0xLTA_50d2d232-59ff-4c2b-adf7-645d7b26d5a4">354.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88ee1f21a1904304a5934d3026a42b57_D20190929-20200926" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEwLTQtMS0xLTA_304cdf36-c2b5-4f14-adbf-22be1c2fe4b3">316.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8b9b630f904fd0b483af12525ec51f_D20180930-20190928" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEwLTYtMS0xLTA_420090b4-6df2-4157-8da1-80558fb91505">350.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzExLTItMS0xLTA_6a7f1cd3-54cf-4ed8-a578-97862c9b86dd">3,795.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzExLTQtMS0xLTA_3d931c65-95a5-46f0-8115-a5d9ef742ffc">2,227.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzExLTYtMS0xLTA_20c03db1-6fe3-476a-b006-a37fa206e40d">1,170.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEzLTItMS0xLTA_f08077e0-45b9-42bc-ba22-5d197eae3f12">276.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEzLTQtMS0xLTA_7b7764e2-6f63-4fd9-bc54-daf6d370c7cb">222.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEzLTYtMS0xLTA_3599e61c-94e9-445a-91c4-fa36ba2a6cff">232.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE0LTItMS0xLTA_465cb7bb-7234-42ca-a4cf-d1ce176c4099">561.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE0LTQtMS0xLTA_1e6eaed4-0fa3-4c34-87cb-ff292a75f0ea">484.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE0LTYtMS0xLTA_5830c18c-fe10-423d-a79d-76d7335ea537">564.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE1LTItMS0xLTA_5eb1b5d1-b122-4187-9dc8-43c0347374aa">433.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE1LTQtMS0xLTA_5a1895ca-e01d-44fb-9f24-11f8ca587606">355.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE1LTYtMS0xLTA_82aceb95-48bb-46b0-93bb-11a885112ab4">332.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE2LTItMS0xLTA_38637a5d-312e-4d5e-abf8-9400f6e824e8">42.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE2LTQtMS0xLTA_e346e610-9937-4973-ad9a-0c77024d4bd2">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE2LTYtMS0xLTA_dfcbcb51-e0cb-4d70-8ce1-704f4cd60735">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE3LTItMS0xLTA_eaab701c-fc39-414a-8ab4-cd39917e9156">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE3LTQtMS0xLTA_8b49e1bd-23a1-4e48-9e7e-2fa48a256008">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE3LTYtMS0xLTA_0a182627-923c-403b-af4e-f425138feee1">106.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration &#8211; fair value adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE5LTItMS0xLTA_8d3243aa-1c0c-446f-a7c7-1f43cfc4ed63">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE5LTQtMS0xLTA_e6bfb57a-b589-421c-825a-307909c6b14b">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE5LTYtMS0xLTA_f150e1e4-a225-461d-bf66-27f2bf631191">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and divestiture charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI0LTItMS0xLTA_f5e0029c-c95b-4557-812e-93e7475ea1a0">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI0LTQtMS0xLTA_0decb07c-6db9-47ad-9290-77cea236e6af">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI0LTYtMS0xLTA_6e8a0cba-7b17-4353-9d1c-038ac6f80c88">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI1LTItMS0xLTA_f77a5998-ab04-4336-b945-345ab333354d">1,315.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI1LTQtMS0xLTA_da7c0cb5-0a58-4755-9288-cb98af8fbf00">1,122.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI1LTYtMS0xLTA_99301ae5-1b46-40c7-8344-40c65f32ab5d">1,294.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI2LTItMS0xLTA_82f7a404-309a-4e6b-aaab-cf7ca53c89ee">2,480.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI2LTQtMS0xLTA_699565e6-965a-4b37-8866-af6a4d24ce23">1,105.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI2LTYtMS0xLTA_24491850-2887-4d47-8625-5bf603c59ab6">123.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI3LTItMS0xLTA_8e1aebf8-8709-4950-9b6c-0d741da553b8">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI3LTQtMS0xLTA_f5b2abe0-9d6f-4030-9160-639c8a47e8c8">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI3LTYtMS0xLTA_05515100-967e-4fa4-bb80-829e45fe1404">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI4LTItMS0xLTA_cd3ba7a8-c2d0-4d04-b99f-0f2b7cc45195">93.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI4LTQtMS0xLTA_6389d4c2-f928-472c-94f4-d74ed01da87a">116.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI4LTYtMS0xLTA_7a44d98e-1baa-415a-9636-4b6df1994a66">140.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI5LTItMS0xLTA_de9aa226-e857-4979-909d-ef6b5eeef045">21.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI5LTQtMS0xLTA_813e2778-6ca2-4253-af12-05aa997b1795">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI5LTYtMS0xLTA_62428596-b180-469e-a1d4-a9a652aad524">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMwLTItMS0xLTA_7fd7cf16-074d-4662-99d3-8d6521707fee">5.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMwLTQtMS0xLTA_30b65abb-9f38-4826-94f9-e1a18447cbc9">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMwLTYtMS0xLTA_8a8e09ff-6b88-49f6-a88d-2750b4ae7dfa">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMxLTItMS0xLTA_356e08df-a365-4c20-b506-3d380fca7bff">2,361.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMxLTQtMS0xLTA_797e4e0b-87c5-4f2a-857c-406372be34c5">1,001.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMxLTYtMS0xLTA_802ffcde-461b-4462-b440-be294c57ae7d">257.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMyLTItMS0xLTA_7c4740ce-3537-4760-b45a-7f588881c2ec">491.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMyLTQtMS0xLTA_ff9cace7-481e-4ef4-8420-bd22eb9f889b">108.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMyLTYtMS0xLTA_8c5f2516-f455-4b98-9767-b10f8e449e63">54.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMzLTItMS0xLTA_1dcf447a-194b-490e-9cff-ab1a27b06554">1,869.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMzLTQtMS0xLTA_3473b0b5-b5d0-4803-8cb2-6b2004c8da47">1,110.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMzLTYtMS0xLTA_483f3bae-e9f9-4d92-8769-fe3cc6dbbdd4">203.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM0LTItMS0xLTA_b2b27795-5f3e-45a2-b339-09a6f14bb5bc">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM0LTQtMS0xLTA_e6d465f3-f8cc-4c62-bb07-25d030569e0d">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM0LTYtMS0xLTA_af850368-1881-46c2-a359-6ba1f09e11b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Hologic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM1LTItMS0xLTA_fa824cb7-f26a-418c-8a0d-fbcdc0be6795">1,871.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM1LTQtMS0xLTA_b4fdecf7-e31c-42d7-8a3d-b4db78674101">1,115.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM1LTYtMS0xLTA_46f9b5cd-0de8-4b1a-bd7c-5b11700b5a13">203.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per common share attributable to Hologic:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM3LTItMS0xLTA_af580723-9ba6-4e17-bf7f-572e5fddd2b7">7.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM3LTQtMS0xLTA_51162ee5-7d21-4fa0-acc7-283847f19b86">4.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM3LTYtMS0xLTA_7ccf75ff-0029-4fec-a8e0-3dd68c0f6e26">0.76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM4LTItMS0xLTA_20b575ef-3f4e-4177-bd96-b3cea7907734">7.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM4LTQtMS0xLTA_0325c60f-07d5-4b11-9c3f-b8c52e834862">4.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM4LTYtMS0xLTA_fb5b7624-1b2b-48a8-b207-afbbbddf6b4c">0.76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQwLTItMS0xLTA_282a886b-ec7c-41a8-b990-b5726498dc9f">257,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQwLTQtMS0xLTA_57a0f7ac-9918-438c-8fbf-ebe538f0ab46">262,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQwLTYtMS0xLTA_ff5da366-6717-4d2b-8625-604cb9c8136a">269,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQxLTItMS0xLTA_eab60768-250a-46b8-a615-050cd77284f2">259,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQxLTQtMS0xLTA_b204b688-4000-4bc1-a058-372a097d4f51">264,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQxLTYtMS0xLTA_d4ce6d85-eea7-4b15-8f80-d4487e4a3aa8">269,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income (Loss)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.426%"><tr><td style="width:1.0%"></td><td style="width:53.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.448%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzItMi0xLTEtMA_3b35fe5e-e164-420a-8df8-7061a91babbc">1,869.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzItNC0xLTEtMA_12494bb9-ebe0-40c2-bfd4-5f6e34bc503d">1,110.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzItNi0xLTEtMA_8fafcbaa-8ca6-4aec-8e9e-97414edc82a2">203.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzMtMi0xLTEtMA_5534fe0c-d0a1-4866-95d8-99a2033f7bb3">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzMtNC0xLTEtMA_98cc7d84-f079-4f5d-b12f-1c0fe1a222bd">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzMtNi0xLTEtMA_e86d1a6a-394d-49b2-a4de-b2c2a3572e69">14.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in pension plans, net of taxes of $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctMC0xLTEtMC90ZXh0cmVnaW9uOjhhNmExMTZiMjAyNzQ0M2NiOTQxMGQ3NWYwZGY2MmYyXzQ2_dd09c741-542a-4c77-be0c-082befeef9e8">0.2</ix:nonFraction> in 2021, $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctMC0xLTEtMC90ZXh0cmVnaW9uOjhhNmExMTZiMjAyNzQ0M2NiOTQxMGQ3NWYwZGY2MmYyXzU4_19534b2c-f7e4-4537-bc9a-467c0740e742">0.1</ix:nonFraction> in 2020, and $<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctMC0xLTEtMC90ZXh0cmVnaW9uOjhhNmExMTZiMjAyNzQ0M2NiOTQxMGQ3NWYwZGY2MmYyXzc0_1bb16f0f-3653-4ab9-a15c-82e27fd52fd2">0.3</ix:nonFraction> in 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctMi0xLTEtMA_273632e6-2dd3-46d8-9b09-0f950aa04bc5">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctNC0xLTEtMA_071b53ee-74d2-4458-b6c7-c860a90b7f68">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctNi0xLTEtMA_99241978-b2cf-4e2b-9a08-9bce4dabeb3e">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) gain recognized, net of tax of $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:TaxOnInterestRateSwap" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmZkOWQ3OWM4NjA3YTQ2YWM5ZDA4MWQ5Y2NhYWU1MGQ1XzQy_0bd248be-697c-4ca6-b6cd-c0ad896ac716">2.5</ix:nonFraction> million in 2021 $(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="holx:TaxOnInterestRateSwap" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmZkOWQ3OWM4NjA3YTQ2YWM5ZDA4MWQ5Y2NhYWU1MGQ1XzY1_dd9d2d4c-09de-4b95-9a43-01df0a062ae1">8.3</ix:nonFraction>) million in 2020, and $<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:TaxOnInterestRateSwap" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmZkOWQ3OWM4NjA3YTQ2YWM5ZDA4MWQ5Y2NhYWU1MGQ1XzEwOTk1MTE2Mjc5NTE_cc1f960c-d1c7-4cff-9609-734744eb1781">1.2</ix:nonFraction> million in 2019 for interest rate swaps</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtMi0xLTEtMA_d3a70c1c-d642-4d59-8467-a505dc4b35a3">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtNC0xLTEtMA_459d6a76-4d42-4097-b837-08c7132ad178">27.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3278f0ce96b40519a22ae965c771b3f_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtNi0xLTEtMA_b404e3a7-a177-41bb-a136-3836e5c82c34">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in value of hedged interest rate caps, net of tax of $<ix:nonFraction unitRef="usd" contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzktMC0xLTEtMC90ZXh0cmVnaW9uOmFlMTkxMTc1MmFmYjQyM2ZiOTc1NmU0MGJlZjcxYmYyXzY1_1c053598-cd98-42e6-9408-500c8839b054">0.2</ix:nonFraction> in 2021, $<ix:nonFraction unitRef="usd" contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzktMC0xLTEtMC90ZXh0cmVnaW9uOmFlMTkxMTc1MmFmYjQyM2ZiOTc1NmU0MGJlZjcxYmYyXzc3_4620fc9c-c6bb-48d7-8185-cfd55487392f">0.5</ix:nonFraction> in 2020, and $<ix:nonFraction unitRef="usd" contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzktMC0xLTEtMC90ZXh0cmVnaW9uOmFlMTkxMTc1MmFmYjQyM2ZiOTc1NmU0MGJlZjcxYmYyXzkz_cc4a64d1-218c-4861-ad7e-8f2655def429">1.1</ix:nonFraction> in 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Loss recognized in other comprehensive income    <br/>&#160;&#160;&#160;&#160;&#160;&#160;&#160;(loss), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEwLTItMS0xLTA_0cffaae0-9153-435a-a475-b06cefcea76a">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEwLTQtMS0xLTA_363eada0-1e4b-4fdf-b583-cf0ba43c61f5">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEwLTYtMS0xLTA_570b357c-0d49-4420-962e-4091957f0918">8.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Loss reclassified from accumulated other    <br/>&#160;&#160;&#160;&#160;&#160;&#160;comprehensive loss to the statement of operations, <br/>&#160;&#160;&#160;&#160;&#160;&#160;net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzExLTItMS0xLTA_041e9544-954a-4ff8-bf1e-f0f6438ae81e">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzExLTQtMS0xLTA_21bc88b1-3c0d-4619-9f48-b97377539e9e">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzExLTYtMS0xLTA_a46c8e5d-fa6a-4c87-817e-2a0893faeaad">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEyLTItMS0xLTA_439ded84-52ea-4f9a-a664-0d606aba3f3a">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEyLTQtMS0xLTA_98846f1c-909a-4565-bb5e-9df18954613c">7.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEyLTYtMS0xLTA_bac0b1a6-2099-4235-9512-572e6744b5c6">16.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEzLTItMS0xLTA_f89ae462-dece-4c5e-be9a-ca8febce151a">1,860.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEzLTQtMS0xLTA_05867af2-8789-429b-bde4-986b3a901f24">1,103.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEzLTYtMS0xLTA_5bf16581-c267-48cf-9dd5-6e7f67d97ac4">220.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of comprehensive income (loss) attributable to noncontrolling interest:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE1LTItMS0xLTA_e4907b21-f5a1-45cd-be18-18a511f38085">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE1LTQtMS0xLTA_61a2684a-64ea-40ad-b48c-1d8cd9348125">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE1LTYtMS0xLTA_af850368-1881-46c2-a359-6ba1f09e11b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE2LTItMS0xLTA_62ac35ff-1e92-4911-bd4d-560f0c3a29df">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE2LTQtMS0xLTA_9c4ee89c-1a87-4529-8228-9077bc509a55">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE2LTYtMS0xLTA_96934125-9670-4f15-993f-95461d44c879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss) attributable to Hologic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE3LTItMS0xLTA_1d03207e-02ea-42c6-8f65-7b9201f00155">1,862.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE3LTQtMS0xLTA_9e7fd85a-d301-4b47-bb09-6189b2ff760f">1,107.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE3LTYtMS0xLTA_f141cbcb-5076-44fa-8c08-96f62c2352ff">220.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and par value)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMtMS0xLTEtMA_1dbc7463-132c-4e9e-ae95-f6fc959c899a">1,170.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMtMy0xLTEtMA_961e8e1c-1297-4fae-837c-5632367c7a4c">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzUtMS0xLTEtMA_87a0cbd7-b9c8-4129-aefc-53fc2dd113ad">942.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzUtMy0xLTEtMA_fd33931f-c701-4a2f-ac18-75850b835708">1,028.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzYtMS0xLTEtMA_f85f8170-ebdc-49e6-bbd2-e11396f8ca63">501.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzYtMy0xLTEtMA_306faacb-ffa6-435d-a6ff-e89eac4ace8a">395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzgtMS0xLTEtMA_1b59ed51-fdfa-4dcc-b743-c0b8a9dd741b">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzgtMy0xLTEtMA_3a61912e-8eb6-4019-b2cf-db350e1f7c01">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzktMS0xLTEtMA_0198630a-2687-40ef-ad0c-101bffae2f92">528.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzktMy0xLTEtMA_9a0ea386-7800-4ae3-8bb1-5c455451afce">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzExLTEtMS0xLTA_6facea3f-3f16-47e7-93b0-8a871727ce74">3,168.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzExLTMtMS0xLTA_3e604866-0767-4191-946c-8d18b48d4b9c">2,222.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzEyLTEtMS0xLTA_bffef25e-5819-44fe-9049-9217a51ce396">564.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzEyLTMtMS0xLTA_87143de2-9b92-4e29-a9da-b21d0f4b72d0">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzEzLTEtMS0xLTA_5e77717b-02bc-4078-9f88-bd15cccbf7a4">1,659.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzEzLTMtMS0xLTA_7c903662-4641-4d09-bcf3-f47c242ac61d">1,307.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE0LTEtMS0xLTA_b3c05b64-f070-4eef-8e9d-96f5e49daebb">3,281.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE0LTMtMS0xLTA_7bd56083-07c6-4acd-983b-0cfc09c277c1">2,657.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE1LTEtMS0xLTA_e5515425-9731-4bb8-9a50-3de6cd46be9b">245.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE1LTMtMS0xLTA_46b4de41-84e7-4278-9c22-0af2443ef579">516.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE2LTEtMS0xLTA_2e3a48ab-9dba-4da2-8b6b-f782bd4d534d">8,919.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE2LTMtMS0xLTA_9f40f6e5-0703-4219-b413-08626a5c1dcd">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE5LTEtMS0xLTA_554167f1-4836-4952-a629-3f7831d0959d">313.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE5LTMtMS0xLTA_9ad95b57-f8c4-4069-a581-222598b56d79">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIwLTEtMS0xLTA_194868c0-c936-47d3-acd5-2ba9f75e20a9">215.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIwLTMtMS0xLTA_b40e97fa-741a-4510-97ae-b1ad9a2790fe">178.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIxLTEtMS0xLTA_d18a884e-bd27-4336-9191-ec389d09c7fb">596.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIxLTMtMS0xLTA_f368794c-e669-4e42-934e-2de8480e861e">547.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIyLTEtMS0xLTA_711eff5b-b333-4b67-b0d0-e93e6fdf9017">198.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIyLTMtMS0xLTA_2e333a6f-3d96-4094-b572-abbb8b6d45d2">186.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations<br/></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI0LTEtMS0xLTA_5e5708f6-1f80-4e23-b395-3b134b291b3d">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI0LTMtMS0xLTA_871e1d91-e7e1-44a9-aec3-0f2d645396e5">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI1LTEtMS0xLTA_92025596-72c2-4d19-a203-0f97d0a3342e">1,326.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI1LTMtMS0xLTA_119eccc9-bf09-4a9d-a466-dc235748e427">1,239.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI2LTEtMS0xLTA_f8a7e9d4-7383-42a0-81cd-15ba796be8ef">2,712.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI2LTMtMS0xLTA_3861c576-4108-4968-84c2-2e734e756b94">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI3LTEtMS0xLTA_bac99511-450f-478c-8d28-a5b267e7e371">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI3LTMtMS0xLTA_9340faa2-8418-4f92-be5a-211865783a31">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI4LTEtMS0xLTA_31db819e-451e-4d55-81ce-c1961074ba43">250.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI4LTMtMS0xLTA_c31bfe6f-3f69-4526-b319-eab355058da0">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI5LTEtMS0xLTA_c0209f57-2fa5-4fb0-8cf9-35d827b9a717">20.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI5LTMtMS0xLTA_3b944593-2fce-45fe-8331-000013052ab5">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMwLTEtMS0xLTA_bf003fad-ec27-4a10-b898-1e5ab8ebb572">368.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMwLTMtMS0xLTA_c13b3d02-497d-4dc1-aa45-078ad630a4c2">303.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 13 and 14)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMxLTEtMS0xLTA_61539d76-2a94-4aa7-8dba-6ed1c8b2cb51"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMxLTMtMS0xLTA_3b77f3d6-a2cf-4f6c-8489-51223c32d214"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY18yMQ_5572bf94-f079-4309-bfeb-9785b594fdee"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY18yMQ_807c4fb0-794a-43de-9825-af457c6af98b">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY18zNg_2864592d-4b76-4145-8f19-b31568eabdbe"><ix:nonFraction unitRef="shares" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY18zNg_a3dbe6c1-7a47-4b61-9adc-7cef15074d94">1,623</ix:nonFraction></ix:nonFraction> shares autho</span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">rized; <ix:nonFraction unitRef="shares" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY181OA_9300666a-c582-4eb6-b98a-95cdc5491066"><ix:nonFraction unitRef="shares" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY181OA_e7b1173d-be4f-4456-abca-6b5ca695cd78">0</ix:nonFraction></ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shares issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTEtMS0xLTA_9e05e380-140e-40b4-827a-a584f6f1b343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTMtMS0xLTA_54e8f4bb-d01f-4533-a7bd-0f22c4c4ddf8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF8xOA_4beb7a66-b198-4e28-b284-b9f52958ab23"><ix:nonFraction unitRef="usdPerShare" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF8xOA_cf4be3c2-aba5-491d-bfab-06d4e64919d2">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF8zMw_7f7a011c-cdd6-4c7f-b171-e873952a5b77"><ix:nonFraction unitRef="shares" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF8zMw_eb6005b2-f2b6-45d5-9029-9c279033ee98">750,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF81NQ_55ef8cb3-43f1-4b8e-83d7-5200f6a427ef">297,306</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF82Mg_a70968de-0a73-41da-a4eb-57bfdbbb3773">295,107</ix:nonFraction> shares issued, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTEtMS0xLTA_9ea875e8-eb84-4b0a-8f5b-3a4ac59a15cd">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTMtMS0xLTA_09e2dabe-17c0-4409-8772-ca0534f3dc6d">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM1LTEtMS0xLTA_ebf8af37-191d-472e-ac69-962e4986bbe3">5,965.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM1LTMtMS0xLTA_dd075f39-2031-400a-be9a-91bb4d6de05f">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated earnings (deficit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM2LTEtMS0xLTA_b0fa96e2-66f2-4705-bbfd-3dc46251de46">298.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM2LTMtMS0xLTA_a44d297c-86c5-499e-8ef2-9c49a0bf69cb">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost &#8211; <ix:nonFraction unitRef="shares" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpjODg5M2Q4ZjMzYTg0N2E1OWVmYjlkOWI5OThjMGZmY18zMA_ebfbda9f-2b60-4ee3-97fe-eaa196dcb207">43,653</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpjODg5M2Q4ZjMzYTg0N2E1OWVmYjlkOWI5OThjMGZmY18zNw_4fc5b4dc-5f38-49be-8ddd-6cfddfe1bcdf">37,609</ix:nonFraction> shares, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM3LTEtMS0xLTA_1c82f114-af93-4cb5-9cc3-e877223fb95c">1,989.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM3LTMtMS0xLTA_ecae1f30-4a1d-4807-9abd-7887020bb156">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM4LTEtMS0xLTA_c34bb332-535a-435f-810e-bdfbbbf5dfa1">59.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM4LTMtMS0xLTA_69e44eb3-5110-4b1b-ba03-27f8e1354fe2">49.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Hologic's stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM5LTEtMS0xLTA_33355bfa-1f88-4366-8c5d-c33480b6a3e1">4,218.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM5LTMtMS0xLTA_a1f7bb19-efb5-45f5-8316-f3fa2ee46ab6">2,705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQwLTEtMS0xLTA_3258db38-f0b0-4e99-8448-0466b8b97847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQwLTMtMS0xLTA_5a0af313-f9a1-49e2-be33-72df4cf7d5ad">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQxLTEtMS0xLTA_1f88c947-cb36-498c-94a4-7797e372f9f6">4,218.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQxLTMtMS0xLTA_27e77cfa-7550-4631-bcd2-a0f6e1560770">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQyLTEtMS0xLTA_0f2b5d9c-a96a-4a4e-bf19-8f8d9c75f902">8,919.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQyLTMtMS0xLTA_d5a87e02-b6a3-4dc1-877a-735528ca61a0">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.833%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.908%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in-<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Earnings (Deficit)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par&#160;<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 29, 2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia927c77ddd4b4c3f9e25433620cafd9a_I20180929" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTItMS0xLTA_ab49954d-dea9-458d-8045-2e4605cd62dd">289,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia927c77ddd4b4c3f9e25433620cafd9a_I20180929" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTQtMS0xLTA_56db00a1-41f0-49d2-84cb-a616159677dc">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f8eca055a24f3ba805ccce80af7729_I20180929" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTYtMS0xLTA_e87af301-5407-4538-90c5-8a9b48bd0971">5,671.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic258825922e845e48ae770d90cf914bf_I20180929" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTgtMS0xLTA_a2cbd919-e828-4117-b910-177ed92a7abe">2,494.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i684e08be393948ad91d177dd16acf8c5_I20180929" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTEwLTEtMS0w_2c65af54-d7e2-48e2-9766-16c9e9bb33fa">25.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7511415f2519453297890d5928acc96d_I20180929" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTEyLTEtMS0w_1f571271-2ed0-4fc8-b15e-45e3182dd3c9">19,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7511415f2519453297890d5928acc96d_I20180929" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTE0LTEtMS0w_a13766f1-4e46-4056-944b-0d20562e0d89">725.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5428b64a6a64d48acae1ca5892619ff_I20180929" decimals="-5" format="ixt:fixed-zero" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTE4LTEtMS0w_c084af84-cef4-4bb9-83a0-59539cc1630d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTIwLTEtMS0w_64db766c-e525-4912-8d97-b62f59cd0442">2,428.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting standard transition adjustment - ASC 606</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330e64f51bae41568645cc62f16c3c3c_D20180930-20190928" decimals="-5" sign="-" name="holx:AccountingstandardtransitionadjustmentASC606" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE4LTgtMS0xLTA_f958115e-c6e6-4228-b69a-cc35de9f449a">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="holx:AccountingstandardtransitionadjustmentASC606" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE4LTIwLTEtMS0w_0ec5ccbd-f529-4dfa-9e2f-993c7ae80a0d">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting standard transition adjustment - ASU 2016-16</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330e64f51bae41568645cc62f16c3c3c_D20180930-20190928" decimals="-5" sign="-" name="holx:AccountingstandardtransitionadjustmentASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE5LTgtMS0xLTA_481bde5d-7e36-426c-b254-8deafe854c9f">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="holx:AccountingstandardtransitionadjustmentASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE5LTIwLTEtMS0w_4f8680fe-74c8-4d08-8523-efa04a7b0b06">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4332687a95c44e4381175f1e41bb50d2_D20180930-20190928" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIwLTItMS0xLTA_710babab-3b62-4416-9f87-f3e7ff72843b">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide57006743114d5bbe3750f80d39e212_D20180930-20190928" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIwLTYtMS0xLTA_9dd414ea-ff71-4743-9ae6-a1f070eec94b">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIwLTIwLTEtMS0w_2b37acad-341c-4ba7-a0b2-a7c1e798ea8b">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4332687a95c44e4381175f1e41bb50d2_D20180930-20190928" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIxLTItMS0xLTA_544c9836-706a-4b01-9842-54331bc34b74">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide57006743114d5bbe3750f80d39e212_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIxLTYtMS0xLTA_e14e01a6-5c3b-4e52-8a9f-09f3186b82e2">12.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIxLTIwLTEtMS0w_bff5d188-4180-49a5-b9b7-24368e153caa">12.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4332687a95c44e4381175f1e41bb50d2_D20180930-20190928" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIyLTItMS0xLTA_3e43194c-01ca-4c58-85fc-9165fa6dc8e8">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide57006743114d5bbe3750f80d39e212_D20180930-20190928" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIyLTYtMS0xLTA_0856378c-a01e-40ac-937b-3d93dc514d09">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIyLTIwLTEtMS0w_eec6dc6d-f72e-4ea5-93d4-93bbd6e68c0c">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide57006743114d5bbe3750f80d39e212_D20180930-20190928" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIzLTYtMS0xLTA_dc5170aa-891d-4634-b270-b453a4ac450c">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIzLTIwLTEtMS0w_c384a1a8-f33e-45d5-ae3e-facd702c95da">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i330e64f51bae41568645cc62f16c3c3c_D20180930-20190928" decimals="5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI0LTgtMS0xLTA_b27f4909-3c12-40f5-ab55-8893fc5f879b">203.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI0LTIwLTEtMS0w_08d0bb89-435c-4058-9fe3-269d87740bf3">203.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI1LTEwLTEtMS0w_7b861eff-4289-4566-8320-3ab65140aa9b">14.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI1LTIwLTEtMS0w_63284825-3722-4a72-aa01-3011db027f9f">14.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to minimum pension liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI2LTEwLTEtMS0w_1493be93-ccac-4f47-a58b-ee1b91f93e69">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI2LTIwLTEtMS0w_5b88d616-6036-4f65-b1de-0ae9a316d963">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2bc815063394f1c91be4496c525a478_D20180930-20190928" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI3LTEyLTEtMS0w_959b8813-89cb-4899-8cd7-5bb4041c1f91">4,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2bc815063394f1c91be4496c525a478_D20180930-20190928" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI3LTE0LTEtMS0w_ef3ec316-bfc1-40a5-a0cc-24a5a8c37712">200.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI3LTIwLTEtMS0w_bae22ca9-4a77-4a80-9282-2b80ccf1fc3d">200.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on interest rate cap, net of taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI4LTEwLTEtMS0w_21b1fa39-d233-40f6-9c81-3c2974e7f458">8.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI4LTIwLTEtMS0w_b3f2c53c-42f1-425c-ae3d-79fa1c7d7825">8.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928" decimals="-5" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI5LTEwLTEtMS0w_149a683b-1541-41f5-889b-f4cf8b6677a3">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI5LTIwLTEtMS0w_42e308b5-36da-4dae-b6df-9dfea3c1c65c">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest cost of interest rate cap reclassified to statement of operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMwLTEwLTEtMS0w_8a6f2914-cda3-487c-af0f-2424ecda6d8a">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMwLTIwLTEtMS0w_ba9fa6c3-9910-407b-80ca-c5f46b760341">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09031c9523ad42779d78b1cea5ecfffd_I20190928" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTItMS0xLTA_6e8f5ac2-b0ac-4783-911e-2f66ec792eae">292,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09031c9523ad42779d78b1cea5ecfffd_I20190928" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTQtMS0xLTA_a6b7c170-7b15-40fe-b6ca-a15013ef942c">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107888c74437440cbe2fd3eed3be8cb2_I20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTYtMS0xLTA_79f7b6f6-4957-43ff-aa07-bc8efc79e18f">5,769.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifccad0744b37455da40b51a3e9af3cab_I20190928" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTgtMS0xLTA_a5548aac-711e-4d7f-b17c-f91ccd9aee66">2,688.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7986c81bc3444e2bac570e31b4e5a5d_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTEwLTEtMS0w_811f2708-883a-4597-8ac1-af18273dfff0">42.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8210852c21614405a339fbf5ee62cbc2_I20190928" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTEyLTEtMS0w_5181612d-168e-44cb-845d-a907247a4f4c">24,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8210852c21614405a339fbf5ee62cbc2_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTE0LTEtMS0w_7e5608bf-036e-4081-8033-d43568c4d77c">926.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb44d2cf92b48549d1472c325455031_I20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTE4LTEtMS0w_e4886653-ea8d-4138-8c7c-1e7a33913f62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTIwLTEtMS0w_af3c9a2f-a1a7-4fa1-83b1-35f45edc2a17">2,115.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interest created in acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMzLTE4LTEtMS0w_ea507b2d-c90c-4ce9-9fca-d0c77b1e53e5">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMzLTIwLTEtMS0w_bbf88dcf-2c02-4ac7-b482-432e678bf9c1">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting standard transition adjustment - ASC 842</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba28c6f4ffe544f5845e9d09779a223b_D20190929-20200926" decimals="-5" name="holx:AccountingStandardTransitionAdjustmentASU842" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTgtMS0xLTA_c22cfe3a-5543-430c-8779-fb0e19382cd9">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba28c6f4ffe544f5845e9d09779a223b_D20190929-20200926" decimals="-5" name="holx:AccountingStandardTransitionAdjustmentASU842" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTIwLTEtMS0w_633d5baa-641f-4037-8616-8bef7bcc62f8">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7190f0470994899bbd92415a32894ec_D20190929-20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTItMS0xLTA_c4e2229d-e207-4cc6-ad5a-e683e0a769ff">1,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTYtMS0xLTA_e738a0b3-7a8d-435d-bd2b-c6fd9b9511e4">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTIwLTEtMS0w_02f49b89-ef98-4b79-a99b-962cd3f497f2">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7190f0470994899bbd92415a32894ec_D20190929-20200926" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTItMS0xLTA_4ce1eb88-d2e4-430e-a7ee-72093ca05cb5">611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTYtMS0xLTA_d5b4ced8-0614-4003-bcfe-8c1ee779e92c">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTIwLTEtMS0w_440d5ab7-c9b9-4e1f-b220-f01ccbfb69e5">14.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7190f0470994899bbd92415a32894ec_D20190929-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTItMS0xLTA_efd4c48a-82ef-48f2-9082-0ec047ea60ef">412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTYtMS0xLTA_7d35cd61-1c7a-4a09-be1a-deee534d5bc4">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTIwLTEtMS0w_49091aef-0d5d-4aae-a990-c69ae061793e">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTYtMS0xLTA_d5ed3c58-a7ff-42c0-90e8-ae10948344d3">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTIwLTEtMS0w_5bdf31a0-ab7b-43f2-8bad-2792aa5fd04c">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4afe6a62c1ae4038bd5fc9a1b0c45638_D20190929-20200926" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTgtMS0xLTA_5883a74b-a39a-4670-a60a-cd0b8e29d0f0">1,115.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTE4LTEtMS0w_0494d001-c472-43a0-9144-b54da2d50862">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTIwLTEtMS0w_a99805ae-5f7f-4826-aa9b-8c86d8a114b3">1,110.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQwLTEwLTEtMS0w_610bbbee-d765-4a48-a78b-8d2d99c2e850">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQwLTIwLTEtMS0w_07f7cd6d-960c-437a-9d66-33bf76490fb0">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to minimum pension liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTEwLTEtMS0w_044a040b-040a-4315-bb56-08535d469a2f">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTIwLTEtMS0w_8f6e9b8c-2b0f-4281-a272-5900a3842575">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7452f8bbde6a4dc0b0d39086f1ec6fb2_D20190929-20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQyLTEyLTEtMS0w_455af024-1af3-4bc0-a933-ce35dbbc1f4d">9,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7452f8bbde6a4dc0b0d39086f1ec6fb2_D20190929-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQyLTE0LTEtMS0w_2cd0778a-32a8-4670-aaad-7d2e5dfb9cb1">448.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQyLTIwLTEtMS0w_fcded0af-9a5f-4e10-aec3-1b91bb9f40d1">448.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated share repurchase agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22b5647d92ba43c1addee91de2482e15_D20190929-20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTEyLTEtMS0w_6b0ae54b-8cb6-40c3-ac55-62f16065e061">3,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22b5647d92ba43c1addee91de2482e15_D20190929-20200926" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTE0LTEtMS0w_73b3af2e-71d0-4e7b-bfbd-2cbe3fb71da9">205.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f80aa9ecc24057bc66c2e40b7eb278_D20190929-20200926" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTIwLTEtMS0w_3d2b3fc7-8d25-401f-a205-a1f2d4414433">205.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on interest rate cap, net of taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926" decimals="-5" sign="-" name="holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ0LTEwLTEtMS0w_92739674-28fb-45ae-ba23-bf6d6b29df2b">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ0LTIwLTEtMS0w_b4c4a4aa-be7e-4f68-8bca-5623ab0c3b30">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTEwLTEtMS0w_ebda1e59-9b39-41d7-ae9b-a7625c621231">27.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTIwLTEtMS0w_4e22e488-e091-4b75-bab3-8b3ee70748fe">27.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest cost of interest rate cap reclassified to statement of operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTEwLTEtMS0w_045efa46-3100-4a89-b05a-5df1bb69bcf4">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTIwLTEtMS0w_3dbc41d8-7ce7-445a-883b-cbbcce55e920">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ3LTE4LTEtMS0w_1ef0a82e-c1b9-47a4-925f-0feb432ce296">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ3LTIwLTEtMS0w_348e0ff2-7773-4e48-81b4-f6ccddcd99c9">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i349d16b63da54ca1a91efd54fc2025a2_I20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTItMS0xLTA_6545b1b5-a4a2-464a-813b-7b180d46e990">295,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349d16b63da54ca1a91efd54fc2025a2_I20200926" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTQtMS0xLTA_193c32d8-5c71-4a8c-9531-54dbba7f02b6">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife279decce604602a60f3488e853f6ec_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTYtMS0xLTA_642319a9-fc82-42ba-9e08-30824ae4db11">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i270a8009f56048a5aeb8b08ad88b3013_I20200926" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTgtMS0xLTA_64d3b654-9d42-4c9a-b71c-e777e1b39c9f">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib61d23ac15c4492d8dadef811af5939a_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTEwLTEtMS0w_a3df75d2-6e0f-4463-baeb-170c7442bb90">49.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0b95455d5e674ece8cf4c41a77810b2f_I20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTEyLTEtMS0w_7d26aa8a-c964-4cb5-a192-e529d396c97f">37,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b95455d5e674ece8cf4c41a77810b2f_I20200926" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTE0LTEtMS0w_80ac53a6-c607-4e82-b6ff-78edd34791d6">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4910978b239f42caab2d6ea6ebc0a8a4_I20200926" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTE4LTEtMS0w_c259faae-d3d1-4424-9be0-87389775adb2">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTIwLTEtMS0w_e23299dc-d575-4a37-a819-6afe292ead08">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c0525997c5f435fb443ec3494b56714_D20200927-20210925" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTItMS0xLTM0MTQ0_46a62bcb-8118-4881-ab91-cfa1899aa7ad">857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTYtMS0xLTM0MTQ4_51bace4f-07a0-4f94-b214-4cf838758c87">32.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTIwLTEtMS0zNDE4Mg_b97b0f4e-652c-43ea-a8f7-0b04c37dc181">32.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c0525997c5f435fb443ec3494b56714_D20200927-20210925" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTItMS0xLTM0MTUw_ee3ded33-733b-4292-aa30-5fadec19982d">980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="5" name="holx:ChangeInParValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTQtMS0xLTM0MTUy_c1366944-8894-42fb-81a5-41e37300ca1f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTYtMS0xLTM0MTU0_8beb8a85-ecb1-4383-9ea1-572479910285">47.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTIwLTEtMS0zNDE4NA_3c4b083d-a2b5-4120-8cd9-ae66cc6894df">47.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c0525997c5f435fb443ec3494b56714_D20200927-20210925" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTItMS0xLTM0MTU2_42843114-f171-414e-8da4-3deb68c6aca4">362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTYtMS0xLTM0MTU4_bc5b7395-8738-48d1-ba2a-c75fac03f749">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTIwLTEtMS0zNDE4Ng_ece1a85d-de9a-41d8-911c-af82fa81ff1f">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTYtMS0xLTIxMjU4_08e3c58a-3093-4e0a-bd87-4ec984531491">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTIwLTEtMS0zNDE4OA_6e68cd28-b838-48b9-b5b0-c91fcd52734a">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74767d9ffa3c4e68806179884dda54ac_D20200927-20210925" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTgtMS0xLTM0MTYy_0e0814f9-0973-4f77-9d5c-e46c72263e86">1,871.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7c492a6bad949d8bbe9a19b9f847e6a_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTE4LTEtMS0zNDE4MA_13979608-e586-4b23-8e3d-1a99ab6faac3">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTIwLTEtMS0zNDE5MA_b0a477e1-e686-4b00-9293-11c37254109a">1,869.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTEwLTEtMS0zNDE2NA_817dbbc4-a842-4838-8703-f5ac1aa23c57">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTIwLTEtMS0zNDE5Mg_51a7e764-522c-4b3f-af57-0ed0c75047fc">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustment to minimum pension liability, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQwLTEwLTEtMS0zNDE2Ng_df6b5661-1d00-4222-b979-afa159e2da96">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQwLTIwLTEtMS0zNDE5NA_8614d850-0cbf-46c4-a6e2-699e922965b9">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41abe384e7ed44d0b93eb28da26c630d_D20200927-20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTEyLTEtMS0zNDE3Ng_8c50986d-318a-4775-97ff-e594a6924adc">6,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41abe384e7ed44d0b93eb28da26c630d_D20200927-20210925" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTE0LTEtMS0zNDE3OA_0beb7989-6d94-440d-a2bf-4df25aa93084">409.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTIwLTEtMS0zNDE5Ng_4891d004-63ab-488d-acb3-683622cbed39">409.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on interest rate cap, net of taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925" decimals="-5" name="holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTEwLTEtMS0yODM1MA_4ef28d41-9d62-4a75-a046-8c6a61152680">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQyLTIwLTEtMS0zNDE5OA_f0d31d1e-17c7-4f28-8438-fd354dc7c9ac">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925" decimals="-5" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTEwLTEtMS0zNDE3MA_262b0a26-d793-416e-8d49-889da31b5704">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTIwLTEtMS0zNDIwMA_a20bfa28-bf4b-4342-a12a-2d699557cb50">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest cost of interest rate cap reclassified to statement of operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ0LTEwLTEtMS0zNDE3Mg_cfdd9d4d-d1fd-4fcb-a159-654b22277eea">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ0LTIwLTEtMS0zNDIwMg_7754a05e-6e13-4ce4-ae54-10afd257bd2d">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925" decimals="-5" sign="-" name="holx:PurchaseOfNonControllingInterestReclassifiedToAPIC" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTYtMS0xLTM0MTc0_1cfc37b0-ecdb-40c7-b3cb-250f91292379">8.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7c492a6bad949d8bbe9a19b9f847e6a_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTE4LTEtMS0zNDIwNg_ec0ce987-9b7c-4150-ac4b-b603f6467c0f">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTIwLTEtMS0zNDIwNA_1adb8f3d-bb2e-4d5e-9df9-0f6018b96baf">8.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6fdf1c3d1c24fc2b1d849ed7b49afa5_I20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTItMS0xLTM0MjA4_89d82d7a-e0fe-4ebe-880e-72c019541b76">297,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6fdf1c3d1c24fc2b1d849ed7b49afa5_I20210925" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTQtMS0xLTM0MjEw_c057e411-4054-408f-b349-d507bed36cec">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc5988aecbc4312a8f722462e31ba5d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTYtMS0xLTM0MjEy_58dca81b-6017-4642-8102-c800b51c3cfe">5,965.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2bcf88f2cd249149361fc0e5b495fa2_I20210925" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTgtMS0xLTM0MjE0_b6d91f96-2379-46c8-b317-f595062e31fd">298.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i284bf3087c864f18b52aa92132f5472a_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTEwLTEtMS0zNDIxNg_49145a49-ebd8-46b1-a831-202f2d9c31e3">59.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a56c91d1533454184368992ce4da0cb_I20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTEyLTEtMS0zNDIxOA_4cf92242-7f17-478c-b81b-6b7a5939a18b">43,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a56c91d1533454184368992ce4da0cb_I20210925" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTE0LTEtMS0zNDIyMA_1d0c37b1-f033-4e5f-8acc-a44a16212c40">1,989.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie460e7e6ecc64b75bae28b8d8803defd_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTE4LTEtMS0zNDIyMg_788a8c3f-84e0-488b-bc2a-503d67faad9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTIwLTEtMS0zNDIyNA_fcef63c4-5ce5-468c-8f8c-7db413a45583">4,218.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:60.071%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMtMS0xLTEtMA_271ae9f0-80e7-4b45-8bc5-e10750cc1a86">1,869.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMtMy0xLTEtMA_dda1a292-d824-4eec-876d-f801aa47b7b6">1,110.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMtNS0xLTEtMA_59da46f8-82f7-40ea-99f8-cc1d009a9e9b">203.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUtMS0xLTEtMA_f4f40ac1-75ba-4721-a9cb-97657b863208">88.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUtMy0xLTEtMA_01886121-30f0-4552-8d16-1b5314893c5e">83.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUtNS0xLTEtMA_c1f5e229-a1ff-45d0-90c3-c9e06253650c">92.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYtMS0xLTEtMA_6fb61712-764f-4568-bd31-18a7a6b5785a">318.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYtMy0xLTEtMA_9e0c18fb-d860-4f16-a932-7cac1cb80608">292.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYtNS0xLTEtMA_b3d1ea4e-7970-4bde-8a99-d283dfc59aae">370.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzgtMS0xLTEtMA_5f3116a4-ef3d-4397-9ce9-3a7618908e64">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzgtMy0xLTEtMA_578a8f6a-8fd7-4f32-99ab-bb1576bb4558">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzgtNS0xLTEtMA_00078a20-4d43-4e39-a30d-a64c824e5f0a">62.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes and other non-cash taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEwLTEtMS0xLTA_090d3802-4055-4c2a-b8e3-ba5f5a5e56a5">70.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEwLTMtMS0xLTA_acf606af-0d98-4d16-b23c-ffbfa3826a56">94.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEwLTUtMS0xLTA_80e14ed5-1751-4c02-8640-0c1aece00cff">235.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible asset and equipment impairment charges<br/></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:Impairmentofintangibleassetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEzLTEtMS0xLTA_57b9cf0c-e548-4e26-9297-96fd7b2d2fff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="holx:Impairmentofintangibleassetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEzLTMtMS0xLTA_574acf92-b2ab-43da-9dac-864963bfc3dd">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:Impairmentofintangibleassetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEzLTUtMS0xLTA_e78a88fb-c404-4dfc-91fd-6be0650fe648">685.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzE4LTEtMS0xLTA_1b51c5ed-7dc4-43e9-b2da-04ca3de295a9">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzE4LTMtMS0xLTA_854974fd-7839-447a-ba23-83a6de063ea1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzE4LTUtMS0xLTA_5e1dd862-44a8-4de4-9c22-bbc105ec866a">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments and non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzIzLTEtMS0xLTA_e2ebec78-23d4-4b99-92c7-a27ea98e3544">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzIzLTMtMS0xLTA_fe405f09-cf6d-4e95-92eb-0d3209722f17">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzIzLTUtMS0xLTA_d3fbd7cb-00b1-4f9e-a5b9-229e7b41492f">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI1LTEtMS0xLTA_148900a9-3540-478e-9eeb-288d2b53081f">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI1LTMtMS0xLTA_7fc9d5ad-a233-4027-a585-5e78b48b497c">427.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI1LTUtMS0xLTA_0acb7e95-7aef-4739-b185-54a90430cfa2">76.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI2LTEtMS0xLTA_a38a76a2-ed8f-43c7-958b-b6b608502ebc">84.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI2LTMtMS0xLTA_715f2c22-6268-48b4-befc-7867a4112332">25.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI2LTUtMS0xLTA_aab3f2f9-a109-444e-b5d0-65b927137948">63.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI3LTEtMS0xLTA_7ae7d904-dafe-4fa3-a2a5-c754bf83e54d">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI3LTMtMS0xLTA_c3a068b5-7e46-4d60-bd5c-49abad512e85">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI3LTUtMS0xLTA_dd0912a7-7ce4-49af-aa66-c71375e5ef6a">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI4LTEtMS0xLTA_c5cd408a-9a30-452b-8be6-043a6bed9c80">56.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI4LTMtMS0xLTA_54a43502-f16b-4469-885c-5b67e6573757">286.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI4LTUtMS0xLTA_1bd439be-9a02-4363-a56f-aab2aef0762c">6.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI5LTEtMS0xLTA_cfedfd12-3d18-46e6-a9f8-4eaa9887b4dc">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI5LTMtMS0xLTA_0d8ffc9c-81a6-4617-b845-96d3996d4a32">4.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI5LTUtMS0xLTA_59cb98ee-9bc6-4e4c-8daf-0584af4c75a2">5.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMwLTEtMS0xLTA_fec43955-6d16-44bb-a6ed-eaf685f5b63d">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMwLTMtMS0xLTA_f4f7dbac-c25e-4faa-a702-826995898c79">96.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMwLTUtMS0xLTA_84821743-45eb-40b4-99d9-469c920f61f0">16.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMxLTEtMS0xLTA_3a216795-1c9d-4319-a395-e46e6c968d52">14.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMxLTMtMS0xLTA_c2517e04-c3ac-49e8-a071-d7d8197bd189">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMxLTUtMS0xLTA_4ee5f04c-fd6c-4c23-879b-075f895efacf">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMyLTEtMS0xLTA_35fad1d5-6043-4b9b-9041-ef8000dc1ac8">2,330.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMyLTMtMS0xLTA_f7df3b40-1cdf-4ac8-8154-168784c70c59">896.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMyLTUtMS0xLTA_785002e6-0f7f-4e36-80a1-7ad157bec1d3">649.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM0LTEtMS0xLTA_4146b6c0-de80-4aa5-b530-fa3f6bcdf74b">1,164.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM0LTMtMS0xLTA_0666a86d-ffad-419d-b882-277aea2984b8">119.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM0LTUtMS0xLTA_ff41b9a8-defd-4966-b90f-0528a1ed4f75">110.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM2LTEtMS0xLTA_03963bbf-15e1-4174-8dfd-16769f215a58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM2LTMtMS0xLTA_e8ca2e1c-101b-4e1c-aa82-3243df138d1f">139.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM2LTUtMS0xLTA_f7df7f18-1c8a-4523-88f7-d7e2761a88c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equity method investment in SSI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM3LTEtMS0xLTA_05c4f8f5-e220-42fe-8b0d-2e092aa45a4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM3LTMtMS0xLTA_f1f01f92-6153-4e41-ae91-00a67a4d9f6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM3LTUtMS0xLTA_32535954-f3c4-417e-8a6c-a350edad6884">18.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loans to SSI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:FundingOfLoansToSSI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM4LTEtMS0xLTA_f50ca7e4-4a7c-4f45-8b20-36b2f1a43dbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:FundingOfLoansToSSI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM4LTMtMS0xLTA_f2ae6a73-31ba-4652-9e9e-2f634429c5d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:FundingOfLoansToSSI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM4LTUtMS0xLTA_a283516c-d50f-4d90-aeec-12a90b7d8f50">28.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM5LTEtMS0xLTA_a02ce008-e1e7-4e17-9048-68cfe814f2c2">96.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM5LTMtMS0xLTA_acfd2d0d-ea24-428f-8ce4-6d639d847018">98.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM5LTUtMS0xLTA_bde67461-3489-441b-8949-5d16dceb1d9f">57.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase in equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQwLTEtMS0xLTA_cc3b195b-9300-49de-b0db-13069079fb5f">59.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQwLTMtMS0xLTA_7c978f01-8688-4a5e-bfb9-5b41003de092">58.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQwLTUtMS0xLTA_4718bd70-87b1-445b-b80e-5d2b2ca42154">52.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of intellectual property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ3LTEtMS0xLTA_dd5313a5-2ee3-4b02-970e-0098be9cbbba">6.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ3LTMtMS0xLTA_5ab25a74-c79f-4816-ab91-b0645b6f150d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ3LTUtMS0xLTA_b302f9b4-892f-4d0b-964e-5bd0166f6223">4.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other activity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ5LTEtMS0xLTA_35926249-3b92-407f-9090-d440172407d1">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ5LTMtMS0xLTA_fef5fa19-09f2-413b-a4c6-9185f175f069">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ5LTUtMS0xLTA_485a4339-4b62-4c60-b4cc-593b70e4950f">9.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUwLTEtMS0xLTA_ccb74ec5-01d1-4611-8b06-10b8836fa0c1">1,329.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUwLTMtMS0xLTA_7ac03abe-32f9-411e-9804-8f073baf7b77">141.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUwLTUtMS0xLTA_62b63881-553b-4f3b-8e69-25e8a9c0d5b8">280.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from long-term debt, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUyLTEtMS0xLTA_639be62c-8a31-4677-aaff-30e0e6c8d0aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUyLTMtMS0xLTA_c23baa41-d3eb-47e2-8185-7fc3652efdd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUyLTUtMS0xLTA_3ac7361f-7038-4a9e-babf-998077709223">1,497.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUzLTEtMS0xLTA_dcda110e-9fd6-43a5-b05a-7cb6251bccd0">75.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUzLTMtMS0xLTA_411eb874-d175-4190-ada5-0abba1ceda38">45.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUzLTUtMS0xLTA_539622fc-0b2d-456e-979f-182a6a6b8e86">1,465.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from senior notes, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:ProceedsfromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU0LTEtMS0xLTA_4bb24555-28ed-40bd-85f0-f894ae26cff0">936.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:ProceedsfromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU0LTMtMS0xLTA_f7a26cba-3cac-46ca-8826-983888f9569b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:ProceedsfromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU0LTUtMS0xLTA_3f6702e3-1f56-4bf1-89be-41331e0f3d5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:RepaymentofSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU1LTEtMS0xLTA_463a9991-46db-42ba-bd1d-231c2b24b598">970.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:RepaymentofSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU1LTMtMS0xLTA_e9b9271c-e25e-4b8e-8a7a-02b2f707a34c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:RepaymentofSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU1LTUtMS0xLTA_0d094cc5-13d6-4ec7-94db-19ba7846e32b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from revolving credit line</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU4LTEtMS0xLTA_9269f440-bce1-4169-bbf3-ead5c624fd40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU4LTMtMS0xLTA_8172f43e-4372-4f4f-9feb-a036b03078d8">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU4LTUtMS0xLTA_221d514e-2bea-42db-84be-40466b1abd4d">480.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments under revolving credit line</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU5LTEtMS0xLTA_54fa8619-ab6f-41c6-8b22-c84266269418">250.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU5LTMtMS0xLTA_94ae7cbf-2c7e-4bab-84dc-e1b815b5478c">500.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU5LTUtMS0xLTA_952ccb52-f558-498e-9d26-e8c73529845a">780.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from accounts receivable securitization agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYwLTEtMS0xLTA_c8f68fc1-a134-40b0-ab78-73ffc0ba6f53">320.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYwLTMtMS0xLTA_2e84eecf-e9b5-4020-bc32-f07f4269b236">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYwLTUtMS0xLTA_b7f6691b-211a-4d2f-992f-1ea125b20150">43.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments under accounts receivable securitization agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYxLTEtMS0xLTA_5fc60c3f-9db2-45ce-8a9f-61134b5b5bce">71.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYxLTMtMS0xLTA_1500b55e-bb16-47c4-b326-5dc2a14f7e17">250.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYxLTUtMS0xLTA_c92060ea-1e1d-43a1-ac99-c875f002bd81">34.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYyLTEtMS0xLTA_1839882d-e1c2-484f-8462-7af19c936321">8.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYyLTMtMS0xLTA_2096aab3-7245-433c-a261-18a0d82ef76c">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYyLTUtMS0xLTA_4e3697b2-cb7f-48c3-ab59-f52772390706">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYzLTEtMS0xLTA_fc8181f7-7394-443e-9f15-8ad8363b81bf">409.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYzLTMtMS0xLTA_ba2c482a-2491-4fa1-9a97-2b2b17d0b8b6">653.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYzLTUtMS0xLTA_ad84ba6f-cc71-4007-abc5-20e4166f3560">200.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of deferred acquisition consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:PaymentsForDeferredAcquisitionConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY2LTEtMS0xLTA_6324808f-abad-4802-817a-11f4f3d34fc7">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="holx:PaymentsForDeferredAcquisitionConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY2LTMtMS0xLTA_b3ea35d2-048e-423f-82d7-3967a0e99755">24.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:PaymentsForDeferredAcquisitionConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY2LTUtMS0xLTA_33d6be43-02d0-486d-84c9-de6c6012b2eb">6.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of interest rate caps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY3LTEtMS0xLTA_7e9d6289-4361-4205-a3e8-5c5fe5972ac7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY3LTMtMS0xLTA_48b4df3d-00da-4676-a326-45bacb636765">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY3LTUtMS0xLTA_45319570-0d33-4567-a16e-b84f2bc8169d">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY5LTEtMS0xLTA_cf9b69ed-b8c7-4162-8fe0-1410bfaaab47">51.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY5LTMtMS0xLTA_afbe2840-45da-440b-b785-4c6130eafb2c">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY5LTUtMS0xLTA_b985b077-e0be-4bfc-9a11-afd526f385bf">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of minimum tax withholdings on net share settlements of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcxLTEtMS0xLTA_ff0d1ebc-8bf8-42dc-8f00-cdf516839ccc">47.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcxLTMtMS0xLTA_562e957d-2cdb-4308-bf9d-20beb29f9062">14.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcxLTUtMS0xLTA_79a7d0ca-2961-4e66-8eb3-8ecc6b050ca5">12.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments under finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:PaymentsUnderFinanceLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcyLTEtMS0xLTA_2ed2b825-583c-4217-8ecd-bb3e5c9967f7">2.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="holx:PaymentsUnderFinanceLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcyLTMtMS0xLTA_ee78993c-eb11-4231-ba8c-eb0ed9bb562a">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:PaymentsUnderFinanceLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcyLTUtMS0xLTA_be56cf6b-1fc0-497b-9a90-2297c21c8ef7">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzczLTEtMS0xLTA_a8849c50-47f7-4a7e-b986-28ddf9e68e84">529.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzczLTMtMS0xLTA_4f368cea-deec-48af-802d-9993ef03da3a">659.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzczLTUtMS0xLTA_6aee9c69-85b5-4dc2-bd5e-cc2b0bf813cc">431.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc0LTEtMS0xLTA_93ccef96-9260-4391-a1ea-aa58f5348917">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc0LTMtMS0xLTA_0cf56616-2a95-48a8-9b0c-4e0c20f355a2">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc0LTUtMS0xLTA_3d214129-e958-4f84-be04-d2573af6f7b7">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc1LTEtMS0xLTA_d62c351a-90b0-4935-ac52-c22c3f71b0ce">469.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc1LTMtMS0xLTA_dd1fd9a0-5956-45e9-8964-c77f42ba743d">99.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc1LTUtMS0xLTA_54c72cea-e7f9-44b7-bcf6-75a51b76a505">64.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc2LTEtMS0xLTA_e7a5afd5-dd37-4add-85c6-62ca5d5db3ea">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc2LTMtMS0xLTA_4e2495dd-d509-413f-988d-dd34dfc59d97">601.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc2LTUtMS0xLTA_90755662-29fc-430b-a089-2f9410530397">666.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc3LTEtMS0xLTA_818401df-b07c-413e-b24d-c1b594b619c3">1,170.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc3LTMtMS0xLTA_f498c0af-0714-40a0-ba87-ce45a90c7c1c">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc3LTUtMS0xLTA_cd04a353-dcfc-4e20-9125-df6b5b967da4">601.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(all tabular amounts in millions, except number of shares which are reflected in thousands)</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_130"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzAvZnJhZzplMTI5ZDIxNjUyMDI0ODU2YTJjMzljNWIyNWIyNGNjMS90ZXh0cmVnaW9uOmUxMjlkMjE2NTIwMjQ4NTZhMmMzOWM1YjI1YjI0Y2MxXzY3NDU_e5a3e22e-39e6-4201-9cba-c83f88c7151d" continuedAt="ifb6d96f3abf7485fb023904e800d3a51" escape="true">Operations</ix:nonNumeric></span></div><ix:continuation id="ifb6d96f3abf7485fb023904e800d3a51"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic, Inc. (the &#8220;Company&#8221; or &#8220;Hologic&#8221;) develops, manufactures and supplies premium diagnostics products, medical imaging systems, and surgical products with an emphasis on women's health and well-being through early detection and treatment. Until December 30, 2019, the Company's product portfolio included light-based aesthetic and medical treatment systems sold by its former Medical Aesthetics business. The Company completed the sale of its Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Considerations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption in the markets the Company sells its products into, primarily the U.S., Europe and Asia-Pacific. Starting in the second quarter of fiscal 2020, the spread of COVID-19 negatively impacted business and healthcare activity globally. In particular, due to government measures, elective procedures and exams were delayed or cancelled, there were significant reductions in physician office visits, and hospitals postponed or canceled capital purchases as well as limited or eliminated services; however, in the second half of the third quarter of fiscal 2020, the Company started to see a recovery of elective procedures and exams as economies were opened back up and restrictions eased, which has continued through the fourth quarter of fiscal 2021. The reductions in testing and procedures had a negative impact on the Company's operating results and cash flows in fiscal 2020, however, the impact of the commercial release of its COVID-19 assays more than offset those negative impacts as the Company generated significant revenue from the sales of these assays starting in the third quarter of fiscal 2020 through the fourth quarter of fiscal 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company's results of operations and cash flows since the third quarter of fiscal 2020 have been positively impacted by the sale of its COVID-19 assays as well the continued recovery of its other primary product lines and businesses to pre-COVID levels, the COVID-19 pandemic could have an adverse impact on its operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: reduced demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products as well as the timing and effectiveness of distributing vaccines; the severity and duration of the COVID-19 pandemic; the resurgence of COVID-19 infections; the emergence of new COVID strain variants; the COVID-19 pandemic's impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic and associated economic disruptions. The Company expects that as the current COVID-19 pandemic subsides, there may be a significantly reduced demand for ongoing testing, and thus, for its COVID-19 assays. As expected in the third quarter of fiscal 2021, revenues generated from the sale of its COVID-19 assays decreased significantly in the U.S. compared to the prior year period and the first and second quarters of fiscal 2021 as the population of vaccinated people continues to grow in the U.S. In the fourth quarter of fiscal 2021, COVID-19 assay revenues increased compared to the preceding quarter primarily due to the impact of the delta strain of COVID-19 resulting in higher demand for testing, however COVID-19 assay revenues decreased compared to the corresponding prior year period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the negative impact of COVID-19 on the Company's business, in April 2020, the Company initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but the Company also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances, effected employee terminations. Further in April 2020, the Company shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of its products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased During fiscal 2021, the majority of the impacted manufacturing facilities were back to pre-COVID levels. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also taken and continue to take measures to ensure the safety of its employees and to comply with governmental orders. These measures could require that the Company's employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in the Company's commercial and marketing activities. In addition, complying with government and customer vaccine mandates that apply to the Company may lead to employee attrition, disruption to the Company's workforce and result in additional costs associated with implementation and on-going compliance, which could have an adverse impact on the Company's operating results, cash flows and financial condition.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_133"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTg5_b129b23d-eee6-49ae-9402-622542c108b3" continuedAt="ic44bdb53dd4440d3acf5ab2358d57ecc" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ic44bdb53dd4440d3acf5ab2358d57ecc" continuedAt="id2d407f7f78e4d87908a79bd3ef261fa"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTg3_20a95afd-9954-48ba-b2a0-a9496854f54b" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#8217;s fiscal year ends on the last Saturday in September. Fiscal 2021, 2020 and 2019 ended on September&#160;25, 2021, September&#160;26, 2020 and September&#160;28, 2019, respectively. Fiscal 2021, 2020 and 2019 were 52-week years.</span></div></ix:nonNumeric><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events Consideration</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events, except as described below, recorded in the consolidated financial statements as of and for the year ended September&#160;25, 2021. On September 27, 2021, the Company refinanced its term loan and revolving credit facility. For additional information, refer to Note 7. On October 14, 2021, the Company announced that it had entered into an agreement to acquire Bolder Surgical, Inc. ("Bolder Surgical") for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="i39e4f5900241494c9567649e19c96f03_D20211014-20211014" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MjQxOTk_90b555b1-20a4-4b6c-a8e2-ff19d302a168">160.0</ix:nonFraction>&#160;million. The closing is subject to certain regulatory approvals, but the Company expects to close this acquisition by the end of calendar 2021. Bolder Surgical, located in Louisville, CO, is a developer and manufacturer of energy vessel sealing surgical devices in both laparoscopic and open procedures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTEz_eb7fd8d4-67d5-4eec-9ef9-17050db37808" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Estimates and Uncertainties</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#8217;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#8217;s net deferred tax assets and related valuation allowances, and stock-based compensation.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#8217;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTM3_7e8ddc47-a241-482e-8dd1-6b53abbfbff6" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:CashEquivalentsMaturityPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDk1_cc767b8d-e62b-453e-b3f1-f72118a68201">three months or less</ix:nonNumeric> at the time of acquisition.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDcy_4f274ed3-ef00-425f-ac13-870938ab3c17" continuedAt="i0efd52ea4088487e880ca511cecc6fbb" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers are principally located in the U.S., Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="id2d407f7f78e4d87908a79bd3ef261fa" continuedAt="i9574a0a5401f44aeae9d37b63a8be9be"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0efd52ea4088487e880ca511cecc6fbb" continuedAt="ia24e53c4eeeb42dea626dd2b192ad294">directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;25, 2021. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.</ix:continuation></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia24e53c4eeeb42dea626dd2b192ad294">There were <ix:nonFraction unitRef="customer" contextRef="i5ab554f4731046f5a8db6df08f11e210_I20210925" decimals="INF" format="ixt:fixed-zero" name="holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDk_ef69e941-9f13-4615-a35e-7427068cd706">no</ix:nonFraction> customers with a balance greater than <ix:nonFraction unitRef="number" contextRef="i31b7d848d9294ea0bcafe1e9b98352e2_D20200927-20210925" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3NDk_0d610819-d5d5-422f-bd48-1e8f86fa4269">10</ix:nonFraction>% of accounts receivable as of September&#160;25, 2021. There was <ix:nonFraction unitRef="customer" contextRef="i257fac080d6542d2b019c98a7b842cab_I20200926" decimals="INF" format="ixt-sec:numwordsen" name="holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ4MDY_8bd15d10-dad5-4c67-99d4-2bb1413f09d1">one</ix:nonFraction> customer with a balance greater than <ix:nonFraction unitRef="number" contextRef="i20cf81a427114e06a602d55fd54d095a_D20190929-20200926" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ4NDc_92d40374-ad3a-4c67-b272-c861d1ddd150">10</ix:nonFraction>% of accounts receivable as of September&#160;26, 2020, at <ix:nonFraction unitRef="number" contextRef="ic8d9c018e3364bb88f017d0ea722c968_D20190929-20200926" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzIxOTkwMjMzNzkyMjU_5df7205f-cced-40e0-95bb-3f8299f72529">11.9</ix:nonFraction>%. There were no customers that represented greater than <ix:nonFraction unitRef="number" contextRef="i1760e146b45f410688b3ff89a82a6684_D20190630-20190928" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ5Mzc_53f466e4-6674-45bd-890a-91e3d070ffbc"><ix:nonFraction unitRef="number" contextRef="i8ecce514a4df495b8d3d8479bdf9d0f2_D20190929-20200926" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ5Mzc_9125f56a-b18e-4478-b56c-11c4ad1bb16b"><ix:nonFraction unitRef="number" contextRef="ib977b0b83f104827aef9be1e2307b7e3_D20200927-20210925" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ5Mzc_ff063d3c-bef6-4432-83c9-75a77e213230">10</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of consolidated revenues for fiscal years 2021, 2020 and 2019</ix:continuation>.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Suppliers</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases certain components of its products from a single or small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which could adversely affect results of operations.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTI0_dd59e676-0444-4fcf-bbee-6f6d85a847e2" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flow Statement Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.674%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.911%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzItMi0xLTEtMA_b0aa0dd8-69b6-4057-97df-07b7960940da">615.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzItNC0xLTEtMA_22bbdbb1-80e1-4d0a-b591-fdc26af6c0b9">265.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzItNi0xLTEtMA_9fe63299-e074-4cbc-9bb4-b4c7c6070281">180.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzMtMi0xLTEtMA_1792f273-cc44-4cec-8c72-e1401e70f39e">93.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzMtNC0xLTEtMA_7b3f79a7-9c84-4fe6-b407-0e7c2ba52f63">109.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzMtNi0xLTEtMA_4d06b965-4d08-4471-8715-a67effd2e30e">132.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration at acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzUtMi0xLTEtMzExMjY_8c8f0e78-0872-4bbd-bcd3-1e195d92a6b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzUtNC0xLTEtMzQxMTc_4247645b-9f9d-43e6-953c-12192f06e698">82.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzUtNi0xLTEtMzQxMjE_b3a4585c-5542-44d1-8168-4d3bde65ad0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDIw_317b2372-7bf6-429a-8525-e89c236c8fea" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#8217;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#8217;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTk3_ef8c9a8b-34d4-4a3d-9f42-48a3ddd3307f" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:52.471%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzEtMi0xLTEtMA_2fd2c114-0295-4ff7-a2ac-9fc6687ee570">163.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:InventoryRawMaterials" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzEtNC0xLTEtMA_492519c2-eff3-4b66-9739-63f20c372f68">152.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzItMi0xLTEtMA_72e2c7e8-0c55-4509-bb4c-600ed0cecaef">53.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:InventoryWorkInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzItNC0xLTEtMA_be87cc58-aa51-45e0-97c4-a0bf85a4e249">46.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzMtMi0xLTEtMA_1e6ab32a-0fc5-4219-9725-ebdac74823db">284.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzMtNC0xLTEtMA_4267c829-48e3-49fe-b439-603a51c14d7a">196.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzQtMi0xLTEtMA_650e6bf1-b29d-4bc9-9e3b-83e335e6524d">501.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzQtNC0xLTEtMA_495e5b94-1348-4284-93ac-bb64ec982639">395.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ2OTYw_c8b7d89a-ec30-4a74-80ad-34ce11b6325d" continuedAt="i19e47948a23246258e26d29f575d218a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDAx_20b03354-d3af-4a49-abed-696174ee609d" continuedAt="ib77a20cc82f84fe0ae5ba9e5256e51b6" escape="true">Property, plant and equipment consisted of the following:</ix:nonNumeric></span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i9574a0a5401f44aeae9d37b63a8be9be" continuedAt="ic8ef0c6192b741cf808f859a0ce5cb3e"><ix:continuation id="i19e47948a23246258e26d29f575d218a" continuedAt="icdaf17f2ab854296820ab12936c1919d"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ib77a20cc82f84fe0ae5ba9e5256e51b6"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:36.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.308%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9b633f8acdd4e20aa3c715419399907_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzEtMS0xLTEtMC90ZXh0cmVnaW9uOmM5OTBlYzZkOTcyZjQ2YmViZWIxNjBjMGRiMmQwZWFlXzQ_c8389513-6cb8-4f08-bcba-86097cd98e48">3</ix:nonNumeric>&#8211;<ix:nonNumeric contextRef="i5a0e94b8d14543b8b882b82d9c97b4ca_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzEtMS0xLTEtMC90ZXh0cmVnaW9uOmM5OTBlYzZkOTcyZjQ2YmViZWIxNjBjMGRiMmQwZWFlXzc_90139572-87bd-46e0-a45e-702c80727fb0">10</ix:nonNumeric> years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzEtMy0xLTEtMA_7f42b521-b8d9-4117-a0b2-7f8160063084">467.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzEtNS0xLTEtMA_f505e29d-ecdf-4bcf-bfe5-cbe7ee7f0f57">460.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1d36b248dea543d9b31d755d693a800a_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzItMS0xLTEtMC90ZXh0cmVnaW9uOmM0YTBlMWYwMjYwYjRhYjg5NmI2MTViYjcxYzdkNTFkXzQ_2a028083-4e47-4d38-8a3c-764f4791871a">3</ix:nonNumeric>&#8211;<ix:nonNumeric contextRef="i240c4a4b528e48fcbae1ae3adac1be94_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzItMS0xLTEtMC90ZXh0cmVnaW9uOmM0YTBlMWYwMjYwYjRhYjg5NmI2MTViYjcxYzdkNTFkXzc_bf7b737e-5b31-42e8-b797-2d69f03e7e5d">8</ix:nonNumeric> years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzItMy0xLTEtMA_fb8ffe4c-0d4f-4635-89e3-9812b3e729c1">484.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzItNS0xLTEtMA_ecb0b1a5-c934-45f8-b9c7-79b2a45b71a2">456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff4e30233d1a415382913c229d305f89_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmMwYjY3YjIzZjdkMzQzYjE4NzgwZWUxOGE0MzUzMDA4XzQ_fea9d93e-5ed7-4bce-a19c-84f892495986">20</ix:nonNumeric>&#8211;<ix:nonNumeric contextRef="i9a1a54208b5e468786e129cb05b9304d_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmMwYjY3YjIzZjdkMzQzYjE4NzgwZWUxOGE0MzUzMDA4Xzc_8bf8bf62-12de-43b1-af65-dc47e9b04b07">35</ix:nonNumeric> years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzMtMy0xLTEtMA_93beec60-0f0b-415a-8094-ce86eba2db64">191.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzMtNS0xLTEtMA_51fcd7fd-af95-43de-9194-45562510f8f0">167.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the Original Term of Lease</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or Estimated Useful Life</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzQtMy0xLTEtMA_8c0eb7a8-5b03-4377-bcd3-e784aab1102e">49.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzQtNS0xLTEtMA_c7f31af6-5278-4ccc-ad88-e46fb260df44">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzUtMy0xLTEtMA_a5adb425-ac96-4c73-a635-dd1dcca894e5">41.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzUtNS0xLTEtMA_3945ae99-a573-411f-b29d-11b43552eaca">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8c6c435d399d423185f62c22c21c3f26_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzYtMS0xLTEtMC90ZXh0cmVnaW9uOmZkMTkzYzIwYWQ2YzRkZjY4MGZiYTQ1OWQ0MTljMGI2XzQ_9a7123e0-5953-4022-bbe9-8f9aa80e69cf">5</ix:nonNumeric>&#8211;<ix:nonNumeric contextRef="id78ad9f144ef4c5f824abd84cc11f14d_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzYtMS0xLTEtMC90ZXh0cmVnaW9uOmZkMTkzYzIwYWQ2YzRkZjY4MGZiYTQ1OWQ0MTljMGI2Xzc_afff7081-aed1-47fe-aee9-017061be8fee">7</ix:nonNumeric> years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzYtMy0xLTEtMA_e6783a3d-6102-4ac7-a77e-1735e17edd66">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzYtNS0xLTEtMA_9b52a7ff-c40a-4d97-a390-d5b4a6054b3b">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c305b597ae44238fbe77067406d53b_I20210925" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzctMy0xLTEtMjEyMTg_ca6097f8-e5ec-4911-a8a8-6309c2f689ee">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzctNS0xLTEtMjEyMjY_3ad5b38a-3551-4dcc-9b85-f020c16df4ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzctMy0xLTEtMA_fe48d9e7-5af7-4c11-9a42-e5b47646d09c">1,260.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzctNS0xLTEtMA_7cc1e22b-b839-4af3-b2f8-4492c0390ef3">1,185.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzgtMy0xLTEtMA_52b96d0a-68eb-4564-86da-c36dcc869e2c">695.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzgtNS0xLTEtMA_85a11c5e-6925-41b6-81ec-e13f52ff1b13">694.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzktMy0xLTEtMA_bf7b6b4e-a365-4ed2-98a1-c6b3a8311729">564.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzktNS0xLTEtMA_90fda27a-34d3-4ba9-b56d-fad021481e3a">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred.</span></div></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icdaf17f2ab854296820ab12936c1919d">In September 2020 and October 2020, the Company was awarded grants of $<ix:nonFraction unitRef="usd" contextRef="i759a6a937e3f4b359b04123f53698e83_D20200628-20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:GrantsReceivedFromDepartmentOfDefense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE2Nzk0NzA_3335ba2d-b755-4ac2-85a0-897a162489cd">7.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3f5a4fc2e0a249feb5e822c662f420e2_D20200927-20201226" decimals="-5" format="ixt:num-dot-decimal" name="holx:GrantsReceivedFromDepartmentOfDefense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE2Nzk0ODQ_0651a488-f2c4-4bc3-9f73-3361abaf90c2">119.3</ix:nonFraction>&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants are specifically to fund the capital equipment and labor investments needed to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procures and pays for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to paying for the capital equipment, the DOD will reimburse the Company upon it meeting certain requirements  However, the DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts. As of September 25, 2021, the Company had $95.2 million of capital equipment related to the DOD grant that was awaiting approval. In fiscal 2021, the Company received $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:DepartmentOfDefenseFundsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MjQyMzg_3bb2f681-68b8-44cf-98be-803e76805cde">21.2</ix:nonFraction>&#160;million from the DOD under these grants which has been recorded as a reduction of the cost basis of the purchased equipment.</ix:continuation> Payments under these grants are subject to satisfaction of the conditions of the grants.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:LongLivedAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDgy_110e133b-c131-40fe-b039-e9f058e3f6b9" continuedAt="i832ce92e65cb4a669fe1d09544e7891b" escape="true">Long-Lived Assets</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><ix:continuation id="i832ce92e65cb4a669fe1d09544e7891b" continuedAt="i0c9b76eef93a45ae83817f63fd6b31b9"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment&#8212;Impairment or Disposal of Long-Lived Assets</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0c9b76eef93a45ae83817f63fd6b31b9"> (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique.</ix:continuation> </span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTE2_2d3cfcbe-d932-4906-9318-512732cd9e65" continuedAt="ied87e41b45e7452a9a46af0e12df2852" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations and Acquisition of Intangible Assets</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company accounts for the acquisition of a business in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="ic8ef0c6192b741cf808f859a0ce5cb3e" continuedAt="ic20001c1e0e94d0dad41acbd3d41ce8f"><ix:continuation id="ied87e41b45e7452a9a46af0e12df2852" continuedAt="iaba4b00928da4f21a154fdaee2044bd0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results specifically revenue growth rates. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaba4b00928da4f21a154fdaee2044bd0">The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names</ix:continuation>.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets and Goodwill</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are initially recorded at fair value and stated net of accumulated amortization and impairments. The Company amortizes its intangible assets that have finite lives using either the straight-line method, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be utilized. Amortization is recorded over the estimated useful lives ranging from <ix:nonNumeric contextRef="i7133ee75e2dd4ac999d32c90c55818c6_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzExODkw_b4933c13-4ee8-4ea2-af5a-14704f8b83ff">2</ix:nonNumeric> to <ix:nonNumeric contextRef="ib5f33f2bd0484efea0b8ae4a94ebb11e_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzExODk2_a7ed45a9-6fdd-4fdc-8cda-b3b3024e019a">30</ix:nonNumeric> years. The Company evaluates the recoverability of its definite lived intangible assets whenever events or changes in circumstances or business conditions indicate that the carrying value of these assets may not be recoverable based on expectations of future undiscounted cash flows for each asset group. If the carrying value of an asset or asset group exceeds its undiscounted cash flows, the Company estimates the fair value of the assets, generally utilizing a discounted cash flow analysis based on the present value of estimated future cash flows to be generated by the assets using a risk-adjusted discount rate. To estimate the fair value of the assets, the Company uses market participant assumptions pursuant to ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite lived intangible assets, such as IPR&amp;D assets, are required to be tested for impairment annually, or more frequently if indicators of impairment are present. The Company&#8217;s annual impairment test date is as of the first day of its fourth quarter. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="ic20001c1e0e94d0dad41acbd3d41ce8f" continuedAt="i061b895d812d48c48eef067b4131e67a"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDM5_5fb4d581-0c87-4331-8860-782f25823193" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:36.547%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.757%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d30cd544794d8bad91533ff053e6f2_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzMtMi0xLTEtMA_de9c65b1-10b7-49b8-b2b6-906cb2c7f170">4,597.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d30cd544794d8bad91533ff053e6f2_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzMtNC0xLTEtMA_2524ac81-7835-4c9f-9819-33ab71eee707">3,184.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a8c525301944a9944a49cff920233b_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzMtNi0xLTEtMA_123dca94-ae63-497f-b8d3-7b2ab8977879">4,054.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a8c525301944a9944a49cff920233b_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzMtOC0xLTEtMA_5f47fb0b-2b18-4afc-b701-f166aaad4f93">2,907.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad6095503c64c51a121bfc7570d481c_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzQtMi0xLTEtMA_3e21d4d1-ef04-4fcc-862f-a8cc1d9395f4">71.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad6095503c64c51a121bfc7570d481c_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzQtNC0xLTEtMA_fad642be-6c69-496c-b3cb-2d4e9c326ec0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65a3feacdfc4f8db0941415413e890d_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzQtNi0xLTEtMA_ae718a2e-bca0-45c3-90a0-9933669c3a47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65a3feacdfc4f8db0941415413e890d_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzQtOC0xLTEtMA_5682689c-e16e-4925-8422-1b5665f75eb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae31be4bb5c4a43a23c3e6238becfc2_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzUtMi0xLTEtMA_b3b2a3b5-4017-40b3-a81d-861cc692f252">591.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ae31be4bb5c4a43a23c3e6238becfc2_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzUtNC0xLTEtMA_bb7a758b-3334-425f-8b0f-64ba56309d7b">510.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8cbc783b5949dbb79a0305af7adb43_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzUtNi0xLTEtMA_65e363d0-9814-4d67-80cb-f0d50298cb95">549.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8cbc783b5949dbb79a0305af7adb43_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzUtOC0xLTEtMA_55ceadd8-8161-457d-81b1-f506b9deacc4">477.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6c3f788c0bb4582bfe4f3e18fdab22e_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzYtMi0xLTEtMA_9a1d23f7-353d-4210-a078-bcb0929f61f2">268.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6c3f788c0bb4582bfe4f3e18fdab22e_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzYtNC0xLTEtMA_d6a3e2f7-db60-4a51-afac-caef52da2c6f">191.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614f3db626964b0ba19f7be4c30f7447_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzYtNi0xLTEtMA_39adb151-3322-4162-a8af-c57577bf3cf8">245.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614f3db626964b0ba19f7be4c30f7447_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzYtOC0xLTEtMA_64678f01-d3e9-4362-9059-21e978c06dc6">181.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id938fd73f4344d9cbe5e4513a3d14cde_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzgtMi0xLTEtMA_4acbca63-fb01-43c3-80cb-8c48730e0d4d">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id938fd73f4344d9cbe5e4513a3d14cde_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzgtNC0xLTEtMA_de2ec47f-3a2a-489d-94be-df4f4122427c">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1bf447986ca4495be7ba966e2186eea_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzgtNi0xLTEtMA_d069399a-b28b-4b33-84a5-772c7e05e12a">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1bf447986ca4495be7ba966e2186eea_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzgtOC0xLTEtMA_761edb63-c004-4410-827a-510834b2fe08">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f935dfa1dfc42c1819964e91a6a8a64_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzktMi0xLTEtMA_5dfde564-b5bf-4e69-b580-4bd0f42dc232">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f935dfa1dfc42c1819964e91a6a8a64_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzktNC0xLTEtMA_fc316097-dde3-4622-9b71-6b1524d38da5">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d5d0520adb34afba7a74726aaf4fd2e_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzktNi0xLTEtMA_b4a51091-c11a-437d-83a9-861462876ff0">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d5d0520adb34afba7a74726aaf4fd2e_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzktOC0xLTEtMA_9b5830ba-e220-4b11-a70e-ef59034891ab">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153284bf00784fb3b525b3a99606668e_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEwLTItMS0xLTA_9f1a743e-52f8-45d1-9ddb-d166c475f71d">5,533.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153284bf00784fb3b525b3a99606668e_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEwLTQtMS0xLTA_ab781659-8ef3-41cc-af1a-73a15a2d07e4">3,890.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1075d2362f62458aa8909dd277c391b9_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEwLTYtMS0xLTA_9fd57e08-61c0-478b-ad8b-959bdb1e0616">4,852.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1075d2362f62458aa8909dd277c391b9_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEwLTgtMS0xLTA_e2aef005-7007-4f48-bb6b-f5124e42d7ac">3,569.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba0c605799354665aaf32f5e35c613c0_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEyLTItMS0xLTA_7cd3f226-5274-4c40-a7a2-0eefc721313e">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba0c605799354665aaf32f5e35c613c0_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEyLTQtMS0xLTA_ae7f4778-dcd7-4bf9-afa2-140020171fcc">17.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397c8ef1ac694286900c772850590741_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEyLTYtMS0xLTA_c5d44f75-c6a2-4c21-afc6-27c609617c1c">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397c8ef1ac694286900c772850590741_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEyLTgtMS0xLTA_d100ab4a-426b-4223-b701-8bfbfe1c1c2b">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a58be7c5d3a47b2a567894820bae0e7_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEzLTItMS0xLTA_1de84574-0763-48b9-979e-7fedeacad5aa">25.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a58be7c5d3a47b2a567894820bae0e7_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEzLTQtMS0xLTA_9d6d6bc1-754c-4b79-9f6d-a41fd0c5a6de">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie735dea6c3194f28bea2b55697a00db1_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEzLTYtMS0xLTA_89172bd1-41b4-4fd8-acc2-204841fdf79c">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie735dea6c3194f28bea2b55697a00db1_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEzLTgtMS0xLTA_1f5d33a1-3816-4a3d-bfeb-9f5a7742b70c">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzE0LTItMS0xLTA_1a10e47b-6d6c-4c01-b0ec-c85166b8c3cc">5,582.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzE0LTQtMS0xLTA_8b5ec413-79b2-44f8-b77a-f1c31fc0d5bd">3,922.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzE0LTYtMS0xLTA_880ce48c-fd94-4127-a939-ab711a16659e">4,931.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzE0LTgtMS0xLTA_69b848de-6a1a-4883-8199-a5fde9e73554">3,623.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Aesthetics Impairment</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, the Company's Medical Aesthetics business met the criteria to be designated as assets held-for-sale. As a result, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i693d74165a33465a96c1b16aaf3362ee_D20190929-20191228" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEzMTcw_f8cd5ebd-81e9-435d-99fe-6fdd1b11c527">30.2</ix:nonFraction>&#160;million charge to record the asset group at fair value less costs to sell. See Note 15 for additional information.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company identified indicators of impairment for its Medical Aesthetics reporting unit as a result of reductions in forecasts during the year, and in connection with the Company&#8217;s efforts to sell the business that began prior to the end of fiscal 2019. In performing the undiscounted cash flow analysis pursuant to ASC 360, the expected undiscounted cash flows of the asset group were determined using a probability-weighted approach taking into consideration the planned disposition, which was deemed to be highly probable as of the balance sheet date. Based on this analysis, the undiscounted cash flows were not sufficient to recover the carrying value of the asset group. As a result, the Company was required to perform Step 3 of the impairment test and determine the fair value of the asset group. The Company executed a definitive agreement on November 20, 2019 to sell the business. Although this agreement was signed subsequent to the balance sheet date, the Company concluded that it provided evidence regarding the estimate of fair value of the asset group at September 28, 2019 and that there were no events that occurred between September 28, 2019 and the date the Company entered into the definitive agreement that would significantly affect the fair value of the asset group. As a result, the Company recorded total impairment charges of $<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MDA0_11963302-d964-4050-8d84-a27d4c265efd">685.4</ix:nonFraction>&#160;million in fiscal 2019. The impairment charge was allocated to the long-lived assets as follows: $<ix:nonFraction unitRef="usd" contextRef="ic6e41df507bc48da9b9dbf2c59f4e28f_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MDk2_9307496b-a542-4afa-ba1c-cf811e5b17da">576.9</ix:nonFraction> million to developed technology, $<ix:nonFraction unitRef="usd" contextRef="i4c123a5aa5c74f40857a7f1a499427f9_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MTI0_5708cab1-ecd3-448f-8dcd-1d505d4f6f04">22.4</ix:nonFraction> million to customer relationships, $<ix:nonFraction unitRef="usd" contextRef="ib52deda671d64acda80d8851600a5b3f_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MTU0_52623e32-fdb8-4524-ba91-2a36d830f73d">48.6</ix:nonFraction> million to trade names, $<ix:nonFraction unitRef="usd" contextRef="i3ca56ec6117e459a933cdc1284e27c76_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MTcz_beb25c31-8084-4918-85d5-a6caa9e51985">27.7</ix:nonFraction> million to distribution agreements and $<ix:nonFraction unitRef="usd" contextRef="if3da811ec6224b7aaf2247ddbed15752_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MjA3_13457ce1-259c-4e10-8fc8-dc727d2ec49f">9.8</ix:nonFraction> million to equipment. On November 20, 2019, this asset group met the assets held-for-sale criteria and was recorded at fair value less the costs to sell as noted above.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Activity</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, the Company acquired Mobidiag Oy and recorded $<ix:nonFraction unitRef="usd" contextRef="i24181a753fcf40f4955b32c1fa5f7f67_I20210626" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3Mjc3OTI_5e672c66-184a-4438-9ce1-0a1ceea41124">285.0</ix:nonFraction>&#160;million of developed technology, $<ix:nonFraction unitRef="usd" contextRef="i8cf9e1877cd24f22b338685574b8c19a_I20210626" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAyMDE_2be8e923-290d-45a9-9f4a-89b1f860a185">74.0</ix:nonFraction>&#160;million of in-process research and development, $<ix:nonFraction unitRef="usd" contextRef="i1764f8386ed1463785aedd29aa1705e0_I20210626" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAyMTY_38cb66a6-3ab5-44ce-9940-5546ac71cc06">20.9</ix:nonFraction>&#160;million of customer relationships and $<ix:nonFraction unitRef="usd" contextRef="i044591b70cf04ae2890d5b307e363d47_I20210626" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAyMzE_cb819cf4-cf4c-4b17-a65f-a98620d97efb">20.0</ix:nonFraction>&#160;million of trade names based on its preliminary purchase accounting. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2021, the Company acquired Biotheranostics, Inc. and recorded $<ix:nonFraction unitRef="usd" contextRef="id726e42e341143488233910071609e4e_I20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxNzE_4fde6a27-c2ae-47d7-a42d-af77a4fb1055">160.3</ix:nonFraction>&#160;million of developed technology and $<ix:nonFraction unitRef="usd" contextRef="i1b99fdca3c5843718c49fe1d11331a75_I20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxODc_0f96b0bd-529f-436f-94f1-82bc8ea69764">2.1</ix:nonFraction>&#160;million of trade names based on its preliminary purchase accounting. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2021, the Company acquired Diagenode SA and recorded $<ix:nonFraction unitRef="usd" contextRef="i6c23227b249540639f90d63654aa0b54_I20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxNDI_4b608e29-2c32-4ecb-b0b6-1b1d355f2c24">69.8</ix:nonFraction>&#160;million of developed technology and $<ix:nonFraction unitRef="usd" contextRef="ida01d42fd7b44dfcb8af2d9a4e61fe93_I20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxNTc_6c572369-1cf7-4bce-91b8-bce29faee4d2">9.2</ix:nonFraction>&#160;million of customer relationships based on its preliminary purchase accounting. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2021, the Company acquired Somatex Medical Technologies GmbH and recorded $<ix:nonFraction unitRef="usd" contextRef="i2e1fee5b3bff48a6968339ee9bea5f5d_I20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxMTM_315ae14f-ba23-4c32-b6f8-db327e9b23aa">38.0</ix:nonFraction>&#160;million of developed technology, $<ix:nonFraction unitRef="usd" contextRef="i710936347b24460c9bd5ba52032b894d_I20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxMjg_26158e13-88b5-43b2-999e-4e063b87da2f">1.2</ix:nonFraction>&#160;million of customer relationships and $<ix:nonFraction unitRef="usd" contextRef="ibbbed19de9d04478a40050d57d4eb672_I20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAyNDY_dd66b8b9-3394-485d-82be-40ac1dc160c8">0.9</ix:nonFraction>&#160;million of trade names based on its preliminary purchase accounting.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i061b895d812d48c48eef067b4131e67a" continuedAt="ibf2199821b984cd4b820cc345d8e17b5"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2020, the Company acquired Acessa Health, Inc. and recorded $<ix:nonFraction unitRef="usd" contextRef="ib512458f54004c1c91782978a54d120e_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1NzY1_da3717cc-cc34-4e6b-a753-d24005ef964f">127.0</ix:nonFraction>&#160;million of developed technology and $<ix:nonFraction unitRef="usd" contextRef="iee6a5a2a7a4f4e3c92f42828d7360c4d_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1Nzk2_20794497-c261-476b-985e-bd4d1d63bc2e">1.2</ix:nonFraction>&#160;million of trade names.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to developed technology is classified as cost of product revenues&#8212;amortization of intangible assets. Amortization expense related to customer relationships, contracts, trade names, and business licenses is classified as a component of amortization of intangible assets within operating expenses.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDEy_d0de343d-a4d3-4b55-9de1-f6f672e0363e" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amortization expense at September&#160;25, 2021 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzAtMS0xLTEtMA_7d3b4d1a-e1ca-422a-887b-0f66bef6f9db">326.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzEtMS0xLTEtMA_8e887b2e-7c1f-4c67-b751-7d7302c81a1d">231.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzItMS0xLTEtMA_d6edea68-68d2-408a-b3d2-24159de001e5">222.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzMtMS0xLTEtMA_b21aaa92-2ebe-449c-98e5-ae8352425792">208.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzQtMS0xLTEtMA_0d8e2ef6-dbe1-4553-8537-cccd77f287e0">178.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 350), the Company tests goodwill for impairment annually at the reporting unit level and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying value. Events that could indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate, operational performance of the business or key personnel, and an adverse action or assessment by a regulator. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the impairment test, the Company utilizes the single-step approach prescribed under Accounting Standards Update No. 2017-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2017-04). This approach requires a comparison of the carrying value of each reporting unit to its estimated fair value and to the extent the carrying value exceeds the fair value a charge is recorded up to the amount of goodwill in the reporting unit. To estimate the fair value of its reporting units, the Company primarily utilizes the income approach. The income approach is based on a DCF analysis and calculates the fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting the after-tax cash flows to present value using a risk-adjusted discount rate. Assumptions used in the DCF require significant judgment, including judgment about appropriate discount rates and terminal values, growth rates, and the amount and timing of expected future cash flows. The forecasted cash flows are based on the Company&#8217;s most recent budget and strategic plan and for years beyond this period, the Company&#8217;s estimates are based on assumed growth rates expected as of the measurement date. The Company believes its assumptions are consistent with the plans and estimates used to manage the underlying businesses. The discount rates used are intended to reflect the risks inherent in future cash flow projections and are based on estimates of the weighted-average cost of capital (&#8220;WACC&#8221;) of market participants relative to each respective reporting unit. The market approach considers comparable market data based on multiples of revenue or earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) and is primarily used as a corroborative analysis to the results of the DCF analysis. The Company believes its assumptions used to determine the fair value of its reporting units are reasonable. If different assumptions were used, particularly with respect to forecasted cash flows, terminal values, WACCs, or market multiples, different estimates of fair value may result and there could be the potential that an impairment charge could result. Actual operating results and the related cash flows of the reporting units could differ from the estimated operating results and related cash flows.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducted its fiscal 2021 impairment test for its reporting units on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of June 27, 2021, and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of the Company's reporting units had fair values exceeding their carrying values. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;25, 2021, the Company believes that its reporting units, with goodwill aggregating $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-6" format="ixt:num-dot-decimal" name="holx:GoodwillNotAtRiskOfFailingImpairment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzIwODYx_9c0848d5-9c91-4ca0-8761-44a37200f3fa">3.3</ix:nonFraction>&#160;billion, were not at risk of failing the goodwill impairment test based on its current forecasts and qualitative assessment.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducted its fiscal 2020 impairment test for its reporting units on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of June 28, 2020, and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of the Company's reporting units had fair </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="ibf2199821b984cd4b820cc345d8e17b5" continuedAt="i6328a5684ab8431d960248a30031ce35"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">values exceeding their carrying values. For illustrative purposes, had the fair value of each of the reporting units been lower by 10%, all of the reporting units would still have passed the goodwill impairment test.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:ScheduleOfGoodwillBySegmentTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MjA0_6c2fee56-c914-4156-ac63-7cfab1b1be6f" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of goodwill activity by reportable segment from September&#160;26, 2020 to September&#160;25, 2021 is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"><tr><td style="width:1.0pt"></td><td style="width:130.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:57.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:57.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Breast&#160;Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GYN&#160;Surgical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skeletal&#160;Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d0b62cc24e442bb94c648589df1886_I20200926" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtMS0xLTEtMA_c041a6da-bb32-4a7a-87e1-1187219b9a22">821.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aac6887b6f64875a859a71ba2b4b94b_I20200926" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtMy0xLTEtMA_b1f67777-0138-4855-bac8-939535fcfe29">764.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc0b83aa93c48f48c108df5541f41ff_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtNS0xLTEtMA_5d3e8f91-2951-4954-a4e7-e1ef935d6151">1,063.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054b061ff3bb4c10a95c6b96ddc407f6_I20200926" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtNy0xLTEtMA_c7c164d5-057a-435e-80db-426a433856ba">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtOS0xLTEtMA_4fecfeed-2da2-4210-84d5-a192f55643c4">2,657.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mobidiag acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6346aa91d524afe85aa61f0161caa3d_D20200927-20210925" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzUtMS0xLTEtMjg0NDI_badf8663-7bfa-4855-8eff-b4a15d7fd6ae">432.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i164438a7cadc4df1b56c4a64d8637889_D20200927-20210925" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzUtOS0xLTEtMzQ4NTY_b855207d-01b1-4eb4-b2a9-066dbf2f1a0e">432.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagenode acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e559bc22d7d4793b38e4a328c0efdc2_D20200927-20210925" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzUtMS0xLTEtMA_fad8e6d5-24ae-42f2-9a4b-8ae93e951688">83.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86d3e4855ffd49b4a75816f598968a6b_D20200927-20210925" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzUtOS0xLTEtMA_c5905a46-856f-4cbe-ba42-c8fc738b20f4">83.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biotheranostics acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26606deeae75471ca65b268474556c52_D20200927-20210925" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzYtMS0xLTEtMjMxOTA_9742d192-9852-4494-852d-93c66f0844ee">80.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieee384db572047e4bc0a55fa16caac03_D20200927-20210925" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzctOS0xLTEtMjg0NDk_c073e2db-c1c8-4255-b902-43ca02c3d4c3">80.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somatex acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e026b96a0148719035aed371e20da8_D20200927-20210925" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtMy0xLTEtMjUwODA_2044fdff-4705-488e-8c03-8ae21058cb60">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4497464c0da44052a7c519318511a239_D20200927-20210925" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtOS0xLTEtMzQ4NTM_b7c4b58c-0104-46af-a817-7335c56f4a3b">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtMS0xLTEtMA_ad2849dd-0a1f-4942-a0c4-aad7d183334d">7.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtMy0xLTEtMA_bf134f43-8521-4b24-a36c-dead26a77ee4">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925" decimals="-5" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtNS0xLTEtMA_449e2888-2182-4518-affb-2a44d0331462">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtNy0xLTEtMA_f506f16e-c522-4b23-b063-ac53a2cb94e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtOS0xLTEtMA_8f1a6e7e-ff09-45b7-be16-abbf3578e6de">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 25, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b69d34963e43d5a345ff8d104b509c_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktMS0xLTEtMA_cd9caaff-b50f-41c7-971f-940e844830c2">1,410.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e61574a9b46411bb0ae2371322a832e_I20210925" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktMy0xLTEtMA_2b1be60c-74b5-458a-b715-884055919fe8">797.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac209011a2246ed84b08c9d11d3ec13_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktNS0xLTEtMA_de9b3142-99f0-4f0b-875c-685ca160f6f7">1,065.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32aed22715f404fa87eea8875fb1bed_I20210925" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktNy0xLTEtMA_9cf56115-890f-4cba-b9ba-0d655884c487">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktOS0xLTEtMA_9099c14f-c20a-4994-a032-5dcf392b6866">3,281.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:OtherAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDU1_e59b9ae3-50e8-4a7a-ab66-310216a5f025" continuedAt="i9a851dbd938e417da2e58eec74fbd360" escape="true"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDEz_5af70bcf-07f2-4fa8-a63c-fe69f56cf90a" escape="true"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"><tr><td style="width:1.0%"></td><td style="width:40.734%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.866%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:IncomeTaxReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzMtMi0xLTEtMA_fcae4e56-c2bd-4dcf-b6c4-14b276db3d14">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:IncomeTaxReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzMtNC0xLTEtMA_2aa43f50-b79d-421c-8124-609b12283a75">325.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzQtMi0xLTEtMA_26a2ae2c-21f3-4ca5-9f37-8fec7fc107a4">83.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzQtNC0xLTEtMA_de05b3e4-ff1b-4748-af33-df1579fd5527">80.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzUtMi0xLTEtMA_85a86044-6e85-49bc-9264-b7fe85d09509">64.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:CashSurrenderValueOfLifeInsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzUtNC0xLTEtMA_5c2be24d-65a0-4623-89de-b01ed73b279e">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzYtMi0xLTEtMA_4f8a1a35-a9af-439d-b225-c52c4e96d6d5">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzYtNC0xLTEtMA_f2e9d7fd-2850-4def-872a-11c6f06baf74">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-method equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:CostMethodEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzEwLTItMS0xLTA_0cd5515f-9af1-4cd6-9730-9d01637e18da">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="holx:CostMethodEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzEwLTQtMS0xLTA_2fa2425f-f45e-48ef-b524-d3b39b6cc434">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OtherAssetsMiscellaneous" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzEzLTItMS0xLTA_1dbdf53f-5a18-410a-8d92-781912537106">41.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:OtherAssetsMiscellaneous" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzEzLTQtMS0xLTA_1efc7f13-eb1d-44f3-9149-9dc33923a636">34.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzE0LTItMS0xLTA_920ef038-16f6-4891-8d09-af38a8586820">245.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzE0LTQtMS0xLTA_eca51916-0b5a-49d7-a399-e4c3f2073341">516.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><ix:continuation id="i9a851dbd938e417da2e58eec74fbd360" continuedAt="i70ca574b31db41d18c22f51e9e7a44cd"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax receivable in fiscal 2020 primarily related to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. This receivable was reclassified to a current asset in fiscal 2021 as the Company filed the carryback claim and expects to receive the refund within the next twelve months, subject to Internal Revenue Service processing times. The right of use assets were recorded in connection with the adoption of ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i70ca574b31db41d18c22f51e9e7a44cd">, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#8217;s Nonqualified Deferred Compensation Plan (&#8220;DCP&#8221;) and are recorded at their cash surrender value (see Note 12 for further discussion).</ix:continuation> </span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDMw_7a2029b8-224d-4317-bd31-e7f911587371" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Software Development Costs</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred for the research and development of the Company&#8217;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the development costs of software embedded in the Company&#8217;s products in accordance with ASC 985, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#8217;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimated useful life and recorded within cost of revenues - product.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTg1_e3773fcd-b345-4305-af00-e1471ce3103a" continuedAt="i1881d5c3bfac460b9000e512f4935e6b" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries are translated in accordance with ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#8217;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i6328a5684ab8431d960248a30031ce35" continuedAt="id0e201b9238c4d37a43b0d622f318b66"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1881d5c3bfac460b9000e512f4935e6b">is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income (expense), net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss), which is a separate component of stockholders&#8217; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income (expense), net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented.</ix:continuation> </span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDE3_a5602b52-da2e-49fa-9b64-97f720c394ea" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#8217; equity. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDY0_f5618527-cf47-475f-9142-022d417faecd" continuedAt="ic4b0f99b0ccc44128c9e269cbbc84bbd" escape="true">The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:11pt"><ix:continuation id="ic4b0f99b0ccc44128c9e269cbbc84bbd"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMS0xLTEtMA_f88655f0-a177-4ba9-8464-12d0ebe295c2">22.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMy0xLTEtMA_9edf9609-dc42-4347-8828-ed63a7c04eda">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItNS0xLTEtMA_e851f865-8867-4144-96df-b39b1002ab21">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItNy0xLTEtMA_5c0afbe5-7156-4637-b225-f6e8ed6202bd">24.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItOS0xLTEtMA_359df85d-d698-4726-b76f-1cc20309d45f">49.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTEtMS0xLTA_a991959b-9974-4598-a3f4-934095fd74d5">41.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTMtMS0xLTA_7dc3161e-e319-4b7b-8dca-b6cdf75cbc2f">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTUtMS0xLTA_25d450d8-6338-4c45-886b-0d606a9c7b77">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib54386ce9dbd4629889a414173ff052f_I20190928" decimals="-5" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTctMS0xLTA_bc918945-e17b-410b-bf1e-56c9f4d5c30b">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTktMS0xLTA_de3fb8a2-3539-4087-b071-6c7eaeb6ac9c">42.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMS0xLTEtMA_342940ef-a1b5-473f-a34b-fa961a52283e">20.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMy0xLTEtMA_273632e6-2dd3-46d8-9b09-0f950aa04bc5">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtNS0xLTEtMA_3c1ba60b-24be-4c80-acac-4ce2e483be25">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtNy0xLTEtMA_ba0348d6-2287-49fe-ba57-89efa9faf046">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtOS0xLTEtMA_7003ceb9-c790-4709-96cb-2bbf13814815">9.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTEtMS0xLTA_c2a5e4ec-1833-4edc-bf96-5fdc87e35ce8">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTMtMS0xLTA_071b53ee-74d2-4458-b6c7-c860a90b7f68">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTUtMS0xLTA_378f53bf-ba26-4f28-b623-6774e5592054">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTctMS0xLTA_541d0eaa-f119-4195-9e66-303611db0080">27.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTktMS0xLTA_dac50a0d-9c5e-422e-bdbb-9fbff6d3b37f">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charges (gains) reclassified to statement of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767c4b13fb8b4298b5e3c88d7d4a412b_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMS0xLTEtMA_5814df64-56a4-4167-8d71-5f9440c222ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d9385d2791424fa11a988430cc65d1_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMy0xLTEtMA_77f97468-f05b-464a-91ee-3659b9622cb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0deccf8630d14bf58974f26313ae1cf6_D20200927-20210925" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtNS0xLTEtMA_6ce82463-f381-472c-9be8-0864af598552">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtNy0xLTEtMA_cf3aec1e-034a-419a-a79d-759e865059ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtOS0xLTEtMA_3d074bef-eedd-49f6-87e1-aa2ba6387583">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02ce74e9dbd343d6a1cd77cfa6108906_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTEtMS0xLTA_78faeddd-8bf4-4c67-aa5b-5176ec7df463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic351d3dbbd53499fba2fea622656b21d_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTMtMS0xLTA_cd1da61b-8fbe-4d1f-b02b-9970089a9b2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fa9316ea07a42e7bebfbfaa9b69e71a_D20190929-20200926" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTUtMS0xLTA_1ad1ddbd-d3be-4d6d-b9b2-842150a6b3b3">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTctMS0xLTA_20e4eb7b-95c5-4c31-8327-2b12412c1fe3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTktMS0xLTA_bd4807a2-181b-410b-bc2d-aa0860a867a6">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMS0xLTEtMA_ce718dd4-f059-4c8f-bfd7-a63069d9a308">43.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMy0xLTEtMA_2eae72bb-ed6d-48c7-a8a9-9e55b6e855bf">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:fixed-zero" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtNS0xLTEtMA_fd57c2c9-72ea-4e1f-8421-15cb2967c43c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0e3770e763f4ddb888efca3f38034da_I20210925" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtNy0xLTEtMA_c67c62bf-34cf-4c9d-88ae-3b3bde58c679">14.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtOS0xLTEtMA_2113d22c-6b8f-41a0-a6e0-1015afda64b5">59.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTEtMS0xLTA_f88655f0-a177-4ba9-8464-12d0ebe295c2">22.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTMtMS0xLTA_9edf9609-dc42-4347-8828-ed63a7c04eda">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTUtMS0xLTA_e851f865-8867-4144-96df-b39b1002ab21">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926" decimals="-5" sign="-" name="holx:AccumulatedothercomprehensiveIncomelossHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTctMS0xLTA_c781af7b-f224-40ba-81b9-252649b68e87">24.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTktMS0xLTA_8b02fbf0-6001-4af1-af9f-3c91b622c646">49.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTMy_0883355d-ea66-4860-a076-871a3a447246" continuedAt="i649085cc7ea14287a0c071376d3a9728" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $<ix:nonFraction unitRef="usd" contextRef="ic8ab0ba57c4c4db1ad33b536e3e7e589_D20171001-20171230" decimals="-5" format="ixt:num-dot-decimal" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMxMDMy_f4254ae6-19f3-499e-a0a2-1aba4a00ef0d">3.7</ix:nonFraction>&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $<ix:nonFraction unitRef="usd" contextRef="i05d2321cba894df2b8040fb7171ae337_D20180930-20181229" decimals="-5" format="ixt:num-dot-decimal" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAzOTc_6184c1ff-7965-4c1a-808e-81fe0009b82a">1.5</ix:nonFraction>&#160;million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-8" format="ixt:num-dot-decimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMxODkx_0f9be397-54d9-4815-b925-bd6f2b57d6a7">1.0</ix:nonFraction> billion of principal, which ended on December 27, 2019 (the first quarter of fiscal 2020) for the contracts entered into in fiscal 2018, and on December 23, 2020 (the first quarter of fiscal 2021) for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, 2020 and 2019, interest expense of $<ix:nonFraction unitRef="usd" contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMyMzM1_041e9544-954a-4ff8-bf1e-f0f6438ae81e">0.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMyMzM5_c20983f0-19ff-4ff8-8c93-4042dd3c7f7b">2.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMyMzQ2_b186cd57-b644-4666-88a3-47b198d1e790">3.1</ix:nonFraction> million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The last interest rate cap agreement matured as of December 26, 2020.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="id0e201b9238c4d37a43b0d622f318b66" continuedAt="i65d6b5a6c6834d62b04b8f16146a1d82"><ix:continuation id="i649085cc7ea14287a0c071376d3a9728" continuedAt="i668cc50286804186a5c4ff2c4347f6cb"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzMjgz_6c00261b-bf39-4b17-8515-fc188b4a6a70">1.0</ix:nonFraction> billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzMzgx_977e6841-83ff-4c38-8a4d-d88e25323457">1.0</ix:nonFraction> billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-8" format="ixt:num-dot-decimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzNzkx_0f9be397-54d9-4815-b925-bd6f2b57d6a7">1.0</ix:nonFraction> billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI and net of taxes were a gain of $<ix:nonFraction unitRef="usd" contextRef="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzOTUz_db892b62-6f60-48ee-abb0-4c32a44714d1">9.4</ix:nonFraction>&#160;million, a loss of $<ix:nonFraction unitRef="usd" contextRef="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzOTg1_1e1179c3-060b-43db-a9c2-610964fa040d">27.6</ix:nonFraction>&#160;million and a gain of $<ix:nonFraction unitRef="usd" contextRef="ib3278f0ce96b40519a22ae965c771b3f_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzIxOTkwMjMzNjU2ODM_b404e3a7-a177-41bb-a136-3836e5c82c34">3.5</ix:nonFraction> million for fiscal years 2021, 2020, and 2019, respectively. The fair value of this derivative was in a liability position of $<ix:nonFraction unitRef="usd" contextRef="ic0e3770e763f4ddb888efca3f38034da_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestRateCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM0MTMw_73cbaa82-024b-4578-b409-6bc553126e97">18.7</ix:nonFraction> million as of September 25, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of <ix:nonNumeric contextRef="i6827d7fb33684f72ad15f7ec7825491c_D20200927-20210925" format="ixt-sec:durwordsen" name="us-gaap:DerivativeTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM0ODkx_49dea6bd-da3d-46d7-b75b-4c3547e163b7">one year</ix:nonNumeric> or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTgz_eec51f61-7dcb-48e2-8616-512433c82a0f" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6827d7fb33684f72ad15f7ec7825491c_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzMtMS0xLTEtMA_e15f91bc-68b3-4596-a874-a9c1c97b0040">3.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c63be7c32ce4ddd8e21e1134530b893_D20190929-20200926" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzMtMy0xLTEtMA_b026bf0b-fc90-429b-80b4-0593fad948d7">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a83c89446b8446ab0792c574b8e11bc_D20180930-20190928" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzMtNS0xLTEtMA_cee993b3-277e-4934-96ad-1207ee499bb2">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i824c5596d87e486cbcedd0f0406ca67e_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzQtMS0xLTEtMA_797e86f9-f4e0-4523-8d1d-263069d95a48">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0448f6218dcc4bb79af08c1f322d677c_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzQtMy0xLTEtMA_93c54459-84c4-4351-a71e-4279b955fa36">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42d6e39bab1d429394487dda896a9573_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzQtNS0xLTEtMA_30751d75-4659-4a01-8644-acb8b769c47d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzUtMS0xLTEtMA_18669d3c-b537-4595-8521-5ca5ef20cd9f">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzUtMy0xLTEtMA_23b4a671-8229-4315-bcbb-9341cbdf997e">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzUtNS0xLTEtMA_2691c29a-bf26-4824-abe2-8bb92ddfe9f6">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6827d7fb33684f72ad15f7ec7825491c_D20200927-20210925" decimals="-5" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzgtMS0xLTEtMA_4ee866b0-a5fa-492e-9555-02476ddbf394">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c63be7c32ce4ddd8e21e1134530b893_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzgtMy0xLTEtMA_4527a87a-1c98-4e04-944e-51c09de98d23">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a83c89446b8446ab0792c574b8e11bc_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzgtNS0xLTEtMA_9fae859d-63bc-42b9-807c-53da1457427b">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i824c5596d87e486cbcedd0f0406ca67e_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzktMS0xLTEtMA_9e211895-bb84-4088-9c37-286fef512c1c">4.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0448f6218dcc4bb79af08c1f322d677c_D20190929-20200926" decimals="-5" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzktMy0xLTEtMA_0e70321f-2e8f-4673-b2ea-09b673120e4b">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42d6e39bab1d429394487dda896a9573_D20180930-20190928" decimals="-5" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzktNS0xLTEtMA_4c09b8b3-ca5f-41cf-9dc3-9d3daa5d4a9e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzEwLTEtMS0xLTA_6d2937aa-2ed6-4e12-91a7-08c957fe787a">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzEwLTMtMS0xLTA_b2a0c59e-a20d-4c98-860f-f8837410b18d">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzEwLTUtMS0xLTA_e45a9942-66cd-416b-aae8-b83ac2379106">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzExLTEtMS0xLTM0ODc2_085e27cc-d206-4d70-86fc-b29a9a14d918">13.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzExLTMtMS0xLTM0ODc4_1451965c-f59f-4632-9205-9264b70ea33b">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzExLTUtMS0xLTM0ODgw_004e2231-34c1-44c6-aef7-dc3ec7d02ed0">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 25, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of certain of the Company's cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM1NDk1_2b6de2dd-1c0f-4ef7-840b-e6b4b636cebd">861.5</ix:nonFraction> million. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDY5_89d99c8e-35c8-4b8a-b9b0-8dde963272b6" continuedAt="i1d810624fdb5479892b21d855c9ba307" escape="true">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;25, 2021:</ix:nonNumeric></span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i65d6b5a6c6834d62b04b8f16146a1d82" continuedAt="i9cdc99560b0346c780c3269e7c9d7cd5"><ix:continuation id="i668cc50286804186a5c4ff2c4347f6cb"><div style="margin-bottom:5pt;margin-top:23pt;text-align:center"><ix:continuation id="i1d810624fdb5479892b21d855c9ba307"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:47.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.286%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef043735b8b4239bd022e3c816a7d5e_I20210925" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzktMy0xLTEtMA_7724e0e7-93a0-4798-bf2c-31e61d080f2c">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89ac9c9ef5e4b44bc94c7ab3aadfbf0_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzktNS0xLTEtMA_cbc3fdf8-f8d6-4ba2-a4a0-b6b90af837ce">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if412fa8d384c47b689b9c1cc6f70fb14_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzEwLTMtMS0xLTA_b2f524fc-801b-44be-a7b7-94df2df33aa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e51833b6bb54770a5cad8d4c19d8fcc_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzEwLTUtMS0xLTA_645aecb9-44dc-4c47-aae0-1f6abdebda23">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d6987883e2244438841300f24394299_I20210925" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzExLTMtMS0xLTA_f28fa12a-341d-4b7a-9284-5df34db128b2">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8608e05ef25e4918a0697a01f20908b8_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzExLTUtMS0xLTA_5eb88a08-bdcd-4152-933f-bf4505dabbd3">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c981e5c311541219a8ce678b8f5e556_I20210925" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE1LTMtMS0xLTA_fc8497be-b4cd-42c3-9dde-3b4e74e06423">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7021a097ba6b45e4b62b6e9a182526c0_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE1LTUtMS0xLTA_39ed5d84-918d-4ff4-b5f8-87fcdf8fb01d">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35128fa0cb9b4182a1faa4cc5d635680_I20210925" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE2LTMtMS0xLTA_35ab1bed-d924-4f78-85cc-4c3d895d4ed4">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3d88d570654a5eba0e1150c061cbc6_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE2LTUtMS0xLTA_f0696457-b020-403e-9a42-7efb63621366">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE3LTMtMS0xLTA_399b0099-ac95-460d-ab1e-924b07490625">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE3LTUtMS0xLTA_a912d802-4a72-49bc-aed0-e595a8cc6237">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e58ad8c5574352954de0afd7c3c79e_I20210925" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE5LTMtMS0xLTA_77162e8b-e97b-4770-afd8-0b19cec07bd3">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d9b9f86933044f9b736c54f4167a157_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE5LTUtMS0xLTA_657d9054-5c6a-4c4e-9821-c4aeb714ea8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDc5_fdcacf52-9d2c-4d2b-b287-c6a6cf6e0482" escape="true"><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.280%"><tr><td style="width:1.0%"></td><td style="width:48.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082d8e77f8fd4606afa5130d1718f9f4_D20200927-20210925" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzMtMS0xLTEtMA_c3ac6c5f-9274-44f6-a90d-87c026bb7f3c">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic627db3203ae4b219001b3708f0efa7f_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzMtMy0xLTEtMA_4002bf6d-849f-4b06-a5f4-09ce171b9990">27.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id50b2a3739074642949584da79fb2ae6_D20180930-20190928" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzMtNS0xLTEtMA_07e4cc88-5960-4aec-a441-878c68be077e">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzQtMS0xLTEtMA_4fea9a11-cbe0-484a-8ba9-7bd4d9f34c5f">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzQtMy0xLTEtMA_363eada0-1e4b-4fdf-b583-cf0ba43c61f5">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzQtNS0xLTEtMA_570b357c-0d49-4420-962e-4091957f0918">8.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzUtMS0xLTEtMA_24fc7384-ae9e-442c-b192-e38d03572d8f">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzUtMy0xLTEtMA_55db29d9-a19b-45c4-b879-711a611c3eed">28.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzUtNS0xLTEtMA_f0ebff6b-f80f-4b5a-b6c7-2844a6de416f">4.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trade Receivables and Allowance for Credit Losses</span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:AccountsReceivableAndReservesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ2OTc1_287c7489-49e6-466e-8bc3-ebba6c12457f" continuedAt="i321330a39ae84c1fa08f6ac031ef2522" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective September 27, 2020, the Company adopted ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the COVID-19 pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i9cdc99560b0346c780c3269e7c9d7cd5" continuedAt="i8d43bd9027a54697b6e521e7d682472a"><ix:continuation id="i321330a39ae84c1fa08f6ac031ef2522"><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a rollforward of the allowance for credit losses for fiscal <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTg4_bb52d905-24bd-4de8-9d37-970f65c58132" continuedAt="i7809df55ad484b7bb1be2a092dbedd05" escape="true">2021, 2020 and 2019:</ix:nonNumeric></span></div><ix:continuation id="i7809df55ad484b7bb1be2a092dbedd05"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.812%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItMi0xLTEtMA_6129f94f-95f6-4baa-a61e-fbf369895ed9">31.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItNC0xLTEtMA_c787c1b4-9330-4f7b-823e-a10829989f9a">15.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="5" format="ixt:fixed-zero" name="holx:AccountsReceivableReserveDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItNi0xLTEtMA_4e5f6c7c-9605-45ef-a36f-d94bad109a1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:AccountsReceivableAllowanceReduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItOC0xLTEtMA_a9ac098a-d3c0-45e6-96b2-4037659cb676">6.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItMTAtMS0xLTA_e18dd372-06a4-468f-805e-5edeaebcacf2">40.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtMi0xLTEtMA_ce9a1bec-308f-4714-a721-fb76e60f6f81">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtNC0xLTEtMA_e679f716-46eb-427a-b418-0a0562424311">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="5" sign="-" name="holx:AccountsReceivableReserveDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtNi0xLTEtMA_2effed19-1fbb-446d-945f-c79d4d898fef">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="holx:AccountsReceivableAllowanceReduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtOC0xLTEtMA_63416725-f1d8-4b53-9926-f7f49dbe1de7">7.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtMTAtMS0xLTA_d4262a69-0ccd-4f55-8951-3632c11a3a23">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtMi0xLTEtMA_62f1fa11-39b1-4b1e-b1c1-e78286c4e3f8">16.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtNC0xLTEtMA_fa807433-bf68-46f9-a8f1-2584e30e6c33">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="5" format="ixt:fixed-zero" name="holx:AccountsReceivableReserveDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtNi0xLTEtMA_a891306a-478b-4a65-af49-001b4e7803de">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:AccountsReceivableAllowanceReduction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtOC0xLTEtMA_e463ab11-7811-4005-9f50-4cb1a2b44b53">2.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtMTAtMS0xLTA_694a2b68-f290-4ae8-b5db-d0b46a09a2f7">17.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTk1_a83769fc-c8f6-4aca-9b99-e03e3ed82e00" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#8217;s professional services, employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.</span></div></ix:nonNumeric><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDMz_6a6b2029-f340-4e4f-b134-a5bd04446a1b" continuedAt="i6f95a30c6bb34337860ea28d1575ef00" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><ix:continuation id="i6f95a30c6bb34337860ea28d1575ef00" continuedAt="i4ebb40ed0d2f4d388d95c4ec670cf212"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based payments in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 718)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4ebb40ed0d2f4d388d95c4ec670cf212"> As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#8217;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled.</ix:continuation> </span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MjA4_d3e753c3-91d9-4236-93ab-0f031cf4fb22" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options and restricted stock units for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTUz_af664096-0040-4d20-8754-03fcee2462a6" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts for fiscal 2021, 2020, and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.154%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzEtMi0xLTEtMA_282a886b-ec7c-41a8-b990-b5726498dc9f">257,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzEtNC0xLTEtMA_57a0f7ac-9918-438c-8fbf-ebe538f0ab46">262,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzEtNi0xLTEtMA_ff5da366-6717-4d2b-8625-604cb9c8136a">269,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-3" format="ixt:num-dot-decimal" name="holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzItMi0xLTEtMA_9c842910-a36b-48a3-ad4f-52e650c5be0b">2,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-3" format="ixt:num-dot-decimal" name="holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzItNC0xLTEtMA_d5c2a838-1670-4ba6-8730-e1c0d049dae5">1,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-3" format="ixt:fixed-zero" name="holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzItNi0xLTEtMA_e7689a65-0839-423d-8e4f-6177b63cb33c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzMtMi0xLTEtMA_a65fa62c-a41a-42e2-931c-6a68977d059a">259,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzMtNC0xLTEtMA_ed8ea831-35b7-4395-ad7f-feab9260e2a6">264,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzMtNi0xLTEtMA_05d84894-336b-4180-aa63-4f1f60666ff4">269,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec921088a39b409a82dd4e10a4ae0ccc_D20200927-20210925" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzUtMi0xLTEtMA_375dab7c-e4b4-4d78-8d33-6c65767ae0f5">528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i470023b769a94ad0b13e2609e2a72838_D20190929-20200926" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzUtNC0xLTEtMA_067e36fa-31a0-4767-a26e-e101cfba52c2">1,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i35bd7f402edc440a8814d0fd91080075_D20180930-20190928" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzUtNi0xLTEtMA_e9904704-e678-4eb1-bf72-fb7e450c03e2">4,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In those reporting periods in which the Company has reported net income, anti-dilutive shares generally are comprised of those stock options that either have an exercise price above the average stock price for the period or the stock options&#8217; combined exercise price and average unrecognized stock compensation expense upon exercise is greater than the average stock price. In those reporting periods in which the Company has a net loss, anti-dilutive shares are comprised of the impact of those number of shares that would have been dilutive had the Company had net income plus the number of common stock equivalents that would be anti-dilutive had the company had net income.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:StandardProductWarrantyPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDkw_ea339dca-e83c-4ba2-9bb5-a8a1dfd7e23b" continuedAt="i57581391a9734572bfbed6d50b8e89a6" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally offers a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM5NTc0_257c2dd2-2a08-4cdf-8688-8a506165be31">one</span>-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#8217;s warranty reserves include the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i8d43bd9027a54697b6e521e7d682472a" continuedAt="ibacefbed9d63444d8578e780f248a597"><ix:continuation id="i57581391a9734572bfbed6d50b8e89a6"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDY2_1eda4282-3412-42d6-b7d3-be4fdf5107ec" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity for fiscal 2021 and 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.100%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.406%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at&#160;End<br/>of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItMi0xLTEtMA_6924894f-2f9e-4ff9-b024-94b222165315">9.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItNi0xLTEtMA_9b6da271-d212-4b9f-a8fb-6d491ae6fc9e">7.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItOC0xLTEtMA_5a024f01-4cf6-406c-8cf5-4a8e0877f566">0.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItMTAtMS0xLTA_33f7a2e5-da20-4f92-9ebe-a0f14509e1de">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItMTItMS0xLTA_24674f21-e93c-436a-ba94-8b926e9c36c1">9.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItMTQtMS0xLTA_bf945672-1306-4c6d-acfa-66df6436076b">8.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtMi0xLTEtMA_3eb7d2a0-c115-42b9-9113-665c95ac1328">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtNi0xLTEtMA_33a4a050-981c-41b0-9467-c9f2fda1bf2d">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtOC0xLTEtMA_21baff5e-8392-4753-ba14-6548fc1d1846">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtMTAtMS0xLTA_cfc06546-a7a9-4bbb-b162-3dfb8ed56b3e">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtMTItMS0xLTA_8299ce7e-ebf4-4836-beac-5652234ac6b9">10.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtMTQtMS0xLTA_ced94c2d-43d4-473a-bd5c-1de590065c9d">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTQw_06214bf5-9c81-463c-acdc-823c032e99a4" escape="true"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQwMjcy_b1e043e9-eda5-4ad8-9bd1-ec15052a4415">9.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQwMjc2_4bc22aee-9c80-4e1d-9653-c9a616749eaf">15.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQwMjgz_94d8c5de-6356-4178-ae95-dd647e326bd1">29.5</ix:nonFraction> million for fiscal 2021, 2020 and 2019, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.</span></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently a number of improvements. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The Company adopted the standard in the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in this Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the standard in the first quarter of fiscal 2021. The adoption of ASU 2019-08 did not have a material effect on the Company's consolidated financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The FASB issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The FASB issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The FASB issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="ibacefbed9d63444d8578e780f248a597"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842), Lessors - Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU addresses an issue related to a lessor's accounting for certain leases with variable lease payments. The amendments in this Update affect lessors with lease contracts that (1) have variable lease payments that do not depend on a reference index or a rate and (2) would have resulted in the recognition of a selling loss at lease commencement if classified as a sales-type lease or a direct financing lease. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021, and is applicable to the Company in fiscal 2023. The Company is currently evaluating the impact of the adoption of ASU 2021-05 on its consolidated financial position and results of operations.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzE3NDAy_208fe046-c8c1-442f-b85f-95e9e7b740a7" continuedAt="ib9c62d89c3f04a519d3cf992da9194aa" escape="true">Revenue</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib9c62d89c3f04a519d3cf992da9194aa" continuedAt="i9bf54e4d4bf24262add7d8e372c59bd7"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenue pursuant to ASC Update No. 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. Prior to the Cynosure divestiture, the Company also generated revenue from the sale and service of medical aesthetic treatment systems. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzE3NDAz_8fc8d61e-e777-495c-a5c1-afa45767c5a8" continuedAt="iea29dec46a8f447888204830ce5ab7f7" escape="true">The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="iea29dec46a8f447888204830ce5ab7f7" continuedAt="i7b19a87fc8a241e3b5241fca3bf91110"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:2.984%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17dfc20b126b4985b7eda3cc4db3237f_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMi0xLTEtMA_50338f78-7eb2-47ea-8e2b-bfe7f2217338">304.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33cc4a6d3eea43fdb3367b91d64fe447_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMy0xLTEtMA_cd1d2cec-4da1-449a-bcec-e754301e06b2">169.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeea03eaa2ce4eeaba648099e4e98f19_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtNC0xLTEtMA_43fe5157-0f90-4d22-9520-7ff6f9a234f1">473.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44fec30a86bc4fdca0e8af8e653b41eb_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtNi0xLTEtMA_2dead36e-4554-42b8-a705-9023c8d73cfc">266.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id679baf745974c8ba5972d62f85ff59a_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtNy0xLTEtMA_30f29255-f4fe-4be7-8091-5acc56fe00fb">143.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a4d3cf9145043e6a6e200011f21e141_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtOC0xLTEtMA_2261ba43-21c6-4ab5-af01-45f599973cb9">410.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93f6848c1c446b6a57343a9d7193209_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMTAtMS0xLTA_2676485c-7294-49f0-a55d-4a01c00cde77">312.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2899ef5f0e54bf481c6056474080ba9_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMTEtMS0xLTA_d221dcd5-72ff-45fc-9aba-8ccf6b67287e">159.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a41050bbd2f4b08bf819adc739c81b4_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMTItMS0xLTA_20a1eec0-4869-4f54-9310-04bccba20131">472.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3620d49142cd46a09f8dce2f449ad3a0_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMi0xLTEtMA_aa0fea2a-2c27-44ac-8f7e-03d7a6fed72b">2,038.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6eee8b72e7d491c8f95b676990b140d_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMy0xLTEtMA_0f1f2c8e-9fa0-46ce-8aea-bc69f888689e">1,132.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77866d045d77495391adc42c2d578d4f_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtNC0xLTEtMA_750cce7a-98ad-442c-a1fe-5b4b56cbd2fd">3,171.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1d584b446ba445593d7564671b578f3_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtNi0xLTEtMA_a1f663cd-004e-4aca-b606-4ce24f22ed4c">1,272.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27464b40c6284a7ca171e8ecbf4473ed_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtNy0xLTEtMA_7888baeb-a12b-47de-bdc1-84f45cf45df1">375.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4444d39b093b4cc6818d013167b30698_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtOC0xLTEtMA_dd10c9fd-aa2b-4692-a855-df4b1b7f8534">1,648.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic727d8274f6049b8a3d7106820845e16_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMTAtMS0xLTA_beb221be-a0b1-4e4c-9fb6-1418491f8d57">549.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdac9696c83845cbad8c3916522749af_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMTEtMS0xLTA_6e70c0e8-adcf-4a3e-bd40-0f3609afeb7e">125.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271d00413b22420da0972fe262ee308e_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMTItMS0xLTA_1194349c-1344-4d08-954e-097203f6276a">675.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8631f56a67a14a0eaece9796d4d326c6_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMi0xLTEtMA_ef65071e-bf41-476d-879d-8b05d10f7bf3">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad66804c34ae4b02af8b821d199b124c_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMy0xLTEtMA_ba9e221d-994b-4007-8bb3-e67922bc56ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071fdf8810d44be79afb0d4142823f1c_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtNC0xLTEtMA_e17cb45f-b457-4ff5-89e1-856679e2903e">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f2294499fc4cbfbda896074c917f74_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtNi0xLTEtMA_7b1c2506-200b-4f5d-9d0d-d56c6c1b66f8">43.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84014ab98a4b42999ddae99b7c9f17d6_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtNy0xLTEtMA_2ef44520-b514-4611-95a8-e357b02e926e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i650a3c515fb14f28b27a2fc34755a9b6_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtOC0xLTEtMA_ae0c0a57-f3e9-4ae9-b999-18043ecbe785">43.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ce55741e08d45cfb3768da278fa78cd_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMTAtMS0xLTA_9bfbcdf2-e601-435f-924f-a3facf11a884">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff14eff3dae4e748c42b944b71e66c5_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMTEtMS0xLTA_cb2cf76c-b891-4242-82f9-0aa97d2b924b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cce2f2486644d48b444db7df588805c_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMTItMS0xLTA_21a14009-31d2-44ea-87c6-f899be36bb93">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f414a4aae9647f39eb553c172b71177_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMi0xLTEtMA_5247de87-a220-4004-8c19-7c07c4334235">2,393.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c62b7c793f4af4829020516aa6f08f_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMy0xLTEtMA_6d2c93a2-a920-41e5-92af-788155e99640">1,301.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctNC0xLTEtMA_2ab4515f-52d0-43f0-80a4-954b4ecea302">3,695.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17631bcf62d64f15a706d210ecad4fc5_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctNi0xLTEtMA_513fcc0a-5353-4e71-8c34-cfb7fdee0ff9">1,582.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6465511e129b4f2b9244e3f15dc79aaf_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctNy0xLTEtMA_0615e2fb-69f5-458d-bffd-a48598934317">519.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctOC0xLTEtMA_a3972cea-9b81-4fd7-92c2-c25f639081eb">2,102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880e7908395c466ea1496767a0761862_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMTAtMS0xLTA_547da94b-5b1e-4480-8b9d-18ea3d4347a9">921.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12a3197c6b1443fca044a190d98cdcf6_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMTEtMS0xLTA_5e0ae34c-b04b-4bf1-9b8c-b60bb95a847d">284.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMTItMS0xLTA_22c7cc7c-bf5f-423e-8f8b-bd5114c04c71">1,205.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51cd7e31b542458f934ce2f21f3bbf77_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTItMS0xLTA_52ef9900-1c73-4bbd-a0bf-cafeff7ddc6a">830.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia873c88964a74ad8b51878c7599c0ee5_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTMtMS0xLTA_1b71e02e-4739-4e15-8d14-4960a060a760">253.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe5921de4e944419c03317f20e3cf76_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTQtMS0xLTA_3521dab9-3c33-4681-bd26-a74ad5706266">1,083.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66b3e8f28174bfc803903de805bdd71_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTYtMS0xLTA_29632df5-c23d-4f22-9510-243b514cb4e8">722.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i464eee65cbc7418d983a6e014907ca29_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTctMS0xLTA_bd0bea4b-6800-4623-a5cc-46db3bb469cd">231.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d9782966cd04624b4574f83bf76bd86_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTgtMS0xLTA_a0bbceb8-0cd4-4ada-a1d4-e9fbc37eeb5c">953.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51349d90e1e74711bc82d5c52b4c361a_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTEwLTEtMS0w_96ff4853-844d-434c-acea-1936095e7f31">853.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5d7207e8a04d8f95ed445f4e2ca090_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTExLTEtMS0w_e134c804-7108-4491-bc8d-3c068c4fa26a">241.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba6b598c34a40368885f7a795edc3ed_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTEyLTEtMS0w_ee56e3f7-0e63-4858-8354-2e04fc096c6b">1,094.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb689fd1c43b48ba823acc223d5dd95f_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTItMS0xLTA_d799ec85-b9c1-42b0-8d38-7502fcd1f307">221.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fd4ffa7b1c745a1bb74880e80155088_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTMtMS0xLTA_d14f693c-108e-4519-8f3f-4b5220802c11">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233647819a5f40d194dce2a1a9997d5a_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTQtMS0xLTA_478d81f5-7d03-4c57-8f48-ce232edf66b6">268.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i649c6b3f0c7c4dbaad7e0f14df3f9369_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTYtMS0xLTA_99eeb063-1272-4495-996d-1b0173c2a3d3">166.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b0f72609834981a2d8cce09ff40e97_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTctMS0xLTA_f8b2d82a-e741-43f2-b1f4-1df3a56edbcc">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55b5cbb5f9b4ffb9cdc329793b4ec2a_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTgtMS0xLTA_54ff69d5-db09-44d8-8cfa-d54c27ea31aa">198.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d916bf7bc7c4a77b9a424ea474da6ee_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTEwLTEtMS0w_2842b8c3-1292-4081-bbc9-eb51916f4dbd">184.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea5061f31944f2b9ce4b953e7acb45d_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTExLTEtMS0w_3ba9a5f2-492d-42e7-abf7-bf21f24dd6d3">34.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebf4abb2d7924525b0124ad8f4ac294d_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTEyLTEtMS0w_fcba97f4-bcae-4bba-93a1-1843be84636c">219.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf7514aec24c41be8928b4b1735c6c67_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTItMS0xLTA_dacf21fa-7ba1-4747-857f-28c2dfddcbd0">1,051.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7759fd469e4744c1aef40bd5673059f9_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTMtMS0xLTA_18915192-5f95-490a-b701-e50eae78d029">300.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTQtMS0xLTA_a1e0e95c-1bb9-47ea-b6a2-25bf33cc5b2d">1,352.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2987070776a540ddace03c1f2bc15110_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTYtMS0xLTA_93adc63a-93a6-4bf6-9258-ce12b5626adb">888.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc551316da34c2e8fefb62c8a6c00b8_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTctMS0xLTA_4a4050e3-8aa0-4d98-bb05-353088a5526c">263.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTgtMS0xLTA_ca48ddb9-6f97-4080-abaf-b47078fe2998">1,151.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dacb4bf98504ba0adc0104184a6b73e_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTEwLTEtMS0w_ed9332fc-0463-4aaf-8dd1-4297d266a87b">1,037.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93dd5c0ed3164c9592d8fe3882f0a28d_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTExLTEtMS0w_ac1aae99-7adb-421f-a713-55ef7f257515">276.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTEyLTEtMS0w_adf32db4-f942-4556-befd-36cf1d173cca">1,314.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043f4d719f7b44348bdf12b5a66ef493_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTItMS0xLTA_36571d65-07f9-4d20-9548-ac0aeab93eb1">396.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd533908ee6c40dd84ac4f8768c5930c_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTMtMS0xLTA_62db2fb2-5a4f-41f0-a693-ec5300cea260">91.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTQtMS0xLTA_98d2488d-cd34-4ddd-b149-da6f7e70bbac">488.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie54dd0f63ac74f119354986074fabb9f_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTYtMS0xLTA_99dc7a77-080f-4b7f-a2fb-72c6d574ff7d">310.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6f6c97bcbe64066a4c7b7de88fde26f_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTctMS0xLTA_c56ba8a3-1ca0-4db2-8907-6cbba1410670">66.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTgtMS0xLTA_f2b2524c-f7fe-4af6-842e-0fdc257e6019">376.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e752284b89d41fcad2da9334eb55ced_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTEwLTEtMS0w_d4a05a2b-d1a9-4f76-9b0d-e50bd40ce239">362.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i756b9830819145cf947d010150d735da_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTExLTEtMS0w_961629a7-e324-426e-b892-b8184b7af1e9">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTEyLTEtMS0w_54500105-84bf-4a9d-a8e4-1d12cec3abb1">437.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac2499d2fe7f4e5299751553c9849768_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTItMS0xLTA_84ae75ec-bcda-449a-ab83-da2a58645ad2">61.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f774c3730dc47318167508519cccd16_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTMtMS0xLTA_f27dd147-f1cd-4dcf-8931-705322edd9e2">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTQtMS0xLTA_e22b657f-9ac9-42f5-b79b-9f5680ef5677">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i595655c2121c42c4a0d63656cb7b4da9_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTYtMS0xLTA_fe1ce859-5d5d-471d-9c8b-b8a34483de51">51.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd7c0bc86cd4fd797e73c8a52e9c016_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTctMS0xLTA_410aec46-e331-4715-9907-2e4179f32d15">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTgtMS0xLTA_163282be-3463-4a10-9c10-bbff4fb3b3df">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i135f102a0e3348f19dffba8a6b80c845_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTEwLTEtMS0w_b33700fc-7959-4bc6-948c-46dd335ccdde">58.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76f2583244f4da1b4d8e2ffba810bd4_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTExLTEtMS0w_2af4799c-e762-4bc9-9233-30a3695f6cf8">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTEyLTEtMS0w_90ad00aa-fa5e-4396-ad55-6dc474908ff8">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d2066aba8e543da9c51bbcd0eeec832_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTItMS0xLTA_ae773d2b-0dc2-4c8e-880d-aed7bca3c320">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97948eaa2bd440598a0350abca5c22c9_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTMtMS0xLTA_ff6d208a-98b7-4db1-8ecd-6056cac73177">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTQtMS0xLTA_d2bbdcf1-cfd0-40f7-b683-2275135518f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa45be8be374656afd2437b80f21836_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTYtMS0xLTA_6e76ad83-4878-4da0-b68a-814f00f1ff33">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3ec9b2c72414e3986057885d7706597_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTctMS0xLTA_30091c17-7400-48b2-ba91-b5b0cdc20491">34.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTgtMS0xLTA_84b0ee63-93e6-4585-bcab-3a6bb75e8e5a">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f2dd55044054b76a0d73fc9c9908555_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTEwLTEtMS0w_878d6e9d-fc25-421f-88e8-e1baee461d31">155.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb7c94b54a04e06b4612b1dc367c680_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTExLTEtMS0w_39269a1f-73e3-4135-afdc-952e47ee5b19">160.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTEyLTEtMS0w_a46ed008-99ca-41a2-addd-9f65a67f63e3">315.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f02780b07b4af0a4ade42afb9a3277_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTItMS0xLTA_7c282ad6-ec76-4c27-87c1-ca0f235c124a">3,902.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d68382b58894a7a8493d2c3c72f0bdb_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTMtMS0xLTA_ae72da88-19f7-4837-b77b-46e06928004e">1,730.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTQtMS0xLTA_28bcb213-971f-4d82-9ef8-5f9a30b4fa1c">5,632.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b27c44ab2c049dab1ada8ce3e2c9dde_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTYtMS0xLTA_5d0e8290-afc0-4bce-8ef1-fb858440b715">2,863.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if613c1f13698495a8a9033eb60e30394_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTctMS0xLTA_25a8db8a-312b-4613-a0d8-d9dae76ba61a">913.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTgtMS0xLTA_c79c206f-04b8-42ad-b582-82cb0d4b4c32">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471641798bc6486890424f64b25cab0b_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTEwLTEtMS0w_fa123aa7-6a51-4cb5-a028-247731817bf0">2,536.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a75be05e6974cdeabdb5101ca308496_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTExLTEtMS0w_8bf54a62-df38-43c0-af1d-cda6d182a3c1">831.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTEyLTEtMS0w_69648df1-f5e1-4d2a-a589-1ab6c0e117f3">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i9bf54e4d4bf24262add7d8e372c59bd7" continuedAt="if3cff5f0a5a04b12b79379f62de42723"><ix:continuation id="i7b19a87fc8a241e3b5241fca3bf91110"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"><tr><td style="width:1.0%"></td><td style="width:37.510%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.765%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f02780b07b4af0a4ade42afb9a3277_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzItNS0xLTEtMA_98973fea-5f33-4925-8110-45192dda4ebc">3,902.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b27c44ab2c049dab1ada8ce3e2c9dde_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzItNi0xLTEtMA_df7e5dfb-0d29-4377-9677-9815ffbb7944">2,863.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471641798bc6486890424f64b25cab0b_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzItNy0xLTEtMA_20a4c4cb-bb4d-417b-b030-f04fb4429986">2,536.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c981ade86904092ab44cdc3421e6c6c_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzMtNS0xLTEtMA_4139b4d3-91a2-43e5-9cee-5066f0ce4690">1,201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58c230109b9d48e3bb3cde0f8a0abd26_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzMtNi0xLTEtMA_008bc26d-bf1e-462a-bda0-73f0ab6e83f0">569.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80097451dd62453689464503df8df92f_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzMtNy0xLTEtMA_ec429531-5831-4907-b460-2199b9ac2128">396.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cd1f66491984c7bb0dd1d0bc4fb2a69_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzQtNS0xLTEtMA_cc309bda-b8a6-41c2-ac8f-4169ad24085c">365.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fbadaaa41d47dd83cdd5d7dfa70cd8_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzQtNi0xLTEtMA_40b43535-daf9-42b1-90a4-bbfa773cb1e9">226.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae08e83f10e40cfb00da11f047781ec_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzQtNy0xLTEtMA_fbf71d35-bde3-4e1c-a720-e448d6c4ce6b">286.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2cf64befe504f17b267aaa43d3d20d6_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzUtNS0xLTEtMA_867b25c0-12c6-42c0-b921-26bd7eb3ea9d">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e66734d295a41f3bf8bc60c57b17a6f_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzUtNi0xLTEtMA_ce989147-daf6-40c2-b0f5-1de7ae6d577c">116.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13c1a5da1ce942d2aae72b3f00d90f06_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzUtNy0xLTEtMA_7ea5886e-169f-4c10-b9f4-3cda2a1f9ec7">149.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzYtNS0xLTEtMA_a0b1e3df-be25-4e8c-8d6f-11429e9d95cf">5,632.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzYtNi0xLTEtMA_1208c0ab-74de-4936-a96c-56c884384c67">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzYtNy0xLTEtMA_f70033b9-ef7d-4be5-af16-9aac906a7c77">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:32.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:20.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c10cbf1ca23411a80e5d03d6ee6dccd_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzItNS0xLTEtMA_f70fe187-15a5-4dd7-99cd-6796d113fae8">4,198.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13dbf383b09e471e8163112ba23934f4_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzItNi0xLTEtMA_58ec5ad5-ec7a-4b36-8c86-cdfcbe4c0caa">2,561.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf97bcf6dbc8421a9a3716760bcb97e7_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzItNy0xLTEtMA_0126937c-8e1c-4e48-8806-cb83dd42fa69">1,786.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00ab011f780a4f6f8ac17f56d74cdd4b_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzMtNS0xLTEtMA_42e7a493-79de-4f4e-b660-7ec5545cbcc0">769.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3def95246ab34bf5acf9bbbfc8b7d08c_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzMtNi0xLTEtMA_44e48bbe-a6bc-48c2-8156-605d0a0c358b">665.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic55d68378e9b4082aba5a6b9d59fb043_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzMtNy0xLTEtMA_632cec25-10b4-4ccf-9a1d-c1f03bb83308">984.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0068fc5d5747a882ce9ccbd0123f38_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzQtNS0xLTEtMA_80623f06-d40f-4a8e-bb81-8cfb38a34026">598.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88ee1f21a1904304a5934d3026a42b57_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzQtNi0xLTEtMA_6914c6bd-6bf3-4653-a8d8-f9fb6fea5d33">516.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf8b9b630f904fd0b483af12525ec51f_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzQtNy0xLTEtMA_cf14ce5a-fd1b-4bcc-b89b-6a9e4f495e2b">568.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611616cb655d4d7d9572751cfacacf64_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzUtNS0xLTEtMA_07fb0b3f-f5e2-40af-9f3a-b132e7edfdd9">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice08cc7189624f368d50df2bf2de0a54_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzUtNi0xLTEtMA_2716f473-920b-4b0c-9a6b-0d22d4f0570c">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf19b3b6d394dbd927075a441de11a2_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzUtNy0xLTEtMA_d832c465-3253-403d-acca-65e87c2f8cd7">27.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzYtNS0xLTEtMA_c080a8c0-90df-47f3-86ba-7d7facad02bc">5,632.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzYtNi0xLTEtMA_eaf3d000-7c68-44b0-a993-6978a669c6f7">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzYtNy0xLTEtMA_c813bc83-38c5-4f35-a8a2-9c763326a514">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefit of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="if3cff5f0a5a04b12b79379f62de42723"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts. The Company's contracts typically do not provide the right to return product. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 25, 2021, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc2NDM_ea847967-df61-470f-a0c9-0a5ce03be380">830.6</ix:nonFraction> million. These remaining performance obligations primarily relate to extended warranty and support and maintenance obligations in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="idd4c3415bf074cb794ce6b40d287d9c5_I20210925" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc4ODQ_f39aa902-0866-4cc0-856c-0c84e83baab7">40</ix:nonFraction>% of this amount as revenue in 2022, <ix:nonFraction unitRef="number" contextRef="ic46d5dcd82604bcbb61ee95e7645d76f_I20210925" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc5MjI_94b797b0-81ee-4100-9fa8-f19c7f0c50ab">27</ix:nonFraction>% in 2023, <ix:nonFraction unitRef="number" contextRef="i2e8a93ab7a16493487f16e6dd346050c_I20210925" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc5MzQ_90df76a4-9ce3-436e-8e91-d3f914e1889d">18</ix:nonFraction>% in 2024, <ix:nonFraction unitRef="number" contextRef="i9f6243dcc94a4351be212ad078c329c8_I20210925" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc5NDY_f9dd3108-8c9a-4fcd-bd7e-2bcdd1c64932">10</ix:nonFraction>% in 2025, and <ix:nonFraction unitRef="number" contextRef="if08ab3a606434b90acdb237e36cd8380_I20210925" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc5NjI_591a4706-49c3-4337-a5ed-78045470cd95">5</ix:nonFraction>% thereafter. The Company has applied the practical expedient to not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments. Contract liabilities are classified as other current liabilities and other long-term liabilities on the Consolidated Balance Sheets. The Company recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzkzMzk_520cf608-ce9c-42b2-830b-0341ccc7d5c4">112.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzkzNDY_b35ae856-688a-4522-af79-a246be082e98">106.2</ix:nonFraction> million in the years ended September 25, 2021 and September 26, 2020, respectively, that was included in the contract liability balance at September 26, 2020 and September 28, 2019, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical Expedients</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_142"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODQ_367a6052-bda9-4df9-81f6-e75b7b650775" continuedAt="id45eba4ab9b04e6ab9350d758c392a0c" escape="true"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:LessorSalesTypeLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODQ_723814dd-7f7c-4afe-af64-2cdfd57684d5" continuedAt="i1416802e5ea149ac82694c74e71989ef" escape="true"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:OperatingLeasesOfLessorDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODQ_9254561b-52e1-46bd-9603-7627fe5e7d52" continuedAt="i53088e66f7f34143ab45d13ff99b3242" escape="true"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODQ_c1ec1ebd-2bfd-4d5b-ac0f-2e5713b66a47" continuedAt="i399d35ffc59544dba42678a5f87ab934" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="id45eba4ab9b04e6ab9350d758c392a0c" continuedAt="i5a67ba26619d46b78b85023ef3c91e18"><ix:continuation id="i1416802e5ea149ac82694c74e71989ef" continuedAt="ice2c0c2debab452f9c77cc2a7685f471"><ix:continuation id="i53088e66f7f34143ab45d13ff99b3242" continuedAt="i2162d94fdee2487e9aa3d116eb124d4a"><ix:continuation id="i399d35ffc59544dba42678a5f87ab934" continuedAt="i2b89b843467240bdabf4b1fd507d059c"><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, referred to as ASC 842. The purpose of ASU 2016-02 was to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Targeted Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i5a67ba26619d46b78b85023ef3c91e18" continuedAt="i57ea870d57a44b169ab3c7c2adb10672"><ix:continuation id="ice2c0c2debab452f9c77cc2a7685f471" continuedAt="i3fb367db801b45efad7138b93b2618b2"><ix:continuation id="i2162d94fdee2487e9aa3d116eb124d4a" continuedAt="i2a352a77417848159e72fe7505f54d3e"><ix:continuation id="i2b89b843467240bdabf4b1fd507d059c" continuedAt="ie1033e1960b04c59b30ff195d586527d"><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not have a significant amount of sales-type leases. Prior to the adoption of ASC 842, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $<ix:nonFraction unitRef="usd" contextRef="i215e3aea9151448587579caf2488d39e_I20190929" decimals="-5" format="ixt:num-dot-decimal" name="holx:OperatingLeaseRightOfUseAssetAtAdoptionOf842" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI2NzU_85093644-71e8-49e4-be84-867f4747fb3f">91.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i215e3aea9151448587579caf2488d39e_I20190929" decimals="-5" format="ixt:num-dot-decimal" name="holx:FinanceLeaseRightOfUseAssetAtAdoptionOf842" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI2ODI_b35c4f30-32a3-44f6-b4ed-8804e68726eb">10.2</ix:nonFraction>&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156"><ix:nonFraction unitRef="usd" contextRef="i215e3aea9151448587579caf2488d39e_I20190929" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1375f84-ef5f-4e71-b4e1-87dcd926404e">96.6</ix:nonFraction>&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100"><ix:nonFraction unitRef="usd" contextRef="i215e3aea9151448587579caf2488d39e_I20190929" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_1b96eeeb-4f9c-4571-bad3-81c7fa8b8b75">21.0</ix:nonFraction>&#160;million</span>, respectively. This included recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $<ix:nonFraction unitRef="usd" contextRef="ide9bb99b7773447e866b67fabae6a11d_I20190929" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI5Mzc_0eff755c-2969-4d6e-9d08-456d53e2e87d">32.6</ix:nonFraction>&#160;million of property, plant and equipment and $<ix:nonFraction unitRef="usd" contextRef="ide9bb99b7773447e866b67fabae6a11d_I20190929" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI5Nzc_ffc6840e-c10a-405b-827b-cec871bfb435">35.2</ix:nonFraction>&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements were included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:durwordsen" name="holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzM2NDI_55ebc83e-7460-4350-ae4a-891db2b86852">one year</ix:nonNumeric>. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of <ix:nonNumeric contextRef="i7133ee75e2dd4ac999d32c90c55818c6_D20200927-20210925" format="ixt-sec:durwordsen" name="holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzQxNTc_f7d836b1-7dc4-489e-849a-d45fde9c5b2b">one year</ix:nonNumeric> to approximately <ix:nonNumeric contextRef="ib5f33f2bd0484efea0b8ae4a94ebb11e_D20200927-20210925" format="ixt-sec:duryear" name="holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzQxNzc_c1c6bfdf-c04f-440c-8e7e-c4d29bfd1035">14</ix:nonNumeric> years, some of which may include options to extend the leases for up to <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:duryear" name="holx:LesseeOperatingAndFinanceLeasesExtensionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzQyNDY_8e6e5fbf-ce0b-4a48-834d-0c5d96ec3b5b">10</ix:nonNumeric> years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;25, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating and finance lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;25, 2021 was <ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="4" name="holx:LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzU4MjE_ad976b8d-fb24-4518-bffa-47600ee672ce">2.25</ix:nonFraction>%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODY_040ab42c-06ba-4d0c-b9a5-877f170c1956" continuedAt="iea34e84a771a47d197d981b7cd2534b0" escape="true">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</ix:nonNumeric></span></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i57ea870d57a44b169ab3c7c2adb10672" continuedAt="i25faf360fee540c4b5737709c548c4b1"><ix:continuation id="i3fb367db801b45efad7138b93b2618b2" continuedAt="i35bd49ece3904a52ae87a78c5755b4c5"><ix:continuation id="i2a352a77417848159e72fe7505f54d3e" continuedAt="i85b89d76812645cdbad704d163afb90c"><ix:continuation id="ie1033e1960b04c59b30ff195d586527d" continuedAt="if25a6a8ec34d4e05a13903d5f701750d"><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><ix:continuation id="iea34e84a771a47d197d981b7cd2534b0" continuedAt="ifaf09bf372fd46d0974ef2acf8568ad6"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:24.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.827%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80e5c3b505e41f3ac02c7fd4f5a90f6_I20210925" decimals="-2" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMy0xLTEtMA_20e35170-52b0-4615-b0e5-3a793ad57670">83.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd232192ed78407a974ddcf2b2257851_I20200926" decimals="-2" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtNS0xLTEtMzQ0NDQ_7bc651e3-8965-483c-a87b-2ff5eeae4fba">80.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bca38bbb4548949606b34deb9181e6_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzUtNC0xLTEtMzQ0NTI_cd80119b-faf4-4a02-ac17-ebf20e5855d2">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da">Accrued expenses</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc7bf647e314aef9275b300600f7660_I20210925" decimals="-2" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMy0xLTEtMA_0e3031f9-cc3a-4d28-a27f-5c21cfb3eee3">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4cbe84c2c244569ac0c808b9c550275_I20200926" decimals="-2" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzctNS0xLTEtMzQ0NTA_c661ce39-39be-44f1-b12d-64e26df55dc0">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63a69ff36b674be191db12ceabcae07d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzctNC0xLTEtMA_5758555d-e9b6-4e3a-b35b-5eee5ffd3c04">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea319a404a74e32a76dde8d8433c89d_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtNi0xLTEtMzQ0NTY_161a8dbe-0d08-48da-85bd-714247fa910d">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fefdb83fea04155bda0d8947d2e2c81_I20210925" decimals="-2" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMy0xLTEtMA_880a348a-7f46-4779-a52a-a4e2ae08c49b">66.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c5787a7635445a6a57c55963ee616c2_I20200926" decimals="-2" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzktNS0xLTEtMzQ0NTQ_2882e697-23e3-48c2-9100-f31694100405">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bca38bbb4548949606b34deb9181e6_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzktNC0xLTEtMA_5c3e0705-eaaa-4f65-830b-eb2711affc61">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id55ff3c8d27c42eb867928b21b604ce3_I20200926" decimals="-2" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzEwLTYtMS0xLTM0NDU4_2c734a1a-0ec7-4572-a048-1d3e39c5c6a6">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Diagenode SA acquisition, the Company acquired <ix:nonFraction unitRef="segment" contextRef="i474f42fec50e415899f9fcc327fc81f0_D20210301-20210301" decimals="INF" format="ixt-sec:numwordsen" name="holx:NumberOfFinanceLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzIxOTkwMjMyNzQ3NDE_64c3216b-446d-4449-855d-82f3c625f06b">two</ix:nonFraction> finance leases. The Company accounted for these lease agreements pursuant to ASC 842 and ASC 805 and recorded both an asset and liability at the present value of future lease payments as part of the purchase accounting. The finance leases are for two facilities with remaining lease terms of <ix:nonNumeric contextRef="i185383b2d2cf4d63b7121bb5d0c32d01_I20210301" format="ixt-sec:duryear" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzIxOTkwMjMyNzQ3NTI_45dc88e2-839c-4700-96ee-95fdefafb096">7</ix:nonNumeric> and <ix:nonNumeric contextRef="i1fed62fa0ae548ef9551dac57b66c922_I20210301" format="ixt-sec:duryear" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzIxOTkwMjMyNzQ3NTk_b083622d-56b9-4f03-afac-a3d2b7461d89">11</ix:nonNumeric> years and contain a bargain purchase option of <ix:nonFraction unitRef="number" contextRef="i474f42fec50e415899f9fcc327fc81f0_D20210301-20210301" decimals="3" name="holx:LesseeFinanceLeaseBargainPurchaseOptionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzIxOTkwMjMyNzQ3NzI_a6936607-986c-4617-8fe5-f2cfc1965993">3</ix:nonFraction>% at the end of the lease term. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="ifaf09bf372fd46d0974ef2acf8568ad6"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"><tr><td style="width:1.0%"></td><td style="width:36.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.099%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzItMi0xLTEtMA_1e3ac1fa-92d4-49bb-88d1-fa8a64662678">4.95</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzItMy0xLTEtMA_e2ac4f41-e66a-4688-a797-facd238093bb">7.52</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzItNC0xLTEtMzQ0MzY_92fa7093-e127-4e01-b221-43d5ff6fc707">5.58</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzItNS0xLTEtMzQ0NDA_e18d19ff-7676-453a-be1f-1621ad955194">7.64</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzMtMi0xLTEtMA_406bb62d-7c2e-4553-ae2c-eeb5b8407d9d">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzMtMy0xLTEtMA_577e86ae-1a19-4111-b739-d09046414c21">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzMtNC0xLTEtMzQ0Mzg_c09fa0cf-4575-437b-ba0a-8c56ab3f9bac">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzMtNS0xLTEtMzQ0NDI_9e6dc1fc-90c1-4e2f-a351-8f830417898b">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODE_ef882dfe-dac9-4cf2-8d53-d239c8dbada6" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"><tr><td style="width:1.0%"></td><td style="width:2.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.031%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzEtMi0xLTEtMA_de8b0368-9773-4a06-8186-7135335daea6">30.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="2" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzEtMy0xLTEtMzQ0Mjc_2b40b2c3-b500-4b5f-9280-44fe1f07251a">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-2" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzItMi0xLTEtMA_c3bf9f1a-9cd7-4242-addc-b46eac4f8441">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-2" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzItMy0xLTEtMzQ0MjU_5f191f08-e4a1-408c-b093-ba84f302c906">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-2" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzMtMi0xLTEtMA_76bcb893-e8ff-4f41-823a-4ef2ffc4192b">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-2" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzMtMy0xLTEtMzQ0MjM_fb17eec4-7057-416a-aee8-9a815a176b50">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-2" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzUtMi0xLTEtMA_d46a9328-71c1-449a-95dc-31616f1ab506">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-2" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzUtMy0xLTEtMzQ0MjE_3b10055c-aa9c-4913-a514-7509e3f197bc">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-2" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzYtMi0xLTEtMA_6ffbf358-ebe8-4b6f-8ac5-946d42fb3e21">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-2" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzYtMy0xLTEtMzQ0MTk_ed4d8661-78d0-4e70-8d72-4879c697f06c">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="5" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzctMi0xLTEtMA_c253d4e4-bc7f-4d2f-979a-888f297c7ebe">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="5" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzctMy0xLTEtMzQ0MTY_3b76c26a-6b3c-42ef-9c54-d8e13df983cc">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-2" name="holx:OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzgtMi0xLTEtMA_bf6d6964-6e68-466e-822d-db757f5c2ae1">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-2" name="holx:OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzgtMy0xLTEtMzQ0MTQ_3b1aad93-f789-4336-abf7-9f7ba3b86a23">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-2" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzEwLTItMS0xLTA_2ab664f7-cb89-43ff-b887-e7ef7e0ad1a8">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-2" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzEwLTMtMS0xLTM0NDEw_730446e4-82f9-4cb2-ad21-b01af5aebe9a">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new finance lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzExLTItMS0xLTM0NDA2_b8c8a6bd-faa4-4770-a467-5575dcc6ba4a">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="2" format="ixt:fixed-zero" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzExLTMtMS0xLTM0NDA4_8195c05d-6fea-47cf-96e7-11cce90522d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzY1NTU_e5f34291-1b27-4245-bfb4-ec60b9c5b03f">23.1</ix:nonFraction>&#160;million for fiscal 2019.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODI_35ff640a-101f-48f9-ba0e-87faa9f07842" continuedAt="i6a025de36c0d498cb9785aa52903a5e0" escape="true"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODI_d9c3750a-7797-4241-8395-1dd037541eef" continuedAt="i884e284cf9f045789385905906eed491" escape="true">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:</ix:nonNumeric></ix:nonNumeric></span></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i25faf360fee540c4b5737709c548c4b1"><ix:continuation id="i35bd49ece3904a52ae87a78c5755b4c5"><ix:continuation id="i85b89d76812645cdbad704d163afb90c"><ix:continuation id="if25a6a8ec34d4e05a13903d5f701750d"><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><ix:continuation id="i6a025de36c0d498cb9785aa52903a5e0"><ix:continuation id="i884e284cf9f045789385905906eed491"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:64.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzEtMi0xLTEtMA_0397cd2a-ac03-4da3-9e62-5ef3b81a039d">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzEtMy0xLTEtMA_87380ff7-b2f3-471f-9961-6c43512822b8">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzItMi0xLTEtMA_f838ef96-565a-4718-a609-18fbcce67067">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzItMy0xLTEtMA_51999a79-b6af-4d0a-9b91-4f51fcf879bf">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzMtMi0xLTEtMA_7a2f82b3-6aae-4f0b-8c72-842d5a283504">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzMtMy0xLTEtMA_0293f5fb-9b73-4068-a063-f69669bd1446">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzQtMi0xLTEtMA_f8130f61-7382-4913-b8fa-2cf0dc8b536b">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzQtMy0xLTEtMA_974ef300-2f0c-4bdc-bfbf-83d4a2f27921">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzUtMi0xLTEtMA_e68a94df-518e-41ca-9808-8c79168f0850">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzUtMy0xLTEtMA_4dcb5d3b-4ab4-4ca7-a86e-fb1ea0e5c91d">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzYtMi0xLTEtMA_8ba90839-2c6c-4e35-aaa1-08d3ffa22b37">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzYtMy0xLTEtMA_ea1a4b3a-bbe6-47b2-a50a-8d5053e9d1a7">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzctMi0xLTEtMA_6b3ae1c7-8522-40ef-8c75-8ac27bc57cfe">97.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzctMy0xLTEtMA_e0b128b5-e69f-45ec-96ab-44dba7bec2b9">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzgtMi0xLTEtMA_a1bea9d3-ac34-4d3a-ae18-469a77066a86">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzgtMy0xLTEtMA_16b2a4fb-e6cd-4e74-b25d-666332a6539c">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzktMi0xLTEtMA_72ccde44-32bb-49a2-83ad-85b01c861748">92.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-2" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzktMy0xLTEtMA_27708b19-eb6b-434c-a9e7-397cc80be2d1">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than <ix:nonFraction unitRef="number" contextRef="i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925" decimals="2" name="holx:LeaseRevenuePercentageOfTotalRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzc3ODE_cfdf6421-4ded-4d46-9e5f-0e7280c3286f">5</ix:nonFraction>% of the Company&#8217;s consolidated revenue for all periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the disposition of the Medical Aesthetics business in fiscal 2020, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $<ix:nonFraction unitRef="usd" contextRef="i4b68378841c444ef93e2ed5a74fb5f45_D20190929-20200926" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgwNzQ_6d215c98-441a-4286-8aa9-ec7561d1f0d4">10.2</ix:nonFraction>&#160;million for the right-of-use asset for the finance lease and recorded a lease receivable, which is $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" format="ixt:num-dot-decimal" name="holx:LeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgyMTM_09468327-7932-4d54-a767-c1256449a1b6">17.4</ix:nonFraction>&#160;million as of September&#160;25, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases a portion of a building it owns and subleases some of its rented facilities and has received aggregate rental income of $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgzNTg_2f92edbe-4563-4d02-be52-5fd9a050b186">2.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgzNjI_232a7db1-9181-4d5e-9a19-a3df22b8713a">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgzNjk_f701d769-9871-4dd5-ad19-4f6a2d75531f">2.7</ix:nonFraction> million in fiscal 2021, 2020 and 2019, respectively, which has been recorded as an offset to operating lease costs. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:OperatingLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODM_8717ec73-cc3e-45df-b293-040b399fee7a" continuedAt="i077f9624788a4924bae096559837b20c" escape="true">The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:</ix:nonNumeric></span></div><ix:continuation id="i077f9624788a4924bae096559837b20c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"><tr><td style="width:1.0%"></td><td style="width:77.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.019%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:SubLeaseRentalIncomeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzAtMi0xLTEtMA_06907700-99ff-47ed-9333-2bfafb1ca66a">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:SubLeaseRentalIncomeDueIn2Years" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzEtMi0xLTEtMA_1e54b69d-b8b9-45bf-83f6-24bc5218a6ea">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:SubLeaseRentalIncomeDueIn3Years" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzItMi0xLTEtMA_d83d8d93-4a04-4980-8722-6044b32360b5">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:SubLeaseRentalIncomeDueIn4Years" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzMtMi0xLTEtMA_14bfbe78-f07a-41dd-9342-ee6732ca24eb">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:SubLeaseRentalIncomeDueIn5years" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzQtMi0xLTEtMA_cecd0476-ef5e-4692-88b1-f49e2587fd3c">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:SubLeaseRentalIncomeDueThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzUtMi0xLTEtMA_44ef3c8f-895d-44d6-b7d8-724b1340d7b9">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:SubLeaseRentalIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzYtMi0xLTEtMA_41ce1f0e-3388-4ec0-94b9-4276d2911484">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_145"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzE1MzM1_5ad5d15a-7e12-4b29-bbee-296d5bf1634f" continuedAt="i67e4227c7d42474f9898b7d25a825f8b" escape="true">Business Combinations</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i67e4227c7d42474f9898b7d25a825f8b" continuedAt="i2263112a3d1e4612a613f44395ce2682"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During fiscal 2021, 2020, and 2019, the Company completed several business combinations for a total consideration of $1,178.9 million, $269.0 million and $120.1 million, respectively. The business combinations resulted in the recognition of intangible assets, goodwill and other assets and liabilities summarized below. During 2021, the Company also completed an asset acquisition of customer relationship assets of $5.6 million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mobidiag Oy</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2021, the Company completed the acquisition of Mobidiag Oy ("Mobidiag"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i2d1855a726e04afa80871b8a251ccd6f_D20210617-20210617" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY2OTQ_df6f7215-d4b6-46a0-a69f-cdd27b294b14">729.6</ix:nonFraction>&#160;million. Mobidiag, located in Finland, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. Mobidiag's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY2OTA_7741a1f1-d5c0-48be-b4a8-97dbdcbb6b20" continuedAt="ieac14fb0944e466da3659585f2b22a8c" escape="true">The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i2263112a3d1e4612a613f44395ce2682" continuedAt="i26ef36e7f3d04fbf91bb27453826520e"><ix:continuation id="ieac14fb0944e466da3659585f2b22a8c" continuedAt="i935cc34738b74d4daafa7f819f608824"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based on the estimated fair values as of June 17, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzAtMi0xLTEtMzQ5MTQ_58b7d66f-2c2a-4249-b13d-310c6f27b3a7">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzEtMi0xLTEtMzQ5MTQ_15ab9718-8e3e-4a4a-80e2-d44ef1e47c55">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzItMi0xLTEtMzQ5MTQ_a1bb640d-632e-4044-91cd-dea6651115ea">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzQtMi0xLTEtMzQ5MTQ_8ea6d439-f2ad-41d1-a3da-23408381efba">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzUtMi0xLTEtMzQ5MTQ_a9817516-4564-4e1b-920c-6123597d1bab">19.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzYtMi0xLTEtMzQ5MTQ_a6cb012f-fa0b-4824-8440-8b050fda2d70">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzktMi0xLTEtMzQ5MTQ_d412eaac-e9f7-4fc4-a0be-105eea955c67">285.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzEwLTItMS0xLTM0OTE0_f25a6c8e-ee01-437f-9909-407168f598b3">74.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzExLTItMS0xLTM0OTE0_79381167-2527-4150-98ff-566228a197f5">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzEyLTItMS0xLTM0OTE0_1e6d277a-93b1-442a-a6bb-95781a41d570">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzE0LTItMS0xLTM0OTE0_43946e54-2200-411a-b5bb-f6241de4d4ab">66.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzE1LTItMS0xLTM0OTE0_cc410ee2-bc37-4d19-9b62-9b1dc8443e56">60.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzE2LTItMS0xLTIzMTg4_ab3f818e-db03-47f6-9f33-edb4a3658c3e">432.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzE3LTItMS0xLTM0OTE0_f3974c4b-f95b-4319-9bc2-fcdcbc31e928">729.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Mobidiag's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily related to deferred income taxes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are development technology, in-process research and development ("IPR&amp;D"), customer relationships and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from <ix:nonFraction unitRef="number" contextRef="i209e37886ec24b4ca152f473bd170893_D20210617-20210617" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3MTA_f77483f1-4b63-4174-bada-1226772329dc">15.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i1adc191bfb1944e6a9cbc20ef1487b58_D20210617-20210617" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3MTc_ea14f8be-8e95-4148-879c-ab377853edf2">19.0</ix:nonFraction>%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology assets are comprised of know-how, patents and technologies embedded in Mobidiag's products and relate to currently marketed products. The developed technology assets comprise the primary product families under the Novodiag and Amplidiag technology platforms.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D project relates to an in-process project that has not reached technological feasibility as of the acquisition date and has no alternative future use. The primary basis for determining technological feasibility of the project is obtaining regulatory approval to market the underlying product. The asset recorded relates to one project, and the Company expects to complete the project over the next three years. In the fourth quarter of fiscal 2021, the Company updated its valuation of IPR&amp;D assets based on facts that existed at the date of acquisition and recorded a $<ix:nonFraction unitRef="usd" contextRef="ia55f2fdbeb5742f7b3342b8cee59d144_D20210627-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE3MTE2NzE_9939fbea-bc30-4f72-a069-6748209bff36">29.0</ix:nonFraction>&#160;million decrease to the IPR&amp;D intangible asset value. Given the uncertainties inherent with product development and introduction, there can be no assurance that the Company's product development efforts will be successful, completed on a timely basis or within budget, if at all. The IPR&amp;D asset was valued using the income approach.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary estimate of the weighted average life for the developed technology assets range from <ix:nonNumeric contextRef="i942be4914a6f424abf0ee50bc8e25578_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3Mjg_85cffaab-d3c1-4de4-a1fd-7a32e7c20b60">8</ix:nonNumeric> to <ix:nonNumeric contextRef="ic2e17b8f966541f782e6ed141bb9f99d_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3MzU_29bb0e4a-519d-46f7-a0fb-50c2868d8a08">12</ix:nonNumeric> years, customer relationships range from <ix:nonNumeric contextRef="i989b3c343b4149569fea2cd1610908f1_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3NTI_f7d7eed9-6e16-4f3d-989b-4737e7e18631">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i190577d230694c6db7092cbe00fd5262_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3NTc_e564769a-d5ad-48ee-b624-13e45c153db1">10</ix:nonNumeric> years, and tradenames range from <ix:nonNumeric contextRef="ice6517c799d444b38d8fd28d773fafac_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3NzI_a97c1696-b977-4893-baf3-be8c1feb2515">8</ix:nonNumeric> to <ix:nonNumeric contextRef="i1aef7229f2fb43e2bf47467c959ff49f_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3Nzk_7d8ab02d-7b34-4d74-bfac-8db299c88f58">12</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Mobidiag acquisition. These benefits include expanding the Company's molecular diagnostics portfolio into the near-patient testing market and utilizing the Diagnostic's commercial sales, manufacturing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biotheranostics</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i26ef36e7f3d04fbf91bb27453826520e" continuedAt="ieca9c5dd122c436d914ea4229867a057"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, the Company completed the acquisition of Biotheranostics, Inc. ("Biotheranostics"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i79d7a89a26634ea88d3359abf077c8ba_D20210222-20210222" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzMyOTg1MzQ5MTA1Nzk_8ba4f5e2-25ee-4a26-ac96-846ee54e47c5">231.3</ix:nonFraction>&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs the lab testing procedures at its facility. Biotheranostics' results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition and its revenues are reported within service and other revenue in the Company's consolidated statement of income and within service revenue in the disclosure of disaggregated revenue in Note 3.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="i935cc34738b74d4daafa7f819f608824" continuedAt="i2c902ba80bd04adba52db91105ec7a42"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzEtMi0xLTEtMzUwMjY_bd19f066-9c3e-460a-86d4-6596c296bc26">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzItMi0xLTEtMzUwMjY_19ac66af-892b-4d55-bfe8-146e3ca05b57">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzUtMi0xLTEtMzUwMjY_cac82022-8061-42f6-b38b-127e199740be">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzYtMi0xLTEtMzUwMjY_de0a2e97-7ad0-4090-8dda-80a89107e28c">8.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzctMi0xLTEtMzUwMjY_190fe991-a324-4c0d-85ba-ef6e120d45cc">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzktMi0xLTEtMzUwMjY_65ed17e3-0686-4ded-b7fa-0f0625f3b70d">160.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzExLTItMS0xLTM1MDI2_c2b42267-5061-47e7-9aae-8c9a62fd2c8a">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzE0LTItMS0xLTM1MDI2_118f3b3c-013f-4e24-8342-b1a3302a41bf">18.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzE1LTItMS0xLTIzMTgw_ad688a33-0ff0-44c8-9c5a-fa00e6b0563f">80.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzE2LTItMS0xLTI1MTQ5_7bdf7347-37ef-45fc-a267-c7ca8d6013b8">231.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Biotheranostics' business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="i79d7a89a26634ea88d3359abf077c8ba_D20210222-20210222" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3OTI_cee62dac-8653-426d-ace8-20f8a0a72a35">18.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is <ix:nonNumeric contextRef="i79d7a89a26634ea88d3359abf077c8ba_D20210222-20210222" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4MDE_36f4b31b-e4d9-4ffc-be1c-fcd6af0cce34">10</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated synergistic benefits of adding Biotheranostics' Clinical Laboratory Improvement Amendments (CLIA) lab to the Company's portfolio of offerings and of utilizing Diagnostic's marketing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagenode</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, the Company completed the acquisition of Diagenode SA ("Diagenode") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i36c42ab7aefa4f41aab159b7a5733d71_D20210301-20210301" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzMyOTg1MzQ5MTA2MTA_7ebd2aa5-d6f7-4285-b814-69679e7e55e4">155.1</ix:nonFraction>&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR (polymerase chain reaction) technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2c902ba80bd04adba52db91105ec7a42" continuedAt="ib9d389b0373a471d9a344eb4f9878e41">The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.</ix:continuation></span></div></ix:continuation><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="ieca9c5dd122c436d914ea4229867a057" continuedAt="i47f37bfc3cf642fdb2e582889ad5e343"><div style="text-align:center"><ix:continuation id="ib9d389b0373a471d9a344eb4f9878e41" continuedAt="id382a2b317b341288e25d91241de1658"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzEtMi0xLTEtMzUwNjY_a62ffe5f-7009-4691-bb96-6a37833c96f6">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzItMi0xLTEtMzUwNjY_77e7f1b0-be5d-4a1b-9c34-6024321f451c">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzMtMi0xLTEtMzUwNjY_3c255ac8-92a6-472f-a72b-31d92ae89bc1">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzUtMi0xLTEtMzUwNjY_2e34f0d0-075b-4a93-82c6-98fa8011a6d3">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzYtMi0xLTEtMzUwNjY_ae54c51a-ffc3-45b5-b5da-558bd5dadb40">16.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzctMi0xLTEtMzUwNjY_005ae7e6-bcde-4081-b80c-1871c4033d11">9.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzktMi0xLTEtMzUwNjY_c799f8a1-91ce-4852-a274-dbf624de7a64">69.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzExLTItMS0xLTM1MDY2_71ab8c84-6b27-4731-8c1d-777f6c825297">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzE0LTItMS0xLTM1MDY2_962f6e32-46af-4f56-a009-fc10aae95250">19.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzE1LTItMS0xLTIzMTkz_a811092d-d441-4ca6-8509-c5d3d84c6685">83.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzE2LTItMS0xLTM1MDY2_f4f8d584-5238-4e68-96bc-676c273dd5fb">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Diagenode's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily related to deferred income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and customer relationships. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="if659372cd83b4bd4bc8116d8668b1a35_D20210301-20210301" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4MTQ_43b3040f-a6e0-4809-abce-b052980143dd">14.5</ix:nonFraction>% rate for developed technology and a <ix:nonFraction unitRef="number" contextRef="i7f176b8a88dd4e52a616432565abdf82_D20210301-20210301" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4MjE_e66edf6a-938e-47e1-bb3f-cdf18608c5c7">13.5</ix:nonFraction>% rate for customer relationships. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and customer relationships is <ix:nonNumeric contextRef="i36c42ab7aefa4f41aab159b7a5733d71_D20210301-20210301" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4MzA_863273af-27f2-4788-96e7-7377bd0ee3b7">10</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Diagenode's products broadening the Diagnostics portfolio of molecular diagnostics products primarily in the transplant and acute care gastrointestinal and respiratory space as customers seek a broader menu of tests, utilizing Diagnostic's sales force to drive menu expansion and revenue growth and gaining additional PCR assay development expertise. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Somatex Medical Technologies</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2020, the Company completed the acquisition of Somatex Medical Technologies GmbH ("Somatex") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i2946643ddc6a41b8bc328cd550813b7c_D20210104-20210104" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzU5Nzk_89c7cb76-6ea0-4269-86bf-0a531b42d81b">62.9</ix:nonFraction>&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. The allocation of the purchase price is based on the Company's preliminary valuation, and it allocated $<ix:nonFraction unitRef="usd" contextRef="i4dbe228069a44bdeab333d84de471731_I20210104" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzYwNzU_0703638f-b7c8-46c4-b5b4-928f9ca474b4">38.0</ix:nonFraction>&#160;million to the preliminary value of developed technology, $<ix:nonFraction unitRef="usd" contextRef="i4dbe228069a44bdeab333d84de471731_I20210104" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzYwOTA_4e52cd0b-7d55-494e-a4a9-cfb48a77cead">1.2</ix:nonFraction>&#160;million to customer relationships, $<ix:nonFraction unitRef="usd" contextRef="i4dbe228069a44bdeab333d84de471731_I20210104" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4NDM_1fe99631-5d08-48b0-890b-e110850575b6">0.9</ix:nonFraction>&#160;million to trade names and $<ix:nonFraction unitRef="usd" contextRef="i4dbe228069a44bdeab333d84de471731_I20210104" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzYxMDQ_16cf07a6-61f7-49f2-9e73-cf807718cb7e">32.4</ix:nonFraction>&#160;million to goodwill. The remaining $<ix:nonFraction unitRef="usd" contextRef="i4dbe228069a44bdeab333d84de471731_I20210104" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzYxNjA_cf23401a-a2a4-4c9d-8528-c76fb3cc8d2d">9.6</ix:nonFraction>&#160;million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily related to deferred income taxes. Somatex' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i764422f35a5940fb9fd05f652236cf3a_D20200928-20200928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4NTc_6ff0aa27-61fc-43b0-9796-f99c365167a4">5.6</ix:nonFraction>&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal Health products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of <ix:nonNumeric contextRef="i5ee9425976bd4c5ea618b0d36430a7c8_D20200928-20200928" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4NzM_0e12bfaa-fe8b-47f9-b4d0-5205838b2f3e">5</ix:nonNumeric> years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ib9077d45e6f24c7586761d31add141ac_D20200823-20200823" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzE2Mw_dd699b37-1c30-4f04-82a8-5feaccf5d1c3">162.0</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="iec517cd2e58d49acbb42aa527e1d9b85_I20200823" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzE5Nw_75f39e62-8ace-4830-8188-f848fad13627">3.0</ix:nonFraction>&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $<ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzMyMA_c8507a94-c93d-4e6e-abd6-9b61442c640e">81.8</ix:nonFraction>&#160;million as of the measurement date. Acessa, located in Austin, Texas, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i47f37bfc3cf642fdb2e582889ad5e343" continuedAt="i5024cfe77ed84bdbb5d8ce77efa8e90f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company is required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. For the year ended September 25, 2021, the Company remeasured the contingent consideration liability and recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i6087fbabae0944f982d1de9eb1a1ed44_D20200927-20210925" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NTU3OTM_b4028874-5764-41e4-99fd-9e73ed566234">6.7</ix:nonFraction>&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period, partially offset by a lower discount rate and accretion of the liability based on the passage of time. As of September 25, 2021, the Company&#8217;s contingent consideration liability was $75.1 million, $16.3 million of which was recorded within accrued expenses and $58.8 million was recorded within other long-term liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id382a2b317b341288e25d91241de1658" continuedAt="i3b1ce9a6eeba4c59a18ca4a2685a7588"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"><tr><td style="width:1.0%"></td><td style="width:5.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzAtMi0xLTEtMA_6f0e3da3-f9ad-49b9-96be-d7ea5b420c54">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzEtMi0xLTEtMA_aca64fd2-1307-4fa4-a3f0-606f0923d137">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzItMi0xLTEtMA_cdae2047-effa-4444-8fbd-ddb1fbfcb120">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzMtMi0xLTEtMzUxNjA_04160184-a881-4219-bd66-4628591c148f">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzQtMi0xLTEtMA_19b5c24d-4e5f-4ece-9496-a9568833ccd6">127.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzYtMi0xLTEtMA_b6b984b6-b806-45a9-8abe-2cdf38c989d1">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzgtMi0xLTEtMA_3e9ac41d-11e2-4d7e-acff-7ccee794525f">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzktMi0xLTEtMA_db5a3061-5ff7-47af-b83f-a60485e8d0ab">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzEwLTItMS0xLTA_415e698c-2e24-4d84-9ab9-437648b593af">162.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using an <ix:nonFraction unitRef="number" contextRef="ib9077d45e6f24c7586761d31add141ac_D20200823-20200823" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzI2OTU_b8bfe9ed-75b9-44ba-958c-ff3bf693df74">18.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is <ix:nonNumeric contextRef="ib9077d45e6f24c7586761d31add141ac_D20200823-20200823" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzMwMDI_ec130c3a-b1d2-4ea5-b20d-f368aab8b9a8">10</ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i1e4b2db5b6ae4c4ba84f02771907f7a4_D20210328-20210626" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzM2ODU_a1811b93-145d-4bda-b72e-78f7f67e0084">19.7</ix:nonFraction>&#160;million, which included hold-backs of $<ix:nonFraction unitRef="usd" contextRef="i5e988670f72849c99fb52b89dee92904_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzM3MTg_e3d48cb2-1437-4aec-91e5-20c73275f20b">2.3</ix:nonFraction>&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's valuation, it allocated $<ix:nonFraction unitRef="usd" contextRef="i5e988670f72849c99fb52b89dee92904_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzM5MDQ_aad39d19-ba31-4be5-877f-1e96501de620">10.7</ix:nonFraction>&#160;million to developed technology and $<ix:nonFraction unitRef="usd" contextRef="i5e988670f72849c99fb52b89dee92904_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzM5ODI_adaa88c8-383e-4640-8bb5-0c293bc3638f">6.2</ix:nonFraction>&#160;million to goodwill. The remaining $<ix:nonFraction unitRef="usd" contextRef="i5e988670f72849c99fb52b89dee92904_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzQwMTI_ce7397ce-71f9-4fb9-a325-f337f26846e6">2.8</ix:nonFraction>&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="i5024cfe77ed84bdbb5d8ce77efa8e90f" continuedAt="if59defc53be5482b9fb23a545cb62f97"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="id68fc41b2dac49ce95512717f490a715_D20191230-20191230" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzQ1MzI_a3dbbc39-79e5-4194-90d4-db865e7944ca">18.0</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="ib93bd6cff06a4e7f87214f6eb2cbfd4b_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzQ1NjY_e293d5af-f686-4d0b-ab63-ba37c47f9558">1.0</ix:nonFraction>&#160;million and contingent consideration which the Company estimated at $<ix:nonFraction unitRef="usd" contextRef="i16b5a1f413384f9ca72737023db38188_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzQ2MzM_bebfaca5-9997-46b6-9d71-96cdbb9242c4">0.9</ix:nonFraction>&#160;million. The contingent consideration was payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal Health products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased <ix:nonFraction unitRef="number" contextRef="i36618631bdde40eab7a2277b4c960865_I20190801" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzUyNzQ_f2f9201c-b394-4557-ad75-036af8675f05">46</ix:nonFraction>% of the outstanding shares of SuperSonic Imagine SA ("SSI") for $<ix:nonFraction unitRef="usd" contextRef="iedf53a2286ab4650ab8d967009ff9c57_D20190801-20190801" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzUzMzc_5137a6c9-1625-43c2-b67d-0a2c7ff43beb">18.2</ix:nonFraction>&#160;million. SSI was a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;<ix:nonFraction unitRef="usdPerShare" contextRef="i6917f131714d4eaa8f02a7754033309b_D20190901-20190930" decimals="INF" name="holx:BusinessAcquisitionCashTenderOfferPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzU1ODc_2342fb6f-1f47-4b88-a4bf-39e9c196ee09">1.50</ix:nonFraction> per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded <ix:nonFraction unitRef="number" contextRef="ifa9b0872e98f4d10ad0e93ab1bc740eb_I20191120" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzU5MDc_b7b604a5-2ca1-4a14-b5a5-93a4dc3f65db">50</ix:nonFraction>%. Accordingly, the Company initially accounted for this investment under the equity method of accounting and included its proportionate share of SSI's net loss of $<ix:nonFraction unitRef="usd" contextRef="ie280a98b55e94f6c8d1901932bc65953_D20190728-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzYwNzI_01ecf24b-38d5-4d80-bc7a-d8739d4a7bb7">3.3</ix:nonFraction>&#160;million for the two months ended September 28, 2019 within Other income (expense), net. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional <ix:nonFraction unitRef="shares" contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzYyMDQ_319567d6-dc85-43b1-9b9f-7da7c7b44085">7.6</ix:nonFraction>&#160;million of SSI's common shares for $<ix:nonFraction unitRef="usd" contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121" decimals="-5" format="ixt:num-dot-decimal" name="holx:AdditionalPurchaseConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzYyMzI_1d9ebf54-f6f7-407b-80d0-fe5445ae35d8">12.6</ix:nonFraction>&#160;million. As a result, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121" decimals="2" name="holx:BusinessCombinationOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzYzMDk_3652122d-7aec-4418-816d-8d65aee6cb1d">78</ix:nonFraction>% of the outstanding common shares at November 21, 2019, and controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of <ix:nonFraction unitRef="number" contextRef="i36618631bdde40eab7a2277b4c960865_I20190801" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY3MjU_8228680b-448e-4ee1-b45b-2b7d0736d311">46</ix:nonFraction>% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $<ix:nonFraction unitRef="usd" contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY4Mjc_49eaba03-76c9-4a77-9f68-249d5bf875c6">3.2</ix:nonFraction>&#160;million recorded to other income (expense), net in the first quarter of fiscal 2020. The total accounting purchase price was $<ix:nonFraction unitRef="usd" contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY5MTY_0cf88829-685e-493a-9e68-eb0ace37904b">69.3</ix:nonFraction>&#160;million, which consisted of $<ix:nonFraction unitRef="usd" contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY5Mzk_3ae0ff60-a4f8-4f21-bc6d-a15b1b9f752c">17.9</ix:nonFraction>&#160;million for the equity method investment in SSI, $<ix:nonFraction unitRef="usd" contextRef="i434021f3ec27448fbe1165597b733f5d_D20191101-20191130" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY5ODM_7801b97c-931a-4f91-b5fb-1792e58c62bc">12.6</ix:nonFraction>&#160;million for shares acquired on November 21, 2019, $<ix:nonFraction unitRef="usd" contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzcwMjg_2459b475-fd1f-4e37-9c0c-f39494132eda">30.2</ix:nonFraction>&#160;million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $<ix:nonFraction unitRef="usd" contextRef="i76683b5c18404ee8b099355c544bc298_D20191121-20191121" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzcxNzg_fe1e80f7-aa6f-4d39-9642-9c118c57374b">8.6</ix:nonFraction>&#160;million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional <ix:nonFraction unitRef="shares" contextRef="ic95991b5e000422fbe8ed48efcf4b896_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationAdditionalSharesAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzczMDE_82133647-2201-42f4-881c-3f01803562c4">1.1</ix:nonFraction>&#160;million outstanding shares in fiscal 2020 for $<ix:nonFraction unitRef="usd" contextRef="ic95991b5e000422fbe8ed48efcf4b896_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationAdditionalSharesAcquiredValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzczNDI_51ac09f2-6512-4e16-9504-3417d27e133f">1.8</ix:nonFraction>&#160;million. In the third quarter of fiscal 2021, the Company purchased the remaining <ix:nonFraction unitRef="shares" contextRef="ida7a175c50e343bc88edc64520ef9945_D20210328-20210626" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationAdditionalSharesAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMzk0NzU_3e883aa6-d938-4277-9953-773f900d5f9f">4.8</ix:nonFraction>&#160;million shares outstanding for $<ix:nonFraction unitRef="usd" contextRef="ida7a175c50e343bc88edc64520ef9945_D20210328-20210626" decimals="-5" format="ixt:num-dot-decimal" name="holx:BusinessCombinationAdditionalSharesAcquiredValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMzk0ODg_1f9ff86c-f0ab-4c0c-a8eb-5fbf19e6b165">8.5</ix:nonFraction>&#160;million and as of September 25, 2021, the Company owned <ix:nonFraction unitRef="number" contextRef="ia88c8081745b4259b3951cbc18febc64_I20210925" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzc0MDg_dc555763-8512-4bd6-b99c-bc4ba13529d7">100</ix:nonFraction>% of the outstanding shares of SSI.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="i3b1ce9a6eeba4c59a18ca4a2685a7588" continuedAt="ia552d17d3c3b4534abcc227d1b272df6"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"></td><td style="width:73.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzAtMS0xLTEtMA_ca46d113-28bd-454f-be48-13a04e892067">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzEtMS0xLTEtMA_8e25eebe-ce0e-426f-beed-9a0a31929430">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzItMS0xLTEtMA_cf1d3a47-82d7-45dd-986a-77444b86add9">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzMtMS0xLTEtMA_19f038fa-d195-46dc-b74a-481a417ee944">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzQtMS0xLTEtMA_7e5d79b7-7209-4fdb-a682-63d98cd814bf">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzUtMS0xLTEtMA_92279b14-4375-4fd5-8a52-8ed81133bf5b">24.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzYtMS0xLTEtMA_ebece28e-5244-4160-bd3d-5631d32e121d">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzctMS0xLTEtMA_9a4e4cc6-615e-4002-a35d-26861b69131f">8.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzgtMS0xLTEtMA_741bb6bf-a3ed-4d21-86f9-6bdeef5a850e">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzEwLTEtMS0xLTA_09b83f50-33a2-4e6b-83ae-279458e6422d">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzExLTEtMS0xLTA_768a9be1-5215-4351-bf8b-b1cf261af448">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzEyLTEtMS0xLTA_606ef520-5774-4c37-83fa-d837758a7eb2">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzEzLTEtMS0xLTA_2e24aaa2-cb28-4408-82c4-7ac2be3cf556">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzE0LTEtMS0xLTA_011fc449-c523-4639-b596-cf460d8799f7">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b728effda394302a72ca98b3567ed57_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzE1LTEtMS0xLTA_1674d00a-b92e-47b0-8f2d-15646f758f18">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="if59defc53be5482b9fb23a545cb62f97"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="ic95991b5e000422fbe8ed48efcf4b896_D20190929-20200926" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzg0NzM_e1708b99-fe6c-44c5-bb47-ca453f3ce926">12.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is <ix:nonNumeric contextRef="i8c8888b8e35a4df4a031e6fa6250444b_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzg3NzI_dd28878f-fbce-4468-b246-abf0f96c5fa3">9</ix:nonNumeric> years, customer relationships is <ix:nonNumeric contextRef="i2d53a4eb8eac4b2c99a46ebf3435d28f_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzg4MDI_0b7493f9-9db6-4ce5-ba37-03c55df3ac3e">9</ix:nonNumeric> years and trade names is <ix:nonNumeric contextRef="i8b6dc772990a4dd08e146f2812715ff8_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzg4MjQ_c25ce787-eef2-4c19-832e-723c411075a9">8.6</ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on anticipated synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Focal Therapeutics</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Company completed the acquisition of Focal Therapeutics, Inc. ("Focal") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i2b1421425b23449bb82f2089d54bfb94_D20181001-20181001" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk1MTA_ad5c9a62-1d7b-4523-b0fb-a2cd05704d80">120.1</ix:nonFraction>&#160;million, which included hold-backs of $<ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk1NDM_e9e80ae3-8ea5-41cb-82fd-8d9585862cd4">14.0</ix:nonFraction>&#160;million payable up to <ix:nonNumeric contextRef="i2b1421425b23449bb82f2089d54bfb94_D20181001-20181001" format="ixt-sec:durwordsen" name="holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk1NjA_87d12b9c-d2b2-493c-9fa9-9b69ce013b12">one year</ix:nonNumeric> from the date of acquisition. In the second quarter of fiscal 2019, $<ix:nonFraction unitRef="usd" contextRef="i1d2e8a19c496462f9cfc2bb84de929f2_I20200328" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk2MzE_47914f6e-1225-46f7-aa2f-dd9dd7a5f985">1.5</ix:nonFraction>&#160;million of the hold-back was paid, and the remaining $<ix:nonFraction unitRef="usd" contextRef="iead19d3763124535a6de6bd936833053_D20191001-20191001" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk2Nzk_e44e0ca2-38b8-4945-be02-c342a87aacf6">12.5</ix:nonFraction>&#160;million was paid in the first quarter of fiscal 2020. Focal, headquartered in California, manufactures and markets its BioZorb marker, which is an implantable three-dimensional marker that helps clinicians overcome certain challenges in breast conserving surgery. Focal's results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="ia552d17d3c3b4534abcc227d1b272df6"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"></td><td style="width:73.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzAtMS0xLTEtMA_3342d7d2-1aed-4f06-ba3e-4f99b8a3bad9">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzEtMS0xLTEtMA_931a5f1e-11dd-48c1-affc-b02de4abbb4e">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzItMS0xLTEtMA_9da8e820-1afc-4439-aed5-596042d89ce0">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzMtMS0xLTEtMA_f316f645-e17c-4fdc-8d82-250989c2deec">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzQtMS0xLTEtMA_aa2bc6ae-b59b-437b-b1b5-20110902c396">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzUtMS0xLTEtMA_ac144b9d-081e-465c-b65a-63eea1219356">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzctMS0xLTEtMA_33583564-0725-4aa3-b374-b280cc7df8c1">83.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzgtMS0xLTEtMA_cf9c927e-4c27-499e-875f-1195b8a57eba">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzktMS0xLTEtMA_d6885888-dbba-4085-aca1-1a37c040de78">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzEwLTEtMS0xLTA_d694ab52-88c6-45a4-8afe-22d9e9457c60">12.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzExLTEtMS0xLTA_801b5997-9270-4b62-aa63-53ba135be87a">31.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzEyLTEtMS0xLTA_03a08be3-ff39-4886-b7c1-f9fcbe256a6b">120.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Focal's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, in-process research and development, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from&#160;<ix:nonFraction unitRef="number" contextRef="i71d4407f36384a78ab3fd3c29df58e1a_D20181001-20181001" decimals="INF" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwODUw_3a8b75f6-bf41-4b17-817d-73e9cf997a1b">15.5</ix:nonFraction>%&#160;to <ix:nonFraction unitRef="number" contextRef="iecc2544b7c7d4f2181bf059594fbb073_D20181001-20181001" decimals="INF" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwODU2_81a6342c-b519-4139-995e-ba3b5d84523f">16.5</ix:nonFraction>%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names was <ix:nonNumeric contextRef="i05a15ceda3194f6a95ab1a2052135e7b_D20181001-20181001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzExMTYy_627b75f3-f9b4-47ae-9c38-01e7e84d4174">11</ix:nonNumeric> years and <ix:nonNumeric contextRef="ia45d1465e59545618e64088cd88eaf9a_D20181001-20181001" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzExMTY5_0aba4350-ddbf-4cb0-a909-5df38fbcfcd6">13</ix:nonNumeric> years, respectively. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the amount of goodwill were based on synergistic benefits that are expected to be realized from this acquisition. Benefits include the expectation of broadening the Company's Breast Health portfolio of products and technology. None of the goodwill is expected to be deductible for income tax purposes.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzIxOTkwMjMyNjg4MTg_05b59f2e-e255-4b51-b2ac-0346fa4e76a4" continuedAt="ibae931f60c3b4e2bb39276ed9593e77e" escape="true">Restructuring and Divestiture Charges</ix:nonNumeric></span></div><ix:continuation id="ibae931f60c3b4e2bb39276ed9593e77e" continuedAt="i1ac5580c17a54617a63c1320f54ccd37"><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its operations for opportunities to improve operational effectiveness and efficiency, including facility and operations consolidation, and to better align expenses with revenues. As a result of these assessments, the Company has undertaken various restructuring actions which are described below. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzU4NTQ_e6856d11-f25d-4633-9683-5bbf8f932da5" continuedAt="i60b51efec9ea4dae93c963b52c3c2455" escape="true">The following table displays charges taken related to restructuring actions in fiscal 2021, 2020 and 2019 and a rollforward of the charges to the accrued balances as of September&#160;25, 2021:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i60b51efec9ea4dae93c963b52c3c2455"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.596%"><tr><td style="width:1.0%"></td><td style="width:34.708%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.946%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.946%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.946%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2021 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Restructuring Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 charges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTEtMS0xLTA_14f4e910-1217-45cf-8969-ee4903fd986b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTMtMS0xLTA_f604ddac-bc36-4395-b0af-62dd62b0d537">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTUtMS0xLTA_b0c3d38c-e831-42e6-ab90-819e534c5e1f">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica09cd88fe9a4e17bb42730a0eb48197_D20180930-20190928" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTctMS0xLTA_7612849b-e520-4af1-90da-058878fcd1d0">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTExLTEtMS0w_f67b0b4a-318c-4012-b3f6-e18eebcceb7f">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTEtMS0xLTA_fd52980b-35b7-46f2-aa7a-0c22e86d611c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTMtMS0xLTA_1942709b-6dd2-4a9a-9f29-9e4eb49859b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTUtMS0xLTA_010e923d-b9f1-44b3-885a-d505f1b1b40d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica09cd88fe9a4e17bb42730a0eb48197_D20180930-20190928" decimals="-5" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTctMS0xLTA_4c5c8731-a451-4893-ae12-b519ae68484f">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928" decimals="-5" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTExLTEtMS0w_78351182-de08-4006-addb-98d9730e0fbe">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTEtMS0xLTA_0fe888b7-3eed-4cba-b727-830067e9e130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTMtMS0xLTA_8002d8d4-9d17-456f-a0ef-f85a03ebc0f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTUtMS0xLTA_a21b16aa-3828-4ebe-8b28-d6a80e24fc52">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica09cd88fe9a4e17bb42730a0eb48197_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTctMS0xLTA_dbbcf376-d094-42b5-ad10-71ac24f673d4">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTExLTEtMS0w_751caf9f-84eb-43ad-b7ab-13f4eddcb329">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTEtMS0xLTA_eff43de7-d707-4e35-bada-08bfb9a43a2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTMtMS0xLTA_e8c4c521-9db4-46ba-8af3-7d98b227adfc">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTUtMS0xLTA_821f2b4b-1f54-44c7-9386-635898e30b17">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7936fd11ed2e4b85af34c8ff95ea99bb_D20190929-20200926" decimals="-5" sign="-" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTctMS0xLTA_94cf360c-2006-49f8-a8e6-e0dc45a44077">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTExLTEtMS0w_cb6fed72-b833-4223-bf3b-bd6da83e456c">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTEtMS0xLTA_cde1f0c7-c7d1-4093-9757-b5f1370790e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926" decimals="-5" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTMtMS0xLTA_d60de74f-e95d-469b-ae36-477bceed5c2e">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTUtMS0xLTA_477d0d31-9f8c-42fd-8b30-7d88176e249d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7936fd11ed2e4b85af34c8ff95ea99bb_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTctMS0xLTA_66c322f1-cf12-43a2-beef-926b000ee9e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926" decimals="-5" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTExLTEtMS0w_eb28bcba-618e-4737-8a53-3383f8b96ad8">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTEtMS0xLTA_e24a07b6-364e-4926-91f5-9e48d5c8467b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTMtMS0xLTA_76b95bd4-320b-4e76-985c-21b633868f8a">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTUtMS0xLTA_2a23e1e5-586b-4ff3-87de-783780a243ce">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7936fd11ed2e4b85af34c8ff95ea99bb_D20190929-20200926" decimals="-5" sign="-" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTctMS0xLTA_e9b6afc7-3e63-4e0d-984c-8ba61db8f320">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTExLTEtMS0w_58e2e405-aaa4-4cc3-ba0e-c506cf3c77ef">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTEtMS0xLTA_b6d7d8be-3292-45c7-934b-4cfacd278cfd">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTMtMS0xLTA_e45586db-5f0a-45dd-b771-12e3aa0656a4">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTUtMS0xLTA_fcf386f4-7e9b-41a7-aa20-bb2d0906e1b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32aaf02b449b417fbbb6835a78a46b59_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTctMS0xLTA_a28c9873-a10b-4d85-a200-626d047dcd1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925" decimals="-5" name="holx:ReductionOfWorkforceExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTExLTEtMS0w_a14b51df-2691-48b1-9681-60b627cedbf2">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021 restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTEtMS0xLTA_2ffa3f52-3647-49a6-a556-4c8167d761e7">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTMtMS0xLTA_75720441-e4cd-4cd1-9a57-b33cd9d549b7">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTUtMS0xLTA_e81843b7-f434-4b3c-9dcc-06812d761832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32aaf02b449b417fbbb6835a78a46b59_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTctMS0xLTA_956d59d0-134d-4d36-ba25-5709cdc4641f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTExLTEtMS0w_a2fbb59c-751a-4df5-b3fb-39ba75e04a6f">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzU4NjI_0d891f9d-90d5-4dde-9ea3-b87811748313" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.523%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.523%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.523%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.523%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2021 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2018 Actions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Previous Other Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Rollforward of Accrued Restructuring</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 29, 2018</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fea61ca81bf4d459c97ba34e9961f73_I20180929" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItMS0xLTEtMA_6739ad53-f0f4-4e29-a28c-b5c8ad2ec0ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d4b7a8cc9a44411b8b72747d549afa1_I20180929" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItMy0xLTEtMA_9c4170c8-f294-4c5a-bcdb-0284a850d82e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589c665e90724c12916b1829bbe8611d_I20180929" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItNS0xLTEtMA_9d889a1a-9583-44b2-9eee-91a6a019268e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i363a0363e6354e97b13c269c6820cf5a_I20180929" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItNy0xLTEtMA_7e31336c-48e5-4cc7-9eef-72baf2b94e7d">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8f2a1f7b45b44309d99d3e69e91b1a6_I20180929" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItOS0xLTEtMA_d40a8529-3991-4f9c-ab93-0d98ff69b99d">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd04b96a2ff54f9fb515dc126ab745cf_I20180929" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItMTEtMS0xLTA_802589f8-fa7c-4664-94b9-57574e238dbb">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtMS0xLTEtMA_12a45731-0de1-4d4e-a26f-75d3c60e4d72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtMy0xLTEtMA_85460c08-eb84-41ed-b37f-8411bfc79de8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtNS0xLTEtMA_ed2b460f-7213-44c4-934e-592b70b46838">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6820742ad8bf45d0b4eb5cacd1ed2d5b_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtNy0xLTEtMA_3a33ac1d-12c0-4e0a-bf4f-d9eb480f2ca3">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0d1533cac054998bd77025d6327d119_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtOS0xLTEtMA_13a74c74-d2fc-4b78-90be-2a4b97cdd4cb">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtMTEtMS0xLTA_6c9ed424-3f46-400e-8322-3fd1a5245c5d">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtMS0xLTEtMA_a05f8d7f-f52e-4a4d-b154-a0adee2c3ac0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtMy0xLTEtMA_74c53fdd-c99e-4d87-9cef-2d67d016172a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtNS0xLTEtMA_1407a70b-2e71-451a-a30f-7a91e97d2706">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6820742ad8bf45d0b4eb5cacd1ed2d5b_D20180930-20190928" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtNy0xLTEtMA_dd963362-27a7-455f-a014-05a4b9e51aec">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0d1533cac054998bd77025d6327d119_D20180930-20190928" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtOS0xLTEtMA_98c416d4-426b-47b7-9baf-1cc708d1cef6">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtMTEtMS0xLTA_6728db97-205e-4b64-ac74-90806c843aec">7.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctMS0xLTEtMA_a8074274-91f1-4b35-a001-36318735c157">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctMy0xLTEtMA_735c2a3e-7857-4f6b-a436-c31bfb0ddb67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctNS0xLTEtMA_cbcfc539-bbbd-44aa-86da-3c6181893a98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6820742ad8bf45d0b4eb5cacd1ed2d5b_D20180930-20190928" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctNy0xLTEtMA_c343d510-ea73-4c5e-b98c-23a599150a28">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0d1533cac054998bd77025d6327d119_D20180930-20190928" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctOS0xLTEtMA_a11b2456-10ef-494b-9306-18443f96493d">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctMTEtMS0xLTA_c84a62f3-c06f-4884-accc-b35a913ee78d">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 28, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74335c4192849e4962d43b0b1fc20f4_I20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtMS0xLTEtMA_0bf708a0-82c1-4fb8-874f-16f46ae2dcce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4bdf24b380d49bf82bd81fb2c06d677_I20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtMy0xLTEtMA_929a72dd-f3c0-40a7-9925-8282ab7152a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic611866316f1423b90b7f3d0aa696327_I20190928" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtNS0xLTEtMA_babab46c-93e7-4108-bd87-945f27d7f001">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c37f79fbe241d9b526e41c78b64391_I20190928" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtNy0xLTEtMA_f4da3b78-d8af-4bc7-a3a1-89ea5279d03a">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9761cec969414f2dac8d0f65e729f1f5_I20190928" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtOS0xLTEtMA_f79866d5-32d7-43ea-b611-c9e7673e6e48">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1dbf3209e94bba8c72c6ae4d7bccc0_I20190928" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtMTEtMS0xLTA_4e170f65-f5d8-4fbc-b887-c4b70b7937d6">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTEtMS0xLTA_bb2402de-19ad-4ec9-b094-e7696e710b60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTMtMS0xLTA_3392740e-4331-45d7-9371-5c92b455f2b5">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTUtMS0xLTA_fb63b884-62b2-4bed-9f11-3c237006e020">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926" decimals="-5" sign="-" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTctMS0xLTA_2d7c7c4a-b307-468f-aca3-5e8e6bbff79e">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTktMS0xLTA_6466ab0e-5ddc-46b8-94ae-78de81cf7dac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTExLTEtMS0w_56bc83d8-60f9-41b7-a31d-533436edbedb">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTEtMS0xLTM1MTg0_b1406139-b6c9-4482-bf72-3c365676016c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926" decimals="-5" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTMtMS0xLTM1MTg0_65b59169-85e3-4df5-bf3b-0a807cd00643">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTUtMS0xLTM1MTg0_0d325133-4872-440c-b64b-ca01feb66cb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTctMS0xLTM1MTg0_8a75a68a-4dd3-40a5-b1ed-2ebb18f1a02d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTktMS0xLTM1MTg0_d393f376-32f0-4f49-a2a5-9dc05db869ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926" decimals="-5" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTExLTEtMS0zNTE4NA_a57cc9e6-e7c6-4c4e-8733-fe850515b6b3">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTEtMS0xLTA_4dc18b33-9e8b-4c63-a443-46d68417c6ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTMtMS0xLTA_952192b2-919a-4fe4-834b-df3bc265c5dd">4.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTUtMS0xLTA_54aa8d7c-0b29-46a6-b8f8-2b609f5baae4">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTctMS0xLTA_b216c2f5-8f32-46d5-91ca-4f0204656d90">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTktMS0xLTA_44554b1e-58f7-4791-87b7-675f6bdcc194">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTExLTEtMS0w_aafd414e-3be6-4c7b-be1f-b7a3216c5b11">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments and adjustments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTEtMS0xLTA_5d1c744e-6f99-48e7-b5b8-3e73ba64be99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926" decimals="-5" sign="-" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTMtMS0xLTA_b66aa617-f068-4ae5-bcf0-08034a590f86">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTUtMS0xLTA_711fbb05-a455-4e6f-b653-f7cfee630dbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTctMS0xLTA_059c801a-e384-4733-9cce-3bdd3255cfb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTktMS0xLTA_0acb032a-358a-417a-8ce7-128638ef66a9">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926" decimals="-5" name="holx:OtherRestructuringPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTExLTEtMS0w_e8de84b3-505e-49d4-b58a-5daa12edd124">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 26, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibef98710ecdd4cd1aab89a2c225d4bb4_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTEtMS0xLTA_4faff3f6-7472-4bb7-8e26-8fbe86699bb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6b1f0af679346b0bae0f56c6a024a23_I20200926" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTMtMS0xLTA_1adbbda5-2fc2-446f-a299-5229d6a4d3b1">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d06325cd28b4c4abb1d24a6b9f3b7e1_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTUtMS0xLTA_fd750187-0f72-47ff-b8ae-75faa03f5687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ed1a363cfc4dcdbd9da0e0010b4605_I20200926" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTctMS0xLTA_e0304d23-0f61-4861-86cb-a27e0270beed">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i237590b8c9a24937a685c8ff3cfc59a0_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTktMS0xLTA_56ac9dbf-2730-4287-8771-97c94bf536e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b56d54de384d5e85d583af397a2df1_I20200926" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTExLTEtMS0w_7e51516b-20c6-448e-b4e8-691f38216459">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021 restructuring charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTEtMS0xLTA_d87a9ad4-8afc-40a6-aaf2-83b743d74a17">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTMtMS0xLTA_ca11eb33-1ede-49a6-ac2a-f00b961162ab">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTUtMS0xLTA_bd18c678-63c6-4f63-9860-084433be2aa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37821908786c4b708eab490638465e93_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTctMS0xLTA_d91529b8-7e20-4928-a3b0-a6ca666f20e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf618176c7846639223696bf6423a6b_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTktMS0xLTA_a96ac626-7028-4a33-a58f-1ce3620f72e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925" decimals="-5" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTExLTEtMS0w_c22efd0b-fc45-4420-8d28-592994d7f3e2">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925" decimals="-5" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTEtMS0xLTA_49b49fce-ac8b-4e91-b58a-37de4b1ae68c">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTMtMS0xLTA_6534f89c-5ceb-4426-af94-f455a051bc3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTUtMS0xLTA_e5f2e093-9135-4eb4-8709-ca38d106e45d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37821908786c4b708eab490638465e93_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTctMS0xLTA_818e159e-80eb-4be3-9415-94625b65ab85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf618176c7846639223696bf6423a6b_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTktMS0xLTA_80d01c8e-d2f8-47cd-9961-29b325948235">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925" decimals="-5" name="holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTExLTEtMS0w_5e9d7811-9afb-4d2f-aa91-28c25b10e78b">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTEtMS0xLTA_9a4f090b-c915-4f35-95e2-ec76f3e8875e">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTMtMS0xLTA_dd92ad3d-46f0-4f3d-8171-b8faad189ad9">3.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTUtMS0xLTA_171824f7-849e-452c-a007-a4dd6bd5782c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37821908786c4b708eab490638465e93_D20200927-20210925" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTctMS0xLTA_698da74b-cacf-4632-b441-7611dbceeb4b">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf618176c7846639223696bf6423a6b_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTktMS0xLTA_c3f40cfc-781f-4c1a-a68b-f47948fe6400">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925" decimals="-5" name="holx:CashSeverancePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTExLTEtMS0w_edb39468-8644-46d5-8552-06d61ba8f05a">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 25, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a345959c154a2d8df036461ee29971_I20210925" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTEtMS0xLTA_e0ddc7af-80d7-4708-ad46-aa793bb79f0b">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20c9c1045bba4ae987407ffe8c49f36c_I20210925" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTMtMS0xLTA_f6721dc8-ddeb-4bcf-814f-78d1da223e46">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i226927fc24ca401dbaa730834a36cc50_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTUtMS0xLTA_64273755-9ffd-4b19-9595-bff69c965d71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2db2f22615e94b14baa99827dcd76f70_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTctMS0xLTA_b77aa3a1-c160-45be-955b-fff9dd2e829a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c8b3bd2cb5743559dcb3f8b8dd002a9_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTktMS0xLTA_64a33916-7352-47f4-9b5e-c6f8029c8b11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6661f7e6f8814fa0a6d62d9cf0f20dbf_I20210925" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTExLTEtMS0w_867239d0-32c0-4f6c-bb20-8f09a9e86b99">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) In fiscal 2020, as part of the adoption of ASC 842, the Company reclassified $<ix:nonFraction unitRef="usd" contextRef="ia255713509bd43e8bcf5ee357d39d247_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:RemainingLeaseBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzYyMg_374f8514-f844-437e-a7e6-c24c267ddea4">3.8</ix:nonFraction>&#160;million from a lease liability to offset the right of use asset on the Company's consolidated balance sheet.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i1ac5580c17a54617a63c1320f54ccd37"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021 Actions</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, the Company made various decisions to terminate certain individuals across all divisions in multiple departments and close certain manufacturing facilities for minor product lines. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i052b6805906a4d2c89ee54aabd364d66_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:RestructuringChargesUnderExitOrDisposalPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzIxOTkwMjMyNjg4MjA_c5ac2bfb-f747-434a-969d-2527adc173b0">8.7</ix:nonFraction>&#160;million for severance and benefits related to these actions, which occurred in the U.S. and various international locations. The charges were recorded pursuant to ASC 712, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Postemployment Benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 712) or ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 420), depending on the employee.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020 Actions</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, the Company made various decisions to terminate certain personnel across all divisions in multiple departments, transfer production and close certain manufacturing facilities for minor product lines. The Company recorded charges totaling $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzEwMDQ_3fa360dd-5c9d-4488-9985-8e2cfd65cec6">13.4</ix:nonFraction>&#160;million for severance and benefits related to these actions. The charges were recorded pursuant to ASC 712 or ASC 420, depending on the employee. Included within this charge was $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzEyODQ_a7733417-0860-493e-adc0-27f4e6f1f1e0">5.0</ix:nonFraction>&#160;million related to the modification of equity awards for a certain executive. These actions are complete.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, the Company recorded net divestiture charges of $<ix:nonFraction unitRef="usd" contextRef="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327" decimals="5" format="ixt:num-dot-decimal" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzE2OTM_1ed56bc5-6872-4bbb-a483-118a696efe11">1.9</ix:nonFraction>&#160;million. The charge included $<ix:nonFraction unitRef="usd" contextRef="i7aaac8bd6b554479a2fec5dc2c597d98_D20201227-20210327" decimals="5" format="ixt:num-dot-decimal" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzE3MTc_3cb03102-757a-4316-a545-79438e8107d3">1.3</ix:nonFraction>&#160;million to dispose of the Company's life sciences testing business located in the UK, which performed research testing for pharmaceutical companies. Separately, in connection with the Cynosure divestiture, the Company accelerated stock compensation expense and other benefits of $<ix:nonFraction unitRef="usd" contextRef="ie1bf8affe32c4e59ac455013cb5723b4_D20201227-20210327" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzE5OTA_aaf92e03-3093-4f82-ba31-446469a3afb4">2.6</ix:nonFraction>&#160;million, partially offset by other adjustments of $<ix:nonFraction unitRef="usd" contextRef="ie1bf8affe32c4e59ac455013cb5723b4_D20201227-20210327" decimals="-6" format="ixt:num-dot-decimal" name="holx:DivestitureCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzIwMzU_91d7a499-c493-40bc-a615-9f972dccc935">2.0</ix:nonFraction>&#160;million.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019 Actions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company decided to transfer certain shared services positions to its Costa Rica facility from its Marlborough location and announced the termination of certain personnel and implemented other employee termination actions. The charges for these actions were recorded pursuant to ASC 420 for one-time termination benefits. The Company recorded severance benefits charges of $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzI0NTY_8f6771df-8290-4311-93e6-21d94a9e6213">4.0</ix:nonFraction> million in fiscal 2019 related to these actions and this action was completed in the first quarter of fiscal 2020. The Company also recorded $<ix:nonFraction unitRef="usd" contextRef="i3d2e5c8508f041c0baa077405508f177_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzIxOTkwMjMyNjg4MzQ_eebb67bf-086f-4a42-a472-70a8eb99460d">1.0</ix:nonFraction>&#160;million of severance charges in fiscal 2019 related to 2018 actions that were recorded pursuant to ASC 420.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closure of the Bedford location during the first quarter of fiscal 2017, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="ibe6803d94cea48cf812f89fc284feb20_D20180930-20181229" decimals="-5" format="ixt:num-dot-decimal" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzQzODU_d2af8e24-a0d9-43b2-8697-629110629262">3.5</ix:nonFraction> million for lease obligation charges related to the first floor of the facility as the Company determined it had met the cease-use date criteria. The Company made certain assumptions regarding the time period it would take to obtain a subtenant and the sublease rates it could obtain. During the third quarter of fiscal 2017, the Company updated its assumption regarding the time period it would take to obtain a subtenant at the Bedford location and as a result recorded an additional $<ix:nonFraction unitRef="usd" contextRef="iaa3e68e1e5d546bfae26d63f7380f8b2_D20180401-20180630" decimals="-5" format="ixt:num-dot-decimal" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzQ4NjY_b92a24ae-e274-4da3-8ca0-110ea16b07ac">1.3</ix:nonFraction> million lease obligation charge. During the third quarter of fiscal 2018, the Company further adjusted its assumptions and lowered the estimate of the sublease income rate and extended the time period to obtain a sub-tenant. As a result, the Company recorded an additional charge of $<ix:nonFraction unitRef="usd" contextRef="ie3ab4cd18b9a4591a4f3349bf628b8ea_D20190331-20190629" decimals="-5" format="ixt:num-dot-decimal" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzUxNDQ_9418358e-a745-4e16-baa2-1b65a8d0a858">1.6</ix:nonFraction> million. During the third quarter of fiscal 2019, the Company further updated its assumption regarding its ability to sublet the first floor and recorded an additional lease obligation charge of $<ix:nonFraction unitRef="usd" contextRef="if5ac9a1dd0c24e55b09475fe7b9368e8_D20200329-20200627" decimals="-5" format="ixt:num-dot-decimal" name="holx:FacilityClosureCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzUzMzQ_2368af98-63b9-4a8b-aa90-8967495941fa">1.4</ix:nonFraction> million. These estimates may vary from the actual sublease agreements executed, if any, resulting in an adjustment to the charge. The Company has vacated other portions of the building but not the entire facility, and at this time does not meet the cease-use date criteria to record additional restructuring charges. In connection with the adoption of ASC 842, the Company reclassified the remaining accrued lease balance of $<ix:nonFraction unitRef="usd" contextRef="ia255713509bd43e8bcf5ee357d39d247_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:RemainingLeaseBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzU3NTQ_73e71c07-0182-4a01-bc4b-fa77e9b4847d">3.8</ix:nonFraction>&#160;million from restructuring to offset the right of use assets on the consolidated balance sheet.</span></div></ix:continuation><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3ODk_2ed11d72-ad5c-4734-bfda-28610949a872" continuedAt="ie8ab9e51c735485c972ae5f7a84ba2a1" escape="true">Borrowings and Credit Agreements</ix:nonNumeric></span></div><ix:continuation id="ie8ab9e51c735485c972ae5f7a84ba2a1" continuedAt="i26d97374f9f049969cc811e69edb976e"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1Njg0_fe9b06f8-91cb-41de-b4b3-01f02fb2ea29" continuedAt="i9848b0e7cdee4d2588c44e01fb8c3175" escape="true"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzItMS0xLTEtMA_2c9c391c-3001-483c-be8f-2f69893f50fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486e6244f19a4457ac36f56cf1470533_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzItMy0xLTEtMA_5444fe09-6ebc-4f78-ba9c-443adf31189e">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3f1f73d7de842cb99735553e7abceab_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzMtMS0xLTEtMA_27029ded-cb30-463e-bdbe-f6cfb4feca68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacf8cf06e1004995ae54b544e1d55f8a_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzMtMy0xLTEtMA_da406f1a-a409-423d-9f06-3b5264aa3d1c">250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzQtMS0xLTEtMA_95bf18ab-ecc8-4c7f-8ee2-1a98b1212ebf">248.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i700525be08934f2c83c783a70ee542dc_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzQtMy0xLTEtMA_2ed534bd-c36d-4de5-ada7-d93a6292c807">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzUtMS0xLTEtMA_d341cc5b-3bec-45dc-91d2-688ae64d2092">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib071bc950aab4dea8b04dd63bb5fcf90_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzUtMy0xLTEtMA_19f2e74c-d9ee-4b3b-8623-b3d1bd9489b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzYtMS0xLTEtMA_554167f1-4836-4952-a629-3f7831d0959d">313.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzYtMy0xLTEtMA_9ad95b57-f8c4-4069-a581-222598b56d79">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzgtMS0xLTEtMA_f6083c24-1a09-4560-9d40-20eae139f673">1,382.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486e6244f19a4457ac36f56cf1470533_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzgtMy0xLTEtMA_ae56413f-90b6-423f-93af-e5a99854b6d5">1,379.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d92969a5ba412c8c5427576dc4c085_I20210925" decimals="-5" format="ixt:fixed-zero" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzExLTEtMS0xLTA_2471d4a7-e2ca-4c5d-b0ba-ab586a64963e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1525cddd894988b24e75e818155953_I20200926" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzExLTMtMS0xLTA_1cdb76e6-de6d-4024-9937-cb20a43b364f">939.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzEyLTEtMS0xLTA_909efb85-9235-4c5e-93ae-bb33bf044cf8">395.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70090c579bcd4961b00c27f03e26059b_I20200926" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzEyLTMtMS0xLTA_40731e6f-a4e2-4702-92a2-7429e3bbd984">394.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzEzLTEtMS0xLTA_1753f08a-d88c-4bda-b96c-8a5baee43e8e">934.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia81fd6cc362e4e8ba3a639e55937a919_I20200926" decimals="-5" format="ixt:fixed-zero" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzEzLTMtMS0xLTA_b1cd33cf-6301-4c63-adcf-b2ade659f812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzE0LTEtMS0xLTA_f8a7e9d4-7383-42a0-81cd-15ba796be8ef">2,712.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzE0LTMtMS0xLTA_3861c576-4108-4968-84c2-2e734e756b94">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzE1LTEtMS0xLTA_ffdd3354-62c5-4529-8a53-6ca5fc4cbb0f">3,025.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzE1LTMtMS0xLTA_c5e60af9-0575-4a91-ad70-3ed13a3f34cd">3,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1Njcy_75432f62-8d91-4678-93ce-b9aa41cd1d6e" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt maturity schedule for the Company&#8217;s obligations as of September&#160;25, 2021 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.583%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2027 and Thereafter </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtMi0xLTEtMA_ed612e0d-8b28-45a0-9153-abbab40975e1">75.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtNC0xLTEtMA_61abef8c-ba3b-4e17-9a8d-16951af4dd5c">112.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtNi0xLTEtMA_64bcc1c1-3a4b-4fb7-b909-28abed99d2ee">1,200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtOC0xLTEtMA_8ce2a9c1-489d-4c51-8ed7-c3b14b8c5e86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtMTAtMS0xLTA_94988c0e-4075-4390-bd91-97a594f3755c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtMTItMS0xLTA_b7def73e-99f3-456f-83ca-a2765746b64f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtMTQtMS0xLTA_e8578cf6-3504-4f34-bdc4-e03caf946def">1,387.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtMi0xLTEtMA_ba7a55c5-48ef-4ee0-bc45-33f773961e7c">248.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtNC0xLTEtMA_69cb9eac-d757-44d4-8b0c-f5b2c499e5da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtNi0xLTEtMA_034a84f4-951b-470b-911b-1048dddd73d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtOC0xLTEtMA_219738b3-fb1b-4021-98bc-04fcf72cfe5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtMTAtMS0xLTA_8a53f183-5576-4488-b2b7-969abe8582b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtMTItMS0xLTA_e4feee61-1a6e-421c-a65e-0179894eefb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtMTQtMS0xLTA_b8120354-8c21-43db-941d-5f2281eea4c4">248.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMi0xLTEtMA_3599ab30-08df-42b0-aebe-d95597d67e00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtNC0xLTEtMA_1bd72d4c-7166-451c-9a7f-f46c998a947e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtNi0xLTEtMA_bd3c1394-4643-46de-a2ec-f41ec182da41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtOC0xLTEtMA_2cdf2173-8e55-44f7-bafa-a551ac1c3b06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTAtMS0xLTA_3a7b8ffd-0e48-4341-9fe5-65ce5787fafe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTItMS0xLTA_9178da25-9c33-4d4e-85e1-0e6a3d604eae">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTQtMS0xLTA_9c6252c9-4a3b-4aca-aa64-feb3452b3d31">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMi0xLTEtMzY1NTc_30961692-4356-4de8-b168-a6a9e9793ca6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtNC0xLTEtMzY1NTc_ddef73dc-cedd-45a9-9b9d-1931d46be24f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtNi0xLTEtMzY1NTc_336e6a72-2409-418e-90c1-7694460536fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtOC0xLTEtMzY1NTc_81957c0d-ba0e-41ed-b20e-69d9ba0a0f41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTAtMS0xLTM2NTU3_d52dc6e5-0940-4301-8036-a639b28483f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTItMS0xLTYyNjE_66f5ecde-4ae2-4cad-bbe7-f38f43bdc530">950.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTQtMS0xLTM2NTU3_d93264ca-85e2-4ccf-a7f0-3a22341b6449">950.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMi0xLTEtMzY1NjQ_cf17984e-795f-4094-bf22-1fc050f7bf66">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtNC0xLTEtMzY1NjQ_3d370dfd-0eeb-4c29-b014-3f058c0a197d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtNi0xLTEtMzY1NjQ_b8161ee6-3045-4cbe-ac9b-2f95d373581b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtOC0xLTEtMzY1NjQ_577c20e5-8a33-41ea-a05b-e73a5be8fcf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTAtMS0xLTM2NTY0_d8bb12ec-0a49-484a-82d5-71269a216669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTItMS0xLTM2NTY0_8dc48a91-9474-4fae-a82e-ffb7290af8b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925" decimals="-5" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTQtMS0xLTM2NTY0_21f3e476-a175-4bd8-9180-f94e13d7d5c8">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMi0xLTEtMA_8cb3d99a-dab8-4c87-8d18-ef3f615f7e73">388.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtNC0xLTEtMA_7c95feb5-8672-497a-b22f-ba1adbdb3260">112.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtNi0xLTEtMA_7db53fb5-3f0f-47c6-994b-9ddbf434f725">1,200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtOC0xLTEtMA_c7ef62f7-d8c3-4a00-9cd1-4c7748f58ab2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTAtMS0xLTA_2df3f49a-4a7b-4e57-97e1-5acb882fff0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTItMS0xLTA_ca9cbb25-c490-4005-837b-bd609b123fd2">1,350.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTQtMS0xLTA_8103dcad-ee71-4ff5-aef4-1fec89e91e85">3,050.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;*The Term Loan debt maturity schedule herein represents the 2018 Credit Agreement as of September 25, 2021. The Company amended the credit agreement on September 27, 2021, which resulted in a change in the principal maturity schedule.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement as of October 3, 2017 ("2017 Credit Agreement"). </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2018 Credit Agreement consisted of:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $<ix:nonFraction unitRef="usd" contextRef="i987fbf31a45c43e3bae95b8e5240af87_I20181217" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzgyMw_865ea013-91b9-45ab-8961-6f64863fd109">1.5</ix:nonFraction> billion secured term loan ("2018 Term Loan") with a maturity date of December 17, 2023; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility ("2018 Revolver") under which the Company could borrow up to $<ix:nonFraction unitRef="usd" contextRef="i55f8ef212efb4b25bf5f4170fbe2cf4e_I20181217" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwNzM_8ed95285-65bd-424a-b520-70772fc85531">1.5</ix:nonFraction> billion, subject to certain sublimits, with a maturity date of December 17, 2023.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2018 Credit Agreement bore interest, at the Company's option and in each case plus an applicable margin as follows: </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">2018 Term Loan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: at the Base Rate, Eurocurrency Rate or LIBOR Daily Floating Rate,&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">2018 Revolver</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: if funded in U.S. dollars, the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate, and, if funded in an alternative currency, the Eurocurrency Rate; and if requested under the swing line sublimit, the Base Rate.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i26d97374f9f049969cc811e69edb976e" continuedAt="i76764107d47f4881827a78e313dd8743"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 25, 2021, the Company had no amounts outstanding under the 2018 Revolver and the interest rate under the 2018 Term Loan was <ix:nonFraction unitRef="number" contextRef="if3f1f73d7de842cb99735553e7abceab_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIwMDE_0174d9d2-8ff9-445c-8e93-409cf7342b4f">1.08</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable margin to the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate was subject to specified changes depending on the total net leverage ratio as defined in the 2018 Credit Agreement. The borrowings of the 2018 Term Loan initially bore interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate equal to <ix:nonFraction unitRef="number" contextRef="icfe44565012b45bcaa3449fb3bb9f8e5_D20181217-20181217" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIzNzU_b24f13d3-320c-4a5a-a6b3-9905a8d6a9ba">1.00</ix:nonFraction>%. The borrowings of the 2018 Revolver initially bore interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was <ix:nonFraction unitRef="number" contextRef="icd947cfb444742399b5c1ace77c408b1_D20181217-20181217" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1MjE_0c860262-5ead-4375-bfc8-4f615808f102">1.00</ix:nonFraction>% at September 25, 2021. The Company was also required to pay a quarterly commitment fee calculated on the undrawn committed amount available under the 2018 Revolver.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was required to make scheduled principal payments under the 2018 Term Loan in increasing amounts ranging from $<ix:nonFraction unitRef="usd" contextRef="iafd7f93a96974c4bb03d8ef2216bde64_D20181217-20181217" decimals="-3" format="ixt:num-dot-decimal" name="holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI3ODg_a37ff270-8481-498e-8a1d-25cc9ec118aa">9.375</ix:nonFraction> million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $<ix:nonFraction unitRef="usd" contextRef="i3ff7dff07c19479d8d7294b3f41e4502_D20181217-20181217" decimals="-3" format="ixt:num-dot-decimal" name="holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI4ODQ_c14c1e26-f25c-49b6-a9b2-bdc5f010f526">28.125</ix:nonFraction> million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Term Loan after the scheduled principal payments, which was $<ix:nonFraction unitRef="usd" contextRef="ie832e870ba2c42c59c28352c2f958f69_I20210925" decimals="-8" format="ixt:num-dot-decimal" name="holx:DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzMxMDQ_455c02f9-2a90-4354-ba10-fe6524622bb1">1.2</ix:nonFraction> billion, and any amounts outstanding under the 2018 Revolver were due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, the Company could have been required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments were required to be applied by the Company,&#160;first, to the 2018 Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company could have voluntarily prepaid any of the 2018 Credit Facilities without premium or penalty.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contained affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement required the Company to maintain certain financial ratios. The 2018 Credit Agreement also contained customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings were secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company and its U.S. subsidiaries, with certain exceptions. The 2018 Credit Agreement contained total net leverage ratio and interest coverage ratio financial covenants measured as of the last day of each fiscal quarter. The total net leverage ratio covenant was <ix:nonFraction unitRef="number" contextRef="i652ebb0e49d2467fb5a2db3d5fb30206_D20200927-20210925" decimals="INF" name="holx:LeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzU1NTc_264fb31b-d764-46bb-a26b-4910ae2024d9">5.00</ix:nonFraction>:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and would have remained as such until it decreased to <ix:nonFraction unitRef="number" contextRef="ic0cc2fe65c6840608feb94760bc0727f_D20220625-20220625" decimals="INF" name="holx:LeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzU2NzQ_7602a83f-605e-4a81-a93e-1584ce718cd5">4.50</ix:nonFraction>:1.00 for the quarter ending June 25, 2022. The interest coverage ratio covenant was <ix:nonFraction unitRef="number" contextRef="i652ebb0e49d2467fb5a2db3d5fb30206_D20200927-20210925" decimals="INF" name="holx:InterestCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzU3NjE_32bb9d26-a780-4985-8ef7-b2601d629233">3.75</ix:nonFraction>:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and remained as such for each quarter thereafter. The total net leverage ratio was defined as the ratio of the Company's consolidated net debt as of the quarter end to its consolidated adjusted EBITDA (as defined in the 2018 Credit Agreement) for the four-fiscal quarter period ending on the measurement date. The interest coverage ratio was defined as the ratio of the Company's consolidated adjusted EBITDA for the prior four-fiscal quarter period ending on the measurement date to adjusted consolidated cash interest expense (as defined in the 2018 Credit Agreement) for the same measurement period. The Company was in compliance with these covenants as of September 25, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2018 Credit Agreement for derivatives pursuant to ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and identified embedded derivatives that required bifurcation as the features were not clearly and closely related to the host instrument. The embedded derivatives were a default provision, which could require additional interest payments, and a provision requiring contingent payments to compensate the lenders for changes in tax deductions. The Company determined that the fair value of these embedded derivatives was nominal as of September 25, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 470), the accounting related to entering into the 2018 Credit Agreement and using the proceeds to pay off the 2017 Credit Agreement was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2017 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $<ix:nonFraction unitRef="usd" contextRef="ie810eb40b7d8415ebbbf9fc97518f0ac_D20200927-20201226" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3Xzc1OTU_44fe63d2-ce50-43e6-9d40-3ba3ee9b178b">0.8</ix:nonFraction> million in the first quarter of fiscal 2019. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the <ix:nonFraction unitRef="debt_instrument" contextRef="ie810eb40b7d8415ebbbf9fc97518f0ac_D20200927-20201226" decimals="INF" format="ixt-sec:numwordsen" name="holx:DebtInstrumentNumberOfInstruments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3Xzc4MTI_f5dc0f7d-c9f4-4d4e-8653-fd4402d61652">two</ix:nonFraction> debt instruments before and after the transaction was less than <ix:nonFraction unitRef="number" contextRef="ie810eb40b7d8415ebbbf9fc97518f0ac_D20200927-20201226" decimals="INF" name="holx:MaximumRangeofPresentValueofCashFlowPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3Xzc4Nzk_33a2873e-1911-4327-b814-c0cf430c6452">10</ix:nonFraction>%. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="i76764107d47f4881827a78e313dd8743" continuedAt="i1bb13326e7a44954bc1ff905fdf4725f"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1Njc2_b2ae76da-569b-4349-9827-dfb16fd1286c" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement and the 2017 Credit Agreement was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ae73b31aa74566b4be619e65396e03_D20200927-20210925" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzItMS0xLTEtMA_8d30b352-08aa-4b59-8df3-eb0f0b80b6b4">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica7ec8355d2a4b94a212d956ffd6cb98_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzItMi0xLTEtMA_41331baa-fc57-4ab4-854e-36774211e727">46.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37227dbc9a1b4b84b8f8518571a9c190_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzItMy0xLTEtMA_aad63cc3-55d8-4c17-97ba-5ec6597a8f73">67.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ae73b31aa74566b4be619e65396e03_D20200927-20210925" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzMtMS0xLTEtMA_10080e6d-ca18-49f3-ad84-e1c433ac2f98">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica7ec8355d2a4b94a212d956ffd6cb98_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzMtMi0xLTEtMA_ab3ed552-4bd5-405f-b82e-832217d69dd8">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37227dbc9a1b4b84b8f8518571a9c190_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzMtMy0xLTEtMA_810883a7-6db3-4860-84ee-f244798882ac">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08ae73b31aa74566b4be619e65396e03_D20200927-20210925" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzQtMS0xLTEtMA_01362ce5-e3cc-4a56-909f-bede25c16eea">1.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica7ec8355d2a4b94a212d956ffd6cb98_D20190929-20200926" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzQtMi0xLTEtMA_fe44ab9c-2d54-45ee-ba7a-9ac54b36db0f">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i37227dbc9a1b4b84b8f8518571a9c190_D20180930-20190928" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzQtMy0xLTEtMA_f4c2b7e6-edf1-43d2-8cc1-545509331a7c">3.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2aae87d5ebc4b419aaf8b70fa7a9da0_I20210925" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzUtMS0xLTEtMA_9ebe208b-44ee-4c03-94a5-ce0cbe6cb4cf">1.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie74af5ae594d4d13ba8933a5998eadeb_I20200926" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzUtMi0xLTEtMA_aa2a2350-8afd-4001-99d2-1d7164ed3d36">1.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c788b804fa84fb88a30f3178cfe6010_I20180929" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzUtMy0xLTEtMA_1c6dd81e-ce93-4e9e-ae46-f559aec23637">3.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Credit Agreement - Subsequent Event</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2021, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility under the 2018 Credit Agreement by entering into Refinancing Amendment No. 2 dated as of September 27, 2021, to the Amended and Restated Credit and Guaranty Agreement as of October 3, 2017, as amended (the "2021 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2021 Credit Agreement amends the Company's 2018 Credit Agreement. Substantially all of the proceeds under the 2021 Credit Agreement of $<ix:nonFraction unitRef="usd" contextRef="i60bf2cb0eaf6478486595f6f3d4f3b1c_D20210927-20210927" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM2NTk_300465a7-36b0-440f-a6b4-d02d5d3f6bbc">1.5</ix:nonFraction>&#160;billion were used to repay the amounts outstanding under the 2018 Credit Agreement. Borrowings under the 2021 Credit Agreement are secured by first-priority liens on, and a first-priority security interest in (in each case subject to certain liens permitted under the 2021 Credit Agreement), substantially all of the Company's U.S. assets of the Subsidiary Guarantors. These liens are subject to release during the term of the facilities if the Company is able to achieve certain corporate or corporate family ratings and other conditions are met. The credit facilities under the 2021 Credit Agreement consist of:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $<ix:nonFraction unitRef="usd" contextRef="i4ef80047f7894c36ae90aa6a3c52242a_I20210927" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM2NzM_d5912370-b8cc-43db-8c17-2d819aa4a625">1.5</ix:nonFraction>&#160;billion secured term loan ("2021 Term Loan") with a maturity date of September 25, 2026; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility ("2021 Revolver") under which the Company may borrow up to $<ix:nonFraction unitRef="usd" contextRef="i08e28b6fbb1c4a4284c842f3cbf9792a_I20210927" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM2ODc_fa16bc76-14e4-4b5b-9442-f92a48b2b8b3">2.0</ix:nonFraction>&#160;billion, subject to certain sublimits, with a maturity date of September 25, 2026.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2021 Credit Agreement, other than Swing Line Loans (as defined in the 2021 Credit Agreement), bear interest, at the Company's option, at the Base Rate (as defined in the 2021 Credit Agreement), at the Eurocurrency Rate (as defined in the 2021 Credit Agreement), at the Alternative Currency Daily Rate (as defined in the 2021 Credit Agreement), or at the LIBOR Daily Floating Rate (as defined in the 2021 Credit Agreement), in each case plus the Applicable Rate (as defined in the 2021 Credit Agreement).</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Applicable Rate in regards to the Base Rate, the Eurocurrency Rate, the Alternative Currency Daily Rate, the Alternative Currency Term Rate, and the LIBOR Daily Floating Rate is subject to change depending on the Total Net Leverage Ratio (as defined in the 2021 Credit Agreement). The borrowings of the Term Loan under the 2021 Credit Facilities initially bear interest at an annual rate equal to the Eurocurrency Rate for a one month interest period plus an Applicable Rate equal to <ix:nonFraction unitRef="number" contextRef="ibf897b14244c423cbe46652e18311bcc_D20210927-20210927" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3MDE_c3c5159e-33ae-4506-aa30-6a20de45057e">1.00</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also required to pay a quarterly commitment fee calculated on daily basis equal to the Applicable Rate as of such day multiplied by the undrawn committed amount available under the Revolver (taking into account any outstanding amounts under the LC Sublimit). This commitment fee is initially <ix:nonFraction unitRef="number" contextRef="ibf897b14244c423cbe46652e18311bcc_D20210927-20210927" decimals="4" name="holx:DebtInstrumentCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3MDg_b44d8fbf-1c0b-48fe-8a8f-9e7d74ac4045">0.15</ix:nonFraction>% per annum for the Revolver.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i1bb13326e7a44954bc1ff905fdf4725f" continuedAt="i5769ef0063e340a2854c77cab80f8ca2"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to make scheduled principal payments under the 2021 Term Loan in increasing amounts ranging from $<ix:nonFraction unitRef="usd" contextRef="i2ade552830964807a4049d7ee32b7074_D20210927-20210927" decimals="-4" format="ixt:num-dot-decimal" name="holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3Mjk_54a452d6-fee2-4cd8-aa1a-2715bc41b332">3.75</ix:nonFraction>&#160;million per three-month period commencing with the three-month period ending on December 29, 2022 to $<ix:nonFraction unitRef="usd" contextRef="i4b582144f7fd4f718cb0fe6f6d00dc2a_D20210927-20210927" decimals="-4" format="ixt:num-dot-decimal" name="holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3MzE_166514d5-bdb2-4118-8a7d-17f249a5459c">18.75</ix:nonFraction>&#160;million per three-month period commencing with the three month period ending on December 26, 2025. The remaining balance of $<ix:nonFraction unitRef="usd" contextRef="ibf897b14244c423cbe46652e18311bcc_D20210927-20210927" decimals="-6" format="ixt:num-dot-decimal" name="holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3NDc_7731ef61-2e0e-4573-a247-459cdc6b610e">1.335</ix:nonFraction>&#160;billion (or such lesser aggregate principal amount of Term Loans then outstanding) on the 2021 Term Loan and any amounts outstanding under the 2021 Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2021 Credit Agreement, the Company is required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). Certain of the mandatory prepayments are subject to reduction or elimination if certain financial covenants are met. These mandatory prepayments are required to be applied by the Company, first to the 2021 Term Loan, second to any outstanding amount under any Swing Line Loans, third to the 2021 Revolver, fourth to prepay any outstanding reimbursement obligations with respect to Letters of Credit and fifth to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2021 Credit Facilities without premium or penalty.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2021 Credit Agreement requires the Borrowers to maintain certain financial ratios. The 2021 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 19, 2018, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="ia77e5b12c3d44c7fb98f381230c562a4_D20180119-20180119" decimals="-8" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEyNjY5_b0e596ac-cd4e-43a8-b0e5-60e5d619894d">1.0</ix:nonFraction> billion aggregate principal amount of senior notes and allocated $<ix:nonFraction unitRef="usd" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEyNzI5_4ada35ab-c9a6-40f1-8f34-18dedc8c6e56">400</ix:nonFraction> million in aggregate principal amount to its <ix:nonFraction unitRef="number" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEyNzY5_e7f1ff36-c179-42d5-a9e2-1a700e8faa03">4.625</ix:nonFraction>% Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of <ix:nonFraction unitRef="number" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEyODQ0_147eebfb-1f0a-4190-9370-b1cc8669c1d0">100</ix:nonFraction>% of the aggregate principal amount of the 2028 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;<ix:nonFraction unitRef="number" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEzMTQ4_b750087a-b6b9-45b7-a9a3-54927a58717c">4.625</ix:nonFraction>%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;<ix:nonFraction unitRef="number" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEzMzU5_5bb1e133-e0b0-4ac6-9eee-f60aaf66150f">100</ix:nonFraction>%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;<ix:nonFraction unitRef="number" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="INF" name="holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0MDA2_5264b61f-d2b2-40fa-a446-91aacea338ea">102.312</ix:nonFraction>%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;<ix:nonFraction unitRef="number" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="INF" name="holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0MDYy_93d4433e-9b82-49f8-892c-fa0708ae667b">101.541</ix:nonFraction>%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;<ix:nonFraction unitRef="number" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="5" name="holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0MTE4_825e8310-2e4e-40c5-9d9f-83a4533a8f96">100.770</ix:nonFraction>%&#160;of par; and February 1, 2026 and thereafter at&#160;<ix:nonFraction unitRef="number" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="INF" name="holx:DebtInstrumentPercentageRedemptionPriceSixthPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0MTY4_596512be-5de2-43fc-b273-f5be98429663">100</ix:nonFraction>%&#160;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;<ix:nonFraction unitRef="number" contextRef="iad19ce928cc147b4a6d313f0bee64c59_D20200927-20210925" decimals="INF" name="holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0NDEy_e7b11b65-c093-453c-85e4-62466460b5a5">101</ix:nonFraction>%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2028 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="id41609d12cf047148859a8228474e2bd_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3NzY_16362c49-db72-43a6-8044-04a38d324822">950</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="id41609d12cf047148859a8228474e2bd_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4MDA_a9b79374-5a96-412d-861d-5b52e15f1e25">3.250</ix:nonFraction>% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of <ix:nonFraction unitRef="number" contextRef="i5b7aafeef10b4cb39da754e699f15172_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4MTM_fec66621-57f1-415b-aab6-3b18a8451c55">100</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="id41609d12cf047148859a8228474e2bd_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2NzY4MzQ_9a4436f9-cd85-4173-b9e2-52ae773e1ee1">3.250</ix:nonFraction>%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to <ix:nonFraction unitRef="number" contextRef="i5b7aafeef10b4cb39da754e699f15172_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2NzcwNTI_38472fd5-c89d-4eb4-8628-f60e9b3165e9">100</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to <ix:nonFraction unitRef="number" contextRef="i608d5220bab04a068eb77c0863e0e36a_D20200928-20200928" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2NzcyNTU_7285363e-c977-42b5-9958-bee8d74cfb39">40</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i7e507642eb964db6860b69fb5f71596c_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2Nzc0NjU_11c904ab-bc42-4b7a-8525-e15c5b06a153">103.250</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i5769ef0063e340a2854c77cab80f8ca2" continuedAt="i83f00a3fc8e9417daf5b3239c6c2edf0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at <ix:nonFraction unitRef="number" contextRef="ie12d730be0c14e1f9f1c5feaed78db40_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2Nzc3MDg_5b13301b-05cd-4ba1-b74b-d007d7cef1e0">101.625</ix:nonFraction>% of par; September 28, 2024 through September 27, 2025 at <ix:nonFraction unitRef="number" contextRef="i02f6ad83b4ca4d948d52c4704f2e4326_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2Nzc3Njk_9e129259-7745-4965-98fa-ae9774559b42">100.813</ix:nonFraction>% of par; and September 28, 2025 and thereafter at <ix:nonFraction unitRef="number" contextRef="i03accd3c4a404ba1becc118185a02608_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2Nzc4MjI_46fa3727-8819-4e6a-927e-5fa1ef985036">100</ix:nonFraction>% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="ibaa36a6d1efb41cb8948ae469d7b66a1_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2NzgwNjc_bc5db875-4448-4ec4-aa05-29c1ad8375dc">101</ix:nonFraction>% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="number" contextRef="i3adbde1625f143509c7660ebf25386e1_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4MTk_20d4af21-7b41-4e07-b32b-6146a500f5d6">4.375</ix:nonFraction>% Senior Notes due 2025 (the &#8220;2025 Senior Notes&#8221;) outstanding and bore interest at the rate of <ix:nonFraction unitRef="number" contextRef="i3adbde1625f143509c7660ebf25386e1_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4Mjc_a7b0480d-d2a5-4b81-8c59-74faddd5349b">4.375</ix:nonFraction>%&#160;per year, payable semi-annually on April 15 and October 15 of each year. The Company used the net proceeds of the 2029 Senior Notes offering in the first quarter of fiscal 2021 to redeem in full the 2025 Senior Notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i3adbde1625f143509c7660ebf25386e1_I20210925" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4MzU_fa5d6931-1ba0-4496-8c74-12f5826aca0f">950.0</ix:nonFraction>&#160;million on October 15, 2020 at an aggregate redemption price of $<ix:nonFraction unitRef="usd" contextRef="ie51341073d8740bab85b03dc5cbb80c6_D20201015-20201015" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4NTE_748f25fb-88a0-4a4f-9abb-17fad7f34902">970.8</ix:nonFraction>&#160;million, which included a premium payment of $<ix:nonFraction unitRef="usd" contextRef="ie51341073d8740bab85b03dc5cbb80c6_D20201015-20201015" decimals="-5" format="ixt:num-dot-decimal" name="holx:DebtRedemptionPremiumPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4Njc_0578290e-2d99-4e9d-abdf-a15f158fdb16">20.8</ix:nonFraction>&#160;million. Since the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $<ix:nonFraction unitRef="usd" contextRef="ifcae078f20ac485186d995bbd72b5c6c_D20201227-20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4ODI_bef93a42-26c1-4fe0-a795-aee0c6caae5b">21.6</ix:nonFraction>&#160;million, which comprised pro-rata amounts of the premium payment, debt discount and debt issuance costs. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $<ix:nonFraction unitRef="usd" contextRef="ifcae078f20ac485186d995bbd72b5c6c_D20201227-20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4OTc_3c597d67-d9e8-4e8c-bd0b-e8cac5f11076">5.8</ix:nonFraction>&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i54d531947d51410a8d540905838b6d9d_I20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5MTE_d6b99c39-752b-488b-9fac-a8662a4728ca">7.9</ix:nonFraction>&#160;million and debt discount of $<ix:nonFraction unitRef="usd" contextRef="i54d531947d51410a8d540905838b6d9d_I20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5MjU_4b9ffc7a-c2e3-47f6-b5b3-cdb3028bbbcd">6.4</ix:nonFraction>&#160;million related to the modified debt are being amortized over the new term of the 2029 Senior Notes using the effective interest method.</span></div><ix:continuation id="i9848b0e7cdee4d2588c44e01fb8c3175"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:20.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id41609d12cf047148859a8228474e2bd_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMS0xLTEtMzY3OTU_be8e7283-fcda-4106-a53f-96acc27c4c49">3.250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccbfebd983b455f947f37aab7a949b0_D20200927-20210925" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMy0xLTEtMzY3OTU_e185cbbc-c1f7-4f69-9866-3a465ae59dc0">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ccbfebd983b455f947f37aab7a949b0_D20200927-20210925" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNC0xLTEtMzY3OTU_60ff27c0-6732-419c-b62d-68733e505edf">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd6b00bf571a45b79bec794d5b438566_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNi0xLTEtMzY3OTU_b3357c37-7249-47b2-8616-e0ec3fef714b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd6b00bf571a45b79bec794d5b438566_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNy0xLTEtMzY3OTU_dae68441-a236-4d0c-af5b-625d191dfd7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b31f3326de4002a60eb9c0311715ac_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtOS0xLTEtMzY3OTU_8a7e43cd-796d-48d5-9e02-8580dbc0644b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0b31f3326de4002a60eb9c0311715ac_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMTAtMS0xLTM2Nzk1_3b8c2944-d6e7-4303-894a-f9d056a9a8bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMS0xLTEtMA_1a2803ae-c0d2-41d8-b47e-20ed6b26d6d5">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad19ce928cc147b4a6d313f0bee64c59_D20200927-20210925" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMy0xLTEtMA_3d4259bd-c7df-43b9-b110-018f22d48935">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad19ce928cc147b4a6d313f0bee64c59_D20200927-20210925" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNC0xLTEtMA_8ce4d665-1aee-4393-8184-93dc0bbf6331">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4b04bc14144fa5b03735e07bd838a6_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNi0xLTEtMA_d8c2d917-1189-434b-a21f-3ca611be60d6">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4b04bc14144fa5b03735e07bd838a6_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNy0xLTEtMA_66b4996b-c8a5-4276-85d5-5171eb5b3c1b">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfc1f74a5de948999cd82322770f0eba_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtOS0xLTEtMA_f89ae70f-f2c4-4e28-b77d-98ff14f61838">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfc1f74a5de948999cd82322770f0eba_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMTAtMS0xLTA_dd954e7f-080a-41cb-bc48-cda7b4ab6d3f">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3adbde1625f143509c7660ebf25386e1_I20210925" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtMS0xLTEtMA_fd8ac996-974a-4361-88b8-377aa1bcf537">4.375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b892bb7bdd405aa700578ed296fdde_D20200927-20210925" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtMy0xLTEtMA_3d308101-4608-4519-b471-4a702298ded8">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b892bb7bdd405aa700578ed296fdde_D20200927-20210925" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtNC0xLTEtMA_92d07186-da38-4e49-ad9c-a8c0b65faccb">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i580c0405f9b548989c3f94ad170c061b_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtNi0xLTEtMA_f4479096-3223-4908-a5fe-0554beb010ff">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i580c0405f9b548989c3f94ad170c061b_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtNy0xLTEtMA_3ade6185-70b5-4a9a-bff0-72a2a083b42c">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8eae7b7b71e466b8c9e1876e7f31390_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtOS0xLTEtMA_a2a863f6-5a9a-468b-9b22-6a1443a8129c">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8eae7b7b71e466b8c9e1876e7f31390_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtMTAtMS0xLTA_b35bd0ac-d8eb-40ae-872d-f1c9cf3fd34c">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79503f9eb2e64b5383905a0821499fdd_D20200927-20210925" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtMy0xLTEtMA_19fc59bd-7d30-4f5c-bb5f-367a4145c7b8">54.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79503f9eb2e64b5383905a0821499fdd_D20200927-20210925" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtNC0xLTEtMA_807c3e56-02ae-4147-a521-9960bcc96a20">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90abd2f2507648759350a4c487e7133b_D20190929-20200926" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtNi0xLTEtMA_e1f6e7cd-6f95-41a7-962b-d081e5d50b4d">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90abd2f2507648759350a4c487e7133b_D20190929-20200926" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtNy0xLTEtMA_dacf83a5-e8f0-486a-a2bc-6febebc35811">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859a66c6b93d4b9887cc31492d39939f_D20180930-20190928" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtOS0xLTEtMA_479aee1a-8393-4dac-9e38-418bdb02659e">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859a66c6b93d4b9887cc31492d39939f_D20180930-20190928" decimals="-5" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtMTAtMS0xLTA_bbf027b1-a111-4b55-acc1-204ade196ccb">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i83f00a3fc8e9417daf5b3239c6c2edf0"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2016, the Company entered into a <ix:nonNumeric contextRef="i875c28ce0ee54237b5b3ae2cc86658a0_D20160425-20160425" format="ixt-sec:durwordsen" name="holx:TermARSecuritizationProgram" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1NjY5_49d97c8f-129d-48ce-8b38-c197428ea3e8">one-year</ix:nonNumeric> $<ix:nonFraction unitRef="usd" contextRef="i6cfd402b776d44a0a41a299cca8f7ede_I20160425" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableFromSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIwODQ5_1c2061f9-b87a-4b28-9086-dd6b8089b030">200.0</ix:nonFraction> million accounts receivable securitization program (the "Securitization Program") with several of its wholly owned subsidiaries and certain financial institutions, which provides for annual renewals. Under the terms of the Securitization Program, the Company and certain of its wholly-owned subsidiaries sell their respective customer receivables to a bankruptcy remote special purpose entity, which is also a wholly-owned subsidiary of the Company. In addition, the Company also contributed a portion of its customer receivables to the special purpose entity in connection with its establishment. The Company retains servicing responsibility. The special purpose entity, as borrower, and the Company, as servicer, entered into a Credit and Security Agreement with several lenders pursuant to which the special purpose entity, at that time, could borrow up to $<ix:nonFraction unitRef="usd" contextRef="i6cfd402b776d44a0a41a299cca8f7ede_I20160425" decimals="-5" format="ixt:num-dot-decimal" name="holx:MaximumBorrowingUnderSecuritizationProgram" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxNjg3_8f0eb51d-2fe9-4648-b0e9-d600fbb54444">200.0</ix:nonFraction> million from the lenders, with the loans secured by the receivables. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. Borrowings outstanding under the Securitization Program bear interest at LIBOR plus the applicable margin of <ix:nonFraction unitRef="number" contextRef="i875c28ce0ee54237b5b3ae2cc86658a0_D20160425-20160425" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIyMTQ3_100d919b-9992-4b2a-9de6-0ff596c3116f">0.8</ix:nonFraction>% and are included as a component of current liabilities in the Company's consolidated balance sheet, while the accounts receivable securing these obligations remain as a component of net receivables in the Company's consolidated balance sheet. The Company and the special purpose entity are operated and maintained as separate legal entities. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay other debts or liabilities of the Company. In subsequent years, the Company amended the agreement to extend it for one-year periods and increased the borrowing capacity up to $<ix:nonFraction unitRef="usd" contextRef="i4812438b158c4e59a58edb46ec6692b1_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:MaximumBorrowingUnderSecuritizationProgram" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5Mzk_a2ea80e4-b9ad-47dd-ba3a-6d17e4472720">250.0</ix:nonFraction>&#160;million and lowered the applicable margin to <ix:nonFraction unitRef="number" contextRef="id66308ea8ebc4fd4838c14af38426030_D20200927-20210925" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5NTU_cae4810d-0468-41f1-aad1-e5eb5d7d0186">0.7</ix:nonFraction>%. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, the Company paid off the total amount outstanding of $<ix:nonFraction unitRef="usd" contextRef="i5d6eb9a53b2c48879a529442ab3b794a_D20210627-20210925" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIyOTUw_1f08c7ad-76a1-4676-bc85-6f579d36fc21">250.0</ix:nonFraction>&#160;million previously borrowed. On April 13, 2020, the Company amended the Credit and Security Agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. On June 11, 2021, the Company amended and restated the Credit and Security Agreement to restart the Securitization Program and increased the maximum borrowing amount to $<ix:nonFraction unitRef="usd" contextRef="i397a73cea4db4782a2daff7fe814251a_I20210611" decimals="-5" format="ixt:num-dot-decimal" name="holx:MaximumBorrowingUnderSecuritizationProgram" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5NjE_b4f5a7d4-7340-4f2f-864d-90d2f056d70d">320.0</ix:nonFraction>&#160;million. As of September 25, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2OTIzNzA_64907978-3399-4425-bbfc-5194ceec20f6">248.5</ix:nonFraction>&#160;million outstanding under this program. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Securitization Program for fiscal 2021 had a weighted-average interest rate of <ix:nonFraction unitRef="number" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5Nzc_d5c7c813-f45d-4eda-8157-a4d566173f69">0.8</ix:nonFraction>%. Interest expense under the Securitization Program was $<ix:nonFraction unitRef="usd" contextRef="id66308ea8ebc4fd4838c14af38426030_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIzMzA2_76b6d20e-05e1-4db2-81ed-02f39ff26e13">0.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ife9157147e3b4536a9046a87f5a4d781_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIzMzEw_e28c9361-2255-4029-a8da-0811d7c95dc3">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4c371851af5c4029b78c5f593a1a596f_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIzMzE3_0877aebf-6787-48a6-847f-70a6281f0505">7.1</ix:nonFraction> million for fiscal 2021, 2020 and 2019, respectively. The interest rate on the amounts outstanding at September 25, 2021 was <ix:nonFraction unitRef="number" contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5ODM_5d855c6f-7c33-45a6-b0eb-a669d64963ef">0.8</ix:nonFraction>%.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit and Security Agreement contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, and an event of default upon a change of control of the Company. In addition, it contains financial covenants consistent with that of the Credit Agreement. As of September&#160;25, 2021, the Company was not required to be in compliance with the Credit and Security Agreement covenants.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other represents debt acquired in the Mobidiag acquisition, which is primarily with the European Investment Bank ("EIB"). Multiple tranches were withdrawn under the agreement and were primarily used to fund research and development projects and expansion efforts. The debt agreement contains change-in-control provisions allowing the EIB to call the debt at any time after a change-in-control, which occurred as a result of Hologic acquiring Mobidiag. Accordingly, the Company has classified the debt as current. The tranches withdrawn under this agreement have interest rates ranging from <ix:nonFraction unitRef="number" contextRef="ia65923c3b6874551939bf4e2608b53bb_I20210617" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5OTQ_679ed043-9ceb-4641-b8d1-e08d4d0d849d">6.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7f11d3ec54a14c5e9eb1e8a150c8bc11_I20210617" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5OTY_8338190e-25bb-46e3-8f1a-8084c38344f4">7.0</ix:nonFraction>%. The debt agreement includes additional payments to the EIB based on revenues generated by products developed under the funding as well as prepayment penalties.</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_154"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. Fair Value Measurements</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the provisions of ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value each reporting period and its nonfinancial assets and liabilities that are re-measured and reported at fair value on a non-recurring basis. Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability.</span></div><div style="margin-top:14pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hierarchy</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. Financial assets and liabilities are categorized within the valuation hierarchy based upon the lowest level of input that is significant to the measurement of fair value. The three levels of the hierarchy are defined as follows:</span></div><div style="margin-top:5pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third-party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 2 for further discussion and information on these derivative contracts. In addition, the Company has contingent consideration liabilities that are recorded at fair value and are based on Level 3 inputs. The contingent consideration liability as of September 25, 2021 and September 26, 2020 was related to the Acessa acquisition (see Note 5). </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzU1NjI_f951e3d2-9629-4f3e-9645-e3cb2c9ad538" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:37.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 25, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc96b1d6d081406abb844157f1ed6e5c_I20210925" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzgtMS0xLTEtMA_c450e36f-5a81-4842-aa77-74defdbda9e1">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1406035f87284cafbfec6b6f722dc49c_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzgtMy0xLTEtMA_e773a3d5-8082-4046-a733-2a3730929bc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc463bd6a5a1402f90b9512aff6a663a_I20210925" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzgtNS0xLTEtMA_6e594839-f8ac-4184-bed5-ca52a728b3b1">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie913b1898868426c83630108b0931936_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzgtNy0xLTEtMA_c56e5759-e66f-41ea-92bf-b0fbfcbffedc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzktMS0xLTEtMA_9dae6a79-80fd-4f0d-8b4a-668e21cbb19f">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8ebd59017941e09e4b709e2c259721_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzktMy0xLTEtMA_a01ff24d-6c78-42d8-b09e-fc2ff4c0938c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1e254ea6d6943bb8318cf1919f88ee6_I20210925" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzktNS0xLTEtMA_b48e94c2-4229-4518-a46e-8483ead8d1d0">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125f4bfdd8b84928ab52d980197004dc_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzktNy0xLTEtMA_24275157-f213-453f-a1ab-a6d2f3951ca3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0150b9393b4c8b954b2e122c43851c_I20210925" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzExLTEtMS0xLTA_ead33514-ae1e-408d-8bda-64fd34dff48f">75.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dcaf65163dc4875a6d42ef1db4db39a_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzExLTMtMS0xLTA_bed582eb-3a5a-4a87-b1f7-cac55fd80c9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i038a6263f66c4604975a68690f426831_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzExLTUtMS0xLTA_a1ecf723-11f1-4bca-ba3f-88238eb865a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73170ab8f09241c6addd83b14085fb1d_I20210925" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzExLTctMS0xLTA_23618f2e-62e4-4578-9b1e-b021feafb54d">75.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - derivative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e3770e763f4ddb888efca3f38034da_I20210925" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEyLTEtMS0xLTA_3e25a59c-80a0-478f-bc91-553e40aa9cb3">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd0a92c2fbda45e5a76e08e7693a71ee_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEyLTMtMS0xLTA_01aa5e38-45c1-4d47-9ac5-d402d26a5f00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f31160d70448a4bc9dc1766821eb8d_I20210925" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEyLTUtMS0xLTA_f9ba2139-66d5-4911-949e-d62f8e41c6bf">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15a2dcf988324496812e93ba7fe0dbfe_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEyLTctMS0xLTA_14664bcb-25b6-4921-8cb3-4c0da2758904">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e5c21e5481b48d39c7959cb8bc8c777_I20210925" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEzLTEtMS0xLTA_90cae5ab-2fb5-4172-89b7-12874504f37c">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie36b916fb59a49dd9387e30c28f5ec5b_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEzLTMtMS0xLTA_f920e7dc-b88f-4263-ab35-8245d01497a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b282273a4c84a8caba87fd238f92b67_I20210925" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEzLTUtMS0xLTA_b0c99a15-d3bc-4582-bc5c-a6c8dfbcde1b">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id901e08a99744558bdb5e1f2583dcbbe_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEzLTctMS0xLTA_efca0d70-ec53-4675-ab6c-fa7dc354f12e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzE0LTEtMS0xLTA_a68deec9-7260-4a47-946b-107c69c8ce10">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8ebd59017941e09e4b709e2c259721_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzE0LTMtMS0xLTA_94e282ab-1c54-45db-aae4-8ffee286051e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1e254ea6d6943bb8318cf1919f88ee6_I20210925" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzE0LTUtMS0xLTA_6a7711ad-799f-4274-a44b-47fcbbdd120f">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125f4bfdd8b84928ab52d980197004dc_I20210925" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzE0LTctMS0xLTA_da756c3f-01fb-469c-b443-64133c060979">75.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:484.50pt"><tr><td style="width:1.0pt"></td><td style="width:183.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:64.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 26, 2020</span></td></tr><tr style="height:42pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c2fff5e4e74c19ad8880629979f011_I20200926" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzYtMS0xLTEtMA_d0a7ee79-3044-442a-8050-bbf9800d0a6c">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib332bb7657f04489b5fa9e02f29ad82b_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzYtMy0xLTEtMA_3d865426-90ac-4e64-a080-e820b87efd52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a8c569fd753446ebfcdbe23ec063f7c_I20200926" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzYtNS0xLTEtMA_71125dca-e9de-4a98-aa0e-067f6c787cb8">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia383a042e26d453ea66d7eaa8d23c21a_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzYtNy0xLTEtMA_b8d1755e-c390-48bc-b6d8-73401ecca402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3a7bf1b1614469fb146d97f9eaddd6b_I20200926" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzctMS0xLTEtMA_12e7b63f-4890-4d49-96e9-4e5695a5ee7b">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ca8c80f7c34ee4800d09f086e64eaf_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzctMy0xLTEtMA_bff13ff3-a2f3-4da2-b3df-1ad5f6df2354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59b0c160a0424f80895466659951d8a5_I20200926" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzctNS0xLTEtMA_25f71777-c8bb-4a24-a042-001a0284b032">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43b4fa2b20c49fb8a55c4a741714682_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzctNy0xLTEtMA_82a7bf0d-864f-40d3-ac4d-951183fe06b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzgtMS0xLTEtMA_06936598-1ace-418b-b08c-a9d9ea5095d3">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id66df1a2532a483f863906f0802057c7_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzgtMy0xLTEtMA_cc1fa6cc-6510-48d1-8d69-ab8f5d6c9dfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d7b55ffbe4550b988ae9a14a17fb7_I20200926" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzgtNS0xLTEtMA_8a9c00a9-85e5-4b85-ba39-3f3da27ec40f">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91dece30b943448ab8d1ec46e9bc104e_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzgtNy0xLTEtMA_52f7c96c-6de3-4425-92ba-7d0ba0470e6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b57f07560240bbb91b31af0add8433_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEwLTEtMS0xLTA_a34b0508-7b9a-452a-84e1-a6af80da7413">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11ee15324c14f1bb58ad7901a2e8f89_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEwLTMtMS0xLTA_2e8beb85-4c74-4be6-ba08-0f8a2653648f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d46afcc2f043149b8d49cfd5f03353_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEwLTUtMS0xLTA_efafa05b-ad45-4877-b6f8-9563306933f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b57f07560240bbb91b31af0add8433_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEwLTctMS0xLTA_a506170e-c23a-4487-b096-b693bd01ba1a">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - derivative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzExLTEtMS0xLTMzNjY3_afdf1694-26ea-4ae9-81fe-c5a48489fcfd">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzExLTUtMS0xLTMzNjY5_1f5ff77a-9e71-4035-9c49-60f14227158f">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEyLTEtMS0xLTA_45c89819-3462-4d62-8d84-93d165465864">113.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id66df1a2532a483f863906f0802057c7_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEyLTMtMS0xLTA_a90be668-b301-4eee-b6ee-1f71fbb88481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib91d7b55ffbe4550b988ae9a14a17fb7_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEyLTUtMS0xLTA_bf9b15ef-fa59-4931-a485-84ad704ed9b6">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91dece30b943448ab8d1ec46e9bc104e_I20200926" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEyLTctMS0xLTA_fae1aa9e-3af5-4e6e-9c48-d8d2dce6089e">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the years ended September 25, 2021, September 26, 2020, and September 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.510%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzItMi0xLTEtMA_51c72457-0847-40ea-93da-66b48b50b223">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzItNC0xLTEtMA_79190505-75d3-4cfb-a0fa-1b8943cdcd9d">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzItNi0xLTEtMA_a9e69a8d-c43e-49a4-955a-4b01d1b7509d">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzMtMi0xLTEtMA_4e71fb35-5045-45ea-82fd-60ef3862710c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzMtNC0xLTEtMA_6ee314bc-d95b-40e5-8e7a-33ecc0f2e2a6">82.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzMtNi0xLTEtMA_c8ba527a-f488-43f4-887e-e52ce5bcb6df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzQtMi0xLTEtMA_668a8fca-5130-4dc3-870c-8fa4d688c666">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzQtNC0xLTEtMA_0a358956-10b3-4a65-a240-404d106ff23a">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzQtNi0xLTEtMA_ed1166a7-82a7-4203-8842-7202b9e43551">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzUtMi0xLTEtMA_2e7e6185-4b94-4588-b736-9f618dd24508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzUtNC0xLTEtMA_736a3365-4f10-478c-8ee3-94d12d23edbb">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzUtNi0xLTEtMA_4469edb1-ff4f-43ee-8483-10bf83f79e85">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzYtMi0xLTEtMA_d4dce786-e40f-4fce-ac5e-79f3064cf219">75.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzYtNC0xLTEtMA_2ea8c3ea-26b2-4255-b33c-34ef454c0b92">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzYtNi0xLTEtMA_2ed9b8f0-15e3-416f-a4c0-c8bd25a9ea96">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:18pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="if91afb4383874bc4926b10047930d0c4_D20190929-20191228" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzM0MzQ_1be55260-c9e9-4c6f-a220-a908437b4623">30.2</ix:nonFraction>&#160;million loss to record the asset group at its fair value less costs to sell. This is a level 1 measurement. During the second quarter of fiscal 2019, the Company identified indicators of impairment related to its long-lived assets of its Medical Aesthetics reportable segment and recorded impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i382a342e009b41b7ba2429981f375e2f_D20181230-20190330" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzM3NDA_b5206aaa-b3d7-463f-86e3-13fa367ecca3">685.4</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="i273f68028b9048b4bcb9cc44e3765361_D20181230-20190330" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzM3NTM_4261df4d-0c35-4568-8d4a-23fb367a211e">675.6</ix:nonFraction>&#160;million was allocated to intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i6960dde2df794b28bb51b31c7a27d8d7_D20181230-20190330" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzM3OTU_69774b2d-4427-4f6f-ae76-f90cf234a440">9.8</ix:nonFraction>&#160;million was allocated to equipment. This was a level 3 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measurement. During the fourth quarter of fiscal 2021, the Company recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzEwOTk1MTE2NDEyMjU_85c97f5d-9e25-4d5c-9eaf-b1c736917bd5">1.8</ix:nonFraction>&#160;million to record an equity investment to its fair value. There were no such remeasurements in fiscal 2020 and 2019. Refer to Note 6 for disclosure of the nonrecurring fair value measurement related to the debt extinguishment losses recorded in fiscal 2021 and 2019. </span></div><div style="margin-top:18pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, cost-method equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts outstanding under the Company&#8217;s 2018 Credit Agreement of $<ix:nonFraction unitRef="usd" contextRef="i461d1a7632c3438dbb6d29204125214d_I20210925" decimals="-7" format="ixt:num-dot-decimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzUxNTk_1cacef56-2329-4bc9-8a34-2edf8533d071">1.39</ix:nonFraction> billion aggregate principal as of September&#160;25, 2021 are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2028 Senior Notes and 2029 Senior Notes had fair values of approximately $<ix:nonFraction unitRef="usd" contextRef="ia06d0a30712b4655924b65bdcb87307c_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzU0NTE_435be862-7268-490d-81f5-606ca2a0afc5">424.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibc9edb45f9c24890a42f08ce96b5a3d5_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzU0NTg_76e6341f-74ca-4428-b815-8c9a16f81405">964.7</ix:nonFraction> million, respectively, as of September&#160;25, 2021 based on their trading price, representing a Level 1 measurement.</span></div><div style="text-align:center"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_157"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. Income Taxes</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjUz_66308a9c-b622-4cb6-b794-3159ee334a2a" escape="true"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income (loss) before income taxes consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:42.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.500%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzItMi0xLTEtMA_122d040a-a817-461d-90c8-0ea89aaf0cd9">2,267.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzItNC0xLTEtMA_81144280-e5f1-4d34-a36c-eda0d03491b4">921.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzItNi0xLTEtMA_f730bb22-4395-4eb2-8d01-181562c7c38b">174.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzMtMi0xLTEtMA_52208572-c53a-410f-9433-873509c53900">93.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzMtNC0xLTEtMA_f490e154-b844-453d-9b1e-ebf20b6bc71c">80.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzMtNi0xLTEtMA_f86428fe-ea05-4c48-afd7-ec86918d87f6">83.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzQtMi0xLTEtMA_cd0b45fe-9acd-4c52-9839-e02c4ac57b4a">2,361.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzQtNC0xLTEtMA_daff4178-3a07-4bb4-9597-69da2daa5883">1,001.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzQtNi0xLTEtMA_0d082d3e-bb08-4b73-b401-3da877067ce6">257.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjMy_acdabe02-cff1-46f9-9c7c-ee5e84ed3a9c" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes contained the following components:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:42.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.500%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzMtMi0xLTEtMA_06253c70-a7f8-4aa8-9533-734ab3a4677f">453.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzMtNC0xLTEtMA_a0d56390-5c13-45d5-b67d-c338956d9f0a">62.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzMtNi0xLTEtMA_5c572aed-2840-416f-9d5c-7eb2a46a07dc">142.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzQtMi0xLTEtMA_d24bee96-32e4-4690-8318-7107dd549074">45.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzQtNC0xLTEtMA_0aaa8ba6-2146-41dd-bc00-d8daf39ccb35">76.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzQtNi0xLTEtMA_0c1552f6-7d36-40f2-a0fe-fc1fb282f4d6">189.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzUtMi0xLTEtMA_8dea109e-8cb7-4d6b-a52e-7a9366eea6d7">408.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzUtNC0xLTEtMA_f506ab86-6ff5-405e-919e-3afcac5ecc65">138.7</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzUtNi0xLTEtMA_4aa66ad0-6e33-43f1-bb72-fdc6d24d924d">47.0</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzctMi0xLTEtMA_0b63610d-7e76-461e-8dd0-32749ea6eaad">84.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzctNC0xLTEtMA_2cc99c0f-ac98-461e-a16a-ac4d90ce18c6">33.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzctNi0xLTEtMA_ca01e809-a518-4d3b-a976-8af05d247c51">22.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzgtMi0xLTEtMA_78c58dd8-863c-4106-a236-8682be5b04b7">11.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzgtNC0xLTEtMA_9940a6dd-f1d8-4d0b-b7ef-5d135b8a6001">12.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzgtNi0xLTEtMA_ff794671-e0a8-421d-9a15-f09d3d447511">41.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzktMi0xLTEtMA_a0c397a3-2dd8-4636-ab1a-59f9fa2a4caa">72.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzktNC0xLTEtMA_6889c067-aed3-4195-b746-bd1e8ac05ef4">21.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzktNi0xLTEtMA_f5a91c2d-93dd-4fc4-87be-55f0813e08f2">18.9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzExLTItMS0xLTA_30b12be3-63b1-43f2-85d2-0ac684387032">23.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzExLTQtMS0xLTA_45bc9c16-a16e-4a7c-a29b-c3839bc03dc6">14.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzExLTYtMS0xLTA_c5c62c81-d7c5-4ba6-8d78-8c1df5d450d9">16.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEyLTItMS0xLTA_9a62adff-4c14-4d4e-bf34-f91748981347">12.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEyLTQtMS0xLTA_0e47545c-5ffc-4e01-a7dd-62111c24234f">5.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEyLTYtMS0xLTA_241ec769-10bd-458c-9d2d-7379a82b6c4c">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEzLTItMS0xLTA_22ed7425-10c4-430f-a314-63861f8531c1">10.6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEzLTQtMS0xLTA_e0e38ad8-a2e9-4cb4-a7d6-a312b5a5ea3c">8.7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEzLTYtMS0xLTA_4b214f90-e94f-439f-bf51-26959a5dc26a">11.8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzE0LTItMS0xLTA_7c4740ce-3537-4760-b45a-7f588881c2ec">491.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzE0LTQtMS0xLTA_ff9cace7-481e-4ef4-8420-bd22eb9f889b">108.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzE0LTYtMS0xLTA_8c5f2516-f455-4b98-9767-b10f8e449e63">54.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjM1_0ec1f08c-95c3-4366-ad82-634ba8e07790" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) differed from the tax provision (benefit) computed at the U.S. federal statutory rate due to the following:</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.187%"><tr><td style="width:1.0%"></td><td style="width:51.448%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.838%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) provision at federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzItMi0xLTEtMA_9cfe048b-cfd0-42bc-b74b-abe3ab6c1711">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzItNC0xLTEtMA_d3b94e36-c330-46e6-bb49-cc5382e3920a">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzItNi0xLTEtMA_01c3b6a9-a40c-4e59-b152-ad238bdbb0c5">21.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in tax resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale of Cynosure</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" format="ixt:fixed-zero" name="holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzQtMi0xLTEtMA_8ae9969f-6e1c-476b-ba97-967fd0cbc944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzQtNC0xLTEtMA_4c26ab97-7ae9-4a2f-aff2-a9f5dac2725c">31.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" format="ixt:fixed-zero" name="holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzQtNi0xLTEtMA_e1c2d75d-e624-4581-9ba6-7108f6c6e917">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzYtMi0xLTEtMA_c81bde5d-91d7-41c9-8171-d64c8c4a3bd7">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzYtNC0xLTEtMA_2562d57f-5e0d-4727-97f1-dbd0993a0994">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzYtNi0xLTEtMA_9bed425b-8e1f-406d-b4a7-02355838ca48">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on foreign earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzctMi0xLTEtMA_55205175-3e3d-4b3c-a7be-f53deb984bf8">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzctNC0xLTEtMA_007f6fec-09c3-4172-b9da-82e7ab4ee5a5">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzctNi0xLTEtMA_341c26f9-5404-4aea-8619-e9e42a37a008">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal restructuring</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" format="ixt:fixed-zero" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzgtMi0xLTEtMA_8bc9b8c0-a1cb-4cf5-8878-5fd61be21415">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" format="ixt:fixed-zero" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzgtNC0xLTEtMA_ed4d7aa5-4784-44ca-b31a-9619550dc9c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzgtNi0xLTEtMA_19d42acb-8cc1-4e64-9f6b-04ded9052b75">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEwLTItMS0xLTA_617026df-8509-40e7-9acb-5c500f6b4219">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEwLTQtMS0xLTA_f98c09af-7bb3-448b-ad98-c1e210bf50c2">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEwLTYtMS0xLTA_2f330a65-7cd7-4300-99f3-58d875bb72af">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax reform</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" format="ixt:fixed-zero" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzExLTItMS0xLTA_ebbc71d3-b415-451e-8516-f7749356b98c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" format="ixt:fixed-zero" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzExLTQtMS0xLTA_2984d48e-9db4-48d6-ab80-29934af5e58f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzExLTYtMS0xLTA_ac46de73-b017-4f4c-9163-33fa2b203662">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEyLTItMS0xLTA_7553e1cd-cb3a-4907-b5a5-abe5da8a8740">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" format="ixt:fixed-zero" name="holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEyLTQtMS0xLTA_94936997-bf61-48c5-8a8d-67c013759ae4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" sign="-" name="holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEyLTYtMS0xLTA_5e0bb12d-9b53-464e-90a9-96ec8bd2f2ae">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE2LTItMS0xLTA_0b778144-19ca-442f-b4e1-bb1c07275d2c">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE2LTQtMS0xLTA_77e5abee-569a-4482-93eb-b2159f8c2958">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE2LTYtMS0xLTA_4286b71c-b590-44eb-b546-cfac010da997">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE3LTItMS0xLTA_266c59e3-bf05-49dd-9a35-74426b5cfa30">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE3LTQtMS0xLTA_90ea7a49-d4b0-44c7-9a00-aab3a9056fcf">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE3LTYtMS0xLTA_c82b1466-6bb5-4471-9482-737598104c8f">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE4LTItMS0xLTA_5c96eb39-3045-4b8b-a996-d368283a4d7f">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE4LTQtMS0xLTA_9c5cee70-c251-4530-a5b7-590ea84bafe9">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" format="ixt:fixed-zero" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE4LTYtMS0xLTA_51d7ce21-8b94-41c5-9c54-02950054fa63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" format="ixt:fixed-zero" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE5LTItMS0xLTA_fae5becf-f59b-469f-8d07-bb575d474302">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE5LTQtMS0xLTA_47548e18-f247-4894-ac6e-c06a95424758">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE5LTYtMS0xLTA_0ea80172-0d69-4377-86b7-32d521406ba9">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIwLTItMS0xLTA_89833d03-cf3b-4be0-9ddb-975f57ccbc95">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIwLTQtMS0xLTA_88cdb266-04d1-44a6-8665-db059a9e1f05">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIwLTYtMS0xLTA_07ac7444-d49c-442c-a400-564c8746dbf4">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIxLTItMS0xLTA_f344223e-2bd7-495c-bda8-cae7cf638287">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIxLTQtMS0xLTA_fcf02160-4779-4465-a6ae-8ed70a8ae776">10.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIxLTYtMS0xLTA_d1d97465-e002-4641-8b1b-2342c6648f01">21.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for fiscal 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by the Company's international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes and the global intangible low-taxed income inclusion.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for fiscal 2020, which was a net benefit, differed from the U.S. statutory tax rate primarily due to a $<ix:nonFraction unitRef="usd" contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQyOQ_c8262198-83ba-4541-bfb8-3c3b1154e044">313.4</ix:nonFraction>&#160;million net tax benefit related to the sale of the Medical Aesthetics business, which was recorded in other assets net of unrecognized tax benefits, the impact of the U.S. deduction for foreign derived intangible income, federal and state tax credits, and the geographic mix of income earned by the Company's international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, partially offset by state income taxes, reserves for uncertain tax positions net of releases resulting from statute of limitations expirations and favorable audit settlements, the global intangible low-taxed income inclusion, and unbenefited foreign losses. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> fiscal 2019, which was applied to an overall pre-tax loss resulting in a tax benefit, was equal to the U.S. statutory tax rate primarily due to the offsetting impacts of a discrete tax benefit related to an internal </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restructuring, the geographic mix of income earned by the Company's international subsidiaries which are taxed at rates lower than the U.S. statutory tax rate, reserves for uncertain tax positions, reserve releases resulting from statute of limitations expirations and favorable audit settlements, a valuation allowance resulting from the Medical Aesthetics impairment charge, and finalizing the impact of the enactment of the Tax Cuts and Jobs Act in the first quarter of fiscal 2019. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the asset and liability method to account for income taxes in accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under this method, deferred income tax assets and liabilities are recognized for the future tax consequences of differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and also for operating loss and tax credit carry-forwards at each reporting period. Deferred income taxes are based on enacted tax laws and statutory tax rates applicable to the period and jurisdiction in which these differences are expected to affect taxable income. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjI5_f55360b1-9779-41c5-bc11-fea07f5be186" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s significant deferred tax assets and liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:61.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzItMi0xLTEtMA_55dd4ba8-7d96-4b44-a53a-347b7acea166">91.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzItNC0xLTEtMA_46442185-d89b-490a-85f3-65d94d93ab02">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzMtMi0xLTEtMA_2ecaa506-0997-4e7e-88f0-a85dd648c170">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzMtNC0xLTEtMA_f10a1990-75e3-4c9c-aeeb-355bee7985fa">57.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible accruals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzQtMi0xLTEtMA_0bad2b98-0046-4e24-afc4-cb06c94e767b">34.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzQtNC0xLTEtMA_7e2a4bf2-cb12-46dd-8616-999f03a718f7">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzUtMi0xLTEtMA_f9f43a34-1ed4-4b4d-9f95-3cc1e6ad01b1">41.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzUtNC0xLTEtMA_0d8204f9-d588-4800-a383-57026e19d749">33.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzctMi0xLTEtMA_a4fa6c7d-4d69-459f-b9b0-53dacc380a55">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzctNC0xLTEtMA_7178020d-6941-47c8-9239-971e6b564b59">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzgtMi0xLTEtMA_82e5a3ec-d721-4733-a53c-89078d0b5e2a">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzgtNC0xLTEtMA_3009aeef-d55c-4899-9fe2-5e5abca02a09">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified deferred compensation plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzktMi0xLTEtMA_762bbb5e-3f4e-425c-ad10-36e5af32f182">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzktNC0xLTEtMA_b316ade1-6dfa-4e0d-9f72-3cd5a7f7bb28">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" name="holx:DeferredTaxAssetsLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEwLTItMS0xLTA_bfe63fe2-57e3-49a2-b524-872e90456a8a">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="5" name="holx:DeferredTaxAssetsLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEwLTQtMS0xLTA_82518167-c2fc-4335-9587-bc394b7a5743">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEyLTItMS0xLTA_172fe48d-dcf7-4795-89fb-b4c09e3f31f0">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEyLTQtMS0xLTA_678b95db-8380-42a7-8b78-5e759667e9a9">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEzLTItMS0xLTA_6cebe2ac-509a-4445-a7ca-ef4a37f3b4a3">298.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEzLTQtMS0xLTA_01002817-fbb6-4d1a-90d2-0eb34c888926">281.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE0LTItMS0xLTA_4c640641-f843-4ed2-b3b5-7bf42c26235d">121.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE0LTQtMS0xLTA_446acb02-3318-4983-8ad3-f42896f16069">118.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE1LTItMS0xLTA_a0a0b82f-ea7c-4d79-a1a5-fa5fc140119b">176.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE1LTQtMS0xLTA_6a8a6258-9690-4c96-8209-6c1d3450ea2e">163.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation&#160;and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:DeferredTaxLiabilitiesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE3LTItMS0xLTA_5b49f69c-f8b7-48b1-b623-f142e537365c">389.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="holx:DeferredTaxLiabilitiesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE3LTQtMS0xLTA_7f3442db-a792-4de7-9abc-501c54c4a4f4">333.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:DeferredTaxLiabilitiesRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE4LTItMS0xLTA_7b3f0932-33e2-4764-b0d3-a33e285b6dda">15.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="holx:DeferredTaxLiabilitiesRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE4LTQtMS0xLTA_edf0637b-6e28-476d-a621-f13df294d1a2">15.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzIyLTItMS0xLTA_68c0e18e-d980-4c7e-8dec-a27bc9f50861">405.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzIyLTQtMS0xLTA_e6054977-a274-4edf-813d-e97996c17149">349.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzIzLTItMS0xLTA_6ec7e064-9b5a-4ac3-992b-e668a3f4f53f">228.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzIzLTQtMS0xLTA_3aa9fc7f-6d17-4cf0-a6af-d4f33b690c18">186.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Under ASC 740, the Company can only recognize the future benefit of deferred tax assets to the extent that it is &#8220;more likely than not&#8221; that these assets will be realized. After considering all available positive and negative evidence, the Company established a valuation allowance against specifically identified deferred tax assets because it is more-likely-than-not that these assets will not be realized. In making this determination, the Company considered numerous factors including historical profitability, estimated future taxable income and the character of such income. The valuation allowance increased $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQzODE_ec89ae20-c4b7-4c3c-b78c-aaaf4b638dca">2.8</ix:nonFraction> million in fiscal 2021 from fiscal 2020 primarily due to loss carryforwards and increases in foreign statutory tax rates, partially offset by the liquidation of a foreign subsidiary, attribute expiration, and valuation allowance releases. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At September&#160;25, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i20b6f0eac2434262a3cac9fb4d6a84a8_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ2NTI_c1696799-229f-4997-ac1a-c762cacce1d6">89.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6d960bac02334aadb2300cb9a53f0809_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ2NTY_4fde53f9-5d6a-49af-92ee-31c472e3b114">135.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i276f90f490c64954a3fcb6fce34ac50d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ2NjQ_d8b8b3d5-df58-4df5-be86-4ee6765f18ec">263.2</ix:nonFraction> million in gross federal, state, and foreign net operating losses, respectively, $<ix:nonFraction unitRef="usd" contextRef="i20b6f0eac2434262a3cac9fb4d6a84a8_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ3NDA_468aeeee-f5b2-4cf0-bd5c-a2cc833cddff">4.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6d960bac02334aadb2300cb9a53f0809_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ3NDQ_8b908d43-4ae7-4191-a567-7c93ab8a208c">6.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i276f90f490c64954a3fcb6fce34ac50d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ3NTI_500ef7eb-bcfd-4a36-819a-4faeb655042c">0.5</ix:nonFraction> million in federal, state, and foreign credit carryforwards, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" format="ixt:num-dot-decimal" name="holx:GrossStateLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzIxOTkwMjMyNzk2NTc_03d5e1a3-c52a-4df8-8d6c-4c69120d9b8d">26.2</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" format="ixt:num-dot-decimal" name="holx:GrossForeignLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ4MjY_ff734010-d41d-4b48-8ee3-bd61918349c2">33.0</ix:nonFraction>&#160;million in gross state and foreign capital loss carryforwards, respectively. These losses, credits, and capital loss carryforwards expire between 2022 and 2041, except for $<ix:nonFraction unitRef="usd" contextRef="ib5ffdf58eb9f4baeb95351040e234393_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ5OTY_c0e4fbd7-fbc0-45d4-95d5-e629970230a4">235.4</ix:nonFraction> million in losses, $<ix:nonFraction unitRef="usd" contextRef="i5daaef3be8904e43aea1b5d817ea7ea9_D20200927-20210925" decimals="4" format="ixt:num-dot-decimal" name="holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUwMTE_8e0d5058-9a1b-4a3c-bcd1-849c7637f15d">2.3</ix:nonFraction> million in credits, and $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUwMzA_e055a4ab-96af-4ca4-83b5-1e89564fb26a">33.0</ix:nonFraction>&#160;million in capital loss carryforwards that have unlimited carryforward periods. The federal, state, and foreign net operating losses include $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUxNjY_d67a96c5-0819-4ca5-af6c-f9bedfc1db2d">1.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUxNzA_9e47e13d-5c02-415c-bede-c84d818ce03a">48.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUxNzg_08559968-a73c-45f4-ae24-e16f7442381a">0.9</ix:nonFraction> million, respectively, and the state capital loss carryforwards include $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" format="ixt:num-dot-decimal" name="holx:StateLossCarryforwardExpectedToUnutilize" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUyNDU_07cf51a0-5c4a-47b5-a4ab-83999abb243b">26.2</ix:nonFraction>&#160;million, that the Company expects will expire unutilized.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;25, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:GrossUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzU4OTA_ff399505-6ffb-40de-8de3-f7e287254add">212.8</ix:nonFraction> million in gross unrecognized tax benefits excluding interest, of which $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzU5NTc_bb44fdb1-c8eb-496d-942b-2a0b4480c5b4">197.0</ix:nonFraction> million, if recognized, would reduce the Company's effective tax rate. As of September&#160;26, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:GrossUnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzYwNDk_b89141c2-4d68-4e4b-8d21-924b5ff0756e">197.1</ix:nonFraction> million in gross unrecognized tax benefits excluding interest, of which $<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzYxMTY_74b6ae57-6fbd-4540-b6ed-0fafa081459f">184.9</ix:nonFraction> million, if recognized, would have reduced the Company's effective tax rate. The $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzYxOTI_524cd502-e96f-4a83-9f72-620fc7fff09f">15.7</ix:nonFraction> million increase in gross unrecognized tax benefits from fiscal 2020 was primarily related to intercompany transfer pricing for ordinary business operations, capital losses, federal and state carryback </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">claims, acquisition related reserves, and other current year positions, partially offset by reserve releases resulting from statute of limitations expirations. In the next twelve months it is reasonably possible that the Company will reduce its gross unrecognized tax benefits excluding interest by up to $<ix:nonFraction unitRef="usd" contextRef="icd8d2cba4a8d4ac4869ea733f58a335d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzY2OTY_c5c5c52a-bf62-4ece-9f77-6794745bb44b">13.0</ix:nonFraction> million due to expiring statutes of limitations.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjUx_82e8d8dd-140e-4543-a07a-8d496018885e" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unrecognized income tax benefits activity for fiscal 2021 and 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:61.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzEtMi0xLTEtMA_eaef8ee2-bce3-482c-b8c8-5a4d5c7b5e1e">197.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzEtNC0xLTEtMA_c622ef86-34c0-4b57-b5dd-6d90acd11ed0">101.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax positions related to current year:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzMtMi0xLTEtMA_b2882df4-73ce-4997-a32c-7d45a1e103af">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzMtNC0xLTEtMA_1176f465-4c80-43c2-b124-d6c80d85ca6f">109.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzQtMi0xLTEtMA_e4322423-707a-49ba-bd87-f9de42bb7264">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzQtNC0xLTEtMA_6102d949-539c-4c76-8f5c-cc929a522539">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax positions related to prior years:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions related to change in estimate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzYtMi0xLTEtMA_e6ce6fef-a853-402d-96a0-4bcc6e5042dd">7.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzYtNC0xLTEtMA_f02dbf71-939c-4b6c-bea5-151500ca1227">1.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzctMi0xLTEtMA_c0de23d9-be72-4cb2-b7bd-6557a681d57b">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzctNC0xLTEtMA_a6213207-f680-4637-ac8f-6bf3b4d7c492">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzgtMi0xLTEtMA_3f9317c7-8994-4bb6-8190-d30fdd8cf3a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzgtNC0xLTEtMA_ab1c53e1-4a2e-498d-a919-ec53d55af689">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapses in statutes of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzktMi0xLTEtMA_49149c13-ee10-48cb-abee-66b2d4d6ba52">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzktNC0xLTEtMA_41840e03-44a3-4030-bb2d-f8fc0d04d906">15.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired tax positions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions related to reserves acquired from acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzExLTItMS0xLTA_0b3c73fe-b861-4bd9-8dd9-4b3d482d7b4c">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzExLTQtMS0xLTA_647faab3-fa17-42e1-a2b7-92c9404a7ef6">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of the end of the fiscal year</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzEyLTItMS0xLTA_0b3992af-1def-431c-8935-ad11cb35e2f0">212.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzEyLTQtMS0xLTA_fe74f159-73a1-4cef-9878-c06fa684b08c">197.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy is to include accrued interest and penalties related to unrecognized tax benefits and income tax liabilities, when applicable, as a component of income tax expense. As of September&#160;25, 2021, and September&#160;26, 2020, gross accrued interest was $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzcwNjg_640050ad-0cb8-4435-bd0d-6af2815480ab">13.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzcwNzU_adaf8645-46ff-4b17-beed-953b6438e755">11.9</ix:nonFraction> million, respectively, and accrued penalties were immaterial. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its subsidiaries are subject to examination by U.S. federal, state, and foreign tax authorities. The Company&#8217;s U.S. federal and state income tax returns are generally no longer subject to examination prior to fiscal year 2017. The Company is undergoing tax examinations in California (fiscal years 2017-2018), Massachusetts (fiscal years 2016-2017), and the United Kingdom (fiscal years 2016-2019). The Massachusetts income tax examination for fiscal years 2014-2015 was settled and the amount assessed was not material.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed federal and state carryback claims during the fourth quarter of fiscal 2021 and as a result, has reclassified $<ix:nonFraction unitRef="usd" contextRef="i1d836e99e1744b98a12d054959a730e7_D20210627-20210925" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="holx:IncomeTaxReceivableReclassification" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzEwOTk1MTE2NTgyOTc_9fb94a70-9050-43ef-a245-edbc44559611">310.0</ix:nonFraction>&#160;million from its long-term receivable account, of which $<ix:nonFraction unitRef="usd" contextRef="i5aa941ab35ec45b98ce91c612351ba23_D20210627-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:IncomeTaxReceivableReclassification" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzIxOTkwMjMyNzk2NzM_65cfe4c5-deba-4606-907f-450751890087">404.9</ix:nonFraction>&#160;million was recorded as a current tax receivable and included in prepaid expenses and other current assets in the Consolidated Balance Sheet and the remainder of which was recorded as a long-term tax payable and included in other long-term liabilities in the Consolidated Balance Sheet.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that unremitted foreign earnings are not considered indefinitely reinvested to the extent foreign earnings can be distributed without a significant tax cost.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As such, the Company records foreign withholding tax liabilities related to the future repatriation of such earnings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to indefinitely reinvest all other outside basis differences to the extent reversal would incur a significant tax liability. It is not practicable for the Company to calculate the unrecognized deferred tax liability related to such incremental tax costs on those outside basis differences.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Tax Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 24, 2016, the FASB issued ASU 2016-16, which removes the prohibition in ASC 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. Under ASU 2016-16, the selling (transferring) entity is required to recognize a current tax expense&#160;or benefit upon transfer of the asset. Similarly, the purchasing (receiving) entity is required&#160;to recognize a deferred tax asset or deferred tax liability, as well as the related&#160;deferred tax benefit or expense, upon receipt of the asset. The Company adopted ASU 2016-16 in the first quarter of fiscal 2019 on a modified retrospective basis as of September 30, 2018, the first day of fiscal 2019. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was required to account for an internal restructuring under ASU 2016-16 and recorded a $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:IncreasetoincometaxexpenseadoptionofASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0Xzk3ODM_3f4d960a-2363-4d2a-97a1-a3606e2b2f88">27.8</ix:nonFraction> million increase to income tax expense and income tax liabilities and a decrease of $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:DecreaseindeferredtaxliabilitiesduetoASC201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0Xzk4NjI_2f2931a4-7a6b-4c15-a81c-5d907caf8887">37.7</ix:nonFraction> million to deferred tax expense and net deferred tax liabilities for the fiscal year ended September 28, 2019. The net result was a reduction to net loss of $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:IncreasetoNetIncomeresultedfromadoptionofASU201616" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzEwMDE0_8c654706-737a-4b9e-a3cf-8b6eadd34172">9.9</ix:nonFraction> million, or $<ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="holx:IncreasetoEarningsperShareresultedfromadoptionofASC201616" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzEwMDIx_d3a04e10-5525-40b0-a2f8-d5c6e1c1eb2e">0.04</ix:nonFraction> to diluted net loss per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-49</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to tax examinations for value added, sales-based, payroll and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates and records loss contingencies pursuant to ASC 450. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2021, based in part on developments in an ongoing tax audit as well as ongoing operations, the Company determined that it was probable it had incurred a loss related to a non-income tax issue. The Company estimated the probable amount of additional loss to be $<ix:nonFraction unitRef="usd" contextRef="iaffd59eb8187474fb5a4d8af030af483_D20181230-20190330" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="holx:NonIncomeTaxLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMTQ0_1a08af37-f8aa-483f-8d26-f5ce56c8423d">11.2</ix:nonFraction>&#160;million for all open years and recorded this charge to general and administrative expenses. While the Company believes its estimate is reasonable and appropriate, this matter is still ongoing and additional charges could be recorded in the future. </span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_160"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDQ5_80814899-478d-4820-a7ae-d2d61809f49e" continuedAt="ibba4aeee71c84671aa630c9bcb1e262c" escape="true">Stockholders' Equity and Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="ibba4aeee71c84671aa630c9bcb1e262c" continuedAt="i7813a1bcfd6e4743b81f0d8466d2e6f5"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 13, 2018, the Board of Directors authorized the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="i814cfc79d9f948ac96c6d5e239cf1326_I20160613" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ2OQ_cf7d92e2-631a-4d37-8a82-2a98361e0f6e">500.0</ix:nonFraction> million of the Company's outstanding common stock. This share repurchase plan was effective August 1, 2018 and expired March 27, 2020. Under this authorization, during fiscal 2019, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzgyMQ_8f26dc1a-00e7-475c-90cb-feba5964f2ce">4.8</ix:nonFraction> million shares of its common stock for total consideration of $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzg3OA_d9d157c5-459c-4333-8356-9f414249e615">200.1</ix:nonFraction> million. During the first and second quarters of fiscal 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i88b3d268274c46d98f224f8c6c9816fb_D20201227-20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk1OQ_cabb6d6c-d41c-4d92-a2fb-dcd7b98043a1">3.9</ix:nonFraction>&#160;million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="i88b3d268274c46d98f224f8c6c9816fb_D20201227-20210327" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwMTg_6c661c49-256e-4719-afad-36d510ae0500">210.9</ix:nonFraction>&#160;million. As of March 28, 2020, the Company had completed this authorization. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, the Board of Directors authorized a new share repurchase plan to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i12da8222241d4afe9a4fd7ee1a5a6030_I20191211" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzExOTU_4c31320b-baa2-45ce-b423-bd9cd2dc38c3">500.0</ix:nonFraction>&#160;million of the Company's outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020 the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020. Under this revised authorization during fiscal 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i945e50292f26455c9fb03af3ee5dc38d_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzE1MzQ_252e6d76-0ac4-4409-885b-2e726f36e004">5.1</ix:nonFraction>&#160;million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="i945e50292f26455c9fb03af3ee5dc38d_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzE1OTM_ca275826-e85d-4614-a71a-e081c9f988e9">237.7</ix:nonFraction>&#160;million. During the first quarter of fiscal 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="icc5c3fa0816048caa2da1ed91c216daf_D20200927-20201226" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU4MDk_015ff84c-2ded-4192-adb1-e4fb89b7741f">1.5</ix:nonFraction>&#160;million shares of its common stock under this plan for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="icc5c3fa0816048caa2da1ed91c216daf_D20200927-20201226" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU5MTc_ecc15c4b-752f-4bd8-bfe6-6c6ce133182f">101.3</ix:nonFraction>&#160;million. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Board of Directors authorized a new five-year share repurchase plan to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="ie11a3dc3cc614addb28fd00bd0cf9a2c_I20201209" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU4MzQ_316f7b6e-7bc9-4083-8142-95739009427e">1.0</ix:nonFraction>&#160;billion of the Company's outstanding common stock. The prior plan was terminated in connection with this new authorization. Under the new authorization, during fiscal 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="id1a4a87513914de081e110fe2f694f1d_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU4NjE_14de8eaa-780f-4ea2-905b-91091c6ef145">4.6</ix:nonFraction>&#160;million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="id1a4a87513914de081e110fe2f694f1d_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU4ODY_14971440-4dbb-4fdc-9a67-34b4122afb89">308.5</ix:nonFraction>&#160;million. As of September 25, 2021 $<ix:nonFraction unitRef="usd" contextRef="i3e1998ffb6bc4561a84610ab181828cb_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzE2MjM_d6d8d838-bf23-4af6-a7ce-5b38b1160be3">691.6</ix:nonFraction>&#160;million remained available under this authorization. Subsequent to September 25, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i747e381970ad4c3992a6131bcbfc5461_D20210926-20211116" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDE1NTg_d0dcaccf-0dd8-41c4-964f-da6786c702ed">2.3</ix:nonFraction>&#160;million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i747e381970ad4c3992a6131bcbfc5461_D20210926-20211116" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDE1NDE_6f8a17a3-13ad-455f-8f76-5160ef248750">167.0</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2019, the Board of Directors authorized the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925" decimals="5" format="ixt:num-dot-decimal" name="holx:ASRAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzE4NzA_e51579b9-2e00-45ad-9045-ec601202a9f4">205</ix:nonFraction> million of its outstanding shares pursuant to an accelerated share repurchase ("ASR") agreement. On November 22, 2019, the Company executed the ASR agreement with Goldman Sachs &amp; Co. ("Goldman Sachs") pursuant to which the Company repurchased $<ix:nonFraction unitRef="usd" contextRef="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327" decimals="-6" format="ixt:num-dot-decimal" name="holx:ASRAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzIxMDc_85f1bc97-a1a1-461e-b514-daf0aca0c03e">205</ix:nonFraction>&#160;million of the Company's common stock. The initial delivery of approximately 80% of the shares under the ASR was 3.3&#160;million shares for which the Company initially allocated $<ix:nonFraction unitRef="usd" contextRef="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327" decimals="-5" format="ixt:num-dot-decimal" name="holx:AmountpaidduringtheperiodunderASRAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzIyNjc_544609b5-1cb7-40ac-aef1-d247dd599207">164.0</ix:nonFraction>&#160;million of the $<ix:nonFraction unitRef="usd" contextRef="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327" decimals="-6" format="ixt:num-dot-decimal" name="holx:ASRAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzIyNzc_99c1ba6f-1120-4e7e-9fa5-12479d6cc670">205</ix:nonFraction>&#160;million paid to Goldman Sachs during the first quarter of fiscal 2020. The Company evaluated the nature of the forward contract aspect of the ASR under ASC 815 and concluded equity classification was appropriate. Final settlement of the transaction under the ASR occurred in the second quarter of fiscal 2020. At settlement, Goldman Sachs delivered an additional <ix:nonFraction unitRef="usd" contextRef="i57712fb9ed674d6ebb6261cb65be3db3_D20210328-20210626" decimals="-5" format="ixt:num-dot-decimal" name="holx:ASRSharesRepurchasedduringtheperiod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzI2MzU_4b5b492c-7729-4237-97f9-855b10f09c9d">0.6</ix:nonFraction>&#160;million shares of the Company's common stock.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-50</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i7813a1bcfd6e4743b81f0d8466d2e6f5" continuedAt="i0f58cdf657cb48f38347b16746224aa8"><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Compensation Plans</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has one share-based compensation plan pursuant to which awards are currently being issued&#8212;the 2008 amended and restated Equity Incentive Plan (&#8220;2008 Equity Plan&#8221;). The purpose of the 2008 Equity Plan is to provide stock options, restricted stock units and other equity interests in the Company to employees, officers, directors, consultants and advisors of the Company and any other person who is determined by the Board of Directors to have made (or is expected to make) contributions to the Company. The 2008 Equity Plan is administered by the Board of Directors of the Company, and a total of <ix:nonFraction unitRef="shares" contextRef="i748a99e2a6c74677886bd3b4e6b89ac2_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzMzMzU_f2ee3f75-9ec4-4602-aac5-5c6130489912">31.5</ix:nonFraction> million shares were reserved for issuance under this plan. As of September&#160;25, 2021, the Company had <ix:nonFraction unitRef="shares" contextRef="i748a99e2a6c74677886bd3b4e6b89ac2_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzM0MTU_1a24fc44-a2aa-44e4-bca0-ad3751cdcd6e">4.6</ix:nonFraction> million shares available for future grant under the 2008 Equity Plan.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDMy_06b460e8-5fe1-4394-839a-cbda47c65d29" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Operations in fiscal 2021, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i623fe63350cc4f4bbf60f09a3b45072a_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzEtMi0xLTEtMA_a7a8c700-c2fd-49e6-a204-fbacb05d3d9c">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0202135faa1f4b469d6ecb622791638d_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzEtNC0xLTEtMA_6811c0b3-2479-405a-a8b4-91338d2cd477">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452f1577e5c942c4a2cebac00daff1d2_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzEtNi0xLTEtMA_231a9eee-b7c7-4d66-885c-c47e7f6812eb">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb317bb99ad84ae3a58c21783556ecaa_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzItMi0xLTEtMA_b5a2edf3-d044-4a40-9e09-37c521fec701">7.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34f9b5ebf6940d8862b1e4e259514e0_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzItNC0xLTEtMA_b5e96a4a-0f96-4aba-9e8b-227e27dc37bc">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacda269ea4f047c08ae1a3627ce6fcf9_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzItNi0xLTEtMA_18aaa823-dabb-4c12-a981-b7ba8d7147ae">9.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db32da71cc1455088030b8c7b621bf0_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzMtMi0xLTEtMA_c6d55023-7962-4ed2-bc29-d664da935362">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic05d68681e5c4f9eacb730bfede1f07c_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzMtNC0xLTEtMA_0e02a790-807e-4963-9302-b3c0dc8a8a63">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b47832b29e04b3bb2ed3c90cfc6f1fa_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzMtNi0xLTEtMA_135d8d6f-3598-4d47-948d-5bf69bf29929">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i920ca50d08084b8b97e8598c37fc6711_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzQtMi0xLTEtMA_bde80b37-3379-4c08-96ab-9b24e00e4db9">38.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i199364dd0aa84ab9b4bd4fb3a7b46bee_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzQtNC0xLTEtMA_844c7cd0-59d2-4765-9859-f43cccc0a007">50.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i935c7d53d46d4c65944f086fdbf09aec_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzQtNi0xLTEtMA_2a2e705e-359f-45de-867f-2cb65b771dae">35.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c14b446dbbc4ed1ba4f1d985a7197ec_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzUtMi0xLTEtMA_83a907b6-7703-4ac9-a34f-f7b22ecf0070">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b1b0c9c5604d23ab52ca8f9713a3d9_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzUtNC0xLTEtMA_d275b359-456d-4953-9e30-f7466ce0adde">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9133708dc8a4713aad750ae0f4663a0_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzUtNi0xLTEtMA_92044db1-866a-4031-b566-aedd8249347c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzYtMi0xLTEtMA_6361ef5d-4c44-48de-87cb-64ecc94add8a">65.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzYtNC0xLTEtMA_78b6049a-76a0-4eb3-91b2-babe758842b0">83.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzYtNi0xLTEtMA_4e5190ae-f2d5-48eb-a338-ebcdd2117a8a">62.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Grant-Date Fair Value</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The Company considers a number of factors to determine the fair value of options including the assistance of an outside valuation adviser. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDYx_ebfd0d7d-6c0e-4f47-b928-f8f2d493cc52" continuedAt="i5ae45bda7e7b4268bfd5e92fd56bcc08" escape="true">Information pertaining to stock options granted during fiscal 2021, 2020 and 2019 and related assumptions are noted in the following table:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i5ae45bda7e7b4268bfd5e92fd56bcc08"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted (in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzItMi0xLTEtMA_82fdd974-56fe-4838-a5de-71a83ded69e9">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzItNC0xLTEtMA_455a1ece-9880-4716-a77a-4638644ace36">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzItNi0xLTEtMA_f982dc03-c868-43ed-bdd7-12176c915ec1">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzMtMi0xLTEtMA_8cc51df3-275d-4ee6-905a-0e560b6ff2b6">68.62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzMtNC0xLTEtMA_88490bd2-b92d-451a-bfdf-3d935d205187">45.96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzMtNi0xLTEtMA_96b0a20c-cf0b-4ce3-b1f7-0b60bc9fcd1b">41.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzQtMi0xLTEtMA_d398f05e-1905-43fd-b074-bf6bd16f3045">19.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzQtNC0xLTEtMA_2cb91cdc-a14e-4d0a-b212-e868ad75d58d">13.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzQtNi0xLTEtMA_6f44bcf1-3c69-42ec-abf7-28b3d90bbee4">13.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzYtMi0xLTEtMA_a3b23426-256a-4c8a-a247-5e91456fda52">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzYtNC0xLTEtMA_7c992f57-bd30-4697-be70-fd1d72f1e7c5">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzYtNi0xLTEtMA_fad8c232-e73a-4b06-932f-2733edd6dbce">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzctMi0xLTEtMA_20edfa73-7670-49c2-ad70-effa7e21431f">4.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzctNC0xLTEtMA_0f500521-0aa6-494c-be27-6a9573b86d59">4.8</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzctNi0xLTEtMA_eee708ec-5b4f-4f1e-83b0-21b15f1488d1">4.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzgtMi0xLTEtMA_32941b36-bc90-4648-9448-a86d1afd68fe">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzgtNC0xLTEtMA_b0c7d497-ce8b-447b-a76b-7cb99ed62f68">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzgtNi0xLTEtMA_cb20992c-a125-4336-a468-8482cb4a9e59">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzktMi0xLTEtMA_a1c8c88c-a87f-4d69-bc7c-deec642fc824">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzktNC0xLTEtMA_7ece0542-e4ce-449c-aba6-7f353826d817">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzktNi0xLTEtMA_ea895767-c8a0-409f-9bcc-4907c137d695">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. In projecting expected stock price volatility, the Company uses a combination of historical stock price volatility and implied volatility from observable market prices of similar equity instruments. The Company estimated the expected life of stock options based on historical experience using employee exercise and option expiration data.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation Expense Attribution</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the straight-line attribution method to recognize stock-based compensation expense for stock options and restricted stock units ("RSUs"). The vesting term of stock options is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ3MTk_de8b43b0-f008-41d7-b826-9f3a463875ab">four</span> years with annual vesting of <ix:nonFraction unitRef="number" contextRef="ie9a15e5e0d5f4a248aab637516ec83a5_D20200927-20210925" decimals="2" name="holx:PercentageOfVestingForStockOptionsGrantedToEmployees" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ3NTc_a4760967-67f8-44e2-a507-52b68f0905f3">25</ix:nonFraction>%&#160;per year on the anniversary of the grant date, and RSUs generally vest over <ix:nonNumeric contextRef="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDM5_1c1c72c0-b478-4224-9852-84fe78e8fbe5">three years</ix:nonNumeric> with annual vesting at <ix:nonFraction unitRef="number" contextRef="i7e32118662c4420ba5a02eec6689e797_D20200927-20210925" decimals="2" name="holx:PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ4OTA_cd66b152-0590-4a0e-aa73-a816192e2bf9">33</ix:nonFraction>% per year on the anniversary of the grant date. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company's accounting policy is to estimate forfeitures at the time awards are granted and revise, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based on an analysis of historical forfeitures, the Company has determined a specific forfeiture rate for certain employee groups and has applied forfeiture rates ranging from <ix:nonFraction unitRef="number" contextRef="i7133ee75e2dd4ac999d32c90c55818c6_D20200927-20210925" decimals="INF" name="holx:ShareBasedCompensationPercentageOfForfeitureRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU0NzY_5104c38c-49c8-4aac-853b-b6e6abe7265d">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ib5f33f2bd0484efea0b8ae4a94ebb11e_D20200927-20210925" decimals="3" name="holx:ShareBasedCompensationPercentageOfForfeitureRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU0ODI_4b64c032-2829-40a9-a81e-784f5c959d1a">6.0</ix:nonFraction>% as of September&#160;25, 2021 depending on the specific employee group. This analysis is re-evaluated annually and the forfeiture rate adjusted as necessary. Ultimately, the actual stock-based compensation expense recognized will only be for those stock options and RSUs that vest.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-51</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i0f58cdf657cb48f38347b16746224aa8" continuedAt="icf12ddab080d48b080f11d59a5291009"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to stock options was $<ix:nonFraction unitRef="usd" contextRef="i16882582e0204737b097e2891c7c65e4_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU4MDg_6d317f73-5a4e-4c63-8c2c-f75794382cf1">13.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i14ca5f4e78bb437a81cded9e6c66f121_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU4MTI_3ad85379-ae3f-49f8-adb9-eabe8b3dc4ea">15.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ie582e31fa38344bea5db72aa1a9ab369_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU4MjA_d03bbde7-7313-4344-9b3e-7f3b0b52abfd">14.1</ix:nonFraction> million in fiscal 2021, 2020 and 2019, respectively. Stock compensation expense related to stock units, including RSUs, performance stock units ("PSUs"), free cash flow performance stock units ("FCFs") and market stock units ("MSUs") was $<ix:nonFraction unitRef="usd" contextRef="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYwNDc_77fbc0c9-b4c1-4194-bb83-ea4dc33670e8">46.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i74b0294ab860440d9476b34210f76f37_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYwNTE_2e23f669-adef-40b8-8dbd-5b5cbdec2a39">63.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i8b62684619cf449b9f9b6a4e0bef8642_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYwNTk_c60cabf6-7e3e-49be-a7dd-d7fa5e5d1f92">43.7</ix:nonFraction> million in fiscal 2021, 2020 and 2019, respectively. The related tax benefit recorded in the Consolidated Statements of Operations was $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYxODM_d05ba6cd-ea96-4c93-9675-23ab8a86fca1">7.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYxODc_6aec81c5-103b-4f30-8051-a04f27aaafe4">9.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYxOTQ_efe6f4d5-ed6f-4df1-90b3-c84fb71311fd">8.9</ix:nonFraction> million in fiscal 2021, 2020 and 2019, respectively. At September&#160;25, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="ib0bd21f9a30840228f9a47abe615910a_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYyNTc_a42f4029-8a0d-4589-99a8-36921343cda6">15.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i05ae9481304b4cbda64fdf0b97da2601_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYyNjQ_e5f4d5db-333a-450f-8d3c-d9987c205be8">50.3</ix:nonFraction> million of unrecognized compensation expense related to stock options and RSUs, respectively, to be recognized over a weighted average period of <ix:nonNumeric contextRef="i16882582e0204737b097e2891c7c65e4_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzY0MDQ_be2bf0c1-b075-4a09-a121-58613f9af45e">2.3</ix:nonNumeric> years and <ix:nonNumeric contextRef="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzY0MTc_c78bb018-8f95-49c9-8dd4-c27976e15bc8">1.8</ix:nonNumeric> years, respectively.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment Activity</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDQz_ace668cd-6c30-4f14-902c-6abead6b7eba" escape="true"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all stock option activity under the Company&#8217;s stock option plans for the year ended September&#160;25, 2021:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.181%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.181%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.181%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.183%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares<br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzEtMi0xLTEtMA_6f8e2bf5-93f0-41b6-9fab-56df1ea59bf9">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzEtNC0xLTEtMA_6e3e1dbe-4e51-4fed-8522-212b840d806f">40.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" format="ixt-sec:duryear" name="holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzEtNi0xLTEtMA_1788c9f9-d4bb-4d93-9ed0-4b020cda2331">7.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzEtOC0xLTEtMA_e4a708b6-bd54-4ace-8b1f-606d137cf581">109.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzItMi0xLTEtMA_c0236133-f06e-4dde-a2c0-f5e65c488e07">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzItNC0xLTEtMA_e1f21f94-ac83-4b14-b695-00b019f41066">68.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/ forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzMtMi0xLTEtMA_21189a35-c633-478a-84c1-a4bcafcdc1a1">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzMtNC0xLTEtMA_e3c82263-eb76-43dd-8454-4527d73fbea9">49.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzQtMi0xLTEtMA_c36bfd41-ef43-4c30-b0d6-9b5e651501a3">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzQtNC0xLTEtMA_5b173b66-0a7e-4a14-a032-6e5f27fffcb4">38.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzQtOC0xLTEtMA_ed3b8f9a-0574-4de4-9a13-58649ad253f8">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzUtMi0xLTEtMA_85cadd8d-15c7-4fd3-9f88-328ae6691fb9">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzUtNC0xLTEtMA_77f18d81-d373-4d36-9aef-1e32d39f3f09">44.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:duryear" name="holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzUtNi0xLTEtMA_ebd89463-10e8-4271-a4ef-a53eb71b89d5">6.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzUtOC0xLTEtMA_08edf727-f00e-460d-919f-a97dbb08c19b">132.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzYtMi0xLTEtMA_8f569bdc-e2f0-42dd-ab2f-dd2e4c781bf4">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzYtNC0xLTEtMA_cc670644-e6e8-4341-a251-cd5f5193c3de">39.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzYtNi0xLTEtMA_f4ed0102-5824-4b1a-b10f-25df197d9839">5.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzYtOC0xLTEtMA_264578e7-31c2-4c5d-94ee-f6ba5d7ae6d2">85.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest at September 25, 2021 (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzctMi0xLTEtMA_041fe7b0-37f7-4b9e-95f3-58dbf5e07ce6">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzctNC0xLTEtMA_9895bb3f-98ff-4d72-82fd-fe8aab46d4ad">44.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzctNi0xLTEtMA_bf49d0e9-1c39-4ec2-b491-f0ac22f8776f">6.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzctOC0xLTEtMA_e6f8b6da-45f2-490f-850a-f3a5b7f14944">132.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This represents the number of vested stock options as of September&#160;25, 2021 plus the unvested outstanding options at September&#160;25, 2021 expected to vest in the future, adjusted for estimated forfeitures.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020 and 2019, the total intrinsic value of options exercised (i.e., the difference between the market price on the date of exercise and the price paid by the employee to exercise the options) was $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzY5NzU_1aa5a41c-d80c-4341-9221-20eccd627387">44.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzY5ODI_7bc48f7b-7ecd-44a1-adf6-9db82180d35d">26.1</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDUz_cf572387-7a2f-443b-8512-fa9607012a1f" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s RSU, PSU, FCF and MSU activity during the year ended September&#160;25, 2021 is presented below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"><tr><td style="width:1.0%"></td><td style="width:50.978%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-vested Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-Date&#160;Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzEtMi0xLTEtMA_d9354683-cdb9-4902-93eb-6786b2d55cdf">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzEtNC0xLTEtMA_401b6ee8-770a-4893-a2e2-a2f0e0ea9bc5">44.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzItMi0xLTEtMA_448be3c6-850e-4d43-bd17-5a5db0c1bba4">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzItNC0xLTEtMA_1f410be1-a16b-499f-8d58-219f815fe27d">69.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzMtMi0xLTEtMA_06c29bcd-c6f6-4917-84ee-2a9ec5933579">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzMtNC0xLTEtMA_c0c84348-72f6-4f31-a23c-2d9a3c098674">43.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzQtMi0xLTEtMA_d54e63b3-0da2-46d8-a094-53aff9855eb1">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzQtNC0xLTEtMA_7f97fb3c-80c0-4521-947d-38df1f89a35f">52.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzUtMi0xLTEtMA_4cc5d21e-4a5e-4e97-9736-3b90a43b7d15">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzUtNC0xLTEtMA_0db51c75-e3cd-4ecd-b48c-4ad3c8a8afa5">54.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of RSUs vested includes shares withheld on behalf of employees to satisfy minimum statutory tax withholding requirements. The Company pays the minimum statutory tax withholding requirement on behalf of its employees. During fiscal 2021, 2020 and 2019 the total fair value of RSUs vested was $<ix:nonFraction unitRef="usd" contextRef="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0MTI_57dc471e-d22c-4ba1-be35-7a85416cea07">73.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i74b0294ab860440d9476b34210f76f37_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0MTY_3de0e735-f651-40cd-a2aa-86a4c5ff263a">34.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8b62684619cf449b9f9b6a4e0bef8642_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0MjM_f09825b3-840c-4017-ae8c-102f6138b39b">34.6</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted <ix:nonFraction unitRef="shares" contextRef="ia618e91ec0fc43d09d5b6352f024ece8_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0NjE_6bb97772-30aa-4475-9ea6-fb3e70899598">0.5</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="shares" contextRef="ia28511c78fc648ccac995a4d5840b7b8_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0NjU_63f37442-fbac-43de-b81d-1d6f966c09e4">0.6</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i0cc04f37c6b947d3b9bc3cda079ee134_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0NzI_fb6aa0e3-2886-4329-8e7e-368aa2e6d7e2">0.9</ix:nonFraction>&#160;million RSUs during fiscal 2021, 2020 and 2019, respectively. In addition, included in the above chart, the Company also granted <ix:nonFraction unitRef="shares" contextRef="ia51b0591bb904743909f38530873e249_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc1OTY_d48e5e77-f63b-4666-a2e4-6ea18ef7bc44">0.1</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="i313b0dcd780d4e46bd994d7390ef9a63_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc2MDA_26260f83-d4fe-4d81-9023-d172f9274daa">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ic1f36b739b804d62873d875e6ab53e6e_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc2MDc_786da667-a3aa-4be7-8714-13047f2b5702">0.1</ix:nonFraction> million PSUs during fiscal 2021, 2020, and 2019 respectively, to members of the Company's senior management team, which includes additional shares issued upon achieving metrics within the performance criteria. The PSUs were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="ia51b0591bb904743909f38530873e249_D20200927-20210925" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc4MzI_50868876-0bec-4e8c-925e-b8a1d515749e">68.51</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i313b0dcd780d4e46bd994d7390ef9a63_D20190929-20200926" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc4MzY_def8ebdb-05ab-4428-8aaf-a60644123d88">45.38</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ic1f36b739b804d62873d875e6ab53e6e_D20180930-20190928" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc4NDM_5f512eed-05bb-4946-bebb-61bf9f14d717">40.97</ix:nonFraction> per share based on the ending stock price on the date of grant in fiscal 2021, 2020 and 2019, respectively. Each recipient of the PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="INF" format="ixt:fixed-zero" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzgwMTI_09cf0684-8a39-4d4c-886f-8d44cc6c0686">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzgwMTk_610ec02d-c124-4120-8129-356397d75927">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDU0_0a47c5f7-5f11-4bcc-96bc-eacbaf7ee7f3" continuedAt="i9c12bdef761d404b8ee679bb7ff9c990">three </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-52</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="icf12ddab080d48b080f11d59a5291009"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9c12bdef761d404b8ee679bb7ff9c990">year</ix:continuation> performance period provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted <ix:nonFraction unitRef="shares" contextRef="ifb7931cabae1458c905c13e1f1be44c6_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzgyMjk_5194b3f8-8972-4de9-9fba-d7e7e5708b1e">0.1</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="id8e24c06b55c4c71852aa0419edcd4c1_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDM5OTU_33b9d09a-79e8-4dd5-b496-2cc8b1eca3c8">0.1</ix:nonFraction>&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team in fiscal 2021 and 2020, respectively. Each recipient of FCF PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="ifb7931cabae1458c905c13e1f1be44c6_D20200927-20210925" decimals="INF" format="ixt:fixed-zero" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDQxMDI_154ad65d-91b1-4d7f-ade3-0306c00fafb6">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="ifb7931cabae1458c905c13e1f1be44c6_D20200927-20210925" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDQxMTU_58bfc04b-d225-4d76-9127-96a8a39c6805">200</ix:nonFraction>% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" format="ixt-sec:durwordsen" name="holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzg2MDA_12c6813c-83e5-477a-b4df-5a91296c202e">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted <ix:nonFraction unitRef="shares" contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkwMzg_9f3df506-1ed2-4275-b0d8-d97af974e8a7">0.1</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="idcf0307d722e405a9d4239a5969664a9_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkwNDI_2d160899-bc17-4533-88b4-1f5a51372323">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i00a4b6b947964d0c9cf7a620d260cdb8_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkwNDk_630f6e99-ff76-4c6c-ac52-c1d7a2f44c01">0.1</ix:nonFraction> million MSUs during fiscal 2021, 2020 and 2019, respectively, to its senior management team. Each recipient of MSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925" decimals="INF" format="ixt:fixed-zero" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkxOTE_3bd47824-0b81-477d-9c88-d6a01fac5a6b">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkxOTg_aca29ab0-5e0f-4c8b-8954-bed433a5b81f">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of three year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk0MTc_01d7d3e0-01b1-4a20-948c-f9e93c47561a">82.31</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="idcf0307d722e405a9d4239a5969664a9_D20190929-20200926" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk0MjE_c61d128e-63bb-4e09-ac3f-3465de021981">43.54</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i00a4b6b947964d0c9cf7a620d260cdb8_D20180930-20190928" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk0Mjg_9f54316a-6a07-4b4e-a957-b0d695a21fbb">55.13</ix:nonFraction> per share using the Monte Carlo simulation model in fiscal 2021, 2020 and 2019, respectively. These awards cliff-vest <ix:nonNumeric contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925" format="ixt-sec:durwordsen" name="holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDQ0_34398713-0f46-4dc4-b714-f9951367bf85">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hologic, Inc. 2012 Employee Stock Purchase Plan (&#8220;2012 ESPP&#8221;) provides for the granting of up to <ix:nonFraction unitRef="shares" contextRef="ib4dbd93a38124c16a4fcf7162433450f_D20120301-20120331" decimals="-5" format="ixt:num-dot-decimal" name="holx:NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk4MDY_c65523db-1c76-4e6e-9a57-c667bb902aa4">2.5</ix:nonFraction> million shares of the Company&#8217;s common stock to eligible employees. The 2012 ESPP plan period is semi-annual and allows participants to purchase the Company&#8217;s common stock at <ix:nonFraction unitRef="number" contextRef="ib4dbd93a38124c16a4fcf7162433450f_D20120301-20120331" decimals="2" name="holx:PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk5NzY_af8532a2-6d79-49c9-bcb0-70c68b1f59dc">85</ix:nonFraction>% of the lower of (i)&#160;the market value per share of the common stock on the first day of the offering period or (ii)&#160;the market value per share of the common stock on the purchase date. Stock-based compensation expense in fiscal 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i3222582dc9e54de994fbc83070afcdca_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwMjI0_ecb92b24-bae8-4d43-8788-a36e91c8c05c">5.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i46abb586bf124b4085396c348e397ede_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwMjI4_ad882148-2f6b-4d13-9f0a-e1b605d2d912">4.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i59c4542075c04499bd7780fac311ed3c_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwMjM1_26c27c11-453d-48c2-ac27-87cf39f7b049">4.2</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDM0_888fa52c-6b84-4679-833d-0bd419a207c8" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:42.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.498%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzItMi0xLTEtMA_75327289-0a61-4a20-a89c-1d7bf69856d6">0.26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzItNC0xLTEtMA_4545c993-caa8-4816-8016-2164f384876a">1.32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide2dd65f185944a7af648c12349053bf_D20180930-20190928" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzItNi0xLTEtMA_ec4954ef-7f88-4b7c-be67-bfd4723655d5">2.27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzMtMi0xLTEtMA_06e47cb8-bc06-4c2f-be4f-5eb91a881ff0">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzMtNC0xLTEtMA_f7ae2278-50a4-4382-9385-125cd21e6c17">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ide2dd65f185944a7af648c12349053bf_D20180930-20190928" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzMtNi0xLTEtMA_8a962d62-ab97-4e2f-8b33-9938f479e757">0.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzQtMi0xLTEtMA_5f406848-93b9-46e2-81eb-0e9036efb0d6">34.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzQtNC0xLTEtMA_d5b8057b-3d2e-424f-b998-75994eeafa88">26.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide2dd65f185944a7af648c12349053bf_D20180930-20190928" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzQtNi0xLTEtMA_aa857561-8f90-4247-93fe-60666d1976a7">27.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzUtMi0xLTEtMA_e2d1e4e6-dc72-4fef-acd9-85f67f67e09c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzUtNC0xLTEtMA_0f09a300-3183-4c68-9492-845d1b44345a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide2dd65f185944a7af648c12349053bf_D20180930-20190928" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzUtNi0xLTEtMA_55d995d9-5d96-498e-867a-8bb24eb12fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_166"></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:MultiemployerPlanTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjYvZnJhZzo1MjQwN2VmNzc2ZmQ0ODBkODI4NDQ3ODk4MDg2NzJjNS90ZXh0cmVnaW9uOjUyNDA3ZWY3NzZmZDQ4MGQ4Mjg0NDc4OTgwODY3MmM1XzEwOTk1MTE2Mjc5OTA_06fa8628-4811-4bf5-93ba-46ee6efb5b76" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. 401(k) Plan</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. employees have access to a qualified 401(k) defined contribution plan. The Company made contributions of $<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjYvZnJhZzo1MjQwN2VmNzc2ZmQ0ODBkODI4NDQ3ODk4MDg2NzJjNS90ZXh0cmVnaW9uOjUyNDA3ZWY3NzZmZDQ4MGQ4Mjg0NDc4OTgwODY3MmM1XzE0NQ_6c969105-d36a-4ec3-ae97-e349426dae2c">20.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjYvZnJhZzo1MjQwN2VmNzc2ZmQ0ODBkODI4NDQ3ODk4MDg2NzJjNS90ZXh0cmVnaW9uOjUyNDA3ZWY3NzZmZDQ4MGQ4Mjg0NDc4OTgwODY3MmM1XzE0OQ_716e2c11-1f83-4241-9470-330fb8aab3c3">19.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjYvZnJhZzo1MjQwN2VmNzc2ZmQ0ODBkODI4NDQ3ODk4MDg2NzJjNS90ZXh0cmVnaW9uOjUyNDA3ZWY3NzZmZDQ4MGQ4Mjg0NDc4OTgwODY3MmM1XzE1Ng_af1b7063-6505-41df-9db7-27b5e3b876d5">19.2</ix:nonFraction> million for fiscal 2021, 2020 and 2019, respectively.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-53</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. Deferred Compensation Plans</span></div><div style="margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nonqualified Deferred Compensation Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March&#160;15, 2006, the Company adopted its Nonqualified Deferred Compensation Plan ("DCP") to provide non-qualified retirement benefits to a select group of executive officers, senior management and highly compensated employees of the Company. Eligible employees may elect to contribute up to <ix:nonFraction unitRef="number" contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925" decimals="INF" name="holx:MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzM3Nw_481eaff8-7be2-40fa-9b24-7d7bddb07dd1">75</ix:nonFraction>% of their annual base salary and <ix:nonFraction unitRef="number" contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925" decimals="INF" name="holx:MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzQxMg_d540f331-1271-4826-b284-9991e115c6e7">100</ix:nonFraction>% of their annual bonus to the DCP and such employee contributions are <ix:nonFraction unitRef="number" contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925" decimals="INF" name="holx:EmployeeContributionsVestedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzQ4NA_f2b2c4a6-c478-4843-a35a-05223d202090">100</ix:nonFraction>% vested. In addition, the Company may elect to make annual discretionary contributions on behalf of participants in the DCP. Each Company contribution is subject to a <ix:nonNumeric contextRef="ie7174a6cf5674cc7a6e006b12d20074f_D20200927-20210925" format="ixt-sec:durwordsen" name="holx:EmployerContributionsVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzM2ODc_3cc6ea11-2ee7-47de-a52c-a492da82747f">three-year</ix:nonNumeric> vesting schedule, such that each contribution vests one third annually. Employee contributions are recorded within accrued expenses.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon enrollment into the DCP, employees make investment elections for both their voluntary contributions and discretionary contributions, if any, made by the Company. Earnings and losses on contributions based on these investment elections are recorded as a component of compensation expense in the period earned.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annually, the Compensation Committee of the Board of Directors has approved a discretionary cash contribution to the DCP for each year. Discretionary contributions by the Company to the DCP are held in a Rabbi Trust. The Company records compensation expense for the DCP discretionary contributions ratably over the <ix:nonNumeric contextRef="ie7174a6cf5674cc7a6e006b12d20074f_D20200927-20210925" format="ixt-sec:durwordsen" name="holx:EmployerContributionsVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzM2Nzk_a28131a6-2179-4343-9916-2f88a09fa606">three-year</ix:nonNumeric> vesting period of each annual contribution, unless the participant meets the plan retirement provision of reaching a certain age and years of service criteria in which case the expense is accelerated to match the required service period to receive such benefit. Under the DCP, the Company recorded compensation expense related to Company contributions of $<ix:nonFraction unitRef="usd" contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:NonqualifiedDeferredCompensationPlanAnnualContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE3ODY_b438f7be-3465-4710-acf5-738cdc6d6782">3.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i09879e74afc8419ebec21bb3b905b88d_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:NonqualifiedDeferredCompensationPlanAnnualContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE3OTA_cacbcb4f-450d-4c38-9757-e85382ad74ba">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idf5f8f1317384761bd3f09365e030290_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="holx:NonqualifiedDeferredCompensationPlanAnnualContribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE3OTc_b9bcb4ed-d0c0-4f9a-abcb-72da158fdaa7">2.7</ix:nonFraction> million in fiscal 2021, 2020 and 2019, respectively. The full amount of the discretionary contribution, net of forfeitures, along with employee deferrals is recorded within accrued expenses and totaled $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE5ODg_2528de07-ae44-4672-88ee-5a3cdebd30f8">76.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE5OTU_44d6b887-d477-4a57-b078-f780aa51007a">57.7</ix:nonFraction> million at September&#160;25, 2021 and September&#160;26, 2020, respectively.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has purchased Company-owned group life insurance contracts, in which both voluntary and discretionary Company DCP contributions are invested, to partially fund payment of the Company&#8217;s obligation to the DCP participants. The total amount invested at September&#160;25, 2021 and September&#160;26, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i539c042130bf4c0ea0ca1aaf167a10a3_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:InvestmentInGroupLifeInsuranceContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzIzMDI_ed99d956-9997-44c9-bb15-b30414e6562f">64.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic2b78f80558e4fa2aa90758d4605b59c_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:InvestmentInGroupLifeInsuranceContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzIzMDk_b800cecf-3625-4676-a647-c62f8b1d3f9b">49.3</ix:nonFraction> million, respectively. The values of these life insurance contracts are recorded in other long-term assets. Changes in the cash surrender value of life insurance contracts, which were not significant in fiscal 2021, 2020 and 2019, are recorded within other income (expense), net.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Equity Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 17, 2015, the Company adopted the Hologic, Inc. Deferred Equity Plan (the &#8220;DEP&#8221;). The DEP is designed to allow executives and non-employee Directors to accumulate Company stock in a tax-efficient manner to meet their long-term equity accumulation goals and shareholder ownership guidelines. Under the DEP, eligible participants may elect to defer the settlement of RSUs and PSUs granted under the 2008 Equity Plan until separation from service or separation from service plus a fixed number of years. Participants may defer settlement by vesting tranche. Although the equity will vest on schedule, if deferral of settlement is elected, no shares are issued until the settlement date. The settlement date is the earlier of death, disability, change in control of the Company or separation from service plus the number of years of deferral elected by the participant. While these shares upon vesting are not distributed to the individuals and are not outstanding, these shares are included in basic weighted average shares outstanding used to calculate earnings per share.</span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_175"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. Non-cancelable Purchase Commitments</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90ZXh0cmVnaW9uOmNlM2QyMTY0YTJjNjRlNzBhM2RkMWY5YjJiZDVmM2UyXzY2NA_b1398118-85d2-42c6-8b7d-1c848c3e3b59" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain non-cancelable purchase obligations primarily related to inventory purchases and diagnostics instruments, primarily Panther systems, and to a lesser extent other operating expense commitments. These obligations are not recorded in the Consolidated Balance Sheets. For reasons of quality assurance, sole source availability or cost effectiveness, certain key components and raw materials and instruments are available only from a sole supplier and the Company has certain long-term supply contracts to assure continuity of supply. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90ZXh0cmVnaW9uOmNlM2QyMTY0YTJjNjRlNzBhM2RkMWY5YjJiZDVmM2UyXzY3NQ_dc4e9218-caf0-48e1-9f76-bbd656b29273" continuedAt="i365d72f091aa40cd915d52b556f126fb" escape="true">At September&#160;25, 2021, non-cancelable purchase commitments are as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i365d72f091aa40cd915d52b556f126fb"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"></td><td style="width:70.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzAtMS0xLTEtMA_ffbbb4e9-5a25-412b-bda4-595e35eddbb0">290.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PurchaseObligationDueInSecondYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzEtMS0xLTEtMA_a9888281-8d1b-4b87-84e8-98fe32c55323">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PurchaseObligationDueInThirdYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzItMS0xLTEtMA_de6f95b3-8b4b-4aa3-8b05-5b86a3f3a648">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PurchaseObligationDueInFourthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzMtMS0xLTEtMA_2cccaa8a-84da-4719-86eb-6ffe6a36fa0c">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PurchaseObligationDueInFifthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzQtMS0xLTEtMA_65896a75-814a-4e84-8b0d-152f354cd55c">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:Purchaseobligationthereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzUtMS0xLTEtMA_983ec5eb-4858-4e03-bbad-ee3bc72299ac">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PurchaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzYtMS0xLTEtMA_6d30a404-3464-43f1-92ec-a9304b72ff4c">322.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-54</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="margin-top:14pt"><span><br/></span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_178"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:LitigationAndOtherMattersTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzgvZnJhZzpiZmU5ZjMxYWVhZGE0MDEyODcxNmFmZjQwYjY2OGJhZC90ZXh0cmVnaW9uOmJmZTlmMzFhZWFkYTQwMTI4NzE2YWZmNDBiNjY4YmFkXzgyOTc_8a1d0a27-6d6e-45d6-bbac-7055f05da87d" continuedAt="i9c1f9cbdf25c4912b2d8caccd410c59e" escape="true">Litigation and Related Matters</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i9c1f9cbdf25c4912b2d8caccd410c59e" continuedAt="i6b514a31e95e455bbec6b2ab55c28633"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $<ix:nonFraction unitRef="usd" contextRef="i8f565dc1ab5b4eb6aef305378185c37c_D20180727-20180727" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzgvZnJhZzpiZmU5ZjMxYWVhZGE0MDEyODcxNmFmZjQwYjY2OGJhZC90ZXh0cmVnaW9uOmJmZTlmMzFhZWFkYTQwMTI4NzE2YWZmNDBiNjY4YmFkXzE5NTE_eabc5ce1-1cd2-4abc-95c5-7c541c08d5a9">4.8</ix:nonFraction> million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continued its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the &#8216;348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, the Company filed a cross- petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva's petition to address the issue of assignor estoppel and denied the Company's petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold the assignor estoppel but limited its application to situations in which an assignor's claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208 (the '208 patent). Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10 day trial beginning on August 9, 2021. On July 27. 2021, the Delaware district court granted Hologic's motion for summary judgment on invalidity of the '208 patent and entered judgment in favor of the Company. On August 24, 2021, Minerva appealed this and the other rulings to the Court of Appeals. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-55</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i6b514a31e95e455bbec6b2ab55c28633"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 15, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $<ix:nonFraction unitRef="usd" contextRef="ia2f30513167641b4843c24f196c963b3_I20210925" decimals="5" format="ixt:num-dot-decimal" name="holx:LegalAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzgvZnJhZzpiZmU5ZjMxYWVhZGE0MDEyODcxNmFmZjQwYjY2OGJhZC90ZXh0cmVnaW9uOmJmZTlmMzFhZWFkYTQwMTI4NzE2YWZmNDBiNjY4YmFkXzc1MzQ_dbe80f8e-c146-45d3-a1c1-8f37ada70678">8.5</ix:nonFraction>&#160;million accrued for such matters as of September 25, 2021. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div></ix:continuation><div id="i07bbd5e33a1f472e83c59d8668de41f8_181"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzMyNjc_dac81be3-b5e8-4db5-af5e-37213bd2e5c9" continuedAt="i6b27c8a2f8c948b9bdc20a8a917f9352" escape="true">Disposition</ix:nonNumeric></span></div><ix:continuation id="i6b27c8a2f8c948b9bdc20a8a917f9352"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Medical Aesthetics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$<ix:nonFraction unitRef="usd" contextRef="i219e75a86551445f84f935b59c0a9995_I20191120" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzIxNg_7eb90136-dd0f-46ef-9bf8-f6e440e55a3d">205.0</ix:nonFraction>&#160;million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i4e21c713b33d4b199f4353e62c47d003_D20191120-20191120" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzM0MQ_75daa96f-4485-4ee6-a387-45b5833fd059">153.4</ix:nonFraction>&#160;million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $<ix:nonFraction unitRef="usd" contextRef="i04f6b978d03c4001921c33d5129a2d94_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzUyMw_bcb65062-b98c-44b9-ac57-f75506e4da8a">150.0</ix:nonFraction>&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzYyNg_91ec9144-43e9-4830-8cd0-3e6aa51ccfb1">three</span> to <ix:nonNumeric contextRef="i31bd370f6c9d45cbb9bf2321aef87fe9_D20210627-20210925" format="ixt-sec:durwordsen" name="holx:TransitionServicesAgreementTerm" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzYzMg_fc11ea21-d30f-41ba-90a2-041ab33b2cef">fifteen months</ix:nonNumeric>, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $<ix:nonFraction unitRef="usd" contextRef="i04f6b978d03c4001921c33d5129a2d94_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:IndemnificationLiabily" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzg5Ng_96a39fd6-4fa6-49aa-bbf4-8c6fb1ef2f5f">10.9</ix:nonFraction>&#160;million within accrued expenses associated with its obligations under the sale agreement. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment and Disposal of Long-Lived Assets, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or that will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i3f5a4fc2e0a249feb5e822c662f420e2_D20200927-20201226" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzE4NzI_aedae782-5a4d-460a-90b6-8b415ad6804c">30.2</ix:nonFraction>&#160;million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $<ix:nonFraction unitRef="usd" contextRef="ie6a08f19521748068ae388682bbfb97b_D20200927-20201226" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzE5OTg_8878ddb8-e10b-49d8-a910-61b5a31292f7">25.8</ix:nonFraction>&#160;million was allocated to cost of product revenues and $<ix:nonFraction unitRef="usd" contextRef="iaa33bf2f57be45678091ef0f4e3cb31e_D20200927-20201226" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzIwNDc_03eff36d-e84b-44f4-8c3b-8e8e57ae1e01">4.4</ix:nonFraction>&#160;million to operating expenses.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations of the disposed business presented below represents the operating loss of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business. As noted above, the Company had performed a number of transition services and the financial impact from these services are not included in the amounts presented below. In addition, the Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition. Subsequent to the disposition, the Company recorded additional expenses of $<ix:nonFraction unitRef="usd" contextRef="ied23a24d717e4da1895598ce729fd2bf_D20210627-20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:Expensesfromdisposition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzI5ODE_6c2a4078-9413-4ad7-9c66-c4d896e736c1">6.2</ix:nonFraction>&#160;million in fiscal 2020 primarily for accelerated stock compensation, inventory reserves under the manufacturing supply agreement, and legal expenses and settlements, which are not included in the below amounts. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzMyNzE_06e1cd83-cd3e-4c0f-b5b3-8024853f38a3" continuedAt="i54cb6c7b9d6b4ee195d09439b0a97074" escape="true">Loss from operations of the disposed business for fiscal 2020 and 2019 was as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i54cb6c7b9d6b4ee195d09439b0a97074"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"><tr><td style="width:1.0%"></td><td style="width:47.412%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:23.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-2" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90YWJsZTpmNjczOTdjZmYzZTQ0NGU4YTUxZjYwNTYwM2E1ZTA3OS90YWJsZXJhbmdlOmY2NzM5N2NmZjNlNDQ0ZThhNTFmNjA1NjAzYTVlMDc5XzMtNS0xLTEtMA_e92586e2-6c87-40c7-84f0-476fa4ce83e5">46.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-2" sign="-" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90YWJsZTpmNjczOTdjZmYzZTQ0NGU4YTUxZjYwNTYwM2E1ZTA3OS90YWJsZXJhbmdlOmY2NzM5N2NmZjNlNDQ0ZThhNTFmNjA1NjAzYTVlMDc5XzMtNy0xLTEtMA_5355629e-b5d0-450e-9a92-6f5726ce05d1">781.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i07bbd5e33a1f472e83c59d8668de41f8_184"></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzI3ODk_82e20843-93a6-4c2e-a72c-8e4a04009753" continuedAt="i8c8cdd51b03248429e5fce3ee1c8c8b5" escape="true">Business Segments and Geographic Information</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><ix:continuation id="i8c8cdd51b03248429e5fce3ee1c8c8b5" continuedAt="i848725c13bef4b449822878922d81f08"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports segment information in accordance with ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions about how to allocate resources and assess performance. The Company&#8217;s chief operating decision maker is its chief executive officer, and the Company&#8217;s reportable segments have been identified based on the types of products manufactured and the end markets to which the products are sold. Each reportable segment generates revenue from either the sale of medical equipment and related services and/or sale of disposable supplies, primarily used for diagnostic testing and surgical procedures. During fiscal 2021, the Company had <ix:nonFraction unitRef="segment" contextRef="i982ea739818b424cbe9228324e052c58_D20200927-20210925" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzEwOTk1MTE2MzExNzY_357fd994-5c8a-4256-95f6-04b70014dc00">four</ix:nonFraction> reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During the first quarter of fiscal 2020 and </span></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-56</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i848725c13bef4b449822878922d81f08" continuedAt="i167a8a421af243ba864f16cf25f14876">fiscal 2019, the Company had five reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-57</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="i167a8a421af243ba864f16cf25f14876" continuedAt="if2b1a50dc6a742edb60ad3910ee448c2"><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were <ix:nonFraction unitRef="usd" contextRef="id1a7761670014c0e89cd95059279c22a_D20180930-20190928" decimals="INF" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzE5OTU_2b97a269-fbdd-47ec-89d0-4925a42d6638"><ix:nonFraction unitRef="usd" contextRef="i982ea739818b424cbe9228324e052c58_D20200927-20210925" decimals="INF" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzE5OTU_5a88904b-0e1a-4b27-820d-98c3d66354fc"><ix:nonFraction unitRef="usd" contextRef="i54b63b6326364b86b8c1c35e06779d17_D20190929-20200926" decimals="INF" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzE5OTU_7bcec00e-9d88-4fdb-8740-a3bbc685c9e8">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> intersegment revenues. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzI3OTQ_e41559be-6378-491d-a6dd-360115b932f0" continuedAt="i07a586349f1445c8a547f0f17e7643e9" escape="true">Segment information for fiscal 2021, 2020, and 2019 was as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i07a586349f1445c8a547f0f17e7643e9"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:52.954%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMtMi0xLTEtMA_8c935f80-1129-4576-b3c9-c9df516fc5b1">3,695.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMtNC0xLTEtMA_1bbb1d0f-53ac-4bb4-8c34-245fc22d8b50">2,102.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMtNi0xLTEtMA_b7b1e411-2d09-4839-b38f-29320ba0a6c7">1,205.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzQtMi0xLTEtMA_96add575-e98f-498e-9a07-71fd21e8fab1">1,352.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzQtNC0xLTEtMA_fe21e985-b121-47ad-8faf-e001be795356">1,151.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzQtNi0xLTEtMA_505594c0-bda4-45ea-b51d-eba34dec120b">1,314.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzUtMi0xLTEtMA_fe62b342-5a07-42a1-81d5-19cc4a684bc9">488.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzUtNC0xLTEtMA_cd204485-0e64-4149-998a-cb914d9c06e3">376.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzUtNi0xLTEtMA_672b2d8f-c120-4c56-8294-b67b98d7d0eb">437.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzYtMi0xLTEtMA_31d0a01c-fac3-4bad-bd3c-74806fe755ef">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzYtNC0xLTEtMA_3c777c4a-5c9e-4800-b949-c99c7c229cb9">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzYtNi0xLTEtMA_52b1299b-61fb-45ba-9462-c22a2277fadd">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzctMi0xLTEtMA_06c06319-499d-40b7-84c7-e8c01e4d9f90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzctNC0xLTEtMA_45d41914-5073-4c3d-a7eb-dd6d334d4870">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzctNi0xLTEtMA_e66375d9-f8b5-4290-881d-f4b64c8c4ce3">315.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzgtMi0xLTEtMA_f455cb4c-c851-4be3-831d-fa234d6d7cd7">5,632.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzgtNC0xLTEtMA_58b320dc-d166-4391-b179-5807ee53552e">3,776.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzgtNi0xLTEtMA_c9dab760-dd68-4f1a-9c69-f51275e8d8a9">3,367.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEwLTItMS0xLTA_3bfbd38c-5301-42ba-9bda-d7202a2594aa">2,140.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEwLTQtMS0xLTA_474edb23-2c03-49c6-bb14-2213f09ddfb1">929.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEwLTYtMS0xLTA_c8741cc6-1794-4b3a-8b55-0d250efa9cf0">163.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzExLTItMS0xLTA_dea1b806-c565-422a-9001-6e14178662d0">284.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzExLTQtMS0xLTA_866314df-e696-4fed-bf3b-dfe29b707f6a">192.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzExLTYtMS0xLTA_3ada317c-2c15-416f-a711-4b9dfdcd9eab">399.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEyLTItMS0xLTA_4a3e737d-cc99-4d9f-8949-ea37ff882eb2">58.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEyLTQtMS0xLTA_2e0cce5f-39c5-49c8-bde6-b6ad743bc7fb">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEyLTYtMS0xLTA_13414a94-919e-4502-a757-48fd7dc0d5dc">99.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEzLTItMS0xLTA_0507e891-4f9c-491a-9b7a-45a174bde568">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEzLTQtMS0xLTA_d1d9710b-bb87-43f7-b30e-b6ad4196114f">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEzLTYtMS0xLTA_c75d67de-c438-4a37-9f78-c1c5cc347a46">4.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE0LTItMS0xLTA_e6ac5e55-56a3-4283-8c22-d4202f71b3e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE0LTQtMS0xLTA_1a9a4566-e2fa-496b-8432-82ac812df865">57.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE0LTYtMS0xLTA_e75be0cd-c273-47ac-83ce-5ef6d7e3d424">781.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE1LTItMS0xLTA_46681aba-4277-4a58-b843-1751596518eb">2,480.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE1LTQtMS0xLTA_2991d67e-7195-4a47-b374-8325ef932cf9">1,105.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE1LTYtMS0xLTA_2977ff5d-7541-486c-8416-1e5e2f08de4d">123.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE3LTItMS0xLTA_99e6c34d-6d7e-4aaa-ac65-6c8f58405f6c">260.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE3LTQtMS0xLTA_7e6f223b-8b9e-43fa-ab05-e2d561c9b2f9">237.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE3LTYtMS0xLTA_9670796f-f03c-4d10-b85b-814a3a94993b">246.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE4LTItMS0xLTA_60e567dd-0479-4ce8-abf8-fbcc77f49a59">52.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE4LTQtMS0xLTA_479409e3-b220-4b82-aed9-42efdc002f3f">48.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE4LTYtMS0xLTA_98657c72-0cd2-441b-9a27-cb5196445409">36.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE5LTItMS0xLTA_f4ea22a0-065e-4c4e-83eb-39b1a0ca35b0">93.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE5LTQtMS0xLTA_083d442b-ee6d-4555-9aee-4b6a2e45bbcd">85.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE5LTYtMS0xLTA_409bff17-d6af-415d-be92-b317423a6fe0">87.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIwLTItMS0xLTA_543133a2-6dab-4276-ac0d-4b2d55740ba1">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIwLTQtMS0xLTA_a17ef2b4-edb1-4dc5-9069-ac5f2f02a0c3">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIwLTYtMS0xLTA_7ffcad16-98fb-4eb5-85af-839cdcfbc642">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIxLTItMS0xLTA_3be7e719-5978-400b-a6b1-9b573753c222">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIxLTQtMS0xLTA_5032cdb9-c2ee-4691-94f2-924c58972896">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIxLTYtMS0xLTA_146c2f8e-b3f3-4b75-837f-2a2939d8f1fc">91.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIyLTItMS0xLTA_cd2df446-edb1-441c-b11d-c551f1f4d6e4">406.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIyLTQtMS0xLTA_964edad2-5862-4023-a451-a90e35e96515">376.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIyLTYtMS0xLTA_d03d4f57-43ce-4d27-8a3f-40d091d67c6e">463.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI0LTItMS0xLTA_9c65315f-98df-49df-aa1a-da91c1a597e6">126.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI0LTQtMS0xLTA_bc44ffac-4471-402a-8b85-5ed575832f05">110.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI0LTYtMS0xLTA_985539b9-a02a-4093-8368-9559d5209404">59.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI1LTItMS0xLTA_e3b188bd-f480-4385-918e-bf0ef720cf47">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI1LTQtMS0xLTA_35d6f161-ac07-4f4b-ad82-4deafcb3bc64">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI1LTYtMS0xLTA_764673f1-c8f4-42cd-a691-41c4fdea78ad">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI2LTItMS0xLTA_ad783537-aa1a-4f71-bace-42efb578bcd0">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI2LTQtMS0xLTA_bb66b3cf-4da9-4c90-8a5a-a9b99e7d4390">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI2LTYtMS0xLTA_628718f9-e467-405e-8e6e-178fa268ce0e">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI3LTItMS0xLTA_31b66bdb-5370-4478-9b7f-472e4246eb0b">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI3LTQtMS0xLTA_c41691f2-a491-4a8b-be2e-c7e1d04cdffc">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI3LTYtMS0xLTA_a7506c4e-b3b3-4bf6-950c-e309201a34ae">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI4LTItMS0xLTA_b23a3aaf-ff3f-45d3-8cc1-ccc06b28e2d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI4LTQtMS0xLTA_e883a775-50e5-4196-8338-78f05537f47b">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI4LTYtMS0xLTA_1653d342-95d2-4870-9d51-9bd0a69754ef">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a986aa268d54c1c9fed13658c3b20ec_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI5LTItMS0xLTA_3f626724-4711-4ec9-9443-9cccf3f2274e">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26018f332aa24e47a89ddb88990c5d5f_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI5LTQtMS0xLTA_cc8f0b9d-ea4e-4aeb-bb9f-08765d07f05e">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103c26400f644d6794e2701b7b92414f_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI5LTYtMS0xLTA_c528cd5c-3d28-4aa7-8f5e-f5f6b56c0fde">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMwLTItMS0xLTA_1914ca45-e80f-4f8e-af18-37ee6fcf6f05">156.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMwLTQtMS0xLTA_47a1c612-4bbc-4a4b-91be-13dad121e536">156.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMwLTYtMS0xLTA_b89abf23-eab5-4ec6-8c91-0895b3bacb66">109.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3b69d34963e43d5a345ff8d104b509c_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMyLTItMS0xLTA_14f86505-c776-4cb6-9e56-e4d3da2c4bce">3,348.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d0b62cc24e442bb94c648589df1886_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMyLTQtMS0xLTA_0c7c357b-73b2-4549-bd6d-3459caafefa7">2,161.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98caa293bf89418e947a8f295926a7d8_I20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMyLTYtMS0xLTA_6c7fee52-fd18-4704-9db4-a3d52bf2103a">2,276.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e61574a9b46411bb0ae2371322a832e_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMzLTItMS0xLTA_22176d34-17c4-4fb3-a4b3-3741248abf3a">1,233.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aac6887b6f64875a859a71ba2b4b94b_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMzLTQtMS0xLTA_bd5f3218-afa8-4b36-98d8-88f4e08d074b">1,200.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb68d71446d14424bd72697ac3285509_I20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMzLTYtMS0xLTA_04ab61c2-1732-464e-8e98-ec5d3d434b13">1,127.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac209011a2246ed84b08c9d11d3ec13_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM0LTItMS0xLTA_799051c4-3e8a-4444-8a7b-70ae99a6aee9">1,369.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc0b83aa93c48f48c108df5541f41ff_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM0LTQtMS0xLTA_8756a2dc-37f2-46df-aad2-6810e99e315c">1,438.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b6afa22e0f493095f052e3a37c80f9_I20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM0LTYtMS0xLTA_00dc8e8c-06fd-4202-b7e8-c83d62e789a8">1,328.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32aed22715f404fa87eea8875fb1bed_I20210925" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM1LTItMS0xLTA_535ea068-7c84-425b-ab98-b4a86c036d40">31.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054b061ff3bb4c10a95c6b96ddc407f6_I20200926" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM1LTQtMS0xLTA_6f1eaeb3-0e6b-40c4-9a4a-4a7856d0e16f">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0490b02597f34bb0a3d9b518df6ea31c_I20190928" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM1LTYtMS0xLTA_cf58db0c-a3c8-4e12-8bb4-d2ef8ab0c8c0">27.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb7a6e4fce84451a598a007a83c7c2e_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM2LTItMS0xLTA_6d7504d1-439e-4f95-bb24-5dd17c95116a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad80942a21184b6099e93a927140cccc_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM2LTQtMS0xLTA_b1c3b1c0-2687-4cfa-a6b7-5cb5feaf1537">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d7dce3b25048bebda69f0f9c683dc0_I20190928" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM2LTYtMS0xLTA_8b096932-3ff4-4621-9b68-f2b328499881">159.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe9fe13010940de8718a210bf402a2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM3LTItMS0xLTA_3feddcac-90ec-4121-bd19-4edea93a01a9">2,935.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i680aa07110f848c0a9f91bc57d1d9d9d_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM3LTQtMS0xLTA_69a40eac-8301-421b-b27b-74e5827b8f62">2,355.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e0820fa934740988bc68c46b00eaa05_I20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM3LTYtMS0xLTA_caa1828d-b34a-4e17-bd47-00ab4660bf5a">1,522.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM4LTItMS0xLTA_f15d5f16-8692-47e4-ad11-4f4b5aed28e7">8,919.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM4LTQtMS0xLTA_8a63e1ca-b45e-4fbc-ac3e-9442ee25a52c">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM4LTYtMS0xLTA_c9f79ff8-3062-4292-8196-6bc0c4441db8">6,442.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-58</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="if2b1a50dc6a742edb60ad3910ee448c2"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzI3ODA_1c861621-c274-4b81-871f-1354b383fb67" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:53.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia6f02780b07b4af0a4ade42afb9a3277_D20200927-20210925" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzItMi0xLTEtMA_4f2aa5ce-a5ee-465c-89da-f87ae43d3fd9">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b27c44ab2c049dab1ada8ce3e2c9dde_D20190929-20200926" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzItNC0xLTEtMA_79dac747-dbe2-4fac-9afb-c5dcd38c2e3f">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i471641798bc6486890424f64b25cab0b_D20180930-20190928" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzItNi0xLTEtMA_867c8474-aee5-4589-9b2d-dd89e92b44e4">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c981ade86904092ab44cdc3421e6c6c_D20200927-20210925" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzMtMi0xLTEtMA_3e7c3904-da2c-47df-812c-e179f31a9ac0">21.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58c230109b9d48e3bb3cde0f8a0abd26_D20190929-20200926" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzMtNC0xLTEtMA_8e16c57c-193e-4d4b-9692-c5b472d34662">15.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i80097451dd62453689464503df8df92f_D20180930-20190928" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzMtNi0xLTEtMA_44ef9f78-38f2-42ae-b6a0-589369425e3d">11.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3cd1f66491984c7bb0dd1d0bc4fb2a69_D20200927-20210925" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzQtMi0xLTEtMA_bcf214ca-e2da-4770-826d-cd14dd6c5443">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53fbadaaa41d47dd83cdd5d7dfa70cd8_D20190929-20200926" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzQtNC0xLTEtMA_ae1d55b5-a32b-44ff-be08-179dcb4842eb">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaae08e83f10e40cfb00da11f047781ec_D20180930-20190928" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzQtNi0xLTEtMA_a560400c-37b7-46ee-91f5-563269c2c7ca">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74b686e1df1549aca26f39228fe341fa_D20200927-20210925" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzUtMi0xLTEtMA_23b6a8cf-68a3-466a-9d72-ca189fe5840f">2.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c4ff82c84e041298fcbdf87e237dcf5_D20190929-20200926" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzUtNC0xLTEtMA_2c1aacde-14c7-449a-bda9-587461bbf053">3.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5b4e0cf7b6d4802a7d62ddca53a82db_D20180930-20190928" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzUtNi0xLTEtMA_c8322406-61bb-477b-8296-ddf7d803ac75">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzYtMi0xLTEtMA_04f3a672-140f-43ff-b626-0c24aea4c432">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzYtNC0xLTEtMA_9d43833d-c8a9-46a4-8d0a-bd5e4d3d22d2">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzYtNi0xLTEtMA_0a7a34a3-ef6d-4211-b8fe-4e850d2162bf">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzI3OTY_10594204-a6b8-4c64-95a8-6b07b1fe5f3b" continuedAt="id6df1102c5444d06a98c7ed4365ed5ef" escape="true">The Company&#8217;s property, plant and equipment, net were geographically located as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt"><ix:continuation id="id6df1102c5444d06a98c7ed4365ed5ef"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:53.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe57ae2fbed04a638154dae73a66c811_I20210925" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzEtMi0xLTEtMA_874f8735-2cfb-48a4-b8a5-d77dbbcd3144">403.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355f32c131b14099b97cc874503e497f_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzEtNC0xLTEtMA_0c548bea-2089-4637-9cf1-1037a4876065">383.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c83bdbf9ef94aa59101a9aea2be7873_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzEtNi0xLTEtMA_f69a4992-c96d-470b-856b-839faea1fb71">355.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i548c9eddb08b4f14967120bc035c9ec8_I20210925" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzItMi0xLTEtMA_380e83ab-3e98-4bbc-8d9a-19d472f3c5be">122.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b55414cc384a68b8e3567008300ae5_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzItNC0xLTEtMA_e18c7c2e-dca7-44a0-8afe-8ac421b64648">77.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib41f0019abbb463c9a8e10c2f96a5e29_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzItNi0xLTEtMA_abfc9aa7-624b-4068-ac41-846fc9f3c09e">64.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66522b5564db479e9fd59f735b53bcda_I20210925" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzMtMi0xLTEtMA_1ebf10cb-1040-48c6-940a-66fb4747c2be">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e2c2ca6c4484232a21bb281c44dd840_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzMtNC0xLTEtMA_9541c63d-207d-4032-890a-40a737cd0f05">20.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36c8c111abcf4b43a4042a7c166306fe_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzMtNi0xLTEtMA_9b133014-6439-4c21-8ba6-c3b45fd23fbf">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecc61f191e354207a73d576c73bc8d42_I20210925" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzQtMi0xLTEtMA_ecf1e484-d8d6-4f96-ad52-0cb9978575b5">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58fd21fdaa0f4e66ab9388859b3f172e_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzQtNC0xLTEtMA_0a203fd4-7534-495b-b496-9d0133b86341">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b547462cf5d4b5597648a8fe55a37e6_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzQtNi0xLTEtMA_cc75f390-89c8-498e-a18f-35d6bd21f058">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzUtMi0xLTEtMA_380ab4c0-ecfd-4982-a997-3ccc21e4c6bd">564.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzUtNC0xLTEtMA_d8a85720-eb74-4833-82b5-bcc8b6e07f89">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzUtNi0xLTEtMA_08230316-ed6f-4907-8ae2-5162b44fde7f">470.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:18pt"><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_187"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90ZXh0cmVnaW9uOjg2NGY2MDZiNDdmZjQ2NWZhNTU5MWI3ZjVhZGQwN2RjXzE0OA_6373440a-1277-427f-ab84-eabd39b8e808" continuedAt="i816f6868a496478db00e566b67a24b37" escape="true">Accrued Expenses and Other Long-Term Liabilities</ix:nonNumeric></span></div><ix:continuation id="i816f6868a496478db00e566b67a24b37"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90ZXh0cmVnaW9uOjg2NGY2MDZiNDdmZjQ2NWZhNTU5MWI3ZjVhZGQwN2RjXzE1MQ_0294d9a3-6745-4cac-826c-815492464e80" escape="true"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other long-term liabilities consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"></td><td style="width:59.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzItMi0xLTEtMA_6669c45d-6700-4dc6-a086-8d4a120157a8">297.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzItNC0xLTEtMA_1eefe457-b273-4fe0-93ac-9dd3e6936020">262.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income and other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="holx:AccruedIncomeAndOtherTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzQtMi0xLTEtMA_a92ea640-3e5c-4401-8324-99d9b2d1e3eb">70.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="holx:AccruedIncomeAndOtherTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzQtNC0xLTEtMA_1bea17b3-3295-4cdd-96a6-401e77e519d1">125.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzUtMi0xLTEtMA_207eb605-eb3d-4214-afc2-fbdce441f132">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="5" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzUtNC0xLTEtMA_02d37d3a-186e-4dc1-a81b-af382bb254ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzYtMi0xLTEtMA_bcb56c1e-4601-4ced-80ce-a246ab76631a">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzYtNC0xLTEtMA_2fa07063-930a-497b-9847-8030eeee38bd">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="5" name="holx:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzctMi0xLTEtMA_4efa8836-c831-47a6-84e4-ccea2b0f3280">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="5" name="holx:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzctNC0xLTEtMA_9e9f3a42-2fba-4de8-870c-bfd3732141d9">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzgtMi0xLTEtMA_984cde74-7a04-4e34-809e-961e341e67fa">168.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzgtNC0xLTEtMA_66bcb777-cc6a-47cc-a493-e4455ac63e20">114.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzktMi0xLTEtMA_d18a884e-bd27-4336-9191-ec389d09c7fb">596.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzktNC0xLTEtMA_f368794c-e669-4e42-934e-2de8480e861e">547.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:OtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90ZXh0cmVnaW9uOjg2NGY2MDZiNDdmZjQ2NWZhNTU5MWI3ZjVhZGQwN2RjXzE2Mg_2e55fb08-b061-4497-9fb8-c2ba4f62e1ef" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"></td><td style="width:59.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.886%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#160;Long-Term Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for income tax uncertainties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzItMi0xLTEtMA_a2a90ef5-54bd-4572-b71d-92798ffae105">210.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzItNC0xLTEtMA_8f845aa2-7243-40e0-ba37-a8c5ad792644">103.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzMtMi0xLTEtMA_5000a41f-b2e1-44bb-a637-0b3687dfc783">58.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzMtNC0xLTEtMA_60a59a25-73b2-4ac9-9cc7-0b3d305cb4e1">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzQtMi0xLTEtMA_5765adba-a671-4bf7-926d-5abf92d707f3">66.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzQtNC0xLTEtMA_a8527b8e-53e3-4dc9-a5ef-2ee4f13b04b7">65.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzUtMi0xLTEtMA_aab7c756-4444-42ea-8d15-b1ed82a00222">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzUtNC0xLTEtMA_fa444e68-74ff-4dee-ae35-ef463346039d">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzYtMi0xLTEtMA_46912d9c-694b-4657-8cd8-f10f4861eb24">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzYtNC0xLTEtMA_7f2b5091-b762-4718-9500-e547902db6fb">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzgtMi0xLTEtMA_b8c3a774-e02c-416b-b017-b6371c273a26"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzgtMi0xLTEtMA_ebc41871-6e62-41bc-ba44-743f2b44358a">16.2</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzgtNC0xLTEtMA_d5901c8a-2b9c-42c0-9bf8-28f942539c91">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzktMi0xLTEtMA_bf003fad-ec27-4a10-b898-1e5ab8ebb572">368.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzktNC0xLTEtMA_c13b3d02-497d-4dc1-aa45-078ad630a4c2">303.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i07bbd5e33a1f472e83c59d8668de41f8_190"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-59</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxODc_fb3f41fc-1cd6-4075-8493-23a8f9453ee9" continuedAt="ifd6f0f528dce44c1bfd3b08089a71ce7" escape="true">Pension and Other Employee Benefits</ix:nonNumeric></span></div><ix:continuation id="ifd6f0f528dce44c1bfd3b08089a71ce7" continuedAt="ifba63e02abd244a38af8b55e97d9d684"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain defined benefit pension plans covering the employees of its Hitec Imaging German subsidiary (the &#8220;Pension Benefits&#8221;).&#160;As of September&#160;25, 2021 and September&#160;26, 2020, the Company&#8217;s pension liability was $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzI0MQ_5ef59938-20fe-4fb5-bd12-4e1126f91688">10.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzI0OA_46e8f3be-1c04-412d-bab1-58a9901d1938">10.9</ix:nonFraction> million, respectively, which is primarily recorded as a component of long-term liabilities in the Consolidated Balance Sheets. Under German law, there are no rules governing investment or statutory supervision of the pension plan. As such, there is no minimum funding requirement imposed on employers. Pension benefits are safeguarded by the Pension Guaranty Fund, a form of compulsory reinsurance that guarantees an employee will receive vested pension benefits in the event of insolvency. The pension plans were closed on December 31, 1997 and only eligible employees at that date could participate in the plans prior to closing to new participants.</span></div><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxODI_bf16c982-0949-4755-9a0e-b29c2c3fe252" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:6pt;padding-left:49.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Benefit Obligation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzItMi0xLTEtMA_b9464128-016a-4ad4-a586-5f1b94a22ee2">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzItNC0xLTEtMA_eabbf612-e4a8-4776-a2aa-d096b5b53ce4">10.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzItNi0xLTEtMA_657d30f7-c906-4941-a30c-a96b92ad9a4d">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzMtMi0xLTEtMA_03ce2aa0-4d80-4d72-bfe4-4c62c2075213">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzMtNC0xLTEtMA_80825d27-074e-4cc2-86b3-47252e2236e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzMtNi0xLTEtMA_8e3a46c2-df1a-4e6f-b210-30442404281f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzQtMi0xLTEtMA_953a4583-8336-48a0-8675-6b1a33f64aaf">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzQtNC0xLTEtMA_2fac3d32-1b40-4b83-ae1b-f28d7a1f57bf">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzQtNi0xLTEtMA_9007804c-6aff-4e5b-86e1-8942ada44a5c">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzUtMi0xLTEtMA_ee250996-ec75-4bc2-b65a-f180f212e2dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzUtNC0xLTEtMA_cf6538a7-fa97-468f-9f07-a16eb416e00c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzUtNi0xLTEtMA_3a08b67c-e8ff-4103-a523-ccdcb37139c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzYtMi0xLTEtMA_f364970d-e158-4a9c-ac82-ef5165b28605">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzYtNC0xLTEtMA_de887257-2d9c-4c9f-8a0b-72dd7c504ecf">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzYtNi0xLTEtMA_cd20deda-9a7c-4b58-a374-f12ceaa0ac4c">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzctMi0xLTEtMA_130ad9d5-f23e-425b-b383-1e02ce6651fb">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzctNC0xLTEtMA_cd08674b-9714-4670-a75b-abd8c087db06">0.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzctNi0xLTEtMA_66e1fea5-cf54-45ef-87fd-5338c36c21d3">0.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzgtMi0xLTEtMA_1577c38e-ceff-4468-997d-e7aecaba67a9">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzgtNC0xLTEtMA_ba636531-f967-4e02-babc-c4a647f268e9">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzgtNi0xLTEtMA_c12d326c-0391-4c5c-a287-d19329191e6d">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzktMi0xLTEtMA_6406f559-5ead-42a5-95a9-ec0d4320675e">10.3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzktNC0xLTEtMA_cffa178c-955e-4c46-8129-dfe397dd0837">10.9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzktNi0xLTEtMA_e7609e53-5f82-4ec9-b42a-b693f6321b8b">10.0</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzEwLTItMS0xLTA_f07f0411-c204-4007-9ee7-a55a12995256">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzEwLTQtMS0xLTA_38f42464-f192-4cba-a7c9-2f3a6ede8dd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzEwLTYtMS0xLTA_45032ca2-5b8e-4937-8481-e3c8babbc016">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzExLTItMS0xLTA_781538c5-be95-4121-b59f-367b83035da5">10.3</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzExLTQtMS0xLTA_ed088adb-48f0-42c8-9678-b1f8cbacc50d">10.9</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzExLTYtMS0xLTA_489df4e7-ddf5-482a-b92a-767a28923618">10.0</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxNzY_7e73a4eb-c240-4d50-bfb2-80b0dbbefb77" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzItMi0xLTEtMA_290841ac-a091-4d82-b2bc-e8537f50e37d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzItNC0xLTEtMA_120198fc-166f-4f5a-adec-edc264159e8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzItNi0xLTEtMA_ae0f0c57-09a9-4af8-b2ad-892bb66a5c08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="holx:ComponentsofNetPeriodicBenefitCostInterestcost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzMtMi0xLTEtMA_3aeba5bb-ebe8-4121-94bd-c419194caa02">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="holx:ComponentsofNetPeriodicBenefitCostInterestcost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzMtNC0xLTEtMA_aa81991a-8ff9-45f7-a834-a609fdb71e90">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="holx:ComponentsofNetPeriodicBenefitCostInterestcost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzMtNi0xLTEtMA_239510bf-5833-4cff-b8af-bd3c1b5338ca">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzQtMi0xLTEtMA_a830d2fb-3d43-4a06-b0e2-b772bcff2059">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzQtNC0xLTEtMA_e6ee67d0-6307-4576-8bfd-8d141d968eb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzQtNi0xLTEtMA_8c95b424-099e-42ef-bfdc-4daf95026799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzUtMi0xLTEtMA_239548c2-5869-437f-aacc-b52f15724f53">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzUtNC0xLTEtMA_c0ad6954-231b-4975-825b-3e28a82fcb5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzUtNi0xLTEtMA_419e84b3-84e0-4f19-92c7-631943d06903">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzYtMi0xLTEtMA_0a780c32-04c7-4e98-bba8-5b0f0db9b777">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzYtNC0xLTEtMA_c135554f-7c72-4980-a7aa-829f3f4539b3">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzYtNi0xLTEtMA_966e6d5e-17dc-4b28-8419-8cc4526d5323">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzctMi0xLTEtMA_8b10ac2b-fa58-41e8-93c4-aa629ad7da1d">0.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzctNC0xLTEtMA_794cef7e-e5fc-40e8-9b18-73d0ab84fc45">0.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzctNi0xLTEtMA_6415bd88-fb7c-4b2d-a978-f1b8a4b3104a">0.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxODU_d79c926e-a25c-4b3e-8ebd-62bf2c8fa4fa" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"></td><td style="width:49.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Net Periodic Benefit Cost Assumptions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzEtMi0xLTEtMA_9f127618-491e-4ec7-8ba2-d64736679f4c">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzEtNC0xLTEtMA_a70863e7-9ece-4656-8a19-b4b3c6438d71">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzEtNi0xLTEtMA_fee0c666-db46-4339-9ba2-9edfd6f922fa">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzItMi0xLTEtMA_2c7bc020-4ad2-44c1-9aa6-d8c10c8bf535">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzItNC0xLTEtMA_597f0340-8c30-40cd-b2d1-b59e8b8a48d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzItNi0xLTEtMA_d324a2e6-c751-44af-8873-1bb0cf4ec15b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzMtMi0xLTEtMA_eb0f2bda-8ed4-4708-b046-e7546ddac8ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzMtNC0xLTEtMA_b3219da7-f4bb-4574-bdb9-9e19f4ebabe7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928" decimals="2" format="ixt:fixed-zero" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzMtNi0xLTEtMA_37f1341e-4531-4cd8-8cb9-693f38a97235">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected benefit obligation for the German Pension Benefits with projected benefit obligations in excess of plan assets was $<ix:nonFraction unitRef="usd" contextRef="ic1d488dc858b49ac92911c8316dc04c3_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzEzNTY_cf19679f-ad6e-4b51-af80-7af5f8186a06">10.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8cb3192812b4442b0a3e479a2307bc0_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzEzNjM_a5ff873c-ea3c-45b9-98c7-ba55733c0d9d">10.9</ix:nonFraction> million at September&#160;25, 2021 and September&#160;26, 2020, respectively, and the accumulated benefit obligation for the German Pension Benefits was $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzE0Njk_e63ec366-26bb-4943-8440-53e9921b97bb">10.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzE0NzY_349621e9-1096-4e43-9068-d268ca7c92b7">10.9</ix:nonFraction> million at September&#160;25, 2021 and September&#160;26, 2020, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also obligated to pay long-term service award benefits under the German Pension Benefits. The projected benefit obligation for long-term service awards was $<ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" format="ixt:num-dot-decimal" name="holx:ProjectedBenefitObligationForLongTermServiceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzE2Nzk_53eefae7-7221-451a-b0fd-966110bf7c26"><ix:nonFraction unitRef="usd" contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926" decimals="-5" format="ixt:num-dot-decimal" name="holx:ProjectedBenefitObligationForLongTermServiceAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzE2Nzk_c164ef19-f7a2-4e83-a6eb-af7432eeb138">0.1</ix:nonFraction></ix:nonFraction> million at both September&#160;25, 2021 and September&#160;26, 2020, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-60</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i07bbd5e33a1f472e83c59d8668de41f8_7">Table of Contents</a></span></div></div><ix:continuation id="ifba63e02abd244a38af8b55e97d9d684" continuedAt="i966fe2173083471f86d51302ff74fe61"><ix:nonNumeric contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxNjY_0ff20dd7-14c9-4eed-89b2-94aa5564dfa1" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"></td><td style="width:70.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.424%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzEtMS0xLTEtMA_49af70f7-6332-4e65-9ba6-29f5ed400a1b">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzItMS0xLTEtMA_bc8fad18-ec9f-43f6-ac8a-7f8d4b405168">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzMtMS0xLTEtMA_9c3b3645-9888-49be-a6cd-f731724a2752">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzQtMS0xLTEtMA_93dd4c26-3ef7-4582-8a45-334638b23143">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzUtMS0xLTEtMA_43876c0a-89e5-42c1-9173-33726c231a60">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2031</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzYtMS0xLTEtMA_8f8b6f9c-080e-4a4f-bd06-a14eb1789ec4">2.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i966fe2173083471f86d51302ff74fe61">The Company also maintains additional contractual pension benefits for its top German executive officers in the form of a defined contribution plan. These contributions were insignificant in fiscal 2021, 2020 and 2019.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-61</span></div><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>ex43-holxx2029notesxfirsts.htm
<DESCRIPTION>EX-4.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i83f3430290eb438c9ddc182f14f48ba1_1"></div><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">FIRST SUPPLEMENTAL INDENTURE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"><br><br><br>dated as of May 18, 2021<br><br>among<br><br>Hologic, Inc.,<br><br><br>The Subsidiary Guarantor Party Hereto<br><br>and<br><br>Wells Fargo Bank, National Association,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">as Trustee<br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:128.75pt;padding-right:128.75pt;text-align:center"><font><br></font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.250% Senior Notes due 2029<br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i83f3430290eb438c9ddc182f14f48ba1_4"></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">This FIRST SUPPLEMENTAL INDENTURE (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), entered into as of May 18, 2021, among HOLOGIC, INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), Biotheranostics Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">New</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), and Wells Fargo Bank, National Association, as trustee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, the Company, the Subsidiary Guarantors party thereto and the Trustee entered into the Indenture, dated as of September 28, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), relating to the Company&#8217;s 3.250% Senior Notes due 2029 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, as a condition to the Trustee entering into the Indenture and the purchase of the Notes by the Holders, the Company agreed pursuant to the Indenture to cause its Restricted Subsidiaries to provide Guarantees in certain circumstances&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, on April 2, 2021, the New Guarantor entered into a Guarantee of the Senior Secured Credit Facilities&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, pursuant to Section 4.10 of the Indenture, if any Wholly Owned Subsidiary (other than a Receivables Entity or an Excluded Disregarded Entity) that is a Restricted Subsidiary (other than a Subsidiary Guarantor, a Receivables Entity, an Excluded Disregarded Entity or an Unrestricted Subsidiary) provides a guarantee of the Senior Secured Credit Facilities, then, within 60 days after such Restricted Subsidiary provides such guarantee, such Restricted Subsidiary will execute a Supplemental Indenture providing for a Subsidiary Guarantee by such Restricted Subsidiary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, in order to comply with Section 4.10 of the Indenture, the New Guarantor is required to become a Subsidiary Guarantor under the Indenture&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, the New Guarantor has agreed to become a Subsidiary Guarantor under the Indenture, and to be bound by the terms of the Indenture applicable to Subsidiary Guarantors.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">NOW, THEREFORE, in consideration of the promises and mutual covenants herein contained and intending to be legally bound, the parties to this Supplemental Indenture hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 1.  Capitalized terms used herein and not otherwise defined herein are used as defined in the Indenture.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 2.  The New Guarantor, by its execution of this Supplemental Indenture, agrees to be a Subsidiary Guarantor under the Indenture and to be bound by the terms of the Indenture applicable to Subsidiary Guarantors, including, but not limited to, Article 10 thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 3.  THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.</font></div><div style="height:77.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">EACH OF THE COMPANY, THE NEW GUARANTOR AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE SUBSIDIARY GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 4.  This Supplemental Indenture may be signed in various counterparts that together will constitute one and the same instrument.  The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or portable document format (&#8220;.pdf&#8221;) transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes.  Signatures of the parties hereto transmitted by facsimile or .pdf shall be deemed to be their original signatures for all purposes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 5.  This Supplemental Indenture is an amendment supplemental to the Indenture and the Indenture and this Supplemental Indenture will henceforth be read together.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 6.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture, the Subsidiary Guarantee of the New Guarantor or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company and the New Guarantor. All of the provisions contained in the Indenture in respect of the rights, privileges, immunities, powers, and duties of the Trustee shall be applicable in respect of this Supplemental Indenture as fully and with like force and effect as though fully set forth in full herein.</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#91;Signature Page Follows&#93;</font></div><div style="height:77.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2</font></div><div><font><br></font></div></div></div><div id="i83f3430290eb438c9ddc182f14f48ba1_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the parties hereto have caused this First Supplemental Indenture to be duly executed as of the date first above written.</font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.448%"><tr><td style="width:1.0%"></td><td style="width:11.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:36pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">HOLOGIC, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, as Issuer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#47;s&#47; Marci J. Lerner</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Marci J. Lerner</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Vice President, Treasurer</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.564%"><tr><td style="width:1.0%"></td><td style="width:12.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">BIOTHERANOSTICS, INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Vice President, Treasurer</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.474%"><tr><td style="width:1.0%"></td><td style="width:13.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:36pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, as Trustee</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Tina D. Gonzalez</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Tina D. Gonzalez</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Vice President</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;First Supplemental Indenture (3.250% Senior Notes due 2029)&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">64034047 v2</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.8
<SEQUENCE>3
<FILENAME>ex48-holxxsecondsupplement.htm
<DESCRIPTION>EX-4.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5512ea43ee8d483c8180d8a3ac8c9231_1"></div><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.6pt;padding-left:347.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Execution Version</font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:158.45pt;padding-right:158.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">SECOND SUPPLEMENTAL INDENTURE</font></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:200.12pt;padding-right:200.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">dated as of November 9, 2018 among</font></div><div style="padding-left:158.42pt;padding-right:158.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Hologic, Inc.,</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:173.67pt;padding-right:173.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:232%">The Subsidiary Guarantor Parties Hereto and</font></div><div style="margin-top:0.05pt;padding-left:173.8pt;padding-right:173.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Wells Fargo Bank, National Association, as Trustee</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:82.05pt;padding-right:82.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.625% Senior Notes due 2028</font></div><div style="height:48.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i5512ea43ee8d483c8180d8a3ac8c9231_4"></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.6pt;padding-left:5pt;padding-right:71.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">THIS SECOND SUPPLEMENTAL INDENTURE (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), entered into as of November 9, 2018, among HOLOGIC, INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), Bioptics, Inc., an Arizona corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Bioptics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) and Faxitron Bioptics, LLC, a Delaware limited liability company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Faxitron</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;, and together with Bioptics, each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">New Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">New Guarantors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and Wells Fargo Bank, National Association, as trustee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:158.45pt;padding-right:158.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">RECITALS</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:71.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the Company, the Subsidiary Guarantors party thereto and the Trustee entered into the Indenture, dated as of January 19, 2018 (as supplemented by that certain First Supplemental Indenture dated as of May 8, 2018, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), relating to the Company&#8217;s 4.625% Senior Notes due 2028 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:71.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, as a condition to the Trustee entering into the Indenture and the purchase of the Notes by the Holders, the Company agreed pursuant to the Indenture to cause its Restricted Subsidiaries to provide Guarantees in certain circumstances&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:71.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, on September 12, 2018, the New Guarantors entered into a Guarantee of the Senior Secured Credit Facilities&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:71.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, pursuant to Section 4.10 of the Indenture, if any Wholly Owned Subsidiary (other than a Receivables Entity or an Excluded Disregarded Entity) that is a Restricted Subsidiary (other than a Subsidiary Guarantor, a Receivables Entity, an Excluded Disregarded Entity or an Unrestricted Subsidiary) and that is not a Subsidiary Guarantor (other than a Receivables Entity or an Excluded Disregarded Entity) provides a guarantee of the Senior Secured Credit Facilities, then, within 60 days after such Restricted Subsidiary provides such guarantee, such Restricted Subsidiary will execute a Supplemental Indenture providing for a Subsidiary Guarantee by such Restricted Subsidiary&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:72.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, in order to comply with Section 4.10 of the Indenture, the New Guarantors are each required to become a Subsidiary Guarantor under the Indenture&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:71.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the New Guarantors have each agreed to become a Subsidiary Guarantor under the Indenture, subject to the terms and conditions set forth herein.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:158.42pt;padding-right:158.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">AGREEMENT</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:71.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NOW, THEREFORE, in consideration of the premises and mutual covenants herein contained and intending to be legally bound, the parties to this Supplemental Indenture hereby agree as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:71.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 1. Capitalized terms used herein and not otherwise defined herein are used as defined in the Indenture.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:71.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 2. Each New Guarantor, by its execution of this Supplemental Indenture, agrees to be a Subsidiary Guarantor under the Indenture and to be bound by the terms of the Indenture applicable to Subsidiary Guarantors, including, but not limited to, Article 10 thereof.</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.477%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2</font></div></td></tr></table></div></div></div><div id="i5512ea43ee8d483c8180d8a3ac8c9231_7"></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.6pt;padding-left:5pt;padding-right:71.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 3. THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:71.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">EACH OF THE COMPANY, THE NEW GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE SUBSIDIARY GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:71.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 4. This Supplemental Indenture may be signed in various counterparts that together will constitute one and the same instrument. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or portable document format (&#8220;PDF&#8221;) transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes.   Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:71.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 5. This Supplemental Indenture is an amendment supplemental to the Indenture and the Indenture and this Supplemental Indenture will henceforth be read together.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:71.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 6. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture, the Subsidiary Guarantee of the New Guarantors or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company and the New Guarantors. All of the provisions contained in the Indenture in respect of the rights, privileges, immunities, powers, and duties of the Trustee shall be applicable in respect of this Supplemental Indenture as fully and with like force and effect as though fully set forth in full herein.</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:2.477%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.5pt;padding-left:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3</font></div></td></tr></table></div></div></div><div id="i5512ea43ee8d483c8180d8a3ac8c9231_10"></div><hr style="page-break-after:always"><div style="min-height:12.8pt;width:100%"><div><font><br></font></div></div><div style="padding-left:431.8pt"><img alt="image_1.jpg" src="image_1.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:75px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </font><img alt="image_2.jpg" src="image_2.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:55px"></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:5.5pt;padding-left:31.2pt;padding-right:47.9pt;text-indent:33.85pt"><font style="color:#383f44;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:105%">IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental </font><font style="color:#2a2b33;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:105%">Indenture </font><font style="color:#383f44;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:105%">to </font><font style="color:#2a2b33;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:105%">be </font><font style="color:#383f44;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">duly </font><font style="color:#383f44;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:105%">executed as of the date first above written</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:230.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.678%"><tr><td style="width:1.0%"></td><td style="width:10.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.812%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">HOLOGIC, INC., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">as Issuer</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Title&#58; Vice President, Treasurer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-left:3.1pt;padding-right:3.1pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">BIOPTICS, INC.</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58;  Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Title&#58; Vice President and Treasurer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-left:3.1pt;padding-right:3.1pt"><font><br></font></div><div style="margin-bottom:24pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">FAXITRON BIOPTICS, LLC</font></div></td></tr><tr><td colspan="6" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Title&#58; Vice President and Treasurer</font></div><div style="padding-right:3.1pt"><font><br></font></div><div style="padding-right:3.1pt"><font><br></font></div><div style="padding-right:3.1pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Tina D. Gonzalez</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58;&#160;&#160;&#160;&#160; Tina D. Gonzalez</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Title&#58;&#160;&#160;&#160;&#160;Vice President</font></td></tr></table></div><div><font><br></font></div><div style="height:73pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.660%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">&#91;Signature Page to Second Supplemental Indenture (2028 Notes) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">Bioptics&#47;Faxitron&#93;</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.9
<SEQUENCE>4
<FILENAME>ex49-holxxthirdsupplementa.htm
<DESCRIPTION>EX-4.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5b6298b0702d41f3ba1db304fb9fd53a_1"></div><div style="min-height:85.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">THIRD SUPPLEMENTAL INDENTURE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br><br><br>dated as of January 8, 2019<br><br>among<br><br>Hologic, Inc.,<br><br><br>The Subsidiary Guarantors Party Hereto<br><br>and<br><br>Wells Fargo Bank, National Association,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">as Trustee<br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:128.75pt;padding-right:128.75pt;text-align:center"><font><br></font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.625% Senior Notes due 2028<br></font></div><div><font><br></font></div><div style="height:79.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><font><br></font></div></div></div><div id="i5b6298b0702d41f3ba1db304fb9fd53a_4"></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">THIS THIRD SUPPLEMENTAL INDENTURE (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), entered into as of January 8, 2019, among HOLOGIC, INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), Focal Therapeutics, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">New Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and Wells Fargo Bank, National Association, as trustee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the Company, the Subsidiary Guarantors party thereto and the Trustee entered into the Indenture, dated as of January 19, 2018 (as amended by the First Supplemental Indenture dated as of May 8, 2018 and the Second Supplemental Indenture dated as of November 9, 2018, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), relating to the Company&#8217;s 4.625% Senior Notes due 2028 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, as a condition to the Trustee entering into the Indenture and the purchase of the Notes by the Holders, the Company agreed pursuant to the Indenture to cause its Restricted Subsidiaries to provide Guarantees in certain circumstances&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, on November 14, 2018, the New Guarantor entered into a Guarantee of the Senior Secured Credit Facilities&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, pursuant to Section 4.10 of the Indenture, if any Wholly Owned Subsidiary (other  than  a  Receivables  Entity  or  an  Excluded  Disregarded  Entity)  that  is  a  Restricted Subsidiary (other than a Subsidiary Guarantor, a Receivables Entity, an Excluded Disregarded Entity  or  an  Unrestricted  Subsidiary)  and  that  is  not  a  Subsidiary  Guarantor  (other  than  a Receivables  Entity  or  an  Excluded  Disregarded  Entity)  provides  a  guarantee  of  the  Senior Secured  Credit  Facilities,  then,  within  60  days  after  such  Restricted  Subsidiary  provides  such guarantee,  such  Restricted  Subsidiary  will  execute  a  Supplemental  Indenture  providing  for  a Subsidiary Guarantee by such Restricted Subsidiary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, in order to comply with Section 4.10 of the Indenture, the New Guarantor is required to become a Subsidiary Guarantor under the Indenture&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the New Guarantor has agreed to become a Subsidiary Guarantor under the Indenture, subject to the terms and conditions set forth herein.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NOW, THEREFORE, in consideration of the promises and mutual covenants herein contained and intending to be legally bound, the parties to this Supplemental Indenture hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 1.  Capitalized terms used herein and not otherwise defined herein are used as defined in the Indenture.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 2.  The New Guarantor, by its execution of this Supplemental Indenture, agrees to be a Subsidiary Guarantor under the Indenture and to be bound by the terms of the Indenture applicable to Subsidiary Guarantors, including, but not limited to, Article 10 thereof.</font></div><div style="height:76.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 3.  THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">EACH OF THE COMPANY, THE NEW GUARANTOR AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE SUBSIDIARY GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 4.  This Supplemental Indenture may be signed in various counterparts that together will constitute one and the same instrument.  The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or portable document format (&#8220;PDF&#8221;) transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes.  Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 5.  This Supplemental Indenture is an amendment supplemental to the Indenture and the Indenture and this Supplemental Indenture will henceforth be read together.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 6.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture, the Subsidiary Guarantee of the New Guarantor or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company and the New Guarantor. All of the provisions contained in the Indenture in respect of the rights, privileges, immunities, powers, and duties of the Trustee shall be applicable in respect of this Supplemental Indenture as fully and with like force and effect as though fully set forth in full herein.</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#91;Signature Page Follows&#93;</font></div><div style="height:76.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2</font></div><div><font><br></font></div></div></div><div id="i5b6298b0702d41f3ba1db304fb9fd53a_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the parties hereto have caused this Third Supplemental Indenture to be duly executed as of the date first above written.</font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.448%"><tr><td style="width:1.0%"></td><td style="width:11.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:36pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">HOLOGIC, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, as Issuer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Vice President and Treasurer</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.564%"><tr><td style="width:1.0%"></td><td style="width:12.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">FOCAL THERAPEUTICS, INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Vice President and Treasurer</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">&#91;Signature Page to Supplemental Indenture (2028) &#8211; Focal Therapeutics&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.474%"><tr><td style="width:1.0%"></td><td style="width:13.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:36pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, as Trustee</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Tina D. Gonzalez</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Tina D. Gonzalez</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Vice President</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">&#91;Signature Page to Supplemental Indenture (2028) &#8211; Focal Therapeutics&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.10
<SEQUENCE>5
<FILENAME>ex410-holxxfourthsupplemen.htm
<DESCRIPTION>EX-4.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3fe382869d8941a4af98d975928adb4d_1"></div><div style="min-height:85.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">FOURTH SUPPLEMENTAL INDENTURE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br><br><br>dated as of March 14, 2019<br><br>among<br><br>Hologic, Inc.,<br><br><br>The Subsidiary Guarantor Party Hereto<br><br>and<br><br>Wells Fargo Bank, National Association,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">as Trustee<br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:128.75pt;padding-right:128.75pt;text-align:center"><font><br></font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.625% Senior Notes due 2028<br></font></div><div><font><br></font></div><div style="height:79.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt"><font><br></font></div></div></div><div id="i3fe382869d8941a4af98d975928adb4d_4"></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">THIS FOURTH SUPPLEMENTAL INDENTURE (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), entered into as of March 14, 2019, among HOLOGIC, INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), Cynosure, LLC, a Delaware limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">New</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and Wells Fargo Bank, National Association, as trustee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the Company, the Subsidiary Guarantors party thereto and the Trustee entered into the Indenture, dated as of January 19, 2018 (as amended by the First Supplemental Indenture dated as of May 8, 2018, the Second Supplemental Indenture dated as of November 9, 2018 and the Third Supplemental Indenture dated as of January 8, 2019, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), relating to the Company&#8217;s 4.625% Senior Notes due 2028 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, as a condition to the Trustee entering into the Indenture and the purchase of the Notes by the Holders, the Company agreed pursuant to the Indenture to cause its Restricted Subsidiaries to provide Guarantees in certain circumstances&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, Cynosure, Inc. was a Subsidiary Guarantor, and on December 28, 2018, Cynosure, Inc. converted into Cynosure, LLC, a Delaware limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Conversion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, in accordance with Section 4.10 of the Indenture, a Subsidiary Guarantor shall be automatically released upon the sale or disposition of such Subsidiary in a transaction that is not prohibited under the Indenture such that such Subsidiary ceases to be a Subsidiary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, upon completion of the Conversion, Cynosure, Inc. was automatically released as a Subsidiary Guarantor pursuant to Section 4.10 of the Indenture&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, on February 8, 2019, the New Guarantor entered into a Guarantee of the Senior Secured Credit Facilities&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, pursuant to Section 4.10 of the Indenture, if any Wholly Owned Subsidiary (other  than  a  Receivables  Entity  or  an  Excluded  Disregarded  Entity)  that  is  a  Restricted Subsidiary (other than a Subsidiary Guarantor, a Receivables Entity, an Excluded Disregarded Entity  or  an  Unrestricted  Subsidiary)  and  that  is  not  a  Subsidiary  Guarantor  (other  than  a Receivables  Entity  or  an  Excluded  Disregarded  Entity)  provides  a  guarantee  of  the  Senior Secured  Credit  Facilities,  then,  within  60  days  after  such  Restricted  Subsidiary  provides  such guarantee,  such  Restricted  Subsidiary  will  execute  a  Supplemental  Indenture  providing  for  a Subsidiary Guarantee by such Restricted Subsidiary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, in order to comply with Section 4.10 of the Indenture, the New Guarantor is required to become a Subsidiary Guarantor under the Indenture&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the New Guarantor has agreed to become a Subsidiary Guarantor under the Indenture, subject to the terms and conditions set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:76.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NOW, THEREFORE, in consideration of the promises and mutual covenants herein contained and intending to be legally bound, the parties to this Supplemental Indenture hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 1.  Capitalized terms used herein and not otherwise defined herein are used as defined in the Indenture.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 2.  The New Guarantor, by its execution of this Supplemental Indenture, agrees to be a Subsidiary Guarantor under the Indenture and to be bound by the terms of the Indenture applicable to Subsidiary Guarantors, including, but not limited to, Article 10 thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 3. Upon completion of the Conversion, Cynosure, Inc. was automatically released as a Subsidiary Guarantor under the Indenture (and from all of the obligations of a Subsidiary Guarantor under the Indenture) pursuant to Section 4.10.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 4.  THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">EACH OF THE COMPANY, THE NEW GUARANTOR AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE SUBSIDIARY GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 5.  This Supplemental Indenture may be signed in various counterparts that together will constitute one and the same instrument.  The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or portable document format (&#8220;PDF&#8221;) transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes.  Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 6.  This Supplemental Indenture is an amendment supplemental to the Indenture and the Indenture and this Supplemental Indenture will henceforth be read together.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Section 7.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture, the Subsidiary Guarantee of the New Guarantor or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company and the New Guarantor. All of the provisions contained in the Indenture in respect of the rights, privileges, immunities, powers, and duties of the Trustee shall </font></div><div style="height:76.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">be applicable in respect of this Supplemental Indenture as fully and with like force and effect as though fully set forth in full herein.</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#91;Signature Page Follows&#93;</font></div><div style="height:76.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3</font></div><div><font><br></font></div></div></div><div id="i3fe382869d8941a4af98d975928adb4d_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be duly executed as of the date first above written.</font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.448%"><tr><td style="width:1.0%"></td><td style="width:11.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:36pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">HOLOGIC, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, as Issuer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Vice President and Treasurer</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.564%"><tr><td style="width:1.0%"></td><td style="width:12.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CYNOSURE, LLC</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Vice President and Treasurer</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">&#91;Signature Page to Supplemental Indenture (2028) &#8211; Cynosure, LLC&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.474%"><tr><td style="width:1.0%"></td><td style="width:13.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:36pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, as Trustee</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Tina D. Gonzalez</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Tina D. Gonzalez</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Vice President</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">63293273 v3</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">&#91;Signature Page to Supplemental Indenture (2028) &#8211; Cynosure, LLC&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.11
<SEQUENCE>6
<FILENAME>ex411-holxx2028notesxfifth.htm
<DESCRIPTION>EX-4.11
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i31413b9e3caf4d779a74628448126432_1"></div><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">FIFTH SUPPLEMENTAL INDENTURE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"><br><br><br>dated as of May 18, 2021<br><br>among<br><br>Hologic, Inc.,<br><br><br>The Subsidiary Guarantor Party Hereto<br><br>and<br><br>Wells Fargo Bank, National Association,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">as Trustee<br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:128.75pt;padding-right:128.75pt;text-align:center"><font><br></font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.625% Senior Notes due 2028<br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i31413b9e3caf4d779a74628448126432_4"></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">This FIFTH SUPPLEMENTAL INDENTURE (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), entered into as of May 18, 2021, among HOLOGIC, INC., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), Biotheranostics Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">New</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), and Wells Fargo Bank, National Association, as trustee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, the Company, the Subsidiary Guarantors party thereto and the Trustee entered into the Indenture, dated as of January 19, 2018 (as supplemented by the First Supplemental Indenture dated as of May 8, 2018, the Second Supplemental Indenture dated as of November 9, 2018, the Third Supplemental Indenture dated as of January 8, 2019, and the Fourth Supplemental Indenture dated as of March 14, 2019, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;), relating to the Company&#8217;s 4.625% Senior Notes due 2028 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, as a condition to the Trustee entering into the Indenture and the purchase of the Notes by the Holders, the Company agreed pursuant to the Indenture to cause its Restricted Subsidiaries to provide Guarantees in certain circumstances&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, on April 2, 2021, the New Guarantor entered into a Guarantee of the Senior Secured Credit Facilities&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, pursuant to Section 4.10 of the Indenture, if any Wholly Owned Subsidiary (other than a Receivables Entity or an Excluded Disregarded Entity) that is a Restricted Subsidiary (other than a Subsidiary Guarantor, a Receivables Entity, an Excluded Disregarded Entity or an Unrestricted Subsidiary) provides a guarantee of the Senior Secured Credit Facilities, then, within 60 days after such Restricted Subsidiary provides such guarantee, such Restricted Subsidiary will execute a Supplemental Indenture providing for a Subsidiary Guarantee by such Restricted Subsidiary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, in order to comply with Section 4.10 of the Indenture, the New Guarantor is required to become a Subsidiary Guarantor under the Indenture&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">WHEREAS, the New Guarantor has agreed to become a Subsidiary Guarantor under the Indenture, and to be bound by the terms of the Indenture applicable to Subsidiary Guarantors.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">NOW, THEREFORE, in consideration of the promises and mutual covenants herein contained and intending to be legally bound, the parties to this Supplemental Indenture hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 1.  Capitalized terms used herein and not otherwise defined herein are used as defined in the Indenture.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 2.  The New Guarantor, by its execution of this Supplemental Indenture, agrees to be a Subsidiary Guarantor under the Indenture and to be bound by the terms of the Indenture applicable to Subsidiary Guarantors, including, but not limited to, Article 10 thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 3.  THE INTERNAL LAW OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF </font></div><div style="height:77.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">EACH OF THE COMPANY, THE NEW GUARANTOR AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE SUBSIDIARY GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 4.  This Supplemental Indenture may be signed in various counterparts that together will constitute one and the same instrument.  The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or portable document format (&#8220;.pdf&#8221;) transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes.  Signatures of the parties hereto transmitted by facsimile or .pdf shall be deemed to be their original signatures for all purposes.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 5.  This Supplemental Indenture is an amendment supplemental to the Indenture and the Indenture and this Supplemental Indenture will henceforth be read together.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Section 6.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture, the Subsidiary Guarantee of the New Guarantor or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company and the New Guarantor. All of the provisions contained in the Indenture in respect of the rights, privileges, immunities, powers, and duties of the Trustee shall be applicable in respect of this Supplemental Indenture as fully and with like force and effect as though fully set forth in full herein.</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#91;Signature Page Follows&#93;</font></div><div style="height:77.28pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2</font></div><div><font><br></font></div></div></div><div id="i31413b9e3caf4d779a74628448126432_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the parties hereto have caused this Fifth Supplemental Indenture to be duly executed as of the date first above written.</font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.448%"><tr><td style="width:1.0%"></td><td style="width:11.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:36pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">HOLOGIC, INC.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, as Issuer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Marci J. Lerner</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Vice President, Treasurer</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.564%"><tr><td style="width:1.0%"></td><td style="width:12.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">BIOTHERANOSTICS, INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Marci J. Lerner</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Marci J. Lerner</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Vice President, Treasurer</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:180pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.474%"><tr><td style="width:1.0%"></td><td style="width:13.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.451%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:36pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, as Trustee</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#47;s&#47; Tina D. Gonzalez</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Tina D. Gonzalez</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Vice President</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#91;Fifth Supplemental Indenture (4.625% Senior Notes due 2028)&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">63986449 v2</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.48
<SEQUENCE>7
<FILENAME>ex1048-creweroadwythenshaw.htm
<DESCRIPTION>EX-10.48
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iba7e46dc854a4cd8a0d4def618fc332f_1"></div><div style="min-height:69.19pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS (I) NOT MATERIAL, AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.  OMISSIONS ARE MARKED &#91;*******&#93;.</font></div><div><font><br></font></div></div><div style="padding-left:48.6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.222%"><tr><td style="width:1.0%"></td><td style="width:28.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.275%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">DATED</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> February</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1988</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">THE COUNCIL OF THE CITY</font></div><div style="padding-left:210.22pt;padding-right:210.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">OF MANCHESTER</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:212pt;padding-right:212pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">- and -</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:99pt;padding-right:99pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">V.G. INSTRUMENTS GROUP LIMITED</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:204.55pt;padding-right:204.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">LEASE</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:204.87pt;padding-right:204.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">-of-</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;text-indent:19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">land situate at</font></div><div style="text-align:center;text-indent:19.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Crewe Road Wythenshawe</font></div><div style="padding-left:10.8pt;padding-right:10.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">in the City of Manchester</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Town Clerk </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Town Hall </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Manchester</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> M60 2LA</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">LC&#47;EM3&#47;CP&#47;55936</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">1103CMM&#47;SP</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:40.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.19pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="height:40.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="iba7e46dc854a4cd8a0d4def618fc332f_4"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:299.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">H.M.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">LAND REGISTRY</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:247.25pt;padding-right:106.6pt;text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">land Registration Acts - 1925 to 1971 </font></div><div style="padding-left:247.25pt;padding-right:106.6pt;text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">County - Greater Manchester</font></div><div style="padding-left:246.35pt;padding-right:106.6pt;text-indent:0.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">District - City of Manchester Registered Title No.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:247.65pt;text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">land situate at Crewe Road Wythenshawe in the <br>City of Manchester</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:75.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Parties</font></div><div style="padding-left:161.3pt;text-indent:28.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">THIS LEASE made the eighth day of February 1988 Between (1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">THE COUNCIL OF THE CITY OF MANCHESTER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> (&#34;the Lessors&#34;) and (2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">V G INSTRUMENTS GROUP LIMITED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> having its Regjstered Office at 29 Brighton Road Crawley West Sussex Rh10 6AE ( &#34;the Lessee&#34;)</font></div><div style="padding-left:75.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Interpretation</font></div><div style="padding-left:193.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">1. 0 IN THIS LEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> where the context so requires or admits</font></div><div style="padding-left:165.3pt;padding-right:1.35pt;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:15.9pt">&#34;the Lessors&#34; includes the persons for the time being entitled to the reversion expectant on the determination of the term hereby granted</font></div><div style="padding-left:167.05pt;padding-right:35.3pt;text-indent:20.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:15.55pt">&#34;the Lessee&#34; includes the persons deriving title under the Lessee</font></div><div style="padding-left:188.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">l. 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">&#34;the Plot of land&#34; means All that plot of land fronting to</font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:51.85pt"><font><br></font></div><div style="padding-left:162pt;text-indent:1.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Crewe Road and Wythenshawe Road Wythenshawe in the City of Manchester containing an area of 1.455 hectares or thereabouts and delineated and described on the plan annexed hereto numbered A2652&#47;6 and thereon edged red</font></div><div style="padding-left:162.7pt;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">&#34;the building&#34; means the building with the outbuildings boundary fences or hedges forecourt hedges or fences and other appurtenances thereto recently erected at the expense of the Lessee on the plot of land</font></div><div style="padding-left:165.15pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">1.5 &#8220;the demised premises&#8221; means both the plot of land and the building together with any alterations or additions thereto</font></div><div style="padding-left:144pt;padding-right:220.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">2.0 WITNESSETH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> as follows&#58;</font></div><div style="padding-left:73.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Demise&#47;Parcels&#47;Reservations&#47;Term</font></div><div style="padding-left:165.6pt;text-indent:25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">2.1 In consideration of the sum of &#91;*******&#93; paid by the Lessee to the Lessors (the receipt of which sum is hereby acknowledged) and in consideration of the yearly rent hereinafter reserved and of the Covenants by the Lessee and the conditions hereinafter contained the Lessors in Exercise of all powers enabling them hereby demise unto the Lessee ALL THAT the plot of land Except thereout any public sewers laid therein TOGETHER with (by way of demise and not of exception) the building AND TOGETHER WITH (a) a right of way for the Lessee the owners or occupiers for the time being of the demised premises and their respective servants and licensees (in common with he Lessors and all other persons having the like right) at all times with or without vehicles for all purposes connected with the use and enjoyment of the demised premises (but not for any other purpose whatsoever) to pass and repass along the roadway leading from Moor Road to the said plot of land known as Crewe Road and shown </font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:166.05pt;text-indent:-1.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">coloured yellow on the plan (b) the free passage and running of water soil gas and electricity through the pipes sewers drains watercourses cables and services now being in or under the adjoining land known as Crewe Road and shown coloured yellow on the plan annexed hereto and the right to make connections thereto or any of them for the purpose of exercising the said right including full rights of access thereto to all times after seven days previous notice in writing to the Lessors (except in the case of emergency) for the purpose of inspecting maintaining renewing repairing and cleansing the same annexed hereto EXCEPT AND RESERVING to the Lessors ALL mines minerals and mineral substances (other than coal and mines of coal as defined by the Coal Act 1938) in or under the plot of land belongs to the Lessors with full power to work and get such mines minerals and mineral substances by underground workings only and without any obligations to leave any subjacent or lateral support for the surface or any buildings for the time being erected thereon or for any adjoining minerals and from time to time or at any time to do all acts and things necessary or proper for working or getting such mines minerals and mineral substances and any adjoining mines minerals and mineral substances but so nevertheless that nothing herein contained shall confer on the Lessors any right to enter on the surface and that proper compensation shall be paid to the Lessee for any damage to the surface or to any buildings thereon by reason of the exercise of the powers and rights hereby reserved by the amount of such compensation in case of dispute to be settled by one independent person to be appointed in accordance with the provisions of the Arbitration Act 1950 to 1979 or any statutory modification or re-enactment thereof AND ALSO EXCEPT AND RESERVING</font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:166.05pt;text-indent:-1.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> to the Lessors free passage and drainage of water sewage and soil coming from or off any land or buildings erected and built or to be erected and built contiguous or near to the demised premises through the sewers drains pipes conduits and watercourses which are now or may within the period of eighty years from the date hereof (which shall be the perpetuity period applicable hereto) be in or under the plot of land TO HOLD (except and reserved as aforesaid) unto the Lessee for the term of 150 years from the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> day of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">December</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> 19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">88</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> (SUBJECT to the covenants and otherwise as more particularly contained in a Conveyance dated the 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:232%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> day of March 1927 made between (1) Robert Henry Grenville Tatton (2) Thomas Francis Egerton Sir Harry Stapleton Mainwaring and (3) The Lord Mayor Aldermen and Citizens of the City of Manchester so far as the same relate to or affect the demised premises and remain enforceable And subject also to&#58; </font></div><div style="padding-left:166.95pt;text-indent:22.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:16.67pt">the term of years reserved by an Underlease dated the 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:232%;position:relative;top:-3.5pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> day of January 1987 made between (1) the Lessors and (2) The North West Electricity Board in respect of the land situated within and forming part of the plot of land and which is more particularly delineated and described on the plan annexed hereto and numbered A2662&#47;6 and thereon edged purple</font></div><div style="padding-left:168.5pt;text-indent:23.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:12.25pt">the respective user rights of The North West Water Authority and the North West Electricity Board in respect of the sewers and electricity cables laid in the parts of the plot of land hatched brown hatched purple horizontally hatched purple and shaded mauve respectively on the plan annexed hereto and numbered A2662&#47;6</font></div><div style="padding-left:169.9pt;text-indent:23.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:8.08pt">the respective rights of the said Authority and the said Board to enter the land hereinbefore mentioned (whichever may </font></div><div style="padding-left:163.2pt;text-indent:24.1pt"><font><br></font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:171.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">be the case) to inspect maintain cleanse repair renew divert conduct work or manage such sewers or electricity cables and sub-station fencing making good any damage or loss caused by the exercise of such rights or any of them and restoring the surface of the said land </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">YIELDING AND PAYING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> unto the Lessors throughout the said term the yearly rent of a &#91;*******&#93; if demanded</font></div><div style="padding-left:73.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Lessees covenants</font></div><div style="padding-left:185.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">3.0 THE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> Lessee hereby covenants with the Lessors as follows&#58;</font></div><div style="padding-left:73.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Rent &#47;rates and taxes</font></div><div style="padding-left:173.7pt;text-indent:12.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.1 To pay the yearly rent hereby reserved at the times and in the manner hereinbefore appointed and also to pay and discharge all rates taxes assessments charges duties impositions and outgoings whatsoever which now are or during the said term shall be charged assessed or imposed on the demised premises or the landlord or the tenant in respect thereof except tax payable by the Lessors as a result of any dealing with any reversion immediately or mediately expectant on the term hereby granted</font></div><div style="padding-left:73.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline"> Easement Area </font></div><div style="padding-left:175.5pt;text-indent:12.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3. 2 Not without the previous consent in writing of the Lessorsto (a) erect any building or projection whatsoever on the parts of the plot of land shown as a brown line hatched brown hatched purple horizontally hatched purple and shaded respectively on the plan annexed hereto or do or permit to be done anything which could damage or impede the maintenance rights or the function of the surface water sewer and electricity cable laid in such land or </font></div><div style="padding-left:75.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Proportion of site to be occupied by buildings</font></div><div style="padding-left:189.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> (b) build over the plot of land to a greater than one third</font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:195.85pt"><font><br></font></div><div style="padding-left:178.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">thereof nor erect any part of the building nearer than 3 metres from the side and rear boundaries of the plot of land</font></div><div><font><br></font></div><div style="padding-left:71.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">To repair</font></div><div style="padding-left:178.65pt;text-indent:23.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.3 From time to time and at all times during the said term at the expense of the Lessee well and substantially to repair maintain and cleanse and in all respects keep in good and substantial repair and condition the demised premises and the fixtures and the same so repaired maintained cleansed and kept at the end or sooner determination of the said term peaceably to surrender and yield up unto the Lessors</font></div><div style="padding-left:73.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">To paint</font></div><div style="padding-left:178.65pt;text-indent:25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Once in every four years of the said term properly to paint to the reasonable satisfaction of the Lessors all such parts of the outside of all buildings and any fences railings or other erections on the plot of land as are usually painted and once in every seven years of the said term properly to paint and decorate to the reasonable satisfaction of the Lessors all such parts of the inside of such buildings as are usually painted and decorated</font></div><div style="padding-left:74.15pt"><font><br></font></div><div style="padding-left:74.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">To keep demised premises in order etc.</font></div><div style="padding-left:180pt;text-indent:25.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">To keep all parts of the demised premises generally in proper and neat order and condition and properly to maintain keep satisfaction of the Lessors any grass lawns flowering shrubs bushes and dwarf hedges within the demised premises </font></div><div style="padding-left:180pt;text-indent:-103.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">No alterations</font></div><div style="padding-left:182.7pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3. 6  Not without the consent in writing of the Lessors such consent not to be unreasonably withheld to make any addition improvement or alteration to the demised premises such as to </font></div><div style="padding-left:182.7pt;text-indent:24.5pt"><font><br></font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:182.9pt;text-indent:0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">change the character exterior design or appearance of the same or of any addition thereto or affect the load bearing capacity of the structure of the demised premises nor without the previous consent in writing of the Lessors such consent not to be unreasonably withheld to erect or maintain or suffer to be erected or maintained upon the said plot of land any building erection wall or fence of any kind whatsoever other than and except the demised premises and if any consent shall be given under this sub-clause to carry out all such additions improvements or alterations in accordance with plans sections elevations and specifications to be prepared by a Registered Architect (who shall supervise the work throughout to completion) and with materials previously approved of in writing by the Lessors (such approval not to be unreasonably withheld)</font></div><div style="padding-left:74.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">User</font></div><div style="padding-left:182.9pt;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3. 7  For to use the plot of land for any other purpose than as the site of the building nor without the consent in writing of the Lessors (such consent not to be unreasonably withheld) use the building for any purpose other than the manufacture assembly and testing of mass spectrometers</font></div><div style="padding-left:73.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Nuisance</font></div><div style="padding-left:184.3pt;padding-right:24.5pt;text-indent:23.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.8  Not to let or use the demised premises or any part or parts thereof or permit or suffer the same to be let or used for a club or for the manufacture distribution sale or supply of intoxicating liquors for consumption on or off the demised premises nor for any noxious offensive noisy or dangerous trade business pursuit or occupation or for any purpose or in any manner which may be deemed by the Lessors to be a nuisance damage grievance or annoyance to the Lessors or their tenants or to the </font></div><div><font><br></font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:184.3pt;padding-right:24.5pt;text-indent:-2.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> owenrs lessee or lessees tenant or tenants of any of the adjoining property or the neighbourhood or to be detrimental to the neighbourhood Provided that the carrying on in a proper manner of the trade or business referred to in the last proceding sub-clause hereof shall not be deemed to be a breach of this covenant</font></div><div style="padding-left:71.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Not to store in open</font></div><div style="padding-left:185.75pt;text-indent:25.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3. 9  Not at any time without the consent in writing of the Lessors to use any part of the plot of land not occupied by the building for the open storage of goods or materials of any nature whatsoever and to comply with any conditions subject to which any such consent may be given</font></div><div style="padding-left:72.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Encroachments</font></div><div style="padding-left:185.05pt;text-align:justify;text-indent:27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.10  To take all necessary steps to prevent any encroachment upon the demised premises or the acquisition of any new right to light passage drainage or other easement over under or upon the demised premises which shall come to the knowledge of the Lessee and to give notice to the Lessors of any threatened encroachments or attempt to acquire any such easement and to cooperate in all reasonable respects with the Lessors in taking any measures the Lessors may deem necessary (including legal action) to resist such encroachment or the acquisition of any such easement  </font></div><div style="padding-left:73.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">As to waste material</font></div><div style="padding-left:185.05pt;text-indent:28.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.11  Not to deposit place or store any bins crates cartons boxes or any receptacle for waste nor any such waste material in such manner as to be visible from any part of the street or road but maintain any such receptacles or material as aforesaid within the boundary walls of the demised premises</font></div><div style="padding-left:73.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">To preserve tress</font></div><div style="padding-left:187.65pt;text-indent:26.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.12  Not to damage or cut down or remove any trees or shrubs </font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:187.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">growing on the said plot of land without first obtaining the written consent of the Lessors other than pruning or the removal of dead timber and&#47;or shrubs </font></div><div style="padding-left:73.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Smokeless fuel</font></div><div style="padding-left:186.3pt;text-indent:29.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.13 (a) Not to erect or install in or upon the demised premises any furnace boiler or other fuel burning apparatus (other than domestic apparatus consuming gas or electricity) without the previous written consent of the Lessors and to use and maintain any apparatus so installed and any alteration or addition thereto to the reasonable satisfaction of the Lessors</font></div><div style="padding-left:186.75pt;text-indent:30.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(b) Not to use or suffer to be used negligently inefficiently improperly any furnace boiler or other fue1 burning apperatus so as to cause or permit any noxious or offensive smoke effluvia gas vapor or grit to be emitted from the same</font></div><div style="padding-left:189.35pt;text-indent:28.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(c) Not to claim exemption under any Smoke Control Order or any similar order regulation bye-law or enactment made by the Lessors in t heir capacity of the Local Authority or by another proper Authority</font></div><div style="padding-left:74pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">No advertising or billposting station</font></div><div style="padding-left:189.9pt;text-indent:27.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Not to use any walls gable ends of buildings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">fences upon or enclosing the plot of land or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">any notice board sign or hoarding for the posting of bills or advertisements and not to use the demised premises for the purpose of an advertising or billposting station and in case of any breach of this covenant the Lessors shall in addition to any other remedy they may possess have the right at any time without notice to the Lessee or the occupier or occupiers to enter upon the demised premises and to remove any bills advertisements or posters displayed or exhibited in contravention of this convenant Provided always that the Lessors </font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:190.1pt;text-indent:0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">shall not refuse their consent to the display on the demised premises of one advertisement indicating the Lessee's nature of business unless such advertisement shall be of such a nature as the Lessors shall take objection to on the ground of unsightliness or disfigurement of the neighbourhood or on other reasonable grounds</font></div><div style="padding-left:76.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Compliance with acts</font></div><div style="padding-left:189pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.15  To execute all such works as are or may under or in pursuance of any Act of Parliament already or hereafter to be passed be directed or required by any local or public authority to be executed at any time during the said term upon or in respect of the demised premises whether by the Lessors or the Lessee and to comply with all Acts of Parliament and observe and perform all the regulations and byelaws and other requirements of any public authority in respect of the demised premises</font></div><div style="padding-left:77.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Inspection</font></div><div style="padding-left:194.85pt;text-indent:23.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.16  To permit the Lessors by their officers and servants with or without workmen or others at reasonable times upon prior written notice save in the case of emergency to enter upon the demised premises to view the state and condition thereof and also at any reasonable time upon prior written notice during the last seven years of the said term to take a schedule of the Landlord&#8217;s fixtures therein and to repair and make good all defects and wants of reparation which shall on any such inspection be discovered for which the Lessee is responsible under the provisions of this Lease and of which notice in writing shall be given to the Lessee or left for the Lessee at or upon the demised premises within two calendar months after the fiving of such notice Provided that in case the Lessee makes default in complying with the requirements </font></div><div><font><br></font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:195.1pt;text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">of any notice given by the Lessors within the aforesaid period then in addition to any other remedy they may possess it shall be lawful for the Lessors to enter into and upon the demised premise and to execute or cause to be executed the works comprised or referred to in the said notice and to recover from the Lessee the actual costs thereof and charges incurred in connection therewith as rent in arrear</font></div><div style="padding-left:74.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Insurance</font></div><div style="padding-left:194.4pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.17 (a) To insure the demised premises from loss or damage by fire explosion lightning storm tempest and aircraft including articles dropped therefrom and any other risks from time to time reasonably required by the Lessors to the full replacement value thereof in the joint names of the Lessee and the Lessors as co-insureds in some well-established insurance office in Great Britain approved of in writing by the Lessors and during the said term to keep the same so insured and to pay all premiums necessary for that purpose within fourteen days after the same shall have become due and upon the request of the Lessors from time to time to produce the policy of such insurance and the receipt for the premium for the then current year</font></div><div style="padding-left:196.2pt;text-indent:17.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:26.59pt">If the demised premises </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">any part or parts shall be destroyed or damaged and as often as the same shall be so destroyed or damaged forthwith to lay out the money received in respect of such insurance in rebuilding and reinstating the Same under the direction and to the reasonable satisfaction of the Lessors and in case such money shall be insufficient for such purpose to make good such deficiency </font></div><div style="padding-left:196.2pt;text-indent:23.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:21.31pt">If the Lessee shall at any time fail to insure or keep insured the demised premises or to produce the policy of insurance </font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:196.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">and the receipt for the current year&#8217;s premium as hereinbefore provided the Lessors may do all things necessary to effect or maintain such insurance and all money expended by the Lessors for that purpose shall be repaid by the Lessee to the Lessors on demand with interest while unpaid in accordance with Clause 4.5 hereof and such money and interest and all incidental costs incurred by the Lessors shall until payment be recoverable as rent in arrear</font></div><div style="padding-left:197.55pt;text-indent:30.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:12.54pt">If at any time the Lessee desires to effect an insurance on the demised premises otherwise than in compliance with the terms of this Lease the Lessee shall first obtain the consent in writing of the Lessors and shall hold all money received by the Lessee in respect of any such insurance in trust for the Lessors to be paid to the Lessors and to be applied by them (so far as may be required) in reinstatement of the demised premises</font></div><div style="padding-left:200.25pt;text-indent:30.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:10.41pt">Not to do or suffer to be done anything which may prejudice any such insurance as aforesaid nor without the consent in writing of the Lessors (which consent shall not be unreasonably withheld) to keep or permit to be kept on the demised premises materials of a dangerous or explosive nature or do or suffer to be done anything whereby the insurance premium for adjacent premises shall require to be increased</font></div><div style="padding-left:75.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Not to assign etc.</font></div><div style="padding-left:203.75pt;text-indent:30.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(a) not to assign part only (as opposed to the whole) of the demised premises</font></div><div style="padding-left:203.05pt;text-indent:31.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:5.44pt">Not to part with or share the possession or occupation of all or any part of the demised premises for all or any part of the term save as permitted pursuant to the provisions of sub-clause (c) below PROVIDED ALWAYS that the occupation</font></div><div style="padding-left:202.5pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">of the demised premises or any part thereof by a wholly owned subsidiary or associated company of the lessee shall not constitute a breach of this Clause</font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="padding-left:164.15pt;text-indent:29.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(c) Not to assign the whole of the demised premises nor to sub-demise the whole or any part of the demised premises without the previous written consent of the Lessors provided always that every permitted underlease shall contain covenants on the part of the underlessee or underlessees as follows</font></div><div style="padding-left:164.15pt;text-indent:30.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:12.17pt">An absolute covenant not to assign part only (as opposed to the whole) of the underlet premises or to part with or share possession or occupation of the whole or any part thereof other than in accordance with sub-clause (ii) hereof</font></div><div style="padding-left:164.9pt;text-indent:30.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:7.95pt">A qualified covenant not to assign the whole of the underlet premises or underlet the whole or any part of the underlet premises without the consent in writing of the I,essors</font></div><div style="padding-left:74.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Notice of assignment</font></div><div style="padding-left:166.95pt;text-indent:31.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:35.6pt">Upon every assignment or sub-demise (except by way of mortgage) or devolution of the demised premises or any part thereof within one calendar month afater the assignment sub-demise or devolution to give to the Town Clerk of the Lessors notice in writing thereof specifying the name and address of the assignee sub-lessee or personal representative or other person in whom the term or any part thereof may have become vested and to produce the assignment sub-demise or evidence of devolution at at the Office of the said Town Clerk for registration and for such consent and registration to pay a reasonable fee</font></div><div style="padding-left:75.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Acquisition of rights</font></div><div style="padding-left:170.65pt;text-indent:29.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.20 That the Lessee shall not (save as herein provided or under a written agreement of the Lessors) acquire any right of light </font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:170.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">air way support watercourse drainage or other easement over under or through any adjoining or neighbouring land of the Lessors</font></div><div style="padding-left:73.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Indemnify re covenants</font></div><div style="padding-left:163.35pt;text-indent:22.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.21 For the purpose of affording to the Lessors a full and sufficient indemnity but not further or otherwise at all times during the said term to duly observe and perform the covenants and the conditions subject to which this demise is made so far as all such covenants and conditions are still subsisting and capable of being enforced and relate to or affect the demised premises and to keep the Lessors indemnified from and against all actions proceedings costs damages claims and demands whatsoever in respect of the non-observance or non-performance thereof</font></div><div style="padding-left:74.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Cost of LPA notices</font></div><div style="padding-left:163.45pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.22 To pay all reasonable expenses including legal costs and Surveyor&#8217;s fees incurred by the Lessors incidental to the preparation and service of a Notice under Section 146 of the Law of Property Act 1925 or incurred in or in contemplation of proceedings under Section 146 or 147 of that Act notwithstanding in any such case forfeiture is avoided otherwise than by relief by the Court</font></div><div style="padding-left:73.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">To comply with statues etc.</font></div><div style="padding-left:164.9pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.23 At all times during the said term to comply in all respects with the provisions and requirements of the Town and Country Planning Acts and all other Acts of Parliament hereafter enacted related to Town Planning and all regulations or orders made thereunder whether as to the permitted use hereunder or otherwise and to indemnify and keep the Lessors indemnified against all liability in respect of any acts or omissions by the Lessee in contravention hereof including costs and expenses in </font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:164.85pt;text-indent:-0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">respect of such matters and forthwith to produce to the Lessors on receipt of notice thereof any notice order or proposal therefor made given or issued to the Lessee by a Planning Authority under or by virtue of the said Acts or any of them affecting or relating to the demised premises </font></div><div style="padding-left:73.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Costs in abating nuisance etc.</font></div><div style="padding-left:162.7pt;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:12.05pt">To pay all costs charges and expenses incurred by the Lessors in abating a nuisance and executing all such works as may be necessary for abating a nuisance or for remedying any other matter in connection with the demised premises in obedience to any notice served by any local or public authority</font></div><div style="padding-left:74.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Costs for consents licenses etc.</font></div><div style="padding-left:163.45pt;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;padding-left:11.3pt">Save where otherwise provided in this Lease to pay to the Lessors all reasonable Solicitors&#8217; costs and Surveyors&#8217; fees incurred by the Lessors attendant upon or incidental to every application made by the Lessee for a consent or license herein required or made necessary whether the same be granted or refused or or proffered subject to any lawful qualification or condition or whether the application be withdrawn </font></div><div style="padding-left:74.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Load bearing</font></div><div style="padding-left:164.15pt;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.26&#160;&#160;&#160;&#160;Not to install or bring or leave upon the demised premises any article of any description whatsoever which would cause any greater strain to be placed upon any part of the demised premises than that which the demised premises are capable of bearing</font></div><div style="padding-left:74.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Not to obstruct drains</font></div><div style="padding-left:164.9pt;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.27&#160;&#160;&#160;&#160; Not to stop up or obstruct or permit or suffer to be stopped up or obstructed or permit or suffer oil grease or other deleterious matter to enter the drains and sewers pipes channels </font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:164.9pt;text-indent:0.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">and watercourses of the demised premises</font></div><div style="padding-left:73.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">To indemnify Lessors</font></div><div style="padding-left:164.15pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3. 28 To indemnify the Lessors against all actions cost claims demands and liability whatsoever in respect of injury (including fatal injury) or damage to any person or property due to or arising from the act default or negligence of the Lessee or the Lessee's agents or servants or licensees or trustees of the Lessee</font></div><div style="padding-left:165.6pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">3.29 &#160;&#160;&#160;&#160;During the subsistence of the term hereby granted to rebuild or replace or cause to be rebuilt or replaced once and in accordance with plans sections elevations specifications and Detailed drawings and of materials previously approved by the Lessors (such approval not to be unreasonably withheld) to the reasonable satisfaction of the Lessors expressed in writing the building </font></div><div style="padding-left:189pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">4.0 PROVIDED ALWAYS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> that&#58; -</font></div><div style="padding-left:75.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Lessors may obstruct lights etc.</font></div><div style="padding-left:165.6pt;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">4.1 It shall be lawful for the Lessors their lessee or lessees tenant or tenants at any time during the said term to erect rebuild or alter any buildings or erections facing adjoining or near to the demised premises to any extent and in any manner they may think fit notwithstanding that the buildings so erected rebuilt or altered may obstruct or interfere with any light or air for the time being appertaining to or enjoyed with the demised premises or any part thereof</font></div><div style="padding-left:76.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Sale or Lease of adjoining</font></div><div style="padding-left:167.05pt;text-indent:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">4. 2 The Lessors may sell or lease any land adjoining or near to the demised premises free from any obligations or restrictions similar to the obligations or restrictions hereby imposed and any obligations or restrictions in relation to any adjoining or</font></div><div><font><br></font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:162pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">neighbouring land may be wholly or partially released or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">any breach thereof waived without thereby releasing the Lessee from any of the covenants or provisions herein contained or giving to the Lessee any right of action against the Lessors or any other person or persons</font></div><div style="padding-left:81pt;padding-right:39.95pt;text-indent:0.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Re-entry</font></div><div style="padding-left:166.3pt;text-indent:27.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">4.3 If there shall be any breach non-performance or non-observance of any of the covenants herein contained and on the Lessee&#8217;s part to be observed and performed then and in every such case it shall be lawful for the Lessors into and upon the demised premises for the time being thereon or any part thereof in the name of the whole to re-enter and thereupon this demise shall absolutely determine without prejudice to any right of action or remedy of the Lessors in respect of any breach non-performance or non-observance of any of the covenants by the Lessee herein contained</font></div><div style="padding-left:73.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Avoidance of doubt re Lessors' Powers</font></div><div style="padding-left:163.45pt;text-indent:31.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">4.4 For the avoidance of doubt nothing herein contained or implied shall prejudice or affect the Lessors rights powers duties and obligations in the exercise of their functions as a local auathority planning authority or in any other capacity whatsoever nor relieve the Lessee from the necessity to obtain all such approvals or consents as may from time to time be requisite from the Lessors in any such capacity as aforesaid and the rights powers duties and obligations of the Lessors under all public and local statutes bye-laws orders and regulations may be as fully and effectually exercised in relation to the demised premises or any part thereof as if they were not the reversioners and this Lease had not been executed by </font></div><div><font><br></font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:74.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Interest on unpaid sums</font></div><div style="padding-left:163.45pt;text-indent:32.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">4.5 All sums payable hereunder by the Lessee to the Lessors shall from the date due to the date paid carry interest while unpaid at a rate equivalent to two per cent above the base rate charged by the Lessors Bankers from time to time and this clause shall operate notwithstanding and without prejudice to the Lessors rights or re-entry and to determine this Lease for non-payment of such sums or breach of covenant</font></div><div style="padding-left:73.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Lessors covenant for quiet enjoyment</font></div><div style="padding-left:163.45pt;text-indent:29.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">5.0&#160;&#160;&#160;&#160;THE LESSORS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> hereby covenant with Lessee (i) that the Lessee paying the rent hereby reserved and observing and performing the covenants and conditions herein contained and on the part of the Lessee to be observed and performed may quietly possess and enjoy the demised premises during the said term without any lawful interruption from or by the Lessors or any person rightly claiming from or under them (ii) until the same shall be adopted as maintainable at the public expense to light and comport all ways roads pavements (including the roadway shown coloured yellow on the plan annexed hereto) sewers drains pipes channels watercourses wires and cables which shall form part of or serve or be used by the demised premises in common with other adjoining or neighbouring premises</font></div><div style="padding-left:73.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Notices</font></div><div style="padding-left:163.45pt;text-indent:31.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">6.0&#160;&#160;&#160;&#160; THE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> regulations as to notices contained in Section 196 of the Law of Property Act 1925 as amended by the Recorded Delivery Service Act 1962 apply to this Lease</font></div><div style="padding-left:72.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">Marginal notes</font></div><div style="padding-left:164.15pt;text-indent:34.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">7.0 &#160;&#160;&#160;&#160; THE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> marginal notes shall not affect the construction hereof</font></div><div><font><br></font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="padding-left:96.3pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%">IN </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">WITNESS whereof the Lessors and the Lessee have hereunto affixed their respective Common Seals the day and year first before written</font></div><div><font><br></font></div><div style="padding-left:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%;text-decoration:underline">THE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">COMMON SEAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">THE COUNCIL</font></div><div style="padding-left:99pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%;text-decoration:underline">OF THE CITY 0F MANCHESTER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%"> was</font></div><div style="padding-left:99pt;text-align:justify;text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">hereunto affixed in pursuance </font></div><div style="padding-left:99pt;text-align:justify;text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">of an Order of the Council of </font></div><div style="padding-left:99pt;text-align:justify;text-indent:-1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%">said </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">City&#58;-</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:232%">&#47;s&#47;</font></div><div style="padding-left:90pt"><font><br></font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:232%">Authorised Signatory</font></div><div style="height:53.64pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>8
<FILENAME>holxq4-2021ex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6d9e09d3c8dd479783d4186d9737bb09_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:250.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries of Hologic*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation or Organization</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acessa Health Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beijing Hologic Technology Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benassar Diagnostica-Equipamientos Medicos Unipessoal, Lda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BioLucent, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bioptics, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biotheranostics, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytyc Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytyc Prenatal Products Corp.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytyc Surgical Products, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagenode Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagenode SA</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagenode SPA</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagenode, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct Radiography Corp.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emsor, Sociedad de responsabilidad limitada </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Faxitron Bioptics, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genewave SAS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gen-Probe Incorporated</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gen-Probe Prodesse, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gen-Probe Sales &#38; Service, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Beacons, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic (Australia &#38; New Zealand) Pty Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic (MA), LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic ASE, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Asia Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Asia Pacific Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Austria GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic BV</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Bermuda Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Canada ULC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Caribbean (Barbados) SRL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbados</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Denmark ApS</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Deutschland GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Espana S.A.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Finance Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic France SARL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic GGO 2, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic GGO 3 LLP</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic GGO 4 LTD</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Global Holding LTD</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Hitec-Imaging GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Holdings Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic HUB LTD</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Iberia, S.L.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:250.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries of Hologic*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation or Organization</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic India LLP</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">India</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic International Holdings B.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic IP LTD</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Ireland Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Italia S.r.l.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Japan KK</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hologic Latin America (Servicos Em Marketing E Negocios) Ltda.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Malaysia SDN. BHD.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Medical Technologies (Beijing) Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Medicor GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Medicor Suisse GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Netherlands B.V.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Nordic Holdings Oy</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic (Shanghai) Medical Supplies Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Singapore Pte. Ltd</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Suisse SA</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Surgical Products Costa Rica, S.R.L.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Sweden AB</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic Taiwan Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic UK Finance Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic US Finance Co LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mobidiag Oy</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finland</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mobidiag UK Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Navigation Three Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NXT-Dx SCRL</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somatex (HK) Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somatex Medical Technologies GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somatex USA Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine SA</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine Ltd</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine Srl</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine HK Ltd</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SuperSonic Imagine (Shanghai) Medical Devices Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suros Surgical Systems, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TCT International Co., Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">British Virgin Islands</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tridaho LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">*</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subsidiaries not included in the list are omitted because, in aggregate, they are insignificant as defined by Item 601(b((21) of Regulation S-K.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>9
<FILENAME>holxq4-2021ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic452bf19ece442bc8e764612209b5048_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:472.50pt"><tr><td style="width:1.0pt"></td><td style="width:16.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:429.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Statement (Form S-3ASR No. 333-235287) pertaining to Hologic, Inc.&#8217;s shelf registration statement for common stock, preferred stock, debt securities, rights, warrants, purchase contracts, units or any combination of the foregoing, and</font></div></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:472.50pt"><tr><td style="width:1.0pt"></td><td style="width:16.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:429.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registration Statements (Form S-8 Nos. 333-79167, 333-60046, 333-112222, 333-121111, 333-130170, 333-139341, 333-150796, 333-181126, 333-183019, 333-188468, 333-224613, 333-210968) pertaining to the equity incentive plans and employee stock purchase plan of Hologic, Inc.&#59;</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated November&#160;16, 2021, with respect to the consolidated financial statements of Hologic, Inc. and the effectiveness of internal control over financial reporting of Hologic, Inc., included in this Annual Report (Form 10-K) of Hologic, Inc. for the year ended September&#160;25, 2021. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP </font></div><div style="margin-bottom:10pt;margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:186.75pt"><tr><td style="width:1.0pt"></td><td style="width:184.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston, Massachusetts</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 16, 2021</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>holxq4-2021ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="icc2ccdac1f9145489ffd0844b06e46ed_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;16, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>holxq4-2021ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib5e72c6b357f4ac483afe106459d203d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;16, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>holxq4-2021ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i748b5bef229f4598ad382719c7565fef_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, Chief Executive Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Annual Report on Form 10-K for the year ended September&#160;25, 2021 (the &#8220;Form 10-K&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November 16, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>holxq4-2021ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib636bec93a0d4d0f82b82a83b9ab0340_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, Chief Financial Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Annual Report on Form 10-K for the year ended September&#160;25, 2021 (the &#8220;Form 10-K&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November 16, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>holx-20210925.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fe647887-7476-401d-8075-31ce3ecd561d,g:aafd6a0b-1c31-49b5-81b9-4feb5a12e92f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:holx="http://www.hologic.com/20210925" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.hologic.com/20210925">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210925_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210925_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210925_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210925_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.hologic.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome">
        <link:definition>100010002 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>100020003 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome_1" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome_1">
        <link:definition>100020003 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncomeParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical">
        <link:definition>100030004 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets">
        <link:definition>100040005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100050006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>100060007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100070008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Operations" roleURI="http://www.hologic.com/role/Operations">
        <link:definition>210011001 - Disclosure - Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperationsDetails" roleURI="http://www.hologic.com/role/OperationsDetails">
        <link:definition>240024001 - Disclosure - Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>210031002 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>240064002 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail">
        <link:definition>240074003 - Disclosure - Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail">
        <link:definition>240084004 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail">
        <link:definition>240094005 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail">
        <link:definition>240104006 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails">
        <link:definition>240114007 - Disclosure - Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail">
        <link:definition>240124008 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail">
        <link:definition>240134009 - Disclosure - Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails">
        <link:definition>240144010 - Disclosure - Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail">
        <link:definition>240154011 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails">
        <link:definition>240164012 - Disclosure - Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails">
        <link:definition>240174013 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails">
        <link:definition>240184014 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails">
        <link:definition>240194015 - Disclosure - Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails">
        <link:definition>240204016 - Disclosure - Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail">
        <link:definition>240214017 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail">
        <link:definition>240224018 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesProductWarrantyDetail" roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail">
        <link:definition>240234019 - Disclosure - Summary of Significant Accounting Policies - Product Warranty (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNotes" roleURI="http://www.hologic.com/role/RevenueNotes">
        <link:definition>210241003 - Disclosure - Revenue (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.hologic.com/role/RevenueTables">
        <link:definition>230253002 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.hologic.com/role/RevenueNarrativeDetails">
        <link:definition>240264020 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueBusinessRevenueDetails" roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails">
        <link:definition>240274021 - Disclosure - Revenue - Business Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueGeographicalRevenueDetails" roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails">
        <link:definition>240284022 - Disclosure - Revenue - Geographical Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenuebyTypeDetails" roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails">
        <link:definition>240294023 - Disclosure - Revenue - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationsDetails" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails">
        <link:definition>240304024 - Disclosure - Revenue - Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationsDetails_1" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1">
        <link:definition>240304024 - Disclosure - Revenue - Remaining Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.hologic.com/role/Leases">
        <link:definition>210311004 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.hologic.com/role/LeasesTables">
        <link:definition>230323003 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.hologic.com/role/LeasesNarrativeDetails">
        <link:definition>240334025 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>240344026 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalLeaseInformationDetails" roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails">
        <link:definition>240354027 - Disclosure - Leases - Additional Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseLiabilityMaturitySchedule2020Details" roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details">
        <link:definition>240364028 - Disclosure - Leases - Lease Liability Maturity Schedule 2020 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseLiabilityMaturitySchedule2020Details_1" roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1">
        <link:definition>240364028 - Disclosure - Leases - Lease Liability Maturity Schedule 2020 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" roleURI="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails">
        <link:definition>240374029 - Disclosure - Leases - Future Minimum Annual Rental Income Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.hologic.com/role/BusinessCombinations">
        <link:definition>210381005 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.hologic.com/role/BusinessCombinationsTables">
        <link:definition>230393004 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationNarrativeDetails" roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails">
        <link:definition>240404030 - Disclosure - Business Combination - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
        <link:definition>240414031 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentDetails" roleURI="http://www.hologic.com/role/EquityMethodInvestmentDetails">
        <link:definition>240424032 - Disclosure - Equity Method Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCharges" roleURI="http://www.hologic.com/role/RestructuringCharges">
        <link:definition>210431006 - Disclosure - Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesTables" roleURI="http://www.hologic.com/role/RestructuringChargesTables">
        <link:definition>230443005 - Disclosure - Restructuring Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail">
        <link:definition>240454033 - Disclosure - Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail">
        <link:definition>240464034 - Disclosure - Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesAdditionalInformationDetail" roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail">
        <link:definition>240474035 - Disclosure - Restructuring Charges - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangements" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements">
        <link:definition>210481007 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsTables" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables">
        <link:definition>230493006 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsCompanysBorrowingsDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
        <link:definition>240504036 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails">
        <link:definition>240514037 - Disclosure - Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
        <link:definition>240524038 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail">
        <link:definition>240534039 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
        <link:definition>240544040 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.hologic.com/role/FairValueMeasurementsTables">
        <link:definition>230553007 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
        <link:definition>240564041 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail">
        <link:definition>240574042 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails">
        <link:definition>240584043 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.hologic.com/role/IncomeTaxesTables">
        <link:definition>230593008 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" roleURI="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail">
        <link:definition>240604044 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesProvisionforIncomeTaxesDetail" roleURI="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail">
        <link:definition>240614045 - Disclosure - Income Taxes - Provision for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" roleURI="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail">
        <link:definition>240624046 - Disclosure - Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" roleURI="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail">
        <link:definition>240634047 - Disclosure - Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetail" roleURI="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail">
        <link:definition>240644048 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" roleURI="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail">
        <link:definition>240654049 - Disclosure - Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensation" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation">
        <link:definition>210661008 - Disclosure - Stockholders' Equity and Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationTables" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables">
        <link:definition>230673009 - Disclosure - Stockholders' Equity and Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail">
        <link:definition>240684050 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail">
        <link:definition>240694051 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail">
        <link:definition>240704052 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail">
        <link:definition>240714053 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail">
        <link:definition>240724054 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail">
        <link:definition>240734055 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="A401kPlan" roleURI="http://www.hologic.com/role/A401kPlan">
        <link:definition>210741009 - Disclosure - 401(k) Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="A401kPlanAdditionalInformationDetail" roleURI="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail">
        <link:definition>240754056 - Disclosure - 401(k) Plan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DeferredCompensationPlanAdditionalInformationDetail" roleURI="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail">
        <link:definition>240764057 - Disclosure - Deferred Compensation Plan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.hologic.com/role/CommitmentsandContingencies">
        <link:definition>210771010 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.hologic.com/role/CommitmentsandContingenciesTables">
        <link:definition>230783010 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" roleURI="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails">
        <link:definition>240794058 - Disclosure - Commitments and Contingencies - Summary of Purchase Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationandRelatedMatters" roleURI="http://www.hologic.com/role/LitigationandRelatedMatters">
        <link:definition>210801011 - Disclosure - Litigation and Related Matters</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LitigationandOtherMattersAdditionalInformationDetail" roleURI="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail">
        <link:definition>240814059 - Disclosure - Litigation and Other Matters - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Disposition" roleURI="http://www.hologic.com/role/Disposition">
        <link:definition>210821012 - Disclosure - Disposition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionTables" roleURI="http://www.hologic.com/role/DispositionTables">
        <link:definition>230833011 - Disclosure - Disposition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionAdditionalInformationDetails" roleURI="http://www.hologic.com/role/DispositionAdditionalInformationDetails">
        <link:definition>240844060 - Disclosure - Disposition - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" roleURI="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails">
        <link:definition>240854061 - Disclosure - Disposition - Schedule of Disposition Related Income Statement Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformation" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation">
        <link:definition>210861013 - Disclosure - Business Segments and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationTables" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables">
        <link:definition>230873012 - Disclosure - Business Segments and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
        <link:definition>240884062 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationSegmentInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail">
        <link:definition>240894063 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
        <link:definition>240904064 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails">
        <link:definition>240914065 - Disclosure - Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherLongTermLiabilities" roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities">
        <link:definition>210921014 - Disclosure - Accrued Expenses and Other Long-Term Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherLongTermLiabilitiesTables" roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables">
        <link:definition>230933013 - Disclosure - Accrued Expenses and Other Long-Term Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail">
        <link:definition>240944066 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail">
        <link:definition>240954067 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefits" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefits">
        <link:definition>210961015 - Disclosure - Pension and Other Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsTables" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables">
        <link:definition>230973014 - Disclosure - Pension and Other Employee Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail">
        <link:definition>240984068 - Disclosure - Pension and Other Employee Benefits - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail">
        <link:definition>240994069 - Disclosure - Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail">
        <link:definition>241004070 - Disclosure - Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail">
        <link:definition>241014071 - Disclosure - Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail">
        <link:definition>241024072 - Disclosure - Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="holx_DebtInstrumentCommitmentFeePercentage" abstract="false" name="DebtInstrumentCommitmentFeePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DeferredTaxLiabilitiesDepreciationAndAmortization" abstract="false" name="DeferredTaxLiabilitiesDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" abstract="false" name="LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_GrossForeignLossCarryforwards" abstract="false" name="GrossForeignLossCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AcquiredintangibleassetsMember" abstract="true" name="AcquiredintangibleassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ChangeInParValue" abstract="false" name="ChangeInParValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_InterestRateCapAgreementsAggregatePremiumPayable" abstract="false" name="InterestRateCapAgreementsAggregatePremiumPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" abstract="false" name="EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" abstract="false" name="PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EurocurrencyRateMember" abstract="true" name="EurocurrencyRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PSUFreeCashFlowMember" abstract="true" name="PSUFreeCashFlowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SuperSonicImagineMember" abstract="true" name="SuperSonicImagineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LeaseRevenuePercentageOfTotalRevenue" abstract="false" name="LeaseRevenuePercentageOfTotalRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_CashEquivalentsMaturityPeriod" abstract="false" name="CashEquivalentsMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_DecreaseindeferredtaxliabilitiesduetoASC201616" abstract="false" name="DecreaseindeferredtaxliabilitiesduetoASC201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_GrantsReceivedFromDepartmentOfDefense" abstract="false" name="GrantsReceivedFromDepartmentOfDefense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_Purchaseobligationthereafter" abstract="false" name="Purchaseobligationthereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LegalAccrual" abstract="false" name="LegalAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AmendedRevolver2018Member" abstract="true" name="AmendedRevolver2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_FocalTherapeuticsInc.Member" abstract="true" name="FocalTherapeuticsInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_TepnelMember" abstract="true" name="TepnelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" abstract="false" name="MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ContingentHoldbackMember" abstract="true" name="ContingentHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_OneThirdAnnuallyMember" abstract="true" name="OneThirdAnnuallyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PaymentsUnderFinanceLeaseObligations" abstract="false" name="PaymentsUnderFinanceLeaseObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Fiscal2020ActionMember" abstract="true" name="Fiscal2020ActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EmployeeContributionsVestedPercentage" abstract="false" name="EmployeeContributionsVestedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_BiotheranosticsMember" abstract="true" name="BiotheranosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PrincipalAmountOfBorrowings" abstract="false" name="PrincipalAmountOfBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" abstract="false" name="LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_FundingOfLoansToSSI" abstract="false" name="FundingOfLoansToSSI" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ProceedsfromSeniorNotes" abstract="false" name="ProceedsfromSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SubLeaseRentalIncomeDueIn4Years" abstract="false" name="SubLeaseRentalIncomeDueIn4Years" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherAssetsPolicyPolicyTextBlock" abstract="false" name="OtherAssetsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_FacilityClosureCosts" abstract="false" name="FacilityClosureCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" abstract="false" name="NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" abstract="false" name="DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccountsReceivableReserveDivested" abstract="false" name="AccountsReceivableReserveDivested" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Fiscal2021ChargesMember" abstract="true" name="Fiscal2021ChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NumberOfFinanceLeases" abstract="false" name="NumberOfFinanceLeases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="holx_Dec112019Member" abstract="true" name="Dec112019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PaymentsForDeferredAcquisitionConsideration" abstract="false" name="PaymentsForDeferredAcquisitionConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" abstract="false" name="ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_DivestitureCharges" abstract="false" name="DivestitureCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PensioninAccumulatedOtherComprehensiveIncomeMember" abstract="true" name="PensioninAccumulatedOtherComprehensiveIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NXCImagingMember" abstract="true" name="NXCImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" abstract="false" name="MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_GynSurgicalMember" abstract="true" name="GynSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ScheduleOfGoodwillBySegmentTableTableTextBlock" abstract="false" name="ScheduleOfGoodwillBySegmentTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_TermARSecuritizationProgram" abstract="false" name="TermARSecuritizationProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_GeographicInformationForPropertyPlantAndEquipmentTable" abstract="true" name="GeographicInformationForPropertyPlantAndEquipmentTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" abstract="false" name="CostOfGoodsSoldImpairmentOfIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" abstract="false" name="NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" abstract="false" name="DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_IncomeTaxReceivableReclassification" abstract="false" name="IncomeTaxReceivableReclassification" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_June132019PlanMember" abstract="true" name="June132019PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" abstract="false" name="DebtInstrumentPercentageRedemptionPriceSixthPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DebtInstrumentNumberOfInstruments" abstract="false" name="DebtInstrumentNumberOfInstruments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="holx_AccountingStandardTransitionAdjustmentASU842" abstract="false" name="AccountingStandardTransitionAdjustmentASU842" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" abstract="false" name="AccountsReceivableAndReservesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_MaximumBorrowingUnderSecuritizationProgram" abstract="false" name="MaximumBorrowingUnderSecuritizationProgram" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_HealthBeaconsMember" abstract="true" name="HealthBeaconsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LongTermDebtObligationsWithoutConvertibleNotes" abstract="false" name="LongTermDebtObligationsWithoutConvertibleNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_WarrantyTermForProducts" abstract="false" name="WarrantyTermForProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842" abstract="false" name="FinanceLeaseRightOfUseAssetAtAdoptionOf842" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_StateLossCarryforwardExpectedToUnutilize" abstract="false" name="StateLossCarryforwardExpectedToUnutilize" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccruedIncomeAndOtherTaxes" abstract="false" name="AccruedIncomeAndOtherTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BreastImagingMember" abstract="true" name="BreastImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NotionalAmount" abstract="false" name="NotionalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CostMethodEquityInvestments" abstract="false" name="CostMethodEquityInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2021RevolverMember" abstract="true" name="A2021RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BreastHealthMember" abstract="true" name="BreastHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DepartmentOfDefenseFundsReceived" abstract="false" name="DepartmentOfDefenseFundsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_InvestmentInGroupLifeInsuranceContracts" abstract="false" name="InvestmentInGroupLifeInsuranceContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CreditAgreement2018Member" abstract="true" name="CreditAgreement2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SecuredTermLoanMember" abstract="true" name="SecuredTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ShareRepurchseAuthorizationDateDomain" abstract="true" name="ShareRepurchseAuthorizationDateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AmendedCreditFacility2018Member" abstract="true" name="AmendedCreditFacility2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_OtherOperatingCostReductionsMember" abstract="true" name="OtherOperatingCostReductionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_OneCustomerMember" abstract="true" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" abstract="false" name="OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SomatexMember" abstract="true" name="SomatexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AuthorizationDateDomain" abstract="true" name="AuthorizationDateDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RemainingLeaseBalance" abstract="false" name="RemainingLeaseBalance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_NetOperatingLossCarryforwardsMember" abstract="true" name="NetOperatingLossCarryforwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NonIncomeTaxLoss" abstract="false" name="NonIncomeTaxLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CreditAgreementPriorMember" abstract="true" name="CreditAgreementPriorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" abstract="false" name="MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_BusinessCombinationAdditionalSharesAcquiredValue" abstract="false" name="BusinessCombinationAdditionalSharesAcquiredValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SubLeaseRentalIncomeCurrent" abstract="false" name="SubLeaseRentalIncomeCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EmployerContributionsVestingPeriod" abstract="false" name="EmployerContributionsVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_OtherTypeofRevenueMember" abstract="true" name="OtherTypeofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" abstract="true" name="AmountoflossrecognizedinothercomprehensiveincomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" abstract="false" name="AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_EquipmentAndSoftwareMember" abstract="true" name="EquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" abstract="false" name="DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_LitigationAndOtherMattersTextBlock" abstract="false" name="LitigationAndOtherMattersTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_SemiAnnualEmployeeStockPurchasePlanMember" abstract="true" name="SemiAnnualEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_TwoThousandEightEquityPlanMember" abstract="true" name="TwoThousandEightEquityPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SubLeaseRentalIncomeDueIn2Years" abstract="false" name="SubLeaseRentalIncomeDueIn2Years" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SubLeaseRentalIncomeDueIn5years" abstract="false" name="SubLeaseRentalIncomeDueIn5years" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtheractionMember" abstract="true" name="OtheractionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationAdditionalSharesAcquiredShares" abstract="false" name="BusinessCombinationAdditionalSharesAcquiredShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_IncreasetoincometaxexpenseadoptionofASU201616" abstract="false" name="IncreasetoincometaxexpenseadoptionofASU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" abstract="false" name="IncreasetoNetIncomeresultedfromadoptionofASU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TransitionServicesAgreementTerm" abstract="false" name="TransitionServicesAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_ASRAuthorized" abstract="false" name="ASRAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2021CreditAgreementMember" abstract="true" name="A2021CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RevenueMember" abstract="true" name="RevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SubLeaseRentalIncome" abstract="false" name="SubLeaseRentalIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_InternalusesoftwareMember" abstract="true" name="InternalusesoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_MobidiagOyMember" abstract="true" name="MobidiagOyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" abstract="false" name="DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_RepaymentofSeniorNotes" abstract="false" name="RepaymentofSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SubLeaseRentalIncomeDueThereafter" abstract="false" name="SubLeaseRentalIncomeDueThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CustomerRelationshipsContractsMember" abstract="true" name="CustomerRelationshipsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccountsReceivableAllowanceReduction" abstract="false" name="AccountsReceivableAllowanceReduction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AcessaHealthMember" abstract="true" name="AcessaHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" abstract="false" name="MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_GrossUnrecognizedTaxBenefits" abstract="false" name="GrossUnrecognizedTaxBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" abstract="false" name="DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TaxCreditCarryforwardMember" abstract="true" name="TaxCreditCarryforwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccountingstandardtransitionadjustmentASU201616" abstract="false" name="AccountingstandardtransitionadjustmentASU201616" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" abstract="true" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_InternationalMember" abstract="true" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationSharesAcquired" abstract="false" name="BusinessCombinationSharesAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_AccumulatedothercomprehensiveIncomelossHedge" abstract="false" name="AccumulatedothercomprehensiveIncomelossHedge" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" abstract="false" name="LesseeOperatingAndFinanceLeasesExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_Fiscal2018ActionMember" abstract="true" name="Fiscal2018ActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PercentageOfRevenues" abstract="false" name="PercentageOfRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" abstract="false" name="PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_PercentageOfVestingForStockOptionsGrantedToEmployees" abstract="false" name="PercentageOfVestingForStockOptionsGrantedToEmployees" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DebtRedemptionPremiumPaid" abstract="false" name="DebtRedemptionPremiumPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Holdback" abstract="false" name="Holdback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LongLivedAssetsPolicyPolicyTextBlock" abstract="false" name="LongLivedAssetsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_OtherGeographicRegionsMember" abstract="true" name="OtherGeographicRegionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Fiscal2020ChargesMember" abstract="true" name="Fiscal2020ChargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RestructuringChargesUnderExitOrDisposalPlan" abstract="false" name="RestructuringChargesUnderExitOrDisposalPlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TwothousandeighteenMember" abstract="true" name="TwothousandeighteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InterestCoverageRatio" abstract="false" name="InterestCoverageRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_TaxPositionsRelatedToCurrentYearAbstract" abstract="true" name="TaxPositionsRelatedToCurrentYearAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_RevolverMember" abstract="true" name="RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842" abstract="false" name="OperatingLeaseRightOfUseAssetAtAdoptionOf842" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsLineItems" abstract="true" name="ScheduleOfGeographicalSegmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_Dec92020Member" abstract="true" name="Dec92020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage" abstract="false" name="LesseeFinanceLeaseBargainPurchaseOptionPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_BolderSurgicalMember" abstract="true" name="BolderSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SubLeaseRentalIncomeDueIn3Years" abstract="false" name="SubLeaseRentalIncomeDueIn3Years" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_GoodwillNotAtRiskOfFailingImpairment" abstract="false" name="GoodwillNotAtRiskOfFailingImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" abstract="false" name="PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" abstract="false" name="DebtInstrumentPeriodicPaymentPrincipalPerQuarter" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes" abstract="false" name="UnrealizedGainLossOnInterestRateCapNetOfTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_DiagenodeMember" abstract="true" name="DiagenodeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DeferredTaxLiabilitiesRightOfUseAsset" abstract="false" name="DeferredTaxLiabilitiesRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" abstract="false" name="DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_IndemnificationLiabily" abstract="false" name="IndemnificationLiabily" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccruedInterest" abstract="false" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CytologyPerinatalMember" abstract="true" name="CytologyPerinatalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Fiscal2019chargesMember" abstract="true" name="Fiscal2019chargesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" abstract="false" name="NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_AllOtherCountriesMember" abstract="true" name="AllOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2025SeniorNotesMember" abstract="true" name="A2025SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" abstract="false" name="DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_MarketBasedStockUnitsMember" abstract="true" name="MarketBasedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AdditionalPurchaseConsideration" abstract="false" name="AdditionalPurchaseConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" abstract="false" name="DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_AccountsReceivableSecuritizationMember" abstract="true" name="AccountsReceivableSecuritizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MolecularDiagnosticsMember" abstract="true" name="MolecularDiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" abstract="false" name="PurchaseOfNonControllingInterestReclassifiedToAPIC" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ProjectedBenefitObligationForLongTermServiceAwards" abstract="false" name="ProjectedBenefitObligationForLongTermServiceAwards" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2021TermLoanMember" abstract="true" name="A2021TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" abstract="false" name="EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DebtInstrumentOfferingPricePercentOfFaceValue" abstract="false" name="DebtInstrumentOfferingPricePercentOfFaceValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_CynosureMember" abstract="true" name="CynosureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BedfordMember" abstract="true" name="BedfordMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" abstract="false" name="IncreasetoEarningsperShareresultedfromadoptionofASC201616" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EquipmentUnderCustomerUsageAgreements" abstract="false" name="EquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" abstract="false" name="EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MaximumRangeofPresentValueofCashFlowPercentage" abstract="false" name="MaximumRangeofPresentValueofCashFlowPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" abstract="false" name="ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AlphaImagingMember" abstract="true" name="AlphaImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SegmentReportingDisclosureLineItems" abstract="true" name="SegmentReportingDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" abstract="true" name="GeographicInformationForPropertyPlantAndEquipmentLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_MedicalAestheticsMember" abstract="true" name="MedicalAestheticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" abstract="false" name="DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" abstract="false" name="LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_Fiscal2019ActionMember" abstract="true" name="Fiscal2019ActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherRestructuringPayments" abstract="false" name="OtherRestructuringPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" abstract="false" name="DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" abstract="false" name="PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_Expensesfromdisposition" abstract="false" name="Expensesfromdisposition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_GrossStateLossCarryforwards" abstract="false" name="GrossStateLossCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ComponentsofNetPeriodicBenefitCostInterestcost" abstract="false" name="ComponentsofNetPeriodicBenefitCostInterestcost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_CashSeverancePayments" abstract="false" name="CashSeverancePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_FinanceLeaseObligationsLongTermMember" abstract="true" name="FinanceLeaseObligationsLongTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" abstract="false" name="CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_EquipmentUnderCustomerUsageAgreementMember" abstract="true" name="EquipmentUnderCustomerUsageAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" abstract="true" name="DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_DistributionagreementMember" abstract="true" name="DistributionagreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TaxOnInterestRateSwap" abstract="false" name="TaxOnInterestRateSwap" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsTable" abstract="true" name="ScheduleOfGeographicalSegmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_Fiscal2021ActionMember" abstract="true" name="Fiscal2021ActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" abstract="false" name="BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_NonqualifiedDeferredCompensationPlanAnnualContribution" abstract="false" name="NonqualifiedDeferredCompensationPlanAnnualContribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" abstract="false" name="WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_EmployerContributionsPercentVestedAnnually" abstract="false" name="EmployerContributionsPercentVestedAnnually" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_ASRSharesRepurchasedduringtheperiod" abstract="false" name="ASRSharesRepurchasedduringtheperiod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" abstract="false" name="PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_ManufacturingEquipmentAndSoftware" abstract="false" name="ManufacturingEquipmentAndSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" abstract="false" name="EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_SkeletalHealthMember" abstract="true" name="SkeletalHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" abstract="false" name="PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SegmentReportingDisclosureTable" abstract="true" name="SegmentReportingDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_InterventionalBreastSolutionsMember" abstract="true" name="InterventionalBreastSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" abstract="false" name="DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_ReductionOfWorkforceExpenses" abstract="false" name="ReductionOfWorkforceExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmountpaidduringtheperiodunderASRAgreement" abstract="false" name="AmountpaidduringtheperiodunderASRAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmendedTermLoan2018Member" abstract="true" name="AmendedTermLoan2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessAcquisitionCashTenderOfferPricePerShare" abstract="false" name="BusinessAcquisitionCashTenderOfferPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="holx_A2029SeniorNotesMember" abstract="true" name="A2029SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Impairmentofintangibleassetsandequipment" abstract="false" name="Impairmentofintangibleassetsandequipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" abstract="false" name="AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_CreditAgreement2017Member" abstract="true" name="CreditAgreement2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LeaseReceivable" abstract="false" name="LeaseReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BloodScreeningMember" abstract="true" name="BloodScreeningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LeverageRatioMaximum" abstract="false" name="LeverageRatioMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_FinanceLeaseObligationsShortTermMember" abstract="true" name="FinanceLeaseObligationsShortTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CompanyVs.MinervaSurgicalInc.Member" abstract="true" name="CompanyVs.MinervaSurgicalInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_UnrecognizedTaxBenefitsIncreasesAbstract" abstract="true" name="UnrecognizedTaxBenefitsIncreasesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_ComprehensiveIncome" abstract="false" name="ComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SomatexMedicalTechnologiesMember" abstract="true" name="SomatexMedicalTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ShareRepurchseAuthorizationDateAxis" abstract="true" name="ShareRepurchseAuthorizationDateAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_CapitalEquipmentComponentsandSoftwareMember" abstract="true" name="CapitalEquipmentComponentsandSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationOwnershipPercentage" abstract="false" name="BusinessCombinationOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_TaxPositionsRelatedToPriorYearsAbstract" abstract="true" name="TaxPositionsRelatedToPriorYearsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_MedicalAestheticsBusinessMember" abstract="true" name="MedicalAestheticsBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccountingstandardtransitionadjustmentASC606" abstract="false" name="AccountingstandardtransitionadjustmentASC606" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CapitalizedsoftwareMember" abstract="true" name="CapitalizedsoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DeferredTaxAssetsLeaseLiability" abstract="false" name="DeferredTaxAssetsLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ShareBasedCompensationPercentageOfForfeitureRate" abstract="false" name="ShareBasedCompensationPercentageOfForfeitureRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_BusinessLicensesMember" abstract="true" name="BusinessLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>holx-20210925_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fe647887-7476-401d-8075-31ce3ecd561d,g:aafd6a0b-1c31-49b5-81b9-4feb5a12e92f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_79815b50-007f-40f8-9746-538e737ece9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fe073c31-47b7-4c4d-a8fd-82e76179442b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_79815b50-007f-40f8-9746-538e737ece9c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_fe073c31-47b7-4c4d-a8fd-82e76179442b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b56a76e6-2763-4a3e-a307-06bd78d440d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_79815b50-007f-40f8-9746-538e737ece9c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b56a76e6-2763-4a3e-a307-06bd78d440d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0803b950-204b-4626-80c1-4da2f2fecf7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_533a379c-0ec2-4371-bf20-11cfc66d8bc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0803b950-204b-4626-80c1-4da2f2fecf7c" xlink:to="loc_us-gaap_SellingAndMarketingExpense_533a379c-0ec2-4371-bf20-11cfc66d8bc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_af482d97-26cd-4d1f-9903-570eafe7678d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0803b950-204b-4626-80c1-4da2f2fecf7c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_af482d97-26cd-4d1f-9903-570eafe7678d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_04429787-6d0e-4f18-8e81-27a3ffee8b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0803b950-204b-4626-80c1-4da2f2fecf7c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_04429787-6d0e-4f18-8e81-27a3ffee8b7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8cd975f7-d0dc-494d-b5ea-1b52fa477d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0803b950-204b-4626-80c1-4da2f2fecf7c" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8cd975f7-d0dc-494d-b5ea-1b52fa477d9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f9b0ee8a-d5bf-465e-9a76-1256e3f230c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0803b950-204b-4626-80c1-4da2f2fecf7c" xlink:to="loc_us-gaap_RestructuringCharges_f9b0ee8a-d5bf-465e-9a76-1256e3f230c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8c47484c-ab65-42b5-b7c0-e133850af98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0803b950-204b-4626-80c1-4da2f2fecf7c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8c47484c-ab65-42b5-b7c0-e133850af98f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_f36a6a71-b997-4fd5-80de-2e665f4d4fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_0803b950-204b-4626-80c1-4da2f2fecf7c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_f36a6a71-b997-4fd5-80de-2e665f4d4fd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_76e37445-ab82-4267-a93d-56fd30864ae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_73ebde7e-3fe1-4db4-a74c-f0a7cca7ce70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_76e37445-ab82-4267-a93d-56fd30864ae9" xlink:to="loc_us-gaap_OperatingIncomeLoss_73ebde7e-3fe1-4db4-a74c-f0a7cca7ce70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8e6a19e4-7a0d-462d-bdeb-5d42cd007d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_76e37445-ab82-4267-a93d-56fd30864ae9" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8e6a19e4-7a0d-462d-bdeb-5d42cd007d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c6b47e86-ed4c-4cfc-9a92-5b261656ddb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_76e37445-ab82-4267-a93d-56fd30864ae9" xlink:to="loc_us-gaap_InterestExpense_c6b47e86-ed4c-4cfc-9a92-5b261656ddb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cc37f869-a1b8-4303-8b7a-9d7b2d343e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_76e37445-ab82-4267-a93d-56fd30864ae9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cc37f869-a1b8-4303-8b7a-9d7b2d343e99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_986c8a14-2abf-4748-8ca8-8f4911a95e1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_76e37445-ab82-4267-a93d-56fd30864ae9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_986c8a14-2abf-4748-8ca8-8f4911a95e1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1ddf1369-dee7-424d-ad20-d013675f8a84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1c82aab6-b5d8-455f-927f-e1a16653c0ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1ddf1369-dee7-424d-ad20-d013675f8a84" xlink:to="loc_us-gaap_GrossProfit_1c82aab6-b5d8-455f-927f-e1a16653c0ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_85352bac-2535-4e35-9d3f-38198d19e48f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1ddf1369-dee7-424d-ad20-d013675f8a84" xlink:to="loc_us-gaap_OperatingExpenses_85352bac-2535-4e35-9d3f-38198d19e48f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76f9167f-6b58-499e-b273-e6fa32d51e82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_18038836-318e-4761-a163-857a281bda58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_76f9167f-6b58-499e-b273-e6fa32d51e82" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_18038836-318e-4761-a163-857a281bda58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1f1577a2-15a4-4ba7-8b33-3021a1761554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_76f9167f-6b58-499e-b273-e6fa32d51e82" xlink:to="loc_us-gaap_ProfitLoss_1f1577a2-15a4-4ba7-8b33-3021a1761554" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1558ce1b-9fb8-4caf-b033-0fd455933bcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_f7d688b9-0753-4135-8acd-9e7020cf4150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1558ce1b-9fb8-4caf-b033-0fd455933bcf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_f7d688b9-0753-4135-8acd-9e7020cf4150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_fa65fe73-15f7-4632-a9b1-0e054a4c50f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1558ce1b-9fb8-4caf-b033-0fd455933bcf" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_fa65fe73-15f7-4632-a9b1-0e054a4c50f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_9c33c7fe-f493-49b0-aa3e-4f54d2e33a3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1558ce1b-9fb8-4caf-b033-0fd455933bcf" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_9c33c7fe-f493-49b0-aa3e-4f54d2e33a3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_19446b35-960f-4e0e-91a5-2942bb4949a2" xlink:href="holx-20210925.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1558ce1b-9fb8-4caf-b033-0fd455933bcf" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_19446b35-960f-4e0e-91a5-2942bb4949a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_19587815-b5f6-4186-9e6a-41e43e78aab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_26f61d1c-5257-4e65-9384-4b3ed367e6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_19587815-b5f6-4186-9e6a-41e43e78aab4" xlink:to="loc_us-gaap_ProfitLoss_26f61d1c-5257-4e65-9384-4b3ed367e6dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_12494eaf-a1a1-4ac0-8f1f-3118254d1eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_19587815-b5f6-4186-9e6a-41e43e78aab4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_12494eaf-a1a1-4ac0-8f1f-3118254d1eb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c4de2913-49f2-4c48-951a-9759bd82e2dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2cacf599-7772-45d0-9232-9c838555a52b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c4de2913-49f2-4c48-951a-9759bd82e2dc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_2cacf599-7772-45d0-9232-9c838555a52b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cf0f30fa-2e50-41a1-adda-2595bbca01b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c4de2913-49f2-4c48-951a-9759bd82e2dc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cf0f30fa-2e50-41a1-adda-2595bbca01b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_378c5dcf-1967-44ba-85e4-8a526dc23283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c4de2913-49f2-4c48-951a-9759bd82e2dc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_378c5dcf-1967-44ba-85e4-8a526dc23283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_3407c04a-c1fc-4085-a496-388376ac9207" xlink:href="holx-20210925.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c4de2913-49f2-4c48-951a-9759bd82e2dc" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_3407c04a-c1fc-4085-a496-388376ac9207" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome_1" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofComprehensiveIncome_1"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_97c18a7d-ca10-47b3-a956-46aa36fbaf8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_9cab9776-ae5d-4eae-aa7a-3c0279fd0f1d" xlink:href="holx-20210925.xsd#holx_ComprehensiveIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_97c18a7d-ca10-47b3-a956-46aa36fbaf8b" xlink:to="loc_holx_ComprehensiveIncome_9cab9776-ae5d-4eae-aa7a-3c0279fd0f1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6af1c153-de57-46e8-b72f-f4d5beea2be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_97c18a7d-ca10-47b3-a956-46aa36fbaf8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_6af1c153-de57-46e8-b72f-f4d5beea2be1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_26250260-1df0-4acb-ba9f-7718bfced178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7d3903a0-9523-45aa-ae79-c41cef74284a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26250260-1df0-4acb-ba9f-7718bfced178" xlink:to="loc_us-gaap_LongTermDebtCurrent_7d3903a0-9523-45aa-ae79-c41cef74284a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3923a16d-8a63-4579-8ad6-4e2c548004f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26250260-1df0-4acb-ba9f-7718bfced178" xlink:to="loc_us-gaap_AccountsPayableCurrent_3923a16d-8a63-4579-8ad6-4e2c548004f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cec0603e-30bd-41ad-9b9a-6ed7936269f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26250260-1df0-4acb-ba9f-7718bfced178" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_cec0603e-30bd-41ad-9b9a-6ed7936269f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_75b463de-99be-41ac-9380-3ef4c226069d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26250260-1df0-4acb-ba9f-7718bfced178" xlink:to="loc_us-gaap_DeferredRevenueCurrent_75b463de-99be-41ac-9380-3ef4c226069d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e0c50477-aaf7-4edd-aea4-53a4bc7b85ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_26250260-1df0-4acb-ba9f-7718bfced178" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e0c50477-aaf7-4edd-aea4-53a4bc7b85ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bae34f66-70bf-4c59-a767-74d4c5ddf306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_edc3bcf7-f058-4fe4-ba7a-e93293115a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bae34f66-70bf-4c59-a767-74d4c5ddf306" xlink:to="loc_us-gaap_PreferredStockValue_edc3bcf7-f058-4fe4-ba7a-e93293115a31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8b5957f9-0c66-4182-be0a-796cffc935b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bae34f66-70bf-4c59-a767-74d4c5ddf306" xlink:to="loc_us-gaap_CommonStockValue_8b5957f9-0c66-4182-be0a-796cffc935b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a3096815-fd67-4b8c-aa74-81b0858d569f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bae34f66-70bf-4c59-a767-74d4c5ddf306" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a3096815-fd67-4b8c-aa74-81b0858d569f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b6471097-7f58-4616-893c-b33d5edbb1b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bae34f66-70bf-4c59-a767-74d4c5ddf306" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b6471097-7f58-4616-893c-b33d5edbb1b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ed310055-e14d-4dc6-906d-a7a196b3ac5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bae34f66-70bf-4c59-a767-74d4c5ddf306" xlink:to="loc_us-gaap_TreasuryStockValue_ed310055-e14d-4dc6-906d-a7a196b3ac5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_721fa48b-5bd3-4a66-bca9-853bad6150a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bae34f66-70bf-4c59-a767-74d4c5ddf306" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_721fa48b-5bd3-4a66-bca9-853bad6150a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7712bf2a-7e37-4137-a71f-bcc303c71259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bc371e84-4287-4e58-be20-6e0ce96662d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7712bf2a-7e37-4137-a71f-bcc303c71259" xlink:to="loc_us-gaap_LiabilitiesCurrent_bc371e84-4287-4e58-be20-6e0ce96662d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_53ebcca8-9434-4a35-9708-357ce31a86f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7712bf2a-7e37-4137-a71f-bcc303c71259" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_53ebcca8-9434-4a35-9708-357ce31a86f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_96df249f-8dd0-4e24-9fa2-f3ba96d0a9fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7712bf2a-7e37-4137-a71f-bcc303c71259" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_96df249f-8dd0-4e24-9fa2-f3ba96d0a9fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_e54df08a-e80b-46f5-9df2-bc33cd3af994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7712bf2a-7e37-4137-a71f-bcc303c71259" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_e54df08a-e80b-46f5-9df2-bc33cd3af994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9576ab16-d596-40d4-84a0-4224f4a0d093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7712bf2a-7e37-4137-a71f-bcc303c71259" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9576ab16-d596-40d4-84a0-4224f4a0d093" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f34f72d9-00b7-46db-9feb-dc87eb36806b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7712bf2a-7e37-4137-a71f-bcc303c71259" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f34f72d9-00b7-46db-9feb-dc87eb36806b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b5094f06-ead8-4017-8a24-7cd0f6bf25ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7712bf2a-7e37-4137-a71f-bcc303c71259" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b5094f06-ead8-4017-8a24-7cd0f6bf25ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9b2af081-989a-4f32-b6d9-327b48ed070b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7712bf2a-7e37-4137-a71f-bcc303c71259" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9b2af081-989a-4f32-b6d9-327b48ed070b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_76019656-6acc-4cf4-970d-5bfaa32f5cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1a8e3508-4267-481a-b381-00e3ec0dc189" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_76019656-6acc-4cf4-970d-5bfaa32f5cc6" xlink:to="loc_us-gaap_AssetsCurrent_1a8e3508-4267-481a-b381-00e3ec0dc189" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1b975ae9-5192-46f5-90e8-49a59bab0e6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_76019656-6acc-4cf4-970d-5bfaa32f5cc6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1b975ae9-5192-46f5-90e8-49a59bab0e6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_721f6e01-c2f6-4685-b2d4-a38dd3103fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_76019656-6acc-4cf4-970d-5bfaa32f5cc6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_721f6e01-c2f6-4685-b2d4-a38dd3103fe3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_483bc798-f0db-4b02-9579-079713e93a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_76019656-6acc-4cf4-970d-5bfaa32f5cc6" xlink:to="loc_us-gaap_Goodwill_483bc798-f0db-4b02-9579-079713e93a6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c6782b7d-ae5e-4e01-b7c7-87dd46e12156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_76019656-6acc-4cf4-970d-5bfaa32f5cc6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c6782b7d-ae5e-4e01-b7c7-87dd46e12156" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dfe26400-25ce-4116-b5ed-5caa22faf5e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ed059d70-f3dd-41cd-bf64-a764df79250d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dfe26400-25ce-4116-b5ed-5caa22faf5e8" xlink:to="loc_us-gaap_StockholdersEquity_ed059d70-f3dd-41cd-bf64-a764df79250d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_793fd6a0-a79a-48f8-9161-13588fc2d6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dfe26400-25ce-4116-b5ed-5caa22faf5e8" xlink:to="loc_us-gaap_MinorityInterest_793fd6a0-a79a-48f8-9161-13588fc2d6ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0353da17-f101-4891-b585-86cfa963ec0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_002e656f-f913-47dc-97ac-ffe619f9e49e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0353da17-f101-4891-b585-86cfa963ec0c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_002e656f-f913-47dc-97ac-ffe619f9e49e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_27e87855-709a-4b82-ae88-416f9baa098b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0353da17-f101-4891-b585-86cfa963ec0c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_27e87855-709a-4b82-ae88-416f9baa098b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_593f97f6-48a6-48dd-9d75-ae933a26c070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0353da17-f101-4891-b585-86cfa963ec0c" xlink:to="loc_us-gaap_InventoryNet_593f97f6-48a6-48dd-9d75-ae933a26c070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_5a7bfa4a-60c8-4fa1-9aba-f81f0e9d817b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0353da17-f101-4891-b585-86cfa963ec0c" xlink:to="loc_us-gaap_PrepaidTaxes_5a7bfa4a-60c8-4fa1-9aba-f81f0e9d817b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_03168a16-0a94-4755-86e6-ba02c123802d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0353da17-f101-4891-b585-86cfa963ec0c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_03168a16-0a94-4755-86e6-ba02c123802d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6722c900-8742-40b7-95e9-14bf3435a115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4505ec5e-7db9-4f69-af10-98c1dfda6d19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6722c900-8742-40b7-95e9-14bf3435a115" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4505ec5e-7db9-4f69-af10-98c1dfda6d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12983b32-d957-4e12-91c4-07abf1635982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6722c900-8742-40b7-95e9-14bf3435a115" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12983b32-d957-4e12-91c4-07abf1635982" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8792d7dc-a719-4edd-8323-62d4996e195a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6722c900-8742-40b7-95e9-14bf3435a115" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8792d7dc-a719-4edd-8323-62d4996e195a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8d60f280-6292-4813-8f07-95265c627d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6722c900-8742-40b7-95e9-14bf3435a115" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8d60f280-6292-4813-8f07-95265c627d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bea395b2-4d22-4431-9d69-29f28f60aa32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_68abf688-248f-4ab1-968d-868537c458d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bea395b2-4d22-4431-9d69-29f28f60aa32" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_68abf688-248f-4ab1-968d-868537c458d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b8a09bac-d9dc-45f9-a5a1-0f953c6fcb77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bea395b2-4d22-4431-9d69-29f28f60aa32" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_b8a09bac-d9dc-45f9-a5a1-0f953c6fcb77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_f2f0242c-701b-48ab-8df5-e62895726991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bea395b2-4d22-4431-9d69-29f28f60aa32" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_f2f0242c-701b-48ab-8df5-e62895726991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FundingOfLoansToSSI_be51d1a6-6528-4de1-bd47-6b776dfde22f" xlink:href="holx-20210925.xsd#holx_FundingOfLoansToSSI"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bea395b2-4d22-4431-9d69-29f28f60aa32" xlink:to="loc_holx_FundingOfLoansToSSI_be51d1a6-6528-4de1-bd47-6b776dfde22f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_086eea26-b63f-4010-8da8-b1550f5f66c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bea395b2-4d22-4431-9d69-29f28f60aa32" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_086eea26-b63f-4010-8da8-b1550f5f66c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_87c324a9-b7b8-4842-94e4-cb1b095f8e8f" xlink:href="holx-20210925.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bea395b2-4d22-4431-9d69-29f28f60aa32" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_87c324a9-b7b8-4842-94e4-cb1b095f8e8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_fe8ef0ea-46e7-4fec-b0df-498932e8ec59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bea395b2-4d22-4431-9d69-29f28f60aa32" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_fe8ef0ea-46e7-4fec-b0df-498932e8ec59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_db44226e-6b11-4e15-991a-30d73518caf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bea395b2-4d22-4431-9d69-29f28f60aa32" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_db44226e-6b11-4e15-991a-30d73518caf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentofSeniorNotes_616c436c-3812-4b6f-abe7-fc48e4440f94" xlink:href="holx-20210925.xsd#holx_RepaymentofSeniorNotes"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_holx_RepaymentofSeniorNotes_616c436c-3812-4b6f-abe7-fc48e4440f94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsForDeferredAcquisitionConsideration_ef2ba4a2-f163-4ed9-a45f-52cbeacdc029" xlink:href="holx-20210925.xsd#holx_PaymentsForDeferredAcquisitionConsideration"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_holx_PaymentsForDeferredAcquisitionConsideration_ef2ba4a2-f163-4ed9-a45f-52cbeacdc029" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_349ea841-6064-437d-b6ad-963e52852c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_349ea841-6064-437d-b6ad-963e52852c7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_c4f444d7-d052-4231-8591-728876407547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_c4f444d7-d052-4231-8591-728876407547" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_7cb1feaa-9e3c-4565-b8d6-c435f47611a9" xlink:href="holx-20210925.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_7cb1feaa-9e3c-4565-b8d6-c435f47611a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_76710baa-b3c1-4aae-81b1-e7a6a2096d50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_76710baa-b3c1-4aae-81b1-e7a6a2096d50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsUnderFinanceLeaseObligations_3a50190e-a2d3-4f9b-83a7-307b2f901831" xlink:href="holx-20210925.xsd#holx_PaymentsUnderFinanceLeaseObligations"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_holx_PaymentsUnderFinanceLeaseObligations_3a50190e-a2d3-4f9b-83a7-307b2f901831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0d89b0f7-8c8a-4cd6-bd81-8deb2ec5e539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0d89b0f7-8c8a-4cd6-bd81-8deb2ec5e539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9587880c-4e79-4801-ad3d-cd66b9647627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_9587880c-4e79-4801-ad3d-cd66b9647627" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_b84c57b5-bcb8-4048-a57b-f4338ccdc68d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_b84c57b5-bcb8-4048-a57b-f4338ccdc68d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_12f3a6eb-199e-4b47-8b44-d8ebd29e651c" xlink:href="holx-20210925.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_12f3a6eb-199e-4b47-8b44-d8ebd29e651c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_8b98c7bc-5114-4174-adec-7f1cc1f11518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_8b98c7bc-5114-4174-adec-7f1cc1f11518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_de6b85d7-afe5-4377-9ba9-27a6c4af9711" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_de6b85d7-afe5-4377-9ba9-27a6c4af9711" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_905f8dde-c6c4-447b-ad66-49ad0921eb23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_905f8dde-c6c4-447b-ad66-49ad0921eb23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsfromSeniorNotes_33602445-0635-4324-b677-ee252fe9303f" xlink:href="holx-20210925.xsd#holx_ProceedsfromSeniorNotes"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d593ab50-a981-4179-962d-50c23eb0defb" xlink:to="loc_holx_ProceedsfromSeniorNotes_33602445-0635-4324-b677-ee252fe9303f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_8048503c-e1e4-40d4-8339-5ab60264b242" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_Depreciation_8048503c-e1e4-40d4-8339-5ab60264b242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_f07b1467-162e-474b-b85b-81e939d6eaa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_AdjustmentForAmortization_f07b1467-162e-474b-b85b-81e939d6eaa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_72b3ab2f-eabc-424b-b7eb-2d3fd69818e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_ShareBasedCompensation_72b3ab2f-eabc-424b-b7eb-2d3fd69818e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0cb3e656-7aee-4353-ba77-3f2fdd0c8749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0cb3e656-7aee-4353-ba77-3f2fdd0c8749" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_95cb4495-9d13-4979-ac71-11c701d5d801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_95cb4495-9d13-4979-ac71-11c701d5d801" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1a0b2b7a-bb16-4c28-bf87-bc898ebabbc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1a0b2b7a-bb16-4c28-bf87-bc898ebabbc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d8e06b8b-edb0-4707-8f6f-29af3ee33c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d8e06b8b-edb0-4707-8f6f-29af3ee33c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6290b416-2590-45f0-864a-038c2c12381c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6290b416-2590-45f0-864a-038c2c12381c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_580a4384-c308-42f3-84b0-d017acc2e918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_580a4384-c308-42f3-84b0-d017acc2e918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e2f8b08a-7f14-46e7-8ac8-149199367549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e2f8b08a-7f14-46e7-8ac8-149199367549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d9edddda-ec38-4d5a-94f5-4390e204a3fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d9edddda-ec38-4d5a-94f5-4390e204a3fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_0c8d8cbb-5fec-453e-b80f-20d2aeb1e0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_0c8d8cbb-5fec-453e-b80f-20d2aeb1e0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_3d91179d-4cf4-47a9-b949-3bdce242f28e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_3d91179d-4cf4-47a9-b949-3bdce242f28e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6e217eb3-3acd-48cc-a911-5cf24bab57fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_us-gaap_ProfitLoss_6e217eb3-3acd-48cc-a911-5cf24bab57fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Impairmentofintangibleassetsandequipment_c9af4ae3-42fe-4986-87d2-d6dc57b5807a" xlink:href="holx-20210925.xsd#holx_Impairmentofintangibleassetsandequipment"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee5fc79f-5a50-457a-a880-7c30f12a66d8" xlink:to="loc_holx_Impairmentofintangibleassetsandequipment_c9af4ae3-42fe-4986-87d2-d6dc57b5807a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7447f7ce-e1e7-4e03-bc32-f8474a155fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_19218867-509e-445b-a2e8-f539cd7f56dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7447f7ce-e1e7-4e03-bc32-f8474a155fd3" xlink:to="loc_us-gaap_InventoryRawMaterials_19218867-509e-445b-a2e8-f539cd7f56dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_6b81949b-12ed-44c5-9c9a-546fba3babb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7447f7ce-e1e7-4e03-bc32-f8474a155fd3" xlink:to="loc_us-gaap_InventoryWorkInProcess_6b81949b-12ed-44c5-9c9a-546fba3babb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_37faf18b-32c5-46d5-b489-bbde9f127af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7447f7ce-e1e7-4e03-bc32-f8474a155fd3" xlink:to="loc_us-gaap_InventoryFinishedGoods_37faf18b-32c5-46d5-b489-bbde9f127af9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cf60f2cc-ea63-4b43-a1a3-4c564806aa4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_30905623-1153-4588-8ec4-f165de74f383" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_cf60f2cc-ea63-4b43-a1a3-4c564806aa4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_30905623-1153-4588-8ec4-f165de74f383" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_64cde7f2-643d-41d9-ba52-b471c87deacd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_cf60f2cc-ea63-4b43-a1a3-4c564806aa4f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_64cde7f2-643d-41d9-ba52-b471c87deacd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7a7db21a-6df8-4a4d-98e8-c733fe7ad7da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_4eb1128b-2461-4377-b9ef-9453b27f35e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7a7db21a-6df8-4a4d-98e8-c733fe7ad7da" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_4eb1128b-2461-4377-b9ef-9453b27f35e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostMethodEquityInvestments_f7f01c1a-8e16-42b8-8d19-29256638a1d5" xlink:href="holx-20210925.xsd#holx_CostMethodEquityInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7a7db21a-6df8-4a4d-98e8-c733fe7ad7da" xlink:to="loc_holx_CostMethodEquityInvestments_f7f01c1a-8e16-42b8-8d19-29256638a1d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_15aa49b2-57b9-4ee3-a3b1-bd6e8740b34c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7a7db21a-6df8-4a4d-98e8-c733fe7ad7da" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_15aa49b2-57b9-4ee3-a3b1-bd6e8740b34c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_d166fab6-23d2-4484-9a4e-62ce68ce4fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7a7db21a-6df8-4a4d-98e8-c733fe7ad7da" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_d166fab6-23d2-4484-9a4e-62ce68ce4fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_728da837-7f94-4b8c-80d5-7aa22b0e9b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7a7db21a-6df8-4a4d-98e8-c733fe7ad7da" xlink:to="loc_us-gaap_IncomeTaxReceivable_728da837-7f94-4b8c-80d5-7aa22b0e9b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6e8ce647-7096-4aec-97e2-fc026a70c0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_7a7db21a-6df8-4a4d-98e8-c733fe7ad7da" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6e8ce647-7096-4aec-97e2-fc026a70c0ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_65e97aca-4468-4028-8ca3-d3ab86f0919d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9bc0604d-4bf8-43e9-9174-8717b548163d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_65e97aca-4468-4028-8ca3-d3ab86f0919d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9bc0604d-4bf8-43e9-9174-8717b548163d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_d409c701-e818-4f76-a889-1ef6cca51453" xlink:href="holx-20210925.xsd#holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_65e97aca-4468-4028-8ca3-d3ab86f0919d" xlink:to="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_d409c701-e818-4f76-a889-1ef6cca51453" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_b89ce517-20e4-4bd5-b7ba-ce9aa95b7626" xlink:href="holx-20210925.xsd#holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_51bf66fd-c175-4641-9035-636f8a025832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_b89ce517-20e4-4bd5-b7ba-ce9aa95b7626" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_51bf66fd-c175-4641-9035-636f8a025832" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_ee1d6bfd-63e2-4bf6-b58d-ff17f213bfd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_b89ce517-20e4-4bd5-b7ba-ce9aa95b7626" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_ee1d6bfd-63e2-4bf6-b58d-ff17f213bfd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_103f9960-79e0-4477-9f4f-48ead6bcc07f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_b89ce517-20e4-4bd5-b7ba-ce9aa95b7626" xlink:to="loc_us-gaap_OperatingLeasePayments_103f9960-79e0-4477-9f4f-48ead6bcc07f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesLeaseLiabilityMaturitySchedule2020Details"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_83b2dca1-7add-4853-95bd-7f74ab50a9eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8963311e-4b76-48b9-8197-fe3d89548c78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_83b2dca1-7add-4853-95bd-7f74ab50a9eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8963311e-4b76-48b9-8197-fe3d89548c78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ad70da35-4a41-403c-af14-680a42fa1543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_83b2dca1-7add-4853-95bd-7f74ab50a9eb" xlink:to="loc_us-gaap_OperatingLeaseLiability_ad70da35-4a41-403c-af14-680a42fa1543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_417145c4-22d0-4ab1-804d-00b1bf017545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_5f14e0d7-f66d-4e08-a258-493a65d6b507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_417145c4-22d0-4ab1-804d-00b1bf017545" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_5f14e0d7-f66d-4e08-a258-493a65d6b507" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c3cfc5d2-1f91-4150-b7b4-e5b5158603e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_417145c4-22d0-4ab1-804d-00b1bf017545" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c3cfc5d2-1f91-4150-b7b4-e5b5158603e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e4ec46c4-066d-4f18-877a-469b5418a4ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_417145c4-22d0-4ab1-804d-00b1bf017545" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e4ec46c4-066d-4f18-877a-469b5418a4ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_7254904b-d215-4bbe-bafa-035e144692cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_417145c4-22d0-4ab1-804d-00b1bf017545" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_7254904b-d215-4bbe-bafa-035e144692cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fe821828-a90f-421a-8c93-34749fe1332e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_417145c4-22d0-4ab1-804d-00b1bf017545" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fe821828-a90f-421a-8c93-34749fe1332e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_3554e6a0-fec2-46d5-a150-8ab68137985b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_417145c4-22d0-4ab1-804d-00b1bf017545" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_3554e6a0-fec2-46d5-a150-8ab68137985b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesLeaseLiabilityMaturitySchedule2020Details_1"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5df61bd8-6f2f-4a41-a639-914997785c08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_99be9954-6a37-438a-8eaf-d4d9851a95b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5df61bd8-6f2f-4a41-a639-914997785c08" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_99be9954-6a37-438a-8eaf-d4d9851a95b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_36406395-bd9d-4cd0-b6f9-08323e3a07c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5df61bd8-6f2f-4a41-a639-914997785c08" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_36406395-bd9d-4cd0-b6f9-08323e3a07c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5db86b5a-4224-4738-8555-1e51debcee9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5df61bd8-6f2f-4a41-a639-914997785c08" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5db86b5a-4224-4738-8555-1e51debcee9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_aac7fec6-172f-402b-9a68-b453ac2c211c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5df61bd8-6f2f-4a41-a639-914997785c08" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_aac7fec6-172f-402b-9a68-b453ac2c211c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_077f0af6-962f-4b85-857a-701ad80848f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5df61bd8-6f2f-4a41-a639-914997785c08" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_077f0af6-962f-4b85-857a-701ad80848f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_06c6fee7-bcbe-4b4e-9785-2800ee4e4e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5df61bd8-6f2f-4a41-a639-914997785c08" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_06c6fee7-bcbe-4b4e-9785-2800ee4e4e26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_46217209-968c-447e-a057-d3a02102eac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_a2bce750-848c-4f87-9971-28e89fb361cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_46217209-968c-447e-a057-d3a02102eac0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_a2bce750-848c-4f87-9971-28e89fb361cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_66bedf92-c486-4144-8596-64a97948cd29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_46217209-968c-447e-a057-d3a02102eac0" xlink:to="loc_us-gaap_FinanceLeaseLiability_66bedf92-c486-4144-8596-64a97948cd29" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f54aae92-943e-46b5-8a86-3665959bb608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f54aae92-943e-46b5-8a86-3665959bb608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a389ef4f-2b4f-44e8-9c21-11798faf66e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a389ef4f-2b4f-44e8-9c21-11798faf66e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4de780fe-7ef5-4ef4-be42-bbe09e38e671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4de780fe-7ef5-4ef4-be42-bbe09e38e671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_28b5b351-15a7-4d6b-82e6-81bb9d79c7eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_28b5b351-15a7-4d6b-82e6-81bb9d79c7eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_896d42db-9032-4c25-9afc-7e747fcce7e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_896d42db-9032-4c25-9afc-7e747fcce7e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_9e76ff5b-4f25-472b-a3ac-33f9add0935a" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_9e76ff5b-4f25-472b-a3ac-33f9add0935a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6fc976bf-ace1-4934-abdd-f12e17b369c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_6fc976bf-ace1-4934-abdd-f12e17b369c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4ebfbb4f-5d07-404e-91b6-a1635c46adc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_4ebfbb4f-5d07-404e-91b6-a1635c46adc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_d628ff56-0d97-4e99-945d-c7ce07f996ae" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_d628ff56-0d97-4e99-945d-c7ce07f996ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_89d5d3b4-8c55-4a78-b087-31b039ff5fd7" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_89d5d3b4-8c55-4a78-b087-31b039ff5fd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ff3b6a90-d441-42af-8f1d-7542079ef45f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_Goodwill_ff3b6a90-d441-42af-8f1d-7542079ef45f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_86a1f318-f285-4fba-bae1-26c47c7c5b82" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_86a1f318-f285-4fba-bae1-26c47c7c5b82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_06eb9115-4f76-4dcd-83e8-201d4559a46e" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_06eb9115-4f76-4dcd-83e8-201d4559a46e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c97a327c-708a-4db7-8a29-5b5fa5d15715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_c97a327c-708a-4db7-8a29-5b5fa5d15715" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_fb3cda33-8ca5-4ca3-9bc2-a62a114521c4" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_fb3cda33-8ca5-4ca3-9bc2-a62a114521c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_15f5d24c-bf95-4c2e-b9f4-d90843cdf0eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_592fb844-7abc-4cb2-95c7-910d54adc873" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_15f5d24c-bf95-4c2e-b9f4-d90843cdf0eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_eafb77bb-1048-49f6-b274-459f50fbc2d4" xlink:href="holx-20210925.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_af98278a-7cfb-490a-aa25-26fe9526863d" xlink:href="holx-20210925.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_eafb77bb-1048-49f6-b274-459f50fbc2d4" xlink:to="loc_holx_ReductionOfWorkforceExpenses_af98278a-7cfb-490a-aa25-26fe9526863d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_e1795e6a-a739-4da3-8393-062338ff596b" xlink:href="holx-20210925.xsd#holx_FacilityClosureCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_eafb77bb-1048-49f6-b274-459f50fbc2d4" xlink:to="loc_holx_FacilityClosureCosts_e1795e6a-a739-4da3-8393-062338ff596b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_3100599e-0a2f-4302-8b28-99ef18dcea35" xlink:href="holx-20210925.xsd#holx_DivestitureCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_eafb77bb-1048-49f6-b274-459f50fbc2d4" xlink:to="loc_holx_DivestitureCharges_3100599e-0a2f-4302-8b28-99ef18dcea35" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c2693998-99ec-4a79-b2b9-6d8766e57950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4aef06da-49a4-4952-8ff6-acda890a231c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c2693998-99ec-4a79-b2b9-6d8766e57950" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4aef06da-49a4-4952-8ff6-acda890a231c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_22ee2669-44e8-4b2c-ab90-0dd643c3b3d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c2693998-99ec-4a79-b2b9-6d8766e57950" xlink:to="loc_us-gaap_LongTermDebtCurrent_22ee2669-44e8-4b2c-ab90-0dd643c3b3d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_adec3a8d-b3fc-4e6b-afca-27b9ffafa8f8" xlink:href="holx-20210925.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c2693998-99ec-4a79-b2b9-6d8766e57950" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_adec3a8d-b3fc-4e6b-afca-27b9ffafa8f8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_83032f12-255b-4e78-a2fe-319ff01c0e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_85eda315-d557-4860-9e70-20ebb9bbebaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_83032f12-255b-4e78-a2fe-319ff01c0e20" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_85eda315-d557-4860-9e70-20ebb9bbebaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d1b328e1-fc94-4f21-a9d0-945a710400ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_83032f12-255b-4e78-a2fe-319ff01c0e20" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d1b328e1-fc94-4f21-a9d0-945a710400ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4a58417a-cac9-4435-9943-00513252c303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_83032f12-255b-4e78-a2fe-319ff01c0e20" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_4a58417a-cac9-4435-9943-00513252c303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f2450de3-044c-498f-af88-cd6c38611172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_83032f12-255b-4e78-a2fe-319ff01c0e20" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_f2450de3-044c-498f-af88-cd6c38611172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_213ecd49-2cc6-41bd-b81c-f0aec931a540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_83032f12-255b-4e78-a2fe-319ff01c0e20" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_213ecd49-2cc6-41bd-b81c-f0aec931a540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_4323d0bf-04af-4da3-93a0-b3d48a641a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_83032f12-255b-4e78-a2fe-319ff01c0e20" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_4323d0bf-04af-4da3-93a0-b3d48a641a31" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d1fc1468-4b70-4b68-9cb4-e58160bfa8f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9d8c3abf-009d-4f73-9c23-ed0094a2b9a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d1fc1468-4b70-4b68-9cb4-e58160bfa8f5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9d8c3abf-009d-4f73-9c23-ed0094a2b9a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_144dd726-7f97-413f-8ffc-464440ae5d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d1fc1468-4b70-4b68-9cb4-e58160bfa8f5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_144dd726-7f97-413f-8ffc-464440ae5d3d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesProvisionforIncomeTaxesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_b9d6e96c-3fc5-436d-b7b7-8f8b0a415854" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ced5505a-e4b5-4cc4-823a-0554d14a448f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_b9d6e96c-3fc5-436d-b7b7-8f8b0a415854" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ced5505a-e4b5-4cc4-823a-0554d14a448f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b8ec8b42-6423-4423-a190-93f53a18ee97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_b9d6e96c-3fc5-436d-b7b7-8f8b0a415854" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b8ec8b42-6423-4423-a190-93f53a18ee97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_a7169948-ac80-43f7-b254-14a80056ce4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2b1d8bb7-16a5-4681-8711-868efd43c5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_a7169948-ac80-43f7-b254-14a80056ce4b" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2b1d8bb7-16a5-4681-8711-868efd43c5a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3939ca6c-ad27-4aa9-a9e2-ed72c8bdc30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_a7169948-ac80-43f7-b254-14a80056ce4b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3939ca6c-ad27-4aa9-a9e2-ed72c8bdc30d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d3f6c438-21e3-41a3-80de-04d975af8ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_829aa234-ef59-40d3-93aa-f8c39b8ec323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d3f6c438-21e3-41a3-80de-04d975af8ab8" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_829aa234-ef59-40d3-93aa-f8c39b8ec323" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_aa71048e-32ba-4dbf-bb23-94212e3a6ed9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d3f6c438-21e3-41a3-80de-04d975af8ab8" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_aa71048e-32ba-4dbf-bb23-94212e3a6ed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_b621cdd2-b391-45f7-8c75-b6ef559637da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d3f6c438-21e3-41a3-80de-04d975af8ab8" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_b621cdd2-b391-45f7-8c75-b6ef559637da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_c212c375-b362-444a-962d-76cd5c7214df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ea4bfe88-d0cd-4e79-a01a-d7b7581d7691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_c212c375-b362-444a-962d-76cd5c7214df" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ea4bfe88-d0cd-4e79-a01a-d7b7581d7691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c0f5c1b6-d840-4e18-a7d1-cece5999925d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_c212c375-b362-444a-962d-76cd5c7214df" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_c0f5c1b6-d840-4e18-a7d1-cece5999925d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a54c58cc-d99c-47d8-89b5-08a163522f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a54c58cc-d99c-47d8-89b5-08a163522f39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_67466707-a906-4d27-bcbc-bc1de0dde1d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_67466707-a906-4d27-bcbc-bc1de0dde1d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_083abf0f-a1ca-468e-9212-51c508d9ad83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_083abf0f-a1ca-468e-9212-51c508d9ad83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_dab25c80-6402-4f7b-b42e-080bbc8c6f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_dab25c80-6402-4f7b-b42e-080bbc8c6f2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_a8920c07-80ec-4075-b51d-f9e5cb18ff9e" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_a8920c07-80ec-4075-b51d-f9e5cb18ff9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_24ca15a0-1b60-43d5-a96c-2c2e2cc39d81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_24ca15a0-1b60-43d5-a96c-2c2e2cc39d81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_38dc1b3e-1864-4273-9feb-0b1afd9580d8" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_38dc1b3e-1864-4273-9feb-0b1afd9580d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_b01daf63-5368-40d3-a7e9-e00e74f078d0" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_b01daf63-5368-40d3-a7e9-e00e74f078d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_05426e93-51a6-40e5-8cd2-a1b5537eef0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_05426e93-51a6-40e5-8cd2-a1b5537eef0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_2a47dc57-cd2c-43c0-968a-887a9d5fb116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_2a47dc57-cd2c-43c0-968a-887a9d5fb116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_eb4ae17c-bc25-4352-8017-df82b5af4295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_eb4ae17c-bc25-4352-8017-df82b5af4295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5aa0cd21-096e-40fc-bcb4-8034b5c2329e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5aa0cd21-096e-40fc-bcb4-8034b5c2329e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_6965b5e5-5375-4647-a93a-dd641b55aed3" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cf6f4d57-dd5b-42e4-9141-675f56ed485e" xlink:to="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_6965b5e5-5375-4647-a93a-dd641b55aed3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_ac36c252-2837-4bbe-bb58-6b4158bbda54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_19cb9954-841c-4448-a112-f9cc3370ca9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_ac36c252-2837-4bbe-bb58-6b4158bbda54" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_19cb9954-841c-4448-a112-f9cc3370ca9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_240cd8fc-6e20-4479-9d1a-bfe77047f7e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_ac36c252-2837-4bbe-bb58-6b4158bbda54" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_240cd8fc-6e20-4479-9d1a-bfe77047f7e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_8de5a003-b458-461f-af6c-6bb959a9233f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_cef94156-7ee0-4304-81ea-e16387e36bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_8de5a003-b458-461f-af6c-6bb959a9233f" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_cef94156-7ee0-4304-81ea-e16387e36bdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_fd61a48c-a328-4613-be05-e38f2d359405" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_8de5a003-b458-461f-af6c-6bb959a9233f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_fd61a48c-a328-4613-be05-e38f2d359405" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c7f3a9f4-2bec-43e4-99b0-a28bd6b89464" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c7f3a9f4-2bec-43e4-99b0-a28bd6b89464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_bfb307b5-06c7-4773-b15c-ebd83b8c94c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_bfb307b5-06c7-4773-b15c-ebd83b8c94c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_bc7e2214-f13c-4d2f-98b4-311c730273cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_bc7e2214-f13c-4d2f-98b4-311c730273cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_3ae8bcc6-0f03-40a0-af4b-99ff40e68fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_3ae8bcc6-0f03-40a0-af4b-99ff40e68fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_dfbc3677-f178-477a-9941-7feb06ea4367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_dfbc3677-f178-477a-9941-7feb06ea4367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5cc5fadf-ca50-492e-872b-ff7ce125a72e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_5cc5fadf-ca50-492e-872b-ff7ce125a72e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_c14cb5bb-e30e-418f-abc1-c55fd37efc40" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:to="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_c14cb5bb-e30e-418f-abc1-c55fd37efc40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_c8eee3ef-52a0-4365-886d-18cb1911cabe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_c8eee3ef-52a0-4365-886d-18cb1911cabe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsLeaseLiability_a35957df-724c-4c8f-bb65-9d629027e599" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsLeaseLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b480cf9a-9f20-480e-af13-f26571919bd3" xlink:to="loc_holx_DeferredTaxAssetsLeaseLiability_a35957df-724c-4c8f-bb65-9d629027e599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a93f509a-077d-41c3-8c9e-43835320d309" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_47be6e59-2f7f-4ee8-9898-49acac8cecb3" xlink:href="holx-20210925.xsd#holx_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_a93f509a-077d-41c3-8c9e-43835320d309" xlink:to="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_47be6e59-2f7f-4ee8-9898-49acac8cecb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset_7fa3af41-2c4c-4405-8264-5e655822145d" xlink:href="holx-20210925.xsd#holx_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_a93f509a-077d-41c3-8c9e-43835320d309" xlink:to="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset_7fa3af41-2c4c-4405-8264-5e655822145d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_c5db9853-526a-445b-9afb-dbf75af4dd39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_abaab187-2cc9-4c07-814d-b399eddb6594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_c5db9853-526a-445b-9afb-dbf75af4dd39" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_abaab187-2cc9-4c07-814d-b399eddb6594" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_b9a8c014-b362-4819-bba5-0574e6a03ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_c5db9853-526a-445b-9afb-dbf75af4dd39" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_b9a8c014-b362-4819-bba5-0574e6a03ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_756fd881-57da-4f7d-a2fa-1337ce221106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_c5db9853-526a-445b-9afb-dbf75af4dd39" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_756fd881-57da-4f7d-a2fa-1337ce221106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_372385ff-efc7-4103-b5cc-eb1bacca31df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_c5db9853-526a-445b-9afb-dbf75af4dd39" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_372385ff-efc7-4103-b5cc-eb1bacca31df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_b54c0030-576b-4cea-8d81-8e03fb2ee995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_c5db9853-526a-445b-9afb-dbf75af4dd39" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_b54c0030-576b-4cea-8d81-8e03fb2ee995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseobligationthereafter_105e29f7-115c-4eef-82e3-b9a1748c25a8" xlink:href="holx-20210925.xsd#holx_Purchaseobligationthereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_c5db9853-526a-445b-9afb-dbf75af4dd39" xlink:to="loc_holx_Purchaseobligationthereafter_105e29f7-115c-4eef-82e3-b9a1748c25a8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_142cef00-23f5-4b03-a111-4eccc5657f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_7ce1394f-189b-4ddb-bf97-1abe9ecdbd5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_142cef00-23f5-4b03-a111-4eccc5657f1e" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_7ce1394f-189b-4ddb-bf97-1abe9ecdbd5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedIncomeAndOtherTaxes_9d54695e-a6c3-4866-b73a-50b92387b173" xlink:href="holx-20210925.xsd#holx_AccruedIncomeAndOtherTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_142cef00-23f5-4b03-a111-4eccc5657f1e" xlink:to="loc_holx_AccruedIncomeAndOtherTaxes_9d54695e-a6c3-4866-b73a-50b92387b173" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2622cb14-bbfe-4bf5-af8d-3d1a24855215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_142cef00-23f5-4b03-a111-4eccc5657f1e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2622cb14-bbfe-4bf5-af8d-3d1a24855215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_deb5994b-feae-42c8-849a-836adc4b8a3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_142cef00-23f5-4b03-a111-4eccc5657f1e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_deb5994b-feae-42c8-849a-836adc4b8a3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedInterest_716b1792-9c08-4d19-8b00-a6b2d8483252" xlink:href="holx-20210925.xsd#holx_AccruedInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_142cef00-23f5-4b03-a111-4eccc5657f1e" xlink:to="loc_holx_AccruedInterest_716b1792-9c08-4d19-8b00-a6b2d8483252" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_05cf6925-649f-46b5-9948-bf259e8d4074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_4c3dde57-398c-4af6-a80a-9f359c633439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_05cf6925-649f-46b5-9948-bf259e8d4074" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_4c3dde57-398c-4af6-a80a-9f359c633439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_8e69666d-e1c2-4363-bccb-129f90581dfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_05cf6925-649f-46b5-9948-bf259e8d4074" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_8e69666d-e1c2-4363-bccb-129f90581dfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_8cc1a422-c894-4f89-9a11-affebab6478c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_05cf6925-649f-46b5-9948-bf259e8d4074" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_8cc1a422-c894-4f89-9a11-affebab6478c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_4ee537cf-146f-405f-ac8e-3210c332ce99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_05cf6925-649f-46b5-9948-bf259e8d4074" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_4ee537cf-146f-405f-ac8e-3210c332ce99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2b3b1929-3f12-4e3b-ae43-b558f636346f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_05cf6925-649f-46b5-9948-bf259e8d4074" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_2b3b1929-3f12-4e3b-ae43-b558f636346f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d909a7be-06e2-4947-9679-5ba85ad8c246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_05cf6925-649f-46b5-9948-bf259e8d4074" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d909a7be-06e2-4947-9679-5ba85ad8c246" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_500607c8-d881-4e68-a660-f38ffcb8a5f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_a7bc3c3d-e20a-41e4-8750-f22a110dcdea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_500607c8-d881-4e68-a660-f38ffcb8a5f8" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_a7bc3c3d-e20a-41e4-8750-f22a110dcdea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f4b51bd2-305b-4384-9e89-33aa88fcd948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_500607c8-d881-4e68-a660-f38ffcb8a5f8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f4b51bd2-305b-4384-9e89-33aa88fcd948" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_201e1158-93d2-40f6-844a-73c8ea4c3079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_43741d44-1a02-40eb-b740-1071dfd2cbde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_201e1158-93d2-40f6-844a-73c8ea4c3079" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_43741d44-1a02-40eb-b740-1071dfd2cbde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost_edd0daaf-4098-4eaf-b78f-983448f0c4ff" xlink:href="holx-20210925.xsd#holx_ComponentsofNetPeriodicBenefitCostInterestcost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_201e1158-93d2-40f6-844a-73c8ea4c3079" xlink:to="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost_edd0daaf-4098-4eaf-b78f-983448f0c4ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_35d662c2-3b4f-46db-89f4-3244333f344d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_201e1158-93d2-40f6-844a-73c8ea4c3079" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_35d662c2-3b4f-46db-89f4-3244333f344d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_16d02f5f-2e3f-479b-b0c1-038af8041919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_201e1158-93d2-40f6-844a-73c8ea4c3079" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_16d02f5f-2e3f-479b-b0c1-038af8041919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_e3fe7e3a-1e63-4df1-8fdc-6dc49502abc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_201e1158-93d2-40f6-844a-73c8ea4c3079" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_e3fe7e3a-1e63-4df1-8fdc-6dc49502abc3" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>holx-20210925_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fe647887-7476-401d-8075-31ce3ecd561d,g:aafd6a0b-1c31-49b5-81b9-4feb5a12e92f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended" id="i296cd8fd849048b7830026d11fab871a_ConsolidatedStatementsofIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6e3df2f2-a8d6-4487-92f1-7dbe6f7b4410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_RevenuesAbstract_6e3df2f2-a8d6-4487-92f1-7dbe6f7b4410" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7852313f-4365-4a96-a909-667ac70af9af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_6e3df2f2-a8d6-4487-92f1-7dbe6f7b4410" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7852313f-4365-4a96-a909-667ac70af9af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1b1617d5-5813-4e8f-b42f-32949772b5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1b1617d5-5813-4e8f-b42f-32949772b5ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_62d8c2bb-13b2-4eb2-9637-cc0c31bc2103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_62d8c2bb-13b2-4eb2-9637-cc0c31bc2103" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_de2cb998-7c03-43ea-97cb-ff7ca9117d30" xlink:href="holx-20210925.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_de2cb998-7c03-43ea-97cb-ff7ca9117d30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4295010d-c35d-4f94-b296-489dc362f0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_GrossProfit_4295010d-c35d-4f94-b296-489dc362f0b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2f9df1b6-93ee-4fce-96ad-ceb0aeb6f302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2f9df1b6-93ee-4fce-96ad-ceb0aeb6f302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_89e50181-c0df-433d-907a-eb3b8a4dd456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_89e50181-c0df-433d-907a-eb3b8a4dd456" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_832c94b9-22b2-4e8c-9fe1-6790a1cd4ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_832c94b9-22b2-4e8c-9fe1-6790a1cd4ea3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1ca152a2-4a2f-4662-b77a-22135da2f66a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1ca152a2-4a2f-4662-b77a-22135da2f66a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4cff905f-20f0-4370-9420-23e9fed4217b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4cff905f-20f0-4370-9420-23e9fed4217b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_7d13d41d-4cc4-48ac-b6c9-11311bc86011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_7d13d41d-4cc4-48ac-b6c9-11311bc86011" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_69a1ea9a-3169-4dad-81a2-586b25e54657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_RestructuringCharges_69a1ea9a-3169-4dad-81a2-586b25e54657" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6946aad7-959c-4b3d-9e3f-538fc116dbcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_OperatingExpenses_6946aad7-959c-4b3d-9e3f-538fc116dbcb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7a78d1a5-5c7d-41a0-a167-67c0d3d80135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_OperatingIncomeLoss_7a78d1a5-5c7d-41a0-a167-67c0d3d80135" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3354fc44-6a8d-4b19-a0cd-5404c83e35bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3354fc44-6a8d-4b19-a0cd-5404c83e35bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b7743694-3877-4943-b27a-809f140785ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_InterestExpense_b7743694-3877-4943-b27a-809f140785ee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3801395c-468d-480c-9111-6507ba8e2e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3801395c-468d-480c-9111-6507ba8e2e4e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_07408105-8dd6-482e-9bd7-1d65c160f3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_07408105-8dd6-482e-9bd7-1d65c160f3d9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af4c4ffa-8ea4-408c-9a24-3a864b027a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af4c4ffa-8ea4-408c-9a24-3a864b027a1a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f3573f2c-da8a-4583-8b37-c2a372292723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f3573f2c-da8a-4583-8b37-c2a372292723" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a09b55a9-d2fd-44b7-b5bf-35809c6fa788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_ProfitLoss_a09b55a9-d2fd-44b7-b5bf-35809c6fa788" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_b40d574d-9378-483f-9102-e9dbc9f9947a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_b40d574d-9378-483f-9102-e9dbc9f9947a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b25fbb04-381f-4c1b-8217-3b3970c4a3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_NetIncomeLoss_b25fbb04-381f-4c1b-8217-3b3970c4a3f9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f717bb79-9424-4efa-988e-ee28fcc1784c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_EarningsPerShareAbstract_f717bb79-9424-4efa-988e-ee28fcc1784c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8870c2cb-3cb9-4029-a374-dc0d5a341bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f717bb79-9424-4efa-988e-ee28fcc1784c" xlink:to="loc_us-gaap_EarningsPerShareBasic_8870c2cb-3cb9-4029-a374-dc0d5a341bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_39d67a09-faf2-410e-a5dd-00c2492bfcff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f717bb79-9424-4efa-988e-ee28fcc1784c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_39d67a09-faf2-410e-a5dd-00c2492bfcff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e3593f1e-ba7c-4a8a-aaec-07562b4e0f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e3593f1e-ba7c-4a8a-aaec-07562b4e0f94" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3d61cb1c-bc60-4412-bc5e-e42ae3296a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e3593f1e-ba7c-4a8a-aaec-07562b4e0f94" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3d61cb1c-bc60-4412-bc5e-e42ae3296a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d918c9a8-51a4-4960-9489-5b5db475abd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e3593f1e-ba7c-4a8a-aaec-07562b4e0f94" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d918c9a8-51a4-4960-9489-5b5db475abd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e3ccae6d-bcf2-44ec-9af5-9e1692e1dc42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_StatementTable_e3ccae6d-bcf2-44ec-9af5-9e1692e1dc42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_670b287a-cace-4f9f-9181-5f4300a1e138" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e3ccae6d-bcf2-44ec-9af5-9e1692e1dc42" xlink:to="loc_srt_ProductOrServiceAxis_670b287a-cace-4f9f-9181-5f4300a1e138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_670b287a-cace-4f9f-9181-5f4300a1e138_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_670b287a-cace-4f9f-9181-5f4300a1e138" xlink:to="loc_srt_ProductsAndServicesDomain_670b287a-cace-4f9f-9181-5f4300a1e138_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_67e766fb-1ed7-4af5-8502-ae5cb9e26b74" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_670b287a-cace-4f9f-9181-5f4300a1e138" xlink:to="loc_srt_ProductsAndServicesDomain_67e766fb-1ed7-4af5-8502-ae5cb9e26b74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_2c1977b6-0868-4af3-b277-89f22b3de3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_67e766fb-1ed7-4af5-8502-ae5cb9e26b74" xlink:to="loc_us-gaap_ProductMember_2c1977b6-0868-4af3-b277-89f22b3de3f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_30f89f5e-b7d3-4a6f-bf78-5a74bb9ad637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_67e766fb-1ed7-4af5-8502-ae5cb9e26b74" xlink:to="loc_us-gaap_ServiceMember_30f89f5e-b7d3-4a6f-bf78-5a74bb9ad637" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="i2ddedb89830444749a936770ef2fe843_ConsolidatedStatementsofComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_44adb336-72fa-47ea-8eb7-ecee012cc380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_ProfitLoss_44adb336-72fa-47ea-8eb7-ecee012cc380" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_25cc392a-ee05-4138-b7f5-709c7096c2b4" xlink:href="holx-20210925.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_25cc392a-ee05-4138-b7f5-709c7096c2b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_66f40bdd-30de-459e-a230-7031f50bc770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_66f40bdd-30de-459e-a230-7031f50bc770" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_709f8d28-cf7b-49bf-90f4-3c07098760cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_709f8d28-cf7b-49bf-90f4-3c07098760cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_14133418-e8c1-45f0-854e-66f5c753a847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_14133418-e8c1-45f0-854e-66f5c753a847" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1a3a0bb8-e374-467e-bdb4-b0a069868e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1a3a0bb8-e374-467e-bdb4-b0a069868e30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_64b2f0b9-7f70-42a0-978b-2f2b6d276c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_64b2f0b9-7f70-42a0-978b-2f2b6d276c97" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c405e8cb-c066-4434-8073-9a2a61acfd70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c405e8cb-c066-4434-8073-9a2a61acfd70" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_6fd4975e-cbc1-400a-a8e1-909d550a2521" xlink:href="holx-20210925.xsd#holx_ComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_holx_ComprehensiveIncome_6fd4975e-cbc1-400a-a8e1-909d550a2521" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2640fb32-146e-4653-930b-a154c54039d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_StatementTable_2640fb32-146e-4653-930b-a154c54039d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca5f75cb-8864-4a24-9777-976aec753ef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2640fb32-146e-4653-930b-a154c54039d3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca5f75cb-8864-4a24-9777-976aec753ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca5f75cb-8864-4a24-9777-976aec753ef9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca5f75cb-8864-4a24-9777-976aec753ef9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca5f75cb-8864-4a24-9777-976aec753ef9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ecb6bd1d-3c73-4fa7-bcb7-c3fb2f35caa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca5f75cb-8864-4a24-9777-976aec753ef9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ecb6bd1d-3c73-4fa7-bcb7-c3fb2f35caa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6180134a-26d0-45a9-977c-0df31cb07a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ecb6bd1d-3c73-4fa7-bcb7-c3fb2f35caa7" xlink:to="loc_us-gaap_InterestRateSwapMember_6180134a-26d0-45a9-977c-0df31cb07a8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f481c65a-a9ff-4a48-b41d-376afdfc8bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2640fb32-146e-4653-930b-a154c54039d3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f481c65a-a9ff-4a48-b41d-376afdfc8bc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f481c65a-a9ff-4a48-b41d-376afdfc8bc4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f481c65a-a9ff-4a48-b41d-376afdfc8bc4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f481c65a-a9ff-4a48-b41d-376afdfc8bc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_06260907-39cf-42e3-9bb7-f7d0cb0668de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f481c65a-a9ff-4a48-b41d-376afdfc8bc4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_06260907-39cf-42e3-9bb7-f7d0cb0668de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_7e268972-dedc-4930-86aa-748f2f42d1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06260907-39cf-42e3-9bb7-f7d0cb0668de" xlink:to="loc_us-gaap_InterestRateCapMember_7e268972-dedc-4930-86aa-748f2f42d1ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended" id="ic0dc43798a894719a795c2e63fc5bbe3_ConsolidatedStatementsofComprehensiveIncomeParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_23203d52-ce1c-461c-b795-2135851a228d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_23203d52-ce1c-461c-b795-2135851a228d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxOnInterestRateSwap_0e8c1b2f-f15c-4044-b3d7-c24ae879cd58" xlink:href="holx-20210925.xsd#holx_TaxOnInterestRateSwap"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:to="loc_holx_TaxOnInterestRateSwap_0e8c1b2f-f15c-4044-b3d7-c24ae879cd58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_b695111e-75cc-4510-acda-e68b0ef4f36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_b695111e-75cc-4510-acda-e68b0ef4f36b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0d3ce839-efe9-4596-95c0-dde98800405e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:to="loc_us-gaap_StatementTable_0d3ce839-efe9-4596-95c0-dde98800405e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_05b45d7f-b494-429d-b5bb-f68eebeeb76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0d3ce839-efe9-4596-95c0-dde98800405e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_05b45d7f-b494-429d-b5bb-f68eebeeb76e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_05b45d7f-b494-429d-b5bb-f68eebeeb76e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_05b45d7f-b494-429d-b5bb-f68eebeeb76e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_05b45d7f-b494-429d-b5bb-f68eebeeb76e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_feabeb2c-6f49-4bf4-a43c-48425cf6fc7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_05b45d7f-b494-429d-b5bb-f68eebeeb76e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_feabeb2c-6f49-4bf4-a43c-48425cf6fc7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_a668b3ea-13b2-49cd-818e-237626b7bbbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_feabeb2c-6f49-4bf4-a43c-48425cf6fc7b" xlink:to="loc_us-gaap_InterestRateCapMember_a668b3ea-13b2-49cd-818e-237626b7bbbc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="ic21eea57e56e4d33b903e5d1625e5737_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_185bd982-9b40-4862-a6e3-d5cca60e9d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_SharesIssued_185bd982-9b40-4862-a6e3-d5cca60e9d0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c9af530f-7b73-4567-9608-3004926a8188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c9af530f-7b73-4567-9608-3004926a8188" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASC606_eae75cce-9adf-4a4e-b880-bb8d8b44a8e7" xlink:href="holx-20210925.xsd#holx_AccountingstandardtransitionadjustmentASC606"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_holx_AccountingstandardtransitionadjustmentASC606_eae75cce-9adf-4a4e-b880-bb8d8b44a8e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASU201616_681ac588-dbd0-4ddc-b9a6-e2ba74e7ba2e" xlink:href="holx-20210925.xsd#holx_AccountingstandardtransitionadjustmentASU201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_holx_AccountingstandardtransitionadjustmentASU201616_681ac588-dbd0-4ddc-b9a6-e2ba74e7ba2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_50a4441b-5848-4b69-a402-c17673cd8558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_50a4441b-5848-4b69-a402-c17673cd8558" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cbff9c3b-4fe1-49f2-9403-13c0d7acc76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cbff9c3b-4fe1-49f2-9403-13c0d7acc76e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_173ad479-4eb0-4f2a-a60b-48e0c94411c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_173ad479-4eb0-4f2a-a60b-48e0c94411c3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2aa002e8-8253-4c0f-a690-a45170a2f074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2aa002e8-8253-4c0f-a690-a45170a2f074" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7bde8651-5a1d-4c97-b38c-b848b920a5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7bde8651-5a1d-4c97-b38c-b848b920a5ed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1f32e0da-ca88-4ef3-aecf-22314525a26e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1f32e0da-ca88-4ef3-aecf-22314525a26e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_189a60f0-0b81-48dc-ba82-72a13e61563c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_189a60f0-0b81-48dc-ba82-72a13e61563c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_33d7f30b-fff3-494c-843c-5f5c1f88412f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_33d7f30b-fff3-494c-843c-5f5c1f88412f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_53e6a31b-268c-4cbe-84d5-979c859694ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_53e6a31b-268c-4cbe-84d5-979c859694ca" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes_772ff123-f598-4830-8f58-f3776cf4f971" xlink:href="holx-20210925.xsd#holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes_772ff123-f598-4830-8f58-f3776cf4f971" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f73684e7-45ab-471c-b204-95341934897a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f73684e7-45ab-471c-b204-95341934897a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_a431ec67-b1ea-46cd-84c0-3c144a4644cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_a431ec67-b1ea-46cd-84c0-3c144a4644cc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1e973ea8-c2bd-4c98-8d59-692456d48774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1e973ea8-c2bd-4c98-8d59-692456d48774" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_df52c312-e8cd-4574-9043-5b04db6059e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_df52c312-e8cd-4574-9043-5b04db6059e2" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_76c77954-ebdd-4f27-ad49-6c8bb25273c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_ProfitLoss_76c77954-ebdd-4f27-ad49-6c8bb25273c4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_b7499979-c4ba-471c-acbc-f93daa0cacbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_b7499979-c4ba-471c-acbc-f93daa0cacbd" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingStandardTransitionAdjustmentASU842_cb7ae3b0-5afd-4053-90dc-1bac1ba707b6" xlink:href="holx-20210925.xsd#holx_AccountingStandardTransitionAdjustmentASU842"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_holx_AccountingStandardTransitionAdjustmentASU842_cb7ae3b0-5afd-4053-90dc-1bac1ba707b6" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_9f721c22-57c8-49fe-95a0-02a8e8cdefb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6f082675-7067-4166-be08-e4233394e044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_b7fca617-15e6-45ee-aaf1-9cf2288720f8" xlink:href="holx-20210925.xsd#holx_PurchaseOfNonControllingInterestReclassifiedToAPIC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_b7fca617-15e6-45ee-aaf1-9cf2288720f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue_e4c2aa09-22ad-45cb-b587-566ac536b6a1" xlink:href="holx-20210925.xsd#holx_ChangeInParValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_holx_ChangeInParValue_e4c2aa09-22ad-45cb-b587-566ac536b6a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax_b5daf5be-6923-4868-9140-e44f67b541fb" xlink:href="holx-20210925.xsd#holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax_b5daf5be-6923-4868-9140-e44f67b541fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_cf8fc8b2-93f4-4694-9fbd-8140eabca4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_cf8fc8b2-93f4-4694-9fbd-8140eabca4ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5202cc05-0e41-4676-903e-0d47505e0817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5202cc05-0e41-4676-903e-0d47505e0817" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5202cc05-0e41-4676-903e-0d47505e0817_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5202cc05-0e41-4676-903e-0d47505e0817" xlink:to="loc_us-gaap_EquityComponentDomain_5202cc05-0e41-4676-903e-0d47505e0817_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5202cc05-0e41-4676-903e-0d47505e0817" xlink:to="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0217f907-872a-41b1-b455-8216b5b2b180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_CommonStockMember_0217f907-872a-41b1-b455-8216b5b2b180" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f8f330f2-9b85-4d4b-b42f-e46190d02830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f8f330f2-9b85-4d4b-b42f-e46190d02830" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_efdc154d-988d-475b-a1c3-1066562494d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_RetainedEarningsMember_efdc154d-988d-475b-a1c3-1066562494d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dfc66aab-a508-4c79-b975-c344db211e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dfc66aab-a508-4c79-b975-c344db211e5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_cf5e1cdd-a78f-48ae-a4be-1474fb6ef8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_TreasuryStockMember_cf5e1cdd-a78f-48ae-a4be-1474fb6ef8e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ba911563-0fb1-49aa-b07e-dd71d369e783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ba911563-0fb1-49aa-b07e-dd71d369e783" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_4cf2b4b0-8620-4c77-9c4d-ff950eb31800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_4cf2b4b0-8620-4c77-9c4d-ff950eb31800" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_4cf2b4b0-8620-4c77-9c4d-ff950eb31800_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4cf2b4b0-8620-4c77-9c4d-ff950eb31800" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_4cf2b4b0-8620-4c77-9c4d-ff950eb31800_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_6c8a88c9-0c25-4237-b479-2ad49aaf243e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4cf2b4b0-8620-4c77-9c4d-ff950eb31800" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_6c8a88c9-0c25-4237-b479-2ad49aaf243e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_25216b50-a334-44c6-8310-76d2c248d308" xlink:href="holx-20210925.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_6c8a88c9-0c25-4237-b479-2ad49aaf243e" xlink:to="loc_holx_ShareRepurchaseProgramMember_25216b50-a334-44c6-8310-76d2c248d308" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_10f25e14-d435-4821-8afd-65f286f747ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_10f25e14-d435-4821-8afd-65f286f747ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_10f25e14-d435-4821-8afd-65f286f747ab_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_10f25e14-d435-4821-8afd-65f286f747ab" xlink:to="loc_us-gaap_TypeOfAdoptionMember_10f25e14-d435-4821-8afd-65f286f747ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fd8d71c2-2f37-4203-9622-800f228b0011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_10f25e14-d435-4821-8afd-65f286f747ab" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fd8d71c2-2f37-4203-9622-800f228b0011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_48719267-b6cf-45a1-a6da-757e13fe628b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_fd8d71c2-2f37-4203-9622-800f228b0011" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_48719267-b6cf-45a1-a6da-757e13fe628b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended" id="i901216be39b442539c2f5b63476c9872_SummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:href="holx-20210925.xsd#holx_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_87532e5e-d2c4-43e7-b5e7-37003ca083f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_AssetImpairmentCharges_87532e5e-d2c4-43e7-b5e7-37003ca083f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashEquivalentsMaturityPeriod_98016e86-1ab2-4d49-9308-347075b42574" xlink:href="holx-20210925.xsd#holx_CashEquivalentsMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_CashEquivalentsMaturityPeriod_98016e86-1ab2-4d49-9308-347075b42574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e2da357d-7756-4978-aa09-c4ccb6026893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e2da357d-7756-4978-aa09-c4ccb6026893" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_50a57f2c-6750-4c4d-bbb7-db9b71415b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_50a57f2c-6750-4c4d-bbb7-db9b71415b83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_da92a0db-5165-4808-a5da-8d4c0403135b" xlink:href="holx-20210925.xsd#holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_da92a0db-5165-4808-a5da-8d4c0403135b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_34704a47-d016-4c75-a492-0e8ba0019024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_34704a47-d016-4c75-a492-0e8ba0019024" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_73bdce36-d13c-41fc-85da-717b5738d4d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_73bdce36-d13c-41fc-85da-717b5738d4d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5366341-1c4c-4e72-8b93-17967fb2065d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5366341-1c4c-4e72-8b93-17967fb2065d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_20259ac3-06d2-4997-a47d-5a65d8772346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_Goodwill_20259ac3-06d2-4997-a47d-5a65d8772346" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_85f689f5-1457-44dd-843a-a2c8bd60cf60" xlink:href="holx-20210925.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_85f689f5-1457-44dd-843a-a2c8bd60cf60" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_f28c7841-eeb3-4b8a-833e-0977dec1b4c7" xlink:href="holx-20210925.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_PrincipalAmountOfBorrowings_f28c7841-eeb3-4b8a-833e-0977dec1b4c7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_b7899754-240b-4129-ab16-168791025c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_DerivativeTermOfContract_b7899754-240b-4129-ab16-168791025c3d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_5ee2988c-959b-41e7-a6d3-3ab1a6f3b31d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_5ee2988c-959b-41e7-a6d3-3ab1a6f3b31d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_254ad7ad-c5f0-4ea8-9ac8-6fda54e92577" xlink:href="holx-20210925.xsd#holx_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_NotionalAmount_254ad7ad-c5f0-4ea8-9ac8-6fda54e92577" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WarrantyTermForProducts_67a07805-5154-44c7-82d8-d5f563bfcd7b" xlink:href="holx-20210925.xsd#holx_WarrantyTermForProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_WarrantyTermForProducts_67a07805-5154-44c7-82d8-d5f563bfcd7b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_65b201db-22f7-4dea-9313-ea9d711a9fca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_AdvertisingExpense_65b201db-22f7-4dea-9313-ea9d711a9fca" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2ea50671-6d81-4107-87c5-1c43000c92cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2ea50671-6d81-4107-87c5-1c43000c92cc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_740283ed-fefa-49f6-9bd8-8a3593059f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_740283ed-fefa-49f6-9bd8-8a3593059f7f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_650e0500-4645-48d6-a99e-7556877b1480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_650e0500-4645-48d6-a99e-7556877b1480" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_96448040-17b3-426e-9d7c-f53672d85fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_96448040-17b3-426e-9d7c-f53672d85fc7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b108c910-63b9-44aa-bc1a-746e4901648d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b108c910-63b9-44aa-bc1a-746e4901648d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_5f05be4c-98fa-4515-b0e3-c1d751eeea6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8e4bd918-819e-4abe-bb3e-00ab51489f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8e4bd918-819e-4abe-bb3e-00ab51489f5b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:href="holx-20210925.xsd#holx_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f04d8eb5-2f7e-49b8-bc3d-f6c9ac3581f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f04d8eb5-2f7e-49b8-bc3d-f6c9ac3581f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f04d8eb5-2f7e-49b8-bc3d-f6c9ac3581f1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f04d8eb5-2f7e-49b8-bc3d-f6c9ac3581f1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f04d8eb5-2f7e-49b8-bc3d-f6c9ac3581f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e1fb5c1-d97f-4284-8f78-f2e76a13923d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f04d8eb5-2f7e-49b8-bc3d-f6c9ac3581f1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e1fb5c1-d97f-4284-8f78-f2e76a13923d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f5ee5d5c-cdd7-473a-bf10-06f7acde3d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e1fb5c1-d97f-4284-8f78-f2e76a13923d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f5ee5d5c-cdd7-473a-bf10-06f7acde3d64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_144871fd-f187-4308-9c56-256cc780b0dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e1fb5c1-d97f-4284-8f78-f2e76a13923d" xlink:to="loc_us-gaap_InterestRateCapMember_144871fd-f187-4308-9c56-256cc780b0dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e92f1a9a-2114-4003-b307-daf7bb7a123b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e92f1a9a-2114-4003-b307-daf7bb7a123b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e92f1a9a-2114-4003-b307-daf7bb7a123b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e92f1a9a-2114-4003-b307-daf7bb7a123b" xlink:to="loc_us-gaap_SegmentDomain_e92f1a9a-2114-4003-b307-daf7bb7a123b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fb78fd4f-f8af-4d80-89b7-e49a54a6227a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e92f1a9a-2114-4003-b307-daf7bb7a123b" xlink:to="loc_us-gaap_SegmentDomain_fb78fd4f-f8af-4d80-89b7-e49a54a6227a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_f3ae42b0-864e-4862-b138-2f9e687c9923" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fb78fd4f-f8af-4d80-89b7-e49a54a6227a" xlink:to="loc_holx_MedicalAestheticsMember_f3ae42b0-864e-4862-b138-2f9e687c9923" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d780c5d4-9ee5-4841-84b2-f93c93551924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d780c5d4-9ee5-4841-84b2-f93c93551924" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d780c5d4-9ee5-4841-84b2-f93c93551924_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d780c5d4-9ee5-4841-84b2-f93c93551924" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d780c5d4-9ee5-4841-84b2-f93c93551924_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74ebd22c-8e5e-4c8b-a3b0-86fe1217bd3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d780c5d4-9ee5-4841-84b2-f93c93551924" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74ebd22c-8e5e-4c8b-a3b0-86fe1217bd3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_f2d5f4ac-5327-458e-8f24-075d23c76d85" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74ebd22c-8e5e-4c8b-a3b0-86fe1217bd3b" xlink:to="loc_holx_AcessaHealthMember_f2d5f4ac-5327-458e-8f24-075d23c76d85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_8b2fc63e-7015-4d99-9965-4725753cdf7e" xlink:href="holx-20210925.xsd#holx_BolderSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74ebd22c-8e5e-4c8b-a3b0-86fe1217bd3b" xlink:to="loc_holx_BolderSurgicalMember_8b2fc63e-7015-4d99-9965-4725753cdf7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1005b9a1-b749-497c-b56f-9bd3d5d58e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1005b9a1-b749-497c-b56f-9bd3d5d58e00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1005b9a1-b749-497c-b56f-9bd3d5d58e00_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1005b9a1-b749-497c-b56f-9bd3d5d58e00" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1005b9a1-b749-497c-b56f-9bd3d5d58e00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5bdda01d-9926-43ba-9057-5dfe566ea1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1005b9a1-b749-497c-b56f-9bd3d5d58e00" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5bdda01d-9926-43ba-9057-5dfe566ea1b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c3b8817e-878c-4073-84d0-9faec6a77062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5bdda01d-9926-43ba-9057-5dfe566ea1b6" xlink:to="loc_us-gaap_InterestRateCapMember_c3b8817e-878c-4073-84d0-9faec6a77062" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_335150a9-6809-4e87-8ea8-5f3daea05874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5bdda01d-9926-43ba-9057-5dfe566ea1b6" xlink:to="loc_us-gaap_InterestRateSwapMember_335150a9-6809-4e87-8ea8-5f3daea05874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3b4233ff-0d22-44a5-933b-231bdc5028ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_srt_RangeAxis_3b4233ff-0d22-44a5-933b-231bdc5028ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b4233ff-0d22-44a5-933b-231bdc5028ea_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3b4233ff-0d22-44a5-933b-231bdc5028ea" xlink:to="loc_srt_RangeMember_3b4233ff-0d22-44a5-933b-231bdc5028ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f179bf83-6a9c-4396-a790-5c0456af81f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3b4233ff-0d22-44a5-933b-231bdc5028ea" xlink:to="loc_srt_RangeMember_f179bf83-6a9c-4396-a790-5c0456af81f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e8f5474a-f951-44df-9c22-07356a7ec4aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f179bf83-6a9c-4396-a790-5c0456af81f3" xlink:to="loc_srt_MinimumMember_e8f5474a-f951-44df-9c22-07356a7ec4aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_12135cf4-38ea-4e37-84bf-3d77232612ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f179bf83-6a9c-4396-a790-5c0456af81f3" xlink:to="loc_srt_MaximumMember_12135cf4-38ea-4e37-84bf-3d77232612ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_50cf09d8-b83a-4aeb-81cb-b49e65976ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_50cf09d8-b83a-4aeb-81cb-b49e65976ae0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_50cf09d8-b83a-4aeb-81cb-b49e65976ae0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_50cf09d8-b83a-4aeb-81cb-b49e65976ae0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_50cf09d8-b83a-4aeb-81cb-b49e65976ae0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6130bfef-518e-4964-a5d3-b3f71ed0d771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_50cf09d8-b83a-4aeb-81cb-b49e65976ae0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6130bfef-518e-4964-a5d3-b3f71ed0d771" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_356a6165-b715-4309-941f-01b4461777c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6130bfef-518e-4964-a5d3-b3f71ed0d771" xlink:to="loc_us-gaap_AccountsReceivableMember_356a6165-b715-4309-941f-01b4461777c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevenueMember_5e806b79-1cec-4a7e-93e3-0aabd464a3cb" xlink:href="holx-20210925.xsd#holx_RevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6130bfef-518e-4964-a5d3-b3f71ed0d771" xlink:to="loc_holx_RevenueMember_5e806b79-1cec-4a7e-93e3-0aabd464a3cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b696fac4-827f-45a3-8c8d-d849da916d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b696fac4-827f-45a3-8c8d-d849da916d12" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b696fac4-827f-45a3-8c8d-d849da916d12_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b696fac4-827f-45a3-8c8d-d849da916d12" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b696fac4-827f-45a3-8c8d-d849da916d12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b696fac4-827f-45a3-8c8d-d849da916d12" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_18780a64-41ef-4e9f-b236-3bc897b50642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_18780a64-41ef-4e9f-b236-3bc897b50642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember_71dd660f-5cba-4b12-b0a5-488e212e2ed4" xlink:href="holx-20210925.xsd#holx_DistributionagreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_holx_DistributionagreementMember_71dd660f-5cba-4b12-b0a5-488e212e2ed4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2e3f7fa5-2288-40c4-9229-94f41d4aab11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2e3f7fa5-2288-40c4-9229-94f41d4aab11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_096f6f19-9be2-4af3-8ee5-9c85a5fa6a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_us-gaap_TradeNamesMember_096f6f19-9be2-4af3-8ee5-9c85a5fa6a25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_f0c12a15-63b3-4602-b376-4653c7773490" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_holx_DevelopedTechnologyMember_f0c12a15-63b3-4602-b376-4653c7773490" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_2a27734d-2786-4fe8-87a9-349092decb05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_2a27734d-2786-4fe8-87a9-349092decb05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e657af3-2cd6-4876-981a-bd305bdb510a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e657af3-2cd6-4876-981a-bd305bdb510a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e657af3-2cd6-4876-981a-bd305bdb510a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e657af3-2cd6-4876-981a-bd305bdb510a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e657af3-2cd6-4876-981a-bd305bdb510a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e657af3-2cd6-4876-981a-bd305bdb510a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ff4ffd24-7aa5-4168-babe-d84b683e350b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:to="loc_us-gaap_TradeNamesMember_ff4ffd24-7aa5-4168-babe-d84b683e350b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_5c31825e-c603-4b73-b452-20fea46a65b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_5c31825e-c603-4b73-b452-20fea46a65b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_594c5d9c-c9ff-453c-b8e9-9e17fcec20ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_594c5d9c-c9ff-453c-b8e9-9e17fcec20ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e7b98b17-91e2-4833-a271-934ed6bf2a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e7b98b17-91e2-4833-a271-934ed6bf2a06" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e7b98b17-91e2-4833-a271-934ed6bf2a06_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e7b98b17-91e2-4833-a271-934ed6bf2a06" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e7b98b17-91e2-4833-a271-934ed6bf2a06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d4c8206a-5ea7-4f90-8249-88e9fc14def6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e7b98b17-91e2-4833-a271-934ed6bf2a06" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d4c8206a-5ea7-4f90-8249-88e9fc14def6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5bbc5836-c4b3-470e-a546-b1d5d23a7951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_d4c8206a-5ea7-4f90-8249-88e9fc14def6" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5bbc5836-c4b3-470e-a546-b1d5d23a7951" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_89b5fb72-ae5b-4cd9-9650-9d15800d46b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_89b5fb72-ae5b-4cd9-9650-9d15800d46b2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_89b5fb72-ae5b-4cd9-9650-9d15800d46b2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_89b5fb72-ae5b-4cd9-9650-9d15800d46b2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_89b5fb72-ae5b-4cd9-9650-9d15800d46b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1fe4e1a8-ca78-4e8a-b01a-c51c51106289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_89b5fb72-ae5b-4cd9-9650-9d15800d46b2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1fe4e1a8-ca78-4e8a-b01a-c51c51106289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_aace323d-b3d8-4162-abad-8f4d98ceaae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1fe4e1a8-ca78-4e8a-b01a-c51c51106289" xlink:to="loc_us-gaap_SubsequentEventMember_aace323d-b3d8-4162-abad-8f4d98ceaae9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_7bb3d3da-b4d5-4d13-a53e-e9ddd4c2ac9e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_srt_MajorCustomersAxis_7bb3d3da-b4d5-4d13-a53e-e9ddd4c2ac9e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7bb3d3da-b4d5-4d13-a53e-e9ddd4c2ac9e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_7bb3d3da-b4d5-4d13-a53e-e9ddd4c2ac9e" xlink:to="loc_srt_NameOfMajorCustomerDomain_7bb3d3da-b4d5-4d13-a53e-e9ddd4c2ac9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_c9faeb87-7595-46e3-9e3b-a41efa65a498" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_7bb3d3da-b4d5-4d13-a53e-e9ddd4c2ac9e" xlink:to="loc_srt_NameOfMajorCustomerDomain_c9faeb87-7595-46e3-9e3b-a41efa65a498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OneCustomerMember_385b6ad4-ed91-4b15-9923-a6511deaae31" xlink:href="holx-20210925.xsd#holx_OneCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_c9faeb87-7595-46e3-9e3b-a41efa65a498" xlink:to="loc_holx_OneCustomerMember_385b6ad4-ed91-4b15-9923-a6511deaae31" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="extended" id="i5d242a3c49674c429eee4cd143c19448_SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_da6995d4-bdf7-424c-9275-e12514d147bb" xlink:href="holx-20210925.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_da6995d4-bdf7-424c-9275-e12514d147bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_3d5b965f-3806-4eff-978d-42cb934419a9" xlink:href="holx-20210925.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_3d5b965f-3806-4eff-978d-42cb934419a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_7bf957ae-1a08-4ff3-ac21-13b563a3e007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_7bf957ae-1a08-4ff3-ac21-13b563a3e007" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_a128ec42-6ca2-434a-8fa2-d34c884b9eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_a128ec42-6ca2-434a-8fa2-d34c884b9eda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_46bc090d-9663-4dc2-8809-9f6b15ee3e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_Land_46bc090d-9663-4dc2-8809-9f6b15ee3e35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_f13c83eb-215b-4aa0-8573-f129f2dd2bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_f13c83eb-215b-4aa0-8573-f129f2dd2bf7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_38a42b10-444e-47e9-909e-8feb913f9a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_38a42b10-444e-47e9-909e-8feb913f9a5f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_16cda6a7-ce1e-45e3-9dd7-c14d9db0c337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_16cda6a7-ce1e-45e3-9dd7-c14d9db0c337" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c3a9cb3d-3d25-4207-a85d-804d21d93595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c3a9cb3d-3d25-4207-a85d-804d21d93595" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9464b801-aa01-40ba-b397-08c9d88ccf78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9464b801-aa01-40ba-b397-08c9d88ccf78" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b53bd0c5-73c2-4ad1-857a-5fec705ee716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b53bd0c5-73c2-4ad1-857a-5fec705ee716" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrantsReceivedFromDepartmentOfDefense_37d3e28e-8a70-432c-8037-7a268ec09daa" xlink:href="holx-20210925.xsd#holx_GrantsReceivedFromDepartmentOfDefense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_holx_GrantsReceivedFromDepartmentOfDefense_37d3e28e-8a70-432c-8037-7a268ec09daa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DepartmentOfDefenseFundsReceived_f8edb25a-a667-4640-b457-3e602f746a22" xlink:href="holx-20210925.xsd#holx_DepartmentOfDefenseFundsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_holx_DepartmentOfDefenseFundsReceived_f8edb25a-a667-4640-b457-3e602f746a22" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49ae222f-87d8-43a9-b5d1-0ed7731f1f14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49ae222f-87d8-43a9-b5d1-0ed7731f1f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49ae222f-87d8-43a9-b5d1-0ed7731f1f14_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49ae222f-87d8-43a9-b5d1-0ed7731f1f14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49ae222f-87d8-43a9-b5d1-0ed7731f1f14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49ae222f-87d8-43a9-b5d1-0ed7731f1f14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentAndSoftwareMember_99e4fa17-aa86-4652-8172-2bdf66e84f66" xlink:href="holx-20210925.xsd#holx_EquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:to="loc_holx_EquipmentAndSoftwareMember_99e4fa17-aa86-4652-8172-2bdf66e84f66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreementMember_dce3ff05-9aad-4923-a131-1f4d50d3bf7f" xlink:href="holx-20210925.xsd#holx_EquipmentUnderCustomerUsageAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreementMember_dce3ff05-9aad-4923-a131-1f4d50d3bf7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_821c297b-1677-4a03-8cc3-70a71a2e835a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_821c297b-1677-4a03-8cc3-70a71a2e835a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_75e61c1a-deb1-4f21-a052-523d9af212f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_75e61c1a-deb1-4f21-a052-523d9af212f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_edcb35d4-f43c-41ae-b4ec-cf479571b7e7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:to="loc_srt_RangeAxis_edcb35d4-f43c-41ae-b4ec-cf479571b7e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_edcb35d4-f43c-41ae-b4ec-cf479571b7e7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_edcb35d4-f43c-41ae-b4ec-cf479571b7e7" xlink:to="loc_srt_RangeMember_edcb35d4-f43c-41ae-b4ec-cf479571b7e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e9ebe19-3449-486d-b27a-4be8c93ce53c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_edcb35d4-f43c-41ae-b4ec-cf479571b7e7" xlink:to="loc_srt_RangeMember_4e9ebe19-3449-486d-b27a-4be8c93ce53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_34c81af1-6358-4df5-a16f-bf7527b06f6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4e9ebe19-3449-486d-b27a-4be8c93ce53c" xlink:to="loc_srt_MinimumMember_34c81af1-6358-4df5-a16f-bf7527b06f6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a13a1df0-6d81-470a-a9ce-44328dc60fac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4e9ebe19-3449-486d-b27a-4be8c93ce53c" xlink:to="loc_srt_MaximumMember_a13a1df0-6d81-470a-a9ce-44328dc60fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_682b674e-966a-4a2a-9cb5-572a77c5370a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_682b674e-966a-4a2a-9cb5-572a77c5370a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_682b674e-966a-4a2a-9cb5-572a77c5370a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_682b674e-966a-4a2a-9cb5-572a77c5370a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_682b674e-966a-4a2a-9cb5-572a77c5370a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8ac46adb-89c8-43e6-8294-14917a169d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_682b674e-966a-4a2a-9cb5-572a77c5370a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8ac46adb-89c8-43e6-8294-14917a169d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_733926fa-286d-4848-8e5b-d984ab21e704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8ac46adb-89c8-43e6-8294-14917a169d95" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_733926fa-286d-4848-8e5b-d984ab21e704" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="extended" id="iaa14e79d96634610a39ac3154ee62f22_SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dd435355-7982-47fd-9353-a579136a1c8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dd435355-7982-47fd-9353-a579136a1c8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8e06c826-86e1-4638-a8e0-a4ca78a52850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8e06c826-86e1-4638-a8e0-a4ca78a52850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_baa13a7b-1ac3-49fa-90f1-eece79c79ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:to="loc_us-gaap_AssetImpairmentCharges_baa13a7b-1ac3-49fa-90f1-eece79c79ffc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_432c09ed-64bb-4c13-80a8-ead85eaf5c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_432c09ed-64bb-4c13-80a8-ead85eaf5c94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_811e772a-2618-44f7-82cd-ffaf871945c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_811e772a-2618-44f7-82cd-ffaf871945c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811e772a-2618-44f7-82cd-ffaf871945c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_811e772a-2618-44f7-82cd-ffaf871945c7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811e772a-2618-44f7-82cd-ffaf871945c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_811e772a-2618-44f7-82cd-ffaf871945c7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_d73610b1-6643-40bb-8fef-c124ad25e4a0" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_MobidiagOyMember_d73610b1-6643-40bb-8fef-c124ad25e4a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_e5954de5-672f-4854-ab35-72922584eec7" xlink:href="holx-20210925.xsd#holx_BiotheranosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_BiotheranosticsMember_e5954de5-672f-4854-ab35-72922584eec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_f338adb3-422c-4a21-923a-199c1106382b" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_DiagenodeMember_f338adb3-422c-4a21-923a-199c1106382b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMember_2686258d-5155-4319-a844-a20669b2a7c9" xlink:href="holx-20210925.xsd#holx_SomatexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_SomatexMember_2686258d-5155-4319-a844-a20669b2a7c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_551c5146-c7b2-4375-8ebf-c89fb1155e8b" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_AcessaHealthMember_551c5146-c7b2-4375-8ebf-c89fb1155e8b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_86730b8c-c5f0-4088-b2d9-f2e108b06344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_86730b8c-c5f0-4088-b2d9-f2e108b06344" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_86730b8c-c5f0-4088-b2d9-f2e108b06344_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_86730b8c-c5f0-4088-b2d9-f2e108b06344" xlink:to="loc_us-gaap_SegmentDomain_86730b8c-c5f0-4088-b2d9-f2e108b06344_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e8b0454c-519e-4a8f-bad3-6a2fe3bd1f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_86730b8c-c5f0-4088-b2d9-f2e108b06344" xlink:to="loc_us-gaap_SegmentDomain_e8b0454c-519e-4a8f-bad3-6a2fe3bd1f89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_043c7713-23a7-4060-bc1b-c6967f750a74" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e8b0454c-519e-4a8f-bad3-6a2fe3bd1f89" xlink:to="loc_holx_MedicalAestheticsMember_043c7713-23a7-4060-bc1b-c6967f750a74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_ce7e8e54-0e11-4396-a4d2-e392cd13063b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_ce7e8e54-0e11-4396-a4d2-e392cd13063b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ce7e8e54-0e11-4396-a4d2-e392cd13063b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ce7e8e54-0e11-4396-a4d2-e392cd13063b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ce7e8e54-0e11-4396-a4d2-e392cd13063b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ce7e8e54-0e11-4396-a4d2-e392cd13063b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_7a2cb2ec-1fd4-41a4-9e52-9d43b51bfec1" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:to="loc_holx_DevelopedTechnologyMember_7a2cb2ec-1fd4-41a4-9e52-9d43b51bfec1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8dce7af5-3ba0-4da5-865f-b272e02f9921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8dce7af5-3ba0-4da5-865f-b272e02f9921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_64967a62-4b95-4127-883e-ac02247c9e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:to="loc_us-gaap_TradeNamesMember_64967a62-4b95-4127-883e-ac02247c9e2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_5904b6cb-7b72-412b-a2a2-6c3bd8b5dcf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_5904b6cb-7b72-412b-a2a2-6c3bd8b5dcf5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c3f266fd-0d9c-4cf8-b97b-e4dbf3f6d509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c3f266fd-0d9c-4cf8-b97b-e4dbf3f6d509" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f266fd-0d9c-4cf8-b97b-e4dbf3f6d509_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c3f266fd-0d9c-4cf8-b97b-e4dbf3f6d509" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c3f266fd-0d9c-4cf8-b97b-e4dbf3f6d509_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c3f266fd-0d9c-4cf8-b97b-e4dbf3f6d509" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6b5efae8-f40f-45cf-af82-68d3e483986e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6b5efae8-f40f-45cf-af82-68d3e483986e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_fdd54ecb-ea84-4b32-b75f-2f93b24c22bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_fdd54ecb-ea84-4b32-b75f-2f93b24c22bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_0507f764-a962-4522-a639-b74b88c40ea2" xlink:href="holx-20210925.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_CustomerRelationshipsContractsMember_0507f764-a962-4522-a639-b74b88c40ea2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a06a9f56-2b8d-4c9d-b3d1-29f0ac1fd954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_TradeNamesMember_a06a9f56-2b8d-4c9d-b3d1-29f0ac1fd954" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_05f02995-88d4-4050-9523-8d98f85bc8e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_05f02995-88d4-4050-9523-8d98f85bc8e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_f884a796-e1d4-4f7a-82b1-714a1c5a88a1" xlink:href="holx-20210925.xsd#holx_BusinessLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_BusinessLicensesMember_f884a796-e1d4-4f7a-82b1-714a1c5a88a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_e710e6f2-7682-4861-9e8e-99905ce0ec86" xlink:href="holx-20210925.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_AcquiredintangibleassetsMember_e710e6f2-7682-4861-9e8e-99905ce0ec86" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_c29b0f57-e5d8-4f6f-ac29-00f3839bd46a" xlink:href="holx-20210925.xsd#holx_InternalusesoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_InternalusesoftwareMember_c29b0f57-e5d8-4f6f-ac29-00f3839bd46a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_49822b55-4fc9-438e-bbb1-4755e304c894" xlink:href="holx-20210925.xsd#holx_CapitalizedsoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_CapitalizedsoftwareMember_49822b55-4fc9-438e-bbb1-4755e304c894" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b4996c03-f12e-463d-aad2-32ea3ae4ffdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b4996c03-f12e-463d-aad2-32ea3ae4ffdf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_aaf92f89-ea89-45ab-bc5b-2757cd141bbf" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_DevelopedTechnologyMember_aaf92f89-ea89-45ab-bc5b-2757cd141bbf" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="extended" id="i9c92086efe0741ec96a6045fa912ead3_SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_e321e1e6-734c-43b8-8f95-65f17ce125e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:to="loc_us-gaap_AssetImpairmentCharges_e321e1e6-734c-43b8-8f95-65f17ce125e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ed27cb62-905d-4b86-877d-dba518a20f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ed27cb62-905d-4b86-877d-dba518a20f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cc8ae196-9b5c-4405-9553-3b53eda7e42c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cc8ae196-9b5c-4405-9553-3b53eda7e42c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_77fb2acf-d608-4273-b67c-f184ff1a16e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_77fb2acf-d608-4273-b67c-f184ff1a16e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_77fb2acf-d608-4273-b67c-f184ff1a16e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_77fb2acf-d608-4273-b67c-f184ff1a16e1" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_77fb2acf-d608-4273-b67c-f184ff1a16e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_77fb2acf-d608-4273-b67c-f184ff1a16e1" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember_b12d9e53-43da-473d-bd00-da3955934f0f" xlink:href="holx-20210925.xsd#holx_DistributionagreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_holx_DistributionagreementMember_b12d9e53-43da-473d-bd00-da3955934f0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ed8c0b23-6020-4f5c-80a3-44fffcdeb506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ed8c0b23-6020-4f5c-80a3-44fffcdeb506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_65dc9a62-853b-46a0-9f75-76befdd73181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_us-gaap_TradeNamesMember_65dc9a62-853b-46a0-9f75-76befdd73181" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_344e79c7-c5f3-4215-bc6c-fd299715b065" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_holx_DevelopedTechnologyMember_344e79c7-c5f3-4215-bc6c-fd299715b065" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_8232be76-b9d7-4add-ad03-927fcc46ed09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_8232be76-b9d7-4add-ad03-927fcc46ed09" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_f1f15e35-70f8-4d52-a235-d31fc2b4b6b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_f1f15e35-70f8-4d52-a235-d31fc2b4b6b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8413badb-e278-4410-9efe-22b68ccd4136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8413badb-e278-4410-9efe-22b68ccd4136" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8413badb-e278-4410-9efe-22b68ccd4136_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8413badb-e278-4410-9efe-22b68ccd4136" xlink:to="loc_us-gaap_SegmentDomain_8413badb-e278-4410-9efe-22b68ccd4136_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8bb09009-f0f0-453e-9256-310b86f68cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8413badb-e278-4410-9efe-22b68ccd4136" xlink:to="loc_us-gaap_SegmentDomain_8bb09009-f0f0-453e-9256-310b86f68cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_8a13fecd-4d42-4533-b139-674385abd270" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8bb09009-f0f0-453e-9256-310b86f68cb1" xlink:to="loc_holx_MedicalAestheticsMember_8a13fecd-4d42-4533-b139-674385abd270" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_79929855-d63f-4a00-b910-d8f9c412535b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_79929855-d63f-4a00-b910-d8f9c412535b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79929855-d63f-4a00-b910-d8f9c412535b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_79929855-d63f-4a00-b910-d8f9c412535b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_79929855-d63f-4a00-b910-d8f9c412535b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18fea7d1-555f-475e-890c-f0255335695a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_79929855-d63f-4a00-b910-d8f9c412535b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18fea7d1-555f-475e-890c-f0255335695a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_79fba838-79e5-4109-ab34-b19f9adb255a" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18fea7d1-555f-475e-890c-f0255335695a" xlink:to="loc_holx_AcessaHealthMember_79fba838-79e5-4109-ab34-b19f9adb255a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd43f887-b2c1-49cf-b8f3-152c1932623a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd43f887-b2c1-49cf-b8f3-152c1932623a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd43f887-b2c1-49cf-b8f3-152c1932623a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd43f887-b2c1-49cf-b8f3-152c1932623a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd43f887-b2c1-49cf-b8f3-152c1932623a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd43f887-b2c1-49cf-b8f3-152c1932623a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3e0491ed-a359-4410-9abf-5e56d1e30ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3e0491ed-a359-4410-9abf-5e56d1e30ae8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_527e410c-2332-4bbc-b62d-92c730527416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:to="loc_us-gaap_TradeNamesMember_527e410c-2332-4bbc-b62d-92c730527416" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_89086c02-1333-4533-a2ff-871f6a3ab19f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_89086c02-1333-4533-a2ff-871f6a3ab19f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="extended" id="ibb2106c75d7f40a584ffe0e7b2f8622b_SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_79b68a37-8527-469f-afba-fc3e7fc009e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_79b68a37-8527-469f-afba-fc3e7fc009e4" xlink:to="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_34c67ba0-ad11-492b-9d06-308edfc5ff4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:to="loc_us-gaap_Goodwill_34c67ba0-ad11-492b-9d06-308edfc5ff4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_d6f146a2-a48f-410d-b84f-8806bb07d563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_d6f146a2-a48f-410d-b84f-8806bb07d563" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_6333aef3-581e-4829-bcd7-fdc096fa7ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_6333aef3-581e-4829-bcd7-fdc096fa7ca7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8ad8c09e-1e09-494c-8195-445badf3f4a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6d1409e5-097c-41bd-a12c-3baa34c94d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_79b68a37-8527-469f-afba-fc3e7fc009e4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6d1409e5-097c-41bd-a12c-3baa34c94d6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c24a1e2f-1839-4990-b7b0-b23fa964edc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6d1409e5-097c-41bd-a12c-3baa34c94d6e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c24a1e2f-1839-4990-b7b0-b23fa964edc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c24a1e2f-1839-4990-b7b0-b23fa964edc0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c24a1e2f-1839-4990-b7b0-b23fa964edc0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c24a1e2f-1839-4990-b7b0-b23fa964edc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c24a1e2f-1839-4990-b7b0-b23fa964edc0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_75b47a6e-0c1a-4b95-8603-259207a8704d" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:to="loc_holx_MobidiagOyMember_75b47a6e-0c1a-4b95-8603-259207a8704d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_742d1596-0607-467f-b25b-26e17d2e42d3" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:to="loc_holx_DiagenodeMember_742d1596-0607-467f-b25b-26e17d2e42d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_49e1a935-dae0-435f-8eaa-9598d0b021c5" xlink:href="holx-20210925.xsd#holx_BiotheranosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:to="loc_holx_BiotheranosticsMember_49e1a935-dae0-435f-8eaa-9598d0b021c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMember_fdad8854-1086-467c-b7bf-cb22f8c07cea" xlink:href="holx-20210925.xsd#holx_SomatexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:to="loc_holx_SomatexMember_fdad8854-1086-467c-b7bf-cb22f8c07cea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4da26b30-6867-42e5-ac06-8b71b9eb4d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6d1409e5-097c-41bd-a12c-3baa34c94d6e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4da26b30-6867-42e5-ac06-8b71b9eb4d2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4da26b30-6867-42e5-ac06-8b71b9eb4d2e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4da26b30-6867-42e5-ac06-8b71b9eb4d2e" xlink:to="loc_us-gaap_SegmentDomain_4da26b30-6867-42e5-ac06-8b71b9eb4d2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4da26b30-6867-42e5-ac06-8b71b9eb4d2e" xlink:to="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_bbf0439b-a1cf-4f93-86b1-97f9a83c30cc" xlink:href="holx-20210925.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:to="loc_holx_DiagnosticsMember_bbf0439b-a1cf-4f93-86b1-97f9a83c30cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_97099577-ee79-4ebe-b279-3d269c63a8a6" xlink:href="holx-20210925.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:to="loc_holx_BreastHealthMember_97099577-ee79-4ebe-b279-3d269c63a8a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_099572fc-1ad5-46a9-a93b-b9ebd8799098" xlink:href="holx-20210925.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:to="loc_holx_GynSurgicalMember_099572fc-1ad5-46a9-a93b-b9ebd8799098" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_0f6a135c-d76d-4a79-98a2-b9966ae5e04e" xlink:href="holx-20210925.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:to="loc_holx_SkeletalHealthMember_0f6a135c-d76d-4a79-98a2-b9966ae5e04e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="extended" id="i784db2f1dc304f74bdeb46480e679b34_SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_574b2239-5b26-4d3e-9352-631495592ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_574b2239-5b26-4d3e-9352-631495592ba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c2af2d26-6493-4f70-b81e-35e271f50c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:to="loc_us-gaap_Goodwill_c2af2d26-6493-4f70-b81e-35e271f50c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GoodwillNotAtRiskOfFailingImpairment_546abdd8-37dd-429e-a995-af1199b255dc" xlink:href="holx-20210925.xsd#holx_GoodwillNotAtRiskOfFailingImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:to="loc_holx_GoodwillNotAtRiskOfFailingImpairment_546abdd8-37dd-429e-a995-af1199b255dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e7ad70ca-72ed-4f0c-b632-1c3ab398c779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e7ad70ca-72ed-4f0c-b632-1c3ab398c779" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0c9497dc-18f3-4b02-b64f-70ea87d068a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e7ad70ca-72ed-4f0c-b632-1c3ab398c779" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0c9497dc-18f3-4b02-b64f-70ea87d068a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c9497dc-18f3-4b02-b64f-70ea87d068a2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0c9497dc-18f3-4b02-b64f-70ea87d068a2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c9497dc-18f3-4b02-b64f-70ea87d068a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_429b9f5e-b227-47de-a1a2-0c474ee89709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0c9497dc-18f3-4b02-b64f-70ea87d068a2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_429b9f5e-b227-47de-a1a2-0c474ee89709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_cbe0cc36-a527-45e7-9663-7ff88211a6b4" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_429b9f5e-b227-47de-a1a2-0c474ee89709" xlink:to="loc_holx_AcessaHealthMember_cbe0cc36-a527-45e7-9663-7ff88211a6b4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="extended" id="ie288684bd5f041d9aad3fd81e6e11819_SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_14a4fbdf-2122-49f4-97e3-25922c42f2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_14a4fbdf-2122-49f4-97e3-25922c42f2b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_83e05ac7-f735-4d25-8f3f-e144844c2805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_83e05ac7-f735-4d25-8f3f-e144844c2805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_8b8440fe-1304-4481-b237-359ae9b143d5" xlink:href="holx-20210925.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_8b8440fe-1304-4481-b237-359ae9b143d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d63039e3-dfe7-40ea-aed2-be362f91247f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d63039e3-dfe7-40ea-aed2-be362f91247f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0c4c10bb-da57-4719-be2a-b3fbcc7f9f52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0c4c10bb-da57-4719-be2a-b3fbcc7f9f52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4ee79b6b-4cbe-40cd-9732-e4de423597ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4ee79b6b-4cbe-40cd-9732-e4de423597ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_229a1692-7ff0-4abf-937f-87ff0bf8bfe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_229a1692-7ff0-4abf-937f-87ff0bf8bfe2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f3fd2a9c-2309-4228-a0e3-7c15487dd497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f3fd2a9c-2309-4228-a0e3-7c15487dd497" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_e3d5fcab-7c85-45ec-9673-eb83fecd8812" xlink:href="holx-20210925.xsd#holx_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_holx_NotionalAmount_e3d5fcab-7c85-45ec-9673-eb83fecd8812" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_203d3919-4498-48cd-8469-1f44079ed100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_203d3919-4498-48cd-8469-1f44079ed100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_203d3919-4498-48cd-8469-1f44079ed100_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_203d3919-4498-48cd-8469-1f44079ed100" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_203d3919-4498-48cd-8469-1f44079ed100_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ae74fba3-fe01-44ab-acef-3ec672b7a715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_203d3919-4498-48cd-8469-1f44079ed100" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ae74fba3-fe01-44ab-acef-3ec672b7a715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_66f2ee80-76f2-44a8-8851-8f281a479aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_66f2ee80-76f2-44a8-8851-8f281a479aaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_66f2ee80-76f2-44a8-8851-8f281a479aaf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66f2ee80-76f2-44a8-8851-8f281a479aaf" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_66f2ee80-76f2-44a8-8851-8f281a479aaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_018a4ef3-97e3-4198-bcd9-315e9726b2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66f2ee80-76f2-44a8-8851-8f281a479aaf" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_018a4ef3-97e3-4198-bcd9-315e9726b2e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_834f617d-140e-47c7-aac6-92b96e45af74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_018a4ef3-97e3-4198-bcd9-315e9726b2e7" xlink:to="loc_us-gaap_InterestRateSwapMember_834f617d-140e-47c7-aac6-92b96e45af74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_1fec7c86-ee1d-42ba-b3ec-c8343e953fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_018a4ef3-97e3-4198-bcd9-315e9726b2e7" xlink:to="loc_us-gaap_InterestRateCapMember_1fec7c86-ee1d-42ba-b3ec-c8343e953fc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_49acec7c-8b84-4133-b544-c8526bd9a7cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_49acec7c-8b84-4133-b544-c8526bd9a7cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_49acec7c-8b84-4133-b544-c8526bd9a7cc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_49acec7c-8b84-4133-b544-c8526bd9a7cc" xlink:to="loc_us-gaap_EquityComponentDomain_49acec7c-8b84-4133-b544-c8526bd9a7cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_59eb5710-5f97-4271-9119-b61fe3c55f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_49acec7c-8b84-4133-b544-c8526bd9a7cc" xlink:to="loc_us-gaap_EquityComponentDomain_59eb5710-5f97-4271-9119-b61fe3c55f24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_2ebd57c2-1b32-467d-abe2-abfc3c05243f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_59eb5710-5f97-4271-9119-b61fe3c55f24" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_2ebd57c2-1b32-467d-abe2-abfc3c05243f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_9c5accbf-e473-473f-842f-3680dd06a112" xlink:href="holx-20210925.xsd#holx_PensioninAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_59eb5710-5f97-4271-9119-b61fe3c55f24" xlink:to="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_9c5accbf-e473-473f-842f-3680dd06a112" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="extended" id="i88370ca781354a848d786ee13a5a7c9e_SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_899bb864-e731-4da2-b6be-83bb8ae4451f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_899bb864-e731-4da2-b6be-83bb8ae4451f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_6244dbce-d3ae-4dff-98b7-37f228b8a15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_6244dbce-d3ae-4dff-98b7-37f228b8a15a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_501100c8-6dce-4ff5-8fdc-629f07b5ee83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_501100c8-6dce-4ff5-8fdc-629f07b5ee83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c0fcf466-a775-4588-9de8-72625741c407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c0fcf466-a775-4588-9de8-72625741c407" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_95685370-3d74-4087-a83d-fbbf8f2586ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c0fcf466-a775-4588-9de8-72625741c407" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_95685370-3d74-4087-a83d-fbbf8f2586ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_95685370-3d74-4087-a83d-fbbf8f2586ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_95685370-3d74-4087-a83d-fbbf8f2586ba" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_95685370-3d74-4087-a83d-fbbf8f2586ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_01cba22a-3d6f-49d0-a7fa-d4cac091b9c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_95685370-3d74-4087-a83d-fbbf8f2586ba" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_01cba22a-3d6f-49d0-a7fa-d4cac091b9c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_c5427e52-6859-4586-b7e6-ce6bed6891d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_01cba22a-3d6f-49d0-a7fa-d4cac091b9c4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_c5427e52-6859-4586-b7e6-ce6bed6891d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_da41780f-24d2-4958-8e23-125c54fb4864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_01cba22a-3d6f-49d0-a7fa-d4cac091b9c4" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_da41780f-24d2-4958-8e23-125c54fb4864" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="extended" id="i3dd6a156b7174af1beeda4349e6b7037_SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c6accb76-4ef7-44ea-8bb4-9d8be79bd290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_6a45ec45-b34e-445c-9278-d0cf8fbb3dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c6accb76-4ef7-44ea-8bb4-9d8be79bd290" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_6a45ec45-b34e-445c-9278-d0cf8fbb3dc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_becc7aaf-83a0-4ecd-bf2c-cc3574a08715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c6accb76-4ef7-44ea-8bb4-9d8be79bd290" xlink:to="loc_us-gaap_DerivativeLiabilities_becc7aaf-83a0-4ecd-bf2c-cc3574a08715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c6accb76-4ef7-44ea-8bb4-9d8be79bd290" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_07bf8c6e-9a3a-4d3b-8a52-1ac64a764517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_07bf8c6e-9a3a-4d3b-8a52-1ac64a764517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07bf8c6e-9a3a-4d3b-8a52-1ac64a764517_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_07bf8c6e-9a3a-4d3b-8a52-1ac64a764517" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_07bf8c6e-9a3a-4d3b-8a52-1ac64a764517_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4a59c7bf-4bf0-4198-a102-2908afe7d02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_07bf8c6e-9a3a-4d3b-8a52-1ac64a764517" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4a59c7bf-4bf0-4198-a102-2908afe7d02d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8b7cdcd1-c632-42fd-a567-58f50e2bb04c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4a59c7bf-4bf0-4198-a102-2908afe7d02d" xlink:to="loc_us-gaap_InterestRateSwapMember_8b7cdcd1-c632-42fd-a567-58f50e2bb04c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4ea02bc9-4218-48b3-b226-479411397efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4ea02bc9-4218-48b3-b226-479411397efc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4ea02bc9-4218-48b3-b226-479411397efc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ea02bc9-4218-48b3-b226-479411397efc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4ea02bc9-4218-48b3-b226-479411397efc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ea02bc9-4218-48b3-b226-479411397efc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_5055134a-8cfa-4d63-bf8c-1af6221dffff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:to="loc_us-gaap_InterestRateCapMember_5055134a-8cfa-4d63-bf8c-1af6221dffff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_394ba48a-7813-405e-87fc-d942b4610a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_394ba48a-7813-405e-87fc-d942b4610a1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_5da93f40-76d4-4358-a16c-6f44fecb494e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_5da93f40-76d4-4358-a16c-6f44fecb494e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_347391c7-9a52-4f23-93db-0c45d8e8e713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:to="loc_us-gaap_InterestRateSwapMember_347391c7-9a52-4f23-93db-0c45d8e8e713" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_333c7173-cac2-4d9c-904d-2b265f7e5c38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_333c7173-cac2-4d9c-904d-2b265f7e5c38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_333c7173-cac2-4d9c-904d-2b265f7e5c38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_333c7173-cac2-4d9c-904d-2b265f7e5c38" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_333c7173-cac2-4d9c-904d-2b265f7e5c38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_333c7173-cac2-4d9c-904d-2b265f7e5c38" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fcf2a265-0b7b-4677-b6a0-98029b83f5b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fcf2a265-0b7b-4677-b6a0-98029b83f5b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_c789fda0-ad3a-44ef-a58c-b0bb0a9e0ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_c789fda0-ad3a-44ef-a58c-b0bb0a9e0ae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d57efc55-d713-4b1e-9cd8-d0f2872150fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d57efc55-d713-4b1e-9cd8-d0f2872150fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_003df135-752f-41dd-ab95-e783fb58a814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:to="loc_us-gaap_HedgingDesignationAxis_003df135-752f-41dd-ab95-e783fb58a814" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_003df135-752f-41dd-ab95-e783fb58a814_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_003df135-752f-41dd-ab95-e783fb58a814" xlink:to="loc_us-gaap_HedgingDesignationDomain_003df135-752f-41dd-ab95-e783fb58a814_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1c120e53-1c4d-4272-b916-9452ab2edd44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_003df135-752f-41dd-ab95-e783fb58a814" xlink:to="loc_us-gaap_HedgingDesignationDomain_1c120e53-1c4d-4272-b916-9452ab2edd44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9a4f23ec-062d-4ee3-95bd-72a57eaf5d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_1c120e53-1c4d-4272-b916-9452ab2edd44" xlink:to="loc_us-gaap_NondesignatedMember_9a4f23ec-062d-4ee3-95bd-72a57eaf5d6d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="extended" id="idb5649edf87141a4ac637abb303d785e_SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_b8e6ed7b-cc46-4c17-822c-3834ccdb46c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_b8e6ed7b-cc46-4c17-822c-3834ccdb46c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_86c8d919-a756-4963-ad19-1c5aa332078d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_86c8d919-a756-4963-ad19-1c5aa332078d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d7126fca-e73a-495f-9d61-7b7a8520175a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d7126fca-e73a-495f-9d61-7b7a8520175a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_62398121-2df6-4e27-ae0a-168124425612" xlink:href="holx-20210925.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_62398121-2df6-4e27-ae0a-168124425612" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2570c625-886f-4ef3-862a-56667ffc8184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2570c625-886f-4ef3-862a-56667ffc8184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2570c625-886f-4ef3-862a-56667ffc8184_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2570c625-886f-4ef3-862a-56667ffc8184" xlink:to="loc_us-gaap_EquityComponentDomain_2570c625-886f-4ef3-862a-56667ffc8184_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1951dd4-9470-413a-bfce-e0b2f25947c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2570c625-886f-4ef3-862a-56667ffc8184" xlink:to="loc_us-gaap_EquityComponentDomain_d1951dd4-9470-413a-bfce-e0b2f25947c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3cdec297-4833-45f0-83d4-d92e13b97d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d1951dd4-9470-413a-bfce-e0b2f25947c9" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3cdec297-4833-45f0-83d4-d92e13b97d4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb437526-881b-4386-98f0-0e3e652f62c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb437526-881b-4386-98f0-0e3e652f62c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fb437526-881b-4386-98f0-0e3e652f62c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb437526-881b-4386-98f0-0e3e652f62c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fb437526-881b-4386-98f0-0e3e652f62c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_798e8bb7-06e7-45e7-9f84-61a8187497b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb437526-881b-4386-98f0-0e3e652f62c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_798e8bb7-06e7-45e7-9f84-61a8187497b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_93b41e95-0aa7-4928-89dc-779f838870c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_798e8bb7-06e7-45e7-9f84-61a8187497b3" xlink:to="loc_us-gaap_TradeNamesMember_93b41e95-0aa7-4928-89dc-779f838870c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5e2b5689-15fd-450c-9be9-4d1ce8f128a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5e2b5689-15fd-450c-9be9-4d1ce8f128a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5e2b5689-15fd-450c-9be9-4d1ce8f128a1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5e2b5689-15fd-450c-9be9-4d1ce8f128a1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5e2b5689-15fd-450c-9be9-4d1ce8f128a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f971e623-4623-48fc-a501-7566d052419f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5e2b5689-15fd-450c-9be9-4d1ce8f128a1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f971e623-4623-48fc-a501-7566d052419f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8bf90fa1-72b0-4fff-a92a-7b07ba9769db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f971e623-4623-48fc-a501-7566d052419f" xlink:to="loc_us-gaap_InterestRateSwapMember_8bf90fa1-72b0-4fff-a92a-7b07ba9769db" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="extended" id="i09ac255f66c243198c476a8a824ac1ce_SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ac9e13ea-5610-4a0f-82c2-3f688b122fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_267a3ea0-6199-4c98-8e38-2595ff8eee9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ac9e13ea-5610-4a0f-82c2-3f688b122fbd" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_267a3ea0-6199-4c98-8e38-2595ff8eee9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_297ebbf7-a036-4a5d-b4b0-2816814d3555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ac9e13ea-5610-4a0f-82c2-3f688b122fbd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_297ebbf7-a036-4a5d-b4b0-2816814d3555" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1ea80b1f-bcaf-422b-b73a-0d4df8607ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ac9e13ea-5610-4a0f-82c2-3f688b122fbd" xlink:to="loc_us-gaap_DerivativeTable_1ea80b1f-bcaf-422b-b73a-0d4df8607ede" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1cadaaa5-a86b-433a-89ed-c5774d5b0d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_1ea80b1f-bcaf-422b-b73a-0d4df8607ede" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1cadaaa5-a86b-433a-89ed-c5774d5b0d2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1cadaaa5-a86b-433a-89ed-c5774d5b0d2e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1cadaaa5-a86b-433a-89ed-c5774d5b0d2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1cadaaa5-a86b-433a-89ed-c5774d5b0d2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f6f8a0bb-e489-47ee-8815-453c1b2bd0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1cadaaa5-a86b-433a-89ed-c5774d5b0d2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f6f8a0bb-e489-47ee-8815-453c1b2bd0ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_94bbab12-f344-456f-a366-1e6817fbce59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f6f8a0bb-e489-47ee-8815-453c1b2bd0ee" xlink:to="loc_us-gaap_InterestRateCapMember_94bbab12-f344-456f-a366-1e6817fbce59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_48c9b91d-aca8-4a85-9ed2-24f9e6e4a713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f6f8a0bb-e489-47ee-8815-453c1b2bd0ee" xlink:to="loc_us-gaap_InterestRateSwapMember_48c9b91d-aca8-4a85-9ed2-24f9e6e4a713" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended" id="i297ef07f0f3549c3b6165364ac113f09_SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:href="holx-20210925.xsd#holx_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b313ee30-c1d1-4e95-9f43-de8c0584b43a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b313ee30-c1d1-4e95-9f43-de8c0584b43a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_f6831ab7-bcf0-4a7e-9d28-37b92164b504" xlink:href="holx-20210925.xsd#holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:to="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_f6831ab7-bcf0-4a7e-9d28-37b92164b504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a7ae67a-2350-48ab-9dd2-e09d0eedd272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a7ae67a-2350-48ab-9dd2-e09d0eedd272" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_10029b6e-e92e-4f4b-90b5-c0a9257a358a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_10029b6e-e92e-4f4b-90b5-c0a9257a358a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_721c1e65-044e-4631-9537-de9599a5d7f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_10029b6e-e92e-4f4b-90b5-c0a9257a358a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_721c1e65-044e-4631-9537-de9599a5d7f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_aa2105da-8066-43cf-abea-143a091f06d0" xlink:href="holx-20210925.xsd#holx_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:to="loc_holx_EarningsPerShareTable_aa2105da-8066-43cf-abea-143a091f06d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27d6309e-cead-4978-9a53-347996b22a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_EarningsPerShareTable_aa2105da-8066-43cf-abea-143a091f06d0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27d6309e-cead-4978-9a53-347996b22a0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_27d6309e-cead-4978-9a53-347996b22a0e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27d6309e-cead-4978-9a53-347996b22a0e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_27d6309e-cead-4978-9a53-347996b22a0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_06283d82-5413-471c-98f5-d992ce6bb3d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27d6309e-cead-4978-9a53-347996b22a0e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_06283d82-5413-471c-98f5-d992ce6bb3d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4f022baf-e546-4706-8223-5a1adef68610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_06283d82-5413-471c-98f5-d992ce6bb3d8" xlink:to="loc_us-gaap_StockCompensationPlanMember_4f022baf-e546-4706-8223-5a1adef68610" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueBusinessRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended" id="i726b9f481815418cb57542d7e85cf759_RevenueBusinessRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_fafe8b60-0484-421e-8c33-dada62ffc67c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_699a1772-de66-48c7-baf2-829bf57ce1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fafe8b60-0484-421e-8c33-dada62ffc67c" xlink:to="loc_us-gaap_Revenues_699a1772-de66-48c7-baf2-829bf57ce1c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fafe8b60-0484-421e-8c33-dada62ffc67c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1373f427-d8e3-4da6-9926-fd964a9deac2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1373f427-d8e3-4da6-9926-fd964a9deac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1373f427-d8e3-4da6-9926-fd964a9deac2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1373f427-d8e3-4da6-9926-fd964a9deac2" xlink:to="loc_us-gaap_SegmentDomain_1373f427-d8e3-4da6-9926-fd964a9deac2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1373f427-d8e3-4da6-9926-fd964a9deac2" xlink:to="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_56323fe4-82d2-458a-826e-3765088882fe" xlink:href="holx-20210925.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_DiagnosticsMember_56323fe4-82d2-458a-826e-3765088882fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_e36e4b48-c79c-4dd5-b929-c708b2ed66a9" xlink:href="holx-20210925.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_BreastHealthMember_e36e4b48-c79c-4dd5-b929-c708b2ed66a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_684516ba-89f8-4c6f-9fbc-632de98ff8e1" xlink:href="holx-20210925.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_GynSurgicalMember_684516ba-89f8-4c6f-9fbc-632de98ff8e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_b6655313-82bb-4218-9255-dad2b40e6c93" xlink:href="holx-20210925.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_SkeletalHealthMember_b6655313-82bb-4218-9255-dad2b40e6c93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_c7a023fa-75af-4a66-ad74-765139710f25" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_MedicalAestheticsMember_c7a023fa-75af-4a66-ad74-765139710f25" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_014e2ac9-19c5-463a-a04b-7f1d2244c9b0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:to="loc_srt_ProductOrServiceAxis_014e2ac9-19c5-463a-a04b-7f1d2244c9b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_014e2ac9-19c5-463a-a04b-7f1d2244c9b0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_014e2ac9-19c5-463a-a04b-7f1d2244c9b0" xlink:to="loc_srt_ProductsAndServicesDomain_014e2ac9-19c5-463a-a04b-7f1d2244c9b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_014e2ac9-19c5-463a-a04b-7f1d2244c9b0" xlink:to="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_08533749-61a0-49c9-94d1-b3b9747fed5d" xlink:href="holx-20210925.xsd#holx_CytologyPerinatalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_CytologyPerinatalMember_08533749-61a0-49c9-94d1-b3b9747fed5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_91a77ccc-b2b5-4256-8b54-bc3a067845fa" xlink:href="holx-20210925.xsd#holx_MolecularDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_MolecularDiagnosticsMember_91a77ccc-b2b5-4256-8b54-bc3a067845fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_7504b3ce-3207-4ede-a8ef-aab6a0ad42ca" xlink:href="holx-20210925.xsd#holx_BloodScreeningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_BloodScreeningMember_7504b3ce-3207-4ede-a8ef-aab6a0ad42ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_2fd106ec-df74-4e5f-a2f8-d95aaf3d630c" xlink:href="holx-20210925.xsd#holx_BreastImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_BreastImagingMember_2fd106ec-df74-4e5f-a2f8-d95aaf3d630c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_39180e81-77dd-487e-9e06-8c46e449ecdb" xlink:href="holx-20210925.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_InterventionalBreastSolutionsMember_39180e81-77dd-487e-9e06-8c46e449ecdb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7902dcdf-954e-420e-9e5e-29cc4f244c09" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:to="loc_srt_StatementGeographicalAxis_7902dcdf-954e-420e-9e5e-29cc4f244c09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7902dcdf-954e-420e-9e5e-29cc4f244c09_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7902dcdf-954e-420e-9e5e-29cc4f244c09" xlink:to="loc_srt_SegmentGeographicalDomain_7902dcdf-954e-420e-9e5e-29cc4f244c09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fbd60dcb-d253-48e0-82f5-3bd5c4cd221c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7902dcdf-954e-420e-9e5e-29cc4f244c09" xlink:to="loc_srt_SegmentGeographicalDomain_fbd60dcb-d253-48e0-82f5-3bd5c4cd221c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e13bdc57-f57f-4d1a-9556-a265e20d0798" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_fbd60dcb-d253-48e0-82f5-3bd5c4cd221c" xlink:to="loc_country_US_e13bdc57-f57f-4d1a-9556-a265e20d0798" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_aa780d22-9348-43f4-afc2-203423d06497" xlink:href="holx-20210925.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_fbd60dcb-d253-48e0-82f5-3bd5c4cd221c" xlink:to="loc_holx_InternationalMember_aa780d22-9348-43f4-afc2-203423d06497" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueGeographicalRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended" id="i0125ba5ce288426198c9d3c20088764d_RevenueGeographicalRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0ed1d37b-d36f-4af0-b3b1-dab1c826f712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fce89274-ab17-462d-b318-e69934ac03a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0ed1d37b-d36f-4af0-b3b1-dab1c826f712" xlink:to="loc_us-gaap_Revenues_fce89274-ab17-462d-b318-e69934ac03a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c8dea8c6-1148-42c4-b2ac-1456dd3fa5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0ed1d37b-d36f-4af0-b3b1-dab1c826f712" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c8dea8c6-1148-42c4-b2ac-1456dd3fa5eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6237d7de-f9db-4653-8f5b-94eb694e536b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c8dea8c6-1148-42c4-b2ac-1456dd3fa5eb" xlink:to="loc_srt_ProductOrServiceAxis_6237d7de-f9db-4653-8f5b-94eb694e536b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6237d7de-f9db-4653-8f5b-94eb694e536b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6237d7de-f9db-4653-8f5b-94eb694e536b" xlink:to="loc_srt_ProductsAndServicesDomain_6237d7de-f9db-4653-8f5b-94eb694e536b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e35698a6-3448-4003-93c2-c8531c535312" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6237d7de-f9db-4653-8f5b-94eb694e536b" xlink:to="loc_srt_ProductsAndServicesDomain_e35698a6-3448-4003-93c2-c8531c535312" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ecf47fba-acdd-4056-9024-81aee0902665" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c8dea8c6-1148-42c4-b2ac-1456dd3fa5eb" xlink:to="loc_srt_StatementGeographicalAxis_ecf47fba-acdd-4056-9024-81aee0902665" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ecf47fba-acdd-4056-9024-81aee0902665_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ecf47fba-acdd-4056-9024-81aee0902665" xlink:to="loc_srt_SegmentGeographicalDomain_ecf47fba-acdd-4056-9024-81aee0902665_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ecf47fba-acdd-4056-9024-81aee0902665" xlink:to="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_37f747c8-fe87-4153-95c1-7e99163208fa" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:to="loc_country_US_37f747c8-fe87-4153-95c1-7e99163208fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_70566e04-e2c4-4785-a662-6afdd433d6b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:to="loc_srt_EuropeMember_70566e04-e2c4-4785-a662-6afdd433d6b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_fc525bb5-5e72-441b-afea-291b018deb3e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:to="loc_srt_AsiaPacificMember_fc525bb5-5e72-441b-afea-291b018deb3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherGeographicRegionsMember_c4354b8c-b154-4c2c-9421-89913e081e08" xlink:href="holx-20210925.xsd#holx_OtherGeographicRegionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:to="loc_holx_OtherGeographicRegionsMember_c4354b8c-b154-4c2c-9421-89913e081e08" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueRevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended" id="ia995121de4604a65b2b0132b4249befa_RevenueRevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3d39ffd9-39df-45c4-be95-04280e35e3e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5abcb527-81c0-4852-84f5-41f57b707eac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d39ffd9-39df-45c4-be95-04280e35e3e1" xlink:to="loc_us-gaap_Revenues_5abcb527-81c0-4852-84f5-41f57b707eac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d39ffd9-39df-45c4-be95-04280e35e3e1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eda1241f-3ace-4b7d-bf3c-f87e971beff0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:to="loc_srt_ProductOrServiceAxis_eda1241f-3ace-4b7d-bf3c-f87e971beff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_eda1241f-3ace-4b7d-bf3c-f87e971beff0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_eda1241f-3ace-4b7d-bf3c-f87e971beff0" xlink:to="loc_srt_ProductsAndServicesDomain_eda1241f-3ace-4b7d-bf3c-f87e971beff0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_eda1241f-3ace-4b7d-bf3c-f87e971beff0" xlink:to="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_0770e671-9b09-4d8a-a90e-ed7973dddeb8" xlink:href="holx-20210925.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_0770e671-9b09-4d8a-a90e-ed7973dddeb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_5ef18e65-a1be-43d2-bee4-a9e9fabfaf43" xlink:href="holx-20210925.xsd#holx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:to="loc_holx_ConsumablesMember_5ef18e65-a1be-43d2-bee4-a9e9fabfaf43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ea228243-e5bf-46cc-8a8e-ccd14d51e81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:to="loc_us-gaap_ServiceMember_ea228243-e5bf-46cc-8a8e-ccd14d51e81b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_a8e0c2f2-238c-4d36-a570-d14a28f5496a" xlink:href="holx-20210925.xsd#holx_OtherTypeofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:to="loc_holx_OtherTypeofRevenueMember_a8e0c2f2-238c-4d36-a570-d14a28f5496a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_70662375-1a22-401c-9ecf-a1afc16237a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:to="loc_srt_StatementGeographicalAxis_70662375-1a22-401c-9ecf-a1afc16237a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_70662375-1a22-401c-9ecf-a1afc16237a0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_70662375-1a22-401c-9ecf-a1afc16237a0" xlink:to="loc_srt_SegmentGeographicalDomain_70662375-1a22-401c-9ecf-a1afc16237a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ccada997-7ce8-40e3-a9a4-7c57f2b45c29" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_70662375-1a22-401c-9ecf-a1afc16237a0" xlink:to="loc_srt_SegmentGeographicalDomain_ccada997-7ce8-40e3-a9a4-7c57f2b45c29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_bca015ff-bec0-4d32-a4c7-dcbce6ca9ede" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ccada997-7ce8-40e3-a9a4-7c57f2b45c29" xlink:to="loc_country_US_bca015ff-bec0-4d32-a4c7-dcbce6ca9ede" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_40571ab9-b9c8-430a-a5f7-01c0e679a528" xlink:href="holx-20210925.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ccada997-7ce8-40e3-a9a4-7c57f2b45c29" xlink:to="loc_holx_InternationalMember_40571ab9-b9c8-430a-a5f7-01c0e679a528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6c2199d0-200d-4a44-9ae9-ea37cb4674e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6c2199d0-200d-4a44-9ae9-ea37cb4674e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6c2199d0-200d-4a44-9ae9-ea37cb4674e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6c2199d0-200d-4a44-9ae9-ea37cb4674e5" xlink:to="loc_us-gaap_SegmentDomain_6c2199d0-200d-4a44-9ae9-ea37cb4674e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2613dfbd-9868-468a-b9a3-fa48c717b8bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6c2199d0-200d-4a44-9ae9-ea37cb4674e5" xlink:to="loc_us-gaap_SegmentDomain_2613dfbd-9868-468a-b9a3-fa48c717b8bc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueRemainingPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="extended" id="ib271bdbd670741d4a26f07c3ce08e4ba_RevenueRemainingPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b5d18d40-e76b-450d-bbef-be1736190d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b5d18d40-e76b-450d-bbef-be1736190d4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_f007d032-c0d7-4000-9085-534b12839bcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_f007d032-c0d7-4000-9085-534b12839bcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4743a050-e081-490c-990f-4b712325a28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4743a050-e081-490c-990f-4b712325a28a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_514cf931-f5b7-40bc-9635-848bd3428e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4743a050-e081-490c-990f-4b712325a28a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_514cf931-f5b7-40bc-9635-848bd3428e43" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueRemainingPerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="extended" id="i9077af5cc10a4fbda6e8eea75f9d2d99_RevenueRemainingPerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b5d18d40-e76b-450d-bbef-be1736190d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b5d18d40-e76b-450d-bbef-be1736190d4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_f007d032-c0d7-4000-9085-534b12839bcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_f007d032-c0d7-4000-9085-534b12839bcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4743a050-e081-490c-990f-4b712325a28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4743a050-e081-490c-990f-4b712325a28a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i5051f9a80108425f8e60ff1574b48268_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_aaab0dd0-92ad-4a91-a084-79eba8d0894f" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_aaab0dd0-92ad-4a91-a084-79eba8d0894f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_fc917350-35a9-4824-8bab-3588162c761e" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_fc917350-35a9-4824-8bab-3588162c761e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_0c0fe5bc-b225-4cd3-a812-79a8a5833599" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeasesExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_0c0fe5bc-b225-4cd3-a812-79a8a5833599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_d542f356-29f2-4810-a26f-74ec2520e74a" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_d542f356-29f2-4810-a26f-74ec2520e74a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_8e45d298-6ae1-47de-9abc-b162c99026e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_8e45d298-6ae1-47de-9abc-b162c99026e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b5b75e42-628c-4d49-815c-3b2237567811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b5b75e42-628c-4d49-815c-3b2237567811" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_64a2a032-90ea-4da3-8390-f9eb1efa408e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_64a2a032-90ea-4da3-8390-f9eb1efa408e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue_12206481-adb7-4481-80b5-53a26158a5f9" xlink:href="holx-20210925.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LeaseRevenuePercentageOfTotalRevenue_12206481-adb7-4481-80b5-53a26158a5f9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_da11e018-80e1-4931-8d3f-bfb1ad1407fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_da11e018-80e1-4931-8d3f-bfb1ad1407fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseReceivable_9fc7e043-c5c9-46c9-b9fb-ccc06dafe37e" xlink:href="holx-20210925.xsd#holx_LeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LeaseReceivable_9fc7e043-c5c9-46c9-b9fb-ccc06dafe37e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ba1a1756-cee0-48c6-80c8-dfa6448f22c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ba1a1756-cee0-48c6-80c8-dfa6448f22c1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_762020f9-7224-4308-af6f-5216e4b229e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_762020f9-7224-4308-af6f-5216e4b229e9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7b4e45d3-4aee-4689-8cf0-99f7000043fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OperatingLeaseLiability_7b4e45d3-4aee-4689-8cf0-99f7000043fe" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7bf7f348-17ab-47b4-bc14-3bd322067266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseLiability_7bf7f348-17ab-47b4-bc14-3bd322067266" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a4e82237-e288-46b4-99fe-27b8912a3f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a4e82237-e288-46b4-99fe-27b8912a3f91" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_eaccfe2e-565d-4f9b-85fe-2f93471ba95e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_eaccfe2e-565d-4f9b-85fe-2f93471ba95e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_b6cb4d88-7f23-4040-9e26-1b8a8ea6c83e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_b6cb4d88-7f23-4040-9e26-1b8a8ea6c83e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1da69d82-a3b6-4763-a455-6fa73ea6f4aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1da69d82-a3b6-4763-a455-6fa73ea6f4aa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ecb5ca86-a175-4472-8c35-f83fe7dbc634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ecb5ca86-a175-4472-8c35-f83fe7dbc634" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cde0a823-9ccb-4fa0-a935-24937bc242c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_f4066da4-f3c2-470a-a6c0-2c1aec25eb8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_SubleaseIncome_f4066da4-f3c2-470a-a6c0-2c1aec25eb8b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0148df3e-0c66-4bda-9199-8d6370e6b553" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:to="loc_srt_RangeAxis_0148df3e-0c66-4bda-9199-8d6370e6b553" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0148df3e-0c66-4bda-9199-8d6370e6b553_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0148df3e-0c66-4bda-9199-8d6370e6b553" xlink:to="loc_srt_RangeMember_0148df3e-0c66-4bda-9199-8d6370e6b553_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dcfa4b6d-d005-42b4-8cf0-e60da62daca2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0148df3e-0c66-4bda-9199-8d6370e6b553" xlink:to="loc_srt_RangeMember_dcfa4b6d-d005-42b4-8cf0-e60da62daca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_10d4057f-564a-408c-8c59-c273b2b95905" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dcfa4b6d-d005-42b4-8cf0-e60da62daca2" xlink:to="loc_srt_MinimumMember_10d4057f-564a-408c-8c59-c273b2b95905" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b8683ba2-e49a-4db2-911e-ca018c4f8210" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dcfa4b6d-d005-42b4-8cf0-e60da62daca2" xlink:to="loc_srt_MaximumMember_b8683ba2-e49a-4db2-911e-ca018c4f8210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e6b79058-3a65-4154-bcb7-df975d37deff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e6b79058-3a65-4154-bcb7-df975d37deff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_e6b79058-3a65-4154-bcb7-df975d37deff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e6b79058-3a65-4154-bcb7-df975d37deff" xlink:to="loc_us-gaap_TypeOfAdoptionMember_e6b79058-3a65-4154-bcb7-df975d37deff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c083475e-9682-4f29-ba49-f3fe03c619ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e6b79058-3a65-4154-bcb7-df975d37deff" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c083475e-9682-4f29-ba49-f3fe03c619ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_908dffa5-98e3-4ed4-8893-30435246d8f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_c083475e-9682-4f29-ba49-f3fe03c619ee" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_908dffa5-98e3-4ed4-8893-30435246d8f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_2dbad7bd-8805-4389-abe0-b10a84478392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_dd257fef-f841-4716-b591-4400389eb04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_dd257fef-f841-4716-b591-4400389eb04b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_64876c39-68b3-43dd-90cb-95ee0411c7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0be7a716-3bda-4162-b0d4-78acbb157421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0be7a716-3bda-4162-b0d4-78acbb157421" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0be7a716-3bda-4162-b0d4-78acbb157421_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0be7a716-3bda-4162-b0d4-78acbb157421" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0be7a716-3bda-4162-b0d4-78acbb157421_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0be7a716-3bda-4162-b0d4-78acbb157421" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_c36495cd-ef51-44b0-9770-0b0f8668a796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_c36495cd-ef51-44b0-9770-0b0f8668a796" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsShortTermMember_73b3f74b-36d9-43a2-af11-41f8c71e41b0" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsShortTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:to="loc_holx_FinanceLeaseObligationsShortTermMember_73b3f74b-36d9-43a2-af11-41f8c71e41b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsLongTermMember_1f871ef0-8c46-4e65-8941-10f14dbac2ab" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsLongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:to="loc_holx_FinanceLeaseObligationsLongTermMember_1f871ef0-8c46-4e65-8941-10f14dbac2ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_69399530-6b6d-464e-9d88-be86d96edb4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_69399530-6b6d-464e-9d88-be86d96edb4a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69399530-6b6d-464e-9d88-be86d96edb4a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_69399530-6b6d-464e-9d88-be86d96edb4a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69399530-6b6d-464e-9d88-be86d96edb4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65f7bed8-01cb-4fcc-9c94-e73874645b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_69399530-6b6d-464e-9d88-be86d96edb4a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65f7bed8-01cb-4fcc-9c94-e73874645b99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_fa8916bb-7ad4-4622-ae38-d1000c69b4e9" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65f7bed8-01cb-4fcc-9c94-e73874645b99" xlink:to="loc_holx_DiagenodeMember_fa8916bb-7ad4-4622-ae38-d1000c69b4e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_f162eaea-a468-4342-938d-e201582ff873" xlink:href="holx-20210925.xsd#holx_CynosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65f7bed8-01cb-4fcc-9c94-e73874645b99" xlink:to="loc_holx_CynosureMember_f162eaea-a468-4342-938d-e201582ff873" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i6f6c0157be7245548fbd2d726ca00db0_LeasesSupplementalBalanceSheetInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e113d40c-e77d-4e1c-b6c4-d4bbffca65cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e113d40c-e77d-4e1c-b6c4-d4bbffca65cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7f10662c-485c-4447-98d3-d0ce5e2d1302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7f10662c-485c-4447-98d3-d0ce5e2d1302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_42a5c783-e481-4ffc-bd9a-b74431feb4a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_42a5c783-e481-4ffc-bd9a-b74431feb4a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_91900f96-c69a-4cef-b142-128aa47c393d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_91900f96-c69a-4cef-b142-128aa47c393d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_93218d67-eb78-4029-b33c-61557b078d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_93218d67-eb78-4029-b33c-61557b078d32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c31dde7f-3e7e-44c3-87a3-bd81738b9365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c31dde7f-3e7e-44c3-87a3-bd81738b9365" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_82669b9e-64bd-47de-a0a1-824bf7d29d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_82669b9e-64bd-47de-a0a1-824bf7d29d17" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_68ab33fa-652c-477a-9e10-b91b83dffd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_68ab33fa-652c-477a-9e10-b91b83dffd00" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_27f7269a-617f-4eee-86f6-7d49ac60933e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_27f7269a-617f-4eee-86f6-7d49ac60933e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b359e213-9515-48b6-ad81-695a8ec862d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b359e213-9515-48b6-ad81-695a8ec862d8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d344e92e-f209-42cc-a817-1e62f2d41aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d344e92e-f209-42cc-a817-1e62f2d41aaf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_4f20ab0d-bb5e-4afa-9d3f-8115c8f3a512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_4f20ab0d-bb5e-4afa-9d3f-8115c8f3a512" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2209a962-4686-4517-8c0f-822121b487b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2209a962-4686-4517-8c0f-822121b487b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e3d0fb79-4e13-4e2f-9c05-2e9c88cf26a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2209a962-4686-4517-8c0f-822121b487b0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e3d0fb79-4e13-4e2f-9c05-2e9c88cf26a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e3d0fb79-4e13-4e2f-9c05-2e9c88cf26a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e3d0fb79-4e13-4e2f-9c05-2e9c88cf26a3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e3d0fb79-4e13-4e2f-9c05-2e9c88cf26a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e3d0fb79-4e13-4e2f-9c05-2e9c88cf26a3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_01ab956e-7e1a-4752-b07d-b7b3520b771c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_us-gaap_OtherAssetsMember_01ab956e-7e1a-4752-b07d-b7b3520b771c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_6ff530c7-fd3a-4a05-81de-fe0f9593bbb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_6ff530c7-fd3a-4a05-81de-fe0f9593bbb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_cd196a71-5bcf-4d9b-8f0e-1ccfd8708c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_cd196a71-5bcf-4d9b-8f0e-1ccfd8708c0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsShortTermMember_efbf0d67-70d6-46f5-92f5-5986756fc3be" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsShortTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_holx_FinanceLeaseObligationsShortTermMember_efbf0d67-70d6-46f5-92f5-5986756fc3be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsLongTermMember_d7a1ea65-e832-4ffa-b789-04c438b263d4" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsLongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_holx_FinanceLeaseObligationsLongTermMember_d7a1ea65-e832-4ffa-b789-04c438b263d4" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended" id="i44cc4cebe1c04ae1bb924b70b1a6630b_LeasesAdditionalLeaseInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfFinanceLeases_c246fe37-65b2-49ef-888d-1c9fde2c0599" xlink:href="holx-20210925.xsd#holx_NumberOfFinanceLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:to="loc_holx_NumberOfFinanceLeases_c246fe37-65b2-49ef-888d-1c9fde2c0599" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_0d570935-a393-4f9b-b6f8-318eac006898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_0d570935-a393-4f9b-b6f8-318eac006898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage_81f3b95a-339a-431d-82f2-7221de6243ce" xlink:href="holx-20210925.xsd#holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:to="loc_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage_81f3b95a-339a-431d-82f2-7221de6243ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_6bf9286a-1861-4870-a6cb-8dbd395c6b45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_6bf9286a-1861-4870-a6cb-8dbd395c6b45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_72caaa02-ef29-49b8-8d34-d92b1e40a3ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_6bf9286a-1861-4870-a6cb-8dbd395c6b45" xlink:to="loc_srt_RangeAxis_72caaa02-ef29-49b8-8d34-d92b1e40a3ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_72caaa02-ef29-49b8-8d34-d92b1e40a3ba_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_72caaa02-ef29-49b8-8d34-d92b1e40a3ba" xlink:to="loc_srt_RangeMember_72caaa02-ef29-49b8-8d34-d92b1e40a3ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8f7d6eda-0c23-4823-bb9c-661e53e5a9e3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_72caaa02-ef29-49b8-8d34-d92b1e40a3ba" xlink:to="loc_srt_RangeMember_8f7d6eda-0c23-4823-bb9c-661e53e5a9e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4c841505-7ff7-4bec-a955-5f84cba25dc3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8f7d6eda-0c23-4823-bb9c-661e53e5a9e3" xlink:to="loc_srt_MinimumMember_4c841505-7ff7-4bec-a955-5f84cba25dc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_20ea879e-30b6-449b-98f1-dc173343ac57" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8f7d6eda-0c23-4823-bb9c-661e53e5a9e3" xlink:to="loc_srt_MaximumMember_20ea879e-30b6-449b-98f1-dc173343ac57" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessCombinationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended" id="icb0a43a70d5b4c40a8032c757a89f1ca_BusinessCombinationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_dd98ee64-f8f8-4c6a-b01d-1c1acf3bd04c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_dd98ee64-f8f8-4c6a-b01d-1c1acf3bd04c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_250e251d-d4b2-433c-a62e-09a11079eb42" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_250e251d-d4b2-433c-a62e-09a11079eb42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f3d01a14-be3e-4a2e-b397-d3eac5af894d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f3d01a14-be3e-4a2e-b397-d3eac5af894d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_0c49c822-286a-4a40-9f71-002b0d9826fd" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_0c49c822-286a-4a40-9f71-002b0d9826fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_911e92ab-dee5-4241-a82f-09c2451f1ac7" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_911e92ab-dee5-4241-a82f-09c2451f1ac7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_649fbed2-5d77-44f9-87ae-bda20ec1a56c" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_649fbed2-5d77-44f9-87ae-bda20ec1a56c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5494e009-fa05-456b-a4ab-cb8ae8cef82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_Goodwill_5494e009-fa05-456b-a4ab-cb8ae8cef82d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c4233df8-9123-4e03-b22e-ceca479546e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c4233df8-9123-4e03-b22e-ceca479546e0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_43fa0c1f-9a0f-417f-b571-ba19d588691f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_43fa0c1f-9a0f-417f-b571-ba19d588691f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e35ff895-0cbc-433e-bcbf-4fef158c3725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e35ff895-0cbc-433e-bcbf-4fef158c3725" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_8ac77d42-32de-47ea-8191-05305e95906e" xlink:href="holx-20210925.xsd#holx_Holdback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_Holdback_8ac77d42-32de-47ea-8191-05305e95906e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e9b9e8aa-adbd-42a7-b04d-2c467b8af870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e9b9e8aa-adbd-42a7-b04d-2c467b8af870" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3b0839ca-bcbb-437d-ab7e-f7cba51ff6b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3b0839ca-bcbb-437d-ab7e-f7cba51ff6b2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5281b356-4d53-4f0d-97a1-2858427595aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5281b356-4d53-4f0d-97a1-2858427595aa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_987f3ed3-6b9c-4a27-b01c-d976bef5c72c" xlink:href="holx-20210925.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_987f3ed3-6b9c-4a27-b01c-d976bef5c72c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_920c3f3c-af1d-45cc-b208-30dd7799d8fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_920c3f3c-af1d-45cc-b208-30dd7799d8fb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired_a7a0ebb7-2bb2-4996-b71e-4391306e69a2" xlink:href="holx-20210925.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationSharesAcquired_a7a0ebb7-2bb2-4996-b71e-4391306e69a2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AdditionalPurchaseConsideration_5695482e-de72-4d9b-9acc-44f13aaf7374" xlink:href="holx-20210925.xsd#holx_AdditionalPurchaseConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_AdditionalPurchaseConsideration_5695482e-de72-4d9b-9acc-44f13aaf7374" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_4e89ef65-b6bb-4a9d-9af2-9c3c5d3ef00b" xlink:href="holx-20210925.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_4e89ef65-b6bb-4a9d-9af2-9c3c5d3ef00b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_2422e790-a9eb-4337-ac43-e6fae7cbb4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_2422e790-a9eb-4337-ac43-e6fae7cbb4bb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_e56a152f-6967-49a6-b3ff-135e2ea86143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_e56a152f-6967-49a6-b3ff-135e2ea86143" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_3bb82d9b-5e7e-4f73-b069-d1550c9df0dd" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_3bb82d9b-5e7e-4f73-b069-d1550c9df0dd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_f6ad0a75-126a-4067-b17f-2cec880c17e0" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_f6ad0a75-126a-4067-b17f-2cec880c17e0" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_4f29dc69-5ec3-4eeb-971c-0d4cd69589e1" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_4f29dc69-5ec3-4eeb-971c-0d4cd69589e1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_79e214df-91fa-49a1-af75-fdfb856d84b9" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_79e214df-91fa-49a1-af75-fdfb856d84b9" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_c6eef68c-6e3f-44e2-aa43-f6445bcf93a5" xlink:href="holx-20210925.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_c6eef68c-6e3f-44e2-aa43-f6445bcf93a5" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_9059510d-6e9c-4da6-b46d-800b7c0a3fad" xlink:href="holx-20210925.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_9059510d-6e9c-4da6-b46d-800b7c0a3fad" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_d185dfe2-67de-43fe-8f97-adae570f94b1" xlink:href="holx-20210925.xsd#holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_d185dfe2-67de-43fe-8f97-adae570f94b1" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess_e29cea26-a10e-496c-ade1-33f113c8f6f1" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess_e29cea26-a10e-496c-ade1-33f113c8f6f1" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2df5c914-cf72-467e-8bf5-7d1ccaa6aa2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2df5c914-cf72-467e-8bf5-7d1ccaa6aa2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2df5c914-cf72-467e-8bf5-7d1ccaa6aa2a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2df5c914-cf72-467e-8bf5-7d1ccaa6aa2a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2df5c914-cf72-467e-8bf5-7d1ccaa6aa2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2df5c914-cf72-467e-8bf5-7d1ccaa6aa2a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_87979864-24b6-493c-93a4-0f31d1aa8471" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_MobidiagOyMember_87979864-24b6-493c-93a4-0f31d1aa8471" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_098a75cf-46d7-4e1d-8027-b07d8bd1e5bc" xlink:href="holx-20210925.xsd#holx_BiotheranosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_BiotheranosticsMember_098a75cf-46d7-4e1d-8027-b07d8bd1e5bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_1613e33b-a89d-483d-a059-a353d81c4652" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_DiagenodeMember_1613e33b-a89d-483d-a059-a353d81c4652" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMedicalTechnologiesMember_c74a7e28-ef8a-4122-9def-df10bdd1e550" xlink:href="holx-20210925.xsd#holx_SomatexMedicalTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_SomatexMedicalTechnologiesMember_c74a7e28-ef8a-4122-9def-df10bdd1e550" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember_1f9b9e5a-0b4a-4a03-b907-96a4aff4ebe7" xlink:href="holx-20210925.xsd#holx_NXCImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_NXCImagingMember_1f9b9e5a-0b4a-4a03-b907-96a4aff4ebe7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_78aed6a4-86be-4456-951f-801c7bf747a1" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_AcessaHealthMember_78aed6a4-86be-4456-951f-801c7bf747a1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_cf857e8b-40e1-4ffc-8600-bbdcf4a68309" xlink:href="holx-20210925.xsd#holx_HealthBeaconsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_HealthBeaconsMember_cf857e8b-40e1-4ffc-8600-bbdcf4a68309" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_04dc33be-d5c0-4e65-9821-16086300a801" xlink:href="holx-20210925.xsd#holx_AlphaImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_AlphaImagingMember_04dc33be-d5c0-4e65-9821-16086300a801" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_c23432d0-3e33-4e5d-b9a8-e359428311f2" xlink:href="holx-20210925.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_SuperSonicImagineMember_c23432d0-3e33-4e5d-b9a8-e359428311f2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_426ebedd-3d67-4d25-8649-a016148a8c59" xlink:href="holx-20210925.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_FocalTherapeuticsInc.Member_426ebedd-3d67-4d25-8649-a016148a8c59" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_5dfb4177-e8a3-44b3-a216-e177cd527978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_5dfb4177-e8a3-44b3-a216-e177cd527978" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_5dfb4177-e8a3-44b3-a216-e177cd527978_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_5dfb4177-e8a3-44b3-a216-e177cd527978" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_5dfb4177-e8a3-44b3-a216-e177cd527978_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f21d767c-ce44-44a1-8a60-070697557852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_5dfb4177-e8a3-44b3-a216-e177cd527978" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f21d767c-ce44-44a1-8a60-070697557852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_84a16b56-938a-4a9b-82b2-299783e72610" xlink:href="holx-20210925.xsd#holx_ContingentHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f21d767c-ce44-44a1-8a60-070697557852" xlink:to="loc_holx_ContingentHoldbackMember_84a16b56-938a-4a9b-82b2-299783e72610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a1536b9d-9611-46d6-a2fd-8c2bba8a47db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a1536b9d-9611-46d6-a2fd-8c2bba8a47db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1536b9d-9611-46d6-a2fd-8c2bba8a47db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a1536b9d-9611-46d6-a2fd-8c2bba8a47db" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a1536b9d-9611-46d6-a2fd-8c2bba8a47db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a1536b9d-9611-46d6-a2fd-8c2bba8a47db" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_c47d2686-00d8-4eb3-87d9-a098378c98ec" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_holx_DevelopedTechnologyMember_c47d2686-00d8-4eb3-87d9-a098378c98ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9418dece-5777-4df1-8e69-37a7f7c10c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9418dece-5777-4df1-8e69-37a7f7c10c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_7c2aa34b-7149-4eec-b74a-678280e42104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_us-gaap_TradeNamesMember_7c2aa34b-7149-4eec-b74a-678280e42104" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_71702abc-a0f4-4eb6-ab2a-1fc3f4436fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_71702abc-a0f4-4eb6-ab2a-1fc3f4436fc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c01ed985-6425-4092-9686-409dbb370103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c01ed985-6425-4092-9686-409dbb370103" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5d3d83a2-8017-449a-b514-b157a8411d7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_srt_RangeAxis_5d3d83a2-8017-449a-b514-b157a8411d7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5d3d83a2-8017-449a-b514-b157a8411d7b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5d3d83a2-8017-449a-b514-b157a8411d7b" xlink:to="loc_srt_RangeMember_5d3d83a2-8017-449a-b514-b157a8411d7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b918254-e3ab-4b08-904d-c16c74ce0e95" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5d3d83a2-8017-449a-b514-b157a8411d7b" xlink:to="loc_srt_RangeMember_7b918254-e3ab-4b08-904d-c16c74ce0e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_514ecdcf-cfab-42d1-93c5-24b0a0a6d317" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7b918254-e3ab-4b08-904d-c16c74ce0e95" xlink:to="loc_srt_MinimumMember_514ecdcf-cfab-42d1-93c5-24b0a0a6d317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9338b73e-9868-42e7-97b9-a3ad328842ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7b918254-e3ab-4b08-904d-c16c74ce0e95" xlink:to="loc_srt_MaximumMember_9338b73e-9868-42e7-97b9-a3ad328842ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f1871b2d-731e-41ac-aea1-5210c860921b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f1871b2d-731e-41ac-aea1-5210c860921b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f1871b2d-731e-41ac-aea1-5210c860921b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f1871b2d-731e-41ac-aea1-5210c860921b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f1871b2d-731e-41ac-aea1-5210c860921b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cca8300a-e1ee-42de-b67a-3e04cbad7341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f1871b2d-731e-41ac-aea1-5210c860921b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cca8300a-e1ee-42de-b67a-3e04cbad7341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_0aa3a39b-3578-4e34-87cf-1a4305f4f6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cca8300a-e1ee-42de-b67a-3e04cbad7341" xlink:to="loc_us-gaap_OtherIncomeMember_0aa3a39b-3578-4e34-87cf-1a4305f4f6c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cc393ede-4a60-4752-962b-ad7676b76655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cc393ede-4a60-4752-962b-ad7676b76655" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_cc393ede-4a60-4752-962b-ad7676b76655_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cc393ede-4a60-4752-962b-ad7676b76655" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_cc393ede-4a60-4752-962b-ad7676b76655_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_d417cf09-3278-47a0-a7e8-dcf5f70565b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cc393ede-4a60-4752-962b-ad7676b76655" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_d417cf09-3278-47a0-a7e8-dcf5f70565b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b2d26de3-cc71-4d02-9781-0996f0479eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_d417cf09-3278-47a0-a7e8-dcf5f70565b0" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b2d26de3-cc71-4d02-9781-0996f0479eff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended" id="iddebe50744894077b900337a5d502e78_BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bbcba14d-79b3-419c-9276-3ca9791a69f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bbcba14d-79b3-419c-9276-3ca9791a69f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d4e98839-945b-43e9-9aed-748e9ccfdb6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d4e98839-945b-43e9-9aed-748e9ccfdb6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_05f27794-d637-42a9-8cb4-dd9a4766ab61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_05f27794-d637-42a9-8cb4-dd9a4766ab61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_3d032238-055a-481c-8e99-5d33b43ed015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_3d032238-055a-481c-8e99-5d33b43ed015" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a16e72fd-de11-4b39-b826-bc051d6ebb70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a16e72fd-de11-4b39-b826-bc051d6ebb70" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d78eb050-dad7-42c8-9e85-c171d1278101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d78eb050-dad7-42c8-9e85-c171d1278101" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_36632b3d-100f-4b96-bfef-343901fb1b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_36632b3d-100f-4b96-bfef-343901fb1b00" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_9b39888d-edcb-47a6-84ff-403dcb2b28fa" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_9b39888d-edcb-47a6-84ff-403dcb2b28fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_796356f0-1291-447e-85fe-3a76db6ee71d" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_796356f0-1291-447e-85fe-3a76db6ee71d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_0b83bd42-1e60-42b9-b584-1b3a79f87c99" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_0b83bd42-1e60-42b9-b584-1b3a79f87c99" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_9a4ce039-a360-41a4-b7b8-b85db4a035e4" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_9a4ce039-a360-41a4-b7b8-b85db4a035e4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_8be2c9d7-4e96-4943-8ae4-aa8f59945ae4" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_8be2c9d7-4e96-4943-8ae4-aa8f59945ae4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_3edb5176-fb4b-4bfe-b6b7-7bb66b27e9dc" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_3edb5176-fb4b-4bfe-b6b7-7bb66b27e9dc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_01613ff6-799e-4d50-8dca-553bc6ab7bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_01613ff6-799e-4d50-8dca-553bc6ab7bb7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0190b84c-c410-4f84-97d0-47b5b1ad1028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0190b84c-c410-4f84-97d0-47b5b1ad1028" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_86e397e1-2ddf-4ebc-bc00-fb92771282d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_Goodwill_86e397e1-2ddf-4ebc-bc00-fb92771282d4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_139074d2-f918-4f79-8330-44968739003b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_139074d2-f918-4f79-8330-44968739003b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_710a8715-91e0-4f2a-9ffb-2f32015e9e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_710a8715-91e0-4f2a-9ffb-2f32015e9e0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_15b7a36e-02a7-49d1-90d7-443f4ee432de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_710a8715-91e0-4f2a-9ffb-2f32015e9e0a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_15b7a36e-02a7-49d1-90d7-443f4ee432de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_15b7a36e-02a7-49d1-90d7-443f4ee432de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_15b7a36e-02a7-49d1-90d7-443f4ee432de" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_15b7a36e-02a7-49d1-90d7-443f4ee432de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_15b7a36e-02a7-49d1-90d7-443f4ee432de" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_f3f0309e-2ae5-4497-ab8e-f4a799da1540" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_MobidiagOyMember_f3f0309e-2ae5-4497-ab8e-f4a799da1540" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_77e223c7-b011-41ae-8ba1-741e0c73d7a9" xlink:href="holx-20210925.xsd#holx_BiotheranosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_BiotheranosticsMember_77e223c7-b011-41ae-8ba1-741e0c73d7a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_2e6fc936-0bb5-46a4-a4a5-3ac2089648ea" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_DiagenodeMember_2e6fc936-0bb5-46a4-a4a5-3ac2089648ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_d1cd2664-69ed-47ff-ba71-413413c1dfb1" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_AcessaHealthMember_d1cd2664-69ed-47ff-ba71-413413c1dfb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_860d3f95-2d91-4a77-b22e-5e65b6520cc2" xlink:href="holx-20210925.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_SuperSonicImagineMember_860d3f95-2d91-4a77-b22e-5e65b6520cc2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_839112cf-bb81-43f5-b968-b4daea5f3043" xlink:href="holx-20210925.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_FocalTherapeuticsInc.Member_839112cf-bb81-43f5-b968-b4daea5f3043" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#EquityMethodInvestmentDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="extended" id="i36da2c3dfa3546928bf0ea80c1984037_EquityMethodInvestmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4779ba48-324a-456e-8a18-0c0abfa7e7cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_11f2f221-438f-412c-9f18-7292110dc673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4779ba48-324a-456e-8a18-0c0abfa7e7cb" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_11f2f221-438f-412c-9f18-7292110dc673" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2f32ecb7-63f6-4f29-886b-1382e5b1d378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4779ba48-324a-456e-8a18-0c0abfa7e7cb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2f32ecb7-63f6-4f29-886b-1382e5b1d378" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_09bddfee-84df-4cf0-913b-76e2a795b265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4779ba48-324a-456e-8a18-0c0abfa7e7cb" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_09bddfee-84df-4cf0-913b-76e2a795b265" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5677abe9-7853-4905-b7e5-ec4f9c6013b6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_09bddfee-84df-4cf0-913b-76e2a795b265" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5677abe9-7853-4905-b7e5-ec4f9c6013b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5677abe9-7853-4905-b7e5-ec4f9c6013b6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5677abe9-7853-4905-b7e5-ec4f9c6013b6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5677abe9-7853-4905-b7e5-ec4f9c6013b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9095455d-0b12-446a-ae48-bb3020a33fd2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5677abe9-7853-4905-b7e5-ec4f9c6013b6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9095455d-0b12-446a-ae48-bb3020a33fd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_6739b314-f6b3-4880-93e2-1eedc6742abc" xlink:href="holx-20210925.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9095455d-0b12-446a-ae48-bb3020a33fd2" xlink:to="loc_holx_SuperSonicImagineMember_6739b314-f6b3-4880-93e2-1eedc6742abc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="extended" id="i23f75cc1ce5c4f77832602582f034922_RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_f1726b6a-b74c-4f4c-bdd0-5ca0bcc93bc4" xlink:href="holx-20210925.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:to="loc_holx_ReductionOfWorkforceExpenses_f1726b6a-b74c-4f4c-bdd0-5ca0bcc93bc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_939c8c3c-9e02-4baf-821f-9bf1094a3188" xlink:href="holx-20210925.xsd#holx_DivestitureCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:to="loc_holx_DivestitureCharges_939c8c3c-9e02-4baf-821f-9bf1094a3188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_09d566aa-b061-43db-9829-d614462fed77" xlink:href="holx-20210925.xsd#holx_FacilityClosureCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:to="loc_holx_FacilityClosureCosts_09d566aa-b061-43db-9829-d614462fed77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_22621c1d-58ac-41c3-b826-dcf2c56cfd44" xlink:href="holx-20210925.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_22621c1d-58ac-41c3-b826-dcf2c56cfd44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1994ec38-e675-4f0e-9d81-a24d65985299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1994ec38-e675-4f0e-9d81-a24d65985299" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1994ec38-e675-4f0e-9d81-a24d65985299_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1994ec38-e675-4f0e-9d81-a24d65985299" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1994ec38-e675-4f0e-9d81-a24d65985299_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1994ec38-e675-4f0e-9d81-a24d65985299" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ActionMember_16dcab9b-7e52-45a1-b993-655887a5e01f" xlink:href="holx-20210925.xsd#holx_Fiscal2021ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:to="loc_holx_Fiscal2021ActionMember_16dcab9b-7e52-45a1-b993-655887a5e01f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember_4795b4a8-7140-4057-8706-f85e0761cbf9" xlink:href="holx-20210925.xsd#holx_Fiscal2020ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:to="loc_holx_Fiscal2020ActionMember_4795b4a8-7140-4057-8706-f85e0761cbf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember_790423c7-00e0-46c3-bdaf-ccc5293e1ecc" xlink:href="holx-20210925.xsd#holx_Fiscal2019ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:to="loc_holx_Fiscal2019ActionMember_790423c7-00e0-46c3-bdaf-ccc5293e1ecc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtheractionMember_697dabe9-44eb-4021-bad9-99f9ecf0870f" xlink:href="holx-20210925.xsd#holx_OtheractionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:to="loc_holx_OtheractionMember_697dabe9-44eb-4021-bad9-99f9ecf0870f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6cc7a935-3399-4439-9204-39554aca3363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:to="loc_us-gaap_RestructuringPlanAxis_6cc7a935-3399-4439-9204-39554aca3363" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_6cc7a935-3399-4439-9204-39554aca3363_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_6cc7a935-3399-4439-9204-39554aca3363" xlink:to="loc_us-gaap_RestructuringPlanDomain_6cc7a935-3399-4439-9204-39554aca3363_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_6cc7a935-3399-4439-9204-39554aca3363" xlink:to="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_66c69cc3-7f67-4cb2-ad94-69cebffc4d1b" xlink:href="holx-20210925.xsd#holx_Fiscal2019chargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:to="loc_holx_Fiscal2019chargesMember_66c69cc3-7f67-4cb2-ad94-69cebffc4d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember_ecb2d95f-39e9-4572-b52d-65161a6933e3" xlink:href="holx-20210925.xsd#holx_Fiscal2020ChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:to="loc_holx_Fiscal2020ChargesMember_ecb2d95f-39e9-4572-b52d-65161a6933e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ChargesMember_55a1dca7-cb54-495d-a9cc-b292f0d640c6" xlink:href="holx-20210925.xsd#holx_Fiscal2021ChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:to="loc_holx_Fiscal2021ChargesMember_55a1dca7-cb54-495d-a9cc-b292f0d640c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_29a3cf84-cec1-478c-b8ed-2caeb00aca34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_29a3cf84-cec1-478c-b8ed-2caeb00aca34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_29a3cf84-cec1-478c-b8ed-2caeb00aca34_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_29a3cf84-cec1-478c-b8ed-2caeb00aca34" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_29a3cf84-cec1-478c-b8ed-2caeb00aca34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b8c7a81a-dabb-4691-8ba2-ae10156dcd97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_29a3cf84-cec1-478c-b8ed-2caeb00aca34" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b8c7a81a-dabb-4691-8ba2-ae10156dcd97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_790f55c1-bdb8-476c-9868-312cf559f04c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b8c7a81a-dabb-4691-8ba2-ae10156dcd97" xlink:to="loc_us-gaap_RestructuringChargesMember_790f55c1-bdb8-476c-9868-312cf559f04c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="extended" id="ibff1004b0441430891e22dbb0b398262_RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_13a39458-3473-480e-88e7-90e834e34152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_13a39458-3473-480e-88e7-90e834e34152" xlink:to="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2066736e-2ed1-4e68-816b-da80eeab74b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_us-gaap_RestructuringReserve_2066736e-2ed1-4e68-816b-da80eeab74b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_33834da9-9163-45d3-96db-239bd15ba07e" xlink:href="holx-20210925.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_33834da9-9163-45d3-96db-239bd15ba07e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_5fccf534-a156-43e3-aad5-4b25a861ca87" xlink:href="holx-20210925.xsd#holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_5fccf534-a156-43e3-aad5-4b25a861ca87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashSeverancePayments_5e58d180-eeca-4502-a8b3-7b1f2117e1f2" xlink:href="holx-20210925.xsd#holx_CashSeverancePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_holx_CashSeverancePayments_5e58d180-eeca-4502-a8b3-7b1f2117e1f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherRestructuringPayments_0d4cf231-b6b6-4799-8e2a-78a67020c0e9" xlink:href="holx-20210925.xsd#holx_OtherRestructuringPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_holx_OtherRestructuringPayments_0d4cf231-b6b6-4799-8e2a-78a67020c0e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_024400b8-f3de-41de-afcb-8293e94bae44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_13a39458-3473-480e-88e7-90e834e34152" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ab7f70b9-fa50-42ef-a1de-b5df7b1f6e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:to="loc_us-gaap_RestructuringPlanAxis_ab7f70b9-fa50-42ef-a1de-b5df7b1f6e01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_ab7f70b9-fa50-42ef-a1de-b5df7b1f6e01_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_ab7f70b9-fa50-42ef-a1de-b5df7b1f6e01" xlink:to="loc_us-gaap_RestructuringPlanDomain_ab7f70b9-fa50-42ef-a1de-b5df7b1f6e01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_ab7f70b9-fa50-42ef-a1de-b5df7b1f6e01" xlink:to="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwothousandeighteenMember_63593905-3792-4eaa-ab28-ccd527dfdf05" xlink:href="holx-20210925.xsd#holx_TwothousandeighteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:to="loc_holx_TwothousandeighteenMember_63593905-3792-4eaa-ab28-ccd527dfdf05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_b8ee1bc9-a268-4690-b83e-f91a75737b80" xlink:href="holx-20210925.xsd#holx_Fiscal2019chargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:to="loc_holx_Fiscal2019chargesMember_b8ee1bc9-a268-4690-b83e-f91a75737b80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember_3e1c9cbe-566a-4ff7-844b-0368fd248c4b" xlink:href="holx-20210925.xsd#holx_Fiscal2020ChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:to="loc_holx_Fiscal2020ChargesMember_3e1c9cbe-566a-4ff7-844b-0368fd248c4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ChargesMember_e729e1ff-27cf-48ff-b0ed-add12f26da5d" xlink:href="holx-20210925.xsd#holx_Fiscal2021ChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:to="loc_holx_Fiscal2021ChargesMember_e729e1ff-27cf-48ff-b0ed-add12f26da5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_412f0405-ecc7-4116-926d-f43d023a5342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_412f0405-ecc7-4116-926d-f43d023a5342" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_412f0405-ecc7-4116-926d-f43d023a5342_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_412f0405-ecc7-4116-926d-f43d023a5342" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_412f0405-ecc7-4116-926d-f43d023a5342_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_412f0405-ecc7-4116-926d-f43d023a5342" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ActionMember_b058d9d1-cde6-41bf-8df3-184ee2ec1151" xlink:href="holx-20210925.xsd#holx_Fiscal2021ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_Fiscal2021ActionMember_b058d9d1-cde6-41bf-8df3-184ee2ec1151" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember_1359f736-5cb4-4bd5-afbb-8e97bd6d5d63" xlink:href="holx-20210925.xsd#holx_Fiscal2020ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_Fiscal2020ActionMember_1359f736-5cb4-4bd5-afbb-8e97bd6d5d63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember_688518c8-2b3a-4f48-a3d4-fe7e2d0f9241" xlink:href="holx-20210925.xsd#holx_Fiscal2019ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_Fiscal2019ActionMember_688518c8-2b3a-4f48-a3d4-fe7e2d0f9241" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember_9d6ae8f5-c772-4433-a98f-64b3beddaa08" xlink:href="holx-20210925.xsd#holx_Fiscal2018ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_Fiscal2018ActionMember_9d6ae8f5-c772-4433-a98f-64b3beddaa08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherOperatingCostReductionsMember_8b9d7086-89cf-4322-9b67-b1bace971cd9" xlink:href="holx-20210925.xsd#holx_OtherOperatingCostReductionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_OtherOperatingCostReductionsMember_8b9d7086-89cf-4322-9b67-b1bace971cd9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7c53d231-c451-4453-8573-3485dd656557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7c53d231-c451-4453-8573-3485dd656557" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7c53d231-c451-4453-8573-3485dd656557_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7c53d231-c451-4453-8573-3485dd656557" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7c53d231-c451-4453-8573-3485dd656557_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_11d65b97-40c4-4f77-b5dc-31323ae732cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7c53d231-c451-4453-8573-3485dd656557" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_11d65b97-40c4-4f77-b5dc-31323ae732cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_220194fa-e9bc-40af-b5f1-947e1ccdf6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_11d65b97-40c4-4f77-b5dc-31323ae732cd" xlink:to="loc_us-gaap_RestructuringChargesMember_220194fa-e9bc-40af-b5f1-947e1ccdf6e2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#RestructuringChargesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="extended" id="i36735238590a4fab8196880fbfc04567_RestructuringChargesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_79628047-3414-4a53-a775-be75d935e247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_us-gaap_SeveranceCosts1_79628047-3414-4a53-a775-be75d935e247" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_2b49bcde-1def-42f1-8f09-ab910573adb0" xlink:href="holx-20210925.xsd#holx_FacilityClosureCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_holx_FacilityClosureCosts_2b49bcde-1def-42f1-8f09-ab910573adb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_04eab9ab-0ccd-4203-951a-cc368c62734f" xlink:href="holx-20210925.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_holx_ReductionOfWorkforceExpenses_04eab9ab-0ccd-4203-951a-cc368c62734f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_b8469524-f8e8-4f88-975b-ca0647b08f32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_b8469524-f8e8-4f88-975b-ca0647b08f32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RemainingLeaseBalance_2042fd6d-67a9-4ffc-af45-80fd2b658e11" xlink:href="holx-20210925.xsd#holx_RemainingLeaseBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_holx_RemainingLeaseBalance_2042fd6d-67a9-4ffc-af45-80fd2b658e11" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_4e503f58-c5bb-42cf-adc3-acdb08fd0910" xlink:href="holx-20210925.xsd#holx_DivestitureCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_holx_DivestitureCharges_4e503f58-c5bb-42cf-adc3-acdb08fd0910" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_40b93510-29be-44d4-bf79-b4812e79f3f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_40b93510-29be-44d4-bf79-b4812e79f3f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_40b93510-29be-44d4-bf79-b4812e79f3f2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_40b93510-29be-44d4-bf79-b4812e79f3f2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_40b93510-29be-44d4-bf79-b4812e79f3f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_494187a2-a694-47b6-9537-c0b5c2bf3b4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_40b93510-29be-44d4-bf79-b4812e79f3f2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_494187a2-a694-47b6-9537-c0b5c2bf3b4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_0d9e81f3-ec74-4fd0-8506-f925fc0bb601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_494187a2-a694-47b6-9537-c0b5c2bf3b4d" xlink:to="loc_us-gaap_RestructuringChargesMember_0d9e81f3-ec74-4fd0-8506-f925fc0bb601" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_caeacccf-2c12-4ab0-9527-d7c5a4a63871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:to="loc_us-gaap_RestructuringPlanAxis_caeacccf-2c12-4ab0-9527-d7c5a4a63871" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_caeacccf-2c12-4ab0-9527-d7c5a4a63871_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_caeacccf-2c12-4ab0-9527-d7c5a4a63871" xlink:to="loc_us-gaap_RestructuringPlanDomain_caeacccf-2c12-4ab0-9527-d7c5a4a63871_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_caeacccf-2c12-4ab0-9527-d7c5a4a63871" xlink:to="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_e138a117-6b8e-439f-b772-7917ba94f21b" xlink:href="holx-20210925.xsd#holx_CynosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:to="loc_holx_CynosureMember_e138a117-6b8e-439f-b772-7917ba94f21b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BedfordMember_63a91db8-d78d-4181-97e1-bb020b6ee2ff" xlink:href="holx-20210925.xsd#holx_BedfordMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:to="loc_holx_BedfordMember_63a91db8-d78d-4181-97e1-bb020b6ee2ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_817237d1-5e69-40d3-8c48-cf07a44f5eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:to="loc_us-gaap_RestructuringChargesMember_817237d1-5e69-40d3-8c48-cf07a44f5eb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_f2aea3ba-f656-4db7-9a2f-bbdd47cf758b" xlink:href="holx-20210925.xsd#holx_Fiscal2019chargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:to="loc_holx_Fiscal2019chargesMember_f2aea3ba-f656-4db7-9a2f-bbdd47cf758b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityByLocationAxis_428d27c9-26ad-4b7d-a409-a0ea62b771ab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityByLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:to="loc_dei_EntityByLocationAxis_428d27c9-26ad-4b7d-a409-a0ea62b771ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocationDomain_428d27c9-26ad-4b7d-a409-a0ea62b771ab_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityByLocationAxis_428d27c9-26ad-4b7d-a409-a0ea62b771ab" xlink:to="loc_dei_LocationDomain_428d27c9-26ad-4b7d-a409-a0ea62b771ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocationDomain_246fdd24-c799-44d6-956c-d2d0ae2fa42a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityByLocationAxis_428d27c9-26ad-4b7d-a409-a0ea62b771ab" xlink:to="loc_dei_LocationDomain_246fdd24-c799-44d6-956c-d2d0ae2fa42a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TepnelMember_7f6470a6-6548-406b-b427-e519e3f29d89" xlink:href="holx-20210925.xsd#holx_TepnelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_LocationDomain_246fdd24-c799-44d6-956c-d2d0ae2fa42a" xlink:to="loc_holx_TepnelMember_7f6470a6-6548-406b-b427-e519e3f29d89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_715efc88-8c7d-4199-a055-49418cb24ce4" xlink:href="holx-20210925.xsd#holx_CynosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_LocationDomain_246fdd24-c799-44d6-956c-d2d0ae2fa42a" xlink:to="loc_holx_CynosureMember_715efc88-8c7d-4199-a055-49418cb24ce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_8e1f1c45-106b-41ad-9301-b65e17560bc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_8e1f1c45-106b-41ad-9301-b65e17560bc0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_8e1f1c45-106b-41ad-9301-b65e17560bc0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_8e1f1c45-106b-41ad-9301-b65e17560bc0" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_8e1f1c45-106b-41ad-9301-b65e17560bc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_05bc2f19-15fd-4b96-84fa-dbb496884545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_8e1f1c45-106b-41ad-9301-b65e17560bc0" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_05bc2f19-15fd-4b96-84fa-dbb496884545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember_a203720d-811c-4036-a250-5d68ce6f3584" xlink:href="holx-20210925.xsd#holx_Fiscal2018ActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_05bc2f19-15fd-4b96-84fa-dbb496884545" xlink:to="loc_holx_Fiscal2018ActionMember_a203720d-811c-4036-a250-5d68ce6f3584" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended" id="i7bb7e4a9c8064233b461ffcbddf14b5f_BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_46adcd53-e078-46d3-b791-c84beed2c470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:to="loc_us-gaap_LongTermDebtCurrent_46adcd53-e078-46d3-b791-c84beed2c470" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5f9cfff9-e2b3-4f03-987e-5de65a4ece0c" xlink:href="holx-20210925.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5f9cfff9-e2b3-4f03-987e-5de65a4ece0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0aa04165-2a3e-4ea8-b5bc-682d223080da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0aa04165-2a3e-4ea8-b5bc-682d223080da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6141546b-5433-42e1-bdf5-a46df00437b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:to="loc_us-gaap_LongTermDebt_6141546b-5433-42e1-bdf5-a46df00437b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d26e4f7f-9191-4d8c-9ddd-3e650cbe5586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:to="loc_us-gaap_DebtInstrumentTable_d26e4f7f-9191-4d8c-9ddd-3e650cbe5586" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_01d5c249-ea48-4c08-9b5e-2faa2287ebb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d26e4f7f-9191-4d8c-9ddd-3e650cbe5586" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_01d5c249-ea48-4c08-9b5e-2faa2287ebb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_01d5c249-ea48-4c08-9b5e-2faa2287ebb1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_01d5c249-ea48-4c08-9b5e-2faa2287ebb1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_01d5c249-ea48-4c08-9b5e-2faa2287ebb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_01d5c249-ea48-4c08-9b5e-2faa2287ebb1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_28ba667f-ee13-4935-8f86-e47f45e9e5ef" xlink:href="holx-20210925.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_TermLoanMember_28ba667f-ee13-4935-8f86-e47f45e9e5ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_950decc0-08cc-4100-bc02-07c615f5cdaf" xlink:href="holx-20210925.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_RevolverMember_950decc0-08cc-4100-bc02-07c615f5cdaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_65aa0630-5a2d-4ac3-bf2e-609ae7b2025a" xlink:href="holx-20210925.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_65aa0630-5a2d-4ac3-bf2e-609ae7b2025a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_73083884-5193-4b89-9b47-e89b66770f25" xlink:href="holx-20210925.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_A2025SeniorNotesMember_73083884-5193-4b89-9b47-e89b66770f25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_22f2fb17-9d19-4782-a8c8-619a92f2b964" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_A2028SeniorNotesMember_22f2fb17-9d19-4782-a8c8-619a92f2b964" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_3f5b104d-bbfa-4e97-a5c8-a4a39855c67f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_3f5b104d-bbfa-4e97-a5c8-a4a39855c67f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_de1686c0-c04b-4f74-816b-f1707ec1a2be" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_A2029SeniorNotesMember_de1686c0-c04b-4f74-816b-f1707ec1a2be" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="extended" id="i5d2aaeb049f24168be11efcf069caba0_BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c9cf212b-b391-47a9-aecc-cd22a4795867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c9cf212b-b391-47a9-aecc-cd22a4795867" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ebf6b61b-a38d-4209-b16f-a44cd8848de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ebf6b61b-a38d-4209-b16f-a44cd8848de5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_218f7949-5c28-4a87-8a45-b806550244e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_218f7949-5c28-4a87-8a45-b806550244e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c296a84f-cba2-452a-a179-9c8c5cfcd8bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c296a84f-cba2-452a-a179-9c8c5cfcd8bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_afbecc7f-d48f-4c6e-bfef-f0baedacbd1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_afbecc7f-d48f-4c6e-bfef-f0baedacbd1c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6b95f9fe-c104-440d-9cde-a327150bc46f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6b95f9fe-c104-440d-9cde-a327150bc46f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_5d81898c-3df2-438f-809a-403c681be7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_5d81898c-3df2-438f-809a-403c681be7c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_db8bfa80-c10e-4cc7-9a89-58a68699c3f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_DebtInstrumentTable_db8bfa80-c10e-4cc7-9a89-58a68699c3f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_966c9ef0-e861-4c61-97cf-498816916f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_db8bfa80-c10e-4cc7-9a89-58a68699c3f7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_966c9ef0-e861-4c61-97cf-498816916f6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_966c9ef0-e861-4c61-97cf-498816916f6f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_966c9ef0-e861-4c61-97cf-498816916f6f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_966c9ef0-e861-4c61-97cf-498816916f6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_966c9ef0-e861-4c61-97cf-498816916f6f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_82dffef9-e674-47fc-b3ca-eb50167a34ab" xlink:href="holx-20210925.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_TermLoanMember_82dffef9-e674-47fc-b3ca-eb50167a34ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_14f37427-c436-4e7a-944c-75626e54c170" xlink:href="holx-20210925.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_14f37427-c436-4e7a-944c-75626e54c170" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_9c3d62bb-b741-48ca-b0a7-34e0b7a25822" xlink:href="holx-20210925.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_A2025SeniorNotesMember_9c3d62bb-b741-48ca-b0a7-34e0b7a25822" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_76e87778-1388-4534-bc94-443444ca6a07" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_A2028SeniorNotesMember_76e87778-1388-4534-bc94-443444ca6a07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_7d04d682-004c-49c5-a28d-87f1267fcf32" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_A2029SeniorNotesMember_7d04d682-004c-49c5-a28d-87f1267fcf32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_aec90876-d3a4-4861-80d7-591ebb7f71fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_aec90876-d3a4-4861-80d7-591ebb7f71fd" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended" id="ic48c42c914b34708a68fdb8f36a8606b_BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_4efbc2a1-cebf-4829-b373-a1532b598b25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:to="loc_us-gaap_InterestExpenseBorrowings_4efbc2a1-cebf-4829-b373-a1532b598b25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8c99b2ec-eb30-4e24-8714-1add3d90fd5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8c99b2ec-eb30-4e24-8714-1add3d90fd5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_17dc900d-034d-4c68-aafe-b64af33fdc29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_17dc900d-034d-4c68-aafe-b64af33fdc29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_c0cac209-d8c9-440c-8a24-75f15e1ed2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_c0cac209-d8c9-440c-8a24-75f15e1ed2a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_45660be5-1f80-4258-9cc2-c769b4cd1f34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_45660be5-1f80-4258-9cc2-c769b4cd1f34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_18f612b8-f225-4ad9-88d2-d375d01947fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_45660be5-1f80-4258-9cc2-c769b4cd1f34" xlink:to="loc_us-gaap_DebtInstrumentAxis_18f612b8-f225-4ad9-88d2-d375d01947fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18f612b8-f225-4ad9-88d2-d375d01947fb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_18f612b8-f225-4ad9-88d2-d375d01947fb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18f612b8-f225-4ad9-88d2-d375d01947fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_18f612b8-f225-4ad9-88d2-d375d01947fb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2018Member_f3cac4f7-d38a-4b4b-871c-b9cdbf535115" xlink:href="holx-20210925.xsd#holx_CreditAgreement2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:to="loc_holx_CreditAgreement2018Member_f3cac4f7-d38a-4b4b-871c-b9cdbf535115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member_996c3ed5-1a9b-4faa-875b-862a8cf93ba0" xlink:href="holx-20210925.xsd#holx_CreditAgreement2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:to="loc_holx_CreditAgreement2017Member_996c3ed5-1a9b-4faa-875b-862a8cf93ba0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember_062f6f1f-bddb-48a9-bd60-62e8f10144b6" xlink:href="holx-20210925.xsd#holx_CreditAgreementPriorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:to="loc_holx_CreditAgreementPriorMember_062f6f1f-bddb-48a9-bd60-62e8f10144b6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended" id="i679b5295364d44329db9619c392f81e9_BorrowingsandCreditArrangementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6baf7086-5da0-4ce5-af73-9d25fb4f6f7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6baf7086-5da0-4ce5-af73-9d25fb4f6f7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_23524989-80f4-4a6a-90e7-3e29cabb0c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_23524989-80f4-4a6a-90e7-3e29cabb0c67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9f233ca1-c938-459d-b50f-8585aa5d15d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9f233ca1-c938-459d-b50f-8585aa5d15d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_588a0ba9-8f85-419f-a4b7-143be1aba510" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_588a0ba9-8f85-419f-a4b7-143be1aba510" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_608dcec9-0ef6-43c7-a7fe-07cebc2f70db" xlink:href="holx-20210925.xsd#holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_608dcec9-0ef6-43c7-a7fe-07cebc2f70db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeverageRatioMaximum_4a046f62-da14-4f6b-be57-71e62558019c" xlink:href="holx-20210925.xsd#holx_LeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_LeverageRatioMaximum_4a046f62-da14-4f6b-be57-71e62558019c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestCoverageRatio_3a1d926c-de17-47f7-b959-badb712b85bb" xlink:href="holx-20210925.xsd#holx_InterestCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_InterestCoverageRatio_3a1d926c-de17-47f7-b959-badb712b85bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6af539c0-27e5-4451-907c-f3b897bfe200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6af539c0-27e5-4451-907c-f3b897bfe200" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentNumberOfInstruments_795f79cb-b8a2-4fad-8ae8-b4b1ff1606b3" xlink:href="holx-20210925.xsd#holx_DebtInstrumentNumberOfInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentNumberOfInstruments_795f79cb-b8a2-4fad-8ae8-b4b1ff1606b3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_88553e3f-2b31-4ad2-87bf-60287759ba0f" xlink:href="holx-20210925.xsd#holx_MaximumRangeofPresentValueofCashFlowPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_88553e3f-2b31-4ad2-87bf-60287759ba0f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9b641f10-c6d5-473d-8734-dfd0d6928336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9b641f10-c6d5-473d-8734-dfd0d6928336" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ff141ff6-6023-4cf9-991b-21491f41f9bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ff141ff6-6023-4cf9-991b-21491f41f9bf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_b60e1113-d0c7-48c1-92ab-52643bf9e059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_b60e1113-d0c7-48c1-92ab-52643bf9e059" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_38127430-316c-44cb-b0d2-9fd61e45454f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_InterestExpenseDebt_38127430-316c-44cb-b0d2-9fd61e45454f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_e3639add-5377-4b35-9513-c2eeb583f4ea" xlink:href="holx-20210925.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_e3639add-5377-4b35-9513-c2eeb583f4ea" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cef5e87e-0e7f-41aa-9a1a-8fe8509327a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cef5e87e-0e7f-41aa-9a1a-8fe8509327a8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_d9e2575b-b093-4454-a684-b00fd8e8a488" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_d9e2575b-b093-4454-a684-b00fd8e8a488" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_7cce4669-7f00-4dcf-a666-3f30e5fe9c2d" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_7cce4669-7f00-4dcf-a666-3f30e5fe9c2d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_f0c0db9f-7131-45fa-b73f-191f55e30d3d" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_f0c0db9f-7131-45fa-b73f-191f55e30d3d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_e28a620c-c393-4181-a0f5-25a3fb671ce6" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_e28a620c-c393-4181-a0f5-25a3fb671ce6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermARSecuritizationProgram_987caf9f-ded9-4fbb-a0a3-123a321eafe2" xlink:href="holx-20210925.xsd#holx_TermARSecuritizationProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_TermARSecuritizationProgram_987caf9f-ded9-4fbb-a0a3-123a321eafe2" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization_de813440-0e32-4eb1-b2af-2d6bb58cfca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_AccountsReceivableFromSecuritization_de813440-0e32-4eb1-b2af-2d6bb58cfca6" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumBorrowingUnderSecuritizationProgram_7d25398f-4f85-4daa-b783-51c45842e6cf" xlink:href="holx-20210925.xsd#holx_MaximumBorrowingUnderSecuritizationProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_MaximumBorrowingUnderSecuritizationProgram_7d25398f-4f85-4daa-b783-51c45842e6cf" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_e15a4078-b33a-45b1-af34-0ab61180595b" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_e15a4078-b33a-45b1-af34-0ab61180595b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_1c09711b-02b0-4922-89cb-d162eaaf131f" xlink:href="holx-20210925.xsd#holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_1c09711b-02b0-4922-89cb-d162eaaf131f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_bdbcaad0-d290-4fb3-9146-33153340a79c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_bdbcaad0-d290-4fb3-9146-33153340a79c" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_4c6c1e82-a33c-48bd-919d-7e67cdb2226a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_RepaymentsOfDebt_4c6c1e82-a33c-48bd-919d-7e67cdb2226a" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_16150cfe-3413-44d3-83dd-351f6240afb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_SeniorNotes_16150cfe-3413-44d3-83dd-351f6240afb7" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_b01cea7e-0cbe-43f3-a052-42f30bd8699c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_b01cea7e-0cbe-43f3-a052-42f30bd8699c" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid_3d18930c-119f-49e6-b7cd-4b621e2b4e7c" xlink:href="holx-20210925.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtRedemptionPremiumPaid_3d18930c-119f-49e6-b7cd-4b621e2b4e7c" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_0aa23101-1e66-42f8-9fe9-54514fbf0e70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_0aa23101-1e66-42f8-9fe9-54514fbf0e70" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6f859955-0d92-4cce-8b91-6aa0b711e758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6f859955-0d92-4cce-8b91-6aa0b711e758" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a16f9dbc-52c2-41a5-9d31-88f5673eb6f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_LongTermDebtCurrent_a16f9dbc-52c2-41a5-9d31-88f5673eb6f9" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_48e43a91-c25b-4964-8be6-829af5f3f904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_48e43a91-c25b-4964-8be6-829af5f3f904" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_7abea465-3360-41ed-b0e0-56d9a926a92f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_7abea465-3360-41ed-b0e0-56d9a926a92f" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentCommitmentFeePercentage_71c07088-b32e-4079-8096-85c38c3fa9c4" xlink:href="holx-20210925.xsd#holx_DebtInstrumentCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentCommitmentFeePercentage_71c07088-b32e-4079-8096-85c38c3fa9c4" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_87fa7ffa-d0cc-47b3-93bb-b79fb7c3912d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_87fa7ffa-d0cc-47b3-93bb-b79fb7c3912d" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5e60861b-652f-4298-bbc0-a6ce8e0b5300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5e60861b-652f-4298-bbc0-a6ce8e0b5300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5e60861b-652f-4298-bbc0-a6ce8e0b5300_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5e60861b-652f-4298-bbc0-a6ce8e0b5300" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5e60861b-652f-4298-bbc0-a6ce8e0b5300_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5e60861b-652f-4298-bbc0-a6ce8e0b5300" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember_496001a6-b5f0-4476-9138-67f626332e8d" xlink:href="holx-20210925.xsd#holx_SecuredTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_holx_SecuredTermLoanMember_496001a6-b5f0-4476-9138-67f626332e8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_a6ee110b-244a-4c05-aa6f-b3f00111ad9e" xlink:href="holx-20210925.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_holx_RevolverMember_a6ee110b-244a-4c05-aa6f-b3f00111ad9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7c111da6-8792-454e-8f5d-9222f05a8a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_us-gaap_LineOfCreditMember_7c111da6-8792-454e-8f5d-9222f05a8a31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c3520183-04d9-4ef2-a0a7-de8dad5cd745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_us-gaap_SeniorNotesMember_c3520183-04d9-4ef2-a0a7-de8dad5cd745" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_8e3aa3f7-8b89-4e6e-8ab0-98faa6ab62d4" xlink:href="holx-20210925.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_8e3aa3f7-8b89-4e6e-8ab0-98faa6ab62d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b67507fe-559e-4f02-a43a-aad5c7ff7add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_DebtInstrumentAxis_b67507fe-559e-4f02-a43a-aad5c7ff7add" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b67507fe-559e-4f02-a43a-aad5c7ff7add_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b67507fe-559e-4f02-a43a-aad5c7ff7add" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b67507fe-559e-4f02-a43a-aad5c7ff7add_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b67507fe-559e-4f02-a43a-aad5c7ff7add" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoan2018Member_8e262222-a489-4279-a696-6e87171acda8" xlink:href="holx-20210925.xsd#holx_AmendedTermLoan2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_AmendedTermLoan2018Member_8e262222-a489-4279-a696-6e87171acda8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedRevolver2018Member_b73bbec6-533b-4ce7-8125-4c11fd54caa3" xlink:href="holx-20210925.xsd#holx_AmendedRevolver2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_AmendedRevolver2018Member_b73bbec6-533b-4ce7-8125-4c11fd54caa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedCreditFacility2018Member_2347117c-ecd1-4775-8c5b-70ab5a26d012" xlink:href="holx-20210925.xsd#holx_AmendedCreditFacility2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_AmendedCreditFacility2018Member_2347117c-ecd1-4775-8c5b-70ab5a26d012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member_9f31a401-10f9-4078-a9f5-d36507e77533" xlink:href="holx-20210925.xsd#holx_CreditAgreement2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_CreditAgreement2017Member_9f31a401-10f9-4078-a9f5-d36507e77533" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember_c0a244e2-fd8f-4882-b90b-982459bc9dfe" xlink:href="holx-20210925.xsd#holx_CreditAgreementPriorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_CreditAgreementPriorMember_c0a244e2-fd8f-4882-b90b-982459bc9dfe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_48cd0c55-c95c-47bb-a4d6-2acb18288c7d" xlink:href="holx-20210925.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2025SeniorNotesMember_48cd0c55-c95c-47bb-a4d6-2acb18288c7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_eb2f1f02-4f53-44c0-9ca3-56cdae13d7b0" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2028SeniorNotesMember_eb2f1f02-4f53-44c0-9ca3-56cdae13d7b0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_d0da50ff-9573-466f-97f7-332975956b8b" xlink:href="holx-20210925.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_d0da50ff-9573-466f-97f7-332975956b8b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_25ce760d-9248-4c21-bc77-8e8c7d18b878" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2029SeniorNotesMember_25ce760d-9248-4c21-bc77-8e8c7d18b878" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021TermLoanMember_fa335ea3-f11f-48eb-98fd-f9c56ccb4a1d" xlink:href="holx-20210925.xsd#holx_A2021TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2021TermLoanMember_fa335ea3-f11f-48eb-98fd-f9c56ccb4a1d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021RevolverMember_c356c122-1afe-409f-b2b4-b4f3c37d1f0d" xlink:href="holx-20210925.xsd#holx_A2021RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2021RevolverMember_c356c122-1afe-409f-b2b4-b4f3c37d1f0d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021CreditAgreementMember_7e20323a-3277-4040-887b-9e2a557769e9" xlink:href="holx-20210925.xsd#holx_A2021CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2021CreditAgreementMember_7e20323a-3277-4040-887b-9e2a557769e9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f3ac5981-2ba1-4fc1-9603-1a47186665e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_VariableRateAxis_f3ac5981-2ba1-4fc1-9603-1a47186665e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f3ac5981-2ba1-4fc1-9603-1a47186665e4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f3ac5981-2ba1-4fc1-9603-1a47186665e4" xlink:to="loc_us-gaap_VariableRateDomain_f3ac5981-2ba1-4fc1-9603-1a47186665e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_600b4772-9ce3-41ba-960e-723a5a0fe9a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f3ac5981-2ba1-4fc1-9603-1a47186665e4" xlink:to="loc_us-gaap_VariableRateDomain_600b4772-9ce3-41ba-960e-723a5a0fe9a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_dceaed8c-7a40-4231-b27d-6692add3dd6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_600b4772-9ce3-41ba-960e-723a5a0fe9a3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_dceaed8c-7a40-4231-b27d-6692add3dd6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EurocurrencyRateMember_86b7b003-5bf3-491e-88a2-2ebc48678b1e" xlink:href="holx-20210925.xsd#holx_EurocurrencyRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_600b4772-9ce3-41ba-960e-723a5a0fe9a3" xlink:to="loc_holx_EurocurrencyRateMember_86b7b003-5bf3-491e-88a2-2ebc48678b1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_16fca586-487e-4675-a94e-b74060e87a8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_srt_StatementScenarioAxis_16fca586-487e-4675-a94e-b74060e87a8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_16fca586-487e-4675-a94e-b74060e87a8e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_16fca586-487e-4675-a94e-b74060e87a8e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_16fca586-487e-4675-a94e-b74060e87a8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5151e3c9-ef03-4e20-b91f-c4b44de0339a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_16fca586-487e-4675-a94e-b74060e87a8e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5151e3c9-ef03-4e20-b91f-c4b44de0339a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_9fdd1c18-f9f9-4afc-ad62-182681a56cf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_5151e3c9-ef03-4e20-b91f-c4b44de0339a" xlink:to="loc_srt_ScenarioForecastMember_9fdd1c18-f9f9-4afc-ad62-182681a56cf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_877e26f3-5c6f-4db9-996d-03252a7785ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_877e26f3-5c6f-4db9-996d-03252a7785ba" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_877e26f3-5c6f-4db9-996d-03252a7785ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_877e26f3-5c6f-4db9-996d-03252a7785ba" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_877e26f3-5c6f-4db9-996d-03252a7785ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_877e26f3-5c6f-4db9-996d-03252a7785ba" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4f4ba241-ce05-4e6e-b7c6-93d39206d777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4f4ba241-ce05-4e6e-b7c6-93d39206d777" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d1f462f2-32cb-4808-9cb0-b9808ef1b0b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d1f462f2-32cb-4808-9cb0-b9808ef1b0b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_0957242f-59a9-47e3-bf9c-2c1d50c3204b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_0957242f-59a9-47e3-bf9c-2c1d50c3204b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_fcbaf99d-ca21-4582-8356-2f88dae27c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_fcbaf99d-ca21-4582-8356-2f88dae27c79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_1b6ba3ed-4b7b-4f58-b318-23c0c9513003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_1b6ba3ed-4b7b-4f58-b318-23c0c9513003" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0e9e5b6f-d113-4917-af65-d84936bf40fb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_srt_RangeAxis_0e9e5b6f-d113-4917-af65-d84936bf40fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0e9e5b6f-d113-4917-af65-d84936bf40fb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0e9e5b6f-d113-4917-af65-d84936bf40fb" xlink:to="loc_srt_RangeMember_0e9e5b6f-d113-4917-af65-d84936bf40fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f62906cb-7926-45ab-9646-123d55987c1e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0e9e5b6f-d113-4917-af65-d84936bf40fb" xlink:to="loc_srt_RangeMember_f62906cb-7926-45ab-9646-123d55987c1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55d92c5b-c68e-41d3-94fc-241caeb2dd5d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f62906cb-7926-45ab-9646-123d55987c1e" xlink:to="loc_srt_MinimumMember_55d92c5b-c68e-41d3-94fc-241caeb2dd5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4297c91e-1a74-493d-9328-bd9c6a027210" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f62906cb-7926-45ab-9646-123d55987c1e" xlink:to="loc_srt_MaximumMember_4297c91e-1a74-493d-9328-bd9c6a027210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9d07aaf8-54ac-46e0-911d-98a9205748bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9d07aaf8-54ac-46e0-911d-98a9205748bb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9d07aaf8-54ac-46e0-911d-98a9205748bb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d07aaf8-54ac-46e0-911d-98a9205748bb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9d07aaf8-54ac-46e0-911d-98a9205748bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ad808d3b-1325-45e1-a297-ccbe0f92d259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d07aaf8-54ac-46e0-911d-98a9205748bb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ad808d3b-1325-45e1-a297-ccbe0f92d259" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fbebf567-fcd3-4d55-be90-230af8b51d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ad808d3b-1325-45e1-a297-ccbe0f92d259" xlink:to="loc_us-gaap_SubsequentEventMember_fbebf567-fcd3-4d55-be90-230af8b51d32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_84ce49b1-47ae-4629-9803-61c34e07cd55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_84ce49b1-47ae-4629-9803-61c34e07cd55" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84ce49b1-47ae-4629-9803-61c34e07cd55_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_84ce49b1-47ae-4629-9803-61c34e07cd55" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84ce49b1-47ae-4629-9803-61c34e07cd55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2d2ff475-3a90-422f-8771-8e6076cd090f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_84ce49b1-47ae-4629-9803-61c34e07cd55" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2d2ff475-3a90-422f-8771-8e6076cd090f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_e0f941b7-2b23-4cb3-b3fe-e25f97fcfda9" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2d2ff475-3a90-422f-8771-8e6076cd090f" xlink:to="loc_holx_MobidiagOyMember_e0f941b7-2b23-4cb3-b3fe-e25f97fcfda9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended" id="i1c9072f52ea342e6b357e80a70471de6_BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_7e000a59-78d3-4e3f-8b76-dc377dc61b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:to="loc_us-gaap_InterestExpenseBorrowings_7e000a59-78d3-4e3f-8b76-dc377dc61b6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_96bdfd54-abed-4338-865b-2258da0fe9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_96bdfd54-abed-4338-865b-2258da0fe9c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2275afd0-165c-4d8f-b42d-0b7ab089c93d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2275afd0-165c-4d8f-b42d-0b7ab089c93d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0e84dd6b-0bef-4d38-b051-0fe3b4d5ca80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:to="loc_us-gaap_DebtInstrumentTable_0e84dd6b-0bef-4d38-b051-0fe3b4d5ca80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f78c0769-f4fc-49c2-a400-ff255b263014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0e84dd6b-0bef-4d38-b051-0fe3b4d5ca80" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f78c0769-f4fc-49c2-a400-ff255b263014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f78c0769-f4fc-49c2-a400-ff255b263014_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f78c0769-f4fc-49c2-a400-ff255b263014" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f78c0769-f4fc-49c2-a400-ff255b263014_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e109f8ee-5f3c-4d70-a6cb-bedff6456912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f78c0769-f4fc-49c2-a400-ff255b263014" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e109f8ee-5f3c-4d70-a6cb-bedff6456912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8de3921a-11e2-43f4-9676-1aa3dc5ebb8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e109f8ee-5f3c-4d70-a6cb-bedff6456912" xlink:to="loc_us-gaap_SeniorNotesMember_8de3921a-11e2-43f4-9676-1aa3dc5ebb8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_de5388eb-0ab2-48e7-bae1-f2175e2afbe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0e84dd6b-0bef-4d38-b051-0fe3b4d5ca80" xlink:to="loc_us-gaap_DebtInstrumentAxis_de5388eb-0ab2-48e7-bae1-f2175e2afbe9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_de5388eb-0ab2-48e7-bae1-f2175e2afbe9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_de5388eb-0ab2-48e7-bae1-f2175e2afbe9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_de5388eb-0ab2-48e7-bae1-f2175e2afbe9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_de5388eb-0ab2-48e7-bae1-f2175e2afbe9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_f14c4243-ddad-4180-b95f-3db1835a66a5" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:to="loc_holx_A2028SeniorNotesMember_f14c4243-ddad-4180-b95f-3db1835a66a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_5cdbc704-8b02-44d7-bceb-53388e9625c1" xlink:href="holx-20210925.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:to="loc_holx_A2025SeniorNotesMember_5cdbc704-8b02-44d7-bceb-53388e9625c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_c6fd3c8d-bdf1-4960-9c44-d63dbc9374fc" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:to="loc_holx_A2029SeniorNotesMember_c6fd3c8d-bdf1-4960-9c44-d63dbc9374fc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended" id="i14f7f4801de249f6a955be620d87e046_FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_17dfacec-bbc1-4a10-87b9-2cb7c8546cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_17dfacec-bbc1-4a10-87b9-2cb7c8546cb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_b463e0e1-447b-418c-b65e-4bdf12bdd9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_17dfacec-bbc1-4a10-87b9-2cb7c8546cb9" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_b463e0e1-447b-418c-b65e-4bdf12bdd9ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b96aa7a2-e412-4f8a-826b-07026eda2f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_17dfacec-bbc1-4a10-87b9-2cb7c8546cb9" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b96aa7a2-e412-4f8a-826b-07026eda2f4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_c19a57af-abdd-43c0-ae52-0d7d20ecf978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_c19a57af-abdd-43c0-ae52-0d7d20ecf978" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_f43c2e76-3acd-4170-9bd1-7d39b738a9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_c19a57af-abdd-43c0-ae52-0d7d20ecf978" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_f43c2e76-3acd-4170-9bd1-7d39b738a9ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_56de576e-11fd-4cfb-bf41-f0c8e91d1f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_56de576e-11fd-4cfb-bf41-f0c8e91d1f08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_388bba8c-5da9-4ebc-abd4-547caa7627a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_388bba8c-5da9-4ebc-abd4-547caa7627a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_caa79133-db94-4ef5-a403-c1a6acd8fd50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_caa79133-db94-4ef5-a403-c1a6acd8fd50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_caa79133-db94-4ef5-a403-c1a6acd8fd50_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_caa79133-db94-4ef5-a403-c1a6acd8fd50" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_caa79133-db94-4ef5-a403-c1a6acd8fd50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_caa79133-db94-4ef5-a403-c1a6acd8fd50" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ec761355-8b62-40b8-a383-bb501db1846f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:to="loc_us-gaap_InterestRateSwapMember_ec761355-8b62-40b8-a383-bb501db1846f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_27bc0b1c-c4a9-415e-b9cb-273be8eb1bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:to="loc_us-gaap_StockOptionMember_27bc0b1c-c4a9-415e-b9cb-273be8eb1bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_23ba0841-d8d0-43cf-b493-602a21225688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_23ba0841-d8d0-43cf-b493-602a21225688" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_4df6cfc5-b275-4a93-866a-83c7b62193b1" xlink:href="holx-20210925.xsd#holx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:to="loc_holx_ContingentConsiderationMember_4df6cfc5-b275-4a93-866a-83c7b62193b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_be81b69b-59d7-48ed-b28f-c3acdc53f740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_be81b69b-59d7-48ed-b28f-c3acdc53f740" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_be81b69b-59d7-48ed-b28f-c3acdc53f740_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_be81b69b-59d7-48ed-b28f-c3acdc53f740" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_be81b69b-59d7-48ed-b28f-c3acdc53f740_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bb36b258-d990-4d51-a9ac-1f4286b81cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_be81b69b-59d7-48ed-b28f-c3acdc53f740" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bb36b258-d990-4d51-a9ac-1f4286b81cdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_e2823a24-b150-45dc-9649-66edf24d4e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb36b258-d990-4d51-a9ac-1f4286b81cdf" xlink:to="loc_us-gaap_AssetsMember_e2823a24-b150-45dc-9649-66edf24d4e54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_31245d09-1a52-4228-acd3-846747e8e50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb36b258-d990-4d51-a9ac-1f4286b81cdf" xlink:to="loc_us-gaap_LiabilityMember_31245d09-1a52-4228-acd3-846747e8e50e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0f97ecf-94f0-422c-9994-f5f1f0c051d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0f97ecf-94f0-422c-9994-f5f1f0c051d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0f97ecf-94f0-422c-9994-f5f1f0c051d2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0f97ecf-94f0-422c-9994-f5f1f0c051d2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0f97ecf-94f0-422c-9994-f5f1f0c051d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0f97ecf-94f0-422c-9994-f5f1f0c051d2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_52ac46d6-df2f-41b0-a75b-96573c809f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_52ac46d6-df2f-41b0-a75b-96573c809f7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8631b413-d9be-40a9-b830-53477ae067b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8631b413-d9be-40a9-b830-53477ae067b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8a37bbe1-1b50-4bae-a5ec-e61037479d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8a37bbe1-1b50-4bae-a5ec-e61037479d4e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="ic614dd251ff2466fa68714334068098e_FairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_0e30c85d-236d-45cd-99f4-034d2a89d990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_0e30c85d-236d-45cd-99f4-034d2a89d990" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_f7f3394b-3e8a-4f52-a8f2-1eeb445931cd" xlink:href="holx-20210925.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:to="loc_holx_PrincipalAmountOfBorrowings_f7f3394b-3e8a-4f52-a8f2-1eeb445931cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_cebeca7c-ae7d-462e-a9eb-af7d2c69dae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_cebeca7c-ae7d-462e-a9eb-af7d2c69dae7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_abed95c2-11b0-4c6b-9226-7265444c224e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:to="loc_us-gaap_AssetImpairmentCharges_abed95c2-11b0-4c6b-9226-7265444c224e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ee6aa267-36bb-487c-b309-d8452fcffb20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ee6aa267-36bb-487c-b309-d8452fcffb20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ee6aa267-36bb-487c-b309-d8452fcffb20_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ee6aa267-36bb-487c-b309-d8452fcffb20" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ee6aa267-36bb-487c-b309-d8452fcffb20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_176fe658-3a19-4e78-be98-f3ae66740c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ee6aa267-36bb-487c-b309-d8452fcffb20" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_176fe658-3a19-4e78-be98-f3ae66740c00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_863e772d-7cea-4d61-8d70-10b9c781ab25" xlink:href="holx-20210925.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_176fe658-3a19-4e78-be98-f3ae66740c00" xlink:to="loc_holx_AcquiredintangibleassetsMember_863e772d-7cea-4d61-8d70-10b9c781ab25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_0bcfe3df-aa85-4752-aac7-2b5b87e6ca85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_176fe658-3a19-4e78-be98-f3ae66740c00" xlink:to="loc_us-gaap_EquipmentMember_0bcfe3df-aa85-4752-aac7-2b5b87e6ca85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_558ee80b-e568-42ea-b3de-828b299c1307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_FinancialInstrumentAxis_558ee80b-e568-42ea-b3de-828b299c1307" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_558ee80b-e568-42ea-b3de-828b299c1307_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_558ee80b-e568-42ea-b3de-828b299c1307" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_558ee80b-e568-42ea-b3de-828b299c1307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c9b4429-cc47-4e0d-bc0e-83aa43fa31e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_558ee80b-e568-42ea-b3de-828b299c1307" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c9b4429-cc47-4e0d-bc0e-83aa43fa31e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_6a720f62-c6da-4047-bddb-22fcd9dfd971" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c9b4429-cc47-4e0d-bc0e-83aa43fa31e2" xlink:to="loc_holx_A2028SeniorNotesMember_6a720f62-c6da-4047-bddb-22fcd9dfd971" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_07214263-eaff-4753-a1a9-2f9318a4c295" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c9b4429-cc47-4e0d-bc0e-83aa43fa31e2" xlink:to="loc_holx_A2029SeniorNotesMember_07214263-eaff-4753-a1a9-2f9318a4c295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0265c8bc-f3e9-4e8e-9897-2c4354b464f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0265c8bc-f3e9-4e8e-9897-2c4354b464f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0265c8bc-f3e9-4e8e-9897-2c4354b464f9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0265c8bc-f3e9-4e8e-9897-2c4354b464f9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0265c8bc-f3e9-4e8e-9897-2c4354b464f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b662af5-231b-49a5-867b-0caab8bcaa78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0265c8bc-f3e9-4e8e-9897-2c4354b464f9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b662af5-231b-49a5-867b-0caab8bcaa78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_44e5ca99-e4f3-459d-b5bf-b8b6bc7ad372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b662af5-231b-49a5-867b-0caab8bcaa78" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_44e5ca99-e4f3-459d-b5bf-b8b6bc7ad372" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_096e3279-cf90-4a53-a037-af146dc61e90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_DebtInstrumentAxis_096e3279-cf90-4a53-a037-af146dc61e90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_096e3279-cf90-4a53-a037-af146dc61e90_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_096e3279-cf90-4a53-a037-af146dc61e90" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_096e3279-cf90-4a53-a037-af146dc61e90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2f98716c-defc-44c5-b0e0-fac747a8c839" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_096e3279-cf90-4a53-a037-af146dc61e90" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2f98716c-defc-44c5-b0e0-fac747a8c839" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_e41dcb07-4101-4ff0-bee0-4a757487335f" xlink:href="holx-20210925.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2f98716c-defc-44c5-b0e0-fac747a8c839" xlink:to="loc_holx_CreditAgreementMember_e41dcb07-4101-4ff0-bee0-4a757487335f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_dab05aa7-3790-4238-8a09-757e8fcc41a5" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2f98716c-defc-44c5-b0e0-fac747a8c839" xlink:to="loc_holx_A2028SeniorNotesMember_dab05aa7-3790-4238-8a09-757e8fcc41a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_399d7736-6cf5-456f-924a-c43779abc76f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_399d7736-6cf5-456f-924a-c43779abc76f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_399d7736-6cf5-456f-924a-c43779abc76f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_399d7736-6cf5-456f-924a-c43779abc76f" xlink:to="loc_us-gaap_SegmentDomain_399d7736-6cf5-456f-924a-c43779abc76f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bbfa2b5a-04d5-4bcc-856e-085f86fe038b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_399d7736-6cf5-456f-924a-c43779abc76f" xlink:to="loc_us-gaap_SegmentDomain_bbfa2b5a-04d5-4bcc-856e-085f86fe038b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_d099b566-7047-4623-8e7f-6373729567c4" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bbfa2b5a-04d5-4bcc-856e-085f86fe038b" xlink:to="loc_holx_MedicalAestheticsBusinessMember_d099b566-7047-4623-8e7f-6373729567c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_abad4f59-e8bc-4472-95bd-dd978d6d8ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_abad4f59-e8bc-4472-95bd-dd978d6d8ce7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_abad4f59-e8bc-4472-95bd-dd978d6d8ce7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_abad4f59-e8bc-4472-95bd-dd978d6d8ce7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_abad4f59-e8bc-4472-95bd-dd978d6d8ce7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7cd536a6-f5ca-4c16-8952-7f82417c3b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_abad4f59-e8bc-4472-95bd-dd978d6d8ce7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7cd536a6-f5ca-4c16-8952-7f82417c3b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_857f27bf-84e8-454b-9259-005d4850aa01" xlink:href="holx-20210925.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7cd536a6-f5ca-4c16-8952-7f82417c3b36" xlink:to="loc_holx_AcquiredintangibleassetsMember_857f27bf-84e8-454b-9259-005d4850aa01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_17351773-af64-4cb1-9ab7-2f7b52a4efe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7cd536a6-f5ca-4c16-8952-7f82417c3b36" xlink:to="loc_us-gaap_EquipmentMember_17351773-af64-4cb1-9ab7-2f7b52a4efe2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended" id="ieaf67d78d6564bb9a8c07c0d6818cc61_IncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:href="holx-20210925.xsd#holx_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_643d6c1c-b743-4d17-889a-cd4f685bc2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_643d6c1c-b743-4d17-889a-cd4f685bc2ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_8f1ce540-2eca-4a67-8518-87a0b547b7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_OperatingLossCarryforwards_8f1ce540-2eca-4a67-8518-87a0b547b7bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_5601cb11-9e82-4f93-aabb-f0aeb3fdf27f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_5601cb11-9e82-4f93-aabb-f0aeb3fdf27f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_792bb1a9-60bf-4e50-a523-09811fc786ec" xlink:href="holx-20210925.xsd#holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_792bb1a9-60bf-4e50-a523-09811fc786ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_9eb3af4e-1a6b-4f03-9e66-cf98840f0343" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_9eb3af4e-1a6b-4f03-9e66-cf98840f0343" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_1ec81f67-5432-4417-8fd7-c98fc3c0510c" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_1ec81f67-5432-4417-8fd7-c98fc3c0510c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_d3313046-c198-4f6b-82c7-a00ff45d5492" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_d3313046-c198-4f6b-82c7-a00ff45d5492" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossUnrecognizedTaxBenefits_86303483-79f4-4e5d-b5ec-c7a6916599c2" xlink:href="holx-20210925.xsd#holx_GrossUnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_GrossUnrecognizedTaxBenefits_86303483-79f4-4e5d-b5ec-c7a6916599c2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_a6a5f2dd-dedd-4700-8b5f-5389c71938a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_a6a5f2dd-dedd-4700-8b5f-5389c71938a9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_c5d6510e-de08-4979-a689-b3d85fd4476f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_c5d6510e-de08-4979-a689-b3d85fd4476f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_6c4d3fd6-52bc-4af5-871c-bfcf4e62e566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_6c4d3fd6-52bc-4af5-871c-bfcf4e62e566" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_92efd768-8fef-43f5-bb0c-78432522a181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_92efd768-8fef-43f5-bb0c-78432522a181" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616_fe103928-6e9b-40f9-ae18-c7291e3c78c6" xlink:href="holx-20210925.xsd#holx_IncreasetoincometaxexpenseadoptionofASU201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616_fe103928-6e9b-40f9-ae18-c7291e3c78c6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_e4c664d9-7620-44be-9dac-0cfe1e0caefd" xlink:href="holx-20210925.xsd#holx_DecreaseindeferredtaxliabilitiesduetoASC201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_e4c664d9-7620-44be-9dac-0cfe1e0caefd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_4af417da-5ec4-4c0a-8cb0-0dd53239b513" xlink:href="holx-20210925.xsd#holx_IncreasetoNetIncomeresultedfromadoptionofASU201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_4af417da-5ec4-4c0a-8cb0-0dd53239b513" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_8322413c-b08f-42e6-a436-d14dfc2ab921" xlink:href="holx-20210925.xsd#holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_8322413c-b08f-42e6-a436-d14dfc2ab921" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonIncomeTaxLoss_324e3756-e309-4569-aeab-4e68903da6dc" xlink:href="holx-20210925.xsd#holx_NonIncomeTaxLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_NonIncomeTaxLoss_324e3756-e309-4569-aeab-4e68903da6dc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_78502d86-14ed-4819-ac14-b9f845d02b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_78502d86-14ed-4819-ac14-b9f845d02b13" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_StateLossCarryforwardExpectedToUnutilize_1569e8cb-2743-4f76-8faa-9de9f36eb833" xlink:href="holx-20210925.xsd#holx_StateLossCarryforwardExpectedToUnutilize"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_StateLossCarryforwardExpectedToUnutilize_1569e8cb-2743-4f76-8faa-9de9f36eb833" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_a2d51c41-a794-480d-8c7e-edff19d7173a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_a2d51c41-a794-480d-8c7e-edff19d7173a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossStateLossCarryforwards_31ad8d64-0bd4-4706-b310-ac57e98d7260" xlink:href="holx-20210925.xsd#holx_GrossStateLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_GrossStateLossCarryforwards_31ad8d64-0bd4-4706-b310-ac57e98d7260" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossForeignLossCarryforwards_17328994-6d9d-4742-9652-a8e37bac2ef5" xlink:href="holx-20210925.xsd#holx_GrossForeignLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_GrossForeignLossCarryforwards_17328994-6d9d-4742-9652-a8e37bac2ef5" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxReceivableReclassification_41b9368a-51b3-455d-8378-bbd6c250064d" xlink:href="holx-20210925.xsd#holx_IncomeTaxReceivableReclassification"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_IncomeTaxReceivableReclassification_41b9368a-51b3-455d-8378-bbd6c250064d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:href="holx-20210925.xsd#holx_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_70576f8e-cec2-4c2b-a39c-7ba3f975c0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_70576f8e-cec2-4c2b-a39c-7ba3f975c0f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_70576f8e-cec2-4c2b-a39c-7ba3f975c0f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_70576f8e-cec2-4c2b-a39c-7ba3f975c0f5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_70576f8e-cec2-4c2b-a39c-7ba3f975c0f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_70576f8e-cec2-4c2b-a39c-7ba3f975c0f5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_95534735-683e-4231-950e-d56e0462437b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:to="loc_us-gaap_DomesticCountryMember_95534735-683e-4231-950e-d56e0462437b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_7148ce80-545d-4f62-b1e2-6e1861de1331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_7148ce80-545d-4f62-b1e2-6e1861de1331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_b7d86a47-264a-4f92-a90c-b997d6f5a282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:to="loc_us-gaap_ForeignCountryMember_b7d86a47-264a-4f92-a90c-b997d6f5a282" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ed3b7f2-f064-413a-a813-f88d7d287b89" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_srt_RangeAxis_1ed3b7f2-f064-413a-a813-f88d7d287b89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1ed3b7f2-f064-413a-a813-f88d7d287b89_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1ed3b7f2-f064-413a-a813-f88d7d287b89" xlink:to="loc_srt_RangeMember_1ed3b7f2-f064-413a-a813-f88d7d287b89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b095f300-b158-4bec-a6a7-e49f7bcab4e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1ed3b7f2-f064-413a-a813-f88d7d287b89" xlink:to="loc_srt_RangeMember_b095f300-b158-4bec-a6a7-e49f7bcab4e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e215e613-ead8-4a73-8c95-7e5c8ff952ca" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b095f300-b158-4bec-a6a7-e49f7bcab4e1" xlink:to="loc_srt_MaximumMember_e215e613-ead8-4a73-8c95-7e5c8ff952ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_c4540791-356d-4d13-9c9a-a2d75507e398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_c4540791-356d-4d13-9c9a-a2d75507e398" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_c4540791-356d-4d13-9c9a-a2d75507e398_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_c4540791-356d-4d13-9c9a-a2d75507e398" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_c4540791-356d-4d13-9c9a-a2d75507e398_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_a25b8e98-3e42-4dbb-b79d-860b17a5246f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_c4540791-356d-4d13-9c9a-a2d75507e398" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_a25b8e98-3e42-4dbb-b79d-860b17a5246f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossCarryforwardsMember_4edc2b57-4176-4083-bda4-ce6eb9358d4b" xlink:href="holx-20210925.xsd#holx_NetOperatingLossCarryforwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_a25b8e98-3e42-4dbb-b79d-860b17a5246f" xlink:to="loc_holx_NetOperatingLossCarryforwardsMember_4edc2b57-4176-4083-bda4-ce6eb9358d4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxCreditCarryforwardMember_a76019e4-34e9-48a5-b7a6-c68c429897d9" xlink:href="holx-20210925.xsd#holx_TaxCreditCarryforwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_a25b8e98-3e42-4dbb-b79d-860b17a5246f" xlink:to="loc_holx_TaxCreditCarryforwardMember_a76019e4-34e9-48a5-b7a6-c68c429897d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f857c78e-5aa7-466b-afdc-14aa17aa7ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f857c78e-5aa7-466b-afdc-14aa17aa7ad6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f857c78e-5aa7-466b-afdc-14aa17aa7ad6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f857c78e-5aa7-466b-afdc-14aa17aa7ad6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f857c78e-5aa7-466b-afdc-14aa17aa7ad6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f857c78e-5aa7-466b-afdc-14aa17aa7ad6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9422cda4-9873-41c5-bf50-f3a275997ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9422cda4-9873-41c5-bf50-f3a275997ac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_e2d835b9-356b-47df-9841-8ea7d2e2a486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_e2d835b9-356b-47df-9841-8ea7d2e2a486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_47a6bac6-cb4c-474e-8dab-0236f50e0575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_47a6bac6-cb4c-474e-8dab-0236f50e0575" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8dc58da2-4a14-4957-a959-fcd25bdfb31a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8dc58da2-4a14-4957-a959-fcd25bdfb31a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8dc58da2-4a14-4957-a959-fcd25bdfb31a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8dc58da2-4a14-4957-a959-fcd25bdfb31a" xlink:to="loc_us-gaap_SegmentDomain_8dc58da2-4a14-4957-a959-fcd25bdfb31a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6dc87f91-8623-4c2f-95bd-bb25efa3ca51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8dc58da2-4a14-4957-a959-fcd25bdfb31a" xlink:to="loc_us-gaap_SegmentDomain_6dc87f91-8623-4c2f-95bd-bb25efa3ca51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_7b700876-7720-4e21-930c-96c65998a859" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_6dc87f91-8623-4c2f-95bd-bb25efa3ca51" xlink:to="loc_holx_MedicalAestheticsMember_7b700876-7720-4e21-930c-96c65998a859" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="extended" id="if59cbac0927b47d0a1e221645931c66a_StockholdersEquityandStockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6761c112-158a-4e14-8ab1-d6231866c273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6761c112-158a-4e14-8ab1-d6231866c273" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be697cb1-0b0c-438a-b400-cef9f9392bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be697cb1-0b0c-438a-b400-cef9f9392bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b4534e35-ee1d-4d88-a788-98b58f4fd42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b4534e35-ee1d-4d88-a788-98b58f4fd42a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5b125ece-c1cd-449d-ad06-a95e04270f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5b125ece-c1cd-449d-ad06-a95e04270f50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8583133b-a2c8-447f-8f3c-2317c29762fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8583133b-a2c8-447f-8f3c-2317c29762fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_60bd4867-e7fc-4c79-95ed-96a8c5f08ca2" xlink:href="holx-20210925.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_60bd4867-e7fc-4c79-95ed-96a8c5f08ca2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_b7fd5fbd-3ca4-4c30-ba51-c0baa38601bb" xlink:href="holx-20210925.xsd#holx_PercentageOfVestingForStockOptionsGrantedToEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_b7fd5fbd-3ca4-4c30-ba51-c0baa38601bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_640e5aca-a97d-4cde-8425-775313fb29b0" xlink:href="holx-20210925.xsd#holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_640e5aca-a97d-4cde-8425-775313fb29b0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate_b09fbd89-b2c1-4074-9d0e-4d7798076d2e" xlink:href="holx-20210925.xsd#holx_ShareBasedCompensationPercentageOfForfeitureRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate_b09fbd89-b2c1-4074-9d0e-4d7798076d2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_95547980-115c-4753-b985-748afd8697d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_95547980-115c-4753-b985-748afd8697d4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_920c7eca-d7c1-4b2a-b15a-e7778f71792f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_920c7eca-d7c1-4b2a-b15a-e7778f71792f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6f7a7047-6c99-4f6a-a05e-ba1ce38cd685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6f7a7047-6c99-4f6a-a05e-ba1ce38cd685" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3b211e10-ce51-410f-af96-cad9afb681d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3b211e10-ce51-410f-af96-cad9afb681d7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3afa9daa-3646-4d97-bf69-6221349e0729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3afa9daa-3646-4d97-bf69-6221349e0729" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e621238a-5303-470c-bb07-94d39fbae076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e621238a-5303-470c-bb07-94d39fbae076" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0b9c3ec3-46f2-4677-9379-2ee0b03faa8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0b9c3ec3-46f2-4677-9379-2ee0b03faa8f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_7fb6d233-cbcc-41c4-8203-2e2a7b46b4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_7fb6d233-cbcc-41c4-8203-2e2a7b46b4db" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_e7e66376-e90d-467a-9aea-a78beaa0c6f4" xlink:href="holx-20210925.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_e7e66376-e90d-467a-9aea-a78beaa0c6f4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_2a8c2486-40cf-4f08-b6eb-547bd4de8fbc" xlink:href="holx-20210925.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_2a8c2486-40cf-4f08-b6eb-547bd4de8fbc" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_28456b72-afa6-4899-a003-7a7827124cec" xlink:href="holx-20210925.xsd#holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_28456b72-afa6-4899-a003-7a7827124cec" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_0a0a6a30-0d9e-4589-9b9d-2c98e23c1322" xlink:href="holx-20210925.xsd#holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_0a0a6a30-0d9e-4589-9b9d-2c98e23c1322" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e8589d59-bb0d-4116-90b2-5e54841a29e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensation_e8589d59-bb0d-4116-90b2-5e54841a29e1" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_7125b821-96c7-4bfc-a84a-7d061891d776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_7125b821-96c7-4bfc-a84a-7d061891d776" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_7db8bb4f-0964-4d2f-8eab-7586a4556034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_7db8bb4f-0964-4d2f-8eab-7586a4556034" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRSharesRepurchasedduringtheperiod_beabc958-4f65-4d54-a610-ec18946a6562" xlink:href="holx-20210925.xsd#holx_ASRSharesRepurchasedduringtheperiod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_ASRSharesRepurchasedduringtheperiod_beabc958-4f65-4d54-a610-ec18946a6562" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRAuthorized_5300423d-5d20-442c-8023-69be892c1cf7" xlink:href="holx-20210925.xsd#holx_ASRAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_ASRAuthorized_5300423d-5d20-442c-8023-69be892c1cf7" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountpaidduringtheperiodunderASRAgreement_d9491cb1-6d0a-47c8-b156-fe607c89ce18" xlink:href="holx-20210925.xsd#holx_AmountpaidduringtheperiodunderASRAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_AmountpaidduringtheperiodunderASRAgreement_d9491cb1-6d0a-47c8-b156-fe607c89ce18" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_1b27766a-95be-44ae-9b48-347ab4d5376d" xlink:href="holx-20210925.xsd#holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_1b27766a-95be-44ae-9b48-347ab4d5376d" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchseAuthorizationDateAxis_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75" xlink:href="holx-20210925.xsd#holx_ShareRepurchseAuthorizationDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_holx_ShareRepurchseAuthorizationDateAxis_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AuthorizationDateDomain_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75_default" xlink:href="holx-20210925.xsd#holx_AuthorizationDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75" xlink:to="loc_holx_AuthorizationDateDomain_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AuthorizationDateDomain_c48ddace-7f71-49b5-b1c4-8bd37ad8cd7f" xlink:href="holx-20210925.xsd#holx_AuthorizationDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75" xlink:to="loc_holx_AuthorizationDateDomain_c48ddace-7f71-49b5-b1c4-8bd37ad8cd7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Dec112019Member_cd4b7bf7-d735-49f7-8b18-4bf63a921ab0" xlink:href="holx-20210925.xsd#holx_Dec112019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_AuthorizationDateDomain_c48ddace-7f71-49b5-b1c4-8bd37ad8cd7f" xlink:to="loc_holx_Dec112019Member_cd4b7bf7-d735-49f7-8b18-4bf63a921ab0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchseAuthorizationDateDomain_cd1ab55c-6d25-42cb-a0df-76c310e97cb7" xlink:href="holx-20210925.xsd#holx_ShareRepurchseAuthorizationDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75" xlink:to="loc_holx_ShareRepurchseAuthorizationDateDomain_cd1ab55c-6d25-42cb-a0df-76c310e97cb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Dec92020Member_4673aa32-3222-4386-b326-607ed87b76d6" xlink:href="holx-20210925.xsd#holx_Dec92020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ShareRepurchseAuthorizationDateDomain_cd1ab55c-6d25-42cb-a0df-76c310e97cb7" xlink:to="loc_holx_Dec92020Member_4673aa32-3222-4386-b326-607ed87b76d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_06978417-1bf6-44d8-b8e5-56789ff57dee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_us-gaap_PlanNameAxis_06978417-1bf6-44d8-b8e5-56789ff57dee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_06978417-1bf6-44d8-b8e5-56789ff57dee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_06978417-1bf6-44d8-b8e5-56789ff57dee" xlink:to="loc_us-gaap_PlanNameDomain_06978417-1bf6-44d8-b8e5-56789ff57dee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_21b162dd-fd96-4cb6-b785-d52699a9e2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_06978417-1bf6-44d8-b8e5-56789ff57dee" xlink:to="loc_us-gaap_PlanNameDomain_21b162dd-fd96-4cb6-b785-d52699a9e2c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandEightEquityPlanMember_3a156145-6f14-4c46-8d52-7ee91214bdf4" xlink:href="holx-20210925.xsd#holx_TwoThousandEightEquityPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_21b162dd-fd96-4cb6-b785-d52699a9e2c0" xlink:to="loc_holx_TwoThousandEightEquityPlanMember_3a156145-6f14-4c46-8d52-7ee91214bdf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember_8c296a3a-214f-4406-b919-70aba5289642" xlink:href="holx-20210925.xsd#holx_SemiAnnualEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_21b162dd-fd96-4cb6-b785-d52699a9e2c0" xlink:to="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember_8c296a3a-214f-4406-b919-70aba5289642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9dcb6996-d784-4c4f-834a-b09f758605a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_us-gaap_AwardTypeAxis_9dcb6996-d784-4c4f-834a-b09f758605a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9dcb6996-d784-4c4f-834a-b09f758605a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9dcb6996-d784-4c4f-834a-b09f758605a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9dcb6996-d784-4c4f-834a-b09f758605a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9dcb6996-d784-4c4f-834a-b09f758605a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_65625afc-60a2-42ce-8b31-6e22293ec9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_us-gaap_StockOptionMember_65625afc-60a2-42ce-8b31-6e22293ec9ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6eb3d49a-7fe9-4119-a8e9-e9b32181bb50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6eb3d49a-7fe9-4119-a8e9-e9b32181bb50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_836dc1d5-dd86-4ea8-aa08-2716b845dc62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_us-gaap_PerformanceSharesMember_836dc1d5-dd86-4ea8-aa08-2716b845dc62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember_528ff0b1-78f8-47d4-9f62-b03a48b750f7" xlink:href="holx-20210925.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_holx_MarketBasedStockUnitsMember_528ff0b1-78f8-47d4-9f62-b03a48b750f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_99f52bbd-6580-448e-a22f-362da27ead02" xlink:href="holx-20210925.xsd#holx_PSUFreeCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_holx_PSUFreeCashFlowMember_99f52bbd-6580-448e-a22f-362da27ead02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0bfb67b3-55d0-4369-8590-4fc998ead556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_us-gaap_RestrictedStockMember_0bfb67b3-55d0-4369-8590-4fc998ead556" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6eec47f1-d913-45cd-94a6-2f59eedcd177" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_srt_RangeAxis_6eec47f1-d913-45cd-94a6-2f59eedcd177" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6eec47f1-d913-45cd-94a6-2f59eedcd177_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6eec47f1-d913-45cd-94a6-2f59eedcd177" xlink:to="loc_srt_RangeMember_6eec47f1-d913-45cd-94a6-2f59eedcd177_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9d1069d6-0165-4b9b-887e-44d765e7476b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6eec47f1-d913-45cd-94a6-2f59eedcd177" xlink:to="loc_srt_RangeMember_9d1069d6-0165-4b9b-887e-44d765e7476b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_84009746-907f-4fb6-93c9-2309967c45a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9d1069d6-0165-4b9b-887e-44d765e7476b" xlink:to="loc_srt_MinimumMember_84009746-907f-4fb6-93c9-2309967c45a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cb268807-5579-44c0-8985-3324ea5f76a7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9d1069d6-0165-4b9b-887e-44d765e7476b" xlink:to="loc_srt_MaximumMember_cb268807-5579-44c0-8985-3324ea5f76a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5d087b3a-ef09-4501-b066-07589412231a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5d087b3a-ef09-4501-b066-07589412231a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5d087b3a-ef09-4501-b066-07589412231a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5d087b3a-ef09-4501-b066-07589412231a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5d087b3a-ef09-4501-b066-07589412231a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_03d35bb9-c13e-44a3-aa4b-5b6639dcbfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5d087b3a-ef09-4501-b066-07589412231a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_03d35bb9-c13e-44a3-aa4b-5b6639dcbfac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_June132019PlanMember_d30a5c06-33d2-4644-829b-6afcf6948027" xlink:href="holx-20210925.xsd#holx_June132019PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_03d35bb9-c13e-44a3-aa4b-5b6639dcbfac" xlink:to="loc_holx_June132019PlanMember_d30a5c06-33d2-4644-829b-6afcf6948027" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_441cbc27-ede1-4dff-b912-a473df57b963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_441cbc27-ede1-4dff-b912-a473df57b963" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_441cbc27-ede1-4dff-b912-a473df57b963_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_441cbc27-ede1-4dff-b912-a473df57b963" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_441cbc27-ede1-4dff-b912-a473df57b963_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ed40aa13-8172-4815-88e5-1994c65ad954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_441cbc27-ede1-4dff-b912-a473df57b963" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ed40aa13-8172-4815-88e5-1994c65ad954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_65752602-768c-4722-b989-5feb3c603de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ed40aa13-8172-4815-88e5-1994c65ad954" xlink:to="loc_us-gaap_SubsequentEventMember_65752602-768c-4722-b989-5feb3c603de7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="extended" id="ibc197ab743654523b29ff5fdc7289538_StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5588278-3e4b-4d1c-adfa-8ddf60adad3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8be4a457-cea4-4de4-ac7f-da68660daa42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5588278-3e4b-4d1c-adfa-8ddf60adad3f" xlink:to="loc_us-gaap_ShareBasedCompensation_8be4a457-cea4-4de4-ac7f-da68660daa42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d669e5-a8dc-400f-8f50-aa35c01abd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5588278-3e4b-4d1c-adfa-8ddf60adad3f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d669e5-a8dc-400f-8f50-aa35c01abd00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dfb1d7c6-9873-4bc5-94c6-842270d9d0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d669e5-a8dc-400f-8f50-aa35c01abd00" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dfb1d7c6-9873-4bc5-94c6-842270d9d0b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dfb1d7c6-9873-4bc5-94c6-842270d9d0b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dfb1d7c6-9873-4bc5-94c6-842270d9d0b7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dfb1d7c6-9873-4bc5-94c6-842270d9d0b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dfb1d7c6-9873-4bc5-94c6-842270d9d0b7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a1c34292-2bd9-45ae-a904-7c7e6666ac39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_CostOfSalesMember_a1c34292-2bd9-45ae-a904-7c7e6666ac39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_79b43e12-7d82-478a-91b2-86e04db73102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_79b43e12-7d82-478a-91b2-86e04db73102" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_b6405e5b-b1d1-474b-9a36-c1939e3fa83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_b6405e5b-b1d1-474b-9a36-c1939e3fa83d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_6e1c052d-0605-4a28-a8ab-800d52c95dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_6e1c052d-0605-4a28-a8ab-800d52c95dbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_ba827d8a-d9c2-4585-891d-0e679f8fd0e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_RestructuringChargesMember_ba827d8a-d9c2-4585-891d-0e679f8fd0e8" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="extended" id="ic0404379175e4ce2a9d2ea54f25ece14_StockholdersEquityandStockBasedCompensationStockOptionActivityDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45b9b903-51dd-4e8f-ba36-ddd42e0c310d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ce6a00c4-42cd-4205-9829-0312debc9193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45b9b903-51dd-4e8f-ba36-ddd42e0c310d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ce6a00c4-42cd-4205-9829-0312debc9193" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b127e2-418a-4d6a-aa25-bda0c63dfcf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45b9b903-51dd-4e8f-ba36-ddd42e0c310d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b127e2-418a-4d6a-aa25-bda0c63dfcf0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a91cdbfa-46f9-40bb-b510-3ba33d0aa990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b127e2-418a-4d6a-aa25-bda0c63dfcf0" xlink:to="loc_us-gaap_AwardTypeAxis_a91cdbfa-46f9-40bb-b510-3ba33d0aa990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a91cdbfa-46f9-40bb-b510-3ba33d0aa990_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a91cdbfa-46f9-40bb-b510-3ba33d0aa990" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a91cdbfa-46f9-40bb-b510-3ba33d0aa990_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a7cead9-852e-4383-a858-ad48f30121a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a91cdbfa-46f9-40bb-b510-3ba33d0aa990" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a7cead9-852e-4383-a858-ad48f30121a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_0307e64b-86d4-4314-b8f9-5482b440093a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a7cead9-852e-4383-a858-ad48f30121a7" xlink:to="loc_us-gaap_PerformanceSharesMember_0307e64b-86d4-4314-b8f9-5482b440093a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember_547725c5-fd3f-4b34-986e-15e4d353decf" xlink:href="holx-20210925.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a7cead9-852e-4383-a858-ad48f30121a7" xlink:to="loc_holx_MarketBasedStockUnitsMember_547725c5-fd3f-4b34-986e-15e4d353decf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="extended" id="i88838b37af4140c985232f366e8f56b7_StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75f72032-6ad7-4ca1-ba45-7b356e8a7ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75f72032-6ad7-4ca1-ba45-7b356e8a7ade" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_bbf66dce-dfe0-4578-b131-bb25a59f2c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_bbf66dce-dfe0-4578-b131-bb25a59f2c95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e85523e2-199d-4ed0-a7c8-8feb371d5cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e85523e2-199d-4ed0-a7c8-8feb371d5cef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_25396c8f-925c-4801-a4c6-4334658c93f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_25396c8f-925c-4801-a4c6-4334658c93f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_9affa90a-7fcb-404a-87ce-13422590c3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_9affa90a-7fcb-404a-87ce-13422590c3d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62291a1f-c174-446f-98a8-d10da91b241b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75f72032-6ad7-4ca1-ba45-7b356e8a7ade" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62291a1f-c174-446f-98a8-d10da91b241b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8730c163-8fb1-4e9f-8244-1bdb31a692fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62291a1f-c174-446f-98a8-d10da91b241b" xlink:to="loc_us-gaap_AwardTypeAxis_8730c163-8fb1-4e9f-8244-1bdb31a692fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8730c163-8fb1-4e9f-8244-1bdb31a692fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8730c163-8fb1-4e9f-8244-1bdb31a692fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8730c163-8fb1-4e9f-8244-1bdb31a692fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c50ab8a3-8081-4762-81c5-0f70f8f5bc1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8730c163-8fb1-4e9f-8244-1bdb31a692fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c50ab8a3-8081-4762-81c5-0f70f8f5bc1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeStockPurchasePlanMember_abf22b48-2416-4e64-90fd-d0ff5917ff0c" xlink:href="holx-20210925.xsd#holx_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c50ab8a3-8081-4762-81c5-0f70f8f5bc1d" xlink:to="loc_holx_EmployeeStockPurchasePlanMember_abf22b48-2416-4e64-90fd-d0ff5917ff0c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#DeferredCompensationPlanAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="extended" id="i07cd61b9f6474126b965be324daecdcb_DeferredCompensationPlanAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_c85b563d-1b89-4cd2-9640-8313be5f8c70" xlink:href="holx-20210925.xsd#holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_c85b563d-1b89-4cd2-9640-8313be5f8c70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_3e606053-b372-428d-b210-02ae81a94de6" xlink:href="holx-20210925.xsd#holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_3e606053-b372-428d-b210-02ae81a94de6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeContributionsVestedPercentage_6a1cf9e1-18e6-483d-af7a-74feb5114c19" xlink:href="holx-20210925.xsd#holx_EmployeeContributionsVestedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_EmployeeContributionsVestedPercentage_6a1cf9e1-18e6-483d-af7a-74feb5114c19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsPercentVestedAnnually_059b5dae-4c3d-4793-bcf5-6a965cd9e236" xlink:href="holx-20210925.xsd#holx_EmployerContributionsPercentVestedAnnually"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_EmployerContributionsPercentVestedAnnually_059b5dae-4c3d-4793-bcf5-6a965cd9e236" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsVestingPeriod_b6662636-34c4-4acb-94ca-afe2efbc7569" xlink:href="holx-20210925.xsd#holx_EmployerContributionsVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_EmployerContributionsVestingPeriod_b6662636-34c4-4acb-94ca-afe2efbc7569" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_fbef4eed-454e-459a-8233-d0e0f36e295e" xlink:href="holx-20210925.xsd#holx_NonqualifiedDeferredCompensationPlanAnnualContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_fbef4eed-454e-459a-8233-d0e0f36e295e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InvestmentInGroupLifeInsuranceContracts_48019380-6c4e-4cc0-b685-546a934986ff" xlink:href="holx-20210925.xsd#holx_InvestmentInGroupLifeInsuranceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_InvestmentInGroupLifeInsuranceContracts_48019380-6c4e-4cc0-b685-546a934986ff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_d37a9b20-b010-43e9-bd14-fe64f16fb91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_d37a9b20-b010-43e9-bd14-fe64f16fb91e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_d0a4f2db-3e10-402c-9c27-e84829c10c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_d0a4f2db-3e10-402c-9c27-e84829c10c4d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_17eeec94-c78b-49d3-9dd0-063b87571af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_d0a4f2db-3e10-402c-9c27-e84829c10c4d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_17eeec94-c78b-49d3-9dd0-063b87571af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_17eeec94-c78b-49d3-9dd0-063b87571af9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_17eeec94-c78b-49d3-9dd0-063b87571af9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_17eeec94-c78b-49d3-9dd0-063b87571af9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e7e2cd8f-9934-43cd-a6c3-1c4a37e15bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_17eeec94-c78b-49d3-9dd0-063b87571af9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e7e2cd8f-9934-43cd-a6c3-1c4a37e15bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8aa7c7f1-a0b6-49a1-9fd7-296022968e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e7e2cd8f-9934-43cd-a6c3-1c4a37e15bb2" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8aa7c7f1-a0b6-49a1-9fd7-296022968e5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_ac556c7b-b87b-4d99-a154-987aadcf2888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_d0a4f2db-3e10-402c-9c27-e84829c10c4d" xlink:to="loc_us-gaap_VestingAxis_ac556c7b-b87b-4d99-a154-987aadcf2888" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ac556c7b-b87b-4d99-a154-987aadcf2888_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_ac556c7b-b87b-4d99-a154-987aadcf2888" xlink:to="loc_us-gaap_VestingDomain_ac556c7b-b87b-4d99-a154-987aadcf2888_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_e8969333-b8e9-434e-b8e9-cf704ee804f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_ac556c7b-b87b-4d99-a154-987aadcf2888" xlink:to="loc_us-gaap_VestingDomain_e8969333-b8e9-434e-b8e9-cf704ee804f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OneThirdAnnuallyMember_4c8f67e3-7f29-4cb3-829e-ec87b7720e40" xlink:href="holx-20210925.xsd#holx_OneThirdAnnuallyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_e8969333-b8e9-434e-b8e9-cf704ee804f4" xlink:to="loc_holx_OneThirdAnnuallyMember_4c8f67e3-7f29-4cb3-829e-ec87b7720e40" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#LitigationandOtherMattersAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="extended" id="ia72274ce43d9466f8068e2144c32bd22_LitigationandOtherMattersAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_169719d3-64ce-43b0-9cad-72feefcc6bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_8369638b-659b-43aa-b965-8b0669c0650e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_169719d3-64ce-43b0-9cad-72feefcc6bb5" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_8369638b-659b-43aa-b965-8b0669c0650e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_be068b99-bafd-45f8-be66-f274986c1536" xlink:href="holx-20210925.xsd#holx_LegalAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_169719d3-64ce-43b0-9cad-72feefcc6bb5" xlink:to="loc_holx_LegalAccrual_be068b99-bafd-45f8-be66-f274986c1536" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_169719d3-64ce-43b0-9cad-72feefcc6bb5" xlink:to="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a2be8be0-b3ab-4ffa-ada7-96c5d43f0173" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:to="loc_dei_LegalEntityAxis_a2be8be0-b3ab-4ffa-ada7-96c5d43f0173" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a2be8be0-b3ab-4ffa-ada7-96c5d43f0173_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a2be8be0-b3ab-4ffa-ada7-96c5d43f0173" xlink:to="loc_dei_EntityDomain_a2be8be0-b3ab-4ffa-ada7-96c5d43f0173_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b2493670-12d7-4dd6-b6d0-0a98b55c2c78" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a2be8be0-b3ab-4ffa-ada7-96c5d43f0173" xlink:to="loc_dei_EntityDomain_b2493670-12d7-4dd6-b6d0-0a98b55c2c78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_7569584e-a4d5-4ff5-a115-397939e98440" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_b2493670-12d7-4dd6-b6d0-0a98b55c2c78" xlink:to="loc_holx_MedicalAestheticsBusinessMember_7569584e-a4d5-4ff5-a115-397939e98440" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_aba60387-3716-45ca-a7fe-0ade7754c966" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:to="loc_srt_LitigationCaseAxis_aba60387-3716-45ca-a7fe-0ade7754c966" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_aba60387-3716-45ca-a7fe-0ade7754c966_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_aba60387-3716-45ca-a7fe-0ade7754c966" xlink:to="loc_srt_LitigationCaseTypeDomain_aba60387-3716-45ca-a7fe-0ade7754c966_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f993bb56-cbd5-4a55-8bd2-102ecaca1dc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_aba60387-3716-45ca-a7fe-0ade7754c966" xlink:to="loc_srt_LitigationCaseTypeDomain_f993bb56-cbd5-4a55-8bd2-102ecaca1dc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CompanyVs.MinervaSurgicalInc.Member_d45714f6-01bf-43fb-a08c-119a7474c395" xlink:href="holx-20210925.xsd#holx_CompanyVs.MinervaSurgicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f993bb56-cbd5-4a55-8bd2-102ecaca1dc5" xlink:to="loc_holx_CompanyVs.MinervaSurgicalInc.Member_d45714f6-01bf-43fb-a08c-119a7474c395" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d61db2d2-37e5-4827-ad3d-20597b0648d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:to="loc_us-gaap_LitigationStatusAxis_d61db2d2-37e5-4827-ad3d-20597b0648d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d61db2d2-37e5-4827-ad3d-20597b0648d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_d61db2d2-37e5-4827-ad3d-20597b0648d9" xlink:to="loc_us-gaap_LitigationStatusDomain_d61db2d2-37e5-4827-ad3d-20597b0648d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1bc0f064-50b2-450f-a8d5-13c1f1f6bd0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_d61db2d2-37e5-4827-ad3d-20597b0648d9" xlink:to="loc_us-gaap_LitigationStatusDomain_1bc0f064-50b2-450f-a8d5-13c1f1f6bd0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_6f078e48-68a0-4beb-b024-2c8b33e21cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_1bc0f064-50b2-450f-a8d5-13c1f1f6bd0a" xlink:to="loc_us-gaap_JudicialRulingMember_6f078e48-68a0-4beb-b024-2c8b33e21cd6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#DispositionAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="extended" id="i374827045aa1402c88b9e4f91142a4bb_DispositionAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_af81fd52-b343-4b9a-97e0-ca665e458af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_af81fd52-b343-4b9a-97e0-ca665e458af0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_37b56f24-92e7-4da2-baa3-0831bcf11e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_37b56f24-92e7-4da2-baa3-0831bcf11e3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_28cfe282-4574-4bd0-9a3f-10815b99bf59" xlink:href="holx-20210925.xsd#holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_28cfe282-4574-4bd0-9a3f-10815b99bf59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TransitionServicesAgreementTerm_72446d3d-f28f-450b-9e4f-a47b49f3feda" xlink:href="holx-20210925.xsd#holx_TransitionServicesAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_holx_TransitionServicesAgreementTerm_72446d3d-f28f-450b-9e4f-a47b49f3feda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily_4e332156-597f-4e2c-b786-8e90ec214943" xlink:href="holx-20210925.xsd#holx_IndemnificationLiabily"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_holx_IndemnificationLiabily_4e332156-597f-4e2c-b786-8e90ec214943" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_df38c55d-2238-4499-b96f-8db154343ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_us-gaap_AssetImpairmentCharges_df38c55d-2238-4499-b96f-8db154343ac0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Expensesfromdisposition_54cf2fbb-666e-407b-a0c5-020e2a537d63" xlink:href="holx-20210925.xsd#holx_Expensesfromdisposition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_holx_Expensesfromdisposition_54cf2fbb-666e-407b-a0c5-020e2a537d63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6146af0c-90b5-4195-952d-eb78091033d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6146af0c-90b5-4195-952d-eb78091033d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6146af0c-90b5-4195-952d-eb78091033d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6146af0c-90b5-4195-952d-eb78091033d7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6146af0c-90b5-4195-952d-eb78091033d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e243c940-f589-4f57-8b63-1e541c13a4a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6146af0c-90b5-4195-952d-eb78091033d7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e243c940-f589-4f57-8b63-1e541c13a4a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_6ec1adc9-ded2-4760-a1c1-7bd5d9502fbf" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e243c940-f589-4f57-8b63-1e541c13a4a1" xlink:to="loc_holx_MedicalAestheticsBusinessMember_6ec1adc9-ded2-4760-a1c1-7bd5d9502fbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_54506c9c-78cc-4830-8b6c-615731e1a3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_54506c9c-78cc-4830-8b6c-615731e1a3a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_54506c9c-78cc-4830-8b6c-615731e1a3a9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_54506c9c-78cc-4830-8b6c-615731e1a3a9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_54506c9c-78cc-4830-8b6c-615731e1a3a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fb842e82-eb28-4390-9bb7-7f2251bba549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_54506c9c-78cc-4830-8b6c-615731e1a3a9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fb842e82-eb28-4390-9bb7-7f2251bba549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a14a650a-284a-4d99-bc55-ae114e92d871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fb842e82-eb28-4390-9bb7-7f2251bba549" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a14a650a-284a-4d99-bc55-ae114e92d871" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c4719ec5-e995-4fef-ba83-6a7da6e34d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c4719ec5-e995-4fef-ba83-6a7da6e34d26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c4719ec5-e995-4fef-ba83-6a7da6e34d26_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c4719ec5-e995-4fef-ba83-6a7da6e34d26" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c4719ec5-e995-4fef-ba83-6a7da6e34d26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eabcfb1d-dfc4-4154-ad61-66b4c16fb18b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c4719ec5-e995-4fef-ba83-6a7da6e34d26" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eabcfb1d-dfc4-4154-ad61-66b4c16fb18b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bf3eafef-c0ba-4698-aba9-4f1bdb6422f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eabcfb1d-dfc4-4154-ad61-66b4c16fb18b" xlink:to="loc_us-gaap_CostOfSalesMember_bf3eafef-c0ba-4698-aba9-4f1bdb6422f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_067a338e-9993-41cf-85f5-9cd56c9fcf5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eabcfb1d-dfc4-4154-ad61-66b4c16fb18b" xlink:to="loc_us-gaap_OperatingExpenseMember_067a338e-9993-41cf-85f5-9cd56c9fcf5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fa6d62da-5f60-4864-9b18-077ab2261c11" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:to="loc_srt_RangeAxis_fa6d62da-5f60-4864-9b18-077ab2261c11" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa6d62da-5f60-4864-9b18-077ab2261c11_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fa6d62da-5f60-4864-9b18-077ab2261c11" xlink:to="loc_srt_RangeMember_fa6d62da-5f60-4864-9b18-077ab2261c11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec045e58-9981-4390-80af-a18fcf967ae1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fa6d62da-5f60-4864-9b18-077ab2261c11" xlink:to="loc_srt_RangeMember_ec045e58-9981-4390-80af-a18fcf967ae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e9b49a2f-b3aa-49ea-8cc6-69c3a419b9fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ec045e58-9981-4390-80af-a18fcf967ae1" xlink:to="loc_srt_MinimumMember_e9b49a2f-b3aa-49ea-8cc6-69c3a419b9fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_84abf669-9e3d-4e59-9c6c-e74cd4e3e555" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ec045e58-9981-4390-80af-a18fcf967ae1" xlink:to="loc_srt_MaximumMember_84abf669-9e3d-4e59-9c6c-e74cd4e3e555" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended" id="i1cb0fb7962084bf28aef9291574c7417_BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_49f7e265-a3d7-4789-96c4-a6dc411043c2" xlink:href="holx-20210925.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_915ce68d-bb90-46fa-b6b1-10654585669e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_49f7e265-a3d7-4789-96c4-a6dc411043c2" xlink:to="loc_us-gaap_NumberOfReportableSegments_915ce68d-bb90-46fa-b6b1-10654585669e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3b671efc-f1f8-4027-87ba-fc728a0fb78e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_49f7e265-a3d7-4789-96c4-a6dc411043c2" xlink:to="loc_us-gaap_Revenues_3b671efc-f1f8-4027-87ba-fc728a0fb78e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureTable_cd8d0005-350f-40e4-a05e-7e40ae115704" xlink:href="holx-20210925.xsd#holx_SegmentReportingDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_49f7e265-a3d7-4789-96c4-a6dc411043c2" xlink:to="loc_holx_SegmentReportingDisclosureTable_cd8d0005-350f-40e4-a05e-7e40ae115704" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_33950b73-3763-41bc-9289-f00dcb3813df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SegmentReportingDisclosureTable_cd8d0005-350f-40e4-a05e-7e40ae115704" xlink:to="loc_srt_ConsolidationItemsAxis_33950b73-3763-41bc-9289-f00dcb3813df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_33950b73-3763-41bc-9289-f00dcb3813df_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_33950b73-3763-41bc-9289-f00dcb3813df" xlink:to="loc_srt_ConsolidationItemsDomain_33950b73-3763-41bc-9289-f00dcb3813df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_14f7f4aa-f80f-488e-ba8d-2a7945377837" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_33950b73-3763-41bc-9289-f00dcb3813df" xlink:to="loc_srt_ConsolidationItemsDomain_14f7f4aa-f80f-488e-ba8d-2a7945377837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_86f2c1d0-38fe-4051-b12c-e0ccc7c3d802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_14f7f4aa-f80f-488e-ba8d-2a7945377837" xlink:to="loc_us-gaap_IntersegmentEliminationMember_86f2c1d0-38fe-4051-b12c-e0ccc7c3d802" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended" id="i8b1178337e684ea89594a25ddb0a2a27_BusinessSegmentsandGeographicInformationSegmentInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_35c22bd9-590a-4b78-b989-2c2f961d0bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_Revenues_35c22bd9-590a-4b78-b989-2c2f961d0bf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_120efa74-4ca6-4d41-964d-90da9c1d86aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_OperatingIncomeLoss_120efa74-4ca6-4d41-964d-90da9c1d86aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_6a81c6c9-542d-4da7-b62b-c0add792e0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_6a81c6c9-542d-4da7-b62b-c0add792e0aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_1b6eb1d8-a672-4a51-a581-f35785a19bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_1b6eb1d8-a672-4a51-a581-f35785a19bde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cc0a03c5-a30b-43e4-a898-46e63f5c2d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_Assets_cc0a03c5-a30b-43e4-a898-46e63f5c2d02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7c823133-ac4f-400d-9b38-d8390eec72e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7c823133-ac4f-400d-9b38-d8390eec72e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_53394e49-7532-4815-9f89-6d8544246220" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7c823133-ac4f-400d-9b38-d8390eec72e0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_53394e49-7532-4815-9f89-6d8544246220" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_53394e49-7532-4815-9f89-6d8544246220_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_53394e49-7532-4815-9f89-6d8544246220" xlink:to="loc_us-gaap_SegmentDomain_53394e49-7532-4815-9f89-6d8544246220_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_53394e49-7532-4815-9f89-6d8544246220" xlink:to="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_5f9072d2-dab1-4d9d-bd16-fcb2ac03cc03" xlink:href="holx-20210925.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_DiagnosticsMember_5f9072d2-dab1-4d9d-bd16-fcb2ac03cc03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_990533c6-4456-4f8c-a1e8-8ad08a7cb269" xlink:href="holx-20210925.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_BreastHealthMember_990533c6-4456-4f8c-a1e8-8ad08a7cb269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_a78efa4f-e321-44c1-9dbc-58c93c80b002" xlink:href="holx-20210925.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_GynSurgicalMember_a78efa4f-e321-44c1-9dbc-58c93c80b002" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_4327b561-d930-424c-83cb-7c9f3c6a45b3" xlink:href="holx-20210925.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_SkeletalHealthMember_4327b561-d930-424c-83cb-7c9f3c6a45b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_5e6ee682-35ad-4953-8736-3b8cc984de42" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_MedicalAestheticsMember_5e6ee682-35ad-4953-8736-3b8cc984de42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_836d9ca6-5cdb-4274-99fa-50d064e59144" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7c823133-ac4f-400d-9b38-d8390eec72e0" xlink:to="loc_srt_ConsolidationItemsAxis_836d9ca6-5cdb-4274-99fa-50d064e59144" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_836d9ca6-5cdb-4274-99fa-50d064e59144_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_836d9ca6-5cdb-4274-99fa-50d064e59144" xlink:to="loc_srt_ConsolidationItemsDomain_836d9ca6-5cdb-4274-99fa-50d064e59144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_97af49b4-39b9-4159-922e-e08a2691eb36" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_836d9ca6-5cdb-4274-99fa-50d064e59144" xlink:to="loc_srt_ConsolidationItemsDomain_97af49b4-39b9-4159-922e-e08a2691eb36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b0da9544-fcc0-459b-8386-eaf0fbb47659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_97af49b4-39b9-4159-922e-e08a2691eb36" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b0da9544-fcc0-459b-8386-eaf0fbb47659" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended" id="idff47fe65ea54d29bfab68cada605138_BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_a8e0b2f8-d028-4579-9ef5-33b28a24da57" xlink:href="holx-20210925.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_716e16a5-470a-4538-99fd-35f093d8f035" xlink:href="holx-20210925.xsd#holx_PercentageOfRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_a8e0b2f8-d028-4579-9ef5-33b28a24da57" xlink:to="loc_holx_PercentageOfRevenues_716e16a5-470a-4538-99fd-35f093d8f035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_69b768a5-3dbd-4463-9341-82aa175778d0" xlink:href="holx-20210925.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_a8e0b2f8-d028-4579-9ef5-33b28a24da57" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_69b768a5-3dbd-4463-9341-82aa175778d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_813b830c-6bc3-491b-8e51-37f55d0060b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_69b768a5-3dbd-4463-9341-82aa175778d0" xlink:to="loc_srt_StatementGeographicalAxis_813b830c-6bc3-491b-8e51-37f55d0060b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_813b830c-6bc3-491b-8e51-37f55d0060b8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_813b830c-6bc3-491b-8e51-37f55d0060b8" xlink:to="loc_srt_SegmentGeographicalDomain_813b830c-6bc3-491b-8e51-37f55d0060b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_813b830c-6bc3-491b-8e51-37f55d0060b8" xlink:to="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_46a84afb-0908-466c-9852-dc01a2224766" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:to="loc_country_US_46a84afb-0908-466c-9852-dc01a2224766" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_057f0b56-7dcb-48f5-9c62-532f2ff22bc1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:to="loc_srt_EuropeMember_057f0b56-7dcb-48f5-9c62-532f2ff22bc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_245d733b-0841-41e6-ba7c-9d0be7ec394c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:to="loc_srt_AsiaPacificMember_245d733b-0841-41e6-ba7c-9d0be7ec394c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_8042444b-242c-492f-bb46-856fe7de9a71" xlink:href="holx-20210925.xsd#holx_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:to="loc_holx_AllOtherCountriesMember_8042444b-242c-492f-bb46-856fe7de9a71" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="extended" id="i748b3279cfaf47d1abc5ab5ddfda1cbd_BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_91935a7d-89e0-4756-85cc-e3eb4b47c997" xlink:href="holx-20210925.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3f9b5fc4-751e-43c7-a89b-229e1be00d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_91935a7d-89e0-4756-85cc-e3eb4b47c997" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3f9b5fc4-751e-43c7-a89b-229e1be00d65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_ceeefc50-d1f6-4221-a0b5-157866f05cbf" xlink:href="holx-20210925.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_91935a7d-89e0-4756-85cc-e3eb4b47c997" xlink:to="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_ceeefc50-d1f6-4221-a0b5-157866f05cbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7e89641a-c9b7-4a35-a405-58366d61cd00" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_ceeefc50-d1f6-4221-a0b5-157866f05cbf" xlink:to="loc_srt_StatementGeographicalAxis_7e89641a-c9b7-4a35-a405-58366d61cd00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7e89641a-c9b7-4a35-a405-58366d61cd00_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7e89641a-c9b7-4a35-a405-58366d61cd00" xlink:to="loc_srt_SegmentGeographicalDomain_7e89641a-c9b7-4a35-a405-58366d61cd00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7e89641a-c9b7-4a35-a405-58366d61cd00" xlink:to="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_aa700470-7e58-48aa-bd3d-d5bac58f6fd6" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:to="loc_country_US_aa700470-7e58-48aa-bd3d-d5bac58f6fd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0aa3a8dc-f3f6-4ec0-a801-47583446189f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:to="loc_srt_EuropeMember_0aa3a8dc-f3f6-4ec0-a801-47583446189f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR_bba8961a-6a83-4378-8fce-bd7e680f96b4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:to="loc_country_CR_bba8961a-6a83-4378-8fce-bd7e680f96b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_3763c39d-679e-4101-9159-dfc0c008b04d" xlink:href="holx-20210925.xsd#holx_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:to="loc_holx_AllOtherCountriesMember_3763c39d-679e-4101-9159-dfc0c008b04d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefitsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="extended" id="i1a7e0f24c09e4fbe834157c6191cebd9_PensionandOtherEmployeeBenefitsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_526fe841-a4d4-423b-aaa0-6477a2e916cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_526fe841-a4d4-423b-aaa0-6477a2e916cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_3ff7077b-b8b6-486a-ab03-f191fb02d3aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_3ff7077b-b8b6-486a-ab03-f191fb02d3aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_9bf8ed5d-f334-47a9-b296-cdba6d501bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_9bf8ed5d-f334-47a9-b296-cdba6d501bdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards_68db8465-e612-4692-a963-f4160a0da729" xlink:href="holx-20210925.xsd#holx_ProjectedBenefitObligationForLongTermServiceAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:to="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards_68db8465-e612-4692-a963-f4160a0da729" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9e46f67c-e30f-470c-ba9f-8f44f0714da5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9e46f67c-e30f-470c-ba9f-8f44f0714da5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5fb01d86-9a90-4787-b332-08cd0a7d8129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9e46f67c-e30f-470c-ba9f-8f44f0714da5" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5fb01d86-9a90-4787-b332-08cd0a7d8129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5fb01d86-9a90-4787-b332-08cd0a7d8129_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5fb01d86-9a90-4787-b332-08cd0a7d8129" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5fb01d86-9a90-4787-b332-08cd0a7d8129_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_36bf37ba-ce61-44e5-94f8-f21ed0f8ff09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5fb01d86-9a90-4787-b332-08cd0a7d8129" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_36bf37ba-ce61-44e5-94f8-f21ed0f8ff09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d80b7774-00a5-4234-ab81-28369dcc117a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_36bf37ba-ce61-44e5-94f8-f21ed0f8ff09" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d80b7774-00a5-4234-ab81-28369dcc117a" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>holx-20210925_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fe647887-7476-401d-8075-31ce3ecd561d,g:aafd6a0b-1c31-49b5-81b9-4feb5a12e92f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9b1fd67a-fffc-405d-bc65-22877f0985aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7e2701fb-d80f-4a2c-a601-5cdc26833fd3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_258739d0-90f2-4437-a202-b28b9ac8350e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 25, 2021</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_64eac636-a93a-430f-9089-86d4a4b14e41_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments/Accruals</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NumberOfFinanceLeases_ecf5ca58-d9f6-487b-9355-017f008091f0_terseLabel_en-US" xlink:label="lab_holx_NumberOfFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of finance leases</link:label>
    <link:label id="lab_holx_NumberOfFinanceLeases_label_en-US" xlink:label="lab_holx_NumberOfFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Finance Leases</link:label>
    <link:label id="lab_holx_NumberOfFinanceLeases_documentation_en-US" xlink:label="lab_holx_NumberOfFinanceLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Finance Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfFinanceLeases" xlink:href="holx-20210925.xsd#holx_NumberOfFinanceLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NumberOfFinanceLeases" xlink:to="lab_holx_NumberOfFinanceLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_9b9cb0de-43b8-4e81-9265-cb7113a8283e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NotionalAmount_91b73b2c-bcb8-408d-8f49-e3ef9efc5a79_terseLabel_en-US" xlink:label="lab_holx_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_holx_NotionalAmount_label_en-US" xlink:label="lab_holx_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_holx_NotionalAmount_documentation_en-US" xlink:label="lab_holx_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount" xlink:href="holx-20210925.xsd#holx_NotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NotionalAmount" xlink:to="lab_holx_NotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsLeaseLiability_c1a91376-64c9-4316-a48c-de99ab74c81b_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsLeaseLiability_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets lease liability</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsLeaseLiability_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets lease liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsLeaseLiability" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsLeaseLiability" xlink:to="lab_holx_DeferredTaxAssetsLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842_c04869aa-bb96-48de-911a-440708075f2d_terseLabel_en-US" xlink:label="lab_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right of use asset at adoption of 842</link:label>
    <link:label id="lab_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842_label_en-US" xlink:label="lab_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right of use asset at adoption of 842</link:label>
    <link:label id="lab_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842_documentation_en-US" xlink:label="lab_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right of use asset at adoption of 842</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842" xlink:href="holx-20210925.xsd#holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842" xlink:to="lab_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_a6a648b1-df81-417b-805c-887a89987f1d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps - derivative</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_83ae632a-f12d-405d-b949-cbe6dbe4c909_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_fddc3918-1193-426b-82ed-8810c3d1b1bb_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional outstanding shares purchased (in shares)</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_label_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Shares</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_documentation_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:href="holx-20210925.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:to="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CR_ca6a8edb-5d8d-4f6f-aec3-14f12e40b593_terseLabel_en-US" xlink:label="lab_country_CR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costa Rica</link:label>
    <link:label id="lab_country_CR_label_en-US" xlink:label="lab_country_CR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COSTA RICA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CR" xlink:to="lab_country_CR" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_60f4436b-c2ce-4d40-a017-f122a850d7b0_terseLabel_en-US" xlink:label="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of vesting for RSUs granted to employees</link:label>
    <link:label id="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_label_en-US" xlink:label="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Vesting For Restricted Stock Units Granted To Employees</link:label>
    <link:label id="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_documentation_en-US" xlink:label="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of restricted stock units that vest annually per the terms of the typical restricted stock unit grant arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:href="holx-20210925.xsd#holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:to="lab_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TaxOnInterestRateSwap_b2da851d-b198-4466-b869-5921accf93dc_terseLabel_en-US" xlink:label="lab_holx_TaxOnInterestRateSwap" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">tax on interest rate swap</link:label>
    <link:label id="lab_holx_TaxOnInterestRateSwap_label_en-US" xlink:label="lab_holx_TaxOnInterestRateSwap" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">tax on interest rate swap</link:label>
    <link:label id="lab_holx_TaxOnInterestRateSwap_documentation_en-US" xlink:label="lab_holx_TaxOnInterestRateSwap" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">tax on interest rate swap</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxOnInterestRateSwap" xlink:href="holx-20210925.xsd#holx_TaxOnInterestRateSwap"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxOnInterestRateSwap" xlink:to="lab_holx_TaxOnInterestRateSwap" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_62022a6e-744e-43ce-9350-fbcb36934719_terseLabel_en-US" xlink:label="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 26, 2020</link:label>
    <link:label id="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_025841d7-4491-49b8-8917-04e63f3f6aaf_verboseLabel_en-US" xlink:label="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 25, 2021</link:label>
    <link:label id="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:href="holx-20210925.xsd#holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:to="lab_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_f71daebb-97e5-4672-a5c7-8b01368d68b7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Software Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastHealthMember_db86b82f-bc28-41c3-9214-7651115faaef_terseLabel_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health</link:label>
    <link:label id="lab_holx_BreastHealthMember_label_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health [Member]</link:label>
    <link:label id="lab_holx_BreastHealthMember_documentation_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember" xlink:href="holx-20210925.xsd#holx_BreastHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastHealthMember" xlink:to="lab_holx_BreastHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_635c14a8-3e8b-4e86-a25d-3a8d361119e9_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f667e1f3-cf24-4ff3-a784-98ec5375155a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1d50da46-cd41-4902-8bcc-1148ae5a0f97_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentCommitmentFeePercentage_84649718-6080-4d8c-9512-d00a39b02a55_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Commitment Fee, Percentage</link:label>
    <link:label id="lab_holx_DebtInstrumentCommitmentFeePercentage_label_en-US" xlink:label="lab_holx_DebtInstrumentCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Commitment Fee, Percentage</link:label>
    <link:label id="lab_holx_DebtInstrumentCommitmentFeePercentage_documentation_en-US" xlink:label="lab_holx_DebtInstrumentCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Commitment Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentCommitmentFeePercentage" xlink:href="holx-20210925.xsd#holx_DebtInstrumentCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentCommitmentFeePercentage" xlink:to="lab_holx_DebtInstrumentCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b74c4990-9f50-48e8-98db-4ce358da21dc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost - amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BolderSurgicalMember_2bb153f7-8442-4ed4-89be-e92b939542a7_terseLabel_en-US" xlink:label="lab_holx_BolderSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolder Surgical</link:label>
    <link:label id="lab_holx_BolderSurgicalMember_label_en-US" xlink:label="lab_holx_BolderSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolder Surgical [Member]</link:label>
    <link:label id="lab_holx_BolderSurgicalMember_documentation_en-US" xlink:label="lab_holx_BolderSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolder Surgical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember" xlink:href="holx-20210925.xsd#holx_BolderSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BolderSurgicalMember" xlink:to="lab_holx_BolderSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_42b0109a-6e00-4ddd-b82c-b9523c77f99d_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9ba03df9-4743-4933-a706-d2d9a425abf2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_9635ad88-d5d0-464c-b612-3ff6287d4a8c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_51444f85-84df-412d-9d19-b72d4d38da59_terseLabel_en-US" xlink:label="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage price of principal amount for repurchase of senior notes</link:label>
    <link:label id="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_label_en-US" xlink:label="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Price of Principal Amount for Repurchase of Senior Notes</link:label>
    <link:label id="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_documentation_en-US" xlink:label="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Price of Principal Amount for Repurchase of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:href="holx-20210925.xsd#holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:to="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SubLeaseRentalIncome_489912e7-975c-4b4f-a4a5-2293e00caacd_terseLabel_en-US" xlink:label="lab_holx_SubLeaseRentalIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncome_label_en-US" xlink:label="lab_holx_SubLeaseRentalIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncome_documentation_en-US" xlink:label="lab_holx_SubLeaseRentalIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncome" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SubLeaseRentalIncome" xlink:to="lab_holx_SubLeaseRentalIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_fa006874-ee9c-467f-8009-7572e7bc403f_negatedTerseLabel_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of interest rate caps</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_cace6bef-3830-4c78-93a9-5d57a6e1715b_terseLabel_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of interest rate caps</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_label_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_documentation_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements aggregate premium payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:href="holx-20210925.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:to="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_f1b36145-5361-45fb-a69d-5909e06575db_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_9ee30bd9-ca52-4e88-b7a6-9bf9d7e8246f_terseLabel_en-US" xlink:label="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of common stock price for ESPP</link:label>
    <link:label id="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_label_en-US" xlink:label="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Purchase Price Of Common Stock Lower Than Fair Market Value Of Common Stock On Date Of Purchase</link:label>
    <link:label id="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_documentation_en-US" xlink:label="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage applied to the lower of the common stock price at the beginning of the plan period and end of the plan period to determine the number of shares to be issued under the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:href="holx-20210925.xsd#holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:to="lab_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_93a81843-7f68-47d4-a76d-23beda3c71c0_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ab69ee16-50fd-4bdd-95cf-60f384eecfd5_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_370e1975-5efa-4a74-a733-7b95be2e25ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_98df8c55-21a4-4f82-b80a-f3c4e6cc9312_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at September 25, 2021</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_ed3b499e-e437-4cae-958f-0486eccfe841_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842_85487c6f-9e7c-4fea-8ea1-feb49988aacf_terseLabel_en-US" xlink:label="lab_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, right of use asset at adoption of 842</link:label>
    <link:label id="lab_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842_label_en-US" xlink:label="lab_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, right of use asset at adoption of 842</link:label>
    <link:label id="lab_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842_documentation_en-US" xlink:label="lab_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, right of use asset at adoption of 842</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842" xlink:href="holx-20210925.xsd#holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842" xlink:to="lab_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_0c5fafc2-8f36-4f3c-b820-0afec587a204_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_718ac6af-e805-4b88-b70c-6b71ac0f4810_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_7d8e0b82-1d5c-47f0-85cc-0482c000c008_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfRevenues_413d1522-30aa-4b60-be33-2749affe2c9f_terseLabel_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_label_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_documentation_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues" xlink:href="holx-20210925.xsd#holx_PercentageOfRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfRevenues" xlink:to="lab_holx_PercentageOfRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2f07cdbf-bd85-4b85-ab23-e526eb569807_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c0164215-c841-4654-a6fb-df9e290b6a89_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_25108ba3-6d05-4744-854e-dc31ef225378_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_abff3a26-8532-4a4c-8403-0a849e7627c2_terseLabel_en-US" xlink:label="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units (in shares)</link:label>
    <link:label id="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_label_en-US" xlink:label="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Common Stock Equivalents From Assumed Exercise Of Stock Options And Restricted Stock Units</link:label>
    <link:label id="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_documentation_en-US" xlink:label="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:href="holx-20210925.xsd#holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:to="lab_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_49f123e5-9357-475e-ae4e-9dc173a2e393_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TwoThousandEightEquityPlanMember_06b95460-14ab-4452-bdb4-416e3c0bfe04_terseLabel_en-US" xlink:label="lab_holx_TwoThousandEightEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2008 Equity Plan</link:label>
    <link:label id="lab_holx_TwoThousandEightEquityPlanMember_label_en-US" xlink:label="lab_holx_TwoThousandEightEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eight Equity Plan [Member]</link:label>
    <link:label id="lab_holx_TwoThousandEightEquityPlanMember_documentation_en-US" xlink:label="lab_holx_TwoThousandEightEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Eight Equity Plan [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandEightEquityPlanMember" xlink:href="holx-20210925.xsd#holx_TwoThousandEightEquityPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwoThousandEightEquityPlanMember" xlink:to="lab_holx_TwoThousandEightEquityPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_a72ae317-8c76-439e-9f9c-96fdee3edc1a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2e3787d5-30da-4094-861e-221b6083850b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_667ef5bf-b5e0-4114-9091-7a4f8d6c21e8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_d6a8a716-795d-4b5f-bf57-1e55cbf77216_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligations Disclosure</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SomatexMedicalTechnologiesMember_14ecb82c-65c5-44ed-81c0-f52e9bfc3a0f_terseLabel_en-US" xlink:label="lab_holx_SomatexMedicalTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex Medical Technologies</link:label>
    <link:label id="lab_holx_SomatexMedicalTechnologiesMember_label_en-US" xlink:label="lab_holx_SomatexMedicalTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex Medical Technologies [Member]</link:label>
    <link:label id="lab_holx_SomatexMedicalTechnologiesMember_documentation_en-US" xlink:label="lab_holx_SomatexMedicalTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex Medical Technologies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMedicalTechnologiesMember" xlink:href="holx-20210925.xsd#holx_SomatexMedicalTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SomatexMedicalTechnologiesMember" xlink:to="lab_holx_SomatexMedicalTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeaseReceivable_716eb759-f5b0-4b33-bb71-65d0859cb64f_terseLabel_en-US" xlink:label="lab_holx_LeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease receivable</link:label>
    <link:label id="lab_holx_LeaseReceivable_label_en-US" xlink:label="lab_holx_LeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Receivable</link:label>
    <link:label id="lab_holx_LeaseReceivable_documentation_en-US" xlink:label="lab_holx_LeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseReceivable" xlink:href="holx-20210925.xsd#holx_LeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeaseReceivable" xlink:to="lab_holx_LeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b04fc1af-b05c-4520-9b3a-cbdcfd2fc9fd_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_05a4e14e-404b-48a1-83ab-45de5b3b45ff_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_be62b489-7bd2-4b8d-afd4-451863e6d12b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_907bb945-b622-4bad-84b4-6c34638826c6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c16c758d-694b-499e-bae9-3c84c1114ce6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 25, 2021</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_82e593fc-a8a3-4561-ad2c-f8213eba298f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ca72c69d-073f-4a80-989d-a89711dbc245_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_de6f9c4c-40b0-4928-a9f5-68ad79c65c84_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_257389fe-abe8-4783-92d4-0858d3d42288_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_db7b6ac6-c98f-4c28-a5db-9c7d179504df_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit carry forwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_92de86a0-105b-43f8-9b07-f919dd94eab9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastImagingMember_6cfec619-6035-4e2c-8897-d0737c477781_terseLabel_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging</link:label>
    <link:label id="lab_holx_BreastImagingMember_label_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:label id="lab_holx_BreastImagingMember_documentation_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember" xlink:href="holx-20210925.xsd#holx_BreastImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastImagingMember" xlink:to="lab_holx_BreastImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_19d85a27-edab-4698-957b-2db5668e63b6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_689a4b2d-f8a9-481a-8552-ce94e6757d4a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_4ff59f54-01cb-4304-8cea-a41237dd6bb4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_800b2afd-e355-4728-9f9e-407de5b82cae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing access fees</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fd43cfaf-0268-497b-943b-e7a55e95d9d9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_dc9c8033-e745-425e-9eca-050d512778a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_e16aece7-de2c-4df6-9e4a-02681ea886b6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_bff2eb55-4e3c-4d4b-b96e-a4ee451485ca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/ forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_5e8b6327-96a0-4edc-914e-3a0daf610a9d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_284f3830-0ba6-407f-b5b2-f10932eae889_terseLabel_en-US" xlink:label="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial gain (loss)</link:label>
    <link:label id="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_label_en-US" xlink:label="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount</link:label>
    <link:label id="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_documentation_en-US" xlink:label="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:href="holx-20210925.xsd#holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:to="lab_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_2df2f05b-f552-4564-b2d8-f5f2f7687f4e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b35079e6-92e9-47ae-a0c5-0938db92541e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn4Years_c85d0eda-73cf-4544-898f-90a62f64d0b8_terseLabel_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn4Years" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 4 years</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn4Years_label_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn4Years" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 4 years</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn4Years_documentation_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn4Years" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 4 years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueIn4Years" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueIn4Years"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SubLeaseRentalIncomeDueIn4Years" xlink:to="lab_holx_SubLeaseRentalIncomeDueIn4Years" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_2bc3dd9e-e8cb-4d43-a256-2eb8fd18f45b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_1b2b3d27-587a-4701-b96b-388b2db6b30e_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SecuredTermLoanMember_0355f329-7cd7-43ad-941b-edcd01c38e05_terseLabel_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_label_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan [Member]</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_documentation_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember" xlink:href="holx-20210925.xsd#holx_SecuredTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SecuredTermLoanMember" xlink:to="lab_holx_SecuredTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_2b435638-6d3a-4486-a7fd-b19724481431_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares related to:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_534ba9b8-c405-43b8-8226-dda070765ca0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions related to reserves acquired from acquisitions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_3237a24d-8235-4d69-87a5-8bdafd5617e0_totalLabel_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal restructuring charges</link:label>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_4fbc2cd5-b113-4e2c-ab61-902c2bfac239_terseLabel_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal restructuring charges</link:label>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_label_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Under Exit Or Disposal Plan</link:label>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_documentation_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring charges under exit or disposal plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:href="holx-20210925.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:to="lab_holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_552f012e-7763-47e4-b4c4-0398018581ce_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_55920255-97dc-4c51-966b-d2bb4eb0da6b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DevelopedTechnologyMember_6555504a-a7f7-43c2-ba0c-dd0923f61ac6_terseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_label_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology [Member]</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DevelopedTechnologyMember" xlink:to="lab_holx_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16876313-fd51-4680-9409-73408d1c9331_terseLabel_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Target Number Of Shares Issued Based On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum target number percentage of shares issued based on stock performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:href="holx-20210925.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:to="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_79660332-343b-4507-82b8-d508784c7e88_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, discount rate</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_46e39788-a593-4505-bb11-90ea88c71f58_terseLabel_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_label_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships Contracts [Member]</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_documentation_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember" xlink:href="holx-20210925.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CustomerRelationshipsContractsMember" xlink:to="lab_holx_CustomerRelationshipsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_7a35708d-d438-4156-a88d-d7f4830fd218_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_896ed283-1588-4658-bca8-a550e50255e3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_544403b0-2511-4368-8fb9-cff745b2eea1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_21a4eb25-b8fd-4bff-8af0-f55c0b54203f_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_1a446c97-c0d7-46c0-a36b-0fb87d673772_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_4f4283e6-4803-4e98-8e2d-399bd1c94b09_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_742ee613-025b-41a4-a2e5-3c040e89a88d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2021CreditAgreementMember_48ab9f73-89b7-4a9b-a4d3-aa360f6ffefe_terseLabel_en-US" xlink:label="lab_holx_A2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Credit Agreement</link:label>
    <link:label id="lab_holx_A2021CreditAgreementMember_label_en-US" xlink:label="lab_holx_A2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_A2021CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_A2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021CreditAgreementMember" xlink:href="holx-20210925.xsd#holx_A2021CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2021CreditAgreementMember" xlink:to="lab_holx_A2021CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_22f5b956-9ce8-49af-b603-e2624a7286b6_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Black-Scholes Model Weighted Average Assumptions Used to Estimate Fair Value of Shares to Be Issued as of Grant Date</link:label>
    <link:label id="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Assumptions For Employee Stock Purchase Plan [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of significant assumptions used during the year to estimate the fair value of employee stock purchase plan shares, including, but not limited to: (a) expected term, (b) expected volatility, (c) risk-free interest rate, and (d) dividend yield.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:href="holx-20210925.xsd#holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:to="lab_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MarketBasedStockUnitsMember_691de6c1-d65a-4554-9138-1e1877986551_terseLabel_en-US" xlink:label="lab_holx_MarketBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Stock Units</link:label>
    <link:label id="lab_holx_MarketBasedStockUnitsMember_label_en-US" xlink:label="lab_holx_MarketBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Stock Units [Member]</link:label>
    <link:label id="lab_holx_MarketBasedStockUnitsMember_documentation_en-US" xlink:label="lab_holx_MarketBasedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember" xlink:href="holx-20210925.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MarketBasedStockUnitsMember" xlink:to="lab_holx_MarketBasedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_55f4d12e-7d99-4b2b-b29a-0c74b01590aa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in deferred tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_bf418910-ada1-4654-91ef-ba7133428db5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivative</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:to="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrossUnrecognizedTaxBenefits_c3c82eb0-fb8c-408f-98fc-05e59761dc9e_terseLabel_en-US" xlink:label="lab_holx_GrossUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized tax benefits, excluding interest</link:label>
    <link:label id="lab_holx_GrossUnrecognizedTaxBenefits_label_en-US" xlink:label="lab_holx_GrossUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrecognized Tax Benefits</link:label>
    <link:label id="lab_holx_GrossUnrecognizedTaxBenefits_documentation_en-US" xlink:label="lab_holx_GrossUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the total unrecognized tax benefits, including interest, that if recognized would result in a reduction to the effective tax rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossUnrecognizedTaxBenefits" xlink:href="holx-20210925.xsd#holx_GrossUnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrossUnrecognizedTaxBenefits" xlink:to="lab_holx_GrossUnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_818749df-2cb3-4126-94fd-02af47898741_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_a475ca49-e85a-414f-b470-f2af8805efb2_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_433e8c94-ef17-4211-8638-acab0b9f9c07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_6f1f7101-53b0-4313-a76b-2b081ffaca6c_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:to="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterestCoverageRatio_643b66bb-b698-4f43-bd8c-6602c26d78c9_terseLabel_en-US" xlink:label="lab_holx_InterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest coverage ratio</link:label>
    <link:label id="lab_holx_InterestCoverageRatio_label_en-US" xlink:label="lab_holx_InterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Coverage Ratio</link:label>
    <link:label id="lab_holx_InterestCoverageRatio_documentation_en-US" xlink:label="lab_holx_InterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestCoverageRatio" xlink:href="holx-20210925.xsd#holx_InterestCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestCoverageRatio" xlink:to="lab_holx_InterestCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_405a4e9b-b4be-4790-a40d-b392daa7c6a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_85f2acee-8a72-494d-9d1a-78bd5f3131c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Agreements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_bba6b595-f2c5-4bdb-9d99-6c8ff99ca2d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_84ed47c2-1ecb-4cbe-b7ed-e49097da82c1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_2c77b5b2-652f-456a-baf1-967275b2bbcf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions:</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_602a940a-a0e5-4483-8859-12e260c4e41e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c456c051-23a5-4ed4-8d01-c223098db34d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b8c07fd7-a291-4fed-8d25-4cd087a5bdd4_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_18fdf46e-ba0b-4e56-a1be-cd59cba779df_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4a4ce418-0b53-41d0-8fcf-fa71b006c21f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_81688508-d7ca-4372-8056-bdf2c50d9a8a_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of minimum tax withholdings on net share settlements of equity awards</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_label_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Tax Withholding Related To Vested And Released Restricted Stock Units</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_documentation_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:href="holx-20210925.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:to="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_4d1113f7-bcc2-45a1-ab36-0928f594347a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_b0dcd69b-c236-4727-a9ff-2ef1b0b648b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_debb33f1-ee83-4499-8b8f-60741e2ab514_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_fb9d959f-4138-41f0-8b55-b9e7a0e6f863_terseLabel_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_label_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_documentation_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware" xlink:href="holx-20210925.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ManufacturingEquipmentAndSoftware" xlink:to="lab_holx_ManufacturingEquipmentAndSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_fa3c8c1a-a7b2-4338-bef7-cf1807923a4d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of senior long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_746f8ac5-9f13-48b0-9c6e-55ed541a418f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss reclassified from accumulated other comprehensive loss to the statement of operations, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_52431f7f-57b7-47c3-a82c-0a122950bc12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EmployeeStockPurchasePlanMember_433de3a7-4f72-43f4-992d-abf7e3516a9d_terseLabel_en-US" xlink:label="lab_holx_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_holx_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_holx_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_holx_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_holx_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeStockPurchasePlanMember" xlink:href="holx-20210925.xsd#holx_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmployeeStockPurchasePlanMember" xlink:to="lab_holx_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ReductionOfWorkforceExpenses_e995de16-e0e3-437a-8ae3-c123c0ebf1ef_terseLabel_en-US" xlink:label="lab_holx_ReductionOfWorkforceExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workforce reductions</link:label>
    <link:label id="lab_holx_ReductionOfWorkforceExpenses_label_en-US" xlink:label="lab_holx_ReductionOfWorkforceExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction Of Workforce Expenses</link:label>
    <link:label id="lab_holx_ReductionOfWorkforceExpenses_documentation_en-US" xlink:label="lab_holx_ReductionOfWorkforceExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents severance and related benefit charges for the termination of employees under an exit or disposal activity. Charges are recorded either as one-time termination benefits, which are recognized ratable over the required service period to receive such benefit, or under an ongoing benefit plan arrangement once the charge is probable and reasonably estimable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses" xlink:href="holx-20210925.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ReductionOfWorkforceExpenses" xlink:to="lab_holx_ReductionOfWorkforceExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_372fa37f-4603-44ca-a223-03e7ee353908_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_8ec865f8-5dc9-471d-8f7a-55627e5bebc5_terseLabel_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension period</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_label_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Extension Period</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_documentation_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeasesExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:to="lab_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_fc0e4ba2-4856-4c26-9311-451feb9b5473_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_ff34d7e4-d57f-4722-afb1-2a9bcbd3e0e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e553cf9-d958-4f4d-a1f2-e1f740387f83_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_b94a9bb8-f30a-41c4-a669-2cf58d525137_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_c4bef057-5998-47f9-ab6b-fd173a688dd3_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_87d7329b-b8ea-4c8e-8b5d-931cb913b118_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_d58c4583-0ba2-4b7a-94ad-81a8ea15bfe6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_21ffadcf-1128-45ad-bb6d-b1d304404b23_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion allocable to newly acquired shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_6ebc7fea-f0c1-4c3a-914e-ddbf0631d8d3_terseLabel_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</link:label>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_label_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</link:label>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_documentation_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:href="holx-20210925.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:to="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_95a11fa8-c773-4654-8855-35634fee66c1_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareTable_8b959669-b4b0-4f11-9250-0ee79e269302_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_label_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_documentation_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable" xlink:href="holx-20210925.xsd#holx_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareTable" xlink:to="lab_holx_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_69b13570-a5b4-4b43-ae65-a9b55294e73f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_1a6d02ec-1b46-43d5-b375-1b6be47c92d9_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering price, percent of face value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_label_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_documentation_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:href="holx-20210925.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:to="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_c6d7edab-8087-4363-964d-c7097ff64533_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_5572769a-f8be-49bd-8719-f512ef0a7057_terseLabel_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_label_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Goods Sold Impairment Of Intangible Assets</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_documentation_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:href="holx-20210925.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:to="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_06ee1906-d886-4ba0-ac19-1ece34c728b5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_ec15029d-0653-4f4f-bf90-cce9b7f88d20_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FinanceLeaseObligationsLongTermMember_ba2db1dd-40b7-4df9-b9ca-f46c3b7ed2f2_terseLabel_en-US" xlink:label="lab_holx_FinanceLeaseObligationsLongTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations - long term</link:label>
    <link:label id="lab_holx_FinanceLeaseObligationsLongTermMember_label_en-US" xlink:label="lab_holx_FinanceLeaseObligationsLongTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations - Long Term [Member]</link:label>
    <link:label id="lab_holx_FinanceLeaseObligationsLongTermMember_documentation_en-US" xlink:label="lab_holx_FinanceLeaseObligationsLongTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations - Long Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsLongTermMember" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsLongTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FinanceLeaseObligationsLongTermMember" xlink:to="lab_holx_FinanceLeaseObligationsLongTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b0201d5-9d25-4f64-89f5-8ee19c4fc57c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_3b892efd-5e2e-4535-b038-4f548c4d6bd4_terseLabel_en-US" xlink:label="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of vesting for stock options granted to employees</link:label>
    <link:label id="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_label_en-US" xlink:label="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Vesting For Stock Options Granted To Employees</link:label>
    <link:label id="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_documentation_en-US" xlink:label="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the percentage of stock options that vest annually per the terms of the typical stock option grant arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:href="holx-20210925.xsd#holx_PercentageOfVestingForStockOptionsGrantedToEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:to="lab_holx_PercentageOfVestingForStockOptionsGrantedToEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_5f954f3b-ba9b-4a4f-8c82-bb9dacfe57f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_3bd41764-65e8-4b8a-a9f4-296795e59a75_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign net operating loss expected to be expired unutilized</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:to="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_f35b7e89-602a-4932-b32d-8d0c522c9679_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_8604feb3-8145-4b54-913d-6ea110cf8227_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_7a202a12-7cc7-4309-a89e-5cd0c4088de8_terseLabel_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_label_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_documentation_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember" xlink:href="holx-20210925.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcquiredintangibleassetsMember" xlink:to="lab_holx_AcquiredintangibleassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cfbbb7fb-c44b-4f80-bcfc-83cd43c62780_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_6bc729d3-c927-47fd-b6eb-6544b205a55b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_063073a9-fcb0-4cf5-83ad-dc18374a5fdf_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_927170b5-d464-4cb2-9829-a9496c3c2b06_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASC606_7e2217c3-b556-47c9-9b09-6173c21a58d3_negatedTerseLabel_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASC606" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASC 606</link:label>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASC606_label_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASC606" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASC 606</link:label>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASC606_documentation_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASC606" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASC 606</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASC606" xlink:href="holx-20210925.xsd#holx_AccountingstandardtransitionadjustmentASC606"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountingstandardtransitionadjustmentASC606" xlink:to="lab_holx_AccountingstandardtransitionadjustmentASC606" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SignificantAccountingPoliciesTable_d2414552-5fb9-4c4d-8e9f-ca90d01fa010_terseLabel_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_holx_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_holx_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesTable" xlink:href="holx-20210925.xsd#holx_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SignificantAccountingPoliciesTable" xlink:to="lab_holx_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_fdf127fe-c352-4067-a924-2e84b3125035_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_58d95f51-7e4b-4e23-9bae-003a76ef8a55_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_00bdf135-e855-442b-b263-b60e18016d4f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SkeletalHealthMember_4a48a9c3-6aaf-41fb-9e1f-d1c68fbf203a_terseLabel_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_label_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health [Member]</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_documentation_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember" xlink:href="holx-20210925.xsd#holx_SkeletalHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SkeletalHealthMember" xlink:to="lab_holx_SkeletalHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock_ef9b230a-9edf-429b-a3c1-bf0dd221f676_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of Goodwill Activity by Reportable Segment</link:label>
    <link:label id="lab_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Goodwill By Segment Table [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of goodwill by segment table.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock" xlink:href="holx-20210925.xsd#holx_ScheduleOfGoodwillBySegmentTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock" xlink:to="lab_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_8563296c-5ca9-48ae-8594-5cbf39f5fa2a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5602e2d5-89ae-451c-84fa-b5c28fc4673a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4679adb0-c746-4389-b772-20a17eefebb0_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested at September 25, 2021</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CynosureMember_e5561436-b673-47f7-80cc-6fecc8ac33cc_terseLabel_en-US" xlink:label="lab_holx_CynosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cynosure</link:label>
    <link:label id="lab_holx_CynosureMember_label_en-US" xlink:label="lab_holx_CynosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cynosure [Member]</link:label>
    <link:label id="lab_holx_CynosureMember_documentation_en-US" xlink:label="lab_holx_CynosureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cynosure [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember" xlink:href="holx-20210925.xsd#holx_CynosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CynosureMember" xlink:to="lab_holx_CynosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_9ae06374-ae18-440c-bf33-feb430dd0afa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d42bf971-1273-427e-9555-d47a0ef9411b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock_ad2b140b-bec6-41e2-9f44-b9de882d7bd7_terseLabel_en-US" xlink:label="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:label id="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="holx-20210925.xsd#holx_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_holx_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_b7699170-290d-4fb8-a218-9b366aeae98e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_5b31a965-b75b-443e-b519-26f73d7f2d80_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c2efba88-48e6-4f82-887e-940632f1c159_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_871e7d8b-cf7f-4962-bd56-220b98cc2fe3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_ca5b93f8-b595-4b58-b029-72b5d8f03aff_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BloodScreeningMember_5368cdec-07b4-4a81-8c00-52117afc9c24_verboseLabel_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening</link:label>
    <link:label id="lab_holx_BloodScreeningMember_label_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:label id="lab_holx_BloodScreeningMember_documentation_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember" xlink:href="holx-20210925.xsd#holx_BloodScreeningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BloodScreeningMember" xlink:to="lab_holx_BloodScreeningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_f76d9d4e-62bd-42e8-98d8-a112505d4593_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_4d50eb22-313a-4dd0-828e-982e69b4efe9_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal Per Quarter</link:label>
    <link:label id="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_label_en-US" xlink:label="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal Per Quarter</link:label>
    <link:label id="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal Per Quarter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:to="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_e0a50269-7871-46e5-b28b-e53546af3e5f_terseLabel_en-US" xlink:label="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Earnings per Share resulted from adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_label_en-US" xlink:label="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Earnings per Share resulted from adoption of ASC 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_documentation_en-US" xlink:label="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Earnings per Share resulted from adoption of ASC 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:href="holx-20210925.xsd#holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:to="lab_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_b63b3005-1182-4518-b91c-4b28b6b16e59_terseLabel_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:to="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_d55c5f3b-b294-4dc1-8ccf-1de9b0f95cd5_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_581b0a3d-001e-4662-a312-ab633ae11783_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension plan, liabilities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_d6983a72-7d05-41c7-a9a3-a8dc7ae15175_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for income tax uncertainties</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_54b30a52-32f6-4920-b7b7-eb765584e612_terseLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Non Deductible Expense Executive Compensation Cost</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to the difference in the deductibility or nondeductibility of executive compensation (i.e., those subject to Section 162(m) limitations), including equity-based compensation and salary and bonus compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:to="lab_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BiotheranosticsMember_df3bab67-31a7-47af-ad66-2070a6fcd78c_terseLabel_en-US" xlink:label="lab_holx_BiotheranosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotheranostics</link:label>
    <link:label id="lab_holx_BiotheranosticsMember_label_en-US" xlink:label="lab_holx_BiotheranosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotheranostics [Member]</link:label>
    <link:label id="lab_holx_BiotheranosticsMember_documentation_en-US" xlink:label="lab_holx_BiotheranosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotheranostics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember" xlink:href="holx-20210925.xsd#holx_BiotheranosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BiotheranosticsMember" xlink:to="lab_holx_BiotheranosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_20ece62b-a11f-40f5-8947-0b7587701fc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss Recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_6bb8f737-aac3-4a82-b859-de8177b10048_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b7be3138-40d0-499a-970d-d111c626dec9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_abf2a38a-e833-4794-a021-4c7441b0a42d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at September 25, 2021 (1)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_a087dcae-1f58-4ab3-bff5-b4f931074cea_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2026</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFifthYear" xlink:to="lab_us-gaap_PurchaseObligationDueInFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b5f542fd-892d-46b3-9d26-23ac56a156c3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EmployerContributionsPercentVestedAnnually_d3d59af0-06cd-47a3-93ca-244e2f3f5866_terseLabel_en-US" xlink:label="lab_holx_EmployerContributionsPercentVestedAnnually" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent vested annually</link:label>
    <link:label id="lab_holx_EmployerContributionsPercentVestedAnnually_label_en-US" xlink:label="lab_holx_EmployerContributionsPercentVestedAnnually" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions, Percent Vested Annually</link:label>
    <link:label id="lab_holx_EmployerContributionsPercentVestedAnnually_documentation_en-US" xlink:label="lab_holx_EmployerContributionsPercentVestedAnnually" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions, Percent Vested Annually</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsPercentVestedAnnually" xlink:href="holx-20210925.xsd#holx_EmployerContributionsPercentVestedAnnually"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmployerContributionsPercentVestedAnnually" xlink:to="lab_holx_EmployerContributionsPercentVestedAnnually" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_cadb5b21-8522-4c51-800b-ccd01d38246d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_9ad4ab58-e0ef-465a-bd5d-a7762af06f60_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration &#8211; fair value adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_ea39b73a-7dfd-4097-934d-3d7685db34af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_5d7b5023-6301-4fc6-bab5-8795f417121e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ceeae26-5e82-4862-b66a-651fd3a32965_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares (in millions)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_c44850db-8765-4263-93f0-37807d20850b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_381f0257-2eb5-45b1-bee8-76317a0a76b5_terseLabel_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations. excluding convertible notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_label_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Obligations Without Convertible Notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_documentation_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations without convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:href="holx-20210925.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:to="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_f343e151-0c9d-4000-a580-8e955883dcc0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested, weighted average grant date fair value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c5ca7bb7-7fa2-4f23-b348-5391f660a4e1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in-Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_4bc0f085-14ed-4908-8e5a-f38da7e8bfc2_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of redemption price, third period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Third Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Third Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_4a0dbcd9-b3dd-4288-8e8f-d88dc308dc60_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_bf85db9d-87a8-4011-9ef5-cc7ad799b837_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MolecularDiagnosticsMember_7c12039d-41a1-4a8f-ac75-3a5222db81b5_terseLabel_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_label_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_documentation_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember" xlink:href="holx-20210925.xsd#holx_MolecularDiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MolecularDiagnosticsMember" xlink:to="lab_holx_MolecularDiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_895d628e-0c4a-4ab6-a581-8abdd2da4baf_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_403c1006-d25d-4e60-88de-28da1af0778d_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_54a68fd1-decf-46fc-892d-f20270ede1b0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost - interest cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_a8b4e5e4-c49d-4dcd-b94a-b9c68567615a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_046e62d6-89f7-46d7-af2f-650a55eaef42_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_4bc38ec2-884e-4c76-b903-cb9217d42b4c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_fc0fe649-b441-4290-819f-b27e2edd1941_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_eb889e92-76c7-479f-a86b-090747e26855_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AdditionalPurchaseConsideration_ba584a46-78d6-4c02-833a-2dbbaac80a34_terseLabel_en-US" xlink:label="lab_holx_AdditionalPurchaseConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional purchase consideration</link:label>
    <link:label id="lab_holx_AdditionalPurchaseConsideration_label_en-US" xlink:label="lab_holx_AdditionalPurchaseConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional purchase consideration</link:label>
    <link:label id="lab_holx_AdditionalPurchaseConsideration_documentation_en-US" xlink:label="lab_holx_AdditionalPurchaseConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional purchase consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AdditionalPurchaseConsideration" xlink:href="holx-20210925.xsd#holx_AdditionalPurchaseConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AdditionalPurchaseConsideration" xlink:to="lab_holx_AdditionalPurchaseConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_5406f1fd-69e0-4d43-aa35-5064cb15c371_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_1c123104-b113-493b-a97b-77474d86cda8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcessaHealthMember_d498e727-4ffc-4f2e-ac91-ccd66399c9b4_terseLabel_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:label id="lab_holx_AcessaHealthMember_label_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health [Member]</link:label>
    <link:label id="lab_holx_AcessaHealthMember_documentation_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcessaHealthMember" xlink:to="lab_holx_AcessaHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4d3bc51e-2bdc-44bd-ada0-1a5aacf8e5ca_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_ce2f3d83-e185-46c1-a7ad-0d4b65e6cfdf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative contract period, or less</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a3974e99-7761-4359-bad4-b6ba41156e43_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_c749740d-0047-4533-bac6-441fc1d52b82_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e7b99d12-75ee-41eb-accd-3c7af28e0502_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_27faad31-401b-441d-9c9f-174538a2e9e8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at September 29, 2018</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_018214e6-249b-431e-bb2a-1c81ad03f510_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_46ae4220-1d57-42b3-826e-292653138903_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_a62f3e78-60cd-4bc2-b997-3f1b9d96b48d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Unit Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_a4b2eaaa-5cd5-48d6-b028-e7bbefda135a_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_14c15a47-bf7b-47a9-b036-12727be68a6a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_7fb840ab-6975-49d2-9367-55ef4bb4174d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherGeographicRegionsMember_25037311-6bec-4f27-8467-0733a5d5c4b6_terseLabel_en-US" xlink:label="lab_holx_OtherGeographicRegionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_OtherGeographicRegionsMember_label_en-US" xlink:label="lab_holx_OtherGeographicRegionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Regions [Member]</link:label>
    <link:label id="lab_holx_OtherGeographicRegionsMember_documentation_en-US" xlink:label="lab_holx_OtherGeographicRegionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographic Regions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherGeographicRegionsMember" xlink:href="holx-20210925.xsd#holx_OtherGeographicRegionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherGeographicRegionsMember" xlink:to="lab_holx_OtherGeographicRegionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_8fa49baa-61d5-4adb-83ce-a6a10762e2c0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_cb1bd397-c6ea-43bb-96c3-ab45467863a7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_8094478d-da4a-4f5c-a3f8-3978f39c93df_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State:</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_24d22bd0-3b5e-4daf-8876-5537ff6f8626_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_f6a5dba1-cad8-42b9-b787-4b1119d58d51_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_89cc2fff-1993-4496-95fe-065cfe924a60_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MedicalAestheticsMember_a22019b0-c530-4c85-aca1-72d0b2e0c811_terseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_label_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics [Member]</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_documentation_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MedicalAestheticsMember" xlink:to="lab_holx_MedicalAestheticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareRepurchseAuthorizationDateDomain_c6ab3d6f-42d9-4fc6-aeac-51c43603e2bb_terseLabel_en-US" xlink:label="lab_holx_ShareRepurchseAuthorizationDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchse Authorization Date [Domain]</link:label>
    <link:label id="lab_holx_ShareRepurchseAuthorizationDateDomain_label_en-US" xlink:label="lab_holx_ShareRepurchseAuthorizationDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchse Authorization Date [Domain]</link:label>
    <link:label id="lab_holx_ShareRepurchseAuthorizationDateDomain_documentation_en-US" xlink:label="lab_holx_ShareRepurchseAuthorizationDateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchse Authorization Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchseAuthorizationDateDomain" xlink:href="holx-20210925.xsd#holx_ShareRepurchseAuthorizationDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareRepurchseAuthorizationDateDomain" xlink:to="lab_holx_ShareRepurchseAuthorizationDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f728e86c-0cd0-4991-84e2-5919a8f7fc73_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b77f48ab-97bc-4dec-a3ca-4acf84dcf6a4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7b499f6c-fe91-419f-bd4c-172ee8cbcdb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_39cc5f0a-8954-4485-956e-0a34992615b8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain on interest rate swap</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f32544e8-42bd-4c0a-a0eb-2fad2b7ee023_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_d72c31de-40b0-46d4-bcc8-379c29982078_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_20b077e4-a3bf-42af-988b-ba8956bd81bb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recorded at acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_e45c3c22-35b0-496b-ad4b-57f60ef2f797_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_fb99019c-ca13-454b-acb8-0c2525b745ab_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management's Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SegmentReportingDisclosureTable_2660f9c5-5fa7-45ed-bb5a-288980e97719_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Table]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureTable_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Table]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureTable_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureTable" xlink:href="holx-20210925.xsd#holx_SegmentReportingDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureTable" xlink:to="lab_holx_SegmentReportingDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_0cf59b38-e5eb-495b-8e20-0cb08b6aa06d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_4b6ac56b-cb99-4d9c-a37d-8f6e59dd7091_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_4db05a94-32c9-4983-956d-1cd279b2719c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_53d1ab49-a631-4ca1-a506-048f0fb46d3d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareLineItems_a7e77101-54db-47e6-8053-06545e10975c_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_label_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems" xlink:href="holx-20210925.xsd#holx_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareLineItems" xlink:to="lab_holx_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset_844cd496-d031-4c7c-bf42-db249fd2e203_negatedTerseLabel_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset_label_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities right of use asset</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset_documentation_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities right of use asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:href="holx-20210925.xsd#holx_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:to="lab_holx_DeferredTaxLiabilitiesRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_53744045-e0db-45a2-804e-05a25752b93e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps - derivative</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_e5d733b0-7aec-40c2-8338-3bc1cdaf3ef1_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_292d5481-9638-48e7-9975-98a199c475b1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_c0d92d85-af94-4512-b9e6-afa073a84ca8_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2029SeniorNotesMember_411bc7e2-edc1-4abc-8c7a-63ca67588254_terseLabel_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2029SeniorNotesMember" xlink:to="lab_holx_A2029SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlanTextBlock_b44d583f-13f2-4fad-9ed1-a8e2702682fb_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlanTextBlock_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlanTextBlock" xlink:to="lab_us-gaap_MultiemployerPlanTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_64f186a2-4d66-458a-9b1d-4ed2d5283f86_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_ddbf2891-12ce-4bb0-9704-9fb4fb5d631b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation over time (percent)</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_a0287951-031f-4c6a-850d-923fb17d8f55_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_eea89bf6-a1bf-4101-a046-a4bb4e4879e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proportionate share of net loss of equity method investment</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_95780200-1fa6-417f-b2af-d773559e3ce4_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagnosticsMember_779f5468-b10e-4568-9c6d-48d685d4a36f_terseLabel_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_holx_DiagnosticsMember_label_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_holx_DiagnosticsMember_documentation_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember" xlink:href="holx-20210925.xsd#holx_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagnosticsMember" xlink:to="lab_holx_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_d8483373-3e99-4409-b96a-daa5b40b1f08_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_e1199989-4704-4815-b9dc-c911ed6ea8c1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 to 2031</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_423f401f-3653-4492-a595-a518cc0028fb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_eea3bc4b-d8d7-44f8-95d5-cf58359eb0eb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_4173711f-37be-4e73-b899-f66f9bd5b6e1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_1cfa7a1c-c3b1-4369-b9ec-dcf0c77c5617_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_2d8516bf-cf16-432f-8c50-baad71947df4_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional outstanding shares purchased, amount</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_label_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Value</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:href="holx-20210925.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:to="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_81be1c7d-4039-4ba1-9fa2-b1dd055e4670_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges Taken Related to Restructuring Actions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_265fbf7d-3238-4d8f-a043-3f2d25672128_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax adjustment</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_a5eadebb-d9c3-48fa-86e7-8b7c5c1e3f95_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract_07079c54-a692-4d69-b29c-7efafc57be4e_terseLabel_en-US" xlink:label="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired tax positions:</link:label>
    <link:label id="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract_label_en-US" xlink:label="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits Increases [Abstract]</link:label>
    <link:label id="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract_documentation_en-US" xlink:label="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits increases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:href="holx-20210925.xsd#holx_UnrecognizedTaxBenefitsIncreasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:to="lab_holx_UnrecognizedTaxBenefitsIncreasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_441ef56a-0840-4ac7-a613-a6baaec5b69d_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, estimated useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SuperSonicImagineMember_4eb1c350-88d0-4f4c-b1e2-b5cd1dd586c5_terseLabel_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_label_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_documentation_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember" xlink:href="holx-20210925.xsd#holx_SuperSonicImagineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SuperSonicImagineMember" xlink:to="lab_holx_SuperSonicImagineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreementMember_5132cee8-a2e2-4eec-ac31-d09dd40ed869_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements [Member]</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreementMember_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreement [Member]</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreementMember_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:href="holx-20210925.xsd#holx_EquipmentUnderCustomerUsageAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_38ccb8b4-033d-444a-8014-af1e6f84b8f6_terseLabel_en-US" xlink:label="lab_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive Income loss Hedge</link:label>
    <link:label id="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_label_en-US" xlink:label="lab_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive Income loss Hedge</link:label>
    <link:label id="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_documentation_en-US" xlink:label="lab_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive Income loss Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:href="holx-20210925.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:to="lab_holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccruedIncomeAndOtherTaxes_ca943846-265c-4c20-984c-05eed6140e2a_terseLabel_en-US" xlink:label="lab_holx_AccruedIncomeAndOtherTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income and other taxes</link:label>
    <link:label id="lab_holx_AccruedIncomeAndOtherTaxes_label_en-US" xlink:label="lab_holx_AccruedIncomeAndOtherTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income And Other Taxes</link:label>
    <link:label id="lab_holx_AccruedIncomeAndOtherTaxes_documentation_en-US" xlink:label="lab_holx_AccruedIncomeAndOtherTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued income and other taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedIncomeAndOtherTaxes" xlink:href="holx-20210925.xsd#holx_AccruedIncomeAndOtherTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccruedIncomeAndOtherTaxes" xlink:to="lab_holx_AccruedIncomeAndOtherTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_4d054bb7-3a6a-48df-aa95-200debc745b0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_acdfbaa2-3813-46f2-9342-6ba5a01dd9d8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EmployeeContributionsVestedPercentage_e08c395a-acf0-4e31-bd22-a16beafe212f_terseLabel_en-US" xlink:label="lab_holx_EmployeeContributionsVestedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions vested, percentage</link:label>
    <link:label id="lab_holx_EmployeeContributionsVestedPercentage_label_en-US" xlink:label="lab_holx_EmployeeContributionsVestedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Contributions Vested Percentage</link:label>
    <link:label id="lab_holx_EmployeeContributionsVestedPercentage_documentation_en-US" xlink:label="lab_holx_EmployeeContributionsVestedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions vested, percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeContributionsVestedPercentage" xlink:href="holx-20210925.xsd#holx_EmployeeContributionsVestedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmployeeContributionsVestedPercentage" xlink:to="lab_holx_EmployeeContributionsVestedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_061ad5a1-5f58-4041-a932-1231772f4377_totalLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal, Total</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_f4efc0de-cd69-40b3-a35e-67e24f4ded0c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_b2d0aa7c-cfb0-4d05-a849-1b6b4d4e32a8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreement2018Member_e5100680-4c89-4e83-bd73-7ef7127ae115_terseLabel_en-US" xlink:label="lab_holx_CreditAgreement2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreement2018Member_label_en-US" xlink:label="lab_holx_CreditAgreement2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2018 [Member]</link:label>
    <link:label id="lab_holx_CreditAgreement2018Member_documentation_en-US" xlink:label="lab_holx_CreditAgreement2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2018Member" xlink:href="holx-20210925.xsd#holx_CreditAgreement2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreement2018Member" xlink:to="lab_holx_CreditAgreement2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_488fa42a-7714-4be3-b268-a510dbae7bf8_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion allocable to loan repaymnet</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_bf99184e-ab9c-46cc-b325-f8b1e24f5480_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cfb7dbda-e526-4b6b-9243-e40e9de87c2e_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_c9b7a064-963a-4b9d-845a-39e294cfd3fb_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements/ Adjustments</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8f96f314-f5b7-426f-a77b-95ff3b819f79_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_HealthBeaconsMember_d549b6f5-47a8-4e65-aa7e-2c1ab4347384_terseLabel_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_label_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_documentation_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember" xlink:href="holx-20210925.xsd#holx_HealthBeaconsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_HealthBeaconsMember" xlink:to="lab_holx_HealthBeaconsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_a32748d7-dda8-4866-ba50-40548bc5abe3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities (current)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_0d1bd1de-9c84-4650-9399-9493fc58ad31_terseLabel_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal:</link:label>
    <link:label id="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_c9a63b56-2b0b-4305-ab2c-604fd966bd56_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning&#160;of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_9d28a9dd-91d7-41ac-8c95-5dc50be682af_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at&#160;End of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_e785c3bd-7c5c-4ed2-a4c6-71a3a53d9e3b_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset obtained in exchange for finance lease liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_b9e50edd-0128-4c96-8f2a-ebfa26f7cc77_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_24482536-3059-4cfa-a28a-b5183cad2681_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information Pertaining to Stock Options Granted and Related Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1b5a49e7-0400-495a-bb9e-72c1b3a3080c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments on the Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_a3f454fe-7d47-4c9d-8a4c-4d89b0eba582_negatedLabel_en-US" xlink:label="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_label_en-US" xlink:label="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Expense Included Other Restructuring Costs</link:label>
    <link:label id="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_documentation_en-US" xlink:label="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation expense included other restructuring costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:href="holx-20210925.xsd#holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:to="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_c3f9a70b-1134-4ee4-8b29-6fc52db58832_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_66845453-24a5-4239-b9ee-07882256d07e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_b8f3b494-a8bc-4620-8833-3d05a21de8c7_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_dd6c026a-2fc8-4ef6-ab02-731629246685_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_76a2731d-2f43-488f-943d-cb860e23677f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_20961806-4427-4996-a767-440ae9642669_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_e7d7208a-4a1e-4bae-8790-43d6f7dcea10_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a428ff34-8899-431b-a91b-0a7366339620_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_558efe79-c4ad-4f09-b0b4-e22a02cb39ee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_80a86e0b-ad79-4a9d-a012-bbd50219d82b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_04cd4571-bcb1-4818-8d68-c97ffaef0371_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1377d370-efef-4557-a573-958ad7e5c5e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_2b0e8f20-8a46-45d4-b295-f2f8b2fdc988_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_e3305395-632f-402c-a1df-f846c75eba4b_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_fd2dabb6-07cb-4399-b81b-e56621b741f2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherTypeofRevenueMember_9140ab35-1580-4af2-8c63-7cc9d77b45c4_terseLabel_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_label_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_documentation_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember" xlink:href="holx-20210925.xsd#holx_OtherTypeofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherTypeofRevenueMember" xlink:to="lab_holx_OtherTypeofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a67a56fe-53e6-48b8-b496-ddb10c05d01a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise&#160;Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TaxPositionsRelatedToPriorYearsAbstract_b8ea9dbd-b5a8-4f79-a1f7-e26933104533_terseLabel_en-US" xlink:label="lab_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax positions related to prior years:</link:label>
    <link:label id="lab_holx_TaxPositionsRelatedToPriorYearsAbstract_label_en-US" xlink:label="lab_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Positions Related To Prior Years [Abstract]</link:label>
    <link:label id="lab_holx_TaxPositionsRelatedToPriorYearsAbstract_documentation_en-US" xlink:label="lab_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax positions related to prior years.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:href="holx-20210925.xsd#holx_TaxPositionsRelatedToPriorYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:to="lab_holx_TaxPositionsRelatedToPriorYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1b9e33c8-e9ff-403d-b9d3-089d005d946a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_cd52728f-fb7c-4949-913a-429bf50b7687_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentNumberOfInstruments_34bdc944-7fba-4765-ab00-577b7ffdb83e_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentNumberOfInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of debt instruments</link:label>
    <link:label id="lab_holx_DebtInstrumentNumberOfInstruments_label_en-US" xlink:label="lab_holx_DebtInstrumentNumberOfInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Instruments</link:label>
    <link:label id="lab_holx_DebtInstrumentNumberOfInstruments_documentation_en-US" xlink:label="lab_holx_DebtInstrumentNumberOfInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number Of Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentNumberOfInstruments" xlink:href="holx-20210925.xsd#holx_DebtInstrumentNumberOfInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentNumberOfInstruments" xlink:to="lab_holx_DebtInstrumentNumberOfInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_9ec014eb-f1d7-405a-9ad3-621ded26c12f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c97d6291-3b6a-4dd4-b75b-6d6ff2bee111_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_b5b40bdc-8dcb-4074-8e3e-118986cbe34e_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Reserves</link:label>
    <link:label id="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable And Reserves Policy Policy [Text Block]</link:label>
    <link:label id="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policy and disclosure of accounts receivable reserves, including activity in the account for the respective periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:href="holx-20210925.xsd#holx_AccountsReceivableAndReservesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:to="lab_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_db98802e-df93-4a4d-be83-1d92986e3bc7_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_18f2f006-c86f-4bf2-8c9e-3768e6b1605f_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASU201616_b0a54a1f-fb19-46a5-a51a-f741a5121ea1_negatedTerseLabel_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASU201616" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASU 2016-16</link:label>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASU201616_label_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASU 2016-16</link:label>
    <link:label id="lab_holx_AccountingstandardtransitionadjustmentASU201616_documentation_en-US" xlink:label="lab_holx_AccountingstandardtransitionadjustmentASU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASU201616" xlink:href="holx-20210925.xsd#holx_AccountingstandardtransitionadjustmentASU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountingstandardtransitionadjustmentASU201616" xlink:to="lab_holx_AccountingstandardtransitionadjustmentASU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b15cafbf-bc53-448f-8ac3-b82a76d8f120_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ConsumablesMember_10e6db04-27ad-4799-b436-ee06fda53933_terseLabel_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_holx_ConsumablesMember_label_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_holx_ConsumablesMember_documentation_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember" xlink:href="holx-20210925.xsd#holx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ConsumablesMember" xlink:to="lab_holx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_6b1136a3-80a7-44d4-9ee2-83b65f71affa_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_21cfa758-5e8e-467b-b255-2c01ae050ac2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_6be5f945-2f83-426b-a1e2-e5812efbe9f7_terseLabel_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Line Items]</link:label>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Line Items]</link:label>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_documentation_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:href="holx-20210925.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:to="lab_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_40d2cfd0-559c-4f4f-8f9a-9b5af802df02_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_3f47f400-a1a3-41bc-b041-57985bcca6f0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_8ec16e57-f080-4279-8e3c-4fb8114aff76_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_812d17fa-d14b-4186-b818-f9efbd349cb9_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3265f131-4325-475a-addf-e99ded3ac7da_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_a17fdee2-0a5b-4a74-b54d-7239917d8d5a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage_9aea98f7-0cd7-471a-8dda-1e0be83989fa_terseLabel_en-US" xlink:label="lab_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Bargain Purchase Option, Percentage</link:label>
    <link:label id="lab_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage_label_en-US" xlink:label="lab_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Bargain Purchase Option, Percentage</link:label>
    <link:label id="lab_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage_documentation_en-US" xlink:label="lab_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Bargain Purchase Option, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage" xlink:href="holx-20210925.xsd#holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage" xlink:to="lab_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_a0d64667-e05b-4d3a-a059-b516d4863478_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_45af2025-dff3-45bc-997c-f0370fc79c85_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September 26, 2020</link:label>
    <link:label id="lab_us-gaap_Goodwill_e83b83c0-7e07-4f74-b3d5-1cad647fceb4_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at September 25, 2021</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherRestructuringPayments_120591ee-4367-4612-912f-3d6efd6b207e_negatedLabel_en-US" xlink:label="lab_holx_OtherRestructuringPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other payments</link:label>
    <link:label id="lab_holx_OtherRestructuringPayments_label_en-US" xlink:label="lab_holx_OtherRestructuringPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Payments</link:label>
    <link:label id="lab_holx_OtherRestructuringPayments_documentation_en-US" xlink:label="lab_holx_OtherRestructuringPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to settle other restructuring charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherRestructuringPayments" xlink:href="holx-20210925.xsd#holx_OtherRestructuringPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherRestructuringPayments" xlink:to="lab_holx_OtherRestructuringPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9e8e3c6f-dc83-436f-8815-1179656cf7a9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_ca68fc5f-788f-4a18-81b1-f57db39545b5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2021ActionMember_e7769143-52d9-4b65-bd4f-8a0d7af8e6ae_terseLabel_en-US" xlink:label="lab_holx_Fiscal2021ActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2021 Actions</link:label>
    <link:label id="lab_holx_Fiscal2021ActionMember_label_en-US" xlink:label="lab_holx_Fiscal2021ActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2021 Action [Member]</link:label>
    <link:label id="lab_holx_Fiscal2021ActionMember_documentation_en-US" xlink:label="lab_holx_Fiscal2021ActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2021 Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ActionMember" xlink:href="holx-20210925.xsd#holx_Fiscal2021ActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2021ActionMember" xlink:to="lab_holx_Fiscal2021ActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GynSurgicalMember_9c1b13c5-0607-4368-8704-31b13b37db2c_terseLabel_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_label_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_documentation_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN surgical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember" xlink:href="holx-20210925.xsd#holx_GynSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GynSurgicalMember" xlink:to="lab_holx_GynSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermARSecuritizationProgram_96904579-f76c-4509-a101-c072883714a3_terseLabel_en-US" xlink:label="lab_holx_TermARSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of accounts receivable securitization program</link:label>
    <link:label id="lab_holx_TermARSecuritizationProgram_label_en-US" xlink:label="lab_holx_TermARSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term AR Securitization Program</link:label>
    <link:label id="lab_holx_TermARSecuritizationProgram_documentation_en-US" xlink:label="lab_holx_TermARSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Accounts Receivable Securitization Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermARSecuritizationProgram" xlink:href="holx-20210925.xsd#holx_TermARSecuritizationProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermARSecuritizationProgram" xlink:to="lab_holx_TermARSecuritizationProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_94357317-155e-45bd-b522-e9beed7defb0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_8d6b8cc9-fb1d-4eb8-b3fa-d9dc6a302ba2_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_dc29b7b5-42e9-4194-90fd-a12a9274d6ea_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment period for contingent consideration</link:label>
    <link:label id="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_label_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Period for Payment of Contingent Consideration Liability</link:label>
    <link:label id="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_documentation_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Period for Payment of Contingent Consideration Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:href="holx-20210925.xsd#holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:to="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_f65500d5-b01b-4088-a957-e4f4cb075ea6_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Improvements [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_051e68e2-7e97-4916-a58e-597ca7ca84c2_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled/ forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_1009b4d7-2b9b-455b-a777-77e613eddf38_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_9de1fec1-09d3-4d36-8aac-39fd5fc3de98_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repurchase of) Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:to="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f96f0261-28b0-452a-9ac2-2a045ac7cca6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_318f1f83-39f9-4785-839e-331b818d25df_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_7cf4b419-836e-4c05-80f1-00b1958c62d7_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_fd01de0c-d87a-43ba-a3a3-c8c42c0f229f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ffab07b6-775f-4006-bdc3-6d4f2e5d5ec1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fff0647c-c0d7-4e32-b9e1-da40a5a9db77_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6be15917-9235-4ccb-821e-5f70f32fc371_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_b9b8172c-11f0-40dd-b207-5b6d533aac71_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Five</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_675174c7-c3fe-41db-96df-7ff96d1fa1ca_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f4a9f78c-bf33-4b65-846b-429e61f03b22_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_58dee276-ed65-4aff-bf4d-ed0b67f8d1b9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_27d9f16d-f90f-42e5-a1de-ec1334c7084a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d55b1397-13b8-459a-9a4c-cabec3caa4f2_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_478bf50f-adea-40bf-a490-1c1deb87c325_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_72ff604d-7224-44ae-bf9c-a34715dcf70a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible accruals</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_66d8887e-4856-4b5e-935b-338526c29016_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SignificantAccountingPoliciesLineItems_d7e93891-491a-4d4e-a8b1-66565c429cee_terseLabel_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_holx_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_holx_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_holx_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesLineItems" xlink:href="holx-20210925.xsd#holx_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems" xlink:to="lab_holx_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_93a4eca3-aa20-456d-99e3-c1a6d94f2126_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated remaining performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumBorrowingUnderSecuritizationProgram_c28e11ae-fcef-4b74-b768-88adb8864c0b_terseLabel_en-US" xlink:label="lab_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing under securitization program</link:label>
    <link:label id="lab_holx_MaximumBorrowingUnderSecuritizationProgram_label_en-US" xlink:label="lab_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Borrowing Under Securitization Program</link:label>
    <link:label id="lab_holx_MaximumBorrowingUnderSecuritizationProgram_documentation_en-US" xlink:label="lab_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing under securitization program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:href="holx-20210925.xsd#holx_MaximumBorrowingUnderSecuritizationProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:to="lab_holx_MaximumBorrowingUnderSecuritizationProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_87ec5b35-9ee0-4153-922f-9f2922acb8eb_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_062f0911-2dc2-4cff-9876-4209d4a85d00_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of the end of the fiscal year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_fd2960d4-cbd4-4216-b364-81827ff1d4bf_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_9894df35-a597-4b29-950c-85c776643aab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 297,306 and 295,107 shares issued, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_fd48d1cc-30a6-4fa9-94f0-751643ec8920_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_479a556b-3df9-4bef-9a92-6a5aae2bd3a9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8439e016-a03d-4280-bce9-cee59c049c9b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4f1053e6-9904-4296-b8bc-0a961247697d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_e227e67d-0016-41f3-87af-6aff8745af11_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State net operating loss expected to be expired unutilized</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized State</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of state net operating losses the company believes will expire unutilized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:to="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_d36ad47d-c8fc-46f0-8ba2-ea28fe6e7c50_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_0edee144-4b6c-4388-930f-0cb7083934cf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current debt obligations, net of debt discount</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_7ea1a0f0-18e6-4b87-824b-5c38d0f66573_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_83c08ba5-b264-4f28-8c49-6b2ad5184f68_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_9c4620c8-ed24-4ca1-af45-7712278f1574_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_a58c9691-868d-41aa-b154-0c1fae356b8c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3f852390-849a-4938-8ad5-833749a62f0f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_49be03cc-46a1-4c67-a2b9-88dd8bb8290a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncomeTaxesLineItems_b913169d-3086-49ab-8248-02c970917443_terseLabel_en-US" xlink:label="lab_holx_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_holx_IncomeTaxesLineItems_label_en-US" xlink:label="lab_holx_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_holx_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_holx_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesLineItems" xlink:href="holx-20210925.xsd#holx_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncomeTaxesLineItems" xlink:to="lab_holx_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneous_13c15141-6a10-4b68-abc9-1db456412595_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneous_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneous" xlink:to="lab_us-gaap_OtherAssetsMiscellaneous" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_209c857d-f790-419e-bf10-900bc41e5ca4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_f79daaba-a259-48e1-9145-8b2597319bfe_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_5a36cc5e-9522-4864-99c0-a7fdb6367a82_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</link:label>
    <link:label id="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_label_en-US" xlink:label="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</link:label>
    <link:label id="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_documentation_en-US" xlink:label="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:href="holx-20210925.xsd#holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:to="lab_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_440324c7-bcc4-44ca-a39b-20eb8fadaed8_terseLabel_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, operating and finance lease, remaining lease term</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Lease, Remaining Lease Term</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_documentation_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:to="lab_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_21afac83-9b24-43a5-bf6f-701a9c81d30b_terseLabel_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember" xlink:href="holx-20210925.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareRepurchaseProgramMember" xlink:to="lab_holx_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ba84407a-5293-434c-98e7-cf7d8b335040_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_48bb4cf2-f847-46fa-a61d-41d84f53524f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OneThirdAnnuallyMember_3fd30450-cf38-4462-832c-2cfc871bc702_terseLabel_en-US" xlink:label="lab_holx_OneThirdAnnuallyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Third Annually [Member]</link:label>
    <link:label id="lab_holx_OneThirdAnnuallyMember_label_en-US" xlink:label="lab_holx_OneThirdAnnuallyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Third Annually [Member]</link:label>
    <link:label id="lab_holx_OneThirdAnnuallyMember_documentation_en-US" xlink:label="lab_holx_OneThirdAnnuallyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Third Annually [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OneThirdAnnuallyMember" xlink:href="holx-20210925.xsd#holx_OneThirdAnnuallyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OneThirdAnnuallyMember" xlink:to="lab_holx_OneThirdAnnuallyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_1fe1507c-3f94-453e-a592-ecaf90454fe0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_143a93ea-f53c-42d1-a153-a40e7eb04535_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_0a5028f2-78c9-4f7f-b16c-f1cd95140a27_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_6c22f0f3-465d-40c1-a83e-d27bece21e5a_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_aba8fce3-bcdc-40a5-b65b-8bf49868395c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocationDomain_268a62cd-f9a6-4057-9f80-d4a4e71571a4_terseLabel_en-US" xlink:label="lab_dei_LocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Location [Domain]</link:label>
    <link:label id="lab_dei_LocationDomain_label_en-US" xlink:label="lab_dei_LocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocationDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocationDomain" xlink:to="lab_dei_LocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_e4d1af30-f726-4674-b4fd-f1ce743bb079_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_6fa17edf-b13f-4821-a769-60f52ca3aac1_terseLabel_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash tender offer price per share</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_label_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_documentation_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:href="holx-20210925.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:to="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_2b11f149-e33d-45e0-93a6-8c7fb19be18b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e6802d78-9f5e-46a6-8f05-b4c84e968fed_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Hologic's stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_9098fcd5-5c9a-4c71-9cb5-a182058b4d52_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_12be82c1-e57a-4bea-8ec6-78b0b59df310_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_97932dd6-bce2-4682-9bd3-d34f5896df15_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_8db7d279-2f38-4190-b208-ab1ac9f2682e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0ffd4438-225b-4269-9a68-e51660b25672_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_abb3b19e-6006-4b60-bdcc-3004d3a7ffd9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_231db3f3-9d46-4432-bc2b-0f7c055b8990_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_54c908d6-21d9-4f13-986f-3fe1ff18deee_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire in Process Research and Development</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_66a2f577-de69-4f21-8689-aa715845fc30_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_9dd9ea5e-2800-48a1-899f-3e5f0cfea4ad_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awarded damages</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_a8f050b3-6195-4e70-a55f-a51e6b3c4565_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_c79681d3-d7d2-46c3-b368-277ead6bc975_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_be32ee69-352b-4d30-ada1-6e62cce3e5e7_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternationalMember_678bb5df-3c93-4915-a364-7a837c526a6b_terseLabel_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_holx_InternationalMember_label_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_holx_InternationalMember_documentation_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember" xlink:href="holx-20210925.xsd#holx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternationalMember" xlink:to="lab_holx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_1127704c-a7e6-46b1-b0c7-59cb7da4fc59_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_WarrantyTermForProducts_e5304af4-01a6-436d-a993-2128c777d3b7_terseLabel_en-US" xlink:label="lab_holx_WarrantyTermForProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Term</link:label>
    <link:label id="lab_holx_WarrantyTermForProducts_label_en-US" xlink:label="lab_holx_WarrantyTermForProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Term For Products</link:label>
    <link:label id="lab_holx_WarrantyTermForProducts_documentation_en-US" xlink:label="lab_holx_WarrantyTermForProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty Term For Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WarrantyTermForProducts" xlink:href="holx-20210925.xsd#holx_WarrantyTermForProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_WarrantyTermForProducts" xlink:to="lab_holx_WarrantyTermForProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_459c0ca2-e4a2-4bc6-9813-649b76ec32f9_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_ec91d038-f34c-4945-9052-bfdede455ac4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_1506d4b7-1108-4cae-85dd-89c10fe38c73_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7365a8eb-e865-41ea-b8ac-2a7f55f08e82_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_4c6c587b-ded2-4d5a-9b96-fa5e1fdd692c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other activity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InvestmentInGroupLifeInsuranceContracts_1cbb638e-205c-4bcc-8613-4e276202b86e_terseLabel_en-US" xlink:label="lab_holx_InvestmentInGroupLifeInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in group life insurance contracts</link:label>
    <link:label id="lab_holx_InvestmentInGroupLifeInsuranceContracts_label_en-US" xlink:label="lab_holx_InvestmentInGroupLifeInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment In Group Life Insurance Contracts</link:label>
    <link:label id="lab_holx_InvestmentInGroupLifeInsuranceContracts_documentation_en-US" xlink:label="lab_holx_InvestmentInGroupLifeInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of group life insurance contracts at the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InvestmentInGroupLifeInsuranceContracts" xlink:href="holx-20210925.xsd#holx_InvestmentInGroupLifeInsuranceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InvestmentInGroupLifeInsuranceContracts" xlink:to="lab_holx_InvestmentInGroupLifeInsuranceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2025SeniorNotesMember_f4c733a7-89dc-40c5-850e-de2a63a48fa6_terseLabel_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember" xlink:href="holx-20210925.xsd#holx_A2025SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2025SeniorNotesMember" xlink:to="lab_holx_A2025SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3788c68f-66f1-4ae9-8447-7a32ec5d6540_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AllOtherCountriesMember_532b7ebb-67bc-4367-884d-07db02c3153b_terseLabel_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_label_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_documentation_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember" xlink:href="holx-20210925.xsd#holx_AllOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AllOtherCountriesMember" xlink:to="lab_holx_AllOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards_1ecca7aa-9baf-47bb-a5c5-5d47637ba679_terseLabel_en-US" xlink:label="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation for long-term service awards</link:label>
    <link:label id="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards_label_en-US" xlink:label="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Benefit Obligation For Long Term Service Awards</link:label>
    <link:label id="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards_documentation_en-US" xlink:label="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Benefit Obligation For Long Term Service Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:href="holx-20210925.xsd#holx_ProjectedBenefitObligationForLongTermServiceAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:to="lab_holx_ProjectedBenefitObligationForLongTermServiceAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_a38fa83d-e9fa-4909-8740-1d97f720b40c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities (non-current)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CashSeverancePayments_c12d236f-25fe-455b-bfd8-3ae6294d676f_negatedLabel_en-US" xlink:label="lab_holx_CashSeverancePayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance payments and adjustments</link:label>
    <link:label id="lab_holx_CashSeverancePayments_label_en-US" xlink:label="lab_holx_CashSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Severance Payments</link:label>
    <link:label id="lab_holx_CashSeverancePayments_documentation_en-US" xlink:label="lab_holx_CashSeverancePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashSeverancePayments" xlink:href="holx-20210925.xsd#holx_CashSeverancePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CashSeverancePayments" xlink:to="lab_holx_CashSeverancePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_ce022264-5e69-4421-b2a3-372ab254998c_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_91beea2e-5962-4fe0-be1b-1fbf1a7e50ac_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MobidiagOyMember_0c8eeb37-0b2f-4b38-b91b-f02209238bd8_terseLabel_en-US" xlink:label="lab_holx_MobidiagOyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobidiag Oy</link:label>
    <link:label id="lab_holx_MobidiagOyMember_label_en-US" xlink:label="lab_holx_MobidiagOyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobidiag Oy [Member]</link:label>
    <link:label id="lab_holx_MobidiagOyMember_documentation_en-US" xlink:label="lab_holx_MobidiagOyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobidiag Oy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MobidiagOyMember" xlink:to="lab_holx_MobidiagOyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_aec145e3-db1c-4cf0-aa77-fe5f02fabf46_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_4cd0cbe4-8c35-4f38-83c1-144d6ed56673_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_5e63f138-033c-4475-bab8-abff45cc111a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_26ddcaca-ef1b-44db-a064-2284d7bab838_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per common share attributable to Hologic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_a5c80c33-05ff-4215-b4b2-d148b7f1f04b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and divestiture charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c3191ae0-f3ea-4fa7-94d1-ca59aaa2058f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Components of the Company's Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a4e6bc66-0f85-4c63-af12-6ce29a324e4e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SomatexMember_1c14b390-928a-4c2c-bbec-0f4ff19fa1a6_terseLabel_en-US" xlink:label="lab_holx_SomatexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex</link:label>
    <link:label id="lab_holx_SomatexMember_label_en-US" xlink:label="lab_holx_SomatexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex [Member]</link:label>
    <link:label id="lab_holx_SomatexMember_documentation_en-US" xlink:label="lab_holx_SomatexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMember" xlink:href="holx-20210925.xsd#holx_SomatexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SomatexMember" xlink:to="lab_holx_SomatexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_c8c31a55-3568-470b-be22-5e7c9abbc268_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f116ae90-ce41-4982-b766-4abd5c015aa7_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6b770e6a-f1bb-4e95-83d4-174bfedd31d8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreementPriorMember_3b41abce-c5dc-4f83-b2cb-a6eb783359a3_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementPriorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementPriorMember_label_en-US" xlink:label="lab_holx_CreditAgreementPriorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Prior [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementPriorMember_documentation_en-US" xlink:label="lab_holx_CreditAgreementPriorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Prior [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember" xlink:href="holx-20210925.xsd#holx_CreditAgreementPriorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementPriorMember" xlink:to="lab_holx_CreditAgreementPriorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermLoanMember_ad1211d3-8545-4930-8b69-021ced844dad_terseLabel_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_holx_TermLoanMember_label_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_holx_TermLoanMember_documentation_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember" xlink:href="holx-20210925.xsd#holx_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermLoanMember" xlink:to="lab_holx_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1cd5e310-e462-40be-9187-d47e873b5ca9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TransitionServicesAgreementTerm_84bf586f-fe8b-402a-8fd9-5a38c0631069_terseLabel_en-US" xlink:label="lab_holx_TransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition services agreement term</link:label>
    <link:label id="lab_holx_TransitionServicesAgreementTerm_label_en-US" xlink:label="lab_holx_TransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement Term</link:label>
    <link:label id="lab_holx_TransitionServicesAgreementTerm_documentation_en-US" xlink:label="lab_holx_TransitionServicesAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TransitionServicesAgreementTerm" xlink:href="holx-20210925.xsd#holx_TransitionServicesAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TransitionServicesAgreementTerm" xlink:to="lab_holx_TransitionServicesAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_851f64d3-8b4b-453e-9cfc-936e7ed71754_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:to="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NonIncomeTaxLoss_23406550-99a7-415e-b9be-c33f78fe8dfb_terseLabel_en-US" xlink:label="lab_holx_NonIncomeTaxLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-income tax loss</link:label>
    <link:label id="lab_holx_NonIncomeTaxLoss_label_en-US" xlink:label="lab_holx_NonIncomeTaxLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Income Tax Loss</link:label>
    <link:label id="lab_holx_NonIncomeTaxLoss_documentation_en-US" xlink:label="lab_holx_NonIncomeTaxLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Income Tax Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonIncomeTaxLoss" xlink:href="holx-20210925.xsd#holx_NonIncomeTaxLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NonIncomeTaxLoss" xlink:to="lab_holx_NonIncomeTaxLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_bea176f3-8ea1-43eb-9a11-20b8b85666e8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_d23cda07-1bb7-431e-8a20-c4f8129a5234_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceived_9d882aa8-1efc-4cbc-8dd8-b44678b3dc8a_terseLabel_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of defense funds received</link:label>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceived_label_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of defense funds received</link:label>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceived_documentation_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of defense funds received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DepartmentOfDefenseFundsReceived" xlink:href="holx-20210925.xsd#holx_DepartmentOfDefenseFundsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DepartmentOfDefenseFundsReceived" xlink:to="lab_holx_DepartmentOfDefenseFundsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_1e000a96-0fd6-41a1-b141-f9c3a2aaa84d_terseLabel_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss Income Policy [Policy Text Block]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss Income Policy [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:href="holx-20210925.xsd#holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:to="lab_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_9a99e0bd-5338-4587-ab75-71396e6c8f3d_terseLabel_en-US" xlink:label="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in deferred tax liabilities due to ASU 2016-16</link:label>
    <link:label id="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_label_en-US" xlink:label="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in deferred tax liabilities due to ASC 2016-16</link:label>
    <link:label id="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_documentation_en-US" xlink:label="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in deferred tax liabilities due to ASC 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:href="holx-20210925.xsd#holx_DecreaseindeferredtaxliabilitiesduetoASC201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:to="lab_holx_DecreaseindeferredtaxliabilitiesduetoASC201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_752bca9e-e62e-4eab-8f33-72b356ea8625_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TwothousandeighteenMember_84cd9d62-2cd1-4055-a81b-bd7017464a02_terseLabel_en-US" xlink:label="lab_holx_TwothousandeighteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2018 restructuring charges</link:label>
    <link:label id="lab_holx_TwothousandeighteenMember_label_en-US" xlink:label="lab_holx_TwothousandeighteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand eighteen [Member]</link:label>
    <link:label id="lab_holx_TwothousandeighteenMember_documentation_en-US" xlink:label="lab_holx_TwothousandeighteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand eighteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwothousandeighteenMember" xlink:href="holx-20210925.xsd#holx_TwothousandeighteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwothousandeighteenMember" xlink:to="lab_holx_TwothousandeighteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_80eb25ba-e2ef-47ef-b205-432f4dfa0b7a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_b77379c7-37b8-4886-90ef-38e83dc054fd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_e6516097-f709-4012-81e9-58738cb54995_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_513b4070-3a03-4f1f-8ab3-a7d55cbd629a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_caeb5e20-77b4-4284-a358-de563465364c_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_6f486d2c-b3ec-4992-b8b6-a64c288124f6_negatedLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LongLivedAssetsPolicyPolicyTextBlock_106cfcf1-448a-4cf8-a8d2-d35565392fdf_terseLabel_en-US" xlink:label="lab_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_holx_LongLivedAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Lived Assets Policy [Policy Text Block]</link:label>
    <link:label id="lab_holx_LongLivedAssetsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Lived Assets Policy [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:href="holx-20210925.xsd#holx_LongLivedAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:to="lab_holx_LongLivedAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_892d8cd4-852a-4aa8-b64f-dfd6e725c0de_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_3915fbf7-5608-4f1a-9f0b-80b9485aa407_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_0ce16edb-bae9-43ab-9bab-56ad99861a61_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in accumulated balances of other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_3f67496c-08c2-47bc-8b07-6612cae99a4f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_2e16ff04-c513-4502-92e0-39b10aea332c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_c9c599cf-ed82-4537-a958-a08ab8f2a92c_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of redemption price, second period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Second Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Second Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_8d793385-ac96-4d61-baeb-d4361b42879f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_dc55e521-14bb-4e85-bca7-229ebe7ccf57_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes principal amount</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_3c894bea-0a78-477e-a2b2-466ba05749bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_d1466cce-86cd-486a-ae5c-90bb355293da_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_30b11709-d9f7-411f-af13-c53123c17617_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion allocable to fair value of noncontrolling interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_2e3b57d0-2d3d-4253-aa4b-fd968f23f97c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation over time</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_a638335f-3f7b-4f9e-8e4d-174596438e38_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Options and stock units [Member]</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RevenueMember_ebc9546b-5595-48cf-9daa-236e9b434a6d_terseLabel_en-US" xlink:label="lab_holx_RevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues [Member]</link:label>
    <link:label id="lab_holx_RevenueMember_label_en-US" xlink:label="lab_holx_RevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Member]</link:label>
    <link:label id="lab_holx_RevenueMember_documentation_en-US" xlink:label="lab_holx_RevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevenueMember" xlink:href="holx-20210925.xsd#holx_RevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevenueMember" xlink:to="lab_holx_RevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_1039c0a0-9dc7-4c93-8a48-c3389fa706de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_16a45852-41d9-4d14-aeda-c7f927f76555_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6035ef9e-ba86-4a02-9763-d94357c8194c_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8b5f567f-8801-4ae9-a93d-e2ccce099ab2_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_74bb27c5-ae01-4028-b4bf-1ce657c848fe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrossStateLossCarryforwards_41974c33-d716-4862-8f28-7363a8612599_terseLabel_en-US" xlink:label="lab_holx_GrossStateLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross state loss carryforwards</link:label>
    <link:label id="lab_holx_GrossStateLossCarryforwards_label_en-US" xlink:label="lab_holx_GrossStateLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross state loss carryforwards</link:label>
    <link:label id="lab_holx_GrossStateLossCarryforwards_documentation_en-US" xlink:label="lab_holx_GrossStateLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross state loss carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossStateLossCarryforwards" xlink:href="holx-20210925.xsd#holx_GrossStateLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrossStateLossCarryforwards" xlink:to="lab_holx_GrossStateLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_e3ba7af2-fe1d-4bec-a177-9c959cf4137e_terseLabel_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee contributions from annual bonus, percentage</link:label>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_label_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Employee Contributions From Annual Bonus Percentage To Dcp</link:label>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_documentation_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee contributions from annual bonus percentage to dcp.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:href="holx-20210925.xsd#holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:to="lab_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_ccb1d784-508c-4796-aabd-0d9e8b72f0b1_terseLabel_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee contributions from base salary, percentage</link:label>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_label_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Employee Contributions From Base Salary Percentage To Dcp</link:label>
    <link:label id="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_documentation_en-US" xlink:label="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee contributions from base salary percentage to dcp.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:href="holx-20210925.xsd#holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:to="lab_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_3362c6e8-bb17-4c58-a186-5a5246cc2726_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_35794d96-4785-40f0-b546-79fb30f993ee_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_9653be57-7a7b-42b5-80de-91744217551b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_0b7d7819-d85b-4750-b59c-2d362339f541_totalLabel_en-US" xlink:label="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash paid for amounts included in the measurement of lease liabilities</link:label>
    <link:label id="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_label_en-US" xlink:label="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability</link:label>
    <link:label id="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_documentation_en-US" xlink:label="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:href="holx-20210925.xsd#holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:to="lab_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3bd0f377-9cda-4973-9cfd-97678e0dffc3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_274656bd-6362-4350-8729-4531224b7fdb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_464d5e3d-7e7c-49b3-9d38-f7d4b83eb3c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_4556a21e-9c9f-41cd-a1a0-5e705fd44897_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_10318b43-14e3-495f-b1ed-e7110ae0ef9b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_844fd570-fd73-4ef4-9f9d-9e9afd25dbca_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e864ed6-bafd-4c5d-969c-e75a2d2b403f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ff7b4247-b4ce-493c-be64-567f873809ab_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operations</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_7afda908-9fda-4337-abfc-d68a6b1acc6f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_fc288b87-d715-4a59-8b0c-c8b9cd4e654f_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_58b7c081-0718-4722-97ec-c105e33296f6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_9660c20c-8d4a-422b-ae16-9944bcad23af_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized net actuarial gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_f0eaf73d-da40-451d-99f2-4dcb47d90cff_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_44943182-963b-4e28-9b17-418fc801dde2_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestiture of businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_60e1be4b-be6b-4f41-a153-4ea6253a4a4e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions made by company</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_7957f88d-28d1-4223-9c5f-a04eec037d58_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d8ff7bed-8819-4bf4-a0e7-8afcefd3d528_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_66c62837-ad56-47c0-9eda-785b5fa08408_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_0717b83c-d9a9-4f84-98e2-1d5ee5586c21_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccruedInterest_b1eacbf0-9c1d-4128-a45f-88095c25e7a7_terseLabel_en-US" xlink:label="lab_holx_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_holx_AccruedInterest_label_en-US" xlink:label="lab_holx_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_holx_AccruedInterest_documentation_en-US" xlink:label="lab_holx_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedInterest" xlink:href="holx-20210925.xsd#holx_AccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccruedInterest" xlink:to="lab_holx_AccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1375814f-ef40-4e0a-8c49-8f194cafa765_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity of the Company's Unrecognized Income Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_017e3056-b21d-43a8-81c0-91f105f7d19b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_e22a3dda-702a-439d-bb93-7158b3064489_terseLabel_en-US" xlink:label="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in other comprehensive income [Abstract]</link:label>
    <link:label id="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_label_en-US" xlink:label="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in other comprehensive income [Abstract]</link:label>
    <link:label id="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_documentation_en-US" xlink:label="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in other comprehensive income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:href="holx-20210925.xsd#holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:to="lab_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_9c9c9116-acd3-49ef-ae3c-40dcf09a0b47_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Borrowings and Interest Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2020ChargesMember_9146131f-eb44-40e8-aca7-f03945ba90db_terseLabel_en-US" xlink:label="lab_holx_Fiscal2020ChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 restructuring charges</link:label>
    <link:label id="lab_holx_Fiscal2020ChargesMember_label_en-US" xlink:label="lab_holx_Fiscal2020ChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 charges [Member]</link:label>
    <link:label id="lab_holx_Fiscal2020ChargesMember_documentation_en-US" xlink:label="lab_holx_Fiscal2020ChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember" xlink:href="holx-20210925.xsd#holx_Fiscal2020ChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2020ChargesMember" xlink:to="lab_holx_Fiscal2020ChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_9359d76d-10f0-4ee5-9bab-4327d18c43a7_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2ba517b1-ebe8-43c7-a155-046aefdd2c32_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_a9d52df6-e13e-45c2-9173-976ea9b693da_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-competition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_03d82eef-acab-40d1-a31a-184e526fc841_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of redemption price, fifth period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fifth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fifth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5d222118-209a-4928-b5ba-999048218e39_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_d40ff17f-cff3-41e8-9751-84b66c8ceaf7_negatedLabel_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Manufacture Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:href="holx-20210925.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_1d0a4ab8-426c-4f99-a3a6-03b9a4a97801_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other non-cash taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_b8cfefbe-2dfc-48eb-b39d-b8e9a87c5f33_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Four</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2018ActionMember_35319409-ba67-457b-92ad-b5bf9e760f05_terseLabel_en-US" xlink:label="lab_holx_Fiscal2018ActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2018 Actions</link:label>
    <link:label id="lab_holx_Fiscal2018ActionMember_label_en-US" xlink:label="lab_holx_Fiscal2018ActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2018 Action [Member]</link:label>
    <link:label id="lab_holx_Fiscal2018ActionMember_documentation_en-US" xlink:label="lab_holx_Fiscal2018ActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2018 Action [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember" xlink:href="holx-20210925.xsd#holx_Fiscal2018ActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2018ActionMember" xlink:to="lab_holx_Fiscal2018ActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e433a11a-d5ca-46ec-adc8-544bc89d4019_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_cb114bbe-3fa4-4632-b3c3-f40d28852c83_terseLabel_en-US" xlink:label="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of award vested upon meeting defined market based criteria</link:label>
    <link:label id="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_label_en-US" xlink:label="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Award Vested Upon Meeting Defined Market Based Criteria</link:label>
    <link:label id="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_documentation_en-US" xlink:label="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of award vested upon meeting defined market based criteria</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:href="holx-20210925.xsd#holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:to="lab_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_c2ac62ad-3394-4fb8-a4b1-fd28a6dcd4f2_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4e165db3-4b57-4e03-a60c-dee05fad53d3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FinanceLeaseObligationsShortTermMember_25d57b0d-6864-4f73-bd08-4302cb832e3a_terseLabel_en-US" xlink:label="lab_holx_FinanceLeaseObligationsShortTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations - short term</link:label>
    <link:label id="lab_holx_FinanceLeaseObligationsShortTermMember_label_en-US" xlink:label="lab_holx_FinanceLeaseObligationsShortTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations - Short Term [Member]</link:label>
    <link:label id="lab_holx_FinanceLeaseObligationsShortTermMember_documentation_en-US" xlink:label="lab_holx_FinanceLeaseObligationsShortTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations - Short Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsShortTermMember" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsShortTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FinanceLeaseObligationsShortTermMember" xlink:to="lab_holx_FinanceLeaseObligationsShortTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_eefffae7-f4cc-44d6-8563-a19ba577feab_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_587cd4a6-e7f7-4b2f-9a77-b75d338e827c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BedfordMember_8a106586-a549-4265-a113-544b01f2fdb0_terseLabel_en-US" xlink:label="lab_holx_BedfordMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bedford</link:label>
    <link:label id="lab_holx_BedfordMember_label_en-US" xlink:label="lab_holx_BedfordMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bedford [Member]</link:label>
    <link:label id="lab_holx_BedfordMember_documentation_en-US" xlink:label="lab_holx_BedfordMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bedford [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BedfordMember" xlink:href="holx-20210925.xsd#holx_BedfordMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BedfordMember" xlink:to="lab_holx_BedfordMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9977aaba-eaed-4ce3-8525-e964a21a6f14_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11150db0-d6d2-4978-a32a-cbeda2263b7a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_57ad3ee0-b0e8-4084-ab7b-c09664f2fc69_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_6e7969da-636e-4aff-93a3-9a137b2bc936_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9761710d-3578-477c-9e87-c373245bfd95_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Deferred Compensation Plan [Member]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3b19968e-6fc8-42af-914a-0a482a828f9c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_bc86faab-3a9c-4675-b386-43111659b55b_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short and long-term debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ee89b6a1-10db-4888-90bf-1d8ca4162e4f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_7a6170ba-ec79-4721-9873-b9e7f47d3167_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5328bfa6-88ee-48b8-8583-637ee1ec1067_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock under employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MedicalAestheticsBusinessMember_cc4ef703-30d7-4951-8b64-6a024d96e5b2_terseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics Business</link:label>
    <link:label id="lab_holx_MedicalAestheticsBusinessMember_label_en-US" xlink:label="lab_holx_MedicalAestheticsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics Business [Member]</link:label>
    <link:label id="lab_holx_MedicalAestheticsBusinessMember_documentation_en-US" xlink:label="lab_holx_MedicalAestheticsBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MedicalAestheticsBusinessMember" xlink:to="lab_holx_MedicalAestheticsBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6cf8aa43-87d2-40f3-abea-51cbde033600_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_5efd16b7-7d37-4664-b8fd-1ee9eed40dbd_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_347cb980-3c22-4947-ab98-4a11316f2e9c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_aa6e1b93-f373-44d9-a3a5-fe7b6184adc7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_78d4145f-8614-4ec7-91a1-a718f34e57c2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_620317f6-8562-4e7d-85d5-cd74f38f18e6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityByLocationAxis_b3ae933f-abf2-406a-9c8e-58bad194bd05_terseLabel_en-US" xlink:label="lab_dei_EntityByLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity by Location [Axis]</link:label>
    <link:label id="lab_dei_EntityByLocationAxis_label_en-US" xlink:label="lab_dei_EntityByLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity by Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityByLocationAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityByLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityByLocationAxis" xlink:to="lab_dei_EntityByLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_af83b230-0492-41fe-924a-c6f76f81da06_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_d1b11a04-90d9-47a5-a375-830f1606852e_terseLabel_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption, Premium Paid</link:label>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_label_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption, Premium Paid</link:label>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_documentation_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption, Premium Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid" xlink:href="holx-20210925.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtRedemptionPremiumPaid" xlink:to="lab_holx_DebtRedemptionPremiumPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_74836cf9-133d-4b51-b473-2f73c60396b4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_f9b4da86-834e-4c31-96cd-db398d9932fb_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2074aa32-a8a7-4960-9c38-b4f98aa7320d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_da60b4a6-8ba9-4911-9f13-dab1c352d724_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_02303626-1244-4415-8809-10f4dc7acf1a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree (as a percent)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_755c625a-ed22-4f58-a3b4-c666ce954a0a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_013bad1e-0f87-4fc0-a9d9-058d3f0e0070_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_cb84fb66-e52f-4058-a7d0-d4abbb5347ef_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_8cf166a4-b155-4905-bba4-d3023ba43ec9_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:href="holx-20210925.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_77e8c5c7-4a4c-4910-ba11-fffc3d1241e7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_9e04140e-4263-403d-a3f5-e9ec8aa6ffba_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0e465770-5e56-4c41-98f4-2d4162112759_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_16ca95e8-8a1a-4719-8df1-32b05acd7a3f_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_cbc04c4c-3e1c-4dc2-bf8e-261b76290bb6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) Related to Derivatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_c5480d86-b5dc-47d2-a2ec-f4d4b1cee91c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_27ba317c-3768-4523-80a4-d3c21e99bd80_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs&#160;(Level&#160;3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b5bcb598-4cda-4c2d-a010-9c4595cfc3fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_68650410-4a82-4079-976e-2666034c9654_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherOperatingCostReductionsMember_acbb12e0-802e-4ac6-b6cf-2a5bcb96fc1e_terseLabel_en-US" xlink:label="lab_holx_OtherOperatingCostReductionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous Other Charges</link:label>
    <link:label id="lab_holx_OtherOperatingCostReductionsMember_label_en-US" xlink:label="lab_holx_OtherOperatingCostReductionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Cost Reductions [Member]</link:label>
    <link:label id="lab_holx_OtherOperatingCostReductionsMember_documentation_en-US" xlink:label="lab_holx_OtherOperatingCostReductionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating cost reductions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherOperatingCostReductionsMember" xlink:href="holx-20210925.xsd#holx_OtherOperatingCostReductionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherOperatingCostReductionsMember" xlink:to="lab_holx_OtherOperatingCostReductionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_7cd02ec8-6f15-4229-b3ac-6255b5e6ce32_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_d08cdcdc-bcbc-434f-b65f-2274624140e7_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_b28b4deb-e48d-497c-a616-a1b9b62bda35_terseLabel_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in foreign currency translation adjustment</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_label_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_documentation_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:href="holx-20210925.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:to="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_f88b3da0-58d5-4d50-8a78-ce3984cef381_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_639524a9-477f-4ec9-afd7-148d5f49eea1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_fe9f6dd0-0906-4e5a-8907-eb6cd00a2b31_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage redemption price, sixth period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Redemption Price Sixth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Redemption Price Sixth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:to="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_1f2a4496-5263-4f64-b575-5d50c2e38fdc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_532a76d0-c4b3-4712-b3f9-1504b4d0a9e7_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentAndSoftwareMember_91c973a0-c698-437e-bcba-61ab29c97e42_terseLabel_en-US" xlink:label="lab_holx_EquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment and Software [Member]</link:label>
    <link:label id="lab_holx_EquipmentAndSoftwareMember_label_en-US" xlink:label="lab_holx_EquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment And Software [Member]</link:label>
    <link:label id="lab_holx_EquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_holx_EquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment And Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentAndSoftwareMember" xlink:href="holx-20210925.xsd#holx_EquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentAndSoftwareMember" xlink:to="lab_holx_EquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_34d8f3bf-4de0-44ba-a0ea-10a4cf8de433_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_e6891eb8-5de5-48ca-b0bb-dffd289ca82a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_945669e9-45eb-451b-9aec-734d43313b0c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f4c7390b-ba4e-47cd-b5b0-86fb5e20af94_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FocalTherapeuticsInc.Member_0765debc-5329-4805-9853-03e13eadf772_terseLabel_en-US" xlink:label="lab_holx_FocalTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Focal Therapeutics</link:label>
    <link:label id="lab_holx_FocalTherapeuticsInc.Member_label_en-US" xlink:label="lab_holx_FocalTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Focal Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_holx_FocalTherapeuticsInc.Member_documentation_en-US" xlink:label="lab_holx_FocalTherapeuticsInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Focal Therapeutics, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member" xlink:href="holx-20210925.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FocalTherapeuticsInc.Member" xlink:to="lab_holx_FocalTherapeuticsInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RepaymentofSeniorNotes_ec57e7a2-ba9b-4b07-8d78-c1aa93769fa3_negatedTerseLabel_en-US" xlink:label="lab_holx_RepaymentofSeniorNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:label id="lab_holx_RepaymentofSeniorNotes_label_en-US" xlink:label="lab_holx_RepaymentofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:label id="lab_holx_RepaymentofSeniorNotes_documentation_en-US" xlink:label="lab_holx_RepaymentofSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentofSeniorNotes" xlink:href="holx-20210925.xsd#holx_RepaymentofSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RepaymentofSeniorNotes" xlink:to="lab_holx_RepaymentofSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_5ce56eb3-723a-41a4-9694-9fad44fd653c_terseLabel_en-US" xlink:label="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense for the DCP discretionary contributions</link:label>
    <link:label id="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_label_en-US" xlink:label="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified Deferred Compensation Plan Annual Contribution</link:label>
    <link:label id="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_documentation_en-US" xlink:label="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified deferred compensation plan annual contribution.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:href="holx-20210925.xsd#holx_NonqualifiedDeferredCompensationPlanAnnualContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:to="lab_holx_NonqualifiedDeferredCompensationPlanAnnualContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_88faa5ca-b20b-422f-b081-3b0b58a0abbe_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance charges</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_72f7eaaf-cf4f-4ffc-a872-3a14e3cb9122_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c9ac6908-518a-438c-9af9-d11476df87b0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2edf00f0-82ba-4ad7-ba80-28e707bb6fff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_07565780-7907-4874-ad83-d5d156cd1996_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 13 and 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_3bb1b877-eb46-4e57-b401-60b91f86e990_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_f888a7d7-3043-45c1-b299-523edfc52bc7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_053e63e3-37f8-49b2-bc14-6b9774b19f95_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation, period of vest term granted to employees, years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6aba2057-5b67-49e1-96be-68f39760a12d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_56556a43-1392-40fa-a8bf-22217d0caaee_terseLabel_en-US" xlink:label="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Service and Other Revenues</link:label>
    <link:label id="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Service And Other Revenues Policy [Policy Text Block]</link:label>
    <link:label id="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of the costs comprising costs of service and other revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:href="holx-20210925.xsd#holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:to="lab_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_69ac8be7-1185-4fe2-8e20-8e356960874f_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_84c1cdbb-786b-4da2-a44a-04042ad50a90_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b70e5496-25af-4111-80de-62bb4507b442_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_aa6acc8c-b396-40b3-ba98-1fbeac1ecd8a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_415d4f3c-45e8-4305-a26f-2f4da51a8ca4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_b1b6f076-aa33-485c-a895-8235659f2d02_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AlphaImagingMember_96f0fe53-164b-4d81-ae27-62cd05409cbb_terseLabel_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging</link:label>
    <link:label id="lab_holx_AlphaImagingMember_label_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:label id="lab_holx_AlphaImagingMember_documentation_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember" xlink:href="holx-20210925.xsd#holx_AlphaImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AlphaImagingMember" xlink:to="lab_holx_AlphaImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Purchaseobligationthereafter_f2606568-85c6-411f-b6b5-c7880245c2b5_terseLabel_en-US" xlink:label="lab_holx_Purchaseobligationthereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_holx_Purchaseobligationthereafter_label_en-US" xlink:label="lab_holx_Purchaseobligationthereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation thereafter</link:label>
    <link:label id="lab_holx_Purchaseobligationthereafter_documentation_en-US" xlink:label="lab_holx_Purchaseobligationthereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseobligationthereafter" xlink:href="holx-20210925.xsd#holx_Purchaseobligationthereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Purchaseobligationthereafter" xlink:to="lab_holx_Purchaseobligationthereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessLicensesMember_11447e5e-bbc0-40b9-a16f-bb19e87412c0_terseLabel_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_label_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Licenses [Member]</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_documentation_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember" xlink:href="holx-20210925.xsd#holx_BusinessLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessLicensesMember" xlink:to="lab_holx_BusinessLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_25b014db-28f2-4b8c-b91b-d539c1ebaab9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated earnings (deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5b3d7d2e-63b5-4343-8b16-29f7bd246667_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_52ff294e-8069-4160-8d19-c3fa2aa77855_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under revolving credit line</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_df4ba6a8-d8bd-43b3-88b4-deeae1fdbb08_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_65c9bdfe-0a13-416a-92c1-281493b9891a_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment losses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_22bf779a-2ce2-4ffb-a3d1-2168c17515b1_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_59408a5d-49fc-4cf6-af83-c45ebb157538_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2028SeniorNotesMember_cfa90927-a89b-4048-a239-bf6a2fcf39a8_terseLabel_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028SeniorNotesMember" xlink:to="lab_holx_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_92caaf60-986b-4c4b-9395-5e9a7d57976a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2b7822f2-f377-4f0a-94b8-5d67ba5850a2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_6b11d392-b0f9-47c5-9362-afb3188acaa1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProceedsfromSeniorNotes_d9c95ccd-89fc-4797-87ee-1723bdaec22d_terseLabel_en-US" xlink:label="lab_holx_ProceedsfromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Senior Notes</link:label>
    <link:label id="lab_holx_ProceedsfromSeniorNotes_label_en-US" xlink:label="lab_holx_ProceedsfromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Senior Notes</link:label>
    <link:label id="lab_holx_ProceedsfromSeniorNotes_documentation_en-US" xlink:label="lab_holx_ProceedsfromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsfromSeniorNotes" xlink:href="holx-20210925.xsd#holx_ProceedsfromSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsfromSeniorNotes" xlink:to="lab_holx_ProceedsfromSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_415f8cc5-84d9-4dbe-880e-96284ff6bc5f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_36146544-12dd-4b5f-9980-32774cff4bce_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_40c9ed37-63c1-44cd-8293-2eceeedda9b2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_63ddf245-6b37-4166-8fb4-ef174b2ee55d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_076020d9-60ae-429e-bcf8-c089fa736e8e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_1ed5f822-fa30-44a6-a730-b19f55e4ad96_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_468ba4b9-f992-462c-b25e-9d7625492f7e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 25, 2021</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_047fef90-1668-4b98-8a4d-08ebcaf8728f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_fb313060-580a-40b0-a150-a6fb5f866409_terseLabel_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_label_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_documentation_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrantsReceivedFromDepartmentOfDefense" xlink:href="holx-20210925.xsd#holx_GrantsReceivedFromDepartmentOfDefense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrantsReceivedFromDepartmentOfDefense" xlink:to="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_4868a95a-ebcc-4bae-9768-d1925dab4e50_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 and Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_738aeeb9-8d95-4220-8113-c744ae59cf3b_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising cost</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DistributionagreementMember_f4848aa3-576f-4dec-b246-41a418a9ac7d_terseLabel_en-US" xlink:label="lab_holx_DistributionagreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution agreement [Member]</link:label>
    <link:label id="lab_holx_DistributionagreementMember_label_en-US" xlink:label="lab_holx_DistributionagreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution agreement [Member]</link:label>
    <link:label id="lab_holx_DistributionagreementMember_documentation_en-US" xlink:label="lab_holx_DistributionagreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember" xlink:href="holx-20210925.xsd#holx_DistributionagreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DistributionagreementMember" xlink:to="lab_holx_DistributionagreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_a1ce2e76-6654-485f-b330-5ad1a22c5fba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_23b2e032-ca68-49ac-91bf-fea451588800_negatedLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Benefit Expense Research And Development</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation benefit expense research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:to="lab_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0b2df810-e200-4626-ad8b-48935b30f19f_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_28915003-a76a-4ca3-96f5-578adfc21628_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_37cf48c5-4941-4b08-a05a-f124ffca2afd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_797f417e-142f-474d-9453-05f486221e10_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes_efb91755-15b1-4fa1-b50c-30503b5e328e_terseLabel_en-US" xlink:label="lab_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on interest rate cap, net of taxes</link:label>
    <link:label id="lab_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes_label_en-US" xlink:label="lab_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on interest rate cap, net of taxes</link:label>
    <link:label id="lab_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes_documentation_en-US" xlink:label="lab_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on interest rate cap, net of taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes" xlink:href="holx-20210925.xsd#holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes" xlink:to="lab_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_d84b0e51-e6cc-4dcb-beaf-a61b398cf8f3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_22b74645-6875-4531-ab08-ca6db2cf4cf6_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncomeTaxesTable_615fb297-54ba-41f1-a92f-5b5a519a0c0c_terseLabel_en-US" xlink:label="lab_holx_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_holx_IncomeTaxesTable_label_en-US" xlink:label="lab_holx_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_holx_IncomeTaxesTable_documentation_en-US" xlink:label="lab_holx_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesTable" xlink:href="holx-20210925.xsd#holx_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncomeTaxesTable" xlink:to="lab_holx_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_f08580be-6622-46b1-bc2f-ed2de2dc0cc1_terseLabel_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_label_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_documentation_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember" xlink:href="holx-20210925.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterventionalBreastSolutionsMember" xlink:to="lab_holx_InterventionalBreastSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_7a844cd5-fa70-4785-86f3-a944afa6ed0e_terseLabel_en-US" xlink:label="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest reclassified to APIC</link:label>
    <link:label id="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_label_en-US" xlink:label="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest reclassified to APIC</link:label>
    <link:label id="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_documentation_en-US" xlink:label="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest reclassified to APIC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:href="holx-20210925.xsd#holx_PurchaseOfNonControllingInterestReclassifiedToAPIC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:to="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_a7ce6cab-3079-4f5c-9bc1-4b67b7927918_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_73e238c8-1254-4503-865e-8ae4773a87b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_7958b0d2-9b02-4723-a157-c03d5d5854c4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_5f7d5e8b-ee02-42d5-91a7-8136eae39375_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_577797ec-e964-4df4-a3cd-ea6f16e0dbc1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_92eb73d6-00b2-4992-b018-9601e9dcf1db_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current and Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_826193a4-e710-4330-b4e5-4608441bf015_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_46831a35-877c-4884-b61e-345a9d874f88_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_90533cde-7162-41a0-bcda-3fe6d8fe8b70_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess_967d3712-1f74-41d1-8fa6-125b1520936d_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Decrease In Research And Development In Process</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Decrease In Research And Development In Process</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Decrease In Research And Development In Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_09e261a4-aa1a-46b4-bffb-4ca49181fa5a_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securitization Program</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_label_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_documentation_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember" xlink:href="holx-20210925.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableSecuritizationMember" xlink:to="lab_holx_AccountsReceivableSecuritizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d371060f-baed-4e9b-b048-1b247e1fc795_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5846a5f3-8fcc-415e-adfe-029e9e5bfaf2_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense in Consolidated Statement of Operations</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:href="holx-20210925.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:to="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CompanyVs.MinervaSurgicalInc.Member_959617e5-f778-440b-b138-031e15b451ce_terseLabel_en-US" xlink:label="lab_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Vs. Minerva Surgical, Inc.</link:label>
    <link:label id="lab_holx_CompanyVs.MinervaSurgicalInc.Member_label_en-US" xlink:label="lab_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Vs. Minerva Surgical, Inc. [Member]</link:label>
    <link:label id="lab_holx_CompanyVs.MinervaSurgicalInc.Member_documentation_en-US" xlink:label="lab_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Vs. Minerva Surgical, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:href="holx-20210925.xsd#holx_CompanyVs.MinervaSurgicalInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:to="lab_holx_CompanyVs.MinervaSurgicalInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dca62712-9576-4ba5-a5c6-c17afbed2e70_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 25, 2021</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_81bbb3e5-b279-4de1-9dc1-7e06447f652e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_0529bbf7-1fbf-4128-acea-52fdca463b92_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_971cade5-371f-48a9-b727-f44fbc17d9d8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_28619e01-e4f5-44a4-9863-5f94a842d5d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Basic and Diluted Share Amounts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_79974fcc-71ed-4c60-9519-fe8ae52afafa_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_4307bd11-1443-4ea9-9087-9ac8ecb55c58_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreement2017Member_77928c34-8539-455d-8000-9f82ec29358f_terseLabel_en-US" xlink:label="lab_holx_CreditAgreement2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreement2017Member_label_en-US" xlink:label="lab_holx_CreditAgreement2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2017 [Member]</link:label>
    <link:label id="lab_holx_CreditAgreement2017Member_documentation_en-US" xlink:label="lab_holx_CreditAgreement2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member" xlink:href="holx-20210925.xsd#holx_CreditAgreement2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreement2017Member" xlink:to="lab_holx_CreditAgreement2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b54da74b-8e46-4893-a9ea-01b13b26c0ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Purchase Price Allocation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreementMember_f63e8d51-27e3-413c-ba09-5c66a52d1b7a_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_label_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember" xlink:href="holx-20210925.xsd#holx_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementMember" xlink:to="lab_holx_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_6c3631cf-d05e-4915-8ab2-9dfcc76fa0ec_terseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_ca550c06-9209-465e-960e-0eb6e8cdcf28_verboseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowed principal under credit agreement</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_label_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount Of Borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_documentation_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings" xlink:href="holx-20210925.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalAmountOfBorrowings" xlink:to="lab_holx_PrincipalAmountOfBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_fe0adc7d-445b-4efc-b5f0-7f34d8d71549_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_08389a9d-c8e7-4d84-a0e0-69cbbb8e77f8_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6f60cd37-a0b4-4887-95ed-58351e5ea973_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_0babcbbe-09a2-4f90-8191-1a9239e73c22_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#160;Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_16b5893a-0494-4aeb-a3d6-0a438307d132_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_c965e7a9-6f85-4cf6-a4dc-730fe03a9970_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dff17e4c-3f28-4331-b18b-3556a89bf277_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_2c77a00c-0a84-45a6-8501-077a14d3b5b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_7606e21f-7c10-497a-8620-e6e811d8f031_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CytologyPerinatalMember_3c8465a8-f85c-463a-9b02-dc3a1530b538_terseLabel_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_label_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_documentation_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember" xlink:href="holx-20210925.xsd#holx_CytologyPerinatalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CytologyPerinatalMember" xlink:to="lab_holx_CytologyPerinatalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_69509e01-5ecc-46bd-8223-c7fac57c9667_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_4e10d1f0-5430-4e35-ac5c-3b31530ef549_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations and Acquisition of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations and Other Purchase of Business Transactions, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:to="lab_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_345a64c3-85e3-40c6-9999-dc45dec1af7b_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ComprehensiveIncome_b9d82a91-e090-433b-950f-e635a304ebbe_terseLabel_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to Hologic</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_label_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_documentation_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome" xlink:href="holx-20210925.xsd#holx_ComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ComprehensiveIncome" xlink:to="lab_holx_ComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_44fb2cd9-1d4d-408f-bc7c-0012cecb005d_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:href="holx-20210925.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_d2896ce1-3565-47d5-b6e0-21f1641eea19_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_4781dae9-1cea-4b53-bdd8-e31326570602_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_51449f0e-67da-44eb-92c0-38fa0e3f6304_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in pension plans, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a6012cec-d1a3-4543-8d35-906c3256ee0c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_20edfc42-7d26-4d8f-a4a6-36fcbd23431b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Credit Agreements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_0a04f9da-c8b3-4520-be4b-69367a58d167_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_53307831-a9f0-49ff-9f7f-85468e29340a_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_737e59ba-21f6-47d0-8caa-da3feb397049_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_d612ce55-7e36-4623-b89d-24d3aeeb0235_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmendedRevolver2018Member_7f71f8e9-4089-4ce2-a442-3c0718b10077_terseLabel_en-US" xlink:label="lab_holx_AmendedRevolver2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Amended Revolver</link:label>
    <link:label id="lab_holx_AmendedRevolver2018Member_label_en-US" xlink:label="lab_holx_AmendedRevolver2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Revolver 2018 [Member]</link:label>
    <link:label id="lab_holx_AmendedRevolver2018Member_documentation_en-US" xlink:label="lab_holx_AmendedRevolver2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Revolver 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedRevolver2018Member" xlink:href="holx-20210925.xsd#holx_AmendedRevolver2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedRevolver2018Member" xlink:to="lab_holx_AmendedRevolver2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_cbbed2f4-d01d-4d58-b5c0-8b732a62b1fb_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_fae1ac7e-4aa3-4988-9b96-add4bdc7561a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_cbed6de0-0d52-4e59-b33d-e289a1f4a32e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_e0236715-f65c-437b-b2ea-b494aea410cc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_03c558b8-faba-469a-80eb-f4fa64d0700b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_3e7275ad-06a8-40d0-b368-5cb49d9ff562_totalLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State, Total</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_1171cc78-7702-44d1-8aba-7e252b4e74b8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_be331f81-56bd-4a09-8a2c-e841225fd9f3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_7ad29ae6-3ce3-4e44-8077-871d52881f78_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternalusesoftwareMember_a4cd3f22-9f69-4bfd-b6ee-7ed40f6601a3_terseLabel_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_label_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_documentation_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember" xlink:href="holx-20210925.xsd#holx_InternalusesoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternalusesoftwareMember" xlink:to="lab_holx_InternalusesoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_June132019PlanMember_0ed6ca0e-0f74-49ea-b1ed-76e532dd4117_terseLabel_en-US" xlink:label="lab_holx_June132019PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 13, 2019 Plan [Member]</link:label>
    <link:label id="lab_holx_June132019PlanMember_label_en-US" xlink:label="lab_holx_June132019PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 13, 2019 Plan [Member]</link:label>
    <link:label id="lab_holx_June132019PlanMember_documentation_en-US" xlink:label="lab_holx_June132019PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 13, 2019 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_June132019PlanMember" xlink:href="holx-20210925.xsd#holx_June132019PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_June132019PlanMember" xlink:to="lab_holx_June132019PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_1dcd8953-263b-4230-925b-b70fe918a8f2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_8b21d122-589a-4338-ae4a-45bc2b3fb90d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueThereafter_dca908d7-e753-447f-82c2-4d3ce8c5b65f_terseLabel_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due thereafter</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueThereafter_label_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due thereafter</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueThereafter_documentation_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueThereafter" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SubLeaseRentalIncomeDueThereafter" xlink:to="lab_holx_SubLeaseRentalIncomeDueThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_07572254-3fe5-4081-9a54-8e5a55975b8f_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivative</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivatives Recorded in Earnings, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_45165630-211c-48eb-a542-8db84ab04353_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_6296fa49-389f-4e16-a37e-d4a80810bbdd_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_d2a60cc9-b750-45af-af5b-94ec1d051fad_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_925d9c98-3e44-4832-a24c-7db4226e579b_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_66e508a2-0bf3-4732-91a3-9082224fee94_terseLabel_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Target Number Of Shares Issued On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum target number percentage of shares that would be issued based on stock price performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:href="holx-20210925.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:to="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_4f113c12-fc61-478c-a81a-dad2d7e1509d_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonqualified deferred compensation plan</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Nonqualified Deferred Compensation Plan</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The tax effect as of the balance sheet date of the amount of future tax deductions arising from the Company's nonqualified deferred compensation plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:to="lab_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization_1bed5f74-0da2-4966-8291-343be7e3c334_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from accounts receivable securitization agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization_label_en-US" xlink:label="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Accounts Receivable Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:to="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b5b18424-4b3a-4579-a295-5118ec561201_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_f4926638-c106-46c1-a1f3-27bdcc3b7311_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in gross unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_1ca9712f-6e14-43b3-ab31-a6a0a4f76cf3_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_916c1aa8-14b1-44f8-ac7d-98175228d2a7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_38453ee1-a48f-46b1-b5d7-4612bc438ef5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_02ba20fb-26fc-4899-b512-ee88468ad471_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period of unrecognized stock-based compensation, years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fac96562-c3b3-4dbd-a10e-67cad08bc99c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_33985532-ecdb-46e2-85b0-0c32d2c9f55f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableFromSecuritization_5cd0d127-b97e-4743-96db-1367ad694604_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from securitization</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableFromSecuritization_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableFromSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable from Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableFromSecuritization" xlink:to="lab_us-gaap_AccountsReceivableFromSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a8baf8ba-a69d-4da5-b905-1d21a270c310_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_96e155a2-19f7-41c1-a8d3-f8ad670128ff_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was included in contract liability at prior year end</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_10287ad7-a1e1-44e5-bc84-81bcd5bcb5ba_terseLabel_en-US" xlink:label="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Net Income resulted from adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_label_en-US" xlink:label="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Net Income resulted from adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_documentation_en-US" xlink:label="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to Net Income resulted from adoption of ASU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:href="holx-20210925.xsd#holx_IncreasetoNetIncomeresultedfromadoptionofASU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:to="lab_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_c0c9821d-eabb-46ca-a39b-11c3a36f2b14_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_13577176-f515-4c53-a818-41996f0aa4a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2b6f2432-52b4-4035-8a54-32ba7818a7f7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PSUFreeCashFlowMember_b4663aba-06f6-460e-b8b0-2dd48931a7a7_terseLabel_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_label_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_documentation_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember" xlink:href="holx-20210925.xsd#holx_PSUFreeCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PSUFreeCashFlowMember" xlink:to="lab_holx_PSUFreeCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_f584ed4d-5568-4f2f-b3cd-e30834a7e709_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_99363a7a-0044-4edc-9311-f796958ae2b7_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_92a3b979-fa5b-497b-86b9-a658389a56a4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_0d65cf35-58f1-4add-8812-75a12a7c112c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_e9e8c8f3-276d-4563-ae4b-856710a9ec75_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_fb448b9e-f843-4cf7-bcb1-56e4a32f82bf_terseLabel_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period with option to terminate lease</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_label_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Lease, Period With Option To Terminate</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_documentation_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Lease, Period With Option To Terminate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:to="lab_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_89cea159-4ebf-4a1e-896a-b95c6c68bae3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e0a1d692-8d05-40a7-ae71-8c038151e2c8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_0b8ec302-804b-4074-be51-d1b052004c4a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableAllowanceReduction_3450fe7e-13e9-4f9d-bb98-e9c1259eddb1_negatedLabel_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceReduction" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write- offs and Payments</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceReduction_label_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceReduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Allowance Reduction</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceReduction_documentation_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceReduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents reduction to the allowance for doubtful accounts primarily from collection of previously reserved accounts and the elimination of an account from the ledger accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceReduction" xlink:href="holx-20210925.xsd#holx_AccountsReceivableAllowanceReduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableAllowanceReduction" xlink:to="lab_holx_AccountsReceivableAllowanceReduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_e15618d2-6c5d-4a0b-9ba5-632c5a57d274_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrossForeignLossCarryforwards_8e461637-2686-4b03-8e95-7cba5f9c5e50_terseLabel_en-US" xlink:label="lab_holx_GrossForeignLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross foreign loss carryforwards</link:label>
    <link:label id="lab_holx_GrossForeignLossCarryforwards_label_en-US" xlink:label="lab_holx_GrossForeignLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross foreign loss carryforwards</link:label>
    <link:label id="lab_holx_GrossForeignLossCarryforwards_documentation_en-US" xlink:label="lab_holx_GrossForeignLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross foreign loss carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossForeignLossCarryforwards" xlink:href="holx-20210925.xsd#holx_GrossForeignLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrossForeignLossCarryforwards" xlink:to="lab_holx_GrossForeignLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_19006416-5228-4ffd-be7e-4da294cae434_terseLabel_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease revenue as a percentage of total</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_label_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_documentation_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:href="holx-20210925.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:to="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_89399a16-87f4-460b-930a-ed5fdee806ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReceivable" xlink:to="lab_us-gaap_IncomeTaxReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_c106c2bd-b79f-47f0-b339-c4de995810e7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_3119b3a7-b075-4b28-b395-57439f800019_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation in excess of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate_7484fe86-d025-48a5-84df-6d1472ec99c8_terseLabel_en-US" xlink:label="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of forfeiture rates</link:label>
    <link:label id="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate_label_en-US" xlink:label="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Percentage Of Forfeiture Rate</link:label>
    <link:label id="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate_documentation_en-US" xlink:label="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture rate applied to equity awards issued to certain employee groups to determine stock-based compensation expense for the period. The rate is based on an analysis of historical employee exercise and terminations patterns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:href="holx-20210925.xsd#holx_ShareBasedCompensationPercentageOfForfeitureRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:to="lab_holx_ShareBasedCompensationPercentageOfForfeitureRate" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2021RevolverMember_88e1e979-2f62-4eb8-a816-12e5f60ac13e_terseLabel_en-US" xlink:label="lab_holx_A2021RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolver</link:label>
    <link:label id="lab_holx_A2021RevolverMember_label_en-US" xlink:label="lab_holx_A2021RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolver [Member]</link:label>
    <link:label id="lab_holx_A2021RevolverMember_documentation_en-US" xlink:label="lab_holx_A2021RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolver</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021RevolverMember" xlink:href="holx-20210925.xsd#holx_A2021RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2021RevolverMember" xlink:to="lab_holx_A2021RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_8a1a462d-961f-45b0-afd1-8eb93f5f4543_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_86e91e02-8588-4dae-9d14-11d896c8d308_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_98a2917e-f9ce-483a-88f1-ef041fd7ebde_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems" xlink:href="holx-20210925.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureLineItems" xlink:to="lab_holx_SegmentReportingDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ASRAuthorized_9a260ca7-4c86-44c1-9e8b-cc382bba2167_terseLabel_en-US" xlink:label="lab_holx_ASRAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Authorized</link:label>
    <link:label id="lab_holx_ASRAuthorized_label_en-US" xlink:label="lab_holx_ASRAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Authorized</link:label>
    <link:label id="lab_holx_ASRAuthorized_documentation_en-US" xlink:label="lab_holx_ASRAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRAuthorized" xlink:href="holx-20210925.xsd#holx_ASRAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ASRAuthorized" xlink:to="lab_holx_ASRAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_842dbfe5-2ca8-4c44-8800-fc6588e7de89_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_0c6c99c6-81ba-4f95-98e2-f5e113caf834_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_fc2580aa-c3e2-41b0-aa1b-10b461de9c78_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_4437de58-a7e9-459f-aaaf-dbe0188cd8ea_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeOptionMember" xlink:to="lab_us-gaap_ForeignExchangeOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_64913f23-60a2-49e2-bc5a-7253a1628635_terseLabel_en-US" xlink:label="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final sales price</link:label>
    <link:label id="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_label_en-US" xlink:label="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Final Sales Price</link:label>
    <link:label id="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_documentation_en-US" xlink:label="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Final Sales Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:href="holx-20210925.xsd#holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:to="lab_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SubLeaseRentalIncomeCurrent_d7e21d05-1a09-4f3e-9b42-e821b293b57a_terseLabel_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease Rental income current</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeCurrent_label_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease Rental income current</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeCurrent_documentation_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease Rental income current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeCurrent" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SubLeaseRentalIncomeCurrent" xlink:to="lab_holx_SubLeaseRentalIncomeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2021TermLoanMember_facae57b-6b13-4742-ad05-5c284f8afb3d_terseLabel_en-US" xlink:label="lab_holx_A2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan</link:label>
    <link:label id="lab_holx_A2021TermLoanMember_label_en-US" xlink:label="lab_holx_A2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan [Member]</link:label>
    <link:label id="lab_holx_A2021TermLoanMember_documentation_en-US" xlink:label="lab_holx_A2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021TermLoanMember" xlink:href="holx-20210925.xsd#holx_A2021TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2021TermLoanMember" xlink:to="lab_holx_A2021TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_fdad8466-90e2-4bad-a9d1-e0c0a9bcb2e0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities (non-current)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e97e101b-9a32-4ba5-bc6a-cb3ab91d9c06_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_6653787d-984c-4910-a4a2-cf48e2fbe09a_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:href="holx-20210925.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AuthorizationDateDomain_129683b4-0e06-4af2-ac19-48d77422ec73_terseLabel_en-US" xlink:label="lab_holx_AuthorizationDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorization Date [Domain]</link:label>
    <link:label id="lab_holx_AuthorizationDateDomain_label_en-US" xlink:label="lab_holx_AuthorizationDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorization Date [Domain]</link:label>
    <link:label id="lab_holx_AuthorizationDateDomain_documentation_en-US" xlink:label="lab_holx_AuthorizationDateDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Authorization Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AuthorizationDateDomain" xlink:href="holx-20210925.xsd#holx_AuthorizationDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AuthorizationDateDomain" xlink:to="lab_holx_AuthorizationDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_6052b5e5-75a0-4f59-969b-5dae23a513d6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_87c09f1a-74eb-41d4-afe8-f77b9df1f23c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_2b9e2bb7-7a61-4d96-813f-08511588e776_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_7fddbe7b-618b-4667-be0e-37a1a0287430_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_061cd1ab-1711-4541-a4f6-f1c5c6bf3255_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_878425df-f4c3-4d79-aca4-06a37d8f9881_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_f10afff4-1e12-4992-b828-fbb1a4161215_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f0f3edb5-9b95-4965-ac32-07b455589b0e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_273f2453-3a4f-470e-bb14-2553cec42897_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_27c4fd3d-35e7-41e7-8e4e-b78edd6249f4_terseLabel_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital equipment, components and software</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_label_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:href="holx-20210925.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:to="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_847536ea-658e-497c-bfa2-6f3feaa0fa46_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_b5d18791-6211-4b1d-8415-b4e09e5e92ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_4a3e75d1-72b6-40ab-8acd-4b728b2ef76c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_ffcae174-d601-4f65-ac9c-06f7b5f47e24_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_1d279039-6959-4a8c-9d97-9106d4905171_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_1eaa8e4d-021c-43b4-a15d-e2272e7d1adf_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss recognized in other comprehensive income (loss), net</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7b89eb6e-87c3-4e73-9914-f9be52ed7e1a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_f4d3fe19-4340-497e-83df-72b07d082f23_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_614d3610-bee9-487a-8ab3-52c9b3139b7b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_08f7b1be-68e5-4eaf-81bc-90dafd60a7c8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_32ae0aed-4415-4ece-816e-5f68269e986c_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Holdback_697d5006-7187-4764-9c75-9247d5e4184f_terseLabel_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_label_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_documentation_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback" xlink:href="holx-20210925.xsd#holx_Holdback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Holdback" xlink:to="lab_holx_Holdback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_709f4967-1f8e-4e88-b6c3-b1ffc42da9f7_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized value of common shares to be repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_f6f7e229-d6de-4af0-acb5-7aa446effd5d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtheractionMember_2ecbc324-a7d9-4ea2-a269-970bc6d166d9_terseLabel_en-US" xlink:label="lab_holx_OtheractionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_holx_OtheractionMember_label_en-US" xlink:label="lab_holx_OtheractionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other action [Member]</link:label>
    <link:label id="lab_holx_OtheractionMember_documentation_en-US" xlink:label="lab_holx_OtheractionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other action [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtheractionMember" xlink:href="holx-20210925.xsd#holx_OtheractionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtheractionMember" xlink:to="lab_holx_OtheractionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_e6aae1d7-276f-4f63-b63c-4841b437f251_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_e857d881-bc0f-4865-bece-2625582f9b85_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_434d2e6d-ce71-4491-b403-a227c8571582_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_ab5316b5-bc22-4598-be88-912047209681_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Hologic</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_e20061a6-34c8-4c60-882b-f9eaa685901e_negatedTerseLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of Cynosure</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax reconciliation loss on sale of Cynosure</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax reconciliation loss on sale of Cynosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:to="lab_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_ad11404b-46a6-44c4-a63a-7b09d534e437_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c0f54e6f-0669-4f62-84c0-90ce015ba3c1_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_aa405890-688c-48b5-bc33-dec0d2d82da3_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_87abb4ba-7bd4-4649-ae37-a1a2e1b85cc8_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal net operating loss expected to be expired unutilized</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Federal</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of federal net operating losses the company believes will expire unutilized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:to="lab_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_37d9ea0d-0811-41bd-ab38-d88b44d9e50e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_00efb254-d4df-4431-9372-0261aa35989e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_7a7996e0-35bb-4da3-935a-bc2489024ecb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ee11c476-ae0f-4225-b6f7-ae980f3a4229_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_e59763c5-e2c2-4d25-98a3-4fa5906d9fac_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LegalAccrual_04e6cae1-44bc-4309-b354-cf3298b320a0_terseLabel_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_label_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_documentation_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual" xlink:href="holx-20210925.xsd#holx_LegalAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LegalAccrual" xlink:to="lab_holx_LegalAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_9fbcd4e6-d103-41e2-bb7b-f021144de931_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_6e9a4b2c-779f-47ef-b8ef-c25f5a7f6594_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_c4a4e569-4977-4a40-a8eb-6cd5cc9f7959_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_67a3b01d-a2d6-4b91-9063-e3b557f57e99_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_bfdd820e-49a9-41c0-b2f9-f4c2d664a741_terseLabel_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition</link:label>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_label_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]</link:label>
    <link:label id="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_documentation_en-US" xlink:label="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:href="holx-20210925.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:to="lab_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_c77f314a-a46b-49c3-9ad0-51a720de5e4d_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_dc4d9470-e314-4b70-b217-6cfea0012d6d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_592a45a2-7648-4637-b9e8-cfc1d5aca88f_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired shares</link:label>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_label_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Shares Acquired</link:label>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_documentation_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Shares Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired" xlink:href="holx-20210925.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationSharesAcquired" xlink:to="lab_holx_BusinessCombinationSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn2Years_5eba66ef-b41b-47e1-b3a4-f725db292746_terseLabel_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn2Years" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 2 years</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn2Years_label_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn2Years" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 2 years</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn2Years_documentation_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn2Years" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 2 years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueIn2Years" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueIn2Years"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SubLeaseRentalIncomeDueIn2Years" xlink:to="lab_holx_SubLeaseRentalIncomeDueIn2Years" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CostMethodEquityInvestments_5bf2bcce-77e9-47e9-aeb3-243f52051af2_terseLabel_en-US" xlink:label="lab_holx_CostMethodEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost-method equity investments</link:label>
    <link:label id="lab_holx_CostMethodEquityInvestments_label_en-US" xlink:label="lab_holx_CostMethodEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Method Equity Investments</link:label>
    <link:label id="lab_holx_CostMethodEquityInvestments_documentation_en-US" xlink:label="lab_holx_CostMethodEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate carrying value of the Company's cost-method investments at the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostMethodEquityInvestments" xlink:href="holx-20210925.xsd#holx_CostMethodEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CostMethodEquityInvestments" xlink:to="lab_holx_CostMethodEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_1a9dd324-0486-49aa-bd16-b6e0e16ca3f6_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_d04a9c03-27dd-4cb5-9e79-f962d8d34d81_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_48e358c4-ee52-4cc5-ad07-b19c5600ae48_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_c9ee2bb5-8665-4fd0-9a55-40b1444d1eb4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan participants&#8217; contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_b0266d5c-4fee-4d5b-9227-f6a71b3327bf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_e32ffc78-668e-47a7-9e3c-198e8d3c089d_terseLabel_en-US" xlink:label="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount with unlimited carry forward periods</link:label>
    <link:label id="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_label_en-US" xlink:label="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss And Tax Credit Carryforwards With Unlimited Expiration Period</link:label>
    <link:label id="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_documentation_en-US" xlink:label="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and tax credit carry forwards with unlimited expiration period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:href="holx-20210925.xsd#holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:to="lab_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentHoldbackMember_a9577a7c-5287-4003-a3fb-e860526e0cf1_terseLabel_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_label_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback [Member]</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_documentation_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember" xlink:href="holx-20210925.xsd#holx_ContingentHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentHoldbackMember" xlink:to="lab_holx_ContingentHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_e1a93e8d-146e-4e68-8ebc-417d22b82899_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_b5850f68-95c9-409d-bf40-bd34ebb4864c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_77dc5180-c92a-4136-a78b-53d83d067958_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods and services sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentConsiderationMember_a369195c-0ed4-4bed-8b9a-84d65febd826_terseLabel_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_label_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration [Member]</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember" xlink:href="holx-20210925.xsd#holx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentConsiderationMember" xlink:to="lab_holx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_cf66f033-954d-4221-8a2d-6a502a45038e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_748fc35f-4dd3-4dcf-97ec-05fa99c1a83f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsForDeferredAcquisitionConsideration_5940d1ad-b9cf-4aa3-904a-02ed2082c795_terseLabel_en-US" xlink:label="lab_holx_PaymentsForDeferredAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Previous Acquisition</link:label>
    <link:label id="lab_holx_PaymentsForDeferredAcquisitionConsideration_label_en-US" xlink:label="lab_holx_PaymentsForDeferredAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Deferred Acquisition Consideration</link:label>
    <link:label id="lab_holx_PaymentsForDeferredAcquisitionConsideration_documentation_en-US" xlink:label="lab_holx_PaymentsForDeferredAcquisitionConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Deferred Acquisition Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsForDeferredAcquisitionConsideration" xlink:href="holx-20210925.xsd#holx_PaymentsForDeferredAcquisitionConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsForDeferredAcquisitionConsideration" xlink:to="lab_holx_PaymentsForDeferredAcquisitionConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a285f170-5aab-49fa-baf5-f55245eacb08_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_1a99a86b-df75-4398-ac8f-85b014340ad2_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, gross</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmendedCreditFacility2018Member_052936f3-200b-41ff-a771-16edff95a54f_terseLabel_en-US" xlink:label="lab_holx_AmendedCreditFacility2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Amended Credit Facility</link:label>
    <link:label id="lab_holx_AmendedCreditFacility2018Member_label_en-US" xlink:label="lab_holx_AmendedCreditFacility2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Facility 2018 [Member]</link:label>
    <link:label id="lab_holx_AmendedCreditFacility2018Member_documentation_en-US" xlink:label="lab_holx_AmendedCreditFacility2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Facility 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedCreditFacility2018Member" xlink:href="holx-20210925.xsd#holx_AmendedCreditFacility2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedCreditFacility2018Member" xlink:to="lab_holx_AmendedCreditFacility2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3441eb70-2027-4a65-84e6-62a9539ca37a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_f9c78c59-6c42-4a58-9f3c-4de86802021b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_e07b7662-4b40-494d-bddc-9a09535fd825_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_6e71c64a-fe1c-4a58-a3c6-af1ed2d4037a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_cc71cd39-5918-49d9-9984-05126d04c718_terseLabel_en-US" xlink:label="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares that may be issued under Employee Stock Purchase Plan</link:label>
    <link:label id="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Shares Issuable Under Employee Stock Purchase Plan</link:label>
    <link:label id="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issuable under employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:href="holx-20210925.xsd#holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:to="lab_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_91fde87d-80f1-469b-838a-b4f8a4c99516_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_97d0b3a7-18c3-41ef-b4cd-105ef28eb84b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Statement Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f36716a6-26e8-4f9f-8eb1-dbc2c9190745_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsUnderFinanceLeaseObligations_cec384e1-e4d7-458e-862a-b4b177a59a2d_terseLabel_en-US" xlink:label="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_holx_PaymentsUnderFinanceLeaseObligations_label_en-US" xlink:label="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_holx_PaymentsUnderFinanceLeaseObligations_documentation_en-US" xlink:label="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsUnderFinanceLeaseObligations" xlink:href="holx-20210925.xsd#holx_PaymentsUnderFinanceLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsUnderFinanceLeaseObligations" xlink:to="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_d0730661-3fbc-4b88-a39f-03fdfe601803_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ab2d22c3-e9cb-450d-8b2a-1a9d2a2afd3c_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_2916fafa-bbf3-4b6b-93ea-c5b583a361e9_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_c42c1b12-613a-4ad9-9d1c-332860ef27e9_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b6b30e69-fc02-4d77-a910-9b5baf7e0fc5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncomeTaxReceivableReclassification_87b8e8d8-e90a-4ac1-8a74-e73b1fb99427_negatedTerseLabel_en-US" xlink:label="lab_holx_IncomeTaxReceivableReclassification" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Receivable Reclassification</link:label>
    <link:label id="lab_holx_IncomeTaxReceivableReclassification_label_en-US" xlink:label="lab_holx_IncomeTaxReceivableReclassification" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Receivable Reclassification</link:label>
    <link:label id="lab_holx_IncomeTaxReceivableReclassification_documentation_en-US" xlink:label="lab_holx_IncomeTaxReceivableReclassification" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Receivable Reclassification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxReceivableReclassification" xlink:href="holx-20210925.xsd#holx_IncomeTaxReceivableReclassification"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncomeTaxReceivableReclassification" xlink:to="lab_holx_IncomeTaxReceivableReclassification" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b839b92f-0eaf-4f51-8f72-a1de10ec0468_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_068bd43f-a442-4953-85b0-d8bd50131a50_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_5bcd84d4-dbb8-4933-b14a-6600d9677ec8_totalLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1e69d591-a6d5-4fae-80c0-8385b0b4a464_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ae627984-f7a4-4c5c-b40a-4af6fde374c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_ccb2ced9-b522-4d59-8028-a624cc10c63e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Benefit Obligations, Plan Assets, Funded Status and Related Actuarial Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_JudicialRulingMember_e17a50f5-cdf0-48b5-b082-fef268ce2778_terseLabel_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling</link:label>
    <link:label id="lab_us-gaap_JudicialRulingMember_label_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_JudicialRulingMember" xlink:to="lab_us-gaap_JudicialRulingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_fbbcd97a-8655-4900-8b6c-6b3c2d7a4bd8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_04223861-ced7-46e0-b8d3-6f40d290628e_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_23280e10-b4c5-4c63-b4f6-2f1be1783c45_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_760372d1-880b-4fda-b030-d21baeee2ebd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FundingOfLoansToSSI_2fe377d3-8f44-46f7-a751-97b3ef4824f5_negatedTerseLabel_en-US" xlink:label="lab_holx_FundingOfLoansToSSI" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans to SSI</link:label>
    <link:label id="lab_holx_FundingOfLoansToSSI_label_en-US" xlink:label="lab_holx_FundingOfLoansToSSI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding Of Loans To SSI</link:label>
    <link:label id="lab_holx_FundingOfLoansToSSI_documentation_en-US" xlink:label="lab_holx_FundingOfLoansToSSI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans to SSI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FundingOfLoansToSSI" xlink:href="holx-20210925.xsd#holx_FundingOfLoansToSSI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FundingOfLoansToSSI" xlink:to="lab_holx_FundingOfLoansToSSI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_39a81c79-97fb-4dc7-914c-d48a813ecf4b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ASRSharesRepurchasedduringtheperiod_4853b90f-71a6-4bff-a295-568a1de38cb8_terseLabel_en-US" xlink:label="lab_holx_ASRSharesRepurchasedduringtheperiod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Shares Repurchased during the period</link:label>
    <link:label id="lab_holx_ASRSharesRepurchasedduringtheperiod_label_en-US" xlink:label="lab_holx_ASRSharesRepurchasedduringtheperiod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Shares Repurchased during the period</link:label>
    <link:label id="lab_holx_ASRSharesRepurchasedduringtheperiod_documentation_en-US" xlink:label="lab_holx_ASRSharesRepurchasedduringtheperiod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Shares Repurchased during the period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRSharesRepurchasedduringtheperiod" xlink:href="holx-20210925.xsd#holx_ASRSharesRepurchasedduringtheperiod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ASRSharesRepurchasedduringtheperiod" xlink:to="lab_holx_ASRSharesRepurchasedduringtheperiod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_d79a6d49-b293-43e4-a707-8979314f2800_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_b75c26bf-090f-4247-8a10-4068d778b691_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_83df1fe1-75c6-4f0a-8c1b-eea1d08fc4fc_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Doubtful Accounts Receivable [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_1af0a3fe-5fbc-41d6-b0d7-636c6902548e_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OneCustomerMember_b860b316-113f-4410-b112-f1aaed5a8e33_terseLabel_en-US" xlink:label="lab_holx_OneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Customer</link:label>
    <link:label id="lab_holx_OneCustomerMember_label_en-US" xlink:label="lab_holx_OneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Customer [Member]</link:label>
    <link:label id="lab_holx_OneCustomerMember_documentation_en-US" xlink:label="lab_holx_OneCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OneCustomerMember" xlink:href="holx-20210925.xsd#holx_OneCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OneCustomerMember" xlink:to="lab_holx_OneCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_ccc2db04-9239-4629-ad63-54a976442fa2_terseLabel_en-US" xlink:label="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum range of present value of cash flow (percent)</link:label>
    <link:label id="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_label_en-US" xlink:label="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Range of Present Value of Cash Flow Percentage</link:label>
    <link:label id="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_documentation_en-US" xlink:label="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Range of Present Value of Cash Flow Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:href="holx-20210925.xsd#holx_MaximumRangeofPresentValueofCashFlowPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:to="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e1c5d67d-a44f-45f0-9d42-c924e39dcd91_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a4ccb913-94e3-4e3a-943c-4d89dc5aa1d8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_d33b9ddc-e340-4306-b443-14d8ff34a8f6_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_a89b2105-e58d-4b62-acb7-da737a60f6a5_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in unrecognized tax benefits is reasonably possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_6670d2b0-37a4-4141-8022-d11006a67e4f_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of redemption price, fourth period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fourth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fourth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_75441c3a-9d3d-4a90-bfda-1a01146711c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_9971e891-b284-4ee5-bd61-4839ddefe460_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments under accounts receivable securitization agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Accounts Receivable Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:to="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_7c0405a1-3e37-48ed-a74b-6eca10628542_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_732c7048-f9da-4bbf-bd4b-ba76875a0cf6_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_34067885-ffc9-4940-b943-f7ae968b2e4a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_93f75c6b-657e-4388-a488-b6db26aeb85b_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_76438db5-4d75-43eb-bf6b-dd9779e2331b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmountpaidduringtheperiodunderASRAgreement_8041ffa0-804f-4609-b0a7-97d061602a93_terseLabel_en-US" xlink:label="lab_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount paid during the period under ASR Agreement</link:label>
    <link:label id="lab_holx_AmountpaidduringtheperiodunderASRAgreement_label_en-US" xlink:label="lab_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount paid during the period under ASR Agreement</link:label>
    <link:label id="lab_holx_AmountpaidduringtheperiodunderASRAgreement_documentation_en-US" xlink:label="lab_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount paid during the period under ASR Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:href="holx-20210925.xsd#holx_AmountpaidduringtheperiodunderASRAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:to="lab_holx_AmountpaidduringtheperiodunderASRAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e3a016b6-edf5-4a73-a9da-dc605c2932c5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c4916c94-059c-458c-a651-081d336a68da_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_52f4af43-48ad-4165-bd0c-3cb3be1a5c2c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_11e87f95-5d42-47c3-8102-6b1dcace9ccc_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_59a53476-416e-4d98-9d04-86b344e9af48_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other temporary differences</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_77ff3181-b86a-4643-9512-cb99661b7aa3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal restructuring</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TepnelMember_0f2ca211-9302-4f59-9811-caff4aef6799_terseLabel_en-US" xlink:label="lab_holx_TepnelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tepnel [Member]</link:label>
    <link:label id="lab_holx_TepnelMember_label_en-US" xlink:label="lab_holx_TepnelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tepnel [Member]</link:label>
    <link:label id="lab_holx_TepnelMember_documentation_en-US" xlink:label="lab_holx_TepnelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tepnel</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TepnelMember" xlink:href="holx-20210925.xsd#holx_TepnelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TepnelMember" xlink:to="lab_holx_TepnelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_9ebf8e34-3240-40a1-9b3b-7063296618c3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest accrued on unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesMember_d48383d4-3b70-4312-a41b-a695e76296cb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesMember_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesMember" xlink:to="lab_us-gaap_RestructuringChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_a4d8c826-a481-4757-8222-7bc093d4a4ef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c6b762ed-8991-47f1-9730-47334099a8da_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a7b63c39-fbd5-44bf-b8f8-68af701bc737_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_09b4c31a-927e-40f0-af98-4658eb8b46cc_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_c74bbbbf-c14c-4ea3-8000-e6d8b28ecd0d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2020ActionMember_2f7ad106-c999-4417-8e15-39881527cb8d_terseLabel_en-US" xlink:label="lab_holx_Fiscal2020ActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 Actions</link:label>
    <link:label id="lab_holx_Fiscal2020ActionMember_label_en-US" xlink:label="lab_holx_Fiscal2020ActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 Action [Member]</link:label>
    <link:label id="lab_holx_Fiscal2020ActionMember_documentation_en-US" xlink:label="lab_holx_Fiscal2020ActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2020 Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember" xlink:href="holx-20210925.xsd#holx_Fiscal2020ActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2020ActionMember" xlink:to="lab_holx_Fiscal2020ActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ChangeInParValue_29fdde72-7168-4803-beff-5ec7dd9c374b_terseLabel_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:label id="lab_holx_ChangeInParValue_label_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:label id="lab_holx_ChangeInParValue_documentation_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue" xlink:href="holx-20210925.xsd#holx_ChangeInParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ChangeInParValue" xlink:to="lab_holx_ChangeInParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_fd5fc71a-8e4c-4089-980c-78e4bea9240e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs&#160;(Level&#160;2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_267fb6b2-be8d-41ca-8461-86e8e55721b8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales price</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_94b4bda3-52cb-4889-affc-b5312505cca5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_4d380611-31e9-42ce-8051-adf6bbfc14d6_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_c18446be-c9c3-46f8-bfb7-374d8ed20ba6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign:</link:label>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_c5b87d15-9266-4e9d-a969-f4ebaab97b22_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Dec92020Member_331dcd95-a93c-4ce9-ad0b-2ade056337c5_terseLabel_en-US" xlink:label="lab_holx_Dec92020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dec 9, 2020</link:label>
    <link:label id="lab_holx_Dec92020Member_label_en-US" xlink:label="lab_holx_Dec92020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dec 9, 2020 [Member]</link:label>
    <link:label id="lab_holx_Dec92020Member_documentation_en-US" xlink:label="lab_holx_Dec92020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dec 9, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Dec92020Member" xlink:href="holx-20210925.xsd#holx_Dec92020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Dec92020Member" xlink:to="lab_holx_Dec92020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_15647beb-1f51-4637-87b2-d2858a52077e_terseLabel_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cliff vesting period from grant date</link:label>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_label_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date</link:label>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_documentation_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:href="holx-20210925.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:to="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_fba5bdb1-97b8-441f-b9f4-7ef696fc57bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at September 25, 2021 (1)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Impairmentofintangibleassetsandequipment_8c8025da-120d-43ec-8f7f-65f35b08ecd1_terseLabel_en-US" xlink:label="lab_holx_Impairmentofintangibleassetsandequipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_holx_Impairmentofintangibleassetsandequipment_label_en-US" xlink:label="lab_holx_Impairmentofintangibleassetsandequipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_holx_Impairmentofintangibleassetsandequipment_documentation_en-US" xlink:label="lab_holx_Impairmentofintangibleassetsandequipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Impairmentofintangibleassetsandequipment" xlink:href="holx-20210925.xsd#holx_Impairmentofintangibleassetsandequipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Impairmentofintangibleassetsandequipment" xlink:to="lab_holx_Impairmentofintangibleassetsandequipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_33a7d4c2-90d1-4336-a97c-6c8fa6cc1800_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_03eb5eed-6538-4a3f-9527-4cd5a71d4e8a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_eb15fb1f-0aa6-4b44-a902-3187266ef070_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_404b7424-52fc-4fed-8be9-424b69f378d5_totalLabel_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign, Total</link:label>
    <link:label id="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0cf14108-04bc-46f2-b816-38307c123d5b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_95d21ce4-153d-4614-86ea-3e3a2423040c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9cb5ce12-d5cc-4939-8ffb-38f7afc542f8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_a48aa072-7389-461e-ad21-baba7c5b775f_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_a21837a2-b949-4c2b-b5d4-a3a89071dbff_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b770686e-dc28-40c8-a1f8-73e8c77010f8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_2be58ec1-e580-4d35-8ef3-0b7855c36aa9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disposed Business, Income from Operations and Assets held-for-sale</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_00f37628-df8b-491c-bcca-4f9bb1edb168_terseLabel_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value (in millions)</link:label>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:href="holx-20210925.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="lab_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagenodeMember_99359836-4d8a-4084-ae25-e06e5ba9323b_terseLabel_en-US" xlink:label="lab_holx_DiagenodeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagenode</link:label>
    <link:label id="lab_holx_DiagenodeMember_label_en-US" xlink:label="lab_holx_DiagenodeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagenode [Member]</link:label>
    <link:label id="lab_holx_DiagenodeMember_documentation_en-US" xlink:label="lab_holx_DiagenodeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagenode</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagenodeMember" xlink:to="lab_holx_DiagenodeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_7a727c59-4511-49a8-aa8f-68bc79e2a513_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_b20f3284-4b95-46d2-bbf3-25d6c77b2561_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_acf6924f-d664-4e4a-a03a-13be3c3edda5_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3d000c11-74ab-4e61-a995-c07c379f2d19_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from product and services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_6e155c8e-1c56-456a-849f-91430e6d98b4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax reform</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2021ChargesMember_6ff85354-e7bb-4ea9-9a8d-c7b658650cfd_terseLabel_en-US" xlink:label="lab_holx_Fiscal2021ChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2021 restructuring charges</link:label>
    <link:label id="lab_holx_Fiscal2021ChargesMember_label_en-US" xlink:label="lab_holx_Fiscal2021ChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2021 charges [Member]</link:label>
    <link:label id="lab_holx_Fiscal2021ChargesMember_documentation_en-US" xlink:label="lab_holx_Fiscal2021ChargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2021 charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ChargesMember" xlink:href="holx-20210925.xsd#holx_Fiscal2021ChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2021ChargesMember" xlink:to="lab_holx_Fiscal2021ChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7f1bc4f3-1a06-403e-bc2d-fea8ff25e72d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_08562b1e-1393-4dbe-b477-530fe56241fb_terseLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to changes in unrecognized tax benefits recorded in the statement of operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:to="lab_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_5f2e7ce4-269c-4cc8-b876-6ce090afc971_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_53fc5b1d-b3c7-4ae9-9152-49f355a88b9d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 25, 2021</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_27f0a5a8-f46e-4e02-908e-cabf105017ee_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit related to stock based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_5ac1c172-81d6-45e7-9530-839583ca8987_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Reserve Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable_553c8518-263c-4954-8f09-48ff4fea9d8e_terseLabel_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Table]</link:label>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Table]</link:label>
    <link:label id="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable_documentation_en-US" xlink:label="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information For Property Plant And Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:href="holx-20210925.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:to="lab_holx_GeographicInformationForPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b1c6f6a8-fd0a-4551-b230-e02e15fdf4cc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2019ActionMember_35a61b76-abcd-4e2a-8f19-33391f4ef375_verboseLabel_en-US" xlink:label="lab_holx_Fiscal2019ActionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 Actions</link:label>
    <link:label id="lab_holx_Fiscal2019ActionMember_415cb69c-636b-4a3c-a58a-d136d9431433_terseLabel_en-US" xlink:label="lab_holx_Fiscal2019ActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 Actions</link:label>
    <link:label id="lab_holx_Fiscal2019ActionMember_label_en-US" xlink:label="lab_holx_Fiscal2019ActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 Action [Member]</link:label>
    <link:label id="lab_holx_Fiscal2019ActionMember_documentation_en-US" xlink:label="lab_holx_Fiscal2019ActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 Action [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember" xlink:href="holx-20210925.xsd#holx_Fiscal2019ActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2019ActionMember" xlink:to="lab_holx_Fiscal2019ActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_bd992169-0c47-48c9-a75d-ed5ee64f4e72_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_bb65710c-0b4a-4c3b-bece-d7f7652818c4_terseLabel_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_documentation_en-US" xlink:label="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:to="lab_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlanEmployerContributionCostAbstract_6de47f78-40d5-45fd-9c81-60a9f7b90c67_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlanEmployerContributionCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Employer Contribution, Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlanEmployerContributionCostAbstract_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlanEmployerContributionCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Employer Contribution, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanEmployerContributionCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanEmployerContributionCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlanEmployerContributionCostAbstract" xlink:to="lab_us-gaap_MultiemployerPlanEmployerContributionCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EurocurrencyRateMember_5239d09c-124e-4724-b66a-3828a3a2ae50_terseLabel_en-US" xlink:label="lab_holx_EurocurrencyRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurocurrency Rate</link:label>
    <link:label id="lab_holx_EurocurrencyRateMember_label_en-US" xlink:label="lab_holx_EurocurrencyRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurocurrency Rate [Member]</link:label>
    <link:label id="lab_holx_EurocurrencyRateMember_documentation_en-US" xlink:label="lab_holx_EurocurrencyRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurocurrency Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EurocurrencyRateMember" xlink:href="holx-20210925.xsd#holx_EurocurrencyRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EurocurrencyRateMember" xlink:to="lab_holx_EurocurrencyRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_74d7022a-2111-444d-8488-2786ae260510_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NetOperatingLossCarryforwardsMember_bec6b3b5-c444-4e65-8f8a-0a73056c1dcc_terseLabel_en-US" xlink:label="lab_holx_NetOperatingLossCarryforwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Losses Carryforwards</link:label>
    <link:label id="lab_holx_NetOperatingLossCarryforwardsMember_label_en-US" xlink:label="lab_holx_NetOperatingLossCarryforwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryforwards [Member]</link:label>
    <link:label id="lab_holx_NetOperatingLossCarryforwardsMember_documentation_en-US" xlink:label="lab_holx_NetOperatingLossCarryforwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Operating Loss Carryforwards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossCarryforwardsMember" xlink:href="holx-20210925.xsd#holx_NetOperatingLossCarryforwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NetOperatingLossCarryforwardsMember" xlink:to="lab_holx_NetOperatingLossCarryforwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_f72d4027-2f43-40fc-af60-c7425fb2f904_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net acquired tangible assets and liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_39ab3abb-e804-44e7-b821-456e293facf2_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_812e8395-0e07-40bc-b0d3-7835b5dbbc09_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_46a22152-4848-40a8-8afd-99e67e783f88_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_8e06ca94-3f3f-4201-a17b-bd4720dc657b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn5years_e16dbdd4-30c8-420c-a2e0-a9bf18d57a37_terseLabel_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn5years" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 5years</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn5years_label_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn5years" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 5years</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn5years_documentation_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn5years" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 5years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueIn5years" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueIn5years"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SubLeaseRentalIncomeDueIn5years" xlink:to="lab_holx_SubLeaseRentalIncomeDueIn5years" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TaxPositionsRelatedToCurrentYearAbstract_d21959a1-daa1-45c9-8791-bb4154f637b4_terseLabel_en-US" xlink:label="lab_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax positions related to current year:</link:label>
    <link:label id="lab_holx_TaxPositionsRelatedToCurrentYearAbstract_label_en-US" xlink:label="lab_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Positions Related To Current Year [Abstract]</link:label>
    <link:label id="lab_holx_TaxPositionsRelatedToCurrentYearAbstract_documentation_en-US" xlink:label="lab_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax positions related to current year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:href="holx-20210925.xsd#holx_TaxPositionsRelatedToCurrentYearAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:to="lab_holx_TaxPositionsRelatedToCurrentYearAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616_df615302-7c88-4afc-925b-9ef964331ee1_terseLabel_en-US" xlink:label="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to income tax expense adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616_label_en-US" xlink:label="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to income tax expense adoption of ASU 2016-16</link:label>
    <link:label id="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616_documentation_en-US" xlink:label="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to income tax expense adoption of ASU 2016-16</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:href="holx-20210925.xsd#holx_IncreasetoincometaxexpenseadoptionofASU201616"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:to="lab_holx_IncreasetoincometaxexpenseadoptionofASU201616" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_65f7feac-8406-4eee-97c5-14bfdaf04b52_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_638dd2ec-d375-45e2-a741-34c2d44da20e_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_f08aecc5-3e4b-40e2-82db-dfc434b55a26_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_30699ed0-9d81-410d-9efd-c3877d8300fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_555e9c1b-2269-47ba-8ae2-a25cdb948b47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_9bf9f76c-f983-416a-b8dd-78f1a1af5651_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_81667972-f4d0-4e74-a16d-b753b73f9bde_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_138765a9-9099-47fe-a008-f30f7d8a561a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_0be7a7f6-c6d2-495e-9f0c-87a5d20914e2_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_460adec6-2a08-4fef-8dcf-8c0278cc6069_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6780d9c4-ae90-43b6-8b72-68712c92992e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_43910363-9346-41bc-8992-98ebd383b35d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_85cada22-283c-4904-ad94-9d114470a427_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_9468d1b8-e369-41ee-b3f1-909f51e41aaa_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lapses in statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_b962f80e-d4c3-4468-bc98-c5c080ec2e82_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_29d72794-3ef4-4dfb-b457-b3513b629f8d_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_a865c86d-98d0-4ef4-8f20-25ddfaac319b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired tangible assets and liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember_f5cfc803-486d-4b02-b1e8-81afb667584e_terseLabel_en-US" xlink:label="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Semi Annual Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Semi Annual Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:href="holx-20210925.xsd#holx_SemiAnnualEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:to="lab_holx_SemiAnnualEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_aee700f5-d34d-4830-b1be-ea984b3f5383_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IndemnificationLiabily_2d7c0758-8927-4b61-bafe-13e83215f881_terseLabel_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:label id="lab_holx_IndemnificationLiabily_label_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:label id="lab_holx_IndemnificationLiabily_documentation_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily" xlink:href="holx-20210925.xsd#holx_IndemnificationLiabily"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IndemnificationLiabily" xlink:to="lab_holx_IndemnificationLiabily" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Expensesfromdisposition_eb49352e-31c9-4bb9-86bf-0d34ea5f7b5b_terseLabel_en-US" xlink:label="lab_holx_Expensesfromdisposition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from disposition</link:label>
    <link:label id="lab_holx_Expensesfromdisposition_label_en-US" xlink:label="lab_holx_Expensesfromdisposition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from disposition</link:label>
    <link:label id="lab_holx_Expensesfromdisposition_documentation_en-US" xlink:label="lab_holx_Expensesfromdisposition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from disposition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Expensesfromdisposition" xlink:href="holx-20210925.xsd#holx_Expensesfromdisposition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Expensesfromdisposition" xlink:to="lab_holx_Expensesfromdisposition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_814dddd8-1f12-48e8-a44c-faadc87cd15b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. tax on foreign earnings</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6d062518-7f66-4c52-a8e3-5e85bbe42876_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_034ac5f4-1eb4-4938-be34-85112dc40829_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_64ff2aaa-114b-4821-80f5-898af2133351_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_7573c848-6193-4642-a983-05533fa77ed5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments and non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_000c87c7-1d10-4f82-9873-45a6b1a21b61_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions related to change in estimate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_ec160d3e-e340-4685-b6e7-9991ce1919c6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9dad9ae9-3a42-4dd5-8692-44d16777c122_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_30dd9ff7-9859-414a-b210-c083e12f9a5b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_529dcd8d-ee30-4645-bd28-452017f81ba8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Pension Benefit</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_91f93e0e-5681-4b6f-9057-93663e4360b7_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_de7c3ba2-1812-4e5a-a5ba-c418f6bc28a6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_6d3271e2-4866-42ed-8ecf-55fb5136460d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_059b17e1-f9ab-4e41-8258-ef8ea356931a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3ab9d7ae-d7bd-4bc0-98fa-1049c96ed852_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_76ae2502-cb78-4b68-ab33-920d88812b26_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_fba92f54-a708-4b8f-b916-5bc59c08b6cb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ed388362-be4c-44a1-96fc-01b2bfc5abe5_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity and Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d0031d04-f607-4624-9551-bb7cdf9142c9_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Hologic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9481a8f8-2893-43a4-bcd5-296ab51656d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_09d1c737-447a-41fa-bc29-5a0547a6b230_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_75bb43a9-6da1-4a6d-8da3-80c3bed5f7d0_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_d5ee44ae-7378-4452-87d5-f6deda64987c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_c06af32b-4ae7-4073-98cb-3ea7682456f4_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_b54066ef-2a7b-4798-9ce6-ccb5e5900a18_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_8f0fc01f-2599-4d1f-b7dd-d844a4d5605f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost_1b3c76a5-4de6-46cd-ae63-993fefeca46c_terseLabel_en-US" xlink:label="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost_label_en-US" xlink:label="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost, Interest cost</link:label>
    <link:label id="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost_documentation_en-US" xlink:label="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost, Interest cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:href="holx-20210925.xsd#holx_ComponentsofNetPeriodicBenefitCostInterestcost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:to="lab_holx_ComponentsofNetPeriodicBenefitCostInterestcost" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EmployerContributionsVestingPeriod_ca64e63c-e7c9-4606-8b14-d89afd5522c4_terseLabel_en-US" xlink:label="lab_holx_EmployerContributionsVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions, vesting period, years</link:label>
    <link:label id="lab_holx_EmployerContributionsVestingPeriod_label_en-US" xlink:label="lab_holx_EmployerContributionsVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer Contributions Vesting Period</link:label>
    <link:label id="lab_holx_EmployerContributionsVestingPeriod_documentation_en-US" xlink:label="lab_holx_EmployerContributionsVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The vesting period for discretionary employer contributions, which vest ratably on an annual basis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsVestingPeriod" xlink:href="holx-20210925.xsd#holx_EmployerContributionsVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmployerContributionsVestingPeriod" xlink:to="lab_holx_EmployerContributionsVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_957ea355-196b-495c-a3c4-17b279b1eb85_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_b48295e8-1cba-4451-8767-e142698a336b_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_3f45cf74-28dc-408b-9b21-102323f39d1c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsAbstract_93addfb4-337d-4ae0-b469-860f532f220f_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsAbstract" xlink:to="lab_us-gaap_CompensationRelatedCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NXCImagingMember_ec3b81d8-cb3e-433a-865e-72b7d803c86a_terseLabel_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging</link:label>
    <link:label id="lab_holx_NXCImagingMember_label_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging [Member]</link:label>
    <link:label id="lab_holx_NXCImagingMember_documentation_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember" xlink:href="holx-20210925.xsd#holx_NXCImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NXCImagingMember" xlink:to="lab_holx_NXCImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_099f4dd7-27ae-4224-baae-94015f167cdf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7dca6fca-ad50-4029-aff4-e80f394c99e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_01348814-e14b-428c-9fa5-da145639168b_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_c0de8d23-ba37-45dd-a475-d2d5e4e3a649_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed&#160;technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5f93a52c-021c-43e4-bba5-ce5a99726b79_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of&#160;Shares (in millions)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a85095b5-3c2d-40ee-866a-7665633bf677_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_0fedd2a5-d9d6-4e7c-9d70-fc4ad8a3f38d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeverageRatioMaximum_95e89b2d-cfde-4fe3-ad4c-aa8567dc795f_terseLabel_en-US" xlink:label="lab_holx_LeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio maximum</link:label>
    <link:label id="lab_holx_LeverageRatioMaximum_label_en-US" xlink:label="lab_holx_LeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Maximum</link:label>
    <link:label id="lab_holx_LeverageRatioMaximum_documentation_en-US" xlink:label="lab_holx_LeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeverageRatioMaximum" xlink:href="holx-20210925.xsd#holx_LeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeverageRatioMaximum" xlink:to="lab_holx_LeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_80656e93-3828-450c-9beb-fbed762b29bd_terseLabel_en-US" xlink:label="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Long-Term Liabilities</link:label>
    <link:label id="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_label_en-US" xlink:label="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Long Term Liabilities [Text Block]</link:label>
    <link:label id="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_documentation_en-US" xlink:label="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses And Other Long-Term Liabilities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:href="holx-20210925.xsd#holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:to="lab_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_5cba9d84-2c7b-44bb-b205-04cf3f2a56cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in pension plans, net of taxes of $0.2 in 2021, $0.1 in 2020, and $0.3 in 2019</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_d416e2ec-d8fd-4b18-8449-94f5b6379902_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_85bf4642-f221-4f11-a314-64b7e7f0b37a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_9ccb11c1-945a-40c3-8222-c515d56b255c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_d69152e0-b91a-4ac4-b616-37227d20e639_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_2d2dc8ca-2c81-4df2-b446-a24adae0e14f_terseLabel_en-US" xlink:label="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension in Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension in Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_documentation_en-US" xlink:label="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension in Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:href="holx-20210925.xsd#holx_PensioninAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_holx_PensioninAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_e466cf34-601c-4c9c-9ba4-9c80df1a6888_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_c6b766fd-8d30-4d7e-8b79-2eb3f664f277_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in tax resulting from:</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_f8fbd052-565d-4387-b56d-85c354e89d26_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_1b0691c7-8fe0-4bb8-97f7-60e044af49b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FacilityClosureCosts_be9cbc2f-6e5b-46f2-b1ed-45460783becc_terseLabel_en-US" xlink:label="lab_holx_FacilityClosureCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility closure costs</link:label>
    <link:label id="lab_holx_FacilityClosureCosts_label_en-US" xlink:label="lab_holx_FacilityClosureCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closure Costs</link:label>
    <link:label id="lab_holx_FacilityClosureCosts_documentation_en-US" xlink:label="lab_holx_FacilityClosureCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts" xlink:href="holx-20210925.xsd#holx_FacilityClosureCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FacilityClosureCosts" xlink:to="lab_holx_FacilityClosureCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountingStandardTransitionAdjustmentASU842_22da7a09-7bd7-4ef0-a9df-dd47483feb71_terseLabel_en-US" xlink:label="lab_holx_AccountingStandardTransitionAdjustmentASU842" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASC 842</link:label>
    <link:label id="lab_holx_AccountingStandardTransitionAdjustmentASU842_label_en-US" xlink:label="lab_holx_AccountingStandardTransitionAdjustmentASU842" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASU 842</link:label>
    <link:label id="lab_holx_AccountingStandardTransitionAdjustmentASU842_documentation_en-US" xlink:label="lab_holx_AccountingStandardTransitionAdjustmentASU842" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting standard transition adjustment - ASU 842</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingStandardTransitionAdjustmentASU842" xlink:href="holx-20210925.xsd#holx_AccountingStandardTransitionAdjustmentASU842"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountingStandardTransitionAdjustmentASU842" xlink:to="lab_holx_AccountingStandardTransitionAdjustmentASU842" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_43c4d5bc-b354-4698-9082-1e14541be225_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_2adec38e-f1b5-4f9c-bc95-3fc393882f3b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Fiscal2019chargesMember_f4461642-e33a-4f10-a5f7-5d3bd97221fb_terseLabel_en-US" xlink:label="lab_holx_Fiscal2019chargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 restructuring charges</link:label>
    <link:label id="lab_holx_Fiscal2019chargesMember_label_en-US" xlink:label="lab_holx_Fiscal2019chargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 charges [Member]</link:label>
    <link:label id="lab_holx_Fiscal2019chargesMember_documentation_en-US" xlink:label="lab_holx_Fiscal2019chargesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2019 charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember" xlink:href="holx-20210925.xsd#holx_Fiscal2019chargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2019chargesMember" xlink:to="lab_holx_Fiscal2019chargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c03ed116-e112-47c0-9ee7-294e22f9b867_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TaxCreditCarryforwardMember_4ad1fdbf-a1e9-42cd-81e2-2c91b6ab1554_terseLabel_en-US" xlink:label="lab_holx_TaxCreditCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward</link:label>
    <link:label id="lab_holx_TaxCreditCarryforwardMember_label_en-US" xlink:label="lab_holx_TaxCreditCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Member]</link:label>
    <link:label id="lab_holx_TaxCreditCarryforwardMember_documentation_en-US" xlink:label="lab_holx_TaxCreditCarryforwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxCreditCarryforwardMember" xlink:href="holx-20210925.xsd#holx_TaxCreditCarryforwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxCreditCarryforwardMember" xlink:to="lab_holx_TaxCreditCarryforwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e5ad5609-9177-4585-9b94-6c2133d2574a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RevolverMember_854e873c-c043-4eea-883f-17b35e7cc103_terseLabel_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver</link:label>
    <link:label id="lab_holx_RevolverMember_label_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:label id="lab_holx_RevolverMember_documentation_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember" xlink:href="holx-20210925.xsd#holx_RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevolverMember" xlink:to="lab_holx_RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_6b4cdba7-82ee-4fc1-9117-f82900b6fb22_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RemainingLeaseBalance_43772b75-0069-4aee-80bc-556873df9453_terseLabel_en-US" xlink:label="lab_holx_RemainingLeaseBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease balance</link:label>
    <link:label id="lab_holx_RemainingLeaseBalance_label_en-US" xlink:label="lab_holx_RemainingLeaseBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease balance</link:label>
    <link:label id="lab_holx_RemainingLeaseBalance_documentation_en-US" xlink:label="lab_holx_RemainingLeaseBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RemainingLeaseBalance" xlink:href="holx-20210925.xsd#holx_RemainingLeaseBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RemainingLeaseBalance" xlink:to="lab_holx_RemainingLeaseBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5a85b930-6058-4c69-80e5-fc2e6a26403b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GoodwillNotAtRiskOfFailingImpairment_e626f83d-dc40-42b2-a3f4-2f9b63e86926_terseLabel_en-US" xlink:label="lab_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill not at risk of failing impairment</link:label>
    <link:label id="lab_holx_GoodwillNotAtRiskOfFailingImpairment_label_en-US" xlink:label="lab_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill not at risk of failing impairment</link:label>
    <link:label id="lab_holx_GoodwillNotAtRiskOfFailingImpairment_documentation_en-US" xlink:label="lab_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill not at risk of failing impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:href="holx-20210925.xsd#holx_GoodwillNotAtRiskOfFailingImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:to="lab_holx_GoodwillNotAtRiskOfFailingImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_51209fa0-066e-454b-beb5-f236549d5a74_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged&#160;to Costs and Expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_d1bec2f3-a17b-4047-aa38-78624d87854f_terseLabel_en-US" xlink:label="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers with balance greater than specified percentage</link:label>
    <link:label id="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_label_en-US" xlink:label="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Customers With Balance Greater Than Specified Percentage</link:label>
    <link:label id="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_documentation_en-US" xlink:label="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of customers with balance greater than specified percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:href="holx-20210925.xsd#holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:to="lab_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_03c01fcc-aacd-42c7-a40a-a672fdaebcc4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less - accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_52b1a385-91fc-4047-b902-bd9be45c81ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at September 25, 2021 (1)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_35ce8232-2ae1-4c88-8c9f-1d99628a86f2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_bc4e26dd-c127-4548-b8f0-70b18d1aeec7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherAssetsPolicyPolicyTextBlock_fb498e18-2590-4f24-9c76-67f7acfd5793_terseLabel_en-US" xlink:label="lab_holx_OtherAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_holx_OtherAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_holx_OtherAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Policy [Policy Text Block]</link:label>
    <link:label id="lab_holx_OtherAssetsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_holx_OtherAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets Policy [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherAssetsPolicyPolicyTextBlock" xlink:href="holx-20210925.xsd#holx_OtherAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherAssetsPolicyPolicyTextBlock" xlink:to="lab_holx_OtherAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareRepurchseAuthorizationDateAxis_3a4f23d2-7cf5-4ef8-9170-59330d95f221_terseLabel_en-US" xlink:label="lab_holx_ShareRepurchseAuthorizationDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchse Authorization Date [Axis]</link:label>
    <link:label id="lab_holx_ShareRepurchseAuthorizationDateAxis_label_en-US" xlink:label="lab_holx_ShareRepurchseAuthorizationDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchse Authorization Date [Axis]</link:label>
    <link:label id="lab_holx_ShareRepurchseAuthorizationDateAxis_documentation_en-US" xlink:label="lab_holx_ShareRepurchseAuthorizationDateAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Authorization Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchseAuthorizationDateAxis" xlink:href="holx-20210925.xsd#holx_ShareRepurchseAuthorizationDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis" xlink:to="lab_holx_ShareRepurchseAuthorizationDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11b1bcad-4e94-4186-994f-58bf973dbb58_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_86bb2576-1ecd-4988-80ac-9fcdf68f10f9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_95336004-cd72-47ac-bb42-906d2890657a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5be635f9-a629-43a8-8cf7-939ac7909d8d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rates</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_ebf7f92c-7376-4ecc-8bd2-04ecb33cdde2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_31ec6211-147a-44ab-80be-ff45d385e428_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_5c28c51f-9c1b-4b66-80fa-e2df5270efb7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_fdc819ed-dfaa-41e4-9e1a-7d80608594e3_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7c080f5f-e09c-4251-9884-a4d77e28f9fd_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DivestitureCharges_b2925196-6e19-4253-8282-3d6360c64205_terseLabel_en-US" xlink:label="lab_holx_DivestitureCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture charges</link:label>
    <link:label id="lab_holx_DivestitureCharges_label_en-US" xlink:label="lab_holx_DivestitureCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture charges</link:label>
    <link:label id="lab_holx_DivestitureCharges_documentation_en-US" xlink:label="lab_holx_DivestitureCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges" xlink:href="holx-20210925.xsd#holx_DivestitureCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DivestitureCharges" xlink:to="lab_holx_DivestitureCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_32ce98f5-c251-49dd-9ad6-942b3f821434_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_53753469-5592-4405-a379-3b994f0d1d12_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_fb5655f3-2740-41d3-ad98-bc923ad02c38_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets arising from entering into new operating lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_8c4ed2a2-5302-4473-8ea7-4a3c26b22d69_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_af302e21-4e26-47a7-b798-bb68567c12d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_749d104c-08cc-43f9-ab8f-26de18166b57_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_b2ae6774-2040-415f-885a-646879ffa2a6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9759e7b2-236c-442f-951c-1938bca7ff8c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_66daa031-b140-461c-83f8-73ac31efafe1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c5f7596f-2884-4078-b587-86bd00a29fcb_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_e9f465cb-d594-41dd-b158-eff7684e8783_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_25ead628-6c6d-4bcd-99ca-58a43a640c3d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Term Debt By Maturity Table</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_27991c94-cc35-4958-9f54-8268d24276ec_negatedLabel_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation&#160;and amortization</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_label_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Depreciation And Amortization</link:label>
    <link:label id="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount as of the balance sheet date of the estimated future tax effects attributable to amortization of intangible assets, and to a lesser extent, depreciation of property and equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:href="holx-20210925.xsd#holx_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_holx_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_67d96709-265a-4ea2-a4b3-637c36c3dbbe_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities (current)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e0ae9092-b564-4824-8917-e48749e3f09c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_f2eb5aba-1be6-4b9d-9704-28b44251408c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_95ac7719-b596-429c-a354-7469f44a9ba4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn3Years_68baf674-b1d0-4bb0-a228-08843245e39b_terseLabel_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn3Years" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 3 years</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn3Years_label_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn3Years" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 3 years</link:label>
    <link:label id="lab_holx_SubLeaseRentalIncomeDueIn3Years_documentation_en-US" xlink:label="lab_holx_SubLeaseRentalIncomeDueIn3Years" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sub lease rental income due in 3 years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueIn3Years" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueIn3Years"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SubLeaseRentalIncomeDueIn3Years" xlink:to="lab_holx_SubLeaseRentalIncomeDueIn3Years" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_a371cf8c-b30c-4f31-a67d-0835571f6c46_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LitigationAndOtherMattersTextBlock_853e5e6e-d8ab-4aee-891d-fc2784439b2b_terseLabel_en-US" xlink:label="lab_holx_LitigationAndOtherMattersTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and Related Matters</link:label>
    <link:label id="lab_holx_LitigationAndOtherMattersTextBlock_label_en-US" xlink:label="lab_holx_LitigationAndOtherMattersTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation And Other Matters [Text Block]</link:label>
    <link:label id="lab_holx_LitigationAndOtherMattersTextBlock_documentation_en-US" xlink:label="lab_holx_LitigationAndOtherMattersTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation And Other Matters [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LitigationAndOtherMattersTextBlock" xlink:href="holx-20210925.xsd#holx_LitigationAndOtherMattersTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LitigationAndOtherMattersTextBlock" xlink:to="lab_holx_LitigationAndOtherMattersTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_79b90fbd-ff84-4a50-a7f6-e7ae1f745219_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of option exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_89cb1060-68da-4bd8-a169-ef92183c6888_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_e73c87d5-7d22-4d14-86d4-20a838d0388c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableReserveDivested_2ac96eae-78f3-4413-ba5c-540f1b89cdaa_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableReserveDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable reserve divested</link:label>
    <link:label id="lab_holx_AccountsReceivableReserveDivested_label_en-US" xlink:label="lab_holx_AccountsReceivableReserveDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable reserve divested</link:label>
    <link:label id="lab_holx_AccountsReceivableReserveDivested_documentation_en-US" xlink:label="lab_holx_AccountsReceivableReserveDivested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable reserve divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableReserveDivested" xlink:href="holx-20210925.xsd#holx_AccountsReceivableReserveDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableReserveDivested" xlink:to="lab_holx_AccountsReceivableReserveDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_9d7148c9-2cc8-4b37-b97f-284fdba2f61f_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9b5d96b6-85df-4db4-8189-5acc48da43bf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3775efce-1ab1-4258-9b0f-983e684cf4e3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_abe08c74-81e9-4535-8303-7297943231a1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseBorrowings" xlink:to="lab_us-gaap_InterestExpenseBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c3cd7ed1-4a07-4475-9c6a-4439e7d9be80_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax_9ff65d6a-e75d-49ce-b2bb-a261e4a7217e_negatedTerseLabel_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax_label_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclass Adj. from AOCI on Derivatives, Net of Tax</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax_documentation_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclass Adj. from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" xlink:href="holx-20210925.xsd#holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" xlink:to="lab_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d45f0679-ad32-4621-8cc1-4bc2c6f72d5d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalizedsoftwareMember_1652a09e-83ad-4326-8e01-539cb8cfcff1_terseLabel_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_label_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember" xlink:href="holx-20210925.xsd#holx_CapitalizedsoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalizedsoftwareMember" xlink:to="lab_holx_CapitalizedsoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_6c33e74d-5235-4257-8ec3-3462ae2166e0_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b0a4ba40-30e2-4970-96c5-226ca4c1d8ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant-Date&#160;Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b88e67f1-772b-4bca-be12-c0f822517343_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fbd8486a-6a46-491b-887f-fc3ae34d86bc_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_253fd635-db3f-4b65-b7bf-6a16fd6881cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of RSUs vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_07072ad8-33e8-4638-89b0-8743b1276494_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_0bbd93b5-a027-4ed2-b62c-b5db7f079a1e_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2022</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_798957ae-602e-4edb-8343-05d1eae3a323_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_57cb2b26-a9eb-4d7b-9e1f-8b85f8d54b59_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CashEquivalentsMaturityPeriod_1180ae22-e57b-40c4-a9cf-cf0462a6c8dd_terseLabel_en-US" xlink:label="lab_holx_CashEquivalentsMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Maturity Period</link:label>
    <link:label id="lab_holx_CashEquivalentsMaturityPeriod_label_en-US" xlink:label="lab_holx_CashEquivalentsMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Maturity Period</link:label>
    <link:label id="lab_holx_CashEquivalentsMaturityPeriod_documentation_en-US" xlink:label="lab_holx_CashEquivalentsMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of time from the date of acquisition for liquid investments in debt securities to be categorized as cash in the consolidated balance sheet.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashEquivalentsMaturityPeriod" xlink:href="holx-20210925.xsd#holx_CashEquivalentsMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CashEquivalentsMaturityPeriod" xlink:to="lab_holx_CashEquivalentsMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_606c5efe-db8d-4ebc-bd40-7ee4a957063a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost and Related Actuarial Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_3fb94625-62c9-4f74-b76a-2c73994378f0_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_78bf1467-fff1-43c7-9b6a-e8a8871d31b9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4330c89e-7d1e-4a41-9347-71073e265345_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual&#160;Life (in Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd9b575e-79ec-49d8-be09-494a37d718c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Dec112019Member_83c95c91-5a88-43e8-8c26-84a208d8f775_terseLabel_en-US" xlink:label="lab_holx_Dec112019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dec 11, 2019 [Member]</link:label>
    <link:label id="lab_holx_Dec112019Member_label_en-US" xlink:label="lab_holx_Dec112019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dec 11, 2019 [Member]</link:label>
    <link:label id="lab_holx_Dec112019Member_documentation_en-US" xlink:label="lab_holx_Dec112019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dec 11, 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Dec112019Member" xlink:href="holx-20210925.xsd#holx_Dec112019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Dec112019Member" xlink:to="lab_holx_Dec112019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_d50d24a2-d7c2-4798-9782-283eb435cb3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges Taken Related to Accrued Restructuring Actions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_f070c52a-1dbe-487c-8efb-e717d41ee402_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d28c01aa-5acd-4358-b532-608a0799154e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable at September 25, 2021</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_462e3e9c-32cd-4fb9-9959-0aed45066f72_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_db4f8642-94c7-4cb9-a407-1a35b859d534_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_022d61de-ac80-4292-ac1f-de020b92d9cc_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life insurance contracts</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_d96d44b6-355f-4390-8157-c12d2b47b3a9_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:to="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_700dac17-5ffd-414f-b00b-d5cd7d61f75d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost &#8211; 43,653 and 37,609 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_a5259cf4-be01-477f-9f6e-ae390c768da3_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_142d239d-bf29-49ff-b5ac-94f9765a5780_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion allocable to equity method investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_6019b490-4726-4750-b23b-43cc2b3fbaf5_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership of outstanding shares (as a percent)</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_label_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_documentation_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage" xlink:href="holx-20210925.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationOwnershipPercentage" xlink:to="lab_holx_BusinessCombinationOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_StateLossCarryforwardExpectedToUnutilize_92ecf25b-e285-4d2d-b7f8-a81e88597115_terseLabel_en-US" xlink:label="lab_holx_StateLossCarryforwardExpectedToUnutilize" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">state loss carryforward expected to unutilize</link:label>
    <link:label id="lab_holx_StateLossCarryforwardExpectedToUnutilize_label_en-US" xlink:label="lab_holx_StateLossCarryforwardExpectedToUnutilize" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">state loss carryforward expected to unutilize</link:label>
    <link:label id="lab_holx_StateLossCarryforwardExpectedToUnutilize_documentation_en-US" xlink:label="lab_holx_StateLossCarryforwardExpectedToUnutilize" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">state loss carryforward expected to unutilize</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_StateLossCarryforwardExpectedToUnutilize" xlink:href="holx-20210925.xsd#holx_StateLossCarryforwardExpectedToUnutilize"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_StateLossCarryforwardExpectedToUnutilize" xlink:to="lab_holx_StateLossCarryforwardExpectedToUnutilize" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f5b0e399-93cd-466d-a6bf-e1c7768f127e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_eeda2a49-f948-4e70-bd8d-14ba7a8f4e49_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax (benefit) provision at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmendedTermLoan2018Member_c8be1af8-8e32-4510-93fd-b8977b27daa7_terseLabel_en-US" xlink:label="lab_holx_AmendedTermLoan2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Amended Term Loan</link:label>
    <link:label id="lab_holx_AmendedTermLoan2018Member_label_en-US" xlink:label="lab_holx_AmendedTermLoan2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan 2018 [Member]</link:label>
    <link:label id="lab_holx_AmendedTermLoan2018Member_documentation_en-US" xlink:label="lab_holx_AmendedTermLoan2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoan2018Member" xlink:href="holx-20210925.xsd#holx_AmendedTermLoan2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedTermLoan2018Member" xlink:to="lab_holx_AmendedTermLoan2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_7ca75652-f764-4c66-a634-6193ad3a9e26_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest at September 25, 2021 (1)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_db78c935-4e64-4596-8485-89891f65a268_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit line</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_36c9077d-2d21-41ef-a725-f93b7de98938_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_14203903-7ce4-4da9-8039-887ff914a237_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>holx-20210925_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:fe647887-7476-401d-8075-31ce3ecd561d,g:aafd6a0b-1c31-49b5-81b9-4feb5a12e92f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20210925.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a437778f-a190-450a-9fce-33e717d30932" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_DocumentType_a437778f-a190-450a-9fce-33e717d30932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_c3c9bf35-a2b2-4740-9225-faaed23d6d6d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_DocumentAnnualReport_c3c9bf35-a2b2-4740-9225-faaed23d6d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_07aa81a9-48a7-4c31-8911-89ae30c09428" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_DocumentPeriodEndDate_07aa81a9-48a7-4c31-8911-89ae30c09428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_45983a61-1865-4df4-a197-eafe4addbad1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_DocumentTransitionReport_45983a61-1865-4df4-a197-eafe4addbad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e92c5e63-7c13-45e4-9ffd-dd47d15e0698" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityFileNumber_e92c5e63-7c13-45e4-9ffd-dd47d15e0698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_bf792a28-1d60-41c3-aaa5-d8f6cf81c5ab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityRegistrantName_bf792a28-1d60-41c3-aaa5-d8f6cf81c5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f7504309-48bf-415b-81f2-027801801e7e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityCentralIndexKey_f7504309-48bf-415b-81f2-027801801e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_8aa5f4dd-066c-46f8-bc10-ba5682bee9a7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_CurrentFiscalYearEndDate_8aa5f4dd-066c-46f8-bc10-ba5682bee9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_44f5f206-3cbb-4530-b6e8-ba2b9dcd39e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_DocumentFiscalYearFocus_44f5f206-3cbb-4530-b6e8-ba2b9dcd39e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_300c869c-1ea7-4a4c-87ef-582b11012b36" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_DocumentFiscalPeriodFocus_300c869c-1ea7-4a4c-87ef-582b11012b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_82a659c9-c8de-4550-bdee-2695e3a7ba91" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_AmendmentFlag_82a659c9-c8de-4550-bdee-2695e3a7ba91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1400b77b-92eb-402c-992b-0da7f38c4eb0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1400b77b-92eb-402c-992b-0da7f38c4eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a4ee3a4e-a271-4e94-b8ed-feaf19077e73" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityTaxIdentificationNumber_a4ee3a4e-a271-4e94-b8ed-feaf19077e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9ab790d4-9ec4-4a11-96f9-533321057939" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityAddressAddressLine1_9ab790d4-9ec4-4a11-96f9-533321057939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d74981a6-7c96-4d0f-b88c-f5e7f8489bec" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityAddressCityOrTown_d74981a6-7c96-4d0f-b88c-f5e7f8489bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_bd0d2380-09b2-4347-abb5-fcfde53926f3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityAddressStateOrProvince_bd0d2380-09b2-4347-abb5-fcfde53926f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5647b136-9302-49b4-866e-f948ae24d313" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityAddressPostalZipCode_5647b136-9302-49b4-866e-f948ae24d313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_1a921a3e-b4e5-4cb3-82cd-c484a591cc66" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_CityAreaCode_1a921a3e-b4e5-4cb3-82cd-c484a591cc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b4a4d4ff-7e10-4532-8d16-75adca02c5b3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_LocalPhoneNumber_b4a4d4ff-7e10-4532-8d16-75adca02c5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0f21da76-0771-4776-958c-d70166851d75" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_Security12bTitle_0f21da76-0771-4776-958c-d70166851d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_74e7f8e6-e556-48c3-82d0-b0eb773b8cf8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_TradingSymbol_74e7f8e6-e556-48c3-82d0-b0eb773b8cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8b5fd799-fad1-42ac-80c4-0a1d2e7147d3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_SecurityExchangeName_8b5fd799-fad1-42ac-80c4-0a1d2e7147d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_81f272f9-a282-4c25-a6ac-7d43ec9b5e63" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_81f272f9-a282-4c25-a6ac-7d43ec9b5e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_0def28e4-1716-47df-94ca-4c27da6dffff" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityVoluntaryFilers_0def28e4-1716-47df-94ca-4c27da6dffff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4cdcf233-c93b-4283-a531-ea1ba51bfa72" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityCurrentReportingStatus_4cdcf233-c93b-4283-a531-ea1ba51bfa72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ad8e81c9-91ae-4f48-9df2-ae6e763cd33c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityInteractiveDataCurrent_ad8e81c9-91ae-4f48-9df2-ae6e763cd33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_cae32ab2-c29d-444e-a2fa-7535e3d4b974" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityFilerCategory_cae32ab2-c29d-444e-a2fa-7535e3d4b974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_571b798b-e429-4ab6-b466-09d2b4b6f2a2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntitySmallBusiness_571b798b-e429-4ab6-b466-09d2b4b6f2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_da37d521-a42f-4683-be5f-940b3759b01b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityEmergingGrowthCompany_da37d521-a42f-4683-be5f-940b3759b01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_cf9fa76f-3a8e-45ea-81c2-e40cf92f00ac" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_IcfrAuditorAttestationFlag_cf9fa76f-3a8e-45ea-81c2-e40cf92f00ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ce0ecbbf-9360-46d6-ad03-1cf56a665588" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityShellCompany_ce0ecbbf-9360-46d6-ad03-1cf56a665588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_0037d939-4f7d-4a46-a6e3-f0f36580cf21" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityPublicFloat_0037d939-4f7d-4a46-a6e3-f0f36580cf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_905a6ca5-6764-4bcd-b939-9a56dcecd33e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_905a6ca5-6764-4bcd-b939-9a56dcecd33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_e14c225c-92e6-4e9b-b9f9-dd0781689564" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c3526e54-114b-4ab3-90b2-790cb1859ffe" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_e14c225c-92e6-4e9b-b9f9-dd0781689564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_42c5e225-3f9b-4315-8bf4-184ef8ea101a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e3ccae6d-bcf2-44ec-9af5-9e1692e1dc42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_42c5e225-3f9b-4315-8bf4-184ef8ea101a" xlink:to="loc_us-gaap_StatementTable_e3ccae6d-bcf2-44ec-9af5-9e1692e1dc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_670b287a-cace-4f9f-9181-5f4300a1e138" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3ccae6d-bcf2-44ec-9af5-9e1692e1dc42" xlink:to="loc_srt_ProductOrServiceAxis_670b287a-cace-4f9f-9181-5f4300a1e138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_67e766fb-1ed7-4af5-8502-ae5cb9e26b74" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_670b287a-cace-4f9f-9181-5f4300a1e138" xlink:to="loc_srt_ProductsAndServicesDomain_67e766fb-1ed7-4af5-8502-ae5cb9e26b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_2c1977b6-0868-4af3-b277-89f22b3de3f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_67e766fb-1ed7-4af5-8502-ae5cb9e26b74" xlink:to="loc_us-gaap_ProductMember_2c1977b6-0868-4af3-b277-89f22b3de3f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_30f89f5e-b7d3-4a6f-bf78-5a74bb9ad637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_67e766fb-1ed7-4af5-8502-ae5cb9e26b74" xlink:to="loc_us-gaap_ServiceMember_30f89f5e-b7d3-4a6f-bf78-5a74bb9ad637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3ccae6d-bcf2-44ec-9af5-9e1692e1dc42" xlink:to="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6e3df2f2-a8d6-4487-92f1-7dbe6f7b4410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_RevenuesAbstract_6e3df2f2-a8d6-4487-92f1-7dbe6f7b4410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7852313f-4365-4a96-a909-667ac70af9af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_6e3df2f2-a8d6-4487-92f1-7dbe6f7b4410" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7852313f-4365-4a96-a909-667ac70af9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1b1617d5-5813-4e8f-b42f-32949772b5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1b1617d5-5813-4e8f-b42f-32949772b5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_62d8c2bb-13b2-4eb2-9637-cc0c31bc2103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_62d8c2bb-13b2-4eb2-9637-cc0c31bc2103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_de2cb998-7c03-43ea-97cb-ff7ca9117d30" xlink:href="holx-20210925.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_6eeebbc6-4c8b-4da5-9077-9e15a4cc414d" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets_de2cb998-7c03-43ea-97cb-ff7ca9117d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4295010d-c35d-4f94-b296-489dc362f0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_GrossProfit_4295010d-c35d-4f94-b296-489dc362f0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2f9df1b6-93ee-4fce-96ad-ceb0aeb6f302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2f9df1b6-93ee-4fce-96ad-ceb0aeb6f302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_89e50181-c0df-433d-907a-eb3b8a4dd456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_SellingAndMarketingExpense_89e50181-c0df-433d-907a-eb3b8a4dd456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_832c94b9-22b2-4e8c-9fe1-6790a1cd4ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_832c94b9-22b2-4e8c-9fe1-6790a1cd4ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_1ca152a2-4a2f-4662-b77a-22135da2f66a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_1ca152a2-4a2f-4662-b77a-22135da2f66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4cff905f-20f0-4370-9420-23e9fed4217b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_4cff905f-20f0-4370-9420-23e9fed4217b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_7d13d41d-4cc4-48ac-b6c9-11311bc86011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_7d13d41d-4cc4-48ac-b6c9-11311bc86011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_69a1ea9a-3169-4dad-81a2-586b25e54657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_RestructuringCharges_69a1ea9a-3169-4dad-81a2-586b25e54657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6946aad7-959c-4b3d-9e3f-538fc116dbcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_4c94a51b-a2c6-4f0e-a82a-f51df5421ee4" xlink:to="loc_us-gaap_OperatingExpenses_6946aad7-959c-4b3d-9e3f-538fc116dbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7a78d1a5-5c7d-41a0-a167-67c0d3d80135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_OperatingIncomeLoss_7a78d1a5-5c7d-41a0-a167-67c0d3d80135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3354fc44-6a8d-4b19-a0cd-5404c83e35bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3354fc44-6a8d-4b19-a0cd-5404c83e35bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b7743694-3877-4943-b27a-809f140785ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_InterestExpense_b7743694-3877-4943-b27a-809f140785ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3801395c-468d-480c-9111-6507ba8e2e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3801395c-468d-480c-9111-6507ba8e2e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_07408105-8dd6-482e-9bd7-1d65c160f3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_07408105-8dd6-482e-9bd7-1d65c160f3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af4c4ffa-8ea4-408c-9a24-3a864b027a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af4c4ffa-8ea4-408c-9a24-3a864b027a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f3573f2c-da8a-4583-8b37-c2a372292723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f3573f2c-da8a-4583-8b37-c2a372292723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a09b55a9-d2fd-44b7-b5bf-35809c6fa788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_ProfitLoss_a09b55a9-d2fd-44b7-b5bf-35809c6fa788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_b40d574d-9378-483f-9102-e9dbc9f9947a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_b40d574d-9378-483f-9102-e9dbc9f9947a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b25fbb04-381f-4c1b-8217-3b3970c4a3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_NetIncomeLoss_b25fbb04-381f-4c1b-8217-3b3970c4a3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f717bb79-9424-4efa-988e-ee28fcc1784c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_EarningsPerShareAbstract_f717bb79-9424-4efa-988e-ee28fcc1784c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8870c2cb-3cb9-4029-a374-dc0d5a341bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f717bb79-9424-4efa-988e-ee28fcc1784c" xlink:to="loc_us-gaap_EarningsPerShareBasic_8870c2cb-3cb9-4029-a374-dc0d5a341bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_39d67a09-faf2-410e-a5dd-00c2492bfcff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f717bb79-9424-4efa-988e-ee28fcc1784c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_39d67a09-faf2-410e-a5dd-00c2492bfcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e3593f1e-ba7c-4a8a-aaec-07562b4e0f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b2826e0-22dc-4cc7-b37d-a965c5a2ae79" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e3593f1e-ba7c-4a8a-aaec-07562b4e0f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3d61cb1c-bc60-4412-bc5e-e42ae3296a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e3593f1e-ba7c-4a8a-aaec-07562b4e0f94" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3d61cb1c-bc60-4412-bc5e-e42ae3296a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d918c9a8-51a4-4960-9489-5b5db475abd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e3593f1e-ba7c-4a8a-aaec-07562b4e0f94" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d918c9a8-51a4-4960-9489-5b5db475abd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_30c83bdf-b6a0-484e-946e-944d7a9ad728" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2640fb32-146e-4653-930b-a154c54039d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_30c83bdf-b6a0-484e-946e-944d7a9ad728" xlink:to="loc_us-gaap_StatementTable_2640fb32-146e-4653-930b-a154c54039d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca5f75cb-8864-4a24-9777-976aec753ef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2640fb32-146e-4653-930b-a154c54039d3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca5f75cb-8864-4a24-9777-976aec753ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ecb6bd1d-3c73-4fa7-bcb7-c3fb2f35caa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca5f75cb-8864-4a24-9777-976aec753ef9" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ecb6bd1d-3c73-4fa7-bcb7-c3fb2f35caa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_6180134a-26d0-45a9-977c-0df31cb07a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ecb6bd1d-3c73-4fa7-bcb7-c3fb2f35caa7" xlink:to="loc_us-gaap_InterestRateSwapMember_6180134a-26d0-45a9-977c-0df31cb07a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f481c65a-a9ff-4a48-b41d-376afdfc8bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2640fb32-146e-4653-930b-a154c54039d3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f481c65a-a9ff-4a48-b41d-376afdfc8bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_06260907-39cf-42e3-9bb7-f7d0cb0668de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f481c65a-a9ff-4a48-b41d-376afdfc8bc4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_06260907-39cf-42e3-9bb7-f7d0cb0668de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_7e268972-dedc-4930-86aa-748f2f42d1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_06260907-39cf-42e3-9bb7-f7d0cb0668de" xlink:to="loc_us-gaap_InterestRateCapMember_7e268972-dedc-4930-86aa-748f2f42d1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2640fb32-146e-4653-930b-a154c54039d3" xlink:to="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_44adb336-72fa-47ea-8eb7-ecee012cc380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_ProfitLoss_44adb336-72fa-47ea-8eb7-ecee012cc380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_25cc392a-ee05-4138-b7f5-709c7096c2b4" xlink:href="holx-20210925.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI_25cc392a-ee05-4138-b7f5-709c7096c2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_66f40bdd-30de-459e-a230-7031f50bc770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_66f40bdd-30de-459e-a230-7031f50bc770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_709f8d28-cf7b-49bf-90f4-3c07098760cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_709f8d28-cf7b-49bf-90f4-3c07098760cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_14133418-e8c1-45f0-854e-66f5c753a847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_14133418-e8c1-45f0-854e-66f5c753a847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1a3a0bb8-e374-467e-bdb4-b0a069868e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1a3a0bb8-e374-467e-bdb4-b0a069868e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_64b2f0b9-7f70-42a0-978b-2f2b6d276c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_64b2f0b9-7f70-42a0-978b-2f2b6d276c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c405e8cb-c066-4434-8073-9a2a61acfd70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c405e8cb-c066-4434-8073-9a2a61acfd70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_6fd4975e-cbc1-400a-a8e1-909d550a2521" xlink:href="holx-20210925.xsd#holx_ComprehensiveIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c3b301f-6f91-4af1-8e75-34040780f24d" xlink:to="loc_holx_ComprehensiveIncome_6fd4975e-cbc1-400a-a8e1-909d550a2521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome_1" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofComprehensiveIncome_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofComprehensiveIncomeParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7298ce22-1965-4e55-81dc-fd6a314de67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0d3ce839-efe9-4596-95c0-dde98800405e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7298ce22-1965-4e55-81dc-fd6a314de67a" xlink:to="loc_us-gaap_StatementTable_0d3ce839-efe9-4596-95c0-dde98800405e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_05b45d7f-b494-429d-b5bb-f68eebeeb76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0d3ce839-efe9-4596-95c0-dde98800405e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_05b45d7f-b494-429d-b5bb-f68eebeeb76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_feabeb2c-6f49-4bf4-a43c-48425cf6fc7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_05b45d7f-b494-429d-b5bb-f68eebeeb76e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_feabeb2c-6f49-4bf4-a43c-48425cf6fc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_a668b3ea-13b2-49cd-818e-237626b7bbbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_feabeb2c-6f49-4bf4-a43c-48425cf6fc7b" xlink:to="loc_us-gaap_InterestRateCapMember_a668b3ea-13b2-49cd-818e-237626b7bbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0d3ce839-efe9-4596-95c0-dde98800405e" xlink:to="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_23203d52-ce1c-461c-b795-2135851a228d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_23203d52-ce1c-461c-b795-2135851a228d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxOnInterestRateSwap_0e8c1b2f-f15c-4044-b3d7-c24ae879cd58" xlink:href="holx-20210925.xsd#holx_TaxOnInterestRateSwap"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:to="loc_holx_TaxOnInterestRateSwap_0e8c1b2f-f15c-4044-b3d7-c24ae879cd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_b695111e-75cc-4510-acda-e68b0ef4f36b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dd249899-4f0c-4175-99eb-11a2adf21a7d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_b695111e-75cc-4510-acda-e68b0ef4f36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2926aea8-7c2e-4ee9-93a1-0faeda75e53b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0c34b8b8-e506-4510-91d2-8dcf43921696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2926aea8-7c2e-4ee9-93a1-0faeda75e53b" xlink:to="loc_us-gaap_AssetsAbstract_0c34b8b8-e506-4510-91d2-8dcf43921696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_79eb1ee1-d9b3-415d-9bfe-7a8fb1c916a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0c34b8b8-e506-4510-91d2-8dcf43921696" xlink:to="loc_us-gaap_AssetsCurrentAbstract_79eb1ee1-d9b3-415d-9bfe-7a8fb1c916a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5aba3b93-d59c-4349-b42a-ce4af66e004c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_79eb1ee1-d9b3-415d-9bfe-7a8fb1c916a1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5aba3b93-d59c-4349-b42a-ce4af66e004c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_493344af-e22f-436a-8905-5681034d10fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_79eb1ee1-d9b3-415d-9bfe-7a8fb1c916a1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_493344af-e22f-436a-8905-5681034d10fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_df2bbe7f-d944-484b-8e11-b073f4bbb696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_79eb1ee1-d9b3-415d-9bfe-7a8fb1c916a1" xlink:to="loc_us-gaap_InventoryNet_df2bbe7f-d944-484b-8e11-b073f4bbb696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_696dc77a-6aca-40d1-9d60-89879d69f723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_79eb1ee1-d9b3-415d-9bfe-7a8fb1c916a1" xlink:to="loc_us-gaap_PrepaidTaxes_696dc77a-6aca-40d1-9d60-89879d69f723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b1d334ad-8abc-4ce6-8aa2-448fac02b521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_79eb1ee1-d9b3-415d-9bfe-7a8fb1c916a1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b1d334ad-8abc-4ce6-8aa2-448fac02b521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9084fc57-42eb-4ea4-9be4-fbb1ad5f6ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_79eb1ee1-d9b3-415d-9bfe-7a8fb1c916a1" xlink:to="loc_us-gaap_AssetsCurrent_9084fc57-42eb-4ea4-9be4-fbb1ad5f6ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_71a24229-30d5-4172-bba8-239fe7dbc47a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0c34b8b8-e506-4510-91d2-8dcf43921696" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_71a24229-30d5-4172-bba8-239fe7dbc47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a535e487-acf7-4d8c-99ae-25da57c18c6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0c34b8b8-e506-4510-91d2-8dcf43921696" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a535e487-acf7-4d8c-99ae-25da57c18c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3ed011f1-b0b1-4f12-9d05-b74bd7aeb919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0c34b8b8-e506-4510-91d2-8dcf43921696" xlink:to="loc_us-gaap_Goodwill_3ed011f1-b0b1-4f12-9d05-b74bd7aeb919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_387c8567-707a-40c1-a009-d078eadc2a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0c34b8b8-e506-4510-91d2-8dcf43921696" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_387c8567-707a-40c1-a009-d078eadc2a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c36c4778-b1f7-4599-a59f-b0cc0dcc2174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0c34b8b8-e506-4510-91d2-8dcf43921696" xlink:to="loc_us-gaap_Assets_c36c4778-b1f7-4599-a59f-b0cc0dcc2174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2926aea8-7c2e-4ee9-93a1-0faeda75e53b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6017d1c8-3063-4af8-b7cf-d30aec147f16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6017d1c8-3063-4af8-b7cf-d30aec147f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e6dd441b-e2a2-4ba8-87a7-d45ea20680df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6017d1c8-3063-4af8-b7cf-d30aec147f16" xlink:to="loc_us-gaap_LongTermDebtCurrent_e6dd441b-e2a2-4ba8-87a7-d45ea20680df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_8cf3a787-f90b-4674-8fda-fc001b2a8adf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6017d1c8-3063-4af8-b7cf-d30aec147f16" xlink:to="loc_us-gaap_AccountsPayableCurrent_8cf3a787-f90b-4674-8fda-fc001b2a8adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_48d8fb3d-7dd2-40b9-95b5-2194b8b438f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6017d1c8-3063-4af8-b7cf-d30aec147f16" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_48d8fb3d-7dd2-40b9-95b5-2194b8b438f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_3261d68d-2d8c-4062-bcce-590461146a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6017d1c8-3063-4af8-b7cf-d30aec147f16" xlink:to="loc_us-gaap_DeferredRevenueCurrent_3261d68d-2d8c-4062-bcce-590461146a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c948036f-8925-422f-a03b-056cbaf4a1bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6017d1c8-3063-4af8-b7cf-d30aec147f16" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c948036f-8925-422f-a03b-056cbaf4a1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_62ebaa88-d7c7-47ad-801a-f48287349f06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6017d1c8-3063-4af8-b7cf-d30aec147f16" xlink:to="loc_us-gaap_LiabilitiesCurrent_62ebaa88-d7c7-47ad-801a-f48287349f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5da92c26-d9b0-4be4-9cc3-6d5f82da6b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5da92c26-d9b0-4be4-9cc3-6d5f82da6b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_0c790024-6a90-465d-aa72-4f6bdafb00c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_0c790024-6a90-465d-aa72-4f6bdafb00c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9b3c8c2f-e1be-4838-87a4-1b6258bfafaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9b3c8c2f-e1be-4838-87a4-1b6258bfafaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_ad9f840c-11b2-4253-b17c-22c3583634b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_ad9f840c-11b2-4253-b17c-22c3583634b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d3b4d6af-7be9-40ea-ab06-7760c4b485fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d3b4d6af-7be9-40ea-ab06-7760c4b485fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d8c1a2d2-d9be-4a1a-9064-8bcdfce2d86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d8c1a2d2-d9be-4a1a-9064-8bcdfce2d86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_cc45edba-22cf-4775-8343-b364db1510bd" xlink:to="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_95ff8816-0964-4c7d-9143-3d1cf98f71ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_PreferredStockValue_95ff8816-0964-4c7d-9143-3d1cf98f71ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_e28d6065-e953-4a76-8bfe-6b1ce0480ff1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_CommonStockValue_e28d6065-e953-4a76-8bfe-6b1ce0480ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a92ed2ad-8888-4236-8c71-1dd9b067a589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a92ed2ad-8888-4236-8c71-1dd9b067a589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4ca047b4-0451-4638-b0b9-c8d22cd13ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4ca047b4-0451-4638-b0b9-c8d22cd13ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_016f3069-6e7c-4fd0-bed1-12e1a84a405a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_TreasuryStockValue_016f3069-6e7c-4fd0-bed1-12e1a84a405a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_013f3b1f-209b-4b98-829b-6272cf8c7831" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_013f3b1f-209b-4b98-829b-6272cf8c7831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_75c6a009-7bcf-44ef-902c-4883485b83f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_StockholdersEquity_75c6a009-7bcf-44ef-902c-4883485b83f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_1f9908fb-5a34-475f-aead-2c74ab51ca75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_MinorityInterest_1f9908fb-5a34-475f-aead-2c74ab51ca75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5d16b874-24fc-4de8-9b08-2008e8603ea7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5d16b874-24fc-4de8-9b08-2008e8603ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2b899ee7-1a6b-4012-9857-f60833416926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_bcbe1b32-5137-4197-953a-8ee357af6ad3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2b899ee7-1a6b-4012-9857-f60833416926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5b9326a1-f66a-4c42-8a07-fc612dfbd1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9ae53d09-38e6-41de-a6e8-7aa6d109a6ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b9326a1-f66a-4c42-8a07-fc612dfbd1c9" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9ae53d09-38e6-41de-a6e8-7aa6d109a6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_c9f7e8c9-4fa0-40f7-9683-720dbd924bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b9326a1-f66a-4c42-8a07-fc612dfbd1c9" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_c9f7e8c9-4fa0-40f7-9683-720dbd924bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_bb5b48d5-d20b-432a-9b4e-fa55bb124305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b9326a1-f66a-4c42-8a07-fc612dfbd1c9" xlink:to="loc_us-gaap_PreferredStockSharesIssued_bb5b48d5-d20b-432a-9b4e-fa55bb124305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_fa65cd93-142f-49ff-996b-40b0da503057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b9326a1-f66a-4c42-8a07-fc612dfbd1c9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_fa65cd93-142f-49ff-996b-40b0da503057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7bf6394c-2e8f-43d2-87ea-7091ab96525d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b9326a1-f66a-4c42-8a07-fc612dfbd1c9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7bf6394c-2e8f-43d2-87ea-7091ab96525d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_3894e0da-c965-4a77-8b9e-54836d6ba3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b9326a1-f66a-4c42-8a07-fc612dfbd1c9" xlink:to="loc_us-gaap_CommonStockSharesIssued_3894e0da-c965-4a77-8b9e-54836d6ba3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_698dd88b-92a0-461e-a328-38cf729fa850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5b9326a1-f66a-4c42-8a07-fc612dfbd1c9" xlink:to="loc_us-gaap_TreasuryStockShares_698dd88b-92a0-461e-a328-38cf729fa850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_81a6846b-ed56-41a6-bd07-1e824bef358a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_81a6846b-ed56-41a6-bd07-1e824bef358a" xlink:to="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5202cc05-0e41-4676-903e-0d47505e0817" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5202cc05-0e41-4676-903e-0d47505e0817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5202cc05-0e41-4676-903e-0d47505e0817" xlink:to="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0217f907-872a-41b1-b455-8216b5b2b180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_CommonStockMember_0217f907-872a-41b1-b455-8216b5b2b180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f8f330f2-9b85-4d4b-b42f-e46190d02830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f8f330f2-9b85-4d4b-b42f-e46190d02830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_efdc154d-988d-475b-a1c3-1066562494d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_RetainedEarningsMember_efdc154d-988d-475b-a1c3-1066562494d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dfc66aab-a508-4c79-b975-c344db211e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dfc66aab-a508-4c79-b975-c344db211e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_cf5e1cdd-a78f-48ae-a4be-1474fb6ef8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_TreasuryStockMember_cf5e1cdd-a78f-48ae-a4be-1474fb6ef8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ba911563-0fb1-49aa-b07e-dd71d369e783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ef23841a-aa71-4bad-8b15-a30da3fe5734" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ba911563-0fb1-49aa-b07e-dd71d369e783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_4cf2b4b0-8620-4c77-9c4d-ff950eb31800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_4cf2b4b0-8620-4c77-9c4d-ff950eb31800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_6c8a88c9-0c25-4237-b479-2ad49aaf243e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4cf2b4b0-8620-4c77-9c4d-ff950eb31800" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_6c8a88c9-0c25-4237-b479-2ad49aaf243e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_25216b50-a334-44c6-8310-76d2c248d308" xlink:href="holx-20210925.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_6c8a88c9-0c25-4237-b479-2ad49aaf243e" xlink:to="loc_holx_ShareRepurchaseProgramMember_25216b50-a334-44c6-8310-76d2c248d308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_10f25e14-d435-4821-8afd-65f286f747ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_10f25e14-d435-4821-8afd-65f286f747ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_fd8d71c2-2f37-4203-9622-800f228b0011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_10f25e14-d435-4821-8afd-65f286f747ab" xlink:to="loc_us-gaap_TypeOfAdoptionMember_fd8d71c2-2f37-4203-9622-800f228b0011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_48719267-b6cf-45a1-a6da-757e13fe628b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_fd8d71c2-2f37-4203-9622-800f228b0011" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_48719267-b6cf-45a1-a6da-757e13fe628b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_78d54d4f-ffec-45bc-ae8b-bc3ab8659e04" xlink:to="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_185bd982-9b40-4862-a6e3-d5cca60e9d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_SharesIssued_185bd982-9b40-4862-a6e3-d5cca60e9d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c9af530f-7b73-4567-9608-3004926a8188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c9af530f-7b73-4567-9608-3004926a8188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASC606_eae75cce-9adf-4a4e-b880-bb8d8b44a8e7" xlink:href="holx-20210925.xsd#holx_AccountingstandardtransitionadjustmentASC606"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_holx_AccountingstandardtransitionadjustmentASC606_eae75cce-9adf-4a4e-b880-bb8d8b44a8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingstandardtransitionadjustmentASU201616_681ac588-dbd0-4ddc-b9a6-e2ba74e7ba2e" xlink:href="holx-20210925.xsd#holx_AccountingstandardtransitionadjustmentASU201616"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_holx_AccountingstandardtransitionadjustmentASU201616_681ac588-dbd0-4ddc-b9a6-e2ba74e7ba2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_50a4441b-5848-4b69-a402-c17673cd8558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_50a4441b-5848-4b69-a402-c17673cd8558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cbff9c3b-4fe1-49f2-9403-13c0d7acc76e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cbff9c3b-4fe1-49f2-9403-13c0d7acc76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_173ad479-4eb0-4f2a-a60b-48e0c94411c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_173ad479-4eb0-4f2a-a60b-48e0c94411c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2aa002e8-8253-4c0f-a690-a45170a2f074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2aa002e8-8253-4c0f-a690-a45170a2f074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7bde8651-5a1d-4c97-b38c-b848b920a5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7bde8651-5a1d-4c97-b38c-b848b920a5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1f32e0da-ca88-4ef3-aecf-22314525a26e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1f32e0da-ca88-4ef3-aecf-22314525a26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_189a60f0-0b81-48dc-ba82-72a13e61563c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_189a60f0-0b81-48dc-ba82-72a13e61563c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_33d7f30b-fff3-494c-843c-5f5c1f88412f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_33d7f30b-fff3-494c-843c-5f5c1f88412f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_53e6a31b-268c-4cbe-84d5-979c859694ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_53e6a31b-268c-4cbe-84d5-979c859694ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes_772ff123-f598-4830-8f58-f3776cf4f971" xlink:href="holx-20210925.xsd#holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes_772ff123-f598-4830-8f58-f3776cf4f971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f73684e7-45ab-471c-b204-95341934897a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f73684e7-45ab-471c-b204-95341934897a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_a431ec67-b1ea-46cd-84c0-3c144a4644cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_a431ec67-b1ea-46cd-84c0-3c144a4644cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1e973ea8-c2bd-4c98-8d59-692456d48774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1e973ea8-c2bd-4c98-8d59-692456d48774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_df52c312-e8cd-4574-9043-5b04db6059e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_df52c312-e8cd-4574-9043-5b04db6059e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_76c77954-ebdd-4f27-ad49-6c8bb25273c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_ProfitLoss_76c77954-ebdd-4f27-ad49-6c8bb25273c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_b7499979-c4ba-471c-acbc-f93daa0cacbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_b7499979-c4ba-471c-acbc-f93daa0cacbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountingStandardTransitionAdjustmentASU842_cb7ae3b0-5afd-4053-90dc-1bac1ba707b6" xlink:href="holx-20210925.xsd#holx_AccountingStandardTransitionAdjustmentASU842"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_holx_AccountingStandardTransitionAdjustmentASU842_cb7ae3b0-5afd-4053-90dc-1bac1ba707b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_9f721c22-57c8-49fe-95a0-02a8e8cdefb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_SharesIssued_9f721c22-57c8-49fe-95a0-02a8e8cdefb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6f082675-7067-4166-be08-e4233394e044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d1e437c4-101a-4a1f-a710-8f7da58ef21b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6f082675-7067-4166-be08-e4233394e044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_b7fca617-15e6-45ee-aaf1-9cf2288720f8" xlink:href="holx-20210925.xsd#holx_PurchaseOfNonControllingInterestReclassifiedToAPIC"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_b7fca617-15e6-45ee-aaf1-9cf2288720f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue_e4c2aa09-22ad-45cb-b587-566ac536b6a1" xlink:href="holx-20210925.xsd#holx_ChangeInParValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_holx_ChangeInParValue_e4c2aa09-22ad-45cb-b587-566ac536b6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax_b5daf5be-6923-4868-9140-e44f67b541fb" xlink:href="holx-20210925.xsd#holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax_b5daf5be-6923-4868-9140-e44f67b541fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_cf8fc8b2-93f4-4694-9fbd-8140eabca4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2bd9392c-e0cf-4e84-bd41-b30acd88f6dd" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_cf8fc8b2-93f4-4694-9fbd-8140eabca4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20210925.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_6a2fdd7b-8622-47ce-aba0-ad67bd531b2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3ebcaebc-f4fa-45ce-829c-60b602c7cfd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6a2fdd7b-8622-47ce-aba0-ad67bd531b2d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3ebcaebc-f4fa-45ce-829c-60b602c7cfd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ec16f8d6-8155-4101-8a61-5db00f20f2a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3ebcaebc-f4fa-45ce-829c-60b602c7cfd1" xlink:to="loc_us-gaap_ProfitLoss_ec16f8d6-8155-4101-8a61-5db00f20f2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3ebcaebc-f4fa-45ce-829c-60b602c7cfd1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1a38ffd6-5c6e-4313-bd34-2e4ab2f78cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:to="loc_us-gaap_Depreciation_1a38ffd6-5c6e-4313-bd34-2e4ab2f78cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_2f9f2e00-b264-4d2d-8b98-0e324098f0a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:to="loc_us-gaap_AdjustmentForAmortization_2f9f2e00-b264-4d2d-8b98-0e324098f0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e3f37a22-30ea-48f1-808e-9e6c9112021e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:to="loc_us-gaap_ShareBasedCompensation_e3f37a22-30ea-48f1-808e-9e6c9112021e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_93f4cf12-080e-433e-af73-0e61b19ce139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_93f4cf12-080e-433e-af73-0e61b19ce139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Impairmentofintangibleassetsandequipment_7b941e83-4202-430f-a6da-21cdbeffc077" xlink:href="holx-20210925.xsd#holx_Impairmentofintangibleassetsandequipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:to="loc_holx_Impairmentofintangibleassetsandequipment_7b941e83-4202-430f-a6da-21cdbeffc077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4d036132-e053-4383-9b6a-ac86df802404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4d036132-e053-4383-9b6a-ac86df802404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_3018368e-19b7-4e0a-b8b3-1bcfaad32edb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_3018368e-19b7-4e0a-b8b3-1bcfaad32edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3b50871-6b02-4e51-baa2-ca836a0e5094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2f96bd3-a604-4fc4-8109-c62e105a5ada" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3b50871-6b02-4e51-baa2-ca836a0e5094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_afb8ffe4-35fc-4d1f-8ccd-e2eee410c9e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3b50871-6b02-4e51-baa2-ca836a0e5094" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_afb8ffe4-35fc-4d1f-8ccd-e2eee410c9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c6930d46-21df-4c10-a16e-88533d2b3a1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3b50871-6b02-4e51-baa2-ca836a0e5094" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c6930d46-21df-4c10-a16e-88533d2b3a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_0a1e8f42-d3cf-4773-8cf1-8a8abd1f438e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3b50871-6b02-4e51-baa2-ca836a0e5094" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_0a1e8f42-d3cf-4773-8cf1-8a8abd1f438e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_dc328294-d966-4e7e-abc8-aa51039ebe34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3b50871-6b02-4e51-baa2-ca836a0e5094" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_dc328294-d966-4e7e-abc8-aa51039ebe34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_40dce5b6-b445-4163-a9aa-25e11d28a1ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3b50871-6b02-4e51-baa2-ca836a0e5094" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_40dce5b6-b445-4163-a9aa-25e11d28a1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9f852e6c-d52c-44ea-a5b4-d007f1887600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3b50871-6b02-4e51-baa2-ca836a0e5094" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9f852e6c-d52c-44ea-a5b4-d007f1887600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_400103cd-4255-4725-a4e0-e473b0188695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3b50871-6b02-4e51-baa2-ca836a0e5094" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_400103cd-4255-4725-a4e0-e473b0188695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0220baca-5d48-4bd8-b56f-7b1229fa2c35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3ebcaebc-f4fa-45ce-829c-60b602c7cfd1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0220baca-5d48-4bd8-b56f-7b1229fa2c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6a2fdd7b-8622-47ce-aba0-ad67bd531b2d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5fdb1d8d-cc07-4d3d-b64f-207fa88195de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5fdb1d8d-cc07-4d3d-b64f-207fa88195de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_117186b7-0273-4656-860f-7e8a7dae6b25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_117186b7-0273-4656-860f-7e8a7dae6b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a59e6edf-d713-4653-a71a-b94ee8f5d781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a59e6edf-d713-4653-a71a-b94ee8f5d781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FundingOfLoansToSSI_35b8079a-1d2c-4421-8b2d-7d795dc5b870" xlink:href="holx-20210925.xsd#holx_FundingOfLoansToSSI"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:to="loc_holx_FundingOfLoansToSSI_35b8079a-1d2c-4421-8b2d-7d795dc5b870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3b86cfdd-06eb-4879-a6c5-9807697fcb6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3b86cfdd-06eb-4879-a6c5-9807697fcb6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_d56d2707-b287-4f68-8aee-1e3f1f024e0d" xlink:href="holx-20210925.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_d56d2707-b287-4f68-8aee-1e3f1f024e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_9331a6cf-3e47-47b0-9cfd-235c7fb49baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_9331a6cf-3e47-47b0-9cfd-235c7fb49baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2fc9773b-7aaf-4e0f-8ce6-5d5011adf616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2fc9773b-7aaf-4e0f-8ce6-5d5011adf616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_743f24ac-3bcb-452b-8d0e-a20613a5997b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3b3776de-cfe0-4540-93a5-679a006b1ff4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_743f24ac-3bcb-452b-8d0e-a20613a5997b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6a2fdd7b-8622-47ce-aba0-ad67bd531b2d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_b0846b72-6619-4ba9-ad5e-6f646d751cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_b0846b72-6619-4ba9-ad5e-6f646d751cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_df0384c2-efdf-4b1d-861c-922739d86317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_df0384c2-efdf-4b1d-861c-922739d86317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsfromSeniorNotes_66cbd357-d23d-47ca-96a9-7c56acf5cf8b" xlink:href="holx-20210925.xsd#holx_ProceedsfromSeniorNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_holx_ProceedsfromSeniorNotes_66cbd357-d23d-47ca-96a9-7c56acf5cf8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentofSeniorNotes_9b6d85dd-d72f-49ab-82e6-bd32bf46ba7d" xlink:href="holx-20210925.xsd#holx_RepaymentofSeniorNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_holx_RepaymentofSeniorNotes_9b6d85dd-d72f-49ab-82e6-bd32bf46ba7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_644ca2ec-6c08-495c-994e-c2148223dc06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_644ca2ec-6c08-495c-994e-c2148223dc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_81ded27b-8d55-4398-b10e-9714d6496864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_81ded27b-8d55-4398-b10e-9714d6496864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_a162f7a2-2953-498e-af12-5cb743763dc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_a162f7a2-2953-498e-af12-5cb743763dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_b4072636-9d03-435a-bd38-12f8ecf3b173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_b4072636-9d03-435a-bd38-12f8ecf3b173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_7a493a02-5b5b-4785-9110-41b821d0c7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_7a493a02-5b5b-4785-9110-41b821d0c7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e327645e-ee65-44f1-b89a-e6051f069234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e327645e-ee65-44f1-b89a-e6051f069234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsForDeferredAcquisitionConsideration_b9fdcfe1-67b0-4acd-a850-35066eaa642e" xlink:href="holx-20210925.xsd#holx_PaymentsForDeferredAcquisitionConsideration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_holx_PaymentsForDeferredAcquisitionConsideration_b9fdcfe1-67b0-4acd-a850-35066eaa642e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_72165a0f-842f-4f54-9512-12c8b596bcc3" xlink:href="holx-20210925.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_72165a0f-842f-4f54-9512-12c8b596bcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_24b7e1cd-0999-4d1c-ad5c-2f663b3f8bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_24b7e1cd-0999-4d1c-ad5c-2f663b3f8bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_1237b877-87d5-4c48-88e0-67b89942ad02" xlink:href="holx-20210925.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_1237b877-87d5-4c48-88e0-67b89942ad02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsUnderFinanceLeaseObligations_b1a86a6e-80bd-4e03-a6f9-559c7975d764" xlink:href="holx-20210925.xsd#holx_PaymentsUnderFinanceLeaseObligations"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_holx_PaymentsUnderFinanceLeaseObligations_b1a86a6e-80bd-4e03-a6f9-559c7975d764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7784d021-d5ef-4613-8dc9-ad125060d61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c06bd69f-f2b5-4dfa-b4db-70073790e513" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7784d021-d5ef-4613-8dc9-ad125060d61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_313dc44d-9c3a-494b-a3ee-9a33b3417f28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6a2fdd7b-8622-47ce-aba0-ad67bd531b2d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_313dc44d-9c3a-494b-a3ee-9a33b3417f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55c59ead-fe55-421d-86dd-96856d0024c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6a2fdd7b-8622-47ce-aba0-ad67bd531b2d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_55c59ead-fe55-421d-86dd-96856d0024c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3b6cb581-b3ac-48ff-8c69-0cd504306192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6a2fdd7b-8622-47ce-aba0-ad67bd531b2d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3b6cb581-b3ac-48ff-8c69-0cd504306192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ba5486a-fa96-4742-9149-21ea578d9448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6a2fdd7b-8622-47ce-aba0-ad67bd531b2d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ba5486a-fa96-4742-9149-21ea578d9448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Operations" xlink:type="simple" xlink:href="holx-20210925.xsd#Operations"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Operations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a56c9f49-d347-4007-97d1-cb9b4837e26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_64fd81bd-f8a6-4a73-a1f3-46ed8abe1406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a56c9f49-d347-4007-97d1-cb9b4837e26c" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_64fd81bd-f8a6-4a73-a1f3-46ed8abe1406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OperationsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#OperationsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_410a427e-2239-4b42-80b4-d586a1a7514c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_96e74804-df75-4403-b1f7-7a53ff7182f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c20f2ed5-1e57-482a-b428-0df72092c671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_96e74804-df75-4403-b1f7-7a53ff7182f5" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c20f2ed5-1e57-482a-b428-0df72092c671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_3341ecbb-b797-4bae-8144-ed0721236d23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_3341ecbb-b797-4bae-8144-ed0721236d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5b1ae03b-a8d4-4785-8f12-2bb9fea27d5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_UseOfEstimates_5b1ae03b-a8d4-4785-8f12-2bb9fea27d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_68f5ee8f-cd15-4044-baac-2d98d176ac1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_68f5ee8f-cd15-4044-baac-2d98d176ac1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_9b4d5e0a-8da8-4b4d-80cd-79737eb64cc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_9b4d5e0a-8da8-4b4d-80cd-79737eb64cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_906a120a-fd19-4127-83d4-231c555ee11b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_906a120a-fd19-4127-83d4-231c555ee11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d122e71b-f85a-4aaf-9b75-c73e6d06cdec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d122e71b-f85a-4aaf-9b75-c73e6d06cdec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongLivedAssetsPolicyPolicyTextBlock_901e66e7-bfa4-4b58-a46e-9ff3c05121b9" xlink:href="holx-20210925.xsd#holx_LongLivedAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_holx_LongLivedAssetsPolicyPolicyTextBlock_901e66e7-bfa4-4b58-a46e-9ff3c05121b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_b4da3547-87e2-4d75-b039-da319f7d6116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_b4da3547-87e2-4d75-b039-da319f7d6116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherAssetsPolicyPolicyTextBlock_94ac2fa6-314f-478f-886d-d9759b477271" xlink:href="holx-20210925.xsd#holx_OtherAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_holx_OtherAssetsPolicyPolicyTextBlock_94ac2fa6-314f-478f-886d-d9759b477271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_b9368717-3bb7-48fe-a120-7e3bab03e604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_b9368717-3bb7-48fe-a120-7e3bab03e604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ed1f0681-5efe-4c65-87c0-0d9128845722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ed1f0681-5efe-4c65-87c0-0d9128845722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_64a431f3-8b80-44d3-9497-c4a76bb716fd" xlink:href="holx-20210925.xsd#holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock_64a431f3-8b80-44d3-9497-c4a76bb716fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_8720ff04-9b0a-42eb-af83-49b3848c7ebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_8720ff04-9b0a-42eb-af83-49b3848c7ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_2052b3eb-8adc-482f-b194-b881c652d626" xlink:href="holx-20210925.xsd#holx_AccountsReceivableAndReservesPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock_2052b3eb-8adc-482f-b194-b881c652d626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_c2fffaea-6001-4e25-bcc5-a3ee5d4048d6" xlink:href="holx-20210925.xsd#holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock_c2fffaea-6001-4e25-bcc5-a3ee5d4048d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8314f5aa-8a91-44af-8fb3-a751ffc98c4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_8314f5aa-8a91-44af-8fb3-a751ffc98c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_e03a3b13-9c14-46a9-8391-e5516a96841e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_e03a3b13-9c14-46a9-8391-e5516a96841e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_bd233b27-0df0-4f6c-a74c-20f81597b212" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_bd233b27-0df0-4f6c-a74c-20f81597b212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_4332e1e8-1efa-43dd-a339-3ec025dd4357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8bd6e66d-2494-4ff2-a536-36e5069fd673" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_4332e1e8-1efa-43dd-a339-3ec025dd4357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_abfe3993-017e-4d0c-aa72-8a6582db3e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_abfe3993-017e-4d0c-aa72-8a6582db3e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_fffcec34-03a3-4289-ac0e-b7714fab2c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_fffcec34-03a3-4289-ac0e-b7714fab2c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7efb5e7e-93b7-44f6-9430-d4eb948c3fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7efb5e7e-93b7-44f6-9430-d4eb948c3fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_7f9a9837-a0c4-4344-b499-de528173e629" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_7f9a9837-a0c4-4344-b499-de528173e629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_bfea178e-2024-40d6-9330-9dea30055d48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_bfea178e-2024-40d6-9330-9dea30055d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock_2ac37181-8968-4205-ab8c-ddfaeb6646b8" xlink:href="holx-20210925.xsd#holx_ScheduleOfGoodwillBySegmentTableTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock_2ac37181-8968-4205-ab8c-ddfaeb6646b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_dd9a4ab9-c56e-4f80-b2aa-fea9c673a699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_dd9a4ab9-c56e-4f80-b2aa-fea9c673a699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_2ca5e5a4-e2df-4485-be55-2bea97980922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_2ca5e5a4-e2df-4485-be55-2bea97980922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c12f3818-77f3-4b47-8beb-79a1ebbbf7d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c12f3818-77f3-4b47-8beb-79a1ebbbf7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_fac5e1be-64e4-4f94-8282-0df8dfbccf7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_fac5e1be-64e4-4f94-8282-0df8dfbccf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2fe5aee9-7f87-4bbd-b101-2d40e3fe5617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_2fe5aee9-7f87-4bbd-b101-2d40e3fe5617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_c6590b32-b546-4a0a-83d2-0353fd601855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_c6590b32-b546-4a0a-83d2-0353fd601855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5cdf3d68-32dc-43e8-a5b2-d51d62241f14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5cdf3d68-32dc-43e8-a5b2-d51d62241f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_89bb0e1d-29e1-4ae7-8723-e0fb52de5df7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b019e1ad-ab4f-45e8-bc0b-ff65bb7db5e3" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_89bb0e1d-29e1-4ae7-8723-e0fb52de5df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_095e31f7-cb0b-41ae-a4e0-84f06c180e98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:href="holx-20210925.xsd#holx_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_095e31f7-cb0b-41ae-a4e0-84f06c180e98" xlink:to="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f04d8eb5-2f7e-49b8-bc3d-f6c9ac3581f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f04d8eb5-2f7e-49b8-bc3d-f6c9ac3581f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3e1fb5c1-d97f-4284-8f78-f2e76a13923d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f04d8eb5-2f7e-49b8-bc3d-f6c9ac3581f1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3e1fb5c1-d97f-4284-8f78-f2e76a13923d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_f5ee5d5c-cdd7-473a-bf10-06f7acde3d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e1fb5c1-d97f-4284-8f78-f2e76a13923d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_f5ee5d5c-cdd7-473a-bf10-06f7acde3d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_144871fd-f187-4308-9c56-256cc780b0dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3e1fb5c1-d97f-4284-8f78-f2e76a13923d" xlink:to="loc_us-gaap_InterestRateCapMember_144871fd-f187-4308-9c56-256cc780b0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e92f1a9a-2114-4003-b307-daf7bb7a123b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e92f1a9a-2114-4003-b307-daf7bb7a123b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fb78fd4f-f8af-4d80-89b7-e49a54a6227a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e92f1a9a-2114-4003-b307-daf7bb7a123b" xlink:to="loc_us-gaap_SegmentDomain_fb78fd4f-f8af-4d80-89b7-e49a54a6227a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_f3ae42b0-864e-4862-b138-2f9e687c9923" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fb78fd4f-f8af-4d80-89b7-e49a54a6227a" xlink:to="loc_holx_MedicalAestheticsMember_f3ae42b0-864e-4862-b138-2f9e687c9923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d780c5d4-9ee5-4841-84b2-f93c93551924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d780c5d4-9ee5-4841-84b2-f93c93551924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74ebd22c-8e5e-4c8b-a3b0-86fe1217bd3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d780c5d4-9ee5-4841-84b2-f93c93551924" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74ebd22c-8e5e-4c8b-a3b0-86fe1217bd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_f2d5f4ac-5327-458e-8f24-075d23c76d85" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74ebd22c-8e5e-4c8b-a3b0-86fe1217bd3b" xlink:to="loc_holx_AcessaHealthMember_f2d5f4ac-5327-458e-8f24-075d23c76d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_8b2fc63e-7015-4d99-9965-4725753cdf7e" xlink:href="holx-20210925.xsd#holx_BolderSurgicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74ebd22c-8e5e-4c8b-a3b0-86fe1217bd3b" xlink:to="loc_holx_BolderSurgicalMember_8b2fc63e-7015-4d99-9965-4725753cdf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1005b9a1-b749-497c-b56f-9bd3d5d58e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1005b9a1-b749-497c-b56f-9bd3d5d58e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5bdda01d-9926-43ba-9057-5dfe566ea1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1005b9a1-b749-497c-b56f-9bd3d5d58e00" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5bdda01d-9926-43ba-9057-5dfe566ea1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c3b8817e-878c-4073-84d0-9faec6a77062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5bdda01d-9926-43ba-9057-5dfe566ea1b6" xlink:to="loc_us-gaap_InterestRateCapMember_c3b8817e-878c-4073-84d0-9faec6a77062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_335150a9-6809-4e87-8ea8-5f3daea05874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5bdda01d-9926-43ba-9057-5dfe566ea1b6" xlink:to="loc_us-gaap_InterestRateSwapMember_335150a9-6809-4e87-8ea8-5f3daea05874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3b4233ff-0d22-44a5-933b-231bdc5028ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_srt_RangeAxis_3b4233ff-0d22-44a5-933b-231bdc5028ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f179bf83-6a9c-4396-a790-5c0456af81f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3b4233ff-0d22-44a5-933b-231bdc5028ea" xlink:to="loc_srt_RangeMember_f179bf83-6a9c-4396-a790-5c0456af81f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e8f5474a-f951-44df-9c22-07356a7ec4aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f179bf83-6a9c-4396-a790-5c0456af81f3" xlink:to="loc_srt_MinimumMember_e8f5474a-f951-44df-9c22-07356a7ec4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_12135cf4-38ea-4e37-84bf-3d77232612ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f179bf83-6a9c-4396-a790-5c0456af81f3" xlink:to="loc_srt_MaximumMember_12135cf4-38ea-4e37-84bf-3d77232612ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_50cf09d8-b83a-4aeb-81cb-b49e65976ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_50cf09d8-b83a-4aeb-81cb-b49e65976ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6130bfef-518e-4964-a5d3-b3f71ed0d771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_50cf09d8-b83a-4aeb-81cb-b49e65976ae0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6130bfef-518e-4964-a5d3-b3f71ed0d771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_356a6165-b715-4309-941f-01b4461777c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6130bfef-518e-4964-a5d3-b3f71ed0d771" xlink:to="loc_us-gaap_AccountsReceivableMember_356a6165-b715-4309-941f-01b4461777c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevenueMember_5e806b79-1cec-4a7e-93e3-0aabd464a3cb" xlink:href="holx-20210925.xsd#holx_RevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6130bfef-518e-4964-a5d3-b3f71ed0d771" xlink:to="loc_holx_RevenueMember_5e806b79-1cec-4a7e-93e3-0aabd464a3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b696fac4-827f-45a3-8c8d-d849da916d12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b696fac4-827f-45a3-8c8d-d849da916d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b696fac4-827f-45a3-8c8d-d849da916d12" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_18780a64-41ef-4e9f-b236-3bc897b50642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_18780a64-41ef-4e9f-b236-3bc897b50642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember_71dd660f-5cba-4b12-b0a5-488e212e2ed4" xlink:href="holx-20210925.xsd#holx_DistributionagreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_holx_DistributionagreementMember_71dd660f-5cba-4b12-b0a5-488e212e2ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_2e3f7fa5-2288-40c4-9229-94f41d4aab11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_us-gaap_CustomerRelationshipsMember_2e3f7fa5-2288-40c4-9229-94f41d4aab11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_096f6f19-9be2-4af3-8ee5-9c85a5fa6a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_us-gaap_TradeNamesMember_096f6f19-9be2-4af3-8ee5-9c85a5fa6a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_f0c12a15-63b3-4602-b376-4653c7773490" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_holx_DevelopedTechnologyMember_f0c12a15-63b3-4602-b376-4653c7773490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_2a27734d-2786-4fe8-87a9-349092decb05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_273fff3b-dd84-405b-8067-0cf316742437" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_2a27734d-2786-4fe8-87a9-349092decb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e657af3-2cd6-4876-981a-bd305bdb510a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e657af3-2cd6-4876-981a-bd305bdb510a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e657af3-2cd6-4876-981a-bd305bdb510a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_ff4ffd24-7aa5-4168-babe-d84b683e350b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:to="loc_us-gaap_TradeNamesMember_ff4ffd24-7aa5-4168-babe-d84b683e350b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_5c31825e-c603-4b73-b452-20fea46a65b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_5c31825e-c603-4b73-b452-20fea46a65b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_594c5d9c-c9ff-453c-b8e9-9e17fcec20ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4016f5a9-bc91-4fb3-8369-976f35d47110" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_594c5d9c-c9ff-453c-b8e9-9e17fcec20ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e7b98b17-91e2-4833-a271-934ed6bf2a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e7b98b17-91e2-4833-a271-934ed6bf2a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_d4c8206a-5ea7-4f90-8249-88e9fc14def6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e7b98b17-91e2-4833-a271-934ed6bf2a06" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_d4c8206a-5ea7-4f90-8249-88e9fc14def6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_5bbc5836-c4b3-470e-a546-b1d5d23a7951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_d4c8206a-5ea7-4f90-8249-88e9fc14def6" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_5bbc5836-c4b3-470e-a546-b1d5d23a7951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_89b5fb72-ae5b-4cd9-9650-9d15800d46b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_89b5fb72-ae5b-4cd9-9650-9d15800d46b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1fe4e1a8-ca78-4e8a-b01a-c51c51106289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_89b5fb72-ae5b-4cd9-9650-9d15800d46b2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1fe4e1a8-ca78-4e8a-b01a-c51c51106289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_aace323d-b3d8-4162-abad-8f4d98ceaae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1fe4e1a8-ca78-4e8a-b01a-c51c51106289" xlink:to="loc_us-gaap_SubsequentEventMember_aace323d-b3d8-4162-abad-8f4d98ceaae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_7bb3d3da-b4d5-4d13-a53e-e9ddd4c2ac9e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_srt_MajorCustomersAxis_7bb3d3da-b4d5-4d13-a53e-e9ddd4c2ac9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_c9faeb87-7595-46e3-9e3b-a41efa65a498" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_7bb3d3da-b4d5-4d13-a53e-e9ddd4c2ac9e" xlink:to="loc_srt_NameOfMajorCustomerDomain_c9faeb87-7595-46e3-9e3b-a41efa65a498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OneCustomerMember_385b6ad4-ed91-4b15-9923-a6511deaae31" xlink:href="holx-20210925.xsd#holx_OneCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_c9faeb87-7595-46e3-9e3b-a41efa65a498" xlink:to="loc_holx_OneCustomerMember_385b6ad4-ed91-4b15-9923-a6511deaae31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:href="holx-20210925.xsd#holx_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesTable_65e002b3-f69e-488c-a369-492bde3e4305" xlink:to="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_87532e5e-d2c4-43e7-b5e7-37003ca083f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_AssetImpairmentCharges_87532e5e-d2c4-43e7-b5e7-37003ca083f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashEquivalentsMaturityPeriod_98016e86-1ab2-4d49-9308-347075b42574" xlink:href="holx-20210925.xsd#holx_CashEquivalentsMaturityPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_CashEquivalentsMaturityPeriod_98016e86-1ab2-4d49-9308-347075b42574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e2da357d-7756-4978-aa09-c4ccb6026893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e2da357d-7756-4978-aa09-c4ccb6026893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_50a57f2c-6750-4c4d-bbb7-db9b71415b83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_50a57f2c-6750-4c4d-bbb7-db9b71415b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_da92a0db-5165-4808-a5da-8d4c0403135b" xlink:href="holx-20210925.xsd#holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage_da92a0db-5165-4808-a5da-8d4c0403135b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_34704a47-d016-4c75-a492-0e8ba0019024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_34704a47-d016-4c75-a492-0e8ba0019024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_73bdce36-d13c-41fc-85da-717b5738d4d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_73bdce36-d13c-41fc-85da-717b5738d4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5366341-1c4c-4e72-8b93-17967fb2065d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5366341-1c4c-4e72-8b93-17967fb2065d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_20259ac3-06d2-4997-a47d-5a65d8772346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_Goodwill_20259ac3-06d2-4997-a47d-5a65d8772346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_85f689f5-1457-44dd-843a-a2c8bd60cf60" xlink:href="holx-20210925.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_85f689f5-1457-44dd-843a-a2c8bd60cf60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_f28c7841-eeb3-4b8a-833e-0977dec1b4c7" xlink:href="holx-20210925.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_PrincipalAmountOfBorrowings_f28c7841-eeb3-4b8a-833e-0977dec1b4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_b7899754-240b-4129-ab16-168791025c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_DerivativeTermOfContract_b7899754-240b-4129-ab16-168791025c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_5ee2988c-959b-41e7-a6d3-3ab1a6f3b31d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_5ee2988c-959b-41e7-a6d3-3ab1a6f3b31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_254ad7ad-c5f0-4ea8-9ac8-6fda54e92577" xlink:href="holx-20210925.xsd#holx_NotionalAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_NotionalAmount_254ad7ad-c5f0-4ea8-9ac8-6fda54e92577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WarrantyTermForProducts_67a07805-5154-44c7-82d8-d5f563bfcd7b" xlink:href="holx-20210925.xsd#holx_WarrantyTermForProducts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_holx_WarrantyTermForProducts_67a07805-5154-44c7-82d8-d5f563bfcd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_65b201db-22f7-4dea-9313-ea9d711a9fca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_AdvertisingExpense_65b201db-22f7-4dea-9313-ea9d711a9fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2ea50671-6d81-4107-87c5-1c43000c92cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2ea50671-6d81-4107-87c5-1c43000c92cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_740283ed-fefa-49f6-9bd8-8a3593059f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_740283ed-fefa-49f6-9bd8-8a3593059f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_650e0500-4645-48d6-a99e-7556877b1480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_650e0500-4645-48d6-a99e-7556877b1480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_96448040-17b3-426e-9d7c-f53672d85fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_96448040-17b3-426e-9d7c-f53672d85fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b108c910-63b9-44aa-bc1a-746e4901648d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b108c910-63b9-44aa-bc1a-746e4901648d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_5f05be4c-98fa-4515-b0e3-c1d751eeea6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8e4bd918-819e-4abe-bb3e-00ab51489f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SignificantAccountingPoliciesLineItems_c7b22f36-814e-420c-b1b4-5ad75e1e7910" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8e4bd918-819e-4abe-bb3e-00ab51489f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_44fbbc70-8fe8-41b1-878f-91a7236d2245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_dade19e9-933f-424b-a024-c081fcd9cbbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44fbbc70-8fe8-41b1-878f-91a7236d2245" xlink:to="loc_us-gaap_IncomeTaxesPaid_dade19e9-933f-424b-a024-c081fcd9cbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_90175e7b-ba56-47e1-be15-3aa756b82ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44fbbc70-8fe8-41b1-878f-91a7236d2245" xlink:to="loc_us-gaap_InterestPaid_90175e7b-ba56-47e1-be15-3aa756b82ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_399ef1ab-347f-454b-b230-2fea8be3f11c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44fbbc70-8fe8-41b1-878f-91a7236d2245" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_399ef1ab-347f-454b-b230-2fea8be3f11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_75b7a4cc-ac35-4d4f-bc61-44de8c6fb8d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_1724a288-33f9-4585-9df1-97a9c7bd2b0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_75b7a4cc-ac35-4d4f-bc61-44de8c6fb8d6" xlink:to="loc_us-gaap_InventoryRawMaterials_1724a288-33f9-4585-9df1-97a9c7bd2b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_5e88584c-741d-4215-a8be-7c8a943fd514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_75b7a4cc-ac35-4d4f-bc61-44de8c6fb8d6" xlink:to="loc_us-gaap_InventoryWorkInProcess_5e88584c-741d-4215-a8be-7c8a943fd514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_a22ea170-d92c-45bd-acf3-b703e901c338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_75b7a4cc-ac35-4d4f-bc61-44de8c6fb8d6" xlink:to="loc_us-gaap_InventoryFinishedGoods_a22ea170-d92c-45bd-acf3-b703e901c338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8a29133b-5f38-480a-a538-4bf63ae26254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_75b7a4cc-ac35-4d4f-bc61-44de8c6fb8d6" xlink:to="loc_us-gaap_InventoryNet_8a29133b-5f38-480a-a538-4bf63ae26254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5359bbed-cf3b-4936-9942-e54da45d4a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5359bbed-cf3b-4936-9942-e54da45d4a66" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49ae222f-87d8-43a9-b5d1-0ed7731f1f14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49ae222f-87d8-43a9-b5d1-0ed7731f1f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49ae222f-87d8-43a9-b5d1-0ed7731f1f14" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentAndSoftwareMember_99e4fa17-aa86-4652-8172-2bdf66e84f66" xlink:href="holx-20210925.xsd#holx_EquipmentAndSoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:to="loc_holx_EquipmentAndSoftwareMember_99e4fa17-aa86-4652-8172-2bdf66e84f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreementMember_dce3ff05-9aad-4923-a131-1f4d50d3bf7f" xlink:href="holx-20210925.xsd#holx_EquipmentUnderCustomerUsageAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreementMember_dce3ff05-9aad-4923-a131-1f4d50d3bf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_821c297b-1677-4a03-8cc3-70a71a2e835a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_821c297b-1677-4a03-8cc3-70a71a2e835a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_75e61c1a-deb1-4f21-a052-523d9af212f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3309988e-07ed-4267-a9d3-8b7db4bc07c3" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_75e61c1a-deb1-4f21-a052-523d9af212f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_edcb35d4-f43c-41ae-b4ec-cf479571b7e7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:to="loc_srt_RangeAxis_edcb35d4-f43c-41ae-b4ec-cf479571b7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4e9ebe19-3449-486d-b27a-4be8c93ce53c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_edcb35d4-f43c-41ae-b4ec-cf479571b7e7" xlink:to="loc_srt_RangeMember_4e9ebe19-3449-486d-b27a-4be8c93ce53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_34c81af1-6358-4df5-a16f-bf7527b06f6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4e9ebe19-3449-486d-b27a-4be8c93ce53c" xlink:to="loc_srt_MinimumMember_34c81af1-6358-4df5-a16f-bf7527b06f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a13a1df0-6d81-470a-a9ce-44328dc60fac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4e9ebe19-3449-486d-b27a-4be8c93ce53c" xlink:to="loc_srt_MaximumMember_a13a1df0-6d81-470a-a9ce-44328dc60fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_682b674e-966a-4a2a-9cb5-572a77c5370a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_682b674e-966a-4a2a-9cb5-572a77c5370a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8ac46adb-89c8-43e6-8294-14917a169d95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_682b674e-966a-4a2a-9cb5-572a77c5370a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8ac46adb-89c8-43e6-8294-14917a169d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_733926fa-286d-4848-8e5b-d984ab21e704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8ac46adb-89c8-43e6-8294-14917a169d95" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_733926fa-286d-4848-8e5b-d984ab21e704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_26052892-9545-4222-9a99-e6ef9cd35953" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_da6995d4-bdf7-424c-9275-e12514d147bb" xlink:href="holx-20210925.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_da6995d4-bdf7-424c-9275-e12514d147bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_3d5b965f-3806-4eff-978d-42cb934419a9" xlink:href="holx-20210925.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_3d5b965f-3806-4eff-978d-42cb934419a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_7bf957ae-1a08-4ff3-ac21-13b563a3e007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_7bf957ae-1a08-4ff3-ac21-13b563a3e007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_a128ec42-6ca2-434a-8fa2-d34c884b9eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_a128ec42-6ca2-434a-8fa2-d34c884b9eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_46bc090d-9663-4dc2-8809-9f6b15ee3e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_Land_46bc090d-9663-4dc2-8809-9f6b15ee3e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_f13c83eb-215b-4aa0-8573-f129f2dd2bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_f13c83eb-215b-4aa0-8573-f129f2dd2bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_38a42b10-444e-47e9-909e-8feb913f9a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_38a42b10-444e-47e9-909e-8feb913f9a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_16cda6a7-ce1e-45e3-9dd7-c14d9db0c337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_16cda6a7-ce1e-45e3-9dd7-c14d9db0c337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c3a9cb3d-3d25-4207-a85d-804d21d93595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c3a9cb3d-3d25-4207-a85d-804d21d93595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9464b801-aa01-40ba-b397-08c9d88ccf78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9464b801-aa01-40ba-b397-08c9d88ccf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b53bd0c5-73c2-4ad1-857a-5fec705ee716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b53bd0c5-73c2-4ad1-857a-5fec705ee716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrantsReceivedFromDepartmentOfDefense_37d3e28e-8a70-432c-8037-7a268ec09daa" xlink:href="holx-20210925.xsd#holx_GrantsReceivedFromDepartmentOfDefense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_holx_GrantsReceivedFromDepartmentOfDefense_37d3e28e-8a70-432c-8037-7a268ec09daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DepartmentOfDefenseFundsReceived_f8edb25a-a667-4640-b457-3e602f746a22" xlink:href="holx-20210925.xsd#holx_DepartmentOfDefenseFundsReceived"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4bc653fb-6dc9-49fc-a770-6bf10b1eea8f" xlink:to="loc_holx_DepartmentOfDefenseFundsReceived_f8edb25a-a667-4640-b457-3e602f746a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d59f260d-705f-4848-b658-e11c68704285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d59f260d-705f-4848-b658-e11c68704285" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_811e772a-2618-44f7-82cd-ffaf871945c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_811e772a-2618-44f7-82cd-ffaf871945c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_811e772a-2618-44f7-82cd-ffaf871945c7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_d73610b1-6643-40bb-8fef-c124ad25e4a0" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_MobidiagOyMember_d73610b1-6643-40bb-8fef-c124ad25e4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_e5954de5-672f-4854-ab35-72922584eec7" xlink:href="holx-20210925.xsd#holx_BiotheranosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_BiotheranosticsMember_e5954de5-672f-4854-ab35-72922584eec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_f338adb3-422c-4a21-923a-199c1106382b" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_DiagenodeMember_f338adb3-422c-4a21-923a-199c1106382b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMember_2686258d-5155-4319-a844-a20669b2a7c9" xlink:href="holx-20210925.xsd#holx_SomatexMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_SomatexMember_2686258d-5155-4319-a844-a20669b2a7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_551c5146-c7b2-4375-8ebf-c89fb1155e8b" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69eb31c8-dfee-4a59-bc61-eafe8cf2140e" xlink:to="loc_holx_AcessaHealthMember_551c5146-c7b2-4375-8ebf-c89fb1155e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_86730b8c-c5f0-4088-b2d9-f2e108b06344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_86730b8c-c5f0-4088-b2d9-f2e108b06344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e8b0454c-519e-4a8f-bad3-6a2fe3bd1f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_86730b8c-c5f0-4088-b2d9-f2e108b06344" xlink:to="loc_us-gaap_SegmentDomain_e8b0454c-519e-4a8f-bad3-6a2fe3bd1f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_043c7713-23a7-4060-bc1b-c6967f750a74" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e8b0454c-519e-4a8f-bad3-6a2fe3bd1f89" xlink:to="loc_holx_MedicalAestheticsMember_043c7713-23a7-4060-bc1b-c6967f750a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_ce7e8e54-0e11-4396-a4d2-e392cd13063b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_ce7e8e54-0e11-4396-a4d2-e392cd13063b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_ce7e8e54-0e11-4396-a4d2-e392cd13063b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_7a2cb2ec-1fd4-41a4-9e52-9d43b51bfec1" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:to="loc_holx_DevelopedTechnologyMember_7a2cb2ec-1fd4-41a4-9e52-9d43b51bfec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_8dce7af5-3ba0-4da5-865f-b272e02f9921" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:to="loc_us-gaap_CustomerRelationshipsMember_8dce7af5-3ba0-4da5-865f-b272e02f9921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_64967a62-4b95-4127-883e-ac02247c9e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:to="loc_us-gaap_TradeNamesMember_64967a62-4b95-4127-883e-ac02247c9e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_5904b6cb-7b72-412b-a2a2-6c3bd8b5dcf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_39f884f9-b2c3-4b07-83c1-8e5874121115" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_5904b6cb-7b72-412b-a2a2-6c3bd8b5dcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c3f266fd-0d9c-4cf8-b97b-e4dbf3f6d509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c3f266fd-0d9c-4cf8-b97b-e4dbf3f6d509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c3f266fd-0d9c-4cf8-b97b-e4dbf3f6d509" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_6b5efae8-f40f-45cf-af82-68d3e483986e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_6b5efae8-f40f-45cf-af82-68d3e483986e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_fdd54ecb-ea84-4b32-b75f-2f93b24c22bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_fdd54ecb-ea84-4b32-b75f-2f93b24c22bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_0507f764-a962-4522-a639-b74b88c40ea2" xlink:href="holx-20210925.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_CustomerRelationshipsContractsMember_0507f764-a962-4522-a639-b74b88c40ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a06a9f56-2b8d-4c9d-b3d1-29f0ac1fd954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_TradeNamesMember_a06a9f56-2b8d-4c9d-b3d1-29f0ac1fd954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_05f02995-88d4-4050-9523-8d98f85bc8e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_05f02995-88d4-4050-9523-8d98f85bc8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_f884a796-e1d4-4f7a-82b1-714a1c5a88a1" xlink:href="holx-20210925.xsd#holx_BusinessLicensesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_BusinessLicensesMember_f884a796-e1d4-4f7a-82b1-714a1c5a88a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_e710e6f2-7682-4861-9e8e-99905ce0ec86" xlink:href="holx-20210925.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_AcquiredintangibleassetsMember_e710e6f2-7682-4861-9e8e-99905ce0ec86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_c29b0f57-e5d8-4f6f-ac29-00f3839bd46a" xlink:href="holx-20210925.xsd#holx_InternalusesoftwareMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_InternalusesoftwareMember_c29b0f57-e5d8-4f6f-ac29-00f3839bd46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_49822b55-4fc9-438e-bbb1-4755e304c894" xlink:href="holx-20210925.xsd#holx_CapitalizedsoftwareMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_CapitalizedsoftwareMember_49822b55-4fc9-438e-bbb1-4755e304c894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b4996c03-f12e-463d-aad2-32ea3ae4ffdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b4996c03-f12e-463d-aad2-32ea3ae4ffdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_aaf92f89-ea89-45ab-bc5b-2757cd141bbf" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3847b00-b394-4cd8-8622-5b5ba6eb5e58" xlink:to="loc_holx_DevelopedTechnologyMember_aaf92f89-ea89-45ab-bc5b-2757cd141bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9b82387-5db4-45a6-aacc-67679ce4534c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dd435355-7982-47fd-9353-a579136a1c8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dd435355-7982-47fd-9353-a579136a1c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8e06c826-86e1-4638-a8e0-a4ca78a52850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8e06c826-86e1-4638-a8e0-a4ca78a52850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_baa13a7b-1ac3-49fa-90f1-eece79c79ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:to="loc_us-gaap_AssetImpairmentCharges_baa13a7b-1ac3-49fa-90f1-eece79c79ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_432c09ed-64bb-4c13-80a8-ead85eaf5c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_7107a0ee-beff-4b4e-a9b0-10e8cd231959" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_432c09ed-64bb-4c13-80a8-ead85eaf5c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_38d5b801-3279-4f9b-8c14-a3174dc0a89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_38d5b801-3279-4f9b-8c14-a3174dc0a89a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_77fb2acf-d608-4273-b67c-f184ff1a16e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_77fb2acf-d608-4273-b67c-f184ff1a16e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_77fb2acf-d608-4273-b67c-f184ff1a16e1" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DistributionagreementMember_b12d9e53-43da-473d-bd00-da3955934f0f" xlink:href="holx-20210925.xsd#holx_DistributionagreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_holx_DistributionagreementMember_b12d9e53-43da-473d-bd00-da3955934f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ed8c0b23-6020-4f5c-80a3-44fffcdeb506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ed8c0b23-6020-4f5c-80a3-44fffcdeb506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_65dc9a62-853b-46a0-9f75-76befdd73181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_us-gaap_TradeNamesMember_65dc9a62-853b-46a0-9f75-76befdd73181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_344e79c7-c5f3-4215-bc6c-fd299715b065" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_holx_DevelopedTechnologyMember_344e79c7-c5f3-4215-bc6c-fd299715b065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_8232be76-b9d7-4add-ad03-927fcc46ed09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_8232be76-b9d7-4add-ad03-927fcc46ed09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_f1f15e35-70f8-4d52-a235-d31fc2b4b6b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_921f4155-7116-4e55-ac3b-b808d1391c47" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_f1f15e35-70f8-4d52-a235-d31fc2b4b6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8413badb-e278-4410-9efe-22b68ccd4136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8413badb-e278-4410-9efe-22b68ccd4136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8bb09009-f0f0-453e-9256-310b86f68cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8413badb-e278-4410-9efe-22b68ccd4136" xlink:to="loc_us-gaap_SegmentDomain_8bb09009-f0f0-453e-9256-310b86f68cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_8a13fecd-4d42-4533-b139-674385abd270" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8bb09009-f0f0-453e-9256-310b86f68cb1" xlink:to="loc_holx_MedicalAestheticsMember_8a13fecd-4d42-4533-b139-674385abd270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_79929855-d63f-4a00-b910-d8f9c412535b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_79929855-d63f-4a00-b910-d8f9c412535b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18fea7d1-555f-475e-890c-f0255335695a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_79929855-d63f-4a00-b910-d8f9c412535b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18fea7d1-555f-475e-890c-f0255335695a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_79fba838-79e5-4109-ab34-b19f9adb255a" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18fea7d1-555f-475e-890c-f0255335695a" xlink:to="loc_holx_AcessaHealthMember_79fba838-79e5-4109-ab34-b19f9adb255a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd43f887-b2c1-49cf-b8f3-152c1932623a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd43f887-b2c1-49cf-b8f3-152c1932623a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd43f887-b2c1-49cf-b8f3-152c1932623a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3e0491ed-a359-4410-9abf-5e56d1e30ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3e0491ed-a359-4410-9abf-5e56d1e30ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_527e410c-2332-4bbc-b62d-92c730527416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:to="loc_us-gaap_TradeNamesMember_527e410c-2332-4bbc-b62d-92c730527416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_89086c02-1333-4533-a2ff-871f6a3ab19f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_492d81de-6b1c-484c-a575-2870fd0b2362" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_89086c02-1333-4533-a2ff-871f6a3ab19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_799f86cd-0fbb-41f1-b6c9-9da0fcf60ebc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_e321e1e6-734c-43b8-8f95-65f17ce125e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:to="loc_us-gaap_AssetImpairmentCharges_e321e1e6-734c-43b8-8f95-65f17ce125e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ed27cb62-905d-4b86-877d-dba518a20f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ed27cb62-905d-4b86-877d-dba518a20f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cc8ae196-9b5c-4405-9553-3b53eda7e42c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9e5cd71d-e857-44fc-a58d-d2e2faa5bd17" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_cc8ae196-9b5c-4405-9553-3b53eda7e42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_df623667-9b2a-4ff0-a04f-5c0802c09f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e3108c46-bef9-444b-9ca8-fcb363104748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df623667-9b2a-4ff0-a04f-5c0802c09f8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e3108c46-bef9-444b-9ca8-fcb363104748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7c4c3c44-9661-421a-9dba-5eb62efdcbad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df623667-9b2a-4ff0-a04f-5c0802c09f8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_7c4c3c44-9661-421a-9dba-5eb62efdcbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_45185cfe-c95a-4c66-8420-99d5ed5df8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df623667-9b2a-4ff0-a04f-5c0802c09f8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_45185cfe-c95a-4c66-8420-99d5ed5df8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fa5bd5c2-7e2a-47f4-9946-7c9afed8683f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df623667-9b2a-4ff0-a04f-5c0802c09f8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fa5bd5c2-7e2a-47f4-9946-7c9afed8683f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0051a8df-fe67-42d4-bd4a-7906d0cc0a4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_df623667-9b2a-4ff0-a04f-5c0802c09f8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0051a8df-fe67-42d4-bd4a-7906d0cc0a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_59813632-41b1-4d05-ba52-c2220e18494f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_6d1409e5-097c-41bd-a12c-3baa34c94d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59813632-41b1-4d05-ba52-c2220e18494f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_6d1409e5-097c-41bd-a12c-3baa34c94d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c24a1e2f-1839-4990-b7b0-b23fa964edc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6d1409e5-097c-41bd-a12c-3baa34c94d6e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c24a1e2f-1839-4990-b7b0-b23fa964edc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c24a1e2f-1839-4990-b7b0-b23fa964edc0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_75b47a6e-0c1a-4b95-8603-259207a8704d" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:to="loc_holx_MobidiagOyMember_75b47a6e-0c1a-4b95-8603-259207a8704d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_742d1596-0607-467f-b25b-26e17d2e42d3" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:to="loc_holx_DiagenodeMember_742d1596-0607-467f-b25b-26e17d2e42d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_49e1a935-dae0-435f-8eaa-9598d0b021c5" xlink:href="holx-20210925.xsd#holx_BiotheranosticsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:to="loc_holx_BiotheranosticsMember_49e1a935-dae0-435f-8eaa-9598d0b021c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMember_fdad8854-1086-467c-b7bf-cb22f8c07cea" xlink:href="holx-20210925.xsd#holx_SomatexMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_950abafd-0bcd-4051-a4bd-07c7c50947dc" xlink:to="loc_holx_SomatexMember_fdad8854-1086-467c-b7bf-cb22f8c07cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4da26b30-6867-42e5-ac06-8b71b9eb4d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6d1409e5-097c-41bd-a12c-3baa34c94d6e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4da26b30-6867-42e5-ac06-8b71b9eb4d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4da26b30-6867-42e5-ac06-8b71b9eb4d2e" xlink:to="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_bbf0439b-a1cf-4f93-86b1-97f9a83c30cc" xlink:href="holx-20210925.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:to="loc_holx_DiagnosticsMember_bbf0439b-a1cf-4f93-86b1-97f9a83c30cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_97099577-ee79-4ebe-b279-3d269c63a8a6" xlink:href="holx-20210925.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:to="loc_holx_BreastHealthMember_97099577-ee79-4ebe-b279-3d269c63a8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_099572fc-1ad5-46a9-a93b-b9ebd8799098" xlink:href="holx-20210925.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:to="loc_holx_GynSurgicalMember_099572fc-1ad5-46a9-a93b-b9ebd8799098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_0f6a135c-d76d-4a79-98a2-b9966ae5e04e" xlink:href="holx-20210925.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2e8fc6f6-56ce-49a5-ab91-bb61523967f9" xlink:to="loc_holx_SkeletalHealthMember_0f6a135c-d76d-4a79-98a2-b9966ae5e04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_79b68a37-8527-469f-afba-fc3e7fc009e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_6d1409e5-097c-41bd-a12c-3baa34c94d6e" xlink:to="loc_us-gaap_GoodwillLineItems_79b68a37-8527-469f-afba-fc3e7fc009e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_79b68a37-8527-469f-afba-fc3e7fc009e4" xlink:to="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_34c67ba0-ad11-492b-9d06-308edfc5ff4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:to="loc_us-gaap_Goodwill_34c67ba0-ad11-492b-9d06-308edfc5ff4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_d6f146a2-a48f-410d-b84f-8806bb07d563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_d6f146a2-a48f-410d-b84f-8806bb07d563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_6333aef3-581e-4829-bcd7-fdc096fa7ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_6333aef3-581e-4829-bcd7-fdc096fa7ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8ad8c09e-1e09-494c-8195-445badf3f4a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e31e3c7a-6285-4e60-a63b-77ceb40eb812" xlink:to="loc_us-gaap_Goodwill_8ad8c09e-1e09-494c-8195-445badf3f4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1619689b-6626-4e78-af07-2d7c6da59cf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e7ad70ca-72ed-4f0c-b632-1c3ab398c779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1619689b-6626-4e78-af07-2d7c6da59cf9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e7ad70ca-72ed-4f0c-b632-1c3ab398c779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0c9497dc-18f3-4b02-b64f-70ea87d068a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e7ad70ca-72ed-4f0c-b632-1c3ab398c779" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0c9497dc-18f3-4b02-b64f-70ea87d068a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_429b9f5e-b227-47de-a1a2-0c474ee89709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0c9497dc-18f3-4b02-b64f-70ea87d068a2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_429b9f5e-b227-47de-a1a2-0c474ee89709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_cbe0cc36-a527-45e7-9663-7ff88211a6b4" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_429b9f5e-b227-47de-a1a2-0c474ee89709" xlink:to="loc_holx_AcessaHealthMember_cbe0cc36-a527-45e7-9663-7ff88211a6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e7ad70ca-72ed-4f0c-b632-1c3ab398c779" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_574b2239-5b26-4d3e-9352-631495592ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_574b2239-5b26-4d3e-9352-631495592ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c2af2d26-6493-4f70-b81e-35e271f50c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:to="loc_us-gaap_Goodwill_c2af2d26-6493-4f70-b81e-35e271f50c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GoodwillNotAtRiskOfFailingImpairment_546abdd8-37dd-429e-a995-af1199b255dc" xlink:href="holx-20210925.xsd#holx_GoodwillNotAtRiskOfFailingImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_96ce324c-b2de-47d1-9e10-f7733abd3ba5" xlink:to="loc_holx_GoodwillNotAtRiskOfFailingImpairment_546abdd8-37dd-429e-a995-af1199b255dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_dd968996-ff0d-4d56-b41e-b4d4d0cd2b8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReceivable_c7c69f24-2d6c-4d65-a5c1-692daa606e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dd968996-ff0d-4d56-b41e-b4d4d0cd2b8d" xlink:to="loc_us-gaap_IncomeTaxReceivable_c7c69f24-2d6c-4d65-a5c1-692daa606e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_45cc3038-34a1-4ac8-a54b-0ffc395aa558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dd968996-ff0d-4d56-b41e-b4d4d0cd2b8d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_45cc3038-34a1-4ac8-a54b-0ffc395aa558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_06f9e453-d109-451d-bb28-be59974b3ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dd968996-ff0d-4d56-b41e-b4d4d0cd2b8d" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_06f9e453-d109-451d-bb28-be59974b3ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_e1ab8af8-92db-4886-846a-b3db08423fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dd968996-ff0d-4d56-b41e-b4d4d0cd2b8d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_e1ab8af8-92db-4886-846a-b3db08423fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostMethodEquityInvestments_c9a436d3-a081-4f78-9004-a9b13d45f114" xlink:href="holx-20210925.xsd#holx_CostMethodEquityInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dd968996-ff0d-4d56-b41e-b4d4d0cd2b8d" xlink:to="loc_holx_CostMethodEquityInvestments_c9a436d3-a081-4f78-9004-a9b13d45f114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneous_44df4f38-0675-4a72-9221-9a5746da1526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMiscellaneous"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dd968996-ff0d-4d56-b41e-b4d4d0cd2b8d" xlink:to="loc_us-gaap_OtherAssetsMiscellaneous_44df4f38-0675-4a72-9221-9a5746da1526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ec192493-946b-41de-9db8-6b6bbbb8e6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_dd968996-ff0d-4d56-b41e-b4d4d0cd2b8d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ec192493-946b-41de-9db8-6b6bbbb8e6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_243aa44e-1f03-4dc0-8f9a-077c0efa80c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_243aa44e-1f03-4dc0-8f9a-077c0efa80c1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_203d3919-4498-48cd-8469-1f44079ed100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_203d3919-4498-48cd-8469-1f44079ed100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ae74fba3-fe01-44ab-acef-3ec672b7a715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_203d3919-4498-48cd-8469-1f44079ed100" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ae74fba3-fe01-44ab-acef-3ec672b7a715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_66f2ee80-76f2-44a8-8851-8f281a479aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_66f2ee80-76f2-44a8-8851-8f281a479aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_018a4ef3-97e3-4198-bcd9-315e9726b2e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_66f2ee80-76f2-44a8-8851-8f281a479aaf" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_018a4ef3-97e3-4198-bcd9-315e9726b2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_834f617d-140e-47c7-aac6-92b96e45af74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_018a4ef3-97e3-4198-bcd9-315e9726b2e7" xlink:to="loc_us-gaap_InterestRateSwapMember_834f617d-140e-47c7-aac6-92b96e45af74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_1fec7c86-ee1d-42ba-b3ec-c8343e953fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_018a4ef3-97e3-4198-bcd9-315e9726b2e7" xlink:to="loc_us-gaap_InterestRateCapMember_1fec7c86-ee1d-42ba-b3ec-c8343e953fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_49acec7c-8b84-4133-b544-c8526bd9a7cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_49acec7c-8b84-4133-b544-c8526bd9a7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_59eb5710-5f97-4271-9119-b61fe3c55f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_49acec7c-8b84-4133-b544-c8526bd9a7cc" xlink:to="loc_us-gaap_EquityComponentDomain_59eb5710-5f97-4271-9119-b61fe3c55f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_2ebd57c2-1b32-467d-abe2-abfc3c05243f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_59eb5710-5f97-4271-9119-b61fe3c55f24" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_2ebd57c2-1b32-467d-abe2-abfc3c05243f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_9c5accbf-e473-473f-842f-3680dd06a112" xlink:href="holx-20210925.xsd#holx_PensioninAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_59eb5710-5f97-4271-9119-b61fe3c55f24" xlink:to="loc_holx_PensioninAccumulatedOtherComprehensiveIncomeMember_9c5accbf-e473-473f-842f-3680dd06a112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_45b5c546-e836-4568-bc63-5ae9eba0483c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_14a4fbdf-2122-49f4-97e3-25922c42f2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_14a4fbdf-2122-49f4-97e3-25922c42f2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_83e05ac7-f735-4d25-8f3f-e144844c2805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_83e05ac7-f735-4d25-8f3f-e144844c2805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_8b8440fe-1304-4481-b237-359ae9b143d5" xlink:href="holx-20210925.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_8b8440fe-1304-4481-b237-359ae9b143d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d63039e3-dfe7-40ea-aed2-be362f91247f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d63039e3-dfe7-40ea-aed2-be362f91247f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0c4c10bb-da57-4719-be2a-b3fbcc7f9f52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0c4c10bb-da57-4719-be2a-b3fbcc7f9f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4ee79b6b-4cbe-40cd-9732-e4de423597ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_4ee79b6b-4cbe-40cd-9732-e4de423597ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_229a1692-7ff0-4abf-937f-87ff0bf8bfe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_229a1692-7ff0-4abf-937f-87ff0bf8bfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f3fd2a9c-2309-4228-a0e3-7c15487dd497" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f3fd2a9c-2309-4228-a0e3-7c15487dd497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_e3d5fcab-7c85-45ec-9673-eb83fecd8812" xlink:href="holx-20210925.xsd#holx_NotionalAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4179daf-244b-4cc9-b724-f6614fe8fcc7" xlink:to="loc_holx_NotionalAmount_e3d5fcab-7c85-45ec-9673-eb83fecd8812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c8dd57a1-cce5-461d-a658-e87127395425" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c0fcf466-a775-4588-9de8-72625741c407" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8dd57a1-cce5-461d-a658-e87127395425" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c0fcf466-a775-4588-9de8-72625741c407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_95685370-3d74-4087-a83d-fbbf8f2586ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c0fcf466-a775-4588-9de8-72625741c407" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_95685370-3d74-4087-a83d-fbbf8f2586ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_01cba22a-3d6f-49d0-a7fa-d4cac091b9c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_95685370-3d74-4087-a83d-fbbf8f2586ba" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_01cba22a-3d6f-49d0-a7fa-d4cac091b9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_c5427e52-6859-4586-b7e6-ce6bed6891d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_01cba22a-3d6f-49d0-a7fa-d4cac091b9c4" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_c5427e52-6859-4586-b7e6-ce6bed6891d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_da41780f-24d2-4958-8e23-125c54fb4864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_01cba22a-3d6f-49d0-a7fa-d4cac091b9c4" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_da41780f-24d2-4958-8e23-125c54fb4864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c0fcf466-a775-4588-9de8-72625741c407" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_899bb864-e731-4da2-b6be-83bb8ae4451f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet_899bb864-e731-4da2-b6be-83bb8ae4451f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_6244dbce-d3ae-4dff-98b7-37f228b8a15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_6244dbce-d3ae-4dff-98b7-37f228b8a15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_501100c8-6dce-4ff5-8fdc-629f07b5ee83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e7725bde-95b2-4d50-bb72-2af1d0c10cc8" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_501100c8-6dce-4ff5-8fdc-629f07b5ee83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a7b42ad-c138-460d-a3da-760e4d8fb563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a7b42ad-c138-460d-a3da-760e4d8fb563" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_07bf8c6e-9a3a-4d3b-8a52-1ac64a764517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:to="loc_us-gaap_FinancialInstrumentAxis_07bf8c6e-9a3a-4d3b-8a52-1ac64a764517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4a59c7bf-4bf0-4198-a102-2908afe7d02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_07bf8c6e-9a3a-4d3b-8a52-1ac64a764517" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4a59c7bf-4bf0-4198-a102-2908afe7d02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8b7cdcd1-c632-42fd-a567-58f50e2bb04c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4a59c7bf-4bf0-4198-a102-2908afe7d02d" xlink:to="loc_us-gaap_InterestRateSwapMember_8b7cdcd1-c632-42fd-a567-58f50e2bb04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4ea02bc9-4218-48b3-b226-479411397efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4ea02bc9-4218-48b3-b226-479411397efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4ea02bc9-4218-48b3-b226-479411397efc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_5055134a-8cfa-4d63-bf8c-1af6221dffff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:to="loc_us-gaap_InterestRateCapMember_5055134a-8cfa-4d63-bf8c-1af6221dffff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_394ba48a-7813-405e-87fc-d942b4610a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_394ba48a-7813-405e-87fc-d942b4610a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_5da93f40-76d4-4358-a16c-6f44fecb494e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_5da93f40-76d4-4358-a16c-6f44fecb494e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_347391c7-9a52-4f23-93db-0c45d8e8e713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a6d27ef4-c18d-4678-8951-38cb49972f97" xlink:to="loc_us-gaap_InterestRateSwapMember_347391c7-9a52-4f23-93db-0c45d8e8e713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_333c7173-cac2-4d9c-904d-2b265f7e5c38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_333c7173-cac2-4d9c-904d-2b265f7e5c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_333c7173-cac2-4d9c-904d-2b265f7e5c38" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fcf2a265-0b7b-4677-b6a0-98029b83f5b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_fcf2a265-0b7b-4677-b6a0-98029b83f5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_c789fda0-ad3a-44ef-a58c-b0bb0a9e0ae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_c789fda0-ad3a-44ef-a58c-b0bb0a9e0ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d57efc55-d713-4b1e-9cd8-d0f2872150fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_522fa90f-d227-44fd-aca2-52b55548c77c" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_d57efc55-d713-4b1e-9cd8-d0f2872150fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_003df135-752f-41dd-ab95-e783fb58a814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:to="loc_us-gaap_HedgingDesignationAxis_003df135-752f-41dd-ab95-e783fb58a814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_1c120e53-1c4d-4272-b916-9452ab2edd44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_003df135-752f-41dd-ab95-e783fb58a814" xlink:to="loc_us-gaap_HedgingDesignationDomain_1c120e53-1c4d-4272-b916-9452ab2edd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_9a4f23ec-062d-4ee3-95bd-72a57eaf5d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_1c120e53-1c4d-4272-b916-9452ab2edd44" xlink:to="loc_us-gaap_NondesignatedMember_9a4f23ec-062d-4ee3-95bd-72a57eaf5d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c6accb76-4ef7-44ea-8bb4-9d8be79bd290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_e5de9e44-14e6-42e8-959c-45d7430b061c" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c6accb76-4ef7-44ea-8bb4-9d8be79bd290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_6a45ec45-b34e-445c-9278-d0cf8fbb3dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c6accb76-4ef7-44ea-8bb4-9d8be79bd290" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_6a45ec45-b34e-445c-9278-d0cf8fbb3dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_becc7aaf-83a0-4ecd-bf2c-cc3574a08715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c6accb76-4ef7-44ea-8bb4-9d8be79bd290" xlink:to="loc_us-gaap_DerivativeLiabilities_becc7aaf-83a0-4ecd-bf2c-cc3574a08715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_7e32c440-9560-4026-8bb8-ab3dd4968968" xlink:href="holx-20210925.xsd#holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract_7e32c440-9560-4026-8bb8-ab3dd4968968" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2570c625-886f-4ef3-862a-56667ffc8184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2570c625-886f-4ef3-862a-56667ffc8184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d1951dd4-9470-413a-bfce-e0b2f25947c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2570c625-886f-4ef3-862a-56667ffc8184" xlink:to="loc_us-gaap_EquityComponentDomain_d1951dd4-9470-413a-bfce-e0b2f25947c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3cdec297-4833-45f0-83d4-d92e13b97d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d1951dd4-9470-413a-bfce-e0b2f25947c9" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3cdec297-4833-45f0-83d4-d92e13b97d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb437526-881b-4386-98f0-0e3e652f62c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb437526-881b-4386-98f0-0e3e652f62c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_798e8bb7-06e7-45e7-9f84-61a8187497b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fb437526-881b-4386-98f0-0e3e652f62c1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_798e8bb7-06e7-45e7-9f84-61a8187497b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_93b41e95-0aa7-4928-89dc-779f838870c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_798e8bb7-06e7-45e7-9f84-61a8187497b3" xlink:to="loc_us-gaap_TradeNamesMember_93b41e95-0aa7-4928-89dc-779f838870c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5e2b5689-15fd-450c-9be9-4d1ce8f128a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5e2b5689-15fd-450c-9be9-4d1ce8f128a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f971e623-4623-48fc-a501-7566d052419f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5e2b5689-15fd-450c-9be9-4d1ce8f128a1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f971e623-4623-48fc-a501-7566d052419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8bf90fa1-72b0-4fff-a92a-7b07ba9769db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f971e623-4623-48fc-a501-7566d052419f" xlink:to="loc_us-gaap_InterestRateSwapMember_8bf90fa1-72b0-4fff-a92a-7b07ba9769db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_db0c16ac-b775-4b16-bb26-30ec6aad15e4" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_b8e6ed7b-cc46-4c17-822c-3834ccdb46c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_b8e6ed7b-cc46-4c17-822c-3834ccdb46c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_86c8d919-a756-4963-ad19-1c5aa332078d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_86c8d919-a756-4963-ad19-1c5aa332078d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d7126fca-e73a-495f-9d61-7b7a8520175a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_d7126fca-e73a-495f-9d61-7b7a8520175a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_62398121-2df6-4e27-ae0a-168124425612" xlink:href="holx-20210925.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b0fa4769-2081-40c2-bf89-610535360d91" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_62398121-2df6-4e27-ae0a-168124425612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0158f8fa-fdd5-4364-b8a9-e6e9b16f561a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_1ea80b1f-bcaf-422b-b73a-0d4df8607ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0158f8fa-fdd5-4364-b8a9-e6e9b16f561a" xlink:to="loc_us-gaap_DerivativeTable_1ea80b1f-bcaf-422b-b73a-0d4df8607ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1cadaaa5-a86b-433a-89ed-c5774d5b0d2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1ea80b1f-bcaf-422b-b73a-0d4df8607ede" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1cadaaa5-a86b-433a-89ed-c5774d5b0d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f6f8a0bb-e489-47ee-8815-453c1b2bd0ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1cadaaa5-a86b-433a-89ed-c5774d5b0d2e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f6f8a0bb-e489-47ee-8815-453c1b2bd0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_94bbab12-f344-456f-a366-1e6817fbce59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f6f8a0bb-e489-47ee-8815-453c1b2bd0ee" xlink:to="loc_us-gaap_InterestRateCapMember_94bbab12-f344-456f-a366-1e6817fbce59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_48c9b91d-aca8-4a85-9ed2-24f9e6e4a713" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f6f8a0bb-e489-47ee-8815-453c1b2bd0ee" xlink:to="loc_us-gaap_InterestRateSwapMember_48c9b91d-aca8-4a85-9ed2-24f9e6e4a713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ac9e13ea-5610-4a0f-82c2-3f688b122fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_1ea80b1f-bcaf-422b-b73a-0d4df8607ede" xlink:to="loc_us-gaap_DerivativeLineItems_ac9e13ea-5610-4a0f-82c2-3f688b122fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_267a3ea0-6199-4c98-8e38-2595ff8eee9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ac9e13ea-5610-4a0f-82c2-3f688b122fbd" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_267a3ea0-6199-4c98-8e38-2595ff8eee9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_297ebbf7-a036-4a5d-b4b0-2816814d3555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ac9e13ea-5610-4a0f-82c2-3f688b122fbd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_297ebbf7-a036-4a5d-b4b0-2816814d3555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d459523d-e55b-407a-93c2-73b6edec9c17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_db2fcbfd-7e86-4060-8bb8-8ddecc0bc699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d459523d-e55b-407a-93c2-73b6edec9c17" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_db2fcbfd-7e86-4060-8bb8-8ddecc0bc699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_8ea9b192-2a13-468b-89f4-026be029e42c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_db2fcbfd-7e86-4060-8bb8-8ddecc0bc699" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_8ea9b192-2a13-468b-89f4-026be029e42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_35773a5a-09f4-4891-9735-7ee5a56b1bac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_db2fcbfd-7e86-4060-8bb8-8ddecc0bc699" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_35773a5a-09f4-4891-9735-7ee5a56b1bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableReserveDivested_ecffd775-a41d-41c2-833d-16c8257ebd10" xlink:href="holx-20210925.xsd#holx_AccountsReceivableReserveDivested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_db2fcbfd-7e86-4060-8bb8-8ddecc0bc699" xlink:to="loc_holx_AccountsReceivableReserveDivested_ecffd775-a41d-41c2-833d-16c8257ebd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceReduction_2fb9da3a-97df-45fb-ab09-9a222a493f1f" xlink:href="holx-20210925.xsd#holx_AccountsReceivableAllowanceReduction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_db2fcbfd-7e86-4060-8bb8-8ddecc0bc699" xlink:to="loc_holx_AccountsReceivableAllowanceReduction_2fb9da3a-97df-45fb-ab09-9a222a493f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c9996f91-733d-4698-a708-2be9f60f5157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_db2fcbfd-7e86-4060-8bb8-8ddecc0bc699" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c9996f91-733d-4698-a708-2be9f60f5157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_39556666-bb6e-4e6d-a5a6-6e502112c201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_aa2105da-8066-43cf-abea-143a091f06d0" xlink:href="holx-20210925.xsd#holx_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_39556666-bb6e-4e6d-a5a6-6e502112c201" xlink:to="loc_holx_EarningsPerShareTable_aa2105da-8066-43cf-abea-143a091f06d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27d6309e-cead-4978-9a53-347996b22a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_aa2105da-8066-43cf-abea-143a091f06d0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27d6309e-cead-4978-9a53-347996b22a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_06283d82-5413-471c-98f5-d992ce6bb3d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_27d6309e-cead-4978-9a53-347996b22a0e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_06283d82-5413-471c-98f5-d992ce6bb3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4f022baf-e546-4706-8223-5a1adef68610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_06283d82-5413-471c-98f5-d992ce6bb3d8" xlink:to="loc_us-gaap_StockCompensationPlanMember_4f022baf-e546-4706-8223-5a1adef68610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:href="holx-20210925.xsd#holx_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_aa2105da-8066-43cf-abea-143a091f06d0" xlink:to="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b313ee30-c1d1-4e95-9f43-de8c0584b43a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b313ee30-c1d1-4e95-9f43-de8c0584b43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_f6831ab7-bcf0-4a7e-9d28-37b92164b504" xlink:href="holx-20210925.xsd#holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:to="loc_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits_f6831ab7-bcf0-4a7e-9d28-37b92164b504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a7ae67a-2350-48ab-9dd2-e09d0eedd272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3a7ae67a-2350-48ab-9dd2-e09d0eedd272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_10029b6e-e92e-4f4b-90b5-c0a9257a358a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_da53be82-7646-492b-ba1b-6ac5ff217fcd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_10029b6e-e92e-4f4b-90b5-c0a9257a358a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_721c1e65-044e-4631-9537-de9599a5d7f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_10029b6e-e92e-4f4b-90b5-c0a9257a358a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_721c1e65-044e-4631-9537-de9599a5d7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#SummaryofSignificantAccountingPoliciesProductWarrantyDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4dc757f0-4be2-4b6e-9850-5812868f6065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_34881139-9cb3-4718-a30a-152e470ccf31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4dc757f0-4be2-4b6e-9850-5812868f6065" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_34881139-9cb3-4718-a30a-152e470ccf31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_201283d1-5058-43cf-8ead-f36e049505ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_34881139-9cb3-4718-a30a-152e470ccf31" xlink:to="loc_us-gaap_ProductWarrantyAccrual_201283d1-5058-43cf-8ead-f36e049505ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5244ca04-6f7d-4903-8508-466137cb4177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_34881139-9cb3-4718-a30a-152e470ccf31" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5244ca04-6f7d-4903-8508-466137cb4177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_57ed1258-aeec-44a0-be2d-4327eb260203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_34881139-9cb3-4718-a30a-152e470ccf31" xlink:to="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_57ed1258-aeec-44a0-be2d-4327eb260203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_f4260e67-c929-4c27-87a5-63e9d4488760" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_34881139-9cb3-4718-a30a-152e470ccf31" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_f4260e67-c929-4c27-87a5-63e9d4488760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_769a4288-1eb1-492a-966d-803b8b702f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_34881139-9cb3-4718-a30a-152e470ccf31" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_769a4288-1eb1-492a-966d-803b8b702f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_522201df-3b93-49ee-8b48-15df15386c21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_34881139-9cb3-4718-a30a-152e470ccf31" xlink:to="loc_us-gaap_ProductWarrantyAccrual_522201df-3b93-49ee-8b48-15df15386c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNotes" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueNotes"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1cc71550-5ead-4877-9f86-21ac7fd579b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_bead7bc7-4e6e-45a0-8f93-fe564a841283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1cc71550-5ead-4877-9f86-21ac7fd579b7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_bead7bc7-4e6e-45a0-8f93-fe564a841283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b8f15f2a-77f5-4377-a186-a6942bf53a4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a58f9966-3b39-494c-ad26-d2c39bd67a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b8f15f2a-77f5-4377-a186-a6942bf53a4a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_a58f9966-3b39-494c-ad26-d2c39bd67a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8a7f11b-8e79-4e5c-a021-a094e12cc446" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7d10e82b-feb5-42ad-b304-20d822ab6d69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8a7f11b-8e79-4e5c-a021-a094e12cc446" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7d10e82b-feb5-42ad-b304-20d822ab6d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4ac44f05-1b79-4c5d-af27-4df46051f486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8a7f11b-8e79-4e5c-a021-a094e12cc446" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4ac44f05-1b79-4c5d-af27-4df46051f486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueBusinessRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f233c0e9-b0cb-4f64-84e5-df161f9620ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f233c0e9-b0cb-4f64-84e5-df161f9620ec" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1373f427-d8e3-4da6-9926-fd964a9deac2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1373f427-d8e3-4da6-9926-fd964a9deac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1373f427-d8e3-4da6-9926-fd964a9deac2" xlink:to="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_56323fe4-82d2-458a-826e-3765088882fe" xlink:href="holx-20210925.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_DiagnosticsMember_56323fe4-82d2-458a-826e-3765088882fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_e36e4b48-c79c-4dd5-b929-c708b2ed66a9" xlink:href="holx-20210925.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_BreastHealthMember_e36e4b48-c79c-4dd5-b929-c708b2ed66a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_684516ba-89f8-4c6f-9fbc-632de98ff8e1" xlink:href="holx-20210925.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_GynSurgicalMember_684516ba-89f8-4c6f-9fbc-632de98ff8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_b6655313-82bb-4218-9255-dad2b40e6c93" xlink:href="holx-20210925.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_SkeletalHealthMember_b6655313-82bb-4218-9255-dad2b40e6c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_c7a023fa-75af-4a66-ad74-765139710f25" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6035b45f-e2fc-4952-882f-cb84348cc111" xlink:to="loc_holx_MedicalAestheticsMember_c7a023fa-75af-4a66-ad74-765139710f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_014e2ac9-19c5-463a-a04b-7f1d2244c9b0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:to="loc_srt_ProductOrServiceAxis_014e2ac9-19c5-463a-a04b-7f1d2244c9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_014e2ac9-19c5-463a-a04b-7f1d2244c9b0" xlink:to="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_08533749-61a0-49c9-94d1-b3b9747fed5d" xlink:href="holx-20210925.xsd#holx_CytologyPerinatalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_CytologyPerinatalMember_08533749-61a0-49c9-94d1-b3b9747fed5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_91a77ccc-b2b5-4256-8b54-bc3a067845fa" xlink:href="holx-20210925.xsd#holx_MolecularDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_MolecularDiagnosticsMember_91a77ccc-b2b5-4256-8b54-bc3a067845fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_7504b3ce-3207-4ede-a8ef-aab6a0ad42ca" xlink:href="holx-20210925.xsd#holx_BloodScreeningMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_BloodScreeningMember_7504b3ce-3207-4ede-a8ef-aab6a0ad42ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_2fd106ec-df74-4e5f-a2f8-d95aaf3d630c" xlink:href="holx-20210925.xsd#holx_BreastImagingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_BreastImagingMember_2fd106ec-df74-4e5f-a2f8-d95aaf3d630c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_39180e81-77dd-487e-9e06-8c46e449ecdb" xlink:href="holx-20210925.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ceea283-b737-446f-bbdf-d1d62fa66084" xlink:to="loc_holx_InterventionalBreastSolutionsMember_39180e81-77dd-487e-9e06-8c46e449ecdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7902dcdf-954e-420e-9e5e-29cc4f244c09" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:to="loc_srt_StatementGeographicalAxis_7902dcdf-954e-420e-9e5e-29cc4f244c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fbd60dcb-d253-48e0-82f5-3bd5c4cd221c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7902dcdf-954e-420e-9e5e-29cc4f244c09" xlink:to="loc_srt_SegmentGeographicalDomain_fbd60dcb-d253-48e0-82f5-3bd5c4cd221c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_e13bdc57-f57f-4d1a-9556-a265e20d0798" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_fbd60dcb-d253-48e0-82f5-3bd5c4cd221c" xlink:to="loc_country_US_e13bdc57-f57f-4d1a-9556-a265e20d0798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_aa780d22-9348-43f4-afc2-203423d06497" xlink:href="holx-20210925.xsd#holx_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_fbd60dcb-d253-48e0-82f5-3bd5c4cd221c" xlink:to="loc_holx_InternationalMember_aa780d22-9348-43f4-afc2-203423d06497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_fafe8b60-0484-421e-8c33-dada62ffc67c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fbb248b6-f1f3-4d0c-bf3a-18268336baf1" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_fafe8b60-0484-421e-8c33-dada62ffc67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_699a1772-de66-48c7-baf2-829bf57ce1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_fafe8b60-0484-421e-8c33-dada62ffc67c" xlink:to="loc_us-gaap_Revenues_699a1772-de66-48c7-baf2-829bf57ce1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueGeographicalRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3e992ce7-1038-4e98-a7ac-5267149d3ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c8dea8c6-1148-42c4-b2ac-1456dd3fa5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3e992ce7-1038-4e98-a7ac-5267149d3ed6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c8dea8c6-1148-42c4-b2ac-1456dd3fa5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6237d7de-f9db-4653-8f5b-94eb694e536b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c8dea8c6-1148-42c4-b2ac-1456dd3fa5eb" xlink:to="loc_srt_ProductOrServiceAxis_6237d7de-f9db-4653-8f5b-94eb694e536b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e35698a6-3448-4003-93c2-c8531c535312" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6237d7de-f9db-4653-8f5b-94eb694e536b" xlink:to="loc_srt_ProductsAndServicesDomain_e35698a6-3448-4003-93c2-c8531c535312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ecf47fba-acdd-4056-9024-81aee0902665" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c8dea8c6-1148-42c4-b2ac-1456dd3fa5eb" xlink:to="loc_srt_StatementGeographicalAxis_ecf47fba-acdd-4056-9024-81aee0902665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ecf47fba-acdd-4056-9024-81aee0902665" xlink:to="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_37f747c8-fe87-4153-95c1-7e99163208fa" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:to="loc_country_US_37f747c8-fe87-4153-95c1-7e99163208fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_70566e04-e2c4-4785-a662-6afdd433d6b4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:to="loc_srt_EuropeMember_70566e04-e2c4-4785-a662-6afdd433d6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_fc525bb5-5e72-441b-afea-291b018deb3e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:to="loc_srt_AsiaPacificMember_fc525bb5-5e72-441b-afea-291b018deb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherGeographicRegionsMember_c4354b8c-b154-4c2c-9421-89913e081e08" xlink:href="holx-20210925.xsd#holx_OtherGeographicRegionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cb36d410-72c5-4356-ba0e-8761e65783c5" xlink:to="loc_holx_OtherGeographicRegionsMember_c4354b8c-b154-4c2c-9421-89913e081e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0ed1d37b-d36f-4af0-b3b1-dab1c826f712" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c8dea8c6-1148-42c4-b2ac-1456dd3fa5eb" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_0ed1d37b-d36f-4af0-b3b1-dab1c826f712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fce89274-ab17-462d-b318-e69934ac03a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0ed1d37b-d36f-4af0-b3b1-dab1c826f712" xlink:to="loc_us-gaap_Revenues_fce89274-ab17-462d-b318-e69934ac03a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueRevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c12ed06-b612-483a-b783-151734c98d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c12ed06-b612-483a-b783-151734c98d7e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eda1241f-3ace-4b7d-bf3c-f87e971beff0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:to="loc_srt_ProductOrServiceAxis_eda1241f-3ace-4b7d-bf3c-f87e971beff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_eda1241f-3ace-4b7d-bf3c-f87e971beff0" xlink:to="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_0770e671-9b09-4d8a-a90e-ed7973dddeb8" xlink:href="holx-20210925.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_0770e671-9b09-4d8a-a90e-ed7973dddeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_5ef18e65-a1be-43d2-bee4-a9e9fabfaf43" xlink:href="holx-20210925.xsd#holx_ConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:to="loc_holx_ConsumablesMember_5ef18e65-a1be-43d2-bee4-a9e9fabfaf43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ea228243-e5bf-46cc-8a8e-ccd14d51e81b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:to="loc_us-gaap_ServiceMember_ea228243-e5bf-46cc-8a8e-ccd14d51e81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_a8e0c2f2-238c-4d36-a570-d14a28f5496a" xlink:href="holx-20210925.xsd#holx_OtherTypeofRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_50ac5e3a-fa41-43b2-aae4-2585dbfd35c7" xlink:to="loc_holx_OtherTypeofRevenueMember_a8e0c2f2-238c-4d36-a570-d14a28f5496a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_70662375-1a22-401c-9ecf-a1afc16237a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:to="loc_srt_StatementGeographicalAxis_70662375-1a22-401c-9ecf-a1afc16237a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ccada997-7ce8-40e3-a9a4-7c57f2b45c29" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_70662375-1a22-401c-9ecf-a1afc16237a0" xlink:to="loc_srt_SegmentGeographicalDomain_ccada997-7ce8-40e3-a9a4-7c57f2b45c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_bca015ff-bec0-4d32-a4c7-dcbce6ca9ede" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ccada997-7ce8-40e3-a9a4-7c57f2b45c29" xlink:to="loc_country_US_bca015ff-bec0-4d32-a4c7-dcbce6ca9ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_40571ab9-b9c8-430a-a5f7-01c0e679a528" xlink:href="holx-20210925.xsd#holx_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ccada997-7ce8-40e3-a9a4-7c57f2b45c29" xlink:to="loc_holx_InternationalMember_40571ab9-b9c8-430a-a5f7-01c0e679a528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6c2199d0-200d-4a44-9ae9-ea37cb4674e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6c2199d0-200d-4a44-9ae9-ea37cb4674e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2613dfbd-9868-468a-b9a3-fa48c717b8bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6c2199d0-200d-4a44-9ae9-ea37cb4674e5" xlink:to="loc_us-gaap_SegmentDomain_2613dfbd-9868-468a-b9a3-fa48c717b8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3d39ffd9-39df-45c4-be95-04280e35e3e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_28efb8d0-b0ea-4104-a1f9-f6cb11793116" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_3d39ffd9-39df-45c4-be95-04280e35e3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5abcb527-81c0-4852-84f5-41f57b707eac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3d39ffd9-39df-45c4-be95-04280e35e3e1" xlink:to="loc_us-gaap_Revenues_5abcb527-81c0-4852-84f5-41f57b707eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueRemainingPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8a9350d0-abc4-42d8-89c6-b784b9861e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4743a050-e081-490c-990f-4b712325a28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8a9350d0-abc4-42d8-89c6-b784b9861e75" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4743a050-e081-490c-990f-4b712325a28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_514cf931-f5b7-40bc-9635-848bd3428e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4743a050-e081-490c-990f-4b712325a28a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_514cf931-f5b7-40bc-9635-848bd3428e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4743a050-e081-490c-990f-4b712325a28a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b5d18d40-e76b-450d-bbef-be1736190d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b5d18d40-e76b-450d-bbef-be1736190d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_f007d032-c0d7-4000-9085-534b12839bcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85da06ec-1c6d-4d7e-86e4-ab4abed9e2c6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_f007d032-c0d7-4000-9085-534b12839bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="holx-20210925.xsd#RevenueRemainingPerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20210925.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2ff46215-61c8-4f7c-84aa-430dc7cb6216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_a1e950ba-5ee5-47e1-87e3-7c8cba7fcd6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ff46215-61c8-4f7c-84aa-430dc7cb6216" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_a1e950ba-5ee5-47e1-87e3-7c8cba7fcd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock_7997476f-774e-42bf-b485-2acb92e02344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ff46215-61c8-4f7c-84aa-430dc7cb6216" xlink:to="loc_us-gaap_LessorSalesTypeLeasesTextBlock_7997476f-774e-42bf-b485-2acb92e02344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_b8524e8b-4632-4d9b-ad68-f37d774645a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ff46215-61c8-4f7c-84aa-430dc7cb6216" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_b8524e8b-4632-4d9b-ad68-f37d774645a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_cbd9ab54-0cf3-48b9-85b5-beea98344a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2ff46215-61c8-4f7c-84aa-430dc7cb6216" xlink:to="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_cbd9ab54-0cf3-48b9-85b5-beea98344a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesTables" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_78271d02-972f-4059-bf3f-c53c0770e312" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsAndLiabilitiesLesseeTableTextBlock_49bdc0b3-30ee-4e2c-aaf9-47f02537d9a6" xlink:href="holx-20210925.xsd#holx_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_78271d02-972f-4059-bf3f-c53c0770e312" xlink:to="loc_holx_AssetsAndLiabilitiesLesseeTableTextBlock_49bdc0b3-30ee-4e2c-aaf9-47f02537d9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_7af415dd-bfa0-48ee-b12e-eba60913f04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_78271d02-972f-4059-bf3f-c53c0770e312" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_7af415dd-bfa0-48ee-b12e-eba60913f04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_bc33f588-e260-4376-8448-3f0f55130763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_78271d02-972f-4059-bf3f-c53c0770e312" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_bc33f588-e260-4376-8448-3f0f55130763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_aaf2d5b5-58bd-4c2c-a631-7d67cdbfde8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_78271d02-972f-4059-bf3f-c53c0770e312" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_aaf2d5b5-58bd-4c2c-a631-7d67cdbfde8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_5b774cf0-e696-4a5e-a526-605419e87c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_78271d02-972f-4059-bf3f-c53c0770e312" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_5b774cf0-e696-4a5e-a526-605419e87c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ca9a3719-4102-4edf-ab71-3d80fd87d8d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ca9a3719-4102-4edf-ab71-3d80fd87d8d9" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0148df3e-0c66-4bda-9199-8d6370e6b553" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:to="loc_srt_RangeAxis_0148df3e-0c66-4bda-9199-8d6370e6b553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dcfa4b6d-d005-42b4-8cf0-e60da62daca2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0148df3e-0c66-4bda-9199-8d6370e6b553" xlink:to="loc_srt_RangeMember_dcfa4b6d-d005-42b4-8cf0-e60da62daca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_10d4057f-564a-408c-8c59-c273b2b95905" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dcfa4b6d-d005-42b4-8cf0-e60da62daca2" xlink:to="loc_srt_MinimumMember_10d4057f-564a-408c-8c59-c273b2b95905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b8683ba2-e49a-4db2-911e-ca018c4f8210" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dcfa4b6d-d005-42b4-8cf0-e60da62daca2" xlink:to="loc_srt_MaximumMember_b8683ba2-e49a-4db2-911e-ca018c4f8210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e6b79058-3a65-4154-bcb7-df975d37deff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e6b79058-3a65-4154-bcb7-df975d37deff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c083475e-9682-4f29-ba49-f3fe03c619ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e6b79058-3a65-4154-bcb7-df975d37deff" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c083475e-9682-4f29-ba49-f3fe03c619ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_908dffa5-98e3-4ed4-8893-30435246d8f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_c083475e-9682-4f29-ba49-f3fe03c619ee" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_908dffa5-98e3-4ed4-8893-30435246d8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_2dbad7bd-8805-4389-abe0-b10a84478392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_dd257fef-f841-4716-b591-4400389eb04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_64876c39-68b3-43dd-90cb-95ee0411c7b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0be7a716-3bda-4162-b0d4-78acbb157421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0be7a716-3bda-4162-b0d4-78acbb157421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0be7a716-3bda-4162-b0d4-78acbb157421" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_c36495cd-ef51-44b0-9770-0b0f8668a796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_c36495cd-ef51-44b0-9770-0b0f8668a796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsShortTermMember_73b3f74b-36d9-43a2-af11-41f8c71e41b0" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsShortTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:to="loc_holx_FinanceLeaseObligationsShortTermMember_73b3f74b-36d9-43a2-af11-41f8c71e41b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsLongTermMember_1f871ef0-8c46-4e65-8941-10f14dbac2ab" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsLongTermMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f745f2e6-66a7-4c3b-84ab-7e8abd2e1748" xlink:to="loc_holx_FinanceLeaseObligationsLongTermMember_1f871ef0-8c46-4e65-8941-10f14dbac2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_69399530-6b6d-464e-9d88-be86d96edb4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_69399530-6b6d-464e-9d88-be86d96edb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65f7bed8-01cb-4fcc-9c94-e73874645b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_69399530-6b6d-464e-9d88-be86d96edb4a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65f7bed8-01cb-4fcc-9c94-e73874645b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_fa8916bb-7ad4-4622-ae38-d1000c69b4e9" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65f7bed8-01cb-4fcc-9c94-e73874645b99" xlink:to="loc_holx_DiagenodeMember_fa8916bb-7ad4-4622-ae38-d1000c69b4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_f162eaea-a468-4342-938d-e201582ff873" xlink:href="holx-20210925.xsd#holx_CynosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_65f7bed8-01cb-4fcc-9c94-e73874645b99" xlink:to="loc_holx_CynosureMember_f162eaea-a468-4342-938d-e201582ff873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a3986d4c-4532-489b-9870-24ef8e53b32a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_aaab0dd0-92ad-4a91-a084-79eba8d0894f" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate_aaab0dd0-92ad-4a91-a084-79eba8d0894f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_fc917350-35a9-4824-8bab-3588162c761e" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm_fc917350-35a9-4824-8bab-3588162c761e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_0c0fe5bc-b225-4cd3-a812-79a8a5833599" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeasesExtensionPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod_0c0fe5bc-b225-4cd3-a812-79a8a5833599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_d542f356-29f2-4810-a26f-74ec2520e74a" xlink:href="holx-20210925.xsd#holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent_d542f356-29f2-4810-a26f-74ec2520e74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_8e45d298-6ae1-47de-9abc-b162c99026e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_8e45d298-6ae1-47de-9abc-b162c99026e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b5b75e42-628c-4d49-815c-3b2237567811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b5b75e42-628c-4d49-815c-3b2237567811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_64a2a032-90ea-4da3-8390-f9eb1efa408e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_64a2a032-90ea-4da3-8390-f9eb1efa408e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue_12206481-adb7-4481-80b5-53a26158a5f9" xlink:href="holx-20210925.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LeaseRevenuePercentageOfTotalRevenue_12206481-adb7-4481-80b5-53a26158a5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_da11e018-80e1-4931-8d3f-bfb1ad1407fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_da11e018-80e1-4931-8d3f-bfb1ad1407fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseReceivable_9fc7e043-c5c9-46c9-b9fb-ccc06dafe37e" xlink:href="holx-20210925.xsd#holx_LeaseReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_holx_LeaseReceivable_9fc7e043-c5c9-46c9-b9fb-ccc06dafe37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ba1a1756-cee0-48c6-80c8-dfa6448f22c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ba1a1756-cee0-48c6-80c8-dfa6448f22c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_762020f9-7224-4308-af6f-5216e4b229e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_762020f9-7224-4308-af6f-5216e4b229e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7b4e45d3-4aee-4689-8cf0-99f7000043fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OperatingLeaseLiability_7b4e45d3-4aee-4689-8cf0-99f7000043fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7bf7f348-17ab-47b4-bc14-3bd322067266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseLiability_7bf7f348-17ab-47b4-bc14-3bd322067266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a4e82237-e288-46b4-99fe-27b8912a3f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a4e82237-e288-46b4-99fe-27b8912a3f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_eaccfe2e-565d-4f9b-85fe-2f93471ba95e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_eaccfe2e-565d-4f9b-85fe-2f93471ba95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_b6cb4d88-7f23-4040-9e26-1b8a8ea6c83e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList_b6cb4d88-7f23-4040-9e26-1b8a8ea6c83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1da69d82-a3b6-4763-a455-6fa73ea6f4aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_1da69d82-a3b6-4763-a455-6fa73ea6f4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ecb5ca86-a175-4472-8c35-f83fe7dbc634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ecb5ca86-a175-4472-8c35-f83fe7dbc634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_cde0a823-9ccb-4fa0-a935-24937bc242c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_f4066da4-f3c2-470a-a6c0-2c1aec25eb8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bfcc7dec-f0de-49cc-bcbc-f0df335f30a7" xlink:to="loc_us-gaap_SubleaseIncome_f4066da4-f3c2-470a-a6c0-2c1aec25eb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842_933633d0-dde8-41e7-81b2-4c6fc6fc6955" xlink:href="holx-20210925.xsd#holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ca9a3719-4102-4edf-ab71-3d80fd87d8d9" xlink:to="loc_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842_933633d0-dde8-41e7-81b2-4c6fc6fc6955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842_e7889f40-b708-4a04-b925-57bfedb23508" xlink:href="holx-20210925.xsd#holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ca9a3719-4102-4edf-ab71-3d80fd87d8d9" xlink:to="loc_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842_e7889f40-b708-4a04-b925-57bfedb23508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_92b7b165-02a5-4e7f-a739-d823074dc31c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2209a962-4686-4517-8c0f-822121b487b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_92b7b165-02a5-4e7f-a739-d823074dc31c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2209a962-4686-4517-8c0f-822121b487b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e3d0fb79-4e13-4e2f-9c05-2e9c88cf26a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2209a962-4686-4517-8c0f-822121b487b0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e3d0fb79-4e13-4e2f-9c05-2e9c88cf26a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e3d0fb79-4e13-4e2f-9c05-2e9c88cf26a3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_01ab956e-7e1a-4752-b07d-b7b3520b771c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_us-gaap_OtherAssetsMember_01ab956e-7e1a-4752-b07d-b7b3520b771c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_6ff530c7-fd3a-4a05-81de-fe0f9593bbb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_6ff530c7-fd3a-4a05-81de-fe0f9593bbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_cd196a71-5bcf-4d9b-8f0e-1ccfd8708c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_cd196a71-5bcf-4d9b-8f0e-1ccfd8708c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsShortTermMember_efbf0d67-70d6-46f5-92f5-5986756fc3be" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsShortTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_holx_FinanceLeaseObligationsShortTermMember_efbf0d67-70d6-46f5-92f5-5986756fc3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FinanceLeaseObligationsLongTermMember_d7a1ea65-e832-4ffa-b789-04c438b263d4" xlink:href="holx-20210925.xsd#holx_FinanceLeaseObligationsLongTermMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f9ca86c1-6b33-4bfa-89a0-b41057e94fc1" xlink:to="loc_holx_FinanceLeaseObligationsLongTermMember_d7a1ea65-e832-4ffa-b789-04c438b263d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2209a962-4686-4517-8c0f-822121b487b0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e113d40c-e77d-4e1c-b6c4-d4bbffca65cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e113d40c-e77d-4e1c-b6c4-d4bbffca65cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7f10662c-485c-4447-98d3-d0ce5e2d1302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7f10662c-485c-4447-98d3-d0ce5e2d1302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_42a5c783-e481-4ffc-bd9a-b74431feb4a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_42a5c783-e481-4ffc-bd9a-b74431feb4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_91900f96-c69a-4cef-b142-128aa47c393d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_91900f96-c69a-4cef-b142-128aa47c393d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_93218d67-eb78-4029-b33c-61557b078d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_93218d67-eb78-4029-b33c-61557b078d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c31dde7f-3e7e-44c3-87a3-bd81738b9365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c31dde7f-3e7e-44c3-87a3-bd81738b9365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_82669b9e-64bd-47de-a0a1-824bf7d29d17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_82669b9e-64bd-47de-a0a1-824bf7d29d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_68ab33fa-652c-477a-9e10-b91b83dffd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_68ab33fa-652c-477a-9e10-b91b83dffd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_27f7269a-617f-4eee-86f6-7d49ac60933e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_27f7269a-617f-4eee-86f6-7d49ac60933e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b359e213-9515-48b6-ad81-695a8ec862d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b359e213-9515-48b6-ad81-695a8ec862d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d344e92e-f209-42cc-a817-1e62f2d41aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d344e92e-f209-42cc-a817-1e62f2d41aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_4f20ab0d-bb5e-4afa-9d3f-8115c8f3a512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_de1083f2-6d04-4c87-9dc7-2217e03baeaa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_4f20ab0d-bb5e-4afa-9d3f-8115c8f3a512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_fce92692-0d4f-4782-8427-73c9a087dfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_49ccfbb4-fcf6-4356-aa30-5b592a62e0e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_us-gaap_OperatingLeaseCost_49ccfbb4-fcf6-4356-aa30-5b592a62e0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e4d20f07-2aaf-4337-871a-3c659a66ffdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_e4d20f07-2aaf-4337-871a-3c659a66ffdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_f6eb7fa1-ef3f-4088-8344-949b255203e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_f6eb7fa1-ef3f-4088-8344-949b255203e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_562a26b4-cd49-42f8-8a2c-92524d3c16ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_562a26b4-cd49-42f8-8a2c-92524d3c16ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_75928f4f-4e7a-4b58-ae3a-ff0081ea53f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_us-gaap_OperatingLeasePayments_75928f4f-4e7a-4b58-ae3a-ff0081ea53f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_164d325b-47b8-4103-9662-669bd8813c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_164d325b-47b8-4103-9662-669bd8813c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_fba5d163-5058-447c-8758-db3e8519743e" xlink:href="holx-20210925.xsd#holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability_fba5d163-5058-447c-8758-db3e8519743e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a568e4ce-2e3f-458d-acbd-fd5bcd4a794f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a568e4ce-2e3f-458d-acbd-fd5bcd4a794f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6281ba72-0da3-47c2-9327-e9639099e511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_6281ba72-0da3-47c2-9327-e9639099e511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_6bf9286a-1861-4870-a6cb-8dbd395c6b45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_73fd9aee-a33c-4c04-80c9-26c32880175e" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_6bf9286a-1861-4870-a6cb-8dbd395c6b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_72caaa02-ef29-49b8-8d34-d92b1e40a3ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_6bf9286a-1861-4870-a6cb-8dbd395c6b45" xlink:to="loc_srt_RangeAxis_72caaa02-ef29-49b8-8d34-d92b1e40a3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8f7d6eda-0c23-4823-bb9c-661e53e5a9e3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_72caaa02-ef29-49b8-8d34-d92b1e40a3ba" xlink:to="loc_srt_RangeMember_8f7d6eda-0c23-4823-bb9c-661e53e5a9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4c841505-7ff7-4bec-a955-5f84cba25dc3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8f7d6eda-0c23-4823-bb9c-661e53e5a9e3" xlink:to="loc_srt_MinimumMember_4c841505-7ff7-4bec-a955-5f84cba25dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_20ea879e-30b6-449b-98f1-dc173343ac57" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8f7d6eda-0c23-4823-bb9c-661e53e5a9e3" xlink:to="loc_srt_MaximumMember_20ea879e-30b6-449b-98f1-dc173343ac57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_6bf9286a-1861-4870-a6cb-8dbd395c6b45" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfFinanceLeases_c246fe37-65b2-49ef-888d-1c9fde2c0599" xlink:href="holx-20210925.xsd#holx_NumberOfFinanceLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:to="loc_holx_NumberOfFinanceLeases_c246fe37-65b2-49ef-888d-1c9fde2c0599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_0d570935-a393-4f9b-b6f8-318eac006898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:to="loc_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_0d570935-a393-4f9b-b6f8-318eac006898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage_81f3b95a-339a-431d-82f2-7221de6243ce" xlink:href="holx-20210925.xsd#holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9f594a3d-70e1-414a-907c-ace6ae401209" xlink:to="loc_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage_81f3b95a-339a-431d-82f2-7221de6243ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesLeaseLiabilityMaturitySchedule2020Details"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_41df1c96-9efc-4fdc-854d-2e16485831dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41df1c96-9efc-4fdc-854d-2e16485831dd" xlink:to="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a606c32a-a520-4d67-a6e9-4b707d2dad6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a606c32a-a520-4d67-a6e9-4b707d2dad6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_07fa9420-4d77-483d-9b47-c71dd007644d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_07fa9420-4d77-483d-9b47-c71dd007644d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_53c1fcbc-cd06-449a-958b-18cb4ab3a5a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_53c1fcbc-cd06-449a-958b-18cb4ab3a5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6f878504-ecdd-409c-b798-58c7bd722516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6f878504-ecdd-409c-b798-58c7bd722516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_12adbba5-3166-4444-b191-44bae330c2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_12adbba5-3166-4444-b191-44bae330c2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_db066b77-0995-46aa-acf7-667af18bc1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_db066b77-0995-46aa-acf7-667af18bc1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66336f75-9f1a-47e1-934b-c968a01863d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_66336f75-9f1a-47e1-934b-c968a01863d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_62cb03e4-46e8-416f-b5b1-afc73cfddac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_62cb03e4-46e8-416f-b5b1-afc73cfddac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_33615c00-d229-443e-bc51-95a4126c1257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_9b4eb85d-579c-40fc-8805-f3918e74b400" xlink:to="loc_us-gaap_OperatingLeaseLiability_33615c00-d229-443e-bc51-95a4126c1257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41df1c96-9efc-4fdc-854d-2e16485831dd" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b68364c6-9bea-4317-91c0-3b39db2a4b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b68364c6-9bea-4317-91c0-3b39db2a4b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_18bf211d-7bec-4c8d-b5f4-3cc3ae09045e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_18bf211d-7bec-4c8d-b5f4-3cc3ae09045e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_58ff6c16-6ae4-4292-adc8-8fa5287801ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_58ff6c16-6ae4-4292-adc8-8fa5287801ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_adb95437-720e-4302-9155-3d60903bd616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_adb95437-720e-4302-9155-3d60903bd616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_cc3a225d-5dcb-46c5-b185-5535f875a58f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_cc3a225d-5dcb-46c5-b185-5535f875a58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_342b1961-efd5-471a-919c-fdb4e74e5bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_342b1961-efd5-471a-919c-fdb4e74e5bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_fcd72479-e452-4d2e-8739-331c011bca5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_fcd72479-e452-4d2e-8739-331c011bca5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c7bd77a4-5e12-4567-8362-f94ae2fdde27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c7bd77a4-5e12-4567-8362-f94ae2fdde27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_71315c9d-5dcb-45e3-a9ea-f230a72da19b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_0889f4df-2df9-49a5-914b-a546b21de72f" xlink:to="loc_us-gaap_FinanceLeaseLiability_71315c9d-5dcb-45e3-a9ea-f230a72da19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesLeaseLiabilityMaturitySchedule2020Details_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_77740266-d1b3-4b7a-9e6d-29452aebc982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeCurrent_9e2eaefe-b08d-47c2-8b50-7a6ffc676834" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77740266-d1b3-4b7a-9e6d-29452aebc982" xlink:to="loc_holx_SubLeaseRentalIncomeCurrent_9e2eaefe-b08d-47c2-8b50-7a6ffc676834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueIn2Years_616e9c83-3cf9-43a9-a9d4-987e9d31e396" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueIn2Years"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77740266-d1b3-4b7a-9e6d-29452aebc982" xlink:to="loc_holx_SubLeaseRentalIncomeDueIn2Years_616e9c83-3cf9-43a9-a9d4-987e9d31e396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueIn3Years_29889238-e666-48fe-848c-584a6d98b83c" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueIn3Years"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77740266-d1b3-4b7a-9e6d-29452aebc982" xlink:to="loc_holx_SubLeaseRentalIncomeDueIn3Years_29889238-e666-48fe-848c-584a6d98b83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueIn4Years_a96b89e8-70b6-40bd-a71e-7e2bf0ddbf30" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueIn4Years"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77740266-d1b3-4b7a-9e6d-29452aebc982" xlink:to="loc_holx_SubLeaseRentalIncomeDueIn4Years_a96b89e8-70b6-40bd-a71e-7e2bf0ddbf30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueIn5years_34849464-4b63-42b4-b76d-a6187853c3a5" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueIn5years"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77740266-d1b3-4b7a-9e6d-29452aebc982" xlink:to="loc_holx_SubLeaseRentalIncomeDueIn5years_34849464-4b63-42b4-b76d-a6187853c3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncomeDueThereafter_f363aff6-cd69-44a2-a3cd-e9b34405b402" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncomeDueThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77740266-d1b3-4b7a-9e6d-29452aebc982" xlink:to="loc_holx_SubLeaseRentalIncomeDueThereafter_f363aff6-cd69-44a2-a3cd-e9b34405b402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SubLeaseRentalIncome_bea24b09-2ccb-48e5-9cba-ba9c091929df" xlink:href="holx-20210925.xsd#holx_SubLeaseRentalIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77740266-d1b3-4b7a-9e6d-29452aebc982" xlink:to="loc_holx_SubLeaseRentalIncome_bea24b09-2ccb-48e5-9cba-ba9c091929df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_f4d9957a-722b-492e-bf48-24559e14359a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c81234ea-6363-4101-a62c-8f92f23de0e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_f4d9957a-722b-492e-bf48-24559e14359a" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c81234ea-6363-4101-a62c-8f92f23de0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e08e6d42-cce3-4a19-a648-1272e7c21440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_96846594-cf9a-4d75-8c90-e72d3a66cea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e08e6d42-cce3-4a19-a648-1272e7c21440" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_96846594-cf9a-4d75-8c90-e72d3a66cea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessCombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1e723453-0d27-4a81-b7ad-022bd8e323e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1e723453-0d27-4a81-b7ad-022bd8e323e2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2df5c914-cf72-467e-8bf5-7d1ccaa6aa2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2df5c914-cf72-467e-8bf5-7d1ccaa6aa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2df5c914-cf72-467e-8bf5-7d1ccaa6aa2a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_87979864-24b6-493c-93a4-0f31d1aa8471" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_MobidiagOyMember_87979864-24b6-493c-93a4-0f31d1aa8471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_098a75cf-46d7-4e1d-8027-b07d8bd1e5bc" xlink:href="holx-20210925.xsd#holx_BiotheranosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_BiotheranosticsMember_098a75cf-46d7-4e1d-8027-b07d8bd1e5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_1613e33b-a89d-483d-a059-a353d81c4652" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_DiagenodeMember_1613e33b-a89d-483d-a059-a353d81c4652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMedicalTechnologiesMember_c74a7e28-ef8a-4122-9def-df10bdd1e550" xlink:href="holx-20210925.xsd#holx_SomatexMedicalTechnologiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_SomatexMedicalTechnologiesMember_c74a7e28-ef8a-4122-9def-df10bdd1e550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember_1f9b9e5a-0b4a-4a03-b907-96a4aff4ebe7" xlink:href="holx-20210925.xsd#holx_NXCImagingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_NXCImagingMember_1f9b9e5a-0b4a-4a03-b907-96a4aff4ebe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_78aed6a4-86be-4456-951f-801c7bf747a1" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_AcessaHealthMember_78aed6a4-86be-4456-951f-801c7bf747a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_cf857e8b-40e1-4ffc-8600-bbdcf4a68309" xlink:href="holx-20210925.xsd#holx_HealthBeaconsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_HealthBeaconsMember_cf857e8b-40e1-4ffc-8600-bbdcf4a68309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_04dc33be-d5c0-4e65-9821-16086300a801" xlink:href="holx-20210925.xsd#holx_AlphaImagingMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_AlphaImagingMember_04dc33be-d5c0-4e65-9821-16086300a801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_c23432d0-3e33-4e5d-b9a8-e359428311f2" xlink:href="holx-20210925.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_SuperSonicImagineMember_c23432d0-3e33-4e5d-b9a8-e359428311f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_426ebedd-3d67-4d25-8649-a016148a8c59" xlink:href="holx-20210925.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_237b047a-1f56-4da2-b7f0-f2f67f780e53" xlink:to="loc_holx_FocalTherapeuticsInc.Member_426ebedd-3d67-4d25-8649-a016148a8c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_5dfb4177-e8a3-44b3-a216-e177cd527978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_5dfb4177-e8a3-44b3-a216-e177cd527978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f21d767c-ce44-44a1-8a60-070697557852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_5dfb4177-e8a3-44b3-a216-e177cd527978" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f21d767c-ce44-44a1-8a60-070697557852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_84a16b56-938a-4a9b-82b2-299783e72610" xlink:href="holx-20210925.xsd#holx_ContingentHoldbackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_f21d767c-ce44-44a1-8a60-070697557852" xlink:to="loc_holx_ContingentHoldbackMember_84a16b56-938a-4a9b-82b2-299783e72610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a1536b9d-9611-46d6-a2fd-8c2bba8a47db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a1536b9d-9611-46d6-a2fd-8c2bba8a47db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a1536b9d-9611-46d6-a2fd-8c2bba8a47db" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_c47d2686-00d8-4eb3-87d9-a098378c98ec" xlink:href="holx-20210925.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_holx_DevelopedTechnologyMember_c47d2686-00d8-4eb3-87d9-a098378c98ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9418dece-5777-4df1-8e69-37a7f7c10c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9418dece-5777-4df1-8e69-37a7f7c10c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_7c2aa34b-7149-4eec-b74a-678280e42104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_us-gaap_TradeNamesMember_7c2aa34b-7149-4eec-b74a-678280e42104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_71702abc-a0f4-4eb6-ab2a-1fc3f4436fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_71702abc-a0f4-4eb6-ab2a-1fc3f4436fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_c01ed985-6425-4092-9686-409dbb370103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5ae885f0-8cca-4ed7-936d-9856f81319fe" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_c01ed985-6425-4092-9686-409dbb370103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5d3d83a2-8017-449a-b514-b157a8411d7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_srt_RangeAxis_5d3d83a2-8017-449a-b514-b157a8411d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b918254-e3ab-4b08-904d-c16c74ce0e95" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5d3d83a2-8017-449a-b514-b157a8411d7b" xlink:to="loc_srt_RangeMember_7b918254-e3ab-4b08-904d-c16c74ce0e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_514ecdcf-cfab-42d1-93c5-24b0a0a6d317" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b918254-e3ab-4b08-904d-c16c74ce0e95" xlink:to="loc_srt_MinimumMember_514ecdcf-cfab-42d1-93c5-24b0a0a6d317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9338b73e-9868-42e7-97b9-a3ad328842ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b918254-e3ab-4b08-904d-c16c74ce0e95" xlink:to="loc_srt_MaximumMember_9338b73e-9868-42e7-97b9-a3ad328842ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f1871b2d-731e-41ac-aea1-5210c860921b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f1871b2d-731e-41ac-aea1-5210c860921b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cca8300a-e1ee-42de-b67a-3e04cbad7341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f1871b2d-731e-41ac-aea1-5210c860921b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cca8300a-e1ee-42de-b67a-3e04cbad7341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_0aa3a39b-3578-4e34-87cf-1a4305f4f6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cca8300a-e1ee-42de-b67a-3e04cbad7341" xlink:to="loc_us-gaap_OtherIncomeMember_0aa3a39b-3578-4e34-87cf-1a4305f4f6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cc393ede-4a60-4752-962b-ad7676b76655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cc393ede-4a60-4752-962b-ad7676b76655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_d417cf09-3278-47a0-a7e8-dcf5f70565b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cc393ede-4a60-4752-962b-ad7676b76655" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_d417cf09-3278-47a0-a7e8-dcf5f70565b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b2d26de3-cc71-4d02-9781-0996f0479eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_d417cf09-3278-47a0-a7e8-dcf5f70565b0" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b2d26de3-cc71-4d02-9781-0996f0479eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1485b9c3-6a38-4b46-923e-06019589eb21" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_dd98ee64-f8f8-4c6a-b01d-1c1acf3bd04c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_dd98ee64-f8f8-4c6a-b01d-1c1acf3bd04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_250e251d-d4b2-433c-a62e-09a11079eb42" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_250e251d-d4b2-433c-a62e-09a11079eb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f3d01a14-be3e-4a2e-b397-d3eac5af894d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f3d01a14-be3e-4a2e-b397-d3eac5af894d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_0c49c822-286a-4a40-9f71-002b0d9826fd" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_0c49c822-286a-4a40-9f71-002b0d9826fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_911e92ab-dee5-4241-a82f-09c2451f1ac7" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_911e92ab-dee5-4241-a82f-09c2451f1ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_649fbed2-5d77-44f9-87ae-bda20ec1a56c" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_649fbed2-5d77-44f9-87ae-bda20ec1a56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5494e009-fa05-456b-a4ab-cb8ae8cef82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_Goodwill_5494e009-fa05-456b-a4ab-cb8ae8cef82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c4233df8-9123-4e03-b22e-ceca479546e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c4233df8-9123-4e03-b22e-ceca479546e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_43fa0c1f-9a0f-417f-b571-ba19d588691f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_43fa0c1f-9a0f-417f-b571-ba19d588691f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e35ff895-0cbc-433e-bcbf-4fef158c3725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e35ff895-0cbc-433e-bcbf-4fef158c3725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_8ac77d42-32de-47ea-8191-05305e95906e" xlink:href="holx-20210925.xsd#holx_Holdback"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_Holdback_8ac77d42-32de-47ea-8191-05305e95906e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e9b9e8aa-adbd-42a7-b04d-2c467b8af870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e9b9e8aa-adbd-42a7-b04d-2c467b8af870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3b0839ca-bcbb-437d-ab7e-f7cba51ff6b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3b0839ca-bcbb-437d-ab7e-f7cba51ff6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5281b356-4d53-4f0d-97a1-2858427595aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5281b356-4d53-4f0d-97a1-2858427595aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_987f3ed3-6b9c-4a27-b01c-d976bef5c72c" xlink:href="holx-20210925.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_987f3ed3-6b9c-4a27-b01c-d976bef5c72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_920c3f3c-af1d-45cc-b208-30dd7799d8fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_920c3f3c-af1d-45cc-b208-30dd7799d8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired_a7a0ebb7-2bb2-4996-b71e-4391306e69a2" xlink:href="holx-20210925.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationSharesAcquired_a7a0ebb7-2bb2-4996-b71e-4391306e69a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AdditionalPurchaseConsideration_5695482e-de72-4d9b-9acc-44f13aaf7374" xlink:href="holx-20210925.xsd#holx_AdditionalPurchaseConsideration"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_AdditionalPurchaseConsideration_5695482e-de72-4d9b-9acc-44f13aaf7374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_4e89ef65-b6bb-4a9d-9af2-9c3c5d3ef00b" xlink:href="holx-20210925.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_4e89ef65-b6bb-4a9d-9af2-9c3c5d3ef00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_2422e790-a9eb-4337-ac43-e6fae7cbb4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_2422e790-a9eb-4337-ac43-e6fae7cbb4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_e56a152f-6967-49a6-b3ff-135e2ea86143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_e56a152f-6967-49a6-b3ff-135e2ea86143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_3bb82d9b-5e7e-4f73-b069-d1550c9df0dd" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_3bb82d9b-5e7e-4f73-b069-d1550c9df0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_f6ad0a75-126a-4067-b17f-2cec880c17e0" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_f6ad0a75-126a-4067-b17f-2cec880c17e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_4f29dc69-5ec3-4eeb-971c-0d4cd69589e1" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_4f29dc69-5ec3-4eeb-971c-0d4cd69589e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_79e214df-91fa-49a1-af75-fdfb856d84b9" xlink:href="holx-20210925.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_79e214df-91fa-49a1-af75-fdfb856d84b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_c6eef68c-6e3f-44e2-aa43-f6445bcf93a5" xlink:href="holx-20210925.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_c6eef68c-6e3f-44e2-aa43-f6445bcf93a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_9059510d-6e9c-4da6-b46d-800b7c0a3fad" xlink:href="holx-20210925.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_9059510d-6e9c-4da6-b46d-800b7c0a3fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_d185dfe2-67de-43fe-8f97-adae570f94b1" xlink:href="holx-20210925.xsd#holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_d185dfe2-67de-43fe-8f97-adae570f94b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess_e29cea26-a10e-496c-ade1-33f113c8f6f1" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_47db45c4-a009-4790-8a9b-03803d1d2951" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess_e29cea26-a10e-496c-ade1-33f113c8f6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_bdcf9077-05a6-4e59-8ab2-da7bf4e12244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_710a8715-91e0-4f2a-9ffb-2f32015e9e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bdcf9077-05a6-4e59-8ab2-da7bf4e12244" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_710a8715-91e0-4f2a-9ffb-2f32015e9e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_15b7a36e-02a7-49d1-90d7-443f4ee432de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_710a8715-91e0-4f2a-9ffb-2f32015e9e0a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_15b7a36e-02a7-49d1-90d7-443f4ee432de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_15b7a36e-02a7-49d1-90d7-443f4ee432de" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_f3f0309e-2ae5-4497-ab8e-f4a799da1540" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_MobidiagOyMember_f3f0309e-2ae5-4497-ab8e-f4a799da1540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_77e223c7-b011-41ae-8ba1-741e0c73d7a9" xlink:href="holx-20210925.xsd#holx_BiotheranosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_BiotheranosticsMember_77e223c7-b011-41ae-8ba1-741e0c73d7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_2e6fc936-0bb5-46a4-a4a5-3ac2089648ea" xlink:href="holx-20210925.xsd#holx_DiagenodeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_DiagenodeMember_2e6fc936-0bb5-46a4-a4a5-3ac2089648ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_d1cd2664-69ed-47ff-ba71-413413c1dfb1" xlink:href="holx-20210925.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_AcessaHealthMember_d1cd2664-69ed-47ff-ba71-413413c1dfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_860d3f95-2d91-4a77-b22e-5e65b6520cc2" xlink:href="holx-20210925.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_SuperSonicImagineMember_860d3f95-2d91-4a77-b22e-5e65b6520cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FocalTherapeuticsInc.Member_839112cf-bb81-43f5-b968-b4daea5f3043" xlink:href="holx-20210925.xsd#holx_FocalTherapeuticsInc.Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_69473d04-2d72-4736-9965-bc5e7c7ea00a" xlink:to="loc_holx_FocalTherapeuticsInc.Member_839112cf-bb81-43f5-b968-b4daea5f3043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_710a8715-91e0-4f2a-9ffb-2f32015e9e0a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bbcba14d-79b3-419c-9276-3ca9791a69f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_bbcba14d-79b3-419c-9276-3ca9791a69f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d4e98839-945b-43e9-9aed-748e9ccfdb6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_d4e98839-945b-43e9-9aed-748e9ccfdb6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_05f27794-d637-42a9-8cb4-dd9a4766ab61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_05f27794-d637-42a9-8cb4-dd9a4766ab61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_3d032238-055a-481c-8e99-5d33b43ed015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_3d032238-055a-481c-8e99-5d33b43ed015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a16e72fd-de11-4b39-b826-bc051d6ebb70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_a16e72fd-de11-4b39-b826-bc051d6ebb70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d78eb050-dad7-42c8-9e85-c171d1278101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d78eb050-dad7-42c8-9e85-c171d1278101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_36632b3d-100f-4b96-bfef-343901fb1b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_36632b3d-100f-4b96-bfef-343901fb1b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_9b39888d-edcb-47a6-84ff-403dcb2b28fa" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_9b39888d-edcb-47a6-84ff-403dcb2b28fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_796356f0-1291-447e-85fe-3a76db6ee71d" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_796356f0-1291-447e-85fe-3a76db6ee71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_0b83bd42-1e60-42b9-b584-1b3a79f87c99" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_0b83bd42-1e60-42b9-b584-1b3a79f87c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_9a4ce039-a360-41a4-b7b8-b85db4a035e4" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_9a4ce039-a360-41a4-b7b8-b85db4a035e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_8be2c9d7-4e96-4943-8ae4-aa8f59945ae4" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_8be2c9d7-4e96-4943-8ae4-aa8f59945ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_3edb5176-fb4b-4bfe-b6b7-7bb66b27e9dc" xlink:href="holx-20210925.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_3edb5176-fb4b-4bfe-b6b7-7bb66b27e9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_01613ff6-799e-4d50-8dca-553bc6ab7bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_01613ff6-799e-4d50-8dca-553bc6ab7bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0190b84c-c410-4f84-97d0-47b5b1ad1028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0190b84c-c410-4f84-97d0-47b5b1ad1028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_86e397e1-2ddf-4ebc-bc00-fb92771282d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_Goodwill_86e397e1-2ddf-4ebc-bc00-fb92771282d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_139074d2-f918-4f79-8330-44968739003b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7d6b3890-8d70-40c5-999f-c485df9b0809" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_139074d2-f918-4f79-8330-44968739003b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#EquityMethodInvestmentDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/EquityMethodInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_b7585558-7678-4f27-8560-02747e86a2c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_09bddfee-84df-4cf0-913b-76e2a795b265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_b7585558-7678-4f27-8560-02747e86a2c6" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_09bddfee-84df-4cf0-913b-76e2a795b265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5677abe9-7853-4905-b7e5-ec4f9c6013b6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_09bddfee-84df-4cf0-913b-76e2a795b265" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5677abe9-7853-4905-b7e5-ec4f9c6013b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9095455d-0b12-446a-ae48-bb3020a33fd2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5677abe9-7853-4905-b7e5-ec4f9c6013b6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9095455d-0b12-446a-ae48-bb3020a33fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_6739b314-f6b3-4880-93e2-1eedc6742abc" xlink:href="holx-20210925.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9095455d-0b12-446a-ae48-bb3020a33fd2" xlink:to="loc_holx_SuperSonicImagineMember_6739b314-f6b3-4880-93e2-1eedc6742abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4779ba48-324a-456e-8a18-0c0abfa7e7cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_09bddfee-84df-4cf0-913b-76e2a795b265" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4779ba48-324a-456e-8a18-0c0abfa7e7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_11f2f221-438f-412c-9f18-7292110dc673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4779ba48-324a-456e-8a18-0c0abfa7e7cb" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_11f2f221-438f-412c-9f18-7292110dc673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2f32ecb7-63f6-4f29-886b-1382e5b1d378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_4779ba48-324a-456e-8a18-0c0abfa7e7cb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2f32ecb7-63f6-4f29-886b-1382e5b1d378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringCharges" xlink:type="simple" xlink:href="holx-20210925.xsd#RestructuringCharges"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ed978ad6-5a9f-4c75-9cb7-0be208127d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_9ddd51e6-0b45-493b-b3e8-82f81f7764e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ed978ad6-5a9f-4c75-9cb7-0be208127d4f" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_9ddd51e6-0b45-493b-b3e8-82f81f7764e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="simple" xlink:href="holx-20210925.xsd#RestructuringChargesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_81123760-c748-4a78-95e1-2994478865c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_358a393f-3608-4cc4-9cc5-68a4be220ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_81123760-c748-4a78-95e1-2994478865c3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_358a393f-3608-4cc4-9cc5-68a4be220ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_8a19ffad-a0a0-4490-8a47-a680238834a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_81123760-c748-4a78-95e1-2994478865c3" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_8a19ffad-a0a0-4490-8a47-a680238834a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8350961b-23c9-4853-aa55-51c8504589e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8350961b-23c9-4853-aa55-51c8504589e8" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_1994ec38-e675-4f0e-9d81-a24d65985299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_1994ec38-e675-4f0e-9d81-a24d65985299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_1994ec38-e675-4f0e-9d81-a24d65985299" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ActionMember_16dcab9b-7e52-45a1-b993-655887a5e01f" xlink:href="holx-20210925.xsd#holx_Fiscal2021ActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:to="loc_holx_Fiscal2021ActionMember_16dcab9b-7e52-45a1-b993-655887a5e01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember_4795b4a8-7140-4057-8706-f85e0761cbf9" xlink:href="holx-20210925.xsd#holx_Fiscal2020ActionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:to="loc_holx_Fiscal2020ActionMember_4795b4a8-7140-4057-8706-f85e0761cbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember_790423c7-00e0-46c3-bdaf-ccc5293e1ecc" xlink:href="holx-20210925.xsd#holx_Fiscal2019ActionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:to="loc_holx_Fiscal2019ActionMember_790423c7-00e0-46c3-bdaf-ccc5293e1ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtheractionMember_697dabe9-44eb-4021-bad9-99f9ecf0870f" xlink:href="holx-20210925.xsd#holx_OtheractionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_beb54b69-aa18-4c51-9f97-346a45adc227" xlink:to="loc_holx_OtheractionMember_697dabe9-44eb-4021-bad9-99f9ecf0870f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_6cc7a935-3399-4439-9204-39554aca3363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:to="loc_us-gaap_RestructuringPlanAxis_6cc7a935-3399-4439-9204-39554aca3363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_6cc7a935-3399-4439-9204-39554aca3363" xlink:to="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_66c69cc3-7f67-4cb2-ad94-69cebffc4d1b" xlink:href="holx-20210925.xsd#holx_Fiscal2019chargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:to="loc_holx_Fiscal2019chargesMember_66c69cc3-7f67-4cb2-ad94-69cebffc4d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember_ecb2d95f-39e9-4572-b52d-65161a6933e3" xlink:href="holx-20210925.xsd#holx_Fiscal2020ChargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:to="loc_holx_Fiscal2020ChargesMember_ecb2d95f-39e9-4572-b52d-65161a6933e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ChargesMember_55a1dca7-cb54-495d-a9cc-b292f0d640c6" xlink:href="holx-20210925.xsd#holx_Fiscal2021ChargesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_20438612-caa0-4427-85e9-1c07f0c34d6a" xlink:to="loc_holx_Fiscal2021ChargesMember_55a1dca7-cb54-495d-a9cc-b292f0d640c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_29a3cf84-cec1-478c-b8ed-2caeb00aca34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_29a3cf84-cec1-478c-b8ed-2caeb00aca34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b8c7a81a-dabb-4691-8ba2-ae10156dcd97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_29a3cf84-cec1-478c-b8ed-2caeb00aca34" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b8c7a81a-dabb-4691-8ba2-ae10156dcd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_790f55c1-bdb8-476c-9868-312cf559f04c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b8c7a81a-dabb-4691-8ba2-ae10156dcd97" xlink:to="loc_us-gaap_RestructuringChargesMember_790f55c1-bdb8-476c-9868-312cf559f04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_3e930470-11cb-48ee-a431-91594e21832d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_f1726b6a-b74c-4f4c-bdd0-5ca0bcc93bc4" xlink:href="holx-20210925.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:to="loc_holx_ReductionOfWorkforceExpenses_f1726b6a-b74c-4f4c-bdd0-5ca0bcc93bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_939c8c3c-9e02-4baf-821f-9bf1094a3188" xlink:href="holx-20210925.xsd#holx_DivestitureCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:to="loc_holx_DivestitureCharges_939c8c3c-9e02-4baf-821f-9bf1094a3188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_09d566aa-b061-43db-9829-d614462fed77" xlink:href="holx-20210925.xsd#holx_FacilityClosureCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:to="loc_holx_FacilityClosureCosts_09d566aa-b061-43db-9829-d614462fed77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_22621c1d-58ac-41c3-b826-dcf2c56cfd44" xlink:href="holx-20210925.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_63d8be1d-7ac4-4a08-8fb6-b391f8cecee2" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_22621c1d-58ac-41c3-b826-dcf2c56cfd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0fa35bd1-902b-4094-a4e4-5c434bf0b04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0fa35bd1-902b-4094-a4e4-5c434bf0b04f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_ab7f70b9-fa50-42ef-a1de-b5df7b1f6e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:to="loc_us-gaap_RestructuringPlanAxis_ab7f70b9-fa50-42ef-a1de-b5df7b1f6e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_ab7f70b9-fa50-42ef-a1de-b5df7b1f6e01" xlink:to="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwothousandeighteenMember_63593905-3792-4eaa-ab28-ccd527dfdf05" xlink:href="holx-20210925.xsd#holx_TwothousandeighteenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:to="loc_holx_TwothousandeighteenMember_63593905-3792-4eaa-ab28-ccd527dfdf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_b8ee1bc9-a268-4690-b83e-f91a75737b80" xlink:href="holx-20210925.xsd#holx_Fiscal2019chargesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:to="loc_holx_Fiscal2019chargesMember_b8ee1bc9-a268-4690-b83e-f91a75737b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ChargesMember_3e1c9cbe-566a-4ff7-844b-0368fd248c4b" xlink:href="holx-20210925.xsd#holx_Fiscal2020ChargesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:to="loc_holx_Fiscal2020ChargesMember_3e1c9cbe-566a-4ff7-844b-0368fd248c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ChargesMember_e729e1ff-27cf-48ff-b0ed-add12f26da5d" xlink:href="holx-20210925.xsd#holx_Fiscal2021ChargesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_73b00f76-c2bb-4037-9689-1f5c7c04196b" xlink:to="loc_holx_Fiscal2021ChargesMember_e729e1ff-27cf-48ff-b0ed-add12f26da5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_412f0405-ecc7-4116-926d-f43d023a5342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_412f0405-ecc7-4116-926d-f43d023a5342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_412f0405-ecc7-4116-926d-f43d023a5342" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2021ActionMember_b058d9d1-cde6-41bf-8df3-184ee2ec1151" xlink:href="holx-20210925.xsd#holx_Fiscal2021ActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_Fiscal2021ActionMember_b058d9d1-cde6-41bf-8df3-184ee2ec1151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2020ActionMember_1359f736-5cb4-4bd5-afbb-8e97bd6d5d63" xlink:href="holx-20210925.xsd#holx_Fiscal2020ActionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_Fiscal2020ActionMember_1359f736-5cb4-4bd5-afbb-8e97bd6d5d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019ActionMember_688518c8-2b3a-4f48-a3d4-fe7e2d0f9241" xlink:href="holx-20210925.xsd#holx_Fiscal2019ActionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_Fiscal2019ActionMember_688518c8-2b3a-4f48-a3d4-fe7e2d0f9241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember_9d6ae8f5-c772-4433-a98f-64b3beddaa08" xlink:href="holx-20210925.xsd#holx_Fiscal2018ActionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_Fiscal2018ActionMember_9d6ae8f5-c772-4433-a98f-64b3beddaa08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherOperatingCostReductionsMember_8b9d7086-89cf-4322-9b67-b1bace971cd9" xlink:href="holx-20210925.xsd#holx_OtherOperatingCostReductionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e2cff737-7e4a-4238-8f9f-4e800a9d5727" xlink:to="loc_holx_OtherOperatingCostReductionsMember_8b9d7086-89cf-4322-9b67-b1bace971cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7c53d231-c451-4453-8573-3485dd656557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7c53d231-c451-4453-8573-3485dd656557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_11d65b97-40c4-4f77-b5dc-31323ae732cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7c53d231-c451-4453-8573-3485dd656557" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_11d65b97-40c4-4f77-b5dc-31323ae732cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_220194fa-e9bc-40af-b5f1-947e1ccdf6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_11d65b97-40c4-4f77-b5dc-31323ae732cd" xlink:to="loc_us-gaap_RestructuringChargesMember_220194fa-e9bc-40af-b5f1-947e1ccdf6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_13a39458-3473-480e-88e7-90e834e34152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_88d9be9a-bbd8-44a7-aa57-699c7b09d1f9" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_13a39458-3473-480e-88e7-90e834e34152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_13a39458-3473-480e-88e7-90e834e34152" xlink:to="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2066736e-2ed1-4e68-816b-da80eeab74b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_us-gaap_RestructuringReserve_2066736e-2ed1-4e68-816b-da80eeab74b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_33834da9-9163-45d3-96db-239bd15ba07e" xlink:href="holx-20210925.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_33834da9-9163-45d3-96db-239bd15ba07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_5fccf534-a156-43e3-aad5-4b25a861ca87" xlink:href="holx-20210925.xsd#holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_5fccf534-a156-43e3-aad5-4b25a861ca87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CashSeverancePayments_5e58d180-eeca-4502-a8b3-7b1f2117e1f2" xlink:href="holx-20210925.xsd#holx_CashSeverancePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_holx_CashSeverancePayments_5e58d180-eeca-4502-a8b3-7b1f2117e1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherRestructuringPayments_0d4cf231-b6b6-4799-8e2a-78a67020c0e9" xlink:href="holx-20210925.xsd#holx_OtherRestructuringPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_holx_OtherRestructuringPayments_0d4cf231-b6b6-4799-8e2a-78a67020c0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_024400b8-f3de-41de-afcb-8293e94bae44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_2a0b5df9-13cc-4df9-996f-a1ae80aaea3a" xlink:to="loc_us-gaap_RestructuringReserve_024400b8-f3de-41de-afcb-8293e94bae44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#RestructuringChargesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_406eab5c-700c-4b55-819a-06d261e144e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_406eab5c-700c-4b55-819a-06d261e144e0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_40b93510-29be-44d4-bf79-b4812e79f3f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_40b93510-29be-44d4-bf79-b4812e79f3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_494187a2-a694-47b6-9537-c0b5c2bf3b4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_40b93510-29be-44d4-bf79-b4812e79f3f2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_494187a2-a694-47b6-9537-c0b5c2bf3b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_0d9e81f3-ec74-4fd0-8506-f925fc0bb601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_494187a2-a694-47b6-9537-c0b5c2bf3b4d" xlink:to="loc_us-gaap_RestructuringChargesMember_0d9e81f3-ec74-4fd0-8506-f925fc0bb601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_caeacccf-2c12-4ab0-9527-d7c5a4a63871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:to="loc_us-gaap_RestructuringPlanAxis_caeacccf-2c12-4ab0-9527-d7c5a4a63871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_caeacccf-2c12-4ab0-9527-d7c5a4a63871" xlink:to="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_e138a117-6b8e-439f-b772-7917ba94f21b" xlink:href="holx-20210925.xsd#holx_CynosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:to="loc_holx_CynosureMember_e138a117-6b8e-439f-b772-7917ba94f21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BedfordMember_63a91db8-d78d-4181-97e1-bb020b6ee2ff" xlink:href="holx-20210925.xsd#holx_BedfordMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:to="loc_holx_BedfordMember_63a91db8-d78d-4181-97e1-bb020b6ee2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_817237d1-5e69-40d3-8c48-cf07a44f5eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:to="loc_us-gaap_RestructuringChargesMember_817237d1-5e69-40d3-8c48-cf07a44f5eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2019chargesMember_f2aea3ba-f656-4db7-9a2f-bbdd47cf758b" xlink:href="holx-20210925.xsd#holx_Fiscal2019chargesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1c2f861f-d821-4f65-84f0-65a9e587aa37" xlink:to="loc_holx_Fiscal2019chargesMember_f2aea3ba-f656-4db7-9a2f-bbdd47cf758b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityByLocationAxis_428d27c9-26ad-4b7d-a409-a0ea62b771ab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityByLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:to="loc_dei_EntityByLocationAxis_428d27c9-26ad-4b7d-a409-a0ea62b771ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocationDomain_246fdd24-c799-44d6-956c-d2d0ae2fa42a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityByLocationAxis_428d27c9-26ad-4b7d-a409-a0ea62b771ab" xlink:to="loc_dei_LocationDomain_246fdd24-c799-44d6-956c-d2d0ae2fa42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TepnelMember_7f6470a6-6548-406b-b427-e519e3f29d89" xlink:href="holx-20210925.xsd#holx_TepnelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LocationDomain_246fdd24-c799-44d6-956c-d2d0ae2fa42a" xlink:to="loc_holx_TepnelMember_7f6470a6-6548-406b-b427-e519e3f29d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CynosureMember_715efc88-8c7d-4199-a055-49418cb24ce4" xlink:href="holx-20210925.xsd#holx_CynosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LocationDomain_246fdd24-c799-44d6-956c-d2d0ae2fa42a" xlink:to="loc_holx_CynosureMember_715efc88-8c7d-4199-a055-49418cb24ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_8e1f1c45-106b-41ad-9301-b65e17560bc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_8e1f1c45-106b-41ad-9301-b65e17560bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_05bc2f19-15fd-4b96-84fa-dbb496884545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_8e1f1c45-106b-41ad-9301-b65e17560bc0" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_05bc2f19-15fd-4b96-84fa-dbb496884545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Fiscal2018ActionMember_a203720d-811c-4036-a250-5d68ce6f3584" xlink:href="holx-20210925.xsd#holx_Fiscal2018ActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_05bc2f19-15fd-4b96-84fa-dbb496884545" xlink:to="loc_holx_Fiscal2018ActionMember_a203720d-811c-4036-a250-5d68ce6f3584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_41827622-68b5-4f10-84e8-b03b0754f77b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_79628047-3414-4a53-a775-be75d935e247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_us-gaap_SeveranceCosts1_79628047-3414-4a53-a775-be75d935e247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FacilityClosureCosts_2b49bcde-1def-42f1-8f09-ab910573adb0" xlink:href="holx-20210925.xsd#holx_FacilityClosureCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_holx_FacilityClosureCosts_2b49bcde-1def-42f1-8f09-ab910573adb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ReductionOfWorkforceExpenses_04eab9ab-0ccd-4203-951a-cc368c62734f" xlink:href="holx-20210925.xsd#holx_ReductionOfWorkforceExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_holx_ReductionOfWorkforceExpenses_04eab9ab-0ccd-4203-951a-cc368c62734f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_b8469524-f8e8-4f88-975b-ca0647b08f32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_b8469524-f8e8-4f88-975b-ca0647b08f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RemainingLeaseBalance_2042fd6d-67a9-4ffc-af45-80fd2b658e11" xlink:href="holx-20210925.xsd#holx_RemainingLeaseBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_holx_RemainingLeaseBalance_2042fd6d-67a9-4ffc-af45-80fd2b658e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DivestitureCharges_4e503f58-c5bb-42cf-adc3-acdb08fd0910" xlink:href="holx-20210925.xsd#holx_DivestitureCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bd846897-7666-4b69-a914-f2e435191909" xlink:to="loc_holx_DivestitureCharges_4e503f58-c5bb-42cf-adc3-acdb08fd0910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6812122f-6e5e-45fb-85a9-9a3a0e066584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_aa560a83-a5bf-4e55-acbd-b54eff1f10b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6812122f-6e5e-45fb-85a9-9a3a0e066584" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_aa560a83-a5bf-4e55-acbd-b54eff1f10b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_38e4789d-5790-40a9-985c-890d682330c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_f445b0c5-cd1e-4f7b-b18b-8fac621555f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_38e4789d-5790-40a9-985c-890d682330c6" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_f445b0c5-cd1e-4f7b-b18b-8fac621555f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_987d5f00-4cab-4521-8f47-3ff33cb886ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_38e4789d-5790-40a9-985c-890d682330c6" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_987d5f00-4cab-4521-8f47-3ff33cb886ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_313fd9c6-8ccf-4054-b2e3-52f9081ed28d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_38e4789d-5790-40a9-985c-890d682330c6" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_313fd9c6-8ccf-4054-b2e3-52f9081ed28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f5ce3f85-6904-4d19-aa57-82ed4a2fe81e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d26e4f7f-9191-4d8c-9ddd-3e650cbe5586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f5ce3f85-6904-4d19-aa57-82ed4a2fe81e" xlink:to="loc_us-gaap_DebtInstrumentTable_d26e4f7f-9191-4d8c-9ddd-3e650cbe5586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_01d5c249-ea48-4c08-9b5e-2faa2287ebb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d26e4f7f-9191-4d8c-9ddd-3e650cbe5586" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_01d5c249-ea48-4c08-9b5e-2faa2287ebb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_01d5c249-ea48-4c08-9b5e-2faa2287ebb1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_28ba667f-ee13-4935-8f86-e47f45e9e5ef" xlink:href="holx-20210925.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_TermLoanMember_28ba667f-ee13-4935-8f86-e47f45e9e5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_950decc0-08cc-4100-bc02-07c615f5cdaf" xlink:href="holx-20210925.xsd#holx_RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_RevolverMember_950decc0-08cc-4100-bc02-07c615f5cdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_65aa0630-5a2d-4ac3-bf2e-609ae7b2025a" xlink:href="holx-20210925.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_65aa0630-5a2d-4ac3-bf2e-609ae7b2025a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_73083884-5193-4b89-9b47-e89b66770f25" xlink:href="holx-20210925.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_A2025SeniorNotesMember_73083884-5193-4b89-9b47-e89b66770f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_22f2fb17-9d19-4782-a8c8-619a92f2b964" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_A2028SeniorNotesMember_22f2fb17-9d19-4782-a8c8-619a92f2b964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_3f5b104d-bbfa-4e97-a5c8-a4a39855c67f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_3f5b104d-bbfa-4e97-a5c8-a4a39855c67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_de1686c0-c04b-4f74-816b-f1707ec1a2be" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_95bd712d-4127-4143-90a4-adc56b121851" xlink:to="loc_holx_A2029SeniorNotesMember_de1686c0-c04b-4f74-816b-f1707ec1a2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d26e4f7f-9191-4d8c-9ddd-3e650cbe5586" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_46adcd53-e078-46d3-b791-c84beed2c470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:to="loc_us-gaap_LongTermDebtCurrent_46adcd53-e078-46d3-b791-c84beed2c470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5f9cfff9-e2b3-4f03-987e-5de65a4ece0c" xlink:href="holx-20210925.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5f9cfff9-e2b3-4f03-987e-5de65a4ece0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0aa04165-2a3e-4ea8-b5bc-682d223080da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0aa04165-2a3e-4ea8-b5bc-682d223080da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6141546b-5433-42e1-bdf5-a46df00437b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2c84ed83-d030-4bb4-8bbf-f84d995a6cf0" xlink:to="loc_us-gaap_LongTermDebt_6141546b-5433-42e1-bdf5-a46df00437b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_691806e5-0f15-4ac6-abca-faa1253e77c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_db8bfa80-c10e-4cc7-9a89-58a68699c3f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_691806e5-0f15-4ac6-abca-faa1253e77c0" xlink:to="loc_us-gaap_DebtInstrumentTable_db8bfa80-c10e-4cc7-9a89-58a68699c3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_966c9ef0-e861-4c61-97cf-498816916f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_db8bfa80-c10e-4cc7-9a89-58a68699c3f7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_966c9ef0-e861-4c61-97cf-498816916f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_966c9ef0-e861-4c61-97cf-498816916f6f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_82dffef9-e674-47fc-b3ca-eb50167a34ab" xlink:href="holx-20210925.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_TermLoanMember_82dffef9-e674-47fc-b3ca-eb50167a34ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_14f37427-c436-4e7a-944c-75626e54c170" xlink:href="holx-20210925.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_14f37427-c436-4e7a-944c-75626e54c170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_9c3d62bb-b741-48ca-b0a7-34e0b7a25822" xlink:href="holx-20210925.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_A2025SeniorNotesMember_9c3d62bb-b741-48ca-b0a7-34e0b7a25822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_76e87778-1388-4534-bc94-443444ca6a07" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_A2028SeniorNotesMember_76e87778-1388-4534-bc94-443444ca6a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_7d04d682-004c-49c5-a28d-87f1267fcf32" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_holx_A2029SeniorNotesMember_7d04d682-004c-49c5-a28d-87f1267fcf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_aec90876-d3a4-4861-80d7-591ebb7f71fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9822647-0a08-4454-bcee-04ecf4434e81" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_aec90876-d3a4-4861-80d7-591ebb7f71fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_db8bfa80-c10e-4cc7-9a89-58a68699c3f7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c9cf212b-b391-47a9-aecc-cd22a4795867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c9cf212b-b391-47a9-aecc-cd22a4795867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ebf6b61b-a38d-4209-b16f-a44cd8848de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ebf6b61b-a38d-4209-b16f-a44cd8848de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_218f7949-5c28-4a87-8a45-b806550244e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_218f7949-5c28-4a87-8a45-b806550244e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c296a84f-cba2-452a-a179-9c8c5cfcd8bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c296a84f-cba2-452a-a179-9c8c5cfcd8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_afbecc7f-d48f-4c6e-bfef-f0baedacbd1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_afbecc7f-d48f-4c6e-bfef-f0baedacbd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6b95f9fe-c104-440d-9cde-a327150bc46f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_6b95f9fe-c104-440d-9cde-a327150bc46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_5d81898c-3df2-438f-809a-403c681be7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3d3a0a69-da76-454b-a6f4-fde66f5d572e" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_5d81898c-3df2-438f-809a-403c681be7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_24aaeccc-8e3b-44df-a925-8cb066fac4ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_45660be5-1f80-4258-9cc2-c769b4cd1f34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_24aaeccc-8e3b-44df-a925-8cb066fac4ff" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_45660be5-1f80-4258-9cc2-c769b4cd1f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_18f612b8-f225-4ad9-88d2-d375d01947fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_45660be5-1f80-4258-9cc2-c769b4cd1f34" xlink:to="loc_us-gaap_DebtInstrumentAxis_18f612b8-f225-4ad9-88d2-d375d01947fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_18f612b8-f225-4ad9-88d2-d375d01947fb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2018Member_f3cac4f7-d38a-4b4b-871c-b9cdbf535115" xlink:href="holx-20210925.xsd#holx_CreditAgreement2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:to="loc_holx_CreditAgreement2018Member_f3cac4f7-d38a-4b4b-871c-b9cdbf535115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member_996c3ed5-1a9b-4faa-875b-862a8cf93ba0" xlink:href="holx-20210925.xsd#holx_CreditAgreement2017Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:to="loc_holx_CreditAgreement2017Member_996c3ed5-1a9b-4faa-875b-862a8cf93ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember_062f6f1f-bddb-48a9-bd60-62e8f10144b6" xlink:href="holx-20210925.xsd#holx_CreditAgreementPriorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dbd19f43-8134-4fc2-8fb5-1a80c95d3950" xlink:to="loc_holx_CreditAgreementPriorMember_062f6f1f-bddb-48a9-bd60-62e8f10144b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_45660be5-1f80-4258-9cc2-c769b4cd1f34" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_4efbc2a1-cebf-4829-b373-a1532b598b25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:to="loc_us-gaap_InterestExpenseBorrowings_4efbc2a1-cebf-4829-b373-a1532b598b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8c99b2ec-eb30-4e24-8714-1add3d90fd5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8c99b2ec-eb30-4e24-8714-1add3d90fd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_17dc900d-034d-4c68-aafe-b64af33fdc29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_17dc900d-034d-4c68-aafe-b64af33fdc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_c0cac209-d8c9-440c-8a24-75f15e1ed2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_304523e4-9034-40f7-ad33-0f9871451166" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_c0cac209-d8c9-440c-8a24-75f15e1ed2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2a0e2ef1-7d8b-40f2-9724-5e38f7285c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2a0e2ef1-7d8b-40f2-9724-5e38f7285c7b" xlink:to="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5e60861b-652f-4298-bbc0-a6ce8e0b5300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5e60861b-652f-4298-bbc0-a6ce8e0b5300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5e60861b-652f-4298-bbc0-a6ce8e0b5300" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember_496001a6-b5f0-4476-9138-67f626332e8d" xlink:href="holx-20210925.xsd#holx_SecuredTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_holx_SecuredTermLoanMember_496001a6-b5f0-4476-9138-67f626332e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_a6ee110b-244a-4c05-aa6f-b3f00111ad9e" xlink:href="holx-20210925.xsd#holx_RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_holx_RevolverMember_a6ee110b-244a-4c05-aa6f-b3f00111ad9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7c111da6-8792-454e-8f5d-9222f05a8a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_us-gaap_LineOfCreditMember_7c111da6-8792-454e-8f5d-9222f05a8a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_c3520183-04d9-4ef2-a0a7-de8dad5cd745" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_us-gaap_SeniorNotesMember_c3520183-04d9-4ef2-a0a7-de8dad5cd745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_8e3aa3f7-8b89-4e6e-8ab0-98faa6ab62d4" xlink:href="holx-20210925.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1aa3f2d1-33de-4081-90e5-351f5d9de7a7" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_8e3aa3f7-8b89-4e6e-8ab0-98faa6ab62d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b67507fe-559e-4f02-a43a-aad5c7ff7add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_DebtInstrumentAxis_b67507fe-559e-4f02-a43a-aad5c7ff7add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b67507fe-559e-4f02-a43a-aad5c7ff7add" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoan2018Member_8e262222-a489-4279-a696-6e87171acda8" xlink:href="holx-20210925.xsd#holx_AmendedTermLoan2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_AmendedTermLoan2018Member_8e262222-a489-4279-a696-6e87171acda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedRevolver2018Member_b73bbec6-533b-4ce7-8125-4c11fd54caa3" xlink:href="holx-20210925.xsd#holx_AmendedRevolver2018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_AmendedRevolver2018Member_b73bbec6-533b-4ce7-8125-4c11fd54caa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedCreditFacility2018Member_2347117c-ecd1-4775-8c5b-70ab5a26d012" xlink:href="holx-20210925.xsd#holx_AmendedCreditFacility2018Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_AmendedCreditFacility2018Member_2347117c-ecd1-4775-8c5b-70ab5a26d012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreement2017Member_9f31a401-10f9-4078-a9f5-d36507e77533" xlink:href="holx-20210925.xsd#holx_CreditAgreement2017Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_CreditAgreement2017Member_9f31a401-10f9-4078-a9f5-d36507e77533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementPriorMember_c0a244e2-fd8f-4882-b90b-982459bc9dfe" xlink:href="holx-20210925.xsd#holx_CreditAgreementPriorMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_CreditAgreementPriorMember_c0a244e2-fd8f-4882-b90b-982459bc9dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_48cd0c55-c95c-47bb-a4d6-2acb18288c7d" xlink:href="holx-20210925.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2025SeniorNotesMember_48cd0c55-c95c-47bb-a4d6-2acb18288c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_eb2f1f02-4f53-44c0-9ca3-56cdae13d7b0" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2028SeniorNotesMember_eb2f1f02-4f53-44c0-9ca3-56cdae13d7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_d0da50ff-9573-466f-97f7-332975956b8b" xlink:href="holx-20210925.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_d0da50ff-9573-466f-97f7-332975956b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_25ce760d-9248-4c21-bc77-8e8c7d18b878" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2029SeniorNotesMember_25ce760d-9248-4c21-bc77-8e8c7d18b878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021TermLoanMember_fa335ea3-f11f-48eb-98fd-f9c56ccb4a1d" xlink:href="holx-20210925.xsd#holx_A2021TermLoanMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2021TermLoanMember_fa335ea3-f11f-48eb-98fd-f9c56ccb4a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021RevolverMember_c356c122-1afe-409f-b2b4-b4f3c37d1f0d" xlink:href="holx-20210925.xsd#holx_A2021RevolverMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2021RevolverMember_c356c122-1afe-409f-b2b4-b4f3c37d1f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021CreditAgreementMember_7e20323a-3277-4040-887b-9e2a557769e9" xlink:href="holx-20210925.xsd#holx_A2021CreditAgreementMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8a051576-1075-40d3-a893-5a9b311e4bdd" xlink:to="loc_holx_A2021CreditAgreementMember_7e20323a-3277-4040-887b-9e2a557769e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f3ac5981-2ba1-4fc1-9603-1a47186665e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_VariableRateAxis_f3ac5981-2ba1-4fc1-9603-1a47186665e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_600b4772-9ce3-41ba-960e-723a5a0fe9a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f3ac5981-2ba1-4fc1-9603-1a47186665e4" xlink:to="loc_us-gaap_VariableRateDomain_600b4772-9ce3-41ba-960e-723a5a0fe9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_dceaed8c-7a40-4231-b27d-6692add3dd6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_600b4772-9ce3-41ba-960e-723a5a0fe9a3" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_dceaed8c-7a40-4231-b27d-6692add3dd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EurocurrencyRateMember_86b7b003-5bf3-491e-88a2-2ebc48678b1e" xlink:href="holx-20210925.xsd#holx_EurocurrencyRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_600b4772-9ce3-41ba-960e-723a5a0fe9a3" xlink:to="loc_holx_EurocurrencyRateMember_86b7b003-5bf3-491e-88a2-2ebc48678b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_16fca586-487e-4675-a94e-b74060e87a8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_srt_StatementScenarioAxis_16fca586-487e-4675-a94e-b74060e87a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5151e3c9-ef03-4e20-b91f-c4b44de0339a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_16fca586-487e-4675-a94e-b74060e87a8e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5151e3c9-ef03-4e20-b91f-c4b44de0339a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_9fdd1c18-f9f9-4afc-ad62-182681a56cf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_5151e3c9-ef03-4e20-b91f-c4b44de0339a" xlink:to="loc_srt_ScenarioForecastMember_9fdd1c18-f9f9-4afc-ad62-182681a56cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_877e26f3-5c6f-4db9-996d-03252a7785ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_877e26f3-5c6f-4db9-996d-03252a7785ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_877e26f3-5c6f-4db9-996d-03252a7785ba" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4f4ba241-ce05-4e6e-b7c6-93d39206d777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_4f4ba241-ce05-4e6e-b7c6-93d39206d777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d1f462f2-32cb-4808-9cb0-b9808ef1b0b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_d1f462f2-32cb-4808-9cb0-b9808ef1b0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_0957242f-59a9-47e3-bf9c-2c1d50c3204b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_0957242f-59a9-47e3-bf9c-2c1d50c3204b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_fcbaf99d-ca21-4582-8356-2f88dae27c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_fcbaf99d-ca21-4582-8356-2f88dae27c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_1b6ba3ed-4b7b-4f58-b318-23c0c9513003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_1cb3cb1f-5f42-4142-b10d-f5fdad91857d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_1b6ba3ed-4b7b-4f58-b318-23c0c9513003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0e9e5b6f-d113-4917-af65-d84936bf40fb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_srt_RangeAxis_0e9e5b6f-d113-4917-af65-d84936bf40fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f62906cb-7926-45ab-9646-123d55987c1e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0e9e5b6f-d113-4917-af65-d84936bf40fb" xlink:to="loc_srt_RangeMember_f62906cb-7926-45ab-9646-123d55987c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_55d92c5b-c68e-41d3-94fc-241caeb2dd5d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f62906cb-7926-45ab-9646-123d55987c1e" xlink:to="loc_srt_MinimumMember_55d92c5b-c68e-41d3-94fc-241caeb2dd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4297c91e-1a74-493d-9328-bd9c6a027210" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f62906cb-7926-45ab-9646-123d55987c1e" xlink:to="loc_srt_MaximumMember_4297c91e-1a74-493d-9328-bd9c6a027210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9d07aaf8-54ac-46e0-911d-98a9205748bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9d07aaf8-54ac-46e0-911d-98a9205748bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ad808d3b-1325-45e1-a297-ccbe0f92d259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d07aaf8-54ac-46e0-911d-98a9205748bb" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ad808d3b-1325-45e1-a297-ccbe0f92d259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fbebf567-fcd3-4d55-be90-230af8b51d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ad808d3b-1325-45e1-a297-ccbe0f92d259" xlink:to="loc_us-gaap_SubsequentEventMember_fbebf567-fcd3-4d55-be90-230af8b51d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_84ce49b1-47ae-4629-9803-61c34e07cd55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_84ce49b1-47ae-4629-9803-61c34e07cd55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2d2ff475-3a90-422f-8771-8e6076cd090f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_84ce49b1-47ae-4629-9803-61c34e07cd55" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2d2ff475-3a90-422f-8771-8e6076cd090f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_e0f941b7-2b23-4cb3-b3fe-e25f97fcfda9" xlink:href="holx-20210925.xsd#holx_MobidiagOyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2d2ff475-3a90-422f-8771-8e6076cd090f" xlink:to="loc_holx_MobidiagOyMember_e0f941b7-2b23-4cb3-b3fe-e25f97fcfda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08139c71-cca9-4476-97b3-47ac51db5305" xlink:to="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6baf7086-5da0-4ce5-af73-9d25fb4f6f7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6baf7086-5da0-4ce5-af73-9d25fb4f6f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_23524989-80f4-4a6a-90e7-3e29cabb0c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_23524989-80f4-4a6a-90e7-3e29cabb0c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9f233ca1-c938-459d-b50f-8585aa5d15d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9f233ca1-c938-459d-b50f-8585aa5d15d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_588a0ba9-8f85-419f-a4b7-143be1aba510" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter_588a0ba9-8f85-419f-a4b7-143be1aba510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_608dcec9-0ef6-43c7-a7fe-07cebc2f70db" xlink:href="holx-20210925.xsd#holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments_608dcec9-0ef6-43c7-a7fe-07cebc2f70db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeverageRatioMaximum_4a046f62-da14-4f6b-be57-71e62558019c" xlink:href="holx-20210925.xsd#holx_LeverageRatioMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_LeverageRatioMaximum_4a046f62-da14-4f6b-be57-71e62558019c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestCoverageRatio_3a1d926c-de17-47f7-b959-badb712b85bb" xlink:href="holx-20210925.xsd#holx_InterestCoverageRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_InterestCoverageRatio_3a1d926c-de17-47f7-b959-badb712b85bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6af539c0-27e5-4451-907c-f3b897bfe200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6af539c0-27e5-4451-907c-f3b897bfe200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentNumberOfInstruments_795f79cb-b8a2-4fad-8ae8-b4b1ff1606b3" xlink:href="holx-20210925.xsd#holx_DebtInstrumentNumberOfInstruments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentNumberOfInstruments_795f79cb-b8a2-4fad-8ae8-b4b1ff1606b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_88553e3f-2b31-4ad2-87bf-60287759ba0f" xlink:href="holx-20210925.xsd#holx_MaximumRangeofPresentValueofCashFlowPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_88553e3f-2b31-4ad2-87bf-60287759ba0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9b641f10-c6d5-473d-8734-dfd0d6928336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_9b641f10-c6d5-473d-8734-dfd0d6928336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ff141ff6-6023-4cf9-991b-21491f41f9bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_ff141ff6-6023-4cf9-991b-21491f41f9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_b60e1113-d0c7-48c1-92ab-52643bf9e059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_b60e1113-d0c7-48c1-92ab-52643bf9e059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_38127430-316c-44cb-b0d2-9fd61e45454f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_InterestExpenseDebt_38127430-316c-44cb-b0d2-9fd61e45454f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_e3639add-5377-4b35-9513-c2eeb583f4ea" xlink:href="holx-20210925.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_e3639add-5377-4b35-9513-c2eeb583f4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cef5e87e-0e7f-41aa-9a1a-8fe8509327a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_cef5e87e-0e7f-41aa-9a1a-8fe8509327a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_d9e2575b-b093-4454-a684-b00fd8e8a488" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_d9e2575b-b093-4454-a684-b00fd8e8a488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_7cce4669-7f00-4dcf-a666-3f30e5fe9c2d" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_7cce4669-7f00-4dcf-a666-3f30e5fe9c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_f0c0db9f-7131-45fa-b73f-191f55e30d3d" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_f0c0db9f-7131-45fa-b73f-191f55e30d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_e28a620c-c393-4181-a0f5-25a3fb671ce6" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_e28a620c-c393-4181-a0f5-25a3fb671ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermARSecuritizationProgram_987caf9f-ded9-4fbb-a0a3-123a321eafe2" xlink:href="holx-20210925.xsd#holx_TermARSecuritizationProgram"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_TermARSecuritizationProgram_987caf9f-ded9-4fbb-a0a3-123a321eafe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableFromSecuritization_de813440-0e32-4eb1-b2af-2d6bb58cfca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableFromSecuritization"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_AccountsReceivableFromSecuritization_de813440-0e32-4eb1-b2af-2d6bb58cfca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumBorrowingUnderSecuritizationProgram_7d25398f-4f85-4daa-b783-51c45842e6cf" xlink:href="holx-20210925.xsd#holx_MaximumBorrowingUnderSecuritizationProgram"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_MaximumBorrowingUnderSecuritizationProgram_7d25398f-4f85-4daa-b783-51c45842e6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_e15a4078-b33a-45b1-af34-0ab61180595b" xlink:href="holx-20210925.xsd#holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_e15a4078-b33a-45b1-af34-0ab61180595b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_1c09711b-02b0-4922-89cb-d162eaaf131f" xlink:href="holx-20210925.xsd#holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_1c09711b-02b0-4922-89cb-d162eaaf131f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_bdbcaad0-d290-4fb3-9146-33153340a79c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_bdbcaad0-d290-4fb3-9146-33153340a79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_4c6c1e82-a33c-48bd-919d-7e67cdb2226a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_RepaymentsOfDebt_4c6c1e82-a33c-48bd-919d-7e67cdb2226a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_16150cfe-3413-44d3-83dd-351f6240afb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_SeniorNotes_16150cfe-3413-44d3-83dd-351f6240afb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_b01cea7e-0cbe-43f3-a052-42f30bd8699c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_b01cea7e-0cbe-43f3-a052-42f30bd8699c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid_3d18930c-119f-49e6-b7cd-4b621e2b4e7c" xlink:href="holx-20210925.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtRedemptionPremiumPaid_3d18930c-119f-49e6-b7cd-4b621e2b4e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_0aa23101-1e66-42f8-9fe9-54514fbf0e70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_0aa23101-1e66-42f8-9fe9-54514fbf0e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6f859955-0d92-4cce-8b91-6aa0b711e758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6f859955-0d92-4cce-8b91-6aa0b711e758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a16f9dbc-52c2-41a5-9d31-88f5673eb6f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_LongTermDebtCurrent_a16f9dbc-52c2-41a5-9d31-88f5673eb6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_48e43a91-c25b-4964-8be6-829af5f3f904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_48e43a91-c25b-4964-8be6-829af5f3f904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_7abea465-3360-41ed-b0e0-56d9a926a92f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_7abea465-3360-41ed-b0e0-56d9a926a92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentCommitmentFeePercentage_71c07088-b32e-4079-8096-85c38c3fa9c4" xlink:href="holx-20210925.xsd#holx_DebtInstrumentCommitmentFeePercentage"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_holx_DebtInstrumentCommitmentFeePercentage_71c07088-b32e-4079-8096-85c38c3fa9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_87fa7ffa-d0cc-47b3-93bb-b79fb7c3912d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_191c749c-5b56-493f-b082-b7aa8b0b2a86" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_87fa7ffa-d0cc-47b3-93bb-b79fb7c3912d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fb4c7747-a348-4008-a72a-2d0a1af686e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0e84dd6b-0bef-4d38-b051-0fe3b4d5ca80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fb4c7747-a348-4008-a72a-2d0a1af686e2" xlink:to="loc_us-gaap_DebtInstrumentTable_0e84dd6b-0bef-4d38-b051-0fe3b4d5ca80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f78c0769-f4fc-49c2-a400-ff255b263014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0e84dd6b-0bef-4d38-b051-0fe3b4d5ca80" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f78c0769-f4fc-49c2-a400-ff255b263014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e109f8ee-5f3c-4d70-a6cb-bedff6456912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f78c0769-f4fc-49c2-a400-ff255b263014" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e109f8ee-5f3c-4d70-a6cb-bedff6456912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_8de3921a-11e2-43f4-9676-1aa3dc5ebb8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e109f8ee-5f3c-4d70-a6cb-bedff6456912" xlink:to="loc_us-gaap_SeniorNotesMember_8de3921a-11e2-43f4-9676-1aa3dc5ebb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_de5388eb-0ab2-48e7-bae1-f2175e2afbe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0e84dd6b-0bef-4d38-b051-0fe3b4d5ca80" xlink:to="loc_us-gaap_DebtInstrumentAxis_de5388eb-0ab2-48e7-bae1-f2175e2afbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_de5388eb-0ab2-48e7-bae1-f2175e2afbe9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_f14c4243-ddad-4180-b95f-3db1835a66a5" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:to="loc_holx_A2028SeniorNotesMember_f14c4243-ddad-4180-b95f-3db1835a66a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_5cdbc704-8b02-44d7-bceb-53388e9625c1" xlink:href="holx-20210925.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:to="loc_holx_A2025SeniorNotesMember_5cdbc704-8b02-44d7-bceb-53388e9625c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_c6fd3c8d-bdf1-4960-9c44-d63dbc9374fc" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ae10345b-9247-4d67-9201-0a26618e5e0b" xlink:to="loc_holx_A2029SeniorNotesMember_c6fd3c8d-bdf1-4960-9c44-d63dbc9374fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0e84dd6b-0bef-4d38-b051-0fe3b4d5ca80" xlink:to="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_7e000a59-78d3-4e3f-8b76-dc377dc61b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:to="loc_us-gaap_InterestExpenseBorrowings_7e000a59-78d3-4e3f-8b76-dc377dc61b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_96bdfd54-abed-4338-865b-2258da0fe9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_96bdfd54-abed-4338-865b-2258da0fe9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2275afd0-165c-4d8f-b42d-0b7ab089c93d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_96f3b9ec-4562-4edf-89b3-31234fd22889" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2275afd0-165c-4d8f-b42d-0b7ab089c93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20210925.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_84e18d78-d728-4278-af18-bbd2da1647cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_35876b8e-7229-4ed1-8a79-90f7972f564b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_84e18d78-d728-4278-af18-bbd2da1647cc" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_35876b8e-7229-4ed1-8a79-90f7972f564b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_42d844d8-46a1-46f7-9fc8-2f692dfa448d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_42d844d8-46a1-46f7-9fc8-2f692dfa448d" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_caa79133-db94-4ef5-a403-c1a6acd8fd50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_caa79133-db94-4ef5-a403-c1a6acd8fd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_caa79133-db94-4ef5-a403-c1a6acd8fd50" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ec761355-8b62-40b8-a383-bb501db1846f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:to="loc_us-gaap_InterestRateSwapMember_ec761355-8b62-40b8-a383-bb501db1846f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_27bc0b1c-c4a9-415e-b9cb-273be8eb1bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:to="loc_us-gaap_StockOptionMember_27bc0b1c-c4a9-415e-b9cb-273be8eb1bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_23ba0841-d8d0-43cf-b493-602a21225688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_23ba0841-d8d0-43cf-b493-602a21225688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_4df6cfc5-b275-4a93-866a-83c7b62193b1" xlink:href="holx-20210925.xsd#holx_ContingentConsiderationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0948885c-b48e-447d-8491-3103018ba94d" xlink:to="loc_holx_ContingentConsiderationMember_4df6cfc5-b275-4a93-866a-83c7b62193b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_be81b69b-59d7-48ed-b28f-c3acdc53f740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_be81b69b-59d7-48ed-b28f-c3acdc53f740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bb36b258-d990-4d51-a9ac-1f4286b81cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_be81b69b-59d7-48ed-b28f-c3acdc53f740" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bb36b258-d990-4d51-a9ac-1f4286b81cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_e2823a24-b150-45dc-9649-66edf24d4e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb36b258-d990-4d51-a9ac-1f4286b81cdf" xlink:to="loc_us-gaap_AssetsMember_e2823a24-b150-45dc-9649-66edf24d4e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_31245d09-1a52-4228-acd3-846747e8e50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_bb36b258-d990-4d51-a9ac-1f4286b81cdf" xlink:to="loc_us-gaap_LiabilityMember_31245d09-1a52-4228-acd3-846747e8e50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0f97ecf-94f0-422c-9994-f5f1f0c051d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0f97ecf-94f0-422c-9994-f5f1f0c051d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b0f97ecf-94f0-422c-9994-f5f1f0c051d2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_52ac46d6-df2f-41b0-a75b-96573c809f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_52ac46d6-df2f-41b0-a75b-96573c809f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8631b413-d9be-40a9-b830-53477ae067b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8631b413-d9be-40a9-b830-53477ae067b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8a37bbe1-1b50-4bae-a5ec-e61037479d4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_77991ac6-06b4-4728-b567-522ca92f2d89" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8a37bbe1-1b50-4bae-a5ec-e61037479d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_8d00448f-3aef-4dc8-acec-4cbef7c5c3f4" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_17dfacec-bbc1-4a10-87b9-2cb7c8546cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_17dfacec-bbc1-4a10-87b9-2cb7c8546cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_b463e0e1-447b-418c-b65e-4bdf12bdd9ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_17dfacec-bbc1-4a10-87b9-2cb7c8546cb9" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_b463e0e1-447b-418c-b65e-4bdf12bdd9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b96aa7a2-e412-4f8a-826b-07026eda2f4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_17dfacec-bbc1-4a10-87b9-2cb7c8546cb9" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b96aa7a2-e412-4f8a-826b-07026eda2f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_c19a57af-abdd-43c0-ae52-0d7d20ecf978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_c19a57af-abdd-43c0-ae52-0d7d20ecf978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_f43c2e76-3acd-4170-9bd1-7d39b738a9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_c19a57af-abdd-43c0-ae52-0d7d20ecf978" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_f43c2e76-3acd-4170-9bd1-7d39b738a9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_56de576e-11fd-4cfb-bf41-f0c8e91d1f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_56de576e-11fd-4cfb-bf41-f0c8e91d1f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_388bba8c-5da9-4ebc-abd4-547caa7627a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ec861826-396e-4e11-b709-74acfe9e9d18" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_388bba8c-5da9-4ebc-abd4-547caa7627a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_affc7a75-8e2e-4e6d-a89f-44f163a127fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_affc7a75-8e2e-4e6d-a89f-44f163a127fd" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ee6aa267-36bb-487c-b309-d8452fcffb20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ee6aa267-36bb-487c-b309-d8452fcffb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_176fe658-3a19-4e78-be98-f3ae66740c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ee6aa267-36bb-487c-b309-d8452fcffb20" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_176fe658-3a19-4e78-be98-f3ae66740c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_863e772d-7cea-4d61-8d70-10b9c781ab25" xlink:href="holx-20210925.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_176fe658-3a19-4e78-be98-f3ae66740c00" xlink:to="loc_holx_AcquiredintangibleassetsMember_863e772d-7cea-4d61-8d70-10b9c781ab25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_0bcfe3df-aa85-4752-aac7-2b5b87e6ca85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_176fe658-3a19-4e78-be98-f3ae66740c00" xlink:to="loc_us-gaap_EquipmentMember_0bcfe3df-aa85-4752-aac7-2b5b87e6ca85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_558ee80b-e568-42ea-b3de-828b299c1307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_FinancialInstrumentAxis_558ee80b-e568-42ea-b3de-828b299c1307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c9b4429-cc47-4e0d-bc0e-83aa43fa31e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_558ee80b-e568-42ea-b3de-828b299c1307" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c9b4429-cc47-4e0d-bc0e-83aa43fa31e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_6a720f62-c6da-4047-bddb-22fcd9dfd971" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c9b4429-cc47-4e0d-bc0e-83aa43fa31e2" xlink:to="loc_holx_A2028SeniorNotesMember_6a720f62-c6da-4047-bddb-22fcd9dfd971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_07214263-eaff-4753-a1a9-2f9318a4c295" xlink:href="holx-20210925.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c9b4429-cc47-4e0d-bc0e-83aa43fa31e2" xlink:to="loc_holx_A2029SeniorNotesMember_07214263-eaff-4753-a1a9-2f9318a4c295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0265c8bc-f3e9-4e8e-9897-2c4354b464f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0265c8bc-f3e9-4e8e-9897-2c4354b464f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b662af5-231b-49a5-867b-0caab8bcaa78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0265c8bc-f3e9-4e8e-9897-2c4354b464f9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b662af5-231b-49a5-867b-0caab8bcaa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_44e5ca99-e4f3-459d-b5bf-b8b6bc7ad372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b662af5-231b-49a5-867b-0caab8bcaa78" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_44e5ca99-e4f3-459d-b5bf-b8b6bc7ad372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_096e3279-cf90-4a53-a037-af146dc61e90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_DebtInstrumentAxis_096e3279-cf90-4a53-a037-af146dc61e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2f98716c-defc-44c5-b0e0-fac747a8c839" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_096e3279-cf90-4a53-a037-af146dc61e90" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2f98716c-defc-44c5-b0e0-fac747a8c839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_e41dcb07-4101-4ff0-bee0-4a757487335f" xlink:href="holx-20210925.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2f98716c-defc-44c5-b0e0-fac747a8c839" xlink:to="loc_holx_CreditAgreementMember_e41dcb07-4101-4ff0-bee0-4a757487335f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_dab05aa7-3790-4238-8a09-757e8fcc41a5" xlink:href="holx-20210925.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2f98716c-defc-44c5-b0e0-fac747a8c839" xlink:to="loc_holx_A2028SeniorNotesMember_dab05aa7-3790-4238-8a09-757e8fcc41a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_399d7736-6cf5-456f-924a-c43779abc76f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_399d7736-6cf5-456f-924a-c43779abc76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bbfa2b5a-04d5-4bcc-856e-085f86fe038b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_399d7736-6cf5-456f-924a-c43779abc76f" xlink:to="loc_us-gaap_SegmentDomain_bbfa2b5a-04d5-4bcc-856e-085f86fe038b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_d099b566-7047-4623-8e7f-6373729567c4" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bbfa2b5a-04d5-4bcc-856e-085f86fe038b" xlink:to="loc_holx_MedicalAestheticsBusinessMember_d099b566-7047-4623-8e7f-6373729567c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_abad4f59-e8bc-4472-95bd-dd978d6d8ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_abad4f59-e8bc-4472-95bd-dd978d6d8ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7cd536a6-f5ca-4c16-8952-7f82417c3b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_abad4f59-e8bc-4472-95bd-dd978d6d8ce7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7cd536a6-f5ca-4c16-8952-7f82417c3b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_857f27bf-84e8-454b-9259-005d4850aa01" xlink:href="holx-20210925.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7cd536a6-f5ca-4c16-8952-7f82417c3b36" xlink:to="loc_holx_AcquiredintangibleassetsMember_857f27bf-84e8-454b-9259-005d4850aa01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_17351773-af64-4cb1-9ab7-2f7b52a4efe2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_7cd536a6-f5ca-4c16-8952-7f82417c3b36" xlink:to="loc_us-gaap_EquipmentMember_17351773-af64-4cb1-9ab7-2f7b52a4efe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_d67bb2c3-f911-47a9-9cf7-21ff229d3c57" xlink:to="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_0e30c85d-236d-45cd-99f4-034d2a89d990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_0e30c85d-236d-45cd-99f4-034d2a89d990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_f7f3394b-3e8a-4f52-a8f2-1eeb445931cd" xlink:href="holx-20210925.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:to="loc_holx_PrincipalAmountOfBorrowings_f7f3394b-3e8a-4f52-a8f2-1eeb445931cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_cebeca7c-ae7d-462e-a9eb-af7d2c69dae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_cebeca7c-ae7d-462e-a9eb-af7d2c69dae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_abed95c2-11b0-4c6b-9226-7265444c224e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_98fdefca-740d-4955-a18b-c1f670c537c6" xlink:to="loc_us-gaap_AssetImpairmentCharges_abed95c2-11b0-4c6b-9226-7265444c224e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_51f3e80a-d483-4881-bf8d-944bf26bd1f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e0cf6bf8-2f82-4626-9321-f21a69ea09a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_51f3e80a-d483-4881-bf8d-944bf26bd1f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e0cf6bf8-2f82-4626-9321-f21a69ea09a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_5e9903d1-a558-460a-a150-77cdbc60c1b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_51f3e80a-d483-4881-bf8d-944bf26bd1f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_5e9903d1-a558-460a-a150-77cdbc60c1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_47e3bdf2-b181-4b8f-9052-a32df49fdd0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_51f3e80a-d483-4881-bf8d-944bf26bd1f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_47e3bdf2-b181-4b8f-9052-a32df49fdd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_40ca45e1-3eb7-40af-8a45-c270b092a6f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_51f3e80a-d483-4881-bf8d-944bf26bd1f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_40ca45e1-3eb7-40af-8a45-c270b092a6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_53188572-c055-4bb3-b5d1-a0cb0ec62fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_51f3e80a-d483-4881-bf8d-944bf26bd1f1" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_53188572-c055-4bb3-b5d1-a0cb0ec62fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4f4c8c4c-cf0e-4949-8e59-76f23dfaaf71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_840a9e6f-137e-4ce3-b315-c9acef4c8995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f4c8c4c-cf0e-4949-8e59-76f23dfaaf71" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_840a9e6f-137e-4ce3-b315-c9acef4c8995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_69daad71-622e-4763-9dd2-dc8a7d4a14b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f4c8c4c-cf0e-4949-8e59-76f23dfaaf71" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_69daad71-622e-4763-9dd2-dc8a7d4a14b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_622cbbe3-7222-4bd3-b106-7c0df5a6ca97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f4c8c4c-cf0e-4949-8e59-76f23dfaaf71" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_622cbbe3-7222-4bd3-b106-7c0df5a6ca97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9f98f8fa-05ba-4cd9-b07f-a5a48e4ad2f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f4c8c4c-cf0e-4949-8e59-76f23dfaaf71" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9f98f8fa-05ba-4cd9-b07f-a5a48e4ad2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_8b152bbb-1b2e-415c-b0f6-6c2e7eaee633" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f4c8c4c-cf0e-4949-8e59-76f23dfaaf71" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_8b152bbb-1b2e-415c-b0f6-6c2e7eaee633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a7ce25ee-9e9e-42eb-9203-012afeec3236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1b381e34-31e0-4c3b-95f3-0e759c1e80cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7ce25ee-9e9e-42eb-9203-012afeec3236" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1b381e34-31e0-4c3b-95f3-0e759c1e80cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_855d0387-8e0c-49ca-a51a-5a3756f0536d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7ce25ee-9e9e-42eb-9203-012afeec3236" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_855d0387-8e0c-49ca-a51a-5a3756f0536d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1a81d243-eb2e-46cf-9449-3deda449d5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a7ce25ee-9e9e-42eb-9203-012afeec3236" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1a81d243-eb2e-46cf-9449-3deda449d5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesProvisionforIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b90d474b-5949-4ce3-a114-a9d8fd43a492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_e76fae10-d97c-40e1-a719-16d703c259d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b90d474b-5949-4ce3-a114-a9d8fd43a492" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_e76fae10-d97c-40e1-a719-16d703c259d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d8bfc81e-aa45-4d59-aa08-5a3cdd569a3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_e76fae10-d97c-40e1-a719-16d703c259d0" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d8bfc81e-aa45-4d59-aa08-5a3cdd569a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_6cb715fc-7e85-43e1-b7b4-0d004d57de76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_e76fae10-d97c-40e1-a719-16d703c259d0" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_6cb715fc-7e85-43e1-b7b4-0d004d57de76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_323acfad-eea9-4ec1-9ca9-2668b09a4b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract_e76fae10-d97c-40e1-a719-16d703c259d0" xlink:to="loc_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_323acfad-eea9-4ec1-9ca9-2668b09a4b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_c139d434-9efd-4170-8366-62e19b963a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b90d474b-5949-4ce3-a114-a9d8fd43a492" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_c139d434-9efd-4170-8366-62e19b963a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_83266926-6f5e-4639-9e1d-5e81e2e0b96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_c139d434-9efd-4170-8366-62e19b963a80" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_83266926-6f5e-4639-9e1d-5e81e2e0b96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0a764958-6b5c-4fe8-9538-6570bfdfe5f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_c139d434-9efd-4170-8366-62e19b963a80" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0a764958-6b5c-4fe8-9538-6570bfdfe5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_da80f50e-793a-4641-8748-ca75d6c19db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract_c139d434-9efd-4170-8366-62e19b963a80" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_da80f50e-793a-4641-8748-ca75d6c19db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_3f71547e-a94e-40be-a179-c94c4068a3fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b90d474b-5949-4ce3-a114-a9d8fd43a492" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_3f71547e-a94e-40be-a179-c94c4068a3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e06fabe6-56b6-408e-a823-50019ee26673" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_3f71547e-a94e-40be-a179-c94c4068a3fc" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_e06fabe6-56b6-408e-a823-50019ee26673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4620fa8f-06e2-4437-be99-79e976ad8082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_3f71547e-a94e-40be-a179-c94c4068a3fc" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4620fa8f-06e2-4437-be99-79e976ad8082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_bc51ee06-a474-4213-82db-863cc6efa456" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract_3f71547e-a94e-40be-a179-c94c4068a3fc" xlink:to="loc_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_bc51ee06-a474-4213-82db-863cc6efa456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f8e7feba-c6ed-46a9-a9a6-c15eceafddba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b90d474b-5949-4ce3-a114-a9d8fd43a492" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f8e7feba-c6ed-46a9-a9a6-c15eceafddba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_193bec80-29f7-41af-b6a6-f9785940cf0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_193bec80-29f7-41af-b6a6-f9785940cf0b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_af100a0a-13b5-4146-9f9e-dfd90926795b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_af100a0a-13b5-4146-9f9e-dfd90926795b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_8a4c5d4a-8921-4d4a-a736-be4bfce9e1d3" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure_8a4c5d4a-8921-4d4a-a736-be4bfce9e1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9871a727-bf31-42e0-ae43-dcf627f0c519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9871a727-bf31-42e0-ae43-dcf627f0c519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_3513b91a-0bf1-4436-a94c-05e8b931e3e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_3513b91a-0bf1-4436-a94c-05e8b931e3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_251d3246-cf14-4557-8c74-5f9d0befac43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_251d3246-cf14-4557-8c74-5f9d0befac43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_f6cd7319-6ff5-4724-9cde-4849a6b4e840" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment_f6cd7319-6ff5-4724-9cde-4849a6b4e840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_e3420d76-e857-4372-8fbb-fb0d78b859d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent_e3420d76-e857-4372-8fbb-fb0d78b859d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_4c23bc3b-a7ca-4e08-935d-1f566a4adf2b" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits_4c23bc3b-a7ca-4e08-935d-1f566a4adf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_6bc7001b-a54b-40c6-88c5-31c3c1e9cf76" xlink:href="holx-20210925.xsd#holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost_6bc7001b-a54b-40c6-88c5-31c3c1e9cf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1a821083-cef9-4720-9c43-de78bb80b578" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1a821083-cef9-4720-9c43-de78bb80b578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_7a31e0ca-7188-481f-b121-49b9203d1bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_7a31e0ca-7188-481f-b121-49b9203d1bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_788b3089-0702-4962-b70f-2d5b241a6379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_788b3089-0702-4962-b70f-2d5b241a6379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a855cae7-7068-4a27-9759-b5b2dce587fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a855cae7-7068-4a27-9759-b5b2dce587fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8f7b3d55-e068-4bd3-8ac3-c7f928fc843a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_bdfb0c51-e4f3-46ca-a3e9-affb5c848ba4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8f7b3d55-e068-4bd3-8ac3-c7f928fc843a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_08507934-4ab7-4567-81da-5c26256b8eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_08507934-4ab7-4567-81da-5c26256b8eca" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_82e30f88-3074-48ba-b51e-9e408357461f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_82e30f88-3074-48ba-b51e-9e408357461f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_ce2093a7-5568-45c2-9d53-7858d1deab1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_ce2093a7-5568-45c2-9d53-7858d1deab1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_621f4eec-85a2-481a-8175-bb4f18b33fc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_621f4eec-85a2-481a-8175-bb4f18b33fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_bd224ca7-e417-455e-9e76-e3cb691564e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_bd224ca7-e417-455e-9e76-e3cb691564e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_b20ea26f-ccb0-433b-b121-34131f93e3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_b20ea26f-ccb0-433b-b121-34131f93e3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_26bb8acc-1010-445d-b562-02f1792c6539" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_26bb8acc-1010-445d-b562-02f1792c6539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_031b6b5d-a0e9-4b2c-a078-8a73bbc91f98" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan_031b6b5d-a0e9-4b2c-a078-8a73bbc91f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsLeaseLiability_bedb01e4-ff3c-414b-9ea0-afa022b74589" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_holx_DeferredTaxAssetsLeaseLiability_bedb01e4-ff3c-414b-9ea0-afa022b74589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_2278a616-720a-4e38-9f7a-4d9493cce76a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_2278a616-720a-4e38-9f7a-4d9493cce76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_ce0012d3-949c-4e53-ba02-6de337883143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_ce0012d3-949c-4e53-ba02-6de337883143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d9c18720-90ff-48bd-9351-07555c73dd56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d9c18720-90ff-48bd-9351-07555c73dd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_a815bd8d-e427-4c9c-ba5a-cf53c89e1380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_a815bd8d-e427-4c9c-ba5a-cf53c89e1380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f6277019-046f-45dc-8daa-4ae9484ade38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f6277019-046f-45dc-8daa-4ae9484ade38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_19c0efdb-2b36-422b-a7a6-f0ae97a72d81" xlink:href="holx-20210925.xsd#holx_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f6277019-046f-45dc-8daa-4ae9484ade38" xlink:to="loc_holx_DeferredTaxLiabilitiesDepreciationAndAmortization_19c0efdb-2b36-422b-a7a6-f0ae97a72d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset_2d759af9-c127-4001-b279-a202a75bc163" xlink:href="holx-20210925.xsd#holx_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f6277019-046f-45dc-8daa-4ae9484ade38" xlink:to="loc_holx_DeferredTaxLiabilitiesRightOfUseAsset_2d759af9-c127-4001-b279-a202a75bc163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_f556de6a-3783-436d-bff1-1a909a079ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_f556de6a-3783-436d-bff1-1a909a079ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_cab8cc9f-0824-4273-a1ea-92804acb02bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_c94d3c5b-1d98-4381-981c-d28f196c32c8" xlink:to="loc_us-gaap_DeferredTaxLiabilities_cab8cc9f-0824-4273-a1ea-92804acb02bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1add9fea-1281-4394-878d-b7589d59e886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:href="holx-20210925.xsd#holx_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1add9fea-1281-4394-878d-b7589d59e886" xlink:to="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_70576f8e-cec2-4c2b-a39c-7ba3f975c0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_70576f8e-cec2-4c2b-a39c-7ba3f975c0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_70576f8e-cec2-4c2b-a39c-7ba3f975c0f5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_95534735-683e-4231-950e-d56e0462437b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:to="loc_us-gaap_DomesticCountryMember_95534735-683e-4231-950e-d56e0462437b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_7148ce80-545d-4f62-b1e2-6e1861de1331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_7148ce80-545d-4f62-b1e2-6e1861de1331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_b7d86a47-264a-4f92-a90c-b997d6f5a282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_6974cc10-f4b3-44e0-a6f6-fc018c9e38b4" xlink:to="loc_us-gaap_ForeignCountryMember_b7d86a47-264a-4f92-a90c-b997d6f5a282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1ed3b7f2-f064-413a-a813-f88d7d287b89" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_srt_RangeAxis_1ed3b7f2-f064-413a-a813-f88d7d287b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b095f300-b158-4bec-a6a7-e49f7bcab4e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1ed3b7f2-f064-413a-a813-f88d7d287b89" xlink:to="loc_srt_RangeMember_b095f300-b158-4bec-a6a7-e49f7bcab4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e215e613-ead8-4a73-8c95-7e5c8ff952ca" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b095f300-b158-4bec-a6a7-e49f7bcab4e1" xlink:to="loc_srt_MaximumMember_e215e613-ead8-4a73-8c95-7e5c8ff952ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_c4540791-356d-4d13-9c9a-a2d75507e398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_c4540791-356d-4d13-9c9a-a2d75507e398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_a25b8e98-3e42-4dbb-b79d-860b17a5246f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_c4540791-356d-4d13-9c9a-a2d75507e398" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_a25b8e98-3e42-4dbb-b79d-860b17a5246f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossCarryforwardsMember_4edc2b57-4176-4083-bda4-ce6eb9358d4b" xlink:href="holx-20210925.xsd#holx_NetOperatingLossCarryforwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_a25b8e98-3e42-4dbb-b79d-860b17a5246f" xlink:to="loc_holx_NetOperatingLossCarryforwardsMember_4edc2b57-4176-4083-bda4-ce6eb9358d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxCreditCarryforwardMember_a76019e4-34e9-48a5-b7a6-c68c429897d9" xlink:href="holx-20210925.xsd#holx_TaxCreditCarryforwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_a25b8e98-3e42-4dbb-b79d-860b17a5246f" xlink:to="loc_holx_TaxCreditCarryforwardMember_a76019e4-34e9-48a5-b7a6-c68c429897d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f857c78e-5aa7-466b-afdc-14aa17aa7ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f857c78e-5aa7-466b-afdc-14aa17aa7ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f857c78e-5aa7-466b-afdc-14aa17aa7ad6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9422cda4-9873-41c5-bf50-f3a275997ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_9422cda4-9873-41c5-bf50-f3a275997ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_e2d835b9-356b-47df-9841-8ea7d2e2a486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_e2d835b9-356b-47df-9841-8ea7d2e2a486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_47a6bac6-cb4c-474e-8dab-0236f50e0575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7ba53cff-cbb0-4646-b487-21e7144d4126" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_47a6bac6-cb4c-474e-8dab-0236f50e0575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8dc58da2-4a14-4957-a959-fcd25bdfb31a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8dc58da2-4a14-4957-a959-fcd25bdfb31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6dc87f91-8623-4c2f-95bd-bb25efa3ca51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8dc58da2-4a14-4957-a959-fcd25bdfb31a" xlink:to="loc_us-gaap_SegmentDomain_6dc87f91-8623-4c2f-95bd-bb25efa3ca51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_7b700876-7720-4e21-930c-96c65998a859" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_6dc87f91-8623-4c2f-95bd-bb25efa3ca51" xlink:to="loc_holx_MedicalAestheticsMember_7b700876-7720-4e21-930c-96c65998a859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:href="holx-20210925.xsd#holx_IncomeTaxesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesTable_dd7f6979-64fd-4d81-81ed-223d2e832c92" xlink:to="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_643d6c1c-b743-4d17-889a-cd4f685bc2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease_643d6c1c-b743-4d17-889a-cd4f685bc2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_8f1ce540-2eca-4a67-8518-87a0b547b7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_OperatingLossCarryforwards_8f1ce540-2eca-4a67-8518-87a0b547b7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_5601cb11-9e82-4f93-aabb-f0aeb3fdf27f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_5601cb11-9e82-4f93-aabb-f0aeb3fdf27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_792bb1a9-60bf-4e50-a523-09811fc786ec" xlink:href="holx-20210925.xsd#holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod_792bb1a9-60bf-4e50-a523-09811fc786ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_9eb3af4e-1a6b-4f03-9e66-cf98840f0343" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal_9eb3af4e-1a6b-4f03-9e66-cf98840f0343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_1ec81f67-5432-4417-8fd7-c98fc3c0510c" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState_1ec81f67-5432-4417-8fd7-c98fc3c0510c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_d3313046-c198-4f6b-82c7-a00ff45d5492" xlink:href="holx-20210925.xsd#holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign_d3313046-c198-4f6b-82c7-a00ff45d5492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossUnrecognizedTaxBenefits_86303483-79f4-4e5d-b5ec-c7a6916599c2" xlink:href="holx-20210925.xsd#holx_GrossUnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_GrossUnrecognizedTaxBenefits_86303483-79f4-4e5d-b5ec-c7a6916599c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_a6a5f2dd-dedd-4700-8b5f-5389c71938a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_a6a5f2dd-dedd-4700-8b5f-5389c71938a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_c5d6510e-de08-4979-a689-b3d85fd4476f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_c5d6510e-de08-4979-a689-b3d85fd4476f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_6c4d3fd6-52bc-4af5-871c-bfcf4e62e566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_6c4d3fd6-52bc-4af5-871c-bfcf4e62e566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_92efd768-8fef-43f5-bb0c-78432522a181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_92efd768-8fef-43f5-bb0c-78432522a181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616_fe103928-6e9b-40f9-ae18-c7291e3c78c6" xlink:href="holx-20210925.xsd#holx_IncreasetoincometaxexpenseadoptionofASU201616"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_IncreasetoincometaxexpenseadoptionofASU201616_fe103928-6e9b-40f9-ae18-c7291e3c78c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_e4c664d9-7620-44be-9dac-0cfe1e0caefd" xlink:href="holx-20210925.xsd#holx_DecreaseindeferredtaxliabilitiesduetoASC201616"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_DecreaseindeferredtaxliabilitiesduetoASC201616_e4c664d9-7620-44be-9dac-0cfe1e0caefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_4af417da-5ec4-4c0a-8cb0-0dd53239b513" xlink:href="holx-20210925.xsd#holx_IncreasetoNetIncomeresultedfromadoptionofASU201616"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616_4af417da-5ec4-4c0a-8cb0-0dd53239b513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_8322413c-b08f-42e6-a436-d14dfc2ab921" xlink:href="holx-20210925.xsd#holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616_8322413c-b08f-42e6-a436-d14dfc2ab921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonIncomeTaxLoss_324e3756-e309-4569-aeab-4e68903da6dc" xlink:href="holx-20210925.xsd#holx_NonIncomeTaxLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_NonIncomeTaxLoss_324e3756-e309-4569-aeab-4e68903da6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_78502d86-14ed-4819-ac14-b9f845d02b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_78502d86-14ed-4819-ac14-b9f845d02b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_StateLossCarryforwardExpectedToUnutilize_1569e8cb-2743-4f76-8faa-9de9f36eb833" xlink:href="holx-20210925.xsd#holx_StateLossCarryforwardExpectedToUnutilize"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_StateLossCarryforwardExpectedToUnutilize_1569e8cb-2743-4f76-8faa-9de9f36eb833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_a2d51c41-a794-480d-8c7e-edff19d7173a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_a2d51c41-a794-480d-8c7e-edff19d7173a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossStateLossCarryforwards_31ad8d64-0bd4-4706-b310-ac57e98d7260" xlink:href="holx-20210925.xsd#holx_GrossStateLossCarryforwards"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_GrossStateLossCarryforwards_31ad8d64-0bd4-4706-b310-ac57e98d7260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrossForeignLossCarryforwards_17328994-6d9d-4742-9652-a8e37bac2ef5" xlink:href="holx-20210925.xsd#holx_GrossForeignLossCarryforwards"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_GrossForeignLossCarryforwards_17328994-6d9d-4742-9652-a8e37bac2ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IncomeTaxReceivableReclassification_41b9368a-51b3-455d-8378-bbd6c250064d" xlink:href="holx-20210925.xsd#holx_IncomeTaxReceivableReclassification"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_IncomeTaxesLineItems_246627c3-da53-46be-b970-281d0c3b95a0" xlink:to="loc_holx_IncomeTaxReceivableReclassification_41b9368a-51b3-455d-8378-bbd6c250064d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ac885b5e-8a9a-4c84-ac3d-897361e85fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_aed2ac78-cb29-4c75-985d-8d83a325f8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ac885b5e-8a9a-4c84-ac3d-897361e85fd9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_aed2ac78-cb29-4c75-985d-8d83a325f8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxPositionsRelatedToCurrentYearAbstract_77943017-a4a1-424c-a4d1-b2609f5109c8" xlink:href="holx-20210925.xsd#holx_TaxPositionsRelatedToCurrentYearAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ac885b5e-8a9a-4c84-ac3d-897361e85fd9" xlink:to="loc_holx_TaxPositionsRelatedToCurrentYearAbstract_77943017-a4a1-424c-a4d1-b2609f5109c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_daf84a48-4958-4498-b0b0-a7584cd69682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToCurrentYearAbstract_77943017-a4a1-424c-a4d1-b2609f5109c8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_daf84a48-4958-4498-b0b0-a7584cd69682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_39b26fae-00da-4dda-a482-e7f76dc83848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToCurrentYearAbstract_77943017-a4a1-424c-a4d1-b2609f5109c8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_39b26fae-00da-4dda-a482-e7f76dc83848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_32e27230-1da5-4d7b-851b-f6a4c9b6ee12" xlink:href="holx-20210925.xsd#holx_TaxPositionsRelatedToPriorYearsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ac885b5e-8a9a-4c84-ac3d-897361e85fd9" xlink:to="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_32e27230-1da5-4d7b-851b-f6a4c9b6ee12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_5ee27dce-b431-41b6-9a10-bdce34dee779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_32e27230-1da5-4d7b-851b-f6a4c9b6ee12" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_5ee27dce-b431-41b6-9a10-bdce34dee779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_a7aecb9a-0be8-4cb5-8eff-c47d6ef89793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_32e27230-1da5-4d7b-851b-f6a4c9b6ee12" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_a7aecb9a-0be8-4cb5-8eff-c47d6ef89793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_6a779266-38c2-4a42-afb8-7546f88e0008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_32e27230-1da5-4d7b-851b-f6a4c9b6ee12" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_6a779266-38c2-4a42-afb8-7546f88e0008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fb63c263-2d35-403b-ab20-825c25c4030b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_TaxPositionsRelatedToPriorYearsAbstract_32e27230-1da5-4d7b-851b-f6a4c9b6ee12" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fb63c263-2d35-403b-ab20-825c25c4030b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract_040af2d0-03e7-4d01-b5c6-b0b8b2cd10b7" xlink:href="holx-20210925.xsd#holx_UnrecognizedTaxBenefitsIncreasesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ac885b5e-8a9a-4c84-ac3d-897361e85fd9" xlink:to="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract_040af2d0-03e7-4d01-b5c6-b0b8b2cd10b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_6cbdfe3e-9d85-4205-b3dd-5183b4345875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_UnrecognizedTaxBenefitsIncreasesAbstract_040af2d0-03e7-4d01-b5c6-b0b8b2cd10b7" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition_6cbdfe3e-9d85-4205-b3dd-5183b4345875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ea1cb3d5-739a-4629-b4eb-e6885644e727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ac885b5e-8a9a-4c84-ac3d-897361e85fd9" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ea1cb3d5-739a-4629-b4eb-e6885644e727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1cdbd80-6dcb-4560-ad89-49974c809601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_603d9192-a5df-4fb2-90d2-cf71ab4efbf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1cdbd80-6dcb-4560-ad89-49974c809601" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_603d9192-a5df-4fb2-90d2-cf71ab4efbf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31c02cb7-cbf3-4f42-bc28-b8501a5d6fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_d7138bb2-4b12-4dec-8173-64b7f1eb9a8a" xlink:href="holx-20210925.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31c02cb7-cbf3-4f42-bc28-b8501a5d6fc1" xlink:to="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_d7138bb2-4b12-4dec-8173-64b7f1eb9a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9d0f7a3c-fa41-44ab-9596-397b7723f88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31c02cb7-cbf3-4f42-bc28-b8501a5d6fc1" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9d0f7a3c-fa41-44ab-9596-397b7723f88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b4c9d3d2-a9eb-4889-a536-06304552dc60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31c02cb7-cbf3-4f42-bc28-b8501a5d6fc1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_b4c9d3d2-a9eb-4889-a536-06304552dc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_451a9b54-9785-4662-a7e6-cd1ce0d8f4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31c02cb7-cbf3-4f42-bc28-b8501a5d6fc1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_451a9b54-9785-4662-a7e6-cd1ce0d8f4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_e3dce4e4-da7c-4207-9f71-f830a2882870" xlink:href="holx-20210925.xsd#holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31c02cb7-cbf3-4f42-bc28-b8501a5d6fc1" xlink:to="loc_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock_e3dce4e4-da7c-4207-9f71-f830a2882870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c138ad3c-eb23-4bf3-b59e-e8845bc68d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c138ad3c-eb23-4bf3-b59e-e8845bc68d36" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchseAuthorizationDateAxis_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75" xlink:href="holx-20210925.xsd#holx_ShareRepurchseAuthorizationDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_holx_ShareRepurchseAuthorizationDateAxis_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AuthorizationDateDomain_c48ddace-7f71-49b5-b1c4-8bd37ad8cd7f" xlink:href="holx-20210925.xsd#holx_AuthorizationDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75" xlink:to="loc_holx_AuthorizationDateDomain_c48ddace-7f71-49b5-b1c4-8bd37ad8cd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Dec112019Member_cd4b7bf7-d735-49f7-8b18-4bf63a921ab0" xlink:href="holx-20210925.xsd#holx_Dec112019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AuthorizationDateDomain_c48ddace-7f71-49b5-b1c4-8bd37ad8cd7f" xlink:to="loc_holx_Dec112019Member_cd4b7bf7-d735-49f7-8b18-4bf63a921ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchseAuthorizationDateDomain_cd1ab55c-6d25-42cb-a0df-76c310e97cb7" xlink:href="holx-20210925.xsd#holx_ShareRepurchseAuthorizationDateDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ShareRepurchseAuthorizationDateAxis_8cd5842e-d1ba-49bc-89d1-ee2a3b5e2f75" xlink:to="loc_holx_ShareRepurchseAuthorizationDateDomain_cd1ab55c-6d25-42cb-a0df-76c310e97cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Dec92020Member_4673aa32-3222-4386-b326-607ed87b76d6" xlink:href="holx-20210925.xsd#holx_Dec92020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ShareRepurchseAuthorizationDateDomain_cd1ab55c-6d25-42cb-a0df-76c310e97cb7" xlink:to="loc_holx_Dec92020Member_4673aa32-3222-4386-b326-607ed87b76d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_06978417-1bf6-44d8-b8e5-56789ff57dee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_us-gaap_PlanNameAxis_06978417-1bf6-44d8-b8e5-56789ff57dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_21b162dd-fd96-4cb6-b785-d52699a9e2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_06978417-1bf6-44d8-b8e5-56789ff57dee" xlink:to="loc_us-gaap_PlanNameDomain_21b162dd-fd96-4cb6-b785-d52699a9e2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TwoThousandEightEquityPlanMember_3a156145-6f14-4c46-8d52-7ee91214bdf4" xlink:href="holx-20210925.xsd#holx_TwoThousandEightEquityPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_21b162dd-fd96-4cb6-b785-d52699a9e2c0" xlink:to="loc_holx_TwoThousandEightEquityPlanMember_3a156145-6f14-4c46-8d52-7ee91214bdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember_8c296a3a-214f-4406-b919-70aba5289642" xlink:href="holx-20210925.xsd#holx_SemiAnnualEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_21b162dd-fd96-4cb6-b785-d52699a9e2c0" xlink:to="loc_holx_SemiAnnualEmployeeStockPurchasePlanMember_8c296a3a-214f-4406-b919-70aba5289642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9dcb6996-d784-4c4f-834a-b09f758605a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_us-gaap_AwardTypeAxis_9dcb6996-d784-4c4f-834a-b09f758605a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9dcb6996-d784-4c4f-834a-b09f758605a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_65625afc-60a2-42ce-8b31-6e22293ec9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_us-gaap_StockOptionMember_65625afc-60a2-42ce-8b31-6e22293ec9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6eb3d49a-7fe9-4119-a8e9-e9b32181bb50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6eb3d49a-7fe9-4119-a8e9-e9b32181bb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_836dc1d5-dd86-4ea8-aa08-2716b845dc62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_us-gaap_PerformanceSharesMember_836dc1d5-dd86-4ea8-aa08-2716b845dc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember_528ff0b1-78f8-47d4-9f62-b03a48b750f7" xlink:href="holx-20210925.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_holx_MarketBasedStockUnitsMember_528ff0b1-78f8-47d4-9f62-b03a48b750f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_99f52bbd-6580-448e-a22f-362da27ead02" xlink:href="holx-20210925.xsd#holx_PSUFreeCashFlowMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_holx_PSUFreeCashFlowMember_99f52bbd-6580-448e-a22f-362da27ead02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0bfb67b3-55d0-4369-8590-4fc998ead556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1b51bda2-a0c9-40bf-9c06-58c18ddc1f42" xlink:to="loc_us-gaap_RestrictedStockMember_0bfb67b3-55d0-4369-8590-4fc998ead556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6eec47f1-d913-45cd-94a6-2f59eedcd177" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_srt_RangeAxis_6eec47f1-d913-45cd-94a6-2f59eedcd177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9d1069d6-0165-4b9b-887e-44d765e7476b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6eec47f1-d913-45cd-94a6-2f59eedcd177" xlink:to="loc_srt_RangeMember_9d1069d6-0165-4b9b-887e-44d765e7476b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_84009746-907f-4fb6-93c9-2309967c45a9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9d1069d6-0165-4b9b-887e-44d765e7476b" xlink:to="loc_srt_MinimumMember_84009746-907f-4fb6-93c9-2309967c45a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cb268807-5579-44c0-8985-3324ea5f76a7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9d1069d6-0165-4b9b-887e-44d765e7476b" xlink:to="loc_srt_MaximumMember_cb268807-5579-44c0-8985-3324ea5f76a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_5d087b3a-ef09-4501-b066-07589412231a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_5d087b3a-ef09-4501-b066-07589412231a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_03d35bb9-c13e-44a3-aa4b-5b6639dcbfac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_5d087b3a-ef09-4501-b066-07589412231a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_03d35bb9-c13e-44a3-aa4b-5b6639dcbfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_June132019PlanMember_d30a5c06-33d2-4644-829b-6afcf6948027" xlink:href="holx-20210925.xsd#holx_June132019PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_03d35bb9-c13e-44a3-aa4b-5b6639dcbfac" xlink:to="loc_holx_June132019PlanMember_d30a5c06-33d2-4644-829b-6afcf6948027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_441cbc27-ede1-4dff-b912-a473df57b963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_441cbc27-ede1-4dff-b912-a473df57b963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ed40aa13-8172-4815-88e5-1994c65ad954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_441cbc27-ede1-4dff-b912-a473df57b963" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ed40aa13-8172-4815-88e5-1994c65ad954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_65752602-768c-4722-b989-5feb3c603de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ed40aa13-8172-4815-88e5-1994c65ad954" xlink:to="loc_us-gaap_SubsequentEventMember_65752602-768c-4722-b989-5feb3c603de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3781b3eb-2a81-4c63-82bb-77e8c5fba1e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6761c112-158a-4e14-8ab1-d6231866c273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6761c112-158a-4e14-8ab1-d6231866c273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be697cb1-0b0c-438a-b400-cef9f9392bf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be697cb1-0b0c-438a-b400-cef9f9392bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b4534e35-ee1d-4d88-a788-98b58f4fd42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b4534e35-ee1d-4d88-a788-98b58f4fd42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5b125ece-c1cd-449d-ad06-a95e04270f50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5b125ece-c1cd-449d-ad06-a95e04270f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8583133b-a2c8-447f-8f3c-2317c29762fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8583133b-a2c8-447f-8f3c-2317c29762fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_60bd4867-e7fc-4c79-95ed-96a8c5f08ca2" xlink:href="holx-20210925.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate_60bd4867-e7fc-4c79-95ed-96a8c5f08ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_b7fd5fbd-3ca4-4c30-ba51-c0baa38601bb" xlink:href="holx-20210925.xsd#holx_PercentageOfVestingForStockOptionsGrantedToEmployees"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_PercentageOfVestingForStockOptionsGrantedToEmployees_b7fd5fbd-3ca4-4c30-ba51-c0baa38601bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_640e5aca-a97d-4cde-8425-775313fb29b0" xlink:href="holx-20210925.xsd#holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees_640e5aca-a97d-4cde-8425-775313fb29b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate_b09fbd89-b2c1-4074-9d0e-4d7798076d2e" xlink:href="holx-20210925.xsd#holx_ShareBasedCompensationPercentageOfForfeitureRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_ShareBasedCompensationPercentageOfForfeitureRate_b09fbd89-b2c1-4074-9d0e-4d7798076d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_95547980-115c-4753-b985-748afd8697d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_95547980-115c-4753-b985-748afd8697d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_920c7eca-d7c1-4b2a-b15a-e7778f71792f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_920c7eca-d7c1-4b2a-b15a-e7778f71792f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6f7a7047-6c99-4f6a-a05e-ba1ce38cd685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6f7a7047-6c99-4f6a-a05e-ba1ce38cd685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3b211e10-ce51-410f-af96-cad9afb681d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3b211e10-ce51-410f-af96-cad9afb681d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3afa9daa-3646-4d97-bf69-6221349e0729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3afa9daa-3646-4d97-bf69-6221349e0729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e621238a-5303-470c-bb07-94d39fbae076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_e621238a-5303-470c-bb07-94d39fbae076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0b9c3ec3-46f2-4677-9379-2ee0b03faa8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_0b9c3ec3-46f2-4677-9379-2ee0b03faa8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_7fb6d233-cbcc-41c4-8203-2e2a7b46b4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_7fb6d233-cbcc-41c4-8203-2e2a7b46b4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_e7e66376-e90d-467a-9aea-a78beaa0c6f4" xlink:href="holx-20210925.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_e7e66376-e90d-467a-9aea-a78beaa0c6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_2a8c2486-40cf-4f08-b6eb-547bd4de8fbc" xlink:href="holx-20210925.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_2a8c2486-40cf-4f08-b6eb-547bd4de8fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_28456b72-afa6-4899-a003-7a7827124cec" xlink:href="holx-20210925.xsd#holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan_28456b72-afa6-4899-a003-7a7827124cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_0a0a6a30-0d9e-4589-9b9d-2c98e23c1322" xlink:href="holx-20210925.xsd#holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase_0a0a6a30-0d9e-4589-9b9d-2c98e23c1322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e8589d59-bb0d-4116-90b2-5e54841a29e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ShareBasedCompensation_e8589d59-bb0d-4116-90b2-5e54841a29e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_7125b821-96c7-4bfc-a84a-7d061891d776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_7125b821-96c7-4bfc-a84a-7d061891d776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_7db8bb4f-0964-4d2f-8eab-7586a4556034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_7db8bb4f-0964-4d2f-8eab-7586a4556034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRSharesRepurchasedduringtheperiod_beabc958-4f65-4d54-a610-ec18946a6562" xlink:href="holx-20210925.xsd#holx_ASRSharesRepurchasedduringtheperiod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_ASRSharesRepurchasedduringtheperiod_beabc958-4f65-4d54-a610-ec18946a6562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ASRAuthorized_5300423d-5d20-442c-8023-69be892c1cf7" xlink:href="holx-20210925.xsd#holx_ASRAuthorized"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_ASRAuthorized_5300423d-5d20-442c-8023-69be892c1cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountpaidduringtheperiodunderASRAgreement_d9491cb1-6d0a-47c8-b156-fe607c89ce18" xlink:href="holx-20210925.xsd#holx_AmountpaidduringtheperiodunderASRAgreement"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_AmountpaidduringtheperiodunderASRAgreement_d9491cb1-6d0a-47c8-b156-fe607c89ce18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_1b27766a-95be-44ae-9b48-347ab4d5376d" xlink:href="holx-20210925.xsd#holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ee7ddaa-a826-4122-843c-6ff44d0e1597" xlink:to="loc_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria_1b27766a-95be-44ae-9b48-347ab4d5376d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5eec72ab-b87c-49ac-821b-7ffd9c5298ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d669e5-a8dc-400f-8f50-aa35c01abd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5eec72ab-b87c-49ac-821b-7ffd9c5298ef" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d669e5-a8dc-400f-8f50-aa35c01abd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dfb1d7c6-9873-4bc5-94c6-842270d9d0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d669e5-a8dc-400f-8f50-aa35c01abd00" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dfb1d7c6-9873-4bc5-94c6-842270d9d0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dfb1d7c6-9873-4bc5-94c6-842270d9d0b7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_a1c34292-2bd9-45ae-a904-7c7e6666ac39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_CostOfSalesMember_a1c34292-2bd9-45ae-a904-7c7e6666ac39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_79b43e12-7d82-478a-91b2-86e04db73102" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_79b43e12-7d82-478a-91b2-86e04db73102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_b6405e5b-b1d1-474b-9a36-c1939e3fa83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_b6405e5b-b1d1-474b-9a36-c1939e3fa83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_6e1c052d-0605-4a28-a8ab-800d52c95dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_6e1c052d-0605-4a28-a8ab-800d52c95dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_ba827d8a-d9c2-4585-891d-0e679f8fd0e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_89849085-6422-40e9-98e5-2dbac02f6f60" xlink:to="loc_us-gaap_RestructuringChargesMember_ba827d8a-d9c2-4585-891d-0e679f8fd0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5588278-3e4b-4d1c-adfa-8ddf60adad3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d669e5-a8dc-400f-8f50-aa35c01abd00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5588278-3e4b-4d1c-adfa-8ddf60adad3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8be4a457-cea4-4de4-ac7f-da68660daa42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a5588278-3e4b-4d1c-adfa-8ddf60adad3f" xlink:to="loc_us-gaap_ShareBasedCompensation_8be4a457-cea4-4de4-ac7f-da68660daa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4affde06-f431-4087-ba4b-a4485487fff9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_7475c97b-4a3b-44bc-a8e0-d8110ff9314a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4affde06-f431-4087-ba4b-a4485487fff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_7475c97b-4a3b-44bc-a8e0-d8110ff9314a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0300724d-ccde-49b6-861d-919bf149d990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4affde06-f431-4087-ba4b-a4485487fff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0300724d-ccde-49b6-861d-919bf149d990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_fd28decb-ee45-4e07-ae6f-78583b7beeb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4affde06-f431-4087-ba4b-a4485487fff9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_fd28decb-ee45-4e07-ae6f-78583b7beeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_6e6c124c-82c7-48ae-b95d-51a1fb80587a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4affde06-f431-4087-ba4b-a4485487fff9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_6e6c124c-82c7-48ae-b95d-51a1fb80587a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f1364aed-2026-47dc-b296-8055be37c4cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_6e6c124c-82c7-48ae-b95d-51a1fb80587a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f1364aed-2026-47dc-b296-8055be37c4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4548aa7c-5702-4491-bf55-04bafe17b04d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_6e6c124c-82c7-48ae-b95d-51a1fb80587a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4548aa7c-5702-4491-bf55-04bafe17b04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_51888999-504f-4f5e-b339-60a03ed394a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_6e6c124c-82c7-48ae-b95d-51a1fb80587a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_51888999-504f-4f5e-b339-60a03ed394a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_eb2986c6-831c-4aea-97e9-1dfc55140945" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_6e6c124c-82c7-48ae-b95d-51a1fb80587a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_eb2986c6-831c-4aea-97e9-1dfc55140945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_667b0d18-0f90-47d6-ab9b-2f4eaa799291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b127e2-418a-4d6a-aa25-bda0c63dfcf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_667b0d18-0f90-47d6-ab9b-2f4eaa799291" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b127e2-418a-4d6a-aa25-bda0c63dfcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a91cdbfa-46f9-40bb-b510-3ba33d0aa990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b127e2-418a-4d6a-aa25-bda0c63dfcf0" xlink:to="loc_us-gaap_AwardTypeAxis_a91cdbfa-46f9-40bb-b510-3ba33d0aa990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a7cead9-852e-4383-a858-ad48f30121a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a91cdbfa-46f9-40bb-b510-3ba33d0aa990" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a7cead9-852e-4383-a858-ad48f30121a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_0307e64b-86d4-4314-b8f9-5482b440093a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a7cead9-852e-4383-a858-ad48f30121a7" xlink:to="loc_us-gaap_PerformanceSharesMember_0307e64b-86d4-4314-b8f9-5482b440093a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedStockUnitsMember_547725c5-fd3f-4b34-986e-15e4d353decf" xlink:href="holx-20210925.xsd#holx_MarketBasedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a7cead9-852e-4383-a858-ad48f30121a7" xlink:to="loc_holx_MarketBasedStockUnitsMember_547725c5-fd3f-4b34-986e-15e4d353decf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45b9b903-51dd-4e8f-ba36-ddd42e0c310d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_17b127e2-418a-4d6a-aa25-bda0c63dfcf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45b9b903-51dd-4e8f-ba36-ddd42e0c310d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ce6a00c4-42cd-4205-9829-0312debc9193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_45b9b903-51dd-4e8f-ba36-ddd42e0c310d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ce6a00c4-42cd-4205-9829-0312debc9193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_313e5f02-b1c2-4caf-8454-c7092368339c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_667b0d18-0f90-47d6-ab9b-2f4eaa799291" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_313e5f02-b1c2-4caf-8454-c7092368339c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_de3d9539-95ab-4522-96f8-cee57a7a7bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_313e5f02-b1c2-4caf-8454-c7092368339c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_de3d9539-95ab-4522-96f8-cee57a7a7bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ba581714-4f54-4f94-8265-abd6a89c7b82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_313e5f02-b1c2-4caf-8454-c7092368339c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ba581714-4f54-4f94-8265-abd6a89c7b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4121305a-4113-4e7a-9190-af7a266cdc02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_313e5f02-b1c2-4caf-8454-c7092368339c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4121305a-4113-4e7a-9190-af7a266cdc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f87030a6-20c0-4b1d-b74e-778a5a4e27a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_313e5f02-b1c2-4caf-8454-c7092368339c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f87030a6-20c0-4b1d-b74e-778a5a4e27a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c0a98b19-e4af-406d-b7a4-5dc70db9eb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_313e5f02-b1c2-4caf-8454-c7092368339c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c0a98b19-e4af-406d-b7a4-5dc70db9eb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_96c681fc-37f9-43bb-b376-8309463cf73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_313e5f02-b1c2-4caf-8454-c7092368339c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_96c681fc-37f9-43bb-b376-8309463cf73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_86fa9c29-8db3-4c3f-9f36-4b5193dd6642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_313e5f02-b1c2-4caf-8454-c7092368339c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_86fa9c29-8db3-4c3f-9f36-4b5193dd6642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_501d6d6b-e2f3-4e19-a949-8bc78c9431f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_667b0d18-0f90-47d6-ab9b-2f4eaa799291" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_501d6d6b-e2f3-4e19-a949-8bc78c9431f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_eb36b749-814d-44ed-bbd5-e193707fab3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_501d6d6b-e2f3-4e19-a949-8bc78c9431f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_eb36b749-814d-44ed-bbd5-e193707fab3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2b319e49-7a26-4b9a-b976-b014abe1c884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_501d6d6b-e2f3-4e19-a949-8bc78c9431f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2b319e49-7a26-4b9a-b976-b014abe1c884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_428609ff-bd03-49dd-b7d8-b7bcf38de41a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_501d6d6b-e2f3-4e19-a949-8bc78c9431f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_428609ff-bd03-49dd-b7d8-b7bcf38de41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5e6f7378-1fa3-4ce4-8bc9-3bd75b02e8e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_501d6d6b-e2f3-4e19-a949-8bc78c9431f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5e6f7378-1fa3-4ce4-8bc9-3bd75b02e8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f054a4dc-d663-4ae5-ad45-3d04f53bc658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_501d6d6b-e2f3-4e19-a949-8bc78c9431f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f054a4dc-d663-4ae5-ad45-3d04f53bc658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_58e42d21-9388-4929-bd63-594adc787c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_501d6d6b-e2f3-4e19-a949-8bc78c9431f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_58e42d21-9388-4929-bd63-594adc787c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e9295250-416c-4bc1-9d3f-320cd39e6862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_501d6d6b-e2f3-4e19-a949-8bc78c9431f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e9295250-416c-4bc1-9d3f-320cd39e6862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8f6809c6-ace8-4a58-929f-0916006779a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_667b0d18-0f90-47d6-ab9b-2f4eaa799291" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8f6809c6-ace8-4a58-929f-0916006779a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_77be0edd-0953-41ac-91e1-f1dbbf0118c6" xlink:href="holx-20210925.xsd#holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8f6809c6-ace8-4a58-929f-0916006779a2" xlink:to="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_77be0edd-0953-41ac-91e1-f1dbbf0118c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e6f04e16-957f-4853-9094-de796c63e801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8f6809c6-ace8-4a58-929f-0916006779a2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e6f04e16-957f-4853-9094-de796c63e801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_7c1f19ce-8b23-4c4f-bf18-9ac52c0b9f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8f6809c6-ace8-4a58-929f-0916006779a2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_7c1f19ce-8b23-4c4f-bf18-9ac52c0b9f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_c313d188-af3e-4c24-9817-dce572805df4" xlink:href="holx-20210925.xsd#holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8f6809c6-ace8-4a58-929f-0916006779a2" xlink:to="loc_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife_c313d188-af3e-4c24-9817-dce572805df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_4842f3a7-5531-46eb-a177-477f074e1773" xlink:href="holx-20210925.xsd#holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_667b0d18-0f90-47d6-ab9b-2f4eaa799291" xlink:to="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_4842f3a7-5531-46eb-a177-477f074e1773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f8d8d1fb-4a94-4ee7-9e5b-c3a285c64bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_4842f3a7-5531-46eb-a177-477f074e1773" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_f8d8d1fb-4a94-4ee7-9e5b-c3a285c64bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d2926b78-a942-4f0e-bc12-06b05c537ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_4842f3a7-5531-46eb-a177-477f074e1773" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d2926b78-a942-4f0e-bc12-06b05c537ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_579e6dac-a7fe-46f5-9c58-378e26ea329b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_4842f3a7-5531-46eb-a177-477f074e1773" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_579e6dac-a7fe-46f5-9c58-378e26ea329b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_7898f042-529c-4552-94ea-3ac8f5ba3a00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_4842f3a7-5531-46eb-a177-477f074e1773" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_7898f042-529c-4552-94ea-3ac8f5ba3a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ab4520c6-86de-4520-973c-227307160640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_4842f3a7-5531-46eb-a177-477f074e1773" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ab4520c6-86de-4520-973c-227307160640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6116010e-a1e1-4248-8439-e5dd8cc78f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d85f6065-0158-42ec-8145-7e0dad7644e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6116010e-a1e1-4248-8439-e5dd8cc78f31" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d85f6065-0158-42ec-8145-7e0dad7644e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_924a41e4-5511-4e8a-a309-1c755e510531" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6116010e-a1e1-4248-8439-e5dd8cc78f31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_924a41e4-5511-4e8a-a309-1c755e510531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_52cb5159-fb82-45fe-bb31-7b8ca26a5d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_924a41e4-5511-4e8a-a309-1c755e510531" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_52cb5159-fb82-45fe-bb31-7b8ca26a5d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_42f45acc-bc9d-4cb1-9bc2-7cc3ca4621e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_924a41e4-5511-4e8a-a309-1c755e510531" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_42f45acc-bc9d-4cb1-9bc2-7cc3ca4621e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4322434c-e152-493a-88a0-448c605dd73a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_924a41e4-5511-4e8a-a309-1c755e510531" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4322434c-e152-493a-88a0-448c605dd73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d4c88f88-7089-4bc6-a88d-ea087b6fd05d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_924a41e4-5511-4e8a-a309-1c755e510531" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d4c88f88-7089-4bc6-a88d-ea087b6fd05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7b562f3-2af4-4d08-a0fd-55c7ac3be116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_924a41e4-5511-4e8a-a309-1c755e510531" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7b562f3-2af4-4d08-a0fd-55c7ac3be116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_94ab52d5-5208-4055-bbca-c64e6e105e04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6116010e-a1e1-4248-8439-e5dd8cc78f31" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_94ab52d5-5208-4055-bbca-c64e6e105e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_29851ecb-51ec-4675-83b4-5947788959b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_94ab52d5-5208-4055-bbca-c64e6e105e04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_29851ecb-51ec-4675-83b4-5947788959b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_83587d74-bae3-4bf4-99e2-43b27dce810c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_94ab52d5-5208-4055-bbca-c64e6e105e04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_83587d74-bae3-4bf4-99e2-43b27dce810c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5fee37c2-ca0d-4cef-9d6a-6d2acfece4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_94ab52d5-5208-4055-bbca-c64e6e105e04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5fee37c2-ca0d-4cef-9d6a-6d2acfece4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c6a9aac2-7489-4c2f-bbf1-f1f625195ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_94ab52d5-5208-4055-bbca-c64e6e105e04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c6a9aac2-7489-4c2f-bbf1-f1f625195ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e1eb104e-f2c3-42bb-a31c-6529dc074a1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_94ab52d5-5208-4055-bbca-c64e6e105e04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e1eb104e-f2c3-42bb-a31c-6529dc074a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5953f10f-41db-407b-bd86-d2b8f4891a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62291a1f-c174-446f-98a8-d10da91b241b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5953f10f-41db-407b-bd86-d2b8f4891a8c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62291a1f-c174-446f-98a8-d10da91b241b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8730c163-8fb1-4e9f-8244-1bdb31a692fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62291a1f-c174-446f-98a8-d10da91b241b" xlink:to="loc_us-gaap_AwardTypeAxis_8730c163-8fb1-4e9f-8244-1bdb31a692fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c50ab8a3-8081-4762-81c5-0f70f8f5bc1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8730c163-8fb1-4e9f-8244-1bdb31a692fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c50ab8a3-8081-4762-81c5-0f70f8f5bc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeStockPurchasePlanMember_abf22b48-2416-4e64-90fd-d0ff5917ff0c" xlink:href="holx-20210925.xsd#holx_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c50ab8a3-8081-4762-81c5-0f70f8f5bc1d" xlink:to="loc_holx_EmployeeStockPurchasePlanMember_abf22b48-2416-4e64-90fd-d0ff5917ff0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75f72032-6ad7-4ca1-ba45-7b356e8a7ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_62291a1f-c174-446f-98a8-d10da91b241b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75f72032-6ad7-4ca1-ba45-7b356e8a7ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75f72032-6ad7-4ca1-ba45-7b356e8a7ade" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_bbf66dce-dfe0-4578-b131-bb25a59f2c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_bbf66dce-dfe0-4578-b131-bb25a59f2c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e85523e2-199d-4ed0-a7c8-8feb371d5cef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e85523e2-199d-4ed0-a7c8-8feb371d5cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_25396c8f-925c-4801-a4c6-4334658c93f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_25396c8f-925c-4801-a4c6-4334658c93f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_9affa90a-7fcb-404a-87ce-13422590c3d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_4447cec9-c9f6-4e1a-9284-dc17f92d2452" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_9affa90a-7fcb-404a-87ce-13422590c3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/A401kPlan" xlink:type="simple" xlink:href="holx-20210925.xsd#A401kPlan"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/A401kPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_72e8a5d6-be8a-4387-8db3-c243051bd34c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanTextBlock_6af01b8f-cb61-40ca-9a97-cdd444140c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_72e8a5d6-be8a-4387-8db3-c243051bd34c" xlink:to="loc_us-gaap_MultiemployerPlanTextBlock_6af01b8f-cb61-40ca-9a97-cdd444140c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#A401kPlanAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/A401kPlanAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanEmployerContributionCostAbstract_971e8baf-b0f1-4a93-8d2f-eb62ffe0a23d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MultiemployerPlanEmployerContributionCostAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_6459fecc-18d1-41ba-a87e-d15ff47dc73f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MultiemployerPlanEmployerContributionCostAbstract_971e8baf-b0f1-4a93-8d2f-eb62ffe0a23d" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_6459fecc-18d1-41ba-a87e-d15ff47dc73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#DeferredCompensationPlanAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsAbstract_98f188f4-4f99-4e2e-8611-303118d3cfa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_d0a4f2db-3e10-402c-9c27-e84829c10c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationRelatedCostsAbstract_98f188f4-4f99-4e2e-8611-303118d3cfa5" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_d0a4f2db-3e10-402c-9c27-e84829c10c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_17eeec94-c78b-49d3-9dd0-063b87571af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_d0a4f2db-3e10-402c-9c27-e84829c10c4d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_17eeec94-c78b-49d3-9dd0-063b87571af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e7e2cd8f-9934-43cd-a6c3-1c4a37e15bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_17eeec94-c78b-49d3-9dd0-063b87571af9" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e7e2cd8f-9934-43cd-a6c3-1c4a37e15bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8aa7c7f1-a0b6-49a1-9fd7-296022968e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e7e2cd8f-9934-43cd-a6c3-1c4a37e15bb2" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_8aa7c7f1-a0b6-49a1-9fd7-296022968e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_ac556c7b-b87b-4d99-a154-987aadcf2888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_d0a4f2db-3e10-402c-9c27-e84829c10c4d" xlink:to="loc_us-gaap_VestingAxis_ac556c7b-b87b-4d99-a154-987aadcf2888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_e8969333-b8e9-434e-b8e9-cf704ee804f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_ac556c7b-b87b-4d99-a154-987aadcf2888" xlink:to="loc_us-gaap_VestingDomain_e8969333-b8e9-434e-b8e9-cf704ee804f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OneThirdAnnuallyMember_4c8f67e3-7f29-4cb3-829e-ec87b7720e40" xlink:href="holx-20210925.xsd#holx_OneThirdAnnuallyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_e8969333-b8e9-434e-b8e9-cf704ee804f4" xlink:to="loc_holx_OneThirdAnnuallyMember_4c8f67e3-7f29-4cb3-829e-ec87b7720e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable_d0a4f2db-3e10-402c-9c27-e84829c10c4d" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_c85b563d-1b89-4cd2-9640-8313be5f8c70" xlink:href="holx-20210925.xsd#holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp_c85b563d-1b89-4cd2-9640-8313be5f8c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_3e606053-b372-428d-b210-02ae81a94de6" xlink:href="holx-20210925.xsd#holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp_3e606053-b372-428d-b210-02ae81a94de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployeeContributionsVestedPercentage_6a1cf9e1-18e6-483d-af7a-74feb5114c19" xlink:href="holx-20210925.xsd#holx_EmployeeContributionsVestedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_EmployeeContributionsVestedPercentage_6a1cf9e1-18e6-483d-af7a-74feb5114c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsPercentVestedAnnually_059b5dae-4c3d-4793-bcf5-6a965cd9e236" xlink:href="holx-20210925.xsd#holx_EmployerContributionsPercentVestedAnnually"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_EmployerContributionsPercentVestedAnnually_059b5dae-4c3d-4793-bcf5-6a965cd9e236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EmployerContributionsVestingPeriod_b6662636-34c4-4acb-94ca-afe2efbc7569" xlink:href="holx-20210925.xsd#holx_EmployerContributionsVestingPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_EmployerContributionsVestingPeriod_b6662636-34c4-4acb-94ca-afe2efbc7569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_fbef4eed-454e-459a-8233-d0e0f36e295e" xlink:href="holx-20210925.xsd#holx_NonqualifiedDeferredCompensationPlanAnnualContribution"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_NonqualifiedDeferredCompensationPlanAnnualContribution_fbef4eed-454e-459a-8233-d0e0f36e295e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InvestmentInGroupLifeInsuranceContracts_48019380-6c4e-4cc0-b685-546a934986ff" xlink:href="holx-20210925.xsd#holx_InvestmentInGroupLifeInsuranceContracts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_holx_InvestmentInGroupLifeInsuranceContracts_48019380-6c4e-4cc0-b685-546a934986ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_d37a9b20-b010-43e9-bd14-fe64f16fb91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems_5b955b69-85ac-49c8-817a-c5ce2f9ac791" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent_d37a9b20-b010-43e9-bd14-fe64f16fb91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20210925.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7561dac8-caf4-43e2-8a64-bc552d963262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_97f3ce12-3335-469b-922f-21347ff8dd86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7561dac8-caf4-43e2-8a64-bc552d963262" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_97f3ce12-3335-469b-922f-21347ff8dd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="holx-20210925.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f823d238-114e-4392-a094-0aca4db6c28c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_f67a1c27-ef81-495c-be33-4868ea3b3273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f823d238-114e-4392-a094-0aca4db6c28c" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock_f67a1c27-ef81-495c-be33-4868ea3b3273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e8f5e2e0-f23c-4a4c-a993-ed5d8a1f59e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d6e407c8-1703-40bc-ba91-ed5d61c6247c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e8f5e2e0-f23c-4a4c-a993-ed5d8a1f59e2" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_d6e407c8-1703-40bc-ba91-ed5d61c6247c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_48d51f0c-169e-4bbc-aaca-6419df71db96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e8f5e2e0-f23c-4a4c-a993-ed5d8a1f59e2" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_48d51f0c-169e-4bbc-aaca-6419df71db96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_aad30a8b-9d63-4e8a-b59e-7edebc628ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e8f5e2e0-f23c-4a4c-a993-ed5d8a1f59e2" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_aad30a8b-9d63-4e8a-b59e-7edebc628ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_fc29fb0f-c826-48de-befc-1dc1dcb2681f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e8f5e2e0-f23c-4a4c-a993-ed5d8a1f59e2" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_fc29fb0f-c826-48de-befc-1dc1dcb2681f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_1b070590-6478-486d-b0d4-3fbfaecc8481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e8f5e2e0-f23c-4a4c-a993-ed5d8a1f59e2" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_1b070590-6478-486d-b0d4-3fbfaecc8481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseobligationthereafter_13baf4f8-868b-4bf5-996e-1d0dd6f90279" xlink:href="holx-20210925.xsd#holx_Purchaseobligationthereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e8f5e2e0-f23c-4a4c-a993-ed5d8a1f59e2" xlink:to="loc_holx_Purchaseobligationthereafter_13baf4f8-868b-4bf5-996e-1d0dd6f90279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_552c81fa-e50d-411b-8692-28cfb4c137f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e8f5e2e0-f23c-4a4c-a993-ed5d8a1f59e2" xlink:to="loc_us-gaap_PurchaseObligation_552c81fa-e50d-411b-8692-28cfb4c137f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LitigationandRelatedMatters" xlink:type="simple" xlink:href="holx-20210925.xsd#LitigationandRelatedMatters"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LitigationandRelatedMatters" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82f34c42-8af5-4beb-8901-9eb37149e7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LitigationAndOtherMattersTextBlock_b4794861-aeab-4409-a5b7-72128b307416" xlink:href="holx-20210925.xsd#holx_LitigationAndOtherMattersTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82f34c42-8af5-4beb-8901-9eb37149e7bf" xlink:to="loc_holx_LitigationAndOtherMattersTextBlock_b4794861-aeab-4409-a5b7-72128b307416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#LitigationandOtherMattersAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1dd2e41d-13c0-4f1c-884a-f8d2d861755f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1dd2e41d-13c0-4f1c-884a-f8d2d861755f" xlink:to="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a2be8be0-b3ab-4ffa-ada7-96c5d43f0173" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:to="loc_dei_LegalEntityAxis_a2be8be0-b3ab-4ffa-ada7-96c5d43f0173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b2493670-12d7-4dd6-b6d0-0a98b55c2c78" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a2be8be0-b3ab-4ffa-ada7-96c5d43f0173" xlink:to="loc_dei_EntityDomain_b2493670-12d7-4dd6-b6d0-0a98b55c2c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_7569584e-a4d5-4ff5-a115-397939e98440" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b2493670-12d7-4dd6-b6d0-0a98b55c2c78" xlink:to="loc_holx_MedicalAestheticsBusinessMember_7569584e-a4d5-4ff5-a115-397939e98440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_aba60387-3716-45ca-a7fe-0ade7754c966" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:to="loc_srt_LitigationCaseAxis_aba60387-3716-45ca-a7fe-0ade7754c966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f993bb56-cbd5-4a55-8bd2-102ecaca1dc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_aba60387-3716-45ca-a7fe-0ade7754c966" xlink:to="loc_srt_LitigationCaseTypeDomain_f993bb56-cbd5-4a55-8bd2-102ecaca1dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CompanyVs.MinervaSurgicalInc.Member_d45714f6-01bf-43fb-a08c-119a7474c395" xlink:href="holx-20210925.xsd#holx_CompanyVs.MinervaSurgicalInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f993bb56-cbd5-4a55-8bd2-102ecaca1dc5" xlink:to="loc_holx_CompanyVs.MinervaSurgicalInc.Member_d45714f6-01bf-43fb-a08c-119a7474c395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d61db2d2-37e5-4827-ad3d-20597b0648d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:to="loc_us-gaap_LitigationStatusAxis_d61db2d2-37e5-4827-ad3d-20597b0648d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_1bc0f064-50b2-450f-a8d5-13c1f1f6bd0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_d61db2d2-37e5-4827-ad3d-20597b0648d9" xlink:to="loc_us-gaap_LitigationStatusDomain_1bc0f064-50b2-450f-a8d5-13c1f1f6bd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_6f078e48-68a0-4beb-b024-2c8b33e21cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_1bc0f064-50b2-450f-a8d5-13c1f1f6bd0a" xlink:to="loc_us-gaap_JudicialRulingMember_6f078e48-68a0-4beb-b024-2c8b33e21cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_169719d3-64ce-43b0-9cad-72feefcc6bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c8867fbf-1f30-4204-8f33-e1d9351d3cf4" xlink:to="loc_us-gaap_LossContingenciesLineItems_169719d3-64ce-43b0-9cad-72feefcc6bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_8369638b-659b-43aa-b965-8b0669c0650e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_169719d3-64ce-43b0-9cad-72feefcc6bb5" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_8369638b-659b-43aa-b965-8b0669c0650e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_be068b99-bafd-45f8-be66-f274986c1536" xlink:href="holx-20210925.xsd#holx_LegalAccrual"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_169719d3-64ce-43b0-9cad-72feefcc6bb5" xlink:to="loc_holx_LegalAccrual_be068b99-bafd-45f8-be66-f274986c1536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20210925.xsd#Disposition"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_d546038a-4af1-4e96-aa06-3f4d3ef89711" xlink:href="holx-20210925.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_78454efb-4736-49ae-b5be-60cee5d1ba7b" xlink:href="holx-20210925.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_d546038a-4af1-4e96-aa06-3f4d3ef89711" xlink:to="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock_78454efb-4736-49ae-b5be-60cee5d1ba7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionTables" xlink:type="simple" xlink:href="holx-20210925.xsd#DispositionTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_088e39e4-1295-4a68-97ed-226f91acffc1" xlink:href="holx-20210925.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0e658373-9505-4e4e-93d4-5bc4cfcc13a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_088e39e4-1295-4a68-97ed-226f91acffc1" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_0e658373-9505-4e4e-93d4-5bc4cfcc13a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#DispositionAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_956fedf4-7a4e-471d-9176-073161ec9476" xlink:href="holx-20210925.xsd#holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract_956fedf4-7a4e-471d-9176-073161ec9476" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6146af0c-90b5-4195-952d-eb78091033d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6146af0c-90b5-4195-952d-eb78091033d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e243c940-f589-4f57-8b63-1e541c13a4a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6146af0c-90b5-4195-952d-eb78091033d7" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e243c940-f589-4f57-8b63-1e541c13a4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsBusinessMember_6ec1adc9-ded2-4760-a1c1-7bd5d9502fbf" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e243c940-f589-4f57-8b63-1e541c13a4a1" xlink:to="loc_holx_MedicalAestheticsBusinessMember_6ec1adc9-ded2-4760-a1c1-7bd5d9502fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_54506c9c-78cc-4830-8b6c-615731e1a3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_54506c9c-78cc-4830-8b6c-615731e1a3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_fb842e82-eb28-4390-9bb7-7f2251bba549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_54506c9c-78cc-4830-8b6c-615731e1a3a9" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_fb842e82-eb28-4390-9bb7-7f2251bba549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a14a650a-284a-4d99-bc55-ae114e92d871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_fb842e82-eb28-4390-9bb7-7f2251bba549" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_a14a650a-284a-4d99-bc55-ae114e92d871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c4719ec5-e995-4fef-ba83-6a7da6e34d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c4719ec5-e995-4fef-ba83-6a7da6e34d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eabcfb1d-dfc4-4154-ad61-66b4c16fb18b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c4719ec5-e995-4fef-ba83-6a7da6e34d26" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eabcfb1d-dfc4-4154-ad61-66b4c16fb18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_bf3eafef-c0ba-4698-aba9-4f1bdb6422f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eabcfb1d-dfc4-4154-ad61-66b4c16fb18b" xlink:to="loc_us-gaap_CostOfSalesMember_bf3eafef-c0ba-4698-aba9-4f1bdb6422f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_067a338e-9993-41cf-85f5-9cd56c9fcf5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_eabcfb1d-dfc4-4154-ad61-66b4c16fb18b" xlink:to="loc_us-gaap_OperatingExpenseMember_067a338e-9993-41cf-85f5-9cd56c9fcf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fa6d62da-5f60-4864-9b18-077ab2261c11" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:to="loc_srt_RangeAxis_fa6d62da-5f60-4864-9b18-077ab2261c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec045e58-9981-4390-80af-a18fcf967ae1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fa6d62da-5f60-4864-9b18-077ab2261c11" xlink:to="loc_srt_RangeMember_ec045e58-9981-4390-80af-a18fcf967ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e9b49a2f-b3aa-49ea-8cc6-69c3a419b9fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ec045e58-9981-4390-80af-a18fcf967ae1" xlink:to="loc_srt_MinimumMember_e9b49a2f-b3aa-49ea-8cc6-69c3a419b9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_84abf669-9e3d-4e59-9c6c-e74cd4e3e555" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ec045e58-9981-4390-80af-a18fcf967ae1" xlink:to="loc_srt_MaximumMember_84abf669-9e3d-4e59-9c6c-e74cd4e3e555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_cd8dccb8-8c8b-41ae-962e-d95dad2917ac" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_af81fd52-b343-4b9a-97e0-ca665e458af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_af81fd52-b343-4b9a-97e0-ca665e458af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_37b56f24-92e7-4da2-baa3-0831bcf11e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_37b56f24-92e7-4da2-baa3-0831bcf11e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_28cfe282-4574-4bd0-9a3f-10815b99bf59" xlink:href="holx-20210925.xsd#holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice_28cfe282-4574-4bd0-9a3f-10815b99bf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TransitionServicesAgreementTerm_72446d3d-f28f-450b-9e4f-a47b49f3feda" xlink:href="holx-20210925.xsd#holx_TransitionServicesAgreementTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_holx_TransitionServicesAgreementTerm_72446d3d-f28f-450b-9e4f-a47b49f3feda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily_4e332156-597f-4e2c-b786-8e90ec214943" xlink:href="holx-20210925.xsd#holx_IndemnificationLiabily"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_holx_IndemnificationLiabily_4e332156-597f-4e2c-b786-8e90ec214943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_df38c55d-2238-4499-b96f-8db154343ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_us-gaap_AssetImpairmentCharges_df38c55d-2238-4499-b96f-8db154343ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Expensesfromdisposition_54cf2fbb-666e-407b-a0c5-020e2a537d63" xlink:href="holx-20210925.xsd#holx_Expensesfromdisposition"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_1ec1ad32-3b93-4515-9151-137cb2b6c14a" xlink:to="loc_holx_Expensesfromdisposition_54cf2fbb-666e-407b-a0c5-020e2a537d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f7c2275-fa9c-444b-b56e-1d9df7b5a474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_199ec97f-c7ca-4ff8-8f61-8b8dfcfc861e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f7c2275-fa9c-444b-b56e-1d9df7b5a474" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_199ec97f-c7ca-4ff8-8f61-8b8dfcfc861e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c584ea4b-c91b-490a-9f1d-b8a2b6c61ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_6fc0ef98-df9a-4756-9edd-8fae06c8f485" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c584ea4b-c91b-490a-9f1d-b8a2b6c61ff2" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_6fc0ef98-df9a-4756-9edd-8fae06c8f485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d9977fed-1913-4a83-a0ae-18c7ed3efcf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b66b768e-8f04-4f84-bcb0-266281fb8a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d9977fed-1913-4a83-a0ae-18c7ed3efcf2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b66b768e-8f04-4f84-bcb0-266281fb8a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_eda87551-0c8c-43f0-863a-1a06c721f88f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d9977fed-1913-4a83-a0ae-18c7ed3efcf2" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_eda87551-0c8c-43f0-863a-1a06c721f88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_a389cd5b-5fd6-4d89-8c2b-e9320dd3b564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d9977fed-1913-4a83-a0ae-18c7ed3efcf2" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_a389cd5b-5fd6-4d89-8c2b-e9320dd3b564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e2181cbe-2480-4426-8296-39b8fd3ed75e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureTable_cd8d0005-350f-40e4-a05e-7e40ae115704" xlink:href="holx-20210925.xsd#holx_SegmentReportingDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e2181cbe-2480-4426-8296-39b8fd3ed75e" xlink:to="loc_holx_SegmentReportingDisclosureTable_cd8d0005-350f-40e4-a05e-7e40ae115704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_33950b73-3763-41bc-9289-f00dcb3813df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureTable_cd8d0005-350f-40e4-a05e-7e40ae115704" xlink:to="loc_srt_ConsolidationItemsAxis_33950b73-3763-41bc-9289-f00dcb3813df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_14f7f4aa-f80f-488e-ba8d-2a7945377837" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_33950b73-3763-41bc-9289-f00dcb3813df" xlink:to="loc_srt_ConsolidationItemsDomain_14f7f4aa-f80f-488e-ba8d-2a7945377837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_86f2c1d0-38fe-4051-b12c-e0ccc7c3d802" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_14f7f4aa-f80f-488e-ba8d-2a7945377837" xlink:to="loc_us-gaap_IntersegmentEliminationMember_86f2c1d0-38fe-4051-b12c-e0ccc7c3d802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_49f7e265-a3d7-4789-96c4-a6dc411043c2" xlink:href="holx-20210925.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureTable_cd8d0005-350f-40e4-a05e-7e40ae115704" xlink:to="loc_holx_SegmentReportingDisclosureLineItems_49f7e265-a3d7-4789-96c4-a6dc411043c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_915ce68d-bb90-46fa-b6b1-10654585669e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_49f7e265-a3d7-4789-96c4-a6dc411043c2" xlink:to="loc_us-gaap_NumberOfReportableSegments_915ce68d-bb90-46fa-b6b1-10654585669e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3b671efc-f1f8-4027-87ba-fc728a0fb78e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_49f7e265-a3d7-4789-96c4-a6dc411043c2" xlink:to="loc_us-gaap_Revenues_3b671efc-f1f8-4027-87ba-fc728a0fb78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e8ad1af8-1918-4421-a925-892cf198cc00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7c823133-ac4f-400d-9b38-d8390eec72e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e8ad1af8-1918-4421-a925-892cf198cc00" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7c823133-ac4f-400d-9b38-d8390eec72e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_53394e49-7532-4815-9f89-6d8544246220" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7c823133-ac4f-400d-9b38-d8390eec72e0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_53394e49-7532-4815-9f89-6d8544246220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_53394e49-7532-4815-9f89-6d8544246220" xlink:to="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_5f9072d2-dab1-4d9d-bd16-fcb2ac03cc03" xlink:href="holx-20210925.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_DiagnosticsMember_5f9072d2-dab1-4d9d-bd16-fcb2ac03cc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_990533c6-4456-4f8c-a1e8-8ad08a7cb269" xlink:href="holx-20210925.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_BreastHealthMember_990533c6-4456-4f8c-a1e8-8ad08a7cb269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_a78efa4f-e321-44c1-9dbc-58c93c80b002" xlink:href="holx-20210925.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_GynSurgicalMember_a78efa4f-e321-44c1-9dbc-58c93c80b002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_4327b561-d930-424c-83cb-7c9f3c6a45b3" xlink:href="holx-20210925.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_SkeletalHealthMember_4327b561-d930-424c-83cb-7c9f3c6a45b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_5e6ee682-35ad-4953-8736-3b8cc984de42" xlink:href="holx-20210925.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d1b06f2-5e06-4ec8-863e-c6fc7452dfb4" xlink:to="loc_holx_MedicalAestheticsMember_5e6ee682-35ad-4953-8736-3b8cc984de42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_836d9ca6-5cdb-4274-99fa-50d064e59144" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7c823133-ac4f-400d-9b38-d8390eec72e0" xlink:to="loc_srt_ConsolidationItemsAxis_836d9ca6-5cdb-4274-99fa-50d064e59144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_97af49b4-39b9-4159-922e-e08a2691eb36" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_836d9ca6-5cdb-4274-99fa-50d064e59144" xlink:to="loc_srt_ConsolidationItemsDomain_97af49b4-39b9-4159-922e-e08a2691eb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b0da9544-fcc0-459b-8386-eaf0fbb47659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_97af49b4-39b9-4159-922e-e08a2691eb36" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b0da9544-fcc0-459b-8386-eaf0fbb47659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_7c823133-ac4f-400d-9b38-d8390eec72e0" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_35c22bd9-590a-4b78-b989-2c2f961d0bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_Revenues_35c22bd9-590a-4b78-b989-2c2f961d0bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_120efa74-4ca6-4d41-964d-90da9c1d86aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_OperatingIncomeLoss_120efa74-4ca6-4d41-964d-90da9c1d86aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_6a81c6c9-542d-4da7-b62b-c0add792e0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_6a81c6c9-542d-4da7-b62b-c0add792e0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_1b6eb1d8-a672-4a51-a581-f35785a19bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_1b6eb1d8-a672-4a51-a581-f35785a19bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cc0a03c5-a30b-43e4-a898-46e63f5c2d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_acd4f1bc-c02c-4d11-9cd9-f3243dae6e0c" xlink:to="loc_us-gaap_Assets_cc0a03c5-a30b-43e4-a898-46e63f5c2d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a0298683-f946-44a4-aabe-dcbbee9a8015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_69b768a5-3dbd-4463-9341-82aa175778d0" xlink:href="holx-20210925.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a0298683-f946-44a4-aabe-dcbbee9a8015" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_69b768a5-3dbd-4463-9341-82aa175778d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_813b830c-6bc3-491b-8e51-37f55d0060b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_69b768a5-3dbd-4463-9341-82aa175778d0" xlink:to="loc_srt_StatementGeographicalAxis_813b830c-6bc3-491b-8e51-37f55d0060b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_813b830c-6bc3-491b-8e51-37f55d0060b8" xlink:to="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_46a84afb-0908-466c-9852-dc01a2224766" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:to="loc_country_US_46a84afb-0908-466c-9852-dc01a2224766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_057f0b56-7dcb-48f5-9c62-532f2ff22bc1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:to="loc_srt_EuropeMember_057f0b56-7dcb-48f5-9c62-532f2ff22bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_245d733b-0841-41e6-ba7c-9d0be7ec394c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:to="loc_srt_AsiaPacificMember_245d733b-0841-41e6-ba7c-9d0be7ec394c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_8042444b-242c-492f-bb46-856fe7de9a71" xlink:href="holx-20210925.xsd#holx_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_50897c75-acb5-4a7e-9dcc-1d08d9f14d2e" xlink:to="loc_holx_AllOtherCountriesMember_8042444b-242c-492f-bb46-856fe7de9a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_a8e0b2f8-d028-4579-9ef5-33b28a24da57" xlink:href="holx-20210925.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_69b768a5-3dbd-4463-9341-82aa175778d0" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsLineItems_a8e0b2f8-d028-4579-9ef5-33b28a24da57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_716e16a5-470a-4538-99fd-35f093d8f035" xlink:href="holx-20210925.xsd#holx_PercentageOfRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_a8e0b2f8-d028-4579-9ef5-33b28a24da57" xlink:to="loc_holx_PercentageOfRevenues_716e16a5-470a-4538-99fd-35f093d8f035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="holx-20210925.xsd#BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bfd040cc-676a-435f-899f-f69c3cab3b23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_ceeefc50-d1f6-4221-a0b5-157866f05cbf" xlink:href="holx-20210925.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bfd040cc-676a-435f-899f-f69c3cab3b23" xlink:to="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_ceeefc50-d1f6-4221-a0b5-157866f05cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7e89641a-c9b7-4a35-a405-58366d61cd00" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_ceeefc50-d1f6-4221-a0b5-157866f05cbf" xlink:to="loc_srt_StatementGeographicalAxis_7e89641a-c9b7-4a35-a405-58366d61cd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7e89641a-c9b7-4a35-a405-58366d61cd00" xlink:to="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_aa700470-7e58-48aa-bd3d-d5bac58f6fd6" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:to="loc_country_US_aa700470-7e58-48aa-bd3d-d5bac58f6fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_0aa3a8dc-f3f6-4ec0-a801-47583446189f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:to="loc_srt_EuropeMember_0aa3a8dc-f3f6-4ec0-a801-47583446189f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR_bba8961a-6a83-4378-8fce-bd7e680f96b4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CR"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:to="loc_country_CR_bba8961a-6a83-4378-8fce-bd7e680f96b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_3763c39d-679e-4101-9159-dfc0c008b04d" xlink:href="holx-20210925.xsd#holx_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f4d8b423-67b6-416b-9efb-75aa4d6c2203" xlink:to="loc_holx_AllOtherCountriesMember_3763c39d-679e-4101-9159-dfc0c008b04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_91935a7d-89e0-4756-85cc-e3eb4b47c997" xlink:href="holx-20210925.xsd#holx_GeographicInformationForPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentTable_ceeefc50-d1f6-4221-a0b5-157866f05cbf" xlink:to="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_91935a7d-89e0-4756-85cc-e3eb4b47c997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3f9b5fc4-751e-43c7-a89b-229e1be00d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems_91935a7d-89e0-4756-85cc-e3eb4b47c997" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3f9b5fc4-751e-43c7-a89b-229e1be00d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities" xlink:type="simple" xlink:href="holx-20210925.xsd#AccruedExpensesandOtherLongTermLiabilities"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_8bb0d761-4d91-4854-8dc2-fc4cfe9ac7b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_db5fcf91-0c26-4503-a19f-2f86392dd4e2" xlink:href="holx-20210925.xsd#holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8bb0d761-4d91-4854-8dc2-fc4cfe9ac7b0" xlink:to="loc_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock_db5fcf91-0c26-4503-a19f-2f86392dd4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables" xlink:type="simple" xlink:href="holx-20210925.xsd#AccruedExpensesandOtherLongTermLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_86619ae4-4f43-4721-a1ef-08d2baaf2d06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_0788c976-b7dc-4e4d-8ac0-1c6f36abf8c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_86619ae4-4f43-4721-a1ef-08d2baaf2d06" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_0788c976-b7dc-4e4d-8ac0-1c6f36abf8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesTableTextBlock_a2c60664-bce0-466a-9246-4c42f6f15a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_86619ae4-4f43-4721-a1ef-08d2baaf2d06" xlink:to="loc_us-gaap_OtherLiabilitiesTableTextBlock_a2c60664-bce0-466a-9246-4c42f6f15a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_83badf72-f96f-440f-8f48-6654982d2ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b21eaf5-aeaa-4bff-b5f9-7e330dd89de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_83badf72-f96f-440f-8f48-6654982d2ffa" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b21eaf5-aeaa-4bff-b5f9-7e330dd89de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_70861491-bff2-49a2-b52c-6efef822dca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b21eaf5-aeaa-4bff-b5f9-7e330dd89de6" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_70861491-bff2-49a2-b52c-6efef822dca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedIncomeAndOtherTaxes_1a6aaca6-2d0c-4058-9817-5bba9989f59a" xlink:href="holx-20210925.xsd#holx_AccruedIncomeAndOtherTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b21eaf5-aeaa-4bff-b5f9-7e330dd89de6" xlink:to="loc_holx_AccruedIncomeAndOtherTaxes_1a6aaca6-2d0c-4058-9817-5bba9989f59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0ea82dfd-5178-440d-b410-c79abcdb419f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b21eaf5-aeaa-4bff-b5f9-7e330dd89de6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0ea82dfd-5178-440d-b410-c79abcdb419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5a3ee002-6d22-4a39-a1eb-d96a39c41693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b21eaf5-aeaa-4bff-b5f9-7e330dd89de6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5a3ee002-6d22-4a39-a1eb-d96a39c41693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccruedInterest_cf72b989-ee95-4153-98d1-01cffd49d824" xlink:href="holx-20210925.xsd#holx_AccruedInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b21eaf5-aeaa-4bff-b5f9-7e330dd89de6" xlink:to="loc_holx_AccruedInterest_cf72b989-ee95-4153-98d1-01cffd49d824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1bab9191-7302-4a82-a402-4d78bbc45289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b21eaf5-aeaa-4bff-b5f9-7e330dd89de6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1bab9191-7302-4a82-a402-4d78bbc45289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_865839c2-02fd-42d3-8324-9a1e0a020740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_9b21eaf5-aeaa-4bff-b5f9-7e330dd89de6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_865839c2-02fd-42d3-8324-9a1e0a020740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e2682532-8d17-44d2-b5ca-5c835425a254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_c27449e9-2942-4c38-ab50-6683095a3032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e2682532-8d17-44d2-b5ca-5c835425a254" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_c27449e9-2942-4c38-ab50-6683095a3032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_adbc9ee7-575d-4cae-ad1f-44aeb7f6543f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_c27449e9-2942-4c38-ab50-6683095a3032" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_adbc9ee7-575d-4cae-ad1f-44aeb7f6543f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_90ad99dd-76a6-4eec-a7a0-781c7d1569bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_c27449e9-2942-4c38-ab50-6683095a3032" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_90ad99dd-76a6-4eec-a7a0-781c7d1569bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6f9b9f77-5f63-4756-8ea6-8c09e499c0ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_c27449e9-2942-4c38-ab50-6683095a3032" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6f9b9f77-5f63-4756-8ea6-8c09e499c0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_3b943e6d-a952-4bcc-aa1c-3e9d4bbbab06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_c27449e9-2942-4c38-ab50-6683095a3032" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_3b943e6d-a952-4bcc-aa1c-3e9d4bbbab06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_7645ed65-1df6-433e-a1ec-508f2e6f01f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_c27449e9-2942-4c38-ab50-6683095a3032" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_7645ed65-1df6-433e-a1ec-508f2e6f01f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_38f1840f-0d83-4e2b-ae40-d77374fca028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_c27449e9-2942-4c38-ab50-6683095a3032" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_38f1840f-0d83-4e2b-ae40-d77374fca028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_160166c4-390e-4430-a4fa-ec2a2c1f0801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_c27449e9-2942-4c38-ab50-6683095a3032" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_160166c4-390e-4430-a4fa-ec2a2c1f0801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefits" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefits"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_aae0276e-5e46-47b7-bc97-ec05ef3709e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_56c7b9a3-a1c9-40ce-9e01-e08407b15b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_aae0276e-5e46-47b7-bc97-ec05ef3709e5" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_56c7b9a3-a1c9-40ce-9e01-e08407b15b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_92678c64-2d2b-452e-bf3d-b26fabf3de5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_f0959048-fcb7-4385-b692-f7ce51731844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_92678c64-2d2b-452e-bf3d-b26fabf3de5b" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_f0959048-fcb7-4385-b692-f7ce51731844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_03a812d8-e970-461d-84bf-147cfcaf1343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_92678c64-2d2b-452e-bf3d-b26fabf3de5b" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_03a812d8-e970-461d-84bf-147cfcaf1343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_1a617978-075b-4881-be35-bb86dfab2142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_92678c64-2d2b-452e-bf3d-b26fabf3de5b" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_1a617978-075b-4881-be35-bb86dfab2142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_22d0e57d-80e4-459f-9e4f-610493ab9258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_92678c64-2d2b-452e-bf3d-b26fabf3de5b" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_22d0e57d-80e4-459f-9e4f-610493ab9258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefitsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_14618930-1f34-4868-914b-f7f07a6a4b4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9e46f67c-e30f-470c-ba9f-8f44f0714da5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_14618930-1f34-4868-914b-f7f07a6a4b4f" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9e46f67c-e30f-470c-ba9f-8f44f0714da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5fb01d86-9a90-4787-b332-08cd0a7d8129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9e46f67c-e30f-470c-ba9f-8f44f0714da5" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5fb01d86-9a90-4787-b332-08cd0a7d8129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_36bf37ba-ce61-44e5-94f8-f21ed0f8ff09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5fb01d86-9a90-4787-b332-08cd0a7d8129" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_36bf37ba-ce61-44e5-94f8-f21ed0f8ff09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_d80b7774-00a5-4234-ab81-28369dcc117a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_36bf37ba-ce61-44e5-94f8-f21ed0f8ff09" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_d80b7774-00a5-4234-ab81-28369dcc117a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_9e46f67c-e30f-470c-ba9f-8f44f0714da5" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_526fe841-a4d4-423b-aaa0-6477a2e916cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities_526fe841-a4d4-423b-aaa0-6477a2e916cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_3ff7077b-b8b6-486a-ab03-f191fb02d3aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation_3ff7077b-b8b6-486a-ab03-f191fb02d3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_9bf8ed5d-f334-47a9-b296-cdba6d501bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_9bf8ed5d-f334-47a9-b296-cdba6d501bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards_68db8465-e612-4692-a963-f4160a0da729" xlink:href="holx-20210925.xsd#holx_ProjectedBenefitObligationForLongTermServiceAwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_276511d7-8e34-4eb5-8fce-38ce1ba54e8f" xlink:to="loc_holx_ProjectedBenefitObligationForLongTermServiceAwards_68db8465-e612-4692-a963-f4160a0da729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_35d86270-6181-4f14-93cb-1cd85fda1cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_35d86270-6181-4f14-93cb-1cd85fda1cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_bf771910-1182-4b8f-acda-62d0f49cad20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_bf771910-1182-4b8f-acda-62d0f49cad20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_521992d1-048d-4e99-945e-c7215f2ea02a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_521992d1-048d-4e99-945e-c7215f2ea02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_e36e412c-abf5-4523-ad5a-0feb667b28d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_e36e412c-abf5-4523-ad5a-0feb667b28d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_cba49b15-bbc4-4323-8ba2-b961ada35c34" xlink:href="holx-20210925.xsd#holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount_cba49b15-bbc4-4323-8ba2-b961ada35c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_62912c6b-d977-46b8-b5c5-f439b3e94843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_62912c6b-d977-46b8-b5c5-f439b3e94843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_4b6e0a73-ad06-4171-8fb6-04ae464020f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_4b6e0a73-ad06-4171-8fb6-04ae464020f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_19fe7a8f-bfff-4a31-9f69-5c1cda9d3e63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_19fe7a8f-bfff-4a31-9f69-5c1cda9d3e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6c291c6e-211e-4578-8788-5cb2be0d79f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_6c291c6e-211e-4578-8788-5cb2be0d79f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_457ce2ca-b598-4efa-9a87-226707b61583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_569b96e8-7b62-42c7-ae96-5f3372a3a902" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_457ce2ca-b598-4efa-9a87-226707b61583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2646bc77-0f95-4f3a-b535-6e83e884d0df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_3ffc4772-2b8d-4a50-b395-c42051a4106d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2646bc77-0f95-4f3a-b535-6e83e884d0df" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_3ffc4772-2b8d-4a50-b395-c42051a4106d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost_5dea026a-d8c6-4b1b-80ee-c7515328f761" xlink:href="holx-20210925.xsd#holx_ComponentsofNetPeriodicBenefitCostInterestcost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2646bc77-0f95-4f3a-b535-6e83e884d0df" xlink:to="loc_holx_ComponentsofNetPeriodicBenefitCostInterestcost_5dea026a-d8c6-4b1b-80ee-c7515328f761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_223af475-51d6-4b63-81d8-4480c87931b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2646bc77-0f95-4f3a-b535-6e83e884d0df" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_223af475-51d6-4b63-81d8-4480c87931b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a47ddb07-2187-47c3-bace-0eca43574c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2646bc77-0f95-4f3a-b535-6e83e884d0df" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_a47ddb07-2187-47c3-bace-0eca43574c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_cb18ad90-d548-40ec-ae72-339050c97771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2646bc77-0f95-4f3a-b535-6e83e884d0df" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_cb18ad90-d548-40ec-ae72-339050c97771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_27e9335f-7c79-4f7c-b66e-8921ee1d54f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_2646bc77-0f95-4f3a-b535-6e83e884d0df" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_27e9335f-7c79-4f7c-b66e-8921ee1d54f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_42f948e3-40c1-47a3-8303-55a9b1a559e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_9b251c1b-a8b4-4210-81bb-c5e38ff2b590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_42f948e3-40c1-47a3-8303-55a9b1a559e5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_9b251c1b-a8b4-4210-81bb-c5e38ff2b590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_4371c2c9-9a84-469e-af64-19112829e74b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_42f948e3-40c1-47a3-8303-55a9b1a559e5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_4371c2c9-9a84-469e-af64-19112829e74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3463dd30-0f52-41ed-8b2b-96c126173a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_42f948e3-40c1-47a3-8303-55a9b1a559e5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3463dd30-0f52-41ed-8b2b-96c126173a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" xlink:type="simple" xlink:href="holx-20210925.xsd#PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_5a9da308-dabb-4722-941d-d0990213b75b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b93bd6a3-f06f-4788-834d-c1f7c0323be1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_5a9da308-dabb-4722-941d-d0990213b75b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b93bd6a3-f06f-4788-834d-c1f7c0323be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_e5115e60-6c8a-40bc-80f2-7b02cad478ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_5a9da308-dabb-4722-941d-d0990213b75b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_e5115e60-6c8a-40bc-80f2-7b02cad478ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_cdaf3278-5e8d-44ae-9008-c3c8a4005ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_5a9da308-dabb-4722-941d-d0990213b75b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_cdaf3278-5e8d-44ae-9008-c3c8a4005ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_d9d5c16b-b181-4dad-b177-dfcb87cce859" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_5a9da308-dabb-4722-941d-d0990213b75b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_d9d5c16b-b181-4dad-b177-dfcb87cce859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_546b2d10-0c43-4608-afcf-93d6f7b16fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_5a9da308-dabb-4722-941d-d0990213b75b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_546b2d10-0c43-4608-afcf-93d6f7b16fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_aaea0ff5-f56b-4a86-a18f-5a9b4cc268c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract_5a9da308-dabb-4722-941d-d0990213b75b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_aaea0ff5-f56b-4a86-a18f-5a9b4cc268c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>holx-20210925_g1.jpg
<TEXT>
begin 644 holx-20210925_g1.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ?E"8(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKD/'WQ@\"_"JW2;QEX
MPT/PNDG^K_M;4(K=I/\ =5F!;\ >AH Z^BO$]%_;8^ NOW_V.S^+7A3[1O"
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M $DG@ 4 6**XC3?CE\.-:U"VL-/^('A:^OKJ188+6VUJVDEE=CA455<EF)(
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MV<+S3RI!"@RTDC!5'U)K._X2S0_^@SI__@5'_C0!K45D_P#"6:'_ -!G3_\
MP*C_ ,:OV=];ZA")K6>*YA)P)(7#J<>XH GHHK"\5>//#/@6&WE\2^(M)\/1
M7#%89-5OHK996 R0ID89(R.GK0!NT5R/AWXO>!/%VJ1Z9H7C7P[K6I2!F2ST
M[58)YF &20B.20!R>*ZZ@ HJ.XN(K6"2>>1(88U+O)(P554#)))Z #O7!_\
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M917'Z!\8O /BO5H-+T3QQX;UC4Y]WE66GZM;SS2;5+-M1'+'"@DX' !-=A0
M445Q.J?&_P"'.AZE<Z?J7C_POI]_;.8I[6ZUFVBEB<=596<%2/0B@#MJ*PF\
M>>&H_"O_  DS>(=*7PWM#_VP;V(6>TML!\[=LQN^7KUXZUSG_#0GPL_Z*7X/
M_P#!]:__ !R@#T"BO/\ _AH3X6?]%+\'_P#@^M?_ (Y1_P -"?"S_HI?@_\
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M *"*_ELU;_D*WO\ UV?_ -"-?U)Z3_R"K+_KBG_H(H ROB%_R(/B;_L&7/\
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M?\%N/^2+_#S_ +&"3_TF>OT?K\X/^"W'_)%_AY_V,$G_ *3/0!X__P $0_\
MDJGQ+_[ MO\ ^CS7U!_P6%_Y,_?_ +&"Q_E+7R__ ,$0_P#DJGQ+_P"P+;_^
MCS7U!_P6%_Y,_?\ [&"Q_E+0!\*_\$>O^3P$_P"Q?OOYQ5^Y-?AM_P $>O\
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M$_\ !8?XP_\ ""?LV67@ZUG\O4?&6HK;NJG#?8[<K-,1W^_]G4^H<_0_%_\
MP2#^"Y^(G[2\OBZ[M_-TGP79->;F7*_;)@T4"GWV^=(#ZQ"@#[\_;H\!Z?\
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M3_XY7ZT_\-^?L\_]%8\/_P#?U_\ XFG1_M\?L]S2*B?%?0&=B% $C\D_\!H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\7ZAYDL,;3>%[JX;YBB@M)99/7:,NGHH=>@05]Z_M8_\FL_&3_L3-9_](9J
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M-_\ 7;5O_0;.OA+]F']CWQW^UI/XBB\$3:1$^@K;O=_VM=/"")C($V;4;/\
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M$4B-("I"*7P1D&4U^3_@+P/XI^/WQ4L/#NC(=6\5^([URK3N%\R5MTDDCMV
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MY=P6BOIED%,\JH#^]DZ9-?K1_P )9H?_ $&=/_\  J/_ !H UJ*R?^$LT/\
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MG_X+C?\ (J_"3_K]U+_T7;T <U_P2=^%>A?&S]G;XY^"/$EO]HT?6;FTMY<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5^RQZ#?HLQ')PHCPWK7HWP<_X)I_'KXN:M;13>#;KP5I+M^_U3Q0ALQ"O?\
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MA7[(?QD^*'[8'C[Q/X4^'NL:YH%]_9_V:_M8U,<NS3[:-\$MV=&7Z@U^BO\
MP3U\ >(OA?\ L?\ @'PQXKTFXT/7['^T/M-A= "2+?J%S(F0#W1U;Z$5]%44
M %<C\6OA9X>^-?P[USP5XIM/MFAZO;F"=5.'0Y#)(AP<.C!64XX*CKTKKJ*
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M'?A>^\,7%_J%I+:QWRA3*JQN&(P3T)'YU]\R1I-&T<BJZ,"K*PR"#U!%.HH
M_$/]L+_@FG\1/"?QPUF3X6>"[[Q'X'U0_P!H6/\ 9RJ18EV.^U8$@C8P.W_8
M9.20:^RO^"2OP1\=_!'X=^/;'QUX8OO#-W?:K!-;0WR@&5!"06&"> >*^\J*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4?MB6?CN;Q+H>D:*WA^2R2 :2)<2><)RV_S';IY2XQCJ:^Q* "BBB@ HHHH
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MB-9H94Z.C %6'L00: +%%?$/[=G[<GCW]F/XJ^"?!O@KPKHWB6X\1V8DCCU
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?!?_  5[
M^,5QX4^!FC?#C1F>37O'>H+;FWAYD:TA9'<#'.7E:! /X@7'K7BO[=G[..H_
MLU_ ?]GKQ_X7"0^(_AK]ETW4+J%<@S,PN%F/^P+H3<=_M&*\Z_:#_:*MO''_
M  4@7QA-X8U?QUX2^&]VMC:Z9HL1E9Y;8N1)G! 7[66;./F5%'N/9OCU_P %
M#+'XZ?!SQ=X#U#X"^/8H=<L)+:.=[?<()OO0RXV<[)%1\?[- 'Z'_"/XDZ9\
M8?ACX8\:Z.P.GZY817L:;LF(LHW1L?[R-N4^ZFOE7]J3_@H5-^R_^U#X?\#:
MWI%G/X&N="_M:^OH8I9-0$A%TL<40#A/FDAB4;A@;R20.1YC_P $9_C=-J7@
MCQ9\(=9DDBU/PW<-J6GV\X*NMM*^V>/:>1Y<WS'/.;C\N=_;'\.V?BK_ (*Q
M? [3M0A2XLWLM+E>&095_+O+N0*1W!*#([T =%XX_;4_;'\.^'+OXB?\*#T?
M1?AS:J;B2+4EDEOHK;AB\JK<I(N%Y+^2%7))'''36/\ P4V\0_&GPKX=TSX%
M?"ZZ\8_$V_LVN=5TV\<BPT,JY3][+E!(&(RIWQC:RY(8[:^T?C!!'=?"7QM#
M*@DBDT.^1T;HRFW<$&OA3_@B3H5I!\#?'VLI$@O[KQ&+.67:-QCBMHG1<^@,
M\AQ[F@"Q\._^"AWQ<^'?QWT'X:?M'_#C3?"#Z],D%GJ>DAU6)I'V1N?WLT<T
M>_"%D<;<Y.<<_H)KFMV'AG1=0U?5;N*PTS3[>2ZNKJ9MJ0Q(I9W8]@%!)^E?
MFS_P68_<>(/V?KF,;+B/4]0VRK]X?/8GK]17T!_P5.\07_A_]BCQM]@9XS?3
M65E/(AP5A>ZCWCZ,!L/LYH \AA_X*$?&O]H[Q;JVG?LT?"2TUOP]IK>3-X@\
M4,8T9B>'QYT21G'(C+NY')4=*U_ O_!1/QY\-?BOIGP__::^&\'P[N]79$L-
M=TMRUCN9@N7)ED4QY(S(DC;.-PQDCV?_ ()R^$--\'_L:_#=-.BB1M1LFU.Z
MDCZRSS2,S,Q[D#:GL$ [5YG_ ,%@/".EZ[^R1-K-W#$=2T/5[2:RG8?.OFOY
M4B*?1E?)'0[ >PH ]T_;*^.FK?LW?L\^)?B#H=A9:GJ>ER6B16NH;_)?S;F*
M%MVQ@>!(2,'J!7RMH_\ P4"^.W[0&@Z9%\ O@_:>);ZWL+<Z]KNJ%HM.AOWA
M5YK:W\R:(9C9L9:0D_W<$,Q^TEXDN_%W_!'71]5OVDDO9M"T!9I93EY&2ZMD
M+D]RVW=^->__ /!.#PW9^&?V+OAG':0QQM>6<M].Z( 9))9Y'+,>YP57)[*!
MVH \8_9U_P""B7CJ]^/EG\&OCUX"M?!'BS4'6&RO+ /%%YS+NB1XW>3(DZ+(
MCD%B!MY)'U=^T=^T)X8_9C^%NH>-_%+226T++;VMC;X\Z]N'SLACR<9.&))Z
M*K'MBOA?_@H]$D7[=W[+]PBA)VU'3U,B\,0NJ1%1GV+'\S3?^"O$DGB;XL?L
M^>#+^0Q>'-1U"4W.20C%Y[:)B2.?E1FZ=-YH Z#P;^U_^V;\5M''CGP?\!O#
MLO@.8--9VUY,R7EQ#V9&>YC:3IPRP@,#P#Q5_P"$G_!3_6OC%^TU\/\ X:V?
M@F'P_::K$]MK]OJR2B_T_4(TN&EB0[@"@\J/!9 WS," 1Q^@=C8V^EV-O9V<
M$=M:6\:PPPQ*%2-% "JH'0   #VK\Q_BIX1TSPO_ ,%G/AS<Z=#'"^M64>I7
M:Q# ,YM;N(L1V)6%"?7.>I- 'Z?U\_\ [?G_ "9M\6/^P,__ *&E?0%?/_[?
MG_)FWQ8_[ S_ /H:4 >$?\$M?B[X%\'_ +(.A:;KWC7P[HFHIJ-\S6>HZK!;
MS*IF)!*.X(!'3BOK?_AH3X6?]%+\'_\ @^M?_CE?FA^PA_P3E^%/[2'[.NE>
M-_%EQXBCUFZO;JW==.OHXH=L<I5<*8F.<#GFOH7_ (<V_ 3_ )_/&'_@TB_^
M,4 >)?L]ZWIWB/\ X+#^/-2TF_M=4TZXM[QH;RRF6:&5?LT(RKJ2",@]#VK[
MD_:V_:Z\)?LB> [?7?$,,VJ:IJ$C0:5HMHP66\D4 L2QX2-<KN?!QN4 $D"O
MSY_8X^%NC?!7_@JGXF\$>'FNGT;1K*]M[9KV023%3;Q-\S  $Y8]A78_MB6"
M?$S_ (*J?!CPCKZ+-X>M;:PD2TGYBE_?3SOD=][1JA]0@% '<:7^U!^W%XJ\
M/Q^,M&^ ?AM/"\D1GAL+IW6_EA(R&$;7:2$X Q^Z!;=D*<\>\_L:_MN:%^U?
MI^JZ7/I,_A/Q_H*C^U_#]T<E?F*&2(D!BH8;6# ,C$ YR"?I>OR_\<6MO\+_
M /@LYX1N-"C%NGB6S634K>V^59'FM)XG+#IR8HY3ZL-W6@"W^T)_RF*^#W_8
M,M?_ $&\K[J_:&_: \*_LS_#&_\ &WBZ:46,#K!;VMLH:>\N&!V0Q D L0K'
MD@ *Q/ KX5_:$_Y3%?![_L&6O_H-Y57_ (+!27'BCXH_ +P5=2M!H.H7LS3_
M #%4=Y)[:(D^Z(6P>WF&@#JO"O[7_P"V-\;M*_X2_P"&?P*\.Q>"9':6R_MR
MY(N+N+.!L9[J#>,$G>L84E< GH?6OV1?V]H_CIXVU'X9>/O"T_P]^*^FB1I=
M)F#"&Z"8+B/?\ZN%.XQG.5&X,PSCZQTO3;31=-M-/L+>.TL;2%((+>%=J11J
MH554=@   /:OS)_X*-6MO\._VZ?V=O'.CQB#6[V\M8[S[/\ *]PD-Y$H#>NZ
M.9X\]U&.@% 'V+^V%^U[X:_9"^']OK>K6DFM:YJ4C6^D:)!*(WNI% +,SD'9
M&N5W-@G+* #FOFC2?VKOVV%\._\ "=7_ .S]H=WX-:+[4-.M6DAU/[/RVX1&
MY>7=M.,>3G@$*.<\C^UQ:Q_$3_@JU\%?"OB!5F\/V=I9316MP,Q2,)+B8Y'?
M<\:(1T.T ]Z_4"@#X9_94_X*,7O[4G[3FJ>"-+\/6NG>"X]&;4K6YN$==1$J
M+;B2.3YRF!))*N5'(5377_&#]L;Q-\.?VX/AW\%++1=)N= \2VEM<7&H7 E^
MU1-))<*0F'"X A7JIZFOG?\ 9G\(Z9X'_P""O?Q=TG2(8[>P&F7ETL4(PB-/
M]CG=0.P#RMP.!T%6OVH_^4O'P,_[!EC_ .C[Z@#Z=_;._;>T']DO2])L(])E
M\6>.M<_Y!?A^VDV%EW!?-E8!BJEOE4!278$#&&(\"U+]J;]M_P '^&9O'?B'
MX$>&?^$0MX_M5S86[.M_#; %BY07;R*=I^;,1*["2BC.>5O+*+XC?\%KGM==
M1;BT\-644NGV]P. T>F)-&5'JLTS2CW&:_3YE#J58!E(P0>AH \?_98_:;\-
M?M6_"RW\8^'HI+&5)3::CI<[;I;&Y4 F,M@!U*LK*P&"&' (('L-><_!O]GG
MX>?L^V>J6OP_\-0^'+?5)5FO$AN)I?-==VTGS';&-S<#'7V%>C4 %%%% 'Y:
M_P#!#7_D%?&3_KMI/_H-Y771?\%3/%4?Q*^)W@&#X=Q>*O&&F^()-#\)Z-H:
M3>;?>7-<I+-<,2^%1(8V.T#.\]%!9>1_X(:_\@KXR?\ 7;2?_0;RC_@G7X;L
M]0_X*$_M&ZS/#'+=:;>ZK%;LZ F,RZFP9E/8[4*Y'9B.] &MXX_;N_:V_9[^
MQ^)/BW\$_#]IX+N)DC=M.=E:/=G:GG)<SK&QP>)$Y/''2OT'^$WQ.T7XS?#;
MP[XW\/2/)H^MVB7< D #QYX:-P"0'1@R, 3@J>:\H_X*!01W'[&?Q725%D4:
M07 89&Y9$93]00#^%>$?L@^(K[PM_P $D]1UG3WD6_T[P[XEN;9TY,<B37C*
MP^C<T ,^(/\ P46\>_$3XM:I\.OV9OAQ;?$2_P!)=DO-=U-V^PDJQ5RN)(E6
M/(PLKRJ&/W5(P6HV_P#P4"^,?[/7C[0= _:<^&.F^&]#UEQ%;^)O#TC-#'@@
M-(P$LRR8R"RJR,H.0IX!U?\ @C/X3T[2?V7]7UR"*(ZGK'B"<75PH^<I#'&L
M4;'T7=(P'_30^M?7OQ@^!_@?X^>&[;0/'V@0^(M(MKM+Z&VFFEB"3*K*K[HV
M5ONNPQG!SR* .V@GCNH8YH766*10Z2(<AE(R"#W&*DJEHNCV?AW1[#2M.@%M
MI]C;QVMM"I)$<:*%1<DDG  ')S5V@ HHHH X'XZ:[\0/#?PQU74/A?X;LO%O
MC6)H19:3J%PL$,P,J"4L[21@;8R[#YARHZ]*_)#_ ()^^./CYX=^*7Q:D^&7
MPZT?Q7?WVHVQ\2PW]_% NG'S[D@1EKB/?RTPX+_<'KS^UM?F5_P2-_Y+1^TM
M_P!A.U_]*;^@#DOV_?B9I?P;_P""EWPN\;:W%<SZ7H>@V=Y/%9H'F<">]PJ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:2/(TP7T+1,\R^62"T;!ADC;7ZHU3U;1M/U^PDL=3L;;4;*3A[:[A66-OJK
M@T ?FY^V%_P42\)?'+X9W/PE^!L&J>./%7C15TQY8;":!;>)R/,0+(JL[L,I
MP-H!9BW !^R_V0?@6?V<OV=_!_@:<I)JEG;&?4I(R&5KN9C+, W\2JS;%/=4
M6N[\(?"GP3\/;B>?PMX/T#PU/<9$TFCZ9!:-)DY.XQJ,\\\]ZZF@ K\M?^"W
M'_(5^ W_ %VUC_T+3Z_4JLK7/"FB>)FMSK&CZ?JQM]QA-]:I-Y><9V[@<9VC
M./04 ?!7_!;#_DVWP;_V-L/_ *1W5?;_ ,)O^25^#?\ L"V7_HA*VM;\.Z3X
MFMDM]8TNSU6W1_,6&^MTF16P1N 8$ X)&?<U>AA2WB2*)%CB10JH@P% X  [
M"@#\S?B)_P IK/ /_8,'_IMNJZ;_ (*??!GQ?H?C/X?_ +1GP_L7U'6/!+Q)
MJ=M#&79;>*4SQ3%1]Z-6:5),<A9%/W0Q'WW)X7T:;6X]9DTBQ?5XQM34&MD-
MPHP1@28W#@D=>A-:E 'P_:?\%?/@3/\ #M=;DGUF/Q,8<GPHNGRO<&;'W%GV
M^25W<;BX..=N>*^=O^":?B+Q-XO_ ."AWQ8U_P 8Z;+HWB/5O#5[J%UITR%'
MMO.O;"1(RIY&U&08//'/.:_3*T^!WPXL/$H\16OP_P#"UMX@5MXU:'1;9;L,
M3G/FA-V<\YSUKI;7PSI%CK%QJUMI5C;ZK<+LFOHK9%GE7@X9P-Q'RKU/8>E
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M-I96T-I:0J$B@@0)'&HZ!5' 'L*L44 %%%% !117Q3^V!^TU\0/A'^UI\ O
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5#>7D&GV<]U<RK!;01M+++(<*BJ,EB?0
M&IJJ:O>66FZ3>W>I2PV^G6\#RW,MR0(DB5279R> H4$G/:@#\XO#?[4G[3'[
M;WCCQ&G[/\VA?#WX>Z)=?9U\0:W;)++/W7=YD4OSLHW;$C^0, S<@GG_ (L?
M&;]LG]A671O$OQ#\1>'_ (I> [B[6TE,-O&H5FW-Y;2+!%+&[*K;6/F(" #G
M[IZG3/\ @H/XF\;>(-<\/_LM?L_KXBTBUNMUSK+P?9;::5OE$KQ1A%3<J#!D
MD#E0,J,8'C7[=FI?M:>*OV?;G5?C+I?A#P?X-CU*U4Z)I3))<S3DMY;*P>?
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M?\$]_#W[7WPY\0^)-8\6:GX?GTS5O[.2"QMXY%=?)CDW$MSG+D?A0!^VFO\
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M (/MO$E_8ZREM;33SSQF.,P*Q4"-U'4D\U]P?\.W?V;?^B6Z?_X&W?\ \>H
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M>?(3.(LJ?G?GUZTG_!7G_DS;4?\ L-6'_H;5[5^RC_R9W\*_^Q,T_P#])$H
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M_@I[_P F#^,?^X5_Z76]=G_P3KTF'1?V*_A7;P#"2:=)<GC'S2W$LK?^/.:
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M3?LW_LO>"_V5_"^HZ#X(_M(6&H7(O+C^TKKSV:4($W#@ 9"KG ["ODWXR_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M444 %%<OXV^)GAOX=_8O^$AU+^S_ +9O\C]Q++OV;=WW%.,;EZ^M<Q_PTO\
M#;_H8_\ R1N?_C= 'I]%16MU#?6L-S;31W%O,BR131,&1U(R&4C@@@Y!%2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/_!2SQM^SK^UDWP^\8>$-)L_ ,-["[ZM'!<27DVG2KD7$7[P(Q4G#85N8I%
MST^E/@=^PQ\'_P!G7QH_BKP-H%UINM/:26333:E/<+Y3LK,-KN1U1><=JZKX
M]?LP_#?]I71;?3_'WAR'57M=WV2_C=H;NUSC/ERH0P!P,J<J<#(.* /A7_@I
M_P#MJ?"SXC?L\0^!_ _B>S\6ZMK=[;7,C:?EDM((F\S<[$?*Y8*H3[W+9QC!
MY/1_V6_$DW_!(748KBPE_MM]3_X3JTL=I:06P")G'8FV$DH [,.YKZO^'/\
MP2O_ &?_ (<^)H-<&@:AXDN;>3S8+?7[TW%M&PZ9B555P/20,/:OKK: NT !
M<8QCB@#\I?\ @F3^W!\+O@K^SSKGA+X@>(E\/ZCI6I3ZA:QO;RR?;+>1$.V/
M8IS('5QM/.&4CC./-_\ @F!X5U/XW?MR>(?BF]H\>FZ4VHZS<S.N56YO3+''
M%G^\1-,P]HFK[M^(W_!+?X ?$CQ5<:_-X=OM"N[J8SW,&AWS6]O,QZ_NB&5
M>N(PO->_?![X*>"_@)X-@\+^!="M]"TB-C(R1DO)-(>LDLC$M(QP!EB>  ,
M 4 =Q1110 5R_P 4O^29>+O^P/>?^B7KJ*Y?XI?\DR\7?]@>\_\ 1+T 'PM_
MY)EX1_[ ]G_Z)2NHKE_A;_R3+PC_ -@>S_\ 1*5U% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5R_Q2_Y)EXN_[ ]Y_P"B7KJ*Y?XI?\DR\7?]@>\_]$O0 ?"W_DF7
MA'_L#V?_ *)2NHKE_A;_ ,DR\(_]@>S_ /1*5U% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5R_P 4O^29>+O^P/>?^B7KJ*Y?XI?\DR\7?]@>\_\ 1+T 'PM_Y)EX
M1_[ ]G_Z)2NHKE_A;_R3+PC_ -@>S_\ 1*5U% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5R_Q2_Y)EXN_[ ]Y_P"B7KJ*Y?XI?\DR\7?]@>\_]$O0 ?"W_DF7A'_L
M#V?_ *)2NHKE_A;_ ,DR\(_]@>S_ /1*5U% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5R_P 4O^29>+O^P/>?^B7KJ*Y?XI?\DR\7?]@>\_\ 1+T 'PM_Y)EX1_[
M]G_Z)2NHKE_A;_R3+PC_ -@>S_\ 1*5U% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5R_Q2_Y)EXN_[ ]Y_P"B7KJ*Y?XI?\DR\7?]@>\_]$O0 ?"W_DF7A'_L#V?_
M *)2NHKE_A;_ ,DR\(_]@>S_ /1*5U% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *Y?XI?\DR\7?]@>\_]$O745R_Q2_Y)EXN
M_P"P/>?^B7H /A;_ ,DR\(_]@>S_ /1*5U%<O\+?^29>$?\ L#V?_HE*ZB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(_\ 8'L__1*5U%<O\+?^29>$?^P/9_\ HE*ZB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_P 4O^29>+O^
MP/>?^B7KJ*Y?XI?\DR\7?]@>\_\ 1+T 'PM_Y)EX1_[ ]G_Z)2NHKE_A;_R3
M+PC_ -@>S_\ 1*5U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?"_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME3U?_P!"6@"U_P *!_:Y_P"CJ-/_ /"$T_\ ^(H_X4#^US_T=1I__A":?_\
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MJ^&OA'QU/!/XD\*Z+XAFMU*0R:KIT-RT:DY(4NIP">PK#_X9[^%G_1-/!_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWBOX4_%6UM[#XN^"&1=0>U 6#5K1L>5>Q 8P&!3<  /WB$!=VQ?IF@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE_BE_P DR\7?]@>\_P#1
M+UU%<O\ %+_DF7B[_L#WG_HEZ #X6_\ ),O"/_8'L_\ T2E=17+_  M_Y)EX
M1_[ ]G_Z)2NHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **YSQY\1O"_P +_#\VN>+O$&G>&])BX:[U*Y6%"<9VKN/S,>RC
M)/85^?W[0'_!9OPCX9^U:9\)_#\OBZ_7*+K6KJ]K8*?[RQ<2RCV/E?4T ?I)
M17YQ_P#!._XY_M0?'GXL7WB3QU'++\*[JSE;SKO3$L[99>/)%D0H:3G@G++M
MW;CNVU^CE 'Q7_P4A^._QS^$.D^$]/\ @[X>O+@:R\T=WKFGZ9_:,\,@VB.!
M(]KA2P9CN93G;A<$&OB/0_\ @GQ^U5^U-J<&M_$O5[G1[=SN6Y\9ZF\TZ(>H
MBM4WM'_N,(Q]*_;"B@#\^_A+_P $9OA3X36*X\=:YK'CR\7&^WC?^SK,^VV-
MC+^/FCZ5]A_#/]GSX:_!N)%\%>!]#\.R*NW[59V2"X8=/FF(,C?\"8UZ#10
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MW(W,!R/T;\;?L2_!7XC_ !7'Q&\2^!K+5_$[!/-DN))#;W#(NU7EM]WER,%
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MQ 50!DDT ?(/QTB3PG_P4@_9VUK3ALO?$FD:SHNIK'UFMH83-%N'HLDA;/\
ML#TK[*KXB^ .I3?M>?M?:K\<[:":/X:>![";PWX0N)D*?VE=2%A=7B \A=K.
MG3D-'T97 ^W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3X3TN'3-#TNRT;38>([/3[=((4_W40 #\!6E10 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_Q2_P"29>+O
M^P/>?^B7KJ*Y?XI?\DR\7?\ 8'O/_1+T 'PM_P"29>$?^P/9_P#HE*ZBN7^%
MO_),O"/_ &![/_T2E=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !163X
MI\6:+X'T&[UOQ#JUGHFCV:>9<7VH3K##$OJS,0!7YM?M0_\ !8W3-':[\/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#*TOQ9HFN:E?Z?IVLZ?J%_I[^7>6MK=))+;-_=D122A]B!6K7XF?M/?
MLO\ Q:_8#^+DWQ:^'&L:A=>%9;QYXM;M\O):"23<;:^0Y#H20N]@4?C.UB!7
MZ ?L1_\ !0'PM^U=I$6C:B+?PW\2+:+==:,7Q%=A1\TUJ6.67N4.63G[P&X@
M'UG1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4457U#4+72;&>\O;F&SLX$,D
MUQ<2!(XU R69CP !W- %BD9@BEF(50,DGH*\0\#?MK?!?XE?%7_A7?ACQU8Z
MUXG9'>*.V20V\Y0%G2*?;Y<C!06PC'@$C.#CY2_X*+?!;]I_X\?%;3_"O@19
MY?A9=V4:F.SU%+2V,O\ RV-[EPSX."JX9< ;06W4 >__ !._X*2? /X5^+;7
MP[?^,5U>^>=8+F30X3>06.3@M-*GRX4YRJ%F&/NU1_X*#_"'XM?'GX-Z7HWP
MAUQ+3S;P2:I9)>_9#J-JR851+P"@)W,A(##U*@'YX^#O_!*_X5_ .RL_&/Q]
M\;Z7J<MLRRFPN+I;#1XW&#M=Y2KW'('!V YP485ZM\6?^"M_P,^&\<MGX:EU
M+Q]J$7[M(]&MC#:*1V,TNT;?>-7% 'F/[./_  1J\-^'%M=7^,.LGQ/J P_]
M@:/(\-BAZ[9)N))?^ ^6/]X5^A5M#X7^$_@VWM8_[+\)^%M)@6*)6>.UM+6)
M1P,DA5%?D#XW_P""L7Q\^-.K'0_A;X7M_#<D^1#;Z-8OJ^IL"<8W,A4]N5B!
MR>O3&7H?_!/7]JO]J+4X=9^).JW.DP,=RW7C357FF13U$=LA=D_W6$8^E 'W
MO\7/^"IWP#^%OGV]EXAG\<ZG&"!:^&8//C)[?Z0Q6(CW5F..W3/QA\3/^"R'
MQ1\>WQTCX7^#;#PP;AO+MY9D;5-0<]BB[5C!/]TQO]:^A/A'_P $9?A9X3\F
MY\=:]K'CN\7!>UB/]G63>H*QL93]1*/I7V?\,_@?\/\ X-V/V3P1X.T;PS&1
MM>33[1$EE_WY,;W/NQ)H _'FV_95_;*_;&N([OQK/K=II,SAQ)XTOVL;6(]<
MK9 ;E_X#"!TKZ0^$O_!%#PGI/DW7Q'\<:AX@G!#-I^A0K9V_^ZTC[W<>X$9K
M]+J* /)?A-^R;\(?@?Y+^#/ &C:5>Q?<U&2#[3>C_MXE+2#Z!L5ZU110 444
M4 %%%% !1110 4444 %%%% !1110 445\I_M1_\ !1WX6?LUK>:2EY_PF?C6
M'*C0-'E4B%_2XGY6'W7YGZ?)CF@#ZEO;VWTVSFN[N>*UM8$,DL\SA$C4#)9F
M/  '<U\ ?M2?\%=O!/PS^V:%\*[>'Q[XD0F-M4D++I-NWJ&!#7!![(54YR'/
M2OC76OB%^TY_P4X\43:/I%K/'X1BF'F:?8EK31;$9R#<2G_6N!SABS=2B#I7
MW7^RW_P2C^''P7^QZYXY\KXB^+8\.%NXL:9:OU_=P'_6$?WI<@\$(IH \._8
M$U+]JCX\_M Z=\5/%7B'7(/AVR2_;/[18P:=>Q,A"0VEIPI^?:?,1<#:<L2<
M-^JU-CC6*-410B*,*JC  ]!3J "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KE_BE_R3+Q=_V![S_P!$O745R_Q2
M_P"29>+O^P/>?^B7H /A;_R3+PC_ -@>S_\ 1*5U%<O\+?\ DF7A'_L#V?\
MZ)2NHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGG=G"B4]\!^<M0!^I%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 445G7WB+2M+U33M-O-3L[34=1+BRLY[A$FNB
MB[G$2$Y?:.3M!P.30!HT444 %%%>/?&;]KOX0_L_R"W\<>.-.TO4#C_B6P;[
MJ\ /0M!"&=1_M, />@#V&N=\=?$3PQ\,= FUOQ;K^G>'-)B^]=ZE<K"F?[H+
M'YF/91DGL*\;_:C_ &AG\)_LGZW\0OAKXD\/OJE[IT=UH%]J5Y#%#.K.F]XA
M,RJ\BQ,[+&>2ZA2I/RG\#/B!\4/%?Q<\0/K7CKQ3JGB/43N"S7T[3L@/.U 2
M%1,]EP!Z4 ?T:?!;]H;X=_M$:/J&I_#SQ/;^)+33YQ;77EPRPR0N1D;HY45P
M",X;&UL'!.#C\DOVE/A[^U'\=OB/X@@^*VKP>!/!%KJ$BQ7'B+5H]+\.P1JY
M\LP@M_I!VXPRK)(<C->+?L[_ !B^-'A[2M7\&? /1=3LKC6I8WU*[T.P-]J5
MP$#!!)/L(B1-[D%%CP&.6/)KW_P3_P $I_C_ /'35EU_XK^*X_#CW&#+<:Y?
M/J^ID'G.Q7*_@TJD9Z=< &%\'/B9^S/^Q'XA@\4:1J.M_'3XF6<;I;W=G;?V
M;HUD[*5?RVE!D9MK,OF;7!!) 6M#Q/\ \%,/VF/VD-6ET#X7: VA"3Y1:^%-
M,>_O@C<#?,X?;_OHL>,'FOM3X/\ _!)7X&_#7R+K7K/4/B#JB?,9-;GV6P;U
M6WBVJ1[2%Z^OO"_A'0O!.DQ:7X=T73]!TR+[EGIEJEO"O&.$0 #\J /QT\'_
M /!+/]HCX^:LGB#XI^)H_#SS\R77B+4'U34BIZ8C5F'_  %I5(]/3Z^^$?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<O\
M4O\ DF7B[_L#WG_HEZZBN7^*7_),O%W_ &![S_T2] !\+?\ DF7A'_L#V?\
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MWXL:C\2;+P'IB^,+Z<W3WTH:5(YR<M-%$Q,<<A/)=5#9).>3GV:BB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFLF_B72YWFC6+R(T&YF1?F)5N #P!S0!]:4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HHHH **** (KJZAL;:6XN)8[>WA0R232L%1% R6)/
M'.37P1^U-_P5M\"?"G[9H/PRB@^(/BA,H=0#D:5:MZF1>9R/2,A3_?R,5T__
M  4H_9K^,G[2>B^$-&^&^KV\?AZ.:5=9TBXO3:)*S;3%/(<?O$3:WR<D%@0K
M?PY7[+/_  2A^'GP9^QZ[X^,/Q$\6QXD$=S%C2[5_P#8A;_6D?WI<@\$(IH
M^(?!?[/_ .TI_P %)O%5OXK\7:G=6/A0L3#K6LHT-A!&3RME:KCS.!C*  E?
MGDSS7Z<?LP_L$?"S]EVW@O='TS^W_%P7$OB76$62Y!QSY*XVP+U^X-V#AF:O
MHZ.-(8UCC5410%55&  .@ IU !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%?)/[8'_!17X?\ [,4FI^%H
MI+G7_B']C9H=/L(5DAL9FCW0M=,SJ%4Y5MB[GVD' # UY]^QY_P52\(?&)=
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ML\GC+Q1_P35\?>']&\8^+[_QM^SWXCG-G8:CJ[&XU3PW.JY"-M&Z6#:.BKP
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M9>']/US0]0M]5T?4(5N+6]M9 \4T;#(92.HK3H **** "BBB@ HHHH ****
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M!&N:H/ME]N_O+(^?+/M&$'M7N=% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG),LI XSD[5"KDDXR2:]>H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "OFS]M;]BGPU^UUX(\N3R='\<:;$W]CZ]L^[U/D38Y:%C^*D[E[A
MOI.B@#\1OV3_ -K#QU_P3Y^*^H?"SXIZ??+X-6[V7VFR R2:9(Q_X^[7L\;
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGPIHS7GB-HC%/XBU5Q->R*<;E4X"QJ<=$5<\9S7OM%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_P 4
MO^29>+O^P/>?^B7KJ*Y?XI?\DR\7?]@>\_\ 1+T 'PM_Y)EX1_[ ]G_Z)2NH
MKE_A;_R3+PC_ -@>S_\ 1*5U% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<E\3?BUX.^#/AF;Q#
MXV\16'AO2(\_Z1>R[3(V,[(T&6D?_90%CZ5^8W[2'_!8C6?$=U+X:^!FARV
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MI2WT/4,CWRT !'T/>O?X?C#X/N?A0WQ*AUR";P2NF-JYU9%8I]E5"[/MQNR
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M2(7SCUW*<_CUH N:'^TAH_B#]F%OC7::1J+:0N@SZ[_990?:2(D=GB'8G*,
MW0C#=*_/63_@N-K19O+^$=@JY.T-KKD@=LGR!FOU?L=-L]+TZWT^RM(+2PMX
ME@AM8(PD4<:C:J*H& H   '  KBG_9_^%TDC2-\-O"+.QW%FT*U))]<^70!\
MA_L1?\%,=:_:F^+[>!-9\!6^D-)8S7L6HZ7<O*D7EXR)59>%.<!L_>*C!W9%
MK]O[_@H=XM_9*^(VA>%/#G@RPU-+[31J+ZIK!E\J3,CIY40C*\KL!8EC]\<#
MJ?MG0_"&@^%VF;1M$T[26F $K6-I'"7 S@-M SC)Z^M7;[2[+5%07EG;W83E
M1/$K[<]<9'% 'XVW?_!;#XNOY?V7P7X)A(;Y_.@O),KZ#%PN#[\_2OTU\.?&
MSQ-X@_9-A^*4?@NX_P"$KE\-2:Q%X77=OEN%B9UC7C=M<@$#!;:PZFO6K'1=
M/TR1I+.PM;1V&TM!"J$CTR!5V@#\6;C_ (*T?M*R3R,OA7P[ K,2(UT&Z(7V
M&9B?S-?2_P"P)^V_\<OVC/C!<^'_ !KX.L4\+1Z?+/+JUCID]J+292NP,[NR
MMOR1L^]W'"FOT/HH ^!?^"A7[1G[2/PC^(F@Z-\(_"UY-X;GTX7,FL6.AMJ;
MS7'F.KQ-\KK&%41G&T$[\Y(X'RE'^VO^W/-(L<>@^(7=B%55\"@DD] !]GK]
MIZ* /&/#/BKXKZI^R=#X@O- M[7XPR>&I+E-'F3RT_M#RF,2LA/RECL)0D8)
M*DC''XY_&;PC^U_^TS<64WQ!^'WB_7[C22T-M-)X02RDC4G)57BMXRZ9YZD=
MZ_?.B@#\'?V6_P!J3XG?\$_?B9'X9\=:'KEIX.O2)M2\*ZI;M#+&K\"[MA(!
MM<;>QVR %3R%9/L+]L?6OVCOCMJW@[Q=^S1XCU#6/A=J&DB2.;POJ,5I(+OS
M'$HGWNCDX\L;3]TJP(!SGZR_:M_9,\'?M9> 6T+Q%%]BUBU#/I.O01AKBPE(
MZCD;XVP-T9.& '1@K#\F_A?\5OBW_P $L_CK>>%/%-A+?^%;N427NE+(3:ZC
M!G:MY9N>%? Z\9QL< @;0#JH?V:_^"A=TR,=:\?Q+(02S_$2)0N>Y47N1],?
MA7Z@^'/ /Q-NOV38?"&M>*UMOBK-X;DL'\11R,WDWK1,J2F0#<64E<R 9)!8
M9-=K\(_B[X5^.7@/3?&'@W58M6T6^7*R)P\+@#=%*O5)%S@J?Y$$]E0!^+$O
M_!+O]JK7YG.I>)M/<Q$[)+[Q+/+NR>2N$8CH.N.HKZ7_ & _^"?OQ9_9I^,%
MUXS\9>,M);3+BPEMYM(TB\N+AKN1R-IGWQHH"8# @L<\<<U^B%% 'PO^W9_P
M3EUG]K;XH:-XOTCQS!H8M=-339K#4;=YD0)([B2(JW&?,.5(ZJ#GGCPK3O\
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M'P_J:I%&JA551]FX    ]J^J+[1[#5&0WEE;W93A3/$K[<]<9'%5?^$3T/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N7^*7_),O%W_8'O/_1+UU%<O\4O^29>
M+O\ L#WG_HEZ #X6_P#),O"/_8'L_P#T2E=17+_"W_DF7A'_ + ]G_Z)2NHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*?PSH:ZAXD";9?$>K!9[ULC#;&P!$I_NQA<CKGK7OU% !1110 4444 %%%%
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M_!?XD>'/&_B+Q]>>)=2T.[2_MK&QL!90>>ARA=C([.H8 X&W. #QD$ ]]_;
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MHH 4>P%7J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_8*_:V_:G^)%]<_%+4O[,M(+IQ_:.N:FLUI&-QR+.VA9L+C[H"HISUZU]@?
MC_@DG\'/A6;>_P#%:7/Q*UN/#%M6416"L.ZVJG##VE:0>U?;U% %+1]%T_P[
MIEOINDV%KIFG6Z[(;2SA6&*)?144  >P%7:** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *Y?XI?\DR\7?]@>\_\ 1+UU%<O\4O\ DF7B[_L#WG_HEZ #X6_\
MDR\(_P#8'L__ $2E=17+_"W_ ))EX1_[ ]G_ .B4KJ* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKR[]I#]H;PU^S#\++[QQ
MXH2ZN+2&5+:WL[)0TUU</G9&N2 .%9B2< *3R< @'J-?&W[47_!4#X7?L_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5%<V\=Y;RP3+OBE0HZYQE2,$?E4M% 'XB_M+?LD_$W_@GG\2H
M/BA\+M6OYO!T5QFUUBW&Z6P#,/\ 1KU.CQMPNXC8_ (5B ?T)_8C_P""@'A7
M]J_1HM'U#[/X;^)%K%FZT5I,1W8 ^::U+'++QDH<LG.=P&X_4VK:39:]I=WI
MNI6<&H:?=Q-!<6MU&)(IHV&&1E(PP()!!K\COVU/^"9FO_!O5I?BA\"3J$FD
MV<WVZ;1;"1_M^D,IW"6U8'?)&IYP/G3&?F&2H!^OE%?F[^PI_P %3K#X@_V=
MX#^,5Y!I7BAML%CXF?;%:Z@W0)/C"Q2GCYN$;_9. WZ0YSR.10 M%%% !111
M0 4444 > _%/]O+X$_!7QQ?^$/&7CQ-)\16 C-U9)I=[<^5O174%X877)5E.
M,Y&>:Y/_ (>C?LQ?]%,_\H&J?_(U<K^SYI=EJG_!0S]J@7EG;W82'0"HGB5]
MN;,9QD<5]??\(GH?_0&T_P#\!8_\* /FO_AZ-^S%_P!%,_\ *!JG_P C5J>%
MO^"D/[.?C3Q+I6@:1\1DN-5U2ZCLK2&31]0A62:1@B*7DMU5<L0,L0.>M?0'
M_")Z'_T!M/\ _ 6/_"OB[_@IK-X;\&Z'\#[Z8:=I"6WQ(TN[N)0J1%+>-9C)
M(<#.Q>"3T'% 'W/17P?\7?\ @L1\&O OGVWA"TU;XA:@A(5K6(V5D2.H,TPW
M]>ZQ,#USZ_(7B;_@I-^TW^TMK$OA_P"&&B2:&LGR_8_".FO>7H0GK).P<I_O
MH(\ ?6@#]B?'7Q(\*?#'1VU;Q=XDTOPSIHSBYU6[CMT8CLI<C<?89/-?&'QD
M_P""P_P?\"+/:^"[+5/B'J:9"R6\9LK'<.QFE7>>>ZQL#SSTS\J^!/\ @E/\
M?/CIJZ^(?BOXI3PVUP0TUQK=Z^K:HRDYSL5ROX-*",].M?:7P;_X)0_ OX7^
M1=:SIEY\0-6CPQG\02YMPP_NV\>U"I_NR;_K0!\,Z[^W=^U?^UUJEQHOPSTJ
M_P!&L&;8UOX+L7\R)3T,UZV6C/\ M!HQ[5U?PN_X([_%#XBZD=<^+?C*W\-O
M<-YEQ#%*=5U*0]Q))N$:DC^(/)]*_7?0] TSPOI<&F:-IMII.FVZ[8;.Q@6&
M&-?144  ?05?H ^8?@K_ ,$W_@3\$S!<VOA)/%.L18/]J>)V%[)D=UB($*GN
M"L8/OP*^G(XUBC5$4(BC"JHP /04ZB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ*ZNH;*WEN+B6."")2\DLK
M!511U))X H EHKY0^-G_  4W^!/P:^T6J>)3XUUJ+*_V?X7470#?[4^1".>#
MARP_NUY7^R=_P4_UO]IW]HRV\"Q_#<:7X=OK:>2*]MKI[F>R\I&<2W#;53RV
MVA. ,,ZC+9Y /T#KYO\ VUOVUM$_8U\+:'>7NA77B37->DGCTW3H9A!&PA"&
M5Y)2K;0/-C& I)W=, D?2%<K\0OA5X.^+6EVVF^-/#&E^*+"VG%S#;ZK:I.D
M<@& RA@<'!(]P2#Q0!^.>N?MP?M9?MAZI/HGPXT[4-(T]V*/:^";-T,0/0S7
MK$M&<'[V^->1QTKM/A/_ ,$;_B+X[OO[:^+7C*W\.&X;S;BULW.I:C(QZB24
MD1JW^T&D^E?KGH>@Z9X8TNWTS1].M-)TVW79#9V,"PPQ+Z*B@ #Z"K] 'Y5^
M$?@GX,_X)S_%S59_BC\,E\=?#74+E9="^)36!U";1^@$%W!RB$=1(B!F.2NX
M';']SZ=^VM\ K_15U&#XN^#X[4*"(YM5BAF /0>2Y$GX;>*]HN;:&\MY(+B)
M)X)%*O'(H964]00>HKR>^_9#^!^I:HVH7/PC\%RW;-O=VT*VP[9R2R[,,3WR
M.>] 'S=\5OVH]?\ VQ/MWPF_9OM+V\T[4,V?B+XDW-O);Z=IEJW$J0,P#/*R
MDCH#@_(#G>GUY\'?A5H?P0^&/AWP-X<B,>DZ+:K;1LP&^5N6DE?'&]W+.V.[
M&NDT70].\.:;!IVDZ?:Z7I\"[8K2RA6&*,>BHH  ^@J]0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %<O\ %+_DF7B[_L#WG_HEZZBN7^*7_),O
M%W_8'O/_ $2] !\+?^29>$?^P/9_^B4KJ*Y?X6_\DR\(_P#8'L__ $2E=10
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5R_Q2_Y)EXN_[ ]Y_P"B7KJ*Y?XI?\DR\7?]@>\_]$O0
M ?"W_DF7A'_L#V?_ *)2NHKE_A;_ ,DR\(_]@>S_ /1*5U% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5!>WMOIMG-=W<\5K:P(9)9YG")&H&2S,>
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MW[+G[6?QO^/VMQ^&-=N9?AE=)%_9T<>OK8V-LGEJ&CEMPX=I-^\E]CY!'/\
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MWX?DTNZAO]FF:C)8FR-] RY;$) X1N!(!AMV.J$GW/X?? WX>?"B-5\'>"-
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MR=*L=[F>\D\R>XE=MSR.0 -Q)Z  #@  "O0Z* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!3NP,']%Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQGJTA$=IH_A&1=3N;J0XVHAB)0$D@?,P';KQ7B_P<_8Z;]IKQ]XE^,OQ_P#
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M).&')&"?5Z* "ORT_:P^'_[<GBSX]>*U\#7OB*/P7-<[=&/A[7(-/MUM=HV
MGSHV5QSN+<[LX.,5^I=% 'XKK_P2_P#VJ_BFP;QCXCLH=QRQ\2^)9KQO7_EF
MLV3\J]_3\.\\+_\ !#W7[AD;Q'\5=-L ,%H]+TB2ZSR,@,\D>.,\X/TK];**
M /ST\(?\$5?A-I,D<OB#Q=XJU]TP3% \%G"_J"!&S8^CCZU] > _^">?[/7P
M[DAFT[X9Z7?7,;!Q/K+RZ@Q8=#MG9U'X "OHNB@!%4*H & . !2T44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?M5R,A23G*Q[B<_?4T >.?$#]J3]H_\ X*)>*+CP9X&TB\T[PU*=LF@Z [)
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M/_@J]K?@U/"W@SXS:=<WVCW65B\:S2RM=[))W FG$A(EB5MR%T(VK'P&*D4
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MCT96*GUK$_9Z_P""J7@K]H7XW:3\/-.\':YHYU=919:C>2Q/F6.-Y2LD:$[
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M9/PH\-L\8 634K3[?(N.X>X+MGWSFO9=)T73]!LUM-,L+;3K13D06D*Q(/\
M@*@#L*NT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%(S;5+'. ,\#)H _!#Q-XLO?V1?VP/C9!XOT*?5)=;M-=TN*<X$HCOPS07D9
M. V59<\CY7<=1BOL[]A/PC^SM^T=^SG\+?"WC.+P]XH\?^%K?4(%T:^NGBNX
M4EO)IB!%N7SEV[&SA@N3TR:]#^.OQ _9B_;2\"^.=+LK[2?&WC+POX8U#6+*
M9+6YMKFT6*,D-'.43<HDV$QAB#D97%?F!XW_ &<;OX5_LP_"+X]Z!XDNX+KQ
M#?3VLT,;>3+8744T_DR02*0V"MNQ/=6 Y^8  '[*_MJ>$_BCJWP!A\,_ ][K
M3?$MQ?6MDKZ?<I:M!9!6$G[YR/+4 +RI#=AG.#^0O[9W[%M[^R+X3^&UQK_B
M :[XN\5/J4NIBVR;6W\G[+L2-F >1B9W+.V,\848);]N?V:?'FI_$_\ 9]^'
M?BS6A_Q-]7T*TN[Q@@0/,T2[W"CH&.6 ]"*_/7_@N=_S1/\ [C?_ +84 ??_
M .R=_P FL_!O_L3-&_\ 2&&OR:\:/%\</^"NGV'6HQJ&GQ>,X;!K69=\;0V0
M5?+*]-I\@Y'?<<]37ZR_LG?\FL_!O_L3-&_](8:_)?289/!'_!8*1=098&F\
M?SNI?@;;MG:+\Q.F/K0!]+?\%N/"-C<?"?X>^*3!&-2L];DTQ9MOSF*:!Y"I
M/<!K<'GIDXZFN"^)WQ@U*[_X(Q^"/,N9/M.J74/AF1]W/DVUW/L7/IY=FB_3
MCI7I_P#P6TU2"'X!^!=.9L7-QXF%PB^J1VLZL?SE3\Z\&^)G@>^M_P#@C+\-
M[@Q%#;^(_P"UK@8/$4MS>Q1M^/FQ?G0!]/?\$>?!.F:?^R7?:DUE#)<>(-;N
MS=R21@F:*-4B6-L_>08?CIEV]37QM^P3<'X1_P#!32^\(Z8QATN;4M=\//&A
MX:&(3O&O/4;[:(_A7W!_P2"U2+4/V.;*WCD5WL=;OH)%7JK%DDP??$@/XBOA
MK]D"U7QM_P %6KC4[$>=8+XF\0ZF9/2(K=E&X]6=!^- '[?4444 ?E;^Q1\
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M%XBN/$UU>Z@^I75Y)#Y$0D:-$VQ1;FVJ%C7DDDG)XX PH?\ @FW^SG'XGO\
M7I/AO:W5Y>3M</%<7UT]LC,=S;(?-\L G^';@=!@<5\(Z?\ \%N?B%'G[=\.
M_#-R,C'V>>XAX[CEGYKK=,_X+E7"L%U'X.1R N,R6OB,IM7O\K6IR>O<?UH
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M** "BBB@ HHHH **** "BBL'7?'WACPN'.L^(])T@)G=]NOHH-N!DYW,,<4
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MI@Y!XZY]?6@#\S]<_P""S'QI\3W/V/POX-\+Z<\O$:K:W-[<=/X?WH4]_P"
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M/#*02"#P0:\?_P"&*?@)_P!$A\'_ /@IB_PKVNB@#Q3_ (8I^ G_ $2'P?\
M^"F+_"C_ (8I^ G_ $2'P?\ ^"F+_"O:Z* .)^&_P3\ _!_[>?!'@[1?"K7^
MS[6VDV20&?9NV!RHY W-C/3<?6NVHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1D<&OC7_ (*$?\$]/$OQJ\=6GQ8^%-Y';^.H5@2\TV2<6S7+0X$-Q#,2 DJ
M(N&(!"*001AOT'HH _'>3]B+]K;]KSQWX>3XZ:C+H_A_1PUN-2U"XLI&@BR/
M,$$%LV'D?:OSL!NP"6. *_3SQI^S[X3\:? "[^#\ML]IX3DTB/1X$B(+VT<2
MJ(9%)ZNC(C@GJ5YS7IE% 'XWZ7^QU^VA^RWJ'B/PO\);^;4/"VM2F-[_ $>^
MLHDG!7"R[+E@]M)MP"Z8(Q@.0 :^K/\ @G!^P/J/[+<.J^,O&\]M-X[UBV^Q
M)9VKB2/3K;>'=#(.'D=E0DC@!  3DFON2B@ HHHH _G>^*FJ:=HW[4WQ%O;I
M](TO4_#_ (VUG64.N07,\&JLE\C16#QPHV 3'(<MM4[V#.O%?HGH'_!7/X1?
M$KX5ZW8>*K?4_ _B6ZTRXMC;26SWMJ\KQ,H\N6)2V"2/OHN,]^M?>6I>!O#>
MLW;76H>']+OKEOO37-E%(Y^K%2:XWXI?"_P:?AIXK8^$M"+)I5TZG^S8<JPA
M<@CY>"#WH ^)_&W_  5Z^'GP]^%.BZ-\/M/O/%WBR'3(+437MN]KI]M*L2H6
MD+8DD (SM51N ^^M?)/[']OIB_\ !0KX7W^F^+M-\:3:M<W&IZA=Z1IMQ906
M]W+;W+30+'-%&=J'D,JA<,,8P0/V/^%WPR\'GX9^$V/A/0RS:3:,Q_LV'))A
M4DGY>I-=GI?@GP[H=V+K3=!TS3[H J)K6SCB< ]1N50: -JBBB@ HHHH P=1
M\ ^&-8P;_P .:3>D$L/M%C%)@GJ>5ZUR.H_LQ_!W6-OV[X4>"+O:"%,WAVS<
MKGK@F/C\*],HH \&U+]@_P#9]U7_ %WPE\-)\I3_ $:U\C@_]<RO/OUKDM4_
MX)A_LT:KN+?#6.VDV; ]KJ]_%MZ\[1/M)YZD&OJ:B@#XLU3_ ()$_L\:AO\
M(TO7M,W  ?9=8D;;[CS _P"N:Y#5O^"*_P %[HL]CXI\;V#LP(5KRTEC48Z
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M?VT-!A=M.\1WVYR-T=EXR>-FZX)S(H./KWH _::BOQ6_X8C_ &Y?^@YX@_\
M"Y'_ ,D4?\,D_M]: H73M:\8LLG+BQ^("1@8Z;MUVN>OO0!^U-%?BM_PS3_P
M4,_Z"_Q _P##CP__ "=1_P ,<_MXZU_I-_K?BI;@_*1>>/5DDP.G(NF&/QH
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M;E^RZ!:18;ID;8QS0!^5VK?\%LOBM=,%TCP)X/M"2 !=I=W)/J/EFC]JS/\
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M@;%'88K;HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*U(XUBC5$4(BC"JHP /04 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE_BE_P D
MR\7?]@>\_P#1+UU%<O\ %+_DF7B[_L#WG_HEZ #X6_\ ),O"/_8'L_\ T2E=
M17+_  M_Y)EX1_[ ]G_Z)2NHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N7^*7_),
MO%W_ &![S_T2]=17+_%+_DF7B[_L#WG_ *)>@ ^%O_),O"/_ &![/_T2E=17
M+_"W_DF7A'_L#V?_ *)2NHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\+?^29>$?^P/9_\ HE*ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE_BE_P DR\7?
M]@>\_P#1+UU%<O\ %+_DF7B[_L#WG_HEZ #X6_\ ),O"/_8'L_\ T2E=17+_
M  M_Y)EX1_[ ]G_Z)2NHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ J":^MK>XA@EN(HYYL^7$[@,^.NT=3^%>,_MB?M)
M6W[*OP-U7QN]FNI:EYL=AI=C(2$GNY,E Y'(555W..2$(&"17X]>)/BE^U!\
M</B7\*?'US=S3>)=2DOY/ QMK:U@'[G_ %XABV\C(V@RY+%<9- '[Y45\,_\
M$T_VZ=?_ &H+37O"'CN*W;QIH4"WBZC:PB%;ZV+!&9XQ\JR(Y4': I#C !!S
MPO\ P4L_;=^)_P  ?C+X3\$_#+4X;2>ZTE;V[A.G17<DTLL[QQ(H=&(.(CP.
MN\>U 'Z045^-?_#5_P#P4!_Z$KQA_P"&\?\ ^1J_3GP?\5;WPA^R[HGQ"^*
MN--U.Q\,0:MX@CGM/L\\<XMU>9#"0NU]^5"8'S$#B@#UNBOQSM_VW_VOOVK?
M%GB'4/@II<VE>'='(F;3=+L;.X\B,Y\M99KE"99&"L=B8W8.$XKZ7_X)U?\
M!036_P!HK7-2^'/Q'M(+7QWI\#W5O?P1>0M]&C!98Y(L825-P/RX#+GY5*G<
M ?>M%%% !7+_ !2_Y)EXN_[ ]Y_Z)>NHKE_BE_R3+Q=_V![S_P!$O0 ?"W_D
MF7A'_L#V?_HE*ZBN7^%O_),O"/\ V![/_P!$I744 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]$_\%*?BEIWBK_@GWJ?B#PS?K?:+XHDTP6]U%_'"\Z3?4']WM(ZCD'O7"_\
M!;+4M#C^ _@>PN'A/B*3Q&)[./(\W[,MM,L[#OLW/ #[[?2O-KSP%KNO?\$3
M]/%Q%*T^FS-K%O 5(?[(-4DR3GMY<CR _P!T"@#V3_@B[HT-C^R[X@OU0?:+
M[Q3<[W[E4MK95'X'<?\ @1KX[^&=U_P@G_!7JY73SY,4GCS4[7:HXV7#3HRX
M],2D#Z"OK+_@BMXPL;_]GGQ=X<^TK_:6E^(Y+N6 L,K!-;PB-\=@6AF'_ :^
M3_V?H5^,_P#P5CNM9T;;=Z2OB[5=8%U%AT^S0F9HY<^C$1@'U<4 ?M[1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<O\4O^29>+
MO^P/>?\ HEZZBN7^*7_),O%W_8'O/_1+T 'PM_Y)EX1_[ ]G_P"B4KJ*Y?X6
M_P#),O"/_8'L_P#T2E=10 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<O\ %+_DF7B[
M_L#WG_HEZZBN7^*7_),O%W_8'O/_ $2] !\+?^29>$?^P/9_^B4KJ*Y?X6_\
MDR\(_P#8'L__ $2E=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<O\4O^29>+O^P/
M>?\ HEZZBN7^*7_),O%W_8'O/_1+T 'PM_Y)EX1_[ ]G_P"B4KJ*Y?X6_P#)
M,O"/_8'L_P#T2E=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<O\ %+_DF7B[_L#W
MG_HEZZBN7^*7_),O%W_8'O/_ $2] !\+?^29>$?^P/9_^B4KJ*Y?X6_\DR\(
M_P#8'L__ $2E=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %<O\4O^29>+O^P/>?\
MHEZZBN7^*7_),O%W_8'O/_1+T 'PM_Y)EX1_[ ]G_P"B4KJ*Y?X6_P#),O"/
M_8'L_P#T2E=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %<O\ %+_DF7B[_L#WG_HE
MZZBN7^*7_),O%W_8'O/_ $2] !\+?^29>$?^P/9_^B4KJ*Y?X6_\DR\(_P#8
M'L__ $2E=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<O\4O^29>+O^P/>?\ HEZZ
MBN7^*7_),O%W_8'O/_1+T 'PM_Y)EX1_[ ]G_P"B4KJ*Y?X6_P#),O"/_8'L
M_P#T2E=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<O\ %+_DF7B[_L#WG_HEZZBN
M7^*7_),O%W_8'O/_ $2] !\+?^29>$?^P/9_^B4KJ*Y?X6_\DR\(_P#8'L__
M $2E=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BN7^&OC;_ (6%X/M-=^Q?V?\
M:'E3[/YOF;=DC)G=M&<[<].]=10 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,?\ Y(W/_P ;H_X:7^&W_0Q_^2-S_P#&Z]/HH \P_P"&E_AM_P!#'_Y(W/\
M\;H_X:7^&W_0Q_\ DC<__&Z]/HH \P_X:7^&W_0Q_P#DC<__ !NC_AI?X;?]
M#'_Y(W/_ ,;KT^B@#S#_ (:7^&W_ $,?_DC<_P#QNC_AI?X;?]#'_P"2-S_\
M;KT^B@#S#_AI?X;?]#'_ .2-S_\ &Z/^&E_AM_T,?_DC<_\ QNO3Z* /,/\
MAI?X;?\ 0Q_^2-S_ /&Z/^&E_AM_T,?_ )(W/_QNO3Z* /,/^&E_AM_T,?\
MY(W/_P ;H_X:7^&W_0Q_^2-S_P#&Z]/HH \P_P"&E_AM_P!#'_Y(W/\ \;H_
MX:7^&W_0Q_\ DC<__&Z]/HH \P_X:7^&W_0Q_P#DC<__ !NC_AI?X;?]#'_Y
M(W/_ ,;KT^B@#S#_ (:7^&W_ $,?_DC<_P#QNC_AI?X;?]#'_P"2-S_\;KT^
MB@#S#_AI?X;?]#'_ .2-S_\ &Z/^&E_AM_T,?_DC<_\ QNO3Z* /,/\ AI?X
M;?\ 0Q_^2-S_ /&Z/^&E_AM_T,?_ )(W/_QNO3Z* /,/^&E_AM_T,?\ Y(W/
M_P ;H_X:7^&W_0Q_^2-S_P#&Z]/HH \P_P"&E_AM_P!#'_Y(W/\ \;H_X:7^
M&W_0Q_\ DC<__&Z]/HH \P_X:7^&W_0Q_P#DC<__ !NC_AI?X;?]#'_Y(W/_
M ,;KT^B@#S#_ (:7^&W_ $,?_DC<_P#QNC_AI?X;?]#'_P"2-S_\;KT^B@#S
M#_AI?X;?]#'_ .2-S_\ &Z/^&E_AM_T,?_DC<_\ QNO3Z* /,/\ AI?X;?\
M0Q_^2-S_ /&Z/^&E_AM_T,?_ )(W/_QNO3Z* /,/^&E_AM_T,?\ Y(W/_P ;
MH_X:7^&W_0Q_^2-S_P#&Z]/HH \P_P"&E_AM_P!#'_Y(W/\ \;KA/"WQR\$Z
M;\5O'&L7&M^7INI1V*VLWV2<^88XBK_*$R,$]P,]J^BJ* /,/^&E_AM_T,?_
M )(W/_QNC_AI?X;?]#'_ .2-S_\ &Z]/HH \P_X:7^&W_0Q_^2-S_P#&Z/\
MAI?X;?\ 0Q_^2-S_ /&Z]/HH \P_X:7^&W_0Q_\ DC<__&Z/^&E_AM_T,?\
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MC_AI?X;?]#'_ .2-S_\ &Z]/HH \P_X:7^&W_0Q_^2-S_P#&Z/\ AI?X;?\
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MA_PTO\-O^AC_ /)&Y_\ C='_  TO\-O^AC_\D;G_ .-UZ?10!YA_PTO\-O\
MH8__ "1N?_C='_#2_P -O^AC_P#)&Y_^-UZ?10!YA_PTO\-O^AC_ /)&Y_\
MC='_  TO\-O^AC_\D;G_ .-UZ?10!YA_PTO\-O\ H8__ "1N?_C='_#2_P -
MO^AC_P#)&Y_^-UZ?10!YA_PTO\-O^AC_ /)&Y_\ C='_  TO\-O^AC_\D;G_
M .-UZ?10!YA_PTO\-O\ H8__ "1N?_C='_#2_P -O^AC_P#)&Y_^-UZ?10!Y
MA_PTO\-O^AC_ /)&Y_\ C='_  TO\-O^AC_\D;G_ .-UZ?10!YA_PTO\-O\
MH8__ "1N?_C='_#2_P -O^AC_P#)&Y_^-UZ?10!YA_PTO\-O^AC_ /)&Y_\
MC='_  TO\-O^AC_\D;G_ .-UZ?10!YA_PTO\-O\ H8__ "1N?_C='_#2_P -
MO^AC_P#)&Y_^-UZ?10!YA_PTO\-O^AC_ /)&Y_\ C='_  TO\-O^AC_\D;G_
M .-UZ?10!YA_PTO\-O\ H8__ "1N?_C='_#2_P -O^AC_P#)&Y_^-UZ?10!Y
MA_PTO\-O^AC_ /)&Y_\ C='_  TO\-O^AC_\D;G_ .-UZ?10!YA_PTO\-O\
MH8__ "1N?_C='_#2_P -O^AC_P#)&Y_^-UZ?10!YA_PTO\-O^AC_ /)&Y_\
MC='_  TO\-O^AC_\D;G_ .-UZ?10!YA_PTO\-O\ H8__ "1N?_C='_#2_P -
MO^AC_P#)&Y_^-UZ?10!YA_PTO\-O^AC_ /)&Y_\ C='_  TO\-O^AC_\D;G_
M .-UZ?10!YA_PTO\-O\ H8__ "1N?_C='_#2_P -O^AC_P#)&Y_^-UZ?10!Y
MA_PTO\-O^AC_ /)&Y_\ C='_  TO\-O^AC_\D;G_ .-UZ?10!\Z_!'XY>"?"
M'PWT[2]7UO[)?PRSL\7V2=\!IG9>50CD$'K7=_\ #2_PV_Z&/_R1N?\ XW7I
M]% 'F'_#2_PV_P"AC_\ )&Y_^-T?\-+_  V_Z&/_ ,D;G_XW7I]% 'F'_#2_
MPV_Z&/\ \D;G_P"-T?\ #2_PV_Z&/_R1N?\ XW7I]% 'F'_#2_PV_P"AC_\
M)&Y_^-T?\-+_  V_Z&/_ ,D;G_XW7I]% 'F'_#2_PV_Z&/\ \D;G_P"-T?\
M#2_PV_Z&/_R1N?\ XW7I]% 'F'_#2_PV_P"AC_\ )&Y_^-T?\-+_  V_Z&/_
M ,D;G_XW7I]% 'F'_#2_PV_Z&/\ \D;G_P"-T?\ #2_PV_Z&/_R1N?\ XW7I
M]% 'F'_#2_PV_P"AC_\ )&Y_^-T?\-+_  V_Z&/_ ,D;G_XW7I]% 'F'_#2_
MPV_Z&/\ \D;G_P"-T?\ #2_PV_Z&/_R1N?\ XW7I]% 'F'_#2_PV_P"AC_\
M)&Y_^-T?\-+_  V_Z&/_ ,D;G_XW7I]% 'F'_#2_PV_Z&/\ \D;G_P"-T?\
M#2_PV_Z&/_R1N?\ XW7I]% 'F'_#2_PV_P"AC_\ )&Y_^-T?\-+_  V_Z&/_
M ,D;G_XW7I]% 'F'_#2_PV_Z&/\ \D;G_P"-T?\ #2_PV_Z&/_R1N?\ XW7I
M]% 'F'_#2_PV_P"AC_\ )&Y_^-T?\-+_  V_Z&/_ ,D;G_XW7I]% 'F'_#2_
MPV_Z&/\ \D;G_P"-T?\ #2_PV_Z&/_R1N?\ XW7I]% 'F'_#2_PV_P"AC_\
M)&Y_^-T?\-+_  V_Z&/_ ,D;G_XW7I]% 'F'_#2_PV_Z&/\ \D;G_P"-T?\
M#2_PV_Z&/_R1N?\ XW7I]% 'F'_#2_PV_P"AC_\ )&Y_^-T?\-+_  V_Z&/_
M ,D;G_XW7I]% 'F'_#2_PV_Z&/\ \D;G_P"-T?\ #2_PV_Z&/_R1N?\ XW7I
M]% 'F'_#2_PV_P"AC_\ )&Y_^-T?\-+_  V_Z&/_ ,D;G_XW7I]% 'F'_#2_
MPV_Z&/\ \D;G_P"-T?\ #2_PV_Z&/_R1N?\ XW7I]% 'F'_#2_PV_P"AC_\
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M#R"",$&NCHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-1!F*1%5?+(0,,<98GO0!Z]1110 4444 %%%% !1110 4444 %%%% !1110
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MN6_8'^ =M<?\$]M-\*:E<7VCCQS97MW?W6FNL=RL5V6C5HV96 8VZQ<E3UH
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M=QC[XKY_N9_%/A7_ ((RVJ.UQ%9ZQXE*(/F0I8-<LV/=6FB)]"'H ]I^(?\
MP6T\':#XBN++PA\.]1\5Z7#*474KS4UTX3*/XTC\F1L'MNVG'4#I7U;^R?\
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M?2*VX-/%;HDA![_,IYKM: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#T% '[!4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'R]^UQ_P4$^'_[)=W;Z+J-O=^)O&%Q$+A=#TY@G
MDQ'.UYI6^5 <'  9N^W!!KQ#X)_\%F/ OQ \8VNA^-?!]U\/K:\E6&#5O[26
M^M8V/ ,Y\J(QKG W ,!G)P,D?+_PYTJS^+7_  5]U:R\=VT>I6O_  EFL*+/
M4 )8Y!:0W'V2-@V05400X!X(4#O7LG_!:;X5>$=%\)^ /&.G:79:7XDFU"73
M9I+2%8FNK?RBX+A1\WELH /;S"/3 !^I4<B31K)&RNC ,K*<@@]"#7R7\/\
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MJMC<9FGV-NR3DDG(S0![5\ ?V@O!O[2WP]M_&'@F^DN=/>0P3V]S'Y=Q:3@
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M4YW;V&#Q7Q]_P0]TO5O^$@^*VHKYB:%]EL+>3*G9)<;YF3!Z$JF_(_Z:#UH
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M<$I41D"YG8J%)R$)% 'Z-Z-I-KH&CV.EV,0@LK*".V@B'1(T4*H_  5\K?\
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M- BC\@*V*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU#5-$\>ZK>S)97VH1)#+ D?D2VS$0A?D\Q&!QR06% 'SOX3_ ."?O[6O[/\
MJNL>&_A-\4--LO!VJS,S7BWS6XP5VB5X6B<Q2[0 6B+'Y5^;@8^8_@9\)7\%
M_P#!2#PCX%M-5;Q%/H'C"*.XU+:4,\EJWF7#XR2 &BDX))XY)KTKX7V'[:W[
M&]GK_@'PGX!UBYL=3NFF^T6NCG5;>.=D53<0SQ[D4E47[_''*Y%?37_!.']@
MCQ=\*?&]]\8/BROD^,;J.9=/TR299YX&FSYUS.ZDCS64LH4$X#ONY.  <O\
M'93^T#_P5T^'?@_'G:5X'@M;FY7[T8>%&OV)_P!YG@C/T K]/J_.O_@G]\+/
M&FM?M>?'7XQ>-_"6O>&!J$LMOI*Z_IDUFTT5Q=&3]T)5!81QV\2DCH' [U^B
ME 'YJ_\ !;S_ ))9\-/^PS<?^B!7U5^P'_R9M\)_^P,G_H;UX;_P5J^"/COX
MW?#OP%8^!?#%]XFN['59YKF&Q4$Q(80 QR1P3Q7T5^QEX0UGP#^RW\-_#WB'
M3IM)UK3]*6&ZLK@ 20N&8[6QWY% 'Y@>)]8US_@HQ_P4 E^'OB7Q#?Z5X TW
M4KZ"TTVVDVB"UM!("R(05\^79R[ E=Y'(4+6K^WQ^Q[I'[#-OX*^)WP?\2Z]
MX?N9-1_LZ1&OB9HI3$\BR12*%;:5C=75L@Y'8D5U_P"U1^Q/\9?@?^TS<?'#
MX#6=SK<5YJ$FK&WL522ZL;F8M]HB,!_UL#[VQM!(#E2!M#'A?B%\/?VPO^"@
MWB7PYI'C;P7+X,T+369E?4--ETJPMV.%>=UE+2RN0, +NZG:%#,: /T__9(^
M+NH?'C]G#P)XZU>*.'5M5L3]L$2[4::*1X9'5>P9HRP';=BO7JX[X._"_3/@
MM\+O#'@;1GDET[0K&.SCFFQOE(&6D;'&68LQQQEJ[&@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[ $CXZ_8._89\3?M&>.H_CM\;'NK[1[FZ&I6=KJ7,VN39RLTH/W;8$#"X <
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M_L7_  A\;^.O$5E_:_Q+U#2Y95TC3$-T]O#"C2):1[,F661PNX)D$A%7.,D
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M /E4XSDFYXR_8]_:"_8<^/U]X[^!6DW7BGPW,TJ6GV"$7<GV61@QL[JV!WL
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#\%I/!_C'QA;:1XX\#W/@C3;J411ZQ;ZD+^&#<< SKY4;*@XRR[O\ = H
M_2"OCC]LC_@HYIW[(/Q.TSP=>>!KKQ-+?:/%JXNX-26W"!YYXMFTQMDCR"<Y
M_BZ<52_9?_X*7:5^TU\;C\.[+P-<Z*_D7-PNIOJB7",L/HHC7[WKFO//^"C'
MQ^^#7PK^-VB:3\1/@?:_$O6IO#T%U#JTU_Y!BMS<W*K!MV'(#)(V<_\ +3VH
M ^_O!?B1?&/@[0M?2 VJ:K807P@9MQC$L:OM)P,XW8SCM6S7(>#_ !1HMI\)
M=#\1%(/#OAV/1(+_ ,N:4"*QM1 KX9S@;43J?1:^#_BQ_P %J/!'A?7[S3O
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M4>F<XK\0_P#@I[X$UKX0_MLOX]OM-75-#UZ6RUC3_MJ[[>Y-O'#'-;/Z@-$
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MH<D^B22L224A?]R.?2%XE_X#0!]74444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M17SU^U)\?/$W@G5_"WPT^&&GVNK?%?QD9/L'VWFUTJTC_P!=?7&.=J\[1CYB
MK<-MVL ?0M%?)>F_\$\M \56_P!O^+GC[QI\4/$\^'GN[G69K&TB?NMM;0,J
MQ)R?ER>IZ9Q6+XQ^!/Q*_9)L)_&WP5\7:]XT\-Z:IN-6^&WBR^:^CGMER9#8
M3,-\4BKR%YW$=6X1@#[.HKD/A'\4M#^-7PU\/>-_#<S3:-K5JMS#Y@ >,Y(>
M-P"0'1PR, 3RIKKZ "BBB@ HHHH ***K:DES)IUTMFZQWC1,(7D^ZKX.TGVS
MB@#XO_:@_P""J?PZ_9[\57WA/1M(NO'_ (HT^3RKV&SN5MK.VD'6)K@JY+CH
M0B, 002&!%>!Z!_P7&/VH+K?PB MF(S+I^O9=!W^1[?#'_@0KXI_91\1?#KP
M;^TQ9WWQZTN34] AEN4ODOH&N4AO<D"2XA +2J'W;EPW)!(.,5^N?BKX/_LS
M?M@?"O6M \"I\/[G5;JSD:PO_#\5M#>V%QM/ER,L0$J@-M+(P&1P10![%^SI
M^TUX$_:C\%R>(O ^H2SQVTBPWVGWD7E75E*5W!)$R1R.C*64X."2#CTS5-4L
M]#TN\U+4;J&QT^SA>XN+JX<)'#&BEG=F/ 4 $DGH!7P=^P-_P3[^(?[(WQ7U
M;Q)K7B[0M5T74M*?3Y]/TTSEG?S$>.0[T4978P[\.U?77[0G@*]^*7P*^('A
M#39#%J6MZ'>6-JV\*#,\+*@8GHI8@'V)H ^#_B9_P6LT+2_$UUIOP_\ AS=^
M*M/A8JFJZCJ'V/S]N=S) L3MM(&0693CJHZ#VW]C_P#X*6>"OVJO$Q\)W.BW
M'@CQC)&\UKI]S=K=07B*,L(I@J$R!<L4*#@$@G!Q^<?_  3S_:;T#]C3XQ^,
M+;XC:)<VMO?6K6%S<QVN^]TZYMV<^5LZX=LHPR/F"$\ D=)^RS9:U^UA_P %
M&$^)?A#PRWAOPU9ZV-<O_LZ@0V5NJX5'8 *99BN"HZL[GH&( /V\K\Z/BG_P
M6,T?X8_$[Q?X.E^%]]J$OA[6+S2&NTUE(Q.8)WB+A?).T-LSC)QGK7Z+U_/G
MKFBV'B7_ (*9ZAI&JV<.H:7J'Q>DM+NSN$#QSPR:R5>-U/!5E)!'<&@#[.7_
M (+BZ%N&?A)J '?&N1__ !BOJ#]E/_@H/\-?VKM2ET+25O/#?BV.-IAHNK[
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MOVJ/A#;^/+70I?#L4UY/:?89KD3L#&0-V\*O7/3%>&_M;?\ !3#3/V4OBT?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M *!DD@"O2_V3O^36?@W_ -B9HW_I##0!^5?_  TM_P %#/\ H$?$#_PW$/\
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M<RHI8@9AZ\5QG_!(?_D\G3?^P-?_ /H"U^VGQ"_Y$'Q-_P!@RY_]%-7XE_\
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M9U]E?\$WO^3)?A;_ ->5Q_Z5SU\:_P#!<K_D*_!O_KCJW_H5G7V5_P $WO\
MDR7X6_\ 7E<?^E<] 'X__P#!.KX5Z'\8/VN/!6A>);"+5="B^TW]S8SJ&CG\
MF!WC5P>"OF!,J>" 0>#7Z2_\%:/A'X2E_9-N_$,.@Z?9:OX?O[/[#=6MLD4D
M<<DJPO%E0/D(?.WIE5..*^$?^"2?_)Z7A_\ [!FH?^B#7Z/?\%8/^3)?%_\
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MR:G;W%L/]7+Y[6\NYF7#, WRDD8&*\H_X:6_X*&?] CX@?\ AN(?_D&OTO\
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M^$^H_ O]JBP\!ZM>6M_J.B>(;&WFN;+=Y,C&2)\KN .,,.HK]1O^"SGQ!O\
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MN_M8?M0>,/\ @H-\8O#6C^'/#=S!86[M9>'_  ] PFGDDE8;YI6  W,$3/\
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MQ _M*PFM=0FO[&\L[0W$<\<BJ3$0O*N'4X)^4[QR,5\E_MJ_&N\_:)^.M_\
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M!\5OJ5S)=W>E^%=>TKSI3EC'$DPA7/HL1C0>RBODO_@HS^W'HW[7EYX3\(^
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M_%'PG?>&/%>DV^N:!?>7]IL+H$QR[)%D3.".CHK?4"N?^%'P!^'GP-_M3_A
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MH[ZT1A(JN,,!ECU'%>M444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY? GA6Q\--KMR+N_%DI"R.%PJJ"2$0?,1&N%!9B ,FL'_AD+X-?\)]_PF_\
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M $EDKV"LWQ)X;TSQAX>U+0M:LX]1TC4K>2TN[2892:%U*NC>Q!(_&@#\?/\
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MTKPT;@8FGM(<SR@= \K9=@,="V*]"HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/^+;W1K2^\6^+XY=0U'4[R(33/$\CB*,,P)">6%)'=F8G.:\I\;:+IG['?\
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M5O#OB+X>^,[DLEM8>(;=42:0 D1!@=RN5!(#JH/0$G /H?Q;_:Y\._!?XZ>
MOAKXAT75(Y/&92/3M=C\K[$LK2&+RG)<,&#&/.%(Q*G/7 ![M129QR>!7S_\
M"?VT/!OQZ@^(NJ:;9WNB^%?!-PT%WXDU9XH[*X5?,+21L')VA(PY+8P)$]:
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M? /]JOX8_M,6-W/X!\21ZG<V8#7>G3Q/;W< / 9HG )7/&Y<KGC.:^9?V#?
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MM(Y!=<8+S$CYW.22QYR:^,/^">6K'X-_M9_'?]GZQO);CPIIL\NLZ/!-)O\
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M/!WBOQWXEU.S^W3^']#M%FFTV+<0!<.A8!R &VJ&P"-Q7(SWW[+_ .W[\/\
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M?01W5M=0MN2:)U#(ZGN"I!!]ZN4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=?"?*S^=#+<F)_=1%:QD=_*/:O._A=\(?%?BC]I'PS^R=KR/=>#_  1XSO\
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M_P!J3]B/P^OPNUGX':A\7?#VFS-%HNL>'[B7:L3,7P94AE_=Y)P)$1ER03@
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M.TK;_P""S7C"\T/]F70M#M))(DU[Q%!#=%6VH\,44LNQCT_UBQ-S_<]JR_\
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M-=2LTLH4]U5G*@\9"@UV_P#P3+_Y,<^&'_7&^_\ 2^YH ^G^G X%?+W_  4
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MB@DO((CDQZ99(JN"!VVNS#WA[8K[G15C5550JJ,!5& !Z4 9?BS_ )%76?\
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MX:_M'?M4>%--79INC:U;V-HI?>5@CN;]8P3W(0+GWS76Z3_P5Z^&FI>#8O\
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M=UM([[QCK.O-:2WTGS/&I07$H7/*AWF&>>?+4=JO_P#!$O\ Y(%XZ_[&8_\
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M^"5OQ(\;^$_%O@_7O$?P5UZ^;5-&U_1(1<-:8&P>9DJN[8(D<,RD>4&4,&Y
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MD&D_\%(OV8M4M(8[>_O)H;>XN$4!I8Q=%0&/?"R./H:E_P""+O\ R2SXG_\
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M'@_+TH Y7_@EO++\._CA^TC\)+2XFF\-^']>=]-A9RZ0^7<SV[G/]YT2#/\
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M\/\ PRO_ ,%!OBK\%I/]%\,^,XO^$@\/1GA PW2B.,>@C:XC)[_9A3OV=?\
ME,#\?/\ L66_]#TJMW_@J-X;U+X=W'PM_:(\-6JS:UX"UF*&^7D":SD<,BR$
M<[/,#1\?\_1H P[@']J[_@JA'$?]*\&_!NRW'O&VH*P/X.+AQ^%G6?\ !;5/
M[#_X*Q?M':B$\TV?@^>XV?WMG]EMC]*]2_X)5?"N[\+? &_^(&NJTGBCXB:E
M+K5U<2#]X\ 9EAS_ +Q,LH]IJ\Y_9]@CNO\ @KU^T!#,@DBD\+NCHW1E+:4"
M#^% "?\ !&OPY;^(O _Q-^*6JA;_ ,8:WXDDLKK49OFF*+%%</@GD;Y+EBW]
MXJN?NBF_\%K/ASI.H?!7P?XX%K$NOZ;KB:7]J&%=[6:&9V0GJV)(4(';<^.I
MKBO@K\1[K_@EC\5/&WP\^).AZK-\+/$&H?VCX?\ $^GV_G(#@J W/S$QK&KJ
M#N1H\A65]U>=?\%)/VO$_:H^&NDQ^ =!U0_"_0M9C-[XEU&W\B.[U)X9A!#"
MI^;"Q^>3GG+#(7"E@#Z>_P""N_CK4/"O[(.B:5I]Q+;KXAUFTL;SRS@26ZP2
MS%"?0O%%QW -<W\'_P!NQ_@Y\,_#G@W0?V8?B5;:;I%E';+Y.F.HE8*-\I_=
M\L[;F)/)+&O?_P!NS]G'4/VG/V7)_#FA[7\2::\&LZ5 S*JW$\4;J82S8 +Q
MRR*"2 &*Y(&:\0^"O_!4_P '^!_ MIX2^-FE>(/!_P 0_#MNMA?P2:8[B[>-
M0H< 89'8#)5@!GH2#0!YA\"?&GB/Q-_P4GT?X@^'OA+XR^'/A7Q3:36/B"WU
M#2YHH))C!(?-=@@0!I8[=B3C+!CU)ST7PC\":7XT_P""R7Q3N]4M(KL^'].;
M5[19EW!)Q#8P*X'0E1<,1GH0".0#7J_[*GQZ^-7[57[06K^-[6"^\'_L\VD!
MCT_3=3L(!+JDFTJCK*8RY.XF1C&^Q<*F6.2>+_9U_P"4P/Q\_P"Q9;_T/2J
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK+AR#M2+"X+;CU_QT_X)H)\-;71?&_[+QU+PM\1-'O(F%F=78PWD)(#DM.Y
M((#%2VQUWJ5.0* /T-K"U3QWX:T.\^QZEXATK3[OC_1[J]BBDYZ?*S U\^?M
M=>#?CQ\6/@!X>\.?#R2R\->*=6, \3S1:CY+6T?E?OH8) ,E3(<%@02JX_B-
M>9ZA_P $N?V8O!/@=+7Q7<W5I?B#$WB;4?$#6DS.%.Z4*S"%>><%"!@9SSD
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M;S>1/$6RWS0_:%;)S\HR2,!0#]B]*8MI=F2<DPH23_NBO@;_ (+,>)-7\,_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4,YY.,C 5B< $U[?\!_'7PF^!W[&UCXZ\.Z=J_@WX806D^KV]GKS[[P+)(Q
M ,KY:5R-BASGS%]:\\\.?\$IOAPOB*PU7QSXQ\:?$R+3S_HFF^(M3#6JJ#PK
M!5#D<+P&53CD$<5[1^TE^R3X6_:@\+:#X8\1:YXAT+PWI$PG32?#D]O;6\[*
MH6/S \+DA%W!0I4#<>^" #\Q-0^'?QH^/UCXK_;5TM(])U;2-8AU+0M%6WWM
M-I]IE7D'3>L2HBG(_>!)SQA0?KOX^_$^S_;B_P"":?B[Q+X.@=]52V@NK_1X
M6WR6EQ:W$,US"PZL!&K.O=E*'&3BOMSP[X9TOPGX;T[0-(L8;#1M/MDL[6SB
M7$<4**%5 /0  5XM\!_V+_!7[-_Q \5^)?!.K>(+.R\2%FN_#,UQ ^E1DN60
MQ1B$.NS<RKF0X5B#GC !\B?L4?L3_LR?M*?L_P#AOQ++H=Q?>)H8%M->ABUJ
MY1XKQ/E9FC63"!\;UP,8;CI@:.O? C]D'X*_M1> _AK8>#/$VK?$.]N[>[M3
MHVJRSQ:;*) \37.^X4I@(9" K$( 2,$9];\<?\$M/AGK'C"^\3>"?$7BOX5Z
MC>G,]OX3OU@M,'[X6,IN0'/W5<(.R@<5Z+^S7^PM\,_V8]6N]>T*+4M?\77B
M,D_B+Q!<"XN]K'+JFU55 3U(7<1P6- '%?%'QA\ _P!J']H34?V>_B+X,N+G
MQ7HEJUS:7^J*EJLA9(I-EG<13>:2T<@D*X4$1'(.VOE;]KC]AO2?V(? ]Q\9
M/A#\2_$'A/5=-O+>./2[NY1FN3)*J^7$ZA"P4$N8Y X94?-?</[37[#OPW_:
MDOM/UCQ"NI:'XJTY!':^(=!N!!=*JMN5&W*RN W(R-PR=K#)KR[PO_P2M^'D
M?BBPUKQWXQ\9?%$:>^;33O$NHB2U50<A74+N8<+\H8*<<J0<4 ?2_P  ?&NI
M_$CX'> /%6M6YM=7UG0K*_NX]FP>;)"C.0O9222!Z$5WU1V]O%:P1P01I##&
MH1(XU"JJ@8  '0 =JDH _-K]C'4+;X)_\%$OVAOA_P"('73+WQ5>2:II'VL@
M?:E^T27$:(Q^\S171; Z^6W=<5]=?M<?M0:-^R;\)9_&.I6::S?/<Q6FGZ+]
MK%M)>R,XWA7VM@)'O<G:?N@<9!JG^TI^Q=\-OVI3I]YXIM+W3/$6G[5M/$6A
MS+;W\2*Q81[V5E9 Q+ ,IVDDJ5R<^8?#O_@E_P##CPOXVTWQ5XN\2^*_BAJ.
MEL&L+?Q5?B:U@*L#&2@4%]NU?E9BAQRO3 !Y9_P4!_:@\>MX ^!7AOP]>7/P
MKF^* 2XU34#.1/IL+?9P(?/7:5V_:=TA7:<(!D G/=:%_P $J_V?O FFRZ[X
MZN-8\726L)N=0U3Q'K#V\)VC+2/Y1CVJ,=&8X Y)KZ'_ &COV8O G[4W@N+P
MYXXL9I([64SV6H6,OE7=E(5VEHW((Y'56#*< D$J"/ _#_\ P2S\$1):V7BW
MXC?$3QSX=M'C,/AS5-;*:>5085'C10<#C&QDQ0!X?_P21U3P_J'[0?[1,OA6
MV6T\,W5U'<:3;QJ52*S^UW)A0 \@!&0 'TK._8G\%W7Q&\-?MS>%[%&EO]8F
MN+&UC5L%II!J2QC/NQ6OMWX/_L9> ?@3\8O$WQ"\&2ZII,VOV@L[CP_$\"Z5
M"@,9!BB6(.I!CR/G(^=^.1C0_9]_91\)?LVZ_P"/=7\,ZCK5]<^,[Y=0U!=6
MGAD2*17F8"$1Q(57,[_>+'A>>N0#P+_@D+\1-,US]F#_ (0WSTA\0^%=4NX+
MS3I,).D<LIF20IUVDNZ9/>-AVKU?XZ?MEV'PA^/7PW^$VE^'3XO\2>+;A8[F
M.VU 0MI43NBQRR+Y;[@097(RN%B)YR*YSXR_\$W/AM\4?'UWXYT35O$7PU\7
MW1:2YO\ PC>+;)<2LVYI9$*GYR>249-QY.3S72_LW_L(_#C]FOQ%>>*--DU;
MQ3XSNU:.3Q%XDNA<7*(P 98]JJJYQRV"^"1NP<4 ?,_QIUBT\ _\%C/A3JVL
MW"Z?IFI:$+5+FX&U&DE@O;>) WJ9C&OU:OJC]N[XA:-\._V2OB?<:O>0VIU3
M0KS1K..1P'GN+F%H41%SECE]Q Z*K'H#5S]I[]CKX=?M9:3IUMXTMKVWO]-W
MBRU;2IUANH%;&Y,LK*RD@'#*<8XQDUXYX _X)3_"WPO=7=YXAU[Q/X[O6LIK
M"QDUR[C=-.21&0/"FS'F(K?*6W*& 8*"!@ I?\$X?^4<UM_UQUK_ -'3U\X_
MLC?&C6_@#_P2O^)WC/PVJC7;;Q3+;6<[Q^8EN\Z6$/G$'CY1(2,Y&X*""#BO
MT:^"G[.?AOX#_!5/ACH%]JMYH"+=(+C4I8GNL3L[/\R1HO!<X^7TSFN:^#O[
M%OP[^#GP.\0?"6!=2\3^#M>N9KF^@\031R2N98XT90T4<>T 1(RD#<K<AL@8
M /E']F7_ ()X^"?VB_A3X7^*GQ:\9^)OB/XA\26POY!)JK"W@#$YAW<R%E(V
MM\X *X"C%>70^&_A7\./^"KGPK\*_"?3[73]"T.$:??QV5Q)<*;\Q7;2%I)'
M8LP62)&^8X*$=017TOI7_!*/P;X=GNK/0_BM\3=!\*W,CR2:#IFM)#$=PP5R
M(\$8X^922  3WKN['_@F[\'O#OBSX=^(O"]OJWA'4O!-P+JVDTFYBSJ$GF*Y
M-XTL4CRYVE>&7Y791@;< 'AO[8TT>G?\%./V:;NXD6*!X(H [$ ;S<SJ!^)=
M1^-9O_!8[P9%)=?!3QMK&G7.I>#M*U6>QUR.!F'[F5[>0("I!4ND,Z[@1R%Y
M!Q7U;^U=^Q;X"_:\TS2(_%<FH:9JFDL_V+5M)E1)D1\;XV#JRLA(!Y&01P1D
M@[?P_P#V6/!?@O\ 9]A^#FI+=^-?!X699D\1,DLLWFSM.Q+(J8(D<LI&&4@$
M-D9H \,\+_\ !,G]E;QKX;T_Q!H6@W&J:+J$"W-K>VVOW31RQD9# ^9_^K!!
MKCOV1?!?[,NI_'#XB^'O@OX:\16^OZ'I=UIEYXFDOFN=*FBE81D1,9V+Y925
M)0 B-B#BMN;_ ()'^ ;47.G:)\2_B+H/A:\9FNM!M=5B\AP3RHS%C&,CYPY]
M2:^H?@+^SOX%_9K\&?\ "->!-(_LZSDD\ZZN)I#+<W<N,>9+(>6..@&%'8"@
M#XN_X(\^);?P7X<^)WP>UR1-.\:Z)XCEOIM-G(65T,45O(4!Y8(]OS@<;T_O
M4W_@M5\2M%L?@QX2\""\@D\1:AK<>J&S!#216L,,R&1AU7<\J!2?O;7QT->_
M_M%?\$^?AS^T'XQB\:?:]7\$>.$ #:]X:G6"6?"[5,JE2&8#C>-K8 !)  '#
MWG_!)GX0ZUX3O=,UO7?&&LZY?7L-[=>*;O4(9=3?RT=1"KO"RK$=^XC;N)5,
ML0H% 'V7I/\ R"K+_KBG_H(I-9TU-:T>^T^5F2.[@D@9D." RE21[\U8MX5M
M;>*%22L:A 6ZX Q4E 'YQ_\ !'WQ9!X)T/XE_!;Q 5TKQOHGB*:_DTVX*K)(
MIBC@EV#/S^6]M\V.@D0Y(/'HO_!6KXJ:+X1_91UCPC/>0GQ!XLN;2UL; ,&F
M9(KF.>279UV 0[=V/O.HZFO0?VAO^"?_ ,,?VAO%D/BZ[;5_!_C.,?-K_A>Y
M2UN+@A=JF7<C!B!QN #X &[  '._"'_@FE\-/ASX[M?&WB+5O$/Q-\56KK+;
M7GBR[%Q'!(IRLBQA1N8-DC>6 ." ",T >/\ [5_@F_\ AS_P2.T+PYJL36^I
MV.G:(EU ^=T4K3PLZ'/=68K^%?8?[)W_ ":S\&_^Q,T;_P!(8:N_M"? ?0/V
ME/A;J7@+Q->:E8Z/?RPRRSZ3+''< Q2+(NUI$=<949RIX]*ZCX>^";'X:^ ?
M#7A'3);B?3?#^F6VE6LMVRM,\4$2Q(SE54%BJ#)  SG '2@#X*^&G_*:3XL?
M]BS!_P"D.F5^BM>+Z'^RCX2\/_M/>(?CK;ZCK3^+M<L5T^YLI9X38)&L4$0*
M((A(&VVR'F0C);CH![10!^=7_!13_D]#]D#_ +&:#_TXV-?97[37_)MOQ7_[
M%+5O_2.6L+XT?LH^$OCI\3OAOXZU[4=:M-7\!WR:AID.G3PI!-(L\4P$ZO$[
M,NZ%1\K*<$\]"/3/'7A&S^(/@GQ#X6U&2>'3]<TZXTRYDM6594CFB:-RA8$!
M@&."01G'!H ^4?\ @DG_ ,F6^'_^PGJ'_H\UYIK'_*:30O\ L66_](9J^R?V
M=_@!X>_9G^&-GX%\+WFIW^D6L\UPDVKRQR3EI'+,"T<:+C)X^7\ZP[K]E'PE
M=?M/6GQU?4=:'BZVL3IZ62SP_8#&8FBR4\KS-VUR?]9C...U 'Q_HNM6G[//
M_!7WQ9-XH?\ LO1OB%HBP:5J-V56)Y)$MF'SD\ SVDL0'J4&.0:^^/B]\4M"
M^"_PXU[QEXCO8;+3-*M9)R97"F5PI*1)D_,[MA54<DD5R?[1G[+/P]_:D\+P
MZ/XYTIII;4LUCJMDXBO;(MC<8I"",' RK!E. 2,@$?/6G?\ !)GX=W&J63>+
M/'OCWQOH=@^ZTT/6-64VZJ.BL50-CEON%/O?7(!QG_!)+P7J6B?LF^/O$5_"
MT$/B'4KJ6SW @2116XC,BCI@R>8O']PUJ_\ !%3_ )-9\4_]CG=?^D-C7W-I
M_A'2-%\)Q>&M*L8=)T2"T^PV]G8QK''!#MVA44#  '3BO./V7_V7_"O[)O@'
M4/"/A&_UC4=-O=3DU6276YHI9A*\4414&.*,;=L*<8SDGGH  ?)7_!4K_DOO
M[)'_ &,UQ_Z5:777_P#!8Z%Y?V1(&49$?B2R=OIY<X_F17OWQ\_91\)?M%>+
M_AUXC\2:CK5E?>!;Y]0TV/2YX8XY9&D@D(F#Q.67-M']TJ<%N>1CK_C5\&?#
M'Q^^&^K>"/%]I)=:+J*KN,$GES0R*0R2QM@X=6 (R".Q!!((!XY\<+R'4?\
M@G/XENK:19K>;X>>9'(A!#*;)2""*H_\$N/^3$_AE_W$_P#TZ7=1?!O_ ()S
M^!?@W\.?B-X+L?%/BK4M*\<Z>NF7YN[BWW6\*B4*8,0X5_W\ARP8'(^7U]O^
M OP5T/\ 9V^$^A?#WPW=:A>Z+H_G^1/JDB27#>;/).V]D1%.&E8#"C@#J>2
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MB_\ X)4?#3Q!KFI2Z-XM\:^#?#NJS--?>%]#U)(].?=R5CC:-MBY)^4[@ <
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M)KCPY:^(])N?$-N"TVDPWT37<8 !):(-O& 1U'<5O5X/X3_8W\%^#?VE]?\
MCA9:GKTOBS6HI(KBSN+B V*AUC4[$$(<'$:]9#U->\4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBN\_9/\ B'\0[_2?&"W?@?Q)<&6Q\+_8VS9;9"T+&=I#DJC/&?D^8;23\N*
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MV\6W8N(U, ))NR_D^6 $4MY>3DC;OSR/2OV1_P!J@?M!?$3XT>'V\(V/AA?
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MD\/_ !_^%N@^//#+3?V1JT3.D5PH66%U<I)$X!(#*ZL#@D'&02"#0!W=%%%
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M]H+4/'7[-=E\4OA!X5D\?7NI0PS:?H,]REG))F813H[G*JT6),\D$QD G(-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN_:!V"BO<O\ @EIX7T[P[^Q/X&N+&*-9]6DO;^]FC&#+,;J6/+>I5(HT_P"
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M7[0O[+G@C6(_^*8U3Q 4O!(3Y<PDN[.)U/T1F_[^5^C<<:0QK'&JHB@*JJ,
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M7^RA\+XO&NK?M$W>NVLFHPZ<+6SC:-PTBNP;++C \L_G7M'_  4!UB]\0?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /+/VJ/"6K^/?V;_B5X
M<T"R;4=:U30;NTL[1&56FE>,A5!8@#)/<BN-_P""?_PW\2?"/]D?P'X2\7Z5
M)HOB+3_M_P!JL971VB\R_N94R4)4Y1T;@]Z^A:* "OF+]KKXQ_'OX<:OI&E?
M!WX80^.(M6LW1M4D#,-/NMQ"[QN5=NW!!8@9')YQ7T[10!\S_L#_ +,VJ_LW
M_"&\'BV6.Z^('B>_?6->G1UDVRMPD.\<-M&22.-\CX)&#7TQ110 5F>)M#7Q
M-X;U;1WN)K1-0M)K1KBW8K)&)$*;E(Z,,Y!]16G10!^='PW\=?M9?L=V>J>#
M/$7PMU7X_P"A0W+RZ5XDL]:D>Y,3$ *Q*32;1C(C9%*Y."5Q5_P;\$?C5^US
M^TYX/^+'QF\*V_PW\%>"9!<:'X7:Y6XNII@XD5FQ_P!-$C9W8)D1HJIR6'Z$
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS^ZA555FVI&,L2Q"_9M%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
MB5!.1PT*&@H    -24A$4@   9<    +" (    \UU?6    3TE$051X7NW4
ML0D ,1 #0???]#L[>('S$\RD0NF>[^\ K!2Q&CGD#V"'B-7((7\ .T2LQG,
MJ*!B0#<5 [JI&-!-Q8!N*@9T4S&@FXH!W2[_=7B>Z+8G<@    !)14Y$KD)@
!@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_2.jpg
<TEXT>
begin 644 image_2.jpg
MB5!.1PT*&@H    -24A$4@   2\    +" (   "A]IP;    4$E$051X7NW3
M,0Z 4 A$0>Y_:6T)(59?W6*F9!.Z5Q>0H>8!^(D:(84:(84:(<5>8P'OF+$U
M^S8? (?,V)I]FP^ 0V9LS=,&?$F-D$*-D.(&1G#<K5.4G),     245.1*Y"
"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>holx-20210925_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:holx="http://www.hologic.com/20210925"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="holx-20210925.xsd" xlink:type="simple"/>
    <context id="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i5ef8678e66ac489db5e4d0fa0f43053b_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i6af15f648ee54b4780a1d239d1bbda85_I20211111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-11-11</instant>
        </period>
    </context>
    <context id="ic5585ae25a954d67a9e131196d3a358a_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ifb9457cf546c4165b579b1ec171ac91f_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i71201bb972ba45a28e50f67d16e6e9a6_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i8c0068fc5d5747a882ce9ccbd0123f38_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i88ee1f21a1904304a5934d3026a42b57_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="idf8b9b630f904fd0b483af12525ec51f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ie676d127765b44e19633b016ca95774d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib3278f0ce96b40519a22ae965c771b3f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ib1da2069ac20464e9013c24fe294ff2d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="id753e6e364a144f8a4338bd5656f66cf_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia927c77ddd4b4c3f9e25433620cafd9a_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i92f8eca055a24f3ba805ccce80af7729_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="ic258825922e845e48ae770d90cf914bf_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i684e08be393948ad91d177dd16acf8c5_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i7511415f2519453297890d5928acc96d_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="ia5428b64a6a64d48acae1ca5892619ff_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i1169eac86c27452c96edd0243c74ad5d_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i330e64f51bae41568645cc62f16c3c3c_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i4332687a95c44e4381175f1e41bb50d2_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ide57006743114d5bbe3750f80d39e212_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ib2bc815063394f1c91be4496c525a478_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i09031c9523ad42779d78b1cea5ecfffd_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i107888c74437440cbe2fd3eed3be8cb2_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ifccad0744b37455da40b51a3e9af3cab_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ic7986c81bc3444e2bac570e31b4e5a5d_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i8210852c21614405a339fbf5ee62cbc2_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i7bb44d2cf92b48549d1472c325455031_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="iebdc63da66e44f02a09288f80627eb36_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iba28c6f4ffe544f5845e9d09779a223b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if7190f0470994899bbd92415a32894ec_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i4afe6a62c1ae4038bd5fc9a1b0c45638_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i7452f8bbde6a4dc0b0d39086f1ec6fb2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i22b5647d92ba43c1addee91de2482e15_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i52f80aa9ecc24057bc66c2e40b7eb278_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i349d16b63da54ca1a91efd54fc2025a2_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ife279decce604602a60f3488e853f6ec_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i270a8009f56048a5aeb8b08ad88b3013_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib61d23ac15c4492d8dadef811af5939a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0b95455d5e674ece8cf4c41a77810b2f_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i4910978b239f42caab2d6ea6ebc0a8a4_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i2c0525997c5f435fb443ec3494b56714_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i74767d9ffa3c4e68806179884dda54ac_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ib7c492a6bad949d8bbe9a19b9f847e6a_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i41abe384e7ed44d0b93eb28da26c630d_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ic6fdf1c3d1c24fc2b1d849ed7b49afa5_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i6cc5988aecbc4312a8f722462e31ba5d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ia2bcf88f2cd249149361fc0e5b495fa2_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i284bf3087c864f18b52aa92132f5472a_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i8a56c91d1533454184368992ce4da0cb_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ie460e7e6ecc64b75bae28b8d8803defd_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i39e4f5900241494c9567649e19c96f03_D20211014-20211014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-14</startDate>
            <endDate>2021-10-14</endDate>
        </period>
    </context>
    <context id="i5ab554f4731046f5a8db6df08f11e210_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i31b7d848d9294ea0bcafe1e9b98352e2_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i257fac080d6542d2b019c98a7b842cab_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i20cf81a427114e06a602d55fd54d095a_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic8d9c018e3364bb88f017d0ea722c968_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">holx:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1760e146b45f410688b3ff89a82a6684_D20190630-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i8ecce514a4df495b8d3d8479bdf9d0f2_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib977b0b83f104827aef9be1e2307b7e3_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">holx:RevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ic9b633f8acdd4e20aa3c715419399907_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i5a0e94b8d14543b8b882b82d9c97b4ca_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i1d36b248dea543d9b31d755d693a800a_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentUnderCustomerUsageAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i240c4a4b528e48fcbae1ae3adac1be94_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">holx:EquipmentUnderCustomerUsageAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="iff4e30233d1a415382913c229d305f89_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i9a1a54208b5e468786e129cb05b9304d_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i8c6c435d399d423185f62c22c21c3f26_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="id78ad9f144ef4c5f824abd84cc11f14d_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i20c305b597ae44238fbe77067406d53b_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i759a6a937e3f4b359b04123f53698e83_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i3f5a4fc2e0a249feb5e822c662f420e2_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i7133ee75e2dd4ac999d32c90c55818c6_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ib5f33f2bd0484efea0b8ae4a94ebb11e_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ia6d30cd544794d8bad91533ff053e6f2_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i22a8c525301944a9944a49cff920233b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7ad6095503c64c51a121bfc7570d481c_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="if65a3feacdfc4f8db0941415413e890d_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6ae31be4bb5c4a43a23c3e6238becfc2_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="icf8cbc783b5949dbb79a0305af7adb43_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia6c3f788c0bb4582bfe4f3e18fdab22e_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i614f3db626964b0ba19f7be4c30f7447_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id938fd73f4344d9cbe5e4513a3d14cde_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="if1bf447986ca4495be7ba966e2186eea_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i3f935dfa1dfc42c1819964e91a6a8a64_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i5d5d0520adb34afba7a74726aaf4fd2e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i153284bf00784fb3b525b3a99606668e_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i1075d2362f62458aa8909dd277c391b9_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iba0c605799354665aaf32f5e35c613c0_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i397c8ef1ac694286900c772850590741_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i4a58be7c5d3a47b2a567894820bae0e7_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ie735dea6c3194f28bea2b55697a00db1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i693d74165a33465a96c1b16aaf3362ee_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ic6e41df507bc48da9b9dbf2c59f4e28f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i4c123a5aa5c74f40857a7f1a499427f9_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ib52deda671d64acda80d8851600a5b3f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i3ca56ec6117e459a933cdc1284e27c76_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="if3da811ec6224b7aaf2247ddbed15752_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i24181a753fcf40f4955b32c1fa5f7f67_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i8cf9e1877cd24f22b338685574b8c19a_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i1764f8386ed1463785aedd29aa1705e0_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i044591b70cf04ae2890d5b307e363d47_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="id726e42e341143488233910071609e4e_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i1b99fdca3c5843718c49fe1d11331a75_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i6c23227b249540639f90d63654aa0b54_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ida01d42fd7b44dfcb8af2d9a4e61fe93_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i2e1fee5b3bff48a6968339ee9bea5f5d_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i710936347b24460c9bd5ba52032b894d_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ibbbed19de9d04478a40050d57d4eb672_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ib512458f54004c1c91782978a54d120e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iee6a5a2a7a4f4e3c92f42828d7360c4d_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i98d0b62cc24e442bb94c648589df1886_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i1aac6887b6f64875a859a71ba2b4b94b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i1cc0b83aa93c48f48c108df5541f41ff_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i054b061ff3bb4c10a95c6b96ddc407f6_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie6346aa91d524afe85aa61f0161caa3d_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i164438a7cadc4df1b56c4a64d8637889_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i0e559bc22d7d4793b38e4a328c0efdc2_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i86d3e4855ffd49b4a75816f598968a6b_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i26606deeae75471ca65b268474556c52_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ieee384db572047e4bc0a55fa16caac03_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i51e026b96a0148719035aed371e20da8_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i4497464c0da44052a7c519318511a239_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i9411184d269b43d689c70581552a716e_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ib3b69d34963e43d5a345ff8d104b509c_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i1e61574a9b46411bb0ae2371322a832e_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ifac209011a2246ed84b08c9d11d3ec13_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ic32aed22715f404fa87eea8875fb1bed_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib54386ce9dbd4629889a414173ff052f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i767c4b13fb8b4298b5e3c88d7d4a412b_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ib6d9385d2791424fa11a988430cc65d1_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">holx:PensioninAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i0deccf8630d14bf58974f26313ae1cf6_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i02ce74e9dbd343d6a1cd77cfa6108906_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic351d3dbbd53499fba2fea622656b21d_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">holx:PensioninAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1fa9316ea07a42e7bebfbfaa9b69e71a_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic0e3770e763f4ddb888efca3f38034da_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ic8ab0ba57c4c4db1ad33b536e3e7e589_D20171001-20171230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-12-30</endDate>
        </period>
    </context>
    <context id="i05d2321cba894df2b8040fb7171ae337_D20180930-20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2018-12-29</endDate>
        </period>
    </context>
    <context id="i6827d7fb33684f72ad15f7ec7825491c_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i3c63be7c32ce4ddd8e21e1134530b893_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6a83c89446b8446ab0792c574b8e11bc_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i824c5596d87e486cbcedd0f0406ca67e_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i0448f6218dcc4bb79af08c1f322d677c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i42d6e39bab1d429394487dda896a9573_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i3ef043735b8b4239bd022e3c816a7d5e_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ic89ac9c9ef5e4b44bc94c7ab3aadfbf0_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="if412fa8d384c47b689b9c1cc6f70fb14_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i3e51833b6bb54770a5cad8d4c19d8fcc_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7d6987883e2244438841300f24394299_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i8608e05ef25e4918a0697a01f20908b8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6c981e5c311541219a8ce678b8f5e556_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i7021a097ba6b45e4b62b6e9a182526c0_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i35128fa0cb9b4182a1faa4cc5d635680_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="iad3d88d570654a5eba0e1150c061cbc6_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id0e58ad8c5574352954de0afd7c3c79e_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i2d9b9f86933044f9b736c54f4167a157_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i082d8e77f8fd4606afa5130d1718f9f4_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ic627db3203ae4b219001b3708f0efa7f_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id50b2a3739074642949584da79fb2ae6_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iec921088a39b409a82dd4e10a4ae0ccc_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i470023b769a94ad0b13e2609e2a72838_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i35bd7f402edc440a8814d0fd91080075_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i17dfc20b126b4985b7eda3cc4db3237f_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i33cc4a6d3eea43fdb3367b91d64fe447_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ibeea03eaa2ce4eeaba648099e4e98f19_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i44fec30a86bc4fdca0e8af8e653b41eb_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id679baf745974c8ba5972d62f85ff59a_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6a4d3cf9145043e6a6e200011f21e141_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic93f6848c1c446b6a57343a9d7193209_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ic2899ef5f0e54bf481c6056474080ba9_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i8a41050bbd2f4b08bf819adc739c81b4_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i3620d49142cd46a09f8dce2f449ad3a0_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="id6eee8b72e7d491c8f95b676990b140d_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i77866d045d77495391adc42c2d578d4f_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="id1d584b446ba445593d7564671b578f3_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i27464b40c6284a7ca171e8ecbf4473ed_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i4444d39b093b4cc6818d013167b30698_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic727d8274f6049b8a3d7106820845e16_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ifdac9696c83845cbad8c3916522749af_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i271d00413b22420da0972fe262ee308e_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i8631f56a67a14a0eaece9796d4d326c6_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="iad66804c34ae4b02af8b821d199b124c_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i071fdf8810d44be79afb0d4142823f1c_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i18f2294499fc4cbfbda896074c917f74_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i84014ab98a4b42999ddae99b7c9f17d6_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i650a3c515fb14f28b27a2fc34755a9b6_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i0ce55741e08d45cfb3768da278fa78cd_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i7ff14eff3dae4e748c42b944b71e66c5_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i0cce2f2486644d48b444db7df588805c_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i9f414a4aae9647f39eb553c172b71177_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="id7c62b7c793f4af4829020516aa6f08f_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i17631bcf62d64f15a706d210ecad4fc5_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i6465511e129b4f2b9244e3f15dc79aaf_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i880e7908395c466ea1496767a0761862_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i12a3197c6b1443fca044a190d98cdcf6_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i51cd7e31b542458f934ce2f21f3bbf77_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ia873c88964a74ad8b51878c7599c0ee5_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i4fe5921de4e944419c03317f20e3cf76_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ia66b3e8f28174bfc803903de805bdd71_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i464eee65cbc7418d983a6e014907ca29_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i5d9782966cd04624b4574f83bf76bd86_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i51349d90e1e74711bc82d5c52b4c361a_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i1c5d7207e8a04d8f95ed445f4e2ca090_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i8ba6b598c34a40368885f7a795edc3ed_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="icb689fd1c43b48ba823acc223d5dd95f_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i4fd4ffa7b1c745a1bb74880e80155088_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i233647819a5f40d194dce2a1a9997d5a_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i649c6b3f0c7c4dbaad7e0f14df3f9369_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i52b0f72609834981a2d8cce09ff40e97_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id55b5cbb5f9b4ffb9cdc329793b4ec2a_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1d916bf7bc7c4a77b9a424ea474da6ee_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i5ea5061f31944f2b9ce4b953e7acb45d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iebf4abb2d7924525b0124ad8f4ac294d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="icf7514aec24c41be8928b4b1735c6c67_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i7759fd469e4744c1aef40bd5673059f9_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i2987070776a540ddace03c1f2bc15110_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i7fc551316da34c2e8fefb62c8a6c00b8_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i5dacb4bf98504ba0adc0104184a6b73e_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i93dd5c0ed3164c9592d8fe3882f0a28d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i043f4d719f7b44348bdf12b5a66ef493_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ifd533908ee6c40dd84ac4f8768c5930c_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ie54dd0f63ac74f119354986074fabb9f_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic6f6c97bcbe64066a4c7b7de88fde26f_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i3e752284b89d41fcad2da9334eb55ced_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i756b9830819145cf947d010150d735da_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iddfef9e089734fc49273fb759f37826d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="iac2499d2fe7f4e5299751553c9849768_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i6f774c3730dc47318167508519cccd16_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i595655c2121c42c4a0d63656cb7b4da9_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i0bd7c0bc86cd4fd797e73c8a52e9c016_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i135f102a0e3348f19dffba8a6b80c845_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ic76f2583244f4da1b4d8e2ffba810bd4_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="id3c88c28c8d849709bac1efc12058749_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i4d2066aba8e543da9c51bbcd0eeec832_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i97948eaa2bd440598a0350abca5c22c9_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="iafa45be8be374656afd2437b80f21836_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic3ec9b2c72414e3986057885d7706597_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i80fdffced13f49329a2ec191679666fc_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1f2dd55044054b76a0d73fc9c9908555_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i5eb7c94b54a04e06b4612b1dc367c680_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ia6f02780b07b4af0a4ade42afb9a3277_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i4d68382b58894a7a8493d2c3c72f0bdb_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i3b27c44ab2c049dab1ada8ce3e2c9dde_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if613c1f13698495a8a9033eb60e30394_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i471641798bc6486890424f64b25cab0b_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i1a75be05e6974cdeabdb5101ca308496_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i5c981ade86904092ab44cdc3421e6c6c_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i58c230109b9d48e3bb3cde0f8a0abd26_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i80097451dd62453689464503df8df92f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i3cd1f66491984c7bb0dd1d0bc4fb2a69_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i53fbadaaa41d47dd83cdd5d7dfa70cd8_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iaae08e83f10e40cfb00da11f047781ec_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="id2cf64befe504f17b267aaa43d3d20d6_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i7e66734d295a41f3bf8bc60c57b17a6f_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i13c1a5da1ce942d2aae72b3f00d90f06_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:OtherGeographicRegionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i2c10cbf1ca23411a80e5d03d6ee6dccd_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i13dbf383b09e471e8163112ba23934f4_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iaf97bcf6dbc8421a9a3716760bcb97e7_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i00ab011f780a4f6f8ac17f56d74cdd4b_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i3def95246ab34bf5acf9bbbfc8b7d08c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic55d68378e9b4082aba5a6b9d59fb043_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i611616cb655d4d7d9572751cfacacf64_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ice08cc7189624f368d50df2bf2de0a54_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iadf19b3b6d394dbd927075a441de11a2_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="idd4c3415bf074cb794ce6b40d287d9c5_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ic46d5dcd82604bcbb61ee95e7645d76f_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i2e8a93ab7a16493487f16e6dd346050c_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i9f6243dcc94a4351be212ad078c329c8_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="if08ab3a606434b90acdb237e36cd8380_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-09-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i215e3aea9151448587579caf2488d39e_I20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-09-29</instant>
        </period>
    </context>
    <context id="ide9bb99b7773447e866b67fabae6a11d_I20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-29</instant>
        </period>
    </context>
    <context id="id80e5c3b505e41f3ac02c7fd4f5a90f6_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ibd232192ed78407a974ddcf2b2257851_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i63bca38bbb4548949606b34deb9181e6_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsLongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i2dc7bf647e314aef9275b300600f7660_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ic4cbe84c2c244569ac0c808b9c550275_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i63a69ff36b674be191db12ceabcae07d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i3ea319a404a74e32a76dde8d8433c89d_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i1fefdb83fea04155bda0d8947d2e2c81_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i7c5787a7635445a6a57c55963ee616c2_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id55ff3c8d27c42eb867928b21b604ce3_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">holx:FinanceLeaseObligationsLongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i474f42fec50e415899f9fcc327fc81f0_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i185383b2d2cf4d63b7121bb5d0c32d01_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i1fed62fa0ae548ef9551dac57b66c922_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-06-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i4b68378841c444ef93e2ed5a74fb5f45_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i2d1855a726e04afa80871b8a251ccd6f_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i9a385ec34dde4c0498c6601386e0ded1_I20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-17</instant>
        </period>
    </context>
    <context id="i209e37886ec24b4ca152f473bd170893_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i1adc191bfb1944e6a9cbc20ef1487b58_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="ia55f2fdbeb5742f7b3342b8cee59d144_D20210627-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i942be4914a6f424abf0ee50bc8e25578_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="ic2e17b8f966541f782e6ed141bb9f99d_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i989b3c343b4149569fea2cd1610908f1_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i190577d230694c6db7092cbe00fd5262_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="ice6517c799d444b38d8fd28d773fafac_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i1aef7229f2fb43e2bf47467c959ff49f_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i79d7a89a26634ea88d3359abf077c8ba_D20210222-20210222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-22</startDate>
            <endDate>2021-02-22</endDate>
        </period>
    </context>
    <context id="i72e70f5d003f4a96987b3a7637d2c815_I20210222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-22</instant>
        </period>
    </context>
    <context id="i36c42ab7aefa4f41aab159b7a5733d71_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i01e7f02a71bb40e3a36976eb57aa9856_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="if659372cd83b4bd4bc8116d8668b1a35_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i7f176b8a88dd4e52a616432565abdf82_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i2946643ddc6a41b8bc328cd550813b7c_D20210104-20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2021-01-04</endDate>
        </period>
    </context>
    <context id="i4dbe228069a44bdeab333d84de471731_I20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-04</instant>
        </period>
    </context>
    <context id="i764422f35a5940fb9fd05f652236cf3a_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i5ee9425976bd4c5ea618b0d36430a7c8_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ib9077d45e6f24c7586761d31add141ac_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="iec517cd2e58d49acbb42aa527e1d9b85_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="i6087fbabae0944f982d1de9eb1a1ed44_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i1e4b2db5b6ae4c4ba84f02771907f7a4_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i5e988670f72849c99fb52b89dee92904_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="id68fc41b2dac49ce95512717f490a715_D20191230-20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2019-12-30</endDate>
        </period>
    </context>
    <context id="ib93bd6cff06a4e7f87214f6eb2cbfd4b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i16b5a1f413384f9ca72737023db38188_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i36618631bdde40eab7a2277b4c960865_I20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="iedf53a2286ab4650ab8d967009ff9c57_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="i6917f131714d4eaa8f02a7754033309b_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifa9b0872e98f4d10ad0e93ab1bc740eb_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="ie280a98b55e94f6c8d1901932bc65953_D20190728-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-28</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i434021f3ec27448fbe1165597b733f5d_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i76683b5c18404ee8b099355c544bc298_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="ic95991b5e000422fbe8ed48efcf4b896_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ida7a175c50e343bc88edc64520ef9945_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ia88c8081745b4259b3951cbc18febc64_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i8b728effda394302a72ca98b3567ed57_I20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-21</instant>
        </period>
    </context>
    <context id="i8c8888b8e35a4df4a031e6fa6250444b_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i2d53a4eb8eac4b2c99a46ebf3435d28f_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i8b6dc772990a4dd08e146f2812715ff8_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i2b1421425b23449bb82f2089d54bfb94_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-01</instant>
        </period>
    </context>
    <context id="i1d2e8a19c496462f9cfc2bb84de929f2_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="iead19d3763124535a6de6bd936833053_D20191001-20191001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-01</endDate>
        </period>
    </context>
    <context id="i71d4407f36384a78ab3fd3c29df58e1a_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="iecc2544b7c7d4f2181bf059594fbb073_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="i05a15ceda3194f6a95ab1a2052135e7b_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="ia45d1465e59545618e64088cd88eaf9a_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:FocalTherapeuticsInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ica09cd88fe9a4e17bb42730a0eb48197_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i7936fd11ed2e4b85af34c8ff95ea99bb_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i00310a9d53394da3824af468349e5507_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i32aaf02b449b417fbbb6835a78a46b59_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtheractionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i0fea61ca81bf4d459c97ba34e9961f73_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i1d4b7a8cc9a44411b8b72747d549afa1_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i589c665e90724c12916b1829bbe8611d_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i363a0363e6354e97b13c269c6820cf5a_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="ib8f2a1f7b45b44309d99d3e69e91b1a6_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="icd04b96a2ff54f9fb515dc126ab745cf_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i6820742ad8bf45d0b4eb5cacd1ed2d5b_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="if0d1533cac054998bd77025d6327d119_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ie74335c4192849e4962d43b0b1fc20f4_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ia4bdf24b380d49bf82bd81fb2c06d677_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ic611866316f1423b90b7f3d0aa696327_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i72c37f79fbe241d9b526e41c78b64391_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i9761cec969414f2dac8d0f65e729f1f5_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="iab1dbf3209e94bba8c72c6ae4d7bccc0_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ibef98710ecdd4cd1aab89a2c225d4bb4_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib6b1f0af679346b0bae0f56c6a024a23_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i9d06325cd28b4c4abb1d24a6b9f3b7e1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i94ed1a363cfc4dcdbd9da0e0010b4605_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i237590b8c9a24937a685c8ff3cfc59a0_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="if6b56d54de384d5e85d583af397a2df1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i37821908786c4b708eab490638465e93_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i9bf618176c7846639223696bf6423a6b_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i45a345959c154a2d8df036461ee29971_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2021ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i20c9c1045bba4ae987407ffe8c49f36c_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2020ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i226927fc24ca401dbaa730834a36cc50_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2019ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i2db2f22615e94b14baa99827dcd76f70_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i6c8b3bd2cb5743559dcb3f8b8dd002a9_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:OtherOperatingCostReductionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i6661f7e6f8814fa0a6d62d9cf0f20dbf_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2021ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ia255713509bd43e8bcf5ee357d39d247_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i052b6805906a4d2c89ee54aabd364d66_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2020ChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i7aaac8bd6b554479a2fec5dc2c597d98_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityByLocationAxis">holx:TepnelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ie1bf8affe32c4e59ac455013cb5723b4_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityByLocationAxis">holx:CynosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i3d2e5c8508f041c0baa077405508f177_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:Fiscal2019chargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ibe6803d94cea48cf812f89fc284feb20_D20180930-20181229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2018-12-29</endDate>
        </period>
    </context>
    <context id="iaa3e68e1e5d546bfae26d63f7380f8b2_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="ie3ab4cd18b9a4591a4f3349bf628b8ea_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="if5ac9a1dd0c24e55b09475fe7b9368e8_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ia15a38914d0c431881116c0c57a58aad_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i486e6244f19a4457ac36f56cf1470533_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="if3f1f73d7de842cb99735553e7abceab_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="iacf8cf06e1004995ae54b544e1d55f8a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic1817a9609f14627a2d7989c9899505b_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i700525be08934f2c83c783a70ee542dc_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia3a3dd46c67d43109e42cbca6545498c_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ib071bc950aab4dea8b04dd63bb5fcf90_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i87d92969a5ba412c8c5427576dc4c085_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i9a1525cddd894988b24e75e818155953_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iff284685ee2f435ea04c0a1a5ca36df5_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i70090c579bcd4961b00c27f03e26059b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id40664d5921a4796ba4b25ff9b2df421_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ia81fd6cc362e4e8ba3a639e55937a919_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i987fbf31a45c43e3bae95b8e5240af87_I20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-17</instant>
        </period>
    </context>
    <context id="i55f8ef212efb4b25bf5f4170fbe2cf4e_I20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-17</instant>
        </period>
    </context>
    <context id="icfe44565012b45bcaa3449fb3bb9f8e5_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="icd947cfb444742399b5c1ace77c408b1_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolver2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="iafd7f93a96974c4bb03d8ef2216bde64_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="i3ff7dff07c19479d8d7294b3f41e4502_D20181217-20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-17</startDate>
            <endDate>2018-12-17</endDate>
        </period>
    </context>
    <context id="ie832e870ba2c42c59c28352c2f958f69_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i652ebb0e49d2467fb5a2db3d5fb30206_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditFacility2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ic0cc2fe65c6840608feb94760bc0727f_D20220625-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditFacility2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-25</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="ie810eb40b7d8415ebbbf9fc97518f0ac_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i08ae73b31aa74566b4be619e65396e03_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ica7ec8355d2a4b94a212d956ffd6cb98_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i37227dbc9a1b4b84b8f8518571a9c190_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ic2aae87d5ebc4b419aaf8b70fa7a9da0_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ie74af5ae594d4d13ba8933a5998eadeb_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreement2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i6c788b804fa84fb88a30f3178cfe6010_I20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementPriorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-29</instant>
        </period>
    </context>
    <context id="i60bf2cb0eaf6478486595f6f3d4f3b1c_D20210927-20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-27</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="i4ef80047f7894c36ae90aa6a3c52242a_I20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="i08e28b6fbb1c4a4284c842f3cbf9792a_I20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021RevolverMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="ibf897b14244c423cbe46652e18311bcc_D20210927-20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">holx:EurocurrencyRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-27</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="i2ade552830964807a4049d7ee32b7074_D20210927-20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">holx:EurocurrencyRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-27</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="i4b582144f7fd4f718cb0fe6f6d00dc2a_D20210927-20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">holx:EurocurrencyRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-27</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <context id="ia77e5b12c3d44c7fb98f381230c562a4_D20180119-20180119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-19</startDate>
            <endDate>2018-01-19</endDate>
        </period>
    </context>
    <context id="i62108c6a80cb45f69acbd92821a7917d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="iad19ce928cc147b4a6d313f0bee64c59_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="id41609d12cf047148859a8228474e2bd_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i5b7aafeef10b4cb39da754e699f15172_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i608d5220bab04a068eb77c0863e0e36a_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i7e507642eb964db6860b69fb5f71596c_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ie12d730be0c14e1f9f1c5feaed78db40_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i02f6ad83b4ca4d948d52c4704f2e4326_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i03accd3c4a404ba1becc118185a02608_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ibaa36a6d1efb41cb8948ae469d7b66a1_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i3adbde1625f143509c7660ebf25386e1_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ie51341073d8740bab85b03dc5cbb80c6_D20201015-20201015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-15</startDate>
            <endDate>2020-10-15</endDate>
        </period>
    </context>
    <context id="ifcae078f20ac485186d995bbd72b5c6c_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i54d531947d51410a8d540905838b6d9d_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i3ccbfebd983b455f947f37aab7a949b0_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ifd6b00bf571a45b79bec794d5b438566_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id0b31f3326de4002a60eb9c0311715ac_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i4d4b04bc14144fa5b03735e07bd838a6_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="idfc1f74a5de948999cd82322770f0eba_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i99b892bb7bdd405aa700578ed296fdde_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i580c0405f9b548989c3f94ad170c061b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib8eae7b7b71e466b8c9e1876e7f31390_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i79503f9eb2e64b5383905a0821499fdd_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i90abd2f2507648759350a4c487e7133b_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i859a66c6b93d4b9887cc31492d39939f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i875c28ce0ee54237b5b3ae2cc86658a0_D20160425-20160425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-25</startDate>
            <endDate>2016-04-25</endDate>
        </period>
    </context>
    <context id="i6cfd402b776d44a0a41a299cca8f7ede_I20160425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-04-25</instant>
        </period>
    </context>
    <context id="i4812438b158c4e59a58edb46ec6692b1_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="id66308ea8ebc4fd4838c14af38426030_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i5d6eb9a53b2c48879a529442ab3b794a_D20210627-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i397a73cea4db4782a2daff7fe814251a_I20210611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-11</instant>
        </period>
    </context>
    <context id="ife9157147e3b4536a9046a87f5a4d781_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i4c371851af5c4029b78c5f593a1a596f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ia65923c3b6874551939bf4e2608b53bb_I20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-17</instant>
        </period>
    </context>
    <context id="i7f11d3ec54a14c5e9eb1e8a150c8bc11_I20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-17</instant>
        </period>
    </context>
    <context id="ifc96b1d6d081406abb844157f1ed6e5c_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i1406035f87284cafbfec6b6f722dc49c_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="icc463bd6a5a1402f90b9512aff6a663a_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ie913b1898868426c83630108b0931936_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i8d8ebd59017941e09e4b709e2c259721_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ic1e254ea6d6943bb8318cf1919f88ee6_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i125f4bfdd8b84928ab52d980197004dc_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="icc0150b9393b4c8b954b2e122c43851c_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i7dcaf65163dc4875a6d42ef1db4db39a_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i038a6263f66c4604975a68690f426831_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i73170ab8f09241c6addd83b14085fb1d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ibd0a92c2fbda45e5a76e08e7693a71ee_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ia1f31160d70448a4bc9dc1766821eb8d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i15a2dcf988324496812e93ba7fe0dbfe_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i2e5c21e5481b48d39c7959cb8bc8c777_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ie36b916fb59a49dd9387e30c28f5ec5b_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i0b282273a4c84a8caba87fd238f92b67_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="id901e08a99744558bdb5e1f2583dcbbe_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i03c2fff5e4e74c19ad8880629979f011_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib332bb7657f04489b5fa9e02f29ad82b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0a8c569fd753446ebfcdbe23ec063f7c_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia383a042e26d453ea66d7eaa8d23c21a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie3a7bf1b1614469fb146d97f9eaddd6b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i87ca8c80f7c34ee4800d09f086e64eaf_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i59b0c160a0424f80895466659951d8a5_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie43b4fa2b20c49fb8a55c4a741714682_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id66df1a2532a483f863906f0802057c7_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib91d7b55ffbe4550b988ae9a14a17fb7_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i91dece30b943448ab8d1ec46e9bc104e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia0b57f07560240bbb91b31af0add8433_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia11ee15324c14f1bb58ad7901a2e8f89_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic9d46afcc2f043149b8d49cfd5f03353_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="if91afb4383874bc4926b10047930d0c4_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i382a342e009b41b7ba2429981f375e2f_D20181230-20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-12-30</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="i273f68028b9048b4bcb9cc44e3765361_D20181230-20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-30</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="i6960dde2df794b28bb51b31c7a27d8d7_D20181230-20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-30</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="i461d1a7632c3438dbb6d29204125214d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ia06d0a30712b4655924b65bdcb87307c_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ibc9edb45f9c24890a42f08ce96b5a3d5_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i20b6f0eac2434262a3cac9fb4d6a84a8_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i6d960bac02334aadb2300cb9a53f0809_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i276f90f490c64954a3fcb6fce34ac50d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ib5ffdf58eb9f4baeb95351040e234393_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">holx:NetOperatingLossCarryforwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i5daaef3be8904e43aea1b5d817ea7ea9_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">holx:TaxCreditCarryforwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="icd8d2cba4a8d4ac4869ea733f58a335d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i1d836e99e1744b98a12d054959a730e7_D20210627-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i5aa941ab35ec45b98ce91c612351ba23_D20210627-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="iaffd59eb8187474fb5a4d8af030af483_D20181230-20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-30</startDate>
            <endDate>2019-03-30</endDate>
        </period>
    </context>
    <context id="i814cfc79d9f948ac96c6d5e239cf1326_I20160613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2016-06-13</instant>
        </period>
    </context>
    <context id="i88b3d268274c46d98f224f8c6c9816fb_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:June132019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i12da8222241d4afe9a4fd7ee1a5a6030_I20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-11</instant>
        </period>
    </context>
    <context id="i945e50292f26455c9fb03af3ee5dc38d_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="icc5c3fa0816048caa2da1ed91c216daf_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ie11a3dc3cc614addb28fd00bd0cf9a2c_I20201209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec92020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-09</instant>
        </period>
    </context>
    <context id="id1a4a87513914de081e110fe2f694f1d_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec92020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i3e1998ffb6bc4561a84610ab181828cb_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="holx:ShareRepurchseAuthorizationDateAxis">holx:Dec112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i747e381970ad4c3992a6131bcbfc5461_D20210926-20211116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-11-16</endDate>
        </period>
    </context>
    <context id="i57712fb9ed674d6ebb6261cb65be3db3_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i748a99e2a6c74677886bd3b4e6b89ac2_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:TwoThousandEightEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i623fe63350cc4f4bbf60f09a3b45072a_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i0202135faa1f4b469d6ecb622791638d_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i452f1577e5c942c4a2cebac00daff1d2_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ieb317bb99ad84ae3a58c21783556ecaa_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ia34f9b5ebf6940d8862b1e4e259514e0_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iacda269ea4f047c08ae1a3627ce6fcf9_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i9db32da71cc1455088030b8c7b621bf0_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ic05d68681e5c4f9eacb730bfede1f07c_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8b47832b29e04b3bb2ed3c90cfc6f1fa_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i920ca50d08084b8b97e8598c37fc6711_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i199364dd0aa84ab9b4bd4fb3a7b46bee_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i935c7d53d46d4c65944f086fdbf09aec_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i6c14b446dbbc4ed1ba4f1d985a7197ec_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i88b1b0c9c5604d23ab52ca8f9713a3d9_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib9133708dc8a4713aad750ae0f4663a0_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ie9a15e5e0d5f4a248aab637516ec83a5_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i7e32118662c4420ba5a02eec6689e797_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i16882582e0204737b097e2891c7c65e4_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i14ca5f4e78bb437a81cded9e6c66f121_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ie582e31fa38344bea5db72aa1a9ab369_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i74b0294ab860440d9476b34210f76f37_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8b62684619cf449b9f9b6a4e0bef8642_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ib0bd21f9a30840228f9a47abe615910a_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i05ae9481304b4cbda64fdf0b97da2601_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ia618e91ec0fc43d09d5b6352f024ece8_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ia28511c78fc648ccac995a4d5840b7b8_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i0cc04f37c6b947d3b9bc3cda079ee134_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ia51b0591bb904743909f38530873e249_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i313b0dcd780d4e46bd994d7390ef9a63_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic1f36b739b804d62873d875e6ab53e6e_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ifb7931cabae1458c905c13e1f1be44c6_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="id8e24c06b55c4c71852aa0419edcd4c1_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="idcf0307d722e405a9d4239a5969664a9_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i00a4b6b947964d0c9cf7a620d260cdb8_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ib4dbd93a38124c16a4fcf7162433450f_D20120301-20120331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2012-03-01</startDate>
            <endDate>2012-03-31</endDate>
        </period>
    </context>
    <context id="i3222582dc9e54de994fbc83070afcdca_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i46abb586bf124b4085396c348e397ede_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i59c4542075c04499bd7780fac311ed3c_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">holx:SemiAnnualEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ide2dd65f185944a7af648c12349053bf_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i92447176f15248e38b97d41aed3a3da5_D20131201-20131231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2013-12-01</startDate>
            <endDate>2013-12-31</endDate>
        </period>
    </context>
    <context id="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ie7174a6cf5674cc7a6e006b12d20074f_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">holx:OneThirdAnnuallyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i09879e74afc8419ebec21bb3b905b88d_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="idf5f8f1317384761bd3f09365e030290_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i539c042130bf4c0ea0ca1aaf167a10a3_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ic2b78f80558e4fa2aa90758d4605b59c_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i8f565dc1ab5b4eb6aef305378185c37c_D20180727-20180727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">holx:CompanyVs.MinervaSurgicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-27</startDate>
            <endDate>2018-07-27</endDate>
        </period>
    </context>
    <context id="ia2f30513167641b4843c24f196c963b3_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i219e75a86551445f84f935b59c0a9995_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="i4e21c713b33d4b199f4353e62c47d003_D20191120-20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-20</startDate>
            <endDate>2019-11-20</endDate>
        </period>
    </context>
    <context id="i04f6b978d03c4001921c33d5129a2d94_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i7b8ac8388fb9456faa4239e3d9f5c6a3_D20210627-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i31bd370f6c9d45cbb9bf2321aef87fe9_D20210627-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="ie6a08f19521748068ae388682bbfb97b_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="iaa33bf2f57be45678091ef0f4e3cb31e_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ied23a24d717e4da1895598ce729fd2bf_D20210627-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i982ea739818b424cbe9228324e052c58_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="id1a7761670014c0e89cd95059279c22a_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i54b63b6326364b86b8c1c35e06779d17_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8a986aa268d54c1c9fed13658c3b20ec_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i26018f332aa24e47a89ddb88990c5d5f_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i103c26400f644d6794e2701b7b92414f_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i98caa293bf89418e947a8f295926a7d8_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ieb68d71446d14424bd72697ac3285509_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id3b6afa22e0f493095f052e3a37c80f9_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i0490b02597f34bb0a3d9b518df6ea31c_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i4bb7a6e4fce84451a598a007a83c7c2e_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="iad80942a21184b6099e93a927140cccc_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id8d7dce3b25048bebda69f0f9c683dc0_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="icbe9fe13010940de8718a210bf402a2d_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i680aa07110f848c0a9f91bc57d1d9d9d_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i1e0820fa934740988bc68c46b00eaa05_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i74b686e1df1549aca26f39228fe341fa_D20200927-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i2c4ff82c84e041298fcbdf87e237dcf5_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id5b4e0cf7b6d4802a7d62ddca53a82db_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ibe57ae2fbed04a638154dae73a66c811_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i355f32c131b14099b97cc874503e497f_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i3c83bdbf9ef94aa59101a9aea2be7873_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i548c9eddb08b4f14967120bc035c9ec8_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="id4b55414cc384a68b8e3567008300ae5_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ib41f0019abbb463c9a8e10c2f96a5e29_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i66522b5564db479e9fd59f735b53bcda_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i4e2c2ca6c4484232a21bb281c44dd840_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i36c8c111abcf4b43a4042a7c166306fe_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="iecc61f191e354207a73d576c73bc8d42_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i58fd21fdaa0f4e66ab9388859b3f172e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i9b547462cf5d4b5597648a8fe55a37e6_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ic1d488dc858b49ac92911c8316dc04c3_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="if8cb3192812b4442b0a3e479a2307bc0_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="customer">
        <measure>holx:Customer</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>holx:Segment</measure>
    </unit>
    <unit id="debt_instrument">
        <measure>holx:debt_instrument</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl8yLTEtMS0xLTA_2699379d-0c53-4a35-9941-674166507e95">0000859737</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl8zLTEtMS0xLTA_50730bf2-85bb-491d-9990-9182261784e8">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl80LTEtMS0xLTA_c1c26683-16da-4f4d-9df2-85a98be0e5a2">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl81LTEtMS0xLTA_47e6f6b5-0623-4f44-9753-d8ffb7e47ff9">FY</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF80L2ZyYWc6ZWM2NzAwMWRkOGIxNDYzNmIyMmI1ZTA2NzAwOThiYTUvdGFibGU6NjMwNDlkMjQ3N2YwNDQ1OTlhMzE3ZTc1OWJkZWRjNzYvdGFibGVyYW5nZTo2MzA0OWQyNDc3ZjA0NDU5OWEzMTdlNzU5YmRlZGM3Nl82LTEtMS0xLTA_757dc244-6085-4437-806b-c6fcbaeec872">--09-25</dei:CurrentFiscalYearEndDate>
    <holx:WarrantyTermForProducts
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM5NTc0_257c2dd2-2a08-4cdf-8688-8a506165be31">P1Y</holx:WarrantyTermForProducts>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="idd4c3415bf074cb794ce6b40d287d9c5_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzItMi0xLTEtMA_02f16d49-6b43-4394-a621-52f2c15316bb">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ic46d5dcd82604bcbb61ee95e7645d76f_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzMtMi0xLTEtMA_165f9ccd-d064-4133-aefd-27a56e4799b1">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i2e8a93ab7a16493487f16e6dd346050c_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzQtMi0xLTEtMA_c22840a2-2884-4a0b-b279-ae99f79104b3">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i9f6243dcc94a4351be212ad078c329c8_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzUtMi0xLTEtMA_52980acb-8f6c-45a9-a169-6a164b03698b">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="if08ab3a606434b90acdb237e36cd8380_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzkvZnJhZzphNjg3NGJlM2M2MzQ0YTRmOWI4YTI0OWRlNGZjOTY4My90YWJsZTpjMmFhN2UyN2Q4OWQ0YjNkYTE0ZDcyNzEwMDkyM2ZhOC90YWJsZXJhbmdlOmMyYWE3ZTI3ZDg5ZDRiM2RhMTRkNzI3MTAwOTIzZmE4XzYtMi0xLTEtMA_be1b099e-d38b-4373-a790-d292079d6c2d"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i215e3aea9151448587579caf2488d39e_I20190929"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156">us-gaap:LiabilitiesAbstract</us-gaap:OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i215e3aea9151448587579caf2488d39e_I20190929"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100">us-gaap:LiabilitiesAbstract</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f">us-gaap:OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da">us-gaap:AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7">us-gaap:OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie9a15e5e0d5f4a248aab637516ec83a5_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ3MTk_de8b43b0-f008-41d7-b826-9f3a463875ab">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <holx:PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria
      contextRef="i92447176f15248e38b97d41aed3a3da5_D20131201-20131231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjMvZnJhZzowYzJhZTc5OWI3ZjI0YzY1YTJlYWE0MzFlOWU5OTY4Yi90YWJsZTpkZTQwNmUzMTFiYmU0ODAwYTQ0MjRkODEyZTMwYmY1OC90YWJsZXJhbmdlOmRlNDA2ZTMxMWJiZTQ4MDBhNDQyNGQ4MTJlMzBiZjU4XzAtMS0xLTEtMA_8f944e65-0878-43d8-b950-b69bbfcf7efa"
      unitRef="number">0.3333</holx:PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria>
    <holx:EmployerContributionsPercentVestedAnnually
      contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzIvZnJhZzpiZWU5ZmQ0MjEwM2U0ZGFjODMwZGMyM2I1MWE0ZWNkMS90ZXh0cmVnaW9uOmJlZTlmZDQyMTAzZTRkYWM4MzBkYzIzYjUxYTRlY2QxXzU4_c8684165-861b-4ef9-8163-7ae8e62edd25"
      unitRef="number">0.3333</holx:EmployerContributionsPercentVestedAnnually>
    <holx:TransitionServicesAgreementTerm
      contextRef="i7b8ac8388fb9456faa4239e3d9f5c6a3_D20210627-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzYyNg_91ec9144-43e9-4830-8cd0-3e6aa51ccfb1">P3M</holx:TransitionServicesAgreementTerm>
    <dei:DocumentType
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTI0_7be1669d-f5af-448f-9623-53047bb63a3d">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6MDVmMmE1YWRmMDU1NGYxNGJhM2U5N2EzODM3ZWQ4ZmQvdGFibGVyYW5nZTowNWYyYTVhZGYwNTU0ZjE0YmEzZTk3YTM4MzdlZDhmZF8wLTAtMS0xLTA_180a94f7-ce87-425f-afd2-a8a261288edb">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8xOTg_4077e848-9bfa-41ae-8b43-1ef9b10b956d">2021-09-25</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6OWY0ZDQyODgzNmNkNGUwZDlkMzAxMmIwNjZiZDI1ZDMvdGFibGVyYW5nZTo5ZjRkNDI4ODM2Y2Q0ZTBkOWQzMDEyYjA2NmJkMjVkM18wLTAtMS0xLTA_3ac90a4f-3dc2-4ae2-bc84-4dc22d245b33">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTI1_23ccaf40-371c-4d47-b07a-2967bcecc693">1-36214</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTI2_86bc7c12-c300-4f84-b03b-b171380b2ccb">HOLOGIC, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6YjQ1ZThjOWZlM2RkNDBkMGEzMjMwNDBkYTFhZTZjNzEvdGFibGVyYW5nZTpiNDVlOGM5ZmUzZGQ0MGQwYTMyMzA0MGRhMWFlNmM3MV8wLTAtMS0xLTA_d2f1d451-c4e3-4d2d-abe3-73c155aaa1e8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6YjQ1ZThjOWZlM2RkNDBkMGEzMjMwNDBkYTFhZTZjNzEvdGFibGVyYW5nZTpiNDVlOGM5ZmUzZGQ0MGQwYTMyMzA0MGRhMWFlNmM3MV8wLTItMS0xLTA_e6690573-003e-46c5-836f-86d8ac8ba63d">04-2902449</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE5_a8986041-a225-4e88-8b7e-c990604d80cd">250 Campus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTEz_78d8aad4-840e-4f0e-831e-680571e89a78">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTI3_e0a9c6d7-b5f6-475c-a7b5-3423fea1d949">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTIz_45406f89-cfdb-4f09-9018-9a849dc92f5c">01752</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE3_1377a17c-d421-49a5-a6f8-d8911eb52fc3">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE0_1c9193b1-0761-4ed2-8c90-f3cf117d9518">263-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6ZDE2M2NhMjNiMWU3NGQzN2I1Yjc5YTgzZDIxNzQ2NmEvdGFibGVyYW5nZTpkMTYzY2EyM2IxZTc0ZDM3YjViNzlhODNkMjE3NDY2YV8yLTAtMS0xLTA_c7d9ac36-fcb2-41bb-83fc-5fcef6e707bf">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6ZDE2M2NhMjNiMWU3NGQzN2I1Yjc5YTgzZDIxNzQ2NmEvdGFibGVyYW5nZTpkMTYzY2EyM2IxZTc0ZDM3YjViNzlhODNkMjE3NDY2YV8yLTEtMS0xLTA_bc112b65-3fff-449e-affe-721948beef85">HOLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6ZDE2M2NhMjNiMWU3NGQzN2I1Yjc5YTgzZDIxNzQ2NmEvdGFibGVyYW5nZTpkMTYzY2EyM2IxZTc0ZDM3YjViNzlhODNkMjE3NDY2YV8yLTItMS0xLTA_938fa241-c798-49c3-bd23-eb86a2c4e871">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTIw_d4318fbd-6d28-4073-aec9-57c616a5823d">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE1_39a56c17-2771-4506-8bea-cf1c9674dde1">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE2_ff6b083c-dac2-4ba2-b0b5-5150ef55f27d">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTIx_52cfb0d6-a7be-41c9-a8db-807d1806a03e">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6Y2FhODY5ZjUwZTkxNDUyYmJmZGYwOWM3ZmIyZjBjOWUvdGFibGVyYW5nZTpjYWE4NjlmNTBlOTE0NTJiYmZkZjA5YzdmYjJmMGM5ZV8wLTAtMS0xLTA_a6d12ccf-e93b-4e2a-828a-099bb6bea128">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6Y2FhODY5ZjUwZTkxNDUyYmJmZGYwOWM3ZmIyZjBjOWUvdGFibGVyYW5nZTpjYWE4NjlmNTBlOTE0NTJiYmZkZjA5YzdmYjJmMGM5ZV8xLTctMS0xLTA_a2b3527d-74f7-4c8d-9503-6779561d1af1">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGFibGU6Y2FhODY5ZjUwZTkxNDUyYmJmZGYwOWM3ZmIyZjBjOWUvdGFibGVyYW5nZTpjYWE4NjlmNTBlOTE0NTJiYmZkZjA5YzdmYjJmMGM5ZV8yLTctMS0xLTA_6ad842a2-732a-428d-b43a-ed81dfd63372">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTE4_f1149a79-b785-4e9a-a448-25afd0f6170b">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTEy_34362930-9dc3-4d4c-bb7b-0306bf8909f5">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i5ef8678e66ac489db5e4d0fa0f43053b_I20210327"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8yOTM4_07a43a84-4d54-41d3-84cd-6083ed771c62"
      unitRef="usd">18639078720</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6af15f648ee54b4780a1d239d1bbda85_I20211111"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zMDQx_4c0cc649-8cbc-4db9-a1ee-c80c7be8e09e"
      unitRef="shares">251420529</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xL2ZyYWc6NmZjNWZmODBlYWU0NGJhZGFlMTQzZmI2ZDgxZDI2ZjgvdGV4dHJlZ2lvbjo2ZmM1ZmY4MGVhZTQ0YmFkYWUxNDNmYjZkODFkMjZmOF8zNTIy_ad47956f-c1f0-4150-9a9b-e1d9059ed7b0">Portions of the registrant&#x2019;s Proxy Statement for the registrant&#x2019;s annual meeting of stockholders to be filed within 120 days of the end of its fiscal year ended September&#160;25, 2021 are incorporated into Part III (Items 10, 11, 12, 13 and 14) of this Annual Report on Form&#160;10-K where indicated.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic5585ae25a954d67a9e131196d3a358a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMtMi0xLTEtMA_f32c8848-713f-4d9a-a274-9abfc35f7316"
      unitRef="usd">4967300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifb9457cf546c4165b579b1ec171ac91f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMtNC0xLTEtMA_32c9ddf7-51ff-46f0-b79c-4351753bad09"
      unitRef="usd">3227000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i71201bb972ba45a28e50f67d16e6e9a6_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMtNi0xLTEtMA_19ec8ad9-50ed-41f1-bcfc-b241fe4044b7"
      unitRef="usd">2771300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8c0068fc5d5747a882ce9ccbd0123f38_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQtMi0xLTEtMA_d57f38e8-3d05-4db2-b13b-6d2eb761693b"
      unitRef="usd">665000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i88ee1f21a1904304a5934d3026a42b57_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQtNC0xLTEtMA_b2947dc1-fb2b-4af5-ad05-c36ec76e19a8"
      unitRef="usd">549400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idf8b9b630f904fd0b483af12525ec51f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQtNi0xLTEtMA_c8dd914b-ecc8-4686-9923-27cb7e04c4bc"
      unitRef="usd">596000000.0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzUtMi0xLTEtMA_55f1dfbc-7d60-49c8-9f17-4e3bc5f46d5c"
      unitRef="usd">5632300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzUtNC0xLTEtMA_4c13d7e1-8ac0-4744-8f2a-5bb29ba924e7"
      unitRef="usd">3776400000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzUtNi0xLTEtMA_ca40360f-c7b7-42fd-b25e-11ad5ddb9c9a"
      unitRef="usd">3367300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic5585ae25a954d67a9e131196d3a358a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzctMi0xLTEtMA_6d5d2df6-65e4-45ce-831c-b591f2d3e9f0"
      unitRef="usd">1205100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ifb9457cf546c4165b579b1ec171ac91f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzctNC0xLTEtMA_5c040142-1a77-48fe-9919-e5cbb66be969"
      unitRef="usd">953700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i71201bb972ba45a28e50f67d16e6e9a6_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzctNi0xLTEtMA_286aa6f1-068b-4cf6-b358-218dedcd504a"
      unitRef="usd">948700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzgtMi0xLTEtMA_55c16596-7c06-41af-b5d2-b99397768a48"
      unitRef="usd">276700000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzgtNC0xLTEtMA_2c34199b-ab03-4553-a737-936cf974af5c"
      unitRef="usd">253200000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzgtNi0xLTEtMA_008ba73d-717e-465c-a85d-66dac3cb61f8"
      unitRef="usd">318500000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssets
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzktMi0xLTEtMA_02efa159-f212-4a47-912c-1673c6c1dfad"
      unitRef="usd">0</holx:CostOfGoodsSoldImpairmentOfIntangibleAssets>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssets
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzktNC0xLTEtMA_50d2c76c-33a5-40fd-911a-b41f906478b3"
      unitRef="usd">25800000</holx:CostOfGoodsSoldImpairmentOfIntangibleAssets>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssets
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzktNi0xLTEtMA_ff135347-fa70-4546-baca-f61c5659ef6b"
      unitRef="usd">578700000</holx:CostOfGoodsSoldImpairmentOfIntangibleAssets>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8c0068fc5d5747a882ce9ccbd0123f38_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEwLTItMS0xLTA_50d2d232-59ff-4c2b-adf7-645d7b26d5a4"
      unitRef="usd">354700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i88ee1f21a1904304a5934d3026a42b57_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEwLTQtMS0xLTA_304cdf36-c2b5-4f14-adbf-22be1c2fe4b3"
      unitRef="usd">316200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idf8b9b630f904fd0b483af12525ec51f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEwLTYtMS0xLTA_420090b4-6df2-4157-8da1-80558fb91505"
      unitRef="usd">350500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzExLTItMS0xLTA_6a7f1cd3-54cf-4ed8-a578-97862c9b86dd"
      unitRef="usd">3795800000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzExLTQtMS0xLTA_3d931c65-95a5-46f0-8115-a5d9ef742ffc"
      unitRef="usd">2227500000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzExLTYtMS0xLTA_20c03db1-6fe3-476a-b006-a37fa206e40d"
      unitRef="usd">1170900000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEzLTItMS0xLTA_f08077e0-45b9-42bc-ba22-5d197eae3f12"
      unitRef="usd">276300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEzLTQtMS0xLTA_7b7764e2-6f63-4fd9-bc54-daf6d370c7cb"
      unitRef="usd">222500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzEzLTYtMS0xLTA_3599e61c-94e9-445a-91c4-fa36ba2a6cff"
      unitRef="usd">232200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE0LTItMS0xLTA_465cb7bb-7234-42ca-a4cf-d1ce176c4099"
      unitRef="usd">561200000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE0LTQtMS0xLTA_1e6eaed4-0fa3-4c34-87cb-ff292a75f0ea"
      unitRef="usd">484600000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE0LTYtMS0xLTA_5830c18c-fe10-423d-a79d-76d7335ea537"
      unitRef="usd">564900000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE1LTItMS0xLTA_5eb1b5d1-b122-4187-9dc8-43c0347374aa"
      unitRef="usd">433200000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE1LTQtMS0xLTA_5a1895ca-e01d-44fb-9f24-11f8ca587606"
      unitRef="usd">355700000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE1LTYtMS0xLTA_82aceb95-48bb-46b0-93bb-11a885112ab4"
      unitRef="usd">332300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE2LTItMS0xLTA_38637a5d-312e-4d5e-abf8-9400f6e824e8"
      unitRef="usd">42200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE2LTQtMS0xLTA_e346e610-9937-4973-ad9a-0c77024d4bd2"
      unitRef="usd">39700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE2LTYtMS0xLTA_dfcbcb51-e0cb-4d70-8ce1-704f4cd60735"
      unitRef="usd">52000000.0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE3LTItMS0xLTA_eaab701c-fc39-414a-8ab4-cd39917e9156"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE3LTQtMS0xLTA_8b49e1bd-23a1-4e48-9e7e-2fa48a256008"
      unitRef="usd">4400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE3LTYtMS0xLTA_0a182627-923c-403b-af4e-f425138feee1"
      unitRef="usd">106700000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE5LTItMS0xLTA_8d3243aa-1c0c-446f-a7c7-1f43cfc4ed63"
      unitRef="usd">6700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE5LTQtMS0xLTA_e6bfb57a-b589-421c-825a-307909c6b14b"
      unitRef="usd">-300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzE5LTYtMS0xLTA_f150e1e4-a225-461d-bf66-27f2bf631191"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:RestructuringCharges
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI0LTItMS0xLTA_f5e0029c-c95b-4557-812e-93e7475ea1a0"
      unitRef="usd">9300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI0LTQtMS0xLTA_0decb07c-6db9-47ad-9290-77cea236e6af"
      unitRef="usd">15300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI0LTYtMS0xLTA_6e8a0cba-7b17-4353-9d1c-038ac6f80c88"
      unitRef="usd">6600000</us-gaap:RestructuringCharges>
    <us-gaap:OperatingExpenses
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI1LTItMS0xLTA_f77a5998-ab04-4336-b945-345ab333354d"
      unitRef="usd">1315500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI1LTQtMS0xLTA_da7c0cb5-0a58-4755-9288-cb98af8fbf00"
      unitRef="usd">1122500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI1LTYtMS0xLTA_99301ae5-1b46-40c7-8344-40c65f32ab5d"
      unitRef="usd">1294700000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI2LTItMS0xLTA_82f7a404-309a-4e6b-aaab-cf7ca53c89ee"
      unitRef="usd">2480300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI2LTQtMS0xLTA_699565e6-965a-4b37-8866-af6a4d24ce23"
      unitRef="usd">1105000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI2LTYtMS0xLTA_24491850-2887-4d47-8625-5bf603c59ab6"
      unitRef="usd">-123800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI3LTItMS0xLTA_8e1aebf8-8709-4950-9b6c-0d741da553b8"
      unitRef="usd">1400000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI3LTQtMS0xLTA_f5b2abe0-9d6f-4030-9160-639c8a47e8c8"
      unitRef="usd">4300000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI3LTYtMS0xLTA_05515100-967e-4fa4-bb80-829e45fe1404"
      unitRef="usd">4600000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI4LTItMS0xLTA_cd3ba7a8-c2d0-4d04-b99f-0f2b7cc45195"
      unitRef="usd">93600000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI4LTQtMS0xLTA_6389d4c2-f928-472c-94f4-d74ed01da87a"
      unitRef="usd">116500000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI4LTYtMS0xLTA_7a44d98e-1baa-415a-9636-4b6df1994a66"
      unitRef="usd">140800000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI5LTItMS0xLTA_de9aa226-e857-4979-909d-ef6b5eeef045"
      unitRef="usd">-21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI5LTQtMS0xLTA_813e2778-6ca2-4253-af12-05aa997b1795"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzI5LTYtMS0xLTA_62428596-b180-469e-a1d4-a9a652aad524"
      unitRef="usd">-800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMwLTItMS0xLTA_7fd7cf16-074d-4662-99d3-8d6521707fee"
      unitRef="usd">-5400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMwLTQtMS0xLTA_30b65abb-9f38-4826-94f9-e1a18447cbc9"
      unitRef="usd">9100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMwLTYtMS0xLTA_8a8e09ff-6b88-49f6-a88d-2750b4ae7dfa"
      unitRef="usd">3100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMxLTItMS0xLTA_356e08df-a365-4c20-b506-3d380fca7bff"
      unitRef="usd">2361100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMxLTQtMS0xLTA_797e4e0b-87c5-4f2a-857c-406372be34c5"
      unitRef="usd">1001900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMxLTYtMS0xLTA_802ffcde-461b-4462-b440-be294c57ae7d"
      unitRef="usd">-257700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMyLTItMS0xLTA_7c4740ce-3537-4760-b45a-7f588881c2ec"
      unitRef="usd">491400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMyLTQtMS0xLTA_ff9cace7-481e-4ef4-8420-bd22eb9f889b"
      unitRef="usd">-108600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMyLTYtMS0xLTA_8c5f2516-f455-4b98-9767-b10f8e449e63"
      unitRef="usd">-54100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMzLTItMS0xLTA_1dcf447a-194b-490e-9cff-ab1a27b06554"
      unitRef="usd">1869700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMzLTQtMS0xLTA_3473b0b5-b5d0-4803-8cb2-6b2004c8da47"
      unitRef="usd">1110500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzMzLTYtMS0xLTA_483f3bae-e9f9-4d92-8769-fe3cc6dbbdd4"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM0LTItMS0xLTA_b2b27795-5f3e-45a2-b339-09a6f14bb5bc"
      unitRef="usd">-1800000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM0LTQtMS0xLTA_e6d465f3-f8cc-4c62-bb07-25d030569e0d"
      unitRef="usd">-4700000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM0LTYtMS0xLTA_af850368-1881-46c2-a359-6ba1f09e11b5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM1LTItMS0xLTA_fa824cb7-f26a-418c-8a0d-fbcdc0be6795"
      unitRef="usd">1871500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM1LTQtMS0xLTA_b4fdecf7-e31c-42d7-8a3d-b4db78674101"
      unitRef="usd">1115200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM1LTYtMS0xLTA_46f9b5cd-0de8-4b1a-bd7c-5b11700b5a13"
      unitRef="usd">-203600000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM3LTItMS0xLTA_af580723-9ba6-4e17-bf7f-572e5fddd2b7"
      unitRef="usdPerShare">7.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM3LTQtMS0xLTA_51162ee5-7d21-4fa0-acc7-283847f19b86"
      unitRef="usdPerShare">4.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM3LTYtMS0xLTA_7ccf75ff-0029-4fec-a8e0-3dd68c0f6e26"
      unitRef="usdPerShare">-0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM4LTItMS0xLTA_20b575ef-3f4e-4177-bd96-b3cea7907734"
      unitRef="usdPerShare">7.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM4LTQtMS0xLTA_0325c60f-07d5-4b11-9c3f-b8c52e834862"
      unitRef="usdPerShare">4.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzM4LTYtMS0xLTA_fb5b7624-1b2b-48a8-b207-afbbbddf6b4c"
      unitRef="usdPerShare">-0.76</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQwLTItMS0xLTA_282a886b-ec7c-41a8-b990-b5726498dc9f"
      unitRef="shares">257046000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQwLTQtMS0xLTA_57a0f7ac-9918-438c-8fbf-ebe538f0ab46"
      unitRef="shares">262727000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQwLTYtMS0xLTA_ff5da366-6717-4d2b-8625-604cb9c8136a"
      unitRef="shares">269413000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQxLTItMS0xLTA_eab60768-250a-46b8-a615-050cd77284f2"
      unitRef="shares">259706000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQxLTQtMS0xLTA_b204b688-4000-4bc1-a058-372a097d4f51"
      unitRef="shares">264613000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTIvZnJhZzphYjU0OTIwNTUwMDk0YzMwODAwODIyNDk1ZDM1YjYzNy90YWJsZToyN2MzYTkwYjY2ZTY0NWE4OTIzMjNhMDJmMzZhNzYwYy90YWJsZXJhbmdlOjI3YzNhOTBiNjZlNjQ1YTg5MjMyM2EwMmYzNmE3NjBjXzQxLTYtMS0xLTA_d4ce6d85-eea7-4b15-8f80-d4487e4a3aa8"
      unitRef="shares">269413000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzItMi0xLTEtMA_3b35fe5e-e164-420a-8df8-7061a91babbc"
      unitRef="usd">1869700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzItNC0xLTEtMA_12494bb9-ebe0-40c2-bfd4-5f6e34bc503d"
      unitRef="usd">1110500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzItNi0xLTEtMA_8fafcbaa-8ca6-4aec-8e9e-97414edc82a2"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzMtMi0xLTEtMA_5534fe0c-d0a1-4866-95d8-99a2033f7bb3"
      unitRef="usd">-20200000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzMtNC0xLTEtMA_98cc7d84-f079-4f5d-b12f-1c0fe1a222bd"
      unitRef="usd">18500000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzMtNi0xLTEtMA_e86d1a6a-394d-49b2-a4de-b2c2a3572e69"
      unitRef="usd">-14800000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctMC0xLTEtMC90ZXh0cmVnaW9uOjhhNmExMTZiMjAyNzQ0M2NiOTQxMGQ3NWYwZGY2MmYyXzQ2_dd09c741-542a-4c77-be0c-082befeef9e8"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctMC0xLTEtMC90ZXh0cmVnaW9uOjhhNmExMTZiMjAyNzQ0M2NiOTQxMGQ3NWYwZGY2MmYyXzU4_19534b2c-f7e4-4537-bc9a-467c0740e742"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctMC0xLTEtMC90ZXh0cmVnaW9uOjhhNmExMTZiMjAyNzQ0M2NiOTQxMGQ3NWYwZGY2MmYyXzc0_1bb16f0f-3653-4ab9-a15c-82e27fd52fd2"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctMi0xLTEtMA_273632e6-2dd3-46d8-9b09-0f950aa04bc5"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctNC0xLTEtMA_071b53ee-74d2-4458-b6c7-c860a90b7f68"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzctNi0xLTEtMA_99241978-b2cf-4e2b-9a08-9bce4dabeb3e"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <holx:TaxOnInterestRateSwap
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmZkOWQ3OWM4NjA3YTQ2YWM5ZDA4MWQ5Y2NhYWU1MGQ1XzQy_0bd248be-697c-4ca6-b6cd-c0ad896ac716"
      unitRef="usd">2500000</holx:TaxOnInterestRateSwap>
    <holx:TaxOnInterestRateSwap
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmZkOWQ3OWM4NjA3YTQ2YWM5ZDA4MWQ5Y2NhYWU1MGQ1XzY1_dd9d2d4c-09de-4b95-9a43-01df0a062ae1"
      unitRef="usd">-8300000</holx:TaxOnInterestRateSwap>
    <holx:TaxOnInterestRateSwap
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtMC0xLTEtMC90ZXh0cmVnaW9uOmZkOWQ3OWM4NjA3YTQ2YWM5ZDA4MWQ5Y2NhYWU1MGQ1XzEwOTk1MTE2Mjc5NTE_cc1f960c-d1c7-4cff-9609-734744eb1781"
      unitRef="usd">1200000</holx:TaxOnInterestRateSwap>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtMi0xLTEtMA_d3a70c1c-d642-4d59-8467-a505dc4b35a3"
      unitRef="usd">9400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtNC0xLTEtMA_459d6a76-4d42-4097-b837-08c7132ad178"
      unitRef="usd">-27600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib3278f0ce96b40519a22ae965c771b3f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzgtNi0xLTEtMA_b404e3a7-a177-41bb-a136-3836e5c82c34"
      unitRef="usd">3500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzktMC0xLTEtMC90ZXh0cmVnaW9uOmFlMTkxMTc1MmFmYjQyM2ZiOTc1NmU0MGJlZjcxYmYyXzY1_1c053598-cd98-42e6-9408-500c8839b054"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzktMC0xLTEtMC90ZXh0cmVnaW9uOmFlMTkxMTc1MmFmYjQyM2ZiOTc1NmU0MGJlZjcxYmYyXzc3_4620fc9c-c6bb-48d7-8185-cfd55487392f"
      unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzktMC0xLTEtMC90ZXh0cmVnaW9uOmFlMTkxMTc1MmFmYjQyM2ZiOTc1NmU0MGJlZjcxYmYyXzkz_cc4a64d1-218c-4861-ad7e-8f2655def429"
      unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEwLTItMS0xLTA_0cffaae0-9153-435a-a475-b06cefcea76a"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEwLTQtMS0xLTA_363eada0-1e4b-4fdf-b583-cf0ba43c61f5"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEwLTYtMS0xLTA_570b357c-0d49-4420-962e-4091957f0918"
      unitRef="usd">-8000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzExLTItMS0xLTA_041e9544-954a-4ff8-bf1e-f0f6438ae81e"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzExLTQtMS0xLTA_21bc88b1-3c0d-4619-9f48-b97377539e9e"
      unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzExLTYtMS0xLTA_a46c8e5d-fa6a-4c87-817e-2a0893faeaad"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEyLTItMS0xLTA_439ded84-52ea-4f9a-a664-0d606aba3f3a"
      unitRef="usd">-9400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEyLTQtMS0xLTA_98846f1c-909a-4565-bb5e-9df18954613c"
      unitRef="usd">-7400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEyLTYtMS0xLTA_bac0b1a6-2099-4235-9512-572e6744b5c6"
      unitRef="usd">-16800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEzLTItMS0xLTA_f89ae462-dece-4c5e-be9a-ca8febce151a"
      unitRef="usd">1860300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEzLTQtMS0xLTA_05867af2-8789-429b-bde4-986b3a901f24"
      unitRef="usd">1103100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzEzLTYtMS0xLTA_5bf16581-c267-48cf-9dd5-6e7f67d97ac4"
      unitRef="usd">-220400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE1LTItMS0xLTA_e4907b21-f5a1-45cd-be18-18a511f38085"
      unitRef="usd">1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE1LTQtMS0xLTA_61a2684a-64ea-40ad-b48c-1d8cd9348125"
      unitRef="usd">4700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE1LTYtMS0xLTA_af850368-1881-46c2-a359-6ba1f09e11b5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE2LTItMS0xLTA_62ac35ff-1e92-4911-bd4d-560f0c3a29df"
      unitRef="usd">1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE2LTQtMS0xLTA_9c4ee89c-1a87-4529-8228-9077bc509a55"
      unitRef="usd">4700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE2LTYtMS0xLTA_96934125-9670-4f15-993f-95461d44c879"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <holx:ComprehensiveIncome
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE3LTItMS0xLTA_1d03207e-02ea-42c6-8f65-7b9201f00155"
      unitRef="usd">1862100000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE3LTQtMS0xLTA_9e7fd85a-d301-4b47-bb09-6189b2ff760f"
      unitRef="usd">1107800000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTUvZnJhZzo1NTZhOThlOGMwOGI0N2VlYWExODA1MDlhNmMxMzg4ZC90YWJsZTphYzc4MzRhZjUyNjE0MTk1YjU3ZjZkMGFhMzYxMTE4MC90YWJsZXJhbmdlOmFjNzgzNGFmNTI2MTQxOTViNTdmNmQwYWEzNjExMTgwXzE3LTYtMS0xLTA_f141cbcb-5076-44fa-8c08-96f62c2352ff"
      unitRef="usd">-220400000</holx:ComprehensiveIncome>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMtMS0xLTEtMA_1dbc7463-132c-4e9e-ae95-f6fc959c899a"
      unitRef="usd">1170300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMtMy0xLTEtMA_961e8e1c-1297-4fae-837c-5632367c7a4c"
      unitRef="usd">701000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzUtMS0xLTEtMA_87a0cbd7-b9c8-4129-aefc-53fc2dd113ad"
      unitRef="usd">942700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzUtMy0xLTEtMA_fd33931f-c701-4a2f-ac18-75850b835708"
      unitRef="usd">1028900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzYtMS0xLTEtMA_f85f8170-ebdc-49e6-bbd2-e11396f8ca63"
      unitRef="usd">501200000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzYtMy0xLTEtMA_306faacb-ffa6-435d-a6ff-e89eac4ace8a"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzgtMS0xLTEtMA_1b59ed51-fdfa-4dcc-b743-c0b8a9dd741b"
      unitRef="usd">25700000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzgtMy0xLTEtMA_3a61912e-8eb6-4019-b2cf-db350e1f7c01"
      unitRef="usd">38800000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzktMS0xLTEtMA_0198630a-2687-40ef-ad0c-101bffae2f92"
      unitRef="usd">528800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzktMy0xLTEtMA_9a0ea386-7800-4ae3-8bb1-5c455451afce"
      unitRef="usd">58500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzExLTEtMS0xLTA_6facea3f-3f16-47e7-93b0-8a871727ce74"
      unitRef="usd">3168700000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzExLTMtMS0xLTA_3e604866-0767-4191-946c-8d18b48d4b9c"
      unitRef="usd">2222300000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzEyLTEtMS0xLTA_bffef25e-5819-44fe-9049-9217a51ce396"
      unitRef="usd">564700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzEyLTMtMS0xLTA_87143de2-9b92-4e29-a9da-b21d0f4b72d0"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzEzLTEtMS0xLTA_5e77717b-02bc-4078-9f88-bd15cccbf7a4"
      unitRef="usd">1659200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzEzLTMtMS0xLTA_7c903662-4641-4d09-bcf3-f47c242ac61d"
      unitRef="usd">1307500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE0LTEtMS0xLTA_b3c05b64-f070-4eef-8e9d-96f5e49daebb"
      unitRef="usd">3281600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE0LTMtMS0xLTA_7bd56083-07c6-4acd-983b-0cfc09c277c1"
      unitRef="usd">2657900000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE1LTEtMS0xLTA_e5515425-9731-4bb8-9a50-3de6cd46be9b"
      unitRef="usd">245700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE1LTMtMS0xLTA_46b4de41-84e7-4278-9c22-0af2443ef579"
      unitRef="usd">516600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE2LTEtMS0xLTA_2e3a48ab-9dba-4da2-8b6b-f782bd4d534d"
      unitRef="usd">8919900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE2LTMtMS0xLTA_9f40f6e5-0703-4219-b413-08626a5c1dcd"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE5LTEtMS0xLTA_554167f1-4836-4952-a629-3f7831d0959d"
      unitRef="usd">313000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzE5LTMtMS0xLTA_9ad95b57-f8c4-4069-a581-222598b56d79"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIwLTEtMS0xLTA_194868c0-c936-47d3-acd5-2ba9f75e20a9"
      unitRef="usd">215900000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIwLTMtMS0xLTA_b40e97fa-741a-4510-97ae-b1ad9a2790fe"
      unitRef="usd">178800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIxLTEtMS0xLTA_d18a884e-bd27-4336-9191-ec389d09c7fb"
      unitRef="usd">596200000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIxLTMtMS0xLTA_f368794c-e669-4e42-934e-2de8480e861e"
      unitRef="usd">547600000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIyLTEtMS0xLTA_711eff5b-b333-4b67-b0d0-e93e6fdf9017"
      unitRef="usd">198000000.0</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzIyLTMtMS0xLTA_2e333a6f-3d96-4094-b572-abbb8b6d45d2"
      unitRef="usd">186100000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI0LTEtMS0xLTA_5e5708f6-1f80-4e23-b395-3b134b291b3d"
      unitRef="usd">3700000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI0LTMtMS0xLTA_871e1d91-e7e1-44a9-aec3-0f2d645396e5"
      unitRef="usd">1900000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI1LTEtMS0xLTA_92025596-72c2-4d19-a203-0f97d0a3342e"
      unitRef="usd">1326800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI1LTMtMS0xLTA_119eccc9-bf09-4a9d-a466-dc235748e427"
      unitRef="usd">1239300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI2LTEtMS0xLTA_f8a7e9d4-7383-42a0-81cd-15ba796be8ef"
      unitRef="usd">2712200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI2LTMtMS0xLTA_3861c576-4108-4968-84c2-2e734e756b94"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI3LTEtMS0xLTA_bac99511-450f-478c-8d28-a5b267e7e371"
      unitRef="usd">22800000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI3LTMtMS0xLTA_9340faa2-8418-4f92-be5a-211865783a31"
      unitRef="usd">17400000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI4LTEtMS0xLTA_31db819e-451e-4d55-81ce-c1961074ba43"
      unitRef="usd">250500000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI4LTMtMS0xLTA_c31bfe6f-3f69-4526-b319-eab355058da0"
      unitRef="usd">201800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI5LTEtMS0xLTA_c0209f57-2fa5-4fb0-8cf9-35d827b9a717"
      unitRef="usd">20300000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzI5LTMtMS0xLTA_3b944593-2fce-45fe-8331-000013052ab5"
      unitRef="usd">12900000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMwLTEtMS0xLTA_bf003fad-ec27-4a10-b898-1e5ab8ebb572"
      unitRef="usd">368700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMwLTMtMS0xLTA_c13b3d02-497d-4dc1-aa45-078ad630a4c2"
      unitRef="usd">303200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMxLTEtMS0xLTA_61539d76-2a94-4aa7-8dba-6ed1c8b2cb51"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMxLTMtMS0xLTA_3b77f3d6-a2cf-4f6c-8489-51223c32d214"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY18yMQ_5572bf94-f079-4309-bfeb-9785b594fdee"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY18yMQ_807c4fb0-794a-43de-9825-af457c6af98b"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY18zNg_2864592d-4b76-4145-8f19-b31568eabdbe"
      unitRef="shares">1623000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY18zNg_a3dbe6c1-7a47-4b61-9adc-7cef15074d94"
      unitRef="shares">1623000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY181OA_9300666a-c582-4eb6-b98a-95cdc5491066"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowNmY2ZDg5N2Q3NzI0YzRmOTUwZDc2OTk4NDA2MTFiY181OA_e7b1173d-be4f-4456-abca-6b5ca695cd78"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTEtMS0xLTA_9e05e380-140e-40b4-827a-a584f6f1b343"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzMzLTMtMS0xLTA_54e8f4bb-d01f-4533-a7bd-0f22c4c4ddf8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF8xOA_4beb7a66-b198-4e28-b284-b9f52958ab23"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF8xOA_cf4be3c2-aba5-491d-bfab-06d4e64919d2"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF8zMw_7f7a011c-cdd6-4c7f-b171-e873952a5b77"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF8zMw_eb6005b2-f2b6-45d5-9029-9c279033ee98"
      unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF81NQ_55ef8cb3-43f1-4b8e-83d7-5200f6a427ef"
      unitRef="shares">297306000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5MTgwYjMyZDk0MDY0NWE0YThjYmNiMjIzOTU0MmQyZF82Mg_a70968de-0a73-41da-a4eb-57bfdbbb3773"
      unitRef="shares">295107000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTEtMS0xLTA_9ea875e8-eb84-4b0a-8f5b-3a4ac59a15cd"
      unitRef="usd">3000000.0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM0LTMtMS0xLTA_09e2dabe-17c0-4409-8772-ca0534f3dc6d"
      unitRef="usd">2900000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM1LTEtMS0xLTA_ebf8af37-191d-472e-ac69-962e4986bbe3"
      unitRef="usd">5965800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM1LTMtMS0xLTA_dd075f39-2031-400a-be9a-91bb4d6de05f"
      unitRef="usd">5904800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM2LTEtMS0xLTA_b0fa96e2-66f2-4705-bbfd-3dc46251de46"
      unitRef="usd">298300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM2LTMtMS0xLTA_a44d297c-86c5-499e-8ef2-9c49a0bf69cb"
      unitRef="usd">-1573200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpjODg5M2Q4ZjMzYTg0N2E1OWVmYjlkOWI5OThjMGZmY18zMA_ebfbda9f-2b60-4ee3-97fe-eaa196dcb207"
      unitRef="shares">43653000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpjODg5M2Q4ZjMzYTg0N2E1OWVmYjlkOWI5OThjMGZmY18zNw_4fc5b4dc-5f38-49be-8ddd-6cfddfe1bcdf"
      unitRef="shares">37609000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM3LTEtMS0xLTA_1c82f114-af93-4cb5-9cc3-e877223fb95c"
      unitRef="usd">1989400000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM3LTMtMS0xLTA_ecae1f30-4a1d-4807-9abd-7887020bb156"
      unitRef="usd">1579600000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM4LTEtMS0xLTA_c34bb332-535a-435f-810e-bdfbbbf5dfa1"
      unitRef="usd">-59100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM4LTMtMS0xLTA_69e44eb3-5110-4b1b-ba03-27f8e1354fe2"
      unitRef="usd">-49700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM5LTEtMS0xLTA_33355bfa-1f88-4366-8c5d-c33480b6a3e1"
      unitRef="usd">4218600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzM5LTMtMS0xLTA_a1f7bb19-efb5-45f5-8316-f3fa2ee46ab6"
      unitRef="usd">2705200000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQwLTEtMS0xLTA_3258db38-f0b0-4e99-8448-0466b8b97847"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQwLTMtMS0xLTA_5a0af313-f9a1-49e2-be33-72df4cf7d5ad"
      unitRef="usd">2100000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQxLTEtMS0xLTA_1f88c947-cb36-498c-94a4-7797e372f9f6"
      unitRef="usd">4218600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQxLTMtMS0xLTA_27e77cfa-7550-4631-bcd2-a0f6e1560770"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQyLTEtMS0xLTA_0f2b5d9c-a96a-4a4e-bf19-8f8d9c75f902"
      unitRef="usd">8919900000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMTgvZnJhZzoxYzA4NDc3ZjZiY2Y0NDM1YWM0ZmE3OGVmYjM3YTBmMC90YWJsZToxMDk1ZGJkYjMwYTQ0MzVhYWU5NmMwMGIzM2YwNWFkNC90YWJsZXJhbmdlOjEwOTVkYmRiMzBhNDQzNWFhZTk2YzAwYjMzZjA1YWQ0XzQyLTMtMS0xLTA_d5a87e02-b6a3-4dc1-877a-735528ca61a0"
      unitRef="usd">7195800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ia927c77ddd4b4c3f9e25433620cafd9a_I20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTItMS0xLTA_ab49954d-dea9-458d-8045-2e4605cd62dd"
      unitRef="shares">289900000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia927c77ddd4b4c3f9e25433620cafd9a_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTQtMS0xLTA_56db00a1-41f0-49d2-84cb-a616159677dc"
      unitRef="usd">2900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92f8eca055a24f3ba805ccce80af7729_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTYtMS0xLTA_e87af301-5407-4538-90c5-8a9b48bd0971"
      unitRef="usd">5671300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic258825922e845e48ae770d90cf914bf_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTgtMS0xLTA_a2cbd919-e828-4117-b910-177ed92a7abe"
      unitRef="usd">-2494000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i684e08be393948ad91d177dd16acf8c5_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTEwLTEtMS0w_2c65af54-d7e2-48e2-9766-16c9e9bb33fa"
      unitRef="usd">-25500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i7511415f2519453297890d5928acc96d_I20180929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTEyLTEtMS0w_1f571271-2ed0-4fc8-b15e-45e3182dd3c9"
      unitRef="shares">19812000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7511415f2519453297890d5928acc96d_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTE0LTEtMS0w_a13766f1-4e46-4056-944b-0d20562e0d89"
      unitRef="usd">-725900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5428b64a6a64d48acae1ca5892619ff_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTE4LTEtMS0w_c084af84-cef4-4bb9-83a0-59539cc1630d"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE3LTIwLTEtMS0w_64db766c-e525-4912-8d97-b62f59cd0442"
      unitRef="usd">2428800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <holx:AccountingstandardtransitionadjustmentASC606
      contextRef="i330e64f51bae41568645cc62f16c3c3c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE4LTgtMS0xLTA_f958115e-c6e6-4228-b69a-cc35de9f449a"
      unitRef="usd">-6400000</holx:AccountingstandardtransitionadjustmentASC606>
    <holx:AccountingstandardtransitionadjustmentASC606
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE4LTIwLTEtMS0w_0ec5ccbd-f529-4dfa-9e2f-993c7ae80a0d"
      unitRef="usd">-6400000</holx:AccountingstandardtransitionadjustmentASC606>
    <holx:AccountingstandardtransitionadjustmentASU201616
      contextRef="i330e64f51bae41568645cc62f16c3c3c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE5LTgtMS0xLTA_481bde5d-7e36-426c-b254-8deafe854c9f"
      unitRef="usd">-2500000</holx:AccountingstandardtransitionadjustmentASU201616>
    <holx:AccountingstandardtransitionadjustmentASU201616
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzE5LTIwLTEtMS0w_4f8680fe-74c8-4d08-8523-efa04a7b0b06"
      unitRef="usd">-2500000</holx:AccountingstandardtransitionadjustmentASU201616>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4332687a95c44e4381175f1e41bb50d2_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIwLTItMS0xLTA_710babab-3b62-4416-9f87-f3e7ff72843b"
      unitRef="shares">1304000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ide57006743114d5bbe3750f80d39e212_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIwLTYtMS0xLTA_9dd414ea-ff71-4743-9ae6-a1f070eec94b"
      unitRef="usd">32800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIwLTIwLTEtMS0w_2b37acad-341c-4ba7-a0b2-a7c1e798ea8b"
      unitRef="usd">32800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i4332687a95c44e4381175f1e41bb50d2_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIxLTItMS0xLTA_544c9836-706a-4b01-9842-54331bc34b74"
      unitRef="shares">645000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ide57006743114d5bbe3750f80d39e212_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIxLTYtMS0xLTA_e14e01a6-5c3b-4e52-8a9f-09f3186b82e2"
      unitRef="usd">-12800000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIxLTIwLTEtMS0w_bff5d188-4180-49a5-b9b7-24368e153caa"
      unitRef="usd">-12800000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i4332687a95c44e4381175f1e41bb50d2_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIyLTItMS0xLTA_3e43194c-01ca-4c58-85fc-9165fa6dc8e8"
      unitRef="shares">474000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ide57006743114d5bbe3750f80d39e212_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIyLTYtMS0xLTA_0856378c-a01e-40ac-937b-3d93dc514d09"
      unitRef="usd">16500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIyLTIwLTEtMS0w_eec6dc6d-f72e-4ea5-93d4-93bbd6e68c0c"
      unitRef="usd">16500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ide57006743114d5bbe3750f80d39e212_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIzLTYtMS0xLTA_dc5170aa-891d-4634-b270-b453a4ac450c"
      unitRef="usd">62000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzIzLTIwLTEtMS0w_c384a1a8-f33e-45d5-ae3e-facd702c95da"
      unitRef="usd">62000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="i330e64f51bae41568645cc62f16c3c3c_D20180930-20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI0LTgtMS0xLTA_b27f4909-3c12-40f5-ab55-8893fc5f879b"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI0LTIwLTEtMS0w_08d0bb89-435c-4058-9fe3-269d87740bf3"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI1LTEwLTEtMS0w_7b861eff-4289-4566-8320-3ab65140aa9b"
      unitRef="usd">-14800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI1LTIwLTEtMS0w_63284825-3722-4a72-aa01-3011db027f9f"
      unitRef="usd">-14800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI2LTEwLTEtMS0w_1493be93-ccac-4f47-a58b-ee1b91f93e69"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI2LTIwLTEtMS0w_5b88d616-6036-4f65-b1de-0ae9a316d963"
      unitRef="usd">600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib2bc815063394f1c91be4496c525a478_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI3LTEyLTEtMS0w_959b8813-89cb-4899-8cd7-5bb4041c1f91"
      unitRef="shares">4826000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ib2bc815063394f1c91be4496c525a478_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI3LTE0LTEtMS0w_ef3ec316-bfc1-40a5-a0cc-24a5a8c37712"
      unitRef="usd">200100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI3LTIwLTEtMS0w_bae22ca9-4a77-4a80-9282-2b80ccf1fc3d"
      unitRef="usd">200100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI4LTEwLTEtMS0w_21b1fa39-d233-40f6-9c81-3c2974e7f458"
      unitRef="usd">-8000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI4LTIwLTEtMS0w_b3f2c53c-42f1-425c-ae3d-79fa1c7d7825"
      unitRef="usd">-8000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI5LTEwLTEtMS0w_149a683b-1541-41f5-889b-f4cf8b6677a3"
      unitRef="usd">3500000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzI5LTIwLTEtMS0w_42e308b5-36da-4dae-b6df-9dfea3c1c65c"
      unitRef="usd">3500000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax
      contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMwLTEwLTEtMS0w_8a6f2914-cda3-487c-af0f-2424ecda6d8a"
      unitRef="usd">-3100000</holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax>
    <holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax
      contextRef="id07b8aa07d324dbeae303fa509af960d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMwLTIwLTEtMS0w_ba9fa6c3-9910-407b-80ca-c5f46b760341"
      unitRef="usd">-3100000</holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i09031c9523ad42779d78b1cea5ecfffd_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTItMS0xLTA_6e8f5ac2-b0ac-4783-911e-2f66ec792eae"
      unitRef="shares">292323000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i09031c9523ad42779d78b1cea5ecfffd_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTQtMS0xLTA_a6b7c170-7b15-40fe-b6ca-a15013ef942c"
      unitRef="usd">2900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i107888c74437440cbe2fd3eed3be8cb2_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTYtMS0xLTA_79f7b6f6-4957-43ff-aa07-bc8efc79e18f"
      unitRef="usd">5769800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifccad0744b37455da40b51a3e9af3cab_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTgtMS0xLTA_a5548aac-711e-4d7f-b17c-f91ccd9aee66"
      unitRef="usd">-2688700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7986c81bc3444e2bac570e31b4e5a5d_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTEwLTEtMS0w_811f2708-883a-4597-8ac1-af18273dfff0"
      unitRef="usd">-42300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i8210852c21614405a339fbf5ee62cbc2_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTEyLTEtMS0w_5181612d-168e-44cb-845d-a907247a4f4c"
      unitRef="shares">24638000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8210852c21614405a339fbf5ee62cbc2_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTE0LTEtMS0w_7e5608bf-036e-4081-8033-d43568c4d77c"
      unitRef="usd">-926000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7bb44d2cf92b48549d1472c325455031_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTE4LTEtMS0w_e4886653-ea8d-4138-8c7c-1e7a33913f62"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMyLTIwLTEtMS0w_af3c9a2f-a1a7-4fa1-83b1-35f45edc2a17"
      unitRef="usd">2115700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMzLTE4LTEtMS0w_ea507b2d-c90c-4ce9-9fca-d0c77b1e53e5"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzMzLTIwLTEtMS0w_bbf88dcf-2c02-4ac7-b482-432e678bf9c1"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <holx:AccountingStandardTransitionAdjustmentASU842
      contextRef="iba28c6f4ffe544f5845e9d09779a223b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTgtMS0xLTA_c22cfe3a-5543-430c-8779-fb0e19382cd9"
      unitRef="usd">300000</holx:AccountingStandardTransitionAdjustmentASU842>
    <holx:AccountingStandardTransitionAdjustmentASU842
      contextRef="iba28c6f4ffe544f5845e9d09779a223b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTIwLTEtMS0w_633d5baa-641f-4037-8616-8bef7bcc62f8"
      unitRef="usd">300000</holx:AccountingStandardTransitionAdjustmentASU842>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if7190f0470994899bbd92415a32894ec_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTItMS0xLTA_c4e2229d-e207-4cc6-ad5a-e683e0a769ff"
      unitRef="shares">1761000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTYtMS0xLTA_e738a0b3-7a8d-435d-bd2b-c6fd9b9511e4"
      unitRef="usd">48300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTIwLTEtMS0w_02f49b89-ef98-4b79-a99b-962cd3f497f2"
      unitRef="usd">48300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="if7190f0470994899bbd92415a32894ec_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTItMS0xLTA_4ce1eb88-d2e4-430e-a7ee-72093ca05cb5"
      unitRef="shares">611000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTYtMS0xLTA_d5b4ced8-0614-4003-bcfe-8c1ee779e92c"
      unitRef="usd">-14200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTIwLTEtMS0w_440d5ab7-c9b9-4e1f-b220-f01ccbfb69e5"
      unitRef="usd">-14200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if7190f0470994899bbd92415a32894ec_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTItMS0xLTA_efd4c48a-82ef-48f2-9082-0ec047ea60ef"
      unitRef="shares">412000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTYtMS0xLTA_7d35cd61-1c7a-4a09-be1a-deee534d5bc4"
      unitRef="usd">17600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTIwLTEtMS0w_49091aef-0d5d-4aae-a990-c69ae061793e"
      unitRef="usd">17600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i22fcbece8ec241eb8238bf9ccdf2e7e2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTYtMS0xLTA_d5ed3c58-a7ff-42c0-90e8-ae10948344d3"
      unitRef="usd">83300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTIwLTEtMS0w_5bdf31a0-ab7b-43f2-8bad-2792aa5fd04c"
      unitRef="usd">83300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="i4afe6a62c1ae4038bd5fc9a1b0c45638_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTgtMS0xLTA_5883a74b-a39a-4670-a60a-cd0b8e29d0f0"
      unitRef="usd">1115200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTE4LTEtMS0w_0494d001-c472-43a0-9144-b54da2d50862"
      unitRef="usd">-4700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTIwLTEtMS0w_a99805ae-5f7f-4826-aa9b-8c86d8a114b3"
      unitRef="usd">1110500000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQwLTEwLTEtMS0w_610bbbee-d765-4a48-a78b-8d2d99c2e850"
      unitRef="usd">18500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQwLTIwLTEtMS0w_07f7cd6d-960c-437a-9d66-33bf76490fb0"
      unitRef="usd">18500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTEwLTEtMS0w_044a040b-040a-4315-bb56-08535d469a2f"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTIwLTEtMS0w_8f6e9b8c-2b0f-4281-a272-5900a3842575"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i7452f8bbde6a4dc0b0d39086f1ec6fb2_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQyLTEyLTEtMS0w_455af024-1af3-4bc0-a933-ce35dbbc1f4d"
      unitRef="shares">9064000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i7452f8bbde6a4dc0b0d39086f1ec6fb2_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQyLTE0LTEtMS0w_2cd0778a-32a8-4670-aaad-7d2e5dfb9cb1"
      unitRef="usd">448600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQyLTIwLTEtMS0w_fcded0af-9a5f-4e10-aec3-1b91bb9f40d1"
      unitRef="usd">448600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i22b5647d92ba43c1addee91de2482e15_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTEyLTEtMS0w_6b0ae54b-8cb6-40c3-ac55-62f16065e061"
      unitRef="shares">3907000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i22b5647d92ba43c1addee91de2482e15_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTE0LTEtMS0w_73b3af2e-71d0-4e7b-bfbd-2cbe3fb71da9"
      unitRef="usd">205000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i52f80aa9ecc24057bc66c2e40b7eb278_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTIwLTEtMS0w_3d2b3fc7-8d25-401f-a205-a1f2d4414433"
      unitRef="usd">205000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes
      contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ0LTEwLTEtMS0w_92739674-28fb-45ae-ba23-bf6d6b29df2b"
      unitRef="usd">-500000</holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes>
    <holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ0LTIwLTEtMS0w_b4c4a4aa-be7e-4f68-8bca-5623ab0c3b30"
      unitRef="usd">-500000</holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTEwLTEtMS0w_ebda1e59-9b39-41d7-ae9b-a7625c621231"
      unitRef="usd">-27600000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTIwLTEtMS0w_4e22e488-e091-4b75-bab3-8b3ee70748fe"
      unitRef="usd">-27600000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax
      contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTEwLTEtMS0w_045efa46-3100-4a89-b05a-5df1bb69bcf4"
      unitRef="usd">-2300000</holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax>
    <holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax
      contextRef="i99b75ace48164fc8a37918a8d894ab9f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTIwLTEtMS0w_3dbc41d8-7ce7-445a-883b-cbbcce55e920"
      unitRef="usd">-2300000</holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ3LTE4LTEtMS0w_1ef0a82e-c1b9-47a4-925f-0feb432ce296"
      unitRef="usd">1800000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i20137030de3e4f1d904a2fca15e11e90_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ3LTIwLTEtMS0w_348e0ff2-7773-4e48-81b4-f6ccddcd99c9"
      unitRef="usd">1800000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:SharesIssued
      contextRef="i349d16b63da54ca1a91efd54fc2025a2_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTItMS0xLTA_6545b1b5-a4a2-464a-813b-7b180d46e990"
      unitRef="shares">295107000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i349d16b63da54ca1a91efd54fc2025a2_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTQtMS0xLTA_193c32d8-5c71-4a8c-9531-54dbba7f02b6"
      unitRef="usd">2900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife279decce604602a60f3488e853f6ec_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTYtMS0xLTA_642319a9-fc82-42ba-9e08-30824ae4db11"
      unitRef="usd">5904800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i270a8009f56048a5aeb8b08ad88b3013_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTgtMS0xLTA_64d3b654-9d42-4c9a-b71c-e777e1b39c9f"
      unitRef="usd">-1573200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib61d23ac15c4492d8dadef811af5939a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTEwLTEtMS0w_a3df75d2-6e0f-4463-baeb-170c7442bb90"
      unitRef="usd">-49700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i0b95455d5e674ece8cf4c41a77810b2f_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTEyLTEtMS0w_7d26aa8a-c964-4cb5-a192-e529d396c97f"
      unitRef="shares">37609000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b95455d5e674ece8cf4c41a77810b2f_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTE0LTEtMS0w_80ac53a6-c607-4e82-b6ff-78edd34791d6"
      unitRef="usd">-1579600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4910978b239f42caab2d6ea6ebc0a8a4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTE4LTEtMS0w_c259faae-d3d1-4424-9be0-87389775adb2"
      unitRef="usd">2100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ4LTIwLTEtMS0w_e23299dc-d575-4a37-a819-6afe292ead08"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2c0525997c5f435fb443ec3494b56714_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTItMS0xLTM0MTQ0_46a62bcb-8118-4881-ab91-cfa1899aa7ad"
      unitRef="shares">857000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTYtMS0xLTM0MTQ4_51bace4f-07a0-4f94-b214-4cf838758c87"
      unitRef="usd">32900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM0LTIwLTEtMS0zNDE4Mg_b97b0f4e-652c-43ea-a8f7-0b04c37dc181"
      unitRef="usd">32900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i2c0525997c5f435fb443ec3494b56714_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTItMS0xLTM0MTUw_ee3ded33-733b-4292-aa30-5fadec19982d"
      unitRef="shares">980000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <holx:ChangeInParValue
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTQtMS0xLTM0MTUy_c1366944-8894-42fb-81a5-41e37300ca1f"
      unitRef="usd">100000</holx:ChangeInParValue>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTYtMS0xLTM0MTU0_8beb8a85-ecb1-4383-9ea1-572479910285"
      unitRef="usd">-47600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM1LTIwLTEtMS0zNDE4NA_3c4b083d-a2b5-4120-8cd9-ae66cc6894df"
      unitRef="usd">-47500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i2c0525997c5f435fb443ec3494b56714_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTItMS0xLTM0MTU2_42843114-f171-414e-8da4-3deb68c6aca4"
      unitRef="shares">362000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTYtMS0xLTM0MTU4_bc5b7395-8738-48d1-ba2a-c75fac03f749"
      unitRef="usd">18900000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM2LTIwLTEtMS0zNDE4Ng_ece1a85d-de9a-41d8-911c-af82fa81ff1f"
      unitRef="usd">18900000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTYtMS0xLTIxMjU4_08e3c58a-3093-4e0a-bd87-4ec984531491"
      unitRef="usd">65000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM3LTIwLTEtMS0zNDE4OA_6e68cd28-b838-48b9-b5b0-c91fcd52734a"
      unitRef="usd">65000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss
      contextRef="i74767d9ffa3c4e68806179884dda54ac_D20200927-20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTgtMS0xLTM0MTYy_0e0814f9-0973-4f77-9d5c-e46c72263e86"
      unitRef="usd">1871500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib7c492a6bad949d8bbe9a19b9f847e6a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTE4LTEtMS0zNDE4MA_13979608-e586-4b23-8e3d-1a99ab6faac3"
      unitRef="usd">-1800000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM4LTIwLTEtMS0zNDE5MA_b0a477e1-e686-4b00-9293-11c37254109a"
      unitRef="usd">1869700000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTEwLTEtMS0zNDE2NA_817dbbc4-a842-4838-8703-f5ac1aa23c57"
      unitRef="usd">-20200000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzM5LTIwLTEtMS0zNDE5Mg_51a7e764-522c-4b3f-af57-0ed0c75047fc"
      unitRef="usd">-20200000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQwLTEwLTEtMS0zNDE2Ng_df6b5661-1d00-4222-b979-afa159e2da96"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQwLTIwLTEtMS0zNDE5NA_8614d850-0cbf-46c4-a6e2-699e922965b9"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i41abe384e7ed44d0b93eb28da26c630d_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTEyLTEtMS0zNDE3Ng_8c50986d-318a-4775-97ff-e594a6924adc"
      unitRef="shares">6044000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i41abe384e7ed44d0b93eb28da26c630d_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTE0LTEtMS0zNDE3OA_0beb7989-6d94-440d-a2bf-4df25aa93084"
      unitRef="usd">409800000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQxLTIwLTEtMS0zNDE5Ng_4891d004-63ab-488d-acb3-683622cbed39"
      unitRef="usd">409800000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes
      contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTEwLTEtMS0yODM1MA_4ef28d41-9d62-4a75-a046-8c6a61152680"
      unitRef="usd">400000</holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes>
    <holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQyLTIwLTEtMS0zNDE5OA_f0d31d1e-17c7-4f28-8438-fd354dc7c9ac"
      unitRef="usd">400000</holx:UnrealizedGainLossOnInterestRateCapNetOfTaxes>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTEwLTEtMS0zNDE3MA_262b0a26-d793-416e-8d49-889da31b5704"
      unitRef="usd">9400000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQzLTIwLTEtMS0zNDIwMA_a20bfa28-bf4b-4342-a12a-2d699557cb50"
      unitRef="usd">9400000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax
      contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ0LTEwLTEtMS0zNDE3Mg_cfdd9d4d-d1fd-4fcb-a159-654b22277eea"
      unitRef="usd">-500000</holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax>
    <holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax
      contextRef="i18be40b839954c45998b2e3707ae29b8_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ0LTIwLTEtMS0zNDIwMg_7754a05e-6e13-4ce4-ae54-10afd257bd2d"
      unitRef="usd">-500000</holx:OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax>
    <holx:PurchaseOfNonControllingInterestReclassifiedToAPIC
      contextRef="i0b8b754192c34166af1ef896ffb1d995_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTYtMS0xLTM0MTc0_1cfc37b0-ecdb-40c7-b3cb-250f91292379"
      unitRef="usd">-8200000</holx:PurchaseOfNonControllingInterestReclassifiedToAPIC>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ib7c492a6bad949d8bbe9a19b9f847e6a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTE4LTEtMS0zNDIwNg_ec0ce987-9b7c-4150-ac4b-b603f6467c0f"
      unitRef="usd">-300000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ1LTIwLTEtMS0zNDIwNA_1adb8f3d-bb2e-4d5e-9df9-0f6018b96baf"
      unitRef="usd">8500000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:SharesIssued
      contextRef="ic6fdf1c3d1c24fc2b1d849ed7b49afa5_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTItMS0xLTM0MjA4_89d82d7a-e0fe-4ebe-880e-72c019541b76"
      unitRef="shares">297306000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6fdf1c3d1c24fc2b1d849ed7b49afa5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTQtMS0xLTM0MjEw_c057e411-4054-408f-b349-d507bed36cec"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6cc5988aecbc4312a8f722462e31ba5d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTYtMS0xLTM0MjEy_58dca81b-6017-4642-8102-c800b51c3cfe"
      unitRef="usd">5965800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2bcf88f2cd249149361fc0e5b495fa2_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTgtMS0xLTM0MjE0_b6d91f96-2379-46c8-b317-f595062e31fd"
      unitRef="usd">298300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i284bf3087c864f18b52aa92132f5472a_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTEwLTEtMS0zNDIxNg_49145a49-ebd8-46b1-a831-202f2d9c31e3"
      unitRef="usd">-59100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesIssued
      contextRef="i8a56c91d1533454184368992ce4da0cb_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTEyLTEtMS0zNDIxOA_4cf92242-7f17-478c-b81b-6b7a5939a18b"
      unitRef="shares">43653000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8a56c91d1533454184368992ce4da0cb_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTE0LTEtMS0zNDIyMA_1d0c37b1-f033-4e5f-8acc-a44a16212c40"
      unitRef="usd">-1989400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie460e7e6ecc64b75bae28b8d8803defd_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTE4LTEtMS0zNDIyMg_788a8c3f-84e0-488b-bc2a-503d67faad9a"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjEvZnJhZzpiNmM2YmEyMmM0YWY0ZmZiODYzMjI3NDQ2OGNkYmRmYi90YWJsZTo0YjM4MmIyM2VmMzM0ZjNkYmIyNGU1NjlkYmJlZDZmMC90YWJsZXJhbmdlOjRiMzgyYjIzZWYzMzRmM2RiYjI0ZTU2OWRiYmVkNmYwXzQ2LTIwLTEtMS0zNDIyNA_fcef63c4-5ce5-468c-8f8c-7db413a45583"
      unitRef="usd">4218600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMtMS0xLTEtMA_271ae9f0-80e7-4b45-8bc5-e10750cc1a86"
      unitRef="usd">1869700000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMtMy0xLTEtMA_dda1a292-d824-4eec-876d-f801aa47b7b6"
      unitRef="usd">1110500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMtNS0xLTEtMA_59da46f8-82f7-40ea-99f8-cc1d009a9e9b"
      unitRef="usd">-203600000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUtMS0xLTEtMA_f4f40ac1-75ba-4721-a9cb-97657b863208"
      unitRef="usd">88000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUtMy0xLTEtMA_01886121-30f0-4552-8d16-1b5314893c5e"
      unitRef="usd">83100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUtNS0xLTEtMA_c1f5e229-a1ff-45d0-90c3-c9e06253650c"
      unitRef="usd">92500000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYtMS0xLTEtMA_6fb61712-764f-4568-bd31-18a7a6b5785a"
      unitRef="usd">318900000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYtMy0xLTEtMA_9e0c18fb-d860-4f16-a932-7cac1cb80608"
      unitRef="usd">292900000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYtNS0xLTEtMA_b3d1ea4e-7970-4bde-8a99-d283dfc59aae"
      unitRef="usd">370600000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzgtMS0xLTEtMA_5f3116a4-ef3d-4397-9ce9-3a7618908e64"
      unitRef="usd">65000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzgtMy0xLTEtMA_578a8f6a-8fd7-4f32-99ab-bb1576bb4558"
      unitRef="usd">83300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzgtNS0xLTEtMA_00078a20-4d43-4e39-a30d-a64c824e5f0a"
      unitRef="usd">62000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEwLTEtMS0xLTA_090d3802-4055-4c2a-b8e3-ba5f5a5e56a5"
      unitRef="usd">-70100000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEwLTMtMS0xLTA_acf606af-0d98-4d16-b23c-ffbfa3826a56"
      unitRef="usd">-94400000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEwLTUtMS0xLTA_80e14ed5-1751-4c02-8640-0c1aece00cff"
      unitRef="usd">-235700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <holx:Impairmentofintangibleassetsandequipment
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEzLTEtMS0xLTA_57b9cf0c-e548-4e26-9297-96fd7b2d2fff"
      unitRef="usd">0</holx:Impairmentofintangibleassetsandequipment>
    <holx:Impairmentofintangibleassetsandequipment
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEzLTMtMS0xLTA_574acf92-b2ab-43da-9dac-864963bfc3dd"
      unitRef="usd">30200000</holx:Impairmentofintangibleassetsandequipment>
    <holx:Impairmentofintangibleassetsandequipment
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzEzLTUtMS0xLTA_e78a88fb-c404-4dfc-91fd-6be0650fe648"
      unitRef="usd">685400000</holx:Impairmentofintangibleassetsandequipment>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzE4LTEtMS0xLTA_1b51c5ed-7dc4-43e9-b2da-04ca3de295a9"
      unitRef="usd">-21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzE4LTMtMS0xLTA_854974fd-7839-447a-ba23-83a6de063ea1"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzE4LTUtMS0xLTA_5e1dd862-44a8-4de4-9c22-bbc105ec866a"
      unitRef="usd">-800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzIzLTEtMS0xLTA_e2ebec78-23d4-4b99-92c7-a27ea98e3544"
      unitRef="usd">-24300000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzIzLTMtMS0xLTA_fe405f09-cf6d-4e95-92eb-0d3209722f17"
      unitRef="usd">-27300000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzIzLTUtMS0xLTA_d3fbd7cb-00b1-4f9e-a5b9-229e7b41492f"
      unitRef="usd">-33800000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI1LTEtMS0xLTA_148900a9-3540-478e-9eeb-288d2b53081f"
      unitRef="usd">-110900000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI1LTMtMS0xLTA_7fc9d5ad-a233-4027-a585-5e78b48b497c"
      unitRef="usd">427100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI1LTUtMS0xLTA_0acb7e95-7aef-4739-b185-54a90430cfa2"
      unitRef="usd">76500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI2LTEtMS0xLTA_a38a76a2-ed8f-43c7-958b-b6b608502ebc"
      unitRef="usd">84100000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI2LTMtMS0xLTA_715f2c22-6268-48b4-befc-7867a4112332"
      unitRef="usd">25300000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI2LTUtMS0xLTA_aab3f2f9-a109-444e-b5d0-65b927137948"
      unitRef="usd">63000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI3LTEtMS0xLTA_7ae7d904-dafe-4fa3-a2a5-c754bf83e54d"
      unitRef="usd">-13000000.0</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI3LTMtMS0xLTA_c3a068b5-7e46-4d60-bd5c-49abad512e85"
      unitRef="usd">3800000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI3LTUtMS0xLTA_dd0912a7-7ce4-49af-aa66-c71375e5ef6a"
      unitRef="usd">3200000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI4LTEtMS0xLTA_c5cd408a-9a30-452b-8be6-043a6bed9c80"
      unitRef="usd">56300000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI4LTMtMS0xLTA_54a43502-f16b-4469-885c-5b67e6573757"
      unitRef="usd">286200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI4LTUtMS0xLTA_1bd439be-9a02-4363-a56f-aab2aef0762c"
      unitRef="usd">6000000.0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI5LTEtMS0xLTA_cfedfd12-3d18-46e6-a9f8-4eaa9887b4dc"
      unitRef="usd">20400000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI5LTMtMS0xLTA_0d8ffc9c-81a6-4617-b845-96d3996d4a32"
      unitRef="usd">-4900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzI5LTUtMS0xLTA_59cb98ee-9bc6-4e4c-8daf-0584af4c75a2"
      unitRef="usd">-5500000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMwLTEtMS0xLTA_fec43955-6d16-44bb-a6ed-eaf685f5b63d"
      unitRef="usd">-4900000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMwLTMtMS0xLTA_f4f7dbac-c25e-4faa-a702-826995898c79"
      unitRef="usd">96000000.0</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMwLTUtMS0xLTA_84821743-45eb-40b4-99d9-469c920f61f0"
      unitRef="usd">-16500000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMxLTEtMS0xLTA_3a216795-1c9d-4319-a395-e46e6c968d52"
      unitRef="usd">14000000.0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMxLTMtMS0xLTA_c2517e04-c3ac-49e8-a071-d7d8197bd189"
      unitRef="usd">15000000.0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMxLTUtMS0xLTA_4ee5f04c-fd6c-4c23-879b-075f895efacf"
      unitRef="usd">14400000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMyLTEtMS0xLTA_35fad1d5-6043-4b9b-9041-ef8000dc1ac8"
      unitRef="usd">2330400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMyLTMtMS0xLTA_f7df3b40-1cdf-4ac8-8154-168784c70c59"
      unitRef="usd">896600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzMyLTUtMS0xLTA_785002e6-0f7f-4e36-80a1-7ad157bec1d3"
      unitRef="usd">649500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM0LTEtMS0xLTA_4146b6c0-de80-4aa5-b530-fa3f6bcdf74b"
      unitRef="usd">1164700000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM0LTMtMS0xLTA_0666a86d-ffad-419d-b882-277aea2984b8"
      unitRef="usd">119400000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM0LTUtMS0xLTA_ff41b9a8-defd-4966-b90f-0528a1ed4f75"
      unitRef="usd">110600000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM2LTEtMS0xLTA_03963bbf-15e1-4174-8dfd-16769f215a58"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM2LTMtMS0xLTA_e8ca2e1c-101b-4e1c-aa82-3243df138d1f"
      unitRef="usd">139300000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM2LTUtMS0xLTA_f7df7f18-1c8a-4523-88f7-d7e2761a88c2"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM3LTEtMS0xLTA_05c4f8f5-e220-42fe-8b0d-2e092aa45a4e"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM3LTMtMS0xLTA_f1f01f92-6153-4e41-ae91-00a67a4d9f6c"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM3LTUtMS0xLTA_32535954-f3c4-417e-8a6c-a350edad6884"
      unitRef="usd">18200000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <holx:FundingOfLoansToSSI
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM4LTEtMS0xLTA_f50ca7e4-4a7c-4f45-8b20-36b2f1a43dbc"
      unitRef="usd">0</holx:FundingOfLoansToSSI>
    <holx:FundingOfLoansToSSI
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM4LTMtMS0xLTA_f2ae6a73-31ba-4652-9e9e-2f634429c5d9"
      unitRef="usd">0</holx:FundingOfLoansToSSI>
    <holx:FundingOfLoansToSSI
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM4LTUtMS0xLTA_a283516c-d50f-4d90-aeec-12a90b7d8f50"
      unitRef="usd">28400000</holx:FundingOfLoansToSSI>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM5LTEtMS0xLTA_a02ce008-e1e7-4e17-9048-68cfe814f2c2"
      unitRef="usd">96800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM5LTMtMS0xLTA_acfd2d0d-ea24-428f-8ce4-6d639d847018"
      unitRef="usd">98300000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzM5LTUtMS0xLTA_bde67461-3489-441b-8949-5d16dceb1d9f"
      unitRef="usd">57000000.0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQwLTEtMS0xLTA_cc3b195b-9300-49de-b0db-13069079fb5f"
      unitRef="usd">59400000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQwLTMtMS0xLTA_7c978f01-8688-4a5e-bfb9-5b41003de092"
      unitRef="usd">58100000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQwLTUtMS0xLTA_4718bd70-87b1-445b-b80e-5d2b2ca42154"
      unitRef="usd">52100000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ3LTEtMS0xLTA_dd5313a5-2ee3-4b02-970e-0098be9cbbba"
      unitRef="usd">6500000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ3LTMtMS0xLTA_5ab25a74-c79f-4816-ab91-b0645b6f150d"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ3LTUtMS0xLTA_b302f9b4-892f-4d0b-964e-5bd0166f6223"
      unitRef="usd">4500000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ5LTEtMS0xLTA_35926249-3b92-407f-9090-d440172407d1"
      unitRef="usd">2200000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ5LTMtMS0xLTA_fef5fa19-09f2-413b-a4c6-9185f175f069"
      unitRef="usd">5100000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzQ5LTUtMS0xLTA_485a4339-4b62-4c60-b4cc-593b70e4950f"
      unitRef="usd">9900000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUwLTEtMS0xLTA_ccb74ec5-01d1-4611-8b06-10b8836fa0c1"
      unitRef="usd">-1329600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUwLTMtMS0xLTA_7ac03abe-32f9-411e-9804-8f073baf7b77"
      unitRef="usd">-141600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUwLTUtMS0xLTA_62b63881-553b-4f3b-8e69-25e8a9c0d5b8"
      unitRef="usd">-280700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUyLTEtMS0xLTA_639be62c-8a31-4677-aaff-30e0e6c8d0aa"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUyLTMtMS0xLTA_c23baa41-d3eb-47e2-8185-7fc3652efdd9"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUyLTUtMS0xLTA_3ac7361f-7038-4a9e-babf-998077709223"
      unitRef="usd">1497300000</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUzLTEtMS0xLTA_dcda110e-9fd6-43a5-b05a-7cb6251bccd0"
      unitRef="usd">75000000.0</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUzLTMtMS0xLTA_411eb874-d175-4190-ada5-0abba1ceda38"
      unitRef="usd">45800000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzUzLTUtMS0xLTA_539622fc-0b2d-456e-979f-182a6a6b8e86"
      unitRef="usd">1465000000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <holx:ProceedsfromSeniorNotes
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU0LTEtMS0xLTA_4bb24555-28ed-40bd-85f0-f894ae26cff0"
      unitRef="usd">936300000</holx:ProceedsfromSeniorNotes>
    <holx:ProceedsfromSeniorNotes
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU0LTMtMS0xLTA_f7a26cba-3cac-46ca-8826-983888f9569b"
      unitRef="usd">0</holx:ProceedsfromSeniorNotes>
    <holx:ProceedsfromSeniorNotes
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU0LTUtMS0xLTA_3f6702e3-1f56-4bf1-89be-41331e0f3d5d"
      unitRef="usd">0</holx:ProceedsfromSeniorNotes>
    <holx:RepaymentofSeniorNotes
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU1LTEtMS0xLTA_463a9991-46db-42ba-bd1d-231c2b24b598"
      unitRef="usd">970800000</holx:RepaymentofSeniorNotes>
    <holx:RepaymentofSeniorNotes
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU1LTMtMS0xLTA_e9b9271c-e25e-4b8e-8a7a-02b2f707a34c"
      unitRef="usd">0</holx:RepaymentofSeniorNotes>
    <holx:RepaymentofSeniorNotes
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU1LTUtMS0xLTA_0d094cc5-13d6-4ec7-94db-19ba7846e32b"
      unitRef="usd">0</holx:RepaymentofSeniorNotes>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU4LTEtMS0xLTA_9269f440-bce1-4169-bbf3-ead5c624fd40"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU4LTMtMS0xLTA_8172f43e-4372-4f4f-9feb-a036b03078d8"
      unitRef="usd">750000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU4LTUtMS0xLTA_221d514e-2bea-42db-84be-40466b1abd4d"
      unitRef="usd">480000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU5LTEtMS0xLTA_54fa8619-ab6f-41c6-8b22-c84266269418"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU5LTMtMS0xLTA_94ae7cbf-2c7e-4bab-84dc-e1b815b5478c"
      unitRef="usd">500000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzU5LTUtMS0xLTA_952ccb52-f558-498e-9d26-e8c73529845a"
      unitRef="usd">780000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYwLTEtMS0xLTA_c8f68fc1-a134-40b0-ab78-73ffc0ba6f53"
      unitRef="usd">320000000.0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYwLTMtMS0xLTA_2e84eecf-e9b5-4020-bc32-f07f4269b236"
      unitRef="usd">16000000.0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYwLTUtMS0xLTA_b7f6691b-211a-4d2f-992f-1ea125b20150"
      unitRef="usd">43000000.0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYxLTEtMS0xLTA_5fc60c3f-9db2-45ce-8a9f-61134b5b5bce"
      unitRef="usd">71500000</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYxLTMtMS0xLTA_1500b55e-bb16-47c4-b326-5dc2a14f7e17"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYxLTUtMS0xLTA_c92060ea-1e1d-43a1-ac99-c875f002bd81"
      unitRef="usd">34000000.0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYyLTEtMS0xLTA_1839882d-e1c2-484f-8462-7af19c936321"
      unitRef="usd">8500000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYyLTMtMS0xLTA_2096aab3-7245-433c-a261-18a0d82ef76c"
      unitRef="usd">1800000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYyLTUtMS0xLTA_4e3697b2-cb7f-48c3-ab59-f52772390706"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYzLTEtMS0xLTA_fc8181f7-7394-443e-9f15-8ad8363b81bf"
      unitRef="usd">409800000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYzLTMtMS0xLTA_ba2c482a-2491-4fa1-9a97-2b2b17d0b8b6"
      unitRef="usd">653600000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzYzLTUtMS0xLTA_ad84ba6f-cc71-4007-abc5-20e4166f3560"
      unitRef="usd">200100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <holx:PaymentsForDeferredAcquisitionConsideration
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY2LTEtMS0xLTA_6324808f-abad-4802-817a-11f4f3d34fc7"
      unitRef="usd">1900000</holx:PaymentsForDeferredAcquisitionConsideration>
    <holx:PaymentsForDeferredAcquisitionConsideration
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY2LTMtMS0xLTA_b3ea35d2-048e-423f-82d7-3967a0e99755"
      unitRef="usd">24300000</holx:PaymentsForDeferredAcquisitionConsideration>
    <holx:PaymentsForDeferredAcquisitionConsideration
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY2LTUtMS0xLTA_33d6be43-02d0-486d-84c9-de6c6012b2eb"
      unitRef="usd">6500000</holx:PaymentsForDeferredAcquisitionConsideration>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY3LTEtMS0xLTA_7e9d6289-4361-4205-a3e8-5c5fe5972ac7"
      unitRef="usd">0</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY3LTMtMS0xLTA_48b4df3d-00da-4676-a326-45bacb636765"
      unitRef="usd">0</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY3LTUtMS0xLTA_45319570-0d33-4567-a16e-b84f2bc8169d"
      unitRef="usd">1500000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY5LTEtMS0xLTA_cf9b69ed-b8c7-4162-8fe0-1410bfaaab47"
      unitRef="usd">51300000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY5LTMtMS0xLTA_afbe2840-45da-440b-b785-4c6130eafb2c"
      unitRef="usd">65600000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzY5LTUtMS0xLTA_b985b077-e0be-4bfc-9a11-afd526f385bf"
      unitRef="usd">49800000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcxLTEtMS0xLTA_ff0d1ebc-8bf8-42dc-8f00-cdf516839ccc"
      unitRef="usd">47500000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcxLTMtMS0xLTA_562e957d-2cdb-4308-bf9d-20beb29f9062"
      unitRef="usd">14300000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcxLTUtMS0xLTA_79a7d0ca-2961-4e66-8eb3-8ecc6b050ca5"
      unitRef="usd">12800000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentsUnderFinanceLeaseObligations
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcyLTEtMS0xLTA_2ed2b825-583c-4217-8ecd-bb3e5c9967f7"
      unitRef="usd">2400000</holx:PaymentsUnderFinanceLeaseObligations>
    <holx:PaymentsUnderFinanceLeaseObligations
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcyLTMtMS0xLTA_ee78993c-eb11-4231-ba8c-eb0ed9bb562a"
      unitRef="usd">1700000</holx:PaymentsUnderFinanceLeaseObligations>
    <holx:PaymentsUnderFinanceLeaseObligations
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzcyLTUtMS0xLTA_be56cf6b-1fc0-497b-9a90-2297c21c8ef7"
      unitRef="usd">1700000</holx:PaymentsUnderFinanceLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzczLTEtMS0xLTA_a8849c50-47f7-4a7e-b986-28ddf9e68e84"
      unitRef="usd">-529800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzczLTMtMS0xLTA_4f368cea-deec-48af-802d-9993ef03da3a"
      unitRef="usd">-659900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4XzczLTUtMS0xLTA_6aee9c69-85b5-4dc2-bd5e-cc2b0bf813cc"
      unitRef="usd">-431500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc0LTEtMS0xLTA_93ccef96-9260-4391-a1ea-aa58f5348917"
      unitRef="usd">-1700000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc0LTMtMS0xLTA_0cf56616-2a95-48a8-9b0c-4e0c20f355a2"
      unitRef="usd">4100000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc0LTUtMS0xLTA_3d214129-e958-4f84-be04-d2573af6f7b7"
      unitRef="usd">-2200000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc1LTEtMS0xLTA_d62c351a-90b0-4935-ac52-c22c3f71b0ce"
      unitRef="usd">469300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc1LTMtMS0xLTA_dd1fd9a0-5956-45e9-8964-c77f42ba743d"
      unitRef="usd">99200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc1LTUtMS0xLTA_54c72cea-e7f9-44b7-bcf6-75a51b76a505"
      unitRef="usd">-64900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc2LTEtMS0xLTA_e7a5afd5-dd37-4add-85c6-62ca5d5db3ea"
      unitRef="usd">701000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc2LTMtMS0xLTA_4e2495dd-d509-413f-988d-dd34dfc59d97"
      unitRef="usd">601800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc2LTUtMS0xLTA_90755662-29fc-430b-a089-2f9410530397"
      unitRef="usd">666700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc3LTEtMS0xLTA_818401df-b07c-413e-b24d-c1b594b619c3"
      unitRef="usd">1170300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc3LTMtMS0xLTA_f498c0af-0714-40a0-ba87-ce45a90c7c1c"
      unitRef="usd">701000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMjQvZnJhZzo4YzE0ZWU3MDA3NTY0NDQwYTRlY2FmNmFjMGQ4ZTNjZS90YWJsZTplNjNhNWZkMDUwZTY0Mjc5YjlmNjI5NjY1MjkxZmEzOC90YWJsZXJhbmdlOmU2M2E1ZmQwNTBlNjQyNzliOWY2Mjk2NjUyOTFmYTM4Xzc3LTUtMS0xLTA_cd04a353-dcfc-4e20-9125-df6b5b967da4"
      unitRef="usd">601800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzAvZnJhZzplMTI5ZDIxNjUyMDI0ODU2YTJjMzljNWIyNWIyNGNjMS90ZXh0cmVnaW9uOmUxMjlkMjE2NTIwMjQ4NTZhMmMzOWM1YjI1YjI0Y2MxXzY3NDU_e5a3e22e-39e6-4201-9cba-c83f88c7151d">Operations&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hologic, Inc. (the &#x201c;Company&#x201d; or &#x201c;Hologic&#x201d;) develops, manufactures and supplies premium diagnostics products, medical imaging systems, and surgical products with an emphasis on women's health and well-being through early detection and treatment. Until December 30, 2019, the Company's product portfolio included light-based aesthetic and medical treatment systems sold by its former Medical Aesthetics business. The Company completed the sale of its Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;COVID-19 Considerations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The global COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption in the markets the Company sells its products into, primarily the U.S., Europe and Asia-Pacific. Starting in the second quarter of fiscal 2020, the spread of COVID-19 negatively impacted business and healthcare activity globally. In particular, due to government measures, elective procedures and exams were delayed or cancelled, there were significant reductions in physician office visits, and hospitals postponed or canceled capital purchases as well as limited or eliminated services; however, in the second half of the third quarter of fiscal 2020, the Company started to see a recovery of elective procedures and exams as economies were opened back up and restrictions eased, which has continued through the fourth quarter of fiscal 2021. The reductions in testing and procedures had a negative impact on the Company's operating results and cash flows in fiscal 2020, however, the impact of the commercial release of its COVID-19 assays more than offset those negative impacts as the Company generated significant revenue from the sales of these assays starting in the third quarter of fiscal 2020 through the fourth quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the Company's results of operations and cash flows since the third quarter of fiscal 2020 have been positively impacted by the sale of its COVID-19 assays as well the continued recovery of its other primary product lines and businesses to pre-COVID levels, the COVID-19 pandemic could have an adverse impact on its operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: reduced demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products as well as the timing and effectiveness of distributing vaccines; the severity and duration of the COVID-19 pandemic; the resurgence of COVID-19 infections; the emergence of new COVID strain variants; the COVID-19 pandemic's impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic and associated economic disruptions. The Company expects that as the current COVID-19 pandemic subsides, there may be a significantly reduced demand for ongoing testing, and thus, for its COVID-19 assays. As expected in the third quarter of fiscal 2021, revenues generated from the sale of its COVID-19 assays decreased significantly in the U.S. compared to the prior year period and the first and second quarters of fiscal 2021 as the population of vaccinated people continues to grow in the U.S. In the fourth quarter of fiscal 2021, COVID-19 assay revenues increased compared to the preceding quarter primarily due to the impact of the delta strain of COVID-19 resulting in higher demand for testing, however COVID-19 assay revenues decreased compared to the corresponding prior year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In response to the negative impact of COVID-19 on the Company's business, in April 2020, the Company initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but the Company also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances, effected employee terminations. Further in April 2020, the Company shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of its products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased During fiscal 2021, the majority of the impacted manufacturing facilities were back to pre-COVID levels. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has also taken and continue to take measures to ensure the safety of its employees and to comply with governmental orders. These measures could require that the Company's employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in the Company's commercial and marketing activities. In addition, complying with government and customer vaccine mandates that apply to the Company may lead to employee attrition, disruption to the Company's workforce and result in additional costs associated with implementation and on-going compliance, which could have an adverse impact on the Company's operating results, cash flows and financial condition.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTg5_b129b23d-eee6-49ae-9402-622542c108b3">Summary of Significant Accounting Policies&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#x2019;s fiscal year ends on the last Saturday in September. Fiscal 2021, 2020 and 2019 ended on September&#160;25, 2021, September&#160;26, 2020 and September&#160;28, 2019, respectively. Fiscal 2021, 2020 and 2019 were 52-week years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Subsequent Events Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events, except as described below, recorded in the consolidated financial statements as of and for the year ended September&#160;25, 2021. On September 27, 2021, the Company refinanced its term loan and revolving credit facility. For additional information, refer to Note 7. On October 14, 2021, the Company announced that it had entered into an agreement to acquire Bolder Surgical, Inc. ("Bolder Surgical") for a purchase price of approximately $160.0&#160;million. The closing is subject to certain regulatory approvals, but the Company expects to close this acquisition by the end of calendar 2021. Bolder Surgical, located in Louisville, CO, is a developer and manufacturer of energy vessel sealing surgical devices in both laparoscopic and open procedures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Management&#x2019;s Estimates and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#x2019;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#x2019;s net deferred tax assets and related valuation allowances, and stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#x2019;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customers are principally located in the U.S., Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;25, 2021. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no customers with a balance greater than 10% of accounts receivable as of September&#160;25, 2021. There was one customer with a balance greater than 10% of accounts receivable as of September&#160;26, 2020, at 11.9%. There were no customers that represented greater than 10% of consolidated revenues for fiscal years 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Suppliers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company purchases certain components of its products from a single or small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which could adversely affect results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Statement Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.674%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the period for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the period for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Financing Activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#x2019;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#x2019;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;10 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;8 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#x2013;35 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of the Original Term of Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;or Estimated Useful Life&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#x2013;7 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less - accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020 and October 2020, the Company was awarded grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants are specifically to fund the capital equipment and labor investments needed to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procures and pays for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to paying for the capital equipment, the DOD will reimburse the Company upon it meeting certain requirements  However, the DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts. As of September 25, 2021, the Company had $95.2 million of capital equipment related to the DOD grant that was awaiting approval. In fiscal 2021, the Company received $21.2&#160;million from the DOD under these grants which has been recorded as a reduction of the cost basis of the purchased equipment. Payments under these grants are subject to satisfaction of the conditions of the grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment&#x2014;Impairment or Disposal of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Combinations and Acquisition of Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company accounts for the acquisition of a business in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results specifically revenue growth rates. These significant assumptions are forward looking and could be affected by future economic and market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets and Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are initially recorded at fair value and stated net of accumulated amortization and impairments. The Company amortizes its intangible assets that have finite lives using either the straight-line method, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be utilized. Amortization is recorded over the estimated useful lives ranging from 2 to 30 years. The Company evaluates the recoverability of its definite lived intangible assets whenever events or changes in circumstances or business conditions indicate that the carrying value of these assets may not be recoverable based on expectations of future undiscounted cash flows for each asset group. If the carrying value of an asset or asset group exceeds its undiscounted cash flows, the Company estimates the fair value of the assets, generally utilizing a discounted cash flow analysis based on the present value of estimated future cash flows to be generated by the assets using a risk-adjusted discount rate. To estimate the fair value of the assets, the Company uses market participant assumptions pursuant to ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite lived intangible assets, such as IPR&amp;amp;D assets, are required to be tested for impairment annually, or more frequently if indicators of impairment are present. The Company&#x2019;s annual impairment test date is as of the first day of its fourth quarter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,597.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,184.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,533.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,890.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,582.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,922.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Medical Aesthetics Impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal 2020, the Company's Medical Aesthetics business met the criteria to be designated as assets held-for-sale. As a result, the Company recorded a $30.2&#160;million charge to record the asset group at fair value less costs to sell. See Note 15 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019, the Company identified indicators of impairment for its Medical Aesthetics reporting unit as a result of reductions in forecasts during the year, and in connection with the Company&#x2019;s efforts to sell the business that began prior to the end of fiscal 2019. In performing the undiscounted cash flow analysis pursuant to ASC 360, the expected undiscounted cash flows of the asset group were determined using a probability-weighted approach taking into consideration the planned disposition, which was deemed to be highly probable as of the balance sheet date. Based on this analysis, the undiscounted cash flows were not sufficient to recover the carrying value of the asset group. As a result, the Company was required to perform Step 3 of the impairment test and determine the fair value of the asset group. The Company executed a definitive agreement on November 20, 2019 to sell the business. Although this agreement was signed subsequent to the balance sheet date, the Company concluded that it provided evidence regarding the estimate of fair value of the asset group at September 28, 2019 and that there were no events that occurred between September 28, 2019 and the date the Company entered into the definitive agreement that would significantly affect the fair value of the asset group. As a result, the Company recorded total impairment charges of $685.4&#160;million in fiscal 2019. The impairment charge was allocated to the long-lived assets as follows: $576.9 million to developed technology, $22.4 million to customer relationships, $48.6 million to trade names, $27.7 million to distribution agreements and $9.8 million to equipment. On November 20, 2019, this asset group met the assets held-for-sale criteria and was recorded at fair value less the costs to sell as noted above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of fiscal 2021, the Company acquired Mobidiag Oy and recorded $285.0&#160;million of developed technology, $74.0&#160;million of in-process research and development, $20.9&#160;million of customer relationships and $20.0&#160;million of trade names based on its preliminary purchase accounting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2021, the Company acquired Biotheranostics, Inc. and recorded $160.3&#160;million of developed technology and $2.1&#160;million of trade names based on its preliminary purchase accounting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2021, the Company acquired Diagenode SA and recorded $69.8&#160;million of developed technology and $9.2&#160;million of customer relationships based on its preliminary purchase accounting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2021, the Company acquired Somatex Medical Technologies GmbH and recorded $38.0&#160;million of developed technology, $1.2&#160;million of customer relationships and $0.9&#160;million of trade names based on its preliminary purchase accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of fiscal 2020, the Company acquired Acessa Health, Inc. and recorded $127.0&#160;million of developed technology and $1.2&#160;million of trade names.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense related to developed technology is classified as cost of product revenues&#x2014;amortization of intangible assets. Amortization expense related to customer relationships, contracts, trade names, and business licenses is classified as a component of amortization of intangible assets within operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated amortization expense at September&#160;25, 2021 for each of the five succeeding fiscal years was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 350), the Company tests goodwill for impairment annually at the reporting unit level and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying value. Events that could indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate, operational performance of the business or key personnel, and an adverse action or assessment by a regulator. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the impairment test, the Company utilizes the single-step approach prescribed under Accounting Standards Update No. 2017-04,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASU 2017-04). This approach requires a comparison of the carrying value of each reporting unit to its estimated fair value and to the extent the carrying value exceeds the fair value a charge is recorded up to the amount of goodwill in the reporting unit. To estimate the fair value of its reporting units, the Company primarily utilizes the income approach. The income approach is based on a DCF analysis and calculates the fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting the after-tax cash flows to present value using a risk-adjusted discount rate. Assumptions used in the DCF require significant judgment, including judgment about appropriate discount rates and terminal values, growth rates, and the amount and timing of expected future cash flows. The forecasted cash flows are based on the Company&#x2019;s most recent budget and strategic plan and for years beyond this period, the Company&#x2019;s estimates are based on assumed growth rates expected as of the measurement date. The Company believes its assumptions are consistent with the plans and estimates used to manage the underlying businesses. The discount rates used are intended to reflect the risks inherent in future cash flow projections and are based on estimates of the weighted-average cost of capital (&#x201c;WACC&#x201d;) of market participants relative to each respective reporting unit. The market approach considers comparable market data based on multiples of revenue or earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) and is primarily used as a corroborative analysis to the results of the DCF analysis. The Company believes its assumptions used to determine the fair value of its reporting units are reasonable. If different assumptions were used, particularly with respect to forecasted cash flows, terminal values, WACCs, or market multiples, different estimates of fair value may result and there could be the potential that an impairment charge could result. Actual operating results and the related cash flows of the reporting units could differ from the estimated operating results and related cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducted its fiscal 2021 impairment test for its reporting units on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of June 27, 2021, and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of the Company's reporting units had fair values exceeding their carrying values. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;25, 2021, the Company believes that its reporting units, with goodwill aggregating $3.3&#160;billion, were not at risk of failing the goodwill impairment test based on its current forecasts and qualitative assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducted its fiscal 2020 impairment test for its reporting units on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of June 28, 2020, and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of the Company's reporting units had fair &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;values exceeding their carrying values. For illustrative purposes, had the fair value of each of the reporting units been lower by 10%, all of the reporting units would still have passed the goodwill impairment test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of goodwill activity by reportable segment from September&#160;26, 2020 to September&#160;25, 2021 is as follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:130.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:57.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:57.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Breast&#160;Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;GYN&#160;Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Skeletal&#160;Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,063.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,657.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mobidiag acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagenode acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biotheranostics acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Somatex acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,065.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,281.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost-method equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax receivable in fiscal 2020 primarily related to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. This receivable was reclassified to a current asset in fiscal 2021 as the Company filed the carryback claim and expects to receive the refund within the next twelve months, subject to Internal Revenue Service processing times. The right of use assets were recorded in connection with the adoption of ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#x2019;s Nonqualified Deferred Compensation Plan (&#x201c;DCP&#x201d;) and are recorded at their cash surrender value (see Note 12 for further discussion). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred for the research and development of the Company&#x2019;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for the development costs of software embedded in the Company&#x2019;s products in accordance with ASC 985, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#x2019;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimated useful life and recorded within cost of revenues - product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s foreign subsidiaries are translated in accordance with ASC 830, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Matters.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#x2019;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income (expense), net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss), which is a separate component of stockholders&#x2019; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income (expense), net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#x2019; equity. The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Charges (gains) reclassified to statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(59.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Cap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5&#160;million, which was the initial fair value of the instruments recorded in the Company&#x2019;s financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical terms of the interest rate caps were designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $1.0 billion of principal, which ended on December 27, 2019 (the first quarter of fiscal 2020) for the contracts entered into in fiscal 2018, and on December 23, 2020 (the first quarter of fiscal 2021) for the interest rate cap agreements entered into in fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, 2020 and 2019, interest expense of $0.5 million, $2.3 million and $3.1 million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The last interest rate cap agreement matured as of December 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI and net of taxes were a gain of $9.4&#160;million, a loss of $27.6&#160;million and a gain of $3.5 million for fiscal years 2021, 2020, and 2019, respectively. The fair value of this derivative was in a liability position of $18.7 million as of September 25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Foreign Currency Contracts and Foreign Currency Option Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 25, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of certain of the Company's cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $861.5 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instrument Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:23pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.280%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Trade Receivables and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Effective September 27, 2020, the Company adopted ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Financial Instruments - Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the COVID-19 pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following is a rollforward of the allowance for credit losses for fiscal 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Costs and&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-&lt;br/&gt;offs and&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cost of Service and Other Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#x2019;s professional services, employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for share-based payments in accordance with ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 718)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#x2019;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options and restricted stock units for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts for fiscal 2021, 2020, and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In those reporting periods in which the Company has reported net income, anti-dilutive shares generally are comprised of those stock options that either have an exercise price above the average stock price for the period or the stock options&#x2019; combined exercise price and average unrecognized stock compensation expense upon exercise is greater than the average stock price. In those reporting periods in which the Company has a net loss, anti-dilutive shares are comprised of the impact of those number of shares that would have been dilutive had the Company had net income plus the number of common stock equivalents that would be anti-dilutive had the company had net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally offers a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM5NTc0_257c2dd2-2a08-4cdf-8688-8a506165be31"&gt;one&lt;/span&gt;-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#x2019;s warranty reserves include the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity for fiscal 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&#160;End&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $9.8 million, $15.6 million and $29.5 million for fiscal 2021, 2020 and 2019, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and subsequently a number of improvements. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The Company adopted the standard in the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, the FASB issued ASU No. 2019-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in this Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the standard in the first quarter of fiscal 2021. The adoption of ASU 2019-08 did not have a material effect on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The FASB issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The FASB issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The FASB issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the FASB issued ASU No. 2021-05, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842), Lessors - Certain Leases with Variable Lease Payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU addresses an issue related to a lessor's accounting for certain leases with variable lease payments. The amendments in this Update affect lessors with lease contracts that (1) have variable lease payments that do not depend on a reference index or a rate and (2) would have resulted in the recognition of a selling loss at lease commencement if classified as a sales-type lease or a direct financing lease. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021, and is applicable to the Company in fiscal 2023. The Company is currently evaluating the impact of the adoption of ASU 2021-05 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTg3_20a95afd-9954-48ba-b2a0-a9496854f54b">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#x2019;s fiscal year ends on the last Saturday in September. Fiscal 2021, 2020 and 2019 ended on September&#160;25, 2021, September&#160;26, 2020 and September&#160;28, 2019, respectively. Fiscal 2021, 2020 and 2019 were 52-week years.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i39e4f5900241494c9567649e19c96f03_D20211014-20211014"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MjQxOTk_90b555b1-20a4-4b6c-a8e2-ff19d302a168"
      unitRef="usd">160000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:UseOfEstimates
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTEz_eb7fd8d4-67d5-4eec-9ef9-17050db37808">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Management&#x2019;s Estimates and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#x2019;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#x2019;s net deferred tax assets and related valuation allowances, and stock-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#x2019;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTM3_7e8ddc47-a241-482e-8dd1-6b53abbfbff6">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <holx:CashEquivalentsMaturityPeriod
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDk1_cc767b8d-e62b-453e-b3f1-f72118a68201">three months or less</holx:CashEquivalentsMaturityPeriod>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDcy_4f274ed3-ef00-425f-ac13-870938ab3c17">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customers are principally located in the U.S., Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is &lt;/span&gt;&lt;/div&gt;directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;25, 2021. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.There were no customers with a balance greater than 10% of accounts receivable as of September&#160;25, 2021. There was one customer with a balance greater than 10% of accounts receivable as of September&#160;26, 2020, at 11.9%. There were no customers that represented greater than 10% of consolidated revenues for fiscal years 2021, 2020 and 2019</us-gaap:ConcentrationRiskCreditRisk>
    <holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage
      contextRef="i5ab554f4731046f5a8db6df08f11e210_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDk_ef69e941-9f13-4615-a35e-7427068cd706"
      unitRef="customer">0</holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i31b7d848d9294ea0bcafe1e9b98352e2_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3NDk_0d610819-d5d5-422f-bd48-1e8f86fa4269"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage
      contextRef="i257fac080d6542d2b019c98a7b842cab_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ4MDY_8bd15d10-dad5-4c67-99d4-2bb1413f09d1"
      unitRef="customer">1</holx:NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i20cf81a427114e06a602d55fd54d095a_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ4NDc_92d40374-ad3a-4c67-b272-c861d1ddd150"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic8d9c018e3364bb88f017d0ea722c968_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzIxOTkwMjMzNzkyMjU_5df7205f-cced-40e0-95bb-3f8299f72529"
      unitRef="number">0.119</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1760e146b45f410688b3ff89a82a6684_D20190630-20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ5Mzc_53f466e4-6674-45bd-890a-91e3d070ffbc"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8ecce514a4df495b8d3d8479bdf9d0f2_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ5Mzc_9125f56a-b18e-4478-b56c-11c4ad1bb16b"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib977b0b83f104827aef9be1e2307b7e3_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ5Mzc_ff063d3c-bef6-4432-83c9-75a77e213230"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTI0_dd59e676-0444-4fcf-bbee-6f6d85a847e2">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Statement Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.674%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the period for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during the period for interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Cash Financing Activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of contingent consideration at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:IncomeTaxesPaid
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzItMi0xLTEtMA_b0aa0dd8-69b6-4057-97df-07b7960940da"
      unitRef="usd">615100000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzItNC0xLTEtMA_22bbdbb1-80e1-4d0a-b591-fdc26af6c0b9"
      unitRef="usd">265900000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzItNi0xLTEtMA_9fe63299-e074-4cbc-9bb4-b4c7c6070281"
      unitRef="usd">180600000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaid
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzMtMi0xLTEtMA_1792f273-cc44-4cec-8c72-e1401e70f39e"
      unitRef="usd">93200000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzMtNC0xLTEtMA_7b3f79a7-9c84-4fe6-b407-0e7c2ba52f63"
      unitRef="usd">109500000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzMtNi0xLTEtMA_4d06b965-4d08-4471-8715-a67effd2e30e"
      unitRef="usd">132500000</us-gaap:InterestPaid>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzUtMi0xLTEtMzExMjY_8c8f0e78-0872-4bbd-bcd3-1e195d92a6b7"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzUtNC0xLTEtMzQxMTc_4247645b-9f9d-43e6-953c-12192f06e698"
      unitRef="usd">82700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMThjMWMwOWJkYTE0ZmZjYjY3YmI1NDYwN2E1NmZlZC90YWJsZXJhbmdlOjIxOGMxYzA5YmRhMTRmZmNiNjdiYjU0NjA3YTU2ZmVkXzUtNi0xLTEtMzQxMjE_b3a4585c-5542-44d1-8168-4d3bde65ad0a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDIw_317b2372-7bf6-429a-8525-e89c236c8fea">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#x2019;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#x2019;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTk3_ef8c9a8b-34d4-4a3d-9f42-48a3ddd3307f">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzEtMi0xLTEtMA_2fd2c114-0295-4ff7-a2ac-9fc6687ee570"
      unitRef="usd">163300000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzEtNC0xLTEtMA_492519c2-eff3-4b66-9739-63f20c372f68"
      unitRef="usd">152300000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzItMi0xLTEtMA_72e2c7e8-0c55-4509-bb4c-600ed0cecaef"
      unitRef="usd">53000000.0</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzItNC0xLTEtMA_be87cc58-aa51-45e0-97c4-a0bf85a4e249"
      unitRef="usd">46500000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzMtMi0xLTEtMA_1e6ab32a-0fc5-4219-9725-ebdac74823db"
      unitRef="usd">284900000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzMtNC0xLTEtMA_4267c829-48e3-49fe-b439-603a51c14d7a"
      unitRef="usd">196300000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzQtMi0xLTEtMA_650e6bf1-b29d-4bc9-9e3b-83e335e6524d"
      unitRef="usd">501200000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo2OGE3NTk2OWQ1YzI0ZjY4YTk5MTBjZGU2OWIzODZmNS90YWJsZXJhbmdlOjY4YTc1OTY5ZDVjMjRmNjhhOTkxMGNkZTY5YjM4NmY1XzQtNC0xLTEtMA_495e5b94-1348-4284-93ac-bb64ec982639"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ2OTYw_c8b7d89a-ec30-4a74-80ad-34ce11b6325d">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;10 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;8 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#x2013;35 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of the Original Term of Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;or Estimated Useful Life&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#x2013;7 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less - accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred.&lt;/span&gt;&lt;/div&gt;In September 2020 and October 2020, the Company was awarded grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants are specifically to fund the capital equipment and labor investments needed to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procures and pays for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to paying for the capital equipment, the DOD will reimburse the Company upon it meeting certain requirements  However, the DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts. As of September 25, 2021, the Company had $95.2 million of capital equipment related to the DOD grant that was awaiting approval. In fiscal 2021, the Company received $21.2&#160;million from the DOD under these grants which has been recorded as a reduction of the cost basis of the purchased equipment.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDAx_20b03354-d3af-4a49-abed-696174ee609d">Property, plant and equipment consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.030%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;10 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#x2013;8 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#x2013;35 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of the Original Term of Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;or Estimated Useful Life&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#x2013;7 years&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less - accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic9b633f8acdd4e20aa3c715419399907_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzEtMS0xLTEtMC90ZXh0cmVnaW9uOmM5OTBlYzZkOTcyZjQ2YmViZWIxNjBjMGRiMmQwZWFlXzQ_c8389513-6cb8-4f08-bcba-86097cd98e48">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5a0e94b8d14543b8b882b82d9c97b4ca_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzEtMS0xLTEtMC90ZXh0cmVnaW9uOmM5OTBlYzZkOTcyZjQ2YmViZWIxNjBjMGRiMmQwZWFlXzc_90139572-87bd-46e0-a45e-702c80727fb0">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzEtMy0xLTEtMA_7f42b521-b8d9-4117-a0b2-7f8160063084"
      unitRef="usd">467100000</holx:ManufacturingEquipmentAndSoftware>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzEtNS0xLTEtMA_f505e29d-ecdf-4bcf-bfe5-cbe7ee7f0f57"
      unitRef="usd">460700000</holx:ManufacturingEquipmentAndSoftware>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1d36b248dea543d9b31d755d693a800a_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzItMS0xLTEtMC90ZXh0cmVnaW9uOmM0YTBlMWYwMjYwYjRhYjg5NmI2MTViYjcxYzdkNTFkXzQ_2a028083-4e47-4d38-8a3c-764f4791871a">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i240c4a4b528e48fcbae1ae3adac1be94_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzItMS0xLTEtMC90ZXh0cmVnaW9uOmM0YTBlMWYwMjYwYjRhYjg5NmI2MTViYjcxYzdkNTFkXzc_bf7b737e-5b31-42e8-b797-2d69f03e7e5d">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzItMy0xLTEtMA_fb8ffe4c-0d4f-4635-89e3-9812b3e729c1"
      unitRef="usd">484600000</holx:EquipmentUnderCustomerUsageAgreements>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzItNS0xLTEtMA_ecb0b1a5-c934-45f8-b9c7-79b2a45b71a2"
      unitRef="usd">456800000</holx:EquipmentUnderCustomerUsageAgreements>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iff4e30233d1a415382913c229d305f89_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmMwYjY3YjIzZjdkMzQzYjE4NzgwZWUxOGE0MzUzMDA4XzQ_fea9d93e-5ed7-4bce-a19c-84f892495986">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9a1a54208b5e468786e129cb05b9304d_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzMtMS0xLTEtMC90ZXh0cmVnaW9uOmMwYjY3YjIzZjdkMzQzYjE4NzgwZWUxOGE0MzUzMDA4Xzc_8bf8bf62-12de-43b1-af65-dc47e9b04b07">P35Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzMtMy0xLTEtMA_93beec60-0f0b-415a-8094-ce86eba2db64"
      unitRef="usd">191200000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzMtNS0xLTEtMA_51fcd7fd-af95-43de-9194-45562510f8f0"
      unitRef="usd">167300000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzQtMy0xLTEtMA_8c0eb7a8-5b03-4377-bcd3-e784aab1102e"
      unitRef="usd">49700000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzQtNS0xLTEtMA_c7f31af6-5278-4ccc-ad88-e46fb260df44"
      unitRef="usd">44300000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:Land
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzUtMy0xLTEtMA_a5adb425-ac96-4c73-a635-dd1dcca894e5"
      unitRef="usd">41300000</us-gaap:Land>
    <us-gaap:Land
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzUtNS0xLTEtMA_3945ae99-a573-411f-b29d-11b43552eaca"
      unitRef="usd">40700000</us-gaap:Land>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8c6c435d399d423185f62c22c21c3f26_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzYtMS0xLTEtMC90ZXh0cmVnaW9uOmZkMTkzYzIwYWQ2YzRkZjY4MGZiYTQ1OWQ0MTljMGI2XzQ_9a7123e0-5953-4022-bbe9-8f9aa80e69cf">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id78ad9f144ef4c5f824abd84cc11f14d_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzYtMS0xLTEtMC90ZXh0cmVnaW9uOmZkMTkzYzIwYWQ2YzRkZjY4MGZiYTQ1OWQ0MTljMGI2Xzc_afff7081-aed1-47fe-aee9-017061be8fee">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzYtMy0xLTEtMA_e6783a3d-6102-4ac7-a77e-1735e17edd66"
      unitRef="usd">16800000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzYtNS0xLTEtMA_9b52a7ff-c40a-4d97-a390-d5b4a6054b3b"
      unitRef="usd">16100000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i20c305b597ae44238fbe77067406d53b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzctMy0xLTEtMjEyMTg_ca6097f8-e5ec-4911-a8a8-6309c2f689ee"
      unitRef="usd">9900000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzctNS0xLTEtMjEyMjY_3ad5b38a-3551-4dcc-9b85-f020c16df4ff"
      unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzctMy0xLTEtMA_fe48d9e7-5af7-4c11-9a42-e5b47646d09c"
      unitRef="usd">1260600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzctNS0xLTEtMA_7cc1e22b-b839-4af3-b2f8-4492c0390ef3"
      unitRef="usd">1185900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzgtMy0xLTEtMA_52b96d0a-68eb-4564-86da-c36dcc869e2c"
      unitRef="usd">695900000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzgtNS0xLTEtMA_85a11c5e-6925-41b6-81ec-e13f52ff1b13"
      unitRef="usd">694400000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzktMy0xLTEtMA_bf7b6b4e-a365-4ed2-98a1-c6b3a8311729"
      unitRef="usd">564700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyNzM3ZmIwNTk5YmY0NzJiODgzZmY2ZDkwMjZhYmFlMi90YWJsZXJhbmdlOjI3MzdmYjA1OTliZjQ3MmI4ODNmZjZkOTAyNmFiYWUyXzktNS0xLTEtMA_90fda27a-34d3-4ba9-b56d-fad021481e3a"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <holx:GrantsReceivedFromDepartmentOfDefense
      contextRef="i759a6a937e3f4b359b04123f53698e83_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE2Nzk0NzA_3335ba2d-b755-4ac2-85a0-897a162489cd"
      unitRef="usd">7600000</holx:GrantsReceivedFromDepartmentOfDefense>
    <holx:GrantsReceivedFromDepartmentOfDefense
      contextRef="i3f5a4fc2e0a249feb5e822c662f420e2_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE2Nzk0ODQ_0651a488-f2c4-4bc3-9f73-3361abaf90c2"
      unitRef="usd">119300000</holx:GrantsReceivedFromDepartmentOfDefense>
    <holx:DepartmentOfDefenseFundsReceived
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MjQyMzg_3bb2f681-68b8-44cf-98be-803e76805cde"
      unitRef="usd">21200000</holx:DepartmentOfDefenseFundsReceived>
    <holx:LongLivedAssetsPolicyPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDgy_110e133b-c131-40fe-b039-e9f058e3f6b9">Long-Lived Assets&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property, Plant and Equipment&#x2014;Impairment or Disposal of Long-Lived Assets&lt;/span&gt; (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique.</holx:LongLivedAssetsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTE2_2d3cfcbe-d932-4906-9318-512732cd9e65">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Combinations and Acquisition of Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company accounts for the acquisition of a business in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results specifically revenue growth rates. These significant assumptions are forward looking and could be affected by future economic and market conditions.&lt;/span&gt;&lt;/div&gt;The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names</us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7133ee75e2dd4ac999d32c90c55818c6_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzExODkw_b4933c13-4ee8-4ea2-af5a-14704f8b83ff">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib5f33f2bd0484efea0b8ae4a94ebb11e_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzExODk2_a7ed45a9-6fdd-4fdc-8cda-b3b3024e019a">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDM5_5fb4d581-0c87-4331-8860-782f25823193">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,597.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,184.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,533.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,890.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,582.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,922.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia6d30cd544794d8bad91533ff053e6f2_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzMtMi0xLTEtMA_de9c65b1-10b7-49b8-b2b6-906cb2c7f170"
      unitRef="usd">4597700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia6d30cd544794d8bad91533ff053e6f2_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzMtNC0xLTEtMA_2524ac81-7835-4c9f-9819-33ab71eee707"
      unitRef="usd">3184200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i22a8c525301944a9944a49cff920233b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzMtNi0xLTEtMA_123dca94-ae63-497f-b8d3-7b2ab8977879"
      unitRef="usd">4054000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i22a8c525301944a9944a49cff920233b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzMtOC0xLTEtMA_5f47fb0b-2b18-4afc-b701-f166aaad4f93"
      unitRef="usd">2907200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7ad6095503c64c51a121bfc7570d481c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzQtMi0xLTEtMA_3e21d4d1-ef04-4fcc-862f-a8cc1d9395f4"
      unitRef="usd">71600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7ad6095503c64c51a121bfc7570d481c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzQtNC0xLTEtMA_fad642be-6c69-496c-b3cb-2d4e9c326ec0"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if65a3feacdfc4f8db0941415413e890d_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzQtNi0xLTEtMA_ae718a2e-bca0-45c3-90a0-9933669c3a47"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if65a3feacdfc4f8db0941415413e890d_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzQtOC0xLTEtMA_5682689c-e16e-4925-8422-1b5665f75eb0"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6ae31be4bb5c4a43a23c3e6238becfc2_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzUtMi0xLTEtMA_b3b2a3b5-4017-40b3-a81d-861cc692f252"
      unitRef="usd">591700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6ae31be4bb5c4a43a23c3e6238becfc2_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzUtNC0xLTEtMA_bb7a758b-3334-425f-8b0f-64ba56309d7b"
      unitRef="usd">510100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icf8cbc783b5949dbb79a0305af7adb43_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzUtNi0xLTEtMA_65e363d0-9814-4d67-80cb-f0d50298cb95"
      unitRef="usd">549100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icf8cbc783b5949dbb79a0305af7adb43_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzUtOC0xLTEtMA_55ceadd8-8161-457d-81b1-f506b9deacc4"
      unitRef="usd">477800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia6c3f788c0bb4582bfe4f3e18fdab22e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzYtMi0xLTEtMA_9a1d23f7-353d-4210-a078-bcb0929f61f2"
      unitRef="usd">268100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia6c3f788c0bb4582bfe4f3e18fdab22e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzYtNC0xLTEtMA_d6a3e2f7-db60-4a51-afac-caef52da2c6f"
      unitRef="usd">191800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i614f3db626964b0ba19f7be4c30f7447_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzYtNi0xLTEtMA_39adb151-3322-4162-a8af-c57577bf3cf8"
      unitRef="usd">245500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i614f3db626964b0ba19f7be4c30f7447_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzYtOC0xLTEtMA_64678f01-d3e9-4362-9059-21e978c06dc6"
      unitRef="usd">181200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id938fd73f4344d9cbe5e4513a3d14cde_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzgtMi0xLTEtMA_4acbca63-fb01-43c3-80cb-8c48730e0d4d"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id938fd73f4344d9cbe5e4513a3d14cde_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzgtNC0xLTEtMA_de2ec47f-3a2a-489d-94be-df4f4122427c"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if1bf447986ca4495be7ba966e2186eea_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzgtNi0xLTEtMA_d069399a-b28b-4b33-84a5-772c7e05e12a"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if1bf447986ca4495be7ba966e2186eea_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzgtOC0xLTEtMA_761edb63-c004-4410-827a-510834b2fe08"
      unitRef="usd">1300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3f935dfa1dfc42c1819964e91a6a8a64_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzktMi0xLTEtMA_5dfde564-b5bf-4e69-b580-4bd0f42dc232"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3f935dfa1dfc42c1819964e91a6a8a64_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzktNC0xLTEtMA_fc316097-dde3-4622-9b71-6b1524d38da5"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5d5d0520adb34afba7a74726aaf4fd2e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzktNi0xLTEtMA_b4a51091-c11a-437d-83a9-861462876ff0"
      unitRef="usd">2400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5d5d0520adb34afba7a74726aaf4fd2e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzktOC0xLTEtMA_9b5830ba-e220-4b11-a70e-ef59034891ab"
      unitRef="usd">2300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i153284bf00784fb3b525b3a99606668e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEwLTItMS0xLTA_9f1a743e-52f8-45d1-9ddb-d166c475f71d"
      unitRef="usd">5533100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i153284bf00784fb3b525b3a99606668e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEwLTQtMS0xLTA_ab781659-8ef3-41cc-af1a-73a15a2d07e4"
      unitRef="usd">3890100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1075d2362f62458aa8909dd277c391b9_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEwLTYtMS0xLTA_9fd57e08-61c0-478b-ad8b-959bdb1e0616"
      unitRef="usd">4852500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1075d2362f62458aa8909dd277c391b9_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEwLTgtMS0xLTA_e2aef005-7007-4f48-bb6b-f5124e42d7ac"
      unitRef="usd">3569800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iba0c605799354665aaf32f5e35c613c0_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEyLTItMS0xLTA_7cd3f226-5274-4c40-a7a2-0eefc721313e"
      unitRef="usd">23500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iba0c605799354665aaf32f5e35c613c0_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEyLTQtMS0xLTA_ae7f4778-dcd7-4bf9-afa2-140020171fcc"
      unitRef="usd">17200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i397c8ef1ac694286900c772850590741_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEyLTYtMS0xLTA_c5d44f75-c6a2-4c21-afc6-27c609617c1c"
      unitRef="usd">51800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i397c8ef1ac694286900c772850590741_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEyLTgtMS0xLTA_d100ab4a-426b-4223-b701-8bfbfe1c1c2b"
      unitRef="usd">43200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4a58be7c5d3a47b2a567894820bae0e7_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEzLTItMS0xLTA_1de84574-0763-48b9-979e-7fedeacad5aa"
      unitRef="usd">25500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4a58be7c5d3a47b2a567894820bae0e7_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEzLTQtMS0xLTA_9d6d6bc1-754c-4b79-9f6d-a41fd0c5a6de"
      unitRef="usd">15600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie735dea6c3194f28bea2b55697a00db1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEzLTYtMS0xLTA_89172bd1-41b4-4fd8-acc2-204841fdf79c"
      unitRef="usd">26800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie735dea6c3194f28bea2b55697a00db1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzEzLTgtMS0xLTA_1f5d33a1-3816-4a3d-bfeb-9f5a7742b70c"
      unitRef="usd">10600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzE0LTItMS0xLTA_1a10e47b-6d6c-4c01-b0ec-c85166b8c3cc"
      unitRef="usd">5582100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzE0LTQtMS0xLTA_8b5ec413-79b2-44f8-b77a-f1c31fc0d5bd"
      unitRef="usd">3922900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzE0LTYtMS0xLTA_880ce48c-fd94-4127-a939-ab711a16659e"
      unitRef="usd">4931100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowNzgxNmIwOGU1NDI0ZWE3YWJjYjBkZmE1ZmU0OGM2OS90YWJsZXJhbmdlOjA3ODE2YjA4ZTU0MjRlYTdhYmNiMGRmYTVmZTQ4YzY5XzE0LTgtMS0xLTA_69b848de-6a1a-4883-8199-a5fde9e73554"
      unitRef="usd">3623600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="i693d74165a33465a96c1b16aaf3362ee_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEzMTcw_f8cd5ebd-81e9-435d-99fe-6fdd1b11c527"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MDA0_11963302-d964-4050-8d84-a27d4c265efd"
      unitRef="usd">685400000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:AssetImpairmentCharges
      contextRef="ic6e41df507bc48da9b9dbf2c59f4e28f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MDk2_9307496b-a542-4afa-ba1c-cf811e5b17da"
      unitRef="usd">576900000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4c123a5aa5c74f40857a7f1a499427f9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MTI0_5708cab1-ecd3-448f-8dcd-1d505d4f6f04"
      unitRef="usd">22400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ib52deda671d64acda80d8851600a5b3f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MTU0_52623e32-fdb8-4524-ba91-2a36d830f73d"
      unitRef="usd">48600000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3ca56ec6117e459a933cdc1284e27c76_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MTcz_beb25c31-8084-4918-85d5-a6caa9e51985"
      unitRef="usd">27700000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if3da811ec6224b7aaf2247ddbed15752_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1MjA3_13457ce1-259c-4e10-8fc8-dc727d2ec49f"
      unitRef="usd">9800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i24181a753fcf40f4955b32c1fa5f7f67_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3Mjc3OTI_5e672c66-184a-4438-9ce1-0a1ceea41124"
      unitRef="usd">285000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i8cf9e1877cd24f22b338685574b8c19a_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAyMDE_2be8e923-290d-45a9-9f4a-89b1f860a185"
      unitRef="usd">74000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i1764f8386ed1463785aedd29aa1705e0_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAyMTY_38cb66a6-3ab5-44ce-9940-5546ac71cc06"
      unitRef="usd">20900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i044591b70cf04ae2890d5b307e363d47_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAyMzE_cb819cf4-cf4c-4b17-a65f-a98620d97efb"
      unitRef="usd">20000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="id726e42e341143488233910071609e4e_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxNzE_4fde6a27-c2ae-47d7-a42d-af77a4fb1055"
      unitRef="usd">160300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i1b99fdca3c5843718c49fe1d11331a75_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxODc_0f96b0bd-529f-436f-94f1-82bc8ea69764"
      unitRef="usd">2100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i6c23227b249540639f90d63654aa0b54_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxNDI_4b608e29-2c32-4ecb-b0b6-1b1d355f2c24"
      unitRef="usd">69800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ida01d42fd7b44dfcb8af2d9a4e61fe93_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxNTc_6c572369-1cf7-4bce-91b8-bce29faee4d2"
      unitRef="usd">9200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i2e1fee5b3bff48a6968339ee9bea5f5d_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxMTM_315ae14f-ba23-4c32-b6f8-db327e9b23aa"
      unitRef="usd">38000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i710936347b24460c9bd5ba52032b894d_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAxMjg_26158e13-88b5-43b2-999e-4e063b87da2f"
      unitRef="usd">1200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ibbbed19de9d04478a40050d57d4eb672_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAyNDY_dd66b8b9-3394-485d-82be-40ac1dc160c8"
      unitRef="usd">900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ib512458f54004c1c91782978a54d120e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1NzY1_da3717cc-cc34-4e6b-a753-d24005ef964f"
      unitRef="usd">127000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="iee6a5a2a7a4f4e3c92f42828d7360c4d_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzE1Nzk2_20794497-c261-476b-985e-bd4d1d63bc2e"
      unitRef="usd">1200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDEy_d0de343d-a4d3-4b55-9de1-f6f672e0363e">&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated amortization expense at September&#160;25, 2021 for each of the five succeeding fiscal years was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzAtMS0xLTEtMA_7d3b4d1a-e1ca-422a-887b-0f66bef6f9db"
      unitRef="usd">326500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzEtMS0xLTEtMA_8e887b2e-7c1f-4c67-b751-7d7302c81a1d"
      unitRef="usd">231300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzItMS0xLTEtMA_d6edea68-68d2-408a-b3d2-24159de001e5"
      unitRef="usd">222300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzMtMS0xLTEtMA_b21aaa92-2ebe-449c-98e5-ae8352425792"
      unitRef="usd">208900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpmMDlmYmFkMjQyYTM0NzM3YjQ1YzYwMWQ2MzZiNDYxMi90YWJsZXJhbmdlOmYwOWZiYWQyNDJhMzQ3MzdiNDVjNjAxZDYzNmI0NjEyXzQtMS0xLTEtMA_0d8e2ef6-dbe1-4553-8537-cccd77f287e0"
      unitRef="usd">178100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <holx:GoodwillNotAtRiskOfFailingImpairment
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzIwODYx_9c0848d5-9c91-4ca0-8761-44a37200f3fa"
      unitRef="usd">3300000000</holx:GoodwillNotAtRiskOfFailingImpairment>
    <holx:ScheduleOfGoodwillBySegmentTableTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MjA0_6c2fee56-c914-4156-ac63-7cfab1b1be6f">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A rollforward of goodwill activity by reportable segment from September&#160;26, 2020 to September&#160;25, 2021 is as follows:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:130.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:57.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:57.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Breast&#160;Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;GYN&#160;Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Skeletal&#160;Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,063.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,657.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mobidiag acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagenode acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biotheranostics acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Somatex acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,065.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,281.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfGoodwillBySegmentTableTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i98d0b62cc24e442bb94c648589df1886_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtMS0xLTEtMA_c041a6da-bb32-4a7a-87e1-1187219b9a22"
      unitRef="usd">821600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1aac6887b6f64875a859a71ba2b4b94b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtMy0xLTEtMA_b1f67777-0138-4855-bac8-939535fcfe29"
      unitRef="usd">764800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1cc0b83aa93c48f48c108df5541f41ff_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtNS0xLTEtMA_5d3e8f91-2951-4954-a4e7-e1ef935d6151"
      unitRef="usd">1063400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i054b061ff3bb4c10a95c6b96ddc407f6_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtNy0xLTEtMA_c7c164d5-057a-435e-80db-426a433856ba"
      unitRef="usd">8100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzEtOS0xLTEtMA_4fecfeed-2da2-4210-84d5-a192f55643c4"
      unitRef="usd">2657900000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ie6346aa91d524afe85aa61f0161caa3d_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzUtMS0xLTEtMjg0NDI_badf8663-7bfa-4855-8eff-b4a15d7fd6ae"
      unitRef="usd">432600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i164438a7cadc4df1b56c4a64d8637889_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzUtOS0xLTEtMzQ4NTY_b855207d-01b1-4eb4-b2a9-066dbf2f1a0e"
      unitRef="usd">432600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0e559bc22d7d4793b38e4a328c0efdc2_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzUtMS0xLTEtMA_fad8e6d5-24ae-42f2-9a4b-8ae93e951688"
      unitRef="usd">83500000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i86d3e4855ffd49b4a75816f598968a6b_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzUtOS0xLTEtMA_c5905a46-856f-4cbe-ba42-c8fc738b20f4"
      unitRef="usd">83500000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i26606deeae75471ca65b268474556c52_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzYtMS0xLTEtMjMxOTA_9742d192-9852-4494-852d-93c66f0844ee"
      unitRef="usd">80900000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ieee384db572047e4bc0a55fa16caac03_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzctOS0xLTEtMjg0NDk_c073e2db-c1c8-4255-b902-43ca02c3d4c3"
      unitRef="usd">80900000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i51e026b96a0148719035aed371e20da8_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtMy0xLTEtMjUwODA_2044fdff-4705-488e-8c03-8ae21058cb60"
      unitRef="usd">32400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4497464c0da44052a7c519318511a239_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtOS0xLTEtMzQ4NTM_b7c4b58c-0104-46af-a817-7335c56f4a3b"
      unitRef="usd">32400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtMS0xLTEtMA_ad2849dd-0a1f-4942-a0c4-aad7d183334d"
      unitRef="usd">-7800000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtMy0xLTEtMA_bf134f43-8521-4b24-a36c-dead26a77ee4"
      unitRef="usd">-100000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtNS0xLTEtMA_449e2888-2182-4518-affb-2a44d0331462"
      unitRef="usd">2200000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtNy0xLTEtMA_f506f16e-c522-4b23-b063-ac53a2cb94e4"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzgtOS0xLTEtMA_8f1a6e7e-ff09-45b7-be16-abbf3578e6de"
      unitRef="usd">-5700000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ib3b69d34963e43d5a345ff8d104b509c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktMS0xLTEtMA_cd9caaff-b50f-41c7-971f-940e844830c2"
      unitRef="usd">1410800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1e61574a9b46411bb0ae2371322a832e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktMy0xLTEtMA_2b1be60c-74b5-458a-b715-884055919fe8"
      unitRef="usd">797100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifac209011a2246ed84b08c9d11d3ec13_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktNS0xLTEtMA_de9b3142-99f0-4f0b-875c-685ca160f6f7"
      unitRef="usd">1065600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic32aed22715f404fa87eea8875fb1bed_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktNy0xLTEtMA_9cf56115-890f-4cba-b9ba-0d655884c487"
      unitRef="usd">8100000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTozZjA3ZDg2NmIxYTI0ZWMyOGMyM2I0ZTg2YTAxMjhiYi90YWJsZXJhbmdlOjNmMDdkODY2YjFhMjRlYzI4YzIzYjRlODZhMDEyOGJiXzktOS0xLTEtMA_9099c14f-c20a-4994-a032-5dcf392b6866"
      unitRef="usd">3281600000</us-gaap:Goodwill>
    <holx:OtherAssetsPolicyPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDU1_e59b9ae3-50e8-4a7a-ab66-310216a5f025">&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost-method equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax receivable in fiscal 2020 primarily related to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. This receivable was reclassified to a current asset in fiscal 2021 as the Company filed the carryback claim and expects to receive the refund within the next twelve months, subject to Internal Revenue Service processing times. The right of use assets were recorded in connection with the adoption of ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#x2019;s Nonqualified Deferred Compensation Plan (&#x201c;DCP&#x201d;) and are recorded at their cash surrender value (see Note 12 for further discussion).</holx:OtherAssetsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDEz_5af70bcf-07f2-4fa8-a63c-fe69f56cf90a">&lt;div style="margin-top:5pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.734%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.918%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Life insurance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost-method equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:IncomeTaxReceivable
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzMtMi0xLTEtMA_fcae4e56-c2bd-4dcf-b6c4-14b276db3d14"
      unitRef="usd">24700000</us-gaap:IncomeTaxReceivable>
    <us-gaap:IncomeTaxReceivable
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzMtNC0xLTEtMA_2aa43f50-b79d-421c-8124-609b12283a75"
      unitRef="usd">325700000</us-gaap:IncomeTaxReceivable>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzQtMi0xLTEtMA_26a2ae2c-21f3-4ca5-9f37-8fec7fc107a4"
      unitRef="usd">83600000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzQtNC0xLTEtMA_de05b3e4-ff1b-4748-af33-df1579fd5527"
      unitRef="usd">80700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzUtMi0xLTEtMA_85a86044-6e85-49bc-9264-b7fe85d09509"
      unitRef="usd">64300000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzUtNC0xLTEtMA_5c2be24d-65a0-4623-89de-b01ed73b279e"
      unitRef="usd">49300000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzYtMi0xLTEtMA_4f8a1a35-a9af-439d-b225-c52c4e96d6d5"
      unitRef="usd">21900000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzYtNC0xLTEtMA_f2e9d7fd-2850-4def-872a-11c6f06baf74"
      unitRef="usd">15500000</us-gaap:DeferredIncomeTaxAssetsNet>
    <holx:CostMethodEquityInvestments
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzEwLTItMS0xLTA_0cd5515f-9af1-4cd6-9730-9d01637e18da"
      unitRef="usd">9500000</holx:CostMethodEquityInvestments>
    <holx:CostMethodEquityInvestments
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzEwLTQtMS0xLTA_2fa2425f-f45e-48ef-b524-d3b39b6cc434"
      unitRef="usd">11400000</holx:CostMethodEquityInvestments>
    <us-gaap:OtherAssetsMiscellaneous
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzEzLTItMS0xLTA_1dbdf53f-5a18-410a-8d92-781912537106"
      unitRef="usd">41700000</us-gaap:OtherAssetsMiscellaneous>
    <us-gaap:OtherAssetsMiscellaneous
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzEzLTQtMS0xLTA_1efc7f13-eb1d-44f3-9149-9dc33923a636"
      unitRef="usd">34000000.0</us-gaap:OtherAssetsMiscellaneous>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzE0LTItMS0xLTA_920ef038-16f6-4891-8d09-af38a8586820"
      unitRef="usd">245700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTphN2Y5MjExNTJiNGQ0MTI0ODY3MjM4ZDc1OTdmMTVkNS90YWJsZXJhbmdlOmE3ZjkyMTE1MmI0ZDQxMjQ4NjcyMzhkNzU5N2YxNWQ1XzE0LTQtMS0xLTA_eca51916-0b5a-49d7-a399-e4c3f2073341"
      unitRef="usd">516600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDMw_7a2029b8-224d-4317-bd31-e7f911587371">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred for the research and development of the Company&#x2019;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for the development costs of software embedded in the Company&#x2019;s products in accordance with ASC 985, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Software.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#x2019;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimated useful life and recorded within cost of revenues - product.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTg1_e3773fcd-b345-4305-af00-e1471ce3103a">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s foreign subsidiaries are translated in accordance with ASC 830, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Matters.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#x2019;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency &lt;/span&gt;&lt;/div&gt;is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income (expense), net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss), which is a separate component of stockholders&#x2019; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income (expense), net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDE3_a5602b52-da2e-49fa-9b64-97f720c394ea">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#x2019; equity. The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Charges (gains) reclassified to statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(59.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDY0_f5618527-cf47-475f-9142-022d417faecd">The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Foreign Currency Translation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Charges (gains) reclassified to statement of operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(59.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMS0xLTEtMA_f88655f0-a177-4ba9-8464-12d0ebe295c2"
      unitRef="usd">-22900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMy0xLTEtMA_9edf9609-dc42-4347-8828-ed63a7c04eda"
      unitRef="usd">1800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItNS0xLTEtMA_e851f865-8867-4144-96df-b39b1002ab21"
      unitRef="usd">-900000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItNy0xLTEtMA_5c0afbe5-7156-4637-b225-f6e8ed6202bd"
      unitRef="usd">-24100000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItOS0xLTEtMA_359df85d-d698-4726-b76f-1cc20309d45f"
      unitRef="usd">-49700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTEtMS0xLTA_a991959b-9974-4598-a3f4-934095fd74d5"
      unitRef="usd">-41400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTMtMS0xLTA_7dc3161e-e319-4b7b-8dca-b6cdf75cbc2f"
      unitRef="usd">1700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTUtMS0xLTA_25d450d8-6338-4c45-886b-0d606a9c7b77"
      unitRef="usd">-2700000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="ib54386ce9dbd4629889a414173ff052f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTctMS0xLTA_bc918945-e17b-410b-bf1e-56c9f4d5c30b"
      unitRef="usd">3500000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzItMTktMS0xLTA_de3fb8a2-3539-4087-b071-6c7eaeb6ac9c"
      unitRef="usd">-42300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMS0xLTEtMA_342940ef-a1b5-473f-a34b-fa961a52283e"
      unitRef="usd">-20200000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMy0xLTEtMA_273632e6-2dd3-46d8-9b09-0f950aa04bc5"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtNS0xLTEtMA_3c1ba60b-24be-4c80-acac-4ce2e483be25"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtNy0xLTEtMA_ba0348d6-2287-49fe-ba57-89efa9faf046"
      unitRef="usd">9400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtOS0xLTEtMA_7003ceb9-c790-4709-96cb-2bbf13814815"
      unitRef="usd">-9900000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTEtMS0xLTA_c2a5e4ec-1833-4edc-bf96-5fdc87e35ce8"
      unitRef="usd">18500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTMtMS0xLTA_071b53ee-74d2-4458-b6c7-c860a90b7f68"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTUtMS0xLTA_378f53bf-ba26-4f28-b623-6774e5592054"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTctMS0xLTA_541d0eaa-f119-4195-9e66-303611db0080"
      unitRef="usd">-27600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzMtMTktMS0xLTA_dac50a0d-9c5e-422e-bdbb-9fbff6d3b37f"
      unitRef="usd">-9700000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i767c4b13fb8b4298b5e3c88d7d4a412b_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMS0xLTEtMA_5814df64-56a4-4167-8d71-5f9440c222ea"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib6d9385d2791424fa11a988430cc65d1_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMy0xLTEtMA_77f97468-f05b-464a-91ee-3659b9622cb3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0deccf8630d14bf58974f26313ae1cf6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtNS0xLTEtMA_6ce82463-f381-472c-9be8-0864af598552"
      unitRef="usd">500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtNy0xLTEtMA_cf3aec1e-034a-419a-a79d-759e865059ae"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtOS0xLTEtMA_3d074bef-eedd-49f6-87e1-aa2ba6387583"
      unitRef="usd">500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i02ce74e9dbd343d6a1cd77cfa6108906_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTEtMS0xLTA_78faeddd-8bf4-4c67-aa5b-5176ec7df463"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic351d3dbbd53499fba2fea622656b21d_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTMtMS0xLTA_cd1da61b-8fbe-4d1f-b02b-9970089a9b2e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1fa9316ea07a42e7bebfbfaa9b69e71a_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTUtMS0xLTA_1ad1ddbd-d3be-4d6d-b9b2-842150a6b3b3"
      unitRef="usd">2300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTctMS0xLTA_20e4eb7b-95c5-4c31-8327-2b12412c1fe3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzQtMTktMS0xLTA_bd4807a2-181b-410b-bc2d-aa0860a867a6"
      unitRef="usd">2300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMS0xLTEtMA_ce718dd4-f059-4c8f-bfd7-a63069d9a308"
      unitRef="usd">-43100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMy0xLTEtMA_2eae72bb-ed6d-48c7-a8a9-9e55b6e855bf"
      unitRef="usd">1300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtNS0xLTEtMA_fd57c2c9-72ea-4e1f-8421-15cb2967c43c"
      unitRef="usd">0</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="ic0e3770e763f4ddb888efca3f38034da_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtNy0xLTEtMA_c67c62bf-34cf-4c9d-88ae-3b3bde58c679"
      unitRef="usd">-14700000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtOS0xLTEtMA_2113d22c-6b8f-41a0-a6e0-1015afda64b5"
      unitRef="usd">-59100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTEtMS0xLTA_f88655f0-a177-4ba9-8464-12d0ebe295c2"
      unitRef="usd">-22900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTMtMS0xLTA_9edf9609-dc42-4347-8828-ed63a7c04eda"
      unitRef="usd">1800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTUtMS0xLTA_e851f865-8867-4144-96df-b39b1002ab21"
      unitRef="usd">-900000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <holx:AccumulatedothercomprehensiveIncomelossHedge
      contextRef="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTctMS0xLTA_c781af7b-f224-40ba-81b9-252649b68e87"
      unitRef="usd">-24100000</holx:AccumulatedothercomprehensiveIncomelossHedge>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZToyMTkxMGNmYjQ4MTI0MWU1OTFkMGEzMjEyZGJiZmZkYi90YWJsZXJhbmdlOjIxOTEwY2ZiNDgxMjQxZTU5MWQwYTMyMTJkYmJmZmRiXzUtMTktMS0xLTA_8b02fbf0-6001-4af1-af9f-3c91b622c646"
      unitRef="usd">-49700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTMy_0883355d-ea66-4860-a076-871a3a447246">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Cap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5&#160;million, which was the initial fair value of the instruments recorded in the Company&#x2019;s financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical terms of the interest rate caps were designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $1.0 billion of principal, which ended on December 27, 2019 (the first quarter of fiscal 2020) for the contracts entered into in fiscal 2018, and on December 23, 2020 (the first quarter of fiscal 2021) for the interest rate cap agreements entered into in fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, 2020 and 2019, interest expense of $0.5 million, $2.3 million and $3.1 million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The last interest rate cap agreement matured as of December 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI and net of taxes were a gain of $9.4&#160;million, a loss of $27.6&#160;million and a gain of $3.5 million for fiscal years 2021, 2020, and 2019, respectively. The fair value of this derivative was in a liability position of $18.7 million as of September 25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Foreign Currency Contracts and Foreign Currency Option Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 25, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of certain of the Company's cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $861.5 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instrument Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:23pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.280%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="ic8ab0ba57c4c4db1ad33b536e3e7e589_D20171001-20171230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMxMDMy_f4254ae6-19f3-499e-a0a2-1aba4a00ef0d"
      unitRef="usd">3700000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="i05d2321cba894df2b8040fb7171ae337_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzEwOTk1MTE3MzAzOTc_6184c1ff-7965-4c1a-808e-81fe0009b82a"
      unitRef="usd">1500000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:PrincipalAmountOfBorrowings
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMxODkx_0f9be397-54d9-4815-b925-bd6f2b57d6a7"
      unitRef="usd">1000000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMyMzM1_041e9544-954a-4ff8-bf1e-f0f6438ae81e"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMyMzM5_c20983f0-19ff-4ff8-8c93-4042dd3c7f7b"
      unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMyMzQ2_b186cd57-b644-4666-88a3-47b198d1e790"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzMjgz_6c00261b-bf39-4b17-8515-fc188b4a6a70"
      unitRef="usd">1000000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzMzgx_977e6841-83ff-4c38-8a4d-d88e25323457"
      unitRef="usd">1000000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <holx:PrincipalAmountOfBorrowings
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzNzkx_0f9be397-54d9-4815-b925-bd6f2b57d6a7"
      unitRef="usd">1000000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4d5eab2047cf4ae9ae2fd5d2d53bd62a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzOTUz_db892b62-6f60-48ee-abb0-4c32a44714d1"
      unitRef="usd">9400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i06b63e94bdb0440c91659016bea171f3_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzMzOTg1_1e1179c3-060b-43db-a9c2-610964fa040d"
      unitRef="usd">-27600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib3278f0ce96b40519a22ae965c771b3f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzIxOTkwMjMzNjU2ODM_b404e3a7-a177-41bb-a136-3836e5c82c34"
      unitRef="usd">3500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:InterestRateCashFlowHedgeAssetAtFairValue
      contextRef="ic0e3770e763f4ddb888efca3f38034da_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM0MTMw_73cbaa82-024b-4578-b409-6bc553126e97"
      unitRef="usd">18700000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
    <us-gaap:DerivativeTermOfContract
      contextRef="i6827d7fb33684f72ad15f7ec7825491c_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM0ODkx_49dea6bd-da3d-46d7-b75b-4c3547e163b7">P1Y</us-gaap:DerivativeTermOfContract>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTgz_eec51f61-7dcb-48e2-8616-512433c82a0f">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i6827d7fb33684f72ad15f7ec7825491c_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzMtMS0xLTEtMA_e15f91bc-68b3-4596-a874-a9c1c97b0040"
      unitRef="usd">-3600000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i3c63be7c32ce4ddd8e21e1134530b893_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzMtMy0xLTEtMA_b026bf0b-fc90-429b-80b4-0593fad948d7"
      unitRef="usd">700000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i6a83c89446b8446ab0792c574b8e11bc_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzMtNS0xLTEtMA_cee993b3-277e-4934-96ad-1207ee499bb2"
      unitRef="usd">11000000.0</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i824c5596d87e486cbcedd0f0406ca67e_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzQtMS0xLTEtMA_797e86f9-f4e0-4523-8d1d-263069d95a48"
      unitRef="usd">-6100000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i0448f6218dcc4bb79af08c1f322d677c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzQtMy0xLTEtMA_93c54459-84c4-4351-a71e-4279b955fa36"
      unitRef="usd">-1900000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i42d6e39bab1d429394487dda896a9573_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzQtNS0xLTEtMA_30751d75-4659-4a01-8644-acb8b769c47d"
      unitRef="usd">0</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzUtMS0xLTEtMA_18669d3c-b537-4595-8521-5ca5ef20cd9f"
      unitRef="usd">-9700000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzUtMy0xLTEtMA_23b4a671-8229-4315-bcbb-9341cbdf997e"
      unitRef="usd">-1200000</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzUtNS0xLTEtMA_2691c29a-bf26-4824-abe2-8bb92ddfe9f6"
      unitRef="usd">11000000.0</us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i6827d7fb33684f72ad15f7ec7825491c_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzgtMS0xLTEtMA_4ee866b0-a5fa-492e-9555-02476ddbf394"
      unitRef="usd">500000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i3c63be7c32ce4ddd8e21e1134530b893_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzgtMy0xLTEtMA_4527a87a-1c98-4e04-944e-51c09de98d23"
      unitRef="usd">-200000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i6a83c89446b8446ab0792c574b8e11bc_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzgtNS0xLTEtMA_9fae859d-63bc-42b9-807c-53da1457427b"
      unitRef="usd">-2200000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i824c5596d87e486cbcedd0f0406ca67e_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzktMS0xLTEtMA_9e211895-bb84-4088-9c37-286fef512c1c"
      unitRef="usd">-4000000.0</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i0448f6218dcc4bb79af08c1f322d677c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzktMy0xLTEtMA_0e70321f-2e8f-4673-b2ea-09b673120e4b"
      unitRef="usd">4000000.0</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i42d6e39bab1d429394487dda896a9573_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzktNS0xLTEtMA_4c09b8b3-ca5f-41cf-9dc3-9d3daa5d4a9e"
      unitRef="usd">100000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzEwLTEtMS0xLTA_6d2937aa-2ed6-4e12-91a7-08c957fe787a"
      unitRef="usd">-3500000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzEwLTMtMS0xLTA_b2a0c59e-a20d-4c98-860f-f8837410b18d"
      unitRef="usd">3800000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzEwLTUtMS0xLTA_e45a9942-66cd-416b-aae8-b83ac2379106"
      unitRef="usd">-2100000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzExLTEtMS0xLTM0ODc2_085e27cc-d206-4d70-86fc-b29a9a14d918"
      unitRef="usd">-13200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzExLTMtMS0xLTM0ODc4_1451965c-f59f-4632-9205-9264b70ea33b"
      unitRef="usd">2600000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo5Nzk3N2YyODViYWU0NzUwOTk5OGM3YWJmNzE4NmRhMi90YWJsZXJhbmdlOjk3OTc3ZjI4NWJhZTQ3NTA5OTk4YzdhYmY3MTg2ZGEyXzExLTUtMS0xLTM0ODgw_004e2231-34c1-44c6-aef7-dc3ec7d02ed0"
      unitRef="usd">8900000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <holx:NotionalAmount
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM1NDk1_2b6de2dd-1c0f-4ef7-840b-e6b4b636cebd"
      unitRef="usd">861500000</holx:NotionalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDY5_89d99c8e-35c8-4b8a-b9b0-8dde963272b6">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;25, 2021:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.286%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i3ef043735b8b4239bd022e3c816a7d5e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzktMy0xLTEtMA_7724e0e7-93a0-4798-bf2c-31e61d080f2c"
      unitRef="usd">1700000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ic89ac9c9ef5e4b44bc94c7ab3aadfbf0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzktNS0xLTEtMA_cbc3fdf8-f8d6-4ba2-a4a0-b6b90af837ce"
      unitRef="usd">1100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="if412fa8d384c47b689b9c1cc6f70fb14_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzEwLTMtMS0xLTA_b2f524fc-801b-44be-a7b7-94df2df33aa7"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i3e51833b6bb54770a5cad8d4c19d8fcc_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzEwLTUtMS0xLTA_645aecb9-44dc-4c47-aae0-1f6abdebda23"
      unitRef="usd">10100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i7d6987883e2244438841300f24394299_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzExLTMtMS0xLTA_f28fa12a-341d-4b7a-9284-5df34db128b2"
      unitRef="usd">1700000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i8608e05ef25e4918a0697a01f20908b8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzExLTUtMS0xLTA_5eb88a08-bdcd-4152-933f-bf4505dabbd3"
      unitRef="usd">11200000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i6c981e5c311541219a8ce678b8f5e556_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE1LTMtMS0xLTA_fc8497be-b4cd-42c3-9dde-3b4e74e06423"
      unitRef="usd">11100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i7021a097ba6b45e4b62b6e9a182526c0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE1LTUtMS0xLTA_39ed5d84-918d-4ff4-b5f8-87fcdf8fb01d"
      unitRef="usd">8200000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i35128fa0cb9b4182a1faa4cc5d635680_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE2LTMtMS0xLTA_35ab1bed-d924-4f78-85cc-4c3d895d4ed4"
      unitRef="usd">7600000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="iad3d88d570654a5eba0e1150c061cbc6_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE2LTUtMS0xLTA_f0696457-b020-403e-9a42-7efb63621366"
      unitRef="usd">23000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeLiabilities
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE3LTMtMS0xLTA_399b0099-ac95-460d-ab1e-924b07490625"
      unitRef="usd">18700000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE3LTUtMS0xLTA_a912d802-4a72-49bc-aed0-e595a8cc6237"
      unitRef="usd">31200000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="id0e58ad8c5574352954de0afd7c3c79e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE5LTMtMS0xLTA_77162e8b-e97b-4770-afd8-0b19cec07bd3"
      unitRef="usd">600000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i2d9b9f86933044f9b736c54f4167a157_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjMDBlYWZlYWJlOWQ0OWUzOGRmNzA3YjQ1NzdlZjAxZS90YWJsZXJhbmdlOmMwMGVhZmVhYmU5ZDQ5ZTM4ZGY3MDdiNDU3N2VmMDFlXzE5LTUtMS0xLTA_657d9054-5c6a-4c4e-9821-c4aeb714ea8c"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDc5_fdcacf52-9d2c-4d2b-b287-c6a6cf6e0482">&lt;div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.280%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i082d8e77f8fd4606afa5130d1718f9f4_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzMtMS0xLTEtMA_c3ac6c5f-9274-44f6-a90d-87c026bb7f3c"
      unitRef="usd">9400000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ic627db3203ae4b219001b3708f0efa7f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzMtMy0xLTEtMA_4002bf6d-849f-4b06-a5f4-09ce171b9990"
      unitRef="usd">-27600000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="id50b2a3739074642949584da79fb2ae6_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzMtNS0xLTEtMA_07e4cc88-5960-4aec-a441-878c68be077e"
      unitRef="usd">3500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if0e8647d6f2d4b4dadf2402926192fb9_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzQtMS0xLTEtMA_4fea9a11-cbe0-484a-8ba9-7bd4d9f34c5f"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4c41151c2fe04d54b10c77d5bdcf59df_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzQtMy0xLTEtMA_363eada0-1e4b-4fdf-b583-cf0ba43c61f5"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib0ae0d5006ec4e7abf71fdfcb2874ab3_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzQtNS0xLTEtMA_570b357c-0d49-4420-962e-4091957f0918"
      unitRef="usd">-8000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzUtMS0xLTEtMA_24fc7384-ae9e-442c-b192-e38d03572d8f"
      unitRef="usd">9800000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzUtMy0xLTEtMA_55db29d9-a19b-45c4-b879-711a611c3eed"
      unitRef="usd">-28100000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTowZThjYjhlZWUxNGE0ZWI5ODk5YjMyOWUxMDQxMzYzMi90YWJsZXJhbmdlOjBlOGNiOGVlZTE0YTRlYjk4OTliMzI5ZTEwNDEzNjMyXzUtNS0xLTEtMA_f0ebff6b-f80f-4b5a-b6c7-2844a6de416f"
      unitRef="usd">-4500000</us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent>
    <holx:AccountsReceivableAndReservesPolicyPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ2OTc1_287c7489-49e6-466e-8bc3-ebba6c12457f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Effective September 27, 2020, the Company adopted ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Financial Instruments - Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the COVID-19 pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. &lt;/span&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following is a rollforward of the allowance for credit losses for fiscal 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Costs and&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-&lt;br/&gt;offs and&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:AccountsReceivableAndReservesPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTg4_bb52d905-24bd-4de8-9d37-970f65c58132">2021, 2020 and 2019:&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Charged&#160;to&lt;br/&gt;Costs and&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-&lt;br/&gt;offs and&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItMi0xLTEtMA_6129f94f-95f6-4baa-a61e-fbf369895ed9"
      unitRef="usd">31600000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItNC0xLTEtMA_c787c1b4-9330-4f7b-823e-a10829989f9a"
      unitRef="usd">15000000.0</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableReserveDivested
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItNi0xLTEtMA_4e5f6c7c-9605-45ef-a36f-d94bad109a1a"
      unitRef="usd">0</holx:AccountsReceivableReserveDivested>
    <holx:AccountsReceivableAllowanceReduction
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItOC0xLTEtMA_a9ac098a-d3c0-45e6-96b2-4037659cb676"
      unitRef="usd">6100000</holx:AccountsReceivableAllowanceReduction>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzItMTAtMS0xLTA_e18dd372-06a4-468f-805e-5edeaebcacf2"
      unitRef="usd">40500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtMi0xLTEtMA_ce9a1bec-308f-4714-a721-fb76e60f6f81"
      unitRef="usd">17800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtNC0xLTEtMA_e679f716-46eb-427a-b418-0a0562424311"
      unitRef="usd">26800000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableReserveDivested
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtNi0xLTEtMA_2effed19-1fbb-446d-945f-c79d4d898fef"
      unitRef="usd">-5800000</holx:AccountsReceivableReserveDivested>
    <holx:AccountsReceivableAllowanceReduction
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtOC0xLTEtMA_63416725-f1d8-4b53-9926-f7f49dbe1de7"
      unitRef="usd">7200000</holx:AccountsReceivableAllowanceReduction>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzMtMTAtMS0xLTA_d4262a69-0ccd-4f55-8951-3632c11a3a23"
      unitRef="usd">31600000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtMi0xLTEtMA_62f1fa11-39b1-4b1e-b1c1-e78286c4e3f8"
      unitRef="usd">16200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtNC0xLTEtMA_fa807433-bf68-46f9-a8f1-2584e30e6c33"
      unitRef="usd">4400000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableReserveDivested
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtNi0xLTEtMA_a891306a-478b-4a65-af49-001b4e7803de"
      unitRef="usd">0</holx:AccountsReceivableReserveDivested>
    <holx:AccountsReceivableAllowanceReduction
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtOC0xLTEtMA_e463ab11-7811-4005-9f50-4cb1a2b44b53"
      unitRef="usd">2800000</holx:AccountsReceivableAllowanceReduction>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpkMmNiZmZiNWNkYzk0NTY1YTI2YjhmNDdiMDdiNmYzMy90YWJsZXJhbmdlOmQyY2JmZmI1Y2RjOTQ1NjVhMjZiOGY0N2IwN2I2ZjMzXzQtMTAtMS0xLTA_694a2b68-f290-4ae8-b5db-d0b46a09a2f7"
      unitRef="usd">17800000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <holx:CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTk1_a83769fc-c8f6-4aca-9b99-e03e3ed82e00">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cost of Service and Other Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#x2019;s professional services, employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.&lt;/span&gt;&lt;/div&gt;</holx:CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDMz_6a6b2029-f340-4e4f-b134-a5bd04446a1b">Stock-Based Compensation&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for share-based payments in accordance with ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 718)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt; As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#x2019;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MjA4_d3e753c3-91d9-4236-93ab-0f031cf4fb22">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options and restricted stock units for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTUz_af664096-0040-4d20-8754-03fcee2462a6">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts for fiscal 2021, 2020, and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.154%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzEtMi0xLTEtMA_282a886b-ec7c-41a8-b990-b5726498dc9f"
      unitRef="shares">257046000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzEtNC0xLTEtMA_57a0f7ac-9918-438c-8fbf-ebe538f0ab46"
      unitRef="shares">262727000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzEtNi0xLTEtMA_ff5da366-6717-4d2b-8625-604cb9c8136a"
      unitRef="shares">269413000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzItMi0xLTEtMA_9c842910-a36b-48a3-ad4f-52e650c5be0b"
      unitRef="shares">2660000</holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits>
    <holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzItNC0xLTEtMA_d5c2a838-1670-4ba6-8730-e1c0d049dae5"
      unitRef="shares">1886000</holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits>
    <holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzItNi0xLTEtMA_e7689a65-0839-423d-8e4f-6177b63cb33c"
      unitRef="shares">0</holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzMtMi0xLTEtMA_a65fa62c-a41a-42e2-931c-6a68977d059a"
      unitRef="shares">259706000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzMtNC0xLTEtMA_ed8ea831-35b7-4395-ad7f-feab9260e2a6"
      unitRef="shares">264613000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzMtNi0xLTEtMA_05d84894-336b-4180-aa63-4f1f60666ff4"
      unitRef="shares">269413000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iec921088a39b409a82dd4e10a4ae0ccc_D20200927-20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzUtMi0xLTEtMA_375dab7c-e4b4-4d78-8d33-6c65767ae0f5"
      unitRef="shares">528000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i470023b769a94ad0b13e2609e2a72838_D20190929-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzUtNC0xLTEtMA_067e36fa-31a0-4767-a26e-e101cfba52c2"
      unitRef="shares">1158000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i35bd7f402edc440a8814d0fd91080075_D20180930-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTo0YWVkNzY3MmI5YTk0YjRiOTExMzVmNzE3YWZkMTI3Mi90YWJsZXJhbmdlOjRhZWQ3NjcyYjlhOTRiNGI5MTEzNWY3MTdhZmQxMjcyXzUtNi0xLTEtMA_e9904704-e678-4eb1-bf72-fb7e450c03e2"
      unitRef="shares">4098000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StandardProductWarrantyPolicy
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDkw_ea339dca-e83c-4ba2-9bb5-a8a1dfd7e23b">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally offers a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM5NTc0_257c2dd2-2a08-4cdf-8688-8a506165be31"&gt;one&lt;/span&gt;-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#x2019;s warranty reserves include the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity for fiscal 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&#160;End&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MDY2_1eda4282-3412-42d6-b7d3-be4fdf5107ec">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity for fiscal 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&#160;End&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Period ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItMi0xLTEtMA_6924894f-2f9e-4ff9-b024-94b222165315"
      unitRef="usd">9900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItNi0xLTEtMA_9b6da271-d212-4b9f-a8fb-6d491ae6fc9e"
      unitRef="usd">7700000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItOC0xLTEtMA_5a024f01-4cf6-406c-8cf5-4a8e0877f566"
      unitRef="usd">300000</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItMTAtMS0xLTA_33f7a2e5-da20-4f92-9ebe-a0f14509e1de"
      unitRef="usd">0</us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItMTItMS0xLTA_24674f21-e93c-436a-ba94-8b926e9c36c1"
      unitRef="usd">9100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzItMTQtMS0xLTA_bf945672-1306-4c6d-acfa-66df6436076b"
      unitRef="usd">8800000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtMi0xLTEtMA_3eb7d2a0-c115-42b9-9113-665c95ac1328"
      unitRef="usd">13900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtNi0xLTEtMA_33a4a050-981c-41b0-9467-c9f2fda1bf2d"
      unitRef="usd">11700000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtOC0xLTEtMA_21baff5e-8392-4753-ba14-6548fc1d1846"
      unitRef="usd">500000</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtMTAtMS0xLTA_cfc06546-a7a9-4bbb-b162-3dfb8ed56b3e"
      unitRef="usd">-6100000</us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtMTItMS0xLTA_8299ce7e-ebf4-4836-beac-5652234ac6b9"
      unitRef="usd">10100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90YWJsZTpjYmQxYjUxMTA4MDk0Njc4OTNiNTc4ZWJkMGY0NDNmMS90YWJsZXJhbmdlOmNiZDFiNTExMDgwOTQ2Nzg5M2I1NzhlYmQwZjQ0M2YxXzMtMTQtMS0xLTA_ced94c2d-43d4-473a-bd5c-1de590065c9d"
      unitRef="usd">9900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQ3MTQw_06214bf5-9c81-463c-acdc-823c032e99a4">&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $9.8 million, $15.6 million and $29.5 million for fiscal 2021, 2020 and 2019, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQwMjcy_b1e043e9-eda5-4ad8-9bd1-ec15052a4415"
      unitRef="usd">9800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQwMjc2_4bc22aee-9c80-4e1d-9653-c9a616749eaf"
      unitRef="usd">15600000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzQwMjgz_94d8c5de-6356-4178-ae95-dd647e326bd1"
      unitRef="usd">29500000</us-gaap:AdvertisingExpense>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzE3NDAy_208fe046-c8c1-442f-b85f-95e9e7b740a7">Revenue&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for revenue pursuant to ASC Update No. 2014-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. Prior to the Cynosure divestiture, the Company also generated revenue from the sale and service of medical aesthetic treatment systems. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,171.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,695.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,582.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,051.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,352.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,902.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,730.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,536.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;831.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.510%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,902.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,536.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,198.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,786.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefit of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts. The Company's contracts typically do not provide the right to return product. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 25, 2021, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $830.6 million. These remaining performance obligations primarily relate to extended warranty and support and maintenance obligations in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately 40% of this amount as revenue in 2022, 27% in 2023, 18% in 2024, 10% in 2025, and 5% thereafter. The Company has applied the practical expedient to not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments. Contract liabilities are classified as other current liabilities and other long-term liabilities on the Consolidated Balance Sheets. The Company recognized revenue of $112.1&#160;million and $106.2 million in the years ended September 25, 2021 and September 26, 2020, respectively, that was included in the contract liability balance at September 26, 2020 and September 28, 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Practical Expedients&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzE3NDAz_8fc8d61e-e777-495c-a5c1-afa45767c5a8">The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intl.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,171.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,695.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,582.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;519.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;830.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,094.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,051.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,352.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,902.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,730.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;913.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,536.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;831.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.510%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,902.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,863.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,536.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;365.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.403%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,198.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,786.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;984.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i17dfc20b126b4985b7eda3cc4db3237f_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMi0xLTEtMA_50338f78-7eb2-47ea-8e2b-bfe7f2217338"
      unitRef="usd">304600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i33cc4a6d3eea43fdb3367b91d64fe447_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMy0xLTEtMA_cd1d2cec-4da1-449a-bcec-e754301e06b2"
      unitRef="usd">169300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibeea03eaa2ce4eeaba648099e4e98f19_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtNC0xLTEtMA_43fe5157-0f90-4d22-9520-7ff6f9a234f1"
      unitRef="usd">473900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i44fec30a86bc4fdca0e8af8e653b41eb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtNi0xLTEtMA_2dead36e-4554-42b8-a705-9023c8d73cfc"
      unitRef="usd">266300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id679baf745974c8ba5972d62f85ff59a_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtNy0xLTEtMA_30f29255-f4fe-4be7-8091-5acc56fe00fb"
      unitRef="usd">143800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a4d3cf9145043e6a6e200011f21e141_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtOC0xLTEtMA_2261ba43-21c6-4ab5-af01-45f599973cb9"
      unitRef="usd">410100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic93f6848c1c446b6a57343a9d7193209_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMTAtMS0xLTA_2676485c-7294-49f0-a55d-4a01c00cde77"
      unitRef="usd">312900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2899ef5f0e54bf481c6056474080ba9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMTEtMS0xLTA_d221dcd5-72ff-45fc-9aba-8ccf6b67287e"
      unitRef="usd">159100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8a41050bbd2f4b08bf819adc739c81b4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzQtMTItMS0xLTA_20a1eec0-4869-4f54-9310-04bccba20131"
      unitRef="usd">472000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3620d49142cd46a09f8dce2f449ad3a0_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMi0xLTEtMA_aa0fea2a-2c27-44ac-8f7e-03d7a6fed72b"
      unitRef="usd">2038900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id6eee8b72e7d491c8f95b676990b140d_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMy0xLTEtMA_0f1f2c8e-9fa0-46ce-8aea-bc69f888689e"
      unitRef="usd">1132600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i77866d045d77495391adc42c2d578d4f_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtNC0xLTEtMA_750cce7a-98ad-442c-a1fe-5b4b56cbd2fd"
      unitRef="usd">3171500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id1d584b446ba445593d7564671b578f3_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtNi0xLTEtMA_a1f663cd-004e-4aca-b606-4ce24f22ed4c"
      unitRef="usd">1272500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i27464b40c6284a7ca171e8ecbf4473ed_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtNy0xLTEtMA_7888baeb-a12b-47de-bdc1-84f45cf45df1"
      unitRef="usd">375900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4444d39b093b4cc6818d013167b30698_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtOC0xLTEtMA_dd10c9fd-aa2b-4692-a855-df4b1b7f8534"
      unitRef="usd">1648400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic727d8274f6049b8a3d7106820845e16_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMTAtMS0xLTA_beb221be-a0b1-4e4c-9fb6-1418491f8d57"
      unitRef="usd">549900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifdac9696c83845cbad8c3916522749af_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMTEtMS0xLTA_6e70c0e8-adcf-4a3e-bd40-0f3609afeb7e"
      unitRef="usd">125100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i271d00413b22420da0972fe262ee308e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzUtMTItMS0xLTA_1194349c-1344-4d08-954e-097203f6276a"
      unitRef="usd">675000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8631f56a67a14a0eaece9796d4d326c6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMi0xLTEtMA_ef65071e-bf41-476d-879d-8b05d10f7bf3"
      unitRef="usd">49600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad66804c34ae4b02af8b821d199b124c_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMy0xLTEtMA_ba9e221d-994b-4007-8bb3-e67922bc56ef"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i071fdf8810d44be79afb0d4142823f1c_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtNC0xLTEtMA_e17cb45f-b457-4ff5-89e1-856679e2903e"
      unitRef="usd">49600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18f2294499fc4cbfbda896074c917f74_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtNi0xLTEtMA_7b1c2506-200b-4f5d-9d0d-d56c6c1b66f8"
      unitRef="usd">43600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84014ab98a4b42999ddae99b7c9f17d6_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtNy0xLTEtMA_2ef44520-b514-4611-95a8-e357b02e926e"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i650a3c515fb14f28b27a2fc34755a9b6_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtOC0xLTEtMA_ae0c0a57-f3e9-4ae9-b999-18043ecbe785"
      unitRef="usd">43600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0ce55741e08d45cfb3768da278fa78cd_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMTAtMS0xLTA_9bfbcdf2-e601-435f-924f-a3facf11a884"
      unitRef="usd">58500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7ff14eff3dae4e748c42b944b71e66c5_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMTEtMS0xLTA_cb2cf76c-b891-4242-82f9-0aa97d2b924b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0cce2f2486644d48b444db7df588805c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzYtMTItMS0xLTA_21a14009-31d2-44ea-87c6-f899be36bb93"
      unitRef="usd">58500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f414a4aae9647f39eb553c172b71177_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMi0xLTEtMA_5247de87-a220-4004-8c19-7c07c4334235"
      unitRef="usd">2393100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7c62b7c793f4af4829020516aa6f08f_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMy0xLTEtMA_6d2c93a2-a920-41e5-92af-788155e99640"
      unitRef="usd">1301900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctNC0xLTEtMA_2ab4515f-52d0-43f0-80a4-954b4ecea302"
      unitRef="usd">3695000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i17631bcf62d64f15a706d210ecad4fc5_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctNi0xLTEtMA_513fcc0a-5353-4e71-8c34-cfb7fdee0ff9"
      unitRef="usd">1582400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6465511e129b4f2b9244e3f15dc79aaf_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctNy0xLTEtMA_0615e2fb-69f5-458d-bffd-a48598934317"
      unitRef="usd">519700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctOC0xLTEtMA_a3972cea-9b81-4fd7-92c2-c25f639081eb"
      unitRef="usd">2102100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i880e7908395c466ea1496767a0761862_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMTAtMS0xLTA_547da94b-5b1e-4480-8b9d-18ea3d4347a9"
      unitRef="usd">921300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i12a3197c6b1443fca044a190d98cdcf6_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMTEtMS0xLTA_5e0ae34c-b04b-4bf1-9b8c-b60bb95a847d"
      unitRef="usd">284200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzctMTItMS0xLTA_22c7cc7c-bf5f-423e-8f8b-bd5114c04c71"
      unitRef="usd">1205500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i51cd7e31b542458f934ce2f21f3bbf77_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTItMS0xLTA_52ef9900-1c73-4bbd-a0bf-cafeff7ddc6a"
      unitRef="usd">830400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia873c88964a74ad8b51878c7599c0ee5_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTMtMS0xLTA_1b71e02e-4739-4e15-8d14-4960a060a760"
      unitRef="usd">253000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fe5921de4e944419c03317f20e3cf76_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTQtMS0xLTA_3521dab9-3c33-4681-bd26-a74ad5706266"
      unitRef="usd">1083400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia66b3e8f28174bfc803903de805bdd71_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTYtMS0xLTA_29632df5-c23d-4f22-9510-243b514cb4e8"
      unitRef="usd">722000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i464eee65cbc7418d983a6e014907ca29_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTctMS0xLTA_bd0bea4b-6800-4623-a5cc-46db3bb469cd"
      unitRef="usd">231600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d9782966cd04624b4574f83bf76bd86_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTgtMS0xLTA_a0bbceb8-0cd4-4ada-a1d4-e9fbc37eeb5c"
      unitRef="usd">953600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i51349d90e1e74711bc82d5c52b4c361a_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTEwLTEtMS0w_96ff4853-844d-434c-acea-1936095e7f31"
      unitRef="usd">853100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1c5d7207e8a04d8f95ed445f4e2ca090_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTExLTEtMS0w_e134c804-7108-4491-bc8d-3c068c4fa26a"
      unitRef="usd">241500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ba6b598c34a40368885f7a795edc3ed_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEwLTEyLTEtMS0w_ee56e3f7-0e63-4858-8354-2e04fc096c6b"
      unitRef="usd">1094600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb689fd1c43b48ba823acc223d5dd95f_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTItMS0xLTA_d799ec85-b9c1-42b0-8d38-7502fcd1f307"
      unitRef="usd">221400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fd4ffa7b1c745a1bb74880e80155088_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTMtMS0xLTA_d14f693c-108e-4519-8f3f-4b5220802c11"
      unitRef="usd">47500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i233647819a5f40d194dce2a1a9997d5a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTQtMS0xLTA_478d81f5-7d03-4c57-8f48-ce232edf66b6"
      unitRef="usd">268900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i649c6b3f0c7c4dbaad7e0f14df3f9369_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTYtMS0xLTA_99eeb063-1272-4495-996d-1b0173c2a3d3"
      unitRef="usd">166600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i52b0f72609834981a2d8cce09ff40e97_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTctMS0xLTA_f8b2d82a-e741-43f2-b1f4-1df3a56edbcc"
      unitRef="usd">31700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id55b5cbb5f9b4ffb9cdc329793b4ec2a_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTgtMS0xLTA_54ff69d5-db09-44d8-8cfa-d54c27ea31aa"
      unitRef="usd">198300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1d916bf7bc7c4a77b9a424ea474da6ee_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTEwLTEtMS0w_2842b8c3-1292-4081-bbc9-eb51916f4dbd"
      unitRef="usd">184800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5ea5061f31944f2b9ce4b953e7acb45d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTExLTEtMS0w_3ba9a5f2-492d-42e7-abf7-bf21f24dd6d3"
      unitRef="usd">34800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iebf4abb2d7924525b0124ad8f4ac294d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzExLTEyLTEtMS0w_fcba97f4-bcae-4bba-93a1-1843be84636c"
      unitRef="usd">219600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf7514aec24c41be8928b4b1735c6c67_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTItMS0xLTA_dacf21fa-7ba1-4747-857f-28c2dfddcbd0"
      unitRef="usd">1051800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7759fd469e4744c1aef40bd5673059f9_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTMtMS0xLTA_18915192-5f95-490a-b701-e50eae78d029"
      unitRef="usd">300500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTQtMS0xLTA_a1e0e95c-1bb9-47ea-b6a2-25bf33cc5b2d"
      unitRef="usd">1352300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2987070776a540ddace03c1f2bc15110_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTYtMS0xLTA_93adc63a-93a6-4bf6-9258-ce12b5626adb"
      unitRef="usd">888600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7fc551316da34c2e8fefb62c8a6c00b8_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTctMS0xLTA_4a4050e3-8aa0-4d98-bb05-353088a5526c"
      unitRef="usd">263300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTgtMS0xLTA_ca48ddb9-6f97-4080-abaf-b47078fe2998"
      unitRef="usd">1151900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5dacb4bf98504ba0adc0104184a6b73e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTEwLTEtMS0w_ed9332fc-0463-4aaf-8dd1-4297d266a87b"
      unitRef="usd">1037900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i93dd5c0ed3164c9592d8fe3882f0a28d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTExLTEtMS0w_ac1aae99-7adb-421f-a713-55ef7f257515"
      unitRef="usd">276300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzEzLTEyLTEtMS0w_adf32db4-f942-4556-befd-36cf1d173cca"
      unitRef="usd">1314200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i043f4d719f7b44348bdf12b5a66ef493_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTItMS0xLTA_36571d65-07f9-4d20-9548-ac0aeab93eb1"
      unitRef="usd">396400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd533908ee6c40dd84ac4f8768c5930c_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTMtMS0xLTA_62db2fb2-5a4f-41f0-a693-ec5300cea260"
      unitRef="usd">91700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTQtMS0xLTA_98d2488d-cd34-4ddd-b149-da6f7e70bbac"
      unitRef="usd">488100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie54dd0f63ac74f119354986074fabb9f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTYtMS0xLTA_99dc7a77-080f-4b7f-a2fb-72c6d574ff7d"
      unitRef="usd">310100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic6f6c97bcbe64066a4c7b7de88fde26f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTctMS0xLTA_c56ba8a3-1ca0-4db2-8907-6cbba1410670"
      unitRef="usd">66000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTgtMS0xLTA_f2b2524c-f7fe-4af6-842e-0fdc257e6019"
      unitRef="usd">376100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e752284b89d41fcad2da9334eb55ced_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTEwLTEtMS0w_d4a05a2b-d1a9-4f76-9b0d-e50bd40ce239"
      unitRef="usd">362800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i756b9830819145cf947d010150d735da_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTExLTEtMS0w_961629a7-e324-426e-b892-b8184b7af1e9"
      unitRef="usd">74400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE1LTEyLTEtMS0w_54500105-84bf-4a9d-a8e4-1d12cec3abb1"
      unitRef="usd">437200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac2499d2fe7f4e5299751553c9849768_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTItMS0xLTA_84ae75ec-bcda-449a-ab83-da2a58645ad2"
      unitRef="usd">61000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f774c3730dc47318167508519cccd16_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTMtMS0xLTA_f27dd147-f1cd-4dcf-8931-705322edd9e2"
      unitRef="usd">35900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTQtMS0xLTA_e22b657f-9ac9-42f5-b79b-9f5680ef5677"
      unitRef="usd">96900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i595655c2121c42c4a0d63656cb7b4da9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTYtMS0xLTA_fe1ce859-5d5d-471d-9c8b-b8a34483de51"
      unitRef="usd">51200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0bd7c0bc86cd4fd797e73c8a52e9c016_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTctMS0xLTA_410aec46-e331-4715-9907-2e4179f32d15"
      unitRef="usd">29800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTgtMS0xLTA_163282be-3463-4a10-9c10-bbff4fb3b3df"
      unitRef="usd">81000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i135f102a0e3348f19dffba8a6b80c845_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTEwLTEtMS0w_b33700fc-7959-4bc6-948c-46dd335ccdde"
      unitRef="usd">58600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic76f2583244f4da1b4d8e2ffba810bd4_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTExLTEtMS0w_2af4799c-e762-4bc9-9233-30a3695f6cf8"
      unitRef="usd">36200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE3LTEyLTEtMS0w_90ad00aa-fa5e-4396-ad55-6dc474908ff8"
      unitRef="usd">94800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4d2066aba8e543da9c51bbcd0eeec832_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTItMS0xLTA_ae773d2b-0dc2-4c8e-880d-aed7bca3c320"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i97948eaa2bd440598a0350abca5c22c9_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTMtMS0xLTA_ff6d208a-98b7-4db1-8ecd-6056cac73177"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTQtMS0xLTA_d2bbdcf1-cfd0-40f7-b683-2275135518f5"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iafa45be8be374656afd2437b80f21836_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTYtMS0xLTA_6e76ad83-4878-4da0-b68a-814f00f1ff33"
      unitRef="usd">30900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic3ec9b2c72414e3986057885d7706597_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTctMS0xLTA_30091c17-7400-48b2-ba91-b5b0cdc20491"
      unitRef="usd">34400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTgtMS0xLTA_84b0ee63-93e6-4585-bcab-3a6bb75e8e5a"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1f2dd55044054b76a0d73fc9c9908555_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTEwLTEtMS0w_878d6e9d-fc25-421f-88e8-e1baee461d31"
      unitRef="usd">155400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5eb7c94b54a04e06b4612b1dc367c680_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTExLTEtMS0w_39269a1f-73e3-4135-afdc-952e47ee5b19"
      unitRef="usd">160200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzE5LTEyLTEtMS0w_a46ed008-99ca-41a2-addd-9f65a67f63e3"
      unitRef="usd">315600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia6f02780b07b4af0a4ade42afb9a3277_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTItMS0xLTA_7c282ad6-ec76-4c27-87c1-ca0f235c124a"
      unitRef="usd">3902300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4d68382b58894a7a8493d2c3c72f0bdb_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTMtMS0xLTA_ae72da88-19f7-4837-b77b-46e06928004e"
      unitRef="usd">1730000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTQtMS0xLTA_28bcb213-971f-4d82-9ef8-5f9a30b4fa1c"
      unitRef="usd">5632300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3b27c44ab2c049dab1ada8ce3e2c9dde_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTYtMS0xLTA_5d0e8290-afc0-4bce-8ef1-fb858440b715"
      unitRef="usd">2863200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if613c1f13698495a8a9033eb60e30394_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTctMS0xLTA_25a8db8a-312b-4613-a0d8-d9dae76ba61a"
      unitRef="usd">913200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTgtMS0xLTA_c79c206f-04b8-42ad-b582-82cb0d4b4c32"
      unitRef="usd">3776400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i471641798bc6486890424f64b25cab0b_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTEwLTEtMS0w_fa123aa7-6a51-4cb5-a028-247731817bf0"
      unitRef="usd">2536000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1a75be05e6974cdeabdb5101ca308496_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTExLTEtMS0w_8bf54a62-df38-43c0-af1d-cda6d182a3c1"
      unitRef="usd">831300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo5ZWRhNWViN2Q4YTI0OWZlYmJiNTc0ODI3MGQyYWNlOS90YWJsZXJhbmdlOjllZGE1ZWI3ZDhhMjQ5ZmViYmI1NzQ4MjcwZDJhY2U5XzIwLTEyLTEtMS0w_69648df1-f5e1-4d2a-a589-1ab6c0e117f3"
      unitRef="usd">3367300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia6f02780b07b4af0a4ade42afb9a3277_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzItNS0xLTEtMA_98973fea-5f33-4925-8110-45192dda4ebc"
      unitRef="usd">3902300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3b27c44ab2c049dab1ada8ce3e2c9dde_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzItNi0xLTEtMA_df7e5dfb-0d29-4377-9677-9815ffbb7944"
      unitRef="usd">2863200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i471641798bc6486890424f64b25cab0b_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzItNy0xLTEtMA_20a4c4cb-bb4d-417b-b030-f04fb4429986"
      unitRef="usd">2536000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5c981ade86904092ab44cdc3421e6c6c_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzMtNS0xLTEtMA_4139b4d3-91a2-43e5-9cee-5066f0ce4690"
      unitRef="usd">1201800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58c230109b9d48e3bb3cde0f8a0abd26_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzMtNi0xLTEtMA_008bc26d-bf1e-462a-bda0-73f0ab6e83f0"
      unitRef="usd">569800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80097451dd62453689464503df8df92f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzMtNy0xLTEtMA_ec429531-5831-4907-b460-2199b9ac2128"
      unitRef="usd">396000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3cd1f66491984c7bb0dd1d0bc4fb2a69_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzQtNS0xLTEtMA_cc309bda-b8a6-41c2-ac8f-4169ad24085c"
      unitRef="usd">365000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53fbadaaa41d47dd83cdd5d7dfa70cd8_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzQtNi0xLTEtMA_40b43535-daf9-42b1-90a4-bbfa773cb1e9"
      unitRef="usd">226800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaae08e83f10e40cfb00da11f047781ec_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzQtNy0xLTEtMA_fbf71d35-bde3-4e1c-a720-e448d6c4ce6b"
      unitRef="usd">286000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id2cf64befe504f17b267aaa43d3d20d6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzUtNS0xLTEtMA_867b25c0-12c6-42c0-b921-26bd7eb3ea9d"
      unitRef="usd">163200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e66734d295a41f3bf8bc60c57b17a6f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzUtNi0xLTEtMA_ce989147-daf6-40c2-b0f5-1de7ae6d577c"
      unitRef="usd">116600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i13c1a5da1ce942d2aae72b3f00d90f06_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzUtNy0xLTEtMA_7ea5886e-169f-4c10-b9f4-3cda2a1f9ec7"
      unitRef="usd">149300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzYtNS0xLTEtMA_a0b1e3df-be25-4e8c-8d6f-11429e9d95cf"
      unitRef="usd">5632300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzYtNi0xLTEtMA_1208c0ab-74de-4936-a96c-56c884384c67"
      unitRef="usd">3776400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTo1ZWMxODZmZjM5YWQ0NDkwOTc3MDg5MzA0ZmI1NTAwMC90YWJsZXJhbmdlOjVlYzE4NmZmMzlhZDQ0OTA5NzcwODkzMDRmYjU1MDAwXzYtNy0xLTEtMA_f70033b9-ef7d-4be5-af16-9aac906a7c77"
      unitRef="usd">3367300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c10cbf1ca23411a80e5d03d6ee6dccd_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzItNS0xLTEtMA_f70fe187-15a5-4dd7-99cd-6796d113fae8"
      unitRef="usd">4198200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i13dbf383b09e471e8163112ba23934f4_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzItNi0xLTEtMA_58ec5ad5-ec7a-4b36-8c86-cdfcbe4c0caa"
      unitRef="usd">2561100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf97bcf6dbc8421a9a3716760bcb97e7_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzItNy0xLTEtMA_0126937c-8e1c-4e48-8806-cb83dd42fa69"
      unitRef="usd">1786400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00ab011f780a4f6f8ac17f56d74cdd4b_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzMtNS0xLTEtMA_42e7a493-79de-4f4e-b660-7ec5545cbcc0"
      unitRef="usd">769100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3def95246ab34bf5acf9bbbfc8b7d08c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzMtNi0xLTEtMA_44e48bbe-a6bc-48c2-8156-605d0a0c358b"
      unitRef="usd">665900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic55d68378e9b4082aba5a6b9d59fb043_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzMtNy0xLTEtMA_632cec25-10b4-4ccf-9a1d-c1f03bb83308"
      unitRef="usd">984900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8c0068fc5d5747a882ce9ccbd0123f38_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzQtNS0xLTEtMA_80623f06-d40f-4a8e-bb81-8cfb38a34026"
      unitRef="usd">598100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88ee1f21a1904304a5934d3026a42b57_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzQtNi0xLTEtMA_6914c6bd-6bf3-4653-a8d8-f9fb6fea5d33"
      unitRef="usd">516600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf8b9b630f904fd0b483af12525ec51f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzQtNy0xLTEtMA_cf14ce5a-fd1b-4bcc-b89b-6a9e4f495e2b"
      unitRef="usd">568300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i611616cb655d4d7d9572751cfacacf64_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzUtNS0xLTEtMA_07fb0b3f-f5e2-40af-9f3a-b132e7edfdd9"
      unitRef="usd">66900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ice08cc7189624f368d50df2bf2de0a54_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzUtNi0xLTEtMA_2716f473-920b-4b0c-9a6b-0d22d4f0570c"
      unitRef="usd">32800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iadf19b3b6d394dbd927075a441de11a2_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzUtNy0xLTEtMA_d832c465-3253-403d-acca-65e87c2f8cd7"
      unitRef="usd">27700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzYtNS0xLTEtMA_c080a8c0-90df-47f3-86ba-7d7facad02bc"
      unitRef="usd">5632300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzYtNi0xLTEtMA_eaf3d000-7c68-44b0-a993-6978a669c6f7"
      unitRef="usd">3776400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90YWJsZTphNjgzMTYwZTZjN2E0YjRlOTQzNTNkMzlmYmRhZTY1MC90YWJsZXJhbmdlOmE2ODMxNjBlNmM3YTRiNGU5NDM1M2QzOWZiZGFlNjUwXzYtNy0xLTEtMA_c813bc83-38c5-4f35-a8a2-9c763326a514"
      unitRef="usd">3367300000</us-gaap:Revenues>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc2NDM_ea847967-df61-470f-a0c9-0a5ce03be380"
      unitRef="usd">830600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="idd4c3415bf074cb794ce6b40d287d9c5_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc4ODQ_f39aa902-0866-4cc0-856c-0c84e83baab7"
      unitRef="number">0.40</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ic46d5dcd82604bcbb61ee95e7645d76f_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc5MjI_94b797b0-81ee-4100-9fa8-f19c7f0c50ab"
      unitRef="number">0.27</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i2e8a93ab7a16493487f16e6dd346050c_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc5MzQ_90df76a4-9ce3-436e-8e91-d3f914e1889d"
      unitRef="number">0.18</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i9f6243dcc94a4351be212ad078c329c8_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc5NDY_f9dd3108-8c9a-4fcd-bd7e-2bcdd1c64932"
      unitRef="number">0.10</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="if08ab3a606434b90acdb237e36cd8380_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzc5NjI_591a4706-49c3-4337-a5ed-78045470cd95"
      unitRef="number">0.05</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzkzMzk_520cf608-ce9c-42b2-830b-0341ccc7d5c4"
      unitRef="usd">112100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzYvZnJhZzozODVjZGNkMzgyNWE0YzdkOTZiY2NiOGExMzE1YjEzYS90ZXh0cmVnaW9uOjM4NWNkY2QzODI1YTRjN2Q5NmJjY2I4YTEzMTViMTNhXzkzNDY_b35ae856-688a-4522-af79-a246be082e98"
      unitRef="usd">106200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODQ_367a6052-bda9-4df9-81f6-e75b7b650775">Leases&lt;div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, referred to as ASC 842. The purpose of ASU 2016-02 was to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Targeted Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not have a significant amount of sales-type leases. Prior to the adoption of ASC 842, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156"&gt;96.6&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100"&gt;21.0&#160;million&lt;/span&gt;, respectively. This included recording the Company&#x2019;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements were included within the total amount recognized upon adoption of the new lease standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee Activity - Leases where Hologic is the Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 14 years, some of which may include options to extend the leases for up to 10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating and finance lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;25, 2021 was 2.25%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Diagenode SA acquisition, the Company acquired two finance leases. The Company accounted for these lease agreements pursuant to ASC 842 and ASC 805 and recorded both an asset and liability at the present value of future lease payments as part of the purchase accounting. The finance leases are for two facilities with remaining lease terms of 7 and 11 years and contain a bargain purchase option of 3% at the end of the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity - Leases where Hologic is the Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company&#x2019;s consolidated revenue for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the disposition of the Medical Aesthetics business in fiscal 2020, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease and recorded a lease receivable, which is $17.4&#160;million as of September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases a portion of a building it owns and subleases some of its rented facilities and has received aggregate rental income of $2.6 million, $2.0 million and $2.7 million in fiscal 2021, 2020 and 2019, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LessorSalesTypeLeasesTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODQ_723814dd-7f7c-4afe-af64-2cdfd57684d5">Leases&lt;div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, referred to as ASC 842. The purpose of ASU 2016-02 was to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Targeted Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not have a significant amount of sales-type leases. Prior to the adoption of ASC 842, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156"&gt;96.6&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100"&gt;21.0&#160;million&lt;/span&gt;, respectively. This included recording the Company&#x2019;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements were included within the total amount recognized upon adoption of the new lease standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee Activity - Leases where Hologic is the Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 14 years, some of which may include options to extend the leases for up to 10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating and finance lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;25, 2021 was 2.25%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Diagenode SA acquisition, the Company acquired two finance leases. The Company accounted for these lease agreements pursuant to ASC 842 and ASC 805 and recorded both an asset and liability at the present value of future lease payments as part of the purchase accounting. The finance leases are for two facilities with remaining lease terms of 7 and 11 years and contain a bargain purchase option of 3% at the end of the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity - Leases where Hologic is the Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company&#x2019;s consolidated revenue for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the disposition of the Medical Aesthetics business in fiscal 2020, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease and recorded a lease receivable, which is $17.4&#160;million as of September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases a portion of a building it owns and subleases some of its rented facilities and has received aggregate rental income of $2.6 million, $2.0 million and $2.7 million in fiscal 2021, 2020 and 2019, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LessorSalesTypeLeasesTextBlock>
    <us-gaap:OperatingLeasesOfLessorDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODQ_9254561b-52e1-46bd-9603-7627fe5e7d52">Leases&lt;div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, referred to as ASC 842. The purpose of ASU 2016-02 was to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Targeted Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not have a significant amount of sales-type leases. Prior to the adoption of ASC 842, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156"&gt;96.6&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100"&gt;21.0&#160;million&lt;/span&gt;, respectively. This included recording the Company&#x2019;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements were included within the total amount recognized upon adoption of the new lease standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee Activity - Leases where Hologic is the Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 14 years, some of which may include options to extend the leases for up to 10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating and finance lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;25, 2021 was 2.25%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Diagenode SA acquisition, the Company acquired two finance leases. The Company accounted for these lease agreements pursuant to ASC 842 and ASC 805 and recorded both an asset and liability at the present value of future lease payments as part of the purchase accounting. The finance leases are for two facilities with remaining lease terms of 7 and 11 years and contain a bargain purchase option of 3% at the end of the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity - Leases where Hologic is the Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company&#x2019;s consolidated revenue for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the disposition of the Medical Aesthetics business in fiscal 2020, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease and recorded a lease receivable, which is $17.4&#160;million as of September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases a portion of a building it owns and subleases some of its rented facilities and has received aggregate rental income of $2.6 million, $2.0 million and $2.7 million in fiscal 2021, 2020 and 2019, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OperatingLeasesOfLessorDisclosureTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODQ_c1ec1ebd-2bfd-4d5b-ac0f-2e5713b66a47">Leases&lt;div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, referred to as ASC 842. The purpose of ASU 2016-02 was to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842): Targeted Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not have a significant amount of sales-type leases. Prior to the adoption of ASC 842, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156"&gt;96.6&#160;million&lt;/span&gt; and $&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100"&gt;21.0&#160;million&lt;/span&gt;, respectively. This included recording the Company&#x2019;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements were included within the total amount recognized upon adoption of the new lease standard.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee Activity - Leases where Hologic is the Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 14 years, some of which may include options to extend the leases for up to 10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating and finance lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;25, 2021 was 2.25%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Diagenode SA acquisition, the Company acquired two finance leases. The Company accounted for these lease agreements pursuant to ASC 842 and ASC 805 and recorded both an asset and liability at the present value of future lease payments as part of the purchase accounting. The finance leases are for two facilities with remaining lease terms of 7 and 11 years and contain a bargain purchase option of 3% at the end of the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity - Leases where Hologic is the Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company&#x2019;s consolidated revenue for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the disposition of the Medical Aesthetics business in fiscal 2020, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease and recorded a lease receivable, which is $17.4&#160;million as of September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases a portion of a building it owns and subleases some of its rented facilities and has received aggregate rental income of $2.6 million, $2.0 million and $2.7 million in fiscal 2021, 2020 and 2019, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <holx:OperatingLeaseRightOfUseAssetAtAdoptionOf842
      contextRef="i215e3aea9151448587579caf2488d39e_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI2NzU_85093644-71e8-49e4-be84-867f4747fb3f"
      unitRef="usd">91700000</holx:OperatingLeaseRightOfUseAssetAtAdoptionOf842>
    <holx:FinanceLeaseRightOfUseAssetAtAdoptionOf842
      contextRef="i215e3aea9151448587579caf2488d39e_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI2ODI_b35c4f30-32a3-44f6-b4ed-8804e68726eb"
      unitRef="usd">10200000</holx:FinanceLeaseRightOfUseAssetAtAdoptionOf842>
    <us-gaap:OperatingLeaseLiability
      contextRef="i215e3aea9151448587579caf2488d39e_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1375f84-ef5f-4e71-b4e1-87dcd926404e"
      unitRef="usd">96600000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i215e3aea9151448587579caf2488d39e_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_1b96eeeb-4f9c-4571-bad3-81c7fa8b8b75"
      unitRef="usd">21000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ide9bb99b7773447e866b67fabae6a11d_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI5Mzc_0eff755c-2969-4d6e-9d08-456d53e2e87d"
      unitRef="usd">-32600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ide9bb99b7773447e866b67fabae6a11d_I20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI5Nzc_ffc6840e-c10a-405b-827b-cec871bfb435"
      unitRef="usd">-35200000</us-gaap:OtherLiabilitiesNoncurrent>
    <holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzM2NDI_55ebc83e-7460-4350-ae4a-891db2b86852">P1Y</holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate>
    <holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm
      contextRef="i7133ee75e2dd4ac999d32c90c55818c6_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzQxNTc_f7d836b1-7dc4-489e-849a-d45fde9c5b2b">P1Y</holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm>
    <holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm
      contextRef="ib5f33f2bd0484efea0b8ae4a94ebb11e_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzQxNzc_c1c6bfdf-c04f-440c-8e7e-c4d29bfd1035">P14Y</holx:LesseeOperatingAndFinanceLeaseRemainingLeaseTerm>
    <holx:LesseeOperatingAndFinanceLeasesExtensionPeriod
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzQyNDY_8e6e5fbf-ce0b-4a48-834d-0c5d96ec3b5b">P10Y</holx:LesseeOperatingAndFinanceLeasesExtensionPeriod>
    <holx:LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzU4MjE_ad976b8d-fb24-4518-bffa-47600ee672ce"
      unitRef="number">0.0225</holx:LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent>
    <holx:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODY_040ab42c-06ba-4d0c-b9a5-877f170c1956">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease right-of-use assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da"&gt;Accrued expenses&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - short term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Finance lease obligations - long term&lt;br/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.099%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id80e5c3b505e41f3ac02c7fd4f5a90f6_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMy0xLTEtMA_20e35170-52b0-4615-b0e5-3a793ad57670"
      unitRef="usd">83600</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ibd232192ed78407a974ddcf2b2257851_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtNS0xLTEtMzQ0NDQ_7bc651e3-8965-483c-a87b-2ff5eeae4fba"
      unitRef="usd">80700</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i63bca38bbb4548949606b34deb9181e6_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzUtNC0xLTEtMzQ0NTI_cd80119b-faf4-4a02-ac17-ebf20e5855d2"
      unitRef="usd">9300</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i2dc7bf647e314aef9275b300600f7660_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMy0xLTEtMA_0e3031f9-cc3a-4d28-a27f-5c21cfb3eee3"
      unitRef="usd">26800</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic4cbe84c2c244569ac0c808b9c550275_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzctNS0xLTEtMzQ0NTA_c661ce39-39be-44f1-b12d-64e26df55dc0"
      unitRef="usd">23500</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i63a69ff36b674be191db12ceabcae07d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzctNC0xLTEtMA_5758555d-e9b6-4e3a-b35b-5eee5ffd3c04"
      unitRef="usd">3700</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i3ea319a404a74e32a76dde8d8433c89d_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtNi0xLTEtMzQ0NTY_161a8dbe-0d08-48da-85bd-714247fa910d"
      unitRef="usd">1900</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1fefdb83fea04155bda0d8947d2e2c81_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMy0xLTEtMA_880a348a-7f46-4779-a52a-a4e2ae08c49b"
      unitRef="usd">66100</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7c5787a7635445a6a57c55963ee616c2_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzktNS0xLTEtMzQ0NTQ_2882e697-23e3-48c2-9100-f31694100405"
      unitRef="usd">65600</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i63bca38bbb4548949606b34deb9181e6_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzktNC0xLTEtMA_5c3e0705-eaaa-4f65-830b-eb2711affc61"
      unitRef="usd">22800</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="id55ff3c8d27c42eb867928b21b604ce3_I20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzEwLTYtMS0xLTM0NDU4_2c734a1a-0ec7-4572-a048-1d3e39c5c6a6"
      unitRef="usd">17400</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <holx:NumberOfFinanceLeases
      contextRef="i474f42fec50e415899f9fcc327fc81f0_D20210301-20210301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzIxOTkwMjMyNzQ3NDE_64c3216b-446d-4449-855d-82f3c625f06b"
      unitRef="segment">2</holx:NumberOfFinanceLeases>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm
      contextRef="i185383b2d2cf4d63b7121bb5d0c32d01_I20210301"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzIxOTkwMjMyNzQ3NTI_45dc88e2-839c-4700-96ee-95fdefafb096">P7Y</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm
      contextRef="i1fed62fa0ae548ef9551dac57b66c922_I20210301"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzIxOTkwMjMyNzQ3NTk_b083622d-56b9-4f03-afac-a3d2b7461d89">P11Y</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <holx:LesseeFinanceLeaseBargainPurchaseOptionPercentage
      contextRef="i474f42fec50e415899f9fcc327fc81f0_D20210301-20210301"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzIxOTkwMjMyNzQ3NzI_a6936607-986c-4617-8fe5-f2cfc1965993"
      unitRef="number">0.03</holx:LesseeFinanceLeaseBargainPurchaseOptionPercentage>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzItMi0xLTEtMA_1e3ac1fa-92d4-49bb-88d1-fa8a64662678">P4Y11M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzItMy0xLTEtMA_e2ac4f41-e66a-4688-a797-facd238093bb">P7Y6M7D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzItNC0xLTEtMzQ0MzY_92fa7093-e127-4e01-b221-43d5ff6fc707">P5Y6M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzItNS0xLTEtMzQ0NDA_e18d19ff-7676-453a-be1f-1621ad955194">P7Y7M20D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzMtMi0xLTEtMA_406bb62d-7c2e-4553-ae2c-eeb5b8407d9d"
      unitRef="number">0.016</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzMtMy0xLTEtMA_577e86ae-1a19-4111-b739-d09046414c21"
      unitRef="number">0.043</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzMtNC0xLTEtMzQ0Mzg_c09fa0cf-4575-437b-ba0a-8c56ab3f9bac"
      unitRef="number">0.020</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpmMDExYzEzNzllYWU0YjA3OGZhM2ZiNjhhZTUyZTIwYS90YWJsZXJhbmdlOmYwMTFjMTM3OWVhZTRiMDc4ZmEzZmI2OGFlNTJlMjBhXzMtNS0xLTEtMzQ0NDI_9e6dc1fc-90c1-4e2f-a351-8f830417898b"
      unitRef="number">0.051</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODE_ef882dfe-dac9-4cf2-8d53-d239c8dbada6">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information related to the Company&#x2019;s operating and finance leases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost - interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new operating lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets arising from entering into new finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzEtMi0xLTEtMA_de8b0368-9773-4a06-8186-7135335daea6"
      unitRef="usd">30100</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzEtMy0xLTEtMzQ0Mjc_2b40b2c3-b500-4b5f-9280-44fe1f07251a"
      unitRef="usd">27500</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzItMi0xLTEtMA_c3bf9f1a-9cd7-4242-addc-b46eac4f8441"
      unitRef="usd">600</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzItMy0xLTEtMzQ0MjU_5f191f08-e4a1-408c-b093-ba84f302c906"
      unitRef="usd">300</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzMtMi0xLTEtMA_76bcb893-e8ff-4f41-823a-4ef2ffc4192b"
      unitRef="usd">1000.0</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzMtMy0xLTEtMzQ0MjM_fb17eec4-7057-416a-aee8-9a815a176b50"
      unitRef="usd">1000.0</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzUtMi0xLTEtMA_d46a9328-71c1-449a-95dc-31616f1ab506"
      unitRef="usd">1000.0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzUtMy0xLTEtMzQ0MjE_3b10055c-aa9c-4913-a514-7509e3f197bc"
      unitRef="usd">1000.0</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:OperatingLeasePayments
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzYtMi0xLTEtMA_6ffbf358-ebe8-4b6f-8ac5-946d42fb3e21"
      unitRef="usd">28200</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzYtMy0xLTEtMzQ0MTk_ed4d8661-78d0-4e70-8d72-4879c697f06c"
      unitRef="usd">23900</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzctMi0xLTEtMA_c253d4e4-bc7f-4d2f-979a-888f297c7ebe"
      unitRef="usd">2400</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzctMy0xLTEtMzQ0MTY_3b76c26a-6b3c-42ef-9c54-d8e13df983cc"
      unitRef="usd">1700</us-gaap:FinanceLeasePrincipalPayments>
    <holx:OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzgtMi0xLTEtMA_bf6d6964-6e68-466e-822d-db757f5c2ae1"
      unitRef="usd">31600</holx:OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability>
    <holx:OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzgtMy0xLTEtMzQ0MTQ_3b1aad93-f789-4336-abf7-9f7ba3b86a23"
      unitRef="usd">26600</holx:OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzEwLTItMS0xLTA_2ab664f7-cb89-43ff-b887-e7ef7e0ad1a8"
      unitRef="usd">28600</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzEwLTMtMS0xLTM0NDEw_730446e4-82f9-4cb2-ad21-b01af5aebe9a"
      unitRef="usd">13300</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzExLTItMS0xLTM0NDA2_b8c8a6bd-faa4-4770-a467-5575dcc6ba4a"
      unitRef="usd">9100</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo0ZmJmZjFiYWJlZTc0OTgyYmY1YjE3YTIxZTRkOWNlNS90YWJsZXJhbmdlOjRmYmZmMWJhYmVlNzQ5ODJiZjViMTdhMjFlNGQ5Y2U1XzExLTMtMS0xLTM0NDA4_8195c05d-6fea-47cf-96e7-11cce90522d0"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzY1NTU_e5f34291-1b27-4245-bfb4-ec60b9c5b03f"
      unitRef="usd">23100000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODI_35ff640a-101f-48f9-ba0e-87faa9f07842">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODI_d9c3750a-7797-4241-8395-1dd037541eef">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Lease&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzEtMi0xLTEtMA_0397cd2a-ac03-4da3-9e62-5ef3b81a039d"
      unitRef="usd">28200</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzEtMy0xLTEtMA_87380ff7-b2f3-471f-9961-6c43512822b8"
      unitRef="usd">4400</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzItMi0xLTEtMA_f838ef96-565a-4718-a609-18fbcce67067"
      unitRef="usd">22000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzItMy0xLTEtMA_51999a79-b6af-4d0a-9b91-4f51fcf879bf"
      unitRef="usd">4200</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzMtMi0xLTEtMA_7a2f82b3-6aae-4f0b-8c72-842d5a283504"
      unitRef="usd">16400</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzMtMy0xLTEtMA_0293f5fb-9b73-4068-a063-f69669bd1446"
      unitRef="usd">3900</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzQtMi0xLTEtMA_f8130f61-7382-4913-b8fa-2cf0dc8b536b"
      unitRef="usd">11800</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzQtMy0xLTEtMA_974ef300-2f0c-4bdc-bfbf-83d4a2f27921"
      unitRef="usd">3900</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzUtMi0xLTEtMA_e68a94df-518e-41ca-9808-8c79168f0850"
      unitRef="usd">7400</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzUtMy0xLTEtMA_4dcb5d3b-4ab4-4ca7-a86e-fb1ea0e5c91d"
      unitRef="usd">3900</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzYtMi0xLTEtMA_8ba90839-2c6c-4e35-aaa1-08d3ffa22b37"
      unitRef="usd">11700</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzYtMy0xLTEtMA_ea1a4b3a-bbe6-47b2-a50a-8d5053e9d1a7"
      unitRef="usd">10200</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzctMi0xLTEtMA_6b3ae1c7-8522-40ef-8c75-8ac27bc57cfe"
      unitRef="usd">97500</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzctMy0xLTEtMA_e0b128b5-e69f-45ec-96ab-44dba7bec2b9"
      unitRef="usd">30500</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzgtMi0xLTEtMA_a1bea9d3-ac34-4d3a-ae18-469a77066a86"
      unitRef="usd">4600</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzgtMy0xLTEtMA_16b2a4fb-e6cd-4e74-b25d-666332a6539c"
      unitRef="usd">4000.0</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzktMi0xLTEtMA_72ccde44-32bb-49a2-83ad-85b01c861748"
      unitRef="usd">92900</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTpiNDY4NjA3ZGM5YTI0YTRhOTc5ZGRjMGM1MTNlMDRmOS90YWJsZXJhbmdlOmI0Njg2MDdkYzlhMjRhNGE5NzlkZGMwYzUxM2UwNGY5XzktMy0xLTEtMA_27708b19-eb6b-434c-a9e7-397cc80be2d1"
      unitRef="usd">26500</us-gaap:FinanceLeaseLiability>
    <holx:LeaseRevenuePercentageOfTotalRevenue
      contextRef="i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzc3ODE_cfdf6421-4ded-4d46-9e5f-0e7280c3286f"
      unitRef="number">0.05</holx:LeaseRevenuePercentageOfTotalRevenue>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i4b68378841c444ef93e2ed5a74fb5f45_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgwNzQ_6d215c98-441a-4286-8aa9-ec7561d1f0d4"
      unitRef="usd">10200000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <holx:LeaseReceivable
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgyMTM_09468327-7932-4d54-a767-c1256449a1b6"
      unitRef="usd">17400000</holx:LeaseReceivable>
    <us-gaap:SubleaseIncome
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgzNTg_2f92edbe-4563-4d02-be52-5fd9a050b186"
      unitRef="usd">2600000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgzNjI_232a7db1-9181-4d5e-9a19-a3df22b8713a"
      unitRef="usd">2000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzgzNjk_f701d769-9871-4dd5-ad19-4f6a2d75531f"
      unitRef="usd">2700000</us-gaap:SubleaseIncome>
    <us-gaap:OperatingLeaseLeaseIncomeTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4Xzg1ODM_8717ec73-cc3e-45df-b293-040b399fee7a">The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.019%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OperatingLeaseLeaseIncomeTableTextBlock>
    <holx:SubLeaseRentalIncomeCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzAtMi0xLTEtMA_06907700-99ff-47ed-9333-2bfafb1ca66a"
      unitRef="usd">3100000</holx:SubLeaseRentalIncomeCurrent>
    <holx:SubLeaseRentalIncomeDueIn2Years
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzEtMi0xLTEtMA_1e54b69d-b8b9-45bf-83f6-24bc5218a6ea"
      unitRef="usd">3000000.0</holx:SubLeaseRentalIncomeDueIn2Years>
    <holx:SubLeaseRentalIncomeDueIn3Years
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzItMi0xLTEtMA_d83d8d93-4a04-4980-8722-6044b32360b5"
      unitRef="usd">3000000.0</holx:SubLeaseRentalIncomeDueIn3Years>
    <holx:SubLeaseRentalIncomeDueIn4Years
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzMtMi0xLTEtMA_14bfbe78-f07a-41dd-9342-ee6732ca24eb"
      unitRef="usd">2000000.0</holx:SubLeaseRentalIncomeDueIn4Years>
    <holx:SubLeaseRentalIncomeDueIn5years
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzQtMi0xLTEtMA_cecd0476-ef5e-4692-88b1-f49e2587fd3c"
      unitRef="usd">900000</holx:SubLeaseRentalIncomeDueIn5years>
    <holx:SubLeaseRentalIncomeDueThereafter
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzUtMi0xLTEtMA_44ef3c8f-895d-44d6-b7d8-724b1340d7b9"
      unitRef="usd">2300000</holx:SubLeaseRentalIncomeDueThereafter>
    <holx:SubLeaseRentalIncome
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTo4M2RmNWM2ZWRhN2E0NzQ2OGJhMTdmZDhjNzEwM2I1OC90YWJsZXJhbmdlOjgzZGY1YzZlZGE3YTQ3NDY4YmExN2ZkOGM3MTAzYjU4XzYtMi0xLTEtMA_41ce1f0e-3388-4ec0-94b9-4276d2911484"
      unitRef="usd">14300000</holx:SubLeaseRentalIncome>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzE1MzM1_5ad5d15a-7e12-4b29-bbee-296d5bf1634f">Business Combinations&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During fiscal 2021, 2020, and 2019, the Company completed several business combinations for a total consideration of $1,178.9 million, $269.0 million and $120.1 million, respectively. The business combinations resulted in the recognition of intangible assets, goodwill and other assets and liabilities summarized below. During 2021, the Company also completed an asset acquisition of customer relationship assets of $5.6 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Mobidiag Oy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 17, 2021, the Company completed the acquisition of Mobidiag Oy ("Mobidiag"), for a purchase price of $729.6&#160;million. Mobidiag, located in Finland, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. Mobidiag's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;based on the estimated fair values as of June 17, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Mobidiag's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily related to deferred income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are development technology, in-process research and development ("IPR&amp;amp;D"), customer relationships and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 15.0% to 19.0%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The developed technology assets are comprised of know-how, patents and technologies embedded in Mobidiag's products and relate to currently marketed products. The developed technology assets comprise the primary product families under the Novodiag and Amplidiag technology platforms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The IPR&amp;amp;D project relates to an in-process project that has not reached technological feasibility as of the acquisition date and has no alternative future use. The primary basis for determining technological feasibility of the project is obtaining regulatory approval to market the underlying product. The asset recorded relates to one project, and the Company expects to complete the project over the next three years. In the fourth quarter of fiscal 2021, the Company updated its valuation of IPR&amp;amp;D assets based on facts that existed at the date of acquisition and recorded a $29.0&#160;million decrease to the IPR&amp;amp;D intangible asset value. Given the uncertainties inherent with product development and introduction, there can be no assurance that the Company's product development efforts will be successful, completed on a timely basis or within budget, if at all. The IPR&amp;amp;D asset was valued using the income approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary estimate of the weighted average life for the developed technology assets range from 8 to 12 years, customer relationships range from 5 to 10 years, and tradenames range from 8 to 12 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Mobidiag acquisition. These benefits include expanding the Company's molecular diagnostics portfolio into the near-patient testing market and utilizing the Diagnostic's commercial sales, manufacturing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Biotheranostics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 22, 2021, the Company completed the acquisition of Biotheranostics, Inc. ("Biotheranostics"), for a purchase price of $231.3&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs the lab testing procedures at its facility. Biotheranostics' results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition and its revenues are reported within service and other revenue in the Company's consolidated statement of income and within service revenue in the disclosure of disaggregated revenue in Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Biotheranostics' business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated synergistic benefits of adding Biotheranostics' Clinical Laboratory Improvement Amendments (CLIA) lab to the Company's portfolio of offerings and of utilizing Diagnostic's marketing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Diagenode&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, the Company completed the acquisition of Diagenode SA ("Diagenode") for a purchase price of $155.1&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR (polymerase chain reaction) technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Diagenode's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily related to deferred income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and customer relationships. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 14.5% rate for developed technology and a 13.5% rate for customer relationships. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and customer relationships is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Diagenode's products broadening the Diagnostics portfolio of molecular diagnostics products primarily in the transplant and acute care gastrointestinal and respiratory space as customers seek a broader menu of tests, utilizing Diagnostic's sales force to drive menu expansion and revenue growth and gaining additional PCR assay development expertise. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Somatex Medical Technologies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2020, the Company completed the acquisition of Somatex Medical Technologies GmbH ("Somatex") for a purchase price of $62.9&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. The allocation of the purchase price is based on the Company's preliminary valuation, and it allocated $38.0&#160;million to the preliminary value of developed technology, $1.2&#160;million to customer relationships, $0.9&#160;million to trade names and $32.4&#160;million to goodwill. The remaining $9.6&#160;million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily related to deferred income taxes. Somatex' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NXC Imaging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging for a purchase price of $5.6&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal Health products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acessa Health&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$162.0&#160;million, which included a hold-back of $3.0&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Business Combinations,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company is required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. For the year ended September 25, 2021, the Company remeasured the contingent consideration liability and recorded a gain of $6.7&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period, partially offset by a lower discount rate and accretion of the liability based on the passage of time. As of September 25, 2021, the Company&#x2019;s contingent consideration liability was $75.1 million, $16.3 million of which was recorded within accrued expenses and $58.8 million was recorded within other long-term liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Acessa's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using an 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Health Beacons&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons") for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's valuation, it allocated $10.7&#160;million to developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Alpha Imaging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging") for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration which the Company estimated at $0.9&#160;million. The contingent consideration was payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal Health products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SuperSonic Imagine&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine SA ("SSI") for $18.2&#160;million. SSI was a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#x20ac;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#x201c;VIE&#x201d;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting and included its proportionate share of SSI's net loss of $3.3&#160;million for the two months ended September 28, 2019 within Other income (expense), net. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 21, 2019, the Company acquired an additional 7.6&#160;million of SSI's common shares for $12.6&#160;million. As a result, the Company owned approximately 78% of the outstanding common shares at November 21, 2019, and controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2&#160;million recorded to other income (expense), net in the first quarter of fiscal 2020. The total accounting purchase price was $69.3&#160;million, which consisted of $17.9&#160;million for the equity method investment in SSI, $12.6&#160;million for shares acquired on November 21, 2019, $30.2&#160;million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6&#160;million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1&#160;million outstanding shares in fiscal 2020 for $1.8&#160;million. In the third quarter of fiscal 2021, the Company purchased the remaining 4.8&#160;million shares outstanding for $8.5&#160;million and as of September 25, 2021, the Company owned 100% of the outstanding shares of SSI.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on anticipated synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Focal Therapeutics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2018, the Company completed the acquisition of Focal Therapeutics, Inc. ("Focal") for a purchase price of $120.1&#160;million, which included hold-backs of $14.0&#160;million payable up to one year from the date of acquisition. In the second quarter of fiscal 2019, $1.5&#160;million of the hold-back was paid, and the remaining $12.5&#160;million was paid in the first quarter of fiscal 2020. Focal, headquartered in California, manufactures and markets its BioZorb marker, which is an implantable three-dimensional marker that helps clinicians overcome certain challenges in breast conserving surgery. Focal's results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Focal's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, in-process research and development, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from&#160;15.5%&#160;to 16.5%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names was 11 years and 13 years, respectively. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the amount of goodwill were based on synergistic benefits that are expected to be realized from this acquisition. Benefits include the expectation of broadening the Company's Breast Health portfolio of products and technology. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2d1855a726e04afa80871b8a251ccd6f_D20210617-20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY2OTQ_df6f7215-d4b6-46a0-a69f-cdd27b294b14"
      unitRef="usd">729600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY2OTA_7741a1f1-d5c0-48be-b4a8-97dbdcbb6b20">The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;based on the estimated fair values as of June 17, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Acessa's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzAtMi0xLTEtMzQ5MTQ_58b7d66f-2c2a-4249-b13d-310c6f27b3a7"
      unitRef="usd">7000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzEtMi0xLTEtMzQ5MTQ_15ab9718-8e3e-4a4a-80e2-d44ef1e47c55"
      unitRef="usd">4200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzItMi0xLTEtMzQ5MTQ_a1bb640d-632e-4044-91cd-dea6651115ea"
      unitRef="usd">13700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzQtMi0xLTEtMzQ5MTQ_8ea6d439-f2ad-41d1-a3da-23408381efba"
      unitRef="usd">29600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzUtMi0xLTEtMzQ5MTQ_a9817516-4564-4e1b-920c-6123597d1bab"
      unitRef="usd">19100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzYtMi0xLTEtMzQ5MTQ_a6cb012f-fa0b-4824-8440-8b050fda2d70"
      unitRef="usd">11700000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzktMi0xLTEtMzQ5MTQ_d412eaac-e9f7-4fc4-a0be-105eea955c67"
      unitRef="usd">285000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzEwLTItMS0xLTM0OTE0_f25a6c8e-ee01-437f-9909-407168f598b3"
      unitRef="usd">74000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzExLTItMS0xLTM0OTE0_79381167-2527-4150-98ff-566228a197f5"
      unitRef="usd">20900000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzEyLTItMS0xLTM0OTE0_1e6d277a-93b1-442a-a6bb-95781a41d570"
      unitRef="usd">20000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzE0LTItMS0xLTM0OTE0_43946e54-2200-411a-b5bb-f6241de4d4ab"
      unitRef="usd">66100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzE1LTItMS0xLTM0OTE0_cc410ee2-bc37-4d19-9b62-9b1dc8443e56"
      unitRef="usd">60500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzE2LTItMS0xLTIzMTg4_ab3f818e-db03-47f6-9f33-edb4a3658c3e"
      unitRef="usd">432600000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i9a385ec34dde4c0498c6601386e0ded1_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowOTgwZDYzMDlkZmM0YTExOTkyNDE3OTBkNjFiMDViMy90YWJsZXJhbmdlOjA5ODBkNjMwOWRmYzRhMTE5OTI0MTc5MGQ2MWIwNWIzXzE3LTItMS0xLTM0OTE0_f3974c4b-f95b-4319-9bc2-fcdcbc31e928"
      unitRef="usd">729600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i209e37886ec24b4ca152f473bd170893_D20210617-20210617"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3MTA_f77483f1-4b63-4174-bada-1226772329dc"
      unitRef="number">0.150</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i1adc191bfb1944e6a9cbc20ef1487b58_D20210617-20210617"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3MTc_ea14f8be-8e95-4148-879c-ab377853edf2"
      unitRef="number">0.190</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess
      contextRef="ia55f2fdbeb5742f7b3342b8cee59d144_D20210627-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE3MTE2NzE_9939fbea-bc30-4f72-a069-6748209bff36"
      unitRef="usd">29000000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i942be4914a6f424abf0ee50bc8e25578_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3Mjg_85cffaab-d3c1-4de4-a1fd-7a32e7c20b60">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic2e17b8f966541f782e6ed141bb9f99d_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3MzU_29bb0e4a-519d-46f7-a0fb-50c2868d8a08">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i989b3c343b4149569fea2cd1610908f1_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3NTI_f7d7eed9-6e16-4f3d-989b-4737e7e18631">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i190577d230694c6db7092cbe00fd5262_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3NTc_e564769a-d5ad-48ee-b624-13e45c153db1">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ice6517c799d444b38d8fd28d773fafac_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3NzI_a97c1696-b977-4893-baf3-be8c1feb2515">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1aef7229f2fb43e2bf47467c959ff49f_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3Nzk_7d8ab02d-7b34-4d74-bfac-8db299c88f58">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i79d7a89a26634ea88d3359abf077c8ba_D20210222-20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzMyOTg1MzQ5MTA1Nzk_8ba4f5e2-25ee-4a26-ac96-846ee54e47c5"
      unitRef="usd">231300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzEtMi0xLTEtMzUwMjY_bd19f066-9c3e-460a-86d4-6596c296bc26"
      unitRef="usd">9600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzItMi0xLTEtMzUwMjY_19ac66af-892b-4d55-bfe8-146e3ca05b57"
      unitRef="usd">6600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzUtMi0xLTEtMzUwMjY_cac82022-8061-42f6-b38b-127e199740be"
      unitRef="usd">6500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzYtMi0xLTEtMzUwMjY_de0a2e97-7ad0-4090-8dda-80a89107e28c"
      unitRef="usd">8200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzctMi0xLTEtMzUwMjY_190fe991-a324-4c0d-85ba-ef6e120d45cc"
      unitRef="usd">8100000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzktMi0xLTEtMzUwMjY_65ed17e3-0686-4ded-b7fa-0f0625f3b70d"
      unitRef="usd">160300000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzExLTItMS0xLTM1MDI2_c2b42267-5061-47e7-9aae-8c9a62fd2c8a"
      unitRef="usd">2100000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzE0LTItMS0xLTM1MDI2_118f3b3c-013f-4e24-8342-b1a3302a41bf"
      unitRef="usd">18400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzE1LTItMS0xLTIzMTgw_ad688a33-0ff0-44c8-9c5a-fa00e6b0563f"
      unitRef="usd">80900000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i72e70f5d003f4a96987b3a7637d2c815_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo2ZWM5YTk2N2FjNmE0YmYxYjE5MmE3ZDdkNDk1MWNlOC90YWJsZXJhbmdlOjZlYzlhOTY3YWM2YTRiZjFiMTkyYTdkN2Q0OTUxY2U4XzE2LTItMS0xLTI1MTQ5_7bdf7347-37ef-45fc-a267-c7ca8d6013b8"
      unitRef="usd">231300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i79d7a89a26634ea88d3359abf077c8ba_D20210222-20210222"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY3OTI_cee62dac-8653-426d-ace8-20f8a0a72a35"
      unitRef="number">0.180</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i79d7a89a26634ea88d3359abf077c8ba_D20210222-20210222"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4MDE_36f4b31b-e4d9-4ffc-be1c-fcd6af0cce34">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i36c42ab7aefa4f41aab159b7a5733d71_D20210301-20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzMyOTg1MzQ5MTA2MTA_7ebd2aa5-d6f7-4285-b814-69679e7e55e4"
      unitRef="usd">155100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzEtMi0xLTEtMzUwNjY_a62ffe5f-7009-4691-bb96-6a37833c96f6"
      unitRef="usd">5600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzItMi0xLTEtMzUwNjY_77e7f1b0-be5d-4a1b-9c34-6024321f451c"
      unitRef="usd">9300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzMtMi0xLTEtMzUwNjY_3c255ac8-92a6-472f-a72b-31d92ae89bc1"
      unitRef="usd">9000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzUtMi0xLTEtMzUwNjY_2e34f0d0-075b-4a93-82c6-98fa8011a6d3"
      unitRef="usd">13900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzYtMi0xLTEtMzUwNjY_ae54c51a-ffc3-45b5-b5da-558bd5dadb40"
      unitRef="usd">16700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzctMi0xLTEtMzUwNjY_005ae7e6-bcde-4081-b80c-1871c4033d11"
      unitRef="usd">9200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzktMi0xLTEtMzUwNjY_c799f8a1-91ce-4852-a274-dbf624de7a64"
      unitRef="usd">69800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzExLTItMS0xLTM1MDY2_71ab8c84-6b27-4731-8c1d-777f6c825297"
      unitRef="usd">9200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzE0LTItMS0xLTM1MDY2_962f6e32-46af-4f56-a009-fc10aae95250"
      unitRef="usd">19300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzE1LTItMS0xLTIzMTkz_a811092d-d441-4ca6-8509-c5d3d84c6685"
      unitRef="usd">83500000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i01e7f02a71bb40e3a36976eb57aa9856_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphZjFlN2ViMmNiYWE0YjE2OGI4NDViMzUyOTY5YmJhYy90YWJsZXJhbmdlOmFmMWU3ZWIyY2JhYTRiMTY4Yjg0NWIzNTI5NjliYmFjXzE2LTItMS0xLTM1MDY2_f4f8d584-5238-4e68-96bc-676c273dd5fb"
      unitRef="usd">155100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="if659372cd83b4bd4bc8116d8668b1a35_D20210301-20210301"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4MTQ_43b3040f-a6e0-4809-abce-b052980143dd"
      unitRef="number">0.145</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i7f176b8a88dd4e52a616432565abdf82_D20210301-20210301"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4MjE_e66edf6a-938e-47e1-bb3f-cdf18608c5c7"
      unitRef="number">0.135</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i36c42ab7aefa4f41aab159b7a5733d71_D20210301-20210301"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4MzA_863273af-27f2-4788-96e7-7377bd0ee3b7">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2946643ddc6a41b8bc328cd550813b7c_D20210104-20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzU5Nzk_89c7cb76-6ea0-4269-86bf-0a531b42d81b"
      unitRef="usd">62900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i4dbe228069a44bdeab333d84de471731_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzYwNzU_0703638f-b7c8-46c4-b5b4-928f9ca474b4"
      unitRef="usd">38000000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i4dbe228069a44bdeab333d84de471731_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzYwOTA_4e52cd0b-7d55-494e-a4a9-cfb48a77cead"
      unitRef="usd">1200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i4dbe228069a44bdeab333d84de471731_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4NDM_1fe99631-5d08-48b0-890b-e110850575b6"
      unitRef="usd">900000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:Goodwill
      contextRef="i4dbe228069a44bdeab333d84de471731_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzYxMDQ_16cf07a6-61f7-49f2-9e73-cf807718cb7e"
      unitRef="usd">32400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i4dbe228069a44bdeab333d84de471731_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NzYxNjA_cf23401a-a2a4-4c9d-8528-c76fb3cc8d2d"
      unitRef="usd">9600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i764422f35a5940fb9fd05f652236cf3a_D20200928-20200928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4NTc_6ff0aa27-61fc-43b0-9796-f99c365167a4"
      unitRef="usd">5600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i5ee9425976bd4c5ea618b0d36430a7c8_D20200928-20200928"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMTY4NzM_0e12bfaa-fe8b-47f9-b4d0-5205838b2f3e">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ib9077d45e6f24c7586761d31add141ac_D20200823-20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzE2Mw_dd699b37-1c30-4f04-82a8-5feaccf5d1c3"
      unitRef="usd">162000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iec517cd2e58d49acbb42aa527e1d9b85_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzE5Nw_75f39e62-8ace-4830-8188-f848fad13627"
      unitRef="usd">3000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzMyMA_c8507a94-c93d-4e6e-abd6-9b61442c640e"
      unitRef="usd">81800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6087fbabae0944f982d1de9eb1a1ed44_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwOTk1MTE2NTU3OTM_b4028874-5764-41e4-99fd-9e73ed566234"
      unitRef="usd">-6700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzAtMi0xLTEtMA_6f0e3da3-f9ad-49b9-96be-d7ea5b420c54"
      unitRef="usd">1200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzEtMi0xLTEtMA_aca64fd2-1307-4fa4-a3f0-606f0923d137"
      unitRef="usd">4000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzItMi0xLTEtMA_cdae2047-effa-4444-8fbd-ddb1fbfcb120"
      unitRef="usd">4400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzMtMi0xLTEtMzUxNjA_04160184-a881-4219-bd66-4628591c148f"
      unitRef="usd">4700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzQtMi0xLTEtMA_19b5c24d-4e5f-4ece-9496-a9568833ccd6"
      unitRef="usd">127000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzYtMi0xLTEtMA_b6b984b6-b806-45a9-8abe-2cdf38c989d1"
      unitRef="usd">1200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzgtMi0xLTEtMA_3e9ac41d-11e2-4d7e-acff-7ccee794525f"
      unitRef="usd">20200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzktMi0xLTEtMA_db5a3061-5ff7-47af-b83f-a60485e8d0ab"
      unitRef="usd">49100000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i00d0af71f2ae4f1ab6f873a0f873e804_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTphOTBkZDQzMDVlNTQ0YmY0OTM1OTU2OTE4YjZiN2Y4NC90YWJsZXJhbmdlOmE5MGRkNDMwNWU1NDRiZjQ5MzU5NTY5MThiNmI3Zjg0XzEwLTItMS0xLTA_415e698c-2e24-4d84-9ab9-437648b593af"
      unitRef="usd">162000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="ib9077d45e6f24c7586761d31add141ac_D20200823-20200823"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzI2OTU_b8bfe9ed-75b9-44ba-958c-ff3bf693df74"
      unitRef="number">0.180</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib9077d45e6f24c7586761d31add141ac_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzMwMDI_ec130c3a-b1d2-4ea5-b20d-f368aab8b9a8">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1e4b2db5b6ae4c4ba84f02771907f7a4_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzM2ODU_a1811b93-145d-4bda-b72e-78f7f67e0084"
      unitRef="usd">19700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="i5e988670f72849c99fb52b89dee92904_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzM3MTg_e3d48cb2-1437-4aec-91e5-20c73275f20b"
      unitRef="usd">2300000</holx:Holdback>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5e988670f72849c99fb52b89dee92904_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzM5MDQ_aad39d19-ba31-4be5-877f-1e96501de620"
      unitRef="usd">10700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i5e988670f72849c99fb52b89dee92904_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzM5ODI_adaa88c8-383e-4640-8bb5-0c293bc3638f"
      unitRef="usd">6200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i5e988670f72849c99fb52b89dee92904_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzQwMTI_ce7397ce-71f9-4fb9-a325-f337f26846e6"
      unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="id68fc41b2dac49ce95512717f490a715_D20191230-20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzQ1MzI_a3dbbc39-79e5-4194-90d4-db865e7944ca"
      unitRef="usd">18000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="ib93bd6cff06a4e7f87214f6eb2cbfd4b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzQ1NjY_e293d5af-f686-4d0b-ab63-ba37c47f9558"
      unitRef="usd">1000000</holx:Holdback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i16b5a1f413384f9ca72737023db38188_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzQ2MzM_bebfaca5-9997-46b6-9d71-96cdbb9242c4"
      unitRef="usd">900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i36618631bdde40eab7a2277b4c960865_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzUyNzQ_f2f9201c-b394-4557-ad75-036af8675f05"
      unitRef="number">0.46</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iedf53a2286ab4650ab8d967009ff9c57_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzUzMzc_5137a6c9-1625-43c2-b67d-0a2c7ff43beb"
      unitRef="usd">18200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessAcquisitionCashTenderOfferPricePerShare
      contextRef="i6917f131714d4eaa8f02a7754033309b_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzU1ODc_2342fb6f-1f47-4b88-a4bf-39e9c196ee09"
      unitRef="usdPerShare">1.50</holx:BusinessAcquisitionCashTenderOfferPricePerShare>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ifa9b0872e98f4d10ad0e93ab1bc740eb_I20191120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzU5MDc_b7b604a5-2ca1-4a14-b5a5-93a4dc3f65db"
      unitRef="number">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie280a98b55e94f6c8d1901932bc65953_D20190728-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzYwNzI_01ecf24b-38d5-4d80-bc7a-d8739d4a7bb7"
      unitRef="usd">3300000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <holx:BusinessCombinationSharesAcquired
      contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzYyMDQ_319567d6-dc85-43b1-9b9f-7da7c7b44085"
      unitRef="shares">7600000</holx:BusinessCombinationSharesAcquired>
    <holx:AdditionalPurchaseConsideration
      contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzYyMzI_1d9ebf54-f6f7-407b-80d0-fe5445ae35d8"
      unitRef="usd">12600000</holx:AdditionalPurchaseConsideration>
    <holx:BusinessCombinationOwnershipPercentage
      contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzYzMDk_3652122d-7aec-4418-816d-8d65aee6cb1d"
      unitRef="number">0.78</holx:BusinessCombinationOwnershipPercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i36618631bdde40eab7a2277b4c960865_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY3MjU_8228680b-448e-4ee1-b45b-2b7d0736d311"
      unitRef="number">0.46</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY4Mjc_49eaba03-76c9-4a77-9f68-249d5bf875c6"
      unitRef="usd">3200000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY5MTY_0cf88829-685e-493a-9e68-eb0ace37904b"
      unitRef="usd">69300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment
      contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY5Mzk_3ae0ff60-a4f8-4f21-bc6d-a15b1b9f752c"
      unitRef="usd">17900000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares
      contextRef="i434021f3ec27448fbe1165597b733f5d_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzY5ODM_7801b97c-931a-4f91-b5fb-1792e58c62bc"
      unitRef="usd">12600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment
      contextRef="i28a78daa96174b73adda087efc9ccda4_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzcwMjg_2459b475-fd1f-4e37-9c0c-f39494132eda"
      unitRef="usd">30200000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest
      contextRef="i76683b5c18404ee8b099355c544bc298_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzcxNzg_fe1e80f7-aa6f-4d39-9642-9c118c57374b"
      unitRef="usd">8600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest>
    <holx:BusinessCombinationAdditionalSharesAcquiredShares
      contextRef="ic95991b5e000422fbe8ed48efcf4b896_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzczMDE_82133647-2201-42f4-881c-3f01803562c4"
      unitRef="shares">1100000</holx:BusinessCombinationAdditionalSharesAcquiredShares>
    <holx:BusinessCombinationAdditionalSharesAcquiredValue
      contextRef="ic95991b5e000422fbe8ed48efcf4b896_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzczNDI_51ac09f2-6512-4e16-9504-3417d27e133f"
      unitRef="usd">1800000</holx:BusinessCombinationAdditionalSharesAcquiredValue>
    <holx:BusinessCombinationAdditionalSharesAcquiredShares
      contextRef="ida7a175c50e343bc88edc64520ef9945_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMzk0NzU_3e883aa6-d938-4277-9953-773f900d5f9f"
      unitRef="shares">4800000</holx:BusinessCombinationAdditionalSharesAcquiredShares>
    <holx:BusinessCombinationAdditionalSharesAcquiredValue
      contextRef="ida7a175c50e343bc88edc64520ef9945_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzIxOTkwMjMzMzk0ODg_1f9ff86c-f0ab-4c0c-a8eb-5fbf19e6b165"
      unitRef="usd">8500000</holx:BusinessCombinationAdditionalSharesAcquiredValue>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="ia88c8081745b4259b3951cbc18febc64_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzc0MDg_dc555763-8512-4bd6-b99c-bc4ba13529d7"
      unitRef="number">1</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzAtMS0xLTEtMA_ca46d113-28bd-454f-be48-13a04e892067"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzEtMS0xLTEtMA_8e25eebe-ce0e-426f-beed-9a0a31929430"
      unitRef="usd">7100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzItMS0xLTEtMA_cf1d3a47-82d7-45dd-986a-77444b86add9"
      unitRef="usd">10000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzMtMS0xLTEtMA_19f038fa-d195-46dc-b74a-481a417ee944"
      unitRef="usd">6500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzQtMS0xLTEtMA_7e5d79b7-7209-4fdb-a682-63d98cd814bf"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzUtMS0xLTEtMA_92279b14-4375-4fd5-8a52-8ed81133bf5b"
      unitRef="usd">24500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzYtMS0xLTEtMA_ebece28e-5244-4160-bd3d-5631d32e121d"
      unitRef="usd">1800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzctMS0xLTEtMA_9a4e4cc6-615e-4002-a35d-26861b69131f"
      unitRef="usd">8800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzgtMS0xLTEtMA_741bb6bf-a3ed-4d21-86f9-6bdeef5a850e"
      unitRef="usd">3800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzEwLTEtMS0xLTA_09b83f50-33a2-4e6b-83ae-279458e6422d"
      unitRef="usd">38300000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzExLTEtMS0xLTA_768a9be1-5215-4351-bf8b-b1cf261af448"
      unitRef="usd">4000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzEyLTEtMS0xLTA_606ef520-5774-4c37-83fa-d837758a7eb2"
      unitRef="usd">3000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzEzLTEtMS0xLTA_2e24aaa2-cb28-4408-82c4-7ac2be3cf556"
      unitRef="usd">1900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzE0LTEtMS0xLTA_011fc449-c523-4639-b596-cf460d8799f7"
      unitRef="usd">34300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8b728effda394302a72ca98b3567ed57_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTowZWIyMzU5MzE3MTQ0OTk4OTQ5N2M5YTQzOWM2MmJjOC90YWJsZXJhbmdlOjBlYjIzNTkzMTcxNDQ5OTg5NDk3YzlhNDM5YzYyYmM4XzE1LTEtMS0xLTA_1674d00a-b92e-47b0-8f2d-15646f758f18"
      unitRef="usd">69300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="ic95991b5e000422fbe8ed48efcf4b896_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzg0NzM_e1708b99-fe6c-44c5-bb47-ca453f3ce926"
      unitRef="number">0.120</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8c8888b8e35a4df4a031e6fa6250444b_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzg3NzI_dd28878f-fbce-4468-b246-abf0f96c5fa3">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2d53a4eb8eac4b2c99a46ebf3435d28f_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzg4MDI_0b7493f9-9db6-4ce5-ba37-03c55df3ac3e">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8b6dc772990a4dd08e146f2812715ff8_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzg4MjQ_c25ce787-eef2-4c19-832e-723c411075a9">P8Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2b1421425b23449bb82f2089d54bfb94_D20181001-20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk1MTA_ad5c9a62-1d7b-4523-b0fb-a2cd05704d80"
      unitRef="usd">120100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk1NDM_e9e80ae3-8ea5-41cb-82fd-8d9585862cd4"
      unitRef="usd">14000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability
      contextRef="i2b1421425b23449bb82f2089d54bfb94_D20181001-20181001"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk1NjA_87d12b9c-d2b2-493c-9fa9-9b69ce013b12">P1Y</holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1d2e8a19c496462f9cfc2bb84de929f2_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk2MzE_47914f6e-1225-46f7-aa2f-dd9dd7a5f985"
      unitRef="usd">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iead19d3763124535a6de6bd936833053_D20191001-20191001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0Xzk2Nzk_e44e0ca2-38b8-4945-be02-c342a87aacf6"
      unitRef="usd">12500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzAtMS0xLTEtMA_3342d7d2-1aed-4f06-ba3e-4f99b8a3bad9"
      unitRef="usd">2200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzEtMS0xLTEtMA_931a5f1e-11dd-48c1-affc-b02de4abbb4e"
      unitRef="usd">2000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzItMS0xLTEtMA_9da8e820-1afc-4439-aed5-596042d89ce0"
      unitRef="usd">7900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzMtMS0xLTEtMA_f316f645-e17c-4fdc-8d82-250989c2deec"
      unitRef="usd">500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzQtMS0xLTEtMA_aa2bc6ae-b59b-437b-b1b5-20110902c396"
      unitRef="usd">5600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzUtMS0xLTEtMA_ac144b9d-081e-465c-b65a-63eea1219356"
      unitRef="usd">2500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzctMS0xLTEtMA_33583564-0725-4aa3-b374-b280cc7df8c1"
      unitRef="usd">83100000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzgtMS0xLTEtMA_cf9c927e-4c27-499e-875f-1195b8a57eba"
      unitRef="usd">11400000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzktMS0xLTEtMA_d6885888-dbba-4085-aca1-1a37c040de78"
      unitRef="usd">2700000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzEwLTEtMS0xLTA_d694ab52-88c6-45a4-8afe-22d9e9457c60"
      unitRef="usd">12700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzExLTEtMS0xLTA_801b5997-9270-4b62-aa63-53ba135be87a"
      unitRef="usd">31100000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8c28711a7c6e4bf4876d7b692fe2a5cb_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90YWJsZTo5ZjYyNzkxYmEyMDY0YzUxYmM3NmFjMGViMjU0NmRmZC90YWJsZXJhbmdlOjlmNjI3OTFiYTIwNjRjNTFiYzc2YWMwZWIyNTQ2ZGZkXzEyLTEtMS0xLTA_03a08be3-ff39-4886-b7c1-f9fcbe256a6b"
      unitRef="usd">120100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i71d4407f36384a78ab3fd3c29df58e1a_D20181001-20181001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwODUw_3a8b75f6-bf41-4b17-817d-73e9cf997a1b"
      unitRef="number">0.155</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="iecc2544b7c7d4f2181bf059594fbb073_D20181001-20181001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzEwODU2_81a6342c-b519-4139-995e-ba3b5d84523f"
      unitRef="number">0.165</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i05a15ceda3194f6a95ab1a2052135e7b_D20181001-20181001"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzExMTYy_627b75f3-f9b4-47ae-9c38-01e7e84d4174">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia45d1465e59545618e64088cd88eaf9a_D20181001-20181001"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDUvZnJhZzo2MDIzYzY0MTg4MWQ0ZGIzOTY0N2I4Njc4OGM0ZTNmNC90ZXh0cmVnaW9uOjYwMjNjNjQxODgxZDRkYjM5NjQ3Yjg2Nzg4YzRlM2Y0XzExMTY5_0aba4350-ddbf-4cb0-a909-5df38fbcfcd6">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzIxOTkwMjMyNjg4MTg_05b59f2e-e255-4b51-b2ac-0346fa4e76a4">Restructuring and Divestiture Charges&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its operations for opportunities to improve operational effectiveness and efficiency, including facility and operations consolidation, and to better align expenses with revenues. As a result of these assessments, the Company has undertaken various restructuring actions which are described below. The following table displays charges taken related to restructuring actions in fiscal 2021, 2020 and 2019 and a rollforward of the charges to the accrued balances as of September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2021 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2020 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2019 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Restructuring Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019 charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Workforce reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility closure costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020 charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Workforce reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility closure costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2021 charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Workforce reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2021 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2021 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2020 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2019 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2018 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Previous Other Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Rollforward of Accrued Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Severance payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Severance payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other payments and adjustments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2021 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Severance payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1) In fiscal 2020, as part of the adoption of ASC 842, the Company reclassified $3.8&#160;million from a lease liability to offset the right of use asset on the Company's consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2021 Actions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2021, the Company made various decisions to terminate certain individuals across all divisions in multiple departments and close certain manufacturing facilities for minor product lines. The Company recorded $8.7&#160;million for severance and benefits related to these actions, which occurred in the U.S. and various international locations. The charges were recorded pursuant to ASC 712, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation-Nonretirement Postemployment Benefits &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 712) or ASC 420, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit or Disposal Cost Obligations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 420), depending on the employee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2020 Actions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020, the Company made various decisions to terminate certain personnel across all divisions in multiple departments, transfer production and close certain manufacturing facilities for minor product lines. The Company recorded charges totaling $13.4&#160;million for severance and benefits related to these actions. The charges were recorded pursuant to ASC 712 or ASC 420, depending on the employee. Included within this charge was $5.0&#160;million related to the modification of equity awards for a certain executive. These actions are complete.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2020, the Company recorded net divestiture charges of $1.9&#160;million. The charge included $1.3&#160;million to dispose of the Company's life sciences testing business located in the UK, which performed research testing for pharmaceutical companies. Separately, in connection with the Cynosure divestiture, the Company accelerated stock compensation expense and other benefits of $2.6&#160;million, partially offset by other adjustments of $2.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fiscal 2019 Actions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019, the Company decided to transfer certain shared services positions to its Costa Rica facility from its Marlborough location and announced the termination of certain personnel and implemented other employee termination actions. The charges for these actions were recorded pursuant to ASC 420 for one-time termination benefits. The Company recorded severance benefits charges of $4.0 million in fiscal 2019 related to these actions and this action was completed in the first quarter of fiscal 2020. The Company also recorded $1.0&#160;million of severance charges in fiscal 2019 related to 2018 actions that were recorded pursuant to ASC 420.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the closure of the Bedford location during the first quarter of fiscal 2017, the Company recorded $3.5 million for lease obligation charges related to the first floor of the facility as the Company determined it had met the cease-use date criteria. The Company made certain assumptions regarding the time period it would take to obtain a subtenant and the sublease rates it could obtain. During the third quarter of fiscal 2017, the Company updated its assumption regarding the time period it would take to obtain a subtenant at the Bedford location and as a result recorded an additional $1.3 million lease obligation charge. During the third quarter of fiscal 2018, the Company further adjusted its assumptions and lowered the estimate of the sublease income rate and extended the time period to obtain a sub-tenant. As a result, the Company recorded an additional charge of $1.6 million. During the third quarter of fiscal 2019, the Company further updated its assumption regarding its ability to sublet the first floor and recorded an additional lease obligation charge of $1.4 million. These estimates may vary from the actual sublease agreements executed, if any, resulting in an adjustment to the charge. The Company has vacated other portions of the building but not the entire facility, and at this time does not meet the cease-use date criteria to record additional restructuring charges. In connection with the adoption of ASC 842, the Company reclassified the remaining accrued lease balance of $3.8&#160;million from restructuring to offset the right of use assets on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzU4NTQ_e6856d11-f25d-4633-9683-5bbf8f932da5">The following table displays charges taken related to restructuring actions in fiscal 2021, 2020 and 2019 and a rollforward of the charges to the accrued balances as of September&#160;25, 2021:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2021 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2020 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2019 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Restructuring Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019 charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Workforce reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility closure costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020 charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Workforce reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Facility closure costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2021 charges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Workforce reductions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2021 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTEtMS0xLTA_14f4e910-1217-45cf-8969-ee4903fd986b"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTMtMS0xLTA_f604ddac-bc36-4395-b0af-62dd62b0d537"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTUtMS0xLTA_b0c3d38c-e831-42e6-ab90-819e534c5e1f"
      unitRef="usd">4000000.0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="ica09cd88fe9a4e17bb42730a0eb48197_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTctMS0xLTA_7612849b-e520-4af1-90da-058878fcd1d0"
      unitRef="usd">1400000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEwLTExLTEtMS0w_f67b0b4a-318c-4012-b3f6-e18eebcceb7f"
      unitRef="usd">5400000</holx:ReductionOfWorkforceExpenses>
    <holx:FacilityClosureCosts
      contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTEtMS0xLTA_fd52980b-35b7-46f2-aa7a-0c22e86d611c"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTMtMS0xLTA_1942709b-6dd2-4a9a-9f29-9e4eb49859b1"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTUtMS0xLTA_010e923d-b9f1-44b3-885a-d505f1b1b40d"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="ica09cd88fe9a4e17bb42730a0eb48197_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTctMS0xLTA_4c5c8731-a451-4893-ae12-b519ae68484f"
      unitRef="usd">1200000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzExLTExLTEtMS0w_78351182-de08-4006-addb-98d9730e0fbe"
      unitRef="usd">1200000</holx:FacilityClosureCosts>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTEtMS0xLTA_0fe888b7-3eed-4cba-b727-830067e9e130"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTMtMS0xLTA_8002d8d4-9d17-456f-a0ef-f85a03ebc0f7"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTUtMS0xLTA_a21b16aa-3828-4ebe-8b28-d6a80e24fc52"
      unitRef="usd">4000000.0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="ica09cd88fe9a4e17bb42730a0eb48197_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTctMS0xLTA_dbbcf376-d094-42b5-ad10-71ac24f673d4"
      unitRef="usd">2600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzEzLTExLTEtMS0w_751caf9f-84eb-43ad-b7ab-13f4eddcb329"
      unitRef="usd">6600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTEtMS0xLTA_eff43de7-d707-4e35-bada-08bfb9a43a2f"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTMtMS0xLTA_e8c4c521-9db4-46ba-8af3-7d98b227adfc"
      unitRef="usd">13200000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTUtMS0xLTA_821f2b4b-1f54-44c7-9386-635898e30b17"
      unitRef="usd">300000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i7936fd11ed2e4b85af34c8ff95ea99bb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTctMS0xLTA_94cf360c-2006-49f8-a8e6-e0dc45a44077"
      unitRef="usd">-100000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE1LTExLTEtMS0w_cb6fed72-b833-4223-bf3b-bd6da83e456c"
      unitRef="usd">13400000</holx:ReductionOfWorkforceExpenses>
    <holx:FacilityClosureCosts
      contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTEtMS0xLTA_cde1f0c7-c7d1-4093-9757-b5f1370790e4"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTMtMS0xLTA_d60de74f-e95d-469b-ae36-477bceed5c2e"
      unitRef="usd">1900000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTUtMS0xLTA_477d0d31-9f8c-42fd-8b30-7d88176e249d"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i7936fd11ed2e4b85af34c8ff95ea99bb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTctMS0xLTA_66c322f1-cf12-43a2-beef-926b000ee9e5"
      unitRef="usd">0</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE2LTExLTEtMS0w_eb28bcba-618e-4737-8a53-3383f8b96ad8"
      unitRef="usd">1900000</holx:FacilityClosureCosts>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTEtMS0xLTA_e24a07b6-364e-4926-91f5-9e48d5c8467b"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTMtMS0xLTA_76b95bd4-320b-4e76-985c-21b633868f8a"
      unitRef="usd">15100000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTUtMS0xLTA_2a23e1e5-586b-4ff3-87de-783780a243ce"
      unitRef="usd">300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i7936fd11ed2e4b85af34c8ff95ea99bb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTctMS0xLTA_e9b6afc7-3e63-4e0d-984c-8ba61db8f320"
      unitRef="usd">-100000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE3LTExLTEtMS0w_58e2e405-aaa4-4cc3-ba0e-c506cf3c77ef"
      unitRef="usd">15300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTEtMS0xLTA_b6d7d8be-3292-45c7-934b-4cfacd278cfd"
      unitRef="usd">8700000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTMtMS0xLTA_e45586db-5f0a-45dd-b771-12e3aa0656a4"
      unitRef="usd">600000</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTUtMS0xLTA_fcf386f4-7e9b-41a7-aa20-bb2d0906e1b7"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="i32aaf02b449b417fbbb6835a78a46b59_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTctMS0xLTA_a28c9873-a10b-4d85-a200-626d047dcd1e"
      unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
    <holx:ReductionOfWorkforceExpenses
      contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzE5LTExLTEtMS0w_a14b51df-2691-48b1-9681-60b627cedbf2"
      unitRef="usd">9300000</holx:ReductionOfWorkforceExpenses>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTEtMS0xLTA_2ffa3f52-3647-49a6-a556-4c8167d761e7"
      unitRef="usd">8700000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTMtMS0xLTA_75720441-e4cd-4cd1-9a57-b33cd9d549b7"
      unitRef="usd">600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTUtMS0xLTA_e81843b7-f434-4b3c-9dcc-06812d761832"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i32aaf02b449b417fbbb6835a78a46b59_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTctMS0xLTA_956d59d0-134d-4d36-ba25-5709cdc4641f"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZTphZjQyNzY0ZThiYzc0YmY1YWQ0MmY5NDMxY2M3ZmM0ZS90YWJsZXJhbmdlOmFmNDI3NjRlOGJjNzRiZjVhZDQyZjk0MzFjYzdmYzRlXzIxLTExLTEtMS0w_a2fbb59c-751a-4df5-b3fb-39ba75e04a6f"
      unitRef="usd">9300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzU4NjI_0d891f9d-90d5-4dde-9ea3-b87811748313">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2021 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2020 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2019 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal 2018 Actions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Previous Other Charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Rollforward of Accrued Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 29, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2019 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Severance payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2020 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Severance payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other payments and adjustments (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Fiscal 2021 restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Severance payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i0fea61ca81bf4d459c97ba34e9961f73_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItMS0xLTEtMA_6739ad53-f0f4-4e29-a28c-b5c8ad2ec0ad"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1d4b7a8cc9a44411b8b72747d549afa1_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItMy0xLTEtMA_9c4170c8-f294-4c5a-bcdb-0284a850d82e"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i589c665e90724c12916b1829bbe8611d_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItNS0xLTEtMA_9d889a1a-9583-44b2-9eee-91a6a019268e"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i363a0363e6354e97b13c269c6820cf5a_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItNy0xLTEtMA_7e31336c-48e5-4cc7-9eef-72baf2b94e7d"
      unitRef="usd">4300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib8f2a1f7b45b44309d99d3e69e91b1a6_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItOS0xLTEtMA_d40a8529-3991-4f9c-ab93-0d98ff69b99d"
      unitRef="usd">4800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="icd04b96a2ff54f9fb515dc126ab745cf_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzItMTEtMS0xLTA_802589f8-fa7c-4664-94b9-57574e238dbb"
      unitRef="usd">9100000</us-gaap:RestructuringReserve>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtMS0xLTEtMA_12a45731-0de1-4d4e-a26f-75d3c60e4d72"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtMy0xLTEtMA_85460c08-eb84-41ed-b37f-8411bfc79de8"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtNS0xLTEtMA_ed2b460f-7213-44c4-934e-592b70b46838"
      unitRef="usd">4000000.0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i6820742ad8bf45d0b4eb5cacd1ed2d5b_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtNy0xLTEtMA_3a33ac1d-12c0-4e0a-bf4f-d9eb480f2ca3"
      unitRef="usd">1200000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="if0d1533cac054998bd77025d6327d119_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtOS0xLTEtMA_13a74c74-d2fc-4b78-90be-2a4b97cdd4cb"
      unitRef="usd">1400000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzQtMTEtMS0xLTA_6c9ed424-3f46-400e-8322-3fd1a5245c5d"
      unitRef="usd">6600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:CashSeverancePayments
      contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtMS0xLTEtMA_a05f8d7f-f52e-4a4d-b154-a0adee2c3ac0"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtMy0xLTEtMA_74c53fdd-c99e-4d87-9cef-2d67d016172a"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtNS0xLTEtMA_1407a70b-2e71-451a-a30f-7a91e97d2706"
      unitRef="usd">3000000.0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i6820742ad8bf45d0b4eb5cacd1ed2d5b_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtNy0xLTEtMA_dd963362-27a7-455f-a014-05a4b9e51aec"
      unitRef="usd">3900000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="if0d1533cac054998bd77025d6327d119_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtOS0xLTEtMA_98c416d4-426b-47b7-9baf-1cc708d1cef6"
      unitRef="usd">800000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzYtMTEtMS0xLTA_6728db97-205e-4b64-ac74-90806c843aec"
      unitRef="usd">7700000</holx:CashSeverancePayments>
    <holx:OtherRestructuringPayments
      contextRef="i51f1a38c1c5f4d7d96046d2eea9a124d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctMS0xLTEtMA_a8074274-91f1-4b35-a001-36318735c157"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="ic9086f62323f4190b55230ec9cdfe779_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctMy0xLTEtMA_735c2a3e-7857-4f6b-a436-c31bfb0ddb67"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i30f0c780a26c4088b04b19a3310bb854_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctNS0xLTEtMA_cbcfc539-bbbd-44aa-86da-3c6181893a98"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i6820742ad8bf45d0b4eb5cacd1ed2d5b_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctNy0xLTEtMA_c343d510-ea73-4c5e-b98c-23a599150a28"
      unitRef="usd">500000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="if0d1533cac054998bd77025d6327d119_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctOS0xLTEtMA_a11b2456-10ef-494b-9306-18443f96493d"
      unitRef="usd">1600000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i2929089b0339424f96387fa33b7bc1ab_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzctMTEtMS0xLTA_c84a62f3-c06f-4884-accc-b35a913ee78d"
      unitRef="usd">2100000</holx:OtherRestructuringPayments>
    <us-gaap:RestructuringReserve
      contextRef="ie74335c4192849e4962d43b0b1fc20f4_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtMS0xLTEtMA_0bf708a0-82c1-4fb8-874f-16f46ae2dcce"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia4bdf24b380d49bf82bd81fb2c06d677_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtMy0xLTEtMA_929a72dd-f3c0-40a7-9925-8282ab7152a1"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic611866316f1423b90b7f3d0aa696327_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtNS0xLTEtMA_babab46c-93e7-4108-bd87-945f27d7f001"
      unitRef="usd">1000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i72c37f79fbe241d9b526e41c78b64391_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtNy0xLTEtMA_f4da3b78-d8af-4bc7-a3a1-89ea5279d03a"
      unitRef="usd">1100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9761cec969414f2dac8d0f65e729f1f5_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtOS0xLTEtMA_f79866d5-32d7-43ea-b611-c9e7673e6e48"
      unitRef="usd">3800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iab1dbf3209e94bba8c72c6ae4d7bccc0_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzgtMTEtMS0xLTA_4e170f65-f5d8-4fbc-b887-c4b70b7937d6"
      unitRef="usd">5900000</us-gaap:RestructuringReserve>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTEtMS0xLTA_bb2402de-19ad-4ec9-b094-e7696e710b60"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTMtMS0xLTA_3392740e-4331-45d7-9371-5c92b455f2b5"
      unitRef="usd">15100000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTUtMS0xLTA_fb63b884-62b2-4bed-9f11-3c237006e020"
      unitRef="usd">300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTctMS0xLTA_2d7c7c4a-b307-468f-aca3-5e8e6bbff79e"
      unitRef="usd">-100000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTktMS0xLTA_6466ab0e-5ddc-46b8-94ae-78de81cf7dac"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEwLTExLTEtMS0w_56bc83d8-60f9-41b7-a31d-533436edbedb"
      unitRef="usd">15300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTEtMS0xLTM1MTg0_b1406139-b6c9-4482-bf72-3c365676016c"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTMtMS0xLTM1MTg0_65b59169-85e3-4df5-bf3b-0a807cd00643"
      unitRef="usd">7500000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTUtMS0xLTM1MTg0_0d325133-4872-440c-b64b-ca01feb66cb5"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTctMS0xLTM1MTg0_8a75a68a-4dd3-40a5-b1ed-2ebb18f1a02d"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTktMS0xLTM1MTg0_d393f376-32f0-4f49-a2a5-9dc05db869ff"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzExLTExLTEtMS0zNTE4NA_a57cc9e6-e7c6-4c4e-8733-fe850515b6b3"
      unitRef="usd">7500000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:CashSeverancePayments
      contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTEtMS0xLTA_4dc18b33-9e8b-4c63-a443-46d68417c6ff"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTMtMS0xLTA_952192b2-919a-4fe4-834b-df3bc265c5dd"
      unitRef="usd">4400000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTUtMS0xLTA_54aa8d7c-0b29-46a6-b8f8-2b609f5baae4"
      unitRef="usd">1300000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTctMS0xLTA_b216c2f5-8f32-46d5-91ca-4f0204656d90"
      unitRef="usd">200000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTktMS0xLTA_44554b1e-58f7-4791-87b7-675f6bdcc194"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEyLTExLTEtMS0w_aafd414e-3be6-4c7b-be1f-b7a3216c5b11"
      unitRef="usd">5900000</holx:CashSeverancePayments>
    <holx:OtherRestructuringPayments
      contextRef="i4a25f155142b4753ad08206cace1e91b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTEtMS0xLTA_5d1c744e-6f99-48e7-b5b8-3e73ba64be99"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i1ba769a4db19407abd2bcbcf79fd2577_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTMtMS0xLTA_b66aa617-f068-4ae5-bcf0-08034a590f86"
      unitRef="usd">-500000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="ibda74ad37f3641428d8938a5736e58eb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTUtMS0xLTA_711fbb05-a455-4e6f-b653-f7cfee630dbd"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="ib41a85e080c04defa98ea0abf62ca5fb_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTctMS0xLTA_059c801a-e384-4733-9cce-3bdd3255cfb8"
      unitRef="usd">0</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i85e5abb3e7074076bb7e013bbae540b0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTktMS0xLTA_0acb032a-358a-417a-8ce7-128638ef66a9"
      unitRef="usd">3800000</holx:OtherRestructuringPayments>
    <holx:OtherRestructuringPayments
      contextRef="i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzEzLTExLTEtMS0w_e8de84b3-505e-49d4-b58a-5daa12edd124"
      unitRef="usd">3300000</holx:OtherRestructuringPayments>
    <us-gaap:RestructuringReserve
      contextRef="ibef98710ecdd4cd1aab89a2c225d4bb4_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTEtMS0xLTA_4faff3f6-7472-4bb7-8e26-8fbe86699bb4"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib6b1f0af679346b0bae0f56c6a024a23_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTMtMS0xLTA_1adbbda5-2fc2-446f-a299-5229d6a4d3b1"
      unitRef="usd">3700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9d06325cd28b4c4abb1d24a6b9f3b7e1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTUtMS0xLTA_fd750187-0f72-47ff-b8ae-75faa03f5687"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i94ed1a363cfc4dcdbd9da0e0010b4605_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTctMS0xLTA_e0304d23-0f61-4861-86cb-a27e0270beed"
      unitRef="usd">800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i237590b8c9a24937a685c8ff3cfc59a0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTktMS0xLTA_56ac9dbf-2730-4287-8771-97c94bf536e2"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if6b56d54de384d5e85d583af397a2df1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE0LTExLTEtMS0w_7e51516b-20c6-448e-b4e8-691f38216459"
      unitRef="usd">4500000</us-gaap:RestructuringReserve>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTEtMS0xLTA_d87a9ad4-8afc-40a6-aaf2-83b743d74a17"
      unitRef="usd">8700000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTMtMS0xLTA_ca11eb33-1ede-49a6-ac2a-f00b961162ab"
      unitRef="usd">600000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTUtMS0xLTA_bd18c678-63c6-4f63-9860-084433be2aa5"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i37821908786c4b708eab490638465e93_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTctMS0xLTA_d91529b8-7e20-4928-a3b0-a6ca666f20e2"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i9bf618176c7846639223696bf6423a6b_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTktMS0xLTA_a96ac626-7028-4a33-a58f-1ce3620f72e0"
      unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE2LTExLTEtMS0w_c22efd0b-fc45-4420-8d28-592994d7f3e2"
      unitRef="usd">9300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTEtMS0xLTA_49b49fce-ac8b-4e91-b58a-37de4b1ae68c"
      unitRef="usd">900000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTMtMS0xLTA_6534f89c-5ceb-4426-af94-f455a051bc3d"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTUtMS0xLTA_e5f2e093-9135-4eb4-8709-ca38d106e45d"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i37821908786c4b708eab490638465e93_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTctMS0xLTA_818e159e-80eb-4be3-9415-94625b65ab85"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="i9bf618176c7846639223696bf6423a6b_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTktMS0xLTA_80d01c8e-d2f8-47cd-9961-29b325948235"
      unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts
      contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE3LTExLTEtMS0w_5e9d7811-9afb-4d2f-aa91-28c25b10e78b"
      unitRef="usd">900000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
    <holx:CashSeverancePayments
      contextRef="i00310a9d53394da3824af468349e5507_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTEtMS0xLTA_9a4f090b-c915-4f35-95e2-ec76f3e8875e"
      unitRef="usd">4600000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="ib02a3f74ed9048dba416a26c2b95b241_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTMtMS0xLTA_dd92ad3d-46f0-4f3d-8171-b8faad189ad9"
      unitRef="usd">3400000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i64fd61f9d68b4e7a8bf0d458bc249809_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTUtMS0xLTA_171824f7-849e-452c-a007-a4dd6bd5782c"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i37821908786c4b708eab490638465e93_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTctMS0xLTA_698da74b-cacf-4632-b441-7611dbceeb4b"
      unitRef="usd">800000</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="i9bf618176c7846639223696bf6423a6b_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTktMS0xLTA_c3f40cfc-781f-4c1a-a68b-f47948fe6400"
      unitRef="usd">0</holx:CashSeverancePayments>
    <holx:CashSeverancePayments
      contextRef="icb702d3eb2c245e3a1ebb978cca4ebf2_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzE4LTExLTEtMS0w_edb39468-8644-46d5-8552-06d61ba8f05a"
      unitRef="usd">8800000</holx:CashSeverancePayments>
    <us-gaap:RestructuringReserve
      contextRef="i45a345959c154a2d8df036461ee29971_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTEtMS0xLTA_e0ddc7af-80d7-4708-ad46-aa793bb79f0b"
      unitRef="usd">3200000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i20c9c1045bba4ae987407ffe8c49f36c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTMtMS0xLTA_f6721dc8-ddeb-4bcf-814f-78d1da223e46"
      unitRef="usd">900000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i226927fc24ca401dbaa730834a36cc50_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTUtMS0xLTA_64273755-9ffd-4b19-9595-bff69c965d71"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2db2f22615e94b14baa99827dcd76f70_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTctMS0xLTA_b77aa3a1-c160-45be-955b-fff9dd2e829a"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6c8b3bd2cb5743559dcb3f8b8dd002a9_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTktMS0xLTA_64a33916-7352-47f4-9b5e-c6f8029c8b11"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6661f7e6f8814fa0a6d62d9cf0f20dbf_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90YWJsZToyN2I4ZjE5OTljOWY0ZTI0YTZhNjUzMDY3MjA1OGFlNC90YWJsZXJhbmdlOjI3YjhmMTk5OWM5ZjRlMjRhNmE2NTMwNjcyMDU4YWU0XzIwLTExLTEtMS0w_867239d0-32c0-4f6c-bb20-8f09a9e86b99"
      unitRef="usd">4100000</us-gaap:RestructuringReserve>
    <holx:RemainingLeaseBalance
      contextRef="ia255713509bd43e8bcf5ee357d39d247_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzYyMg_374f8514-f844-437e-a7e6-c24c267ddea4"
      unitRef="usd">3800000</holx:RemainingLeaseBalance>
    <holx:RestructuringChargesUnderExitOrDisposalPlan
      contextRef="i052b6805906a4d2c89ee54aabd364d66_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzIxOTkwMjMyNjg4MjA_c5ac2bfb-f747-434a-969d-2527adc173b0"
      unitRef="usd">8700000</holx:RestructuringChargesUnderExitOrDisposalPlan>
    <us-gaap:SeveranceCosts1
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzEwMDQ_3fa360dd-5c9d-4488-9985-8e2cfd65cec6"
      unitRef="usd">13400000</us-gaap:SeveranceCosts1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzEyODQ_a7733417-0860-493e-adc0-27f4e6f1f1e0"
      unitRef="usd">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <holx:DivestitureCharges
      contextRef="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzE2OTM_1ed56bc5-6872-4bbb-a483-118a696efe11"
      unitRef="usd">1900000</holx:DivestitureCharges>
    <holx:DivestitureCharges
      contextRef="i7aaac8bd6b554479a2fec5dc2c597d98_D20201227-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzE3MTc_3cb03102-757a-4316-a545-79438e8107d3"
      unitRef="usd">1300000</holx:DivestitureCharges>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="ie1bf8affe32c4e59ac455013cb5723b4_D20201227-20210327"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzE5OTA_aaf92e03-3093-4f82-ba31-446469a3afb4"
      unitRef="usd">2600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <holx:DivestitureCharges
      contextRef="ie1bf8affe32c4e59ac455013cb5723b4_D20201227-20210327"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzIwMzU_91d7a499-c493-40bc-a615-9f972dccc935"
      unitRef="usd">2000000</holx:DivestitureCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzI0NTY_8f6771df-8290-4311-93e6-21d94a9e6213"
      unitRef="usd">4000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i3d2e5c8508f041c0baa077405508f177_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzIxOTkwMjMyNjg4MzQ_eebb67bf-086f-4a42-a472-70a8eb99460d"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <holx:FacilityClosureCosts
      contextRef="ibe6803d94cea48cf812f89fc284feb20_D20180930-20181229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzQzODU_d2af8e24-a0d9-43b2-8697-629110629262"
      unitRef="usd">3500000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="iaa3e68e1e5d546bfae26d63f7380f8b2_D20180401-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzQ4NjY_b92a24ae-e274-4da3-8ca0-110ea16b07ac"
      unitRef="usd">1300000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="ie3ab4cd18b9a4591a4f3349bf628b8ea_D20190331-20190629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzUxNDQ_9418358e-a745-4e16-baa2-1b65a8d0a858"
      unitRef="usd">1600000</holx:FacilityClosureCosts>
    <holx:FacilityClosureCosts
      contextRef="if5ac9a1dd0c24e55b09475fe7b9368e8_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzUzMzQ_2368af98-63b9-4a8b-aa90-8967495941fa"
      unitRef="usd">1400000</holx:FacilityClosureCosts>
    <holx:RemainingLeaseBalance
      contextRef="ia255713509bd43e8bcf5ee357d39d247_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDgvZnJhZzo2YTYyZDQ0NTVlOWU0NTc0YWZhZmJjMmVhNDA1OTkxZS90ZXh0cmVnaW9uOjZhNjJkNDQ1NWU5ZTQ1NzRhZmFmYmMyZWE0MDU5OTFlXzU3NTQ_73e71c07-0182-4a01-bc4b-fa77e9b4847d"
      unitRef="usd">3800000</holx:RemainingLeaseBalance>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3ODk_2ed11d72-ad5c-4734-bfda-28610949a872">Borrowings and Credit Agreements&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securitization Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,382.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,712.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,025.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The debt maturity schedule for the Company&#x2019;s obligations as of September&#160;25, 2021 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2027 and Thereafter &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securitization Program &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;*The Term Loan debt maturity schedule herein represents the 2018 Credit Agreement as of September 25, 2021. The Company amended the credit agreement on September 27, 2021, which resulted in a change in the principal maturity schedule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2018 Amended and Restated Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement as of October 3, 2017 ("2017 Credit Agreement"). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit facilities under the 2018 Credit Agreement consisted of:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A $1.5 billion secured term loan ("2018 Term Loan") with a maturity date of December 17, 2023; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A secured revolving credit facility ("2018 Revolver") under which the Company could borrow up to $1.5 billion, subject to certain sublimits, with a maturity date of December 17, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the 2018 Credit Agreement bore interest, at the Company's option and in each case plus an applicable margin as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;2018 Term Loan&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: at the Base Rate, Eurocurrency Rate or LIBOR Daily Floating Rate,&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;2018 Revolver&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: if funded in U.S. dollars, the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate, and, if funded in an alternative currency, the Eurocurrency Rate; and if requested under the swing line sublimit, the Base Rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 25, 2021, the Company had no amounts outstanding under the 2018 Revolver and the interest rate under the 2018 Term Loan was 1.08%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The applicable margin to the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate was subject to specified changes depending on the total net leverage ratio as defined in the 2018 Credit Agreement. The borrowings of the 2018 Term Loan initially bore interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate equal to 1.00%. The borrowings of the 2018 Revolver initially bore interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% at September 25, 2021. The Company was also required to pay a quarterly commitment fee calculated on the undrawn committed amount available under the 2018 Revolver.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was required to make scheduled principal payments under the 2018 Term Loan in increasing amounts ranging from $9.375 million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $28.125 million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Term Loan after the scheduled principal payments, which was $1.2 billion, and any amounts outstanding under the 2018 Revolver were due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, the Company could have been required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments were required to be applied by the Company,&#160;first, to the 2018 Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company could have voluntarily prepaid any of the 2018 Credit Facilities without premium or penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2018 Credit Agreement contained affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement required the Company to maintain certain financial ratios. The 2018 Credit Agreement also contained customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings were secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company and its U.S. subsidiaries, with certain exceptions. The 2018 Credit Agreement contained total net leverage ratio and interest coverage ratio financial covenants measured as of the last day of each fiscal quarter. The total net leverage ratio covenant was 5.00:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and would have remained as such until it decreased to 4.50:1.00 for the quarter ending June 25, 2022. The interest coverage ratio covenant was 3.75:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and remained as such for each quarter thereafter. The total net leverage ratio was defined as the ratio of the Company's consolidated net debt as of the quarter end to its consolidated adjusted EBITDA (as defined in the 2018 Credit Agreement) for the four-fiscal quarter period ending on the measurement date. The interest coverage ratio was defined as the ratio of the Company's consolidated adjusted EBITDA for the prior four-fiscal quarter period ending on the measurement date to adjusted consolidated cash interest expense (as defined in the 2018 Credit Agreement) for the same measurement period. The Company was in compliance with these covenants as of September 25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2018 Credit Agreement for derivatives pursuant to ASC 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and identified embedded derivatives that required bifurcation as the features were not clearly and closely related to the host instrument. The embedded derivatives were a default provision, which could require additional interest payments, and a provision requiring contingent payments to compensate the lenders for changes in tax deductions. The Company determined that the fair value of these embedded derivatives was nominal as of September 25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to ASC 470, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 470), the accounting related to entering into the 2018 Credit Agreement and using the proceeds to pay off the 2017 Credit Agreement was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2017 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $0.8 million in the first quarter of fiscal 2019. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two debt instruments before and after the transaction was less than 10%. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement and the 2017 Credit Agreement was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Credit Agreement - Subsequent Event&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 27, 2021, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility under the 2018 Credit Agreement by entering into Refinancing Amendment No. 2 dated as of September 27, 2021, to the Amended and Restated Credit and Guaranty Agreement as of October 3, 2017, as amended (the "2021 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2021 Credit Agreement amends the Company's 2018 Credit Agreement. Substantially all of the proceeds under the 2021 Credit Agreement of $1.5&#160;billion were used to repay the amounts outstanding under the 2018 Credit Agreement. Borrowings under the 2021 Credit Agreement are secured by first-priority liens on, and a first-priority security interest in (in each case subject to certain liens permitted under the 2021 Credit Agreement), substantially all of the Company's U.S. assets of the Subsidiary Guarantors. These liens are subject to release during the term of the facilities if the Company is able to achieve certain corporate or corporate family ratings and other conditions are met. The credit facilities under the 2021 Credit Agreement consist of:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A $1.5&#160;billion secured term loan ("2021 Term Loan") with a maturity date of September 25, 2026; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A secured revolving credit facility ("2021 Revolver") under which the Company may borrow up to $2.0&#160;billion, subject to certain sublimits, with a maturity date of September 25, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the 2021 Credit Agreement, other than Swing Line Loans (as defined in the 2021 Credit Agreement), bear interest, at the Company's option, at the Base Rate (as defined in the 2021 Credit Agreement), at the Eurocurrency Rate (as defined in the 2021 Credit Agreement), at the Alternative Currency Daily Rate (as defined in the 2021 Credit Agreement), or at the LIBOR Daily Floating Rate (as defined in the 2021 Credit Agreement), in each case plus the Applicable Rate (as defined in the 2021 Credit Agreement).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Applicable Rate in regards to the Base Rate, the Eurocurrency Rate, the Alternative Currency Daily Rate, the Alternative Currency Term Rate, and the LIBOR Daily Floating Rate is subject to change depending on the Total Net Leverage Ratio (as defined in the 2021 Credit Agreement). The borrowings of the Term Loan under the 2021 Credit Facilities initially bear interest at an annual rate equal to the Eurocurrency Rate for a one month interest period plus an Applicable Rate equal to 1.00%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also required to pay a quarterly commitment fee calculated on daily basis equal to the Applicable Rate as of such day multiplied by the undrawn committed amount available under the Revolver (taking into account any outstanding amounts under the LC Sublimit). This commitment fee is initially 0.15% per annum for the Revolver.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to make scheduled principal payments under the 2021 Term Loan in increasing amounts ranging from $3.75&#160;million per three-month period commencing with the three-month period ending on December 29, 2022 to $18.75&#160;million per three-month period commencing with the three month period ending on December 26, 2025. The remaining balance of $1.335&#160;billion (or such lesser aggregate principal amount of Term Loans then outstanding) on the 2021 Term Loan and any amounts outstanding under the 2021 Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2021 Credit Agreement, the Company is required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). Certain of the mandatory prepayments are subject to reduction or elimination if certain financial covenants are met. These mandatory prepayments are required to be applied by the Company, first to the 2021 Term Loan, second to any outstanding amount under any Swing Line Loans, third to the 2021 Revolver, fourth to prepay any outstanding reimbursement obligations with respect to Letters of Credit and fifth to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2021 Credit Facilities without premium or penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2021 Credit Agreement requires the Borrowers to maintain certain financial ratios. The 2021 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 19, 2018, the Company completed a private placement of $1.0 billion aggregate principal amount of senior notes and allocated $400 million in aggregate principal amount to its 4.625% Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2028 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2028 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had 4.375% Senior Notes due 2025 (the &#x201c;2025 Senior Notes&#x201d;) outstanding and bore interest at the rate of 4.375%&#160;per year, payable semi-annually on April 15 and October 15 of each year. The Company used the net proceeds of the 2029 Senior Notes offering in the first quarter of fiscal 2021 to redeem in full the 2025 Senior Notes in the aggregate principal amount of $950.0&#160;million on October 15, 2020 at an aggregate redemption price of $970.8&#160;million, which included a premium payment of $20.8&#160;million. Since the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $21.6&#160;million, which comprised pro-rata amounts of the premium payment, debt discount and debt issuance costs. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $5.8&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $7.9&#160;million and debt discount of $6.4&#160;million related to the modified debt are being amortized over the new term of the 2029 Senior Notes using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable Securitization Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 25, 2016, the Company entered into a one-year $200.0 million accounts receivable securitization program (the "Securitization Program") with several of its wholly owned subsidiaries and certain financial institutions, which provides for annual renewals. Under the terms of the Securitization Program, the Company and certain of its wholly-owned subsidiaries sell their respective customer receivables to a bankruptcy remote special purpose entity, which is also a wholly-owned subsidiary of the Company. In addition, the Company also contributed a portion of its customer receivables to the special purpose entity in connection with its establishment. The Company retains servicing responsibility. The special purpose entity, as borrower, and the Company, as servicer, entered into a Credit and Security Agreement with several lenders pursuant to which the special purpose entity, at that time, could borrow up to $200.0 million from the lenders, with the loans secured by the receivables. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. Borrowings outstanding under the Securitization Program bear interest at LIBOR plus the applicable margin of 0.8% and are included as a component of current liabilities in the Company's consolidated balance sheet, while the accounts receivable securing these obligations remain as a component of net receivables in the Company's consolidated balance sheet. The Company and the special purpose entity are operated and maintained as separate legal entities. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay other debts or liabilities of the Company. In subsequent years, the Company amended the agreement to extend it for one-year periods and increased the borrowing capacity up to $250.0&#160;million and lowered the applicable margin to 0.7%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, the Company paid off the total amount outstanding of $250.0&#160;million previously borrowed. On April 13, 2020, the Company amended the Credit and Security Agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. On June 11, 2021, the Company amended and restated the Credit and Security Agreement to restart the Securitization Program and increased the maximum borrowing amount to $320.0&#160;million. As of September 25, 2021, there was $248.5&#160;million outstanding under this program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings under the Securitization Program for fiscal 2021 had a weighted-average interest rate of 0.8%. Interest expense under the Securitization Program was $0.9 million, $3.1 million and $7.1 million for fiscal 2021, 2020 and 2019, respectively. The interest rate on the amounts outstanding at September 25, 2021 was 0.8%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit and Security Agreement contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, and an event of default upon a change of control of the Company. In addition, it contains financial covenants consistent with that of the Credit Agreement. As of September&#160;25, 2021, the Company was not required to be in compliance with the Credit and Security Agreement covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other represents debt acquired in the Mobidiag acquisition, which is primarily with the European Investment Bank ("EIB"). Multiple tranches were withdrawn under the agreement and were primarily used to fund research and development projects and expansion efforts. The debt agreement contains change-in-control provisions allowing the EIB to call the debt at any time after a change-in-control, which occurred as a result of Hologic acquiring Mobidiag. Accordingly, the Company has classified the debt as current. The tranches withdrawn under this agreement have interest rates ranging from 6.0% to 7.0%. The debt agreement includes additional payments to the EIB based on revenues generated by products developed under the funding as well as prepayment penalties.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1Njg0_fe9b06f8-91cb-41de-b4b3-01f02fb2ea29">&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securitization Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,382.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,712.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,025.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Interest Expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-Cash Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzItMS0xLTEtMA_2c9c391c-3001-483c-be8f-2f69893f50fc"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i486e6244f19a4457ac36f56cf1470533_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzItMy0xLTEtMA_5444fe09-6ebc-4f78-ba9c-443adf31189e"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="if3f1f73d7de842cb99735553e7abceab_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzMtMS0xLTEtMA_27029ded-cb30-463e-bdbe-f6cfb4feca68"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="iacf8cf06e1004995ae54b544e1d55f8a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzMtMy0xLTEtMA_da406f1a-a409-423d-9f06-3b5264aa3d1c"
      unitRef="usd">250000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzQtMS0xLTEtMA_95bf18ab-ecc8-4c7f-8ee2-1a98b1212ebf"
      unitRef="usd">248500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i700525be08934f2c83c783a70ee542dc_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzQtMy0xLTEtMA_2ed534bd-c36d-4de5-ada7-d93a6292c807"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzUtMS0xLTEtMA_d341cc5b-3bec-45dc-91d2-688ae64d2092"
      unitRef="usd">64500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib071bc950aab4dea8b04dd63bb5fcf90_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzUtMy0xLTEtMA_19f2e74c-d9ee-4b3b-8623-b3d1bd9489b0"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzYtMS0xLTEtMA_554167f1-4836-4952-a629-3f7831d0959d"
      unitRef="usd">313000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzYtMy0xLTEtMA_9ad95b57-f8c4-4069-a581-222598b56d79"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzgtMS0xLTEtMA_f6083c24-1a09-4560-9d40-20eae139f673"
      unitRef="usd">1382300000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i486e6244f19a4457ac36f56cf1470533_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzgtMy0xLTEtMA_ae56413f-90b6-423f-93af-e5a99854b6d5"
      unitRef="usd">1379900000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i87d92969a5ba412c8c5427576dc4c085_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzExLTEtMS0xLTA_2471d4a7-e2ca-4c5d-b0ba-ab586a64963e"
      unitRef="usd">0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i9a1525cddd894988b24e75e818155953_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzExLTMtMS0xLTA_1cdb76e6-de6d-4024-9937-cb20a43b364f"
      unitRef="usd">939400000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzEyLTEtMS0xLTA_909efb85-9235-4c5e-93ae-bb33bf044cf8"
      unitRef="usd">395400000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i70090c579bcd4961b00c27f03e26059b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzEyLTMtMS0xLTA_40731e6f-a4e2-4702-92a2-7429e3bbd984"
      unitRef="usd">394600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzEzLTEtMS0xLTA_1753f08a-d88c-4bda-b96c-8a5baee43e8e"
      unitRef="usd">934500000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ia81fd6cc362e4e8ba3a639e55937a919_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzEzLTMtMS0xLTA_b1cd33cf-6301-4c63-adcf-b2ade659f812"
      unitRef="usd">0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzE0LTEtMS0xLTA_f8a7e9d4-7383-42a0-81cd-15ba796be8ef"
      unitRef="usd">2712200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzE0LTMtMS0xLTA_3861c576-4108-4968-84c2-2e734e756b94"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzE1LTEtMS0xLTA_ffdd3354-62c5-4529-8a53-6ca5fc4cbb0f"
      unitRef="usd">3025200000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphZjRlNTE4Mzk5YTc0ZTk1YmZhMmNlNWEyMmRhMzc2YS90YWJsZXJhbmdlOmFmNGU1MTgzOTlhNzRlOTViZmEyY2U1YTIyZGEzNzZhXzE1LTMtMS0xLTA_c5e60af9-0575-4a91-ad70-3ed13a3f34cd"
      unitRef="usd">3038800000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1Njcy_75432f62-8d91-4678-93ce-b9aa41cd1d6e">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The debt maturity schedule for the Company&#x2019;s obligations as of September&#160;25, 2021 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2027 and Thereafter &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,387.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securitization Program &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,050.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;*The Term Loan debt maturity schedule herein represents the 2018 Credit Agreement as of September 25, 2021. The Company amended the credit agreement on September 27, 2021, which resulted in a change in the principal maturity schedule.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtMi0xLTEtMA_ed612e0d-8b28-45a0-9153-abbab40975e1"
      unitRef="usd">75000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtNC0xLTEtMA_61abef8c-ba3b-4e17-9a8d-16951af4dd5c"
      unitRef="usd">112500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtNi0xLTEtMA_64bcc1c1-3a4b-4fb7-b909-28abed99d2ee"
      unitRef="usd">1200000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtOC0xLTEtMA_8ce2a9c1-489d-4c51-8ed7-c3b14b8c5e86"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtMTAtMS0xLTA_94988c0e-4075-4390-bd91-97a594f3755c"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtMTItMS0xLTA_b7def73e-99f3-456f-83ca-a2765746b64f"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ia15a38914d0c431881116c0c57a58aad_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzEtMTQtMS0xLTA_e8578cf6-3504-4f34-bdc4-e03caf946def"
      unitRef="usd">1387500000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtMi0xLTEtMA_ba7a55c5-48ef-4ee0-bc45-33f773961e7c"
      unitRef="usd">248500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtNC0xLTEtMA_69cb9eac-d757-44d4-8b0c-f5b2c499e5da"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtNi0xLTEtMA_034a84f4-951b-470b-911b-1048dddd73d7"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtOC0xLTEtMA_219738b3-fb1b-4021-98bc-04fcf72cfe5a"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtMTAtMS0xLTA_8a53f183-5576-4488-b2b7-969abe8582b9"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtMTItMS0xLTA_e4feee61-1a6e-421c-a65e-0179894eefb7"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzMtMTQtMS0xLTA_b8120354-8c21-43db-941d-5f2281eea4c4"
      unitRef="usd">248500000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMi0xLTEtMA_3599ab30-08df-42b0-aebe-d95597d67e00"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtNC0xLTEtMA_1bd72d4c-7166-451c-9a7f-f46c998a947e"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtNi0xLTEtMA_bd3c1394-4643-46de-a2ec-f41ec182da41"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtOC0xLTEtMA_2cdf2173-8e55-44f7-bafa-a551ac1c3b06"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTAtMS0xLTA_3a7b8ffd-0e48-4341-9fe5-65ce5787fafe"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTItMS0xLTA_9178da25-9c33-4d4e-85e1-0e6a3d604eae"
      unitRef="usd">400000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="iff284685ee2f435ea04c0a1a5ca36df5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTQtMS0xLTA_9c6252c9-4a3b-4aca-aa64-feb3452b3d31"
      unitRef="usd">400000000.0</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMi0xLTEtMzY1NTc_30961692-4356-4de8-b168-a6a9e9793ca6"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtNC0xLTEtMzY1NTc_ddef73dc-cedd-45a9-9b9d-1931d46be24f"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtNi0xLTEtMzY1NTc_336e6a72-2409-418e-90c1-7694460536fd"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtOC0xLTEtMzY1NTc_81957c0d-ba0e-41ed-b20e-69d9ba0a0f41"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTAtMS0xLTM2NTU3_d52dc6e5-0940-4301-8036-a639b28483f2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTItMS0xLTYyNjE_66f5ecde-4ae2-4cad-bbe7-f38f43bdc530"
      unitRef="usd">950000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="id40664d5921a4796ba4b25ff9b2df421_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzUtMTQtMS0xLTM2NTU3_d93264ca-85e2-4ccf-a7f0-3a22341b6449"
      unitRef="usd">950000000.0</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMi0xLTEtMzY1NjQ_cf17984e-795f-4094-bf22-1fc050f7bf66"
      unitRef="usd">64500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtNC0xLTEtMzY1NjQ_3d370dfd-0eeb-4c29-b014-3f058c0a197d"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtNi0xLTEtMzY1NjQ_b8161ee6-3045-4cbe-ac9b-2f95d373581b"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtOC0xLTEtMzY1NjQ_577c20e5-8a33-41ea-a05b-e73a5be8fcf0"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTAtMS0xLTM2NTY0_d8bb12ec-0a49-484a-82d5-71269a216669"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTItMS0xLTM2NTY0_8dc48a91-9474-4fae-a82e-ffb7290af8b1"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ia3a3dd46c67d43109e42cbca6545498c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTQtMS0xLTM2NTY0_21f3e476-a175-4bd8-9180-f94e13d7d5c8"
      unitRef="usd">64500000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMi0xLTEtMA_8cb3d99a-dab8-4c87-8d18-ef3f615f7e73"
      unitRef="usd">388000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtNC0xLTEtMA_7c95feb5-8672-497a-b22f-ba1adbdb3260"
      unitRef="usd">112500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtNi0xLTEtMA_7db53fb5-3f0f-47c6-994b-9ddbf434f725"
      unitRef="usd">1200000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtOC0xLTEtMA_c7ef62f7-d8c3-4a00-9cd1-4c7748f58ab2"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTAtMS0xLTA_2df3f49a-4a7b-4e57-97e1-5acb882fff0b"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTItMS0xLTA_ca9cbb25-c490-4005-837b-bd609b123fd2"
      unitRef="usd">1350000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTphMzQ2YzMxYjgwMmI0NDU4OGFjZTgzYjNkY2QzZTRkMi90YWJsZXJhbmdlOmEzNDZjMzFiODAyYjQ0NTg4YWNlODNiM2RjZDNlNGQyXzYtMTQtMS0xLTA_8103dcad-ee71-4ff5-aef4-1fec89e91e85"
      unitRef="usd">3050500000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i987fbf31a45c43e3bae95b8e5240af87_I20181217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzgyMw_865ea013-91b9-45ab-8961-6f64863fd109"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i55f8ef212efb4b25bf5f4170fbe2cf4e_I20181217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwNzM_8ed95285-65bd-424a-b520-70772fc85531"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if3f1f73d7de842cb99735553e7abceab_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIwMDE_0174d9d2-8ff9-445c-8e93-409cf7342b4f"
      unitRef="number">0.0108</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icfe44565012b45bcaa3449fb3bb9f8e5_D20181217-20181217"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIzNzU_b24f13d3-320c-4a5a-a6b3-9905a8d6a9ba"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="icd947cfb444742399b5c1ace77c408b1_D20181217-20181217"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1MjE_0c860262-5ead-4375-bfc8-4f615808f102"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter
      contextRef="iafd7f93a96974c4bb03d8ef2216bde64_D20181217-20181217"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI3ODg_a37ff270-8481-498e-8a1d-25cc9ec118aa"
      unitRef="usd">9375000</holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter>
    <holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter
      contextRef="i3ff7dff07c19479d8d7294b3f41e4502_D20181217-20181217"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI4ODQ_c14c1e26-f25c-49b6-a9b2-bdc5f010f526"
      unitRef="usd">28125000</holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter>
    <holx:DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments
      contextRef="ie832e870ba2c42c59c28352c2f958f69_I20210925"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzMxMDQ_455c02f9-2a90-4354-ba10-fe6524622bb1"
      unitRef="usd">1200000000</holx:DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments>
    <holx:LeverageRatioMaximum
      contextRef="i652ebb0e49d2467fb5a2db3d5fb30206_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzU1NTc_264fb31b-d764-46bb-a26b-4910ae2024d9"
      unitRef="number">5.00</holx:LeverageRatioMaximum>
    <holx:LeverageRatioMaximum
      contextRef="ic0cc2fe65c6840608feb94760bc0727f_D20220625-20220625"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzU2NzQ_7602a83f-605e-4a81-a93e-1584ce718cd5"
      unitRef="number">4.50</holx:LeverageRatioMaximum>
    <holx:InterestCoverageRatio
      contextRef="i652ebb0e49d2467fb5a2db3d5fb30206_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzU3NjE_32bb9d26-a780-4985-8ef7-b2601d629233"
      unitRef="number">3.75</holx:InterestCoverageRatio>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ie810eb40b7d8415ebbbf9fc97518f0ac_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3Xzc1OTU_44fe63d2-ce50-43e6-9d40-3ba3ee9b178b"
      unitRef="usd">800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <holx:DebtInstrumentNumberOfInstruments
      contextRef="ie810eb40b7d8415ebbbf9fc97518f0ac_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3Xzc4MTI_f5dc0f7d-c9f4-4d4e-8653-fd4402d61652"
      unitRef="debt_instrument">2</holx:DebtInstrumentNumberOfInstruments>
    <holx:MaximumRangeofPresentValueofCashFlowPercentage
      contextRef="ie810eb40b7d8415ebbbf9fc97518f0ac_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3Xzc4Nzk_33a2873e-1911-4327-b814-c0cf430c6452"
      unitRef="number">0.10</holx:MaximumRangeofPresentValueofCashFlowPercentage>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1Njc2_b2ae76da-569b-4349-9827-dfb16fd1286c">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement and the 2017 Credit Agreement was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:72pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:22.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i08ae73b31aa74566b4be619e65396e03_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzItMS0xLTEtMA_8d30b352-08aa-4b59-8df3-eb0f0b80b6b4"
      unitRef="usd">22000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ica7ec8355d2a4b94a212d956ffd6cb98_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzItMi0xLTEtMA_41331baa-fc57-4ab4-854e-36774211e727"
      unitRef="usd">46600000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i37227dbc9a1b4b84b8f8518571a9c190_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzItMy0xLTEtMA_aad63cc3-55d8-4c17-97ba-5ec6597a8f73"
      unitRef="usd">67000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i08ae73b31aa74566b4be619e65396e03_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzMtMS0xLTEtMA_10080e6d-ca18-49f3-ad84-e1c433ac2f98"
      unitRef="usd">2500000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ica7ec8355d2a4b94a212d956ffd6cb98_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzMtMi0xLTEtMA_ab3ed552-4bd5-405f-b82e-832217d69dd8"
      unitRef="usd">2500000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i37227dbc9a1b4b84b8f8518571a9c190_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzMtMy0xLTEtMA_810883a7-6db3-4860-84ee-f244798882ac"
      unitRef="usd">2600000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i08ae73b31aa74566b4be619e65396e03_D20200927-20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzQtMS0xLTEtMA_01362ce5-e3cc-4a56-909f-bede25c16eea"
      unitRef="number">0.0113</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="ica7ec8355d2a4b94a212d956ffd6cb98_D20190929-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzQtMi0xLTEtMA_fe44ab9c-2d54-45ee-ba7a-9ac54b36db0f"
      unitRef="number">0.0225</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i37227dbc9a1b4b84b8f8518571a9c190_D20180930-20190928"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzQtMy0xLTEtMA_f4c2b7e6-edf1-43d2-8cc1-545509331a7c"
      unitRef="number">0.0379</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ic2aae87d5ebc4b419aaf8b70fa7a9da0_I20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzUtMS0xLTEtMA_9ebe208b-44ee-4c03-94a5-ce0cbe6cb4cf"
      unitRef="number">0.0108</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ie74af5ae594d4d13ba8933a5998eadeb_I20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzUtMi0xLTEtMA_aa2a2350-8afd-4001-99d2-1d7164ed3d36"
      unitRef="number">0.0140</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i6c788b804fa84fb88a30f3178cfe6010_I20180929"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTozZWM4MDE0N2ZmN2I0MDU3OGJjMTA0Y2Y3YjA4OTY3ZS90YWJsZXJhbmdlOjNlYzgwMTQ3ZmY3YjQwNTc4YmMxMDRjZjdiMDg5NjdlXzUtMy0xLTEtMA_1c6dd81e-ce93-4e9e-ae46-f559aec23637"
      unitRef="number">0.0343</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i60bf2cb0eaf6478486595f6f3d4f3b1c_D20210927-20210927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM2NTk_300465a7-36b0-440f-a6b4-d02d5d3f6bbc"
      unitRef="usd">1500000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4ef80047f7894c36ae90aa6a3c52242a_I20210927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM2NzM_d5912370-b8cc-43db-8c17-2d819aa4a625"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i08e28b6fbb1c4a4284c842f3cbf9792a_I20210927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM2ODc_fa16bc76-14e4-4b5b-9442-f92a48b2b8b3"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibf897b14244c423cbe46652e18311bcc_D20210927-20210927"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3MDE_c3c5159e-33ae-4506-aa30-6a20de45057e"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <holx:DebtInstrumentCommitmentFeePercentage
      contextRef="ibf897b14244c423cbe46652e18311bcc_D20210927-20210927"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3MDg_b44d8fbf-1c0b-48fe-8a8f-9e7d74ac4045"
      unitRef="number">0.0015</holx:DebtInstrumentCommitmentFeePercentage>
    <holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter
      contextRef="i2ade552830964807a4049d7ee32b7074_D20210927-20210927"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3Mjk_54a452d6-fee2-4cd8-aa1a-2715bc41b332"
      unitRef="usd">3750000</holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter>
    <holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter
      contextRef="i4b582144f7fd4f718cb0fe6f6d00dc2a_D20210927-20210927"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3MzE_166514d5-bdb2-4118-8a7d-17f249a5459c"
      unitRef="usd">18750000</holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter>
    <holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter
      contextRef="ibf897b14244c423cbe46652e18311bcc_D20210927-20210927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3NDc_7731ef61-2e0e-4573-a247-459cdc6b610e"
      unitRef="usd">1335000000</holx:DebtInstrumentPeriodicPaymentPrincipalPerQuarter>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="ia77e5b12c3d44c7fb98f381230c562a4_D20180119-20180119"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEyNjY5_b0e596ac-cd4e-43a8-b0e5-60e5d619894d"
      unitRef="usd">1000000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEyNzI5_4ada35ab-c9a6-40f1-8f34-18dedc8c6e56"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEyNzY5_e7f1ff36-c179-42d5-a9e2-1a700e8faa03"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEyODQ0_147eebfb-1f0a-4190-9370-b1cc8669c1d0"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEzMTQ4_b750087a-b6b9-45b7-a9a3-54927a58717c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEzMzU5_5bb1e133-e0b0-4ac6-9eee-f60aaf66150f"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0MDA2_5264b61f-d2b2-40fa-a446-91aacea338ea"
      unitRef="number">1.02312</holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod>
    <holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0MDYy_93d4433e-9b82-49f8-892c-fa0708ae667b"
      unitRef="number">1.01541</holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod>
    <holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0MTE4_825e8310-2e4e-40c5-9d9f-83a4533a8f96"
      unitRef="number">1.00770</holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod>
    <holx:DebtInstrumentPercentageRedemptionPriceSixthPeriod
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0MTY4_596512be-5de2-43fc-b273-f5be98429663"
      unitRef="number">1</holx:DebtInstrumentPercentageRedemptionPriceSixthPeriod>
    <holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes
      contextRef="iad19ce928cc147b4a6d313f0bee64c59_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzE0NDEy_e7b11b65-c093-453c-85e4-62466460b5a5"
      unitRef="number">1.01</holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="id41609d12cf047148859a8228474e2bd_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM3NzY_16362c49-db72-43a6-8044-04a38d324822"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id41609d12cf047148859a8228474e2bd_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4MDA_a9b79374-5a96-412d-861d-5b52e15f1e25"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i5b7aafeef10b4cb39da754e699f15172_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4MTM_fec66621-57f1-415b-aab6-3b18a8451c55"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id41609d12cf047148859a8228474e2bd_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2NzY4MzQ_9a4436f9-cd85-4173-b9e2-52ae773e1ee1"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i5b7aafeef10b4cb39da754e699f15172_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2NzcwNTI_38472fd5-c89d-4eb4-8628-f60e9b3165e9"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i608d5220bab04a068eb77c0863e0e36a_D20200928-20200928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2NzcyNTU_7285363e-c977-42b5-9958-bee8d74cfb39"
      unitRef="number">0.40</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i7e507642eb964db6860b69fb5f71596c_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2Nzc0NjU_11c904ab-bc42-4b7a-8525-e15c5b06a153"
      unitRef="number">1.03250</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ie12d730be0c14e1f9f1c5feaed78db40_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2Nzc3MDg_5b13301b-05cd-4ba1-b74b-d007d7cef1e0"
      unitRef="number">1.01625</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i02f6ad83b4ca4d948d52c4704f2e4326_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2Nzc3Njk_9e129259-7745-4965-98fa-ae9774559b42"
      unitRef="number">1.00813</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i03accd3c4a404ba1becc118185a02608_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2Nzc4MjI_46fa3727-8819-4e6a-927e-5fa1ef985036"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ibaa36a6d1efb41cb8948ae469d7b66a1_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2NzgwNjc_bc5db875-4448-4ec4-aa05-29c1ad8375dc"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3adbde1625f143509c7660ebf25386e1_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4MTk_20d4af21-7b41-4e07-b32b-6146a500f5d6"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3adbde1625f143509c7660ebf25386e1_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4Mjc_a7b0480d-d2a5-4b81-8c59-74faddd5349b"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3adbde1625f143509c7660ebf25386e1_I20210925"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4MzU_fa5d6931-1ba0-4496-8c74-12f5826aca0f"
      unitRef="usd">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ie51341073d8740bab85b03dc5cbb80c6_D20201015-20201015"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4NTE_748f25fb-88a0-4a4f-9abb-17fad7f34902"
      unitRef="usd">970800000</us-gaap:ExtinguishmentOfDebtAmount>
    <holx:DebtRedemptionPremiumPaid
      contextRef="ie51341073d8740bab85b03dc5cbb80c6_D20201015-20201015"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4Njc_0578290e-2d99-4e9d-abdf-a15f158fdb16"
      unitRef="usd">20800000</holx:DebtRedemptionPremiumPaid>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ifcae078f20ac485186d995bbd72b5c6c_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4ODI_bef93a42-26c1-4fe0-a795-aee0c6caae5b"
      unitRef="usd">21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ifcae078f20ac485186d995bbd72b5c6c_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM4OTc_3c597d67-d9e8-4e8c-bd0b-e8cac5f11076"
      unitRef="usd">5800000</us-gaap:InterestExpenseDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i54d531947d51410a8d540905838b6d9d_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5MTE_d6b99c39-752b-488b-9fac-a8662a4728ca"
      unitRef="usd">7900000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i54d531947d51410a8d540905838b6d9d_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5MjU_4b9ffc7a-c2e3-47f6-b5b3-cdb3028bbbcd"
      unitRef="usd">6400000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id41609d12cf047148859a8228474e2bd_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMS0xLTEtMzY3OTU_be8e7283-fcda-4106-a53f-96acc27c4c49"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i3ccbfebd983b455f947f37aab7a949b0_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMy0xLTEtMzY3OTU_e185cbbc-c1f7-4f69-9866-3a465ae59dc0"
      unitRef="usd">32700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i3ccbfebd983b455f947f37aab7a949b0_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNC0xLTEtMzY3OTU_60ff27c0-6732-419c-b62d-68733e505edf"
      unitRef="usd">2100000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ifd6b00bf571a45b79bec794d5b438566_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNi0xLTEtMzY3OTU_b3357c37-7249-47b2-8616-e0ec3fef714b"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ifd6b00bf571a45b79bec794d5b438566_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNy0xLTEtMzY3OTU_dae68441-a236-4d0c-af5b-625d191dfd7e"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="id0b31f3326de4002a60eb9c0311715ac_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtOS0xLTEtMzY3OTU_8a7e43cd-796d-48d5-9e02-8580dbc0644b"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="id0b31f3326de4002a60eb9c0311715ac_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMTAtMS0xLTM2Nzk1_3b8c2944-d6e7-4303-894a-f9d056a9a8bc"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i62108c6a80cb45f69acbd92821a7917d_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMS0xLTEtMA_1a2803ae-c0d2-41d8-b47e-20ed6b26d6d5"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="iad19ce928cc147b4a6d313f0bee64c59_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMy0xLTEtMA_3d4259bd-c7df-43b9-b110-018f22d48935"
      unitRef="usd">19200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="iad19ce928cc147b4a6d313f0bee64c59_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNC0xLTEtMA_8ce4d665-1aee-4393-8184-93dc0bbf6331"
      unitRef="usd">700000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i4d4b04bc14144fa5b03735e07bd838a6_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNi0xLTEtMA_d8c2d917-1189-434b-a21f-3ca611be60d6"
      unitRef="usd">19200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i4d4b04bc14144fa5b03735e07bd838a6_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtNy0xLTEtMA_66b4996b-c8a5-4276-85d5-5171eb5b3c1b"
      unitRef="usd">700000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="idfc1f74a5de948999cd82322770f0eba_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtOS0xLTEtMA_f89ae70f-f2c4-4e28-b77d-98ff14f61838"
      unitRef="usd">19200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="idfc1f74a5de948999cd82322770f0eba_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzMtMTAtMS0xLTA_dd954e7f-080a-41cb-bc48-cda7b4ab6d3f"
      unitRef="usd">700000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3adbde1625f143509c7660ebf25386e1_I20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtMS0xLTEtMA_fd8ac996-974a-4361-88b8-377aa1bcf537"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i99b892bb7bdd405aa700578ed296fdde_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtMy0xLTEtMA_3d308101-4608-4519-b471-4a702298ded8"
      unitRef="usd">2300000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i99b892bb7bdd405aa700578ed296fdde_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtNC0xLTEtMA_92d07186-da38-4e49-ad9c-a8c0b65faccb"
      unitRef="usd">100000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i580c0405f9b548989c3f94ad170c061b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtNi0xLTEtMA_f4479096-3223-4908-a5fe-0554beb010ff"
      unitRef="usd">43500000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i580c0405f9b548989c3f94ad170c061b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtNy0xLTEtMA_3ade6185-70b5-4a9a-bff0-72a2a083b42c"
      unitRef="usd">2100000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ib8eae7b7b71e466b8c9e1876e7f31390_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtOS0xLTEtMA_a2a863f6-5a9a-468b-9b22-6a1443a8129c"
      unitRef="usd">43500000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ib8eae7b7b71e466b8c9e1876e7f31390_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzQtMTAtMS0xLTA_b35bd0ac-d8eb-40ae-872d-f1c9cf3fd34c"
      unitRef="usd">2100000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i79503f9eb2e64b5383905a0821499fdd_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtMy0xLTEtMA_19fc59bd-7d30-4f5c-bb5f-367a4145c7b8"
      unitRef="usd">54200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i79503f9eb2e64b5383905a0821499fdd_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtNC0xLTEtMA_807c3e56-02ae-4147-a521-9960bcc96a20"
      unitRef="usd">2900000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i90abd2f2507648759350a4c487e7133b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtNi0xLTEtMA_e1f6e7cd-6f95-41a7-962b-d081e5d50b4d"
      unitRef="usd">62700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i90abd2f2507648759350a4c487e7133b_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtNy0xLTEtMA_dacf83a5-e8f0-486a-a2bc-6febebc35811"
      unitRef="usd">2800000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i859a66c6b93d4b9887cc31492d39939f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtOS0xLTEtMA_479aee1a-8393-4dac-9e38-418bdb02659e"
      unitRef="usd">62700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i859a66c6b93d4b9887cc31492d39939f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90YWJsZTo3NTkwYmU1MTMzMGE0ZTM3ODUwMmUwYzFiMTg4MTY3MC90YWJsZXJhbmdlOjc1OTBiZTUxMzMwYTRlMzc4NTAyZTBjMWIxODgxNjcwXzYtMTAtMS0xLTA_bbf027b1-a111-4b55-acc1-204ade196ccb"
      unitRef="usd">2800000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <holx:TermARSecuritizationProgram
      contextRef="i875c28ce0ee54237b5b3ae2cc86658a0_D20160425-20160425"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzI1NjY5_49d97c8f-129d-48ce-8b38-c197428ea3e8">P1Y</holx:TermARSecuritizationProgram>
    <us-gaap:AccountsReceivableFromSecuritization
      contextRef="i6cfd402b776d44a0a41a299cca8f7ede_I20160425"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIwODQ5_1c2061f9-b87a-4b28-9086-dd6b8089b030"
      unitRef="usd">200000000</us-gaap:AccountsReceivableFromSecuritization>
    <holx:MaximumBorrowingUnderSecuritizationProgram
      contextRef="i6cfd402b776d44a0a41a299cca8f7ede_I20160425"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxNjg3_8f0eb51d-2fe9-4648-b0e9-d600fbb54444"
      unitRef="usd">200000000</holx:MaximumBorrowingUnderSecuritizationProgram>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i875c28ce0ee54237b5b3ae2cc86658a0_D20160425-20160425"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIyMTQ3_100d919b-9992-4b2a-9de6-0ff596c3116f"
      unitRef="number">0.008</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <holx:MaximumBorrowingUnderSecuritizationProgram
      contextRef="i4812438b158c4e59a58edb46ec6692b1_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5Mzk_a2ea80e4-b9ad-47dd-ba3a-6d17e4472720"
      unitRef="usd">250000000</holx:MaximumBorrowingUnderSecuritizationProgram>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id66308ea8ebc4fd4838c14af38426030_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5NTU_cae4810d-0468-41f1-aad1-e5eb5d7d0186"
      unitRef="number">0.007</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:RepaymentsOfDebt
      contextRef="i5d6eb9a53b2c48879a529442ab3b794a_D20210627-20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIyOTUw_1f08c7ad-76a1-4676-bc85-6f579d36fc21"
      unitRef="usd">250000000</us-gaap:RepaymentsOfDebt>
    <holx:MaximumBorrowingUnderSecuritizationProgram
      contextRef="i397a73cea4db4782a2daff7fe814251a_I20210611"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5NjE_b4f5a7d4-7340-4f2f-864d-90d2f056d70d"
      unitRef="usd">320000000</holx:MaximumBorrowingUnderSecuritizationProgram>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzEwOTk1MTE2OTIzNzA_64907978-3399-4425-bbfc-5194ceec20f6"
      unitRef="usd">248500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5Nzc_d5c7c813-f45d-4eda-8157-a4d566173f69"
      unitRef="number">0.008</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:InterestExpenseDebt
      contextRef="id66308ea8ebc4fd4838c14af38426030_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIzMzA2_76b6d20e-05e1-4db2-81ed-02f39ff26e13"
      unitRef="usd">900000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ife9157147e3b4536a9046a87f5a4d781_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIzMzEw_e28c9361-2255-4029-a8da-0811d7c95dc3"
      unitRef="usd">3100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i4c371851af5c4029b78c5f593a1a596f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIzMzE3_0877aebf-6787-48a6-847f-70a6281f0505"
      unitRef="usd">7100000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ic1817a9609f14627a2d7989c9899505b_I20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5ODM_5d855c6f-7c33-45a6-b0eb-a669d64963ef"
      unitRef="number">0.008</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia65923c3b6874551939bf4e2608b53bb_I20210617"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5OTQ_679ed043-9ceb-4641-b8d1-e08d4d0d849d"
      unitRef="number">0.060</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7f11d3ec54a14c5e9eb1e8a150c8bc11_I20210617"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTEvZnJhZzpkNmRiZjZiOWY1NmY0MmI3OTRkMjIxZjI0OGU0OWIyNy90ZXh0cmVnaW9uOmQ2ZGJmNmI5ZjU2ZjQyYjc5NGQyMjFmMjQ4ZTQ5YjI3XzIxOTkwMjM0NDM5OTY_8338190e-25bb-46e3-8f1a-8084c38344f4"
      unitRef="number">0.070</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzU1NjI_f951e3d2-9629-4f3e-9645-e3cb2c9ad538">&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:14pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps - derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:484.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:183.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:64.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:72.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:73.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:42pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps - derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the years ended September 25, 2021, September 26, 2020, and September 28, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.980%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.510%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments/Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ifc96b1d6d081406abb844157f1ed6e5c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzgtMS0xLTEtMA_c450e36f-5a81-4842-aa77-74defdbda9e1"
      unitRef="usd">1700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i1406035f87284cafbfec6b6f722dc49c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzgtMy0xLTEtMA_e773a3d5-8082-4046-a733-2a3730929bc5"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="icc463bd6a5a1402f90b9512aff6a663a_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzgtNS0xLTEtMA_6e594839-f8ac-4184-bed5-ca52a728b3b1"
      unitRef="usd">1700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ie913b1898868426c83630108b0931936_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzgtNy0xLTEtMA_c56e5759-e66f-41ea-92bf-b0fbfcbffedc"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzktMS0xLTEtMA_9dae6a79-80fd-4f0d-8b4a-668e21cbb19f"
      unitRef="usd">1700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i8d8ebd59017941e09e4b709e2c259721_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzktMy0xLTEtMA_a01ff24d-6c78-42d8-b09e-fc2ff4c0938c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ic1e254ea6d6943bb8318cf1919f88ee6_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzktNS0xLTEtMA_b48e94c2-4229-4518-a46e-8483ead8d1d0"
      unitRef="usd">1700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i125f4bfdd8b84928ab52d980197004dc_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzktNy0xLTEtMA_24275157-f213-453f-a1ab-a6d2f3951ca3"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="icc0150b9393b4c8b954b2e122c43851c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzExLTEtMS0xLTA_ead33514-ae1e-408d-8bda-64fd34dff48f"
      unitRef="usd">75100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i7dcaf65163dc4875a6d42ef1db4db39a_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzExLTMtMS0xLTA_bed582eb-3a5a-4a87-b1f7-cac55fd80c9a"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i038a6263f66c4604975a68690f426831_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzExLTUtMS0xLTA_a1ecf723-11f1-4bca-ba3f-88238eb865a4"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i73170ab8f09241c6addd83b14085fb1d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzExLTctMS0xLTA_23618f2e-62e4-4578-9b1e-b021feafb54d"
      unitRef="usd">75100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ic0e3770e763f4ddb888efca3f38034da_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEyLTEtMS0xLTA_3e25a59c-80a0-478f-bc91-553e40aa9cb3"
      unitRef="usd">18700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibd0a92c2fbda45e5a76e08e7693a71ee_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEyLTMtMS0xLTA_01aa5e38-45c1-4d47-9ac5-d402d26a5f00"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia1f31160d70448a4bc9dc1766821eb8d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEyLTUtMS0xLTA_f9ba2139-66d5-4911-949e-d62f8e41c6bf"
      unitRef="usd">18700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i15a2dcf988324496812e93ba7fe0dbfe_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEyLTctMS0xLTA_14664bcb-25b6-4921-8cb3-4c0da2758904"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i2e5c21e5481b48d39c7959cb8bc8c777_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEzLTEtMS0xLTA_90cae5ab-2fb5-4172-89b7-12874504f37c"
      unitRef="usd">600000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ie36b916fb59a49dd9387e30c28f5ec5b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEzLTMtMS0xLTA_f920e7dc-b88f-4263-ab35-8245d01497a7"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i0b282273a4c84a8caba87fd238f92b67_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEzLTUtMS0xLTA_b0c99a15-d3bc-4582-bc5c-a6c8dfbcde1b"
      unitRef="usd">600000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="id901e08a99744558bdb5e1f2583dcbbe_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzEzLTctMS0xLTA_efca0d70-ec53-4675-ab6c-fa7dc354f12e"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzE0LTEtMS0xLTA_a68deec9-7260-4a47-946b-107c69c8ce10"
      unitRef="usd">94400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i8d8ebd59017941e09e4b709e2c259721_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzE0LTMtMS0xLTA_94e282ab-1c54-45db-aae4-8ffee286051e"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ic1e254ea6d6943bb8318cf1919f88ee6_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzE0LTUtMS0xLTA_6a7711ad-799f-4274-a44b-47fcbbdd120f"
      unitRef="usd">19300000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i125f4bfdd8b84928ab52d980197004dc_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTpiYjNiNTc2Y2M0MWU0M2EzOGJkZDhlY2I2MTFmMjdjMC90YWJsZXJhbmdlOmJiM2I1NzZjYzQxZTQzYTM4YmRkOGVjYjYxMWYyN2MwXzE0LTctMS0xLTA_da756c3f-01fb-469c-b443-64133c060979"
      unitRef="usd">75100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i03c2fff5e4e74c19ad8880629979f011_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzYtMS0xLTEtMA_d0a7ee79-3044-442a-8050-bbf9800d0a6c"
      unitRef="usd">10100000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ib332bb7657f04489b5fa9e02f29ad82b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzYtMy0xLTEtMA_3d865426-90ac-4e64-a080-e820b87efd52"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i0a8c569fd753446ebfcdbe23ec063f7c_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzYtNS0xLTEtMA_71125dca-e9de-4a98-aa0e-067f6c787cb8"
      unitRef="usd">10100000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia383a042e26d453ea66d7eaa8d23c21a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzYtNy0xLTEtMA_b8d1755e-c390-48bc-b6d8-73401ecca402"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ie3a7bf1b1614469fb146d97f9eaddd6b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzctMS0xLTEtMA_12e7b63f-4890-4d49-96e9-4e5695a5ee7b"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i87ca8c80f7c34ee4800d09f086e64eaf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzctMy0xLTEtMA_bff13ff3-a2f3-4da2-b3df-1ad5f6df2354"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i59b0c160a0424f80895466659951d8a5_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzctNS0xLTEtMA_25f71777-c8bb-4a24-a042-001a0284b032"
      unitRef="usd">1100000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ie43b4fa2b20c49fb8a55c4a741714682_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzctNy0xLTEtMA_82a7bf0d-864f-40d3-ac4d-951183fe06b6"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzgtMS0xLTEtMA_06936598-1ace-418b-b08c-a9d9ea5095d3"
      unitRef="usd">11200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id66df1a2532a483f863906f0802057c7_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzgtMy0xLTEtMA_cc1fa6cc-6510-48d1-8d69-ab8f5d6c9dfc"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib91d7b55ffbe4550b988ae9a14a17fb7_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzgtNS0xLTEtMA_8a9c00a9-85e5-4b85-ba39-3f3da27ec40f"
      unitRef="usd">11200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i91dece30b943448ab8d1ec46e9bc104e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzgtNy0xLTEtMA_52f7c96c-6de3-4425-92ba-7d0ba0470e6c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ia0b57f07560240bbb91b31af0add8433_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEwLTEtMS0xLTA_a34b0508-7b9a-452a-84e1-a6af80da7413"
      unitRef="usd">81800000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ia11ee15324c14f1bb58ad7901a2e8f89_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEwLTMtMS0xLTA_2e8beb85-4c74-4be6-ba08-0f8a2653648f"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ic9d46afcc2f043149b8d49cfd5f03353_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEwLTUtMS0xLTA_efafa05b-ad45-4877-b6f8-9563306933f8"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ia0b57f07560240bbb91b31af0add8433_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEwLTctMS0xLTA_a506170e-c23a-4487-b096-b693bd01ba1a"
      unitRef="usd">81800000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzExLTEtMS0xLTMzNjY3_afdf1694-26ea-4ae9-81fe-c5a48489fcfd"
      unitRef="usd">31200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1b8b998a0ac54ca3b8a3e53fd874c735_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzExLTUtMS0xLTMzNjY5_1f5ff77a-9e71-4035-9c49-60f14227158f"
      unitRef="usd">31200000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEyLTEtMS0xLTA_45c89819-3462-4d62-8d84-93d165465864"
      unitRef="usd">113000000.0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="id66df1a2532a483f863906f0802057c7_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEyLTMtMS0xLTA_a90be668-b301-4eee-b6ee-1f71fbb88481"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ib91d7b55ffbe4550b988ae9a14a17fb7_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEyLTUtMS0xLTA_bf9b15ef-fa59-4931-a485-84ad704ed9b6"
      unitRef="usd">31200000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i91dece30b943448ab8d1ec46e9bc104e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTplYWJmMGNmNWMyYTk0NjA4ODFlMjc1NWZkMWRmOThkOC90YWJsZXJhbmdlOmVhYmYwY2Y1YzJhOTQ2MDg4MWUyNzU1ZmQxZGY5OGQ4XzEyLTctMS0xLTA_fae1aa9e-3af5-4e6e-9c48-d8d2dce6089e"
      unitRef="usd">81800000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzItMi0xLTEtMA_51c72457-0847-40ea-93da-66b48b50b223"
      unitRef="usd">81800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzItNC0xLTEtMA_79190505-75d3-4cfb-a0fa-1b8943cdcd9d"
      unitRef="usd">9100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzItNi0xLTEtMA_a9e69a8d-c43e-49a4-955a-4b01d1b7509d"
      unitRef="usd">7800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzMtMi0xLTEtMA_4e71fb35-5045-45ea-82fd-60ef3862710c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzMtNC0xLTEtMA_6ee314bc-d95b-40e5-8e7a-33ecc0f2e2a6"
      unitRef="usd">82700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzMtNi0xLTEtMA_c8ba527a-f488-43f4-887e-e52ce5bcb6df"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzQtMi0xLTEtMA_668a8fca-5130-4dc3-870c-8fa4d688c666"
      unitRef="usd">-6700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzQtNC0xLTEtMA_0a358956-10b3-4a65-a240-404d106ff23a"
      unitRef="usd">300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzQtNi0xLTEtMA_ed1166a7-82a7-4203-8842-7202b9e43551"
      unitRef="usd">1700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzUtMi0xLTEtMA_2e7e6185-4b94-4588-b736-9f618dd24508"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzUtNC0xLTEtMA_736a3365-4f10-478c-8ee3-94d12d23edbb"
      unitRef="usd">10300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzUtNi0xLTEtMA_4469edb1-ff4f-43ee-8483-10bf83f79e85"
      unitRef="usd">400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzYtMi0xLTEtMA_d4dce786-e40f-4fce-ac5e-79f3064cf219"
      unitRef="usd">75100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzYtNC0xLTEtMA_2ea8c3ea-26b2-4255-b33c-34ef454c0b92"
      unitRef="usd">81800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90YWJsZTozYmZiODVmODNjYTI0MDY4OGYwMzg5NWU1ZDBmMzYzMi90YWJsZXJhbmdlOjNiZmI4NWY4M2NhMjQwNjg4ZjAzODk1ZTVkMGYzNjMyXzYtNi0xLTEtMA_2ed9b8f0-15e3-416f-a4c0-c8bd25a9ea96"
      unitRef="usd">9100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:AssetImpairmentCharges
      contextRef="if91afb4383874bc4926b10047930d0c4_D20190929-20191228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzM0MzQ_1be55260-c9e9-4c6f-a220-a908437b4623"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i382a342e009b41b7ba2429981f375e2f_D20181230-20190330"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzM3NDA_b5206aaa-b3d7-463f-86e3-13fa367ecca3"
      unitRef="usd">685400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i273f68028b9048b4bcb9cc44e3765361_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzM3NTM_4261df4d-0c35-4568-8d4a-23fb367a211e"
      unitRef="usd">675600000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i6960dde2df794b28bb51b31c7a27d8d7_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzM3OTU_69774b2d-4427-4f6f-ae76-f90cf234a440"
      unitRef="usd">9800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzEwOTk1MTE2NDEyMjU_85c97f5d-9e25-4d5c-9eaf-b1c736917bd5"
      unitRef="usd">1800000</us-gaap:AssetImpairmentCharges>
    <holx:PrincipalAmountOfBorrowings
      contextRef="i461d1a7632c3438dbb6d29204125214d_I20210925"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzUxNTk_1cacef56-2329-4bc9-8a34-2edf8533d071"
      unitRef="usd">1390000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia06d0a30712b4655924b65bdcb87307c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzU0NTE_435be862-7268-490d-81f5-606ca2a0afc5"
      unitRef="usd">424500000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ibc9edb45f9c24890a42f08ce96b5a3d5_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTQvZnJhZzpkYTFlZTI1MTg4ZWU0NDI3OThkMjQ1YzhiZmVlNGI2Ni90ZXh0cmVnaW9uOmRhMWVlMjUxODhlZTQ0Mjc5OGQyNDVjOGJmZWU0YjY2XzU0NTg_76e6341f-74ca-4428-b815-8c9a16f81405"
      unitRef="usd">964700000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjUz_66308a9c-b622-4cb6-b794-3159ee334a2a">&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s income (loss) before income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,267.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;921.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,361.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzItMi0xLTEtMA_122d040a-a817-461d-90c8-0ea89aaf0cd9"
      unitRef="usd">2267800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzItNC0xLTEtMA_81144280-e5f1-4d34-a36c-eda0d03491b4"
      unitRef="usd">921100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzItNi0xLTEtMA_f730bb22-4395-4eb2-8d01-181562c7c38b"
      unitRef="usd">-174300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzMtMi0xLTEtMA_52208572-c53a-410f-9433-873509c53900"
      unitRef="usd">93300000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzMtNC0xLTEtMA_f490e154-b844-453d-9b1e-ebf20b6bc71c"
      unitRef="usd">80800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzMtNi0xLTEtMA_f86428fe-ea05-4c48-afd7-ec86918d87f6"
      unitRef="usd">-83400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzQtMi0xLTEtMA_cd0b45fe-9acd-4c52-9839-e02c4ac57b4a"
      unitRef="usd">2361100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzQtNC0xLTEtMA_daff4178-3a07-4bb4-9597-69da2daa5883"
      unitRef="usd">1001900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyYTNlYzE1NmNjYTE0ZjEwOTg3NzliZTcwOThhNDUwYS90YWJsZXJhbmdlOjJhM2VjMTU2Y2NhMTRmMTA5ODc3OWJlNzA5OGE0NTBhXzQtNi0xLTEtMA_0d082d3e-bb08-4b73-b401-3da877067ce6"
      unitRef="usd">-257700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjMy_acdabe02-cff1-46f9-9c7c-ee5e84ed3a9c">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision (benefit) for income taxes contained the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzMtMi0xLTEtMA_06253c70-a7f8-4aa8-9533-734ab3a4677f"
      unitRef="usd">453600000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzMtNC0xLTEtMA_a0d56390-5c13-45d5-b67d-c338956d9f0a"
      unitRef="usd">-62100000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzMtNi0xLTEtMA_5c572aed-2840-416f-9d5c-7eb2a46a07dc"
      unitRef="usd">142900000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzQtMi0xLTEtMA_d24bee96-32e4-4690-8318-7107dd549074"
      unitRef="usd">-45600000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzQtNC0xLTEtMA_0aaa8ba6-2146-41dd-bc00-d8daf39ccb35"
      unitRef="usd">-76600000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzQtNi0xLTEtMA_0c1552f6-7d36-40f2-a0fe-fc1fb282f4d6"
      unitRef="usd">-189900000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzUtMi0xLTEtMA_8dea109e-8cb7-4d6b-a52e-7a9366eea6d7"
      unitRef="usd">408000000.0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzUtNC0xLTEtMA_f506ab86-6ff5-405e-919e-3afcac5ecc65"
      unitRef="usd">-138700000</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzUtNi0xLTEtMA_4aa66ad0-6e33-43f1-bb72-fdc6d24d924d"
      unitRef="usd">-47000000.0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzctMi0xLTEtMA_0b63610d-7e76-461e-8dd0-32749ea6eaad"
      unitRef="usd">84700000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzctNC0xLTEtMA_2cc99c0f-ac98-461e-a16a-ac4d90ce18c6"
      unitRef="usd">33900000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzctNi0xLTEtMA_ca01e809-a518-4d3b-a976-8af05d247c51"
      unitRef="usd">22100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzgtMi0xLTEtMA_78c58dd8-863c-4106-a236-8682be5b04b7"
      unitRef="usd">-11900000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzgtNC0xLTEtMA_9940a6dd-f1d8-4d0b-b7ef-5d135b8a6001"
      unitRef="usd">-12500000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzgtNi0xLTEtMA_ff794671-e0a8-421d-9a15-f09d3d447511"
      unitRef="usd">-41000000.0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzktMi0xLTEtMA_a0c397a3-2dd8-4636-ab1a-59f9fa2a4caa"
      unitRef="usd">72800000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzktNC0xLTEtMA_6889c067-aed3-4195-b746-bd1e8ac05ef4"
      unitRef="usd">21400000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzktNi0xLTEtMA_f5a91c2d-93dd-4fc4-87be-55f0813e08f2"
      unitRef="usd">-18900000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzExLTItMS0xLTA_30b12be3-63b1-43f2-85d2-0ac684387032"
      unitRef="usd">23200000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzExLTQtMS0xLTA_45bc9c16-a16e-4a7c-a29b-c3839bc03dc6"
      unitRef="usd">14000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzExLTYtMS0xLTA_c5c62c81-d7c5-4ba6-8d78-8c1df5d450d9"
      unitRef="usd">16500000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEyLTItMS0xLTA_9a62adff-4c14-4d4e-bf34-f91748981347"
      unitRef="usd">-12600000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEyLTQtMS0xLTA_0e47545c-5ffc-4e01-a7dd-62111c24234f"
      unitRef="usd">-5300000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEyLTYtMS0xLTA_241ec769-10bd-458c-9d2d-7379a82b6c4c"
      unitRef="usd">-4700000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEzLTItMS0xLTA_22ed7425-10c4-430f-a314-63861f8531c1"
      unitRef="usd">10600000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEzLTQtMS0xLTA_e0e38ad8-a2e9-4cb4-a7d6-a312b5a5ea3c"
      unitRef="usd">8700000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzEzLTYtMS0xLTA_4b214f90-e94f-439f-bf51-26959a5dc26a"
      unitRef="usd">11800000</us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzE0LTItMS0xLTA_7c4740ce-3537-4760-b45a-7f588881c2ec"
      unitRef="usd">491400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzE0LTQtMS0xLTA_ff9cace7-481e-4ef4-8420-bd22eb9f889b"
      unitRef="usd">-108600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZToyZDY0ZWQzYzEyMzU0NTE1ODNjMTdlMGQ5MTEyOGYyOS90YWJsZXJhbmdlOjJkNjRlZDNjMTIzNTQ1MTU4M2MxN2UwZDkxMTI4ZjI5XzE0LTYtMS0xLTA_8c5f2516-f455-4b98-9767-b10f8e449e63"
      unitRef="usd">-54100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjM1_0ec1f08c-95c3-4366-ad82-634ba8e07790">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision (benefit) differed from the tax provision (benefit) computed at the U.S. federal statutory rate due to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.187%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax (benefit) provision at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) in tax resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on sale of Cynosure&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. tax on foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax reform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized tax benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in deferred tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzItMi0xLTEtMA_9cfe048b-cfd0-42bc-b74b-abe3ab6c1711"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzItNC0xLTEtMA_d3b94e36-c330-46e6-bb49-cc5382e3920a"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzItNi0xLTEtMA_01c3b6a9-a40c-4e59-b152-ad238bdbb0c5"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzQtMi0xLTEtMA_8ae9969f-6e1c-476b-ba97-967fd0cbc944"
      unitRef="number">0</holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure>
    <holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzQtNC0xLTEtMA_4c26ab97-7ae9-4a2f-aff2-a9f5dac2725c"
      unitRef="number">0.313</holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure>
    <holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzQtNi0xLTEtMA_e1c2d75d-e624-4581-9ba6-7108f6c6e917"
      unitRef="number">0</holx:EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzYtMi0xLTEtMA_c81bde5d-91d7-41c9-8171-d64c8c4a3bd7"
      unitRef="number">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzYtNC0xLTEtMA_2562d57f-5e0d-4727-97f1-dbd0993a0994"
      unitRef="number">0.029</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzYtNi0xLTEtMA_9bed425b-8e1f-406d-b4a7-02355838ca48"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzctMi0xLTEtMA_55205175-3e3d-4b3c-a7be-f53deb984bf8"
      unitRef="number">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzctNC0xLTEtMA_007f6fec-09c3-4172-b9da-82e7ab4ee5a5"
      unitRef="number">0.026</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzctNi0xLTEtMA_341c26f9-5404-4aea-8619-e9e42a37a008"
      unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzgtMi0xLTEtMA_8bc9b8c0-a1cb-4cf5-8878-5fd61be21415"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzgtNC0xLTEtMA_ed4d7aa5-4784-44ca-b31a-9619550dc9c8"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzgtNi0xLTEtMA_19d42acb-8cc1-4e64-9f6b-04ded9052b75"
      unitRef="number">-0.038</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges>
    <holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEwLTItMS0xLTA_617026df-8509-40e7-9acb-5c500f6b4219"
      unitRef="number">0.003</holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment>
    <holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEwLTQtMS0xLTA_f98c09af-7bb3-448b-ad98-c1e210bf50c2"
      unitRef="number">0.006</holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment>
    <holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEwLTYtMS0xLTA_2f330a65-7cd7-4300-99f3-58d875bb72af"
      unitRef="number">0.033</holx:EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzExLTItMS0xLTA_ebbc71d3-b415-451e-8516-f7749356b98c"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzExLTQtMS0xLTA_2984d48e-9db4-48d6-ab80-29934af5e58f"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzExLTYtMS0xLTA_ac46de73-b017-4f4c-9163-33fa2b203662"
      unitRef="number">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent>
    <holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEyLTItMS0xLTA_7553e1cd-cb3a-4907-b5a5-abe5da8a8740"
      unitRef="number">0.003</holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits>
    <holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEyLTQtMS0xLTA_94936997-bf61-48c5-8a8d-67c013759ae4"
      unitRef="number">0</holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits>
    <holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzEyLTYtMS0xLTA_5e0bb12d-9b53-464e-90a9-96ec8bd2f2ae"
      unitRef="number">-0.001</holx:EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits>
    <holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE2LTItMS0xLTA_0b778144-19ca-442f-b4e1-bb1c07275d2c"
      unitRef="number">0.001</holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost>
    <holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE2LTQtMS0xLTA_77e5abee-569a-4482-93eb-b2159f8c2958"
      unitRef="number">0.004</holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost>
    <holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE2LTYtMS0xLTA_4286b71c-b590-44eb-b546-cfac010da997"
      unitRef="number">0.008</holx:EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE3LTItMS0xLTA_266c59e3-bf05-49dd-9a35-74426b5cfa30"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE3LTQtMS0xLTA_90ea7a49-d4b0-44c7-9a00-aab3a9056fcf"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE3LTYtMS0xLTA_c82b1466-6bb5-4471-9482-737598104c8f"
      unitRef="number">0.054</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE4LTItMS0xLTA_5c96eb39-3045-4b8b-a996-d368283a4d7f"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE4LTQtMS0xLTA_9c5cee70-c251-4530-a5b7-590ea84bafe9"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE4LTYtMS0xLTA_51d7ce21-8b94-41c5-9c54-02950054fa63"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE5LTItMS0xLTA_fae5becf-f59b-469f-8d07-bb575d474302"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE5LTQtMS0xLTA_47548e18-f247-4894-ac6e-c06a95424758"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzE5LTYtMS0xLTA_0ea80172-0d69-4377-86b7-32d521406ba9"
      unitRef="number">0.095</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIwLTItMS0xLTA_89833d03-cf3b-4be0-9ddb-975f57ccbc95"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIwLTQtMS0xLTA_88cdb266-04d1-44a6-8665-db059a9e1f05"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIwLTYtMS0xLTA_07ac7444-d49c-442c-a400-564c8746dbf4"
      unitRef="number">0.031</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIxLTItMS0xLTA_f344223e-2bd7-495c-bda8-cae7cf638287"
      unitRef="number">0.208</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIxLTQtMS0xLTA_fcf02160-4779-4465-a6ae-8ed70a8ae776"
      unitRef="number">-0.108</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTphZjFkOGUyM2ExY2E0NzhjYmM3YTkzODRmYWY1OGEzNy90YWJsZXJhbmdlOmFmMWQ4ZTIzYTFjYTQ3OGNiYzdhOTM4NGZhZjU4YTM3XzIxLTYtMS0xLTA_d1d97465-e002-4641-8b1b-2342c6648f01"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQyOQ_c8262198-83ba-4541-bfb8-3c3b1154e044"
      unitRef="usd">313400000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjI5_f55360b1-9779-41c5-bc11-fea07f5be186">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s significant deferred tax assets and liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonqualified deferred compensation plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&#160;and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(389.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(333.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(349.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzItMi0xLTEtMA_55dd4ba8-7d96-4b44-a53a-347b7acea166"
      unitRef="usd">91500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzItNC0xLTEtMA_46442185-d89b-490a-85f3-65d94d93ab02"
      unitRef="usd">81100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzMtMi0xLTEtMA_2ecaa506-0997-4e7e-88f0-a85dd648c170"
      unitRef="usd">52000000.0</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzMtNC0xLTEtMA_f10a1990-75e3-4c9c-aeeb-355bee7985fa"
      unitRef="usd">57000000.0</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzQtMi0xLTEtMA_0bad2b98-0046-4e24-afc4-cb06c94e767b"
      unitRef="usd">34900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzQtNC0xLTEtMA_7e2a4bf2-cb12-46dd-8616-999f03a718f7"
      unitRef="usd">24900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzUtMi0xLTEtMA_f9f43a34-1ed4-4b4d-9f95-3cc1e6ad01b1"
      unitRef="usd">41800000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzUtNC0xLTEtMA_0d8204f9-d588-4800-a383-57026e19d749"
      unitRef="usd">33200000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzctMi0xLTEtMA_a4fa6c7d-4d69-459f-b9b0-53dacc380a55"
      unitRef="usd">17600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzctNC0xLTEtMA_7178020d-6941-47c8-9239-971e6b564b59"
      unitRef="usd">18600000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzgtMi0xLTEtMA_82e5a3ec-d721-4733-a53c-89078d0b5e2a"
      unitRef="usd">10000000.0</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzgtNC0xLTEtMA_3009aeef-d55c-4899-9fe2-5e5abca02a09"
      unitRef="usd">10200000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzktMi0xLTEtMA_762bbb5e-3f4e-425c-ad10-36e5af32f182"
      unitRef="usd">16800000</holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan>
    <holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzktNC0xLTEtMA_b316ade1-6dfa-4e0d-9f72-3cd5a7f7bb28"
      unitRef="usd">14400000</holx:DeferredTaxAssetsNonqualifiedDeferredCompensationPlan>
    <holx:DeferredTaxAssetsLeaseLiability
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEwLTItMS0xLTA_bfe63fe2-57e3-49a2-b524-872e90456a8a"
      unitRef="usd">16200000</holx:DeferredTaxAssetsLeaseLiability>
    <holx:DeferredTaxAssetsLeaseLiability
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEwLTQtMS0xLTA_82518167-c2fc-4335-9587-bc394b7a5743"
      unitRef="usd">17300000</holx:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEyLTItMS0xLTA_172fe48d-dcf7-4795-89fb-b4c09e3f31f0"
      unitRef="usd">17400000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEyLTQtMS0xLTA_678b95db-8380-42a7-8b78-5e759667e9a9"
      unitRef="usd">25200000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEzLTItMS0xLTA_6cebe2ac-509a-4445-a7ca-ef4a37f3b4a3"
      unitRef="usd">298200000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzEzLTQtMS0xLTA_01002817-fbb6-4d1a-90d2-0eb34c888926"
      unitRef="usd">281900000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE0LTItMS0xLTA_4c640641-f843-4ed2-b3b5-7bf42c26235d"
      unitRef="usd">121300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE0LTQtMS0xLTA_446acb02-3318-4983-8ad3-f42896f16069"
      unitRef="usd">118500000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE1LTItMS0xLTA_a0a0b82f-ea7c-4d79-a1a5-fa5fc140119b"
      unitRef="usd">176900000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE1LTQtMS0xLTA_6a8a6258-9690-4c96-8209-6c1d3450ea2e"
      unitRef="usd">163400000</us-gaap:DeferredTaxAssetsNet>
    <holx:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE3LTItMS0xLTA_5b49f69c-f8b7-48b1-b623-f142e537365c"
      unitRef="usd">389700000</holx:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <holx:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE3LTQtMS0xLTA_7f3442db-a792-4de7-9abc-501c54c4a4f4"
      unitRef="usd">333900000</holx:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <holx:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE4LTItMS0xLTA_7b3f0932-33e2-4764-b0d3-a33e285b6dda"
      unitRef="usd">15800000</holx:DeferredTaxLiabilitiesRightOfUseAsset>
    <holx:DeferredTaxLiabilitiesRightOfUseAsset
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzE4LTQtMS0xLTA_edf0637b-6e28-476d-a621-f13df294d1a2"
      unitRef="usd">15800000</holx:DeferredTaxLiabilitiesRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzIyLTItMS0xLTA_68c0e18e-d980-4c7e-8dec-a27bc9f50861"
      unitRef="usd">405500000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzIyLTQtMS0xLTA_e6054977-a274-4edf-813d-e97996c17149"
      unitRef="usd">349700000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzIzLTItMS0xLTA_6ec7e064-9b5a-4ac3-992b-e668a3f4f53f"
      unitRef="usd">228600000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpmMTI2OTMyZjAyYmI0NDAxODQ2YTdlYTNjY2QxYzFjZi90YWJsZXJhbmdlOmYxMjY5MzJmMDJiYjQ0MDE4NDZhN2VhM2NjZDFjMWNmXzIzLTQtMS0xLTA_3aa9fc7f-6d17-4cf0-a6af-d4f33b690c18"
      unitRef="usd">186300000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQzODE_ec89ae20-c4b7-4c3c-b78c-aaaf4b638dca"
      unitRef="usd">2800000</us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i20b6f0eac2434262a3cac9fb4d6a84a8_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ2NTI_c1696799-229f-4997-ac1a-c762cacce1d6"
      unitRef="usd">89100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i6d960bac02334aadb2300cb9a53f0809_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ2NTY_4fde53f9-5d6a-49af-92ee-31c472e3b114"
      unitRef="usd">135000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i276f90f490c64954a3fcb6fce34ac50d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ2NjQ_d8b8b3d5-df58-4df5-be86-4ee6765f18ec"
      unitRef="usd">263200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i20b6f0eac2434262a3cac9fb4d6a84a8_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ3NDA_468aeeee-f5b2-4cf0-bd5c-a2cc833cddff"
      unitRef="usd">4300000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i6d960bac02334aadb2300cb9a53f0809_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ3NDQ_8b908d43-4ae7-4191-a567-7c93ab8a208c"
      unitRef="usd">6000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i276f90f490c64954a3fcb6fce34ac50d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ3NTI_500ef7eb-bcfd-4a36-819a-4faeb655042c"
      unitRef="usd">500000</us-gaap:TaxCreditCarryforwardAmount>
    <holx:GrossStateLossCarryforwards
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzIxOTkwMjMyNzk2NTc_03d5e1a3-c52a-4df8-8d6c-4c69120d9b8d"
      unitRef="usd">26200000</holx:GrossStateLossCarryforwards>
    <holx:GrossForeignLossCarryforwards
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ4MjY_ff734010-d41d-4b48-8ee3-bd61918349c2"
      unitRef="usd">33000000</holx:GrossForeignLossCarryforwards>
    <holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod
      contextRef="ib5ffdf58eb9f4baeb95351040e234393_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzQ5OTY_c0e4fbd7-fbc0-45d4-95d5-e629970230a4"
      unitRef="usd">235400000</holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod>
    <holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod
      contextRef="i5daaef3be8904e43aea1b5d817ea7ea9_D20200927-20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUwMTE_8e0d5058-9a1b-4a3c-bcd1-849c7637f15d"
      unitRef="usd">2300000</holx:NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUwMzA_e055a4ab-96af-4ca4-83b5-1e89564fb26a"
      unitRef="usd">33000000</us-gaap:OperatingLossCarryforwards>
    <holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUxNjY_d67a96c5-0819-4ca5-af6c-f9bedfc1db2d"
      unitRef="usd">1700000</holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal>
    <holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUxNzA_9e47e13d-5c02-415c-bede-c84d818ce03a"
      unitRef="usd">48000000</holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState>
    <holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUxNzg_08559968-a73c-45f4-ae24-e16f7442381a"
      unitRef="usd">900000</holx:DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign>
    <holx:StateLossCarryforwardExpectedToUnutilize
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzUyNDU_07cf51a0-5c4a-47b5-a4ab-83999abb243b"
      unitRef="usd">26200000</holx:StateLossCarryforwardExpectedToUnutilize>
    <holx:GrossUnrecognizedTaxBenefits
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzU4OTA_ff399505-6ffb-40de-8de3-f7e287254add"
      unitRef="usd">212800000</holx:GrossUnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzU5NTc_bb44fdb1-c8eb-496d-942b-2a0b4480c5b4"
      unitRef="usd">197000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <holx:GrossUnrecognizedTaxBenefits
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzYwNDk_b89141c2-4d68-4e4b-8d21-924b5ff0756e"
      unitRef="usd">197100000</holx:GrossUnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzYxMTY_74b6ae57-6fbd-4540-b6ed-0fafa081459f"
      unitRef="usd">184900000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzYxOTI_524cd502-e96f-4a83-9f72-620fc7fff09f"
      unitRef="usd">15700000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="icd8d2cba4a8d4ac4869ea733f58a335d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzY2OTY_c5c5c52a-bf62-4ece-9f77-6794745bb44b"
      unitRef="usd">13000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMjUx_82e8d8dd-140e-4543-a07a-8d496018885e">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unrecognized income tax benefits activity for fiscal 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax positions related to current year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax positions related to prior years:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions related to change in estimate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lapses in statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired tax positions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions related to reserves acquired from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of the end of the fiscal year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzEtMi0xLTEtMA_eaef8ee2-bce3-482c-b8c8-5a4d5c7b5e1e"
      unitRef="usd">197100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzEtNC0xLTEtMA_c622ef86-34c0-4b57-b5dd-6d90acd11ed0"
      unitRef="usd">101600000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzMtMi0xLTEtMA_b2882df4-73ce-4997-a32c-7d45a1e103af"
      unitRef="usd">8000000.0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzMtNC0xLTEtMA_1176f465-4c80-43c2-b124-d6c80d85ca6f"
      unitRef="usd">109600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzQtMi0xLTEtMA_e4322423-707a-49ba-bd87-f9de42bb7264"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzQtNC0xLTEtMA_6102d949-539c-4c76-8f5c-cc929a522539"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzYtMi0xLTEtMA_e6ce6fef-a853-402d-96a0-4bcc6e5042dd"
      unitRef="usd">7900000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzYtNC0xLTEtMA_f02dbf71-939c-4b6c-bea5-151500ca1227"
      unitRef="usd">1500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzctMi0xLTEtMA_c0de23d9-be72-4cb2-b7bd-6557a681d57b"
      unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzctNC0xLTEtMA_a6213207-f680-4637-ac8f-6bf3b4d7c492"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzgtMi0xLTEtMA_3f9317c7-8994-4bb6-8190-d30fdd8cf3a6"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzgtNC0xLTEtMA_ab1c53e1-4a2e-498d-a919-ec53d55af689"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzktMi0xLTEtMA_49149c13-ee10-48cb-abee-66b2d4d6ba52"
      unitRef="usd">1700000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzktNC0xLTEtMA_41840e03-44a3-4030-bb2d-f8fc0d04d906"
      unitRef="usd">15600000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzExLTItMS0xLTA_0b3c73fe-b861-4bd9-8dd9-4b3d482d7b4c"
      unitRef="usd">1800000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzExLTQtMS0xLTA_647faab3-fa17-42e1-a2b7-92c9404a7ef6"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzEyLTItMS0xLTA_0b3992af-1def-431c-8935-ad11cb35e2f0"
      unitRef="usd">212800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90YWJsZTpjZTczNjQ0NmZkMmQ0NTE4OTIzZmMyNjQ0ZmEwZDA2Zi90YWJsZXJhbmdlOmNlNzM2NDQ2ZmQyZDQ1MTg5MjNmYzI2NDRmYTBkMDZmXzEyLTQtMS0xLTA_fe74f159-73a1-4cef-9878-c06fa684b08c"
      unitRef="usd">197100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzcwNjg_640050ad-0cb8-4435-bd0d-6af2815480ab"
      unitRef="usd">13700000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzcwNzU_adaf8645-46ff-4b17-beed-953b6438e755"
      unitRef="usd">11900000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <holx:IncomeTaxReceivableReclassification
      contextRef="i1d836e99e1744b98a12d054959a730e7_D20210627-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzEwOTk1MTE2NTgyOTc_9fb94a70-9050-43ef-a245-edbc44559611"
      unitRef="usd">-310000000</holx:IncomeTaxReceivableReclassification>
    <holx:IncomeTaxReceivableReclassification
      contextRef="i5aa941ab35ec45b98ce91c612351ba23_D20210627-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzIxOTkwMjMyNzk2NzM_65cfe4c5-deba-4606-907f-450751890087"
      unitRef="usd">404900000</holx:IncomeTaxReceivableReclassification>
    <holx:IncreasetoincometaxexpenseadoptionofASU201616
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0Xzk3ODM_3f4d960a-2363-4d2a-97a1-a3606e2b2f88"
      unitRef="usd">27800000</holx:IncreasetoincometaxexpenseadoptionofASU201616>
    <holx:DecreaseindeferredtaxliabilitiesduetoASC201616
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0Xzk4NjI_2f2931a4-7a6b-4c15-a81c-5d907caf8887"
      unitRef="usd">37700000</holx:DecreaseindeferredtaxliabilitiesduetoASC201616>
    <holx:IncreasetoNetIncomeresultedfromadoptionofASU201616
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzEwMDE0_8c654706-737a-4b9e-a3cf-8b6eadd34172"
      unitRef="usd">9900000</holx:IncreasetoNetIncomeresultedfromadoptionofASU201616>
    <holx:IncreasetoEarningsperShareresultedfromadoptionofASC201616
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzEwMDIx_d3a04e10-5525-40b0-a2f8-d5c6e1c1eb2e"
      unitRef="usdPerShare">0.04</holx:IncreasetoEarningsperShareresultedfromadoptionofASC201616>
    <holx:NonIncomeTaxLoss
      contextRef="iaffd59eb8187474fb5a4d8af030af483_D20181230-20190330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNTcvZnJhZzowZDk1ODg3MmI1ODY0NzE0OTFjMDM3MjJjOTNhOTVhNC90ZXh0cmVnaW9uOjBkOTU4ODcyYjU4NjQ3MTQ5MWMwMzcyMmM5M2E5NWE0XzExMTQ0_1a08af37-f8aa-483f-8d26-f5ce56c8423d"
      unitRef="usd">-11200000</holx:NonIncomeTaxLoss>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDQ5_80814899-478d-4820-a7ae-d2d61809f49e">Stockholders' Equity and Stock-Based Compensation&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 13, 2018, the Board of Directors authorized the repurchase of up to $500.0 million of the Company's outstanding common stock. This share repurchase plan was effective August 1, 2018 and expired March 27, 2020. Under this authorization, during fiscal 2019, the Company repurchased 4.8 million shares of its common stock for total consideration of $200.1 million. During the first and second quarters of fiscal 2020, the Company repurchased 3.9&#160;million shares of its common stock for a total consideration of $210.9&#160;million. As of March 28, 2020, the Company had completed this authorization. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 11, 2019, the Board of Directors authorized a new share repurchase plan to repurchase up to $500.0&#160;million of the Company's outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020 the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020. Under this revised authorization during fiscal 2020, the Company repurchased 5.1&#160;million shares of its common stock for a total consideration of $237.7&#160;million. During the first quarter of fiscal 2021, the Company repurchased 1.5&#160;million shares of its common stock under this plan for a total consideration of $101.3&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 9, 2020, the Board of Directors authorized a new five-year share repurchase plan to repurchase up to $1.0&#160;billion of the Company's outstanding common stock. The prior plan was terminated in connection with this new authorization. Under the new authorization, during fiscal 2021, the Company repurchased 4.6&#160;million shares of its common stock for a total consideration of $308.5&#160;million. As of September 25, 2021 $691.6&#160;million remained available under this authorization. Subsequent to September 25, 2021, the Company repurchased 2.3&#160;million shares of its common stock for $167.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 19, 2019, the Board of Directors authorized the Company to repurchase up to $205 million of its outstanding shares pursuant to an accelerated share repurchase ("ASR") agreement. On November 22, 2019, the Company executed the ASR agreement with Goldman Sachs &amp;amp; Co. ("Goldman Sachs") pursuant to which the Company repurchased $205&#160;million of the Company's common stock. The initial delivery of approximately 80% of the shares under the ASR was 3.3&#160;million shares for which the Company initially allocated $164.0&#160;million of the $205&#160;million paid to Goldman Sachs during the first quarter of fiscal 2020. The Company evaluated the nature of the forward contract aspect of the ASR under ASC 815 and concluded equity classification was appropriate. Final settlement of the transaction under the ASR occurred in the second quarter of fiscal 2020. At settlement, Goldman Sachs delivered an additional 0.6&#160;million shares of the Company's common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Compensation Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has one share-based compensation plan pursuant to which awards are currently being issued&#x2014;the 2008 amended and restated Equity Incentive Plan (&#x201c;2008 Equity Plan&#x201d;). The purpose of the 2008 Equity Plan is to provide stock options, restricted stock units and other equity interests in the Company to employees, officers, directors, consultants and advisors of the Company and any other person who is determined by the Board of Directors to have made (or is expected to make) contributions to the Company. The 2008 Equity Plan is administered by the Board of Directors of the Company, and a total of 31.5 million shares were reserved for issuance under this plan. As of September&#160;25, 2021, the Company had 4.6 million shares available for future grant under the 2008 Equity Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Operations in fiscal 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Grant-Date Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The Company considers a number of factors to determine the fair value of options including the assistance of an outside valuation adviser. Information pertaining to stock options granted during fiscal 2021, 2020 and 2019 and related assumptions are noted in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. In projecting expected stock price volatility, the Company uses a combination of historical stock price volatility and implied volatility from observable market prices of similar equity instruments. The Company estimated the expected life of stock options based on historical experience using employee exercise and option expiration data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-Based Compensation Expense Attribution&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the straight-line attribution method to recognize stock-based compensation expense for stock options and restricted stock units ("RSUs"). The vesting term of stock options is generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ3MTk_de8b43b0-f008-41d7-b826-9f3a463875ab"&gt;four&lt;/span&gt; years with annual vesting of 25%&#160;per year on the anniversary of the grant date, and RSUs generally vest over three years with annual vesting at 33% per year on the anniversary of the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company's accounting policy is to estimate forfeitures at the time awards are granted and revise, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based on an analysis of historical forfeitures, the Company has determined a specific forfeiture rate for certain employee groups and has applied forfeiture rates ranging from 0% to 6.0% as of September&#160;25, 2021 depending on the specific employee group. This analysis is re-evaluated annually and the forfeiture rate adjusted as necessary. Ultimately, the actual stock-based compensation expense recognized will only be for those stock options and RSUs that vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense related to stock options was $13.0 million, $15.5 million, and $14.1 million in fiscal 2021, 2020 and 2019, respectively. Stock compensation expense related to stock units, including RSUs, performance stock units ("PSUs"), free cash flow performance stock units ("FCFs") and market stock units ("MSUs") was $46.1 million, $63.3 million, and $43.7 million in fiscal 2021, 2020 and 2019, respectively. The related tax benefit recorded in the Consolidated Statements of Operations was $7.9 million, $9.5 million and $8.9 million in fiscal 2021, 2020 and 2019, respectively. At September&#160;25, 2021, there was $15.8 million and $50.3 million of unrecognized compensation expense related to stock options and RSUs, respectively, to be recognized over a weighted average period of 2.3 years and 1.8 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Based Payment Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all stock option activity under the Company&#x2019;s stock option plans for the year ended September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/ forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest at September 25, 2021 (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;This represents the number of vested stock options as of September&#160;25, 2021 plus the unvested outstanding options at September&#160;25, 2021 expected to vest in the future, adjusted for estimated forfeitures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2020 and 2019, the total intrinsic value of options exercised (i.e., the difference between the market price on the date of exercise and the price paid by the employee to exercise the options) was $44.8 million and $26.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s RSU, PSU, FCF and MSU activity during the year ended September&#160;25, 2021 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-vested Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-Date&#160;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of RSUs vested includes shares withheld on behalf of employees to satisfy minimum statutory tax withholding requirements. The Company pays the minimum statutory tax withholding requirement on behalf of its employees. During fiscal 2021, 2020 and 2019 the total fair value of RSUs vested was $73.1 million, $34.9 million and $34.6 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted 0.5&#160;million, 0.6&#160;million and 0.9&#160;million RSUs during fiscal 2021, 2020 and 2019, respectively. In addition, included in the above chart, the Company also granted 0.1 million, 0.1 million and 0.1 million PSUs during fiscal 2021, 2020, and 2019 respectively, to members of the Company's senior management team, which includes additional shares issued upon achieving metrics within the performance criteria. The PSUs were valued at $68.51, $45.38 and $40.97 per share based on the ending stock price on the date of grant in fiscal 2021, 2020 and 2019, respectively. Each recipient of the PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;year performance period provided the Company&#x2019;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1&#160;million and 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team in fiscal 2021 and 2020, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million, 0.1 million and 0.1 million MSUs during fiscal 2021, 2020 and 2019, respectively, to its senior management team. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $82.31, $43.54 and $55.13 per share using the Monte Carlo simulation model in fiscal 2021, 2020 and 2019, respectively. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:14pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Hologic, Inc. 2012 Employee Stock Purchase Plan (&#x201c;2012 ESPP&#x201d;) provides for the granting of up to 2.5 million shares of the Company&#x2019;s common stock to eligible employees. The 2012 ESPP plan period is semi-annual and allows participants to purchase the Company&#x2019;s common stock at 85% of the lower of (i)&#160;the market value per share of the common stock on the first day of the offering period or (ii)&#160;the market value per share of the common stock on the purchase date. Stock-based compensation expense in fiscal 2021, 2020 and 2019 was $5.9 million, $4.5 million and $4.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i814cfc79d9f948ac96c6d5e239cf1326_I20160613"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ2OQ_cf7d92e2-631a-4d37-8a82-2a98361e0f6e"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzgyMQ_8f26dc1a-00e7-475c-90cb-feba5964f2ce"
      unitRef="shares">4800000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzg3OA_d9d157c5-459c-4333-8356-9f414249e615"
      unitRef="usd">200100000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i88b3d268274c46d98f224f8c6c9816fb_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk1OQ_cabb6d6c-d41c-4d92-a2fb-dcd7b98043a1"
      unitRef="shares">3900000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i88b3d268274c46d98f224f8c6c9816fb_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwMTg_6c661c49-256e-4719-afad-36d510ae0500"
      unitRef="usd">210900000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i12da8222241d4afe9a4fd7ee1a5a6030_I20191211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzExOTU_4c31320b-baa2-45ce-b423-bd9cd2dc38c3"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i945e50292f26455c9fb03af3ee5dc38d_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzE1MzQ_252e6d76-0ac4-4409-885b-2e726f36e004"
      unitRef="shares">5100000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i945e50292f26455c9fb03af3ee5dc38d_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzE1OTM_ca275826-e85d-4614-a71a-e081c9f988e9"
      unitRef="usd">237700000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="icc5c3fa0816048caa2da1ed91c216daf_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU4MDk_015ff84c-2ded-4192-adb1-e4fb89b7741f"
      unitRef="shares">1500000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="icc5c3fa0816048caa2da1ed91c216daf_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU5MTc_ecc15c4b-752f-4bd8-bfe6-6c6ce133182f"
      unitRef="usd">101300000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ie11a3dc3cc614addb28fd00bd0cf9a2c_I20201209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU4MzQ_316f7b6e-7bc9-4083-8142-95739009427e"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id1a4a87513914de081e110fe2f694f1d_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU4NjE_14de8eaa-780f-4ea2-905b-91091c6ef145"
      unitRef="shares">4600000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="id1a4a87513914de081e110fe2f694f1d_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDU4ODY_14971440-4dbb-4fdc-9a67-34b4122afb89"
      unitRef="usd">308500000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i3e1998ffb6bc4561a84610ab181828cb_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzE2MjM_d6d8d838-bf23-4af6-a7ce-5b38b1160be3"
      unitRef="usd">691600000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i747e381970ad4c3992a6131bcbfc5461_D20210926-20211116"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDE1NTg_d0dcaccf-0dd8-41c4-964f-da6786c702ed"
      unitRef="shares">2300000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i747e381970ad4c3992a6131bcbfc5461_D20210926-20211116"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDE1NDE_6f8a17a3-13ad-455f-8f76-5160ef248750"
      unitRef="usd">167000000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <holx:ASRAuthorized
      contextRef="i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzE4NzA_e51579b9-2e00-45ad-9045-ec601202a9f4"
      unitRef="usd">205</holx:ASRAuthorized>
    <holx:ASRAuthorized
      contextRef="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzIxMDc_85f1bc97-a1a1-461e-b514-daf0aca0c03e"
      unitRef="usd">205000000</holx:ASRAuthorized>
    <holx:AmountpaidduringtheperiodunderASRAgreement
      contextRef="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzIyNjc_544609b5-1cb7-40ac-aef1-d247dd599207"
      unitRef="usd">164000000</holx:AmountpaidduringtheperiodunderASRAgreement>
    <holx:ASRAuthorized
      contextRef="i01010a287c834b8ea30218f9d1acc450_D20201227-20210327"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzIyNzc_99c1ba6f-1120-4e7e-9fa5-12479d6cc670"
      unitRef="usd">205000000</holx:ASRAuthorized>
    <holx:ASRSharesRepurchasedduringtheperiod
      contextRef="i57712fb9ed674d6ebb6261cb65be3db3_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzI2MzU_4b5b492c-7729-4237-97f9-855b10f09c9d"
      unitRef="usd">600000</holx:ASRSharesRepurchasedduringtheperiod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i748a99e2a6c74677886bd3b4e6b89ac2_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzMzMzU_f2ee3f75-9ec4-4602-aac5-5c6130489912"
      unitRef="shares">31500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i748a99e2a6c74677886bd3b4e6b89ac2_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzM0MTU_1a24fc44-a2aa-44e4-bca0-ad3751cdcd6e"
      unitRef="shares">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDMy_06b460e8-5fe1-4394-839a-cbda47c65d29">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Operations in fiscal 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i623fe63350cc4f4bbf60f09a3b45072a_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzEtMi0xLTEtMA_a7a8c700-c2fd-49e6-a204-fbacb05d3d9c"
      unitRef="usd">8000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0202135faa1f4b469d6ecb622791638d_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzEtNC0xLTEtMA_6811c0b3-2479-405a-a8b4-91338d2cd477"
      unitRef="usd">6700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i452f1577e5c942c4a2cebac00daff1d2_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzEtNi0xLTEtMA_231a9eee-b7c7-4d66-885c-c47e7f6812eb"
      unitRef="usd">7100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ieb317bb99ad84ae3a58c21783556ecaa_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzItMi0xLTEtMA_b5a2edf3-d044-4a40-9e09-37c521fec701"
      unitRef="usd">7700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia34f9b5ebf6940d8862b1e4e259514e0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzItNC0xLTEtMA_b5e96a4a-0f96-4aba-9e8b-227e27dc37bc"
      unitRef="usd">8000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iacda269ea4f047c08ae1a3627ce6fcf9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzItNi0xLTEtMA_18aaa823-dabb-4c12-a981-b7ba8d7147ae"
      unitRef="usd">9200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9db32da71cc1455088030b8c7b621bf0_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzMtMi0xLTEtMA_c6d55023-7962-4ed2-bc29-d664da935362"
      unitRef="usd">9500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic05d68681e5c4f9eacb730bfede1f07c_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzMtNC0xLTEtMA_0e02a790-807e-4963-9302-b3c0dc8a8a63"
      unitRef="usd">10200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8b47832b29e04b3bb2ed3c90cfc6f1fa_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzMtNi0xLTEtMA_135d8d6f-3598-4d47-948d-5bf69bf29929"
      unitRef="usd">10200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i920ca50d08084b8b97e8598c37fc6711_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzQtMi0xLTEtMA_bde80b37-3379-4c08-96ab-9b24e00e4db9"
      unitRef="usd">38900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i199364dd0aa84ab9b4bd4fb3a7b46bee_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzQtNC0xLTEtMA_844c7cd0-59d2-4765-9859-f43cccc0a007"
      unitRef="usd">50900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i935c7d53d46d4c65944f086fdbf09aec_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzQtNi0xLTEtMA_2a2e705e-359f-45de-867f-2cb65b771dae"
      unitRef="usd">35500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6c14b446dbbc4ed1ba4f1d985a7197ec_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzUtMi0xLTEtMA_83a907b6-7703-4ac9-a34f-f7b22ecf0070"
      unitRef="usd">900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i88b1b0c9c5604d23ab52ca8f9713a3d9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzUtNC0xLTEtMA_d275b359-456d-4953-9e30-f7466ce0adde"
      unitRef="usd">7500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib9133708dc8a4713aad750ae0f4663a0_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzUtNi0xLTEtMA_92044db1-866a-4031-b566-aedd8249347c"
      unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzYtMi0xLTEtMA_6361ef5d-4c44-48de-87cb-64ecc94add8a"
      unitRef="usd">65000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzYtNC0xLTEtMA_78b6049a-76a0-4eb3-91b2-babe758842b0"
      unitRef="usd">83300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo1NWJiZjkzNTQ4MDE0YjE5OGY3ZjI4ZjBiZDYyODFmOS90YWJsZXJhbmdlOjU1YmJmOTM1NDgwMTRiMTk4ZjdmMjhmMGJkNjI4MWY5XzYtNi0xLTEtMA_4e5190ae-f2d5-48eb-a338-ebcdd2117a8a"
      unitRef="usd">62000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDYx_ebfd0d7d-6c0e-4f47-b928-f8f2d493cc52">Information pertaining to stock options granted during fiscal 2021, 2020 and 2019 and related assumptions are noted in the following table:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzItMi0xLTEtMA_82fdd974-56fe-4838-a5de-71a83ded69e9"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzItNC0xLTEtMA_455a1ece-9880-4716-a77a-4638644ace36"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzItNi0xLTEtMA_f982dc03-c868-43ed-bdd7-12176c915ec1"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzMtMi0xLTEtMA_8cc51df3-275d-4ee6-905a-0e560b6ff2b6"
      unitRef="usdPerShare">68.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzMtNC0xLTEtMA_88490bd2-b92d-451a-bfdf-3d935d205187"
      unitRef="usdPerShare">45.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzMtNi0xLTEtMA_96b0a20c-cf0b-4ce3-b1f7-0b60bc9fcd1b"
      unitRef="usdPerShare">41.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzQtMi0xLTEtMA_d398f05e-1905-43fd-b074-bf6bd16f3045"
      unitRef="usdPerShare">19.86</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzQtNC0xLTEtMA_2cb91cdc-a14e-4d0a-b212-e868ad75d58d"
      unitRef="usdPerShare">13.92</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzQtNi0xLTEtMA_6f44bcf1-3c69-42ec-abf7-28b3d90bbee4"
      unitRef="usdPerShare">13.54</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzYtMi0xLTEtMA_a3b23426-256a-4c8a-a247-5e91456fda52"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzYtNC0xLTEtMA_7c992f57-bd30-4697-be70-fd1d72f1e7c5"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzYtNi0xLTEtMA_fad8c232-e73a-4b06-932f-2733edd6dbce"
      unitRef="number">0.030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzctMi0xLTEtMA_20edfa73-7670-49c2-ad70-effa7e21431f">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzctNC0xLTEtMA_0f500521-0aa6-494c-be27-6a9573b86d59">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzctNi0xLTEtMA_eee708ec-5b4f-4f1e-83b0-21b15f1488d1">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzgtMi0xLTEtMA_32941b36-bc90-4648-9448-a86d1afd68fe"
      unitRef="number">0.350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzgtNC0xLTEtMA_b0c7d497-ce8b-447b-a76b-7cb99ed62f68"
      unitRef="number">0.336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzgtNi0xLTEtMA_cb20992c-a125-4336-a468-8482cb4a9e59"
      unitRef="number">0.343</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzktMi0xLTEtMA_a1c8c88c-a87f-4d69-bc7c-deec642fc824"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzktNC0xLTEtMA_7ece0542-e4ce-449c-aba6-7f353826d817"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTpkZTZjYTJhYzg0NjU0ZWYxYThhMzQ0YjI5ZGI3MjdiZS90YWJsZXJhbmdlOmRlNmNhMmFjODQ2NTRlZjFhOGEzNDRiMjlkYjcyN2JlXzktNi0xLTEtMA_ea895767-c8a0-409f-9bcc-4907c137d695"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <holx:PercentageOfVestingForStockOptionsGrantedToEmployees
      contextRef="ie9a15e5e0d5f4a248aab637516ec83a5_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ3NTc_a4760967-67f8-44e2-a507-52b68f0905f3"
      unitRef="number">0.25</holx:PercentageOfVestingForStockOptionsGrantedToEmployees>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDM5_1c1c72c0-b478-4224-9852-84fe78e8fbe5">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <holx:PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees
      contextRef="i7e32118662c4420ba5a02eec6689e797_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ4OTA_cd66b152-0590-4a0e-aa73-a816192e2bf9"
      unitRef="number">0.33</holx:PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees>
    <holx:ShareBasedCompensationPercentageOfForfeitureRate
      contextRef="i7133ee75e2dd4ac999d32c90c55818c6_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU0NzY_5104c38c-49c8-4aac-853b-b6e6abe7265d"
      unitRef="number">0</holx:ShareBasedCompensationPercentageOfForfeitureRate>
    <holx:ShareBasedCompensationPercentageOfForfeitureRate
      contextRef="ib5f33f2bd0484efea0b8ae4a94ebb11e_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU0ODI_4b64c032-2829-40a9-a81e-784f5c959d1a"
      unitRef="number">0.060</holx:ShareBasedCompensationPercentageOfForfeitureRate>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i16882582e0204737b097e2891c7c65e4_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU4MDg_6d317f73-5a4e-4c63-8c2c-f75794382cf1"
      unitRef="usd">13000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i14ca5f4e78bb437a81cded9e6c66f121_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU4MTI_3ad85379-ae3f-49f8-adb9-eabe8b3dc4ea"
      unitRef="usd">15500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie582e31fa38344bea5db72aa1a9ab369_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzU4MjA_d03bbde7-7313-4344-9b3e-7f3b0b52abfd"
      unitRef="usd">14100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYwNDc_77fbc0c9-b4c1-4194-bb83-ea4dc33670e8"
      unitRef="usd">46100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i74b0294ab860440d9476b34210f76f37_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYwNTE_2e23f669-adef-40b8-8dbd-5b5cbdec2a39"
      unitRef="usd">63300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8b62684619cf449b9f9b6a4e0bef8642_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYwNTk_c60cabf6-7e3e-49be-a7dd-d7fa5e5d1f92"
      unitRef="usd">43700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYxODM_d05ba6cd-ea96-4c93-9675-23ab8a86fca1"
      unitRef="usd">7900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYxODc_6aec81c5-103b-4f30-8051-a04f27aaafe4"
      unitRef="usd">9500000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYxOTQ_efe6f4d5-ed6f-4df1-90b3-c84fb71311fd"
      unitRef="usd">8900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ib0bd21f9a30840228f9a47abe615910a_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYyNTc_a42f4029-8a0d-4589-99a8-36921343cda6"
      unitRef="usd">15800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i05ae9481304b4cbda64fdf0b97da2601_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzYyNjQ_e5f4d5db-333a-450f-8d3c-d9987c205be8"
      unitRef="usd">50300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i16882582e0204737b097e2891c7c65e4_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzY0MDQ_be2bf0c1-b075-4a09-a121-58613f9af45e">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzY0MTc_c78bb018-8f95-49c9-8dd4-c27976e15bc8">P1Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDQz_ace668cd-6c30-4f14-902c-6abead6b7eba">&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes all stock option activity under the Company&#x2019;s stock option plans for the year ended September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.183%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&#160;Life&lt;br/&gt;(in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/ forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest at September 25, 2021 (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;This represents the number of vested stock options as of September&#160;25, 2021 plus the unvested outstanding options at September&#160;25, 2021 expected to vest in the future, adjusted for estimated forfeitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzEtMi0xLTEtMA_6f8e2bf5-93f0-41b6-9fab-56df1ea59bf9"
      unitRef="shares">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzEtNC0xLTEtMA_6e3e1dbe-4e51-4fed-8522-212b840d806f"
      unitRef="usdPerShare">40.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzEtNi0xLTEtMA_1788c9f9-d4bb-4d93-9ed0-4b020cda2331">P7Y</holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzEtOC0xLTEtMA_e4a708b6-bd54-4ace-8b1f-606d137cf581"
      unitRef="usd">109500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzItMi0xLTEtMA_c0236133-f06e-4dde-a2c0-f5e65c488e07"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzItNC0xLTEtMA_e1f21f94-ac83-4b14-b695-00b019f41066"
      unitRef="usdPerShare">68.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzMtMi0xLTEtMA_21189a35-c633-478a-84c1-a4bcafcdc1a1"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzMtNC0xLTEtMA_e3c82263-eb76-43dd-8454-4527d73fbea9"
      unitRef="usdPerShare">49.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzQtMi0xLTEtMA_c36bfd41-ef43-4c30-b0d6-9b5e651501a3"
      unitRef="shares">800000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzQtNC0xLTEtMA_5b173b66-0a7e-4a14-a032-6e5f27fffcb4"
      unitRef="usdPerShare">38.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzQtOC0xLTEtMA_ed3b8f9a-0574-4de4-9a13-58649ad253f8"
      unitRef="usd">30400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzUtMi0xLTEtMA_85cadd8d-15c7-4fd3-9f88-328ae6691fb9"
      unitRef="shares">4200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzUtNC0xLTEtMA_77f18d81-d373-4d36-9aef-1e32d39f3f09"
      unitRef="usdPerShare">44.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzUtNi0xLTEtMA_ebd89463-10e8-4271-a4ef-a53eb71b89d5">P6Y7M6D</holx:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzUtOC0xLTEtMA_08edf727-f00e-460d-919f-a97dbb08c19b"
      unitRef="usd">132700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzYtMi0xLTEtMA_8f569bdc-e2f0-42dd-ab2f-dd2e4c781bf4"
      unitRef="shares">2300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzYtNC0xLTEtMA_cc670644-e6e8-4341-a251-cd5f5193c3de"
      unitRef="usdPerShare">39.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzYtNi0xLTEtMA_f4ed0102-5824-4b1a-b10f-25df197d9839">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzYtOC0xLTEtMA_264578e7-31c2-4c5d-94ee-f6ba5d7ae6d2"
      unitRef="usd">85400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzctMi0xLTEtMA_041fe7b0-37f7-4b9e-95f3-58dbf5e07ce6"
      unitRef="shares">4100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzctNC0xLTEtMA_9895bb3f-98ff-4d72-82fd-fe8aab46d4ad"
      unitRef="usdPerShare">44.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzctNi0xLTEtMA_bf49d0e9-1c39-4ec2-b491-f0ac22f8776f">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTphNWVhOTcxMWI2ZjE0Yzg4YWFjYThlMjQyYjEzZTFjMC90YWJsZXJhbmdlOmE1ZWE5NzExYjZmMTRjODhhYWNhOGUyNDJiMTNlMWMwXzctOC0xLTEtMA_e6f8b6da-45f2-490f-850a-f3a5b7f14944"
      unitRef="usd">132200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzY5NzU_1aa5a41c-d80c-4341-9221-20eccd627387"
      unitRef="usd">44800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzY5ODI_7bc48f7b-7ecd-44a1-adf6-9db82180d35d"
      unitRef="usd">26100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDUz_cf572387-7a2f-443b-8512-fa9607012a1f">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the Company&#x2019;s RSU, PSU, FCF and MSU activity during the year ended September&#160;25, 2021 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.978%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Non-vested Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-Date&#160;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzEtMi0xLTEtMA_d9354683-cdb9-4902-93eb-6786b2d55cdf"
      unitRef="shares">2400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzEtNC0xLTEtMA_401b6ee8-770a-4893-a2e2-a2f0e0ea9bc5"
      unitRef="usdPerShare">44.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzItMi0xLTEtMA_448be3c6-850e-4d43-bd17-5a5db0c1bba4"
      unitRef="shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzItNC0xLTEtMA_1f410be1-a16b-499f-8d58-219f815fe27d"
      unitRef="usdPerShare">69.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzMtMi0xLTEtMA_06c29bcd-c6f6-4917-84ee-2a9ec5933579"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzMtNC0xLTEtMA_c0c84348-72f6-4f31-a23c-2d9a3c098674"
      unitRef="usdPerShare">43.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzQtMi0xLTEtMA_d54e63b3-0da2-46d8-a094-53aff9855eb1"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzQtNC0xLTEtMA_7f97fb3c-80c0-4521-947d-38df1f89a35f"
      unitRef="usdPerShare">52.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzUtMi0xLTEtMA_4cc5d21e-4a5e-4e97-9736-3b90a43b7d15"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo2NzVjYTRlOGRkMWI0ODYyYmIzNzNkYjJjNTZhOGRiNS90YWJsZXJhbmdlOjY3NWNhNGU4ZGQxYjQ4NjJiYjM3M2RiMmM1NmE4ZGI1XzUtNC0xLTEtMA_0db51c75-e3cd-4ecd-b48c-4ad3c8a8afa5"
      unitRef="usdPerShare">54.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i3374ec98f31147f19d4c1ac798ffdef2_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0MTI_57dc471e-d22c-4ba1-be35-7a85416cea07"
      unitRef="usd">73100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i74b0294ab860440d9476b34210f76f37_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0MTY_3de0e735-f651-40cd-a2aa-86a4c5ff263a"
      unitRef="usd">34900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i8b62684619cf449b9f9b6a4e0bef8642_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0MjM_f09825b3-840c-4017-ae8c-102f6138b39b"
      unitRef="usd">34600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia618e91ec0fc43d09d5b6352f024ece8_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0NjE_6bb97772-30aa-4475-9ea6-fb3e70899598"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia28511c78fc648ccac995a4d5840b7b8_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0NjU_63f37442-fbac-43de-b81d-1d6f966c09e4"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0cc04f37c6b947d3b9bc3cda079ee134_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc0NzI_fb6aa0e3-2886-4329-8e7e-368aa2e6d7e2"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia51b0591bb904743909f38530873e249_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc1OTY_d48e5e77-f63b-4666-a2e4-6ea18ef7bc44"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i313b0dcd780d4e46bd994d7390ef9a63_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc2MDA_26260f83-d4fe-4d81-9023-d172f9274daa"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic1f36b739b804d62873d875e6ab53e6e_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc2MDc_786da667-a3aa-4be7-8714-13047f2b5702"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="ia51b0591bb904743909f38530873e249_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc4MzI_50868876-0bec-4e8c-925e-b8a1d515749e"
      unitRef="usdPerShare">68.51</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i313b0dcd780d4e46bd994d7390ef9a63_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc4MzY_def8ebdb-05ab-4428-8aaf-a60644123d88"
      unitRef="usdPerShare">45.38</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="ic1f36b739b804d62873d875e6ab53e6e_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzc4NDM_5f512eed-05bb-4946-bebb-61bf9f14d717"
      unitRef="usdPerShare">40.97</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzgwMTI_09cf0684-8a39-4d4c-886f-8d44cc6c0686"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzgwMTk_610ec02d-c124-4120-8129-356397d75927"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDU0_0a47c5f7-5f11-4bcc-96bc-eacbaf7ee7f3">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ifb7931cabae1458c905c13e1f1be44c6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzgyMjk_5194b3f8-8972-4de9-9fba-d7e7e5708b1e"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id8e24c06b55c4c71852aa0419edcd4c1_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDM5OTU_33b9d09a-79e8-4dd5-b496-2cc8b1eca3c8"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="ifb7931cabae1458c905c13e1f1be44c6_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDQxMDI_154ad65d-91b1-4d7f-ade3-0306c00fafb6"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="ifb7931cabae1458c905c13e1f1be44c6_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwOTk1MTE2NDQxMTU_58bfc04b-d225-4d76-9127-96a8a39c6805"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzg2MDA_12c6813c-83e5-477a-b4df-5a91296c202e">P3Y</holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkwMzg_9f3df506-1ed2-4275-b0d8-d97af974e8a7"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="idcf0307d722e405a9d4239a5969664a9_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkwNDI_2d160899-bc17-4533-88b4-1f5a51372323"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i00a4b6b947964d0c9cf7a620d260cdb8_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkwNDk_630f6e99-ff76-4c6c-ac52-c1d7a2f44c01"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkxOTE_3bd47824-0b81-477d-9c88-d6a01fac5a6b"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzkxOTg_aca29ab0-5e0f-4c8b-8954-bed433a5b81f"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk0MTc_01d7d3e0-01b1-4a20-948c-f9e93c47561a"
      unitRef="usdPerShare">82.31</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="idcf0307d722e405a9d4239a5969664a9_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk0MjE_c61d128e-63bb-4e09-ac3f-3465de021981"
      unitRef="usdPerShare">43.54</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="i00a4b6b947964d0c9cf7a620d260cdb8_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk0Mjg_9f54316a-6a07-4b4e-a957-b0d695a21fbb"
      unitRef="usdPerShare">55.13</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate
      contextRef="id444eb7a43b04a2fa570b14942e9bcaa_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDQ0_34398713-0f46-4dc4-b714-f9951367bf85">P3Y</holx:SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate>
    <holx:NumberOfSharesIssuableUnderEmployeeStockPurchasePlan
      contextRef="ib4dbd93a38124c16a4fcf7162433450f_D20120301-20120331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk4MDY_c65523db-1c76-4e6e-9a57-c667bb902aa4"
      unitRef="shares">2500000</holx:NumberOfSharesIssuableUnderEmployeeStockPurchasePlan>
    <holx:PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase
      contextRef="ib4dbd93a38124c16a4fcf7162433450f_D20120301-20120331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzk5NzY_af8532a2-6d79-49c9-bcb0-70c68b1f59dc"
      unitRef="number">0.85</holx:PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase>
    <us-gaap:ShareBasedCompensation
      contextRef="i3222582dc9e54de994fbc83070afcdca_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwMjI0_ecb92b24-bae8-4d43-8788-a36e91c8c05c"
      unitRef="usd">5900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i46abb586bf124b4085396c348e397ede_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwMjI4_ad882148-2f6b-4d13-9f0a-e1b605d2d912"
      unitRef="usd">4500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i59c4542075c04499bd7780fac311ed3c_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwMjM1_26c27c11-453d-48c2-ac27-87cf39f7b049"
      unitRef="usd">4200000</us-gaap:ShareBasedCompensation>
    <holx:ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzEwNDM0_888fa52c-6b84-4679-833d-0bd419a207c8">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzItMi0xLTEtMA_75327289-0a61-4a20-a89c-1d7bf69856d6"
      unitRef="number">0.0026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzItNC0xLTEtMA_4545c993-caa8-4816-8016-2164f384876a"
      unitRef="number">0.0132</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ide2dd65f185944a7af648c12349053bf_D20180930-20190928"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzItNi0xLTEtMA_ec4954ef-7f88-4b7c-be67-bfd4723655d5"
      unitRef="number">0.0227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzMtMi0xLTEtMA_06e47cb8-bc06-4c2f-be4f-5eb91a881ff0">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzMtNC0xLTEtMA_f7ae2278-50a4-4382-9385-125cd21e6c17">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ide2dd65f185944a7af648c12349053bf_D20180930-20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzMtNi0xLTEtMA_8a962d62-ab97-4e2f-8b33-9938f479e757">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzQtMi0xLTEtMA_5f406848-93b9-46e2-81eb-0e9036efb0d6"
      unitRef="number">0.341</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzQtNC0xLTEtMA_d5b8057b-3d2e-424f-b998-75994eeafa88"
      unitRef="number">0.269</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ide2dd65f185944a7af648c12349053bf_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzQtNi0xLTEtMA_aa857561-8f90-4247-93fe-60666d1976a7"
      unitRef="number">0.271</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzUtMi0xLTEtMA_e2d1e4e6-dc72-4fef-acd9-85f67f67e09c"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="idf164926fc9e44c981d588e7c8f96002_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzUtNC0xLTEtMA_0f09a300-3183-4c68-9492-845d1b44345a"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ide2dd65f185944a7af648c12349053bf_D20180930-20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90YWJsZTo5MGU5ZTIxOGM1NmQ0MGMxYmM1OWY4ZjE3MzE5YjE4MS90YWJsZXJhbmdlOjkwZTllMjE4YzU2ZDQwYzFiYzU5ZjhmMTczMTliMTgxXzUtNi0xLTEtMA_55d995d9-5d96-498e-867a-8bb24eb12fc2"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:MultiemployerPlanTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjYvZnJhZzo1MjQwN2VmNzc2ZmQ0ODBkODI4NDQ3ODk4MDg2NzJjNS90ZXh0cmVnaW9uOjUyNDA3ZWY3NzZmZDQ4MGQ4Mjg0NDc4OTgwODY3MmM1XzEwOTk1MTE2Mjc5OTA_06fa8628-4811-4bf5-93ba-46ee6efb5b76">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;11. 401(k) Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's U.S. employees have access to a qualified 401(k) defined contribution plan. The Company made contributions of $20.9 million, $19.6 million and $19.2 million for fiscal 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:MultiemployerPlanTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjYvZnJhZzo1MjQwN2VmNzc2ZmQ0ODBkODI4NDQ3ODk4MDg2NzJjNS90ZXh0cmVnaW9uOjUyNDA3ZWY3NzZmZDQ4MGQ4Mjg0NDc4OTgwODY3MmM1XzE0NQ_6c969105-d36a-4ec3-ae97-e349426dae2c"
      unitRef="usd">20900000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjYvZnJhZzo1MjQwN2VmNzc2ZmQ0ODBkODI4NDQ3ODk4MDg2NzJjNS90ZXh0cmVnaW9uOjUyNDA3ZWY3NzZmZDQ4MGQ4Mjg0NDc4OTgwODY3MmM1XzE0OQ_716e2c11-1f83-4241-9470-330fb8aab3c3"
      unitRef="usd">19600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjYvZnJhZzo1MjQwN2VmNzc2ZmQ0ODBkODI4NDQ3ODk4MDg2NzJjNS90ZXh0cmVnaW9uOjUyNDA3ZWY3NzZmZDQ4MGQ4Mjg0NDc4OTgwODY3MmM1XzE1Ng_af1b7063-6505-41df-9db7-27b5e3b876d5"
      unitRef="usd">19200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <holx:MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp
      contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzM3Nw_481eaff8-7be2-40fa-9b24-7d7bddb07dd1"
      unitRef="number">0.75</holx:MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp>
    <holx:MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp
      contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzQxMg_d540f331-1271-4826-b284-9991e115c6e7"
      unitRef="number">1</holx:MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp>
    <holx:EmployeeContributionsVestedPercentage
      contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzQ4NA_f2b2c4a6-c478-4843-a35a-05223d202090"
      unitRef="number">1</holx:EmployeeContributionsVestedPercentage>
    <holx:EmployerContributionsVestingPeriod
      contextRef="ie7174a6cf5674cc7a6e006b12d20074f_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzM2ODc_3cc6ea11-2ee7-47de-a52c-a492da82747f">P3Y</holx:EmployerContributionsVestingPeriod>
    <holx:EmployerContributionsVestingPeriod
      contextRef="ie7174a6cf5674cc7a6e006b12d20074f_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzM2Nzk_a28131a6-2179-4343-9916-2f88a09fa606">P3Y</holx:EmployerContributionsVestingPeriod>
    <holx:NonqualifiedDeferredCompensationPlanAnnualContribution
      contextRef="ia27bea7f937142078854cf042f8b20b7_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE3ODY_b438f7be-3465-4710-acf5-738cdc6d6782"
      unitRef="usd">3200000</holx:NonqualifiedDeferredCompensationPlanAnnualContribution>
    <holx:NonqualifiedDeferredCompensationPlanAnnualContribution
      contextRef="i09879e74afc8419ebec21bb3b905b88d_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE3OTA_cacbcb4f-450d-4c38-9757-e85382ad74ba"
      unitRef="usd">3100000</holx:NonqualifiedDeferredCompensationPlanAnnualContribution>
    <holx:NonqualifiedDeferredCompensationPlanAnnualContribution
      contextRef="idf5f8f1317384761bd3f09365e030290_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE3OTc_b9bcb4ed-d0c0-4f9a-abcb-72da158fdaa7"
      unitRef="usd">2700000</holx:NonqualifiedDeferredCompensationPlanAnnualContribution>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE5ODg_2528de07-ae44-4672-88ee-5a3cdebd30f8"
      unitRef="usd">76100000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzE5OTU_44d6b887-d477-4a57-b078-f780aa51007a"
      unitRef="usd">57700000</us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent>
    <holx:InvestmentInGroupLifeInsuranceContracts
      contextRef="i539c042130bf4c0ea0ca1aaf167a10a3_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzIzMDI_ed99d956-9997-44c9-bb15-b30414e6562f"
      unitRef="usd">64300000</holx:InvestmentInGroupLifeInsuranceContracts>
    <holx:InvestmentInGroupLifeInsuranceContracts
      contextRef="ic2b78f80558e4fa2aa90758d4605b59c_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjkvZnJhZzo2OThkY2Q3NGIwODE0OWU4YTMzMGQ2ZmVmYWFkMjhmMC90ZXh0cmVnaW9uOjY5OGRjZDc0YjA4MTQ5ZThhMzMwZDZmZWZhYWQyOGYwXzIzMDk_b800cecf-3625-4676-a647-c62f8b1d3f9b"
      unitRef="usd">49300000</holx:InvestmentInGroupLifeInsuranceContracts>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90ZXh0cmVnaW9uOmNlM2QyMTY0YTJjNjRlNzBhM2RkMWY5YjJiZDVmM2UyXzY2NA_b1398118-85d2-42c6-8b7d-1c848c3e3b59">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain non-cancelable purchase obligations primarily related to inventory purchases and diagnostics instruments, primarily Panther systems, and to a lesser extent other operating expense commitments. These obligations are not recorded in the Consolidated Balance Sheets. For reasons of quality assurance, sole source availability or cost effectiveness, certain key components and raw materials and instruments are available only from a sole supplier and the Company has certain long-term supply contracts to assure continuity of supply. At September&#160;25, 2021, non-cancelable purchase commitments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90ZXh0cmVnaW9uOmNlM2QyMTY0YTJjNjRlNzBhM2RkMWY5YjJiZDVmM2UyXzY3NQ_dc4e9218-caf0-48e1-9f76-bbd656b29273">At September&#160;25, 2021, non-cancelable purchase commitments are as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzAtMS0xLTEtMA_ffbbb4e9-5a25-412b-bda4-595e35eddbb0"
      unitRef="usd">290300000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzEtMS0xLTEtMA_a9888281-8d1b-4b87-84e8-98fe32c55323"
      unitRef="usd">16400000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzItMS0xLTEtMA_de6f95b3-8b4b-4aa3-8b05-5b86a3f3a648"
      unitRef="usd">9200000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligationDueInFourthYear
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzMtMS0xLTEtMA_2cccaa8a-84da-4719-86eb-6ffe6a36fa0c"
      unitRef="usd">4100000</us-gaap:PurchaseObligationDueInFourthYear>
    <us-gaap:PurchaseObligationDueInFifthYear
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzQtMS0xLTEtMA_65896a75-814a-4e84-8b0d-152f354cd55c"
      unitRef="usd">1700000</us-gaap:PurchaseObligationDueInFifthYear>
    <holx:Purchaseobligationthereafter
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzUtMS0xLTEtMA_983ec5eb-4858-4e03-bbad-ee3bc72299ac"
      unitRef="usd">400000</holx:Purchaseobligationthereafter>
    <us-gaap:PurchaseObligation
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzUvZnJhZzpjZTNkMjE2NGEyYzY0ZTcwYTNkZDFmOWIyYmQ1ZjNlMi90YWJsZTpmOTY4ZTA3NjcyNmE0ZTgzYjMyNzYxNTNkYTNmMjNlMS90YWJsZXJhbmdlOmY5NjhlMDc2NzI2YTRlODNiMzI3NjE1M2RhM2YyM2UxXzYtMS0xLTEtMA_6d30a404-3464-43f1-92ec-a9304b72ff4c"
      unitRef="usd">322100000</us-gaap:PurchaseObligation>
    <holx:LitigationAndOtherMattersTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzgvZnJhZzpiZmU5ZjMxYWVhZGE0MDEyODcxNmFmZjQwYjY2OGJhZC90ZXh0cmVnaW9uOmJmZTlmMzFhZWFkYTQwMTI4NzE2YWZmNDBiNjY4YmFkXzgyOTc_8a1d0a27-6d6e-45d6-bbac-7055f05da87d">Litigation and Related Matters&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#x201c;Minerva&#x201d;) in the United States District Court for the District of Delaware, alleging that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#x2019;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#x2019;s motion for a preliminary injunction on its patent claims and denied Minerva&#x2019;s request for preliminary injunction related to the Company&#x2019;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#x2018;183 and &#x2018;348 patents. The Court also granted the Company&#x2019;s motion for summary judgment on assignor estoppel, which bars Minerva&#x2019;s invalidity defenses or any reliance on collateral findings regarding invalidity from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review proceedings. The Court also denied all of Minerva&#x2019;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#x2019;s infringement; (2) found that Minerva&#x2019;s infringement was not willful; and (3) found for the Company regarding Minerva&#x2019;s counterclaims. Damages continued to accrue as Minerva continued its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the &#x2018;348 patent. On April 11, 2016, Minerva filed a petition for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#x2018;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#x2019;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#x2019;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#x2018;348 patent. The Court of Appeals also denied the Company&#x2019;s motion for a permanent injunction and ongoing royalties for infringement of the &#x2018;183 patent. The Court of Appeals denied Minerva&#x2019;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#x2019;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, the Company filed a cross- petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva's petition to address the issue of assignor estoppel and denied the Company's petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold the assignor estoppel but limited its application to situations in which an assignor's claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#x201c;Cytyc&#x201d;) in the United States District Court for the Northern District of California alleging that the Company&#x2019;s and Cytyc&#x2019;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#x2019;s U.S. patent 9,186,208 (the '208 patent). Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#x2019; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10 day trial beginning on August 9, 2021. On July 27. 2021, the Delaware district court granted Hologic's motion for summary judgment on invalidity of the '208 patent and entered judgment in favor of the Company. On August 24, 2021, Minerva appealed this and the other rulings to the Court of Appeals. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 15, the Company has agreed to indemnify CD&amp;amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $8.5&#160;million accrued for such matters as of September 25, 2021. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Legal costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</holx:LitigationAndOtherMattersTextBlock>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i8f565dc1ab5b4eb6aef305378185c37c_D20180727-20180727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzgvZnJhZzpiZmU5ZjMxYWVhZGE0MDEyODcxNmFmZjQwYjY2OGJhZC90ZXh0cmVnaW9uOmJmZTlmMzFhZWFkYTQwMTI4NzE2YWZmNDBiNjY4YmFkXzE5NTE_eabc5ce1-1cd2-4abc-95c5-7c541c08d5a9"
      unitRef="usd">4800000</us-gaap:LossContingencyDamagesAwardedValue>
    <holx:LegalAccrual
      contextRef="ia2f30513167641b4843c24f196c963b3_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNzgvZnJhZzpiZmU5ZjMxYWVhZGE0MDEyODcxNmFmZjQwYjY2OGJhZC90ZXh0cmVnaW9uOmJmZTlmMzFhZWFkYTQwMTI4NzE2YWZmNDBiNjY4YmFkXzc1MzQ_dbe80f8e-c146-45d3-a1c1-8f37ada70678"
      unitRef="usd">8500000</holx:LegalAccrual>
    <holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzMyNjc_dac81be3-b5e8-4db5-af5e-37213bd2e5c9">Disposition&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sale of Medical Aesthetics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp;amp; Rice ("CD&amp;amp;R") for a sales price of&#160;$205.0&#160;million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4&#160;million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzYyNg_91ec9144-43e9-4830-8cd0-3e6aa51ccfb1"&gt;three&lt;/span&gt; to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment and Disposal of Long-Lived Assets, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or that will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;amp;R, the Company recorded an impairment charge of $30.2&#160;million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8&#160;million was allocated to cost of product revenues and $4.4&#160;million to operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss from operations of the disposed business presented below represents the operating loss of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business. As noted above, the Company had performed a number of transition services and the financial impact from these services are not included in the amounts presented below. In addition, the Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition. Subsequent to the disposition, the Company recorded additional expenses of $6.2&#160;million in fiscal 2020 primarily for accelerated stock compensation, inventory reserves under the manufacturing supply agreement, and legal expenses and settlements, which are not included in the below amounts. Loss from operations of the disposed business for fiscal 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(781.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i219e75a86551445f84f935b59c0a9995_I20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzIxNg_7eb90136-dd0f-46ef-9bf8-f6e440e55a3d"
      unitRef="usd">205000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i4e21c713b33d4b199f4353e62c47d003_D20191120-20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzM0MQ_75daa96f-4485-4ee6-a387-45b5833fd059"
      unitRef="usd">153400000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <holx:DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice
      contextRef="i04f6b978d03c4001921c33d5129a2d94_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzUyMw_bcb65062-b98c-44b9-ac57-f75506e4da8a"
      unitRef="usd">150000000</holx:DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice>
    <holx:TransitionServicesAgreementTerm
      contextRef="i31bd370f6c9d45cbb9bf2321aef87fe9_D20210627-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzYzMg_fc11ea21-d30f-41ba-90a2-041ab33b2cef">P15M</holx:TransitionServicesAgreementTerm>
    <holx:IndemnificationLiabily
      contextRef="i04f6b978d03c4001921c33d5129a2d94_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzg5Ng_96a39fd6-4fa6-49aa-bbf4-8c6fb1ef2f5f"
      unitRef="usd">10900000</holx:IndemnificationLiabily>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3f5a4fc2e0a249feb5e822c662f420e2_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzE4NzI_aedae782-5a4d-460a-90b6-8b415ad6804c"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ie6a08f19521748068ae388682bbfb97b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzE5OTg_8878ddb8-e10b-49d8-a910-61b5a31292f7"
      unitRef="usd">25800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iaa33bf2f57be45678091ef0f4e3cb31e_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzIwNDc_03eff36d-e84b-44f4-8c3b-8e8e57ae1e01"
      unitRef="usd">4400000</us-gaap:AssetImpairmentCharges>
    <holx:Expensesfromdisposition
      contextRef="ied23a24d717e4da1895598ce729fd2bf_D20210627-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzI5ODE_6c2a4078-9413-4ad7-9c66-c4d896e736c1"
      unitRef="usd">6200000</holx:Expensesfromdisposition>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzMyNzE_06e1cd83-cd3e-4c0f-b5b3-8024853f38a3">Loss from operations of the disposed business for fiscal 2020 and 2019 was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.412%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(781.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90YWJsZTpmNjczOTdjZmYzZTQ0NGU4YTUxZjYwNTYwM2E1ZTA3OS90YWJsZXJhbmdlOmY2NzM5N2NmZjNlNDQ0ZThhNTFmNjA1NjAzYTVlMDc5XzMtNS0xLTEtMA_e92586e2-6c87-40c7-84f0-476fa4ce83e5"
      unitRef="usd">-46500</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90YWJsZTpmNjczOTdjZmYzZTQ0NGU4YTUxZjYwNTYwM2E1ZTA3OS90YWJsZXJhbmdlOmY2NzM5N2NmZjNlNDQ0ZThhNTFmNjA1NjAzYTVlMDc5XzMtNy0xLTEtMA_5355629e-b5d0-450e-9a92-6f5726ce05d1"
      unitRef="usd">-781200</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzI3ODk_82e20843-93a6-4c2e-a72c-8e4a04009753">Business Segments and Geographic Information&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports segment information in accordance with ASC 280, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions about how to allocate resources and assess performance. The Company&#x2019;s chief operating decision maker is its chief executive officer, and the Company&#x2019;s reportable segments have been identified based on the types of products manufactured and the end markets to which the products are sold. Each reportable segment generates revenue from either the sale of medical equipment and related services and/or sale of disposable supplies, primarily used for diagnostic testing and surgical procedures. During fiscal 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During the first quarter of fiscal 2020 and &lt;/span&gt;fiscal 2019, the Company had five reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.&lt;div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues. Segment information for fiscal 2021, 2020, and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,695.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,352.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(781.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,348.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,276.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,935.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,919.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,442.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#x2019;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#x2019;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#x201c;Rest of world&#x201d; designation includes Canada, Latin America and the Middle East.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company&#x2019;s property, plant and equipment, net were geographically located as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costa Rica&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i982ea739818b424cbe9228324e052c58_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzEwOTk1MTE2MzExNzY_357fd994-5c8a-4256-95f6-04b70014dc00"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:Revenues
      contextRef="id1a7761670014c0e89cd95059279c22a_D20180930-20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzE5OTU_2b97a269-fbdd-47ec-89d0-4925a42d6638"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i982ea739818b424cbe9228324e052c58_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzE5OTU_5a88904b-0e1a-4b27-820d-98c3d66354fc"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54b63b6326364b86b8c1c35e06779d17_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzE5OTU_7bcec00e-9d88-4fdb-8740-a3bbc685c9e8"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzI3OTQ_e41559be-6378-491d-a6dd-360115b932f0">Segment information for fiscal 2021, 2020, and 2019 was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,695.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,102.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,352.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,140.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(781.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,480.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,348.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,276.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,127.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,935.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,919.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,442.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMtMi0xLTEtMA_8c935f80-1129-4576-b3c9-c9df516fc5b1"
      unitRef="usd">3695000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMtNC0xLTEtMA_1bbb1d0f-53ac-4bb4-8c34-245fc22d8b50"
      unitRef="usd">2102100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMtNi0xLTEtMA_b7b1e411-2d09-4839-b38f-29320ba0a6c7"
      unitRef="usd">1205500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzQtMi0xLTEtMA_96add575-e98f-498e-9a07-71fd21e8fab1"
      unitRef="usd">1352300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzQtNC0xLTEtMA_fe21e985-b121-47ad-8faf-e001be795356"
      unitRef="usd">1151900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzQtNi0xLTEtMA_505594c0-bda4-45ea-b51d-eba34dec120b"
      unitRef="usd">1314200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzUtMi0xLTEtMA_fe62b342-5a07-42a1-81d5-19cc4a684bc9"
      unitRef="usd">488100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzUtNC0xLTEtMA_cd204485-0e64-4149-998a-cb914d9c06e3"
      unitRef="usd">376100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzUtNi0xLTEtMA_672b2d8f-c120-4c56-8294-b67b98d7d0eb"
      unitRef="usd">437200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzYtMi0xLTEtMA_31d0a01c-fac3-4bad-bd3c-74806fe755ef"
      unitRef="usd">96900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzYtNC0xLTEtMA_3c777c4a-5c9e-4800-b949-c99c7c229cb9"
      unitRef="usd">81000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzYtNi0xLTEtMA_52b1299b-61fb-45ba-9462-c22a2277fadd"
      unitRef="usd">94800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzctMi0xLTEtMA_06c06319-499d-40b7-84c7-e8c01e4d9f90"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzctNC0xLTEtMA_45d41914-5073-4c3d-a7eb-dd6d334d4870"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzctNi0xLTEtMA_e66375d9-f8b5-4290-881d-f4b64c8c4ce3"
      unitRef="usd">315600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzgtMi0xLTEtMA_f455cb4c-c851-4be3-831d-fa234d6d7cd7"
      unitRef="usd">5632300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzgtNC0xLTEtMA_58b320dc-d166-4391-b179-5807ee53552e"
      unitRef="usd">3776400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzgtNi0xLTEtMA_c9dab760-dd68-4f1a-9c69-f51275e8d8a9"
      unitRef="usd">3367300000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEwLTItMS0xLTA_3bfbd38c-5301-42ba-9bda-d7202a2594aa"
      unitRef="usd">2140100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEwLTQtMS0xLTA_474edb23-2c03-49c6-bb14-2213f09ddfb1"
      unitRef="usd">929700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEwLTYtMS0xLTA_c8741cc6-1794-4b3a-8b55-0d250efa9cf0"
      unitRef="usd">163100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzExLTItMS0xLTA_dea1b806-c565-422a-9001-6e14178662d0"
      unitRef="usd">284200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzExLTQtMS0xLTA_866314df-e696-4fed-bf3b-dfe29b707f6a"
      unitRef="usd">192800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzExLTYtMS0xLTA_3ada317c-2c15-416f-a711-4b9dfdcd9eab"
      unitRef="usd">399300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEyLTItMS0xLTA_4a3e737d-cc99-4d9f-8949-ea37ff882eb2"
      unitRef="usd">58900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEyLTQtMS0xLTA_2e0cce5f-39c5-49c8-bde6-b6ad743bc7fb"
      unitRef="usd">42000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEyLTYtMS0xLTA_13414a94-919e-4502-a757-48fd7dc0d5dc"
      unitRef="usd">99200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEzLTItMS0xLTA_0507e891-4f9c-491a-9b7a-45a174bde568"
      unitRef="usd">-2900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEzLTQtMS0xLTA_d1d9710b-bb87-43f7-b30e-b6ad4196114f"
      unitRef="usd">-2400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzEzLTYtMS0xLTA_c75d67de-c438-4a37-9f78-c1c5cc347a46"
      unitRef="usd">-4200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE0LTItMS0xLTA_e6ac5e55-56a3-4283-8c22-d4202f71b3e9"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE0LTQtMS0xLTA_1a9a4566-e2fa-496b-8432-82ac812df865"
      unitRef="usd">-57100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE0LTYtMS0xLTA_e75be0cd-c273-47ac-83ce-5ef6d7e3d424"
      unitRef="usd">-781200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE1LTItMS0xLTA_46681aba-4277-4a58-b843-1751596518eb"
      unitRef="usd">2480300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE1LTQtMS0xLTA_2991d67e-7195-4a47-b374-8325ef932cf9"
      unitRef="usd">1105000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE1LTYtMS0xLTA_2977ff5d-7541-486c-8416-1e5e2f08de4d"
      unitRef="usd">-123800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE3LTItMS0xLTA_99e6c34d-6d7e-4aaa-ac65-6c8f58405f6c"
      unitRef="usd">260400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE3LTQtMS0xLTA_7e6f223b-8b9e-43fa-ab05-e2d561c9b2f9"
      unitRef="usd">237300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE3LTYtMS0xLTA_9670796f-f03c-4d10-b85b-814a3a94993b"
      unitRef="usd">246600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE4LTItMS0xLTA_60e567dd-0479-4ce8-abf8-fbcc77f49a59"
      unitRef="usd">52700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE4LTQtMS0xLTA_479409e3-b220-4b82-aed9-42efdc002f3f"
      unitRef="usd">48800000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE4LTYtMS0xLTA_98657c72-0cd2-441b-9a27-cb5196445409"
      unitRef="usd">36800000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE5LTItMS0xLTA_f4ea22a0-065e-4c4e-83eb-39b1a0ca35b0"
      unitRef="usd">93100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE5LTQtMS0xLTA_083d442b-ee6d-4555-9aee-4b6a2e45bbcd"
      unitRef="usd">85100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzE5LTYtMS0xLTA_409bff17-d6af-415d-be92-b317423a6fe0"
      unitRef="usd">87700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIwLTItMS0xLTA_543133a2-6dab-4276-ac0d-4b2d55740ba1"
      unitRef="usd">700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIwLTQtMS0xLTA_a17ef2b4-edb1-4dc5-9069-ac5f2f02a0c3"
      unitRef="usd">700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIwLTYtMS0xLTA_7ffcad16-98fb-4eb5-85af-839cdcfbc642"
      unitRef="usd">600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIxLTItMS0xLTA_3be7e719-5978-400b-a6b1-9b573753c222"
      unitRef="usd">0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIxLTQtMS0xLTA_5032cdb9-c2ee-4691-94f2-924c58972896"
      unitRef="usd">4100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIxLTYtMS0xLTA_146c2f8e-b3f3-4b75-837f-2a2939d8f1fc"
      unitRef="usd">91400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIyLTItMS0xLTA_cd2df446-edb1-441c-b11d-c551f1f4d6e4"
      unitRef="usd">406900000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIyLTQtMS0xLTA_964edad2-5862-4023-a451-a90e35e96515"
      unitRef="usd">376000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzIyLTYtMS0xLTA_d03d4f57-43ce-4d27-8a3f-40d091d67c6e"
      unitRef="usd">463100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i9411184d269b43d689c70581552a716e_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI0LTItMS0xLTA_9c65315f-98df-49df-aa1a-da91c1a597e6"
      unitRef="usd">126200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i1f09cf532a65499ca03a618b6131fa02_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI0LTQtMS0xLTA_bc44ffac-4471-402a-8b85-5ed575832f05"
      unitRef="usd">110700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ib1cbd331a3b24a7f9ac84f2940712eb9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI0LTYtMS0xLTA_985539b9-a02a-4093-8368-9559d5209404"
      unitRef="usd">59200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i6ef82ae00b9c411a92c453f7662322c6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI1LTItMS0xLTA_e3b188bd-f480-4385-918e-bf0ef720cf47"
      unitRef="usd">14200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i85868ba3777547ae8bb0356f11bceeb0_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI1LTQtMS0xLTA_35d6f161-ac07-4f4b-ad82-4deafcb3bc64"
      unitRef="usd">22400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i19e8d16c39c541ca95ade6bc6b360218_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI1LTYtMS0xLTA_764673f1-c8f4-42cd-a691-41c4fdea78ad"
      unitRef="usd">18300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i9e3ca133e8f6488880b3681a79ec2146_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI2LTItMS0xLTA_ad783537-aa1a-4f71-bace-42efb578bcd0"
      unitRef="usd">14500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id65d07f80d5b4d589b1b03a5b6e35d26_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI2LTQtMS0xLTA_bb66b3cf-4da9-4c90-8a5a-a9b99e7d4390"
      unitRef="usd">17900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iddfef9e089734fc49273fb759f37826d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI2LTYtMS0xLTA_628718f9-e467-405e-8e6e-178fa268ce0e"
      unitRef="usd">15700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i033758a93ecb4ac898f72e907a09cae6_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI3LTItMS0xLTA_31b66bdb-5370-4478-9b7f-472e4246eb0b"
      unitRef="usd">300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic83f9d2741b946c99f7da1ea4801a717_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI3LTQtMS0xLTA_c41691f2-a491-4a8b-be2e-c7e1d04cdffc"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id3c88c28c8d849709bac1efc12058749_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI3LTYtMS0xLTA_a7506c4e-b3b3-4bf6-950c-e309201a34ae"
      unitRef="usd">1200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i9cf2abf3ba5144c6a42f4852af016373_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI4LTItMS0xLTA_b23a3aaf-ff3f-45d3-8cc1-ccc06b28e2d7"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i80fdffced13f49329a2ec191679666fc_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI4LTQtMS0xLTA_e883a775-50e5-4196-8338-78f05537f47b"
      unitRef="usd">1400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i385998ae580d4d7cb39b38b504cc11ce_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI4LTYtMS0xLTA_1653d342-95d2-4870-9d51-9bd0a69754ef"
      unitRef="usd">7000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8a986aa268d54c1c9fed13658c3b20ec_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI5LTItMS0xLTA_3f626724-4711-4ec9-9443-9cccf3f2274e"
      unitRef="usd">1000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i26018f332aa24e47a89ddb88990c5d5f_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI5LTQtMS0xLTA_cc8f0b9d-ea4e-4aeb-bb9f-08765d07f05e"
      unitRef="usd">3800000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i103c26400f644d6794e2701b7b92414f_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzI5LTYtMS0xLTA_c528cd5c-3d28-4aa7-8f5e-f5f6b56c0fde"
      unitRef="usd">7700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMwLTItMS0xLTA_1914ca45-e80f-4f8e-af18-37ee6fcf6f05"
      unitRef="usd">156200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMwLTQtMS0xLTA_47a1c612-4bbc-4a4b-91be-13dad121e536"
      unitRef="usd">156400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMwLTYtMS0xLTA_b89abf23-eab5-4ec6-8c91-0895b3bacb66"
      unitRef="usd">109100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Assets
      contextRef="ib3b69d34963e43d5a345ff8d104b509c_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMyLTItMS0xLTA_14f86505-c776-4cb6-9e56-e4d3da2c4bce"
      unitRef="usd">3348800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i98d0b62cc24e442bb94c648589df1886_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMyLTQtMS0xLTA_0c7c357b-73b2-4549-bd6d-3459caafefa7"
      unitRef="usd">2161400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i98caa293bf89418e947a8f295926a7d8_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMyLTYtMS0xLTA_6c7fee52-fd18-4704-9db4-a3d52bf2103a"
      unitRef="usd">2276600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1e61574a9b46411bb0ae2371322a832e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMzLTItMS0xLTA_22176d34-17c4-4fb3-a4b3-3741248abf3a"
      unitRef="usd">1233900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1aac6887b6f64875a859a71ba2b4b94b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMzLTQtMS0xLTA_bd5f3218-afa8-4b36-98d8-88f4e08d074b"
      unitRef="usd">1200900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ieb68d71446d14424bd72697ac3285509_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzMzLTYtMS0xLTA_04ab61c2-1732-464e-8e98-ec5d3d434b13"
      unitRef="usd">1127800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifac209011a2246ed84b08c9d11d3ec13_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM0LTItMS0xLTA_799051c4-3e8a-4444-8a7b-70ae99a6aee9"
      unitRef="usd">1369700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1cc0b83aa93c48f48c108df5541f41ff_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM0LTQtMS0xLTA_8756a2dc-37f2-46df-aad2-6810e99e315c"
      unitRef="usd">1438700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id3b6afa22e0f493095f052e3a37c80f9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM0LTYtMS0xLTA_00dc8e8c-06fd-4202-b7e8-c83d62e789a8"
      unitRef="usd">1328600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic32aed22715f404fa87eea8875fb1bed_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM1LTItMS0xLTA_535ea068-7c84-425b-ab98-b4a86c036d40"
      unitRef="usd">31900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i054b061ff3bb4c10a95c6b96ddc407f6_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM1LTQtMS0xLTA_6f1eaeb3-0e6b-40c4-9a4a-4a7856d0e16f"
      unitRef="usd">38900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0490b02597f34bb0a3d9b518df6ea31c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM1LTYtMS0xLTA_cf58db0c-a3c8-4e12-8bb4-d2ef8ab0c8c0"
      unitRef="usd">27300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4bb7a6e4fce84451a598a007a83c7c2e_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM2LTItMS0xLTA_6d7504d1-439e-4f95-bb24-5dd17c95116a"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iad80942a21184b6099e93a927140cccc_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM2LTQtMS0xLTA_b1c3b1c0-2687-4cfa-a6b7-5cb5feaf1537"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id8d7dce3b25048bebda69f0f9c683dc0_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM2LTYtMS0xLTA_8b096932-3ff4-4621-9b68-f2b328499881"
      unitRef="usd">159300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="icbe9fe13010940de8718a210bf402a2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM3LTItMS0xLTA_3feddcac-90ec-4121-bd19-4edea93a01a9"
      unitRef="usd">2935600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i680aa07110f848c0a9f91bc57d1d9d9d_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM3LTQtMS0xLTA_69a40eac-8301-421b-b27b-74e5827b8f62"
      unitRef="usd">2355900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1e0820fa934740988bc68c46b00eaa05_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM3LTYtMS0xLTA_caa1828d-b34a-4e17-bd47-00ab4660bf5a"
      unitRef="usd">1522500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM4LTItMS0xLTA_f15d5f16-8692-47e4-ad11-4f4b5aed28e7"
      unitRef="usd">8919900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM4LTQtMS0xLTA_8a63e1ca-b45e-4fbc-ac3e-9442ee25a52c"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpmZDU5Mzg0MTcwYmI0Y2YxOWM1OTBkMDQ3NjliOWFmMy90YWJsZXJhbmdlOmZkNTkzODQxNzBiYjRjZjE5YzU5MGQwNDc2OWI5YWYzXzM4LTYtMS0xLTA_c9f79ff8-3062-4292-8196-6bc0c4441db8"
      unitRef="usd">6442100000</us-gaap:Assets>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzI3ODA_1c861621-c274-4b81-871f-1354b383fb67">&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <holx:PercentageOfRevenues
      contextRef="ia6f02780b07b4af0a4ade42afb9a3277_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzItMi0xLTEtMA_4f2aa5ce-a5ee-465c-89da-f87ae43d3fd9"
      unitRef="number">0.693</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i3b27c44ab2c049dab1ada8ce3e2c9dde_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzItNC0xLTEtMA_79dac747-dbe2-4fac-9afb-c5dcd38c2e3f"
      unitRef="number">0.758</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i471641798bc6486890424f64b25cab0b_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzItNi0xLTEtMA_867c8474-aee5-4589-9b2d-dd89e92b44e4"
      unitRef="number">0.753</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i5c981ade86904092ab44cdc3421e6c6c_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzMtMi0xLTEtMA_3e7c3904-da2c-47df-812c-e179f31a9ac0"
      unitRef="number">0.213</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i58c230109b9d48e3bb3cde0f8a0abd26_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzMtNC0xLTEtMA_8e16c57c-193e-4d4b-9692-c5b472d34662"
      unitRef="number">0.151</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i80097451dd62453689464503df8df92f_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzMtNi0xLTEtMA_44ef9f78-38f2-42ae-b6a0-589369425e3d"
      unitRef="number">0.118</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i3cd1f66491984c7bb0dd1d0bc4fb2a69_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzQtMi0xLTEtMA_bcf214ca-e2da-4770-826d-cd14dd6c5443"
      unitRef="number">0.065</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i53fbadaaa41d47dd83cdd5d7dfa70cd8_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzQtNC0xLTEtMA_ae1d55b5-a32b-44ff-be08-179dcb4842eb"
      unitRef="number">0.060</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="iaae08e83f10e40cfb00da11f047781ec_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzQtNi0xLTEtMA_a560400c-37b7-46ee-91f5-563269c2c7ca"
      unitRef="number">0.085</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i74b686e1df1549aca26f39228fe341fa_D20200927-20210925"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzUtMi0xLTEtMA_23b6a8cf-68a3-466a-9d72-ca189fe5840f"
      unitRef="number">0.029</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i2c4ff82c84e041298fcbdf87e237dcf5_D20190929-20200926"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzUtNC0xLTEtMA_2c1aacde-14c7-449a-bda9-587461bbf053"
      unitRef="number">0.031</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="id5b4e0cf7b6d4802a7d62ddca53a82db_D20180930-20190928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzUtNi0xLTEtMA_c8322406-61bb-477b-8296-ddf7d803ac75"
      unitRef="number">0.044</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzYtMi0xLTEtMA_04f3a672-140f-43ff-b626-0c24aea4c432"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzYtNC0xLTEtMA_9d43833d-c8a9-46a4-8d0a-bd5e4d3d22d2"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTpiNDg2MDNkYjk2ZjM0MDRkYmVkZDdjNjMyN2IwYjA3Yy90YWJsZXJhbmdlOmI0ODYwM2RiOTZmMzQwNGRiZWRkN2M2MzI3YjBiMDdjXzYtNi0xLTEtMA_0a7a34a3-ef6d-4211-b8fe-4e850d2162bf"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90ZXh0cmVnaW9uOjZkNGQwZjQ2OWJkNjQ5MzE5ZmU3MTcyZTZiODg5MGUwXzI3OTY_10594204-a6b8-4c64-95a8-6b07b1fe5f3b">The Company&#x2019;s property, plant and equipment, net were geographically located as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costa Rica&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibe57ae2fbed04a638154dae73a66c811_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzEtMi0xLTEtMA_874f8735-2cfb-48a4-b8a5-d77dbbcd3144"
      unitRef="usd">403200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i355f32c131b14099b97cc874503e497f_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzEtNC0xLTEtMA_0c548bea-2089-4637-9cf1-1037a4876065"
      unitRef="usd">383000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3c83bdbf9ef94aa59101a9aea2be7873_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzEtNi0xLTEtMA_f69a4992-c96d-470b-856b-839faea1fb71"
      unitRef="usd">355500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i548c9eddb08b4f14967120bc035c9ec8_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzItMi0xLTEtMA_380e83ab-3e98-4bbc-8d9a-19d472f3c5be"
      unitRef="usd">122900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id4b55414cc384a68b8e3567008300ae5_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzItNC0xLTEtMA_e18c7c2e-dca7-44a0-8afe-8ac421b64648"
      unitRef="usd">77500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib41f0019abbb463c9a8e10c2f96a5e29_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzItNi0xLTEtMA_abfc9aa7-624b-4068-ac41-846fc9f3c09e"
      unitRef="usd">64400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i66522b5564db479e9fd59f735b53bcda_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzMtMi0xLTEtMA_1ebf10cb-1040-48c6-940a-66fb4747c2be"
      unitRef="usd">26900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4e2c2ca6c4484232a21bb281c44dd840_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzMtNC0xLTEtMA_9541c63d-207d-4032-890a-40a737cd0f05"
      unitRef="usd">20800000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i36c8c111abcf4b43a4042a7c166306fe_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzMtNi0xLTEtMA_9b133014-6439-4c21-8ba6-c3b45fd23fbf"
      unitRef="usd">33000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iecc61f191e354207a73d576c73bc8d42_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzQtMi0xLTEtMA_ecf1e484-d8d6-4f96-ad52-0cb9978575b5"
      unitRef="usd">11700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i58fd21fdaa0f4e66ab9388859b3f172e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzQtNC0xLTEtMA_0a203fd4-7534-495b-b496-9d0133b86341"
      unitRef="usd">10200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9b547462cf5d4b5597648a8fe55a37e6_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzQtNi0xLTEtMA_cc75f390-89c8-498e-a18f-35d6bd21f058"
      unitRef="usd">18000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzUtMi0xLTEtMA_380ab4c0-ecfd-4982-a997-3ccc21e4c6bd"
      unitRef="usd">564700000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzUtNC0xLTEtMA_d8a85720-eb74-4833-82b5-bcc8b6e07f89"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODQvZnJhZzo2ZDRkMGY0NjliZDY0OTMxOWZlNzE3MmU2Yjg4OTBlMC90YWJsZTo5YzJiNmM1ODUxNzA0NGU1OTE3NzZiMTllMTZlMDQzNy90YWJsZXJhbmdlOjljMmI2YzU4NTE3MDQ0ZTU5MTc3NmIxOWUxNmUwNDM3XzUtNi0xLTEtMA_08230316-ed6f-4907-8ae2-5162b44fde7f"
      unitRef="usd">470900000</us-gaap:PropertyPlantAndEquipmentNet>
    <holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90ZXh0cmVnaW9uOjg2NGY2MDZiNDdmZjQ2NWZhNTU5MWI3ZjVhZGQwN2RjXzE0OA_6373440a-1277-427f-ab84-eabd39b8e808">Accrued Expenses and Other Long-Term Liabilities&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other long-term liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&#160;Long-Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for income tax uncertainties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90ZXh0cmVnaW9uOjg2NGY2MDZiNDdmZjQ2NWZhNTU5MWI3ZjVhZGQwN2RjXzE1MQ_0294d9a3-6745-4cac-826c-815492464e80">&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other long-term liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzItMi0xLTEtMA_6669c45d-6700-4dc6-a086-8d4a120157a8"
      unitRef="usd">297200000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzItNC0xLTEtMA_1eefe457-b273-4fe0-93ac-9dd3e6936020"
      unitRef="usd">262700000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <holx:AccruedIncomeAndOtherTaxes
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzQtMi0xLTEtMA_a92ea640-3e5c-4401-8324-99d9b2d1e3eb"
      unitRef="usd">70900000</holx:AccruedIncomeAndOtherTaxes>
    <holx:AccruedIncomeAndOtherTaxes
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzQtNC0xLTEtMA_1bea17b3-3295-4cdd-96a6-401e77e519d1"
      unitRef="usd">125300000</holx:AccruedIncomeAndOtherTaxes>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzUtMi0xLTEtMA_207eb605-eb3d-4214-afc2-fbdce441f132"
      unitRef="usd">16300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzUtNC0xLTEtMA_02d37d3a-186e-4dc1-a81b-af382bb254ab"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzYtMi0xLTEtMA_bcb56c1e-4601-4ced-80ce-a246ab76631a"
      unitRef="usd">26800000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzYtNC0xLTEtMA_2fa07063-930a-497b-9847-8030eeee38bd"
      unitRef="usd">23500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <holx:AccruedInterest
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzctMi0xLTEtMA_4efa8836-c831-47a6-84e4-ccea2b0f3280"
      unitRef="usd">16900000</holx:AccruedInterest>
    <holx:AccruedInterest
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzctNC0xLTEtMA_9e9f3a42-2fba-4de8-870c-bfd3732141d9"
      unitRef="usd">22100000</holx:AccruedInterest>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzgtMi0xLTEtMA_984cde74-7a04-4e34-809e-961e341e67fa"
      unitRef="usd">168100000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzgtNC0xLTEtMA_66bcb777-cc6a-47cc-a493-e4455ac63e20"
      unitRef="usd">114000000.0</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzktMi0xLTEtMA_d18a884e-bd27-4336-9191-ec389d09c7fb"
      unitRef="usd">596200000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTpmMmI4NjkzZGJhNDE0ZGFmODdiMzE4OGRiNWJjNGI2MS90YWJsZXJhbmdlOmYyYjg2OTNkYmE0MTRkYWY4N2IzMTg4ZGI1YmM0YjYxXzktNC0xLTEtMA_f368794c-e669-4e42-934e-2de8480e861e"
      unitRef="usd">547600000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90ZXh0cmVnaW9uOjg2NGY2MDZiNDdmZjQ2NWZhNTU5MWI3ZjVhZGQwN2RjXzE2Mg_2e55fb08-b061-4497-9fb8-c2ba4f62e1ef">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&#160;Long-Term Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve for income tax uncertainties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzItMi0xLTEtMA_a2a90ef5-54bd-4572-b71d-92798ffae105"
      unitRef="usd">210000000.0</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzItNC0xLTEtMA_8f845aa2-7243-40e0-ba37-a8c5ad792644"
      unitRef="usd">103700000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzMtMi0xLTEtMA_5000a41f-b2e1-44bb-a637-0b3687dfc783"
      unitRef="usd">58800000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzMtNC0xLTEtMA_60a59a25-73b2-4ac9-9cc7-0b3d305cb4e1"
      unitRef="usd">81800000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzQtMi0xLTEtMA_5765adba-a671-4bf7-926d-5abf92d707f3"
      unitRef="usd">66100000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzQtNC0xLTEtMA_a8527b8e-53e3-4dc9-a5ef-2ee4f13b04b7"
      unitRef="usd">65600000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzUtMi0xLTEtMA_aab7c756-4444-42ea-8d15-b1ed82a00222"
      unitRef="usd">7600000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzUtNC0xLTEtMA_fa444e68-74ff-4dee-ae35-ef463346039d"
      unitRef="usd">23000000.0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzYtMi0xLTEtMA_46912d9c-694b-4657-8cd8-f10f4861eb24"
      unitRef="usd">10000000.0</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzYtNC0xLTEtMA_7f2b5091-b762-4718-9500-e547902db6fb"
      unitRef="usd">11100000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzgtMi0xLTEtMA_b8c3a774-e02c-416b-b017-b6371c273a26"
      unitRef="usd">16200000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzgtMi0xLTEtMA_ebc41871-6e62-41bc-ba44-743f2b44358a"
      unitRef="usd">16200000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzgtNC0xLTEtMA_d5901c8a-2b9c-42c0-9bf8-28f942539c91"
      unitRef="usd">18000000.0</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzktMi0xLTEtMA_bf003fad-ec27-4a10-b898-1e5ab8ebb572"
      unitRef="usd">368700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODcvZnJhZzo4NjRmNjA2YjQ3ZmY0NjVmYTU1OTFiN2Y1YWRkMDdkYy90YWJsZTplMjIzZmQwNWUyMTU0ZWI5OTZhM2JjMTAxYWViNGVlYS90YWJsZXJhbmdlOmUyMjNmZDA1ZTIxNTRlYjk5NmEzYmMxMDFhZWI0ZWVhXzktNC0xLTEtMA_c13b3d02-497d-4dc1-aa45-078ad630a4c2"
      unitRef="usd">303200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxODc_fb3f41fc-1cd6-4075-8493-23a8f9453ee9">Pension and Other Employee Benefits&lt;div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has certain defined benefit pension plans covering the employees of its Hitec Imaging German subsidiary (the &#x201c;Pension Benefits&#x201d;).&#160;As of September&#160;25, 2021 and September&#160;26, 2020, the Company&#x2019;s pension liability was $10.3 million and $10.9 million, respectively, which is primarily recorded as a component of long-term liabilities in the Consolidated Balance Sheets. Under German law, there are no rules governing investment or statutory supervision of the pension plan. As such, there is no minimum funding requirement imposed on employers. Pension benefits are safeguarded by the Pension Guaranty Fund, a form of compulsory reinsurance that guarantees an employee will receive vested pension benefits in the event of insolvency. The pension plans were closed on December 31, 1997 and only eligible employees at that date could participate in the plans prior to closing to new participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#x2019;s German Pension Benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:49.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#x2019;s German Pension Benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Components of Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Net Periodic Benefit Cost Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The projected benefit obligation for the German Pension Benefits with projected benefit obligations in excess of plan assets was $10.3 million and $10.9 million at September&#160;25, 2021 and September&#160;26, 2020, respectively, and the accumulated benefit obligation for the German Pension Benefits was $10.3 million and $10.9 million at September&#160;25, 2021 and September&#160;26, 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also obligated to pay long-term service award benefits under the German Pension Benefits. The projected benefit obligation for long-term service awards was $0.1 million at both September&#160;25, 2021 and September&#160;26, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 to 2031&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company also maintains additional contractual pension benefits for its top German executive officers in the form of a defined contribution plan. These contributions were insignificant in fiscal 2021, 2020 and 2019.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzI0MQ_5ef59938-20fe-4fb5-bd12-4e1126f91688"
      unitRef="usd">10300000</us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities>
    <us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzI0OA_46e8f3be-1c04-412d-bab1-58a9901d1938"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxODI_bf16c982-0949-4755-9a0e-b29c2c3fe252">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#x2019;s German Pension Benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:49.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change in Benefit Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzItMi0xLTEtMA_b9464128-016a-4ad4-a586-5f1b94a22ee2"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzItNC0xLTEtMA_eabbf612-e4a8-4776-a2aa-d096b5b53ce4"
      unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i1169eac86c27452c96edd0243c74ad5d_I20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzItNi0xLTEtMA_657d30f7-c906-4941-a30c-a96b92ad9a4d"
      unitRef="usd">9700000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzMtMi0xLTEtMA_03ce2aa0-4d80-4d72-bfe4-4c62c2075213"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzMtNC0xLTEtMA_80825d27-074e-4cc2-86b3-47252e2236e6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzMtNi0xLTEtMA_8e3a46c2-df1a-4e6f-b210-30442404281f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzQtMi0xLTEtMA_953a4583-8336-48a0-8675-6b1a33f64aaf"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzQtNC0xLTEtMA_2fac3d32-1b40-4b83-ae1b-f28d7a1f57bf"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzQtNi0xLTEtMA_9007804c-6aff-4e5b-86e1-8942ada44a5c"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzUtMi0xLTEtMA_ee250996-ec75-4bc2-b65a-f180f212e2dc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzUtNC0xLTEtMA_cf6538a7-fa97-468f-9f07-a16eb416e00c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzUtNi0xLTEtMA_3a08b67c-e8ff-4103-a523-ccdcb37139c8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzYtMi0xLTEtMA_f364970d-e158-4a9c-ac82-ef5165b28605"
      unitRef="usd">500000</holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount>
    <holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzYtNC0xLTEtMA_de887257-2d9c-4c9f-8a0b-72dd7c504ecf"
      unitRef="usd">-500000</holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount>
    <holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzYtNi0xLTEtMA_cd20deda-9a7c-4b58-a374-f12ceaa0ac4c"
      unitRef="usd">-1000000.0</holx:DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzctMi0xLTEtMA_130ad9d5-f23e-425b-b383-1e02ce6651fb"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzctNC0xLTEtMA_cd08674b-9714-4670-a75b-abd8c087db06"
      unitRef="usd">-700000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzctNi0xLTEtMA_66e1fea5-cf54-45ef-87fd-5338c36c21d3"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzgtMi0xLTEtMA_1577c38e-ceff-4468-997d-e7aecaba67a9"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzgtNC0xLTEtMA_ba636531-f967-4e02-babc-c4a647f268e9"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzgtNi0xLTEtMA_c12d326c-0391-4c5c-a287-d19329191e6d"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzktMi0xLTEtMA_6406f559-5ead-42a5-95a9-ec0d4320675e"
      unitRef="usd">10300000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzktNC0xLTEtMA_cffa178c-955e-4c46-8129-dfe397dd0837"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzktNi0xLTEtMA_e7609e53-5f82-4ec9-b42a-b693f6321b8b"
      unitRef="usd">10000000.0</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzEwLTItMS0xLTA_f07f0411-c204-4007-9ee7-a55a12995256"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzEwLTQtMS0xLTA_38f42464-f192-4cba-a7c9-2f3a6ede8dd9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzEwLTYtMS0xLTA_45032ca2-5b8e-4937-8481-e3c8babbc016"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzExLTItMS0xLTA_781538c5-be95-4121-b59f-367b83035da5"
      unitRef="usd">-10300000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzExLTQtMS0xLTA_ed088adb-48f0-42c8-9678-b1f8cbacc50d"
      unitRef="usd">-10900000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="iebdc63da66e44f02a09288f80627eb36_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpmNWI4MmM5ODdjM2I0ZmZkYTgzN2ZhMmFkOWEwNmQ3OC90YWJsZXJhbmdlOmY1YjgyYzk4N2MzYjRmZmRhODM3ZmEyYWQ5YTA2ZDc4XzExLTYtMS0xLTA_489df4e7-ddf5-482a-b92a-767a28923618"
      unitRef="usd">-10000000.0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxNzY_7e73a4eb-c240-4d50-bfb2-80b0dbbefb77">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#x2019;s German Pension Benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Components of Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of prior service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzItMi0xLTEtMA_290841ac-a091-4d82-b2bc-e8537f50e37d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzItNC0xLTEtMA_120198fc-166f-4f5a-adec-edc264159e8d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzItNi0xLTEtMA_ae0f0c57-09a9-4af8-b2ad-892bb66a5c08"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanServiceCost>
    <holx:ComponentsofNetPeriodicBenefitCostInterestcost
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzMtMi0xLTEtMA_3aeba5bb-ebe8-4121-94bd-c419194caa02"
      unitRef="usd">100000</holx:ComponentsofNetPeriodicBenefitCostInterestcost>
    <holx:ComponentsofNetPeriodicBenefitCostInterestcost
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzMtNC0xLTEtMA_aa81991a-8ff9-45f7-a834-a609fdb71e90"
      unitRef="usd">100000</holx:ComponentsofNetPeriodicBenefitCostInterestcost>
    <holx:ComponentsofNetPeriodicBenefitCostInterestcost
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzMtNi0xLTEtMA_239510bf-5833-4cff-b8af-bd3c1b5338ca"
      unitRef="usd">200000</holx:ComponentsofNetPeriodicBenefitCostInterestcost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzQtMi0xLTEtMA_a830d2fb-3d43-4a06-b0e2-b772bcff2059"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzQtNC0xLTEtMA_e6ee67d0-6307-4576-8bfd-8d141d968eb6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzQtNi0xLTEtMA_8c95b424-099e-42ef-bfdc-4daf95026799"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzUtMi0xLTEtMA_239548c2-5869-437f-aacc-b52f15724f53"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzUtNC0xLTEtMA_c0ad6954-231b-4975-825b-3e28a82fcb5d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzUtNi0xLTEtMA_419e84b3-84e0-4f19-92c7-631943d06903"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzYtMi0xLTEtMA_0a780c32-04c7-4e98-bba8-5b0f0db9b777"
      unitRef="usd">-300000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzYtNC0xLTEtMA_c135554f-7c72-4980-a7aa-829f3f4539b3"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzYtNi0xLTEtMA_966e6d5e-17dc-4b28-8419-8cc4526d5323"
      unitRef="usd">-100000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzctMi0xLTEtMA_8b10ac2b-fa58-41e8-93c4-aa629ad7da1d"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzctNC0xLTEtMA_794cef7e-e5fc-40e8-9b18-73d0ab84fc45"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTpiNjk0Njg5MDI0MTY0NWRjOGRjZGFlMTVlNjY1Njc0MS90YWJsZXJhbmdlOmI2OTQ2ODkwMjQxNjQ1ZGM4ZGNkYWUxNWU2NjU2NzQxXzctNi0xLTEtMA_6415bd88-fb7c-4b2d-a978-f1b8a4b3104a"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxODU_d79c926e-a25c-4b3e-8ebd-62bf2c8fa4fa">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Net Periodic Benefit Cost Assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzEtMi0xLTEtMA_9f127618-491e-4ec7-8ba2-d64736679f4c"
      unitRef="number">0.0100</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzEtNC0xLTEtMA_a70863e7-9ece-4656-8a19-b4b3c6438d71"
      unitRef="number">0.0080</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzEtNi0xLTEtMA_fee0c666-db46-4339-9ba2-9edfd6f922fa"
      unitRef="number">0.0110</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzItMi0xLTEtMA_2c7bc020-4ad2-44c1-9aa6-d8c10c8bf535"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzItNC0xLTEtMA_597f0340-8c30-40cd-b2d1-b59e8b8a48d5"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzItNi0xLTEtMA_d324a2e6-c751-44af-8873-1bb0cf4ec15b"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzMtMi0xLTEtMA_eb0f2bda-8ed4-4708-b046-e7546ddac8ef"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i9bdbd30b251748d9a72db6659ac68bfe_D20190929-20200926"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzMtNC0xLTEtMA_b3219da7-f4bb-4574-bdb9-9e19f4ebabe7"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ie676d127765b44e19633b016ca95774d_D20180930-20190928"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo2MjMzMjU3ZmY4ZWM0YzFlYWQyMzE2OTgyZTk3MWJiNS90YWJsZXJhbmdlOjYyMzMyNTdmZjhlYzRjMWVhZDIzMTY5ODJlOTcxYmI1XzMtNi0xLTEtMA_37f1341e-4531-4cd8-8cb9-693f38a97235"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="ic1d488dc858b49ac92911c8316dc04c3_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzEzNTY_cf19679f-ad6e-4b51-af80-7af5f8186a06"
      unitRef="usd">10300000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation
      contextRef="if8cb3192812b4442b0a3e479a2307bc0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzEzNjM_a5ff873c-ea3c-45b9-98c7-ba55733c0d9d"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzE0Njk_e63ec366-26bb-4943-8440-53e9921b97bb"
      unitRef="usd">10300000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzE0NzY_349621e9-1096-4e43-9068-d268ca7c92b7"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <holx:ProjectedBenefitObligationForLongTermServiceAwards
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzE2Nzk_53eefae7-7221-451a-b0fd-966110bf7c26"
      unitRef="usd">100000</holx:ProjectedBenefitObligationForLongTermServiceAwards>
    <holx:ProjectedBenefitObligationForLongTermServiceAwards
      contextRef="id753e6e364a144f8a4338bd5656f66cf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzE2Nzk_c164ef19-f7a2-4e83-a6eb-af7432eeb138"
      unitRef="usd">100000</holx:ProjectedBenefitObligationForLongTermServiceAwards>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90ZXh0cmVnaW9uOmQ1OWY4NzZkYmQ2MjQ4ZjJiMDFlNjI2MzkxNmY0MTk1XzIxNjY_0ff20dd7-14c9-4eed-89b2-94aa5564dfa1">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 to 2031&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzEtMS0xLTEtMA_49af70f7-6332-4e65-9ba6-29f5ed400a1b"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzItMS0xLTEtMA_bc8fad18-ec9f-43f6-ac8a-7f8d4b405168"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzMtMS0xLTEtMA_9c3b3645-9888-49be-a6cd-f731724a2752"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzQtMS0xLTEtMA_93dd4c26-3ef7-4582-8a45-334638b23143"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzUtMS0xLTEtMA_43876c0a-89e5-42c1-9173-33726c231a60"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="ib1da2069ac20464e9013c24fe294ff2d_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xOTAvZnJhZzpkNTlmODc2ZGJkNjI0OGYyYjAxZTYyNjM5MTZmNDE5NS90YWJsZTo4OGIzYWJlZTk4MDk0NTkwOTViNDBiNDc4ZDA1M2MwMi90YWJsZXJhbmdlOjg4YjNhYmVlOTgwOTQ1OTA5NWI0MGI0NzhkMDUzYzAyXzYtMS0xLTEtMA_8f8b6f9c-080e-4a4f-bd06-a14eb1789ec4"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317614360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Nov. 11, 2021</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 25,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-36214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HOLOGIC, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000859737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2902449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">250 Campus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">263-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HOLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,639,078,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,420,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s Proxy Statement for the registrant&#8217;s annual meeting of stockholders to be filed within 120 days of the end of its fiscal year ended September&#160;25, 2021 are incorporated into Part III (Items 10, 11, 12, 13 and 14) of this Annual Report on Form&#160;10-K where indicated.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315676888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from product and services</a></td>
<td class="nump">$ 5,632.3<span></span>
</td>
<td class="nump">$ 3,776.4<span></span>
</td>
<td class="nump">$ 3,367.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">276.7<span></span>
</td>
<td class="nump">253.2<span></span>
</td>
<td class="nump">318.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">25.8<span></span>
</td>
<td class="nump">578.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">3,795.8<span></span>
</td>
<td class="nump">2,227.5<span></span>
</td>
<td class="nump">1,170.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">276.3<span></span>
</td>
<td class="nump">222.5<span></span>
</td>
<td class="nump">232.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">561.2<span></span>
</td>
<td class="nump">484.6<span></span>
</td>
<td class="nump">564.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">433.2<span></span>
</td>
<td class="nump">355.7<span></span>
</td>
<td class="nump">332.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">42.2<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
<td class="nump">52.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">106.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Contingent consideration &#8211; fair value adjustments</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and divestiture charges</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">1,315.5<span></span>
</td>
<td class="nump">1,122.5<span></span>
</td>
<td class="nump">1,294.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">2,480.3<span></span>
</td>
<td class="nump">1,105.0<span></span>
</td>
<td class="num">(123.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(93.6)<span></span>
</td>
<td class="num">(116.5)<span></span>
</td>
<td class="num">(140.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="num">(21.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(5.4)<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">2,361.1<span></span>
</td>
<td class="nump">1,001.9<span></span>
</td>
<td class="num">(257.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">491.4<span></span>
</td>
<td class="num">(108.6)<span></span>
</td>
<td class="num">(54.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">1,869.7<span></span>
</td>
<td class="nump">1,110.5<span></span>
</td>
<td class="num">(203.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Hologic</a></td>
<td class="nump">$ 1,871.5<span></span>
</td>
<td class="nump">$ 1,115.2<span></span>
</td>
<td class="num">$ (203.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income (loss) per common share attributable to Hologic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 7.28<span></span>
</td>
<td class="nump">$ 4.24<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 7.21<span></span>
</td>
<td class="nump">$ 4.21<span></span>
</td>
<td class="num">$ (0.76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">257,046<span></span>
</td>
<td class="nump">262,727<span></span>
</td>
<td class="nump">269,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">259,706<span></span>
</td>
<td class="nump">264,613<span></span>
</td>
<td class="nump">269,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from product and services</a></td>
<td class="nump">$ 4,967.3<span></span>
</td>
<td class="nump">$ 3,227.0<span></span>
</td>
<td class="nump">$ 2,771.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">1,205.1<span></span>
</td>
<td class="nump">953.7<span></span>
</td>
<td class="nump">948.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from product and services</a></td>
<td class="nump">665.0<span></span>
</td>
<td class="nump">549.4<span></span>
</td>
<td class="nump">596.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods and services sold</a></td>
<td class="nump">$ 354.7<span></span>
</td>
<td class="nump">$ 316.2<span></span>
</td>
<td class="nump">$ 350.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CostOfGoodsSoldImpairmentOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317108296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,869.7<span></span>
</td>
<td class="nump">$ 1,110.5<span></span>
</td>
<td class="num">$ (203.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI', window );">Changes in foreign currency translation adjustment</a></td>
<td class="num">(20.2)<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="num">(14.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in pension plans, net of taxes of $0.2 in 2021, $0.1 in 2020, and $0.3 in 2019</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="num">(9.4)<span></span>
</td>
<td class="num">(7.4)<span></span>
</td>
<td class="num">(16.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="nump">1,860.3<span></span>
</td>
<td class="nump">1,103.1<span></span>
</td>
<td class="num">(220.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss attributable to noncontrolling interest</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ComprehensiveIncome', window );">Comprehensive income (loss) attributable to Hologic</a></td>
<td class="nump">1,862.1<span></span>
</td>
<td class="nump">1,107.8<span></span>
</td>
<td class="num">(220.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Loss reclassified from accumulated other comprehensive loss to the statement of operations, net</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="nump">$ 9.4<span></span>
</td>
<td class="num">$ (27.6)<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Comprehensive Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876413635464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent', window );">Change in pension plans, tax</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TaxOnInterestRateSwap', window );">tax on interest rate swap</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="num">(8.3)<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TaxOnInterestRateSwap">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>tax on interest rate swap</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TaxOnInterestRateSwap</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318446712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,170.3<span></span>
</td>
<td class="nump">$ 701.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">942.7<span></span>
</td>
<td class="nump">1,028.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">501.2<span></span>
</td>
<td class="nump">395.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">25.7<span></span>
</td>
<td class="nump">38.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">528.8<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,168.7<span></span>
</td>
<td class="nump">2,222.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">564.7<span></span>
</td>
<td class="nump">491.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,659.2<span></span>
</td>
<td class="nump">1,307.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,281.6<span></span>
</td>
<td class="nump">2,657.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">245.7<span></span>
</td>
<td class="nump">516.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">8,919.9<span></span>
</td>
<td class="nump">7,195.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">313.0<span></span>
</td>
<td class="nump">324.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">215.9<span></span>
</td>
<td class="nump">178.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">596.2<span></span>
</td>
<td class="nump">547.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">198.0<span></span>
</td>
<td class="nump">186.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,326.8<span></span>
</td>
<td class="nump">1,239.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">2,712.2<span></span>
</td>
<td class="nump">2,713.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="nump">22.8<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">250.5<span></span>
</td>
<td class="nump">201.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">20.3<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">368.7<span></span>
</td>
<td class="nump">303.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13 and 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 297,306 and 295,107 shares issued, respectively</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">5,965.8<span></span>
</td>
<td class="nump">5,904.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated earnings (deficit)</a></td>
<td class="nump">298.3<span></span>
</td>
<td class="num">(1,573.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 43,653 and 37,609 shares, respectively</a></td>
<td class="num">(1,989.4)<span></span>
</td>
<td class="num">(1,579.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(59.1)<span></span>
</td>
<td class="num">(49.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Hologic's stockholders&#8217; equity</a></td>
<td class="nump">4,218.6<span></span>
</td>
<td class="nump">2,705.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">4,218.6<span></span>
</td>
<td class="nump">2,707.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 8,919.9<span></span>
</td>
<td class="nump">$ 7,195.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318262760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">1,623,000<span></span>
</td>
<td class="nump">1,623,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">297,306,000<span></span>
</td>
<td class="nump">295,107,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">43,653,000<span></span>
</td>
<td class="nump">37,609,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876309456520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Share Repurchase Program [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in-Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th">
<div>Treasury Stock [Member] </div>
<div>Share Repurchase Program [Member]</div>
</th>
<th class="th"><div>Noncontrolling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 29, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 29, 2018</a></td>
<td class="nump">$ 2,428,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">$ 5,671,300,000<span></span>
</td>
<td class="num">$ (2,494,000,000)<span></span>
</td>
<td class="num">$ (25,500,000)<span></span>
</td>
<td class="num">$ (725,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountingstandardtransitionadjustmentASC606', window );">Accounting standard transition adjustment - ASC 606</a></td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountingstandardtransitionadjustmentASU201616', window );">Accounting standard transition adjustment - ASU 2016-16</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="nump">32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</a></td>
<td class="num">(12,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock Issued During Period, Value, Employee Stock Purchase Plan</a></td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">62,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Treasury Stock, Value, Acquired, Par Value Method</a></td>
<td class="num">(200,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(14,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</a></td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</a></td>
<td class="num">(8,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss', window );">Unrealized gain on interest rate swap</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss) attributable to Hologic</a></td>
<td class="num">(203,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(203,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 28, 2019</a></td>
<td class="nump">2,115,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,769,800,000<span></span>
</td>
<td class="num">(2,688,700,000)<span></span>
</td>
<td class="num">(42,300,000)<span></span>
</td>
<td class="num">$ (926,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="nump">48,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</a></td>
<td class="num">(14,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock Issued During Period, Value, Employee Stock Purchase Plan</a></td>
<td class="nump">17,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">83,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,064<span></span>
</td>
<td class="nump">3,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Treasury Stock, Value, Acquired, Par Value Method</a></td>
<td class="num">(448,600,000)<span></span>
</td>
<td class="num">$ (205,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (448,600,000)<span></span>
</td>
<td class="num">$ (205,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes', window );">Unrealized gain (loss) on interest rate cap, net of taxes</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</a></td>
<td class="nump">18,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss', window );">Unrealized gain on interest rate swap</a></td>
<td class="num">(27,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss) attributable to Hologic</a></td>
<td class="nump">1,110,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,115,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling Interest, Increase from Business Combination</a></td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountingStandardTransitionAdjustmentASU842', window );">Accounting standard transition adjustment - ASC 842 | Accounting Standards Update 2018-01 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 26, 2020</a></td>
<td class="nump">$ 2,707,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,904,800,000<span></span>
</td>
<td class="num">(1,573,200,000)<span></span>
</td>
<td class="num">(49,700,000)<span></span>
</td>
<td class="num">$ (1,579,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock Issued During Period, Value, Stock Options Exercised</a></td>
<td class="nump">$ 32,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</a></td>
<td class="num">(47,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Stock Issued During Period, Value, Employee Stock Purchase Plan</a></td>
<td class="nump">18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">65,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Treasury Stock, Value, Acquired, Par Value Method</a></td>
<td class="num">(409,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (409,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes', window );">Unrealized gain (loss) on interest rate cap, net of taxes</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(20,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss', window );">Unrealized gain on interest rate swap</a></td>
<td class="nump">9,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss) attributable to Hologic</a></td>
<td class="nump">1,869,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,871,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,800,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Sep. 25, 2021</a></td>
<td class="nump">4,218,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">5,965,800,000<span></span>
</td>
<td class="nump">$ 298,300,000<span></span>
</td>
<td class="num">(59,100,000)<span></span>
</td>
<td class="num">$ (1,989,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC', window );">Purchase of non-controlling interest reclassified to APIC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ChangeInParValue', window );">Change in par value</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</a></td>
<td class="nump">$ 8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (300,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountingStandardTransitionAdjustmentASU842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounting standard transition adjustment - ASU 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountingStandardTransitionAdjustmentASU842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountingstandardtransitionadjustmentASC606">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounting standard transition adjustment - ASC 606</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountingstandardtransitionadjustmentASC606</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountingstandardtransitionadjustmentASU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounting standard transition adjustment - ASU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountingstandardtransitionadjustmentASU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ChangeInParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in par value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ChangeInParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Reclass Adj. from AOCI on Derivatives, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of non-controlling interest reclassified to APIC</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PurchaseOfNonControllingInterestReclassifiedToAPIC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrealized gain (loss) on interest rate cap, net of taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315137720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,869,700,000<span></span>
</td>
<td class="nump">$ 1,110,500,000<span></span>
</td>
<td class="num">$ (203,600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">88,000,000.0<span></span>
</td>
<td class="nump">83,100,000<span></span>
</td>
<td class="nump">92,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">318,900,000<span></span>
</td>
<td class="nump">292,900,000<span></span>
</td>
<td class="nump">370,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">65,000,000.0<span></span>
</td>
<td class="nump">83,300,000<span></span>
</td>
<td class="nump">62,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes and other non-cash taxes</a></td>
<td class="num">(70,100,000)<span></span>
</td>
<td class="num">(94,400,000)<span></span>
</td>
<td class="num">(235,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Impairmentofintangibleassetsandequipment', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,200,000<span></span>
</td>
<td class="nump">685,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">21,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments and non-cash items</a></td>
<td class="nump">24,300,000<span></span>
</td>
<td class="nump">27,300,000<span></span>
</td>
<td class="nump">33,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">110,900,000<span></span>
</td>
<td class="num">(427,100,000)<span></span>
</td>
<td class="num">(76,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(84,100,000)<span></span>
</td>
<td class="num">(25,300,000)<span></span>
</td>
<td class="num">(63,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">13,000,000.0<span></span>
</td>
<td class="num">(3,800,000)<span></span>
</td>
<td class="num">(3,200,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(56,300,000)<span></span>
</td>
<td class="num">(286,200,000)<span></span>
</td>
<td class="num">(6,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">20,400,000<span></span>
</td>
<td class="num">(4,900,000)<span></span>
</td>
<td class="num">(5,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(4,900,000)<span></span>
</td>
<td class="nump">96,000,000.0<span></span>
</td>
<td class="num">(16,500,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">14,000,000.0<span></span>
</td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="nump">14,400,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,330,400,000<span></span>
</td>
<td class="nump">896,600,000<span></span>
</td>
<td class="nump">649,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="num">(1,164,700,000)<span></span>
</td>
<td class="num">(119,400,000)<span></span>
</td>
<td class="num">(110,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Net proceeds from sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">139,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to Acquire Equity Method Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FundingOfLoansToSSI', window );">Loans to SSI</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(28,400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(96,800,000)<span></span>
</td>
<td class="num">(98,300,000)<span></span>
</td>
<td class="num">(57,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements', window );">Increase in equipment under customer usage agreements</a></td>
<td class="num">(59,400,000)<span></span>
</td>
<td class="num">(58,100,000)<span></span>
</td>
<td class="num">(52,100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Payments to Acquire in Process Research and Development</a></td>
<td class="nump">6,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other activity</a></td>
<td class="num">(2,200,000)<span></span>
</td>
<td class="num">(5,100,000)<span></span>
</td>
<td class="num">(9,900,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,329,600,000)<span></span>
</td>
<td class="num">(141,600,000)<span></span>
</td>
<td class="num">(280,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt', window );">Proceeds from long-term debt, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,497,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(75,000,000.0)<span></span>
</td>
<td class="num">(45,800,000)<span></span>
</td>
<td class="num">(1,465,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProceedsfromSeniorNotes', window );">Proceeds from Senior Notes</a></td>
<td class="nump">936,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RepaymentofSeniorNotes', window );">Repayment of Senior Notes</a></td>
<td class="num">(970,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">750,000,000.0<span></span>
</td>
<td class="nump">480,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments under revolving credit line</a></td>
<td class="num">(250,000,000.0)<span></span>
</td>
<td class="num">(500,000,000.0)<span></span>
</td>
<td class="num">(780,000,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromAccountsReceivableSecuritization', window );">Proceeds from accounts receivable securitization agreement</a></td>
<td class="nump">320,000,000.0<span></span>
</td>
<td class="nump">16,000,000.0<span></span>
</td>
<td class="nump">43,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization', window );">Repayments under accounts receivable securitization agreement</a></td>
<td class="num">(71,500,000)<span></span>
</td>
<td class="num">(250,000,000.0)<span></span>
</td>
<td class="num">(34,000,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(8,500,000)<span></span>
</td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock</a></td>
<td class="num">(409,800,000)<span></span>
</td>
<td class="num">(653,600,000)<span></span>
</td>
<td class="num">(200,100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentsForDeferredAcquisitionConsideration', window );">Payments for Previous Acquisition</a></td>
<td class="nump">1,900,000<span></span>
</td>
<td class="nump">24,300,000<span></span>
</td>
<td class="nump">6,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestRateCapAgreementsAggregatePremiumPayable', window );">Purchase of interest rate caps</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Net proceeds from issuance of common stock under employee stock plans</a></td>
<td class="nump">51,300,000<span></span>
</td>
<td class="nump">65,600,000<span></span>
</td>
<td class="nump">49,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits', window );">Payment of minimum tax withholdings on net share settlements of equity awards</a></td>
<td class="num">(47,500,000)<span></span>
</td>
<td class="num">(14,300,000)<span></span>
</td>
<td class="num">(12,800,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentsUnderFinanceLeaseObligations', window );">Payments under finance lease obligations</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(529,800,000)<span></span>
</td>
<td class="num">(659,900,000)<span></span>
</td>
<td class="num">(431,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(1,700,000)<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="num">(2,200,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">469,300,000<span></span>
</td>
<td class="nump">99,200,000<span></span>
</td>
<td class="num">(64,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">701,000,000.0<span></span>
</td>
<td class="nump">601,800,000<span></span>
</td>
<td class="nump">666,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 1,170,300,000<span></span>
</td>
<td class="nump">$ 701,000,000.0<span></span>
</td>
<td class="nump">$ 601,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FundingOfLoansToSSI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loans to SSI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FundingOfLoansToSSI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Impairmentofintangibleassetsandequipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment of intangible assets and equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Impairmentofintangibleassetsandequipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestRateCapAgreementsAggregatePremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate cap agreements aggregate premium payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestRateCapAgreementsAggregatePremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsForDeferredAcquisitionConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Deferred Acquisition Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsForDeferredAcquisitionConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsUnderFinanceLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments under finance lease obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsUnderFinanceLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsfromSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsfromSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RepaymentofSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RepaymentofSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from other long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307532120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Operations</a></td>
<td class="text">Operations<div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic, Inc. (the &#8220;Company&#8221; or &#8220;Hologic&#8221;) develops, manufactures and supplies premium diagnostics products, medical imaging systems, and surgical products with an emphasis on women's health and well-being through early detection and treatment. Until December 30, 2019, the Company's product portfolio included light-based aesthetic and medical treatment systems sold by its former Medical Aesthetics business. The Company completed the sale of its Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Considerations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption in the markets the Company sells its products into, primarily the U.S., Europe and Asia-Pacific. Starting in the second quarter of fiscal 2020, the spread of COVID-19 negatively impacted business and healthcare activity globally. In particular, due to government measures, elective procedures and exams were delayed or cancelled, there were significant reductions in physician office visits, and hospitals postponed or canceled capital purchases as well as limited or eliminated services; however, in the second half of the third quarter of fiscal 2020, the Company started to see a recovery of elective procedures and exams as economies were opened back up and restrictions eased, which has continued through the fourth quarter of fiscal 2021. The reductions in testing and procedures had a negative impact on the Company's operating results and cash flows in fiscal 2020, however, the impact of the commercial release of its COVID-19 assays more than offset those negative impacts as the Company generated significant revenue from the sales of these assays starting in the third quarter of fiscal 2020 through the fourth quarter of fiscal 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company's results of operations and cash flows since the third quarter of fiscal 2020 have been positively impacted by the sale of its COVID-19 assays as well the continued recovery of its other primary product lines and businesses to pre-COVID levels, the COVID-19 pandemic could have an adverse impact on its operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: reduced demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products as well as the timing and effectiveness of distributing vaccines; the severity and duration of the COVID-19 pandemic; the resurgence of COVID-19 infections; the emergence of new COVID strain variants; the COVID-19 pandemic's impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic and associated economic disruptions. The Company expects that as the current COVID-19 pandemic subsides, there may be a significantly reduced demand for ongoing testing, and thus, for its COVID-19 assays. As expected in the third quarter of fiscal 2021, revenues generated from the sale of its COVID-19 assays decreased significantly in the U.S. compared to the prior year period and the first and second quarters of fiscal 2021 as the population of vaccinated people continues to grow in the U.S. In the fourth quarter of fiscal 2021, COVID-19 assay revenues increased compared to the preceding quarter primarily due to the impact of the delta strain of COVID-19 resulting in higher demand for testing, however COVID-19 assay revenues decreased compared to the corresponding prior year period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the negative impact of COVID-19 on the Company's business, in April 2020, the Company initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but the Company also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances, effected employee terminations. Further in April 2020, the Company shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of its products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased During fiscal 2021, the majority of the impacted manufacturing facilities were back to pre-COVID levels. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also taken and continue to take measures to ensure the safety of its employees and to comply with governmental orders. These measures could require that the Company's employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in the Company's commercial and marketing activities. In addition, complying with government and customer vaccine mandates that apply to the Company may lead to employee attrition, disruption to the Company's workforce and result in additional costs associated with implementation and on-going compliance, which could have an adverse impact on the Company's operating results, cash flows and financial condition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307289064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#8217;s fiscal year ends on the last Saturday in September. Fiscal 2021, 2020 and 2019 ended on September&#160;25, 2021, September&#160;26, 2020 and September&#160;28, 2019, respectively. Fiscal 2021, 2020 and 2019 were 52-week years.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events Consideration</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events, except as described below, recorded in the consolidated financial statements as of and for the year ended September&#160;25, 2021. On September 27, 2021, the Company refinanced its term loan and revolving credit facility. For additional information, refer to Note 7. On October 14, 2021, the Company announced that it had entered into an agreement to acquire Bolder Surgical, Inc. ("Bolder Surgical") for a purchase price of approximately $160.0&#160;million. The closing is subject to certain regulatory approvals, but the Company expects to close this acquisition by the end of calendar 2021. Bolder Surgical, located in Louisville, CO, is a developer and manufacturer of energy vessel sealing surgical devices in both laparoscopic and open procedures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Estimates and Uncertainties</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#8217;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#8217;s net deferred tax assets and related valuation allowances, and stock-based compensation.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#8217;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers are principally located in the U.S., Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;25, 2021. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no customers with a balance greater than 10% of accounts receivable as of September&#160;25, 2021. There was one customer with a balance greater than 10% of accounts receivable as of September&#160;26, 2020, at 11.9%. There were no customers that represented greater than 10% of consolidated revenues for fiscal years 2021, 2020 and 2019.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Suppliers</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company purchases certain components of its products from a single or small number of suppliers. A change in or loss of these suppliers could cause a delay in filling customer orders and a possible loss of sales, which could adversely affect results of operations.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flow Statement Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.911%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration at acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#8217;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#8217;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"><tr><td style="width:1.0%"/><td style="width:52.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:36.030%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;10 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;8 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#8211;35 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the Original Term of Lease</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or Estimated Useful Life</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#8211;7 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020 and October 2020, the Company was awarded grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants are specifically to fund the capital equipment and labor investments needed to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procures and pays for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to paying for the capital equipment, the DOD will reimburse the Company upon it meeting certain requirements  However, the DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts. As of September 25, 2021, the Company had $95.2 million of capital equipment related to the DOD grant that was awaiting approval. In fiscal 2021, the Company received $21.2&#160;million from the DOD under these grants which has been recorded as a reduction of the cost basis of the purchased equipment. Payments under these grants are subject to satisfaction of the conditions of the grants.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment&#8212;Impairment or Disposal of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique. </span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations and Acquisition of Intangible Assets</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company accounts for the acquisition of a business in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results specifically revenue growth rates. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets and Goodwill</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are initially recorded at fair value and stated net of accumulated amortization and impairments. The Company amortizes its intangible assets that have finite lives using either the straight-line method, or if reliably determinable, based on the pattern in which the economic benefit of the asset is expected to be utilized. Amortization is recorded over the estimated useful lives ranging from 2 to 30 years. The Company evaluates the recoverability of its definite lived intangible assets whenever events or changes in circumstances or business conditions indicate that the carrying value of these assets may not be recoverable based on expectations of future undiscounted cash flows for each asset group. If the carrying value of an asset or asset group exceeds its undiscounted cash flows, the Company estimates the fair value of the assets, generally utilizing a discounted cash flow analysis based on the present value of estimated future cash flows to be generated by the assets using a risk-adjusted discount rate. To estimate the fair value of the assets, the Company uses market participant assumptions pursuant to ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite lived intangible assets, such as IPR&amp;D assets, are required to be tested for impairment annually, or more frequently if indicators of impairment are present. The Company&#8217;s annual impairment test date is as of the first day of its fourth quarter. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:36.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,597.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,533.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,890.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,582.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,922.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Aesthetics Impairment</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, the Company's Medical Aesthetics business met the criteria to be designated as assets held-for-sale. As a result, the Company recorded a $30.2&#160;million charge to record the asset group at fair value less costs to sell. See Note 15 for additional information.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company identified indicators of impairment for its Medical Aesthetics reporting unit as a result of reductions in forecasts during the year, and in connection with the Company&#8217;s efforts to sell the business that began prior to the end of fiscal 2019. In performing the undiscounted cash flow analysis pursuant to ASC 360, the expected undiscounted cash flows of the asset group were determined using a probability-weighted approach taking into consideration the planned disposition, which was deemed to be highly probable as of the balance sheet date. Based on this analysis, the undiscounted cash flows were not sufficient to recover the carrying value of the asset group. As a result, the Company was required to perform Step 3 of the impairment test and determine the fair value of the asset group. The Company executed a definitive agreement on November 20, 2019 to sell the business. Although this agreement was signed subsequent to the balance sheet date, the Company concluded that it provided evidence regarding the estimate of fair value of the asset group at September 28, 2019 and that there were no events that occurred between September 28, 2019 and the date the Company entered into the definitive agreement that would significantly affect the fair value of the asset group. As a result, the Company recorded total impairment charges of $685.4&#160;million in fiscal 2019. The impairment charge was allocated to the long-lived assets as follows: $576.9 million to developed technology, $22.4 million to customer relationships, $48.6 million to trade names, $27.7 million to distribution agreements and $9.8 million to equipment. On November 20, 2019, this asset group met the assets held-for-sale criteria and was recorded at fair value less the costs to sell as noted above.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Activity</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, the Company acquired Mobidiag Oy and recorded $285.0&#160;million of developed technology, $74.0&#160;million of in-process research and development, $20.9&#160;million of customer relationships and $20.0&#160;million of trade names based on its preliminary purchase accounting. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2021, the Company acquired Biotheranostics, Inc. and recorded $160.3&#160;million of developed technology and $2.1&#160;million of trade names based on its preliminary purchase accounting. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2021, the Company acquired Diagenode SA and recorded $69.8&#160;million of developed technology and $9.2&#160;million of customer relationships based on its preliminary purchase accounting. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2021, the Company acquired Somatex Medical Technologies GmbH and recorded $38.0&#160;million of developed technology, $1.2&#160;million of customer relationships and $0.9&#160;million of trade names based on its preliminary purchase accounting.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of fiscal 2020, the Company acquired Acessa Health, Inc. and recorded $127.0&#160;million of developed technology and $1.2&#160;million of trade names.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to developed technology is classified as cost of product revenues&#8212;amortization of intangible assets. Amortization expense related to customer relationships, contracts, trade names, and business licenses is classified as a component of amortization of intangible assets within operating expenses.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amortization expense at September&#160;25, 2021 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 350), the Company tests goodwill for impairment annually at the reporting unit level and between annual tests if events and circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying value. Events that could indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate, operational performance of the business or key personnel, and an adverse action or assessment by a regulator. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the impairment test, the Company utilizes the single-step approach prescribed under Accounting Standards Update No. 2017-04,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASU 2017-04). This approach requires a comparison of the carrying value of each reporting unit to its estimated fair value and to the extent the carrying value exceeds the fair value a charge is recorded up to the amount of goodwill in the reporting unit. To estimate the fair value of its reporting units, the Company primarily utilizes the income approach. The income approach is based on a DCF analysis and calculates the fair value by estimating the after-tax cash flows attributable to a reporting unit and then discounting the after-tax cash flows to present value using a risk-adjusted discount rate. Assumptions used in the DCF require significant judgment, including judgment about appropriate discount rates and terminal values, growth rates, and the amount and timing of expected future cash flows. The forecasted cash flows are based on the Company&#8217;s most recent budget and strategic plan and for years beyond this period, the Company&#8217;s estimates are based on assumed growth rates expected as of the measurement date. The Company believes its assumptions are consistent with the plans and estimates used to manage the underlying businesses. The discount rates used are intended to reflect the risks inherent in future cash flow projections and are based on estimates of the weighted-average cost of capital (&#8220;WACC&#8221;) of market participants relative to each respective reporting unit. The market approach considers comparable market data based on multiples of revenue or earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) and is primarily used as a corroborative analysis to the results of the DCF analysis. The Company believes its assumptions used to determine the fair value of its reporting units are reasonable. If different assumptions were used, particularly with respect to forecasted cash flows, terminal values, WACCs, or market multiples, different estimates of fair value may result and there could be the potential that an impairment charge could result. Actual operating results and the related cash flows of the reporting units could differ from the estimated operating results and related cash flows.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducted its fiscal 2021 impairment test for its reporting units on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of June 27, 2021, and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of the Company's reporting units had fair values exceeding their carrying values. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;25, 2021, the Company believes that its reporting units, with goodwill aggregating $3.3&#160;billion, were not at risk of failing the goodwill impairment test based on its current forecasts and qualitative assessment.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducted its fiscal 2020 impairment test for its reporting units on the first day of the fourth quarter, and as noted above used DCF and market approaches to estimate the fair value of its reporting units as of June 28, 2020, and ultimately used the fair value determined by the DCF approach in making its impairment test conclusions. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing this analysis, all of the Company's reporting units had fair </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">values exceeding their carrying values. For illustrative purposes, had the fair value of each of the reporting units been lower by 10%, all of the reporting units would still have passed the goodwill impairment test.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of goodwill activity by reportable segment from September&#160;26, 2020 to September&#160;25, 2021 is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"><tr><td style="width:1.0pt"/><td style="width:130.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:57.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:57.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Breast&#160;Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GYN&#160;Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skeletal&#160;Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,657.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mobidiag acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagenode acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biotheranostics acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somatex acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 25, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,065.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,281.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"><tr><td style="width:1.0%"/><td style="width:40.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-method equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax receivable in fiscal 2020 primarily related to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. This receivable was reclassified to a current asset in fiscal 2021 as the Company filed the carryback claim and expects to receive the refund within the next twelve months, subject to Internal Revenue Service processing times. The right of use assets were recorded in connection with the adoption of ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#8217;s Nonqualified Deferred Compensation Plan (&#8220;DCP&#8221;) and are recorded at their cash surrender value (see Note 12 for further discussion). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Software Development Costs</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred for the research and development of the Company&#8217;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the development costs of software embedded in the Company&#8217;s products in accordance with ASC 985, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#8217;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimated useful life and recorded within cost of revenues - product.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries are translated in accordance with ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#8217;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income (expense), net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss), which is a separate component of stockholders&#8217; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income (expense), net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#8217; equity. The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charges (gains) reclassified to statement of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5&#160;million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $1.0 billion of principal, which ended on December 27, 2019 (the first quarter of fiscal 2020) for the contracts entered into in fiscal 2018, and on December 23, 2020 (the first quarter of fiscal 2021) for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, 2020 and 2019, interest expense of $0.5 million, $2.3 million and $3.1 million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The last interest rate cap agreement matured as of December 26, 2020.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI and net of taxes were a gain of $9.4&#160;million, a loss of $27.6&#160;million and a gain of $3.5 million for fiscal years 2021, 2020, and 2019, respectively. The fair value of this derivative was in a liability position of $18.7 million as of September 25, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 25, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of certain of the Company's cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $861.5 million. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:23pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:47.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.280%"><tr><td style="width:1.0%"/><td style="width:48.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.983%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trade Receivables and Allowance for Credit Losses</span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective September 27, 2020, the Company adopted ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the COVID-19 pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a rollforward of the allowance for credit losses for fiscal 2021, 2020 and 2019:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#8217;s professional services, employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based payments in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 718)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#8217;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled. </span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options and restricted stock units for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts for fiscal 2021, 2020, and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In those reporting periods in which the Company has reported net income, anti-dilutive shares generally are comprised of those stock options that either have an exercise price above the average stock price for the period or the stock options&#8217; combined exercise price and average unrecognized stock compensation expense upon exercise is greater than the average stock price. In those reporting periods in which the Company has a net loss, anti-dilutive shares are comprised of the impact of those number of shares that would have been dilutive had the Company had net income plus the number of common stock equivalents that would be anti-dilutive had the company had net income.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally offers a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM5NTc0_257c2dd2-2a08-4cdf-8688-8a506165be31">one</span>-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#8217;s warranty reserves include the </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity for fiscal 2021 and 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.406%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at&#160;End<br/>of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $9.8 million, $15.6 million and $29.5 million for fiscal 2021, 2020 and 2019, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently a number of improvements. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The Company adopted the standard in the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in this Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the standard in the first quarter of fiscal 2021. The adoption of ASU 2019-08 did not have a material effect on the Company's consolidated financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The FASB issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The FASB issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The FASB issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the FASB issued ASU No. 2021-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842), Lessors - Certain Leases with Variable Lease Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU addresses an issue related to a lessor's accounting for certain leases with variable lease payments. The amendments in this Update affect lessors with lease contracts that (1) have variable lease payments that do not depend on a reference index or a rate and (2) would have resulted in the recognition of a selling loss at lease commencement if classified as a sales-type lease or a direct financing lease. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021, and is applicable to the Company in fiscal 2023. The Company is currently evaluating the impact of the adoption of ASU 2021-05 on its consolidated financial position and results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876308758984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenue pursuant to ASC Update No. 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. Prior to the Cynosure divestiture, the Company also generated revenue from the sale and service of medical aesthetic treatment systems. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"/><td style="width:2.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.980%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,171.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,301.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,695.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,902.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"><tr><td style="width:1.0%"/><td style="width:37.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.765%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.171%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,902.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"/><td style="width:32.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:20.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefit of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts. The Company's contracts typically do not provide the right to return product. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 25, 2021, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $830.6 million. These remaining performance obligations primarily relate to extended warranty and support and maintenance obligations in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately 40% of this amount as revenue in 2022, 27% in 2023, 18% in 2024, 10% in 2025, and 5% thereafter. The Company has applied the practical expedient to not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments. Contract liabilities are classified as other current liabilities and other long-term liabilities on the Consolidated Balance Sheets. The Company recognized revenue of $112.1&#160;million and $106.2 million in the years ended September 25, 2021 and September 26, 2020, respectively, that was included in the contract liability balance at September 26, 2020 and September 28, 2019, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical Expedients</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317447416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, referred to as ASC 842. The purpose of ASU 2016-02 was to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Targeted Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not have a significant amount of sales-type leases. Prior to the adoption of ASC 842, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156">96.6&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100">21.0&#160;million</span>, respectively. This included recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements were included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 14 years, some of which may include options to extend the leases for up to 10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;25, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating and finance lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;25, 2021 was 2.25%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:24.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da">Accrued expenses</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Diagenode SA acquisition, the Company acquired two finance leases. The Company accounted for these lease agreements pursuant to ASC 842 and ASC 805 and recorded both an asset and liability at the present value of future lease payments as part of the purchase accounting. The finance leases are for two facilities with remaining lease terms of 7 and 11 years and contain a bargain purchase option of 3% at the end of the lease term. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"><tr><td style="width:1.0%"/><td style="width:36.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.099%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"><tr><td style="width:1.0%"/><td style="width:2.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:61.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.031%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new finance lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company&#8217;s consolidated revenue for all periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the disposition of the Medical Aesthetics business in fiscal 2020, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease and recorded a lease receivable, which is $17.4&#160;million as of September&#160;25, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases a portion of a building it owns and subleases some of its rented facilities and has received aggregate rental income of $2.6 million, $2.0 million and $2.7 million in fiscal 2021, 2020 and 2019, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"><tr><td style="width:1.0%"/><td style="width:77.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, referred to as ASC 842. The purpose of ASU 2016-02 was to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Targeted Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not have a significant amount of sales-type leases. Prior to the adoption of ASC 842, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156">96.6&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100">21.0&#160;million</span>, respectively. This included recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements were included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 14 years, some of which may include options to extend the leases for up to 10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;25, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating and finance lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;25, 2021 was 2.25%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:24.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da">Accrued expenses</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Diagenode SA acquisition, the Company acquired two finance leases. The Company accounted for these lease agreements pursuant to ASC 842 and ASC 805 and recorded both an asset and liability at the present value of future lease payments as part of the purchase accounting. The finance leases are for two facilities with remaining lease terms of 7 and 11 years and contain a bargain purchase option of 3% at the end of the lease term. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"><tr><td style="width:1.0%"/><td style="width:36.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.099%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"><tr><td style="width:1.0%"/><td style="width:2.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:61.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.031%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new finance lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company&#8217;s consolidated revenue for all periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the disposition of the Medical Aesthetics business in fiscal 2020, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease and recorded a lease receivable, which is $17.4&#160;million as of September&#160;25, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases a portion of a building it owns and subleases some of its rented facilities and has received aggregate rental income of $2.6 million, $2.0 million and $2.7 million in fiscal 2021, 2020 and 2019, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"><tr><td style="width:1.0%"/><td style="width:77.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, referred to as ASC 842. The purpose of ASU 2016-02 was to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Targeted Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not have a significant amount of sales-type leases. Prior to the adoption of ASC 842, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156">96.6&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100">21.0&#160;million</span>, respectively. This included recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements were included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 14 years, some of which may include options to extend the leases for up to 10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;25, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating and finance lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;25, 2021 was 2.25%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:24.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da">Accrued expenses</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Diagenode SA acquisition, the Company acquired two finance leases. The Company accounted for these lease agreements pursuant to ASC 842 and ASC 805 and recorded both an asset and liability at the present value of future lease payments as part of the purchase accounting. The finance leases are for two facilities with remaining lease terms of 7 and 11 years and contain a bargain purchase option of 3% at the end of the lease term. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"><tr><td style="width:1.0%"/><td style="width:36.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.099%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"><tr><td style="width:1.0%"/><td style="width:2.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:61.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.031%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new finance lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company&#8217;s consolidated revenue for all periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the disposition of the Medical Aesthetics business in fiscal 2020, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease and recorded a lease receivable, which is $17.4&#160;million as of September&#160;25, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases a portion of a building it owns and subleases some of its rented facilities and has received aggregate rental income of $2.6 million, $2.0 million and $2.7 million in fiscal 2021, 2020 and 2019, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"><tr><td style="width:1.0%"/><td style="width:77.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU No. 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, referred to as ASC 842. The purpose of ASU 2016-02 was to increase the transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet, including those previously classified as operating leases under GAAP, and disclosing key information about leasing arrangements. ASC 842, as amended, was effective for the Company in fiscal 2020. The Company adopted the standard using the transition method provided by ASC Update No. 2018-11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842): Targeted Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under this method, the Company applied the new lease standard on September 29, 2019, rather than at the earliest comparative period presented in the financial statements.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon transition, the Company applied the package of practical expedients permitted under ASC 842 transition guidance to its entire lease portfolio at September 29, 2019. As a result, the Company was not required to reassess (i) whether any expired or existing contracts are or contain leases, (ii) the classification of any expired or existing leases, and (iii) initial direct costs for any existing leases. Furthermore, as a lessee the Company elected to combine lease and non-lease components together for the majority of its leases. As a result, for these applicable classes of underlying assets, the Company accounted for each separate lease component and the non-lease components associated with that lease component as a single lease component. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under ASC 842 as a lessor, in instances where the Company places instruments (or equipment) at customer sites as part of its reagent rental contracts, certain of the Company's reagent rental contracts could be classified as sales-type leases. Under sales-type leases, there is accelerated expense recognition for the cost of the placed equipment and potentially up-front revenue in the event there are fixed rental payments, a portion of which would be allocated to the equipment. The Company does not have a significant amount of sales-type leases. Prior to the adoption of ASC 842, all instruments placed under the Company's reagent rental programs were classified as operating leases and instrument revenue and cost were recognized over the term of the contract. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Upon adoption of the new lease standard, the Company recognized operating lease right-of-use assets and finance lease right-of-use assets of $91.7&#160;million and $10.2&#160;million, respectively, and corresponding operating lease liabilities and finance lease liabilities of $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3Nzk_d1c90835-aea0-4d94-9d42-ef6e6f0ee156">96.6&#160;million</span> and $<span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90ZXh0cmVnaW9uOjRkNjk4MzBmMjEwNTQ3OWU5NzFiYTQwNDFkM2FmNWM4XzI3ODY_eff38e26-9a7e-4f8f-877b-132b701b3100">21.0&#160;million</span>, respectively. This included recording the Company&#8217;s existing capital lease as a finance lease at transition. In addition, the Company derecognized $32.6&#160;million of property, plant and equipment and $35.2&#160;million of finance lease obligations recorded in accrued expenses and other long-term liabilities associated with two previously existing build-to-suit lease arrangements. Right-of-use assets and corresponding liabilities for these build-to-suit lease arrangements were included within the total amount recognized upon adoption of the new lease standard.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee Activity - Leases where Hologic is the Lessee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's facilities are occupied under operating lease arrangements with various expiration dates through 2035, some of which include options to extend the term of the lease, and some of which include options to terminate the lease within one year. The Company has operating leases for office space, land, warehouse and manufacturing space, vehicles and certain equipment. Leases with an initial term of 12 months or less are generally not recorded on the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. For leases executed in fiscal 2020 and later, the Company accounts for the lease components and the non-lease components as a single lease component. The Company's leases have remaining lease terms of one year to approximately 14 years, some of which may include options to extend the leases for up to 10 years and some include options to terminate early. These options have been included in the determination of the lease liability when it is reasonably certain that the option will be exercised. The Company does not have any leases that include residual value guarantees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. The right-of-use assets and related liabilities for operating leases are included in other assets, accrued expenses, and other long-term liabilities in the consolidated balance sheet as of September&#160;25, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease contract. Operating and finance lease liabilities and their corresponding right-of-use assets are recorded based on the present value of fixed lease payments over the expected lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the incremental borrowing rate, which is the estimated rate that would be incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The weighted average discount rate utilized on the Company's operating and finance lease liabilities as of September&#160;25, 2021 was 2.25%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:24.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da">Accrued expenses</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Diagenode SA acquisition, the Company acquired two finance leases. The Company accounted for these lease agreements pursuant to ASC 842 and ASC 805 and recorded both an asset and liability at the present value of future lease payments as part of the purchase accounting. The finance leases are for two facilities with remaining lease terms of 7 and 11 years and contain a bargain purchase option of 3% at the end of the lease term. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"><tr><td style="width:1.0%"/><td style="width:36.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.099%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"><tr><td style="width:1.0%"/><td style="width:2.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:61.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.031%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new finance lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity - Leases where Hologic is the Lessor</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company&#8217;s consolidated revenue for all periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the disposition of the Medical Aesthetics business in fiscal 2020, the Company entered into an agreement to sublease to Cynosure its U.S. headquarters and manufacturing location. As such, the Company derecognized $10.2&#160;million for the right-of-use asset for the finance lease and recorded a lease receivable, which is $17.4&#160;million as of September&#160;25, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases a portion of a building it owns and subleases some of its rented facilities and has received aggregate rental income of $2.6 million, $2.0 million and $2.7 million in fiscal 2021, 2020 and 2019, respectively, which has been recorded as an offset to operating lease costs. The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"><tr><td style="width:1.0%"/><td style="width:77.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorSalesTypeLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's sales-type leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorSalesTypeLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph Note 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph Note 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876322179880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During fiscal 2021, 2020, and 2019, the Company completed several business combinations for a total consideration of $1,178.9 million, $269.0 million and $120.1 million, respectively. The business combinations resulted in the recognition of intangible assets, goodwill and other assets and liabilities summarized below. During 2021, the Company also completed an asset acquisition of customer relationship assets of $5.6 million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mobidiag Oy</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2021, the Company completed the acquisition of Mobidiag Oy ("Mobidiag"), for a purchase price of $729.6&#160;million. Mobidiag, located in Finland, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. Mobidiag's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based on the estimated fair values as of June 17, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Mobidiag's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily related to deferred income taxes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are development technology, in-process research and development ("IPR&amp;D"), customer relationships and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 15.0% to 19.0%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology assets are comprised of know-how, patents and technologies embedded in Mobidiag's products and relate to currently marketed products. The developed technology assets comprise the primary product families under the Novodiag and Amplidiag technology platforms.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IPR&amp;D project relates to an in-process project that has not reached technological feasibility as of the acquisition date and has no alternative future use. The primary basis for determining technological feasibility of the project is obtaining regulatory approval to market the underlying product. The asset recorded relates to one project, and the Company expects to complete the project over the next three years. In the fourth quarter of fiscal 2021, the Company updated its valuation of IPR&amp;D assets based on facts that existed at the date of acquisition and recorded a $29.0&#160;million decrease to the IPR&amp;D intangible asset value. Given the uncertainties inherent with product development and introduction, there can be no assurance that the Company's product development efforts will be successful, completed on a timely basis or within budget, if at all. The IPR&amp;D asset was valued using the income approach.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary estimate of the weighted average life for the developed technology assets range from 8 to 12 years, customer relationships range from 5 to 10 years, and tradenames range from 8 to 12 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Mobidiag acquisition. These benefits include expanding the Company's molecular diagnostics portfolio into the near-patient testing market and utilizing the Diagnostic's commercial sales, manufacturing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biotheranostics</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, the Company completed the acquisition of Biotheranostics, Inc. ("Biotheranostics"), for a purchase price of $231.3&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs the lab testing procedures at its facility. Biotheranostics' results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition and its revenues are reported within service and other revenue in the Company's consolidated statement of income and within service revenue in the disclosure of disaggregated revenue in Note 3.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Biotheranostics' business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated synergistic benefits of adding Biotheranostics' Clinical Laboratory Improvement Amendments (CLIA) lab to the Company's portfolio of offerings and of utilizing Diagnostic's marketing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagenode</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, the Company completed the acquisition of Diagenode SA ("Diagenode") for a purchase price of $155.1&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR (polymerase chain reaction) technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Diagenode's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily related to deferred income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and customer relationships. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 14.5% rate for developed technology and a 13.5% rate for customer relationships. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and customer relationships is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Diagenode's products broadening the Diagnostics portfolio of molecular diagnostics products primarily in the transplant and acute care gastrointestinal and respiratory space as customers seek a broader menu of tests, utilizing Diagnostic's sales force to drive menu expansion and revenue growth and gaining additional PCR assay development expertise. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Somatex Medical Technologies</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2020, the Company completed the acquisition of Somatex Medical Technologies GmbH ("Somatex") for a purchase price of $62.9&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. The allocation of the purchase price is based on the Company's preliminary valuation, and it allocated $38.0&#160;million to the preliminary value of developed technology, $1.2&#160;million to customer relationships, $0.9&#160;million to trade names and $32.4&#160;million to goodwill. The remaining $9.6&#160;million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily related to deferred income taxes. Somatex' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging for a purchase price of $5.6&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal Health products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$162.0&#160;million, which included a hold-back of $3.0&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Business Combinations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company is required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. For the year ended September 25, 2021, the Company remeasured the contingent consideration liability and recorded a gain of $6.7&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period, partially offset by a lower discount rate and accretion of the liability based on the passage of time. As of September 25, 2021, the Company&#8217;s contingent consideration liability was $75.1 million, $16.3 million of which was recorded within accrued expenses and $58.8 million was recorded within other long-term liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"><tr><td style="width:1.0%"/><td style="width:5.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:68.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.718%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using an 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons") for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's valuation, it allocated $10.7&#160;million to developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging") for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration which the Company estimated at $0.9&#160;million. The contingent consideration was payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal Health products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine SA ("SSI") for $18.2&#160;million. SSI was a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting and included its proportionate share of SSI's net loss of $3.3&#160;million for the two months ended September 28, 2019 within Other income (expense), net. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional 7.6&#160;million of SSI's common shares for $12.6&#160;million. As a result, the Company owned approximately 78% of the outstanding common shares at November 21, 2019, and controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2&#160;million recorded to other income (expense), net in the first quarter of fiscal 2020. The total accounting purchase price was $69.3&#160;million, which consisted of $17.9&#160;million for the equity method investment in SSI, $12.6&#160;million for shares acquired on November 21, 2019, $30.2&#160;million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6&#160;million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1&#160;million outstanding shares in fiscal 2020 for $1.8&#160;million. In the third quarter of fiscal 2021, the Company purchased the remaining 4.8&#160;million shares outstanding for $8.5&#160;million and as of September 25, 2021, the Company owned 100% of the outstanding shares of SSI.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on anticipated synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Focal Therapeutics</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, the Company completed the acquisition of Focal Therapeutics, Inc. ("Focal") for a purchase price of $120.1&#160;million, which included hold-backs of $14.0&#160;million payable up to one year from the date of acquisition. In the second quarter of fiscal 2019, $1.5&#160;million of the hold-back was paid, and the remaining $12.5&#160;million was paid in the first quarter of fiscal 2020. Focal, headquartered in California, manufactures and markets its BioZorb marker, which is an implantable three-dimensional marker that helps clinicians overcome certain challenges in breast conserving surgery. Focal's results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Focal's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, in-process research and development, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from&#160;15.5%&#160;to 16.5%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names was 11 years and 13 years, respectively. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the amount of goodwill were based on synergistic benefits that are expected to be realized from this acquisition. Benefits include the expectation of broadening the Company's Breast Health portfolio of products and technology. None of the goodwill is expected to be deductible for income tax purposes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307260952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Charges</a></td>
<td class="text">Restructuring and Divestiture Charges<div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its operations for opportunities to improve operational effectiveness and efficiency, including facility and operations consolidation, and to better align expenses with revenues. As a result of these assessments, the Company has undertaken various restructuring actions which are described below. The following table displays charges taken related to restructuring actions in fiscal 2021, 2020 and 2019 and a rollforward of the charges to the accrued balances as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.596%"><tr><td style="width:1.0%"/><td style="width:34.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.781%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.460%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2021 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Restructuring Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 charges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021 restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2021 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2018 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Previous Other Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Rollforward of Accrued Restructuring</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 29, 2018</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 28, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments and adjustments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 26, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021 restructuring charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 25, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1) In fiscal 2020, as part of the adoption of ASC 842, the Company reclassified $3.8&#160;million from a lease liability to offset the right of use asset on the Company's consolidated balance sheet.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2021 Actions</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, the Company made various decisions to terminate certain individuals across all divisions in multiple departments and close certain manufacturing facilities for minor product lines. The Company recorded $8.7&#160;million for severance and benefits related to these actions, which occurred in the U.S. and various international locations. The charges were recorded pursuant to ASC 712, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation-Nonretirement Postemployment Benefits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 712) or ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 420), depending on the employee.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2020 Actions</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020, the Company made various decisions to terminate certain personnel across all divisions in multiple departments, transfer production and close certain manufacturing facilities for minor product lines. The Company recorded charges totaling $13.4&#160;million for severance and benefits related to these actions. The charges were recorded pursuant to ASC 712 or ASC 420, depending on the employee. Included within this charge was $5.0&#160;million related to the modification of equity awards for a certain executive. These actions are complete.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, the Company recorded net divestiture charges of $1.9&#160;million. The charge included $1.3&#160;million to dispose of the Company's life sciences testing business located in the UK, which performed research testing for pharmaceutical companies. Separately, in connection with the Cynosure divestiture, the Company accelerated stock compensation expense and other benefits of $2.6&#160;million, partially offset by other adjustments of $2.0&#160;million.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal 2019 Actions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company decided to transfer certain shared services positions to its Costa Rica facility from its Marlborough location and announced the termination of certain personnel and implemented other employee termination actions. The charges for these actions were recorded pursuant to ASC 420 for one-time termination benefits. The Company recorded severance benefits charges of $4.0 million in fiscal 2019 related to these actions and this action was completed in the first quarter of fiscal 2020. The Company also recorded $1.0&#160;million of severance charges in fiscal 2019 related to 2018 actions that were recorded pursuant to ASC 420.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closure of the Bedford location during the first quarter of fiscal 2017, the Company recorded $3.5 million for lease obligation charges related to the first floor of the facility as the Company determined it had met the cease-use date criteria. The Company made certain assumptions regarding the time period it would take to obtain a subtenant and the sublease rates it could obtain. During the third quarter of fiscal 2017, the Company updated its assumption regarding the time period it would take to obtain a subtenant at the Bedford location and as a result recorded an additional $1.3 million lease obligation charge. During the third quarter of fiscal 2018, the Company further adjusted its assumptions and lowered the estimate of the sublease income rate and extended the time period to obtain a sub-tenant. As a result, the Company recorded an additional charge of $1.6 million. During the third quarter of fiscal 2019, the Company further updated its assumption regarding its ability to sublet the first floor and recorded an additional lease obligation charge of $1.4 million. These estimates may vary from the actual sublease agreements executed, if any, resulting in an adjustment to the charge. The Company has vacated other portions of the building but not the entire facility, and at this time does not meet the cease-use date criteria to record additional restructuring charges. In connection with the adoption of ASC 842, the Company reclassified the remaining accrued lease balance of $3.8&#160;million from restructuring to offset the right of use assets on the consolidated balance sheet.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317614024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Agreements</a></td>
<td class="text">Borrowings and Credit Agreements<div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,382.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,712.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,025.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt maturity schedule for the Company&#8217;s obligations as of September&#160;25, 2021 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.583%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2027 and Thereafter </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;*The Term Loan debt maturity schedule herein represents the 2018 Credit Agreement as of September 25, 2021. The Company amended the credit agreement on September 27, 2021, which resulted in a change in the principal maturity schedule.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement as of October 3, 2017 ("2017 Credit Agreement"). </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2018 Credit Agreement consisted of:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $1.5 billion secured term loan ("2018 Term Loan") with a maturity date of December 17, 2023; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility ("2018 Revolver") under which the Company could borrow up to $1.5 billion, subject to certain sublimits, with a maturity date of December 17, 2023.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2018 Credit Agreement bore interest, at the Company's option and in each case plus an applicable margin as follows: </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">2018 Term Loan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: at the Base Rate, Eurocurrency Rate or LIBOR Daily Floating Rate,&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">2018 Revolver</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: if funded in U.S. dollars, the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate, and, if funded in an alternative currency, the Eurocurrency Rate; and if requested under the swing line sublimit, the Base Rate.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 25, 2021, the Company had no amounts outstanding under the 2018 Revolver and the interest rate under the 2018 Term Loan was 1.08%.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable margin to the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate was subject to specified changes depending on the total net leverage ratio as defined in the 2018 Credit Agreement. The borrowings of the 2018 Term Loan initially bore interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate equal to 1.00%. The borrowings of the 2018 Revolver initially bore interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% at September 25, 2021. The Company was also required to pay a quarterly commitment fee calculated on the undrawn committed amount available under the 2018 Revolver.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was required to make scheduled principal payments under the 2018 Term Loan in increasing amounts ranging from $9.375 million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $28.125 million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Term Loan after the scheduled principal payments, which was $1.2 billion, and any amounts outstanding under the 2018 Revolver were due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, the Company could have been required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments were required to be applied by the Company,&#160;first, to the 2018 Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company could have voluntarily prepaid any of the 2018 Credit Facilities without premium or penalty.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contained affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement required the Company to maintain certain financial ratios. The 2018 Credit Agreement also contained customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings were secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company and its U.S. subsidiaries, with certain exceptions. The 2018 Credit Agreement contained total net leverage ratio and interest coverage ratio financial covenants measured as of the last day of each fiscal quarter. The total net leverage ratio covenant was 5.00:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and would have remained as such until it decreased to 4.50:1.00 for the quarter ending June 25, 2022. The interest coverage ratio covenant was 3.75:1.00 beginning on the Company's fiscal quarter ended December 29, 2018, and remained as such for each quarter thereafter. The total net leverage ratio was defined as the ratio of the Company's consolidated net debt as of the quarter end to its consolidated adjusted EBITDA (as defined in the 2018 Credit Agreement) for the four-fiscal quarter period ending on the measurement date. The interest coverage ratio was defined as the ratio of the Company's consolidated adjusted EBITDA for the prior four-fiscal quarter period ending on the measurement date to adjusted consolidated cash interest expense (as defined in the 2018 Credit Agreement) for the same measurement period. The Company was in compliance with these covenants as of September 25, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2018 Credit Agreement for derivatives pursuant to ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and identified embedded derivatives that required bifurcation as the features were not clearly and closely related to the host instrument. The embedded derivatives were a default provision, which could require additional interest payments, and a provision requiring contingent payments to compensate the lenders for changes in tax deductions. The Company determined that the fair value of these embedded derivatives was nominal as of September 25, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 470), the accounting related to entering into the 2018 Credit Agreement and using the proceeds to pay off the 2017 Credit Agreement was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2017 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $0.8 million in the first quarter of fiscal 2019. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two debt instruments before and after the transaction was less than 10%. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement and the 2017 Credit Agreement was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Credit Agreement - Subsequent Event</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2021, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility under the 2018 Credit Agreement by entering into Refinancing Amendment No. 2 dated as of September 27, 2021, to the Amended and Restated Credit and Guaranty Agreement as of October 3, 2017, as amended (the "2021 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2021 Credit Agreement amends the Company's 2018 Credit Agreement. Substantially all of the proceeds under the 2021 Credit Agreement of $1.5&#160;billion were used to repay the amounts outstanding under the 2018 Credit Agreement. Borrowings under the 2021 Credit Agreement are secured by first-priority liens on, and a first-priority security interest in (in each case subject to certain liens permitted under the 2021 Credit Agreement), substantially all of the Company's U.S. assets of the Subsidiary Guarantors. These liens are subject to release during the term of the facilities if the Company is able to achieve certain corporate or corporate family ratings and other conditions are met. The credit facilities under the 2021 Credit Agreement consist of:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $1.5&#160;billion secured term loan ("2021 Term Loan") with a maturity date of September 25, 2026; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility ("2021 Revolver") under which the Company may borrow up to $2.0&#160;billion, subject to certain sublimits, with a maturity date of September 25, 2026.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the 2021 Credit Agreement, other than Swing Line Loans (as defined in the 2021 Credit Agreement), bear interest, at the Company's option, at the Base Rate (as defined in the 2021 Credit Agreement), at the Eurocurrency Rate (as defined in the 2021 Credit Agreement), at the Alternative Currency Daily Rate (as defined in the 2021 Credit Agreement), or at the LIBOR Daily Floating Rate (as defined in the 2021 Credit Agreement), in each case plus the Applicable Rate (as defined in the 2021 Credit Agreement).</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Applicable Rate in regards to the Base Rate, the Eurocurrency Rate, the Alternative Currency Daily Rate, the Alternative Currency Term Rate, and the LIBOR Daily Floating Rate is subject to change depending on the Total Net Leverage Ratio (as defined in the 2021 Credit Agreement). The borrowings of the Term Loan under the 2021 Credit Facilities initially bear interest at an annual rate equal to the Eurocurrency Rate for a one month interest period plus an Applicable Rate equal to 1.00%.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also required to pay a quarterly commitment fee calculated on daily basis equal to the Applicable Rate as of such day multiplied by the undrawn committed amount available under the Revolver (taking into account any outstanding amounts under the LC Sublimit). This commitment fee is initially 0.15% per annum for the Revolver.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to make scheduled principal payments under the 2021 Term Loan in increasing amounts ranging from $3.75&#160;million per three-month period commencing with the three-month period ending on December 29, 2022 to $18.75&#160;million per three-month period commencing with the three month period ending on December 26, 2025. The remaining balance of $1.335&#160;billion (or such lesser aggregate principal amount of Term Loans then outstanding) on the 2021 Term Loan and any amounts outstanding under the 2021 Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2021 Credit Agreement, the Company is required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). Certain of the mandatory prepayments are subject to reduction or elimination if certain financial covenants are met. These mandatory prepayments are required to be applied by the Company, first to the 2021 Term Loan, second to any outstanding amount under any Swing Line Loans, third to the 2021 Revolver, fourth to prepay any outstanding reimbursement obligations with respect to Letters of Credit and fifth to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2021 Credit Facilities without premium or penalty.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2021 Credit Agreement requires the Borrowers to maintain certain financial ratios. The 2021 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 19, 2018, the Company completed a private placement of $1.0 billion aggregate principal amount of senior notes and allocated $400 million in aggregate principal amount to its 4.625% Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2028 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2028 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had 4.375% Senior Notes due 2025 (the &#8220;2025 Senior Notes&#8221;) outstanding and bore interest at the rate of 4.375%&#160;per year, payable semi-annually on April 15 and October 15 of each year. The Company used the net proceeds of the 2029 Senior Notes offering in the first quarter of fiscal 2021 to redeem in full the 2025 Senior Notes in the aggregate principal amount of $950.0&#160;million on October 15, 2020 at an aggregate redemption price of $970.8&#160;million, which included a premium payment of $20.8&#160;million. Since the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470 to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $21.6&#160;million, which comprised pro-rata amounts of the premium payment, debt discount and debt issuance costs. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $5.8&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $7.9&#160;million and debt discount of $6.4&#160;million related to the modified debt are being amortized over the new term of the 2029 Senior Notes using the effective interest method.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:20.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2016, the Company entered into a one-year $200.0 million accounts receivable securitization program (the "Securitization Program") with several of its wholly owned subsidiaries and certain financial institutions, which provides for annual renewals. Under the terms of the Securitization Program, the Company and certain of its wholly-owned subsidiaries sell their respective customer receivables to a bankruptcy remote special purpose entity, which is also a wholly-owned subsidiary of the Company. In addition, the Company also contributed a portion of its customer receivables to the special purpose entity in connection with its establishment. The Company retains servicing responsibility. The special purpose entity, as borrower, and the Company, as servicer, entered into a Credit and Security Agreement with several lenders pursuant to which the special purpose entity, at that time, could borrow up to $200.0 million from the lenders, with the loans secured by the receivables. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. Borrowings outstanding under the Securitization Program bear interest at LIBOR plus the applicable margin of 0.8% and are included as a component of current liabilities in the Company's consolidated balance sheet, while the accounts receivable securing these obligations remain as a component of net receivables in the Company's consolidated balance sheet. The Company and the special purpose entity are operated and maintained as separate legal entities. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay other debts or liabilities of the Company. In subsequent years, the Company amended the agreement to extend it for one-year periods and increased the borrowing capacity up to $250.0&#160;million and lowered the applicable margin to 0.7%. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, the Company paid off the total amount outstanding of $250.0&#160;million previously borrowed. On April 13, 2020, the Company amended the Credit and Security Agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. On June 11, 2021, the Company amended and restated the Credit and Security Agreement to restart the Securitization Program and increased the maximum borrowing amount to $320.0&#160;million. As of September 25, 2021, there was $248.5&#160;million outstanding under this program. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Securitization Program for fiscal 2021 had a weighted-average interest rate of 0.8%. Interest expense under the Securitization Program was $0.9 million, $3.1 million and $7.1 million for fiscal 2021, 2020 and 2019, respectively. The interest rate on the amounts outstanding at September 25, 2021 was 0.8%.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit and Security Agreement contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, and an event of default upon a change of control of the Company. In addition, it contains financial covenants consistent with that of the Credit Agreement. As of September&#160;25, 2021, the Company was not required to be in compliance with the Credit and Security Agreement covenants.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other represents debt acquired in the Mobidiag acquisition, which is primarily with the European Investment Bank ("EIB"). Multiple tranches were withdrawn under the agreement and were primarily used to fund research and development projects and expansion efforts. The debt agreement contains change-in-control provisions allowing the EIB to call the debt at any time after a change-in-control, which occurred as a result of Hologic acquiring Mobidiag. Accordingly, the Company has classified the debt as current. The tranches withdrawn under this agreement have interest rates ranging from 6.0% to 7.0%. The debt agreement includes additional payments to the EIB based on revenues generated by products developed under the funding as well as prepayment penalties.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876308674472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stockholders' Equity and Stock-Based Compensation</a></td>
<td class="text">Stockholders' Equity and Stock-Based Compensation<div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 13, 2018, the Board of Directors authorized the repurchase of up to $500.0 million of the Company's outstanding common stock. This share repurchase plan was effective August 1, 2018 and expired March 27, 2020. Under this authorization, during fiscal 2019, the Company repurchased 4.8 million shares of its common stock for total consideration of $200.1 million. During the first and second quarters of fiscal 2020, the Company repurchased 3.9&#160;million shares of its common stock for a total consideration of $210.9&#160;million. As of March 28, 2020, the Company had completed this authorization. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, the Board of Directors authorized a new share repurchase plan to repurchase up to $500.0&#160;million of the Company's outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020 the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020. Under this revised authorization during fiscal 2020, the Company repurchased 5.1&#160;million shares of its common stock for a total consideration of $237.7&#160;million. During the first quarter of fiscal 2021, the Company repurchased 1.5&#160;million shares of its common stock under this plan for a total consideration of $101.3&#160;million. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Board of Directors authorized a new five-year share repurchase plan to repurchase up to $1.0&#160;billion of the Company's outstanding common stock. The prior plan was terminated in connection with this new authorization. Under the new authorization, during fiscal 2021, the Company repurchased 4.6&#160;million shares of its common stock for a total consideration of $308.5&#160;million. As of September 25, 2021 $691.6&#160;million remained available under this authorization. Subsequent to September 25, 2021, the Company repurchased 2.3&#160;million shares of its common stock for $167.0&#160;million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 19, 2019, the Board of Directors authorized the Company to repurchase up to $205 million of its outstanding shares pursuant to an accelerated share repurchase ("ASR") agreement. On November 22, 2019, the Company executed the ASR agreement with Goldman Sachs &amp; Co. ("Goldman Sachs") pursuant to which the Company repurchased $205&#160;million of the Company's common stock. The initial delivery of approximately 80% of the shares under the ASR was 3.3&#160;million shares for which the Company initially allocated $164.0&#160;million of the $205&#160;million paid to Goldman Sachs during the first quarter of fiscal 2020. The Company evaluated the nature of the forward contract aspect of the ASR under ASC 815 and concluded equity classification was appropriate. Final settlement of the transaction under the ASR occurred in the second quarter of fiscal 2020. At settlement, Goldman Sachs delivered an additional 0.6&#160;million shares of the Company's common stock.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Compensation Plans</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has one share-based compensation plan pursuant to which awards are currently being issued&#8212;the 2008 amended and restated Equity Incentive Plan (&#8220;2008 Equity Plan&#8221;). The purpose of the 2008 Equity Plan is to provide stock options, restricted stock units and other equity interests in the Company to employees, officers, directors, consultants and advisors of the Company and any other person who is determined by the Board of Directors to have made (or is expected to make) contributions to the Company. The 2008 Equity Plan is administered by the Board of Directors of the Company, and a total of 31.5 million shares were reserved for issuance under this plan. As of September&#160;25, 2021, the Company had 4.6 million shares available for future grant under the 2008 Equity Plan.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Operations in fiscal 2021, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Grant-Date Fair Value</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The Company considers a number of factors to determine the fair value of options including the assistance of an outside valuation adviser. Information pertaining to stock options granted during fiscal 2021, 2020 and 2019 and related assumptions are noted in the following table:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted (in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of the stock options. In projecting expected stock price volatility, the Company uses a combination of historical stock price volatility and implied volatility from observable market prices of similar equity instruments. The Company estimated the expected life of stock options based on historical experience using employee exercise and option expiration data.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-Based Compensation Expense Attribution</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the straight-line attribution method to recognize stock-based compensation expense for stock options and restricted stock units ("RSUs"). The vesting term of stock options is generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNjAvZnJhZzowMzk3MTQyMWEyYzk0MGJiOGRhM2FiNjNjOWM1MzgzZC90ZXh0cmVnaW9uOjAzOTcxNDIxYTJjOTQwYmI4ZGEzYWI2M2M5YzUzODNkXzQ3MTk_de8b43b0-f008-41d7-b826-9f3a463875ab">four</span> years with annual vesting of 25%&#160;per year on the anniversary of the grant date, and RSUs generally vest over three years with annual vesting at 33% per year on the anniversary of the grant date. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. Under ASC 718, the Company's accounting policy is to estimate forfeitures at the time awards are granted and revise, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based on an analysis of historical forfeitures, the Company has determined a specific forfeiture rate for certain employee groups and has applied forfeiture rates ranging from 0% to 6.0% as of September&#160;25, 2021 depending on the specific employee group. This analysis is re-evaluated annually and the forfeiture rate adjusted as necessary. Ultimately, the actual stock-based compensation expense recognized will only be for those stock options and RSUs that vest.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense related to stock options was $13.0 million, $15.5 million, and $14.1 million in fiscal 2021, 2020 and 2019, respectively. Stock compensation expense related to stock units, including RSUs, performance stock units ("PSUs"), free cash flow performance stock units ("FCFs") and market stock units ("MSUs") was $46.1 million, $63.3 million, and $43.7 million in fiscal 2021, 2020 and 2019, respectively. The related tax benefit recorded in the Consolidated Statements of Operations was $7.9 million, $9.5 million and $8.9 million in fiscal 2021, 2020 and 2019, respectively. At September&#160;25, 2021, there was $15.8 million and $50.3 million of unrecognized compensation expense related to stock options and RSUs, respectively, to be recognized over a weighted average period of 2.3 years and 1.8 years, respectively.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Based Payment Activity</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all stock option activity under the Company&#8217;s stock option plans for the year ended September&#160;25, 2021:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares<br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/ forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest at September 25, 2021 (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This represents the number of vested stock options as of September&#160;25, 2021 plus the unvested outstanding options at September&#160;25, 2021 expected to vest in the future, adjusted for estimated forfeitures.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2020 and 2019, the total intrinsic value of options exercised (i.e., the difference between the market price on the date of exercise and the price paid by the employee to exercise the options) was $44.8 million and $26.1 million, respectively.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s RSU, PSU, FCF and MSU activity during the year ended September&#160;25, 2021 is presented below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"><tr><td style="width:1.0%"/><td style="width:50.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-vested Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-Date&#160;Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of RSUs vested includes shares withheld on behalf of employees to satisfy minimum statutory tax withholding requirements. The Company pays the minimum statutory tax withholding requirement on behalf of its employees. During fiscal 2021, 2020 and 2019 the total fair value of RSUs vested was $73.1 million, $34.9 million and $34.6 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 0.5&#160;million, 0.6&#160;million and 0.9&#160;million RSUs during fiscal 2021, 2020 and 2019, respectively. In addition, included in the above chart, the Company also granted 0.1 million, 0.1 million and 0.1 million PSUs during fiscal 2021, 2020, and 2019 respectively, to members of the Company's senior management team, which includes additional shares issued upon achieving metrics within the performance criteria. The PSUs were valued at $68.51, $45.38 and $40.97 per share based on the ending stock price on the date of grant in fiscal 2021, 2020 and 2019, respectively. Each recipient of the PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year performance period provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1&#160;million and 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team in fiscal 2021 and 2020, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million, 0.1 million and 0.1 million MSUs during fiscal 2021, 2020 and 2019, respectively, to its senior management team. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $82.31, $43.54 and $55.13 per share using the Monte Carlo simulation model in fiscal 2021, 2020 and 2019, respectively. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period.</span></div><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hologic, Inc. 2012 Employee Stock Purchase Plan (&#8220;2012 ESPP&#8221;) provides for the granting of up to 2.5 million shares of the Company&#8217;s common stock to eligible employees. The 2012 ESPP plan period is semi-annual and allows participants to purchase the Company&#8217;s common stock at 85% of the lower of (i)&#160;the market value per share of the common stock on the first day of the offering period or (ii)&#160;the market value per share of the common stock on the purchase date. Stock-based compensation expense in fiscal 2021, 2020 and 2019 was $5.9 million, $4.5 million and $4.2 million, respectively.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"/><td style="width:42.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876308689496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlanTextBlock', window );">Multiemployer Plan</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. 401(k) Plan</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's U.S. employees have access to a qualified 401(k) defined contribution plan. The Company made contributions of $20.9 million, $19.6 million and $19.2 million for fiscal 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for multiemployer plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -URI http://asc.fasb.org/subtopic&amp;trid=2235144<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450657-114947<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450678-114947<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450702-114947<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450673-114947<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450655-114947<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=35742348&amp;loc=SL14450788-114948<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450678-114947<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450657-114947<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=35742348&amp;loc=SL14450783-114948<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450678-114947<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307500376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain non-cancelable purchase obligations primarily related to inventory purchases and diagnostics instruments, primarily Panther systems, and to a lesser extent other operating expense commitments. These obligations are not recorded in the Consolidated Balance Sheets. For reasons of quality assurance, sole source availability or cost effectiveness, certain key components and raw materials and instruments are available only from a sole supplier and the Company has certain long-term supply contracts to assure continuity of supply. At September&#160;25, 2021, non-cancelable purchase commitments are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"/><td style="width:70.376%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.424%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876311000088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation and Related Matters<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LitigationAndOtherMattersTextBlock', window );">Litigation and Related Matters</a></td>
<td class="text">Litigation and Related Matters<div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continued its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the &#8216;348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, the Company filed a cross- petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva's petition to address the issue of assignor estoppel and denied the Company's petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold the assignor estoppel but limited its application to situations in which an assignor's claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208 (the '208 patent). Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10 day trial beginning on August 9, 2021. On July 27. 2021, the Delaware district court granted Hologic's motion for summary judgment on invalidity of the '208 patent and entered judgment in favor of the Company. On August 24, 2021, Minerva appealed this and the other rulings to the Court of Appeals. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 15, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $8.5&#160;million accrued for such matters as of September 25, 2021. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LitigationAndOtherMattersTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation And Other Matters [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LitigationAndOtherMattersTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876311450552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract', window );"><strong>Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock', window );">Disposition</a></td>
<td class="text">Disposition<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Medical Aesthetics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$205.0&#160;million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4&#160;million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xODEvZnJhZzozYWQzYjNkYTE2ZDQ0YzM2ODg2YzhiYjBhZmM2MjczMy90ZXh0cmVnaW9uOjNhZDNiM2RhMTZkNDRjMzY4ODZjOGJiMGFmYzYyNzMzXzYyNg_91ec9144-43e9-4830-8cd0-3e6aa51ccfb1">three</span> to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment and Disposal of Long-Lived Assets, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or that will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $30.2&#160;million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8&#160;million was allocated to cost of product revenues and $4.4&#160;million to operating expenses.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss from operations of the disposed business presented below represents the operating loss of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business. As noted above, the Company had performed a number of transition services and the financial impact from these services are not included in the amounts presented below. In addition, the Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition. Subsequent to the disposition, the Company recorded additional expenses of $6.2&#160;million in fiscal 2020 primarily for accelerated stock compensation, inventory reserves under the manufacturing supply agreement, and legal expenses and settlements, which are not included in the below amounts. Loss from operations of the disposed business for fiscal 2020 and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"><tr><td style="width:1.0%"/><td style="width:47.412%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:23.385%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.317%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.386%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(781.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876308777496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments and Geographic Information</a></td>
<td class="text">Business Segments and Geographic Information<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports segment information in accordance with ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Operating segments are identified as components of an enterprise about which separate, discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions about how to allocate resources and assess performance. The Company&#8217;s chief operating decision maker is its chief executive officer, and the Company&#8217;s reportable segments have been identified based on the types of products manufactured and the end markets to which the products are sold. Each reportable segment generates revenue from either the sale of medical equipment and related services and/or sale of disposable supplies, primarily used for diagnostic testing and surgical procedures. During fiscal 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During the first quarter of fiscal 2020 and </span>fiscal 2019, the Company had five reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.<div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no intersegment revenues. Segment information for fiscal 2021, 2020, and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"/><td style="width:52.954%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,695.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(781.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,480.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,348.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,276.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,935.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,919.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,442.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"/><td style="width:53.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company&#8217;s property, plant and equipment, net were geographically located as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"/><td style="width:53.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876308605752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Long-Term Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock', window );">Accrued Expenses and Other Long-Term Liabilities</a></td>
<td class="text">Accrued Expenses and Other Long-Term Liabilities<div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other long-term liabilities consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"/><td style="width:59.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income and other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"/><td style="width:59.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#160;Long-Term Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for income tax uncertainties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Expenses And Other Long-Term Liabilities [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307228408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension and Other Employee Benefits</a></td>
<td class="text">Pension and Other Employee Benefits<div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain defined benefit pension plans covering the employees of its Hitec Imaging German subsidiary (the &#8220;Pension Benefits&#8221;).&#160;As of September&#160;25, 2021 and September&#160;26, 2020, the Company&#8217;s pension liability was $10.3 million and $10.9 million, respectively, which is primarily recorded as a component of long-term liabilities in the Consolidated Balance Sheets. Under German law, there are no rules governing investment or statutory supervision of the pension plan. As such, there is no minimum funding requirement imposed on employers. Pension benefits are safeguarded by the Pension Guaranty Fund, a form of compulsory reinsurance that guarantees an employee will receive vested pension benefits in the event of insolvency. The pension plans were closed on December 31, 1997 and only eligible employees at that date could participate in the plans prior to closing to new participants.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:6pt;padding-left:49.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Benefit Obligation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Net Periodic Benefit Cost Assumptions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The projected benefit obligation for the German Pension Benefits with projected benefit obligations in excess of plan assets was $10.3 million and $10.9 million at September&#160;25, 2021 and September&#160;26, 2020, respectively, and the accumulated benefit obligation for the German Pension Benefits was $10.3 million and $10.9 million at September&#160;25, 2021 and September&#160;26, 2020, respectively. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also obligated to pay long-term service award benefits under the German Pension Benefits. The projected benefit obligation for long-term service awards was $0.1 million at both September&#160;25, 2021 and September&#160;26, 2020, respectively.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"/><td style="width:70.376%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.424%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2031</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The Company also maintains additional contractual pension benefits for its top German executive officers in the form of a defined contribution plan. These contributions were insignificant in fiscal 2021, 2020 and 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876414464632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. The Company&#8217;s fiscal year ends on the last Saturday in September. Fiscal 2021, 2020 and 2019 ended on September&#160;25, 2021, September&#160;26, 2020 and September&#160;28, 2019, respectively. Fiscal 2021, 2020 and 2019 were 52-week years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Management's Estimates</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Estimates and Uncertainties</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles ("GAAP") requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions by management affect the Company&#8217;s revenue recognition for multiple performance obligation arrangements, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions and estimates used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, contingent liabilities, tax reserves, deferred tax rates and recoverability of the Company&#8217;s net deferred tax assets and related valuation allowances, and stock-based compensation.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company regularly assesses these estimates, actual results could differ materially from these estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to a number of risks similar to those of other companies of similar size in its industry, including dependence on third-party reimbursements to support the markets of the Company&#8217;s products, early stage of development of certain products, rapid technological changes, recoverability of long-lived assets (including intangible assets and goodwill), competition, stability of world financial markets, ability to obtain regulatory approvals, changes in the regulatory environment, limited number of suppliers, customer concentration, integration of acquisitions, substantial indebtedness, government regulations, management of international activities, protection of proprietary rights, patent and other litigation, dependence on contract manufacturers and dependence on key individuals.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to credit risk primarily consist of cash and cash equivalents, cost-method investments and trade accounts receivable. The Company invests its cash and cash equivalents with high credit quality financial institutions.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customers are principally located in the U.S., Europe and Asia. The Company performs ongoing credit evaluations of the financial condition of its customers and generally does not require collateral. Although the Company is </span></div>directly affected by the overall financial condition of the healthcare industry, as well as global economic conditions, management does not believe significant credit risk exists as of September&#160;25, 2021. The Company generally has not experienced any material losses related to receivables from individual customers or groups of customers in the healthcare industry. The Company maintains an allowance for doubtful accounts based on accounts past due and historical collection experience.There were no customers with a balance greater than 10% of accounts receivable as of September&#160;25, 2021. There was one customer with a balance greater than 10% of accounts receivable as of September&#160;26, 2020, at 11.9%. There were no customers that represented greater than 10% of consolidated revenues for fiscal years 2021, 2020 and 2019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or market on a first in, first out basis. Work-in-process and finished goods inventories consist of materials, labor and manufacturing overhead. The valuation of inventory requires management to estimate excess and obsolete inventory. The Company employs a variety of methodologies to determine the net realizable value of its inventory. Provisions for excess and obsolete inventory are primarily based on management&#8217;s estimates of forecasted sales, usage levels and expiration dates, as applicable for certain disposable products. A significant change in the timing or level of demand for the Company&#8217;s products compared to forecasted amounts may result in recording additional charges for excess and obsolete inventory in the future. The Company records charges for excess and obsolete inventory within cost of product revenues.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"><tr><td style="width:1.0%"/><td style="width:52.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment is recorded at cost less allowances for depreciation and impairments. The straight-line method of depreciation is used for all property and equipment. </span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:36.030%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;10 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;8 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#8211;35 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the Original Term of Lease</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or Estimated Useful Life</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#8211;7 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment under customer usage agreements primarily consists of diagnostic instrumentation and imaging equipment located at customer sites but owned by the Company. Generally, the customer has the right to use the equipment for a period of time provided they meet certain agreed to conditions. The Company recovers the cost of providing the equipment from the sale of disposables, primarily assays, tests and handpieces. The depreciation costs associated with equipment under customer usage agreements are charged to cost of product revenues over the estimated useful life of the equipment. The costs to maintain the equipment in the field are charged to cost of product revenue as incurred.</span></div>In September 2020 and October 2020, the Company was awarded grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants are specifically to fund the capital equipment and labor investments needed to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procures and pays for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to paying for the capital equipment, the DOD will reimburse the Company upon it meeting certain requirements  However, the DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts. As of September 25, 2021, the Company had $95.2 million of capital equipment related to the DOD grant that was awaiting approval. In fiscal 2021, the Company received $21.2&#160;million from the DOD under these grants which has been recorded as a reduction of the cost basis of the purchased equipment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongLivedAssetsPolicyPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text">Long-Lived Assets<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its long-lived assets, which includes property, plant and equipment and identifiable intangible assets (see below for discussion of intangible assets), for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC&#160;360-10-35-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant and Equipment&#8212;Impairment or Disposal of Long-Lived Assets</span> (ASC 360). Recoverability of these assets is evaluated by comparing the carrying value of the assets to the undiscounted cash flows estimated to be generated by those assets over their remaining economic life. If the undiscounted cash flows are not sufficient to recover the carrying value of the assets, the assets are considered impaired. The impairment loss is measured by comparing the fair value of the assets to their carrying value. Fair value is determined by either a quoted market price, if any, or a value determined by a discounted cash flow technique.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock', window );">Business Combinations and Acquisition of Intangible Assets</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations and Acquisition of Intangible Assets</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company accounts for the acquisition of a business in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (ASC 805). Amounts paid to acquire a business are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. Contingent consideration not deemed to be linked to continuing employment is recorded at fair value as measured on the date of acquisition. The value recorded is based on estimates of future financial projections under various potential scenarios using a Monte Carlo simulation. These cash flow projections are discounted with an appropriate risk adjusted rate. Each quarter until such contingent amounts are earned, the fair value of the liability is remeasured at each reporting period and adjusted as a component of operating expenses based on changes to the underlying assumptions. The </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">estimates used to determine the fair value of the contingent consideration liability are subject to significant judgment and actual results are likely to differ from the amounts originally recorded. The Company determines the fair value of acquired intangible assets based on detailed valuations that use certain information and assumptions provided by management. The Company allocates any excess purchase price over the fair value of the net tangible and intangible assets acquired to goodwill.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company uses the income approach to determine the fair value of developed technology and in-process research and development ("IPR&amp;D") acquired in a business combination. This approach determines fair value by estimating the after-tax cash flows attributable to the respective asset over its useful life and then discounting these after-tax cash flows back to a present value. The Company bases its revenue assumptions on estimates of relevant market sizes, expected market growth rates, expected trends in technology and expected product introductions by competitors. Developed technology represents patented and unpatented technology and know-how. The value of the in-process projects is based on the project's stage of completion, the complexity of the work completed as of the acquisition date, the projected costs to complete, the contribution of core technologies and other acquired assets, the expected introduction date, the estimated cash flows to be generated upon commercial release and the estimated useful life of the technology. The Company believes that the estimated developed technology and IPR&amp;D amounts represent the fair value at the date of acquisition and do not exceed the amount a third-party would pay for the assets. The significant assumptions used to estimate the fair value of intangible assets include discount rates and certain assumptions that form the basis of the forecasted results specifically revenue growth rates. These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div>The Company also uses the income approach, as described above, to determine the estimated fair value of certain other identifiable intangible assets including customer relationships, trade names and business licenses. Customer relationships represent established relationships with customers, which provide a ready channel for the sale of additional products and services. Trade names represent acquired company and product names<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherAssetsPolicyPolicyTextBlock', window );">Other Assets</a></td>
<td class="text"><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"><tr><td style="width:1.0%"/><td style="width:40.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-method equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax receivable in fiscal 2020 primarily related to a discrete tax benefit from the sale of Cynosure in the second quarter of fiscal 2020. This receivable was reclassified to a current asset in fiscal 2021 as the Company filed the carryback claim and expects to receive the refund within the next twelve months, subject to Internal Revenue Service processing times. The right of use assets were recorded in connection with the adoption of ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span>, and pertains to operating leases. Life insurance contracts were purchased in connection with the Company&#8217;s Nonqualified Deferred Compensation Plan (&#8220;DCP&#8221;) and are recorded at their cash surrender value (see Note 12 for further discussion).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Research and Software Development Costs</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Software Development Costs</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred for the research and development of the Company&#8217;s products are expensed as incurred. Nonrefundable advance payments for goods or services to be received in the future by the Company for use in research and development activities are deferred. The deferred costs are expensed as the related goods are delivered or the services are performed.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for the development costs of software embedded in the Company&#8217;s products in accordance with ASC 985, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Costs incurred in the research, design and development of software embedded in products to be sold to customers are charged to expense until technological feasibility of the ultimate product to be sold is established. The Company&#8217;s policy is that technological feasibility is achieved when a working model, with the key features and functions of the product, is available for customer testing. Software development costs incurred after the establishment of technological feasibility and until the product is available for general release are capitalized, provided recoverability is reasonably assured. Capitalized software development costs are amortized over their estimated useful life and recorded within cost of revenues - product.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries are translated in accordance with ASC 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The reporting currency for the Company is the U.S. dollar. The functional currency of the Company&#8217;s foreign subsidiaries is determined based on the guidance in ASC 830. The majority of the Company's foreign subsidiaries' functional currency is the applicable local currency, although certain of the Company's foreign subsidiaries' functional currency </span></div>is the U.S. dollar based on the nature of their operations or functions. Assets and liabilities of subsidiaries whose functional currency is the local currency are translated at the exchange rate in effect at each balance sheet date. Before translation, the Company re-measures foreign currency denominated assets and liabilities, including inter-company accounts receivable and payable, into the functional currency of the respective entity, resulting in unrealized gains or losses recorded in other income (expense), net in the Consolidated Statements of Operations. Revenues and expenses are translated using average exchange rates during the respective period. Foreign currency translation adjustments are accumulated as a component of other comprehensive income (loss), which is a separate component of stockholders&#8217; equity. Gains and losses arising from transactions denominated in foreign currencies are included in other income (expense), net in the Consolidated Statements of Operations and were not significant in any of the reporting periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) includes certain transactions that have generally been reported in the statement of stockholders&#8217; equity. The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charges (gains) reclassified to statement of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on its amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7&#160;million, which was the initial fair value of the instruments recorded in the Company's financial statements. During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5&#160;million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $1.0 billion of principal, which ended on December 27, 2019 (the first quarter of fiscal 2020) for the contracts entered into in fiscal 2018, and on December 23, 2020 (the first quarter of fiscal 2021) for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2021, 2020 and 2019, interest expense of $0.5 million, $2.3 million and $3.1 million, respectively, was reclassified from AOCI to the Company's Consolidated Statements of Operations related to the interest rate cap agreements. The last interest rate cap agreement matured as of December 26, 2020.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI and net of taxes were a gain of $9.4&#160;million, a loss of $27.6&#160;million and a gain of $3.5 million for fiscal years 2021, 2020, and 2019, respectively. The fair value of this derivative was in a liability position of $18.7 million as of September 25, 2021.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income, net. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 25, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and are used to hedge fluctuations in the U.S dollar of certain of the Company's cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $861.5 million. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:23pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:47.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.280%"><tr><td style="width:1.0%"/><td style="width:48.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.983%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock', window );">Accounts Receivable and Reserves</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective September 27, 2020, the Company adopted ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the COVID-19 pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a rollforward of the allowance for credit losses for fiscal 2021, 2020 and 2019:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock', window );">Cost of Service and Other Revenues</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service and other revenues primarily represents payroll and related costs associated with the Company&#8217;s professional services, employees, consultants, infrastructure costs and overhead allocations, including depreciation, rent and materials consumed in providing the service.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based payments in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 718)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span> As such, all share-based payments to employees, including grants of stock options, restricted stock units, performance stock units and market stock units and shares issued under the Company&#8217;s employee stock purchase plan, are recognized in the Consolidated Statements of Operations based on their fair values on the date of grant. In addition, all excess tax benefits and deficiencies are recognized as a component of the provision for income taxes on a discrete basis in the period in which the equity awards vest and/or are settled.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted net income per share is computed by dividing net income by the weighted average number of common shares and the dilutive effect of potential future issuances of common stock from outstanding stock options and restricted stock units for the period outstanding determined by applying the treasury stock method. In accordance with ASC 718, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of in-the-money stock options and restricted stock units. This results in the assumed buyback of additional shares, thereby reducing the dilutive impact of equity awards.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Product Warranties</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Warranties</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally offers a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xMzMvZnJhZzoxMzNlYzhhMzhhOTY0OGU3OTgyMjBlMzA5YWQyMTEzZi90ZXh0cmVnaW9uOjEzM2VjOGEzOGE5NjQ4ZTc5ODIyMGUzMDlhZDIxMTNmXzM5NTc0_257c2dd2-2a08-4cdf-8688-8a506165be31">one</span>-year warranty for its products. The Company provides for the estimated cost of product warranties at the time product revenue is recognized. Factors that affect the Company&#8217;s warranty reserves include the </span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of units sold, historical and anticipated rates of warranty repairs and the cost per repair. The Company periodically assesses the adequacy of the warranty reserve and adjusts the amount as necessary.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity for fiscal 2021 and 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.406%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at&#160;End<br/>of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are charged to operations as incurred. The Company does not have any direct-response advertising. Advertising costs, which include trade shows and conventions, were approximately $9.8 million, $15.6 million and $29.5 million for fiscal 2021, 2020 and 2019, respectively, and were included in selling and marketing expense in the Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountsReceivableAndReservesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Policy and disclosure of accounts receivable reserves, including activity in the account for the respective periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountsReceivableAndReservesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Loss Income Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the costs comprising costs of service and other revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LongLivedAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long Lived Assets Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LongLivedAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Assets Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116873391&amp;loc=d3e408-128459<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=13988685&amp;loc=d3e8784-128493<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19347-109286<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318034728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Statement Information</a></td>
<td class="text"><div style="margin-top:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flow Statement Information</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:45.674%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.911%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Cash Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of contingent consideration at acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.871%"><tr><td style="width:1.0%"/><td style="width:52.471%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment consisted of the following:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"/><td style="width:36.030%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.308%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;10 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#8211;8 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#8211;35 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the Original Term of Lease</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or Estimated Useful Life</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#8211;7 years</span></div><div><span><br/></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:36.547%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.757%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,597.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,533.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,890.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,582.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,922.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amortization expense at September&#160;25, 2021 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:33.625%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock', window );">Rollforward of Goodwill Activity by Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A rollforward of goodwill activity by reportable segment from September&#160;26, 2020 to September&#160;25, 2021 is as follows:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:447.00pt"><tr><td style="width:1.0pt"/><td style="width:130.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:57.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:57.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Diagnostics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Breast&#160;Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">GYN&#160;Surgical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Skeletal&#160;Health</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,657.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mobidiag acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagenode acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biotheranostics acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somatex acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:23pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 25, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,065.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,281.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:65.350%"><tr><td style="width:1.0%"/><td style="width:40.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost-method equity investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Changes in accumulated balances of other comprehensive income</a></td>
<td class="text">The following tables summarize the components and changes in accumulated balances of other comprehensive loss for the periods presented:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign Currency Translation </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pension Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charges (gains) reclassified to statement of operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss) Related to Derivatives</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments on the Consolidated Balance Sheets</a></td>
<td class="text">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of September&#160;25, 2021:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:47.669%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Unrealized Loss Recognized in AOCI</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.280%"><tr><td style="width:1.0%"/><td style="width:48.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.983%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income (loss), net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Accounts Receivable Reserve Activity</a></td>
<td class="text">2021, 2020 and 2019:<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs and<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Reconciliation of Basic and Diluted Share Amounts</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts for fiscal 2021, 2020, and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.154%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,727&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and restricted stock units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Product Warranty Activity</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity for fiscal 2021 and 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.527%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.406%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at&#160;End<br/>of Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Period ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGoodwillBySegmentTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of goodwill by segment table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGoodwillBySegmentTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307227288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The following table provides revenue from contracts with customers by business and geographic region on a disaggregated basis:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"/><td style="width:2.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.977%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.980%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intl.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,171.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,301.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,695.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">519.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">830.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,094.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,902.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,730.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">913.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:75.730%"><tr><td style="width:1.0%"/><td style="width:37.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.765%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.171%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,902.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,863.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,536.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"/><td style="width:32.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:20.403%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">984.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876316854776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Assets And Liabilities, Lessee</a></td>
<td class="text">The following table presents supplemental balance sheet information related to the Company's operating and finance leases:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.391%"><tr><td style="width:1.0%"/><td style="width:24.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease right-of-use assets </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzMtMi0xLTEtMA_7625ff2b-a2d4-4ada-9a80-c2366caa372f">Other assets</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzYtMi0xLTEtMA_32b88e11-8dfa-4919-952c-fa919d9e96da">Accrued expenses</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - short term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA3YmJkNWUzM2ExZjQ3MmU4M2M1OWQ4NjY4ZGU0MWY4L3NlYzowN2JiZDVlMzNhMWY0NzJlODNjNTlkODY2OGRlNDFmOF8xNDIvZnJhZzo0ZDY5ODMwZjIxMDU0NzllOTcxYmE0MDQxZDNhZjVjOC90YWJsZTphNTRmNjA2N2FiYWY0YWY5YjQ5ZjM3ZDA1NDhmODUyYy90YWJsZXJhbmdlOmE1NGY2MDY3YWJhZjRhZjliNDlmMzdkMDU0OGY4NTJjXzgtMi0xLTEtMA_513c0630-1a99-4037-a0cf-be4e1c7a5bb7">Other long-term liabilities</span></span></div><div style="text-align:center"><span><br/></span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Finance lease obligations - long term<br/></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average remaining lease term and discount rate information related to the Company's operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.473%"><tr><td style="width:1.0%"/><td style="width:36.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.616%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.422%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.099%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 25, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.64</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information related to the Company&#8217;s operating and finance leases:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.736%"><tr><td style="width:1.0%"/><td style="width:2.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:61.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.031%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended September 26, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - amortization of right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost - interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new operating lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets arising from entering into new finance lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term lease expense and variable lease costs, which were immaterial for the year ended September&#160;25, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense under FASB ASC Topic 840 was $23.1&#160;million for fiscal 2019.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease, Liability, Maturity</a></td>
<td class="text">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text">The following table presents the future minimum lease payments under non-cancellable operating lease liabilities and finance lease as of September&#160;25, 2021:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Lease</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock', window );">Operating Lease, Lease Income</a></td>
<td class="text">The future minimum annual rental income payments under these lease and sublease agreements at September&#160;25, 2021 are as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.918%"><tr><td style="width:1.0%"/><td style="width:77.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121576215&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307357016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Purchase Price Allocation</a></td>
<td class="text">The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based on the estimated fair values as of June 17, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of August 23, 2020, as set forth below.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.479%"><tr><td style="width:1.0%"/><td style="width:5.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:68.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.718%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Focal's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of October 1, 2018, as set forth below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:77.339%"><tr><td style="width:1.0%"/><td style="width:73.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876310588072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Charges Taken Related to Restructuring Actions</a></td>
<td class="text">The following table displays charges taken related to restructuring actions in fiscal 2021, 2020 and 2019 and a rollforward of the charges to the accrued balances as of September&#160;25, 2021:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.596%"><tr><td style="width:1.0%"/><td style="width:34.708%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.781%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.460%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.946%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.946%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2021 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Restructuring Charges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 charges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Facility closure costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021 charges:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Workforce reductions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021 restructuring charges</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Charges Taken Related to Accrued Restructuring Actions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.523%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2021 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2020 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2019 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2018 Actions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Previous Other Charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Rollforward of Accrued Restructuring</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 29, 2018</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2019 restructuring charges</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 28, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2020 restructuring charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payments and adjustments (1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 26, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal 2021 restructuring charges</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Severance payments and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of September 25, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876415521352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Company's Borrowings and Interest Expense</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,382.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,712.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,025.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:20.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.443%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Interest Expense (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Cash Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule Of Long Term Debt By Maturity Table</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt maturity schedule for the Company&#8217;s obligations as of September&#160;25, 2021 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.075%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.583%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2027 and Thereafter </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,387.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,050.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;*The Term Loan debt maturity schedule herein represents the 2018 Credit Agreement as of September 25, 2021. The Company amended the credit agreement on September 27, 2021, which resulted in a change in the principal maturity schedule.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Credit Agreements</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, non-cash interest expense, the weighted average interest rate, and the interest rate at the end of period under the 2018 Credit Agreement and the 2017 Credit Agreement was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash interest expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Interest expense includes non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876308613736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.444%"><tr><td style="width:1.0%"/><td style="width:37.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.915%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.225%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 25, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - derivative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:484.50pt"><tr><td style="width:1.0pt"/><td style="width:183.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:64.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:72.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:73.00pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 26, 2020</span></td></tr><tr style="height:42pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - derivative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the years ended September 25, 2021, September 26, 2020, and September 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.980%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.378%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.510%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315104312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Income (Loss) Before Income Taxes</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income (loss) before income taxes consisted of the following:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"/><td style="width:42.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.500%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,361.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision (benefit) for income taxes contained the following components:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"/><td style="width:42.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.500%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138.7)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision (benefit) differed from the tax provision (benefit) computed at the U.S. federal statutory rate due to the following:</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.187%"><tr><td style="width:1.0%"/><td style="width:51.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.838%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax (benefit) provision at federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in tax resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale of Cynosure</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. tax on foreign earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal restructuring</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax reform</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized tax benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in deferred tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Significant Components of the Company's Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s significant deferred tax assets and liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.648%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible accruals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonqualified deferred compensation plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other temporary differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation&#160;and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(389.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Activity of the Company's Unrecognized Income Tax Benefits</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unrecognized income tax benefits activity for fiscal 2021 and 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.648%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of fiscal year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax positions related to current year:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax positions related to prior years:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions related to change in estimate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lapses in statutes of limitations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired tax positions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions related to reserves acquired from acquisitions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of the end of the fiscal year</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318067480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock', window );">Stock-Based Compensation Expense in Consolidated Statement of Operations</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Operations in fiscal 2021, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Information Pertaining to Stock Options Granted and Related Assumptions</a></td>
<td class="text">Information pertaining to stock options granted during fiscal 2021, 2020 and 2019 and related assumptions are noted in the following table:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted (in millions)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes all stock option activity under the Company&#8217;s stock option plans for the year ended September&#160;25, 2021:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.567%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.181%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.183%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares<br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual&#160;Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/ forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at September 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at September 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest at September 25, 2021 (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This represents the number of vested stock options as of September&#160;25, 2021 plus the unvested outstanding options at September&#160;25, 2021 expected to vest in the future, adjusted for estimated forfeitures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Restricted Stock Unit Activity</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company&#8217;s RSU, PSU, FCF and MSU activity during the year ended September&#160;25, 2021 is presented below:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:59.795%"><tr><td style="width:1.0%"/><td style="width:50.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-vested Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-Date&#160;Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at September 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.21&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock', window );">Black-Scholes Model Weighted Average Assumptions Used to Estimate Fair Value of Shares to Be Issued as of Grant Date</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to estimate the fair value of shares to be issued as of the grant date using the following weighted average assumptions:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"/><td style="width:42.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.498%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of significant assumptions used during the year to estimate the fair value of employee stock purchase plan shares, including, but not limited to: (a) expected term, (b) expected volatility, (c) risk-free interest rate, and (d) dividend yield.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876308867368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock', window );">Unrecorded Unconditional Purchase Obligations Disclosure</a></td>
<td class="text">At September&#160;25, 2021, non-cancelable purchase commitments are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"/><td style="width:70.376%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.424%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unconditional purchase obligation not recognized as liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876308613736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract', window );"><strong>Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Disposed Business, Income from Operations and Assets held-for-sale</a></td>
<td class="text">Loss from operations of the disposed business for fiscal 2020 and 2019 was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.888%"><tr><td style="width:1.0%"/><td style="width:47.412%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:23.385%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.317%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.386%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(781.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876316469160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text">Segment information for fiscal 2021, 2020, and 2019 was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.549%"><tr><td style="width:1.0%"/><td style="width:52.954%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,695.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,102.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,352.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,140.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(781.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,480.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,348.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,276.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,935.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,919.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,442.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Revenues by Geography</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"/><td style="width:53.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</a></td>
<td class="text">The Company&#8217;s property, plant and equipment, net were geographically located as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"/><td style="width:53.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.306%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.310%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costa Rica</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307269144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Long-Term Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other long-term liabilities consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"/><td style="width:59.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and employee benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income and other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Other Long-Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.251%"><tr><td style="width:1.0%"/><td style="width:59.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.886%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#160;Long-Term Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve for income tax uncertainties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315104840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 25, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of Reconciliation of Benefit Obligations, Plan Assets, Funded Status and Related Actuarial Assumptions</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide a reconciliation of benefit obligations, plan assets, funded status, and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:6pt;padding-left:49.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.970%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change in Benefit Obligation</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan participants&#8217; contributions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of Net Periodic Benefit Cost and Related Actuarial Assumptions</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below outline the components of the net periodic benefit cost and related actuarial assumptions of the Company&#8217;s German Pension Benefits.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Components of Net Periodic Benefit Cost</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years ended</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of prior service cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized net actuarial gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.409%"><tr><td style="width:1.0%"/><td style="width:49.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Net Periodic Benefit Cost Assumptions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Pension Benefit</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reflects the total Pension Benefits expected to be paid for the German Pension Benefits each fiscal year as of September&#160;25, 2021:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.567%"><tr><td style="width:1.0%"/><td style="width:70.376%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.424%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 to 2031</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318582984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="7">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 14, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th">
<div>Mar. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($) </div>
<div>Customer</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 23, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashEquivalentsMaturityPeriod', window );">Cash Equivalents Maturity Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">three months or less<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,582,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,582,100,000<span></span>
</td>
<td class="nump">$ 4,931,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,922,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,922,900,000<span></span>
</td>
<td class="nump">3,623,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,281,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,281,600,000<span></span>
</td>
<td class="nump">2,657,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestRateCapAgreementsAggregatePremiumPayable', window );">Purchase of interest rate caps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Principal amount of borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotionalAmount', window );">Notional Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">861,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 861,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_WarrantyTermForProducts', window );">Product Warranty Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="nump">15,600,000<span></span>
</td>
<td class="nump">29,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage', window );">Number of customers with balance greater than specified percentage | Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 268,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 268,100,000<span></span>
</td>
<td class="nump">$ 245,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,800,000<span></span>
</td>
<td class="nump">181,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,597,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,597,700,000<span></span>
</td>
<td class="nump">4,054,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,184,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,184,200,000<span></span>
</td>
<td class="nump">2,907,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable [Member] | Customer Concentration Risk | One Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Accounts receivable [Member] | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Total revenues [Member] | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,400,000<span></span>
</td>
<td class="num">(27,600,000)<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">$ 160,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Distribution agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Derivative contract period, or less</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="num">$ (500,000)<span></span>
</td>
<td class="num">$ (8,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CashEquivalentsMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time from the date of acquisition for liquid investments in debt securities to be categorized as cash in the consolidated balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CashEquivalentsMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestRateCapAgreementsAggregatePremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate cap agreements aggregate premium payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestRateCapAgreementsAggregatePremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notional Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of customers with balance greater than specified percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Significant Accounting Policies [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_WarrantyTermForProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warranty Term For Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_WarrantyTermForProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=holx_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=holx_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=holx_RevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=holx_RevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317918536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">$ 615.1<span></span>
</td>
<td class="nump">$ 265.9<span></span>
</td>
<td class="nump">$ 180.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Cash paid during the period for interest</a></td>
<td class="nump">93.2<span></span>
</td>
<td class="nump">109.5<span></span>
</td>
<td class="nump">132.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration recorded at acquisition</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 82.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317471512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Inventories (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 163.3<span></span>
</td>
<td class="nump">$ 152.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">53.0<span></span>
</td>
<td class="nump">46.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">284.9<span></span>
</td>
<td class="nump">196.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 501.2<span></span>
</td>
<td class="nump">$ 395.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876310516680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ManufacturingEquipmentAndSoftware', window );">Manufacturing Equipment And Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 460.7<span></span>
</td>
<td class="nump">$ 467.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EquipmentUnderCustomerUsageAgreements', window );">Equipment Under Customer Usage Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">456.8<span></span>
</td>
<td class="nump">484.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and Improvements, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167.3<span></span>
</td>
<td class="nump">191.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold Improvements, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">49.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.7<span></span>
</td>
<td class="nump">41.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and Fixtures, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,185.9<span></span>
</td>
<td class="nump">1,260.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less - accumulated depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(694.4)<span></span>
</td>
<td class="num">(695.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491.5<span></span>
</td>
<td class="nump">564.7<span></span>
</td>
<td class="nump">$ 470.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GrantsReceivedFromDepartmentOfDefense', window );">Grants received from Department of defense</a></td>
<td class="nump">$ 119.3<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DepartmentOfDefenseFundsReceived', window );">Department of defense funds received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentAndSoftwareMember', window );">Equipment and Software [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentAndSoftwareMember', window );">Equipment and Software [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentUnderCustomerUsageAgreementMember', window );">Equipment Under Customer Usage Agreements [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentUnderCustomerUsageAgreementMember', window );">Equipment Under Customer Usage Agreements [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">35 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DepartmentOfDefenseFundsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Department of defense funds received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DepartmentOfDefenseFundsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrantsReceivedFromDepartmentOfDefense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grants received from Department of defense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrantsReceivedFromDepartmentOfDefense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ManufacturingEquipmentAndSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ManufacturingEquipmentAndSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentUnderCustomerUsageAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=holx_EquipmentUnderCustomerUsageAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876312724184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 5,582,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,931,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,922,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,623,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed&#160;technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,597,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,054,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,184,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,907,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">71,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">591,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">549,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">510,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">477,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">268,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">191,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember', window );">Business licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember', window );">Acquired intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">5,533,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,852,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,890,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,569,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember', window );">Internal-use software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">23,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">17,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember', window );">Capitalized software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">25,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 576,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 285,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMember', window );">Somatex | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMember', window );">Somatex | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMember', window );">Somatex | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SomatexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876316414216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Identifiable intangible assets:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember', window );">Distribution agreement [Member] | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember', window );">Trade names | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember', window );">Developed Technology | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member] | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DistributionagreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876310964536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Fiscal 2022</a></td>
<td class="nump">$ 326.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2023</a></td>
<td class="nump">231.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2024</a></td>
<td class="nump">222.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2025</a></td>
<td class="nump">208.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Fiscal 2026</a></td>
<td class="nump">$ 178.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876314077128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">$ 2,657.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="num">(5.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 25, 2021</a></td>
<td class="nump">3,281.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">821.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="num">(7.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 25, 2021</a></td>
<td class="nump">1,410.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">764.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 25, 2021</a></td>
<td class="nump">797.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">1,063.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 25, 2021</a></td>
<td class="nump">1,065.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 26, 2020</a></td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency and other adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at September 25, 2021</a></td>
<td class="nump">8.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Tax adjustment</a></td>
<td class="nump">432.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Tax adjustment</a></td>
<td class="nump">432.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Tax adjustment</a></td>
<td class="nump">83.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode | Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Tax adjustment</a></td>
<td class="nump">83.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Tax adjustment</a></td>
<td class="nump">80.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics | Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Tax adjustment</a></td>
<td class="nump">80.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMember', window );">Somatex</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Tax adjustment</a></td>
<td class="nump">32.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMember', window );">Somatex | Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Tax adjustment</a></td>
<td class="nump">$ 32.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SomatexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307299128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Aug. 23, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,281.6<span></span>
</td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GoodwillNotAtRiskOfFailingImpairment', window );">Goodwill not at risk of failing impairment</a></td>
<td class="nump">$ 3,300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GoodwillNotAtRiskOfFailingImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill not at risk of failing impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GoodwillNotAtRiskOfFailingImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318556200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Other Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReceivable', window );">Income Taxes Receivable</a></td>
<td class="nump">$ 24.7<span></span>
</td>
<td class="nump">$ 325.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">83.6<span></span>
</td>
<td class="nump">80.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Life insurance contracts</a></td>
<td class="nump">64.3<span></span>
</td>
<td class="nump">49.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Manufacturing access fees</a></td>
<td class="nump">21.9<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CostMethodEquityInvestments', window );">Cost-method equity investments</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneous', window );">Other</a></td>
<td class="nump">41.7<span></span>
</td>
<td class="nump">34.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">$ 245.7<span></span>
</td>
<td class="nump">$ 516.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CostMethodEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate carrying value of the Company's cost-method investments at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CostMethodEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneous">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneous</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876316416936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="num">$ (43.1)<span></span>
</td>
<td class="num">$ (22.9)<span></span>
</td>
<td class="num">$ (41.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedothercomprehensiveIncomelossHedge', window );">Accumulated other comprehensive Income loss Hedge</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(59.1)<span></span>
</td>
<td class="num">(49.7)<span></span>
</td>
<td class="num">(42.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</a></td>
<td class="num">(20.2)<span></span>
</td>
<td class="nump">18.5<span></span>
</td>
<td class="num">(14.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in pension plans, net of taxes of $0.2 in 2021, $0.1 in 2020, and $0.3 in 2019</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other Comprehensive Income (Loss), before Reclassifications, before Tax</a></td>
<td class="num">(9.9)<span></span>
</td>
<td class="num">(9.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotionalAmount', window );">Notional Amount</a></td>
<td class="nump">861.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=holx_PensioninAccumulatedOtherComprehensiveIncomeMember', window );">Pension in Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedothercomprehensiveIncomelossHedge', window );">Accumulated other comprehensive Income loss Hedge</a></td>
<td class="num">(14.7)<span></span>
</td>
<td class="num">(24.1)<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedothercomprehensiveIncomelossHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated other comprehensive Income loss Hedge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedothercomprehensiveIncomelossHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notional Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=holx_PensioninAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=holx_PensioninAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876310600168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet', window );">Gain (loss) on derivative</a></td>
<td class="num">$ (9.7)<span></span>
</td>
<td class="num">$ (1.2)<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax', window );">Unrealized gain (loss) on derivative</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</a></td>
<td class="num">(13.2)<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet', window );">Gain (loss) on derivative</a></td>
<td class="num">(3.6)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax', window );">Unrealized gain (loss) on derivative</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign Exchange Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet', window );">Gain (loss) on derivative</a></td>
<td class="num">(6.1)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax', window );">Unrealized gain (loss) on derivative</a></td>
<td class="num">$ (4.0)<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate impact of foreign currency derivatives on earnings for the period. Includes impact of foreign currency cash flow hedge ineffectiveness and the ineffectiveness of fair value hedging derivatives and full change in fair value of the foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318196984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">$ 18.7<span></span>
</td>
<td class="nump">$ 31.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">11.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign Exchange Option | Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Accrued expenses | Not Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Other long-term liabilities | Not Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="nump">$ 23.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876310531144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedothercomprehensiveIncomelossHedge', window );">Accumulated other comprehensive Income loss Hedge</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">$ (2.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="num">(27.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedothercomprehensiveIncomelossHedge', window );">Accumulated other comprehensive Income loss Hedge</a></td>
<td class="num">(14.7)<span></span>
</td>
<td class="num">(24.1)<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedothercomprehensiveIncomelossHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated other comprehensive Income loss Hedge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedothercomprehensiveIncomelossHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317408376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Loss recognized in other comprehensive income (loss), net</a></td>
<td class="nump">$ 9.8<span></span>
</td>
<td class="num">$ (28.1)<span></span>
</td>
<td class="num">$ (4.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(8.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent', window );">Loss recognized in other comprehensive income (loss), net</a></td>
<td class="nump">$ 9.4<span></span>
</td>
<td class="num">$ (27.6)<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307250312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Allowance for Doubtful Accounts Receivable [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 31,600,000<span></span>
</td>
<td class="nump">$ 17,800,000<span></span>
</td>
<td class="nump">$ 16,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Charged&#160;to Costs and Expenses</a></td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="nump">26,800,000<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountsReceivableReserveDivested', window );">Accounts receivable reserve divested</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountsReceivableAllowanceReduction', window );">Write- offs and Payments</a></td>
<td class="num">(6,100,000)<span></span>
</td>
<td class="num">(7,200,000)<span></span>
</td>
<td class="num">(2,800,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance&#160;at End of Period</a></td>
<td class="nump">$ 40,500,000<span></span>
</td>
<td class="nump">$ 31,600,000<span></span>
</td>
<td class="nump">$ 17,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountsReceivableAllowanceReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents reduction to the allowance for doubtful accounts primarily from collection of previously reserved accounts and the elimination of an account from the ledger accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountsReceivableAllowanceReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountsReceivableReserveDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable reserve divested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountsReceivableReserveDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317453928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding (in shares)</a></td>
<td class="nump">257,046<span></span>
</td>
<td class="nump">262,727<span></span>
</td>
<td class="nump">269,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits', window );">Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units (in shares)</a></td>
<td class="nump">2,660<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding (in shares)</a></td>
<td class="nump">259,706<span></span>
</td>
<td class="nump">264,613<span></span>
</td>
<td class="nump">269,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Options and stock units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">4,098<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318017160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Product Warranty (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 13.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Provisions</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">11.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition', window );">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease', window );">Standard Product Warranty Accrual, Period Increase (Decrease)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Settlements/ Adjustments</a></td>
<td class="num">(9.1)<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at&#160;End of Period</a></td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 9.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from a business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the standard product warranty accrual. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317462616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Estimated remaining performance obligation</a></td>
<td class="nump">$ 830.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was included in contract liability at prior year end</a></td>
<td class="nump">$ 112.1<span></span>
</td>
<td class="nump">$ 106.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876314168008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Business Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 5,632.3<span></span>
</td>
<td class="nump">$ 3,776.4<span></span>
</td>
<td class="nump">$ 3,367.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,902.3<span></span>
</td>
<td class="nump">2,863.2<span></span>
</td>
<td class="nump">2,536.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,730.0<span></span>
</td>
<td class="nump">913.2<span></span>
</td>
<td class="nump">831.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,695.0<span></span>
</td>
<td class="nump">2,102.1<span></span>
</td>
<td class="nump">1,205.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,393.1<span></span>
</td>
<td class="nump">1,582.4<span></span>
</td>
<td class="nump">921.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,301.9<span></span>
</td>
<td class="nump">519.7<span></span>
</td>
<td class="nump">284.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">473.9<span></span>
</td>
<td class="nump">410.1<span></span>
</td>
<td class="nump">472.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">304.6<span></span>
</td>
<td class="nump">266.3<span></span>
</td>
<td class="nump">312.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">169.3<span></span>
</td>
<td class="nump">143.8<span></span>
</td>
<td class="nump">159.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,171.5<span></span>
</td>
<td class="nump">1,648.4<span></span>
</td>
<td class="nump">675.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">2,038.9<span></span>
</td>
<td class="nump">1,272.5<span></span>
</td>
<td class="nump">549.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,132.6<span></span>
</td>
<td class="nump">375.9<span></span>
</td>
<td class="nump">125.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">49.6<span></span>
</td>
<td class="nump">43.6<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">49.6<span></span>
</td>
<td class="nump">43.6<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,352.3<span></span>
</td>
<td class="nump">1,151.9<span></span>
</td>
<td class="nump">1,314.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,051.8<span></span>
</td>
<td class="nump">888.6<span></span>
</td>
<td class="nump">1,037.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">300.5<span></span>
</td>
<td class="nump">263.3<span></span>
</td>
<td class="nump">276.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,083.4<span></span>
</td>
<td class="nump">953.6<span></span>
</td>
<td class="nump">1,094.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">830.4<span></span>
</td>
<td class="nump">722.0<span></span>
</td>
<td class="nump">853.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">253.0<span></span>
</td>
<td class="nump">231.6<span></span>
</td>
<td class="nump">241.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">268.9<span></span>
</td>
<td class="nump">198.3<span></span>
</td>
<td class="nump">219.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">221.4<span></span>
</td>
<td class="nump">166.6<span></span>
</td>
<td class="nump">184.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">47.5<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
<td class="nump">34.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">488.1<span></span>
</td>
<td class="nump">376.1<span></span>
</td>
<td class="nump">437.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">Gyn Surgical [Member] | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">396.4<span></span>
</td>
<td class="nump">310.1<span></span>
</td>
<td class="nump">362.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">Gyn Surgical [Member] | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">91.7<span></span>
</td>
<td class="nump">66.0<span></span>
</td>
<td class="nump">74.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">96.9<span></span>
</td>
<td class="nump">81.0<span></span>
</td>
<td class="nump">94.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">61.0<span></span>
</td>
<td class="nump">51.2<span></span>
</td>
<td class="nump">58.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">35.9<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
<td class="nump">36.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">65.3<span></span>
</td>
<td class="nump">315.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">30.9<span></span>
</td>
<td class="nump">155.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 34.4<span></span>
</td>
<td class="nump">$ 160.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CytologyPerinatalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CytologyPerinatalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BloodScreeningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BloodScreeningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BreastImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BreastImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876428599464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Geographical Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 5,632.3<span></span>
</td>
<td class="nump">$ 3,776.4<span></span>
</td>
<td class="nump">$ 3,367.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,902.3<span></span>
</td>
<td class="nump">2,863.2<span></span>
</td>
<td class="nump">2,536.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,201.8<span></span>
</td>
<td class="nump">569.8<span></span>
</td>
<td class="nump">396.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">365.0<span></span>
</td>
<td class="nump">226.8<span></span>
</td>
<td class="nump">286.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_OtherGeographicRegionsMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 163.2<span></span>
</td>
<td class="nump">$ 116.6<span></span>
</td>
<td class="nump">$ 149.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_OtherGeographicRegionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_OtherGeographicRegionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318404808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue by Type (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 5,632.3<span></span>
</td>
<td class="nump">$ 3,776.4<span></span>
</td>
<td class="nump">$ 3,367.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,902.3<span></span>
</td>
<td class="nump">2,863.2<span></span>
</td>
<td class="nump">2,536.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,730.0<span></span>
</td>
<td class="nump">913.2<span></span>
</td>
<td class="nump">831.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember', window );">Capital equipment, components and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">769.1<span></span>
</td>
<td class="nump">665.9<span></span>
</td>
<td class="nump">984.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_ConsumablesMember', window );">Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">4,198.2<span></span>
</td>
<td class="nump">2,561.1<span></span>
</td>
<td class="nump">1,786.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">598.1<span></span>
</td>
<td class="nump">516.6<span></span>
</td>
<td class="nump">568.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 66.9<span></span>
</td>
<td class="nump">$ 32.8<span></span>
</td>
<td class="nump">$ 27.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317719336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Remaining Performance Obligations (Details)<br></strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-09-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-09-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligation over time (percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation over time</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-09-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-09-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315718952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate', window );">Period with option to terminate lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod', window );">Extension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="nump">$ 22,800,000<span></span>
</td>
<td class="nump">22,800,000<span></span>
</td>
<td class="nump">17,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeaseRevenuePercentageOfTotalRevenue', window );">Lease revenue as a percentage of total</a></td>
<td class="nump">0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use asset obtained in exchange for finance lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeaseReceivable', window );">Lease receivable</a></td>
<td class="nump">$ 17,400,000<span></span>
</td>
<td class="nump">17,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">83,600,000<span></span>
</td>
<td class="nump">83,600,000<span></span>
</td>
<td class="nump">80,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">92,900<span></span>
</td>
<td class="nump">92,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">26,500<span></span>
</td>
<td class="nump">26,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="num">(564,700,000)<span></span>
</td>
<td class="num">(564,700,000)<span></span>
</td>
<td class="num">(491,500,000)<span></span>
</td>
<td class="num">(470,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="num">(368,700,000)<span></span>
</td>
<td class="num">(368,700,000)<span></span>
</td>
<td class="num">(303,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Statement of Financial Position [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:LiabilitiesAbstract<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:LiabilitiesAbstract<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">ROU assets arising from entering into new operating lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,600<span></span>
</td>
<td class="nump">13,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842', window );">Operating lease, right of use asset at adoption of 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842', window );">Finance lease, right of use asset at adoption of 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember', window );">Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use asset obtained in exchange for finance lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">9,900,000<span></span>
</td>
<td class="nump">9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsShortTermMember', window );">Finance lease obligations - short term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsLongTermMember', window );">Finance lease obligations - long term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="nump">9,300<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="nump">$ 22,800<span></span>
</td>
<td class="nump">$ 22,800<span></span>
</td>
<td class="nump">$ 17,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm', window );">Lessee, operating and finance lease, remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm', window );">Lessee, operating and finance lease, remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance lease, right of use asset at adoption of 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeaseRevenuePercentageOfTotalRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Revenue, Percentage Of Total Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeaseRevenuePercentageOfTotalRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Lease, Period With Option To Terminate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Lease, Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LesseeOperatingAndFinanceLeasesExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Leases, Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LesseeOperatingAndFinanceLeasesExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease, right of use asset at adoption of 842</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_CynosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsShortTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsShortTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsLongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsLongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315754616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">$ 83,600,000<span></span>
</td>
<td class="nump">$ 80,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (current)</a></td>
<td class="nump">26,800,000<span></span>
</td>
<td class="nump">23,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities (non-current)</a></td>
<td class="nump">$ 66,100,000<span></span>
</td>
<td class="nump">65,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="nump">$ 22,800,000<span></span>
</td>
<td class="nump">$ 17,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases, weighted average remaining lease term</a></td>
<td class="text">4 years 11 months 12 days<span></span>
</td>
<td class="text">5 years 6 months 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases, weighted average remaining lease term</a></td>
<td class="text">7 years 6 months 7 days<span></span>
</td>
<td class="text">7 years 7 months 20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases, weighted average discount rate</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases, weighted average discount rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Accrued expenses<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">$ 83,600<span></span>
</td>
<td class="nump">$ 80,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (current)</a></td>
<td class="nump">26,800<span></span>
</td>
<td class="nump">23,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities (non-current)</a></td>
<td class="nump">66,100<span></span>
</td>
<td class="nump">65,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsShortTermMember', window );">Finance lease obligations - short term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsLongTermMember', window );">Finance lease obligations - long term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities (current)</a></td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities (non-current)</a></td>
<td class="nump">$ 22,800<span></span>
</td>
<td class="nump">$ 17,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsShortTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsShortTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsLongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=holx_FinanceLeaseObligationsLongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317193336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Lease Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 01, 2021 </div>
<div>Segment</div>
</th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,100<span></span>
</td>
<td class="nump">$ 27,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance lease cost - amortization of right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance lease cost - interest cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,200<span></span>
</td>
<td class="nump">23,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability', window );">Total cash paid for amounts included in the measurement of lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,600<span></span>
</td>
<td class="nump">26,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">ROU assets arising from entering into new operating lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,600<span></span>
</td>
<td class="nump">13,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use asset obtained in exchange for finance lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NumberOfFinanceLeases', window );">Number of finance leases | Segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage', window );">Lessee, Finance Lease, Bargain Purchase Option, Percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Lessee, Finance Lease, Remaining Lease Term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Lessee, Finance Lease, Remaining Lease Term</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Finance Lease, Bargain Purchase Option, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NumberOfFinanceLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Finance Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NumberOfFinanceLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876310970280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Liability Maturity Schedule 2020 (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 28,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">22,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">16,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">7,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">97,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(4,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">92,900<span></span>
</td>
<td class="nump">$ 96,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Lease</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">10,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">30,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(4,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 26,500<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876312765096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Minimum Annual Rental Income Payments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SubLeaseRentalIncomeCurrent', window );">Sub lease Rental income current</a></td>
<td class="nump">$ 3.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SubLeaseRentalIncomeDueIn2Years', window );">Sub lease rental income due in 2 years</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SubLeaseRentalIncomeDueIn3Years', window );">Sub lease rental income due in 3 years</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SubLeaseRentalIncomeDueIn4Years', window );">Sub lease rental income due in 4 years</a></td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SubLeaseRentalIncomeDueIn5years', window );">Sub lease rental income due in 5years</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SubLeaseRentalIncomeDueThereafter', window );">Sub lease rental income due thereafter</a></td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SubLeaseRentalIncome', window );">Sub lease rental income</a></td>
<td class="nump">$ 14.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SubLeaseRentalIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sub lease rental income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SubLeaseRentalIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SubLeaseRentalIncomeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sub lease Rental income current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SubLeaseRentalIncomeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SubLeaseRentalIncomeDueIn2Years">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sub lease rental income due in 2 years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SubLeaseRentalIncomeDueIn2Years</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SubLeaseRentalIncomeDueIn3Years">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sub lease rental income due in 3 years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SubLeaseRentalIncomeDueIn3Years</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SubLeaseRentalIncomeDueIn4Years">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sub lease rental income due in 4 years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SubLeaseRentalIncomeDueIn4Years</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SubLeaseRentalIncomeDueIn5years">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sub lease rental income due in 5years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SubLeaseRentalIncomeDueIn5years</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SubLeaseRentalIncomeDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sub lease rental income due thereafter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SubLeaseRentalIncomeDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876297228232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 17, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Feb. 22, 2021</div></th>
<th class="th"><div>Jan. 04, 2021</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
<th class="th"><div>Aug. 23, 2020</div></th>
<th class="th"><div>Dec. 30, 2019</div></th>
<th class="th"><div>Nov. 21, 2019</div></th>
<th class="th"><div>Oct. 01, 2019</div></th>
<th class="th"><div>Aug. 01, 2019</div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
<th class="th"><div>Nov. 20, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,281,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,281,600,000<span></span>
</td>
<td class="nump">$ 2,657,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,659,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,659,200,000<span></span>
</td>
<td class="nump">1,307,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest', window );">Portion allocable to fair value of noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 729,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="nump">285,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="nump">20,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="nump">20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 432,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Decrease In Research And Development In Process</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Developed Technology | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Developed Technology | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Customer Relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Customer Relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Trade names | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Trade names | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMedicalTechnologiesMember', window );">Somatex Medical Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net acquired tangible assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember', window );">NXC Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember', window );">NXC Imaging | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase in contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health | Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Acquired tangible assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember', window );">Alpha Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare', window );">Cash tender offer price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationSharesAcquired', window );">Acquired shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AdditionalPurchaseConsideration', window );">Additional purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationOwnershipPercentage', window );">Ownership of outstanding shares (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Equity interest in acquiree (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment', window );">Portion allocable to equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares', window );">Portion allocable to newly acquired shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment', window );">Portion allocable to loan repaymnet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationAdditionalSharesAcquiredShares', window );">Additional outstanding shares purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationAdditionalSharesAcquiredValue', window );">Additional outstanding shares purchased, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Other Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (loss) from equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability', window );">Payment period for contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | In-process research and development | Minimum | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics | In-process research and development | Maximum | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Fair value, discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AdditionalPurchaseConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional purchase consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AdditionalPurchaseConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Cash Tender Offer Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessAcquisitionCashTenderOfferPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationAdditionalSharesAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Additional Shares Acquired, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationAdditionalSharesAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationAdditionalSharesAcquiredValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Additional Shares Acquired, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationAdditionalSharesAcquiredValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Period for Payment of Contingent Consideration Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Decrease In Research And Development In Process</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Shares Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Holdback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Holdback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMedicalTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SomatexMedicalTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876313280904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations Business Combinations - Purchase Price Allocation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Jun. 17, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Feb. 22, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Aug. 23, 2020</div></th>
<th class="th"><div>Nov. 21, 2019</div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,281.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">432.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 729.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt', window );">Short and long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member', window );">Focal Therapeutics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_FocalTherapeuticsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307245656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investment</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 18.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876316029256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,700,000<span></span>
</td>
<td class="nump">15,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember', window );">Fiscal 2021 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2021ActionMember', window );">Fiscal 2021 Actions | Fiscal 2019 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2021ActionMember', window );">Fiscal 2021 Actions | Fiscal 2020 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2021ActionMember', window );">Fiscal 2021 Actions | Fiscal 2021 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember', window );">Fiscal 2020 Actions | Fiscal 2019 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember', window );">Fiscal 2020 Actions | Fiscal 2020 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember', window );">Fiscal 2020 Actions | Fiscal 2021 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember', window );">Fiscal 2019 Actions | Fiscal 2019 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember', window );">Fiscal 2019 Actions | Fiscal 2020 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember', window );">Fiscal 2019 Actions | Fiscal 2021 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember', window );">Other | Fiscal 2019 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember', window );">Other | Fiscal 2020 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember', window );">Other | Fiscal 2021 restructuring charges | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DivestitureCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DivestitureCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FacilityClosureCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FacilityClosureCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ReductionOfWorkforceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents severance and related benefit charges for the termination of employees under an exit or disposal activity. Charges are recorded either as one-time termination benefits, which are recognized ratable over the required service period to receive such benefit, or under an ongoing benefit plan arrangement once the charge is probable and reasonably estimable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ReductionOfWorkforceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RestructuringChargesUnderExitOrDisposalPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total restructuring charges under exit or disposal plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RestructuringChargesUnderExitOrDisposalPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2021ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2021ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_OtheractionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876407538040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail) - Restructuring Charges - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 restructuring charges | Fiscal 2021 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 restructuring charges | Fiscal 2020 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 restructuring charges | Fiscal 2019 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 restructuring charges | Fiscal 2018 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember', window );">Fiscal 2018 restructuring charges | Previous Other Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 restructuring charges | Fiscal 2021 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 restructuring charges | Fiscal 2020 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 restructuring charges | Fiscal 2019 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 restructuring charges | Fiscal 2018 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 restructuring charges | Previous Other Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">8.7<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 restructuring charges | Fiscal 2021 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 restructuring charges | Fiscal 2020 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 restructuring charges | Fiscal 2019 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 restructuring charges | Fiscal 2018 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember', window );">Fiscal 2020 restructuring charges | Previous Other Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember', window );">Fiscal 2021 restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">9.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="num">(8.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember', window );">Fiscal 2021 restructuring charges | Fiscal 2021 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">8.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember', window );">Fiscal 2021 restructuring charges | Fiscal 2020 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember', window );">Fiscal 2021 restructuring charges | Fiscal 2019 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember', window );">Fiscal 2021 restructuring charges | Fiscal 2018 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember', window );">Fiscal 2021 restructuring charges | Previous Other Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CashSeverancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Severance payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CashSeverancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherRestructuringPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to settle other restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherRestructuringPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RestructuringChargesUnderExitOrDisposalPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total restructuring charges under exit or disposal plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RestructuringChargesUnderExitOrDisposalPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation expense included other restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2021ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2021ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2020ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2019ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_OtherOperatingCostReductionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_OtherOperatingCostReductionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2020ChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2021ChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315978904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Dec. 29, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,400,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityByLocationAxis=holx_TepnelMember', window );">Tepnel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityByLocationAxis=holx_CynosureMember', window );">Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental cost</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DivestitureCharges', window );">Divestiture charges</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_BedfordMember', window );">Bedford</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RemainingLeaseBalance', window );">Remaining lease balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember', window );">Fiscal 2019 restructuring charges | Fiscal 2018 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring Charges | Fiscal 2019 restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DivestitureCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Divestiture charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DivestitureCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FacilityClosureCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FacilityClosureCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ReductionOfWorkforceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents severance and related benefit charges for the termination of employees under an exit or disposal activity. Charges are recorded either as one-time termination benefits, which are recognized ratable over the required service period to receive such benefit, or under an ongoing benefit plan arrangement once the charge is probable and reasonably estimable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ReductionOfWorkforceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RemainingLeaseBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RemainingLeaseBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityByLocationAxis=holx_TepnelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityByLocationAxis=holx_TepnelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityByLocationAxis=holx_CynosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityByLocationAxis=holx_CynosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_BedfordMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_BedfordMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_Fiscal2019chargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315978328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Company's Borrowings (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="nump">$ 313.0<span></span>
</td>
<td class="nump">$ 324.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">2,712.2<span></span>
</td>
<td class="nump">2,713.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">3,025.2<span></span>
</td>
<td class="nump">3,038.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">1,382.3<span></span>
</td>
<td class="nump">1,379.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">250.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Securitization Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="nump">248.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">939.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">395.4<span></span>
</td>
<td class="nump">394.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="nump">64.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">$ 934.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LongTermDebtObligationsWithoutConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term debt obligations without convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LongTermDebtObligationsWithoutConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876313435336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 388.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">112.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">1,200.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2027 and Thereafter</a></td>
<td class="nump">1,350.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">3,050.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">75.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">112.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">1,200.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2027 and Thereafter</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">1,387.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Securitization Program</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">248.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2027 and Thereafter</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">248.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2027 and Thereafter</a></td>
<td class="nump">400.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">400.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2027 and Thereafter</a></td>
<td class="nump">950.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">950.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2020</a></td>
<td class="nump">64.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">2027 and Thereafter</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total</a></td>
<td class="nump">$ 64.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876312504248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2018Member', window );">2018 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="nump">1.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="nump">1.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member', window );">2017 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember', window );">Prior Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.43%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreement2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876301156248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 25, 2022</div></th>
<th class="th">
<div>Sep. 27, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 15, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 28, 2020</div></th>
<th class="th">
<div>Dec. 17, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 19, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 25, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 27, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($) </div>
<div>debt_instrument</div>
</th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 17, 2021</div></th>
<th class="th">
<div>Jun. 11, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,600,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 313,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,000,000.0<span></span>
</td>
<td class="nump">324,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="nump">$ 480,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Mobidiag Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Mobidiag Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditFacility2018Member', window );">2018 Amended Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeverageRatioMaximum', window );">Leverage ratio maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestCoverageRatio', window );">Interest coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditFacility2018Member', window );">2018 Amended Credit Facility | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeverageRatioMaximum', window );">Leverage ratio maximum</a></td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member', window );">2017 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentNumberOfInstruments', window );">Number of debt instruments | debt_instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumRangeofPresentValueofCashFlowPercentage', window );">Maximum range of present value of cash flow (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted-average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember', window );">Prior Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted-average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.43%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember', window );">Securitization Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TermARSecuritizationProgram', window );">Term of accounts receivable securitization program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableFromSecuritization', window );">Accounts receivable from securitization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumBorrowingUnderSecuritizationProgram', window );">Maximum borrowing under securitization program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2021CreditAgreementMember', window );">2021 Credit Agreement | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2018 Amended Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2018 Amended Term Loan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter', window );">Debt Instrument, Periodic Payment, Principal Per Quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments', window );">Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2018 Amended Term Loan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter', window );">Debt Instrument, Periodic Payment, Principal Per Quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2018 Amended Term Loan | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2021 Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2021 Term Loan | Eurocurrency Rate | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter', window );">Debt Instrument, Periodic Payment, Principal Per Quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,335,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentCommitmentFeePercentage', window );">Debt Instrument, Commitment Fee, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2021 Term Loan | Eurocurrency Rate | Minimum | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter', window );">Debt Instrument, Periodic Payment, Principal Per Quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2021 Term Loan | Eurocurrency Rate | Maximum | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter', window );">Debt Instrument, Periodic Payment, Principal Per Quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver | 2021 Revolver | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | 2018 Amended Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | 2018 Amended Revolver | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (21,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 970,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtRedemptionPremiumPaid', window );">Debt Redemption, Premium Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of senior long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue', window );">Offering price, percent of face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod', window );">Percentage of redemption price, third period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.312%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.312%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod', window );">Percentage of redemption price, fourth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.541%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.541%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod', window );">Percentage of redemption price, fifth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod', window );">Percentage redemption price, sixth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes', window );">Percentage price of principal amount for repurchase of senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.813%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Period Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Securitization Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current debt obligations, net of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Debt, Weighted Average Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Commitment Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentNumberOfInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Instruments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentNumberOfInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Offering Price, Percent Of Face Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentOfferingPricePercentOfFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Fifth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Fourth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Third Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Redemption Price Sixth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Principal Per Quarter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtRedemptionPremiumPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Redemption, Premium Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtRedemptionPremiumPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leverage Ratio Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumBorrowingUnderSecuritizationProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing under securitization program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumBorrowingUnderSecuritizationProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumRangeofPresentValueofCashFlowPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Range of Present Value of Cash Flow Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumRangeofPresentValueofCashFlowPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Price of Principal Amount for Repurchase of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TermARSecuritizationProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Accounts Receivable Securitization Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TermARSecuritizationProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableFromSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount owed to the reporting entity by counterparties in securitized loan transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableFromSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditFacility2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedCreditFacility2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreement2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementPriorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2021CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2021CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedTermLoan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2021TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2021TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=holx_EurocurrencyRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=holx_EurocurrencyRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2021RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2021RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedRevolver2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedRevolver2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876306060376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 54.2<span></span>
</td>
<td class="nump">$ 62.7<span></span>
</td>
<td class="nump">$ 62.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">19.2<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">43.5<span></span>
</td>
<td class="nump">43.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 32.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (percent)</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876312619400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 11.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">94.4<span></span>
</td>
<td class="nump">113.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration recorded at acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">82.7<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">11.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">19.3<span></span>
</td>
<td class="nump">31.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">75.1<span></span>
</td>
<td class="nump">81.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">18.7<span></span>
</td>
<td class="nump">31.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">18.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Options | Assets | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Options | Assets | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Options | Assets | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Assets | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Assets | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Assets | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Forward foreign currency contracts</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Liability | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Liability | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Liability | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">75.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">contingent consideration | Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">contingent consideration | Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">contingent consideration | Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">$ 75.1<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317218504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal under credit agreement</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Acquired intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">675,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal under credit agreement</a></td>
<td class="nump">1,390,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="nump">424,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="nump">$ 964,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876316212280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="nump">$ 7.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration recorded at acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">82.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments/Accruals</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 75.1<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307432280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income (Loss) Before Income Taxes (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">$ 2,267.8<span></span>
</td>
<td class="nump">$ 921.1<span></span>
</td>
<td class="num">$ (174.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">93.3<span></span>
</td>
<td class="nump">80.8<span></span>
</td>
<td class="num">(83.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">$ 2,361.1<span></span>
</td>
<td class="nump">$ 1,001.9<span></span>
</td>
<td class="num">$ (257.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318087160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Provision for Income Taxes (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Federal:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">$ 453.6<span></span>
</td>
<td class="num">$ (62.1)<span></span>
</td>
<td class="nump">$ 142.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(45.6)<span></span>
</td>
<td class="num">(76.6)<span></span>
</td>
<td class="num">(189.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal, Total</a></td>
<td class="nump">408.0<span></span>
</td>
<td class="num">(138.7)<span></span>
</td>
<td class="num">(47.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>State:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">84.7<span></span>
</td>
<td class="nump">33.9<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(11.9)<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
<td class="num">(41.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">State, Total</a></td>
<td class="nump">72.8<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
<td class="num">(18.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Foreign:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">23.2<span></span>
</td>
<td class="nump">14.0<span></span>
</td>
<td class="nump">16.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(12.6)<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations', window );">Foreign, Total</a></td>
<td class="nump">10.6<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">$ 491.4<span></span>
</td>
<td class="num">$ (108.6)<span></span>
</td>
<td class="num">$ (54.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315879496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Increase (decrease) in tax resulting from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax (benefit) provision at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure', window );">Loss on sale of Cynosure</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(31.30%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">U.S. tax on foreign earnings</a></td>
<td class="num">(2.70%)<span></span>
</td>
<td class="num">(2.60%)<span></span>
</td>
<td class="num">(2.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges', window );">Internal restructuring</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.80%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment', window );">Tax credits</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(3.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent', window );">Tax reform</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost', window );">Compensation</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(5.40%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Change in deferred tax rate</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">20.80%<span></span>
</td>
<td class="num">(10.80%)<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation benefit expense research and development.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to the difference in the deductibility or nondeductibility of executive compensation (i.e., those subject to Section 162(m) limitations), including equity-based compensation and salary and bonus compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to changes in unrecognized tax benefits recorded in the statement of operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax reconciliation loss on sale of Cynosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318266728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 91,500,000<span></span>
</td>
<td class="nump">$ 81,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital losses</a></td>
<td class="nump">52,000,000.0<span></span>
</td>
<td class="nump">57,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Non-deductible accruals</a></td>
<td class="nump">34,900,000<span></span>
</td>
<td class="nump">24,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Non-deductible reserves</a></td>
<td class="nump">41,800,000<span></span>
</td>
<td class="nump">33,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">17,600,000<span></span>
</td>
<td class="nump">18,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">10,000,000.0<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan', window );">Nonqualified deferred compensation plan</a></td>
<td class="nump">16,800,000<span></span>
</td>
<td class="nump">14,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">16,200,000<span></span>
</td>
<td class="nump">17,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other temporary differences</a></td>
<td class="nump">17,400,000<span></span>
</td>
<td class="nump">25,200,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets, gross</a></td>
<td class="nump">298,200,000<span></span>
</td>
<td class="nump">281,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(121,300,000)<span></span>
</td>
<td class="num">(118,500,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">176,900,000<span></span>
</td>
<td class="nump">163,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation&#160;and amortization</a></td>
<td class="num">(389,700,000)<span></span>
</td>
<td class="num">(333,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxLiabilitiesRightOfUseAsset', window );">Right of use asset</a></td>
<td class="num">(15,800,000)<span></span>
</td>
<td class="num">(15,800,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="num">(405,500,000)<span></span>
</td>
<td class="num">(349,700,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (228,600,000)<span></span>
</td>
<td class="num">$ (186,300,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax effect as of the balance sheet date of the amount of future tax deductions arising from the Company's nonqualified deferred compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount as of the balance sheet date of the estimated future tax effects attributable to amortization of intangible assets, and to a lesser extent, depreciation of property and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxLiabilitiesRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities right of use asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxLiabilitiesRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876310278904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease', window );">Decrease in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal', window );">Federal net operating loss expected to be expired unutilized</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState', window );">State net operating loss expected to be expired unutilized</a></td>
<td class="nump">48,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign', window );">Foreign net operating loss expected to be expired unutilized</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GrossUnrecognizedTaxBenefits', window );">Gross unrecognized tax benefits, excluding interest</a></td>
<td class="nump">212,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,800,000<span></span>
</td>
<td class="nump">$ 197,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefit that would impact effective tax rate</a></td>
<td class="nump">197,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,000,000<span></span>
</td>
<td class="nump">184,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Change in gross unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued', window );">Interest accrued on unrecognized tax benefits</a></td>
<td class="nump">13,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="nump">11,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncreasetoincometaxexpenseadoptionofASU201616', window );">Increase to income tax expense adoption of ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DecreaseindeferredtaxliabilitiesduetoASC201616', window );">Decrease in deferred tax liabilities due to ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616', window );">Increase to Net Income resulted from adoption of ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616', window );">Increase to Earnings per Share resulted from adoption of ASU 2016-16</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_StateLossCarryforwardExpectedToUnutilize', window );">state loss carryforward expected to unutilize</a></td>
<td class="nump">26,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital losses</a></td>
<td class="nump">52,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000,000.0<span></span>
</td>
<td class="nump">$ 57,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GrossStateLossCarryforwards', window );">Gross state loss carryforwards</a></td>
<td class="nump">26,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GrossForeignLossCarryforwards', window );">Gross foreign loss carryforwards</a></td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Other Tax Expense (Benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NonIncomeTaxLoss', window );">Non-income tax loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxReceivableReclassification', window );">Income Tax Receivable Reclassification</a></td>
<td class="nump">310,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxReceivableReclassification', window );">Income Tax Receivable Reclassification</a></td>
<td class="num">(404,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=holx_NetOperatingLossCarryforwardsMember', window );">Net Operating Losses Carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod', window );">Amount with unlimited carry forward periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=holx_TaxCreditCarryforwardMember', window );">Tax Credit Carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod', window );">Amount with unlimited carry forward periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in unrecognized tax benefits is reasonably possible</a></td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">89,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Credit carry forwards</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Credit carry forwards</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">263,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Credit carry forwards</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DecreaseindeferredtaxliabilitiesduetoASC201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in deferred tax liabilities due to ASC 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DecreaseindeferredtaxliabilitiesduetoASC201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of federal net operating losses the company believes will expire unutilized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state net operating losses the company believes will expire unutilized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrossForeignLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross foreign loss carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrossForeignLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrossStateLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross state loss carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrossStateLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrossUnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total unrecognized tax benefits, including interest, that if recognized would result in a reduction to the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrossUnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncomeTaxReceivableReclassification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Receivable Reclassification</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncomeTaxReceivableReclassification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase to Earnings per Share resulted from adoption of ASC 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncreasetoNetIncomeresultedfromadoptionofASU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase to Net Income resulted from adoption of ASU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncreasetoNetIncomeresultedfromadoptionofASU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncreasetoincometaxexpenseadoptionofASU201616">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase to income tax expense adoption of ASU 2016-16</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncreasetoincometaxexpenseadoptionofASU201616</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss and tax credit carry forwards with unlimited expiration period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NonIncomeTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Income Tax Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NonIncomeTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_StateLossCarryforwardExpectedToUnutilize">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>state loss carryforward expected to unutilize</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_StateLossCarryforwardExpectedToUnutilize</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense accrued for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=holx_NetOperatingLossCarryforwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=holx_NetOperatingLossCarryforwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=holx_TaxCreditCarryforwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=holx_TaxCreditCarryforwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876318272872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of fiscal year</a></td>
<td class="nump">$ 197.1<span></span>
</td>
<td class="nump">$ 101.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TaxPositionsRelatedToCurrentYearAbstract', window );"><strong>Tax positions related to current year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">109.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions', window );">Reductions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TaxPositionsRelatedToPriorYearsAbstract', window );"><strong>Tax positions related to prior years:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions related to change in estimate</a></td>
<td class="nump">7.9<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Lapses in statutes of limitations</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(15.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_UnrecognizedTaxBenefitsIncreasesAbstract', window );"><strong>Acquired tax positions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition', window );">Additions related to reserves acquired from acquisitions</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance as of the end of the fiscal year</a></td>
<td class="nump">$ 212.8<span></span>
</td>
<td class="nump">$ 197.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TaxPositionsRelatedToCurrentYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax positions related to current year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TaxPositionsRelatedToCurrentYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TaxPositionsRelatedToPriorYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax positions related to prior years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TaxPositionsRelatedToPriorYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_UnrecognizedTaxBenefitsIncreasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized tax benefits increases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_UnrecognizedTaxBenefitsIncreasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876309493992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2013</div></th>
<th class="th"><div>Mar. 31, 2012</div></th>
<th class="th"><div>Nov. 16, 2021</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Dec. 09, 2020</div></th>
<th class="th"><div>Dec. 11, 2019</div></th>
<th class="th"><div>Jun. 13, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized value of common shares to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock-based compensation, period of vest term granted to employees, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate', window );">Cliff vesting period from grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,900,000<span></span>
</td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of option exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,400,000<span></span>
</td>
<td class="nump">44,800,000<span></span>
</td>
<td class="nump">26,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000,000.0<span></span>
</td>
<td class="nump">$ 83,300,000<span></span>
</td>
<td class="nump">62,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ASRSharesRepurchasedduringtheperiod', window );">ASR Shares Repurchased during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ASRAuthorized', window );">ASR Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmountpaidduringtheperiodunderASRAgreement', window );">Amount paid during the period under ASR Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 164,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria', window );">Percentage of award vested upon meeting defined market based criteria</a></td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 167,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_June132019PlanMember', window );">June 13, 2019 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationPercentageOfForfeitureRate', window );">Percentage of forfeiture rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationPercentageOfForfeitureRate', window );">Percentage of forfeiture rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="nump">15,500,000<span></span>
</td>
<td class="nump">14,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period of unrecognized stock-based compensation, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock-based compensation, period of vest term granted to employees, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfVestingForStockOptionsGrantedToEmployees', window );">Percentage of vesting for stock options granted to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock-based compensation, period of vest term granted to employees, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,100,000<span></span>
</td>
<td class="nump">63,300,000<span></span>
</td>
<td class="nump">43,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period of unrecognized stock-based compensation, years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of RSUs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,100,000<span></span>
</td>
<td class="nump">$ 34,900,000<span></span>
</td>
<td class="nump">$ 34,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees', window );">Percentage of vesting for RSUs granted to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested, weighted average grant date fair value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68.51<span></span>
</td>
<td class="nump">$ 45.38<span></span>
</td>
<td class="nump">$ 40.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember', window );">Market Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate', window );">Cliff vesting period from grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Vested, weighted average grant date fair value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82.31<span></span>
</td>
<td class="nump">$ 43.54<span></span>
</td>
<td class="nump">$ 55.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember', window );">PSU Free Cash Flow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=holx_TwoThousandEightEquityPlanMember', window );">2008 Equity Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=holx_SemiAnnualEmployeeStockPurchasePlanMember', window );">2012 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan', window );">Number of shares that may be issued under Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase', window );">Percentage of common stock price for ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareRepurchseAuthorizationDateAxis=holx_Dec112019Member', window );">Dec 11, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 691,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 691,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized value of common shares to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,300,000<span></span>
</td>
<td class="nump">$ 237,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareRepurchseAuthorizationDateAxis=holx_Dec92020Member', window );">Dec 9, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized value of common shares to be repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Common stock repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 308,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ASRAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASR Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ASRAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ASRSharesRepurchasedduringtheperiod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ASR Shares Repurchased during the period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ASRSharesRepurchasedduringtheperiod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmountpaidduringtheperiodunderASRAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount paid during the period under ASR Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmountpaidduringtheperiodunderASRAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum target number percentage of shares issued based on stock performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum target number percentage of shares that would be issued based on stock price performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuable under employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of award vested upon meeting defined market based criteria</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage applied to the lower of the common stock price at the beginning of the plan period and end of the plan period to determine the number of shares to be issued under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of restricted stock units that vest annually per the terms of the typical restricted stock unit grant arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfVestingForStockOptionsGrantedToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of stock options that vest annually per the terms of the typical stock option grant arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfVestingForStockOptionsGrantedToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareBasedCompensationPercentageOfForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Forfeiture rate applied to equity awards issued to certain employee groups to determine stock-based compensation expense for the period. The rate is based on an analysis of historical employee exercise and terminations patterns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareBasedCompensationPercentageOfForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow resulting from the entity's share transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_June132019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_June132019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=holx_TwoThousandEightEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=holx_TwoThousandEightEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=holx_SemiAnnualEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=holx_SemiAnnualEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareRepurchseAuthorizationDateAxis=holx_Dec112019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareRepurchseAuthorizationDateAxis=holx_Dec112019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareRepurchseAuthorizationDateAxis=holx_Dec92020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareRepurchseAuthorizationDateAxis=holx_Dec92020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876489287432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 65.0<span></span>
</td>
<td class="nump">$ 83.3<span></span>
</td>
<td class="nump">$ 62.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">38.9<span></span>
</td>
<td class="nump">50.9<span></span>
</td>
<td class="nump">35.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876310633912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (in shares)</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price</a></td>
<td class="nump">$ 68.62<span></span>
</td>
<td class="nump">$ 45.96<span></span>
</td>
<td class="nump">$ 41.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in usd per share)</a></td>
<td class="nump">$ 19.86<span></span>
</td>
<td class="nump">$ 13.92<span></span>
</td>
<td class="nump">$ 13.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rates</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">33.60%<span></span>
</td>
<td class="nump">34.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876313378072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of&#160;Shares (in millions)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at September 26, 2020</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled/ forfeited</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at September 25, 2021</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable at September 25, 2021</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest at September 25, 2021 (1)</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise&#160;Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at September 26, 2020</a></td>
<td class="nump">$ 40.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">68.62<span></span>
</td>
<td class="nump">$ 45.96<span></span>
</td>
<td class="nump">$ 41.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Canceled/ forfeited</a></td>
<td class="nump">49.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">38.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at September 29, 2018</a></td>
<td class="nump">44.66<span></span>
</td>
<td class="nump">$ 40.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable at September 25, 2021</a></td>
<td class="nump">39.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest at September 25, 2021 (1)</a></td>
<td class="nump">$ 44.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual&#160;Life (in Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife', window );">Options outstanding at September 26, 2020</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at September 25, 2021</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options vested and expected to vest at September 25, 2021 (1)</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife', window );">Options outstanding at September 25, 2021</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value (in millions)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding at September 26, 2020</a></td>
<td class="nump">$ 109.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Exercised</a></td>
<td class="nump">30.4<span></span>
</td>
<td class="nump">$ 44.8<span></span>
</td>
<td class="nump">$ 26.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding at September 25, 2021</a></td>
<td class="nump">132.7<span></span>
</td>
<td class="nump">$ 109.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable at September 25, 2021</a></td>
<td class="nump">85.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options vested and expected to vest at September 25, 2021 (1)</a></td>
<td class="nump">$ 132.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember', window );">Market Based Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876407612936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit related to stock based compensation</a></td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="nump">$ 9.5<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Shares (in millions)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested at September 26, 2020</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-vested at September 25, 2021</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant-Date&#160;Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested at September 26, 2020</a></td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
<td class="nump">69.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested</a></td>
<td class="nump">43.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited</a></td>
<td class="nump">52.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Non-vested at September 25, 2021</a></td>
<td class="nump">$ 54.21<span></span>
</td>
<td class="nump">$ 44.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876319410152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rates</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">33.60%<span></span>
</td>
<td class="nump">34.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_EmployeeStockPurchasePlanMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rates</a></td>
<td class="nump">0.26%<span></span>
</td>
<td class="nump">1.32%<span></span>
</td>
<td class="nump">2.27%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">34.10%<span></span>
</td>
<td class="nump">26.90%<span></span>
</td>
<td class="nump">27.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307289928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>401(k) Plan - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlanEmployerContributionCostAbstract', window );"><strong>Multiemployer Plan, Employer Contribution, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Contributions made by company</a></td>
<td class="nump">$ 20.9<span></span>
</td>
<td class="nump">$ 19.6<span></span>
</td>
<td class="nump">$ 19.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlanEmployerContributionCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlanEmployerContributionCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876310540104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Compensation Plan - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent', window );">Deferred Compensation Liability, Current and Noncurrent</a></td>
<td class="nump">$ 76,100,000<span></span>
</td>
<td class="nump">$ 57,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Nonqualified Deferred Compensation Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp', window );">Maximum employee contributions from base salary, percentage</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp', window );">Maximum employee contributions from annual bonus, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EmployeeContributionsVestedPercentage', window );">Employee contributions vested, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EmployerContributionsPercentVestedAnnually', window );">Percent vested annually</a></td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NonqualifiedDeferredCompensationPlanAnnualContribution', window );">Compensation expense for the DCP discretionary contributions</a></td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InvestmentInGroupLifeInsuranceContracts', window );">Investment in group life insurance contracts</a></td>
<td class="nump">$ 64,300,000<span></span>
</td>
<td class="nump">$ 49,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Nonqualified Deferred Compensation Plan [Member] | One Third Annually [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EmployerContributionsVestingPeriod', window );">Contributions, vesting period, years</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EmployeeContributionsVestedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee contributions vested, percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EmployeeContributionsVestedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EmployerContributionsPercentVestedAnnually">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employer Contributions, Percent Vested Annually</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EmployerContributionsPercentVestedAnnually</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EmployerContributionsVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The vesting period for discretionary employer contributions, which vest ratably on an annual basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EmployerContributionsVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InvestmentInGroupLifeInsuranceContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash surrender value of group life insurance contracts at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InvestmentInGroupLifeInsuranceContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum employee contributions from annual bonus percentage to dcp.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum employee contributions from base salary percentage to dcp.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NonqualifiedDeferredCompensationPlanAnnualContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonqualified deferred compensation plan annual contribution.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NonqualifiedDeferredCompensationPlanAnnualContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=holx_OneThirdAnnuallyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=holx_OneThirdAnnuallyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307423656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Summary of Purchase Commitments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">Fiscal 2022</a></td>
<td class="nump">$ 290.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">Fiscal 2023</a></td>
<td class="nump">16.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">Fiscal 2024</a></td>
<td class="nump">9.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">Fiscal 2025</a></td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFifthYear', window );">Fiscal 2026</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Purchaseobligationthereafter', window );">Thereafter</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Total</a></td>
<td class="nump">$ 322.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Purchaseobligationthereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase obligation thereafter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Purchaseobligationthereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876316645352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Litigation and Other Matters - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Jul. 27, 2018</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=holx_CompanyVs.MinervaSurgicalInc.Member', window );">Company Vs. Minerva Surgical, Inc. | Judicial Ruling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Awarded damages</a></td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LegalAccrual', window );">Legal Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LegalAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LegalAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=holx_CompanyVs.MinervaSurgicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=holx_CompanyVs.MinervaSurgicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MedicalAestheticsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MedicalAestheticsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315236680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2019</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 30, 2019</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 139,300,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 685,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember', window );">Operating Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Expensesfromdisposition', window );">Expenses from disposition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sales price</a></td>
<td class="nump">$ 205,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestiture of businesses</a></td>
<td class="nump">$ 153,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice', window );">Final sales price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IndemnificationLiabily', window );">Indemnification liabily</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Disposed of by Sale | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TransitionServicesAgreementTerm', window );">Transition services agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember', window );">Medical Aesthetics Business | Disposed of by Sale | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TransitionServicesAgreementTerm', window );">Transition services agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Final Sales Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Expensesfromdisposition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses from disposition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Expensesfromdisposition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IndemnificationLiabily">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification liabily</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IndemnificationLiabily</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TransitionServicesAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transition Services Agreement Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TransitionServicesAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307233240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition - Schedule of Disposition Related Income Statement Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">$ (46,500)<span></span>
</td>
<td class="num">$ (781,200)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307439736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 5,632,300,000<span></span>
</td>
<td class="nump">$ 3,776,400,000<span></span>
</td>
<td class="nump">$ 3,367,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SegmentReportingDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SegmentReportingDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876316005112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Segment Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 5,632.3<span></span>
</td>
<td class="nump">$ 3,776.4<span></span>
</td>
<td class="nump">$ 3,367.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">2,480.3<span></span>
</td>
<td class="nump">1,105.0<span></span>
</td>
<td class="num">(123.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">406.9<span></span>
</td>
<td class="nump">376.0<span></span>
</td>
<td class="nump">463.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">156.2<span></span>
</td>
<td class="nump">156.4<span></span>
</td>
<td class="nump">109.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">8,919.9<span></span>
</td>
<td class="nump">7,195.8<span></span>
</td>
<td class="nump">6,442.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">2,935.6<span></span>
</td>
<td class="nump">2,355.9<span></span>
</td>
<td class="nump">1,522.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">3,695.0<span></span>
</td>
<td class="nump">2,102.1<span></span>
</td>
<td class="nump">1,205.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">2,140.1<span></span>
</td>
<td class="nump">929.7<span></span>
</td>
<td class="nump">163.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">260.4<span></span>
</td>
<td class="nump">237.3<span></span>
</td>
<td class="nump">246.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">126.2<span></span>
</td>
<td class="nump">110.7<span></span>
</td>
<td class="nump">59.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">3,348.8<span></span>
</td>
<td class="nump">2,161.4<span></span>
</td>
<td class="nump">2,276.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,352.3<span></span>
</td>
<td class="nump">1,151.9<span></span>
</td>
<td class="nump">1,314.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">284.2<span></span>
</td>
<td class="nump">192.8<span></span>
</td>
<td class="nump">399.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">52.7<span></span>
</td>
<td class="nump">48.8<span></span>
</td>
<td class="nump">36.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="nump">22.4<span></span>
</td>
<td class="nump">18.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,233.9<span></span>
</td>
<td class="nump">1,200.9<span></span>
</td>
<td class="nump">1,127.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">Gyn Surgical [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">488.1<span></span>
</td>
<td class="nump">376.1<span></span>
</td>
<td class="nump">437.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">58.9<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
<td class="nump">99.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">93.1<span></span>
</td>
<td class="nump">85.1<span></span>
</td>
<td class="nump">87.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">14.5<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">15.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,369.7<span></span>
</td>
<td class="nump">1,438.7<span></span>
</td>
<td class="nump">1,328.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">96.9<span></span>
</td>
<td class="nump">81.0<span></span>
</td>
<td class="nump">94.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(4.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">31.9<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
<td class="nump">27.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">65.3<span></span>
</td>
<td class="nump">315.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(57.1)<span></span>
</td>
<td class="num">(781.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">91.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 159.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876409179672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Revenues by Geography (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">69.30%<span></span>
</td>
<td class="nump">75.80%<span></span>
</td>
<td class="nump">75.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">21.30%<span></span>
</td>
<td class="nump">15.10%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGeographicalSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Geographical Segments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGeographicalSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317938232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 564.7<span></span>
</td>
<td class="nump">$ 491.5<span></span>
</td>
<td class="nump">$ 470.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">403.2<span></span>
</td>
<td class="nump">383.0<span></span>
</td>
<td class="nump">355.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">122.9<span></span>
</td>
<td class="nump">77.5<span></span>
</td>
<td class="nump">64.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CR', window );">Costa Rica</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">26.9<span></span>
</td>
<td class="nump">20.8<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems', window );"><strong>Geographic Information For Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 11.7<span></span>
</td>
<td class="nump">$ 10.2<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GeographicInformationForPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Geographic Information For Property Plant And Equipment [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GeographicInformationForPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317919368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Compensation and employee benefits</a></td>
<td class="nump">$ 297,200,000<span></span>
</td>
<td class="nump">$ 262,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccruedIncomeAndOtherTaxes', window );">Income and other taxes</a></td>
<td class="nump">70,900,000<span></span>
</td>
<td class="nump">125,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">16,300,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (current)</a></td>
<td class="nump">26,800,000<span></span>
</td>
<td class="nump">23,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccruedInterest', window );">Accrued interest</a></td>
<td class="nump">16,900,000<span></span>
</td>
<td class="nump">22,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">168,100,000<span></span>
</td>
<td class="nump">114,000,000.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 596,200,000<span></span>
</td>
<td class="nump">$ 547,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccruedIncomeAndOtherTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued income and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccruedIncomeAndOtherTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876314967816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other&#160;Long-Term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Reserve for income tax uncertainties</a></td>
<td class="nump">$ 210.0<span></span>
</td>
<td class="nump">$ 103.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">58.8<span></span>
</td>
<td class="nump">81.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities (non-current)</a></td>
<td class="nump">66.1<span></span>
</td>
<td class="nump">65.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Interest rate swap</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension liabilities</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">11.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">$ 368.7<span></span>
</td>
<td class="nump">$ 303.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876307376520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities', window );">Defined benefit pension plan, liabilities</a></td>
<td class="num">$ (10.3)<span></span>
</td>
<td class="num">$ (10.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="num">(10.3)<span></span>
</td>
<td class="num">(10.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProjectedBenefitObligationForLongTermServiceAwards', window );">Projected benefit obligation for long-term service awards</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation', window );">Projected benefit obligation in excess of plan assets</a></td>
<td class="num">$ (10.3)<span></span>
</td>
<td class="num">$ (10.9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProjectedBenefitObligationForLongTermServiceAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Projected Benefit Obligation For Long Term Service Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProjectedBenefitObligationForLongTermServiceAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876317114776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="num">$ (10.9)<span></span>
</td>
<td class="num">$ (10.0)<span></span>
</td>
<td class="num">$ (9.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Plan participants&#8217; contributions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount', window );">Actuarial gain (loss)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange gain</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="num">(10.3)<span></span>
</td>
<td class="num">(10.9)<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Benefit obligation at end of year</a></td>
<td class="num">$ (10.3)<span></span>
</td>
<td class="num">$ (10.9)<span></span>
</td>
<td class="num">$ (10.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876309279784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ComponentsofNetPeriodicBenefitCostInterestcost', window );">Interest cost</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Recognized net actuarial gain</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ComponentsofNetPeriodicBenefitCostInterestcost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Components of Net Periodic Benefit Cost, Interest cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ComponentsofNetPeriodicBenefitCostInterestcost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876315111032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract', window );"><strong>Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139876314965864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 25, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract', window );"><strong>Defined Benefit Plan, Expected Future Benefit Payment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2017</a></td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2018</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2019</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2020</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2021</a></td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2027 to 2031</a></td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>132
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( )1$<%,'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "41'!3[*,Y;^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>*$X@#)/ZLK%3"X,5-G8SMMJ:Q8ZQ-9*^_9RL31G; PQ\L?3[
MTR=PIX/00\3G. 2,9#'=3:[W2>BP82>B( "2/J%3J<P)GYN'(3I%^1J/$)3^
M4$>$NJI:<$C**%(P XNP$IGLC!8ZHJ(A7O!&K_CP&?L%9C1@CPX])> E!R;G
MB>$\]1W< #.,,+KT74"S$I?JG]BE ^R2G))=4^,XEF.SY/(.'-YVVY=EW<+Z
M1,IKS*^2%70.N&'7R:_-P^/^B<FZJGG!\VGWO!%-*_C]^^SZP^\F[ 9C#_8?
M&U\%90>__H7\ E!+ P04    " "41'!3F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M )1$<%.AT[Q3?08  -\9   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MI5EM;]LV$/[<_0K"+8H6B&.)\FN;!'#LI#6:)EZ<MNN&?: EVA(BB1Y)Q?&_
MWU&2):>03QH6((G>[N&CX_&YX^EL*^2C\CG7Y#D*8W7>\K7>?.ATE.OSB*E3
ML>$QW%D)&3$-IW+=41O)F9<:16&'6E:_$[$@;EV<I=?F\N),)#H,8CZ71"51
MQ.3NDH=B>]ZR6_L+]\':U^9"Y^)LP]9\P?6WS5S"6:= \8*(QRH0,9%\==X:
MVQ^FSL 8I$]\#_A6'1P3\RI+(1[-R<P[;UF&$0^YJPT$@W]/?,+#T" !CW]R
MT%8QIC$\/-ZC7Z<O#R^S9(I/1/@C\+1_WAJVB,=7+ GUO=A^YOD+]0R>*T*5
M_B7;[-ENMT7<1&D1Y<; ( KB[#][SAUQ8#"TCAC0W(#^8F ?&\')#9Q?#?I'
M#+JY03?U3/8JJ1^F3+.+,RFV1)JG <T<I,Y,K>'U@]C,^T)+N!N G;Z8B"<N
MR1RFF+3)M\64O'OS_JRC =G<[[@YRF6&0H^@V)1\%;'V%;F*/>Z]!.@ I8(7
MW?.ZI"CB@F].">V=$&I1NX+0!#>_%4^GQ+:/FD]Q\Z],PNB#*O,7;^,47G92
M/ ?U\E_CI=(2(OUO!+);0'93R.X1R*EP$UA_FCSL-KQJQG!SVVI_05CT"A:]
M9BS&<9RPD-SSC9"ZB@Z.HV7"$3K]@DZ_&9TYEX'P3#026!:5_L&1]O'WVZM7
M-3$P*+@-&DZ89"";J>H==Q>.M6*APOPU+#@-49RK6 =Z1ZZ#D)/;)%IR6<4%
MQ[#;3I_:783-J& S:L+FGJ\#LT[ 5;<LJIP['.?SW<W=I]GDA,QN)P@MVRHU
MTFI"; *S)R'(9Z!QS^0+WU4*)0YEP<^P-QHX XS9@7K;*-PDD=+$U'6@7&#V
MDS.)!GT-7+MMC=JTAU&C)37:+-X/N5W#155)# >K68-V*<2V\Y]8Y4)QG!<.
M=_T38U5JN8VK\1@H>1FMD*TK>>  =8)@EX)NXTJ<Q_HL=H4$<6)&IT[(0D-
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M\E8P%8%=8:7NROJGDVEKWY5-6\C "59]14#4"Z?2*>T*+ V<!$$FFDEE".Y
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MB_KR*))45 8 W^^EU,\WY@77WUS<_P%02P,$%     @ E$1P4P,]L059!
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MSQB:2BH- -:W0NC3P&Q0M:F+OP%02P,$%     @ E$1P4Q&ZW-S= @  J <
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M(&\LO!Y]-*:A=DSSL@,P-<$%"["X/AY"V35)HQ!J1R$_<@BF)G007M^A:-A
M[;#AY:=@BC1XCU'T9(:0=@W38(#:P<#K3<'4! &L=V6L 8!O!P"O, 7[9JN'
M/$97Q@,HNW9I2.#;(<%K3<&^"04"'\W_(91=XS1N\.VXX?E3L&\VT- 5K*OZ
M.4+EA^ZX1^W6_0G[9N)%9F7?7"XXC 58?$U\[.:!RS%H<8;1]L@]'R:WZR4-
M"'P[(-@<)QI<;DP5TVBY+O-5)4>]9;9Y!QTQ!A!V[=%XP+?C@;_O3L%' $>
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MHA":R@9.@P#1 SU2S\$N[MG%5YQNP\M24>M\OTY^\8HDQ9K(>L=+4LABU,R
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MPFR,KDPDL<BK\Q_GXO;7WS^\.\5R2@G35%B1CFOKEYA9IT#A!BA0 D$3BMP
MM:-9.[."IM#KWELLMR9M9V)P2H>$6D OY#]2Q-/JQL0P]!P^XUA)%($[#9,G
M48+BUD9V1(4-9/D97H&R8  #FOYE_GD^$S\/ <6)M[F)1IY^DHITFE/RAD0
M*CL]ZXX,DUS2Z%,UW.FUI)*!/0VT4V3W&$[>-(-6R:!S<8$'BO?L=H[,A.N@
MAAJL##/1#%HD+];^7@?'\>RTC)1R,Y%KU+TFHY5N:A[J!PF@;30V:+256RB
M?(;3%=RD&]8<WWC"-")!D^LXHO! WVZC :D1PV&"%O<FFE32M/6Q-TG"Z3WR
MN_=NN@>>E>3/HA^" @!(L<@I2K_6=";E!9J>7<:&#O?8)EY"^ 8D ^/WX]!*
MNQJ1FEH3GH],A08%E3+&0PX\#BL5.9-!_[P'H6K!H2[NI*:&PBG5G1AZGHHE
M*9CB-DU4,!.;UJ@V Q^%SKB!,S:3$B>>'P)HZU'U+W+*[\<B81,")FTX4;4%
M]&0%7($;)?P^@_E< + >B]!V9!N5C*U8H;OB'?;\5P- <D:IV?&@(% 6U[H
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M1";TX-" 6 WJ4PM),<;/L.WH*G!L^,&'/G$G^9$-L-(4CBIM[#](\+I<,9>
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MZ\YHUW.WD3#M37OV_DN0,Y"BU1J-PC#:5D3O-;:Y?BSEQ0,:TG@J=371V%H
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M[/Q[5>^_\.6KX26^&H11]Q-THT7=H'\ WI<6E+H;D/_AU0+LQ5LMF95U!:)
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M2>=JOVR*FN_\;_-N*PTAU2AHOG08Q,_'<W\E*[S<*>CG=BL#'!V^J:[_YLW
M0QQP\;]\A3BBJN >\E]$8,RMVGPJ?D.+/7;F7>XMQE7(#@#4^OU9M ]A''?T
M_S,P[D,-@W@'X+CUQG$JT'SCY^YK'GN=6*^.,E\2WWA^.1BJ^?GMZW<?7KUL
MOWOU,F_HGS7]3PQ'_[*?_"9MT^]>;0U9+M>F*!HYH6^/ID?!IV");X^NIE]?
MS8Y>TDC_^'>O=J1M?R'#!]Y0838T=#(^7QX)B]D_VFJ'*:'>VVK+O^+=1J;&
M _3]IB(6UC^P  *-#-YW_Q]02P,$%     @ E$1P4X!)P)^Y#P  IRH  !D
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M>.>B_DF7[&84P&B(V:^/.>P+$82"[R 2Q1-&F9T>C,4D%T#"LW0(E]+#*>I
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MX/>Y)$,I=(5OO];*NR!Y%+8+^Z5>)>NE9-718'#,8V!.\INR;,P90BF)A 7
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MGY%+7?L<MA)%#=55M:&I?N"3!&NYW^00.3LA(&P6Z4T43=X-\N+LM')G)[!
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M,<^^BUJ^_.T&%N*Y+75=(43"49.EL?NZ4+]BD;DKCLG=E,GJ5:B2_!DC'$?
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M=(K]W]L6S$*C;:VWO&BK$=MK_'3*Y$0LC/3GF[(VMB:3@[LVC9EBYGZ/)KY
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MAR!2SRAX'?2^_OGZ6_ZK__41D#==$^&>E#:R)W#N/B@#!F![>[X4M)*,T4N
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MU2IE#^=:,#BG  =J]T24;F!WZM"K1/>AMS';-1$_JD7&:C#@<8A!*Q4KN)N
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M!YE4LMX5A(;*-/D&,C\2\."#S(N%+#: 7WV;M+6Z7]^_$_/1E.D*'HZ2"A6
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M[A8!>W)]FWEID67%L0:E)N#<.GA?=VN198[X^$B@YE*7=I+ALL]1R.)9H7I
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M&G^^BL!T0]D)3C=A$#;:T5B%8T5[#(TWH/M2:W<0O(-A,\[? %!+ P04
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M:'@Q&R/\P*? N#-Z3+ 51[2I9RN%&DXFD8K\SP9@T6A$K+*F17@&"GW7*8G
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MORG!MO!CNK\4WFQ+X3[[?5#MJ%,,4![7OO5\[M/4;Y!_@GI"1779HQ^=E$1
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MO:GYYU*A_K:T ,_G!AJ*%W1 ]R7+V_\ 4$L#!!0    ( )1$<%.3!E;:>08
M /X/   9    >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;)U7:6\;-Q#]*X00
MM V@Z++EN*EMP$>/ $ECV#U0%/U [8ZT3+CDAN1*UK_O&W)WM8YE(>T76\MC
MYLW,>T/R;&/=)U\0!?%0:N//!T4(U9OQV&<%E=*/;$4&,TOK2AGPZ59C7SF2
M>=Q4ZO%L,CD9EU*9P<59'+MU%V>V#EH9NG7"UV4IW?:*M-V<#Z:#=N!.K8K
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MLADSPY>:8>%TY[^.++5#I?&W&RF05W0 SU<:=6M<D(##Y[*+_P!02P,$%
M  @ E$1P4[$3?@ 6 P  +@<  !D   !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&ULM57!CMLV$/V5@1KTU$HB;<GVUC:PNTV0!1+$V$V;0]$#+8UM(A2IDG2\
M^_<94K*B(%TC.>0BDL-Y\]X,Q>'R9.Q'=T#T\-@H[5;)P?OV*LM<=<!&N-2T
MJ&EG9VPC/"WM/G.M15%'4*,RGN=EU@BID_4RVC9VO31'KZ3&C05W;!IAGVY0
MF=,J8<G9<"_W!Q\,V7K9BCT^H/^KW5A:94.46C:HG30:+.Y6R36[NID&_^CP
MM\23&\TA9+(UYF-8W-6K) ^"4&'E0P1!PR>\1:5"()+Q7Q\S&2@#<#P_1W\5
M<Z=<ML+AK5$?9.T/JV2>0(T[<53^WIQ>8Y]/$>)51KGXA5/G.UTD4!V=-TT/
M)@6-U-TH'OLZC #S_!D [P$\ZNZ(HLH_A1?KI34GL,&;HH5)3#6B29S4X5 >
MO*5=23B_OJXJ>\0:7C[2,3MT('0-[_P!+;PQ>O_[>[0-O)%B*Y7T$MTR\\0:
ML%G5,]QT#/P9!L;AK='^X."EKK'^.D!&<@?-_*SYAE^,^(!M"KSX#7C.V85X
MDZ$&DQAO\DR\C7@26]7G'@LBE(-_KK?.6_IK_KU ,1THII%B^A/+?)$A7-XK
MUXH*5PG=3H?V$R8_3 MG (X!)@)4 /@ 4"- 9>A^.D\0LP/R@YU1=-&EWE\!
MG9/'9DO8\V&-364TY?"-QEO3A)GH;BWQ8],J\X0(6]2XD][!"^"+6<K#6/)T
M!G>Z,@V.Q'KQ2)%F>;H QHMT0D&U)U&H?2>Y1ML1L))V?_UESAG_ ]ZUT:SW
MH% $+;Q,Y\ G:3'(E)IJ@,X'X (X3UE?4%;.:<[8-,U)5[$HH[YB.DO+[ZS$
MI8.Y[XZ4RFM)0LR6<H2CKM!ZZKW1B<K!\DC/\@F5Y=FDBSFE-6?T^2;CLJ0L
MRH)$WYTS)0<$=Q(MA%RH&CEL^K8\_A4B-6.C@E %V#SJF5!Q9F$D71S^[T)E
MHQ[6H-W'3AW^KZ/V73L;K,-C<-WUP"_NW4OR5MB]U(XRVA$T3V=% K;KSMW"
MFS9VQ*WQU%_C]$ /&MK@0/L[8_QY$0B&)W+]&5!+ P04    " "41'!3PSL_
MYD8&  !?$0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6RU6%ESVS80
M_BL8U>G$,XH.RO<U(SOG0Q*/W333Z?0!I%8B&A)@ -"R\NO[+7A(BBW;;9,'
MB2"TV./;;Q> 3N;&?G$ID1>W>:;=:2?UOCCJ]UV24BY=SQ2D\<O4V%QZO-I9
MWQ66Y"0LRK-^-!CL]7.I=.?L),Q=VK,34_I,:;JTPI5Y+NWBG#(S/^T,.\W$
ME9JEGB?Z9R>%G-$U^4_%I<5;O]4R43EIIXP6EJ:GG?'PZ'R'Y8/ [XKF;F4L
M.)+8F"_\\FYRVAFP0Y11XEF#Q..&+BC+6!'<^%KK[+0F>>'JN-'^.L2.6&+I
MZ,)DG]7$IZ>=@XZ8T%26F;\R\[=4Q[/+^A*3N? MYI7L:*\CDM)YD]>+X4&N
M=/64MS4.*PL.!AL61/6"*/A=&0I>OI1>GIU8,Q>6I:&-!R'4L!K.*<U)N?86
MORJL\V>7-;Y23\1'GY(5K_(B,PLB<4Z:ILJ[D[Z'(1;O)[72\TIIM$'I,!+O
MC?:I$Z_TA";K"OKPL'4S:MP\CQ[4>$U%3T2[71$-HN$#^D9MV*.@;[1!WQ5Y
M90GD\FV8XL]Q[+P%3?YZP,!.:V G&-CYL;@^J)0+],@5,J'3#BK0D;VASE,L
MB=]2$A<F+Z1>B%0ZD9#U*%BF+TQ,1%P)BJ+656120\K<D%5Z)J!54*W4"3,5
MK/.M\I2(=[F<L<@;0HEHU';LU$2AO,5S7O7K+P=1-#AN?&P<"M/#X^V>& =]
M2*^G/(;O38Y#."O3>V%ZT V^U*&PEN'^L6O=SI2,5:;\0LP1Y-9PT!NA9K*L
M@8=G#IN9+GJ**RATA6S1%?-4):E0T&85^I/*%A!(C 6!!;1)P)$71C-EX'%F
M].R%1]"M405H &GEGW8F4Q/IL?9< LR$Q#77J.N)3R@)V^"5R7D(R9*0^&@C
M;)E!T8RAUPRLTC?D?&"J03/UTI?> %Y7%LB_"G'#'S:[FKV K"N3M%&/P* =
M'43E92ZFI9ZP=DM?RZ80%,)S<!@:ZF1;N-ND+FZXQ'XZ.:59*0,V\2(8;^3>
M8%IJI. U3'0!&V\<["'#5V:.?;>DM"MM@,6GTHM9M8C9)5OKA%:899P$0HH$
MPP!SQ??^U)C339T9Q=CC)5GT N_7.3UG+)*L"?0EE >"C89=,3P\W \\,1K)
MITS-5)RM,A^>!G<YL8BGS.".M%XEJN"9VI/*$%B$?'D3C(4B,D)CDVH7:"8#
M.^AES"F/>8/$,G.C)F!#()].P"SIZQPW56IBN!9F73=8 S\=N-4-:45@@25X
MY5@L98&&Z&L 6<F,A<N\",L;YGQ?4#4[OR_;GKA(I9Z%2.LY\;%U1OQ!TCI!
MP85[*OIN-:].'?#4\+#5NPR288\)72;4 SQ>P([8$L^YFK?KP2 ,#GO[VU"*
MND@X0<Z'!C2,CN\\WX%MJ']?23T?](;;R^]H6UPRK*NYJK&!O/96Q66%WR;U
MXQ;M&??9Y^" VQ:#WBZKWX61(7N,<P5.#2#\;5+A6@DW;NSSBKUE%R^DF@CN
M:8/>3GC>CQ4Q@VN4&)K1=@-5#=3EDC(; WA<]5:C_&XF[K"Z/@T&KK5MM&6?
M)MYY4"\3E;0D#WGY"01>L_X!EB\;RTW(%VSYAW!YC8E;+;;WC=;Y" ;4GTB\
MNN5-BA@(7UHMZE;V6 +'N0%YO[7-H^I'[BFU<87.,]/J&VQR:N0ZERL"1L&_
M#QLSMQ5(NA6DJ^_/X8!,DQ=C;&TX[S\ _G@EP0'N '" ]*5R:+SH])8[+JIH
M()Y!_0$_AKTA/YX(V+-[1U>LMMZM0)X*/J437'@</;(V[#;6_%U9O]NM>2L,
M;-W 3NQW/GU00]CMT"W(!?JNAO6$$P]7\+\X::T?CUB*?9=)4N9E59+_)<2?
MZF9O[:2+(X_$@:-Q#PYC#R[D8N7PUM2#G.,PLSQ3E.&,]D <O:<E>X.A&@:N
MH)688X/L_Z_ 0\^M6RXNMWSS=2$*;SS*]TXRJ*D4X!)3M;\\ED"2."5/4850
M&/8!N>$$?\3?4=T(,!PMASO+X>YRN+<<[K-'T6 TQ%2$7G/?A:R_<NG-R<["
MU9XO+>@.U?VWG6W_/1A7E^:E>/77PWMI<;QP(J,IEF+CW>T(6UWGJQ=OBG"%
M1HIP(0_#E"0XP@+X?6J,;U[80/N?RMD_4$L#!!0    ( )1$<%._Z?! RR$
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M.;$IXOU(.F6PY. Y(SXFQD.!(DQ%"I5I!"/$:#R>('@B%9C$HY%&(@4X):Q
MIB<"UX9J_ S00W3R@X\@_&SULLF3#V:I7T@] 6DS8L'TFW3"84HX_=/S"SA]
M?)V,+Z)'V1?T!CZ+%+4"ZXZM#3?5I<QT"K1UGIR>G8\ODS>-R9%1K4,I2$$9
M-IW(N-F9#$ROD Q3 &.6? !?5*_+O#/H;HWAL\JAY2-8\Q3(^0P"&;^D82B
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MY1J#+CKY1Z,*7R;U/PJV0-]J7T[\HH/#E&6L:.*+-^*@\P9;T85+J7$3+V(
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MKD^$]!/$BW2SVN1&RDP &ZFL8PEDX"NL5/YA!XXBX#PYIFLP#8[) :+ !)4
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M.A<\-TEN&S$-?RIL*9X=LAF244R&FC@H[LBTL:W3)U$X@SE_+N]E!D&V*N0
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M*E?F=BDX=A'T I[/R[)J?A"#]D.]=_\%4$L#!!0    ( )1$<%/^Y/QF/04
M %\+   9    >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;*U676_;-A3]*X0W
M%"V@V2*ISS0QD*1;VX=N0=RN*(8]T#(M"Y5$E:3C9K]^YU*VXPYM-A1[D<C+
M^W'NX;TDSW?&?G0;K3W[W+6]NYALO!_.9C-7;72GW-0,NL?*VMA.>4QM/7.#
MU6H5C+IV)N(XFW6JZ2?S\R"[L?-SL_5MT^L;R]RVZY2]O]*MV5U,^.0@N&WJ
MC2?!;'X^J%HOM'\WW%C,9D<OJZ;3O6M,SZQ>7TPN^=E50OI!X?=&[]S)F%$F
M2V,^TN3UZF(2$R#=ZLJ3!X7?G;[6;4N. ./3WN?D&)(,3\<'[[^$W)'+4CE]
M;=KWS<IO+B;%A*WT6FU;?VMVK_0^GY3\5:9UX<MVHVZ23UBU==YT>V,@Z)I^
M_*O/>QY.#(KX&P9B;R "[C%00/E">34_MV;'+&G#&PU"JL$:X)J>-F7A+58;
MV/GYK;[3_5:SIV_5LM7NV?G,PRNMS:J]AZO1@_B&!R[8&]/[C6,_]RN]^M+!
M#'".F,0!TY5XU.-"#U,FTHB)6/!'_,ECCC+XD_^2X]J:CET#JT4M@&>_8=>!
M86W9'Y=+%^1_/A(P.09,0L#D&P%?-$[5M=6U"I5GUFP/X6OL/NJ*>O+,#:K2
M%Q,TG=/V3D_F;S=(QK1HJ*:OF:>=8X,U=\U*.W3*2;;5/ELWIEOMTW5L><^6
M6X=@SC'5KUBM36W5L&D 2M<!-5J&K1XRT2LJ_\:=L0]:V?UN,^R5U]T2#!XV
M[%24!5%\*BI(Q$MV=8C^M.E1V&V+F.X9>]<W%&GA$="QU[UOI^RM\:K]KI47
MC:I[XWQ3 ?;UO3>MJ>_9$]4-S]F-MDVO2.M')N-DFN'/LW(J\4]R.2WQ%UD6
MYCR1TX+D/)YRTN<BK/.T#/,D%],8;8"S9MLJ>QJ7B2B6!;1YQ*5 %!GQG$]3
MS 6L4B;S-*QF23%-6)J4-!,I_&98B=E5:PR2JZS6/6TW%#+VY(="</%\G #<
MB80F:0''!TF8C'R(2)82GGDD8XXX,LI*BL&CM! 4G9?3'%H\%M J!4?VHDBF
M@M#&*?Q<X>1WGKW2JO6;L\/T=:=JPE;(&%Y$*H//N)"8Y8*X$9(#5YD2NB(E
M#"(968A+XAZ[1K7=4\, Z-[OPK1;DH!%8$G ,TQ$%NC$UH!,#KR\+("3 V?!
M)'T$)UK&E!$@Y;00QR&<3 64BZ* AL@D&48\Y6$+8IGC+_(L2"6GQ%]^^)4M
MMK9N*CB39084)05-X($C/A4$H,38QXP$F4"P/"&P\";8XB-N( (R4L8R3KJT
MY?!5@G'HB!(V!2VD!$MFD)64R!N]"G$OM?,;'<KIL*O__(/YDK)/6)82_#3%
MD&<Q7$F>'NE [49E+,:JCG)8Q1BE429'F8@*D"(P*OGXEU&>4]:TELHLZ!>2
M!VT9R2S'Z/1$>/EPDMR&DP0MSDYZG#W[_D/CRTX_S>4!]P'ESUN+ITLH7-K_
M-".2:0-C=ND:]=.-JIHU0,J,.D"(C JGH.5;L$V']GMCVQ4X)+^<4[GQ9#P?
M'OAZ8.? Q7\ZG*VN3-TW?]&A>L^<V=I*?WFP'BXM+/M[Y/&_<8C+:3 NW/9T
M<D74/7O>4)M\K(N"<KI60T,UHS]MFP$/,1_A/ND&TV,XWAK.K/U.6<WRK Q]
M$.H:C5@BLKUK*LW2DOHD#?2E&37J;RAE2SV#>J5F$3G:Z7%.OW8GSTX>/;C2
MZO"T<T"X[?WX_CE*CZ_'R_'1]* ^/CW?*/0W6&WU&J;Q-$\GS([/N7'BS1">
M4$OC<7^&X08O8&U) >MK8_QA0@&.;^KYWU!+ P04    " "41'!305J@@0\&
M  #;$P  &0   'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6SM6%MOVS84_BN$
MEVX)X,B2;-F.FP1PL@4KD*)!TJX8ACW0,F43I425I.)DOW[GD+(BV;*2ASX-
M>[%U>/D.SW=NE,XW4GW3:\8,>4I%IB]Z:V/RV6"@XS5+J?9DSC*82:1*J0%1
MK08Z5XPN[:94#$+?'P]2RK/>Y;D=NU.7Y[(P@F?L3A%=I"E5SU=,R,U%+^AM
M!^[Y:FUP8'!YGM,5>V#F2WZG0!I4*$N>LDQSF1'%DHO>/)A=37&]7? '9QM=
M>R9HR4+*;RA\6%[T?#P0$RPVB$#A[Y%=,R$0"([QO<3L52IQ8_UYBWYC;0=;
M%E2S:RF^\J597_2F/;)D"2V$N9>;WUEI3X1XL13:_I*-6SN*>B0NM)%IN1E.
MD/+,_=.GDH?:AJE_8$-8;@CMN9TB>\I?J:&7YTINB,+5@(8/UE2[&P[',W3*
M@U$PRV&?N;QE8)(FQY_I0C!]<CXP (I3@[@$N'( X0& ("0?96;6FOR6+=FR
M"3" TU1'"K='N@H[$1]8[I$PZI/0#X,.O&%EXM#B#;M-_&N^T$9!%/S=@3FJ
M,$<6<W0 <ZXU,YK,LR6YY73!!3><Z3ZY93#!VECLQON\9B21 E*$9RMBT!D$
MDDRS#+3H(L\%@TPP5$ ("IK%C+B4Y9G+2Y<B@AJV)$82 W#7,LUI]OR+)I#!
M"I8 ,(7S)CRS ,+2,B- MV'I@JF*\_K0V [YY*I4^V#5WLK8Z?Q409<LWY3H
MI?C:?,FCE8C"##J5R6D! G4SG\ 4M16.R'3HC>'OYY^F81"^QP'?F]0&;NK&
MM0(>9S([C0NE@,X3<J>0'//<)SG89RQ!['O!<V2[3S*PM:[MS!LVY.U3+09J
M)KM#B-K<<:5X'L>J &>Q)RBOR,01<.U-&^CAT(L.VM8.VUPC%X*OK*,T.86(
MD<H0PU3:T#)L$'A$ N^LVX8&@<X_0F:K4XM<7WE$QF,O:("/HX;_.DQJ:.DR
M"W7O6Q6&.V0&$V]$.M,,DV9CJSCXA3X" RL((8:=[84)JPBC9,EU+ L(&2"*
M_8@\G,."I"T;]R:V.=F=7*]-?WV3J2/O+"(3+PI)Y$53>!J/]G<VN0C Q>]@
MXQ!^0\^'WPBBX%U'U8VJJAMU5DE[\#XPJDU;B>W>W.Y[^<B70,WK_K.1-'G_
MFA?_9%2Y3MCFRO;9?7\Z!\1@)SFF)YBDODVD$#RQDPQVT2FA*20W_\=9 .'2
M5OJ.B&^SSP?7M(+P#'S.X-'*6 K\\O>:ZC7)*0>#I4)E!68,SV)1H#$\LU2E
M %8HVZGP#'M9/:N9&"-B M[0)%$RW2&RH?SP)MEDS%;1J1>ZVGE6&ODF;2%4
M!]0V(9\EMMGXAQB,G@LLYU#<Q^3^TY>M+ZCB&@]F3\.0=Y3  1*:SF;7L$;)
MLS8B9C $1[X=,SE81+&QU>LTQMP'9ZIV;:,L[G9GV;)L^#^"3IM)+W$$MZ#-
MFL=KJ*4*"B/<]?$@0"D2B:0]8Q*P RGBD7LD<ZNC@&6*W,P?KLC\X1I\D_.8
M3$<^V5 X-C@Y@$NQ$!CT")] (0)-H1^<>1WU9ES5FW%GR6@4S'[5Y>&V\)&:
M0L%36QGJQ,27K)G.:<PN>K;SJ$?6Z[[^(6=) ?H8O@#PM-@Z(J?/J5WA6+(=
M$\\KA 78C:%Z7.Z5+HBA]O8S@RRRI-K:]4I/@0WA2PZ.(*=@9(C-V <I1&E$
M@C&,8WJ"%)$@@$9=2F,R*:> $'C%3"!R<,&$!#[L=IG93<495DBHEI&]BL\@
M_O+"V(0M2]OQR!N?X*^/MS]+,42Q*-BA!#X+X3PV@2/2$5.3*J8FK_0P?$/H
M[S+YYNCJ1/\_NOZCT36MHFO:&5W[465U0C&7:>MK:2=<1S@U::)95@!YRKVB
M<JMM-X @T'05#A @NEB4PDHQYE92TW9KHLH&D MA785,&0[8 UY&AB#[-7FT
M(T?V2OHBC^$VU B($'JJ"P5HL'B);?/*H/;!)65J93\K:6(OP>[;2S5:?;F:
MNP\V+\O=9Z^/5*TX]&#!$M@*;[-PBU7N4Y(3C,SMYYN%-$:F]G'-*#"*"V ^
MD=)L!510?<^[_!=02P,$%     @ E$1P4_J$E1;M!   SP\  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&ULQ5?;;N,V$/V5@5%@$R K6Y1\"QP#3M)M
M4W2[P3IM'XH^T-+8(E8BM21E)W_?(>6+G#BN-T"[+XE$S8WGG!F:HY727TR&
M:.&QR*6Y:F76EI?MMDDR++@)5(F2OLR5+KBE5[UHFU(C3[U3D;=9I]-K%US(
MUGCDU^[U>*0JFPN)]QI,511</UUCKE97K;"U6?@L%IEU"^WQJ.0+G*+]O;S7
M]-;>1DE%@=(()4'C_*HU"2^O8V?O#?X0N#*-9W [F2GUQ;W<I5>MCBL(<TRL
MB\#IWQ)O,,]=("KCZSIF:YO2.3:?-]$_^+W37F;<X(W*_Q2IS:Y:@Q:D..=5
M;C^KU<^XWD_7Q4M4;OQ?6-6V$1DGE;&J6#M3!860]7_^N,:AX3#HO.+ U@[,
MUUTG\E7><LO'(ZU6H)TU17,/?JO>FXH3TI$RM9J^"O*SX^O*T(HQ<*.*F9#<
M067@[('/<C3GH[:E',ZRG:SC7=?QV"OQ0@8?E;29@1]EBNE^@#85MZV0;2J\
M9D<C3K$,@'4O@'58>"1>M-UQY.-%W[3COR8S8S5IY.\C*>)MBMBGB%\KF5HG
MK7($-8?[2B<9R0;NM4@0)GFN$I_S$+9'P[K^O#0E3_"J10UH4"^Q-7[($*RR
M/(=RDZGTF5;< *^S84HFQ,M,I((OWAFRP%R0FJ@-P7*Y$,0V<)F"2%%:,1>.
M?A!R]\T8M,:;Y/11Y,(*-+X?4J#FLE0%&BL*GVS.A88ESRLRH2H(A5\JB1#V
M:Q(OW"+% YHI-H.9FPP!W'"3P0_0#SHP21)52<JG,4&Q],7$ 8,[N:3R%!4=
M1D$?/E%6O2F-#8/>SK'D3WRS)YXDNJ*J\)$FF:&2SL)A$)ZOW9O;.0O#H'\.
M=T=!N(1;7%+)I4,5DTRJ7"V>@ VZ5/F=?%]JE3AY.88X,>)K2&L7FF86^C$9
MWOC6IOS$1"W!3)2TBTXPA ?-4P3)"_0+SEAKYYGBS,)9K^>JO\4YTBI1)A,*
M1#0^HKD B<ZB$W3/X2>ETI7(<X@C1M@\$R(A[2$[73_70CG$N%1$=&+>_?\J
M^H S7;ELC)V@I#U!-)34H_4]Z?2"[JG*&03LH' &CI(WZ28DLJ)]RH/P*+OA
M((@;[ Z<9%Z0RZ*0PJZ1Z+Z"Q)!,=CTU)*7MX4)--CRYI7JN<PX@,W2(O0F9
MWC 8O-8G%/4X1K2U)D814?P"H[#;):A/;X")ZVM.X_,_%CLIW6;*[$+XI4FU
M("R(6"_]SE'IAWO#,GY.;!S$I_(:?]M ?&@(F[E1WA1V^"^DT:QCS;%%4_H
M:3WFPIY,VG1Z][T8^TTML9@1[&Y0L4XX/,H9>Z5)^X1"X^!SY\&])K"U?;J
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M7!H"K,\%<F8U,!O4/PS._P-02P,$%     @ E$1P4V,C0L<0!   G H  !D
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M-TAI\%?:#/HWUD\#C[M,1J&_V8GRB7Q(<U*3Z2XRM'6H?2?Z0/]1Y'4C6Q
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MFU)0RR7N")K&%Y,(3#?2G>%T$\9HJQT-95A6] JB\0&TO]/:'0V?H']7%W\
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MD5IWP.\.K/H!&0DL8FIMU+@$X$-4^+587,$868EA4QH9XS%Q^O0[=^_]OJ(
MU%ZRKNEW*E>5CIHW*7-P Z^K/JF4OXA$2^$.ZL(=M-:%34@IJ#&X%/U$Y^,<
M%9<QCVID-S9P/U22K:;M07RE,Q;AQ*.35E,RH?>R3LLCUE5/] 2LY0@"G%6
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MX\<'VHZ=HG#@]PZTG?#JQ"VO/6U)HRVYK$VXHV&O:6JN'\U05A=58BJDN4]
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M=(&BN\^ZB>*-O1+67.D+Q@XW^A, P@CT>LFY^IR86V;XJ&3_ 5!+ P04
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MJI(L*MT;KK8NES]/P$U6Z>,B 5<_2KI1>TH*\'Y!)*;9!V7C=KD []]] .\
M+< US3*U7<3,DVHM%2(O;G!?U+C1 =P!N&:%7 MP520DL>@OW/H0.0QX*HAM
M)-%C)"^0T^*"Q$. HA. ?.1; %VZU9=DXU1?'*,^TNK0HGYUC/JD4H=31S""
M=EL%VEYPP)YS/X"_ORIQ\$627/SC<!:VSD+M+#S@[!H79:H8I^35?C5NSI73
M)4OE%G-B2TAM=:RM5H1Z/P\C?SB>>??=N-NDQD/82CV!/&HACYR0#<A;M?TX
MN-25KBYNA:)G<+[BA.C2L>&N34^ZB$;1<+*#VR(U"8>1'7?4XHZ<N"]*FB4J
MRD)G]$N^X>R^!GH"/G,FK'BC/21013#8P6N1FL(ALN,=MWC'3KQ?B6HB:Y8=
MC76\'[5P#ZI%:-K9-T^03EJD$S=2%5 ;H,F^K_T]:A&"'=1/ $U;0%,GH$\E
M+ZBJ*:)3_8D^5->NT$TM:>[428W4*C2Q(X6^:6*^&RLM<!$3H--] O2X<\K2
M4]6FP+D01-KP-C:C#A;_ )!.-X5.($[><\2N,?LD+G R&DYWPF>30XJT#I0U
M1 8XZBD4475X',=E7F:ZQR=$C9XQQ?5 IQ:"<\8E_5<_L"X"[8$[C:;A,-Q=
MA%6NN]BGBS!-!P9'1G_31I^8Z!<']D%@*6<X'.VBWA<;1>%N*5XU8D_ZQ=@_
MN#;3XZ"[R7WFN)JD5$:(&KH2D'*6@P798"YU'U%#F)J/U01O:W47<+^+03C=
M);9+B]CXX-XRO0ZZFYT5)4C+(C'KL4YP^RT,'>P(T+0PZ.YA/;/)-<GO"'?-
M)=!T'SA^_3$(FA8"W3WD5VAPT=CLYGQZ<+N:Y@'=W<.L$G>FL#:ZX#\U^Q<T
M+W/7Y&WX'_FO'V=D6!X=R_)6GB'M:U)9OR9E-+55Y:+'30!^$LR%"[+A=^3F
M]R/R@1_Z\F&(&+W!^(\,-R(W-[Y8/MQNH-^?$$.*Z(7> )Y9,X8&4?0&.3)4
MB-R3^(OER.WFB)HQ=(K<=/IK*>HO(T.B:/KZ*0H,BP;N*?JE4M3C9M*;HL P
M<>"FR,?WT;W7T>=536!X-$!OD)+.9Y3?FFB/3XG;#>IGML"P<>"FR>-RTELF
M@:'28/0&.3'$&1P[/_YF3MQN@E%_3@S[!FY:M+_,/[-(#'$&DS=(B*')P#UK
MOEA"W&[Z\Q$:J@U[/ECTYZ.W0$+#DB%\@Z^QAB-#]ZSY4OGH<3,^G ^O<R"B
M&O9*GT0)H,\TZB_Z[=/VM.M<G_'L/+^ 'R_K,RMCICY"N\9\10L!,I(JD_YP
MK#B*UZ=2]8UD&WWL<L>DFAKTY9I@-4=4 NKWE#'Y>%,Y:,\&Y_\#4$L#!!0
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M]EJ*"!;TAC0(\*LD.UL4>:QMH@M=:E7$,T]E8ZLEZRJJ+A_D3 8$YB$]5$X
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M!F1BLH<D<R 3Q[O?T=A&GDP254W2:BD_NFZ,-R-NICQ";R5QX!;'N;6=\V[
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MX-R"#'=;Z00@2/31UPE@D3C0U[TCK>T=>4RMB8W?]>&<@JP>"P:@C^BCHY,
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M7"JAKU*-4^-EU8*(K]&2I@5=TY@4"DWBF&\*18L4+3BC,06)_D3WD.C+#$U
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M46WRJQ/%2[O'7'&E7=L>9J"M1I@)^OJ:<_5\8@(TGUK&_P-02P,$%     @
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MOF&%;V?%Y<P:@6LSZ[R0^1?7YI2+E-KZ81CBX[$S,F#P[6"X(J/SM4KL.\%
M1(8!OIT!;437%Y69V'XT=F!FDOOQ_PTL_C>!&0+X%U8GK.(UN1P4-G,;>V/O
M')B9C>UKALM!X?-%0NPY4Z_S,\!X;!B +[S:O$[MZF+#9J[CT7=?.MLO]M7#
M%1GV+!>NS- P ML9L1(Y4?39UB,S[7$X=EIFVF/[\_R*M**>K9BAY3HV3,!V
M)C0!Z>*Z]DT:FVF/IR,'%ICI']@?[9<#:P0B>V!N9T<XIW);[7L7H-K4K3>'
MVZOMWOI-O:-L;J\WYI=$OS7R F1THYMZ3J1+4]9[W?6)$OMJ?WDME!)Y=;BC
M)*6RO$%_OA%"O9R47]#^QV'Q#U!+ P04    " "41'!3UR7_?(L"  #1!@
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M@# "_3SE7'UTS.%3?VO,_@%02P,$%     @ E$1P4P26&@8&!0  _A4  !D
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MG7_3<HQ&+&2>-B(H_'ED<Q:&1A+H\5\JM)7=:1B+ZV?I?\;@ <R:*C87X9?
MU[N;UJB%?+:AAU _B.-[E@**%?1$J.+?Z)C2.BWD'9064<H,&D0!3_[2I]00
M!08\.,% 4@9297!/,/12AMZY#&[*X,:62:#$=EA03:<3*8Y(&FJ09A:Q,6-N
M@!]PX_>5EO U #X]727^1F*#5L&6!YO HURCF>>) ]<!WZ*E" ,O8 J]0_,=
MY5M8!<9?WB$ZA%0S'^P>4N[!.0@1>L<D\D0$4;@SX?'(@!SV#%TNF*9!J*Y
MTN?5 EU>7*$+(^L^"$.( 37I:D!D].IZJ?:WB?;DA/:8H'O!]4ZA/[C/_+*
M+I@BLP=YML<ML4I<L7T'D7X;$8?@!H7FY[ /8G:G@7UQ#OO(L..Q!4TO\VXO
MEM<[(6]6\-)?L6?F)<_<I9[Y(!2XY>L'8$=WFD7J'\OE;G:Y&U_NOL;E;03/
M&!XI1_.#E(Q[W]$G2;D"=I,>9OZ_\!8@W^@V^@C9$"+M$WUJ"IA$IV&LDTEZ
MC]-W;J\#KGPL>K&!BI#.N$RU:)*%.VY&53)+/S-+_Y?,<IG8Y0H9N[31@FU
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M:0SP_5H(_38P"Y0WT<E_4$L#!!0    ( )1$<%,#V#RA0P,  (0)   9
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M0J L +^74IISQT[0OJUF_P%02P,$%     @ E$1P4UR#$6IK P   PH  !D
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MTDAJ%43]>Z%W-$VU)F7'KTIIIYY3#]S\O-8^+IQ7SDR)H'<L_9;$<G'5&71
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MY@N0%KZXKK(.FW?6@@"L8$AAH[.P&AJK^L-\&?6#R-=_0^]EFSB+H!_O"NX
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M;-UP;[X]0-H%YOE6"/TPL:?;]FMF^1M02P,$%     @ E$1P4TUPQJEL @
M) <  !D   !X;"]W;W)K<VAE971S+W-H965T-C8N>&ULI97;:N,P$(9?19A>
MM+ ;)\JY.(8>*%O80FCH[L6R%XHSB45U\$IRT[S]CN3$I,0NI;V)3C/_?*.)
M1\E6FV>; SCR*H6RLRAWKKB,8YOE()GMZ (4GJRUD<SATFQB6QA@J^ D14R[
MW5$L&5=1FH2]N4D373K!%<P-L:64S.RN0>CM+.I%AXU'OLF=WXC3I& ;6(![
M*N8&5W&MLN(2E.5:$0/K6735N[R>>OM@\(O#UA[-B<]DJ?6S7]RO9E'7 X&
MS'D%AL,+W( 07@@Q_NTUHSJD=SR>']3O0NZ8RY)9N-'B-U^Y?!9-(K*"-2N%
M>]3;'[#/9^CU,BUL^"7;RG:,QEEIG99[9R207%4C>]W?PY$#[;4XT+T##=Q5
MH$!YRQQ+$Z.WQ'AK5/.3D&KP1CBN?%$6SN I1S^7_@1,R9+OY*YTI0'RP!67
MI2172I5,D$=0#H=[E6D)9,YV6 ]GR?DM.,:%O2!GA"MT$@*OV":Q0R0O'&?[
M\-=5>-H2?@%%A]#A-T*[M/>TN"7G9Q=O56),J,Z*UEG1(-M_/ZL_5TOK#!;^
M[SN:_5JS'S0';:CED@BO>[@47EU*5AJ#&TVY5X+C(.B_CI>TW^DE\4L#Q:"F
M&'R0PKRA6)7@*T')#IAI+$2E.SJ&:489UBC#KZ#TVU&&'T49U2BCKZ ,VE%&
M)RBT&65<HXR_@C)L):ED)T<DW<ZTF652LTP^S>)RP":^=F":8"8G,+334J-I
M#3/]#$Q3].G)=],;G(2/CYJ>?S\>F-EP93'&&MVZG3'^RTS5DZN%TT7H@TOM
ML*N&:8[/&!AO@.=KK=UAX5MK_3"F_P%02P,$%     @ E$1P4\@B&!-[#0
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MV.GNWQ$,%2PXY\"< W88QHYB-P[<4G$$]APXD!MSM-*4S2CD08$W9[@8S1&
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M9.4#_/<'QHKFC_+5F-NW$I_\'U!+ P04    " "41'!3=WEX7TL(   [+@
M&0   'AL+W=O<FMS:&5E=',O<VAE970V."YX;6RUFEMSHT86Q[\*I<I#4C66
MU!>Z6RG;51Y+(Y'*[+CB9/=A:Q\0:EM4$"B [/&WWP8Q:I3F'+ G]L.,+OS[
M].7H=RYP^9SE?Q9;K4OOZRY)BZO1MBSW/T\F1;35N[ 89WN=FF\>LGP7EN9M
M_C@I]KD.-[5HETSH="HFNS!.1]>7]6=W^?5E=BB3.-5WN5<<=KLP?_FHD^SY
M:D1&WS[X+7[<EM4'D^O+??BH[W7YQ_XN-^\FIU$V\4ZG19RE7JX?KD8WY.=
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MCV_*;%\_QKK.2I,#U2^WVOA<7EU@OG_(LO+;F^K)V-/SXM?_!U!+ P04
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M%K4SL.\KI6AW< +=U,[^ %!+ P04    " "41'!32ZG00>,%  "@*0  &0
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M,<-9_[/.WW%(-_4UU^F?6_;G-&=P;B8P->=)D$GFM(>-R<]M\2L:TT88D]A
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M_D+U_^<L*[LW=0/G)RK=_Q]02P,$%     @ E$1P4P:_/V@?!   L1$  !D
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M;7ND[>^.;.CF;77S0-UNXB1>KI?H+W23/L73.'Q&=^] B/A;OOX0JSS8L@]
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M_9*2HJLMNTCR8NLR9\3A&8]\)@<N?LHM@$+/:<+DU-HJM?OH.'*UA91*F^^
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M]H.<,N&-AV[M3HV'LC"<";A31!=Y3M7K%+C<C;S(VR_<L]7:V(5@/-S0%3R
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M^1]H#!F!6YY7YC\ZU[&SR$';4R5YT8"5@H*5]2]];1:B \#Q%0!I &0("*\
M@@80O!<0-H#0K$QMQ:S#FDJZG M^1D)'*S9]81;3H)5]5NJ\;Z103YG"R>7W
M<LL+0#_I*U3H#CT)_L),3E5)H=[#FS5(RO);%?5KLT8WGV[1)\1*],CR7 &J
MN2>5'LWJ;9NY'^JYR96Y,4&/O)2'"GTM,\CZ!)XRTKHA;VX>R"3C!HXN(M%G
M1'R"+8)6[X''!NY;X.OWP!,-Q^F$FZ#-36#X@BM\WR #0?/[":JPI0H-57B%
M:G42 DIIRU$-G!F@WB5>EF$4N/'<>^DNW#CJ+B8N[D>MQU$X)&[:1O6T1ZWV
M:%+[&G:@U&<V\34RZ<H*HY%X2]0L=J.T^S=P8H'@)+UF)6ZMQ)-6FHQ^1C^Y
MI+G-4(V/N]GPDX&=V*(M2-S9P,*8ZBZ<V?7/6OVSR8K<2"IAJAZ3EBCY:#TF
M(W=)./2V&@<%@3O,X3B(=$NV)SQMA:<?+L;4DA<\5+6R11$W&FA/+<F[(AW[
ME[W>GQ1OTC=1? V\JVU&W&'Y6:((=L.! 4N4>H.NO4"X<U[AZ4V1"W66EU-%
MB,F%C'RT#!MDSV7@DN%:D%&>\&@EQDPX[B2\K_UR..#@PY780(=%-MP7;6&1
M&PSU6Z*Z;V1?_^5$PM-'4I/(J7(,QPOGCTV,HQ(W3J<V=QLQ[M1YW]'EG,+3
M!]6E>;IYAA)V3-Z:-HK5;934;9359S0^@M/1&[6RA-UA/QDNR-H6%X6CC<_K
M-(T%B+UIOBNTY:=2UAU7>[=M\+^8MG9P_T$W_J89O=#47PV/5.Q96:$<=HK2
M=W6;+>I&O!Y(?C2MZ3.7JM$UEP?U\0)"!ZCG.\[EVT!/T'X.+?\"4$L#!!0
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MM2:HA68EV&R:OPJI=\HK09@I[5(@#.OG=)"G'WRIMOCI"<\D&#<2C(,\MC8
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MQ'=]K^%"LVO@H8&[#?#H&GA?P[U!BYJ@2HO \ 4?\6F7=Y8F^G-ZQ ]=D8G
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M?431LA83Q7/3Q"VYPI;0#+?8YH/0!KB_YER=)OJ ZA^'\?]02P,$%     @
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MQ.(P<JCSMO# UQMM%KSQ<,O6, ?]N+V7./,*+Q%/(%5<I$3":N1,Z.<9[1J
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M<:/O/"",@7Z_XER]#,P"]2UJ\AM02P,$%     @ E$1P4[_3?E)M @  TP4
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;,U766_;.!#^*X2P"[2
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MA@#OMT+HAXU1T'XKS?X%4$L#!!0    ( )1$<%-];#P?;0(  +L&   9
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M2+O!K!="Z(-A.U[WO<K^ 5!+ P04    " "41'!3V8T_]G8"    !@  &0
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M%GS[ 5H](\.7<BKM-]HVMM&U@]):*EZV8!U!25CSBY_:/.P!O/$)@-<"O&/
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M>H!ZOF!,;ALZ0/T1,_X/4$L#!!0    ( )1$<%.:(1H</P,  $H,   :
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M2%M@QI="Z'W'GD3=B\?T+U!+ P04    " "41'!3F 1_SP,#  "E"   &@
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M>J%Y&[+N4/5$B])UA:70IL>X86Z:.D@;8/8S(?1A8AM-^S>1O -02P,$%
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M3S4'5D%++M8NW(? 3 FE V,KRJ;K0:1^<'#/]:#86IV22Z6;W"Z#^YZVCQ\
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M%" +!4-:R*<6"F"%?T@+^=1" ;)0P&RA?0KPU/DJ3%ND?I#.R:6LA<I[\\H
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MK'IG@-Y9]<X O;/JG0%Z%]6[ /0NJG<!Z%U4[P+0NZC>!:!W4;T+0.^B>A>
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M^5?VS4]02P$"% ,4    " "41'!3!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )1$<%/LHSEO[@
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( )1$<%.97)PC$ 8  )PG   3              "  <P!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ E$1P4Z'3O%-]!@  WQD  !@
M             ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( )1$<%-A'ZTAH0<  '\A   8              " @< .  !X;"]W
M;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "41'!3 SVQ!5D$  "R
M#@  &               @(&7%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L! A0#%     @ E$1P4Q&ZW-S= @  J <  !@              ("!)AL
M 'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( )1$<%.IFXA"
MR 8  +0;   8              " @3D>  !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6Q02P$"% ,4    " "41'!3<@M=K\D"  #L"   &
M@($W)0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ E$1P
M4WV5V.S<"@  8ST  !@              ("!-B@  'AL+W=O<FMS:&5E=',O
M<VAE970W+GAM;%!+ 0(4 Q0    ( )1$<%/XZ>Q*X D   \O   8
M      " @4@S  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M" "41'!3.H]I5:,)  !)&0  &               @(%>/0  >&PO=V]R:W-H
M965T<R]S:&5E=#DN>&UL4$L! A0#%     @ E$1P4UE[U?%0*0  [84  !D
M             ("!-T<  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"
M% ,4    " "41'!3@$G G[D/  "G*@  &0              @(&^<   >&PO
M=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( )1$<%.MZ68:8A
M /BB   9              " @:Z   !X;"]W;W)K<VAE971S+W-H965T,3(N
M>&UL4$L! A0#%     @ E$1P4Z#%SJKQ%@  /&0  !D              ("!
M1Y$  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "41'!3
M"E;^M)4)  #8'0  &0              @(%OJ   >&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;%!+ 0(4 Q0    ( )1$<%-\O1G(.!H  "EH   9
M      " @3NR  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%
M  @ E$1P4\DOG_KU$   IC4  !D              ("!JLP  'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "41'!3-_TB4F0"   E!0
M&0              @('6W0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+
M 0(4 Q0    ( )1$<%-< A8@70,  &D'   9              " @7'@  !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ E$1P4U5P=C54
M#   U2(  !D              ("!!>0  'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6Q02P$"% ,4    " "41'!3DP96VGD&  #^#P  &0
M@(&0\   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( )1$
M<%/:? *#& @  #H3   9              " @4#W  !X;"]W;W)K<VAE971S
M+W-H965T,C$N>&UL4$L! A0#%     @ E$1P4[$3?@ 6 P  +@<  !D
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M=#(V+GAM;%!+ 0(4 Q0    ( )1$<%-!6J"!#P8  -L3   9
M  " @>D] 0!X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @
ME$1P4_J$E1;M!   SP\  !D              ("!+T0! 'AL+W=O<FMS:&5E
M=',O<VAE970R."YX;6Q02P$"% ,4    " "41'!3.;;.=S($  !6#0  &0
M            @(%320$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4
M Q0    ( )1$<%-"R@#H8 4  #P0   9              " @;Q- 0!X;"]W
M;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ E$1P4V,C0L<0!
MG H  !D              ("!4U,! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6Q02P$"% ,4    " "41'!3CXW0[!D'   %$@  &0              @(&:
M5P$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( )1$<%.?
MEL"O6 8   (1   9              " @>I> 0!X;"]W;W)K<VAE971S+W-H
M965T,S,N>&UL4$L! A0#%     @ E$1P4Z+R**%] @  8P4  !D
M     ("!>64! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )1$<%-$G$\^*PH  %XZ   9              "
M@?]X 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ E$1P
M4]+SF=;F @  M@<  !D              ("!88,! 'AL+W=O<FMS:&5E=',O
M<VAE970T,"YX;6Q02P$"% ,4    " "41'!33-!$W7P"  !@!@  &0
M        @(%^A@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0
M   ( )1$<%-,8I53F 4  "<<   9              " @3&) 0!X;"]W;W)K
M<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ E$1P4V@H;T]I"   +38
M !D              ("! (\! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q0
M2P$"% ,4    " "41'!3\ \ E2<$  !V$0  &0              @(&@EP$
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( )1$<%/]]:H/
M4P(  -<%   9              " @?Z; 0!X;"]W;W)K<VAE971S+W-H965T
M-#4N>&UL4$L! A0#%     @ E$1P4T?@WK"^!   ?1@  !D
M ("!B)X! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "4
M1'!3UR7_?(L"  #1!@  &0              @(%]HP$ >&PO=V]R:W-H965T
M<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( )1$<%,U=W55_P(  '<(   9
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M970U,BYX;6Q02P$"% ,4    " "41'!3 ]@\H4,#  "$"0  &0
M    @(':N@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (
M )1$<%,;BA+N+ ,  &<)   9              " @52^ 0!X;"]W;W)K<VAE
M971S+W-H965T-30N>&UL4$L! A0#%     @ E$1P4UR#$6IK P   PH  !D
M             ("!M\$! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"
M% ,4    " "41'!3P/_U530#  #_"   &0              @(%9Q0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( )1$<%/:;ZRWC@(
M .8%   9              " @<3( 0!X;"]W;W)K<VAE971S+W-H965T-3<N
M>&UL4$L! A0#%     @ E$1P4RWW?8EP"   *C@  !D              ("!
MB<L! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " "41'!3
MD/7[WR\#  "/"P  &0              @($PU $ >&PO=V]R:W-H965T<R]S
M:&5E=#4Y+GAM;%!+ 0(4 Q0    ( )1$<%.4[\#KM ,  *X.   9
M      " @9;7 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%
M  @ E$1P4Z!E6P+U @  (A   !D              ("!@=L! 'AL+W=O<FMS
M:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " "41'!3(1@!7-<&  #-(0
M&0              @(&MW@$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+
M 0(4 Q0    ( )1$<%/.1_5MJP0  ",6   9              " @;OE 0!X
M;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ E$1P4Z&? IP>
M!   9 \  !D              ("!G>H! 'AL+W=O<FMS:&5E=',O<VAE970V
M-"YX;6Q02P$"% ,4    " "41'!32;V"JD4#  #9#   &0
M@('R[@$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( )1$
M<%--<,:I; (  "0'   9              " @6[R 0!X;"]W;W)K<VAE971S
M+W-H965T-C8N>&UL4$L! A0#%     @ E$1P4\@B&!-[#0  H5@  !D
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M=#<Q+GAM;%!+ 0(4 Q0    ( )1$<%,&OS]H'P0  +$1   9
M  " @:8= @!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @
ME$1P4YXY^ _H P  !Q$  !D              ("!_"$" 'AL+W=O<FMS:&5E
M=',O<VAE970W,RYX;6Q02P$"% ,4    " "41'!3(%FD6L$$  !K&0  &0
M            @($;)@( >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4
M Q0    ( )1$<%,RYZCS>@,  .L-   9              " @1,K @!X;"]W
M;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ E$1P4S;QFUYS#
MV$\  !D              ("!Q"X" 'AL+W=O<FMS:&5E=',O<VAE970W-BYX
M;6Q02P$"% ,4    " "41'!3/R]!?*,#   E#P  &0              @(%N
M.P( >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( )1$<%/]
M-WJPZP8  (\O   9              " @4@_ @!X;"]W;W)K<VAE971S+W-H
M965T-S@N>&UL4$L! A0#%     @ E$1P4SGE"5PV!   .Q$  !D
M     ("!:D8" 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )1$<%,G:SH=)P0  %P/   9              "
M@:A9 @!X;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ E$1P
M4R[8/M$3!P  $B(  !D              ("!!EX" 'AL+W=O<FMS:&5E=',O
M<VAE970X-2YX;6Q02P$"% ,4    " "41'!3IJOLKJ(#  "U"P  &0
M        @(%090( >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0
M   ( )1$<%/MG.65PPH  *I    9              " @2EI @!X;"]W;W)K
M<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @ E$1P4QFP,!2_ P  #P\
M !D              ("!(W0" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q0
M2P$"% ,4    " "41'!3>0C;:,T#  !$#   &0              @($9> (
M>&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( )1$<%.[?(:_
MEP4   X:   9              " @1U\ @!X;"]W;W)K<VAE971S+W-H965T
M.3 N>&UL4$L! A0#%     @ E$1P4ZFY-V.Y P  'PP  !D
M ("!ZX$" 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6Q02P$"% ,4    " "4
M1'!3@XQ!7E@#  !1#0  &0              @(';A0( >&PO=V]R:W-H965T
M<R]S:&5E=#DR+GAM;%!+ 0(4 Q0    ( )1$<%._TWY2;0(  -,%   9
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M970Y-RYX;6Q02P$"% ,4    " "41'!3S9HJL&D"  !H!0  &0
M    @('QF0( >&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    (
M )1$<%.LWA+NOP(  -P'   9              " @9&< @!X;"]W;W)K<VAE
M971S+W-H965T.3DN>&UL4$L! A0#%     @ E$1P4T6^IP*R!@  #B,  !H
M             ("!AY\" 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L!
M A0#%     @ E$1P4W<2)L84 P  T P  !H              ("!<:8" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#$N>&UL4$L! A0#%     @ E$1P4YHA&AP_
M P  2@P  !H              ("!O:D" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#(N>&UL4$L! A0#%     @ E$1P4YI/ ?S3 @  A @  !H
M ("!-*T" 'AL+W=O<FMS:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%     @
ME$1P4Y@$?\\# P  I0@  !H              ("!/[ " 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#0N>&UL4$L! A0#%     @ E$1P4[34,L?% @    @  !H
M             ("!>K," 'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L!
M A0#%     @ E$1P4_9BX1+- P  ( T  !H              ("!=[8" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#8N>&UL4$L! A0#%     @ E$1P4[<;3]8Y
M P  TPD  !H              ("!?+H" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#<N>&UL4$L! A0#%     @ E$1P4TOS&1K( @  -P@  !H
M ("![;T" 'AL+W=O<FMS:&5E=',O<VAE970Q,#@N>&UL4$L! A0#%     @
ME$1P4VUR3>-9 @  ,@8  !H              ("![< " 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#DN>&UL4$L! A0#%     @ E$1P4TCME*DU P  T!,   T
M             ( !?L," 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "41'!3
MEXJ[',     3 @  "P              @ '>Q@( 7W)E;',O+G)E;'-02P$"
M% ,4    " "41'!3*%A>360'  #C1P  #P              @ ''QP( >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ E$1P4Q1DIV83 P  !$   !H
M         ( !6,\" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ E$1P4]&<,ZAW @  G3T  !,              ( !H](" %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     '4 =0 T(   2]4"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>643</ContextCount>
  <ElementCount>751</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>185</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Operations</Role>
      <ShortName>Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210031002 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210241003 - Disclosure - Revenue (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/RevenueNotes</Role>
      <ShortName>Revenue (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210311004 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210381005 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210431006 - Disclosure - Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringCharges</Role>
      <ShortName>Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210481007 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210661008 - Disclosure - Stockholders' Equity and Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210741009 - Disclosure - 401(k) Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/A401kPlan</Role>
      <ShortName>401(k) Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210771010 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210801011 - Disclosure - Litigation and Related Matters</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LitigationandRelatedMatters</Role>
      <ShortName>Litigation and Related Matters</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210821012 - Disclosure - Disposition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Disposition</Role>
      <ShortName>Disposition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210861013 - Disclosure - Business Segments and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</Role>
      <ShortName>Business Segments and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210921014 - Disclosure - Accrued Expenses and Other Long-Term Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities</Role>
      <ShortName>Accrued Expenses and Other Long-Term Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210961015 - Disclosure - Pension and Other Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefits</Role>
      <ShortName>Pension and Other Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.hologic.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>230253002 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/RevenueNotes</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>230323003 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>230393004 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessCombinations</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>230443005 - Disclosure - Restructuring Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesTables</Role>
      <ShortName>Restructuring Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/RestructuringCharges</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230493006 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BorrowingsandCreditArrangements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230553007 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230593008 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230673009 - Disclosure - Stockholders' Equity and Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230783010 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/CommitmentsandContingencies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230833011 - Disclosure - Disposition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionTables</Role>
      <ShortName>Disposition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Disposition</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230873012 - Disclosure - Business Segments and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables</Role>
      <ShortName>Business Segments and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230933013 - Disclosure - Accrued Expenses and Other Long-Term Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Long-Term Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230973014 - Disclosure - Pension and Other Employee Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables</Role>
      <ShortName>Pension and Other Employee Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/PensionandOtherEmployeeBenefits</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>240064002 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>240074003 - Disclosure - Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>240084004 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>240094005 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>240104006 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>240114007 - Disclosure - Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>240124008 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>240134009 - Disclosure - Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>240144010 - Disclosure - Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240154011 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240164012 - Disclosure - Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240174013 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240184014 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240194015 - Disclosure - Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240204016 - Disclosure - Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240214017 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240224018 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240234019 - Disclosure - Summary of Significant Accounting Policies - Product Warranty (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Product Warranty (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240264020 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240274021 - Disclosure - Revenue - Business Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueBusinessRevenueDetails</Role>
      <ShortName>Revenue - Business Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240284022 - Disclosure - Revenue - Geographical Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueGeographicalRevenueDetails</Role>
      <ShortName>Revenue - Geographical Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240294023 - Disclosure - Revenue - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRevenuebyTypeDetails</Role>
      <ShortName>Revenue - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240304024 - Disclosure - Revenue - Remaining Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails</Role>
      <ShortName>Revenue - Remaining Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240334025 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240344026 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240354027 - Disclosure - Leases - Additional Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails</Role>
      <ShortName>Leases - Additional Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240364028 - Disclosure - Leases - Lease Liability Maturity Schedule 2020 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details</Role>
      <ShortName>Leases - Lease Liability Maturity Schedule 2020 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240374029 - Disclosure - Leases - Future Minimum Annual Rental Income Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails</Role>
      <ShortName>Leases - Future Minimum Annual Rental Income Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240404030 - Disclosure - Business Combination - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationNarrativeDetails</Role>
      <ShortName>Business Combination - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240414031 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combinations Business Combinations - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240424032 - Disclosure - Equity Method Investment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/EquityMethodInvestmentDetails</Role>
      <ShortName>Equity Method Investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240454033 - Disclosure - Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail</Role>
      <ShortName>Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240464034 - Disclosure - Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail</Role>
      <ShortName>Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240474035 - Disclosure - Restructuring Charges - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail</Role>
      <ShortName>Restructuring Charges - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240504036 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Company's Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240514037 - Disclosure - Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240524038 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240534039 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240544040 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240564041 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240574042 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240584043 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240604044 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Income (Loss) Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240614045 - Disclosure - Income Taxes - Provision for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail</Role>
      <ShortName>Income Taxes - Provision for Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240624046 - Disclosure - Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240634047 - Disclosure - Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240644048 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240654049 - Disclosure - Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240684050 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240694051 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240704052 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240714053 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240724054 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240734055 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail</Role>
      <ShortName>Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240754056 - Disclosure - 401(k) Plan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/A401kPlanAdditionalInformationDetail</Role>
      <ShortName>401(k) Plan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240764057 - Disclosure - Deferred Compensation Plan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail</Role>
      <ShortName>Deferred Compensation Plan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240794058 - Disclosure - Commitments and Contingencies - Summary of Purchase Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails</Role>
      <ShortName>Commitments and Contingencies - Summary of Purchase Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240814059 - Disclosure - Litigation and Other Matters - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail</Role>
      <ShortName>Litigation and Other Matters - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240844060 - Disclosure - Disposition - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionAdditionalInformationDetails</Role>
      <ShortName>Disposition - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240854061 - Disclosure - Disposition - Schedule of Disposition Related Income Statement Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails</Role>
      <ShortName>Disposition - Schedule of Disposition Related Income Statement Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240884062 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240894063 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Segment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240904064 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail</Role>
      <ShortName>Business Segments and Geographic Information - Revenues by Geography (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240914065 - Disclosure - Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails</Role>
      <ShortName>Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240944066 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail</Role>
      <ShortName>Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240954067 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail</Role>
      <ShortName>Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240984068 - Disclosure - Pension and Other Employee Benefits - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240994069 - Disclosure - Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>241004070 - Disclosure - Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>241014071 - Disclosure - Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="holx-20210925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>241024072 - Disclosure - Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail</Role>
      <ShortName>Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="holx-20210925.htm">holx-20210925.htm</File>
    <File>ex1048-creweroadwythenshaw.htm</File>
    <File>ex410-holxxfourthsupplemen.htm</File>
    <File>ex411-holxx2028notesxfifth.htm</File>
    <File>ex43-holxx2029notesxfirsts.htm</File>
    <File>ex48-holxxsecondsupplement.htm</File>
    <File>ex49-holxxthirdsupplementa.htm</File>
    <File>holx-20210925.xsd</File>
    <File>holx-20210925_cal.xml</File>
    <File>holx-20210925_def.xml</File>
    <File>holx-20210925_lab.xml</File>
    <File>holx-20210925_pre.xml</File>
    <File>holxq4-2021ex211.htm</File>
    <File>holxq4-2021ex231.htm</File>
    <File>holxq4-2021ex311.htm</File>
    <File>holxq4-2021ex312.htm</File>
    <File>holxq4-2021ex321.htm</File>
    <File>holxq4-2021ex322.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>holx-20210925_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>138
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "holx-20210925.htm": {
   "axisCustom": 1,
   "axisStandard": 45,
   "contextCount": 643,
   "dts": {
    "calculationLink": {
     "local": [
      "holx-20210925_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "holx-20210925_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "holx-20210925.htm"
     ]
    },
    "labelLink": {
     "local": [
      "holx-20210925_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "holx-20210925_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "holx-20210925.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 1081,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 11,
    "http://www.hologic.com/20210925": 4,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 20
   },
   "keyCustom": 164,
   "keyStandard": 587,
   "memberCustom": 89,
   "memberStandard": 77,
   "nsprefix": "holx",
   "nsuri": "http://www.hologic.com/20210925",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://www.hologic.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210031002 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894063 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
     "shortName": "Business Segments and Geographic Information - Segment Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904064 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
     "shortName": "Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240914065 - Disclosure - Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
     "shortName": "Business Segments and Geographic Information - Schedule of Geographically Located Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ibe57ae2fbed04a638154dae73a66c811_I20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944066 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)",
     "role": "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail",
     "shortName": "Accrued Expenses and Other Long-Term Liabilities - Schedule of Accrued Expenses (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUncertainTaxPositionsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954067 - Disclosure - Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)",
     "role": "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail",
     "shortName": "Accrued Expenses and Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUncertainTaxPositionsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984068 - Disclosure - Pension and Other Employee Benefits - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail",
     "shortName": "Pension and Other Employee Benefits - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "id753e6e364a144f8a4338bd5656f66cf_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240994069 - Disclosure - Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail",
     "shortName": "Pension and Other Employee Benefits - Schedule of Reconciliation of Benefit Obligations, Plan Assets Funded Status (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i1169eac86c27452c96edd0243c74ad5d_I20180929",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004070 - Disclosure - Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail",
     "shortName": "Pension and Other Employee Benefits - Components of Net Periodic Benefit Cost and Related Actuarial Assumptions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:ComponentsofNetPeriodicBenefitCostInterestcost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014071 - Disclosure - Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail",
     "shortName": "Pension and Other Employee Benefits - Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024072 - Disclosure - Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail",
     "shortName": "Pension and Other Employee Benefits - Schedule of Expected Pension Benefit (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210241003 - Disclosure - Revenue (Notes)",
     "role": "http://www.hologic.com/role/RevenueNotes",
     "shortName": "Revenue (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210311004 - Disclosure - Leases",
     "role": "http://www.hologic.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210381005 - Disclosure - Business Combinations",
     "role": "http://www.hologic.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210431006 - Disclosure - Restructuring Charges",
     "role": "http://www.hologic.com/role/RestructuringCharges",
     "shortName": "Restructuring Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210481007 - Disclosure - Borrowings and Credit Arrangements",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangements",
     "shortName": "Borrowings and Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210661008 - Disclosure - Stockholders' Equity and Stock-Based Compensation",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation",
     "shortName": "Stockholders' Equity and Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MultiemployerPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210741009 - Disclosure - 401(k) Plan",
     "role": "http://www.hologic.com/role/A401kPlan",
     "shortName": "401(k) Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MultiemployerPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210771010 - Disclosure - Commitments and Contingencies",
     "role": "http://www.hologic.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:LitigationAndOtherMattersTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801011 - Disclosure - Litigation and Related Matters",
     "role": "http://www.hologic.com/role/LitigationandRelatedMatters",
     "shortName": "Litigation and Related Matters",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:LitigationAndOtherMattersTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - Consolidated Statements of Income",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210821012 - Disclosure - Disposition",
     "role": "http://www.hologic.com/role/Disposition",
     "shortName": "Disposition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210861013 - Disclosure - Business Segments and Geographic Information",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation",
     "shortName": "Business Segments and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210921014 - Disclosure - Accrued Expenses and Other Long-Term Liabilities",
     "role": "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities",
     "shortName": "Accrued Expenses and Other Long-Term Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:AccruedExpensesAndOtherLongTermLiabilitiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210961015 - Disclosure - Pension and Other Employee Benefits",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefits",
     "shortName": "Pension and Other Employee Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230253002 - Disclosure - Revenue (Tables)",
     "role": "http://www.hologic.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230323003 - Disclosure - Leases (Tables)",
     "role": "http://www.hologic.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230393004 - Disclosure - Business Combinations (Tables)",
     "role": "http://www.hologic.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230443005 - Disclosure - Restructuring Charges (Tables)",
     "role": "http://www.hologic.com/role/RestructuringChargesTables",
     "shortName": "Restructuring Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230493006 - Disclosure - Borrowings and Credit Arrangements (Tables)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables",
     "shortName": "Borrowings and Credit Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230553007 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230593008 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.hologic.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230673009 - Disclosure - Stockholders' Equity and Stock-Based Compensation (Tables)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables",
     "shortName": "Stockholders' Equity and Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230783010 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.hologic.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230833011 - Disclosure - Disposition (Tables)",
     "role": "http://www.hologic.com/role/DispositionTables",
     "shortName": "Disposition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230873012 - Disclosure - Business Segments and Geographic Information (Tables)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables",
     "shortName": "Business Segments and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230933013 - Disclosure - Accrued Expenses and Other Long-Term Liabilities (Tables)",
     "role": "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables",
     "shortName": "Accrued Expenses and Other Long-Term Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230973014 - Disclosure - Pension and Other Employee Benefits (Tables)",
     "role": "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables",
     "shortName": "Pension and Other Employee Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064002 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "lang": "en-US",
      "name": "holx:CashEquivalentsMaturityPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical",
     "shortName": "Consolidated Statements of Comprehensive Income (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074003 - Disclosure - Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxesPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084004 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventories (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "id753e6e364a144f8a4338bd5656f66cf_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094005 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail",
     "shortName": "Summary of Significant Accounting Policies - Estimated Useful Lives of Property, Plant and Equipments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "id753e6e364a144f8a4338bd5656f66cf_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104006 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i6ae31be4bb5c4a43a23c3e6238becfc2_I20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i1c139a95fff24a0eba96d20dd2c7877d_D20210627-20210925",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114007 - Disclosure - Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
     "shortName": "Summary of Significant Accounting Policies - Medical Aesthetics Impairment and Other Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124008 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Estimated Amortization Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "id753e6e364a144f8a4338bd5656f66cf_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134009 - Disclosure - Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
     "shortName": "Summary of Significant Accounting Policies - Rollforward of Goodwill Activity by Reportable Segments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144010 - Disclosure - Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
     "shortName": "Summary of Significant Accounting Policies - Intangible Assets and Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-6",
      "lang": "en-US",
      "name": "holx:GoodwillNotAtRiskOfFailingImpairment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "holx:OtherAssetsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154011 - Disclosure - Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Other Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "holx:OtherAssetsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164012 - Disclosure - Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
     "shortName": "Summary of Significant Accounting Policies - Changes in accumulated balances of other comprehensive income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174013 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Derivative Instruments in Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184014 - Disclosure - Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Derivative Instruments on the Consolidated Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194015 - Disclosure - Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
     "shortName": "Summary of Significant Accounting Policies - Amount of loss recognized in other comprehensive income, net of taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "holx:AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204016 - Disclosure - Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Unrealized Loss Recognized in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "id753e6e364a144f8a4338bd5656f66cf_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214017 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail",
     "shortName": "Summary of Significant Accounting Policies - Accounts Receivable Reserve Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i1169eac86c27452c96edd0243c74ad5d_I20180929",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224018 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail",
     "shortName": "Summary of Significant Accounting Policies - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-3",
      "lang": "en-US",
      "name": "holx:WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "id753e6e364a144f8a4338bd5656f66cf_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234019 - Disclosure - Summary of Significant Accounting Policies - Product Warranty (Detail)",
     "role": "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail",
     "shortName": "Summary of Significant Accounting Policies - Product Warranty (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "iebdc63da66e44f02a09288f80627eb36_I20190928",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264020 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://www.hologic.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274021 - Disclosure - Revenue - Business Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
     "shortName": "Revenue - Business Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i9f414a4aae9647f39eb553c172b71177_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284022 - Disclosure - Revenue - Geographical Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
     "shortName": "Revenue - Geographical Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i5c981ade86904092ab44cdc3421e6c6c_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294023 - Disclosure - Revenue - Revenue by Type (Details)",
     "role": "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
     "shortName": "Revenue - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i00ab011f780a4f6f8ac17f56d74cdd4b_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "idd4c3415bf074cb794ce6b40d287d9c5_I20210925",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304024 - Disclosure - Revenue - Remaining Performance Obligations (Details)",
     "role": "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails",
     "shortName": "Revenue - Remaining Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "idd4c3415bf074cb794ce6b40d287d9c5_I20210925",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334025 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.hologic.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "holx:OtherAssetsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344026 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354027 - Disclosure - Leases - Additional Lease Information (Details)",
     "role": "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
     "shortName": "Leases - Additional Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364028 - Disclosure - Leases - Lease Liability Maturity Schedule 2020 (Details)",
     "role": "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details",
     "shortName": "Leases - Lease Liability Maturity Schedule 2020 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:SubLeaseRentalIncomeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374029 - Disclosure - Leases - Future Minimum Annual Rental Income Payments (Details)",
     "role": "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails",
     "shortName": "Leases - Future Minimum Annual Rental Income Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:SubLeaseRentalIncomeCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404030 - Disclosure - Business Combination - Narrative (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
     "shortName": "Business Combination - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i76683b5c18404ee8b099355c544bc298_D20191121-20191121",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfGoodwillBySegmentTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414031 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
     "shortName": "Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i9a385ec34dde4c0498c6601386e0ded1_I20210617",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424032 - Disclosure - Equity Method Investment (Details)",
     "role": "http://www.hologic.com/role/EquityMethodInvestmentDetails",
     "shortName": "Equity Method Investment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ia927c77ddd4b4c3f9e25433620cafd9a_I20180929",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ia927c77ddd4b4c3f9e25433620cafd9a_I20180929",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i01010a287c834b8ea30218f9d1acc450_D20201227-20210327",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "holx:DivestitureCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454033 - Disclosure - Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)",
     "role": "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail",
     "shortName": "Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i2b982302033d4608a4f3aa344d4eb809_D20190929-20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:ReductionOfWorkforceExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "icd04b96a2ff54f9fb515dc126ab745cf_I20180929",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464034 - Disclosure - Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)",
     "role": "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
     "shortName": "Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "icd04b96a2ff54f9fb515dc126ab745cf_I20180929",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474035 - Disclosure - Restructuring Charges - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
     "shortName": "Restructuring Charges - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504036 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
     "shortName": "Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514037 - Disclosure - Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
     "shortName": "Borrowings and Credit Arrangements - Debt Maturity Schedule for Components of Company's Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i08ae73b31aa74566b4be619e65396e03_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524038 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i08ae73b31aa74566b4be619e65396e03_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534039 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
     "shortName": "Borrowings and Credit Arrangements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i608d5220bab04a068eb77c0863e0e36a_D20200928-20200928",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i79503f9eb2e64b5383905a0821499fdd_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544040 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i79503f9eb2e64b5383905a0821499fdd_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564041 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574042 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i273f68028b9048b4bcb9cc44e3765361_D20181230-20190330",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "id753e6e364a144f8a4338bd5656f66cf_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584043 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails",
     "shortName": "Fair Value Measurements - Fair Value Assets and Liabilities Measured Using Unobservable Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i1169eac86c27452c96edd0243c74ad5d_I20180929",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604044 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail",
     "shortName": "Income Taxes - Income (Loss) Before Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614045 - Disclosure - Income Taxes - Provision for Income Taxes (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail",
     "shortName": "Income Taxes - Provision for Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624046 - Disclosure - Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail",
     "shortName": "Income Taxes - Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634047 - Disclosure - Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail",
     "shortName": "Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644048 - Disclosure - Income Taxes - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "id753e6e364a144f8a4338bd5656f66cf_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654049 - Disclosure - Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)",
     "role": "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail",
     "shortName": "Income Taxes - Activity of Company's Unrecognized Income Tax Benefits (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "iebdc63da66e44f02a09288f80627eb36_I20190928",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i814cfc79d9f948ac96c6d5e239cf1326_I20160613",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684050 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i814cfc79d9f948ac96c6d5e239cf1326_I20160613",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694051 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statement of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i623fe63350cc4f4bbf60f09a3b45072a_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704052 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Information Pertaining to Stock Options Granted and Related Assumptions (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Operations",
     "role": "http://www.hologic.com/role/Operations",
     "shortName": "Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714053 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Stock Option Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724054 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Restricted Stock Unit Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734055 - Disclosure - Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)",
     "role": "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
     "shortName": "Stockholders' Equity and Stock-Based Compensation - Assumptions to Value Stock Options (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ie590f16215694c4bac4c89d8d98d6e98_D20200927-20210925",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:MultiemployerPlanTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754056 - Disclosure - 401(k) Plan - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/A401kPlanAdditionalInformationDetail",
     "shortName": "401(k) Plan - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:MultiemployerPlanTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764057 - Disclosure - Deferred Compensation Plan - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail",
     "shortName": "Deferred Compensation Plan - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794058 - Disclosure - Commitments and Contingencies - Summary of Purchase Commitments (Details)",
     "role": "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails",
     "shortName": "Commitments and Contingencies - Summary of Purchase Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ib1da2069ac20464e9013c24fe294ff2d_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i8f565dc1ab5b4eb6aef305378185c37c_D20180727-20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240814059 - Disclosure - Litigation and Other Matters - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail",
     "shortName": "Litigation and Other Matters - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i8f565dc1ab5b4eb6aef305378185c37c_D20180727-20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844060 - Disclosure - Disposition - Additional Information (Details)",
     "role": "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
     "shortName": "Disposition - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "ie6a08f19521748068ae388682bbfb97b_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854061 - Disclosure - Disposition - Schedule of Disposition Related Income Statement Information (Details)",
     "role": "http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails",
     "shortName": "Disposition - Schedule of Disposition Related Income Statement Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "if0a06ee7415f46ae87de99a14fc96449_D20200927-20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884062 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
     "shortName": "Business Segments and Geographic Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210925.htm",
      "contextRef": "i982ea739818b424cbe9228324e052c58_D20200927-20210925",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 185,
   "tag": {
    "country_CR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COSTA RICA",
        "terseLabel": "Costa Rica"
       }
      }
     },
     "localname": "CR",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r809",
      "r810",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityByLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity by Location [Axis]",
        "terseLabel": "Entity by Location [Axis]"
       }
      }
     },
     "localname": "EntityByLocationAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r813"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r809",
      "r810",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A domain representing all geographic locations. Depending on the axis, it may contain members that are specific geographies, or synthetic entity-specific geographical groups.",
        "label": "Location [Domain]",
        "terseLabel": "Location [Domain]"
       }
      }
     },
     "localname": "LocationDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "holx_A2021CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Credit Agreement",
        "label": "2021 Credit Agreement [Member]",
        "terseLabel": "2021 Credit Agreement"
       }
      }
     },
     "localname": "A2021CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2021RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Revolver",
        "label": "2021 Revolver [Member]",
        "terseLabel": "2021 Revolver"
       }
      }
     },
     "localname": "A2021RevolverMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2021TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Term Loan",
        "label": "2021 Term Loan [Member]",
        "terseLabel": "2021 Term Loan"
       }
      }
     },
     "localname": "A2021TermLoanMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2025SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Senior Notes [Member]",
        "label": "2025 Senior Notes [Member]",
        "terseLabel": "2025 Senior Notes"
       }
      }
     },
     "localname": "A2025SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Senior Notes [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2029SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2029 Senior Notes",
        "label": "2029 Senior Notes [Member]",
        "terseLabel": "2029 Senior Notes"
       }
      }
     },
     "localname": "A2029SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ASRAuthorized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASR Authorized",
        "label": "ASR Authorized",
        "terseLabel": "ASR Authorized"
       }
      }
     },
     "localname": "ASRAuthorized",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ASRSharesRepurchasedduringtheperiod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASR Shares Repurchased during the period",
        "label": "ASR Shares Repurchased during the period",
        "terseLabel": "ASR Shares Repurchased during the period"
       }
      }
     },
     "localname": "ASRSharesRepurchasedduringtheperiod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountingStandardTransitionAdjustmentASU842": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting standard transition adjustment - ASU 842",
        "label": "Accounting standard transition adjustment - ASU 842",
        "terseLabel": "Accounting standard transition adjustment - ASC 842"
       }
      }
     },
     "localname": "AccountingStandardTransitionAdjustmentASU842",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountingstandardtransitionadjustmentASC606": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting standard transition adjustment - ASC 606",
        "label": "Accounting standard transition adjustment - ASC 606",
        "negatedTerseLabel": "Accounting standard transition adjustment - ASC 606"
       }
      }
     },
     "localname": "AccountingstandardtransitionadjustmentASC606",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountingstandardtransitionadjustmentASU201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting standard transition adjustment - ASU 2016-16",
        "label": "Accounting standard transition adjustment - ASU 2016-16",
        "negatedTerseLabel": "Accounting standard transition adjustment - ASU 2016-16"
       }
      }
     },
     "localname": "AccountingstandardtransitionadjustmentASU201616",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableAllowanceReduction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents reduction to the allowance for doubtful accounts primarily from collection of previously reserved accounts and the elimination of an account from the ledger accounts.",
        "label": "Accounts Receivable Allowance Reduction",
        "negatedLabel": "Write- offs and Payments"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceReduction",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableAndReservesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Policy and disclosure of accounts receivable reserves, including activity in the account for the respective periods.",
        "label": "Accounts Receivable And Reserves Policy Policy [Text Block]",
        "terseLabel": "Accounts Receivable and Reserves"
       }
      }
     },
     "localname": "AccountsReceivableAndReservesPolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_AccountsReceivableReserveDivested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable reserve divested",
        "label": "Accounts receivable reserve divested",
        "terseLabel": "Accounts receivable reserve divested"
       }
      }
     },
     "localname": "AccountsReceivableReserveDivested",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableSecuritizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Securitization [Member]",
        "label": "Accounts Receivable Securitization [Member]",
        "terseLabel": "Securitization Program"
       }
      }
     },
     "localname": "AccountsReceivableSecuritizationMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AccruedExpensesAndOtherLongTermLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Expenses And Other Long-Term Liabilities [Text Block]",
        "label": "Accrued Expenses And Other Long Term Liabilities [Text Block]",
        "terseLabel": "Accrued Expenses and Other Long-Term Liabilities"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherLongTermLiabilitiesTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_AccruedIncomeAndOtherTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued income and other taxes.",
        "label": "Accrued Income And Other Taxes",
        "terseLabel": "Income and other taxes"
       }
      }
     },
     "localname": "AccruedIncomeAndOtherTaxes",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccruedInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued interest",
        "label": "Accrued interest",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "AccruedInterest",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Loss Income Policy [Text Block]",
        "label": "Accumulated Other Comprehensive Loss Income Policy [Policy Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveLossIncomePolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_AccumulatedothercomprehensiveIncomelossHedge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive Income loss Hedge",
        "label": "Accumulated other comprehensive Income loss Hedge",
        "terseLabel": "Accumulated other comprehensive Income loss Hedge"
       }
      }
     },
     "localname": "AccumulatedothercomprehensiveIncomelossHedge",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AcessaHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acessa Health",
        "label": "Acessa Health [Member]",
        "terseLabel": "Acessa Health"
       }
      }
     },
     "localname": "AcessaHealthMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AcquiredintangibleassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired intangible assets [Member]",
        "label": "Acquired intangible assets [Member]",
        "terseLabel": "Acquired intangible assets [Member]"
       }
      }
     },
     "localname": "AcquiredintangibleassetsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AdditionalPurchaseConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional purchase consideration",
        "label": "Additional purchase consideration",
        "terseLabel": "Additional purchase consideration"
       }
      }
     },
     "localname": "AdditionalPurchaseConsideration",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AllOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other countries.",
        "label": "All Other Countries [Member]",
        "terseLabel": "Rest of world"
       }
      }
     },
     "localname": "AllOtherCountriesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AlphaImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alpha Imaging [Member]",
        "label": "Alpha Imaging [Member]",
        "terseLabel": "Alpha Imaging"
       }
      }
     },
     "localname": "AlphaImagingMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmendedCreditFacility2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Credit Facility 2018 [Member]",
        "label": "Amended Credit Facility 2018 [Member]",
        "terseLabel": "2018 Amended Credit Facility"
       }
      }
     },
     "localname": "AmendedCreditFacility2018Member",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmendedRevolver2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Revolver 2018 [Member]",
        "label": "Amended Revolver 2018 [Member]",
        "terseLabel": "2018 Amended Revolver"
       }
      }
     },
     "localname": "AmendedRevolver2018Member",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmendedTermLoan2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Term Loan 2018 [Member]",
        "label": "Amended Term Loan 2018 [Member]",
        "terseLabel": "2018 Amended Term Loan"
       }
      }
     },
     "localname": "AmendedTermLoan2018Member",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmountoflossrecognizedinothercomprehensiveincomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss recognized in other comprehensive income [Abstract]",
        "label": "Amount of loss recognized in other comprehensive income [Abstract]",
        "terseLabel": "Amount of loss recognized in other comprehensive income [Abstract]"
       }
      }
     },
     "localname": "AmountoflossrecognizedinothercomprehensiveincomeAbstract",
     "nsuri": "http://www.hologic.com/20210925",
     "xbrltype": "stringItemType"
    },
    "holx_AmountpaidduringtheperiodunderASRAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount paid during the period under ASR Agreement",
        "label": "Amount paid during the period under ASR Agreement",
        "terseLabel": "Amount paid during the period under ASR Agreement"
       }
      }
     },
     "localname": "AmountpaidduringtheperiodunderASRAgreement",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Assets And Liabilities, Lessee"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_AuthorizationDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Authorization Date [Axis]",
        "label": "Authorization Date [Domain]",
        "terseLabel": "Authorization Date [Domain]"
       }
      }
     },
     "localname": "AuthorizationDateDomain",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BedfordMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bedford [Member]",
        "label": "Bedford [Member]",
        "terseLabel": "Bedford"
       }
      }
     },
     "localname": "BedfordMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BiotheranosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biotheranostics",
        "label": "Biotheranostics [Member]",
        "terseLabel": "Biotheranostics"
       }
      }
     },
     "localname": "BiotheranosticsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BloodScreeningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blood Screening [Member]",
        "label": "Blood Screening [Member]",
        "verboseLabel": "Blood Screening"
       }
      }
     },
     "localname": "BloodScreeningMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BolderSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bolder Surgical",
        "label": "Bolder Surgical [Member]",
        "terseLabel": "Bolder Surgical"
       }
      }
     },
     "localname": "BolderSurgicalMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast health.",
        "label": "Breast Health [Member]",
        "terseLabel": "Breast Health"
       }
      }
     },
     "localname": "BreastHealthMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast Imaging [Member]",
        "label": "Breast Imaging [Member]",
        "terseLabel": "Breast Imaging"
       }
      }
     },
     "localname": "BreastImagingMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BusinessAcquisitionCashTenderOfferPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cash Tender Offer Price Per Share",
        "label": "Business Acquisition, Cash Tender Offer Price Per Share",
        "terseLabel": "Cash tender offer price per share"
       }
      }
     },
     "localname": "BusinessAcquisitionCashTenderOfferPricePerShare",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "holx_BusinessCombinationAdditionalSharesAcquiredShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Additional Shares Acquired, Shares",
        "label": "Business Combination, Additional Shares Acquired, Shares",
        "terseLabel": "Additional outstanding shares purchased (in shares)"
       }
      }
     },
     "localname": "BusinessCombinationAdditionalSharesAcquiredShares",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_BusinessCombinationAdditionalSharesAcquiredValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Additional Shares Acquired, Value",
        "label": "Business Combination, Additional Shares Acquired, Value",
        "terseLabel": "Additional outstanding shares purchased, amount"
       }
      }
     },
     "localname": "BusinessCombinationAdditionalSharesAcquiredValue",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "terseLabel": "Portion allocable to equity method investment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "terseLabel": "Portion allocable to fair value of noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "terseLabel": "Portion allocable to loan repaymnet"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "terseLabel": "Portion allocable to newly acquired shares"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Ownership Percentage",
        "label": "Business Combination, Ownership Percentage",
        "terseLabel": "Ownership of outstanding shares (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationOwnershipPercentage",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Period for Payment of Contingent Consideration Liability",
        "label": "Business Combination, Period for Payment of Contingent Consideration Liability",
        "terseLabel": "Payment period for contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationPeriodforPaymentofContingentConsiderationLiability",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Decrease In Research And Development In Process",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Decrease In Research And Development In Process",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Decrease In Research And Development In Process"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDecreaseInResearchAndDevelopmentInProcess",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "negatedTerseLabel": "Short and long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "terseLabel": "Fair value, discount rate"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationSharesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Shares Acquired",
        "label": "Business Combination, Shares Acquired",
        "terseLabel": "Acquired shares"
       }
      }
     },
     "localname": "BusinessCombinationSharesAcquired",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_BusinessLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business licenses.",
        "label": "Business Licenses [Member]",
        "terseLabel": "Business licenses"
       }
      }
     },
     "localname": "BusinessLicensesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalEquipmentComponentsandSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Equipment, Components and Software [Member]",
        "label": "Capital Equipment, Components and Software [Member]",
        "terseLabel": "Capital equipment, components and software"
       }
      }
     },
     "localname": "CapitalEquipmentComponentsandSoftwareMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalizedsoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software [Member]",
        "label": "Capitalized software [Member]",
        "terseLabel": "Capitalized software [Member]"
       }
      }
     },
     "localname": "CapitalizedsoftwareMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CashEquivalentsMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time from the date of acquisition for liquid investments in debt securities to be categorized as cash in the consolidated balance sheet.",
        "label": "Cash Equivalents Maturity Period",
        "terseLabel": "Cash Equivalents Maturity Period"
       }
      }
     },
     "localname": "CashEquivalentsMaturityPeriod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_CashSeverancePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance payments.",
        "label": "Cash Severance Payments",
        "negatedLabel": "Severance payments and adjustments"
       }
      }
     },
     "localname": "CashSeverancePayments",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ChangeInParValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in par value",
        "label": "Change in par value",
        "terseLabel": "Change in par value"
       }
      }
     },
     "localname": "ChangeInParValue",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CompanyVs.MinervaSurgicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Company Vs. Minerva Surgical, Inc. [Member]",
        "label": "Company Vs. Minerva Surgical, Inc. [Member]",
        "terseLabel": "Company Vs. Minerva Surgical, Inc."
       }
      }
     },
     "localname": "CompanyVs.MinervaSurgicalInc.Member",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ComponentsofNetPeriodicBenefitCostInterestcost": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of Net Periodic Benefit Cost, Interest cost",
        "label": "Components of Net Periodic Benefit Cost, Interest cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "ComponentsofNetPeriodicBenefitCostInterestcost",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ComprehensiveIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome_1": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Comprehensive Income",
        "label": "Comprehensive Income",
        "terseLabel": "Comprehensive income (loss) attributable to Hologic"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration",
        "label": "contingent consideration [Member]",
        "terseLabel": "contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentHoldbackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Holdback [Member]",
        "label": "Contingent Holdback [Member]",
        "terseLabel": "Holdback"
       }
      }
     },
     "localname": "ContingentHoldbackMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CostMethodEquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate carrying value of the Company's cost-method investments at the balance sheet date.",
        "label": "Cost Method Equity Investments",
        "terseLabel": "Cost-method equity investments"
       }
      }
     },
     "localname": "CostMethodEquityInvestments",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CostOfGoodsSoldImpairmentOfIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.",
        "label": "Cost Of Goods Sold Impairment Of Intangible Assets",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "CostOfGoodsSoldImpairmentOfIntangibleAssets",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the costs comprising costs of service and other revenues.",
        "label": "Cost Of Service And Other Revenues Policy [Policy Text Block]",
        "terseLabel": "Cost of Service and Other Revenues"
       }
      }
     },
     "localname": "CostOfServiceAndOtherRevenuesPolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_CreditAgreement2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement 2017 [Member]",
        "label": "Credit Agreement 2017 [Member]",
        "terseLabel": "2017 Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreement2017Member",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CreditAgreement2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement 2018 [Member]",
        "label": "Credit Agreement 2018 [Member]",
        "terseLabel": "2018 Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreement2018Member",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit agreement.",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CreditAgreementPriorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement Prior [Member]",
        "label": "Credit Agreement Prior [Member]",
        "terseLabel": "Prior Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementPriorMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CustomerRelationshipsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationships contracts.",
        "label": "Customer Relationships Contracts [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsContractsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CynosureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cynosure [Member]",
        "label": "Cynosure [Member]",
        "terseLabel": "Cynosure"
       }
      }
     },
     "localname": "CynosureMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CytologyPerinatalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cytology &amp; Perinatal [Member]",
        "label": "Cytology &amp; Perinatal [Member]",
        "terseLabel": "Cytology &amp; Perinatal"
       }
      }
     },
     "localname": "CytologyPerinatalMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DebtInstrumentCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Commitment Fee, Percentage",
        "label": "Debt Instrument, Commitment Fee, Percentage",
        "terseLabel": "Debt Instrument, Commitment Fee, Percentage"
       }
      }
     },
     "localname": "DebtInstrumentCommitmentFeePercentage",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments",
        "label": "Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments",
        "terseLabel": "Debt Instrument, Estimated Due At Maturity After Scheduled Principal Payments"
       }
      }
     },
     "localname": "DebtInstrumentEstimatedDueAtMaturityAfterScheduledPrincipalPayments",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DebtInstrumentNumberOfInstruments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number Of Instruments",
        "label": "Debt Instrument, Number Of Instruments",
        "terseLabel": "Number of debt instruments"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfInstruments",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "holx_DebtInstrumentOfferingPricePercentOfFaceValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Offering Price, Percent Of Face Value",
        "label": "Debt Instrument, Offering Price, Percent Of Face Value",
        "terseLabel": "Offering price, percent of face value"
       }
      }
     },
     "localname": "DebtInstrumentOfferingPricePercentOfFaceValue",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Percentage Of Redemption Price Fifth Period",
        "label": "Debt Instrument Percentage Of Redemption Price Fifth Period",
        "terseLabel": "Percentage of redemption price, fifth period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfRedemptionPriceFifthPeriod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Percentage Of Redemption Price Fourth Period",
        "label": "Debt Instrument Percentage Of Redemption Price Fourth Period",
        "terseLabel": "Percentage of redemption price, fourth period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfRedemptionPriceFourthPeriod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Percentage Of Redemption Price Second Period",
        "label": "Debt Instrument Percentage Of Redemption Price Second Period",
        "terseLabel": "Percentage of redemption price, second period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfRedemptionPriceSecondPeriod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Percentage Of Redemption Price Third Period",
        "label": "Debt Instrument Percentage Of Redemption Price Third Period",
        "terseLabel": "Percentage of redemption price, third period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageOfRedemptionPriceThirdPeriod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Percentage Redemption Price Sixth Period",
        "label": "Debt Instrument Percentage Redemption Price Sixth Period",
        "terseLabel": "Percentage redemption price, sixth period"
       }
      }
     },
     "localname": "DebtInstrumentPercentageRedemptionPriceSixthPeriod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_DebtInstrumentPeriodicPaymentPrincipalPerQuarter": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Principal Per Quarter",
        "label": "Debt Instrument, Periodic Payment, Principal Per Quarter",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal Per Quarter"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipalPerQuarter",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DebtRedemptionPremiumPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption, Premium Paid",
        "label": "Debt Redemption, Premium Paid",
        "terseLabel": "Debt Redemption, Premium Paid"
       }
      }
     },
     "localname": "DebtRedemptionPremiumPaid",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Dec112019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dec 11, 2019",
        "label": "Dec 11, 2019 [Member]",
        "terseLabel": "Dec 11, 2019 [Member]"
       }
      }
     },
     "localname": "Dec112019Member",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Dec92020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dec 9, 2020",
        "label": "Dec 9, 2020 [Member]",
        "terseLabel": "Dec 9, 2020"
       }
      }
     },
     "localname": "Dec92020Member",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DecreaseindeferredtaxliabilitiesduetoASC201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in deferred tax liabilities due to ASC 2016-16",
        "label": "Decrease in deferred tax liabilities due to ASC 2016-16",
        "terseLabel": "Decrease in deferred tax liabilities due to ASU 2016-16"
       }
      }
     },
     "localname": "DecreaseindeferredtaxliabilitiesduetoASC201616",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets lease liability",
        "label": "Deferred tax assets lease liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiability",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsNonqualifiedDeferredCompensationPlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tax effect as of the balance sheet date of the amount of future tax deductions arising from the Company's nonqualified deferred compensation plan.",
        "label": "Deferred Tax Assets Nonqualified Deferred Compensation Plan",
        "terseLabel": "Nonqualified deferred compensation plan"
       }
      }
     },
     "localname": "DeferredTaxAssetsNonqualifiedDeferredCompensationPlan",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of federal net operating losses the company believes will expire unutilized.",
        "label": "Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Federal",
        "terseLabel": "Federal net operating loss expected to be expired unutilized"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedFederal",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign",
        "label": "Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized Foreign",
        "terseLabel": "Foreign net operating loss expected to be expired unutilized"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedForeign",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of state net operating losses the company believes will expire unutilized.",
        "label": "Deferred Tax Assets Operating Loss Carry Forwards That Will Expire Unutilized State",
        "terseLabel": "State net operating loss expected to be expired unutilized"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryForwardsThatWillExpireUnutilizedState",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount as of the balance sheet date of the estimated future tax effects attributable to amortization of intangible assets, and to a lesser extent, depreciation of property and equipment.",
        "label": "Deferred Tax Liabilities Depreciation And Amortization",
        "negatedLabel": "Depreciation\u00a0and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DeferredTaxLiabilitiesRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities right of use asset",
        "label": "Deferred Tax Liabilities right of use asset",
        "negatedTerseLabel": "Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAsset",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount",
        "label": "Defined Benefit Plan Actuarial Net Gains Losses Net Of Tax Amount",
        "terseLabel": "Actuarial gain (loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialNetGainsLossesNetOfTaxAmount",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DepartmentOfDefenseFundsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Department of defense funds received",
        "label": "Department of defense funds received",
        "terseLabel": "Department of defense funds received"
       }
      }
     },
     "localname": "DepartmentOfDefenseFundsReceived",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology.",
        "label": "Developed Technology [Member]",
        "terseLabel": "Developed Technology"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagenodeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagenode",
        "label": "Diagenode [Member]",
        "terseLabel": "Diagenode"
       }
      }
     },
     "localname": "DiagenodeMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics.",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Final Sales Price",
        "label": "Disposal Group, Including Discontinued Operation, Final Sales Price",
        "terseLabel": "Final sales price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationFinalSalesPrice",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]",
        "label": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement [Abstract]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementAbstract",
     "nsuri": "http://www.hologic.com/20210925",
     "xbrltype": "stringItemType"
    },
    "holx_DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]",
        "label": "Disposal Groups, Including Discontinued Operations and Collaborative Agreement, Disclosure [Text Block]",
        "terseLabel": "Disposition"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsandCollaborativeAgreementDisclosureTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/Disposition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_DistributionagreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution agreement [Member]",
        "label": "Distribution agreement [Member]",
        "terseLabel": "Distribution agreement [Member]"
       }
      }
     },
     "localname": "DistributionagreementMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DivestitureCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail": {
       "order": 3.0,
       "parentTag": "holx_RestructuringChargesUnderExitOrDisposalPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divestiture charges",
        "label": "Divestiture charges",
        "terseLabel": "Divestiture charges"
       }
      }
     },
     "localname": "DivestitureCharges",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Line Items]",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Table]",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation benefit expense research and development.",
        "label": "Effective Income Tax Rate Reconciliation Benefit Expense Research And Development",
        "negatedLabel": "Tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationBenefitExpenseResearchAndDevelopment",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to the difference in the deductibility or nondeductibility of executive compensation (i.e., those subject to Section 162(m) limitations), including equity-based compensation and salary and bonus compensation.",
        "label": "Effective Income Tax Rate Reconciliation Non Deductible Expense Executive Compensation Cost",
        "terseLabel": "Compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseExecutiveCompensationCost",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the difference between the effective income tax rate and domestic federal statutory income tax rate attributable to changes in unrecognized tax benefits recorded in the statement of operations",
        "label": "Effective Income Tax Rate Reconciliation Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationUnrecognizedTaxBenefits",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 13.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax reconciliation loss on sale of Cynosure",
        "label": "Effective income tax reconciliation loss on sale of Cynosure",
        "negatedTerseLabel": "Loss on sale of Cynosure"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationLossOnSaleOfCynosure",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EmployeeContributionsVestedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee contributions vested, percentage.",
        "label": "Employee Contributions Vested Percentage",
        "terseLabel": "Employee contributions vested, percentage"
       }
      }
     },
     "localname": "EmployeeContributionsVestedPercentage",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member].",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EmployerContributionsPercentVestedAnnually": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employer Contributions, Percent Vested Annually",
        "label": "Employer Contributions, Percent Vested Annually",
        "terseLabel": "Percent vested annually"
       }
      }
     },
     "localname": "EmployerContributionsPercentVestedAnnually",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_EmployerContributionsVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The vesting period for discretionary employer contributions, which vest ratably on an annual basis.",
        "label": "Employer Contributions Vesting Period",
        "terseLabel": "Contributions, vesting period, years"
       }
      }
     },
     "localname": "EmployerContributionsVestingPeriod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_EquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment And Software [Member]",
        "label": "Equipment And Software [Member]",
        "terseLabel": "Equipment and Software [Member]"
       }
      }
     },
     "localname": "EquipmentAndSoftwareMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EquipmentUnderCustomerUsageAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment Under Customer Usage Agreement [Member]",
        "label": "Equipment Under Customer Usage Agreement [Member]",
        "terseLabel": "Equipment Under Customer Usage Agreements [Member]"
       }
      }
     },
     "localname": "EquipmentUnderCustomerUsageAgreementMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Equipment Under Customer Usage Agreements",
        "terseLabel": "Equipment Under Customer Usage Agreements"
       }
      }
     },
     "localname": "EquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_EurocurrencyRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eurocurrency Rate",
        "label": "Eurocurrency Rate [Member]",
        "terseLabel": "Eurocurrency Rate"
       }
      }
     },
     "localname": "EurocurrencyRateMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Expensesfromdisposition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses from disposition",
        "label": "Expenses from disposition",
        "terseLabel": "Expenses from disposition"
       }
      }
     },
     "localname": "Expensesfromdisposition",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_FacilityClosureCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail": {
       "order": 2.0,
       "parentTag": "holx_RestructuringChargesUnderExitOrDisposalPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.",
        "label": "Facility Closure Costs",
        "terseLabel": "Facility closure costs"
       }
      }
     },
     "localname": "FacilityClosureCosts",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_FinanceLeaseObligationsLongTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Obligations - Long Term [Member]",
        "label": "Finance Lease Obligations - Long Term [Member]",
        "terseLabel": "Finance lease obligations - long term"
       }
      }
     },
     "localname": "FinanceLeaseObligationsLongTermMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FinanceLeaseObligationsShortTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Obligations - Short Term [Member]",
        "label": "Finance Lease Obligations - Short Term [Member]",
        "terseLabel": "Finance lease obligations - short term"
       }
      }
     },
     "localname": "FinanceLeaseObligationsShortTermMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FinanceLeaseRightOfUseAssetAtAdoptionOf842": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance lease, right of use asset at adoption of 842",
        "label": "Finance lease, right of use asset at adoption of 842",
        "terseLabel": "Finance lease, right of use asset at adoption of 842"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAtAdoptionOf842",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Fiscal2018ActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal 2018 Action [Member]",
        "label": "Fiscal 2018 Action [Member]",
        "terseLabel": "Fiscal 2018 Actions"
       }
      }
     },
     "localname": "Fiscal2018ActionMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2019ActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal 2019 Action [Member]",
        "label": "Fiscal 2019 Action [Member]",
        "terseLabel": "Fiscal 2019 Actions",
        "verboseLabel": "Fiscal 2019 Actions"
       }
      }
     },
     "localname": "Fiscal2019ActionMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2019chargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal 2019 charges",
        "label": "Fiscal 2019 charges [Member]",
        "terseLabel": "Fiscal 2019 restructuring charges"
       }
      }
     },
     "localname": "Fiscal2019chargesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2020ActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal 2020 Action",
        "label": "Fiscal 2020 Action [Member]",
        "terseLabel": "Fiscal 2020 Actions"
       }
      }
     },
     "localname": "Fiscal2020ActionMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2020ChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal 2020 charges",
        "label": "Fiscal 2020 charges [Member]",
        "terseLabel": "Fiscal 2020 restructuring charges"
       }
      }
     },
     "localname": "Fiscal2020ChargesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2021ActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal 2021 Action",
        "label": "Fiscal 2021 Action [Member]",
        "terseLabel": "Fiscal 2021 Actions"
       }
      }
     },
     "localname": "Fiscal2021ActionMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Fiscal2021ChargesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal 2021 charges",
        "label": "Fiscal 2021 charges [Member]",
        "terseLabel": "Fiscal 2021 restructuring charges"
       }
      }
     },
     "localname": "Fiscal2021ChargesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FocalTherapeuticsInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Focal Therapeutics, Inc. [Member]",
        "label": "Focal Therapeutics, Inc. [Member]",
        "terseLabel": "Focal Therapeutics"
       }
      }
     },
     "localname": "FocalTherapeuticsInc.Member",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_FundingOfLoansToSSI": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loans to SSI",
        "label": "Funding Of Loans To SSI",
        "negatedTerseLabel": "Loans to SSI"
       }
      }
     },
     "localname": "FundingOfLoansToSSI",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GeographicInformationForPropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographic Information For Property Plant And Equipment [Line Items]",
        "label": "Geographic Information For Property Plant And Equipment [Line Items]",
        "terseLabel": "Geographic Information For Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "GeographicInformationForPropertyPlantAndEquipmentLineItems",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_GeographicInformationForPropertyPlantAndEquipmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographic Information For Property Plant And Equipment [Table]",
        "label": "Geographic Information For Property Plant And Equipment [Table]",
        "terseLabel": "Geographic Information For Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "GeographicInformationForPropertyPlantAndEquipmentTable",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_GoodwillNotAtRiskOfFailingImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill not at risk of failing impairment",
        "label": "Goodwill not at risk of failing impairment",
        "terseLabel": "Goodwill not at risk of failing impairment"
       }
      }
     },
     "localname": "GoodwillNotAtRiskOfFailingImpairment",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GrantsReceivedFromDepartmentOfDefense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grants received from Department of defense",
        "label": "Grants received from Department of defense",
        "terseLabel": "Grants received from Department of defense"
       }
      }
     },
     "localname": "GrantsReceivedFromDepartmentOfDefense",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GrossForeignLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross foreign loss carryforwards",
        "label": "Gross foreign loss carryforwards",
        "terseLabel": "Gross foreign loss carryforwards"
       }
      }
     },
     "localname": "GrossForeignLossCarryforwards",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GrossStateLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross state loss carryforwards",
        "label": "Gross state loss carryforwards",
        "terseLabel": "Gross state loss carryforwards"
       }
      }
     },
     "localname": "GrossStateLossCarryforwards",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GrossUnrecognizedTaxBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total unrecognized tax benefits, including interest, that if recognized would result in a reduction to the effective tax rate.",
        "label": "Gross Unrecognized Tax Benefits",
        "terseLabel": "Gross unrecognized tax benefits, excluding interest"
       }
      }
     },
     "localname": "GrossUnrecognizedTaxBenefits",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GynSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GYN surgical.",
        "label": "Gyn Surgical [Member]",
        "terseLabel": "Gyn Surgical [Member]"
       }
      }
     },
     "localname": "GynSurgicalMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_HealthBeaconsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Beacons [Member]",
        "label": "Health Beacons [Member]",
        "terseLabel": "Health Beacons"
       }
      }
     },
     "localname": "HealthBeaconsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Holdback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Holdback",
        "label": "Holdback",
        "terseLabel": "Holdback"
       }
      }
     },
     "localname": "Holdback",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Impairmentofintangibleassetsandequipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment of intangible assets and equipment",
        "label": "Impairment of intangible assets and equipment",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "Impairmentofintangibleassetsandequipment",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IncomeTaxReceivableReclassification": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Receivable Reclassification",
        "label": "Income Tax Receivable Reclassification",
        "negatedTerseLabel": "Income Tax Receivable Reclassification"
       }
      }
     },
     "localname": "IncomeTaxReceivableReclassification",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_IncreasetoEarningsperShareresultedfromadoptionofASC201616": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase to Earnings per Share resulted from adoption of ASC 2016-16",
        "label": "Increase to Earnings per Share resulted from adoption of ASC 2016-16",
        "terseLabel": "Increase to Earnings per Share resulted from adoption of ASU 2016-16"
       }
      }
     },
     "localname": "IncreasetoEarningsperShareresultedfromadoptionofASC201616",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "holx_IncreasetoNetIncomeresultedfromadoptionofASU201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase to Net Income resulted from adoption of ASU 2016-16",
        "label": "Increase to Net Income resulted from adoption of ASU 2016-16",
        "terseLabel": "Increase to Net Income resulted from adoption of ASU 2016-16"
       }
      }
     },
     "localname": "IncreasetoNetIncomeresultedfromadoptionofASU201616",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IncreasetoincometaxexpenseadoptionofASU201616": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase to income tax expense adoption of ASU 2016-16",
        "label": "Increase to income tax expense adoption of ASU 2016-16",
        "terseLabel": "Increase to income tax expense adoption of ASU 2016-16"
       }
      }
     },
     "localname": "IncreasetoincometaxexpenseadoptionofASU201616",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IndemnificationLiabily": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification liabily",
        "label": "Indemnification liabily",
        "terseLabel": "Indemnification liabily"
       }
      }
     },
     "localname": "IndemnificationLiabily",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InterestCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Coverage Ratio",
        "label": "Interest Coverage Ratio",
        "terseLabel": "Interest coverage ratio"
       }
      }
     },
     "localname": "InterestCoverageRatio",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_InterestRateCapAgreementsAggregatePremiumPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate cap agreements aggregate premium payable.",
        "label": "Interest Rate Cap Agreements Aggregate Premium Payable",
        "negatedTerseLabel": "Purchase of interest rate caps",
        "terseLabel": "Purchase of interest rate caps"
       }
      }
     },
     "localname": "InterestRateCapAgreementsAggregatePremiumPayable",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InternalusesoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internal-use software [Member]",
        "label": "Internal-use software [Member]",
        "terseLabel": "Internal-use software [Member]"
       }
      }
     },
     "localname": "InternalusesoftwareMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InterventionalBreastSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional Breast Solutions [Member]",
        "label": "Interventional Breast Solutions [Member]",
        "terseLabel": "Interventional Breast Solutions"
       }
      }
     },
     "localname": "InterventionalBreastSolutionsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InvestmentInGroupLifeInsuranceContracts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash surrender value of group life insurance contracts at the balance sheet date.",
        "label": "Investment In Group Life Insurance Contracts",
        "terseLabel": "Investment in group life insurance contracts"
       }
      }
     },
     "localname": "InvestmentInGroupLifeInsuranceContracts",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_June132019PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 13, 2019 Plan [Member]",
        "label": "June 13, 2019 Plan [Member]",
        "terseLabel": "June 13, 2019 Plan [Member]"
       }
      }
     },
     "localname": "June132019PlanMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_LeaseReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Receivable",
        "label": "Lease Receivable",
        "terseLabel": "Lease receivable"
       }
      }
     },
     "localname": "LeaseReceivable",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_LeaseRevenuePercentageOfTotalRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Revenue, Percentage Of Total Revenue",
        "label": "Lease Revenue, Percentage Of Total Revenue",
        "terseLabel": "Lease revenue as a percentage of total"
       }
      }
     },
     "localname": "LeaseRevenuePercentageOfTotalRevenue",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LegalAccrual": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Accrual",
        "label": "Legal Accrual",
        "terseLabel": "Legal Accrual"
       }
      }
     },
     "localname": "LegalAccrual",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_LesseeFinanceLeaseBargainPurchaseOptionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Finance Lease, Bargain Purchase Option, Percentage",
        "label": "Lessee, Finance Lease, Bargain Purchase Option, Percentage",
        "terseLabel": "Lessee, Finance Lease, Bargain Purchase Option, Percentage"
       }
      }
     },
     "localname": "LesseeFinanceLeaseBargainPurchaseOptionPercentage",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating And Finance Lease, Period With Option To Terminate",
        "label": "Lessee, Operating And Finance Lease, Period With Option To Terminate",
        "terseLabel": "Period with option to terminate lease"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasePeriodWithOptionToTerminate",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_LesseeOperatingAndFinanceLeaseRemainingLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating And Finance Lease, Remaining Lease Term",
        "label": "Lessee, Operating And Finance Lease, Remaining Lease Term",
        "terseLabel": "Lessee, operating and finance lease, remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeaseRemainingLeaseTerm",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_LesseeOperatingAndFinanceLeasesExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating And Finance Leases, Extension Period",
        "label": "Lessee, Operating And Finance Leases, Extension Period",
        "terseLabel": "Extension period"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesExtensionPeriod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent",
        "label": "Lessee, Operating And Finance Leases, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesWeightedAverageDiscountRatePercent",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Maximum",
        "label": "Leverage Ratio Maximum",
        "terseLabel": "Leverage ratio maximum"
       }
      }
     },
     "localname": "LeverageRatioMaximum",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LitigationAndOtherMattersTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation And Other Matters [Text Block]",
        "label": "Litigation And Other Matters [Text Block]",
        "terseLabel": "Litigation and Related Matters"
       }
      }
     },
     "localname": "LitigationAndOtherMattersTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LitigationandRelatedMatters"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_LongLivedAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Lived Assets Policy [Text Block]",
        "label": "Long Lived Assets Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "LongLivedAssetsPolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_LongTermDebtObligationsWithoutConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt obligations without convertible notes.",
        "label": "Long Term Debt Obligations Without Convertible Notes",
        "terseLabel": "Long term debt obligations. excluding convertible notes"
       }
      }
     },
     "localname": "LongTermDebtObligationsWithoutConvertibleNotes",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ManufacturingEquipmentAndSoftware": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.",
        "label": "Manufacturing Equipment And Software",
        "terseLabel": "Manufacturing Equipment And Software"
       }
      }
     },
     "localname": "ManufacturingEquipmentAndSoftware",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MarketBasedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Based Stock Units [Member]",
        "label": "Market Based Stock Units [Member]",
        "terseLabel": "Market Based Stock Units"
       }
      }
     },
     "localname": "MarketBasedStockUnitsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MaximumBorrowingUnderSecuritizationProgram": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing under securitization program",
        "label": "Maximum Borrowing Under Securitization Program",
        "terseLabel": "Maximum borrowing under securitization program"
       }
      }
     },
     "localname": "MaximumBorrowingUnderSecuritizationProgram",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum employee contributions from annual bonus percentage to dcp.",
        "label": "Maximum Employee Contributions From Annual Bonus Percentage To Dcp",
        "terseLabel": "Maximum employee contributions from annual bonus, percentage"
       }
      }
     },
     "localname": "MaximumEmployeeContributionsFromAnnualBonusPercentageToDcp",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum employee contributions from base salary percentage to dcp.",
        "label": "Maximum Employee Contributions From Base Salary Percentage To Dcp",
        "terseLabel": "Maximum employee contributions from base salary, percentage"
       }
      }
     },
     "localname": "MaximumEmployeeContributionsFromBaseSalaryPercentageToDcp",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MaximumRangeofPresentValueofCashFlowPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Range of Present Value of Cash Flow Percentage",
        "label": "Maximum Range of Present Value of Cash Flow Percentage",
        "terseLabel": "Maximum range of present value of cash flow (percent)"
       }
      }
     },
     "localname": "MaximumRangeofPresentValueofCashFlowPercentage",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum target number percentage of shares issued based on stock performance.",
        "label": "Maximum Target Number Of Shares Issued Based On Stock Performance In Percent",
        "terseLabel": "Maximum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MedicalAestheticsBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Aesthetics Business [Member]",
        "label": "Medical Aesthetics Business [Member]",
        "terseLabel": "Medical Aesthetics Business"
       }
      }
     },
     "localname": "MedicalAestheticsBusinessMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MedicalAestheticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Aesthetics [Member]",
        "label": "Medical Aesthetics [Member]",
        "terseLabel": "Medical Aesthetics"
       }
      }
     },
     "localname": "MedicalAestheticsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum target number percentage of shares that would be issued based on stock price performance.",
        "label": "Minimum Target Number Of Shares Issued On Stock Performance In Percent",
        "terseLabel": "Minimum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MobidiagOyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mobidiag Oy",
        "label": "Mobidiag Oy [Member]",
        "terseLabel": "Mobidiag Oy"
       }
      }
     },
     "localname": "MobidiagOyMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MolecularDiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular Diagnostics [Member]",
        "label": "Molecular Diagnostics [Member]",
        "terseLabel": "Molecular Diagnostics"
       }
      }
     },
     "localname": "MolecularDiagnosticsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_NXCImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NXC Imaging",
        "label": "NXC Imaging [Member]",
        "terseLabel": "NXC Imaging"
       }
      }
     },
     "localname": "NXCImagingMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss and tax credit carry forwards with unlimited expiration period.",
        "label": "Net Operating Loss And Tax Credit Carryforwards With Unlimited Expiration Period",
        "terseLabel": "Amount with unlimited carry forward periods"
       }
      }
     },
     "localname": "NetOperatingLossAndTaxCreditCarryforwardsWithUnlimitedExpirationPeriod",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NetOperatingLossCarryforwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Operating Loss Carryforwards [Member]",
        "label": "Net Operating Loss Carryforwards [Member]",
        "terseLabel": "Net Operating Losses Carryforwards"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_NonIncomeTaxLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Income Tax Loss",
        "label": "Non-Income Tax Loss",
        "terseLabel": "Non-income tax loss"
       }
      }
     },
     "localname": "NonIncomeTaxLoss",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NonqualifiedDeferredCompensationPlanAnnualContribution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonqualified deferred compensation plan annual contribution.",
        "label": "Nonqualified Deferred Compensation Plan Annual Contribution",
        "terseLabel": "Compensation expense for the DCP discretionary contributions"
       }
      }
     },
     "localname": "NonqualifiedDeferredCompensationPlanAnnualContribution",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NotionalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notional Amount",
        "label": "Notional Amount",
        "terseLabel": "Notional Amount"
       }
      }
     },
     "localname": "NotionalAmount",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of customers with balance greater than specified percentage.",
        "label": "Number Of Customers With Balance Greater Than Specified Percentage",
        "terseLabel": "Number of customers with balance greater than specified percentage"
       }
      }
     },
     "localname": "NumberOfCustomersWithBalanceGreaterThanSpecifiedPercentage",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "holx_NumberOfFinanceLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Finance Leases",
        "label": "Number Of Finance Leases",
        "terseLabel": "Number of finance leases"
       }
      }
     },
     "localname": "NumberOfFinanceLeases",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "holx_NumberOfSharesIssuableUnderEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuable under employee stock purchase plan.",
        "label": "Number Of Shares Issuable Under Employee Stock Purchase Plan",
        "terseLabel": "Number of shares that may be issued under Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "NumberOfSharesIssuableUnderEmployeeStockPurchasePlan",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_OneCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Customer",
        "label": "One Customer [Member]",
        "terseLabel": "One Customer"
       }
      }
     },
     "localname": "OneCustomerMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_OneThirdAnnuallyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Third Annually [Member]",
        "label": "One Third Annually [Member]",
        "terseLabel": "One Third Annually [Member]"
       }
      }
     },
     "localname": "OneThirdAnnuallyMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability",
        "label": "Operating And Finance Lease, Total Cash Paid For Amounts Included In Measurement Of Lease Liability",
        "totalLabel": "Total cash paid for amounts included in the measurement of lease liabilities"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OperatingLeaseRightOfUseAssetAtAdoptionOf842": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease, right of use asset at adoption of 842",
        "label": "Operating lease, right of use asset at adoption of 842",
        "terseLabel": "Operating lease, right of use asset at adoption of 842"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAtAdoptionOf842",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Assets Policy [Text Block]",
        "label": "Other Assets Policy [Policy Text Block]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsPolicyPolicyTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI",
        "terseLabel": "Changes in foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationadjustmentnettaxexcludingamountsreclassifiedfromAOCI",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Reclass Adj. from AOCI on Derivatives, Net of Tax",
        "label": "Other Comprehensive Income (Loss), Reclass Adj. from AOCI on Derivatives, Net of Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassAdjFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherGeographicRegionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Geographic Regions [Member]",
        "label": "Other Geographic Regions [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "OtherGeographicRegionsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_OtherOperatingCostReductionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other operating cost reductions.",
        "label": "Other Operating Cost Reductions [Member]",
        "terseLabel": "Previous Other Charges"
       }
      }
     },
     "localname": "OtherOperatingCostReductionsMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_OtherRestructuringPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to settle other restructuring charges.",
        "label": "Other Restructuring Payments",
        "negatedLabel": "Other payments"
       }
      }
     },
     "localname": "OtherRestructuringPayments",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherTypeofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Type of Revenue [Member]",
        "label": "Other Type of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherTypeofRevenueMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_OtheractionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other action [Member]",
        "label": "Other action [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtheractionMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PSUFreeCashFlowMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PSU Free Cash Flow [Member]",
        "label": "PSU Free Cash Flow [Member]",
        "terseLabel": "PSU Free Cash Flow [Member]"
       }
      }
     },
     "localname": "PSUFreeCashFlowMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.",
        "label": "Payment For Tax Withholding Related To Vested And Released Restricted Stock Units",
        "negatedTerseLabel": "Payment of minimum tax withholdings on net share settlements of equity awards"
       }
      }
     },
     "localname": "PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsForDeferredAcquisitionConsideration": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Deferred Acquisition Consideration",
        "label": "Payments For Deferred Acquisition Consideration",
        "terseLabel": "Payments for Previous Acquisition"
       }
      }
     },
     "localname": "PaymentsForDeferredAcquisitionConsideration",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Payments To Manufacture Equipment Under Customer Usage Agreements",
        "negatedLabel": "Increase in equipment under customer usage agreements"
       }
      }
     },
     "localname": "PaymentsToManufactureEquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsUnderFinanceLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments under finance lease obligations",
        "label": "Payments under finance lease obligations",
        "terseLabel": "Payments under finance lease obligations"
       }
      }
     },
     "localname": "PaymentsUnderFinanceLeaseObligations",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PensioninAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension in Accumulated Other Comprehensive Income [Member]",
        "label": "Pension in Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Pension in Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "PensioninAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of award vested upon meeting defined market based criteria",
        "label": "Percentage Of Award Vested Upon Meeting Defined Market Based Criteria",
        "terseLabel": "Percentage of award vested upon meeting defined market based criteria"
       }
      }
     },
     "localname": "PercentageOfAwardVestedUponMeetingDefinedMarketBasedCriteria",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage applied to the lower of the common stock price at the beginning of the plan period and end of the plan period to determine the number of shares to be issued under the employee stock purchase plan.",
        "label": "Percentage Of Purchase Price Of Common Stock Lower Than Fair Market Value Of Common Stock On Date Of Purchase",
        "terseLabel": "Percentage of common stock price for ESPP"
       }
      }
     },
     "localname": "PercentageOfPurchasePriceOfCommonStockLowerThanFairMarketValueOfCommonStockOnDateOfPurchase",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentageOfRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenues.",
        "label": "Percentage Of Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "PercentageOfRevenues",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of restricted stock units that vest annually per the terms of the typical restricted stock unit grant arrangement.",
        "label": "Percentage Of Vesting For Restricted Stock Units Granted To Employees",
        "terseLabel": "Percentage of vesting for RSUs granted to employees"
       }
      }
     },
     "localname": "PercentageOfVestingForRestrictedStockUnitsGrantedToEmployees",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentageOfVestingForStockOptionsGrantedToEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of stock options that vest annually per the terms of the typical stock option grant arrangement.",
        "label": "Percentage Of Vesting For Stock Options Granted To Employees",
        "terseLabel": "Percentage of vesting for stock options granted to employees"
       }
      }
     },
     "localname": "PercentageOfVestingForStockOptionsGrantedToEmployees",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Price of Principal Amount for Repurchase of Senior Notes",
        "label": "Percentage Price of Principal Amount for Repurchase of Senior Notes",
        "terseLabel": "Percentage price of principal amount for repurchase of senior notes"
       }
      }
     },
     "localname": "PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PrincipalAmountOfBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.",
        "label": "Principal Amount Of Borrowings",
        "terseLabel": "Principal amount of borrowings",
        "verboseLabel": "Borrowed principal under credit agreement"
       }
      }
     },
     "localname": "PrincipalAmountOfBorrowings",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProceedsfromSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Senior Notes",
        "label": "Proceeds from Senior Notes",
        "terseLabel": "Proceeds from Senior Notes"
       }
      }
     },
     "localname": "ProceedsfromSeniorNotes",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProjectedBenefitObligationForLongTermServiceAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Projected Benefit Obligation For Long Term Service Awards",
        "label": "Projected Benefit Obligation For Long Term Service Awards",
        "terseLabel": "Projected benefit obligation for long-term service awards"
       }
      }
     },
     "localname": "ProjectedBenefitObligationForLongTermServiceAwards",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PurchaseOfNonControllingInterestReclassifiedToAPIC": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of non-controlling interest reclassified to APIC",
        "label": "Purchase of non-controlling interest reclassified to APIC",
        "terseLabel": "Purchase of non-controlling interest reclassified to APIC"
       }
      }
     },
     "localname": "PurchaseOfNonControllingInterestReclassifiedToAPIC",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Purchaseobligationthereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase obligation thereafter",
        "label": "Purchase obligation thereafter",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "Purchaseobligationthereafter",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ReductionOfWorkforceExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail": {
       "order": 1.0,
       "parentTag": "holx_RestructuringChargesUnderExitOrDisposalPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents severance and related benefit charges for the termination of employees under an exit or disposal activity. Charges are recorded either as one-time termination benefits, which are recognized ratable over the required service period to receive such benefit, or under an ongoing benefit plan arrangement once the charge is probable and reasonably estimable.",
        "label": "Reduction Of Workforce Expenses",
        "terseLabel": "Workforce reductions"
       }
      }
     },
     "localname": "ReductionOfWorkforceExpenses",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RemainingLeaseBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease balance",
        "label": "Remaining lease balance",
        "terseLabel": "Remaining lease balance"
       }
      }
     },
     "localname": "RemainingLeaseBalance",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RepaymentofSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment of Senior Notes",
        "label": "Repayment of Senior Notes",
        "negatedTerseLabel": "Repayment of Senior Notes"
       }
      }
     },
     "localname": "RepaymentofSeniorNotes",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RestructuringChargesUnderExitOrDisposalPlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total restructuring charges under exit or disposal plan.",
        "label": "Restructuring Charges Under Exit Or Disposal Plan",
        "terseLabel": "Fiscal restructuring charges",
        "totalLabel": "Fiscal restructuring charges"
       }
      }
     },
     "localname": "RestructuringChargesUnderExitOrDisposalPlan",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue [Member]",
        "label": "Revenue [Member]",
        "terseLabel": "Total revenues [Member]"
       }
      }
     },
     "localname": "RevenueMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolver [Member]",
        "label": "Revolver [Member]",
        "terseLabel": "Revolver"
       }
      }
     },
     "localname": "RevolverMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of significant assumptions used during the year to estimate the fair value of employee stock purchase plan shares, including, but not limited to: (a) expected term, (b) expected volatility, (c) risk-free interest rate, and (d) dividend yield.",
        "label": "Schedule Of Assumptions For Employee Stock Purchase Plan [Table Text Block]",
        "terseLabel": "Black-Scholes Model Weighted Average Assumptions Used to Estimate Fair Value of Shares to Be Issued as of Grant Date"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsForEmployeeStockPurchasePlanTableTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Line Items]",
        "label": "Schedule Of Geographical Segments [Line Items]",
        "terseLabel": "Schedule Of Geographical Segments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsLineItems",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Table]",
        "label": "Schedule Of Geographical Segments [Table]",
        "terseLabel": "Schedule Of Geographical Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsTable",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfGoodwillBySegmentTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill by segment table.",
        "label": "Schedule Of Goodwill By Segment Table [Table Text Block]",
        "terseLabel": "Rollforward of Goodwill Activity by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillBySegmentTableTableTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share-based compensation expense.",
        "label": "Schedule Of Share Based Compensation Expense [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense in Consolidated Statement of Operations"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationExpenseTableTextBlock",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_SecuredTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Term Loan [Member]",
        "label": "Secured Term Loan [Member]",
        "terseLabel": "Secured Term Loan"
       }
      }
     },
     "localname": "SecuredTermLoanMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SegmentReportingDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Disclosure [Line Items]",
        "label": "Segment Reporting Disclosure [Line Items]",
        "terseLabel": "Segment Reporting Disclosure [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureLineItems",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SegmentReportingDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Disclosure [Table]",
        "label": "Segment Reporting Disclosure [Table]",
        "terseLabel": "Segment Reporting Disclosure [Table]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTable",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SemiAnnualEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Semi Annual Employee Stock Purchase Plan [Member]",
        "label": "Semi Annual Employee Stock Purchase Plan [Member]",
        "terseLabel": "2012 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "SemiAnnualEmployeeStockPurchasePlanMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Life",
        "terseLabel": "Options outstanding at September 26, 2020",
        "verboseLabel": "Options outstanding at September 25, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLife",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation expense included other restructuring costs.",
        "label": "Share Based Compensation Expense Included Other Restructuring Costs",
        "negatedLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationExpenseIncludedOtherRestructuringCosts",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ShareBasedCompensationPercentageOfForfeitureRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forfeiture rate applied to equity awards issued to certain employee groups to determine stock-based compensation expense for the period. The rate is based on an analysis of historical employee exercise and terminations patterns.",
        "label": "Share Based Compensation Percentage Of Forfeiture Rate",
        "terseLabel": "Percentage of forfeiture rates"
       }
      }
     },
     "localname": "ShareBasedCompensationPercentageOfForfeitureRate",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program [Member]",
        "label": "Share Repurchase Program [Member]",
        "terseLabel": "Share Repurchase Program [Member]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ShareRepurchseAuthorizationDateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Authorization Date [Axis]",
        "label": "Share Repurchse Authorization Date [Axis]",
        "terseLabel": "Share Repurchse Authorization Date [Axis]"
       }
      }
     },
     "localname": "ShareRepurchseAuthorizationDateAxis",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ShareRepurchseAuthorizationDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchse Authorization Date [Domain]",
        "label": "Share Repurchse Authorization Date [Domain]",
        "terseLabel": "Share Repurchse Authorization Date [Domain]"
       }
      }
     },
     "localname": "ShareRepurchseAuthorizationDateDomain",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Cliff-Vesting Period from Grant Date",
        "terseLabel": "Cliff vesting period from grant date"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardCliffVestingPeriodfromGrantDate",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value (in millions)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "terseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTable",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SkeletalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skeletal health.",
        "label": "Skeletal Health [Member]",
        "terseLabel": "Skeletal Health"
       }
      }
     },
     "localname": "SkeletalHealthMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SomatexMedicalTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Somatex Medical Technologies",
        "label": "Somatex Medical Technologies [Member]",
        "terseLabel": "Somatex Medical Technologies"
       }
      }
     },
     "localname": "SomatexMedicalTechnologiesMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SomatexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Somatex",
        "label": "Somatex [Member]",
        "terseLabel": "Somatex"
       }
      }
     },
     "localname": "SomatexMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_StateLossCarryforwardExpectedToUnutilize": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "state loss carryforward expected to unutilize",
        "label": "state loss carryforward expected to unutilize",
        "terseLabel": "state loss carryforward expected to unutilize"
       }
      }
     },
     "localname": "StateLossCarryforwardExpectedToUnutilize",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SubLeaseRentalIncome": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sub lease rental income",
        "label": "Sub lease rental income",
        "terseLabel": "Sub lease rental income"
       }
      }
     },
     "localname": "SubLeaseRentalIncome",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SubLeaseRentalIncomeCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sub lease Rental income current",
        "label": "Sub lease Rental income current",
        "terseLabel": "Sub lease Rental income current"
       }
      }
     },
     "localname": "SubLeaseRentalIncomeCurrent",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SubLeaseRentalIncomeDueIn2Years": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sub lease rental income due in 2 years",
        "label": "Sub lease rental income due in 2 years",
        "terseLabel": "Sub lease rental income due in 2 years"
       }
      }
     },
     "localname": "SubLeaseRentalIncomeDueIn2Years",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SubLeaseRentalIncomeDueIn3Years": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sub lease rental income due in 3 years",
        "label": "Sub lease rental income due in 3 years",
        "terseLabel": "Sub lease rental income due in 3 years"
       }
      }
     },
     "localname": "SubLeaseRentalIncomeDueIn3Years",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SubLeaseRentalIncomeDueIn4Years": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sub lease rental income due in 4 years",
        "label": "Sub lease rental income due in 4 years",
        "terseLabel": "Sub lease rental income due in 4 years"
       }
      }
     },
     "localname": "SubLeaseRentalIncomeDueIn4Years",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SubLeaseRentalIncomeDueIn5years": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sub lease rental income due in 5years",
        "label": "Sub lease rental income due in 5years",
        "terseLabel": "Sub lease rental income due in 5years"
       }
      }
     },
     "localname": "SubLeaseRentalIncomeDueIn5years",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SubLeaseRentalIncomeDueThereafter": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sub lease rental income due thereafter",
        "label": "Sub lease rental income due thereafter",
        "terseLabel": "Sub lease rental income due thereafter"
       }
      }
     },
     "localname": "SubLeaseRentalIncomeDueThereafter",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/LeasesFutureMinimumAnnualRentalIncomePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SuperSonicImagineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SuperSonic Imagine [Member]",
        "label": "SuperSonic Imagine [Member]",
        "terseLabel": "SuperSonic Imagine"
       }
      }
     },
     "localname": "SuperSonicImagineMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TaxCreditCarryforwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Credit Carryforward [Member]",
        "label": "Tax Credit Carryforward [Member]",
        "terseLabel": "Tax Credit Carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TaxOnInterestRateSwap": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "tax on interest rate swap",
        "label": "tax on interest rate swap",
        "terseLabel": "tax on interest rate swap"
       }
      }
     },
     "localname": "TaxOnInterestRateSwap",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_TaxPositionsRelatedToCurrentYearAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax positions related to current year.",
        "label": "Tax Positions Related To Current Year [Abstract]",
        "terseLabel": "Tax positions related to current year:"
       }
      }
     },
     "localname": "TaxPositionsRelatedToCurrentYearAbstract",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_TaxPositionsRelatedToPriorYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax positions related to prior years.",
        "label": "Tax Positions Related To Prior Years [Abstract]",
        "terseLabel": "Tax positions related to prior years:"
       }
      }
     },
     "localname": "TaxPositionsRelatedToPriorYearsAbstract",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_TepnelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tepnel",
        "label": "Tepnel [Member]",
        "terseLabel": "Tepnel [Member]"
       }
      }
     },
     "localname": "TepnelMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TermARSecuritizationProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Accounts Receivable Securitization Program",
        "label": "Term AR Securitization Program",
        "terseLabel": "Term of accounts receivable securitization program"
       }
      }
     },
     "localname": "TermARSecuritizationProgram",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TransitionServicesAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Services Agreement Term",
        "label": "Transition Services Agreement Term",
        "terseLabel": "Transition services agreement term"
       }
      }
     },
     "localname": "TransitionServicesAgreementTerm",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_TwoThousandEightEquityPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Eight Equity Plan [Member].",
        "label": "Two Thousand Eight Equity Plan [Member]",
        "terseLabel": "2008 Equity Plan"
       }
      }
     },
     "localname": "TwoThousandEightEquityPlanMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TwothousandeighteenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand eighteen [Member]",
        "label": "Two thousand eighteen [Member]",
        "terseLabel": "Fiscal 2018 restructuring charges"
       }
      }
     },
     "localname": "TwothousandeighteenMember",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_UnrealizedGainLossOnInterestRateCapNetOfTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized gain (loss) on interest rate cap, net of taxes",
        "label": "Unrealized gain (loss) on interest rate cap, net of taxes",
        "terseLabel": "Unrealized gain (loss) on interest rate cap, net of taxes"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInterestRateCapNetOfTaxes",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_UnrecognizedTaxBenefitsIncreasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized tax benefits increases.",
        "label": "Unrecognized Tax Benefits Increases [Abstract]",
        "terseLabel": "Acquired tax positions:"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesAbstract",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_WarrantyTermForProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warranty Term For Products",
        "label": "Warranty Term For Products",
        "terseLabel": "Product Warranty Term"
       }
      }
     },
     "localname": "WarrantyTermForProducts",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units",
        "label": "Weighted Average Common Stock Equivalents From Assumed Exercise Of Stock Options And Restricted Stock Units",
        "terseLabel": "Weighted average common stock equivalents from assumed exercise of stock options and restricted stock units (in shares)"
       }
      }
     },
     "localname": "WeightedAverageCommonStockEquivalentsFromAssumedExerciseOfStockOptionsAndRestrictedStockUnits",
     "nsuri": "http://www.hologic.com/20210925",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia-Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r196",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r216",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r196",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r216",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r227",
      "r360",
      "r365",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r462",
      "r473",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r725",
      "r775",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r462",
      "r473",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r725",
      "r775",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r227",
      "r360",
      "r365",
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r223",
      "r360",
      "r363",
      "r726",
      "r774",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r223",
      "r360",
      "r363",
      "r726",
      "r774",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r400",
      "r462",
      "r473",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r725",
      "r775",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r400",
      "r462",
      "r473",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r725",
      "r775",
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r224",
      "r225",
      "r360",
      "r364",
      "r777",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r224",
      "r225",
      "r360",
      "r364",
      "r777",
      "r793",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r314",
      "r463",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201801Member": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-01 Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842.",
        "label": "Accounting Standards Update 2018-01 [Member]",
        "terseLabel": "Accounting Standards Update 2018-01 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201801Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableFromSecuritization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount owed to the reporting entity by counterparties in securitized loan transactions.",
        "label": "Accounts Receivable from Securitization",
        "terseLabel": "Accounts receivable from securitization"
       }
      }
     },
     "localname": "AccountsReceivableFromSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r17",
      "r40",
      "r229",
      "r230"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "auth_ref": [
      "r25",
      "r26",
      "r62"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Employee Benefits, Current",
        "terseLabel": "Compensation and employee benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r56",
      "r289"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less - accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r83",
      "r88",
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r80",
      "r85",
      "r87",
      "r88",
      "r645"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r85",
      "r87",
      "r88",
      "r761",
      "r787",
      "r791"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r84",
      "r88",
      "r90",
      "r151",
      "r152",
      "r153",
      "r600",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r81",
      "r88",
      "r90",
      "r600",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average amortization period"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r41",
      "r517"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in-Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r129",
      "r279"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r157",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r553",
      "r554",
      "r555",
      "r556",
      "r728",
      "r729",
      "r730",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r476",
      "r478",
      "r520",
      "r521"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r524"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising cost"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r478",
      "r505",
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r231",
      "r246",
      "r248",
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance\u00a0at End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning of Period"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Allowance for Doubtful Accounts Receivable [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r129",
      "r665"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r129",
      "r272",
      "r279"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted-average anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r129",
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charge"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r137",
      "r204",
      "r211",
      "r218",
      "r239",
      "r593",
      "r601",
      "r651",
      "r734",
      "r758"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Identifiable assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r19",
      "r21",
      "r77",
      "r137",
      "r239",
      "r593",
      "r601",
      "r651"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r479",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r614",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r24",
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and Improvements, Gross"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r457",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r457",
      "r464",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r578",
      "r579",
      "r581"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "auth_ref": [
      "r128",
      "r584"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "negatedTerseLabel": "Contingent consideration \u2013 fair value adjustments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r128",
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Increase in contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r577",
      "r580",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Identifiable intangible assets:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r569",
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Acquired tangible assets and liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r569",
      "r570"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Net acquired tangible assets and liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt",
        "negatedTerseLabel": "Long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r569",
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Equity interest in acquiree (as a percent)"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r566"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock": {
     "auth_ref": [
      "r135",
      "r564",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control.",
        "label": "Business Combinations and Other Purchase of Business Transactions, Policy [Policy Text Block]",
        "terseLabel": "Business Combinations and Acquisition of Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r15",
      "r53",
      "r131"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r29",
      "r132",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r125",
      "r131",
      "r134"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r125",
      "r652"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all asset derivatives designated as cash flow hedging instruments.",
        "label": "Cash Flow Hedge Derivative Instrument Assets at Fair Value",
        "terseLabel": "Cash Flow Hedge Derivative Instrument Assets at Fair Value"
       }
      }
     },
     "localname": "CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "auth_ref": [
      "r22",
      "r58"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.",
        "label": "Cash Surrender Value of Life Insurance",
        "terseLabel": "Life insurance contracts"
       }
      }
     },
     "localname": "CashSurrenderValueOfLifeInsurance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r67",
      "r313",
      "r743",
      "r766"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 13 and 14)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r309",
      "r310",
      "r312",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r151",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value \u2013 750,000 shares authorized; 297,306 and 295,107 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Related Costs [Abstract]",
        "terseLabel": "Compensation Related Costs [Abstract]"
       }
      }
     },
     "localname": "CompensationRelatedCostsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r93",
      "r95",
      "r96",
      "r103",
      "r747",
      "r770"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r186",
      "r187",
      "r227",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r186",
      "r187",
      "r227",
      "r649",
      "r650",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r186",
      "r187",
      "r227",
      "r649",
      "r650",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r182",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r186",
      "r187",
      "r227",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r186",
      "r187",
      "r227",
      "r649",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
     "auth_ref": [
      "r637"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
        "label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r361"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was included in contract liability at prior year end"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r220",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r111",
      "r726"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods and services sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Costs of revenues:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r549",
      "r558"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r145",
      "r549"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r549",
      "r558"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r185",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings and Credit Agreements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r32",
      "r33",
      "r34",
      "r735",
      "r738",
      "r757"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "verboseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r664",
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Debt instrument face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r646"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r64",
      "r335",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Effective Percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFiveMember": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Five [Member]",
        "terseLabel": "Period Five"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFiveMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Four [Member]",
        "terseLabel": "Period Four"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFourMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r65",
      "r141",
      "r341",
      "r342",
      "r343",
      "r344",
      "r663",
      "r664",
      "r666",
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r663",
      "r666"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Debt, Weighted Average Interest Rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r532"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in unrecognized tax benefits is reasonably possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]",
        "terseLabel": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.",
        "label": "Deferred Compensation Liability, Current and Noncurrent",
        "terseLabel": "Deferred Compensation Liability, Current and Noncurrent"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r550",
      "r558"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r58",
      "r665"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r550",
      "r558"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r527",
      "r528"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Manufacturing access fees"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r129",
      "r140",
      "r550",
      "r558",
      "r559",
      "r560"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes and other non-cash taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r36",
      "r37",
      "r541",
      "r736",
      "r756"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r527",
      "r528"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r550",
      "r558"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "auth_ref": [
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "terseLabel": "Capital losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r542"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax assets, gross"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other temporary differences"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r545",
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Non-deductible accruals"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Non-deductible reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r528",
      "r544"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesSignificantComponentsofCompanysDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities": {
     "auth_ref": [
      "r375",
      "r399",
      "r737",
      "r759"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan",
        "negatedTerseLabel": "Defined benefit pension plan, liabilities"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r377",
      "r417",
      "r445",
      "r450",
      "r451"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Amortization of prior service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r425",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofWeightedAverageNetPeriodicBenefitCostAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]",
        "terseLabel": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedPeriodEndLabel": "Benefit obligation at end of year",
        "negatedPeriodStartLabel": "Benefit obligation at beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r386",
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Plan participants\u2019 contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanEstimatedFutureBenefitPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2027 to 2031"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2017"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofExpectedPensionBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r377",
      "r415",
      "r443",
      "r450",
      "r451"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r390",
      "r401",
      "r403",
      "r404",
      "r450"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r375",
      "r399",
      "r450"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Benefit obligation at end of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r377",
      "r382",
      "r414",
      "r442",
      "r450",
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "negatedLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r412",
      "r440",
      "r450",
      "r451"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "auth_ref": [
      "r436",
      "r437",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "negatedTerseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "negatedTerseLabel": "Projected benefit obligation in excess of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r378",
      "r419",
      "r447"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedLabel": "Recognized net actuarial gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r380",
      "r413",
      "r441",
      "r450",
      "r451"
     ],
     "calculation": {
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsComponentsofNetPeriodicBenefitCostandRelatedActuarialAssumptionsDetail",
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsScheduleofReconciliationofBenefitObligationsPlanAssetsFundedStatusDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r434",
      "r435",
      "r438",
      "r439",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Contributions made by company"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/A401kPlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r129",
      "r287"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r615",
      "r617",
      "r622",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r621",
      "r623"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r78",
      "r79",
      "r646"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r608",
      "r609",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r607",
      "r610",
      "r611",
      "r612",
      "r613",
      "r619",
      "r622",
      "r630",
      "r632",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Derivative, Term of Contract",
        "terseLabel": "Derivative contract period, or less"
       }
      }
     },
     "localname": "DerivativeTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r146",
      "r607",
      "r610",
      "r612",
      "r613",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology",
        "verboseLabel": "Developed\u00a0technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r360",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stockholders' Equity and Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r286",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by Sale"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Sales price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "terseLabel": "Loss from operations"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionScheduleofDispositionRelatedIncomeStatementInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r457",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income (loss) per common share attributable to Hologic:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r104",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r166",
      "r168",
      "r170",
      "r171",
      "r172",
      "r175",
      "r176",
      "r748",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r104",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r168",
      "r170",
      "r171",
      "r172",
      "r175",
      "r176",
      "r748",
      "r771"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r173",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r652"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r530"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Increase (decrease) in tax resulting from:"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r530",
      "r562"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Income tax (benefit) provision at federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r530",
      "r562"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r530",
      "r562"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Change in deferred tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r530",
      "r562"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "negatedLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges": {
     "auth_ref": [
      "r530",
      "r562"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to restructuring charges.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent",
        "terseLabel": "Internal restructuring"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r530",
      "r562"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": {
     "auth_ref": [
      "r530",
      "r562"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.",
        "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent",
        "negatedTerseLabel": "U.S. tax on foreign earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r530",
      "r562"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent": {
     "auth_ref": [
      "r530"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to Tax Cuts and Jobs Act.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Percent",
        "terseLabel": "Tax reform"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Percent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesReconciliationofIncomeTaxBenefitatUSFederalStatutoryRatetoCompanysEffectiveTaxRateDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r507"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period of unrecognized stock-based compensation, years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "verboseLabel": "Tax benefit related to stock based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r155",
      "r163",
      "r165",
      "r179",
      "r243",
      "r340",
      "r345",
      "r514",
      "r515",
      "r516",
      "r555",
      "r556",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659",
      "r782",
      "r783",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of Debt, Amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r637",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r637",
      "r647",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r450",
      "r638",
      "r698",
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r401",
      "r403",
      "r408",
      "r450",
      "r638",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Prices\u00a0in Active\u00a0Market\u00a0for Identical\u00a0Assets (Level\u00a01)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r401",
      "r403",
      "r408",
      "r450",
      "r638",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs\u00a0(Level\u00a02)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r450",
      "r638",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs\u00a0(Level\u00a03)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Liabilities measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r641"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r642"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Contingent consideration recorded at acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r642"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payments/Accruals"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r640"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredUsingUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r450",
      "r698",
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]",
        "terseLabel": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r139",
      "r529"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "Federal, Total"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Federal:"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r674",
      "r680",
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance lease cost - interest cost"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r676",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails": {
       "order": 1.0,
       "parentTag": "holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Lease"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r672",
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities (current)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease, Liability, Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liabilities (non-current)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r675",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails": {
       "order": 2.0,
       "parentTag": "holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r671"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r674",
      "r680",
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance lease cost - amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r686",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases, weighted average discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r685",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases, weighted average remaining lease term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r233",
      "r234",
      "r247",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r257",
      "r258",
      "r259",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Intangible assets useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Fiscal 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Fiscal 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r273",
      "r275",
      "r278",
      "r281",
      "r727",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r278",
      "r731"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r273",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r136",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).",
        "label": "Foreign Exchange Option [Member]",
        "terseLabel": "Foreign Exchange Option"
       }
      }
     },
     "localname": "ForeignExchangeOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Foreign Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "Foreign, Total"
       }
      }
     },
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Foreign:"
       }
      }
     },
     "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and Fixtures, Gross"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet": {
     "auth_ref": [
      "r615",
      "r622",
      "r625"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate impact of foreign currency derivatives on earnings for the period. Includes impact of foreign currency cash flow hedge ineffectiveness and the ineffectiveness of fair value hedging derivatives and full change in fair value of the foreign currency derivatives not designated as hedging instruments.",
        "label": "Gain (Loss) on Foreign Currency Derivatives Recorded in Earnings, Net",
        "terseLabel": "Gain (loss) on derivative"
       }
      }
     },
     "localname": "GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r129",
      "r337",
      "r338"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Debt extinguishment loss",
        "negatedTerseLabel": "Debt extinguishment loss",
        "terseLabel": "Debt extinguishment losses"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r265",
      "r266",
      "r733"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance at September 25, 2021",
        "periodStartLabel": "Balance at September 26, 2020",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Tax adjustment"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and Intangible Asset Impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency and other adjustments"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r109",
      "r137",
      "r204",
      "r210",
      "r214",
      "r217",
      "r220",
      "r239",
      "r651"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r612",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r129",
      "r282"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r143",
      "r561"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r100",
      "r204",
      "r210",
      "r214",
      "r217",
      "r220",
      "r732",
      "r745",
      "r751",
      "r772"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r143",
      "r561"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r101",
      "r129",
      "r201",
      "r236",
      "r744",
      "r768"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Proportionate share of net loss of equity method investment",
        "terseLabel": "Income (loss) from equity method investments"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r457",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r11",
      "r12",
      "r13",
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r164",
      "r165",
      "r202",
      "r529",
      "r557",
      "r563",
      "r773"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes",
        "totalLabel": "Provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReceivable": {
     "auth_ref": [
      "r52",
      "r755"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.",
        "label": "Income Taxes Receivable",
        "terseLabel": "Income Taxes Receivable"
       }
      }
     },
     "localname": "IncomeTaxReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r126",
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid during the period for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other activity"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r271",
      "r276"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r98",
      "r198",
      "r662",
      "r665",
      "r750"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseBorrowings": {
     "auth_ref": [
      "r749"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of interest expense on all borrowings.",
        "label": "Interest Expense, Borrowings",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r114",
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesSupplementalCashFlowStatementInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate caps - derivative"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeAssetAtFairValue": {
     "auth_ref": [
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.",
        "label": "Interest Rate Cash Flow Hedge Asset at Fair Value",
        "terseLabel": "Interest rate caps - derivative"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap [Member]"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r196",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r216",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r16",
      "r75"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r28",
      "r76",
      "r136",
      "r177",
      "r260",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r113",
      "r197"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value on a recurring basis",
        "verboseLabel": "Investments, fair value"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_JudicialRulingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation outcome that occurs as a result of judicial intervention, supervision, or approval.",
        "label": "Judicial Ruling [Member]",
        "terseLabel": "Judicial Ruling"
       }
      }
     },
     "localname": "JudicialRulingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r23",
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r24",
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold Improvements, Gross"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Remaining Lease Term",
        "terseLabel": "Lessee, Finance Lease, Remaining Lease Term"
       }
      }
     },
     "localname": "LesseeFinanceLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r688"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorSalesTypeLeasesTextBlock": {
     "auth_ref": [
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's sales-type leases.",
        "label": "Lessor, Sales-type Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LessorSalesTypeLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r46",
      "r137",
      "r239",
      "r651",
      "r740",
      "r764"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r63",
      "r137",
      "r239",
      "r594",
      "r601",
      "r602",
      "r651"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Reserve for income tax uncertainties"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate at end of period",
        "verboseLabel": "Interest rate at end of period"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Weighted average interest rate",
        "verboseLabel": "Weighted-average interest rate (percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r60",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r34",
      "r334",
      "r738",
      "r760"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current debt obligations, net of debt discount",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r148",
      "r332"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "2027 and Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r148",
      "r332"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r148",
      "r332"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r148",
      "r332"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r148",
      "r332"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r148",
      "r332"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "verboseLabel": "Total long-term debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r65",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r313",
      "r314",
      "r315",
      "r317",
      "r318",
      "r319",
      "r321",
      "r323",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r313",
      "r316",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Awarded damages"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LitigationandOtherMattersAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r71",
      "r137",
      "r239",
      "r651",
      "r739",
      "r763"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r345",
      "r591",
      "r592"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "terseLabel": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MultiemployerPlanEmployerContributionCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Multiemployer Plan, Employer Contribution, Cost [Abstract]",
        "terseLabel": "Multiemployer Plan, Employer Contribution, Cost [Abstract]"
       }
      }
     },
     "localname": "MultiemployerPlanEmployerContributionCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_MultiemployerPlanTextBlock": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r467",
      "r468",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for multiemployer plan.",
        "label": "Multiemployer Plan [Text Block]",
        "terseLabel": "Multiemployer Plan"
       }
      }
     },
     "localname": "MultiemployerPlanTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/A401kPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r125",
      "r127",
      "r130"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r13",
      "r91",
      "r94",
      "r102",
      "r130",
      "r137",
      "r154",
      "r158",
      "r159",
      "r160",
      "r161",
      "r164",
      "r165",
      "r169",
      "r204",
      "r210",
      "r214",
      "r217",
      "r220",
      "r239",
      "r651",
      "r746",
      "r769"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to Hologic"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-competition agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.",
        "label": "Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable",
        "terseLabel": "Net loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r346",
      "r571",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Noncontrolling Interest, Increase from Business Combination"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r345",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r88",
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.",
        "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent",
        "terseLabel": "Loss recognized in other comprehensive income (loss), net"
       }
      }
     },
     "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating Expense"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r204",
      "r210",
      "r214",
      "r217",
      "r220"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r681",
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r178",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income from operating lease.",
        "label": "Operating Lease, Lease Income [Table Text Block]",
        "terseLabel": "Operating Lease, Lease Income"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesLeaseLiabilityMaturitySchedule2020Details",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities (current)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities (non-current)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease liability.",
        "label": "Operating Lease, Liability, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r677",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails": {
       "order": 3.0,
       "parentTag": "holx_OperatingAndFinanceLeaseTotalCashPaidForAmountsIncludedInMeasurementOfLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r671"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease, right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r686",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases, weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r685",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases, weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": {
     "auth_ref": [
      "r667",
      "r668",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessor's operating leases.",
        "label": "Lessor, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "OperatingLeasesOfLessorDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r669"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r545"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r14",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Operations"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Operations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r25",
      "r26",
      "r27",
      "r62"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofAccruedExpensesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r614",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneous": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets.",
        "label": "Other Assets, Miscellaneous",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneous",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofOtherAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r83",
      "r85",
      "r589",
      "r599"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTerseLabel": "Changes in pension plans, net of taxes of $0.2 in 2021, $0.1 in 2020, and $0.3 in 2019"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent": {
     "auth_ref": [
      "r589",
      "r590",
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent",
        "terseLabel": "Change in pension plans, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r589",
      "r590",
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "verboseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r88",
      "r653",
      "r655",
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r82",
      "r85"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofUnrealizedLossRecognizedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r82",
      "r85",
      "r616",
      "r620",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "verboseLabel": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r85",
      "r89"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "terseLabel": "Loss reclassified from accumulated other comprehensive loss to the statement of operations, net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r92",
      "r95",
      "r589",
      "r590",
      "r599"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome_1": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r92",
      "r95",
      "r589",
      "r590",
      "r599"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r82",
      "r85",
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax",
        "verboseLabel": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r235",
      "r255",
      "r401",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Debt Obligations"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsDebtMaturityScheduleforComponentsofCompanysObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other Income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "negatedTerseLabel": "Other long-term liabilities",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Other\u00a0Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other liabilities.",
        "label": "Other Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Long-Term Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments and non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Noncurrent Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r374",
      "r375",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r425",
      "r426",
      "r428",
      "r431",
      "r435",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Nonqualified Deferred Compensation Plan [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r35",
      "r737",
      "r759"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "auth_ref": [
      "r138",
      "r529",
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other income tax expense (benefit).",
        "label": "Other Tax Expense (Benefit)",
        "terseLabel": "Other Tax Expense (Benefit)"
       }
      }
     },
     "localname": "OtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r117",
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Purchase of equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "terseLabel": "Payments to Acquire in Process Research and Development"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Payments to Noncontrolling Interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r400",
      "r402",
      "r408",
      "r427",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r450",
      "r452",
      "r453",
      "r455",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension and Other Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r35",
      "r375",
      "r376",
      "r399",
      "r450"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Pension liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesScheduleofOtherLongTermLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r373",
      "r375",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r425",
      "r426",
      "r428",
      "r431",
      "r435",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r455",
      "r456",
      "r464",
      "r465",
      "r466",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r479",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value \u2013 1,623 shares authorized; 0 shares issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r19",
      "r51",
      "r52"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r18",
      "r20",
      "r263",
      "r264"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromAccountsReceivableSecuritization": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.",
        "label": "Proceeds from Accounts Receivable Securitization",
        "terseLabel": "Proceeds from accounts receivable securitization agreement"
       }
      }
     },
     "localname": "ProceedsFromAccountsReceivableSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Net proceeds from sale of business",
        "verboseLabel": "Proceeds from divestiture of businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/DispositionAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds from issuance of senior long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r119",
      "r509"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Net proceeds from issuance of common stock under employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r120",
      "r142"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit line"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from other long-term debt.",
        "label": "Proceeds from (Repayments of) Other Long-term Debt",
        "terseLabel": "Proceeds from long-term debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepurchaseOfEquity": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow resulting from the entity's share transaction.",
        "label": "Proceeds from (Repurchase of) Equity",
        "terseLabel": "Common stock repurchases"
       }
      }
     },
     "localname": "ProceedsFromRepurchaseOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r329",
      "r330",
      "r741"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Balance\u00a0at\u00a0End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning\u00a0of Period"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition": {
     "auth_ref": [
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from a business acquisition.",
        "label": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition",
        "terseLabel": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition"
       }
      }
     },
     "localname": "ProductWarrantyAccrualAdditionsFromBusinessAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Settlements/ Adjustments"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r13",
      "r91",
      "r94",
      "r124",
      "r137",
      "r154",
      "r164",
      "r165",
      "r204",
      "r210",
      "r214",
      "r217",
      "r220",
      "r239",
      "r589",
      "r596",
      "r597",
      "r604",
      "r605",
      "r651",
      "r751"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss) attributable to Hologic",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r56",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r55",
      "r288"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, Plant and Equipment, Gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r30",
      "r31",
      "r290",
      "r765"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "negatedTerseLabel": "Property, plant and equipment, net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationScheduleofGeographicallyLocatedPropertyandEquipmentNetDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/LeasesNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r54",
      "r136",
      "r290",
      "r794",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r30",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r30",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "verboseLabel": "Property, plant and equipment, estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r106",
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Charged\u00a0to Costs and Expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableReserveActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFifthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Five",
        "terseLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "PurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInFourthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "PurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Fiscal 2022"
       }
      }
     },
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "Fiscal 2023"
       }
      }
     },
     "localname": "PurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "PurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesSummaryofPurchaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r88",
      "r90",
      "r97",
      "r653",
      "r657",
      "r659"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Changes in accumulated balances of other comprehensive income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfAccountsReceivableSecuritization": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.",
        "label": "Repayments of Accounts Receivable Securitization",
        "negatedTerseLabel": "Repayments under accounts receivable securitization agreement"
       }
      }
     },
     "localname": "RepaymentsOfAccountsReceivableSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r122",
      "r142"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayments under revolving credit line"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
        "label": "Repayments of Other Long-term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r525",
      "r805"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r57",
      "r136",
      "r283",
      "r284",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "terseLabel": "Research and Software Development Costs"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
        "terseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes (in shares)"
       }
      }
     },
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "terseLabel": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r129",
      "r295",
      "r301",
      "r305"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring and divestiture charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesMember": {
     "auth_ref": [
      "r297",
      "r301",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included.",
        "label": "Restructuring Charges [Member]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringChargesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r296",
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r42",
      "r345",
      "r517",
      "r762",
      "r786",
      "r791"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated earnings (deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r155",
      "r163",
      "r165",
      "r243",
      "r514",
      "r515",
      "r516",
      "r555",
      "r556",
      "r782",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r373",
      "r374",
      "r375",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r425",
      "r426",
      "r428",
      "r431",
      "r435",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r464",
      "r465",
      "r466",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail",
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r373",
      "r374",
      "r375",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r425",
      "r426",
      "r428",
      "r431",
      "r435",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r464",
      "r465",
      "r466",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail",
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r195",
      "r196",
      "r209",
      "r215",
      "r216",
      "r223",
      "r224",
      "r227",
      "r359",
      "r360",
      "r726"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Revenue from product and services"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r357",
      "r358",
      "r362",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Estimated remaining performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligation over time"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Remaining performance obligation over time (percent)"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r99",
      "r137",
      "r195",
      "r196",
      "r209",
      "r215",
      "r216",
      "r223",
      "r224",
      "r227",
      "r239",
      "r651",
      "r751"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r684",
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use asset obtained in exchange for finance lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r684",
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "ROU assets arising from entering into new operating lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Accounts Receivable Reserve Activity"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccruedExpensesandOtherLongTermLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r88",
      "r658",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) Related to Derivatives"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Unrealized Loss Recognized in AOCI"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Weighted-Average Net Periodic Benefit Cost Assumptions"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Statement Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Benefit Obligations, Plan Assets, Funded Status and Related Actuarial Assumptions"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Company's Borrowings and Interest Expense"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable": {
     "auth_ref": [
      "r371",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting pension and other postretirement benefit arrangements with individual employees, which are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, usually including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]",
        "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Postretirement Benefits [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualPostretirementBenefitsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Significant Components of the Company's Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments on the Consolidated Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r0",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r11",
      "r12",
      "r13",
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of Disposed Business, Income from Operations and Assets held-for-sale"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Basic and Diluted Share Amounts"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Income Tax (Benefit) at U.S. Federal Statutory Rate to Company's Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r13",
      "r137",
      "r238",
      "r239",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/EquityMethodInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Pension Benefit"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, Off-balance Sheet Risks [Table]",
        "terseLabel": "Schedule of Fair Value, Off-balance Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r273",
      "r277",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesIntangibleAssetsandGoodwillDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r273",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Income (Loss) Before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r28",
      "r48",
      "r49",
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r60",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Credit Agreements"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule Of Long Term Debt By Maturity Table"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Components of Net Periodic Benefit Cost and Related Actuarial Assumptions"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/PensionandOtherEmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.",
        "label": "Schedule of Other Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Schedule of Product Warranty Activity"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r56",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofPropertyPlantandEquipmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Purchase Price Allocation"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r299",
      "r300",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r299",
      "r300",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Charges Taken Related to Restructuring Actions"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r296",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Charges Taken Related to Accrued Restructuring Actions"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r108",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Revenues by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r108",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r204",
      "r207",
      "r213",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r204",
      "r207",
      "r213",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r479",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r484",
      "r496",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Information Pertaining to Stock Options Granted and Related Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r540",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Activity of the Company's Unrecognized Income Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r191",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r227",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r191",
      "r193",
      "r194",
      "r204",
      "r208",
      "r214",
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r226",
      "r227",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r742",
      "r767"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes principal amount"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r129",
      "r295",
      "r301",
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "verboseLabel": "Severance charges"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Stock-based compensation, period of vest term granted to employees, years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Non-vested at September 25, 2021",
        "periodStartLabel": "Non-vested at September 26, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number\u00a0of Shares (in millions)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Non-vested at September 25, 2021",
        "periodStartLabel": "Non-vested at September 26, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant-Date\u00a0Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of RSUs vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockUnitActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Assumptions:"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "verboseLabel": "Risk-free interest rates"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r503"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementofOperationsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- Average Remaining Contractual\u00a0Life (in Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable at September 25, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable at September 25, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Exercised",
        "verboseLabel": "Intrinsic value of option exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled/ forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled/ forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted",
        "verboseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Options outstanding at September 25, 2021",
        "periodStartLabel": "Options outstanding at September 26, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r486",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding at September 25, 2021",
        "periodStartLabel": "Options outstanding at September 26, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of\u00a0Shares (in millions)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding at September 29, 2018",
        "periodStartLabel": "Options outstanding at September 26, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise\u00a0Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r498"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options vested and expected to vest at September 25, 2021 (1)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options vested and expected to vest at September 25, 2021 (1)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options vested and expected to vest at September 25, 2021 (1)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost",
        "terseLabel": "Incremental cost"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r477",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price",
        "verboseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r136",
      "r479",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r501",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAssumptionstoValueStockOptionsDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r508"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options exercisable at September 25, 2021"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable at September 25, 2021"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "terseLabel": "Weighted average grant date fair value (in usd per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationInformationPertainingtoStockOptionsGrantedandRelatedAssumptionsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options vested and expected to vest at September 25, 2021 (1)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested, weighted average grant date fair value (in usd per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the standard product warranty accrual. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Period Increase (Decrease)",
        "terseLabel": "Standard Product Warranty Accrual, Period Increase (Decrease)"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesProductWarrantyDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "auth_ref": [
      "r136",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "StandardProductWarrantyPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r138",
      "r529",
      "r557"
     ],
     "calculation": {
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "totalLabel": "State, Total"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "State:"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesProvisionforIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r191",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r209",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r227",
      "r269",
      "r292",
      "r298",
      "r307",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesRollforwardofGoodwillActivitybyReportableSegmentsDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r69",
      "r151",
      "r152",
      "r153",
      "r155",
      "r163",
      "r165",
      "r179",
      "r243",
      "r340",
      "r345",
      "r514",
      "r515",
      "r516",
      "r555",
      "r556",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r659",
      "r782",
      "r783",
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r179",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Outstanding Stock Options and stock units [Member]"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r38",
      "r39",
      "r340",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under the employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r38",
      "r39",
      "r340",
      "r345",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r38",
      "r39",
      "r340",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "verboseLabel": "Stock Issued During Period, Value, Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r69",
      "r340",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock Issued During Period, Value, Stock Options Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized value of common shares to be repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r38",
      "r39",
      "r340",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r39",
      "r44",
      "r45",
      "r137",
      "r232",
      "r239",
      "r651"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Hologic's stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r137",
      "r151",
      "r152",
      "r153",
      "r155",
      "r163",
      "r239",
      "r243",
      "r345",
      "r514",
      "r515",
      "r516",
      "r555",
      "r556",
      "r587",
      "r588",
      "r603",
      "r651",
      "r653",
      "r654",
      "r659",
      "r783",
      "r784"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r682",
      "r689"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "terseLabel": "Sublease Income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r660",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r660",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r660",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r545"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Credit carry forwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesMedicalAestheticsImpairmentandOtherActivityDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r233",
      "r234",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesAmountoflossrecognizedinothercomprehensiveincomenetoftaxesDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesChangesinaccumulatedbalancesofothercomprehensiveincomeDetails",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsontheConsolidatedBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r68",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r68",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r39",
      "r340",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r68",
      "r347",
      "r348"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost \u2013 43,653 and 37,609 shares, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r340",
      "r345",
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedLabel": "Treasury Stock, Value, Acquired, Par Value Method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r157",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r553",
      "r554",
      "r555",
      "r556",
      "r728",
      "r729",
      "r730",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoAccruedRestructuringActionsDetail",
      "http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedtoRestructuringActionsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax": {
     "auth_ref": [
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.",
        "label": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax",
        "terseLabel": "Unrealized gain (loss) on derivative"
       }
      }
     },
     "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesScheduleofDerivativeInstrumentsinOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.",
        "label": "Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss)",
        "terseLabel": "Unrealized gain on interest rate swap"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r526",
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance as of the end of the fiscal year",
        "periodStartLabel": "Balance at beginning of fiscal year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions",
        "negatedLabel": "Reductions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Reductions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition",
        "terseLabel": "Additions related to reserves acquired from acquisitions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions related to change in estimate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r531"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "terseLabel": "Interest accrued on unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Change in gross unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Lapses in statutes of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesActivityofCompanysUnrecognizedIncomeTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefit that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unconditional purchase obligation not recognized as liability.",
        "label": "Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block]",
        "terseLabel": "Unrecorded Unconditional Purchase Obligations Disclosure"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r180",
      "r181",
      "r183",
      "r184",
      "r188",
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Management's Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesPeriodIncreaseDecrease": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease)",
        "negatedTerseLabel": "Decrease in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DeferredCompensationPlanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r167",
      "r172"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r166",
      "r172"
     ],
     "calculation": {
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average anti-dilutive shares related to:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=SL77927221-108306"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(c))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450655-114947"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450678-114947"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450678-114947"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450678-114947"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450783-114948"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/subtopic&trid=2235144"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116873391&loc=d3e408-128459"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=13988685&loc=d3e8784-128493"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "Note 1",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "Note 3",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888252"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7,8)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r806": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r807": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r808": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r809": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r810": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r811": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r812": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r813": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r814": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>139
<FILENAME>0000859737-21-000023-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000859737-21-000023-xbrl.zip
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M3;29PUR5M%!>KHZPH*.L?I=Q76YMI-SH#KA9^/]X/;^W_MAE4G;FB38FZ/G
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MP&>ECBQLH1SBM7MM@NFM>'=[=6[L*7;]= P#3;00_@1Q?5B*(1A%BRE]3)>
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M>EFN9 G41 V.LF";.!R!@F$E"D.M5;OI8N.,,RY.!.=*6,Z<)9U9:*N[Z96
M$>^Y7&+)GJ#Q^@J+XC6D0>)AZZXMV=ZT(O(P26-\H3_8F["!5H0.-E:0 M+<
M;8TT[_4[HZ&2YK;PM@@(V^Q$' )6).P$ML.R*]N9Z-FLA&G5 3XO/P,>G9-B
MH+.D56P@-O/JD]63J@,\.B"A;W.5,7?R7)(W?NR8;F8 )5$:)U4Q&<IO>6Z1
MU93A,Y,\I]H\<R4.L@FDJCI2^Z6'_"9L6N5RK5^6WNEWF=+;1/VR/=3?[0S)
MEM%E*&$)QULU 8"B=I'\F+H<#"L12ZX^Z0O:L^A! W:?)%4)OJ-%B_;OP\(
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M8%G\3>[KTXUGOGUO*AM\1H81K([/]CDL5>5:-<U37WOR>7V>ZG%\Z!XCRH2
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M#>E*8-4^WL:HF0@F+O<H/?E[^+"2I"6[:>W$FA-G$#B%F*/=60'W(X$\.B*
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M,KW0#M+: ?27/)DDC^_H0D0LN >*R3)O>;/H_GM#NU=]LTZRZD!_BV@ ARK
M2\CF:KZ^NW1?(F=_3:=?ANJ4*A="?LH#D!Q^4Z#% F]E^9]GX=?J['UC#:6S
M]W6UHQ=R&Z/4_9KSO'-><)WO.7'R9+LTZCD!Y0"]^MLHCDGOG#\KYKR8:GSB
M&%#>8E3*R?=F,'QEED#RN4U)]K\?NIEN.>@%T>,DI06E?%;Z)E):4'*YVM/3
MO*)2+CX]>RS7E'+EL#>='S7:G%)Z%E)Z9/1D.X>\TN7^F]KN=$V]WEWGDF_T
M[8V^O=&W-_KVF(F_T;<W^K9C:F_T;1M]*YTII<JWT3=TGL^14RPKI?+NJM_:
M[%E%*1<.2U6^)?\>)FY]K=7J0E,UKCMPI;9_ST!;'K!26Z!VNYVZ+J]>/"MX
M[U7W^Q;^1A:/W!VMDD63>Q8T%+CVO3\ME_VY-L\W"OA& 9,TS4X]>;3Q_\.(
MW5^<U9'DY0YF<T?QJV7?[VA$[O!S)'MWVM_M^[F$]]L/FSSQ7*H'3>6L6*N>
ME4HUN"OL/M.1C7\55?X^ZX?_ U!+ P04    " "41'!3JL;UN-X,   75
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MW"M7RH72<8%U*^6Z<^RZ3K%>ZA4KO4J]:Q?_7<1!YK%X4D=$$X_]>3#D_N&
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M(UA;081-NS$C$W"\<@+;3"[MH5:B-0@2EWD2,@^Q?,^6?,A4 9*5GU:QNZ@
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MC:YV Q6O7.=W'+N.:#M,.#M']*<1C@_^<8_'@Q?/[HD0,):?_W[$<_RA?7[
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M&;:,''^_\U*>]_EOL+-]_W!W^[?3W<?R6NXKCNKPU>L7XHQN72P-+=1$K F
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M1_&&JA=WB!T0A*A0%]&+11,5C!<K[>W/JHVH;G__VHA>&X'L7'3(QF%R4'S
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M-M?@NJ\0J#V C1@RBB2+4T+.9T /);:%_UYT)=C */J9G4N4C2FA0$B6;&1
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MGEV.\CGR?[^="_^M3-IU/HJ@2.OMWND#2Z\,X%^BZ' L1)1S?V\%+H_\%2L
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M9PW8&AZ DRFA@9B4@@@;2OD*P^AW]QY?%:C$7E$1M Y8LC3)SV#B$0==IH$
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MIBUX9*E>J:@2J1]DPV,Y\&LHB]KR8),'C3R8.,3BP +AFF,6T+K![Q()O!Q
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M#DGZ*(YI*A5C-ACNK23&8*.-I:))FX=+)^!2+&K)+"*:&:O  V;(:R:%I0S
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M2E<=EB_AR+SOFNF>_%"<A[X-R&@GO.Q8'D6'2>XZ1EK>H8S0& SVFNE$SL'
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MGS#@#/,"+V[>64.RZ/VJO^$._IUNX'B\_KUJ^8U$Z!_:LKIXZQG%*EK?$9X
MS")).R8XW>'2"2P,5R1E3KT.G^TJWE;T,^?:Q_LQ[[1MP/* XBY&/BA6ZRFQ
M;ZLD:18P]8LA?/+?49X4(NC!F,JYRJH8=? %!4E3@MOUCU)98?WR2G'>"58@
M&JM*Y%42A85C^E]%=]0?FK(JK"L'/QV6[^*W5!LN'(:G)"7N,(Y$!YQ,TW$1
MPX.4S/L )O-!T10H;S9(79R%*L/V!E+]@L?8<@:V4L(HGYEN=PI4LPAFP_@
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M83@6_D>W27ZRZR]"MYO^K;R?RP'8E%5+E]K\3A^.#RU'_9;FRZ4Y.!H^!X@
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M!@F[QC^M^7E0X]' U('662!+\;?Q$K,J4:W,DV62PBU]5P8S"--S)'4V"9_
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M^N!-4=I'J80[Y54_RK8!]$NXTVVP9](FS>\[\+KS5QY C^P$0+1*1]<#<([
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M\_]Y<3(Y/<9'LH%&?B@O=W2:R15@*UX<O=1R#9?9&%O-K%\"]^]<?&4& WR
M"/@TG-84! 05:+'F3+R[)'^<=OT!EV36S)<G*=++0GJ:7_[O;*!#Q##)\G4A
M$HQ3>I!%V2L@\(URR['@R:Q51YS<X2W*:/_%$4V8<AZ/GW)U3)CGL2V6#-N]
MM&&BU2:BI^P6HQV0&8RLQU4Y=3V?H/9K0"2!1LZ2T("!#@=,$#E >K+V0/^N
M+X+QW3N:/%SI:,G\[L[[.TVHP823RBEO7V#/P':Y:<6J,RP+:DJS,$VT<=JY
M=+I:N77$@W?,=FYADU6"K E%0(^9LB+@5GF#H,R,[278TSS 0#J*YAE1N.FM
M8#G8GG^>L!11#7+-HQ]/#P^4/A+_/GQQ0$_%\\%6P.U4>I4SLE+'97'1T/?(
MJM'CUF7^P:*/S^-0>-9,67OAXHL]%!PQR=L.A# 6SX5;P?Z=>5%IB8[KYE*D
M;D;Q3H*KE$V0(" RD(-JC5F:D4_(E:$%^*2L*_K!O?@0>D<CEVM?,Z0X;FZ'
MW01@$TINW$14*L.VELPN<L;=<SS/H822Q^U'=^Z*3C+>DJP#$C[3$M1U+,.B
MFCLF':0L.."BPZ,XJ$2\@Y*'<%X9[ZCR3 W^$93,1,<[I& \)$5;"1#"24YD
MTF_:.F^E?Q]KAY&L"!39ZGY[W]IU .NDDQN-:4%52F[M03>2[0'7>G4 9G8:
M])B=S%N6PDEP%$ZZB;,Q0G(0JKIO1!L1VC7(1>*TL;,_P$Y8OT;-<#QBK0U
M.ML!3P7-,J:]C@/+C0 ,[:>;A_6C)(0L,MX4PIBN$LDU<G)\\GFF/2M38Y]$
M@F*AO)V4=KSILEQI EL:Z"[:YBI8]+%A];7LKBA>RT 8EL+R"F/SX8O%IBH<
M'_;SCF['F0!3A<?W)>W\--_TO8\E)P]HE9W]0_")(RD_Z//^(3 8]/5$%<F
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M['?R4X=G+P>$(("'XX"R@D3\7%U(!%G\1=XK&M.A>"2]TU+?,*_RWN1I<U4
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M$$ZQRS%):?AW1V[7H0E(9$&^V0]0\53-S,;>J1@CJ16$53-[7<P/YEQ9#MW
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M6%E0%P3WV+;F1=M<,;&,4#,("X)"6H5?]IO[]_[V'_9MRR6"7DH3BKL4&(=
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M.5:H7)+M>ZQX]M'MEJ%3?D;@S1P^OCQ;7EUH58]M#DL6K:KJ8NKHM81O<=@
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M,8NP1,K Z_2CZPA5@$1[68T-B8@3E/1LTJJ*M.5><4Z733,W#9R*_9PXI5>
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M,(#[[<VX\W]Z/3IH.WP?H1/OFNG@D?<SL+T2;-10R:DRU4-88*RTED0 &$Y
ML<X19-*(O:3DRDPHL850X&RZC \+R= T!HI;X!A<*!8'FL'2A9\O:8KGO<B,
M6R+[QG2V(MUG4E (%EVDEG9%5I(]P)4LK86Q)VTU^JGVKD^$*HC@BT!3?QG
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M#TMQ4KF)GA79,J8<N2'5'K6"<92[?; \Z#/.NE0F97KFND@K[<F4$^W$\97
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M_=RX:K">7)+T-F?=#DK.10?#CE(Y3#\;.6BY)_TLS?,M^WV#989#>2!DE62
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M#760!GDJW(F?"B:T>.)/V"25NZ?'L296%68)6O+4.I(,5 ,@/LK2F^(J>.&
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M';6..OOU"%GWMA7X5]J2U;=B4>GY,A*MLI*'/=*U0P;[^<'.\1;G]Q@+WS\
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M]TB&)9OQ+(V9;F/,-,;,_1HS]\;T5V37.^O!KH,#!&).@.916?DU)]!_Z?B
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MV "$^3T074URQS+,9VCC8PQ*1[R=Z'06%(^S-166.8$\D5B"K\N'WGL:<L[
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MX=QP/(-NNS-GT,K'C[I']K@JGV=>H27EQ?'YQ=9)^L=65X10\,).!K?M>%+
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M ZS>YEM_W+/;W^V4<U[JE+,E*L#J5CZ-!G;WP7J W 8;L(N/.T=6';!K<=[
MJRS. E;\65FE>88\0+<S,'?D&.[#@)\?XW48?*V:D'H)[@=\M#YAG)X9)TYB
MX%D@G:(QZM8H\$(23Q*<0>79 .:5&Q.]9-KCU1@JF%A*6O<<?V+#>3$+K%<
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MR)9EP[6,MIN,=G2GIM R6LMHCY-JM%L2;4_R>]O>H+ONK6WS>[>7%;%K0)M
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MZL(HT%^$J5]TNX?V,JB3S-SO_)K63, @ .FMTHSM#=3$9M3O7!0BJ6YAZLG
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M&@*)L'&=8S<.0(%V.=#(<OD-UH:.DQ&A &\?W#?LZ[P\HJH'^N\:ITQ3<&;
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M1D$:Z525]^=7;[#U^GCL_>]_!O/%ZW,?%-A%-&*[_=>DXP&G5"Z>GWAF3FK
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MP4W69Z@S#<SIC*6+>OU1/%.DCVLDP5[<W)\)X8"%"AF'N=*X9D_N->JW:+(
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M^G^#;]TFR+?7"_DCL1]1?_VH3S7J]_.A4) NKK))U%>.DBP)%7(7 L ?O62
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MR@D!OA.9]_LB%UT%ZE$!]K_"-*^2<%\!= L0FS+CN-OOI+>R4E\_#^%U(B^
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M_U[F89;TE8JTO;N]A!TNKROM9,.W_T.:=>=?D(4GC.=@4\Y! I]=E5P D/%
M,_[/\*RT!,GC7J0_4U<?Q\?-=? PVEIKCOOV41&ZHU[6'54U8F!4WC ZRK<+
M\B12[16E]@"5+A[,9J\*V;;O%K+=95+%BKL8"O$X4EJ(E(B46X.45HF41VDO
M5['V )(G\(V^JOH"OWZ15XFJCP]0\7D8=)+0. S#=-@;J#(U'Y*LBU"*4(I0
MBE#Z%+JQ4.E$*-T:*+4JI?-(+7(,RZR^5-,Z__N_/$;=7W+CZ/C<Z ^S?"B*
MUH GJM:+8])7P>M7%GVMO@*X.^P4#[@@_UM48HO2O@I K'_S0I6'@7LLDU6]
M;2Y$%HB>S,GY34?> EQK3&>FR1"J$:H1JA&JGPC56,\-H7IKH)K-"]4?[D-U
ML<6(UXC7B-=;<^NVX35#U1KQ>FOPFCU5M::>\4?KHG74&D$OM6SS47SV30?Q
M>2Y\'F:])&\C1B-&(T8OCM&H4R-&;PU&/U6G1HQ&C$:,WI);%\M3;# ZJWHD
M)V<72"J+XNDZ-NM$9[X;_W[WY9,N'"IZH33>IV%1/Y1HD$BJSZ/J\RB%$?32
M@2'Z?2DRN$/?J"K**+Q5?3?>BX$PE!'2"&0HACD\9I 7[QF(*P"H3!JJ,4>D
MVFXIUCIZQGA U?M:.UMM#*VXB#Z(/HNBS\71KT@JFX8^E^(F[:7=6^/X9B![
MN78(AFW9%2,X0AA &$ 80!B8%P:.#C\AJ6P!#!R)3EC%B'Q*>M\#D4L$!00%
M! 4$A85!X?WQ!R25+0"%]ZKK>X*8@)B F("8\#Q,^'3X#DEE"S#ADPAD!^$
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MX=1H1U,<+>.472F\7Z?*#F\<B:R3*OVF#/<!?AQ)G6==O'F1^4VX-&O^R"J
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MVVIGN)O8-?:LW5<^Y] Y%U;:[OB7BER6N]4%9[F7[A38*\_Q_Z?W<C3H!(A
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MD&<R[(@\3^)$1G&6=@_/CTZ0IR[$4T_K2J]M6SR69D@B4U#"/<<AOAUY! X
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MLL4@0@MM])&.L*"-/L!&9Q(2P4FIG"@V&JN:ST"L$(S4_<,$5=R'6O7)6]6
M9AW"!Y/A5],NI!@Z>.I96+,^")+-_<AF[TJ[JY I%=DG K%VN/",DF"=)0R4
M#Q9"/3^WL2VTQ:,@JVRE"QV(A5:Z&"N="1@P$42BG$AG$I$I,N*]K#,-K$]:
M4"]CM5(J6M6'9AT"!B\'Q\?=\3'4MI>^GQJK*M<._5AV?^=O;P9CZ##1O,3D
M_RRR-?WC/((_C[HO^MW>_[LQ'I["U]8]<[,[_?1R]E;1J.]BU%>:2VFFA$M&
M$^Z=+(]>;XBMHY<T)!9MX#$H5DWI*WMNS4R"QWFZX 9\Y TXZV@:DT72Q/.8
MB<PZ$BNM(XIQ+J+@B3-YZP9<!X?OPW@0_SP:]!(,1Q<#9^ _I]WQV?V&C-Q5
MCC[G9SSU0SMU_[KX[/./(/7]+YAMKNDY8'\WO,@"C.H&V.S\][>X[AT,/QSY
M(2Q$4>^^^?%KSKN\FF8WOO/#M\,/8S^&])OOG<+TKY_+:XI$>!<B_%((\(((
M_TH__2;3O_ZW]SOO_17^*/=[_)'__NI0O>&_B#=?=NG'+^^/W^[_^NGW5Y&_
MW?^SW-,.W]O_L?N1V;.]7PY4\9%#+L_P3(TC4M!Z* H"<<:JH(K&2@#??E[>
MLH?N%SO!/;2$>\A2$YMTC''2ESV4@#C+%?%9*A.US\Z&C6VZ1:]W+KKV#YT3
M/^S\59'M-$\M]H_.K9MO5($?+29F)^8ZRG!U3S8;<+1S.CX:# M5I\N]*' O
M/N5>_/+F\(!;+97CB<C0'(N0BMA<YR8*IK0%'U+X%I_=N*7N&6#"+;4:6\J+
MLF=T9,1X:6KO1$:<3Y&8")DI:F2JAVS8IN;7$\_7^6VRPSJ^0GLAQ&>%XJTB
M]:D49+/?YF7=1U*,$S/8'8U.T02>RP38VUH53JG6VI.H+"<2@B;!64^<BBDJ
MZ5AY=5Y6?22!B%NF'5L&3&#,B$0"R$RD5)KX$#W1046OZ\8QMHC".S#F32SY
M5&1XSM;=9CM=QDV*WX^E.8_50"!W/T,B7V X^+:A-^X?9N;FMO"9[D= %0A+
M"9,4B*1!$LN-K[/I9-:9!5&K[ALWC/^C1?4Z6%/7F@PZ&N[3&>XT^:$DV"Q#
M((FR\FQ50A!O0JJ]%7F44::4;1L-]ZGS+BV,S]<LX*#_D.#\PG3SY%(PJKI
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M,*SO*M?D6W,MG:-A?:S]U_<Q,L6KK032&>3.R_I$[(]'__R[OQ'_9]W@-ZW
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MN2%*B!*BA"@A2LN,TA/'0N\FVU]!+A>:?H!^^6;<--%&A?Z("IU?B78RZ40
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MR*)6L6V::6W*-2\LI-SEJ"G)O%:LV1E"[/G1J)N[D&JOU-&XO-(T3BUO'YS
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MDPYV%]!?<-)2<'<T.L6&@O.JB[.B+JJR^/SS_LZ!!IN5CYP$6F?2&%MD!F-
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MQ02L,OHV$#(+]@ZJRU7N^E&]CFO7U32QH_'H9V'V Z"\!O,W"QWT_*DV\OL
MKO$9!AQSL/%9'J:=)OW";VI'Z"SQMPH-Y!CMX7GG<UX_0#41=J^<UCO-Y(4?
MY_2Q?'$W&!^!TG)J89'YP6D3Y\[)6ZWLJ:LC?#_:&^GF]UT6=VM$O1O%_?1J
MNM<\.>!DL^G5UX_1J11TX$BJ(!#/C5E-3 81A04.CBF-]??,II71YW9MWQY6
M>\1,#9\)MUJV[V:YL>VVZX]=O3L=1H#G+(OA"MLI@R?O-SE$5X4,JA2&.ENC
M"@GZK+%D96CN4#F=VYW_V/AM>_L-;*2-HC3*G-+,=B:UDQR_:J<9QH69MZ @
MGIRVM$Q;]YBL4Y1RP"C?^61FT\'W8Q-B[G6MFX8,J\2GF7HWC4[#4*N S16_
MJ>]2*:[?4T^G8>_+AC-+@J@S6H']<BI0J$.:\Q]5<U9'LS87G%173X8[;T]D
M:U8N&I33M,U&[ZSSTG*$."=WY%P5N'&E3U1JN(/UVH2"AL-<DORDUDMKE;<^
MO'9!&8)5D/>4>>+B?&9]VRSJ5&&9.OMCEHP-MK2;1MF?S5.'ZF2]Q?S8IE9Z
ME4Z3,ZORM%11L6K93?]NPO:]:L3-O-49B^W9J\0QF]O)J![55+%O)%.E/=;K
MH?(>]@;]0]0#FS>TE\SA8!#.8!-]-KL@#-]VA],!Y.AK?PQ3V<V._$M_" L&
MUD!]VJQS$L='.:I9Y9+5:^)9YZR2QCAKWCE'.S_H5(T V USFN9T=3VKTZ$G
MT\#Y? *F\P_"&Q[&.BEC*JG6PH<YM%]:-PI9,:^R=O+;L\7X[?Q<MOKZV?1K
M7Z U =/QS-96M93.FHR,*AEK//"?FE,W55XEF)R7! E7]WC*=SEXNY?/=3;9
MSW/3*FN%^313GJDZB[8*P\^6Z[,<E)Y4EF6=.UQ'94,W90-J:G?"!:9Y=.T?
M;W9>-,UX%ZSE^L3IHGW9I,C!7W7P%][+F8,@A]CYU!^<+3JP.JXZ8E E&LR-
M\)PX!D(<5MIA7J'#;F6S3S.,!I/1)>B<FG-@^':!O2KEU^4!VA'8C1E&53"M
MMH*[0S\Y:?)XUF-=M&=UT72PK1/#P^[H4TX-AP'8QI\RJ!.OZ@FMO93=FH&F
M7\O#R!+M5EM[@$?/>:QS;@TQ9WO5^;S].C,(Y:,P>5UV3]QD.)K[9/(90."M
MA0-!5[# _$1@?5 /Q'58#;6Q-NK3:VG&:?/O#^UI-[02I/,Z:MI)/[L61?]C
M_G#?I^%_/FNG;C_+8YQ?MTHL;FW_S?,"%)OOP'P,W'?,.C]'7;VYS+X4^Y^[
MPT&5.O)L=BRG=3"\/FE9Y=!-DTJ MW-X?]AX3K)3^G"NQ[5LP]%"_E:6>'1P
M^3JAL)6RT@RG_D5+K:CWKE8N]#P=)I_K&DR/6^9ZJ\,!J -U&G15P"5_PXZG
M"3'UFLP;S&$SZL6E-DT67+ X&[UMX8N?8O9^ [*[ 3CP1][D.XZEU66-+O9Z
M*4&U@UWV444=@N<*6<H)XII&!&\0))U@UKGD4I*/,JA6U1Y^=4F#R,=L#[ZX
M4$>YT@ARTC>P=:\+[V=% +;B<4W_=>Y8OVVW540!7ZA4Q&IW:CQ(60\=-_O0
M'0'R:-#[\OP"#'?K&Y_7K9>>(@I??B(?O5=2.1U0E-0A+G+Y6I8(2HH2HJW4
M%).-K?'1,,9\C&5\5$5.P'#_)AEB:@_G5,L+V\S#DG![,_P3EMV+*NJ07SU)
MH?OSCSQ1Q6-@*":,$:<B(>L)0UIAP[1US!-U,3$%QQ0$C99CK;D&\M;86T&(
MC][+Y!YG_L/"VJAS(.J05%X=:\';\XI)^3##<-)HY]F FMD-+7,B1Q'J&:@(
M>GYHHO+4C&HE_.K:^E6"?^V@6-@.ZG(;-K3R*_)1)/@A*-N+9F+]L]I0O/).
M]?Z2MY_I</\#RE[6L]/"\W;'D_I\QKK9?3/+::KSUQMRXU>MK/M6(.?*N@J+
M4]\X^D:S@WW-W,:Y<^];1^?\'&USC* UHFP]S?S 80 SD4\632/K,&W9OP.?
MYMR92UP=8-M^?^,HR=_?)G_3DOQ=DK^_D>2EN:D_S#6]H (8H;C%5G ,(^(V
MVF@"4TXRJUTT[NI-_W)F?2",7#X7/U9O%N<"C-8HF.<Q1L=IB%92&0)UQ% ;
MJ.$;6P$XSN<3QW9Z=+ )Q%<NJ5[O*@[-7VD=:)][X5IG_9M"/K.CX+,+++IG
M9I3;.$H7XFCM?;XJ03#-![HR\:>]5\QY/9\_R_>8>V_SL>GS>8)3;U!YJ5O1
MG?G>/ZJ=T'.'36O[ #LC5Q<^K08U?[O9SRZ9HL41GN1P+/PSJI)\IH&#*K25
MJQ&/TZ0WUT;J$,*@/W_G-.=3YD/152F=N9,Z[UJ-5VO^Q)N7;$7KH'%<CI4?
MK_U6JMN5B4]3B5[(?A+6"<&!\1C!7"9A=7 R)*P3(1$LO,O;Y>SLO5[,>DK=
M+S&@KW$X6/ ![%5^T_WT8KJ<_@9%\M<Z$?&WJL+'\.#(]M^>QEQO*H8W<9CW
M2@#4+ \*/TFK\=/'F*2)AA-D$IB*7!*!+!,1*4X5EMH'^/?&5G_P3>)3"[MU
M ;]9YN=A/>-U!:(K%TKMZ[Z8)$><"L#4P<""BQ8[;U,DL L9S8#'Z:6.@0OK
MY0=^@KGLR4SXB#Y!Z>^!]'&0!&MB4! YEX?2A%S@&I&HDY;)<BK-QA;Y-NWM
M_]2^H&^LOFML-IE"X%LW91 J5+(>:QBR 'JB#N?,25!MG.;46W=Y!YB+# *4
MZ7/NY-E@&$:Q7UCDUNN([[Y\_U&[0$0@& 6;UY&7"AD3.*+.D=P'%9M -K8&
M_7@UC2R112CV21-8O(H0'K&T$M,@!*B"/& C;&:1JKF%05>NF<(BUY/^WDO_
MT62+@RF.;&"VEKZCBB*O)0DD!%@;>!DLTIQ1>99]TC=;$1YV%(^)!KM+<N>T
M3IBH@*-5-#=HU65%+&M%[.2,ZK/=8[C;UT]P[7<?14B*8I&0!QL"<1PQ,L(Y
MQ)*FQL!G@N8]AFR:;]?'Q>,5<YVC\G4.XVE=E1NT_%OP!5$21\*EXR)Q EJ/
M=BPE;:RF%@QSWJP.R3"ZK"M.61W7YPNQ^]5_%"SQW'@(20FDP84+2!MLD2&1
M!:QP2LY_IYO1I3+48-%'0;CE(7%87SHP4"2SWR.9@!,M"%^N#'.OH22D10Y8
M%7&N-')">D2(YS80V/>ENZD,G5'*8:=9 B-14V5C,@[4?\JP<BJRHOTO5X8I
M :<%YI$#*Q!DR"C2S!NDA%4*K')&V>7[]H_?^#]-LO7\J-HL)SJ[:EK'74>7
M'2#]UO%RO:IPJQN&K/29:5+76L0@%V),LV+3TUR^G%0'^GZ3$+]0'[SR#>9"
ME/W#[.8>=D8GV7%Z2?+;9F>[2:'+_L&<H3 8M4H/S[XW+>9J<PTZ6Y?>KDLK
M]ZJ32C,;HRYQ56?5YW*YHRHM<'K5JK+Q8M&CIMC1S-][>>7>S?L\A?2VJ0L'
MAJH=';WN#<ZJ=567<^K-NY",JC#"TTY(V\$?0Q F2B41YAR4C>03<BY&)),,
M6EC0$2)]E%D.;:EWJD2NO!;F+90Z._-SME?T#[J__I35B"^T'?Q^WSNQV/:N
MYKEQ79MR&M&MV@U6 >?347P^??%+Z(Y.@0&>=_O5&*H?76PL"-=LXI?&;"JL
MLEL\=Q><]T%LHIN;E<?\0H_$^C,N-D&!O?)CO$E^\C/!V$_]\GN#)6+38%T&
M>S>#)=<>T"4-@:?K%3:->/-O5DTQQ[-H_@QQ-6 6+S,<G-6OZ>R2%_IR/DSC
M7WVM_K:7MRV]YO-=;*H\^QD1UYF+.K?B86;C&_ZO9N-]I3Q751V^-R5WN,8H
MOFR-+;+SM9K!KO9$M\IB-'&,:\SWM1[_RC6YYM/8.'++--YN&INZ3/>%_NOW
ML_<^QE8_^W;+9V)^O,> E.[?IL6S\Q"GMAO:A[6;$Y%5\X-^=0YR;+^T"@)\
M9]7]:&8NKMP?_>[*9;S8I;[SH)OY->?ZOZ_=?_QF#W_]GN(/\=0WJ!CT4[Z"
MQ8I!BYZ#G6KU'N3%^P;6^*.O ?3^[_\=?3@8P-]'Q[M_[Y[M__V_G]X?O,(?
M3CX<OS]^#V/>(7LOW\-87I&]DP^]#R^:W_S[?X_<2>CM'^]\V?]M]\O[?-V3
M/X]V#_X\^7"RU]T[#MWWQ^_P7G[N@W?TP\E?G_[]=6>\V\5??C]X-=[=_NBP
MM3@$C:1Q$G$L%#(J))0=U49BPW&P&UL23 -R1<F@NUG]4YJ] 0I6@K^>.H6M
M+XL9%UQ@V%%!5$[LLHH&)Z4PUDOM4OQ!8*ZPV+)9;._%C,4H=2 =1Y#&D2 >
ML$5.&()2\%3:)#UV9F.+2G%);'[)+%:(K!#9:A-9#B($0I62PG$>B9&,.4RD
MMT8HQ4-%9!J;*[)$"I$MG<CFZIA)43)J#(HX9Y1XYY%QCB/'O?(2*TPUV=@"
MZ6S*QTUD]VS(I^K_UM*0K\L6_)01?V%6KKUW-+]K+1UV.JZ.K?3BD]@\;CX!
M:[-[W($Q7Z_@LG7<>.O8;5OR1!F:J&+(^YP?X*-'VBN*(N&81(43,\"?AFW2
MV^X<-U[]=ZT#%QXK/+8"YGSAL9_FL98MKQQ+"L2!C-<YSRE*T'ZQ0C@J3YT5
M-$F6DSG-IBA$5HCLR1/9'9CSA<A^GLCF"AD/6#HC1?9'ZGRR@""M\K%DJ<#P
M#C0R# H98?31$]E*1.57P8:_/--A;]!'=5YK75(#K/CM62'2YW<1?K_)-:ZW
M:&YSAS+*&X^RN,>NMT^^GE6JO] 48;%T?VZ\,*_W^("^LB8G_$EK9]><@[51
MT);@,?M^Z9BIXI;!\%?&PF[=\CX?GLBE'][U!RYW0\C'!W;ZIY/QZ,]<FBEW
M-:O/$T8_&6;G\J]VU!W]WK12.'\S/0M5E, ;*8'OYEZYKZ^^[!Z__ZB]3F"^
M:H2UHH@[%Y#S@2$"VKH(AEKI5,X*UY307Y:K"UX/;(_#KBWD^?3(<^ENND*2
M*T*2,Y??US^^[![XCYQR);EPR"03$&=1(B.81X020Q/LH-+HC2U--U5AR,*0
MA2&7Z/\KZN7C8LYNBSF/7WUTS'*AA4="<% O>2!($ZD1#\R%*(4-V*Z1>GFG
MOI';7;Q\LXC@47RSB.#!OUE$\.#?+")X\&]6(OA75=EDZT'Z+^WT/X,>.QB>
ME[YWNR]WSCXRHAQEBB+E<BTU:BS2@@H4M?&42:]3M(^RS-!4T.O2 KWU/%5S
MG2H*%J9MSGJ#L[H&6>YYE"N.U2T_JQX"G=0=CG+'NV?-J\%DG%L,=$>;G;\'
MPT_P?.AT./"YP76N,):Z_>[H*-:]1D=5"Z3IC5M]EZ8-%4;/.CT+YD'3/F_:
M#C-'O7-KB:-H0]T)8=XWN>K3V<#PJD;KTZZ\G?AE-K!!;GP3QW'^Z\4>"_'D
MM#<XA^]6S7ICW0NU[O]4=6.M6_.&6#?=KOMFYX[/PPA"_UJ5:)K%%NN6L[/;
MO!D./G='5<^AG(;_W4%->Q\UO:IFS1SF#SCKE]3J/9SRA:.WHUQTL*GH-AGE
MQK.]W'5VUI.]V\0X0]-<>93[M@*55<//8YM6LLOT.QA5;T]+V.6Z= M--V8U
MZII6>974AO4=ZX:W)]6*& R_VRBWJIIGAW4[C=9C3%O+G]CSI@!=IVHYFSLW
M5\V^0]TGI.Z2F[M\7V-VF]'6/=<7%T!]Y=$-+I:+=U=5_^I%W3S0K.CC Q7(
MFVU2+R;#(;PJ%?$./K&/,6EOK':(\< 1MRP@D[('1,/+$!C#*EUSJUKY5B<[
MWY)N)I&FW=D@]X_)WI;K=->ZHVWX7DKG?5O2)M=MNH-B>IIL:D5^IIB>H)M<
M_6Q9M^]])@U=>LDW2C8I?52#O5Z9PA]8=C?(Q/J)KSZV\DO7+P;V!";CLI)>
M:Y2A>GFXZ4][-M??5ZH>U+K'+I]N&0)'@J58&NLIYI)'@PGSE*=(#4^)ALL[
MJ5UV7*'1C6$1[T[7\+K$%.%:K]C>P2<*8R'OO^[@#S">]P>?Q.[!K\<P+GA_
MY^O^RP\G>V\OQA3S]SR!^P@8Z_'N\9\G>\?YOI^^[/ZV]^D#O/_^>)?OG;PG
M__[ZJGV0E*9 /2$<86H$ EDH9*GUH%M[*;6*4:A<35^R3?:X:Q 4%BLL=EL6
M"TJP*".3'$Q[GK3EC&D7A!0R2>G3Y=W<"HO=#8NUCI%RV#B(\13!PF2(.RF1
M4<P@R1+%GBF:I 86 VOMT;#8-8V:E=<V+_B8EV%W7%X&_%*:?=1TLW2E*<MB
MI_^FED3AFQOQS4(A344C]2IJA+T K4E@@YSC'DF,8\ ^>AO3QI9@F]]V(?HN
MW=R=^E- =5=[> '5;4#5VL1=U,I[H9&U@@"H<LM%Y3FRV"4M+(^4FXTM+F]Z
M@OH>=N/'[Q1ZO1#VO=-CRO1FT[9^%+3T?7TJO-^R[ H%W8B"%LMJ16D=HQ;A
MY'-G<6* @G(^C O6*ZXI"VYCBVJ^M-*R*^3P* "],QVA /0V &T;^E0JKZE!
M7$<P]$V*R/%LZ&,&2H,G/"@+AKZ12S/T[]&6OT6 <C$>?O5!C:?BM%S>/*P-
MJ2U=Z]B+XT)E-Z*R/]JZAA0X2I<(<C0?@74>=(W('-(L,B:B%)2'C2V!R8UK
M>"YM\=^/"Z)P5^&N^U;("G?=G+L6XBTB"F<X(HQKL),T1X99CYR#C<4;324S
M&UO,W+R1T(-SUS7.J%S\>]:9>.M_W/!?6_>9-?QFF/MYC\_?]&Q_O-T/K_XS
MZ9[F)/,G?\"%PK7//GKM5-#&HN@91MPJCC2V 3'N(R%.,BH:KNGV)S%LYW/Q
MQ$2N#->6,LHE%3I2&:A)0HE B?[N@9B5.0 S71C/.M72J#+@9XMC+8[$S)_P
M=/:$<?J$G>ZH.0]0GY*I4OQ[U5& G#UM^[XY(!#B*7ROVU2.@TMT3TYM=YBO
M,:J/%XS&0YMOB_(0F@,E]>F(UB_A=I-\T"-?$NZ0CQ)4@UL<U69G+6;^H3CM
M";,9VWVY_>4CQ0Z#;<!18#8!FW&#K(L!22.)XC%*;+YA,Z<4F'W>:YHT&'O8
MPL9M3114R"B  2^RV?=A]=W3"!>WR?92OVP/;09:(6@!#,UJX[1:Y;^<#NI2
MCL^'L0=?_AR;M/U&C6S]L-$;\/PG-I_ZF8RO_LEE9PP> E2O09>ZSH&.A4%>
MIG"T_WTTG!M?AQ&Y8;2?D$UP@>>V=V;/1QO_6F0AH* +DW]QWJZ<G93N;#NK
MN2]D/J\6R_,)T. P?PO&9%=F+)VC8>; _^IBY< X 3/>DL05C9IY88*64H?(
M2=(?U<96=:HKH^A%ID_8;?[G7_9225X 2DU]1BANL14<PQVXC3::P!3H,U:[
M:%R\R )>QX2])(8ZH&:?--9)"V.QC\([%C>NN,^/=:$+]PDV$96H=5IP:J2F
MV#I"#9.>& +L=/L#0)>.\X<L=S<'AXS>U S_S,$A)C<QN_KCGSXUPS89UG=P
MQ$<PL_3!$K7)S%V<1[JSP;('.H_T*,[5O&J.,X?.NU%,DU[G]VZ*Y9Q1.715
M#ET!.+ZQO7\B<G\3Y]?UIF*U%&'\(^O2&U!Q6-+6A\ CZ!:6>44$)X898["Z
MU+IL%3R$,?GG83(\CW9X;;.S9K-,9H_4[IR6+-S[NLL^G.R<[1U\$N]/JGMU
M]U\>?OUP\IY^>/GI;/?XP]'[D]>]W>XW)0O9[M=P\OYXF^P?]+KU<^UP&.?)
MA^,/G_8/ML_W3EYWW__][KPZ7O2V<12_N&#SGNR*_8-?8=SY-_X<KD/?G_S5
M_?#WSI>]XU^/=W_[L[M[\L?9A[]?]\#F_>@UTT80AJ1W&O&$-7+>6:3!SE4^
M&!VYWMAB%VW+JD %^>5[ZTA8' UW.A N.'/::4V=IL%XHQSWMJRC]5E'_F..
M=(/!1)%6+B N(T:6BX@4IEYC155R^8P;OKB0.EF\W]8/^H[I78Z?E>-GJYO!
M<33H?7F^VR[2-.,FX*FW@S0^L\.X+G'1^Z.I\_FYD,2I$Y0@V%H,XH2HG+U.
MD4J:2(PEV.8\I["K&\=%RVG:0F=K1F>W3>HH='8G=+;W=D9G26 1<W9:]"'E
M%+6$7(H">1=5C"KA)%2F,WS[-@TK<JSVNMW2'H&CH5,%)CI^,H+'AQ=U.4%[
M.(Q5%<*?.^-SF]EX9+X&$IATE.L0+=B(P3A&@+%$D(99C7&Q$5> K7:^9R/B
M]V CPG/"O=Z?O3_^\^C]\:'8.]FANP=_==\?^R_OOX9/>P>O/V5? [68:JP9
MXI$KQ /32%OFD9(\<66(5L3^G*^!<NRYY: 69G]%\LY&8B.SP7KBHN%E':W/
M.O(?75).,161 +Y G$:-G#(@6N"-A!GLFR)L;.G[=37\H-_0M0Y^7<+\ZW?P
M:RD6]AR$>0-^T>R_[_+VNSW;?8M:>E. SJWLY'1*D7N$ P>U5#*!M(D,&4VH
M XA1XPFHI9IORB4UP%FAYF %K$NU'PM8[P*L+1LR>H<=L6 T&L81%PDV1.,5
M4L91RX4#O8H"6(7<U"L$UK6/1_\ZZ?;R2$?3I.?AX/,M[,+;//XCLPM3XI%A
MRE@@EA/!-#592: F, RK^_(,YZ+/WRL#[7Y/GS^KVO0=[WS]<!P^[7[]X^O[
MXU=\[^OAV8>_WWW9_^T5WOV:\Z^W>;8+4[0F& ;Z? PJN\ BLL1XI&'#,90;
M8;3<V*+?Q ZO81@:"[3(*=9.1"ZUTC(24%T<%LXP7/=R+ MI/1:2_ZA=@O])
MB@@-$7'F"+))"A0\5]$XS!U6&UM,K%00NI0$6?;I^=F^"Z#<:>VZOPT'ZU,]
M[/[ .3<*#7,Q>HD13M@AV)@MTMAPY"/PJK.YD3C/E4%N?IR^E.YY1#A=UDGQ
M@M-EXK1E#PJ2?% IP.Z7"XXSV P-,=DR%)(*@I-.5<%Q]9@J^#S^L.'OT8[B
MT:"W!%MPS6*$;X\&PW'=7B\?>-R'U=+-/<L.XO DOUG-W(U/[MWW4PR&G>^?
MSR@AA\>M6,X 7':KV^U6?[2U2NUQ=,IJ)!QFL%LIA9P/#$6EN;6.$$SCQA8W
MMT^ *9&&U<7HLI3*@M&E8;2E47J5&+%)(D&51MQ[CVS0&D4NDZ,2A\1STBV_
MO4)9 @PW4"AM/]QI&>EB+J^2]@'2+AQV(PY[U]8SK+#!<2J0]48"ARF&;,YK
M"($$[ZTV/ K@,+)21G%!XZKJ&06--T=C2Z-@A@L;C4%6 ! Y(:DNTDJ(XTP(
M&JVW@,;EI;T7%]5U6E1,A@"=R3!6*0NI^R6_+BZJ'Z0K:"\]+-K C F<,J)%
MDM13^!_Q+%%9HLP/3S[OOQ-E_O!I]^#3U_=?=\Y@?/3]US\_Y?JNN[]]Z+X_
M^"//$=X]Z!WO_K9#<[J"L8I0%C$21@!S84J1<]$@G8RU&D=I?&Y,]1/9"D%I
M&TR"?2DF[D72E%L7-)A;0(^D9"NLTSKR'RW0H\*:(!L#05RE"*]@'6&BL"0N
MZA3CQI8J:>PKJ4<NRZJ;[;B R=?-?EO<53^%R[FI%Z72S+* ),$4<>L5LDI%
M1!03D:@8@I0Y +I2^; %HBMJZA6(+@NB+?O/.$&M2@EYCBWBP0!$F<$H",>M
MQ(([YBJ(WKJ*0_$HWZA%8:[;W>GE*$JGFA$T2&@"?]C1*-ZJLEKQ-M\'Z>5>
MW%@X892-'(Q1G5Q4H% JCF40S%U;+ZE70A5.^S,/93^!I;"=%T&AO1O1GI]K
M)L>O8 R''[W-U=621E%$C[@A8 -HJY%DV/C<1]UDS=^4!HCK#-2?UTY:%O_S
MU/T2 _H:AX,"X+L#\$QOR0 ^?O^165!3F+:(B=Q&.7B/C-,")9"8)S(D, $W
M:H\/_66%0'Q;__5/;=WW>8UKV#RWJX+UJ"GGYWT6;<KI3TY0&%3U^?,WKNUH
M+";3K72'[8\I<AU,5$C8I!#WH#88RREH$8XKR64 [0%,IF=4XJ6=RE^9VG>%
M 59'Z2@,\"#*Q_9'Y3V)E#KD-#.(V\20HV!'<&ZHQ\S@F%AF *+%[8V'^V*
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MO4_PO&\''YES^> !05+G.O#<)V2TBTCG>EI28^%#W-JEYV=V;F1O88I P-:
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MR'4DWN9._UYSQ+>IN6H_NV@5Q9MT_"2O27VD@?GD@>('PRCB!DMD&-%($*K
MG@<#YGS5<,>@5>3$<0%S)Z@U%F8O <^A(5$MZ"H_>1 $N9&17EN4BF%HKYB!
M1KY>V.$5]+]@Q_+R'8Y+MC$W=;>$B!7*5*^%+9:B[/+PV9YK1GH]>^B!F[E!
M?*%T<*UPW'$3+VQ09:MAI,!6/S^J!AQL3+&:9<!S[L;%2&?K9 ?-;F]M@AO+
M55T>JG77?F7R^['L: )JA^QXP\_1L+8^"_LTZ=7,,60>F>=V,=4[,%1E130;
MO<8P5G0D6]R0E] :&P_=^SS?YLTX4RSYT?%@=%KM44Y:"P33MH&T+4-:-7!]
M6[* 5G?,'P0/G7>L(1W%S4^SDODRE8/S?6!\0.OS(D'!@VH=X0M8Z]$,1AQ,
M*C08KIGX.,P?PA630J%[>]G2]5[8\6#4F_1+.'C3E$ELF=+VT_,TM>QMT8A,
MP?-"'%CLW+-Q?_*Y9T/& +@B,Z.=WBL+7LA_9K843\GKT-">&7SD%S-@:QG)
M;XAV#-9]^QRRT4C :37L\^&%@8_Y/>-XG$/7H8_U/GXYM]0TJ*S?9#XS&M8+
MVIEHVW)]_'J<5]]:X]XX)PM.&,>#R@7)LG?<VO _N\^\Y-]>M.]<*PZG!2)_
M!AI?I.)960H%%O_S23],#YN@JM:-=7 ,7MQBW60TF$W/OV4#\I06:_8K(OS:
ME7+6I@UL_3P<-T\XM@<1N7&TGY%-\(!G=G!B3R=;?U^V]6#H5P9_==S.'9V4
M[LS65X8S9" HPO*LDCNX"MID-Z8MO<-Q9LG_U<?*N2 B8Y8DKBAX;EZ8H*74
M 5A8TA\56.#BCN=]K P[I9Z473N3Z^,:=$S82V*H S+ND\8Z:6$L]E%XQ^(J
M ?3 RC'Q).)H>,#!!DZL=X'!?WW4Z3P?]'+BN/P>ZRQWV0'0P?)$B26"IV!C
MI)AS%_"YNO>CJ.1ZX[PP)[-)9=?F3M4YH.O/LY4+-%Y=KH9NEOU4N.73+!S,
MEYCR_I'-VV.3V: &_$'_<ZQV74,_); 1\]7YQBR,ZE);@].Y@5S>:9QW8+*F
M!W,&<79%:P[U(>^P#>#W:MF@F+NR\I2CQ)HML?ZPVM69'X==6(%%F!AXI3!#
M $!G]T,;BI-Y.[B^7_-NYWRKH/)Y%U%49V=AF+<QYQT8KNO/O*LPF >C4<A;
MD>?O!CP)!X"N. "S22TD_2$0@5BQE\P<+M&#$+_$ ;"%4*TN0,L/3NM90'FC
M.\\E2#6P%W]8/J]O*)+_T];KW__\O_;H^.<<Q- 2R#8+]@ORGN4F;]PW;6O)
M=ZM5>?VDTN5F<:98.S2U7Y>6D:;3<=_-IE7,P:C>"F\B,^H5U")W>1VY';-G
MJR"(X9SUU>^9G/.F',Y;*#X(,UP$':^7@-H3D'6N6K)>!.PM]&B5[@(+BE\R
MBM0K0WG:)]N%K/G6@M'!>'0";#03SO:WTW',<0YYAW]YTN97-,&#H$OS@)))
ML^H5I_WI: P4[^6ZR1_'NI?9M\E6K7929L/YGRMO_3P<G:##T4F;\=?*W9*B
MFG)/EGR LJM8??'?$]"?'*29=]"AE=6IS3K<M?S]=;$HVCL9C3\WEU4,N%FV
M:SF^V2O9;K\C+Z<UH9G-S=MS6U#$J=G#'P&$S_O9KZ,]1M6RWMQW:ZU(SH>^
M/>2M%BR66%N2M;K:6D(6H&% L(L3E,4D@V@ML1?'H"YF944RXZ /$SU9[#DL
M'G.N^L\5>VZMYG*QBB+GNZ,58(R*[YGM0A5NW.QT6/BC/PXH1PJ<PH3.!B6<
M9K&$44:WZDO;\+;UJC'U38_6(-Q9<U)O'<W5O]*O*O*F"5%JO:,,6S:1Y>%+
M&^+P:83I+$YA;?J70JX:*&CK<>.,GM>ES!W@N3D\M3<8C3X7QZP$!>4!<AFC
M4B5IH,ZUVSQ?@,\7UMC1"MY^4N'"E]/79?(R&9UK/+<SKH0X\8 ,6=T=F)/M
MLQ9UH4[+DM<(4X4:E^Q"5D)90I6:F/7*588)/.P?9Y096Q#:O!)?R>K<P@Z
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MZ*COR^-!]S['W(9A5?MBLET_J*HD #8MSUS.2=U<:8^+"%8&:QNN::5+[]D
MN#>).4GU\*#<-H@',/P)D'4TGFPOHGC@N4<E^7P=?%/*;M3Y]XMN-94$FAM
M#C['TWS)))=X&%1103 LS3MK:YX+>2Q&Q9V6V3G(!;)&X]L[]W??(+12=F*E
M1,&R1LVF?9BO6"54S"4B!A' )!XO2D(<C^/$C_NN*C]1L@\V1Q%Z[T _@AV'
M2>^OXY);_\UH)^=^5 CS[<V"O%X+\]!9M.O]M#\Z!KG/F/.L]P[&; #SV@SA
M?B[MD-%F?N/9LE#WA9-_-0/^MYP./B?<;&:NKE[1Q+[9<7]2AS:N+8T1JWN6
MP&HZ*A"U""EJ@5M!H+K^R==I52?AS'/CUQP\-%D%1MNDJN^WTGS.CIOGV:,L
M8;E1<ZSO#]=@.O1XM*@Q<19\<]N7[Y@LB_\Q8":,RV!%$0#F1D=Q/I)UGOWE
M#W/3Y^=V;._EBU\7E5R*!;$#7TKOG>D\X$[=YD:^RDD2-+5?V_5-[+3*N%MB
MC&!@SEB2NJK%L-?41[GP<;F$2<XB!^-:-:.I" -B\1G9D*&LJNU2GM4;E\(L
M)?3XN*JQ,YN42AGE%;F[M7PM@?RG63BH\M(M3$7S6<[,FNU/'D 8^#QE2V^K
MQJVJG0* 7UH)\W4P'IT E2I7;,]+>=0B4O[L%ZS+(MP4RDDE(K+5_6H*FQ)!
MRX5DLD%TBP(T9VL"'>6@5[BS& WH3*S>.YGF-AT :N3"..6CC!%5>)R+IZ/2
MU%S8![1[%+;7/KN1WI5FV"KD>ZGSB^XMBND<13N!GI;AK4KIM O*N#CH ZF9
M%$6PK:G,[RKU?29%<>?5D')'JFE8M*M,.T@/H)4]B$U)GC@>%#5O;'"LAWAE
M1LO-^6V9H RK.B<PE&G0U$W)TI<)5J[O4IC*F;G+L<:?8EWGJ=CU]D MVEF/
M2%/4"%DP_;G!3<ARS4YZ/^6QI_CG?SU_\:+\2G[^6_Z^)C& D^"<]6'\"GA4
M!^5*NN,*'R=Y#O)'9Z H3T?UC#E&-#64)C4"%UVN+X+ILHM^',T&T_[QH.I'
M'57=*_&8XR&\(PM4EMZ*Z%5FW'[-"A$BJ+7O5T&>97C:49]-9U_]\GK_Y?-Y
M=TM!K$D;_B:+,.GQ>.3*H:Q<!*>!M!J9JQ(V\\%NH]X51:\1IXNJ)*W![3+K
M8Y!V((,NUP!\G4#64JK$IOV"4B0HOV6[GDM 81#62LCK^<L-6 L&VV?Q)\L)
M_ ?FHIZX^51MMUJP)(>MWAS9TZ9B60U=1?4RK7=5UX]'60?[V1')E#^3^3,5
M7:H;JN?LY/S/V6]9A*8WL]* 8Q-.?[9$V.JH5@^NNM%+X]'14MFF<,X[SC[_
MUHY(W"MY;@MP=GMF!6WS.+529IRI^=74KUL=VU&[7F8 .6C"JI?.U]6^RE+V
M\DI)*N4*JZ 2BS)>C_74%N-_9Z!N5&W7J3_RP[,LY^<T&+#RN%8%.7>Z4/DY
M!\J^7U4R+KO0*P-3U0N;9*T\%QRJMRX4NVT0R[BTC%:A#[5YJ"%RNX+WEHG8
M7M+F596M\N>NL(X+K&FK;E>Q(="!0:R)UE*E.@L<M7[*HOSIZBP<VC:#GM3L
MN*9M\/$R>9X\$I?T^;DG#I;)^%PJZNIR:[A[P?"Y3V /#G*YN7+!M<Z7?M_*
MO;S2R;_#T>#KO"[:F]'T^?1/H#AOTZ\6'(SAP9JZ:.:!KN!__\&<UR?0AJ\?
MC<>YE+9 QAN"N+<8:97/[7'+%,4XL91SQ9P;L>&JTWK;BU*0(#>94-8V>- X
M1 LO<@6AEA(O-(M@BT*BMLJ;- #>6+&A^>+1T[%W^,';NU(%,I]<[^S=?=F[
M+F?)93E+5)>SI,M9<K6<)9?F(%G)62(9U59(S:W3G)%@)*9<6X8Q(SZRZ^8L
MN2<=N2IE_C5;IP' \+1>PCB>C0$1LK>>X>BL^6B?>%T%,)>W"0%9P3D&<T#P
M_[<$?*M7UR6"IYEI'-K\ZDP8PH44Y(><)B^<M#E*_C8U[/27TW>QK,Q6Y\2?
M_&'Q3\_Q1^EI3D\I$5!2CF"L);)>,J1\LH[ _Z),MWA8_'X=L]YX-!@ G3NQ
MX["TVV+K"F-9ZBLIKTXZ5^)2+12M^G2RHEF9K)UWP+R_]LAX=QC\W,/@G*L=
MC(N G',:O'RW_DPWP\V]YYWY_LXOA=JAXBX>3!IMN.T&ZSL:"79' ]&-\"8U
MN X[7O%0**GT\L)09-PC2R^Y7M1RA2VK\%#!TFW;#'T9_RU>0"X@4->868V!
M?$*C\$OVWZ>5$:E2WCWAP?CM_9MJ)-[-P$9"FY[P6+S[' =Q:@>=:)3AV!]-
M5\1A/902<0&4WM;IN+L9B"N>*_C%#DKD8CO[4J^AS-<]2E.3RQ+T?3SM34:#
M?N@U??BN8R/W.C;7/DQW]?Y?&GM_KQV_QI:5T0$[2;VG/').G3/<2ZZ%-B$1
MK>7YR2J7#YL\FE21U?&1T;</T+X/+P_HFZ/77]_OO\8?_K5W^O:WO=,]"K_O
M']#W^SE5_&'__>KQD4]OCO9>AM*>]Y]^/=S[]">\^S6'?[^]A]_?OOQPF+/'
MO?WM?_LKB18\YL3*8)%SN3Z.519I%0DB1"M*C#.6TJU=3<F.O*6S<U<6^*L?
M.ID+_@6VYE+D7;57'7!UP+5:V,]:+W-B$ID KY2P6ABKB+/4<0 QUP'770/7
MZ>+0+TE2P3\($Z9S]0*!0%0U,LP()I+/ 1!;NTKR<RM[=<#5 ==3 2[OL=/,
M6L,\UXEK3[ .20A.$OP_W4IZ\ [5OA/5WBSHF @LZF0(HD80E$M2(LNC0I'$
M9)@(D@BRM4NVL60[O,.U#M>>-JYAP1V6 &#,.0Z89HWPTAD9@N=8I<Z3O'/H
M6A RKSR1/ B$!3B1G(F(- X.<2HM9TP+Z2QXDM=-0]#!5@=;CPVV@A(LRL@D
MMX3SI(M^N""D ,=2^HZ.W2NFO5W0,9XB.)(Q(!HL!20C&.D,<988"NQ9<J#3
M6[MT6PIU:[FE[AS7+DD\U01U0$_BQ5#877GW5W:3]8"N[";K 5UYSNXMO];N
M;2K_/*C=V[V1ZX>^/:CJ'5:G"\[=UJ?7Z_M:BOJ@J5J4C$MK#0F"<INB%M:"
MPXF))-Y:%M8&*E_%U6RJXU6U*G\O614ZJG8MJO;78B/STP%^\_+U1V=#TC)'
M.+MDJTT!#9P*.2#:(J@4I 7]YXS>?#=SO>;?J:.Y\LIS VP>I]+6R=VZ:>JF
MJ9NF;IJ>QC1=9X]/<LZT5=X&ST,B3DC/K>1!2Z:T7G^DJF,J/XBIS!>5OD&?
M]]]_=,!-*%8!8>((XM%QY*@U"$L97**)6+R!3.56?*8'&/&:3PK$X2C$&SM-
M5ZT2\:"A"$<AC/.4!A6X,LPQ';EE5'L<4_"T@Z*-<)J>?TPVZ"B#0.#;1L1I
MHLA8[I"VT;!H!)%:;^UJ=MV:A+=<..%.]N4>N;I^'\'KIJF;IFZ:NFEZH--T
M#8ZB96 QKQ"F%+AQW"JAB4S":".UE:[C*!OA+CW_Z(7!PG*)M)"Y%*B+R%E.
MD=?)*Z8=Q8EO'$=YJIM+O_1'.2NLK8]5=WM,5X$B*B66(48;E>"*>"N%HU)S
MQ8607G3NTCU"T?O6'M/>U[?[SS\:Q6D@!CPE+6BN-L<!F6A AGDI$]:<QPAX
MA&\>$-2MMCX(EM=-4S=-W31UT_1 I^DZP3 Q,LV#$XIBKB)W'EMPH"R1WEJ/
M64=4[H^H^(7/5()A/G_T6+%(@T.>>(TXS2=D#0;*PKS%U+/ /=LXHO)4=YC>
MC7+>Y*]/>'^I6V)[$--T#7,A2,0T'\>SF'"MB,%,V!B8(I'B8'5G+N[/7!PL
M<BE\^NOD[<OG'\&D\Q120EQA@;C6$6FPZ7DO$.9&:.\DWMIE]-;.'7<ZVT%K
M-TW=-#VT:;J&!>3<*"ZY!VO'.1;4*B^(840+0BQE74S>O5K Y9B\O8].>>[
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MS>P(E,,WLE[_>0N[J97H'HX&7Y^]S?'<SR>3.)W\#EWSI]7/?7C!+X.1__Q
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M(*:@0LU[VJ\!,AXGV=WJ3PX;G3PC)L7VYDNGAYEOG/L^N,+ZPW[,L'%R&&$
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MJ=.RLM31VBLJ2_7V-/^>;P0W=GJQ]816Y=V?O.D#&@'6;CM_E/WA\CYP[0#
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M#POP'L)J8>?B?C< ?IX#8(@L.6TI8H*!BXNU0@XK@J17T48GK3=^:Y?3'?8
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M!2<!1VM1(OE@##$"F2@E8IA)0F#BL<9;NU3MR$[)'Z62WX\A[Q;@;EVG6Y&
MU@ML<4#&BX@XI1'!)#MDDDM)!N:82GD%[B9G/FY1I9] 4NL7AW:<"Y#^5&JD
M_ZT5TA=#;SKJ+16_792Z_ZY OS6C\S!0ZQJ@I:3RW)$<\.HX-=J)R+S6005N
M.:'N"KL& #1'-I>?_3I]EOI?8T#?XGAT637@7\>CHRL$-5>+DM/?2\W8+KKY
MNS#MCW94G]"$AR0Y$M)RH"E2(9AM@D0RF9E2P#B[M5M*1=.?;^F$QP8E=ND4
MOSF3)8-A6@2J<EEIGBPAUFC-&?9>BD V6_%9I_A74_Q%D(!2R2@N-4I8.,0E
MM\B0&!$#ANJ,I-0[UBG^XU=\#$KLDY8,!\)=$AJD(E')"+.1^"2O'0;46?9[
M5/!6C)_T45,N&4I,DYS'S2/CHD98@ZXG8;00]%8B>#OEWECEOH48OX[.;[[2
M+ZRZ3P#;GD2$&1AT3HQ%5IF E#!12X$%B$!GU1^_XM]ZZ'ZGX/>HX.WLK $K
M[F)",8:08WLETBH29"UU5C*MA&:=57_<RHVI!\TNZ5,89T%:XH,""V\EP=I@
M>86=A<ZJ;[S2MP, E4X6]#T@[1)'W$L%"@]NNR!*1J\"8'SGK#\!S?=,D,""
M<T#@N3')69JBE91*(1TE8;,UOUNENZKF+\(!?2 !<-TAG?))O4 2<IB6K,08
MP-X:1SM"_P0TGR1K&)'18F4YC<I%EURR,/_21$7LM8-_.]M^KQJ^" 8D%E0<
MJ!P*K&BX#,B!5B/-*1'82L?R0ORZ[$*==C\6[;Z%@,".T3\ K5^$!U(<><S9
MLHWP A@](TBSO!KC".6$>I)BQ^B?@.;?^J&>3L/O5<,7P8(N< UDC2*B29,W
MU=, CCO.1WFT5%9NFEU_ MD!7PUS2WN_V($=^GC=L,PZ/V/5@6<,ACF,9FX0
MYSD:GVINU]L?GXU&^.L$@COPX"F6@.@4<\DC$#OF*4^1&IX2#:48WG42,'2E
MHNX;Z?]JAU!Z\+]U"#Q'4IF<3"DAEX)"5C*8=3#I#.NM7<YNX\CF[>G7/9\3
MZ8"V ]K- =JNWM1&8VTK+66T45'G4,SK9%Q[@%EM#3)1"">CAI^EW-1-4G%W
M4-M![5.$VA^"M!<O4W:57>X:2UL!PBD(Y:DW2 &J(AY)*GL.B COJ,D'P9B_
MM27(APJJM]/@#I([2+YK]NMQ9$KAJ"1+/ 2GM8[)6Y:8QHP'>^5EA@Z$[QR$
M6P';@+.2NH08]PEQ;P+2VD;$'',A"@W?&R"T_#;.E#\X\.W@LX//S5\\Z$IT
MW0N(MH+B*2$L4.J1=!I E%B,K(P8$4R$3<%*[L36KC#="FP'HAV(WB&(!B58
ME)%);@GG25O.F'9!2"&3E+Y4=KU6JJ-NJ^O^@;9]$"%I+85(@*]$*<2=-4B#
MM42$!AP=V$KAZ=8NI;>1A+Q#V@YI.Z2]=:3M]KHV&VP79S],#,E(;%#PG"+.
MN$):4YWWOIA5'O,8;-[LTAW6=EC;8>T&8FVWLOK#X7-QL"9J01+050!-"5P5
MI@X9&1)RS#@0 FH=)?FH?$=5._CLX//NX),X[8S1%ELON+?,:<NB8"EHQ;UB
MHH//#8+/Q0DEKS2Q23F4*.6(8V>1)LX@*JCDQDD=M0)7GW>+JAU^=OCY$.AG
MMS/UHU!T<0I,.TR32QA)C GB-OW_[+U[4UO'LC?\552<YWU/4L60N5^<4U21
MV,GK_6P@B7&R[7]<<P790N)(PAA_^K=GUM(5 1)7 6O7#@9I769ZNG]]F9YN
M@FPR"3%OB,M55F7NQ<KOI&;\XZ-H.3_V4VD&MEWFDQFYW3TMH7CX)+2_;H_F
MN7=Z#*+C1VF']9]W4,9LEME?PU._PON_QL$?,%]_?@!/_Z73\U^>*#=__,\1
M]L=_=^T_YG3_,W N_?OS/G P_"?V@+,_'GBQ__KM^>[O,.[7G:./K]]^VSW8
M._[/=Q@_<.LGK#5C0@04K92(:XF1Q2K7$2.66<X5!99LU2L7PT[.U@2-C[7P
M7D4@/M7*8H\584H&9HVB>J,5 21.@.[#_FD$=H"5'O'KL>T?MKL5U_%9?97W
M9MKI_*XQF. Y$%;S($PS"$^QQEC4"H<N'KQ<./;JHW8WQ.[P%:5;HM@#]S2=
M\L17[2&,P"\QP;<@2OTX&+;^ JQO_6I/6JB5NP"U<AN@5C&1G\C$+U.F99H'
M1S YT&&V>]YJ#UKQVTEO4+5_\ !6MMUM]=N#+X.6A7_RV<_4[QVW +B.6NWA
MH.5.X<,X&$RUAVC9;FA%D(#><85(H5T^WVI-OPK&;7/OB?R0\L[3?BP])T!_
MYG83^?/V: 7Z>07R,%K#(\#NPR/X-[9.!]65,U>!' TV6V=';7\$0XZ@TT=L
MVDKMKNWZMNW +0.0M!QOGQM5Z,&0NKUA>?;DUD'.O&X-3J+/BC\_Z^2TG^D$
MM_\&W]CIUPR/[#!3,L1L060[H66!*# RX)V4>><H\\YFRQ_9;B%!MTPGV7:_
M]=5V3LNL\B=3#\U3Z0-1#[NPM"'?8B=V2*OX<JT99PXNR:9(ZX>-G?U?WV[\
MF&F;GPELEQMZS#T^+WQ*T5?OROT^TB .AWF]\Y5S(QW/!-8_YFO*A *88<-V
MIUQ1?] >QN.6+0^&%]A^%R[.%)\?2K^,("] N1'>,QY-9JX94DV1J1_S:N0Q
M5@^<NJUU4G78+(1K'Q_'T 9*=<[GB#@:4_Z](N*(;,"30,CXXV:K&X>CB?\*
M;)S5?B'ZNU%WE$%>K_TQ_V\]!U1X?=HOPM[.UFN+8J(W:PI4@A*+T&4:9IF-
M)[8(WP51;-G#?JR)=-8&S ".';9/P*KR8(+!Q0CN'+9AW/"88\")PWQCM9;3
MC_K:RRO=:0_/098&/=\N*U">F"_^"N"4S::YNV#Y,XS8X_PNX-5>O]\[*WP*
MK%]NA*N/6YT>T#=%.\P05$./A\FUA\!L/K\U#_"'08RMO1X\5OVXU7I[U4Q/
M^KVO[5#-H]A]>7; >#$S9A&>=B7@_9ABSKF8'SA ';S1NEZ6QF),9+/V%%8B
M?UU!ECV$%Q9R@= ?MT^/6R<6#-(,5/#HP76+ 9#T?U;)C];686>%\MSSX(@-
MC#G!P+&**@I=;$FB2#;3RR^4X:L.KW1/CU'H#5%]Q4R,:D3:K'9!Z^Z,![TS
MFO$?U83_L.=YT9^\AW5SFW3WV^YKL$D3IX+;*!$QB2%N3 2;--?.L,YRBW%,
M.&QLLP5>4G4.!?"C W^-U&;FC4H$@?.!YRXJIBG]60 5'*,PP<B"$/\]F-*W
MXT92 /X7D,5<@2S9J\H#S<^X&Y I2B?4^N>D76%V*Q2XJ$2_J"! "X":[O0
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MD+^?]LERDT;%-$<VFIB!W",';C:*3 <,"$^#3GG?3=]1#.GNQ&C- ^,-H#:
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M.+P,R/IDD90A20 %K*3;V-9;*Y[U;LIIWW"[:/E>PROOX:U"MZ>-HLM-\=G
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M3+8<?0R&>QH09P&@1C&+8&$\(B$*@W$.C8<;',=X[/+2%^LGWF\=L)U01CR
MJ?W:&PP'5;';%UWVZ^#/LT]84L)=$LAX31"7S"/K@T>:,H\9S53F3[**[=1Z
MM\J"/XLBMM.SRA7\ZHK81S"%TLZLU3N)55G'4JZLW?6G_7XNB3I=W2_T8$#=
MWG!4A1P^:?>C'Z)^')ST<LEO.WG-5NO".S?KZMWC8JE]&W*%[MY955X01/<K
MD"H/ BZ-,$![<M+O?2LU7COGK?_S>!FWUW53F$SU357]_,FKKEL@Q%EN=_#)
MD8@YBP;%8'-F?= (/!6"HB<""VHYKXX#7DQY:8$ =."7S956_ [<H&;%;['B
M]!-WGE(;8]8)&/%( C)2,.2-E40J;J)-X-R(K8M=LD=+7G!@E56_;0_59M5O
MM>J'WS\9'K07(2+)A$2<*(UL- *%(+F*C$H0^HUM:A;$^\>K/E<^LTK.JHMH
M$K.9B\2>Q%QK$]3 9OF\J(=:D83<&&(0X5&@:?*7H)F_Q-(Y8M2+HMVM"WEW
M2YV$4NOVW1#^*2&-7)1V?ZP Y\K,+NAO<A<6P,K=41[)'OHKYOI"H'UW0N\D
MDPU\LUR9-U,7O+8N_.[C;,&C*PPEO029'KGQR[].NS&SG=PL+//;SKM?6NV2
MK-#:>?>^M=?;*M\BPC;'I=[O::CEB:_:0R"67V+PO[6[MNO;($1ONP,PN2O>
M1JU?P9)K#UO_[I5JS#\<]$[ 3P+!_/&>AW_E8(N@#D[=(/[O:<5@=JI32OLX
M%_NO^*HR0@]/06R!U0 +2N6UNDI_&L\YEYN&Z1Y'.SB%">>Z__8X-Y#Y/NH/
MX'(#@#C(Y;+"J"U [J12EYK.6.&K[K[Y4B!$I_Q=O=_F KYE !FL?$723D72
M=FX$\=5VZ@+BMI*0:H#P'2#4:7EPZO>.1\6M9P9F!^UZFG7SF,$(FV"Z*0^C
M*HI=3ZY\D?O)S(PBCZL;SSKG4ST-+M!G,YOW9X"5^=_20V$TZ]F'A=-^EO!)
MVZ!J>',#N.1FF#-,"3XN+8"FRHWGZ_OM"%3<;!4/ QX#ZKS>B]^L.\K:0:];
MJ@E7+'*2VP"5OV&&T=O!\&*'AGJQZLK<HR+CXY9,U0IOC22A'F;552'/LM>R
M7VV[DU^"X"5H "H=ELT-0:V,>J.USD!99<;(U.UGK3,\ZO=.#X]R/Z:KN /4
MRM&HZU'I551Y3:TS>&X$:^.LFP=06C)5+SN?=;ML#;Q5TZ9JLW"DT%*[#_SS
MOZ>V/ZP$9TJ+UGP;JA9/^<N,7S5VP2#"E"_7RBY6/[-)K(C:ZTYWOOCO05ZF
MB>J<<-684>?5YLWQ7STF^N]EU"DIXL7PN$(#&(3UNFF 7Z?[<"&P<'*CJ9D/
M:_171/]8Q.NONA-*@:;<D2';9IG7AT>M7V%U (SZ8YTA\>/JC,S1@"UY$=J9
M5]H)Y'*S%2OHC36 U+JCA#ALL>U^W]GYHPAF%7\HF%L%'(Y/.O%;1@P/LRFR
M#5 -ZPP7 @(<VW9W"/]EC,B=:<J#1[!X.HCIM)/SAL;]Q+J5*Y'I7/>J&2D/
MD)!0J>,BN#")]R=9E#(BVFX82;?OG936&.-%RL@P"I>4IF2H M:3:C,NAU!@
M97T5N,DSM*4N:1[C82^W3"L0&OM?VSYKB+S(.2L8IMT[CW%PST"3162-@>:!
M(G+7V-5O:V19V:Q>Q8Y^VKT87P.ME@5E0M<-E-]6)MV!_3:QOA7'/[;> :!T
M@-8C1)EB@2S*T_=M/:JI?C!'\&D  X0] 5 H1GN!-S"62J^J#%T5G$[C;'ML
M'N=ICE &Z)()4!,$3,4")&_'S_IQJ_4;4.3DU ')6Z[.UVQE%3 L*F!X)<CF
M6'<%-WE<4\&&W'ULI#5R$=WV\;C79-: [5$KRMG+W:C8>*MTE)JP)ZFJ$.+Z
MB8,<OX8!%]NU-O%&6 N/GB HG<5AN+$VC@$>:N4VXI'IGI678"ZA&53S8EP"
MI:,>8;6Y/3CM5"&0WF4AD!<).O^R7=!VY_6"7HXY%"-,U@]S<FWN40#@#=@$
M('N3/L^3( #Y<;.U\.+="*P?"HO\JP?"T?H;OC_M3]_+?JP8_36,^FN1T\K>
M^/]B.,S\6E^HB7ATJ_%R_ *Y]!T+#P8;,/:SM5=!P<BH<G%XEMN^#J=C$-EA
MK)W\XN_5-\:*=%,^8^F1UAH3>_/*Q[2GUJ&ZL3CHU4./J_4 ,9W"3WCG>#$V
MQRVZQL\??PU+4-O.I]6L?>DUZ\$E/8RMH]Y9Z2F<T?1\]/C:G)R?U/G4R*:#
M ;8#-.M6P)_ORW>?9?O1USY%J^!W'UY9.O!6L 4$&'TV3;7LW6]6P8/!N,+Z
M"/,6/7C<9;B^9OY%FU/-=:OI94"$&Y<C<]UN,MEVOX1YXFC\M3;K5^0N3E--
M\%R0=KT@86%T\''E,NOTD0ZO0CJ5DS#EA\PJ]5IFQZ!;_+"32K]-N'XPI^QM
M%Y"\,];L]Z&^W]A^YWRBCN%>>-MQ>SB<WT._C6XODVYT^P/K=KYN@OQ73+&?
M8ZBMO[(PP)^]_O%8V7*]QLHVAV,*4P.GCN6UB&BKTP9QR9&-NDE]JCKV@MSE
M P\5JO=RO]#,Y>ZT#WPTYTSDY_3ZX^#W2*HJ+"A"T!]3+O>YS']FRN7]Q['\
MC)O.S^K+$ONM8SJ3*>1P=F@7<,KB%K_Y>#(5B@'T*+Y="3_!1"[N*S:-@*<5
M%**L:03<- *^L)(+&_0NT=CW<;?3%S-YKPMZ?V2Z#C9;1[6O5 DV0,=1^Z2.
M2/2J;:/I"&^QD28H]N^WO^S_5<SM;G7Q',#-[6@&L%AZ=7-D^-O;T\IB7@B+
MM[7.^-+6&2#K^#55O'[7@OG>RI&\D@<RVF<;&VJLRA"YP[!)&?$]FE9/*P5B
MUY[7>3A7F$8$X;7S<?Z=;87!Q!:B/VZV_AT'@UZ_Y$'4;GI]57'7_@;7O^!0
M^; U.N3TV"94O<ME0^A7/;1MMUJ""B@JD0:CJ<SMOP?S9M H(-&9FNG7T4S+
MAZ,=I,%U&U3U)GNGIF)Y5/6$,8I5X/ #^;$"B$M>5%T5>F4S*,23F"$.A&D*
M?C+[?ZO"!P6)LJ#]0'^LG??R\$KNXGA?JK;V1M)LQWE@>?,])WF,QGI\'.L=
ME58[Y9#/8)"W#T.U)9\W_ =H>'XR&G491+U17T- ?FC^[DG%HLFJSBR[0U#-
M$''7H'JEV;RRNUI,B6N-%<+DQO:]]>Q><L,0%N:>C[K4N0"Y),8H$^ ?X+Q1
M&L#ZG'GY,,IT_;[_^N_/'W_?^[+[_?!\[Y\W^,/W\&7_X&/[ ]UK[__^!JY]
M0SY\?O/]P[OY3-==OO?/WI</]$]XQEORX>"OSWOT3[%W_*_/'^A;_N'@S??=
M@[_;NP=[1__Y_H;MO=XY_T2Q3A%SB;SV!'%.$W):)&1$-%$YQ;%557IR,;%V
M<DZQ,U[2H(UG"7,KB G,)V-HL(88;NW\&9EZ#2X>>UHU3W01QR\VI*\=X>R,
MC$N"1QZX U.;2@HZ2@4=F:(@-2Y<:WBOCZ4SD_LP'?7NUTDQ)Z?]P:G-:18]
M@+1?1Q!>[S5SA,VZ&4#+I/,\ZE;R#YF..8^H /YA[&:8+[EX4P,O"2BV<@ZS
M[CBI3H>"NCL!M0CF12<'ZD-)*82_BP,U.!\,X_&@UB.5C93WG7O=<7QFT$O#
M,]"_FZ#8[6&W!^SH6_#R^FNP".QY?>4IF.OYZ;F47F]0E.9D$-.O&.76C,XV
M9?4^&62=O%@GI6>UWBU.T#@CIU:.ETRFWM(967HQ;W0,BP73'0!'5![C9G81
MJQRE:F GMMT'L^X/L!WZ8U5_#M,][6<?,.\QM?-.WN:,$6 [@]YX/<(EZS&5
M39379C1L"X\\BH6:_6C+#M9H"C/6Q']/EK(0"@R",$6M<3[ER/ J5EF6R)PO
M6K+^*T.HV$==6T?AJFS_RO#J%P?SN-<OAG*[$!MH#,LX[+?=Z3";L+6E 79B
MS'0:B4Q[,,GLS%G!,+_J_4/[[=Y5[^OVP!X>]N-AF=1^J@=50B0O7.]^_Z23
MUT&2B*)2"G$C/+("-+!-E@LEE1=6SVNI:*D)T<-RZ,2YTEI3S#7#/@KK5%+S
M>O>@["SF+-YBW8XD/L=[Y\#)SZ*J'R=)NO.)-U"!6^^P;T\ %N !A\4R[A;>
M'B]U#L/DU.]72ZO[.HY01WES=/+R,RCC..E"M7\]@68)JAPQ5BM8"DLYB<P)
M^"=YRUPRA! ,[ZFH-@Y$E_:D.3';G@SBJ]$O/X^JD[:[13V4FQ;4B*[#KD9N
M2:9RY+4N45T_O@[*;I6@[-P1]>H[NF4TO_1;O$4N_>ZJIQ*R);&^\\>J+:/4
MLW_JU=\)(==HK$_IJ0U=KWFJOOS;Z:<NV2!YB1+,UU\Z54VG0LH:TV=[.5_5
MW[["]X>I'&.N"U&4W;$/.2;5>I/SV6>JASP@7<T\62_VQWY:-+U1C^OKY_XB
M";A"UX>&@(L(J#=+BO'UPBV70K=K2/%P1;^6(\2H3G#K!_!!ZZ/K@PMEV5;A
MIB?'"^^[[?'1^<&+FOG;[K"S]:)F?- ;VLX2,UY!?3\?XC2"\')FW A"(PB-
M("P4A.N,O\N*1=Z4)FM7!_;U>"<I1W&OYX5;$6098'F^+W@2@WSZ+W@2@US#
M%ZS<1S.5_]UNM'//> J(^>OY$-YT>-[Z?^WQR<^MW."B:Q<86*O,^;G5#%\T
MQ6=3,YRHD#S%CE#IN-'"J1@L\YX'QRA3:>7NY?5F^3IU)KC93GE5+KPG/O[S
MU]'>/W^W]^B?_,/!6[S_S\<.C#>7"\?[K]^RW=__//_PSUYG?[Y<^.=.Y^/O
M;\C'?]ZRCZ^/CG8__RD^'O_=_G"<RX7_R7<_^[./K_]U](&^%__Y_N=T"TV!
M&=-)::2BRTV;HD4Z4H=<BBI12A1\O;'-,%]0O'/%>N&+,>NF[0D:F'BF,,$R
M)%@96(R6LP3@P*1RA@3)4^1<-3#Q8#!Q/H8)'TB@/GK$@\TIL,8BE_^,2G"&
M2<32T8UM(LT6:V"B@8D'@ D'\(!9M!;8DL/OSDJNL3'PA]&)+%/HO8&).X&)
MO4D+2,#K*(A0""># 2LH1490C%1*,AE+&4]D8YNK.^C(?;<P<1>.6P,USQ1J
M.!@>GF&KI?,\!6]QU#;I* 5SG$2W<J.U!FIN"C43QX6&: .3$7$A..+4:605
M%LA@RKP.BOGD-[:IE(U%TL#$P_1$D\HXFQ071G&O7:Y&0(.D28N4A+$-3#P8
M3$P<%X83!=-/H 0@CKB+"H&52)"PW@N9(L;)@>/"V8)^- U,-#!Q]S A+2\G
M+0D7N4^2M#("&&!"$B61<-+ Q$/!Q'3O>BJ)LYPA2KQ$W#J!;,($C M ;F/
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M6,P=H4X9IDR2-">3*\JVKGB.<L18K9+7EG(2F1/PGP2FM$N&$((79>G$#H^
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M[;E \S\]UCC/=?PZRBB2 ]:(V"%NN4::\8  BH.1T3,G7+O[VB)KS&W!;YJ
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MA<Y;<>^/_I Z#O3Q##F!,>).)&2HQGD:="0)*R"=W=JA:F4SH-<!1?=E0S[
MO)_%#K.5!8DZ]F0 *_QJIUT3JEU%@X0FN<U*;N!RH73ISO']C=N9TM=M%9;B
MMQN\O<MK>I/>C^*+S%4O6GQ7D/M6R+U0KN*92R81BXP/"G'**0+>],AQ&7/F
MON:<;.W@3<E,*ACRR#'DCG9>P9"U8<B"]??^4"1BP,K3*')+$,<:,"17.#BK
M>6*8>H-E!I(-R7<J,<*;V7?=' &.\&/^^YV&@#PR%'YX<TXVQ9)[W;#4JR^G
ML3^*!7EOA;P+>>5*.N]TKB/3*:&JSE)39E'N%):2Y\10E_/*[YQJ5N8C%=SX
MT=9;P8T[XL:"Q;9[F!Q1,7J.%!;@^A%ID8U1(V,U$98 M@B\@>!1(G(SR?S5
MCHX[I[9;MUZV)SFE,^?K^-XDGY!W^U62S@D(SV18-6+.$;H+0[B>WVO)WFKO
ML<J6/3]RC/J/S0'PF6]2;W VZJ3AX&0I4:M8^4]$6Z_%RO^C[L7^IC^;T%$4
M]ZT4]_N%XWZ@DV%4(T5RCCDW%AD1/&)$$IF(!94M-U!G%PAYI!"R%H._0,C=
M(63!]G]UR!R06@B/K,UC$0QAR H"KH# )K)$C')^ W%D35TX[FF([,:!V-46
MX6 Q7[2<X3^5\[>5VX2+B58-E(\*@-\*P _:-J!,R24F-(HN:L2=3$A;+Y#A
M,G":'(NYLP#5VW2SCMH*9CQ2S%BY$5@P8S68T3;Z]C\=QL"#EI(@I0-&/"J,
M=% 4<:V,ET8E+'-C K9M-@LX2ASP'L[Y2QRP./&KL?DNU(VW??@_AEW@M5/;
M*RC^72CN%Y(UJ6"!1XZ<5PGQ0!,RREBDM4[4**_ (LR=9>X\CK=$_PIPW+_A
M5X#C?H%CP?P[.&1.24^E1=(QCSB-@!Y><!1T)"PDHYFO8GYJL]"CQ/Q6*M[[
M@['MU9;?G3,';NL//-FZS5N__Z-1$2N+)U:#<6>!@1?]T%86%5/G;)@_@*5_
M&PQ?U S]NN'GU_W=.2>_2=4EY2SI^_3*4=L@=4D&"71$,DJ-N)01Z3R:.3@E
M5!*>VDBV=MCJ&AO_T.KS@F)/%<56%N$L*+8Q*+9@';_-)^+6!L-04MH@SIA$
MUB6%3%+.,J>EI0Q\:_F@H.QVMO/T*U,IJ?O1_<!HZHI&!#+8P#"8Y'YQR_N[
M$4]XJNG+[]Z\;UH$=.RP.\H1Z2H,774=RW_K]L>#3A\>MI2.T!DX6'U5MUDR
M$Y[**>/*,Q.6JH'?N+&%]8&:??7%']O^4005O'@26;3M=_:*.?OG_NOQ;M4O
M^<4AM6 Z<5"MN70--&U*R&FM4%0QJ8AM(%97^0NEYT!!E@=EW1=D^1'(LML@
MRR[>>_GJ[% QS+F,'&F:<I]FESN:4((<)C8)&UTT=FN'L-*)8&-QZ>:&X4+&
MPG>9A>4,\F&#]ZK;D]X$N]M!FX+<WXG<7^8V84;N%_30::^M= %XRG+$E<+(
M<JF0$$H$[Z6S')#;K*R5:4EO*-!ROSU'6_.%GZ?NEQC0US@<%,CY<9#3-A9?
M\$--C/!8!"13M  Y/B$CHT*$@'%GL* TX#R,15-"?]XLV+F-O;@XYN;BZ(TJ
M"$T746GCAI3\S?Z]TYR%C#JCX\%PC, </&ELOUAW!:D&CWP&J[$:#S)O935Z
MUCD[[OKCSED<QD[W!,025F%[5?Y#SG7(<[_!P%R8+%#3=SI+8?NZ 28/8A??
MY62.Z68!<\9AY[<7?_[2>?'GKYW]P6G7=S3'G3,[ZOSG+: R2B4#H4I)X3B/
MQ$C&P.&2WAJA% \55&IL&$8-9NH%%UHL8F5_<H+"8(R:;WR[/F"47ZEI"K,7
MYWV<Y0,%Q>\?5'1 ]O;?'T:1&*>&(.)HU=)3()<<1]%+[(P7#K-4I?E?94<!
MU_4RO;-HI&[>S4XFVA+_+P]A?Z#R<.\SM$"EQRN"/;MV/!G"?\M\K9>O#YE(
M27)L$<$D(:Z3R6,S(](*W &3L-*<UJC3[4]B>)&A0EI,18A,>ARXT=X9I86U
M@AK,K(CXPCRN^R7VI49:(7*+R,%XI@0062E381-!FAF!2 @8/N DQK1,9*UY
MI)K[!$S A=*&:0&FF<G4 JJ392)?/LPLCG(2<:7JTP0H$CLGW7[W9#*U'TZ;
M-.-&)P*7()^)V>M5-U@^@6QE05Z<==8![3E(5]D1SR] YX6_+^/LXE#"[_M-
M"Y\; .1T6^7Q:J>#43=_YWDUW:W[.3;CT!J'J75A,Z(-SR^Q;C3H3<977W+9
M[+8?@?._(:JO-."N6N3.?[OA3\OT:/UY/,N9.+5'$;EAM)^037"#Y[9W9O\_
M>U_:U$:2K?U7%-P[[_1$D-S<EYX(1[B-W9>)%K1M/'WQ%R)7D"TD1D+&\.O?
MDU6E70+$+JB)"3>@4FUY\CE+GGR>B_[&_TP[1O"*,R]_]KTM?3LIW<O;F=/5
M@K=3>F,(MKJ]PEA^+>9 /@KNR3Z;>VD<]S)2_U<+*^>"B(Q9DKBB43,O3-[:
MJ$/D).E#!2A03MO4>)=!OI-E".S"D9R9*"4N4Y%L8A*G& 7'GCNAF%(X]\MK
M^(UL+/D>$PX@*?K(#.;@A[(;L4I[H00$QEXL^YX63IN@I"94<N&SFJ3"/!#)
M;'(&^V7?2U18:77TC <>L; $+LR"2 H3P-FP<7.A1:*6*"TNO/"UGG?9@UX'
MY@^D[&BVP*_?1ME1\BUS2['$JS\33-R_!*/8$D0]S&EO]@YNJ-?XI%70FTD-
M?B@SGZPXN(**XDM3EQQ3Q/RQ<%/PNC_?D/2\>+JIA[OMAJ)5^CJ?]2H Q*KT
M(:A!Z_[ZNK]^IGSH2+ 42V,]Q5SR:#!AGO(4J>$IT7"X<[.6OBNK+<.-I-N#
MN M7WC^/[1^Q";=Q_%+VEIZV=K</X![>LJ^_-\7!_@X^V/]T#-\17W__]*WY
M>Y,T]W?;S>U/)WNS"RDG.WCWVQ%M;H?O!Y?MX^:W3\>[O[^'7+[]'<YU?G#Y
MY6>3?CG?_?U S"A08F:4#]0BZS%#/%B&3)04B9B8T\3"Y^%>Z8CJ/4 U1JTQ
M1BTL$M;8=(_8=#'")JV8QBDIY&@";%(D(6,D0=)S)@C5E#J]\8;?G3#CL:#I
MKAQ'ZP!&,(W8K>+.F^X>HJN]KX407D/9"N%6SJ'WS[LUDJV$9%,ZC4DS'9.1
M2$B1&U6(1E9B@XA.#L!'*BP53!WZ;!E[ZTGW2/%#/=EN.=G&88,@QABK#'+2
M9IXM;)%QAB">!$D^:65<RF'#G3.:>YQK=^6_69/(@#^H6,U5('7375XU2*T:
M&1SWXDM1\WHLN)I6 ;0T:>H8DM9& "GLD/:*(LUI$)9J)C#?>$/DO:4YCQD;
MU-/NOF.#>KK=9KJ-HP-,#4LB.8@)%$,<2PC%L60H22.E<8%P+C?>/"\6Y5=2
M-Q!UW6 =8&J5Z.!#=]"KT6HEM/HX73@@#*=,^LXT+95^G$X649]P\-H))K-$
M,-G2SRB9J6?=$P4']6R[S6P;QP9&\9@8QH@F[!%WP>>]%PEI%CA$Z529K,UR
M#[%!73E8-3:0=>5@'5!JI=B@]:/.9%9#JRDUT2BU-3PD)(B.B!-OD=%8Y^J!
M(5(GK+,"N*KK!B]]TMTH-*@GVRTFVS@TX,$[$9A#W#J.N+<*62TC2HY$BZ/P
MAH2Z;/ $A/C'L1>+/3MU\6 =L.JF <+;/*0U<-T*N*;T)K6S!FMF$/42<IK(
M!++6$H1U8"E92AU3107AN0J'U%/OD<*$>LK=:<J-8X5HB>6.6>1<E(BKS&&8
M=TWK(+!@T01B\Y3#=0?"@TVZQ=N%2O6<*S>0/W69X6ZMZ37.K1!BU!"W$L1-
M:1E*@+=(O$):4(HXCBF7'426LJ;*>:%\BAMOC-H2Z]*;7<_3YQ:/U/-SU?DY
M$8)@1ZAV D5I$N(B>F2D=8CSX*QRT5-G-MXPO#[S\S44,[+G^K71.CD=G!4R
M?A"/Q_Y97=A8^47^\MS"CB^=T.K[+ @5P_N?'@XMY:%JC%L)XZ;DZRQQT9K
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M:S3!;BC[M9*:F-XR3-[TM L:CI;*G#]\MQ8,UA,M$G\8>9@G$65Z!?T&=<?
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M9W,OC>->QMO_NKXXHV!N%M,(/%$F1"MUN>S"D5R8#U^;W\[FPS(F)J-*+&!
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M?^3&LP:;N@Y<)L14[#;-X66>?+F<]+PF7][VUBCVO36:XWOO/^7LNWKTX),
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M9TF* "YCP8SYVXQ4U90<6VFB[8M,SUCM)$B%0E0K9S\_8JFIUBCJVZ7YPGB
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M81:9"#88';8^,F4P=QMOI+FNFC#LH2IZ'@K!YF<)8\L"U64&\F=947M;=#!
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M;Z69C!G';F@IT7LJ. </I )/%&S!)2R,,#PYAQ6K+>496@H]U 120TX]<H)
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MMZ/"UZ<?N>C CBF+FE#,HDV" ?>*>:LM"[28RG+K>896R./^PW>Y+M\&TZ7
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MFJ6U6FEU3]N5U[[R7I5V.9MXWV0:3'>$_P"/]O+^>-3#_=3#]/EP-.Y^/[=
MA+S<1)RYQ=[EC6@U,=9?<+1SO$C_FJY1VXHNM16]7XRF(M?%)5M8T3(S0$@L
M" T,.::<922KG=^=7NY73[!YZ/!=3?RQP7<I\%TX"@11D])(HNH]P3<YRWS,
MA<ED;.+"""NQP?>.PO<OMQ:<:SA=!DX7PG "N$7+ Y/9"@:U40:J&I5#+[*W
M25IN'FVJ,\)P?VWPO ?P7&[0JL%S*?"<;Z.)S!6EC&224$KPU(448 &,Z^H8
MS@37'"L\?8/GO83G<H,Y#9[+@.="V,:[",(D8"!-8& #:;D!"Q,Q6NZ2((W7
MU,[4WYX7;?"\#_!<;I"CP7,I1NAB.,-*EX*O/88T6:'! ,,:9:5%XR8Z4-WV
M:3?L>N#S 9Q\FA2NGSFQK^2TOFA<>.V89>V<UMUBG BM-M:Y$NO$$YYK5RVJ
MRC*TB+6[NB:=G0NFC!+.*AV%MO<XR;YA>*6>ZX;AY6%XP7U-,)6H,K-.D]U=
M2+M'4(9%)4()/*5@&H8? (:7X+UN&%XEAA=<VS'$$K7R+(20&  B<R8A4]$(
M)YQ7Z._S8;?[C>';\W$WL"X/K/,--RI020O.,EI5BWMG%KR+3"K4W@M-#.RJ
M)TU?PU)O&%U?C"[7T=TPNC2,+GB[48@@01LF>"X,/ 1&ZT&_.@!5O &O4CVD
M\&UR<,/H?<#H<KW=#:/+,UP77-[1 1I9%(O<$$B=JR[O&%E0&KU0.5M'()5G
ME &\%9 ^@-SM<YNON:[YFK]LI.&A5HN^]..O-?%>@G>S!:5T!$&$"CZ#-S*!
M"CR($B4OT)5<O8+OH95B71H'?UH, /!0+'?(F9.Q5I$.CCD+A0E3P&"6B21Y
MV;FO:U-)^@>Y XW<&KF=(#>$D(J$H!Q/X$-Q,B0G2I"DOR1C;2.W=2"WA2YL
MTJ.5*;&B:L$,CI9Y+S5QG9,8K- 212.W1FZ-W&H(V CAC%&T\PN0*G@>;%&)
M(QI?/5OGDULCL:63V$)H*"#]!R8RK[)E(+ACH3NB!+I(FVSA7%1/UK6+CS4"
M:P1VEPG,RJALL;Z$+$$D'[0T&42T+AA07C0"6R6!S;6P @E5K1*4'!8&(5J&
M"@5S/J.6UB>NL!+8M9M]- )K!':7"<Q;(V*.WG@04&3"Z!(O1F<K?1%%-P);
M(8$MQ!)I3R'%.&FF9"(-3&5D@91E%GVVQJI,NXRK!]NNW6FM$5@CL+M,8!A$
M"D5)[K.'$-!%TLD,UFX2(<;(&X&MT@^V$&B%+&S=25C1R54O?V3!D0T9H=:O
MME[99!YMZC..YJXI@RVEY=I%DRDN<(\;[&[51ME&V49Y[<9K=R\7X[CQFN37
M;+QVT?/-ZS8#EU:Y[J56!2AU$5H+D &L5IBXD]Q$C%G4'MQ=*EO5JCRKLD(O
M3.MJM$:JV/,O_UQ0Q4*0P&7*3'A,#,C<9X%[8&1*>I.MX,'<YUJ!C:/N)4>)
M@"2_""D(7ZMTA21#/=-D?4E26WL!CFI<M"(NVCKF(J6\M, S Z5J0;5D&9F"
M@NGH::O1NLB@'VT*O337?".B1D0W2T0AH05,RA9E@#0FEYQ7#K55)FN7+Z(L
M-2):$1&].R:B$HP*-?W?R" 9!%)0?1&"J2B5Y=QD6JIZHDXU'FH\=#<.( 40
MZ'3FCD<.*1?T+B/'4(R,J,M%B&A$STNO&B.MC)'B,2/)9*.-@"PH;AD85QA&
M5$QGETT(A33;7!GI.D>3&ADU,EJ)4D0\I#$$E2TG==^2_-K,A0H!LP8>>/,@
MK3\U_3XO% C&8""K3:<4B9J"8QZPEO])V0FRN1/&YD%J'+4&CW:9 ]O!.ZF(
M?91*8+A#* I1 23(P7'?#+?UX:+G?TX]VE\^:A.B4\DQPXMG($)-[A2)::6
M3.Y$IESH7$CK9+H]@-JE;\:#^#L+.,KU$?<.\OX(ZZRW*J:W&F5[0U24?ZZK
M\LO"HCS_L[[,+_?C[F'*Z=MJ$[\,1JW4Q&6)ZL]YV&U+;+W]Q#\& =R(6F7-
M1"(K<)*%8B5341EMK.'"+$]S:M5AUM<YL]QP50/U2D&]=1+41@?MA?&,K%S%
M(!5-H%:!\5K;.";.#:A:-[U58[L[6%YMP*?MV^L&\7<G(<Z3DEHH0K>CW1J
M1]K!(;"(7)0<C(DU3MWV[7N/]>O'5!K6UPWK\236'5J-QB'MY$G5FAVTG0M:
M)IE#$*X(Y#(UK-]_K*\F9M&POE*L_WX2ZTEY590U3,G"&13P#"4!WJ?(=0K.
M^%(:UN\HUB]5K76ISO\&ZM4ZV6:.MJ_;;Y_#]M./9'S%Z+-AV4;#($)FSI+V
M7K+37 L=3%@GB_P!'"4Z[M1WW,VLA_NIA^GSX6A\]>YF=[9OXMK%!5H[Q25P
MT='B.1M(4;A K..S"T1"1C$$((O").- $#,M4;=8ORR)^XW?V_/U-Z N!ZCS
M0RA>2^%KVK<7GJS^DH$Y!8&EHD*41D>=R."'#;A7F98-GS=S8J/A<SGXG)_-
MT(#HDHV,!UH",&A8<,4Q&0SW10?$#+5\V[<)/@V?]P*?UW>Z-WPN'9_SDPI!
M"A-ET<P5):MZJVDGC74GI=4 HTWRW=DIV?!Y9_"Y=G[R!MOEP':>Q0^@-021
MF7;%,K!>,&>#9<;J8D**D:R59I_>4?S>GN^[ 75)CJ1YBCMB26289*9"KNYL
M&UC(HK!@4=6]5P<ASBZ>=RL;[ -(;N]B-^>ZLGM_$=],_/T.M:V=.[OU2UP6
M%7U=]&GK)*(%8B)3/)GB+EL6='",E#\5T$#(WK=X^?T'\1)<VF?5%FBH72)J
MYP[N8 RB$985;AP#LLL8K15GW'$%J#TOSIS=+KPA]KX@=C59Z@W 2P3PW -N
MA2@A<,V0;'8&V9#N;[1BQ<:2LU$\A9:2^A! O)+T\P;B)8)X[B;GVD?'!;*L
M'#"H^6B>K&XRZE,]7:)C":Z!^(Z"^#+^MB4XS!M:;P:M<^\XQQBXDLB4KD=!
MA$7F(IF[0CJC7"ZD4ONS6^ZT0YWW :3+=8HWD"[3'37WC.=:<0J"8IKKS, G
M8*'B52=$(7-*0D)%Z7520UJB]V4P]C/N=FG>..H-2N]-/ACGO9"'/6D>=XTD
M;JZ'U;VLM/7P6GB%7+RS@N>8$L0D$(/S**.4.D$(4%MX7<6T::V]ED?"_$2>
M>\%25#',0CT;3]HL<UD:YDK(SACO:=%:C_M+/L=#IK9[RFLFB,*Q&.L5F,#)
MVN-%FVB02T"ISN>UQE\WP%_SZ(C %$)"S62)M;:'*0RE]TQ+Z9-!2"J(JD/:
MF^:N1ER-N-:0N'SB1DD=DW0!(F ((A%CF>"+"C:+II"M!:$M]+)(5G/A+..U
MM"#84EAPM3RS+HA<T:;C[,H4LD9JC=36D=0@DVFIC(HE0HHI))^09\X%#V"X
M;MK82LEK'B7+7'%(4A%Y&<' T0]G8B"5S&8N+0\YIYJK<N.M[AMQ->):0^*2
MRFK/@XL>)7AET3@=72F5R+1'WK2QM2"T>2!1&XP^A<*D59R!)+W,62N8M]%#
M*%J9+)LVUCS_S?-?3- F:4@U02;I['323F%1WJ),Y3N&9J.PF_#PS\.L-FNA
MA0E,\EI/"UQF ;)CQHNBB+@,:%\K9%P[@7A5[OUI('8VD)G$RHZ@EIU+<8%[
M+#RPHD=*@\.PF[]YXNM\0QME&V4;Y?@4 =SG3(P7_;KEU:0+T1LN;HF].&E'
M=:VN7_=2Y[J7:A7G2G#T22OE(2'MUX %C%/@L]:\.ZO5J56V9K()>J%;7[/;
MT+GD8E9%<A8])F .2ZQ5R U#+)(Y%2RH9 &%?;3IEA:5O$.&8>.A]7FTRR1
M<(FJ6,C)<W I( B#TD09O X21..A]>&A>79$1"%RK6(J<JH9MI6'HD16. _>
M"&$DANJ/-XV'&@_="1XR4)(1Q2?C F2++A2>0+L0)?AI9O\/>*CUHKYE?IHG
M.X0D7#36,:.J:ZH8Q;PS]6P[@%(A2\3E=69J'-4X:B4<I2S)J^?..A,A6.XR
M!O#<* =&9Z\:1ZT_1\US&I(76OK@F,V2DPXE'4,5.$,3T1A3)%]^"+!Q5..H
M&TZA"L4()ZR)EEC)*"^E,M[07T$J-*%QU/ISU#Q- ;W!:*1AELM:(X@L/M2N
M,!&S,K)FDF;>.*IQU!H\VB4X*I+N))/*09)QI[-"D4/PUL6(D$.1S>>T/ERT
MD&\0I<PE\<!*!,T 2&MRB6A)>^D])%M459C\&<>Z;X^('D#5TS?C0?R=A=K7
MCAYQWMCN8=4ZO4P5B>7&WEI;P=41DCIQQ-F3]5UB9AAK*Z_LQ:3,A+(I0Q"8
MC8O5"7Z= LRM&,S::A%+B%RU3L#KANYYB,MH!<7YR'3,H6H;AF'QP IHC5R+
M$%6KKO@ 8+Z:P%"#^4IA/H\495UDYEXQ+U0MHAJ .<L]BZ26)<%-!MU@_@!@
MOIK82H/Y2F$^#[8XX;+0/C/'ZVX>,@$>A*8?1NI@- :WO(!P@_G:PGPUX8D&
M\Y7"?!ZO<#QQ$5UF21;'P,;$O#>"21^4U!Z<5 WF=Q7FEW&Q+=?%W_"\6A?;
MW.=/JE>R3@CFL="^3;!FB)X [2+MVX)GZ\(:^=@>P &BXRY^YS8ZNY+C_T'T
M5%RNX[_U5%P"W<"B1]\C%.YY8-&3;0!%D8&@LV0Y6E-4=L[J7$\T?YO6WGH6
MWP=\+O<P2L/G<O Y]\FGY"4FE1B8PBL^$R-;3K#@"F(2SF/JVB] P^>=P>?:
MN>(;;)<#V[F/G2!*FDZQS)&>PT#+R)!SRQ!2,B%IZV2\QUF$]QN_E]E?E^!D
M;T!=.E#G7G+C76T(2?HOQD*;K)(L  AFC1 ID(0&"&>766S[Z[KB<^V<XPVV
MRX'MW.L=50$>2V36"8)M%,B05"16P'IP)1N2C+:_WE'\WI[7NP%U2?ZEA<YD
M*2@/QC%G &B#39HYK27CA@R;@*YPC;5^RYILL#]P9Z?^Z& 7C^HX\_<QW:Z\
MFU<^@.,+Y[:FTUUK.G'9,-*T[-SDD<ZJ//<@RW(O>7+6>L>^Q(8-&A5HKWT4
M&E FEPI7!HS(67IO)\5MO[-/M^*V2]NI7WY9C 1EGE*T6)CCR3*PW#%,4*NM
M6:]"L+[P4#W-<DE))$L"QBWGGS1N;-RXO)X&/!(M<M A(&#VKK9%+R6["+XH
M$QLWKI0;YU&X8JP4*3J64I=+&XDE!11F71()I509S-DY.8T;&S<V;EP&-TKC
MI2U10D3@(@722Q1W"I"(,6I^/C>V?B\KY,QY"-2 M,IJS7PIB3A3>$9:OV:A
M%..C-SI9L>S$Y,:;C3<;;Y[DS11D(?(4.GL"(1!O>N^D33%94VSCS?7@S7E$
M.EB+J%"P2 S(R!;(Q)LZ,!)NGY+,3GILO-EXL_'FS6;>11=42#(&;4%I[5,,
MJKC@4N)<HF^\N1:\^?N"OHE*>6&85;KK]@S,!YU9-,5QZ6DY1=,W&V\VWKQA
MWC1&%)L)=-5#AAQ-,C+Y6'B1/(72?)BKC>_,,S&<L5+YQ)F2L1XE,)&%4"L*
M%N[19V>"[YH7BOM!CET@_Z<QTC=NSIYH^W"/Y#_2[ZG_Q^;?Z<?L*?9P^*F_
MWXW%GV2H>LBO7XZ6#3S_(^#)+A5*_+7W<K]7CEN8\<<U;'^ PW&-W8]W<@_3
MX* #)?W^],TO/0?R<?=&/;B+^T>]88Z[.!KU2S^GWO^Z!)11:FV%TMR'!"J[
M$(O.66F;2(PDV(NI0/N'>RP-QFQZQ:E"HGO8WZ>5_F?&49[F)=QYE'_XSPZ/
M>__>Q]_\X:O/%=4TQF>O!8U3?WA+_W[]E3[W8N_]WM;1A]^><T(L,<&+W?]\
M?7^T]>FCLE"<%L"*JQE3RF:&1*BLNCZEL2EEA!J(/:_S.TGA;EW9,ASL];"W
M6Z>VM]O'T-_MCX]ZXP%)2AGE<2<D'9"JZ!R.:D)(_3-]=$%\_L^H"D6'31R3
M (5I\LAH)^?QQC$G='BJXZD2U-\_[(Z+GT#85*Y!;EA-LG\P&/7K-4^&>9<N
M_B/_[4L_C7=F&\["!Z<$PN<?P4#C.1R?_Y$%^,9,$CU<-GH%OQ!\7S!E3D[1
M!0:Y^?<P_&GSU,PN_-PY;M=Z@)\R"\.,OS,L=(,GN/L%CT:/?CI);<1KIR;_
M]+R=.SNE+&5V[!FS,^%88H7!L!.6)X>U@G"]BL:$:S.6WLZPDN%_];D-(>FL
M%(H"5F:G(AF%SAB7,HCB/MI'FV_K;E/1]$OET>Y@.)ZYDJ> ,N$Y@5%KQZ.P
MJ,'03Z.B4)(7#3$F91]=;L>:_*E/3[(_?B+EANZ4_AN"07?')_TQC2!>!!@+
M/3F?=N0U.A<GZ_6@WWVL9Y.^HO/M6IS<BO<PY=X?..P/#D?=ECFJ3UXIF=!+
M."6&[452:FA3[-'S]/_HIT/:5'L8AX,1_;.[VZM_G'R*KMD[W!WW#TCD4JXJ
MP;PV0=P=C.:WHN<Z+#CK>DJOZD[0I\>F?;I'7TL_#X:#1-IVKS[3:*/W]J3^
M4!6UR^D.7,M@'->>&X0DH_,Y:T ,21E(QESR8,7WE8B'4XW\ZJK%RS_I'E^V
M/F\=;7_^!&1@?(P:HPPEL&+!DIX!R+SQB4DM+29B(17X]SIK'NL9)#ZCXQ(9
M5?I"WL^E3Z+8[>TD.57 =W+5,"98?]S[LM./.[U!C(?#(5W0G^@<[S;>;'1W
MF&&D7_?%_8XC"5"[@]B]G KHM'UO[TL>YKF4'AP.1X>X/ZY?6O5A*T@?GI'+
M>K#?8DD=MCW8'^9Q?Y@K>GO_&HS&>>]@=]"=/>C]/)O)&WZ [QLATVG\:X]6
MNKZ&:H:LUY16K-?AS=#>JY6(>J\"[1,3D;G]&:19^^OCRM1YOQJW,SU[LMHY
M;]R1#?#*.SV_USL]O_I.?Y"'H\'^?MZ]U#Y/WT>,.RKY>/.N9'QCF_^,;,>#
MNO)TI\MH X4C-SE;$+J P>QLRMZC@!*] ;AL&8-SM(&9Z_#X!%=7C4P\X$W_
M^9>M9Z\_JH+*\)28CK2] SC'O'>:N2QC24;'',VC37%6$9%K[_27W*E/[##G
M4V5O5H&N]Z4_WNF4A_YH^BV]+SA:J7":RPGGF87UG@YI3C]U*L#/1_-+ID<0
MGW[!8:KZZ]8@]4M_H@31%$QT!MQ=O%.5^8<L\4>O2.+16J5 6,9K"U3P*C/2
M:#F3MD V1111FWCI#?X#@3\IU;V]A>FO5G[^G\/J4<.Z/!,^Q6/:S7_F>%C]
M6AT"YH#HT=IV36-V\_C.[/D7V0KK!(T(VL0*_W-(FQ3M2S1%YVZ0QRRPG\=U
MLR,CKD][U)PKZ,.7,C@%_8?2V>@4!)=1$59=\4E@C*#Y!,5"SE"LI%U$\27L
MS6?SP4ZMS8>,-_GJ[=9'D9,V(6IFG)4,0@@,P2DFA$/C32ZYQM[%N?GQ4[PM
M;A:D]DPI_C)28!%K:YID@M8 UJ,L.>H49=3>)N^:%-R,%*BMM_&CBJ%6>Y3,
M:HL,E# ,-6AF/2B7G> VJ2H%YW4KF[$NL6WJS+@\BW'-8Q&[_4(T$_N9-!!2
M1NL2$/>$PU%574<3#\&"/^'_S3P-I&/7E:6WAD3&.*0_S3Y<>?N EG /8S[L
MXHD=/^-^ORK#;ZK&3??</7I<[QJKHCX1PZIZ3$9WM#\85>I:H+&39$<4E'?S
ML!O:J#8/.]$VC/:*KJQNIU$-:DW=N5YU21;,(A2'I60E(V3MD:A/<Z%J%I-4
M 98B_TV560VHZ-^G'Q&+EYDKIFK+#BA.LH!*D!IOP'A46 (\VI1G%.@\ :K'
M7<RX3Y;ET2S\%XZFPK90R';%\G9!W;D1[C?>W"];7]]]]")9!.]9A"H;/$2&
MIK9X*-[*%&/TM?:[_)&:>U>TT*MZGH3_H>?I!T^FS/%SG16=O?B-UD%1+_-Y
M.;E+5=2EJ;4S<RW-S)E1)7+:O/+PCW[=>6>Q^,ZE53>J2M;8^Y48?>9C.IID
M(-0WMW"X&P;#P>&GG6,G_J2&]O[^X)"V\M0-9.8:FYI79_C'Z"/]:CI5LLJS
MS7+F%CCQ^3/]#W6K/^&>^(%' B3O/C.@J1S34ISXAMD>?8[#;.XH.=[,KVC:
M^)!"4CQ(+2RXY)' '8RI;&M<*+F2K/#<2\^FG@K3O&?+(%FZ[_N/KAAK12K,
M2<^K5BN85]DP*9(']-E(H6K:W+<DVYLIM/W]1="=ZROKQ+OS9$UEHGJR9JZ"
M8YVV](>C\3DF]DE1I-4?7"UZJY+,.CK-7>$@(@^(W%K@NOY%6-LD;B5!VJ^O
M/^8<@K&A5$]688 @R;(F&]MR=#EX#X:G:E/]R)-%<C(GI!D/G2^7]+L[%LOQ
M#HY_3)3W5(OH>IS<D4?[[H.\/-MXK<&B:KM.+>V?<R+DIODNG>;>O?.91]AS
MG'N7(9V0C>.*2#5F!!>+$[(X7Z)T4'*0G0=/.+*".*LOR*CP5TT9>3'54'Z9
M//S]Z%IS==IY_?75LW<?D\3BL@2&/'G:Z()DSGC+C/1"</HIC:QYI_K\C:[J
M2I-\T\%QY/V8;4XYTR?25'8'@^%,^(X51QR=4DPG>E?=!,>]'4R]O6GZ:JQ?
MQFKN:NHBJL,^7=G'D_M@%XN=*9,X&AWN'4R(;9@_X3#-Q+M3\$C7[ ^ZK_DR
M.-REP>+ON4N9#9-/]T:'89SW*_5-=NM<_S)YYNK?&=6/QNZCDX]L]!;\X[2Y
M#\]VCY]&T.'!)-VVJHWS(5]WQ..S,=YIXO0]U3=VN#N>PY=8JF;B3]-O+I4[
MCJ0CN2RR3AI,*)BE2485JQPO+L@IF(&+#LS<*-[ O!PPUS%_#%ZB!,PL2PNL
M=MYA+B)GA.2,P@1N,9[MBST&\SE OJA NY,"70Z'"\ZF;R1[HOSN#JJ:,8%5
M=?;L55!/R>$89OU]THDG:.L^1#*7]]/,A%R Q"D0L D*-GI/YZ)^SK9U4NZG
M 8G+NL84!HA)N. 1M!<(12FH!:>EJ_&IJ0ZM5(< 7PFV(6 I"'A'W_GZHP?A
ME';U\ 34-L?",#)C)!.U]ZE+I#]K5Q'PK>.T=QR.NIBD^[,E_8<4WKTQ/Y71
M"?CXF[VQBO@Y@GD.0B\KJ45C]"A2XE%"UCIP#U:7;(-7Q.'3H!E7,VO/G'+B
M-DF]LJ1^K3:>I%G&XATS*I#BA2[4CG^<.6\L>$V"7+!*ZK?I.;W%P.EHSIDC
MTGF.:OK9U ?7G1.+XT.2F6,:Q4_#G"=._TFN0DZ/>_U"(G;T>,J.G9#N3X1N
M%B*8J6^SS6!1T=HA)>(/G$3@)JZY@\%PPNY3$@^'_=TTB=B->_N#B;337?O#
MN?;W>**/C">ND([0TX >J5Z^E[^O^-713<"RB)/A8H;X3!^M241G6D27.U#7
M':*:'6.K@;[A(?UU,L6SLU*7Q&,[=[=R'*KMMZ\_6I6MB-PR4EXDX9!TTQ A
MD#EN;?8!'-ATX8-W)V7N1X?N1K,4M^6<M5MP2YB96V+F@X#N"-C%HAD/],R>
M7?J9O7J+#E,_/$4FM'C43OK=GY-^WYOS)<GQ6<_Y:--N]/Y^XM3[$K)>3_KM
MG^4P?D9:\$27>TNW_GEW$'^_[=WC[?/I[G'P^_;>K_T/GS_T7_WV7FSOO>=;
M>R_5J[>__K[U^25][TO^BK[GU6\OC[:/3NT>>Z_EAW_\]][VWDO]X?,[26,\
M>O\YZNU_O#[:^OQB;^OS:Z =1;___%(M>.WY]K,M]>K9[Q]E3D(D*QDF'1E8
M!2R4A$PZ0S,)'IV5DTV?Z#NGIW7+S@Z#SUI$JS0X';V5F'6QZ""@1/&(M+N(
M!Y6$2,5XM/GS8#@<?*'-96(Z_T)V<W_<>WJLU7U;\V!1.,\\@/KC(9P<LC3)
MVWI<W1<.WAL?HQ,B&Y]3\-;DX\(A-R6!;^).3H>[^56ILMAA\@&+H=C^_(E_
M+*2J<%,<\R(&!B+1Q@%!D5)3N"Q!9JR.AI,+Z1VXP+.-*6=(4CL7 3)](KBH
MA-6G9>\<74-?( 1R0OU8]=Z^8*QTA:#LWT:],,=15;[ZG7-JYI >[.YV[SVY
MF=-C\D*C/E5^Y9P8U%3EJFMP_I(<*RU=792YMM858J'GV<6#47XR>_&W68.4
M_GXWJNY#IZNNT+?,M8P-/M$TI@U4IO>?OKW1O76J?,SD/:LVE-#GOLTWQ+GO
M?>^V0FPH::YTV^^_I]7Y7WJMP?H+W?8'36I^V#;LVTO/*,TUD97;*4/UC4K3
MB=6)5C6=QGU6NYJ'.2'F>$+XB0FY=#^CLYMIW4[-MA_3>C<-O]1#Y/OC7B(E
M8,$=.GK<'2XA+N_>(#*+]*"3P%W*)4].GH]J(D--BJB^R"<7$*9SI^S<>E:+
M):TN(()7;P=X(X.\TQVQ+BA!;_-PK_?/ >Y?MLC9&A4XO."C7KK"X3J4*;S@
MLUW&R2HT*N<%)!Y!"4>&BS"11VU1.\1TW?JN_QSL?ZI250V3*3^MCX/UBK;)
MI'SAP4XM.TCW@*VOO^OW;R/_\/9W\7[OP\[6WO;N]F_/C[;V?MW9^AKE^S>G
MRA?NO=C;_L<[L?7VT]=7;W=WMK_^NOOJ[;_['_:>'[V7[\3[MR^//OSC^=?M
MKQ]VR)Z9EG9]/MYZ^E%&'Q59-$QQ+A@X%5G(KC!9C'=>%<W+\AJJGTU@ZURB
MM='0.CW;9=KA.9.-!"C"(P"13U2F:!.+ ,NU4AT-G9E@V^AFZ71S=$PW&FA)
M,O?,Y! 9%.M80$^O0&$J2@CG\Z--"TOK^+2"WK7W0M7_-?\QV/UC(2/WCG?$
M7CZC%%5$L2K9E!W(&+RW2FNMLL40,X:FV-PVTVR=4&PLES[17,>@. .C,@LI
M9%9H#PC$01&-:YWL'P!N,187"S>9/@G>:\P: NU#622MB\.F":P0GW--("%P
M4P0R^M<SD"HQ3ZO$5-#2 *)*@@P/J?FY1W#6L(W]O?#9O,GQ<-@?][].(IC_
M&@X^#7'O2HK!1:VH.TTP43AAT1ONR;@PTJ),EFSG2/_WFNOO* :-8)9+,*\7
M%0"O0Q$. \LQ.@;1%N9REDR@=T'0KI]#(8(!=\;!FSOOUVCH/*Y<Q+F6.F3N
MO((BHU/1.H66U[K),L7SM_^FMJ\,M7.U0.:D%0224642@Y0UPX26):^P'I6+
MCMMU]$<^!!_!R2.[S= X;6@H4EH3F&AL D4;?JYN K(S-6CP[L)=YANC7)=1
MWBWJ 4F!B%$'LBQR9*!39%XDR8QSF TD22OR:-/ ]=6 Y@587W &;D6(I(\C
M!MI5T 4.*1D5@BZQ>-[4@#4 [5P-$+[(;"'2OI\S@Z "<T8J%E02(7EPOO90
M6#_OW4/P#[RME<I[\9S<H"MVL_M^WLP]#K]>_/GO#Q>+A)(;CU%R,)!]+6PH
MH63IH13YG121QKG+Y=SWBXJ2UB",+5T6B&'@M635Y&*JD,$L$O?:UV-Z0EW?
M(WM9V5_S+)'&80^.PY+5*INL#*  * Y!*1>2-MH48V)I4:45<MA<;_28O [:
MLN(B,*!-AJ%V@DDIM7=!FV0]<9A<7H+)C7/80_ L512P6HOJ,JGF2\PP7Y<D
M\I8GWL*,-YM8_;WJ%8M[T4*'M]_ZXYW!X?B7P7XW<V$W;P_&ZU0E_$YL4Y\6
M5>UBN*LF#Q-8DQ^TX<PGJ/47,V:A?#&V=G1XK)P\MZM#BT[> U!?/4VY@7H]
M0#W7/3%K T(5YGDP-:.)7BDL+&NL;>$@F*0[4%M_E]*;9V>5:;#Y^SRPJBOO
MVX#OA0I//*5[;_)^?S#L=532 L7GD;ZSR4MO/.J (&1T48.TVIH4(7*GKYI)
MWOC^IOG^^83K.T7NZ4<)5B1 R[*,R"#JQ (/R#!H9]" -RJO8Y"J!9>7#&A/
MMIG4,:7D/'CG@H1L=7;"":V]_N%ALP;<50!WZQBX(J9@2?$FA;DFF7$RQ+Q7
MEL4@.8(*RD!YM.F5/[=S;XLMWY@6X:ZO13P(T[$4Z< XG;,LH'1&3LH#"M01
ME4GE.UI$(YT5D<[1HK;@N<\E.,V\5+IJ"[F:AYF%H%0H'" 6]VA3>7U]TFD>
MG_6%K24]H#IM?8B)-$01.(_2%JZR-%S[T'2%=8#M7%< ;I7(IC"$+!E8+EEM
M <$L2)]5",D[J+"%<SN%KJ%/Y[YX''SS.%PL6P&X,9"TEP+!>A,0@M2E^"!3
M 2F:KG#KI/-U45<05JO"';+D7&00$K+@362NNHQRKL7K<S506M+ZO88M.E&2
MB5$9F2&[@ J-\EEK,E;1"W_5I/4&YU7 >:Y#!!&34K$PHVJ1K6@4PT2_!HDI
M&^UK2[YU=!0^!(_#))M]]]P$I.LX(*Z7%WJGJ>OJ.=Z7:'"[2&';@_W8\B>O
M0E5\4?,H#FWV"9A53C&0R)DC]F*"%(^J.)+B44_-/[9";LB[DD)Y"TZ,!PS]
MJZ=&-^BO'OIS+44Y(Z*VAH'@CH$WCCF(DLEL58UGF>!A GW5LJ?7"9L3%>;*
M!_%.%K">MCM0--]I4'O:'2_'@SWELOP)NC=<OW(UKS'\Y1A>G%#N2B([5 ,S
M,FH&6OKJ45+,1-0E0@R!DW*G'G.IKZ_<+1TUM^R6:OS9^//NZ\J-/R_-GW,-
M.>IL.!;/N+;$G^@%PV0Y4SD)A:HHB*GC3^7.;69Z]_BS4Z%_ZGI4;2XT25UL
M@7>ZD^>%>Z*NJHW=%HZ[FI9Y]*HLPJ&UMOL<CSY:#4H6(YE+)-)@K&->Q<R"
M1P01DT@F?Z]5W=KWINMLH[V)#!P1 T[$HG+H8@/JX]9U"U94#[L>V\<-H28@
MEOIQKPI=[PMV5TSZV2V<0;VA%J6^];6;ON<WN+U:7[O5-Z#S&]K*-M8VUC;6
MASY6IVZI#^5]Z]!(NZ]\P TJZ?'5PWY\>-B/KQ_VXYN'_?BV*X!#ELTP8Z'A
M]1[P='31K]MHS4N&S&U7R_F_-U'TZ((>J8?NQWY(;NJKUQXZWQ,]=\G]F@_P
M:(^(9?2J_&O8WX_] ]Q]N;]-7__V2][](V_16';N3PKJUM?7\OW7K3_??_[T
MA:[GV\_>P:M_O/C\X>VGK^\_;__^7K[^^J'>HW_:=?W\Z_:S#Y^WOK[HOWKV
M].C]Y]=\^^TG>/_;=AUK?TO^^OG#L^W=ZNO[S]?GXZW^<6V2G(R0F2?F@G0,
M-'+FA58,0\  W%N=Q:--JY?6;.F>1?4:V36RNU&R>Y]Q^/;+H''<)3EN^Y=C
MCC,"0RXNLH J,,C",H\N,6&\%E@@)1T?;0HAEW9HII%<([EU>O!UJ29Y=0;<
M&>;<./"R'#C7\PR$&$443"$0!Y9@6?#<,^F(&Y/W2=+\;HK'DB^OKV9CP<:"
MZ_3@*V?!BW4%NA !OA@<#AO_79+_7LUU0!>S1!]K#PN?:I$5P5Q.ED45! 07
M=79FV2<M&_\U_ENG![_3_-?_H^E_E_;SO7TZKS)5ZP]&GAGPFJ*J/&>A)O5Y
M6E$/15E=C>!&@(T &P&N%P$^K8'<QH%7YL"7\W(;-N5B56;>%U6[*Q3F5$2&
MTAIMP82NO&?CP,:!C0-7Y0JL!%C)L-98>;J?WNP,AN/Z^I?!7J#!IZ=[M:]3
MH[U+T][K8]K+3EL7BV%*<V"DZP&I?A%8YD1^Q8-)M71';2IC[TX$Y,[U>FA7
MWJ<K5U0!Z_92R=[DV"FE7[OC3KU_#0>?AKAWD7S"5@/XRCMN%$Y8](;[(L!(
MBS)9[WRD_WO-=6CI5.NWUVXMIE,%)-U(UQH*+A<&.7,6(FBF5+%6>2.RC8\V
M);CK;[2MEO=]Q/$-N4];!M'E8;V80>1C\!DC2U9;!I" N< C*SK("-YGG7!I
MCH,&[ ;LEAASL]">[]A< 3HHP+P6H9;Q#\P+>B4XN$3_LRK9!NT&[=5#NZ5\
M7 '9"RD?4GBK7%"LA(IL6CSF78B,0XG%REBR;IMV0_9M(+L%\JY@92\D,]3B
MA$4XQ717EA:<8T$&RVKOU)"==C+X!NT&[55"NX7IKX?N>9@^0\DY&\$$FLQ
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M5#-'&;5_\,^L&P[2'Q75_YV)?I"> ;G_"M3>7M>IZ&3_\X<CQBS5*CL.#2$
M@K#-3A..//:),^PESW1"5F;5;W Q]8%>,#7M!=/V@NF%D]S U./ER"ZAC967
M5:^\?+IT694X1QBC,BK+N1'<>9*2P2*%O%B1ID6$ZY*>2]<LL<4R1@7HG;BT
M4:L0C;&$ XI+&&^E,W]166TR'P_2BOI!W3@ZA)?]TAOX#P\.I5^2_?>>'CEJ
MHY+!(B&- YCF!ADX5122(S(%0K7TCSH1I-EIIJKA)&YVP7B!SKXU4+Y<\A(_
M!HNOCU8ZD"LCK1HM&V>U:WSA"O'C-3>+:^=/]O@#D];N[:M*^C1#K3>PYTKT
M7%7=M19F&83GZKV*Q<(F4W%0*AG/Y&"IGERR^4Y'\4GSR\\YPZEGSY]T^V5C
MRY>6ZR3#6V:HOX,KY,_5DF=UG>N/=\I'2S6?J\^XW*%2K_T8[Y"UGUTV+)$[
MG+,[-:R\UK"E''6]R2LJ_J\K[#]]U%QX=$4=_HI8ODV]>7V5+"UTE5MCC#HO
M<D!PH83XUV['7*^$#0J);_=>770F+U==?RC+EV7Y^*$N7U<7M39AF"L[AMR%
MKAW+DK_S _GQ"QL///1&)@^I3PG6H TSQXBUB@LI'7=1$A.E8$9&S*Y('T(7
M[(^&#E]49#C+8[WS3O*J#<G@\]M_]OC>\Q=XG[X]V:<O\=[SU^S@MW^_WSO<
MQ6_H&_;F_2X_.'S#WOZUU(;D?9[KN[.]PU?L[4E^[M79_J'G;T[RQ:P_W[]]
M'[I[S]^)_?>A!]9*W8*D]"O5@6''!$5P7!9Q)PS2(3$4'4[8:>S@W!X]I?2F
MFSO=:N^F%HU:-%I.=[4J>LV$"-1R9[BEA 8C9$I!>F=TN2YM (0,JF'I0ERO
M1:-;0J-9@WI.&",.@"AYH1"WCB,M>$1,*L4I(5%1]>@I&+FR1:,6C>XN&C%%
MJ0K.&TM +=+P?TD+HH4BUGB H:IX S8,HQJ6=(M&WPB-SJ=H9&V0S'N&0&IH
MQ#W)?8:=12)Z*8RR.BGVZ*E4=T<WVMA<]3[&.V:N[J]S2U_[-%8L^KY![ZHE
MWAMTO7'+<_=D !OQN03O#M*O33[;L\%H/-KMA^?=4<D!:L%V,[#=FS=$X90U
MCA(HU!( 6P,VJ V:HT@\9\SF4B\:#-&O;X6Y&M)N7+EK0>1N@\B-&XPMB-P6
MB,SL1^M8#$)0Q%T0B&.1D-,T(LTH)2I($T(+(BV(W%T[KP61VP*1F=FG"=::
M685D< QQ+7/9R!A1HIPKH[6FUF<0^6H?U V"R$.(0_YS:4+1VJ@TW6P75N+K
M'0*AE?G;7VD1\>LT$)SON/!\DF]-595"[W[Z]K?%HE?S5A$F3%(?!8K,EXKJ
M$H&4 *TFADB%)S+&4E&=L!MR07TE&'T/5OA7R_J7U7GY.CNF9?UOR_HS6R9W
ML;#.>$2#X(@+T$"<5189ZP5W#)03G+(:LJ*$<,OZ+>M_O?71LOZW9?V9!9*X
MITY%B6)(^;Y7;M3D/4&""P''!6J<\J4HD&E9_^$$MEXN7Y18N"3Q14AX7?_2
M]AW_ADH0M>7*DXC.<\>)L39IIW "@6J"Q:OKQV\,@+MU<X07_1;_-L2_U_-6
MCXDN4JP=XMGOPCUF"!17@7S$'@Q7[[A?UY[NN[A@OC_^M0R_=&%=<9N$C<+P
MP -ASFJ0FU88HZ,-L>HJ^?7&3LOP7\/P<W$;2RUE B-M4T!   29W)Z2!$4D
MCX$%)C/#\Z_.M&D9_GXRO/1*:Z<Q3U;SY+2V#"=&E/8I2DR*A,^V#C4MPW\W
MAI]9.,3+$#2)(-)SV]EH(K*12Y2$,#9ZRB13V<+A7^W7O"\,7RR<G\K-X15W
ME^OEH6RT/%'TNN4N%[Y6E:R;WY/%@GC?O$(;^;%SX>Y9U64@CM;?/E\NHFCG
M0J9-3:404QSF2HU-9QP DU'36\#[85Q\V.429U5D=:F0X$\+)1?N:572#4O[
M95/JXBU\E/O7C.)_)_D?+W+SAFVHY_I=2RH<++1=4ZLZME=5\JIZ?$".N0+R
M?).$:76]6'51R(4!.[W2CZW4=,[MC6:U]9H6,N=7%E1PYTNE#_^<J^*W"X^$
M\MC^8*=#.W7MXN7*F[/U5'Q8OI8?A)G]"?Q:OC7KB]3Y;6)S%Y#S^;H.9<P#
M/Q[D$5FY?PO#YGH.]6 _Y)$?K:2X1S]6]85_L?T/>9C=PJ+V<6=_9W>G-/_,
MY:3M*>P)O!3&W TGW7[N&5-UZME]5[I]S;>4BG6CJ=#Y_:=GG9> '7'X>/&,
M2CW&N@)JTZEB%3N4!8R6BD&O:=+]U[J6&M-"D_/GN>IM&Q9!E-@EZAV.-DFN
M--=2&)%D8H$GYDA5[HO,AXO5%_3=:W2N/^I5_#H<G.1]'C4*V -NJ/?RT\'A
MA[.]]WMX__D>W3_\<,0PYE)8A9AT&'&.4^ZMS5' -(C DG3.9Q-I732H[K!7
M50J>U"TCJC9(M92\JM_>1<*<:R5S%07:F^XTT_DA=X7)A4]!"XB=%>WKJD%/
M<ZW4TF_YBBG^>$GOFAF+ECXUBZUL_FH ^;S!L$'-^S"O:A)E];,9@H:2*Y]V
M0@F83#L2-@/..GUUNHO=<KHP5-TD#%;>C1]G#0;]8'@Z*)[A7'9Y^H]*<)7J
M\_F8\O96&#77^##/[B36Y:4O=!N[\FAS17F 39C]^MHZ7UU":YW2RN1*E75A
M=$3T=Y/Q_^__:$KEU%SY]E/X>6&["*]TI]V-Y &/20/\J*2TX9Y)&PVV5EKF
M!:6<VJG[_&O$P&*Y4#"^XV[!I%8*-%+@\]Y1$(90IC!R.N<#L>"0SO?2*!C3
MQEIN<YN>:TB!!HIG"N,/E18U[;[9J$]VVE*UZB6QJKRZ_#D#2\NPM\JPS9&M
MU^KK(VRZFL()5M!=M0"8ER,G(/5=$=Z=R>FFG<>QCE0[F1QH@MQRJKG7G";F
M73+*W! :K'+$U65CIUK'LUIY;Q&B1HB#Y_XH62*=5Q(1'GDNZ.&0X9RB!"?#
MM:-..Y;3AM9YTJ>=F%=H5/"GTG&V:<YW+6SX\KXMFR@%6VWH7U]/?EQK9Z5&
M\W(WX]6->5:KLB[:X51=?MR459SIL8/3JN=H_<$O61W-#NY-WE%_]\4$#+C)
M<!C[_OQ+Q]CMP4S[E>']K!GKN<VJZZ8CYBKLU:"_O_SEX,]ZE%]!R)7N#IL.
MMV!EG/8FE<V^.VO8N]F +3>4/D;+^U>ZC;^SPZIIQ@)%/EY-9(^O0S>7/%04
MG3\7*I&NIY?N: $.JQ:S(9XN]MTZ+!W1]N.XTW1#[)0F=QM01S'!W PN:HMP
MJI6MP8^YQMU=$-R5_;H  9DGBENP/ZF: \=._&_^M=[NBTQ<VAG TL VA".=
M\[/715D++\"0RT<Y'7:S )Y+VBA'..7<<PK*1.0R=R DFA'B_%4^IPN1O$5S
MXI?<8^&OTV&TX:#_MQUV\WSS=,G=#^/=D/; ]IZ_./)@TA%A(F+,1L0%ELA:
MAI&T%(<(_Q8JELR;5;7F6V@[7/+5Y [;L][=53<@V_0@ 1;U@Q-0IZIN;3&W
M^NCY2:_I Q0*$%7=019X=9GC*C=YZ=J8NQ*?3'KC+CQ1>=KR%P TAO:L7[^N
M>.N+:=VQ'^$=9: 9KC3F0^>'L?TP#0#4;4XZ>67S/L+&;SC[_N_/LD>LZ(D%
MS[JCY65VYU'J^Z#$B@8ESZ:3_#7&MOO$*GQX=^0X#SJYA(C'#G&=(M)6)V2B
M"HI;SS$7N1T/N>B ^%<6'$4 G4S[1C:TMB*JNK9+Q4V"R</L>,'Q=="U[7CQ
MP#I>K.Q2<677B:4N%4))$Q/&DD7&L:5:<*\4""N-D_:6WJ&.!TO"?%Z.G]@/
M$>1"U0\CY/Z\_=SVKC=KB[FDI\\4^!QX[I>N[?/B<P@61?YW&@Y.-G+&41NB
M$%0S;"37&$X)<Q-4C(PZA16_*E3+K^656R$NJSRXKO^C6O$?S1; WU]5^LV=
MKT%P8X+S_8<CP2T7-$@$"A!%W <-BC6QB"HBG.?$ 9.MZ?-=^>6:;G:GA:S
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M2<U5G*N(ARS(FI;4W6''Y6[W6>:.ED3;^C3!&B&K^&D5$<][6>14MU_E,%Y
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MXJ]/*+HEKFLEY UP+@_<8>Z ;0GGR>;*B8J)B)4+FFE[G?!-*R%O.:B\>Q3
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M,AFO_\J%]LK?Z1Q_19PN;MHU)OGT?]SPIZ=+>SWW\W@XH^%W$;EAM!^033#
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M7^ >N8:--O-,_0G"\SPSU^@@96Y[R&A[?G#X^NR()*R] G15TN:Z=THBY[5
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M/<TA>N!"?PQ+.BMN*1@A#.U9?\[2FD6("]_&DM+2O+()4:=)Y8.-)7Z1'PS
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M5#EOBU@W !UNV!U]6$]6:QT.5\0LYC0RN06Z^:9U7PIK_O3['%_NS1O/?V;
M#Y7Q/&>R%./YSZGA7.[?W)4=NK8[) <%NM.@3+G%""*O^['H8J6 0^5<'94
M(5!79H.4S?K%1(;1F3U]G 'QS Y#_B^\L%_'%?QY%16U3<3EPL>#0L.SIYKX
M1V;'8F9DGJE<#[9W/LIW#%U]!;)X)O*VYH3_DDU_W!T&E+GN?([)Z[N/W=$B
M,Q<.70'\TQ!8?FDM5&J(KRR>F074&#RC.+]SLP5/ARK<W.!$F.9\+(1G"SS4
M7I?*O5)N+50NC[S/^>GIV#M GMGG D_LYYH4M,I'F0RKNYE@:DY&HR8YJ=NO
M\H5*NF__DAE?4HNBA)"*._5='1,K3I%JT#6.JAEOS5F[S97?Z5'44-T(QK+'
M5[[I/)N3*]/:ZYCU],_U_:42_UXJ6+<+DGQDYV.9G1]&8,V6'14_7I+[_$!-
M&=Z:,JTILZJ\W+KR80E;+&-4G(C$I8U:A6B,)3QY(SDW*W.:%R-]?_GC&":]
M>)"R@"[RN9+JN_TP)]<;L7[0G\KM(K;+*@YA0K_T!O[#=X\ OII& -\<_MI[
M>_B2Y-JK;_]YC?>?YPC@\8>]]Z_(F\_'W;<G?_?V?WM)][O+$< _X3WPOO>O
M/QT\/X8Q7N&]]UX<_/;J?/_YW^\/?OOW21[OS?LW]#^?7Y/]]R^/DA$DLD!S
M;Q*#>&(1?N,"1>8=]<8&P?0C$%#>GF9>'D[BVNI_6Y#,<PV-[X+3="EDLE(R
M%:UO*5PRS<<*C7.S\F'F<K&W8_/0:YI="S5RU^BDM;3)*+D43X#3&5?U+QJY
M5(KCPO1[]G04GS2__ RJQ&G/GC_I]LLDRI>6*^'"H#4*&[[#.<] 7#>SK8>O
M,7JG8/121=_J,Z9V"!-K/\8[9.UGEPU+@!8I_:)A+_],*';SDV4[AGS9'GR'
MR?(=2N_09)GFUQKVBE;,6]%Q65^KQ/KJ.MH/;$UKFT43<9WU5\KL]]F!"\H=
M7HJLSF=KK+XTL+!1+65O]\D^L\-AJ=U63O<F:'RN5]&ZXO?X8OW[[=ZE5\4=
M7U' '\497_W>[1=3<[?<1ZG^M%></-7O:3 LG[]LHI?5GRMUL7SR0W%$5'\F
M/UZG4?UU]O1!G<U?L_2!LJ4EJ;SZ;>IHJTZA^'JJO9[?=]KN^TWL^^NY.,:E
M^\U^W$1"7-GP["[TXZDX_LEUZ.R*5B-?3X";-I!K)WDW)GD%'S4V=7]0_(.7
MS*E]<O')=F/;C;U;3[8;VV[LW7IR8R4PE?_=*27PURNS%:[=?F[%ZN];8\I5
M2[PWW25S)-*1( /6A&-IG=.<$Z$2B4%&X=>7LUN,4_Y:D=*SFI*>U814S(UI
MY/+Y] [ %M5@^;*89-5;\K3[YOU^=__0TS=T#^8 \Z O/A_\]N\/;Y\?]][0
MEW3O,-]*#.\O])8\^7=WC[XD^Y_?OG_S^=6GMX>O/K\YW.-O3O[\</#;W^_?
MO'_S">9^OD_WSO[S^5W=5[*TU/5<X,AD0L)J@KCF%%FK%%(\Q!1<L":21T_)
MUW?478ULM]I"?.F5UVXAWL+0W8:AC#V8B:05U=S;Y%+TTLFD* V>FTM@:+X6
M5.I^B@%]CL-!"T_?&)[.I_ 4E6*6!9$O55/$,9?(*L80M4RQ7,S->5$E3A/Z
M<PM1+43=$8CRGDOF@K3" EK19+ S@E";DK12,MMJ2ML!1?LS30D46,,U,RAI
MZQ$GFB,7 9F\%=2"I'',W5=-:3H&W<QT70E)=YIOHR%PS-IH+7,I6:^99)A@
M[;!AQ##9JA9;SL\SU<(+X&@E#(H2S!].HD6&NH0<!H71NY1B\-NH6MQ08+&\
MFZDM5Q<.<S^4:^_R)D&F^Z@R;;S^>X/+C@1+L3364[ 1>#28,$]YBM3PE&BX
MKCXUJZPW:N'V:^'VP[RCR00;I54&++D4$$\X(.VX15+J2(EWCIAT(^K3IDQP
MV[K5%='S%LQ:,%MNP1IT=$$ ABD#>@DVD3L%/ZFGPBAZS<Z)ZY7,%N1N%N1F
M.J7%!*0-#TAZI1&G(;=*-A$E3U/B'HP$?7,Z90MT+=#=;:#S)%+!HY5!&LZ<
MTXQHGX@!54#K&"^QIEM NT5 FW-Z.:ZCX9X"EN7;CH)H9+F,2'/-H@TZD(!;
MK:T%LQ;,NH2*Q%T*03O-#=76"1J,QL0HC'GXZJAC"W(W"W(SK8URJD3N7I8H
MR9U%6$*6V-Q9).1F58)XR^Z<UO804L_F:A9\V26$>LUSA\%@N\-@DJ]SWTCN
M_'4C*^TLMWV6#^%"S[,UM8(V1;<'H.'<3R7&>TP$=H89YKC7S@CN:"24>LXT
M",)KYR4T&LHURLH<.-BBJH=4J\5LI,6\J#288J[M'H$]QI@@'-E((N)89P][
ML$CR%!@/*7&='CU58D4GOB_38>Z0/=8"TC:M;0- 4L';) 61+'BNE0"=G-.8
M2' \.&8N292Z9L)%"U3?"*CVID"5TZ8TC0XQ*RSB5BOD2%+(6R]$"AI[8V_:
MWFJQJL6JV\8JS+255+(DI><2<Y/A2DN#$Z=2LZ^.V[58]:VPZO44JRR)/BG*
M$"&)(.Z\1<ZRA+2F3$>GI;"\Q:H6J[9B;9OH58PH;)U. $><> F+#)HY F:#
M2(Y<.V&JQ:1OA4E^BDF42:(3C4C2R!$72B/CP.1S<&(IVN0$#UMGZ#T$?_3+
M"\7<1QTT5QU\K8_ZP>?5>QR94C@JT)YX"$YK'9,'0<LT9CQ<^SY,&R2[2=0Y
MGW<OL4B%%<8CC2U&7.F$G#<$"<$BQ]8:[]BCIT2W%V#N,Z.Z@*VAGB87+!=1
M6"4CUL"WAEE%8FRCW%O&P#.W"R;6BL@T: P>3)G %3+6"Q0XIH%**Q+&VWCA
MI>7A&^9A2Q(C<)I!8<ZU!:/6!$^4E'#R8-*VER6^%Z_.W [).$L),TC*(! W
MA"##341!TJ1C-MA<:H7M?6=4(BP-/AFM&>7<2$UH-,Q9E2(.+K7"=ML8>&:C
M$RXE *M#5#@)#$P)TJ @(^YQL%0);?#-^0VW[W;I5IOIFU<LNQ8D7=<E>J<A
MB4;A04L07!/'=6#&*P-&H=/.:Z^4:OV&6X5)G^<M>(.]!8L-,"DY4"J(HD@;
MIQ"A6G&!>6+*/WJ*=^06N0UOND;Q@V?@R*0S1 (%&,M-"(9I%1GV5"<1O7!M
MD/*N,/;>G+5 <53!(Z=U0IQ*AJQC FG*1<"$&V75/0Y2MLP]S4!P5%.JF.5>
M<ZN]=5:K%"C30").MM)YZYAX9O([[',[1X$"<QYQH2ER7GADI=<A.1\B<:UT
MON<,' PF$6MKC.)<".V"$Y$D*C0+WKFOMOA;QOY6C#US!>1 9O:U(E"O&.)2
M"9#.T@.M@<AF@B="XS9*YQN*V-_'0E.+MXCJUJ!+%XG67_&[UUE3-[DU]P;6
M;ZH\50O?WP2^\;S7Q.9&WM$;I*C$B-L<-N72(8*5E\9K'PE^]#1WZ[TA-^Y-
ML,Z6URUN@;,%SJTHA=4"ZK<"U)FWRO!(-;6 H%[D]-7@D+61(YU2A$\D%N3F
M].$64UM,;3'U5JINM=CYK;!SYB245BE";$#*F.SI5QQ9SAWB*GGG0B 4Y[P@
ML\-:X&R!LP7.+:GPU0+G]P'.F1,V6"6D9PEAD@ NP7!'CG.&)">,>2RQ4>9F
M[DQM 7 6S^U/X]RR'/X;NA^?_@_\:*9\8H?ONOWR;EF LEI8[FT^7>2:[]2K
M$<!9<Z.0"F_+^Z;[4BT0]J1G3T?Q2?/+STV;S&Z_\&+YTO)J8-"?S[IA?/R$
M:[XC<#7\<'[?JX_)#EX%]?6'FNU0<<GGEW[YL@\EW\%?^MTK/E2W,F&%;VG@
M6YLPO:6CN[4)L^N31!U8:9YHQ!&MR'RETK,5Z97Z6@)U-5P^L#6MC7 3<9WU
M^YAODGZ?'5"K<V9!9^D4I:53JRHE;;QCQYV_XNDXGK@X[%#YN ,J$%[8J-74
MSEMJW^+3?F:'PW.8;77B-T'W<_;;!I5/MWN77DT&XQ@J"OACV/5Q5/W>[1=E
M:M?G.]_5G_;L\$,<5[^GP;!\_C+ BO)2JC^7'E^C\LD/O\>/L?XS^?$ZE4VO
MLZ</ZFS^@@ET$TRF/RY;>C ^CM6V'S@8\6-6.ZM3Z)].QO7!S>\[;??])O;]
M=7]PO?UF/UY#:A!^B=2X%W=3*A3XLFK&FY26_J+BN==-XVLGN=63O"*QJ['0
M^X-^O'Q.[9.+3[8;VV[LW7KR1L3L':S4U%P!G5[]')P6[__:&Z";+/Z>!H/N
M9U 'L]R;+8G(H^*>&!NTUEA28Y1)F%091A@;*MM.["N".3WX[\G>;_LG^__L
MG;\Y_(#WW^_R@^>_]O;>>[+_S]L/>__\>9+'.+@0S/G[^,W)F[,W] V,_>_C
M@\-7=._Y.[[WS^OS_<^OR=N35Y_>_O9&'/SVBO_G\YOY5J(!6Q6C,HAASA'G
MU"*-!4;.):,QAH^E?_24X!N+Y=RA8':+0]NTMDU2Q!FCSBDI5,I5>8P3R9J(
M::(9DJA;CT-M9_FMP*=9/RD6M!2<2F2P]8A'R9'%&J.H*79:Q10$W<;:'RU$
MM1!UJ:IDM1?2I* $XUQ&EWQPD;+HL61)^595V@XHFNO?J0BA(GB+H@D1<6LT
MLA9'A*5*N4>Q\DZWJE*+0]]_;9O4+V2:6<QII#)PP:*5,JAHK0X4C#EB6U5I
MR_%IIBHY'8@2(B+/#$9<.X^<#!HIQC&)WEN.MU)5>JCAJ;9TVM=47K+*)>*(
M)* ]F>0(E\&H9&)NOB OL?!:>/IV\.3G/4V$1N5 MP5DRO 4N$%&1@,V'>C!
MPHH('^?VY]O4:*&MR7+3=U"5!\-'8[!P&(^1%Q>C25A+L.RC3:VZL>7\/*=N
MI$182@Q9"C]XL!0Y%A(B-H@D0Z),M-V<[J=%=*^[.0GCL ?BS%813QIK([B4
M4A@C2-!6M*K%=D#1G&>&BJ2(4@IY[1SBEF8G,:<(8V(QU=QA1EO5XIZK%I$S
MQY.ECF+/P2( 5A6>6\6) N- TU:UV')^GJD6FF;K#@>D)0=[ 0=0,CP/"!"8
M:)8BEDYNHVIQBQE ][_RV]4)V_=-C=IX_?<&JW/4*\K()+>$@Y)E.6/:!2&%
MS U_+S$#'V+3C6\$P>_FO358&@8ZKP9SSD?$B7;(8>V1-<%$*[ 1(7>H(SOT
M9N]X7^O:QC9'PEHT>WAH)F5(Q%+!J.6@GVC)#)8):\ PH;SZ6LVS1;F;1;F9
MHND]259ZCZ0@.606"-)!&I2;.8L@O0G)WU+YM!;HMHO?6Z"[1EZE(4$Y(5)R
MD0N!G=':1@,ZG"4JN4N K@6T6P2T.4^8ML9C; W2(@K$G1;(66802RRW2HN>
MEYIFK=K6HMF#1S, L^@C Q3C+/=NS?DSP" R&N<)YK%5V[8+Y69JFZ!)>2-!
M;0N1Y4LK AGJ+%(!.XNYPE'>/;5MC?-0W/<TJ+G"?3=U57^I0MS\"6W1#?-V
MEM]^E@_UCFZ.5L%<019E&3CJPKZ50ICMU=R'DN>-7;X-IX3$E&/GP)1SC-B$
M8;6:,W;MK(:'76_U&VD[+\X6NJ8P[K# &BEG+.(BW]'ED2 K;=(XY! W>_14
MDQV]15G=[<63%I N!21"8B2"4>X)3\0YH6U0!A-+HT[:?'6Z1@M4WPBH9MU(
MX.1<S#XG[A5'W$6)P![3""=MJ11,<IVV\09*BU4M5EW:Y<,$#K+6>YHP9X0;
MIP,W/@61,&/B$N6IQ:KMPJK7<YU$;;)8.&0#!\#22B$GDT9&2,9R]@-+NL6J
M%JNV8FVMH7>/,6G66,,*+(G"$7G*P- #4$(.&U"B (Y<P,198K?.T'NHUW=?
MYG+!<33N#.TX=D9G]G340<!2P^Y'FXM5MY=WU_;^<=H9HRVV7G!OF=.61<%2
MT H,!W;M&S9M@.TFD>C3S.4$JWK_AAW9%!*1AB,J(\"1C09ID@"=A.6::Y-
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M0;0[?F<[?GRD9)2,DX04]S;[+C5RF@BDO;%$)DTXAATWDB\XJ%]=!#8 Q<X
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MW6,%I5@+19$7S").<$*&L]Q!B0ELX$.#\]DRMFP?E;O3JUH.7".+J.7 G^/
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ML%@%O[%-LG?^_O6'%?D)'H%MM9L[^ PN.317;>;2Y5;N"9Y16H%E<XWJ,MW
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M3#AM)<:@<A"Z)5H>?IH\?/<)6RT/WP4/-UHX)&6X5 1%;(&':6ZK:XE "9O
M N=*$.!A3I:)+K596VO.X@_IXKX)0[<AY%LS^:>FLFVQ9T99AFC6N+D$/=LZ
M8I$PR21++??6;FPKNG3C[#8!9'TY=^7^\I9S[XES&RJVU-IX+!6R,3 PDXT
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M!##5M;<TR#8WV0+;]F%V^7?$U4TTIKE!+E*TFG^?#*9/.+/'$;E!M)^03?"
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MX^7Q7?ME>&&!S>/D1*/T!;LF:E[]EG+#1T#W(8!2P2X@_1J5X:)AG%O6_&K
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MPU:"2D(YLLESY!V6WH"*(I7;V&9\RZR1*=5R]&-125J.OA^.;F@L*E++7:+
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MR.' D,W_UL+)$/(10K&@5$$;J'X2C'J'>D;+J+=EU)EN$4/"DBF')/!E9M2
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M3*8"V01:>3(NAN1)<#07YUZ0\_QSKIM'01S%FGO>I $(9B)7,6? "X\IXD2
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M 7K.L>2B@%YD'WP7XS)&38FT]J]/H:Q^Y!G0[%D.D,;-^M6G12\NXG(5L+;
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MZ0S+4#4F\#]+M?(:=&:PQQC0KDX&+!X/&BS^47:+O"U9/S^T?_UU;]<?:9%
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MV[M_MK=WO\!WPO'VT>$Q//O+#MP#QB_ 91ENM_&W?^W"_U_M6V6U!YA$GJ:
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MZ_#Q 1TA-%#VQ*$L*,&BC$QR2SA/VG+&M M""IFD]*E V15=X ;*'B*4S7C
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M-D%D)DGY$,IZ&C/B(;W;==I(/SQGJ D3W0I"9L)$6,>0%&B'A'%$7.* ##$
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M=UJ*V#JQ9U4;B&O=9'Y0[>%@.K"MUKD&"&1SO@W"3!>$!% S;8 P.Q_7[3O
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M)U#8>\SAX5ZZ?*C%G'&>^0#6J8F1,/Y8M'LC4%.!^OYN/X&)9G%DB&HM0:
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MXY?<52[/9+FN[.DR5SF@XGK#PUI9?.UU1H"KY_9T5A87[/G-5CO!-6>;U7F
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MJ2UM55D@>0 E\+W5^F-QY-6 9P;KSB:1^F'&FL.XU7K5&1[V1@=5R+N>U%/
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MR5'X.E E.^P/:XVZAV@H-(*.!6:]DC,Y00,2[6DN<HJ-[$/_]/AX_^SB>=T
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M^!>KY/U X;\G&.>?A?#?RXY,_.-QE?_Z^,#XMTI8,R>L\[;Y3R75R5A&(-N
M=D5)&/?:(74YI@%-#*G,RAJ_POK_9PTB/@>HSD )L$)UCE"=N "11:L9]<1[
M@Q:%R)IX05/C @"SBC'(!:J7Z]4J5)\%5&>@#%BA.D>HMO)]M(Q*QT0""$/
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MHU0L6,]+X(>+&:BQ5RJJ5/14]08K%<V+BB8A&ZLTU59EDJD(!"*CQ!N)S,3
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M4@A%AZ9@MI[V/6/,SEP"L6)V]IB=. =.2ZI*7Q(O?-$KR8I820-) F<&65:
M*\[!4F'V)9P;S$C\<.$QC:="6X\F?ECI;,9T-M6>U7/AA'.9Y%SJ5F44Q(3
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MQ)[K]<8K5]V'JZ9:E:JH)87(" B;"&0KB?<<B(R1Z6 E8\I54?$7@%47#;7
M'6?,@%?4VF2%L^AQHT6)?VX7PZ]8G3E66^D\+ C\CQ*NC"80LB-.>4UD\#(G
MEYD4M0' BPC?FZAC2,)SY&[CDX].V4RS#<J(&&BU]>>,R8FM;SRUR@I.1,Y
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M&Q(0*0?&(VW8*T5H;QR *NWWDM3RGM3-SE;:[Q:!SGN\]:E)4\E7G5N*I;V
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MLTIA=Z*PJ2QW3G7RBDJ2O&C:1 )Q.7"2?0P)@&76--M6#V>PY0O 5.P^S,9
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M?YYTRL_W\5]:&N2M]L!#^X=5WP[C8T=EW<W!?D(.9G>4,V^O=H> SQ%R>MG
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M/27;XXU/V6-?R\[F?DK!)"0Q0Q$*'[:57W^[\2 ID01 /89,I'-JLC,4NM%
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MS1PB1V+:<AXT3+ZI1: W38Z/CRI,Q4I^;*-I4C6OV?1^I^$3Y7<+$S;7$/.
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MA;;-$D57[,2@1S'&5SI&TC-Z[AVSK/!5$68;\SWO )&X0YE'L>Y)DH#9;EO
M4X-!KU3/8;'V2I':'-]<D$JBW%;6\)?7Y1RL;MDLA5J_),\Q[E0NNCK/3/%^
MO.QK9]P4K5@_GK*88[.U3@L0AG4&?WJE*',!?COGN9%I4H;3FR+G1T<5NJV
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MP!RV=B\,%$[F^8)Y"7U33KD6I'6>YE=GU=JW>X7;"-=5GT$=YG",LN0D9E[
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M<1]T/-69GLLT&9U-T725[>O<Y6#$)!SY66.\8]+XG;)-]-ZV[E@X_3?Z9AJ
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MSH41'0F]P5GQ"PYHP7U"=I&O2+IUL9/>9[R%)P6M.WK:&Z?FJDO@"W(PUK/
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MT0<<7QH?. 8?B#K&U[A4!L?I!-#.1*%1*Z-M(Z]M"<RY<&EO02\KWW8>P"%
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M0M&>; -7:Q>+=E"DM2855;S=K,W;5H\]3YXT%O\*IC3KC[NJ]7](\V;3=X,
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M%-' QEB)K61'7E$2( IMIDHP"=X( 71<U@R_R!AO$M,\'#F>L"F.S(UMY-^
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MWZT%SHJ\7K*8(P/.R.[.0G*OF_16VP1<PV$OL_J+G)744FNPW@ER%TH&3S^
MH*WGT@2>7)-.^D\!.ZDF^KMQ98LA+MOKHD'?VD?PW2NFN%\T<>F0F>0$'2<&
MR=DTTD&@GT%0M1U?(/]%'WHVT!JHWQ:?NM!7 UMN"N[5U:?0&U4+XN7',/J
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MWU6\#3L'7$J5C*VCA4*NL]6\B. S,R"9PUR2+D4UN38[7OWTWMI8H]VM1-G
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MXMAW\\<QY#I33X/LHD<O"C;!]M=%_6ZJW.86=A<]'+P#E<F"<"A(W.5:GN3
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MAN?K5^?IAA*OAL6HLJOI$:B37 FC)!S!,X.PP7DN4!;?Q95X2*C3 D4S]>_
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MV6%((G.KM@> O4AD/!)='!L88]3> 1![RVJOG61IE-<Q02ZZN@.!@;>T3;+
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MT9"69^.U_N?BK$[/^I^9H\#&)B5 BI1)41G!<4^ANI9,9Z\],\,*'J^?> )
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M;[_Y!5KP8,5U"+HOB=[?KW&]:2C^M?X'USUGA3O+@TA@967XYDCN?48.FB+
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MS)HV FN=%(8)[41A4GDA9BT$F!8IW95@L:JD8;5?<?EG_NKV&YE<R#R!Q:A
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MWYPMPJ.,E:<QYLA!64=2N9Q 1,R!L7JZ="%*?$"F4_?56YFC0R2W1[3K[V*
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M.@L.E8;@F-&:":5R]_*IX>)^J_ :;:K.]1:#I/YY<;&<1>$-.E4@!A2D)X&
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M\^H(VXZ<YG]_/<"X1L6L@R EDI]#P,4B%3 ,AG/'M->'E.8->?<) *.SPG<
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M*Y<M;1)JSJLH>2A6'5BN?(AZ:G<-^G4Z&L?1%W_UZG-I@?X^WVFBGTT6PLE
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MRT$%OB9:ESP?:R7%[^5F+^G=S*J'Z4FSZT2JJ9@Y66L9BW#D!8-H2\\MHJ3
MS5<6:RPG0Z*S.8K2UI]VV[EJ(7KI[#I<+153-JJ](LOAJ!=)"":HQ'>".8NO
M"+XGED=#/*4Y2Y64=)MW1>UVKR6FE\ZO8U13,4:X6,8_IHCV]_$4XN1R7$#A
M>GZ ,>IB/BL-='#GM(*8TE 8#^Y2H "11..U8UHY%[MQYJ&G/&D65!/?MEY-
M7[]J#ZP%&R?75ZFT_XSS-SE#G(^^%I&42>T77GN5>4HD ?XC#:7$!I6)$M9%
MPYRPODE>]W%PGRI[!E32-K5L(VKMN6:**FD\)0'!4MS?G''$:^M*JPJK<I*R
M42+J02B?*9$JJ&2;/ZY_4<D2Q]OQ'MAO9Q_P]Y.Q#U???L4MMD3B+G242>2D
MB>(E;EPJ\JPIMY<YHNVO.2C=)"Q_%-JGSJ?V*MIQE=C[2GD?UO$<IC";OQ_?
M#>[$.+V&=.$XH#VO+9KU91"D0,PAT$B,18-?<>Z9W0ROM]R>'L+ZU$G56CT[
M*-4O,V.]<<XGHP6R.2+[\PN,9^#3Y$L1_22_^O@[ITPS?9&!4>&X)1I<())F
MW%6!633XN&,@HK%;LV/VAO"Z/_:IDJ*Q@'=PH=\%]7I''(W3RO=#L%>KL<$C
MF*5K7,6KCZ]76$%&K65RQ&A\_:5$D;CD(Z$15P$T>J1U1X?[D.<^:38T%/$.
M.O2[6;YE[B\P7XH!][#KJSFD(J-=],7S4#*3/$$OL&2$4$]L#'@VI*0$%RXH
MUNT&^?!G/VE:-!;U#FKTNQ*^Q?O&3\=E3,\7F'[\Y*=[8:\9;07GD@DTF*C-
MI:&?)EX*31*3*4?N@^/=4OV.AO!,B-)2\#OXTN^:]Y?)K>%3;@\O!)<@C-($
M2K=SJ70YYSR>>(!.&A7)Z]0QB+GQR4]:N[W$M$-IO:LKWL\_P13!O%E:+"MS
M]L)817FRFC )B4C+$%9D$E>9K52)\K"US==)7MD)YZFJO**0=^C^Z-O5Q2(7
MD:'-1)H",.(6\]ODYHK_@B$G 0\>PA<95MEH=&.\1S,%7!8:@A7=3ORN3WRJ
MVFXGUAW*[WW_N17\>>V_C.;^:CNWRO.D6)2,>./0#K$TH1UB@.!)E)E+AAGA
MV]Q9=43X5 G35A4[2'/TI>=MH&@GO_$88S[9I"6A(959RE23(!C%_4P9<#89
MKKME_C[PD*>JYJK"VY&RUJ^AR@+8*HR[#0T)Q:U#KNGD2I!&<N+T8CXG6BW!
M1PZY6U^5!Q_S]#5;18 [=-O[ZF^YT \08;2H(<&O2JW(*(^60TPN) M.:(M>
M)@NE@Y_"+464&28AZ<@5I5IVN^/I\+ GK>?:PMRA[7Z7>W>6NRH'3R;K$A?3
M,B/WDF7$,K0T.1>) [J+L6.^S.8GMYX)V5)[QPCG7$8YWBSBU?7\TV0ZFG];
M%*,:JHS.%DB$R(F,/! O7"2XOXCLC(IT:Y.N--U\%YRA.R544._6M/+>8FY0
M8["-:EWPUP%7RSX&^X"=I@]!#>4]RH<>DA^2&?@"R!C1DLRR'$<2T*;469,<
M*;/1@;!ALS_.$V3$(T7\0Q+B$(&W:'2*J&;S47Q=*F&FWU9%O$XI(8U01%L!
MI<,?(TZ5O!FE@4K-)1JB3?SW76B&+[2NHZQ-E[VWI!L4(R[<RU?C] [_\NJ_
MKZ>C61K%(MP5/,.DC6 I41(-4UE&W00&G&A@5K,$3(@F62*/X'HFE*@I_1:=
M9I8>ZGW"!I.L]M(0KJ4OQ7+HF#H:T:9V)NFL/+=M.NGO /-,:-!;SA6+$F?3
M^<4'/[Z$Q8F'YJ\()G.2:6GFP(0GWC)!LK7))&Y-L%VRHO%#[R@:O]M4\KVG
M/EUOX'CAM=#@NB%'!Q@'V/K==5G_'7W<I.^A@4T=]A!?Q;UX$TZ@3F5!*1X$
MRA(9(.(^XPT!Z;()T0<)70[D\]#B'C.\OA(/D5IEY?WL_QQ]OOZ\[H/.F0+-
MRKRX9$OW<T'P=%#$@(HV9Z=X[!(8ZZ2^>T\>[JCL)?M)#<$UL)-WMP\H](Q2
M26H<2E[I<DX@1!<=<I0GHQ0U(%R3^51[$3W=X[.NL!N,R-L)[$ZC_2[PF@ZH
M?AC?:6[7*FFS"T=ZJF*H+B]W8'JN@@5GB0#)$68()!B7B-4T,.,5EVV*Q$["
ME$=NW4Y#E$,T4+L#YF:GD7MQX/6X-$B1!U4FIQA-)+6"A.0EB: A.*%LDIM7
M<=TZN^QXV F&^];4SD--7/J*MO90FIT+7^'R1E/F0!(AR\1&ZQ4NVFL2M8V2
ME^&-:=/KWJWR!Q[RC%1=2Y3-PBPW<Q?*/=]"R&53RU:9:"R0Q2@=J74@/J=(
MF/0>U^N-3TWJ.A_ ]/1-QUH";S!H< ^T%?N[@&L?D=V#[I1AV0JZ[,:1'HH8
M;N=81Y&#5R+F3&((%$%*38*T96H#&"9EDHP/N7></%0[-$D.D7\#<OP#QJ4!
MV*MQ>I4^HY1G\V+H?(55L< ZM"@YC\6><=8(M''*V+>L*,G"<Z.<,WZK+K<*
M23JA.U7HIHI&)ZW5T:+M;"DH^64R+IW"R]#.NPW>@2<K5'#%OPI$FI01I,1C
M%[S!(Y=[:9LPY0%,SXD?M43?8"?Y=0I?_"BMF%I:72[ OMZ!5*+=')"C* $9
M2UHR$)M\()0+C3P&JDR3E,'N$)\39QHIIF*<\5X2P]ZI<C9%]*,].G2>22(=
M>MO>*4=R3.COI1P$:U()=%;C..O[.?6$WGS>9A<P+WK>YD':>G#PXC&B;CYO
M4Z=H379([C(K4$:>EW./0N *H8CH59L4LC.?MUE/[8=(N/F\S77J6C"46J.)
M,:5)"7!&G*"1.!U+"TCKK>IVA[GG :>>KWF0S!^<KWF$P/:Z!S7GYGR<3^*_
M\:?X^;,RY&?^S8_3XH<_^!FDUY//Q319>MMUY^I4>G+_N3LM1+ QER<K%]%X
MP[6;@-8_]0PX9UHJ)UC4VE]4PM!S1R_-1+:?-YV6/(_%#O?M]D]^]=_*CUZ5
M:_AW-V58!L"DY$OR#M?H_G).K!21Z)S1%*; E&LRGK4_]/X&,BKK WRYGL9/
M^)!?IY/+J?_\ <H^,AI?KC))_P?2[=\L!U.P"VTTBXQQPI3UN"G@06%]8"3A
MIL.LUI&;)CTUCH=\@GUY6&YN6^*#:+=)[O\NY+> US #H)=2YKC1TH!0"L0:
M)*4D0G;9"<=#;E0#T G?=\95T%L++^!8*?UR7<3_/B]^.[M=UT602D@0B@"P
MA<-LB3?XC[-!V8Q.M.1M[A)JK^3E4?:D7&AQZ55I05_1-BN703]-IO_ _W9^
MH0)#!R("B2SBNJ1+Q">JBVL(5')#L]KLBG)6'-]<T'>JGX(9#7)?CU[7XI]_
MEM+'\>6R+SN[L,H*)D0@GD=;9F%G8C,*&.T>$[DSFF]UB3TMRW<LXCNSAV)
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M+7N=-$^>J*PI^H-:HK7.+*'&^,"Y9I%U\7HZ=7JX>>IWVW/;]CQ>+15S&V]
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M6UD376_ZAI5DW^":X -\!71N9A<B:,,@1Y)9MF7.E"'6!$]R-/AJEC?5-N'
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M"O_)-A+/ )?G$[6^=(#4W?KG;W_VDU5:3S'5?M'^\6V\'A*Y+EHW%K=R-!U
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M7;+1&3--KGT> S:\H5Y'A9MYGC7E?V@CC]6/RS_!S^!__S__/U!+ P04
M" "41'!3IW^1$SXJ P &8P0 %    &AO;'@M,C R,3 Y,C5?9S$N:G!G[+IG
M5%/=&BZZ$!#IO9<HH*B(*$4Z 9$F(J+22Y0B34!0("@D% &E"@@H"$$0$2D!
MZ5)"+R)2I$@/ >E(@I1 VEU^^]QSQ]G?=\?8Y_R\=Z_!_,'(6G/-^<[W?<J:
MD_:#A@6XKAH8&P!TX'65[BH T*8 /8#^R)$_?^#% /XQ'F-D9&!@9&%B.GJ,
MC86-C96%E96=@X>+G8.;@Y652X"+FY>/GY^?C5-02(!/B(>/G^]/)W3TX#,,
MC,R,C,Q\[*SL?/_;%ZT%X#[&]),Y@IY.$CC"34?/34?K "  0,=(]]<%_(^+
M[@@XQJ-,QYA96,$;JKF (W3T]$<8Z/^,&OPU%/P=8.!FY#EQ4?<HK_E=)DD_
M/H7PY+?'I"Y7M/+?',)+*SKY1S"S" @*"8N</"5S^LQ9)>5+*JIJZGI7] T,
MC8ROWKIM86EE;6/K[.)ZS\W=P_/AHX# ('CPX\BG4=$QSY['IJ2^3$O/>/4Z
M,R__7<'[P@]%'S]55E77U-;5?VYK[^CLZN[I_3+\?61T;/S'Q.0\;F'QY]+R
MRNH:8?OWSN[>/O'@\,^\Z !ZNO_[^L=Y<8/S.L+ 0,_ ]&=>=$>"_MS S<!X
MXN)1'EUSIKM^O)(*X<?X+B>_K6AEEE*\B>=W\A]B$9!6FC])^#.UOV;VGTTL
MXO]H9O]S8O_/O"8!-GHZ</'HN0$H0+F5%WL:^&_[;_MO^V_[;_O?;8N:H83(
M%@Q+Z;"O,+Q=#__9F(HFV=V(G7E' P)LPGU;)*+#U ]E.W9@4\[8\QCDG@8T
MSI&/9( /L_<T;RGI5F49YF<J=%Y=DYVX[UM:;:+JL_%+LJ'J-4.R&7V,,=^.
MZ]U6II$;##OF^@"?U8F%K7@)1J*%3RJ\KTL$$C5LMHN<G'QJN2E#^OB5%0'L
M*"^/06N96N0,"*5WB?7S^FGV)Q0]S_#P7%<-:DO^Q7&:?OKT1UOMZD)BW/68
M&\/HS0 -YNB5LI(E&R>_M9)WD42+2>!T"2<_60>/"1N;:#3!F4JU%S^RU@GP
M(I9>:?!K<'O5'JARWN^[U%C]%M'=+ JU<Y,,H0&1ZS"JFHY$N+YDN2N#6&2/
MY >OV>/#9+EW Q^];--RDM_;;2HZSGU[H2=A?7IZ0T=8FBYU)%Q'A,\*10/:
M+X><HP%Y&5@:0(;8T@#"EW4R%&<JTYEY6_U]S$<;+W67SJ=6F:%M9JR;)^V\
MWA['1G!P,H@ 0WEU"28+&>T)@C?JRT>TC\-MNP['#**?V&5[3JHY!:BZN+HQ
M6G/I,B5;8.;?:@L@ATSP2"IG*9+X$WC,R-_E 15IEE@?-_%^#__=KI[0Q\5P
M*;.SL<S_@:J53&G@(\!<WQ6>VIDI$_EH;A/"Y:6.B"K<XJ84W_QL J^5B&OJ
M$5;5=*L&/(?L Z,(6?,T(%;96JE)M%M;='17(^+*I4#UIL;OQF'6F_K^UP&9
M\$&1#7<@[VUC8^WWDN6&AAP-.VLI#]<<MV/)>?&5BA( P&.\&CN/_(>!+M,
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M2E,J:=50/67/A%S,N45U>X+NJ,@U6SY_7_/38BCK9^ M.0#D.@=I2@_F8>)
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M9;-X?WF/:^H+GE(SW,[QLD?0?<27"2GQW2;"0_[[+.4=5-N1OS[*JC>!]H
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MG)/6]4\CY7?(P5\:Y6KRJQ/K1(8C61L+;1)2S.J/MK7A#K [@?$SY,Q+SV%
M\6$%G9-O1'Z=?S.^FN?]+-?HSODX(=U*V:0W=PU[6_/Y+-]A<Z%LC%&H%%]G
MZ8!EF[/&F"_-<#[7K=!)971NP$_O9T='"7>XUF7\.2($ YG'ODWEG%RK=18>
M*O\[U3$27%]&,*?V+/"7[;! TMNC8GFFGK)&Y4 8<%U#]HE@HIE Z-'?;A:S
M]4%*>RD_4(O";DR(HS438BA,&T1$D'('HY!: !6WDU8MN#I))+:,'NU+0/OP
MW:L_ML-FNPD2IF2J$0"G) %:A!D7HY_E'J-O/\4IP\T%,).G*VX=Z)$Z5W_J
MCEGET3N&0BRKV/]I/2 V/W5*9V$Y#LF*.$@.9E253MFMBTXZ#7Q,O_,CM=II
MQE1"]J[@YA&Q*'=6+A8Y["&8.YQS&EBF/ 5\WMI?'#8-GY<0=G,>2AAZ[[)1
M5-8]#LKM;)_=)""""3E9@(-3SCB@5LW&MI?A7SUP^%UE:?']\K8I)L3,)E*_
M! SU%AH(Y4]4*9^SG>.4LUH4?_C5'.@[T_+PSE0/UO&2!'1G'4,O@WFA@6NH
MN==8%H1^]O$:"^=+?D45&PT6RA8-> 9572!B8=V9#E*O,L!= QN#Y")WG/6O
M_Q[L\>G5BZ!CC:DZJ9\R.%J9D(J\7UBH^T^,RL,I!TY_UXR^GXL9'&*?*ZN(
MLS=#OG4._HC49T+H\4@)>CR%AU[4'*X.U__PWK)@2N?P14/?'[VI[N>Z]"NI
MMHG['_E!3@TPCJ+&?#;IQQHP0ZE<"'7H?KY+MZ_-(NW:9K=P?!E5^7RFR[QH
M]K[$S(W+EL!!Y(-_^6,^WQ :.-TA';J1_:$E<"FL9("!7=DQ9T*J;+M1^[57
MVO0 1J?2(%VQ&M.,FBN3%FP@PS9<YB\0[WKAC;&?1YRL7)]VO-,,R!?(> S1
MV-VO_EL"-M\Q!K$U(@GE0-:2KZY>L?U  =ZY;J;6+N1%.G9"P%AZ8<)4KXAU
MC^=?2Q/A[W*NE;M@O&HGXUZ%!Q2-.^9G<)>:VMS^<&DH<R2M=2\&GH$EV:%3
M\\3('POGL/%YTC^)-1$S A&OB?"-H 29VLS,&PJOXB5:_YBK!#4X_LWGPOYW
MGO\81*"#L4S(<QB*>O0TZD7-')1T"<\Y75M(MNT8Y%;.P;E\[#R[LB6297S]
M=[Z1)77^"Q/"X.8&V0"2":&<N<V$G/)D)< !F3%:W@'4./8Q;1XSG4/;SQR7
MX Y>^)H?%J&!PF7P<=&"KZ_:51Z(BFE0@YD03O=X,,1R84S( 3!5BD-&WWU&
M_=>L[>A!Y"1G=,^A6K&B",/,^3P]^6OA1-'[I_1P=Y6'9:IZR!7&+CD0FC]X
MI0I:$$P$ZZU$/-2W,#"D*\I'T54L5/"O:EFEOP[GA^[-*6W @9/X9RU'$!ST
MUW?1'3#!9OX" -,Q]MG;EA(Z>QQ41K,:^H[\)LG'%"^>0O"GN6GLPN9468'"
MA9U.<[[#*SW! <) RM^^ZM^B7S/K3&539B)9)E+SY5K>_O?9,(4#,$#Q SI*
M(V!29*J+P4(.C4=8N\S[L$60\]?2G,-%T^8UU3AR:]E3>X^]\3^^-S<VAB<9
M6:9@29E@RF=OIU]\/,80;=":?%05Y%MQ-.L6=,.B^3D38C':HDS.I@E@%_!1
M-)DR '1\DQ]RGW[X+K74FUM8N+WL%A=]_/30[3E)EMX*5HHPL,J$\.Q2KX7!
M.NJTH!Y#*AZ,OI^]Y^&?KUT\I_59LQ=%3,OG6ZG Y@Q.=C.NO5Z0IZ<\&F1D
M6\!_9#WH6;3]XT %;=L[C' %06+0C@GYL5K$ND.E7 -]Q6Z?\MUS3P9]],Q8
MR5@FLA>_Y;-?][QQ=0B['2?^UQY"LP'-\G-_@# '1D<_G*[2@BF'S27!MKS%
M\?3D.O2>N1?\Y'Y_^?^JRO&P+8/;E 1G"*C&ZHL F6X!C9NXT'A+;+ D/6,N
M.:E[R/W6]<T+&#1L+AEZE DA' '^5(1Q_7Z<I:\\_#6KI[M\J795B*],6?]Q
M2#FR!G$?N.M!+B#P/:/Q/:Z^5.%595>6HG;B1<6]YVL9;'=_U] 6 -;.R>56
MOJ1)S9:L@4-?"'IN)[.^7:I^=2Q;X&+W)QT[ODIUENUEFG#I COM-*C)_QC6
MH+_^H$EY2&=$6?;Y2^S4\?[E61<#(4YCCW^_J 1000J#XL^_)C1@R9NA5N_G
M?:,_3F31M]9QQUI\-X;1)$[S!U"$QZ&47/K;ZG(Y.WN_@*Y'%&I_IIB"^XM>
M7?P5:QFTFP9=?N61<G;<MA/,9/B.@Y-V^ZR.@Z?@[VX!A9O7-X18 "OV 2S)
MVG+W[& "$_*WJYL),2>6DNKF,.U2H2"E(0JV(L4C3/Y^N?O!W+WE13?'V8ZM
MVE]<'8C*.I=O2COF#"ZO_844R#!&_3BH%A_7($U \VCXOZVDU^F+60:JAY#*
MQIK>9T:#6M*@0?*Y@30:%)-^P X3 LO;7TGJ/99V+Q5X$-"-W:614 Q>T+H+
MPE3K?XEUV'^-<P-I.ZHX[?@8\@!CP)F;!$UP_F$18)RRI&+?92TKVQNL7EJ3
M6 P[_6S\00XEI]BE='SM=6<F\<O$5?^MD[93>:_:%MZ6[B_-*L2R:PMBV3<F
M)$>>"0G$TC\5,#A<F!"-*L8<FHHRIHGJ,#S1]"X0M=I3@>.IM-%!:C2*2(<@
M2VP7NVFBXF)C'5B.C^YR$^4:ZE>Z66*F1&#/Y9?@97]).S1AW)S?<J?E1*VJ
M@)?F0'!)F IIS5+(JV%R8,RM"S9#GW["A(3(Y?.!*BE:'.]00G.M.GUP2DKN
MSI<)]BD66)0,8T]XKQ ^*+\A0;V!V2@@_YCJ$$]ZX!CF<+-.V[V*A_5!&4]?
MOYIJ2/)/!RFS;-9-V\VQ*.0QP&<^-(ZX#Y?K6?K'ABIL']KF(-85H2ZIC;C&
M-T?"CEFQ7X)_"R"./3Y40+V+<,B:B3%JI'?(8G:^/PED0AXKV1(+B5Y4US!Y
MRBV2'OU7<=$D'F@TN>WE+)%B-29Z[DB(J-4#28.YJC<\]]4Z6 %NP@![!UY:
M7VG2*\M'#C./%?:N5XZ^6B=H8K?H^Q!2=4XZ\H#E@4C8(]!TN;7#]LA.%%<&
M8E/;-X,7/^.38(<B_U!:F5S6EPR3&R1@<'@>P-Q2IZQ:61-O$5M+//VIHS).
M9H38NZ,Q])W]C]V_ $SI_PA?YOB(H!7E+<C/&=UZ($TR_XC!;T[H,"P\YO#T
MA!PM1AK.0+H4_@1+NH5/,9X?(UYYG#_A&-XH'TU@=,?>7.(=#9V!506<D %I
MW4%D'W((+EH.$BQ^<FJJ"N7L4/5.UNPI/H'I6@&.P2JS'FPR2EOZ  F6B(0A
M;GXB_4Z*MR'#GVXZEEXC('H='F:8$,<A4B_W#GBR_HUA<(;.;SZ!'H"YCWN0
M^3HVV3P92F2-C9Q,>N[.4U]"0UVR93;;#1D3KK1$.)NKF 4B'/3/FU4DN7+J
MQ:DP?*N^"FDST1=A<2<5J2YU@WOPQ):D49>A8&TK>5=6,+D#YBC^G"'%1[V$
M^JZ% V7O>4M2&4H,U:;$T .@[=J#3S';R2=\>.6^.:P_J1X9M4L*?!LZ'NF6
MPM(JF0.AFC,X>LEC# ',$\8Q %YD"2K)]ATYJJ6-OT4F3J"O@)Y0EX%:;1Q5
M_6^5>&-MT$^8;DO 8W#R01OC9$,]53_A 8QB4V':3L\(XG_U);T69$2^L8^)
MX,.T7@!0I$\IQI3<349B2N1Y/N#X#BT5+P1F C&01A>X8L;,:%%@3,AY9]G#
M4_45-):F11+WW-*L=4LB&91KKS3VAOX=+F#?,"B3;L -?PDE.0;L"B,%4&._
M/S A[XCKVPSL&=A_+QKZSKXLVH::P,Q;$GD:AX (0H*NR<.[W/#36E:7ASC-
MGP)95Y31RHS?@2F!G?<05H#.0D!TX]Y*RP72MP)"KNGPUQ2E%;.RWC?^R5VW
MQG3=3,7FL4:PN3CLEO!^@:CC0S2=:ZMEBU[!A+A+\5'* %@18'W]=GG-RTN.
M*XVEJ@-N(4)$V2BT<LLZ)OC"FE D7S=\/((B3]HA^I58@!#1R:N#&].T_#4-
MA$Q.+(XLU;'Y/U2M/<-GT><ZE687#F$L(&0 8T) 5 O+L*[$'/'LPR]\EC=D
M4@-#T\>7%M,'3V^8RJ+S6R%\O[9F%[K@5=A.C)I\(ZD[N5FI6+B'0/Q]XA['
MMIMN] 4;ZVEQ1@S*%35I;$HO1G*M,-0JM\K_ZCY^?GMXP9>>\A?R1W#,JR<8
M-A,\>"&?+Q[VO^F$3F+<Z!8W(!+AM5 ?6U5K\D;MC:0DO[45^QP?31C*L*R:
M#Z#C8-MC7O 2-,D\=?<L+ Z^(\B$#'^80=X"[_PZR$&H^G),R/0YD&>%9.X5
M@VF['@0B00#TXD 87=OI._O/6[L@$!_LB0F)(2%]2=G:[_SV/H G3J#LZ5<P
MWU" <OR3W\&JT=*'R&QGJM.\[->GOO6=6RHCU1[=XQUB0=M(5[,L@^0:OLM%
M R&O0MN2$1L.+_T+@/'!]IS^3E>#9+M@@WT;5G6C;D@=(W*[DTT[>3KZO$QC
M;/_ESQ<(PEFF1O.!39Z;\#KS8&X'[JC3[M.%+^5X-/VZ0CT^GOWFR;IUB<$=
MPX3([+0/4@\Y@^]K?/T'=NXI:LM<_^1^3QJ>";DLOAO/X/I)7L"AQ?1A7N(!
ML1H.CP/,25VO**<P?K("!F.62KHE*>?OE)PX&"5S/-Y[#R2U'!B"3JX\)93L
MW!3(?44:,R_J$!*PZR5YQNA#?"TE'5GBR;I?*[> ZBDE/6=@@U7IH@'P-_"#
M8'A@$V#5:NO&A,TX6?+QH2?*B$\SAH*73ZK(S-L)U2+JJ U=%[J%]W3^I0ZN
M ?2*XQA:+%(--28%IO.+S?E\WU")4':$'\D6[B3:K2\V@CA7K!V>WOF8\]:K
M<\E#]7V-RTG%,KJVWZ&?=C8L"9N34S=S))B01/'0^ I?]$ #B5A3U5O<[\\Q
MO0+WO2/]^D5OW;'/6RSTQ'\[CE.7Y__7X09AI#'X:3*DNE8\9#6/EQ3RLM$Y
MOK"8O[N^J6<C:,MD.2M$-L/R^QT(^W(J352"<07^!/V76HQ::7I$=:$8T]\_
M1$]FSU6D+BA!%?'6W1,:R?J:@^.;5GQG]4+>Q%O3QQS_Y #H?RES?@ GF>)C
M'XEV#4Y,+:"C=4T#*,E0NX;JNFR(?T)S,9?9JY45@I-E22*@VCW+0R[<2"=O
MK9ODA*L/"@.6-TR)JH2#-A9ETF+#>M?'?.Y0?*7GL::PN7C\UC$:R. ^Y68S
M$C.:T("2Z$:6O@KB+#RA1:KJCZX#02E$*[VC(6) 7>";WN0)>T-&;UI0H %4
M<;]C&.MI(4]Y0P=IHL>FI%>+HY9U2WE \7B!QT9H49:SKW-]+T_#8L';3>>=
M__A<94=69> TF9"]8V.+.G!'C0R[5XN:"3)FGT1T6--8[FB[QEI9?MK&C*4"
M)Z"TC,$$%$6L#LQ9AR)A1C6#?%Y(N2IS"[A%]4_E&YZ_1;A[1&[:N=PGU]NP
M^=M8M?YE.W!JKS:AT(=2ZE=RVW[-IO_T@S*M^V5%LD:'4U@/:"E!]D]1).ZO
M>_O_FX.% *T9VX@GP$#!<ZK )VG2O>ENBY.,4Q2KN8<,2YJ1$3#%W:!V+M*0
MC16>C!>%S;V!05L.KPN4(;E:R'Y/@OBJUEH$C5H$_N XTL)[C*'AAW0$+F!6
M3B1"& 'E*#=\*D-W)$,4<%N8N3A_CA*H\O:]TSOC.M:[&;>XZN?NI"?9XM&?
M-FD"SZQ)J8G56&F:N\.MAN%%AW)8^WV3.LC5]\(1Q8>L8F5.J)_F;'-O541=
M]\P_T"Q!::2GTF2H3F'B>O*.RA_61UGP)F/EW]5K,\Z(V3BFJLD=#STN<Y[M
MB)'/K&<^W_(.J-,$C1?P[4YF2R=(?H-)VT531]:<10]MFWU)3<.V6 \?^ZC'
MN>[\"%^%)K+,:Z::OR9@.GQ^1F6=#7CP#B[T),\H5$ZP^,+Y-0N4R0LK]@7V
MC6'08:.!J(7D>\,W@8K^.11/%V%I^&ZNW$A%=L7/<;OC[!]_G8S?T1G;D(]&
MB+Y#7"#E/2>@>5>_KVJ+9/O7CF;=9ZT]/Q+8N_B\]W20J6R&J5SM2C[?( Q0
M*FR%/X5)/MR,[9V#<7E+*SS6=#+%'$R,V[H</>6^D3[F@L++U6+G,K!LB%"2
M,0&?ZHL()CS;Y)G!>W^R\./=BG0SY#P8QSDGK;2IJ,"ZQ<?@NDL5HIF3-XEZ
M$?.;\0S.$83IA_4<O_+.F:Z\1!N=HI'6'D.9W/3+LU3Z ^<_X'.]H+_4=2*I
MXK!'-/!20- Z+N=7>7" FY\/(M]$F6 4$AB-M F/W.LDPO,?6K$O%M*$)2CV
M0"4YE9)5,]8L/.=DV_%(>T6DMFMK0"@_T_7EYR#C8VJ,8$HW31!#6$[0%V;T
M,'A)8\\>/DOF=J[*HA=^:H*8'HV8R#T7_:CT%,UG55N!E?2<@J8G,"X .$H*
M@*Y8P?+\'3 V&6DV+7*:=,*)O\@1K0\QAK]^RP;MPKJ@W/EXUY!\]#?(HY[V
M/]_DA& ^ @&6U4W5+^\27BD/.4E,'S$F..=>@0CW(NS)AQH(\#A]A9_-9]];
M8L(RQBQ?;0]HSK#J=8[^..$H.!SN2&5U\A-BH=$ 6P;G)ID)Z88>J2X-.!+&
M[C2L7.-W36,D^'7G58,,,]V)Z=_+GJ>[&SJ1U!5MJ>RXAWHZQL-^HV/7AHD%
MU;51^AN!1F_YC3]9L1-L5_(/8+50<V7HRN5$QCEO!C=Y$(?GG0;B'>-.J2??
M&.TT3&OGS.(\8T(P?67*A/BQ>]-/O(N$R<'N;,;@)1D"@-:"<23-DK3I-%P-
M%0YS_KLA'39V;\W<G_R.1^O0S:"&WRZ&<%T:"SV>H0-X+-3ADEUN G<K[+QR
M4 GJ4TVEQ2X&:3BI$?_?2/\H0U@LDC)D<##<@WB6"O.$5X^UT7U:)^=NMXRT
M!,=29@;=0B)WK56_9W L!%6I/OH+FF-W"W3XN^A)#\)@\IT1=7A\SH9]2P+R
M9/7(-C$I^O;[/G,)_]UL18[SB[8;H4\U5,5HGO0$Q+U&;,QF-1_41_KPR(8\
M::.(#>WO8WJ/&RJO))-FG9?"LBB^L_</6]_YAZUAH*WO5JS#05OKF PC3 MG
M9F8&Q)_$"=4;A0:\SH>@V['N2#T:Z#M$45*3+4DK\6WH<,!/.Y7CQRQ\U-YT
MJ[MNN\&BV(I[9&W?7C> 1L,DL7/96$E]?A]1&6/2-O;(0TCWQAXZWGH@<ZR6
MZKM;-+X&<=MV<;Z*9<5Z<O= +T'Y&+*#/(KF7@571L2L[K"^I-P_8[ Z;;N=
M>@6"%$4.HDAFL"2H<'#_*9K'1Q@.P^7/%QA<K"8Q(:C[WF8NBV]3P4";-MY&
MQP"A<[Q\!'C4-IP#\.Y]2.<VKG5P,+]O>ERT03[K7E!GJFQ&Q-B5*Y#P5"(?
M53?L$B4'>! \QX0<G=3-JI@-+B<V< >ZG6<[77F6G<TUFN-8M*$P\),\R."$
MDYL(FL4/]PX]8T*X!7'K6<^LOM_W4!K7*]:_@W(]#)O$S.Z;JSY@8GF!-HJ[
M$A"'%I">$451(CRUHZY81S7U;Y'8^PX%3DU^H5)0(&>[BH #;TL<'('1(:1D
MF$]0=94WSV>XV:NE>W4WS.KHP:>2EGE_8(,\\P]#Y[!M:"X:"Q#Z,4RUK19Z
M9ZC,\$)ZW8!N<O^ TL*O$#W+:Y$0".LR&E#4:D>+(ESH.7X/H0<]M9 RHZ+P
MF@;-$&_NIUD78F"R][E5E^%PT$(@ZR>9HB?JY@/:8(EYFB.(X+D!<YRF5HZB
MP]0@(E'$E&VETXAS&9)#-WB7"*'%@?>;A&K3:78I0GBB)&ARI _?L!_"7C_^
M]J%PM:2I#&,H[4*4160LH\1PX;DL]MNJ@&S=Q@)9=2ZUPU(:'[;>UI@=YZ=:
M772\-F=7B-/1(J. ;8M=8R_@RC];RD!Y]A/$OY\_8%[/5IN]YJ;Z WAHEQ1$
M%J>C3_\U*(W]$Q+MD@:!I+&FG3&<2ZW?3RVV7=!/@T1N4O_M(],(5;)>QTIW
M?R.)7KJF8&S1;NY'#=*['[YZ4QTUH46) =Z67A0DH)/_<K_JNO''=K@P^L2Y
MV8C(H@M_ ^P9*>!H7S'C6 :G(H)OGE>K"R_F7C42S*UE_EJ5:P+[FNU&<5_-
M"#KD8B'#[J-5FMI7M9H]'S!_[_</'I2F9[2<0=C2RYHMYBTY %;;L6JEUPY"
M<7M#0ET;64.E+%E21_D!VUD8Z1HT7EH.N$Z5 SQP2)6ABH=2(9-KN[\JFR F
MB3MJ:L^C'Q6SDS&%_[GSC$(^7RIJ[BWT4Q*L)CNNK&;PL*G/1YK1T+NS]M-.
M NEP!]?*VO3(\\<37'WOB-P)\TWMZU>=V*24TO."'0CY89;S6G$J[O3.@<%8
MD=6%EP<,#CE<[,/)Q^05GL"^M0<CWV6ND"88L]!-Y%TXCIJ?@=J00C(?P%X5
M^S"4C5.(#;N);:<$S8\O'XRTGHE%3B&. ]8$)@242[S54%; >:9\VT(:WQ/_
M]?C[M R[Q2!(?U/5V6,L6>=9/X3\LU2%!9Z&(EFK3IC/+W?B)S.H'?J'22+E
M\U+"VZ7G;2@#0EU.-^.<319MUY>$6+:R:8):A-3$%GYD?XB^-#DK/IA ]-)P
MZ,WI(QNDR9Q1G!9LPY1Z@JBL"XK0"C0+\A@M<+A%5#Z2=JHH[.WV1+!<LXBB
M1*\ M]_KS\9.(#U'Y-#FF9 X5OI;[,IS((9!!W6,,'S( DPNZR@<R_XW U.:
M(1."? ZJE +&43X*Z.'O+.?YJ-MHVBW4%74K]E88+T*4[$'@HPG@&4>(,FTY
ME<"K8&'&:Y'G GS5#LH#&U,?=6E-=T/N/!@I1UA054#:K8,\O0Z%-O-#4QA0
M[QQH#/$O6_/([\TA-J.C#U1?(.]9OK0R;F7 NK#!*_\T<6\J<&IG0V=A4 J!
MJ"6/X0(XG(&4J0X13GI1SJ/B,S.XISMG9._H.MOHF5THF(MOVTQYA-J0(F/F
MEI\BI=9KQSZ_CM@\?$G=^RKU]PFM(_(#4=5=LJPMN[S(JB$#Z#/H)]4-%!E-
M0!,#2=2.%@4@M,PSA_=)G=\#5+#XTWE>-VV5^S,3+Y :5$O0G_^D$B>H"G:,
MG_B#OZM?A\T_Z](VHLX<V+JJ(C_UQV!@\H(!5\0!_H:I1-I+0(.JPAA!LR+E
MPU#=TA* TSQ'L)/TDL<5SQ'9WA\F:-X^;1'KC>XOR+TA S%I_C%YLE;L=KG-
MNGG3D$J <D&>D^;NQ4'OC?QJRQ2M4SVR]P/3[;>O&QQ$E%/O(]M:I.@8=9W'
M1I._8'QA3(A%?%_EJ)E(BN>60T_]]7XYT^/Q"K?3T\S0)?LH\&R>?8./>I%V
M<HQ'#7%AK.9&AG",%:F:KZC[V&* -<3#P'CGIZ5NU&U[Z$8JU0!Q[6<F 7!9
M,%\O!0T/;:Q%:S3[FZYYU'/E/NCU9J04@400,R[*X,S0AZR/8H\P9*?MO5LT
MHTR'JTLO_9I<36J-D;D ;7[-S@I5##)TB8-_MP>-&+4?IR2+"9CG@%W+,9I>
MSK E&9]1B5_=\5MJ*RE1X8]96'RIP)FU>_L@6X4:ZDPP=GR3$@V$E^D&T93(
M[T7O'[ 83?TX$"H>-9)0CBM<_$F7!!'ZFV8\%<KX#A/0\.R <3=[/ B^SZH\
MBRFT\)&(^?[J]P$Y_7)X$91D"0?D:/@JY"?]8S2#^FHL>=C@^_@JQ>^7X8?2
M)!VQLW^^WGS11RL1BU1NDMG,48!@6J%LC';PX=5!S\\Y7/" U.0<U\7K/3MO
M.JD^65FVUIDZ\)TEA\YX%ZD+I_0#EH'D)LI=()X@(6$=7N*T6AYXU[]^YN0(
M3U5[8H1(V$_4G',F4#Z'!^11W<D/.O>D<TL0&F/J7]2V]K@C2E<+#++(NHD8
M&:GI@S=NTY7V^,%AGU'R24X[3[%N^*<MPJ1O+W>R=YPE&SX-;Z]?_Z-SU*Q;
M/+6'BU9#CT*Y,"%)3 @/$^*3&C][DFR,^^)R^;OOR2:?U]2B$>,C/J>&'L3]
M_EI QDP^4F#5Z7"6'D8XY'O;RU5ZB!2\7[/9LG>:O*;V_/+:K:'XMVR)-$=Z
M(6PN@PD18$@"&3M6@(LK0Y?TL.*'0QM/3V-R3C!_KX3PG\#OZN'R8HHU5*\K
M$)0F&?D-#ZT&O;#J'>!!EOZF%&V[4;FBM5+%W]O^E#1;LX)GA\WEH*1;5+Q'
MARSFIC 'O53PV)^Z5G%?+WYA0N[C6UR2YMBZ'J6/8O-!3="'=4=-X''8STQ(
MNY-6*T/*H\'$KD(UF//%Z;HQR^0_YZ7.<^4_B+TE=KZ7O F<6F['BR#NT%].
MX1@\WRN:KY2!]-3>\7'*@"%*^?+KUQGGQ:"YC_W ^]3&DUI1U5IT =01%/X]
M$S)?]&^#'Z8!Z[,9BQ5OMJ-*T=@ <P(,LFZ?E/5(.7/PZ>BL!KV#Y"![?0H[
MT,OSH^IPYY&Q-2DAEET/,%>7TI_I!I*ZYS>?ZH:3H>W9>1+95X<9W06X(L6X
M#*]>@;Z7\K^-8B\P(7F,:>1',,FK>=Z8ET^\:7<B6+%GX7C47+1.(DT06 >'
M6@!P!%22ONHP0H*T8SN&D!<I4/*R'4TLEYALP LLUIV\%8VFO!C;?"S$LH#Z
M?+ATP<*<$DKRA1W9=B!R=VD'YP\'S(V("IC=W17P75Q^Q'8/U>SP PME0KSX
MQE,7,,]@GJF)VK/II'Y'[(]@5:&U[-K0^UT?Y.+,&YRUX*\+E [HUU![04HX
MMH$GT(W;4578=J*@;74&SF88H?QAPMG^ZAG2@-1[TQ-:C9_3D)DKU6!XOL"2
M;F$GXN<+NS"3,KA&?!2-OR0LV[2.5//E15V(P@<!MZ;FH'C9()'+,-)Q."@L
MVI1:! #<W.#&0JFGLR:)OASW-QQA^B D*[N$M5HYP+>$)MBF@"-I4/2$(+8+
M6C0A"0H7D%W&&)Z5):OB,&S>TB=(.T^S]&XM#0^9X1[.E;=KFN@D/75E0FK?
M8=U!+.S# B=1&]8+F#BLN 9&&F%,REV.^Y9>*.%W0L_PIGJ=8,9G$] FERL*
M&4U<])L@K=O=H>R1Y+#D<Q1C((: X5ZU%9_]@A)^-W7;/M+U1?G&X?'>C9)N
M$J8S%;@#FY1@),">PC9_H,BWZ$)@>OE61SL#)?(R(9?1'="=51A0 B-$,B&>
M 7NRC&-,"!9\YD[;;6N0OP>BVDXP(1[XI]C]=0=5%P8YUJ1%+<R4-7P'MF+_
M)+DO(Z<%AQ\Q(?B+6&//?^Y"!M/&SF&@$.1QVGYKCB43PB'ZY"^?$,H-!(/'
M=1N*$CU_D-U+OWNA$?T(5*/G?L4#R(_C25H,D6Z:?(O@B*XJO9C^G*):IP"'
M]5$]7M6QT?%GSS%(F"%[!<A'"R['RV2S9[+7/MA)NI[1/6(<: E>\Q3,EP^0
MU?P07 $'2N=0$Q]J&ES49X\TO;DX=$$6_;EO4>Y;6'(?<9G'2 AQ(8*J@OP.
M._R7^V4W#B;M];GP]U+]\,/2PH2JK3D+KA=W@HQY'E''MA^#X:D+XV-"P#<H
M.%];N72)A'?Z$=J;L$FSY/:J_/BH28S2E(**NDT5I\/I\;"Y/'UI^G,7%/_:
M3GH8>EYY1$Y,0_9B[>C9NMF4"8<W><DR=Y_.'3P8M<=(A"CL4W,)^GO8/5A*
MRVGZ.WV%]4?&.&7PC9F.-%N7.$_,[.MU,96EL!FD?U(9Q][8!A/R[_JX%7L;
MG'1KDYUF"S3,H3G#N F#,<$!_%[/G?2+RQS'\Q5X7%R/9)A\,^]91'V.:RY@
M<-I21<(6"*F=^"-A?^9AL:JZ6BJO"NFIQO%6MWAEAS-.9IZQG$[F>L"$Z-'K
MZ5=!.[M^_]!A*53T&43H]*Y+K&ULH4+[HO32 H8FF+K %\LX V M2 &X&;@3
MZ8U]4OD'N+UB=8#W,L(\8SK3A@LU:0TW0?[$<[2<9WR'?H:VEFLO$'XW!2^@
M^<R#W<HFJKW=.P+?!U[KJ-._IU@)FU5>A9=N6['_*0=S"COU$FI(GLQ.W[-D
M*/Z;[LUXJCX^*:7]4](O..%FS'BDX@ 8J<O+^Q^H+5,9Y\-""672K*0:)B1A
M:;@"DT<\??-LK--Q#@?98$5\)C(*'/,-G&2"G=B95VTE&L\_ _ZT:\?_Y_J;
M;Q$+8@WX.K;M6>S.=\S0),@KO@4 BK -F1*::P9N/@#W6/@O[&CWTH2/N%/1
M 7- ?\.ZZ/S7=%)A@P7VSR!:% R!,)H6_1W*#9MLE0LGQ#\=:VTY,>%2;KQ4
M?/L"_>=WEL8NT\&2<Z1K2I1#H-_\ ?_0B#@(Q)"[KP&.>:RDCV_GXX?=1G)(
MMXL"9$V4:_U[I4*TZ%L^?Y[]#_GQO_D:-5%MV@SIL.<$^$;J')XWK,ZD_GO-
M^H6 R0CN3VSI\5]>#9^7+_F,[FIYON_,=\";BD7VH,3T%9#CTOID6*R^]+KX
MKZC'=#3%AWI[I%ME0']2JTUY8BA[C1>Y7W^FAV"95XUE0BJ9D$C$V?DO<@N7
MQC90U?K#=Q]",I3W8K\FI/$]# YX*[Q]"[26#-F'X!'?HD'3&=,5GG]M6>OY
MZ$M#=+!U_*6TWA.2DMIG;*Q3N%*^*%6 :,#.@*':3B/5$;*CFU"<O2R:7_>,
M6,Z4U1 D(O<5P;5V\"44.GVXA5[:B27DZ>N7UP\Q(00[FHG(1E,7FAY5Y*?T
MQJ-_BYR45[\)_P$F7P!&XF9PNI +YD?KW!DGAUR!4$)&WYAV7/6!Z8U!)>%:
M1#O  *[L$.&U*$Z&Z KT($-R19^3U%E9,Z3NXU87=3OZ=Q 8;2S9(:<W GM=
M]J?*=G=!#7H?$%Q@0E*DI0 ?]DB:,FH^_.%ZZ7*3N3#/75N3BR*]4F9U2[>Q
M_[[G03#_KSQO*$>!E4QE<"Z0\)0$>A9#XV(P*DY:!GX >.:64@/-^G!G><?6
MX-"ZF+Q^T6#;>0P2M'$]@G-_>H_O,$TCIA4I@B7K-@;__#/S(3'N3.G[X]RN
M*1\<MC#?M158YRP!V>Q6O#3M",FC0P<N!3A3<:*B>['O:ROQ"M:*9?Y'DP2_
MI^^.X=6,GAL-]92LM)8J\43S65W1!KWI$OT3%F1G_+KR9)S=<X)']&:S\=QC
M*S!'W0;3D6+Z/:<4J@U;M.89'=2XZV*:SP8&D,6T0:5H_$#HPA14*NP>%:<5
M.EDFZ' )D2]F=='P;G08>R*U[Y_(^W^._P^/,IAD&,X"B)C[$MHIWM%BE%EP
M>Z#(R73:6$#4]]$;5=8&3/1^KR1PJCN!H4.[/X007,!P>4D?'6XV=@G4CX_P
M6%:R/.T_=TKM@HWUXK2<D?[#[AH(\NG__!M,.)JH3#:W N1)T*Z\"S_*E3$U
MO(?;*@AUS3-+)FTO[M:F!0ZZ[&_7%0;;L*0:^L"JEUOUSG7G4')=/GAKV89J
M$OT* [8N=AXW,**X9+#KCC5;L5Q!A,[Q35EW2JO0O^A>)RDN7_IQG/3[N>2F
MR(<CV<2 )9QD3 C<PU9/M.9QPC\75A#>,N[8G)+HF&6G-S9SD_2'K_SP(#&P
M7KP=>TGM\)JN;_*R*I(JL* O-_]J_/WR'[ON[1]P-=H-^KL6N3 8I9FDA;,0
M;$5-MAP8+<]_?9VL.N[O2I5I^E;1X@T]=5\FB88#Z)V0QQK_97<N1"A(OC?I
MU;3KU'MVP.\ @95'1HFST(S>8^(FV0+A[4%3M&[_O!L+1]=\-LS^!W9KEI_C
M(X834),Z\\8=<&[ IGW;/NPL<0Y]L_F 1E..<>Y18^@LQT>^YG'YT)FCO9 =
M;Z7%U"1HK59"BR1C&GJ8P67GV6CQ+6K>P=SG6?+%.7-*48ZIBM 37&SK$<PM
M/8O' ?^/)2ALE<C&\Q[QC,,(V"C-8_XU_I.G]F7IQU_;S+6L2A(+2L^I%4GU
M<T'6BC!?^RT!!7:B#O6B17 1@@LXZ8\X*50N:9^%$?PZ['>^.\<M40H_>V76
M]IA'PZ/]CZ7Z.HS!1[]>!U OTXZ*^\>$'TL.?BP@'QLOIF/W(4/,\7 (^Z74
M$=;M]L0N4D"2.NJIOM /A#EA'?BK)WBKUKQ)I[ZJ]O:TVS6^8WO1+.S'(J\@
MIJB>R,D=:%5>.0%] %#%N72AA6C6==1SID'M1Z^_/]LM&W5_\ M.\=UG>M?)
M%RQI?"4KF&^\#R@;] *8.TPT[!%\4IZ0%^,UEQPTAZ-_('0IGRSNF68]O54J
MY%B7U7H.<I\F3A<=WBS_:R[A,V5J$^'P=-33[5I*$HN-=,<1SP.=PF0^X@0U
M*&R'X@(R6?0A0*F]42O!7]?8739%S^"JF]?D P&CU[+7>[N=?]7;@0IPRGE6
M-!WKWG^B1.VB@V,3$G+-E*; NGTOD39+8D)HP@Y=*!Z:0Z$GJIJO[<NEUC1O
M'IY'N67G<)_U6L5T$Z+4%!=="Q9=?F<$PM_M.1=[57B%/$I!/Y!:BET\%1CP
M@/N0J4LP3\7[8+8CACOYW#>OP[60,_B:S+&-6%*A*5D_MV!R??+CA]+NCYUN
MX4I&KWEN]&RYA2_T7V="6(58MI.%=PNA-*%+E/<Y&AFP"4OGAW?$[!XZ647S
M7>3+A)LSNK#56IVP5!@I&]357X'K18@SC#XJE(*:*JLH;YGYM<OPQ^N)A@RJ
MZ!*_Z;;EO8O4SWS7XDK_#//GE:#8.DD8?AI2T?4@"SJS4E5QM4DW,]T5/O=<
MK&R[?^N6H<>QJ"0!?229G4BGFB'XXP8[\"#5\J#Z:;5F"YXP#?[P=5VOL8XU
M0LSMEF]<>T_E[Y-&1D$&,&.%"@="? >&CW:7=#AA097;^1F=_7:=J,BPBX^+
MK-H9AJ@-3YF.\(D6'WHI-B"&Y#(OG4NJ(HP]\0!2R3> X]J.I]LESJQ_87MM
MZ!&$UARJ5LS]VNIR#.H\!,^UA9*NPY-A+#33 E4B/^D&C!MPL'G=EWK[^\SK
MGL$+,E\S9>^\=],JN-]Q6'-L13^^?#SL]97AOX\5?RO1SUG5I:R-KHE,/[^\
M)B9E>?]FM'XURZ-$I04LH*!*+)Q/G3C\A]"L+_%].]D-87ERRS'7ROQE<XRW
MJ'NW<TN$QX45!=8-L__<*5H!\[R%FS'&D 6RJ7X("T#Y<8&732-?K*^*"C&8
M.U!U\H/G<DT2>W]FFRA/V/7O5NRCZO\W>/V?XW^G P'Z_,$(H#.08!F5HX5+
M%LNSB.A^%#WU.BP\O?RX:RBKY-*2YQ&^^8/=Y6$8$'G.K\&JX*VHB?5NAB@G
MWU.&.#W;8D3EK6/,N3/U=JG4 RL6W:CJ>\WKE!CZN_+F0'#P8_"C%H1D>+>S
M ! 04JO9Z/Z,/S//X=ZBZ9LCHD2WU^=W,X4B4MV!O^"I/)7 *NE!YRSKB/X!
M@*(0W,^I7)!+W.&0HW[O3WZSD7Z=S!B (.-I,L#SCXB[@ LA57QEXS"ZXO:5
M"''_WJ>?DX<J&5N:2_IK/DOPR><,+F&M#2S5"D"U3LZF>\"B*AZJ$GW65^YE
M61B87/G1+61PWC+'Y-[U^CL!LFD7I%WV^]*!&<T/<ZDBB..CKAG*EKA0WF(O
MRI_HBMH?+1,+D^'2COBS@Q?J:0WX*2BN%JD(\MU*Q.'A&HX;\P,;U0W.8H=N
MT9KZ&PZD3PO$R'R!/'0^3Z^!^:(. T&;\_(T!3WH%>"!]\=YDYJ3&0XKY?7W
MMDJFWS^+7<1F" >92@8.@]RUS:+Y$KFPO45J6/\@0J61G-HQ1=5L^/EPJOL$
M[I+B$BQ"Q<KD:%(Q_NAD?\91(J8:><90:JP=+G%)D?/$\TLMQD8K?7[31WP(
MEL"):[%>[*UXJ,\I 6XJAO_9!;=)K:/SM0E##U9XMB0C<B"5I$T&EQ3Y 0'?
M_9B=4$B$DA8L2#'KP[(BC_(RI&SDTBE&RSM5QNH1I-CTKNG%94E&M$_.3'S<
M0Z=+MC_]YS\-JU/#52HJ/OH5\YA\R!VGL!C*K\)?PTAVJ=-A,11D0Y)O?:KU
MB&8?-@Q!D<>,V'Z'DFYN'H$#*(H"N6Y<;$%KV,[.\H2D<.SO@EG]I$.XC5^1
MNG%00,&X"SNIT]E8FTL%!5KU*$WO8]USK:>Z5EWJ[O+QW;D"1H$]24T-DIE2
M2O!6+.DZ3!JA 6 ^(F#TCRT2;:3?F[:NYKRAYD&C.J^BEWJSKIQ=3.K)T/RF
MQ>.ZOU-3=!!PR8*$VO AS:BOO#,:\7UMW9BA_WE0/>GKUX@TS<)/!CJVKT S
MW-&5^;"._7QY<F#ZK)3YI9]$N<^Y\=]:?'9OG$ ;V?9*'6Z-X(+L6$XI+7PL
MIVHA!_5/ C%OQ^V\'^5EGWQWQ:<H8 L^T) H,E,9-6=BTK9V$%%> (YJT**#
M_"Y^^)5HJVH,)>]D2]VG.FU*4XG(LVMQ=()MSB3^:\[QEQ.566G/Z=-'OB)_
M.,LVD4-I_&/&/P,F357=OU<?S+&[YFQD7NJJ8ADT%8K4V&1"2-?X>"< #XH*
MX"'U_FS76%80_MI*I)AL5KADE?3R05OYSU&3D;HNE/U=G!+"UG86EM!MF%3G
M S4DXV<:[+=],:=9.T7?]#?*ALTL]CQ_UY-B>._0K"G4%CF$KY:/ TE+;&-\
M,NW&#U,_;N4OY<DMNNM3\=]Z7'J[KAW->*1824P$X PN/8$KU%!D_P['6WD_
M8TOK$Z0.E6+^Z^A[W7_4\8!21T;8Z_GNC=VY_ET>9\F18$Z+;Z8<G<NU"0DR
MZ$RQQH>SGJSYI  BBNI.LQGJ3D% 21*XS\#A.\-V4\Y7>\,#^=R-(EY.7GNC
MUL[*VJI[BPEY@B99TWT61(D:((4AE*.C[Y+H'TL%IWPH>Y_-5+?I%]7KO>Y=
MJC\0TY=Z,$WK:VND,30_1%-SSRGY2^X;_BE[AZY/.!XS89DK$,4B*0@$HE?Z
M!SI?^.3A(#=H) ]]R>G5[]W<ZS;7UVQ]CK2>>^U0_XQ_/#.6\^^W1\\-H(5_
M_S AQ-W]SFVR"Z-UD EY^^$Q"QS&P*.WW/$BL T>)F1/W(K]":I-&:D"B+8Q
M(9\/QWY<G]4@_4XH^EB &/ H6OOD\+7$758@92[2^)K2.NJ_;Y<-SX%^BJ<)
M9A,LB<>IVJO.6F2W[J<%H_X8__*9A^LK\_&^09F.IQ)2[E_XU1++A,1KTMB8
M$/3@4=3<#U7&60/IDU2]]4>A3_=7FF+HCE2_ICI97ZNO:_8,./W1[FTF<H"C
MKS&#HT>/SYOZG%)+KV@^23T1=ACO1.8YYYWS\:V,X0?/VB01AUZA QV5!!G'
MBN6VKB6(@ %F$#V^0/!/)MDRN KG ]C"PBO01D-E&#]B#L50MM.BV>+/&8A@
MEEYL"*SV9#3B*NAQ)8BCI)269UKQY7YELN:FNXEPO*7.8NCL4 G4*M**/? #
M8P1:)YK8#(,F50=$(B4LN7OY\R2X"X.Q60)J1XW&O(Z?9X4V'JQS/34H_8<J
MSIC*$27""]<:'?>N,@3)C.@"*ARW8WP2>2_.)($E,4[B]AF>)(,+/?*KCVA8
M<F<YMIT) 4XO/_%75^AL#,L:<!TI)[;<2O]5G2=_6COH7HKU&B[4'E)'O8CJ
MN]?"AQK?7TW>L!G3B/4,F&1MQU;!<!),B$18H]>5I,.?'":G%+PV58Y*I75P
M0BJYNC,@7!TD)0)\4I!A+4R*8+1E8?=XET#WC&XS#9Q/381!FH6#E0SSUT2K
MU)F0LS=#,R(\$_178C]%A,=%:F.X&.#%:K6ZB$H, 28D#G6@64<TVC4DJY\:
MM/CL67U55&7>&N\"6^[ZT1NVD+SX4:PK?&H2EI*G.8(4"Z.V#]/T0-A+$'>2
MN],ND?]210;_IS16)\GCPO7Z<SP+ZU*J%M5##Z<L]-MG=<PE3&YP*!.<BH6\
MW]ZZ&0(Z/ 7S%0TH_"S'XK!3A900\K?4HS$.7YIK4OYL,"%*T[):Z0J\ZXT7
M\G1WKN]OH3R.K14E1A P$]P$>DM=J;UIN4_.B^2 ]YYI9C(1Q4('OGXSG!!?
M"M7D[%> _&KQ_('RWIRZB]!A0CA_,B$;]+<S@,8[JM5PN;U),*QJ:^J)T=+2
M3/6"]+4P-H5EW51BH ^TPQ)0'&N#<P%1-@%\$Y-V%L+EK5]OG,F8=TG'/^AZ
M:GRIFG46:Z7 2D!/["^%'4&]@1S.*8Q6Q_+9K\YRIQKYF8W^(D@%\RLJUV=<
MT ]Z*6"JN&1\_.88G!Q#Z2)KX=!3,01\F[FRJ&G#=UUS+[_ P")'3N1/0=.3
M[6DO[]<?$%XK+,;D,B'N*([5/';0A%]H3C\>/G6I^R3NMO2CDZ-=QI)R8<9@
M@[5O^C"[H0W6&[9KWMTZ2#T$YNP5ZAID+Y3RC5Y7#9U0-?_A*_/#C>R14C.X
M>Q! 3EK$9M^':]JP)!8'9!K<<(IB/7I/E_L&O1CKQX2P ^X!4D#\G'$<BG"D
M+I5HJRFRL8[B_73PV0O1@!.YA;^^7JYH-U/X%N[0K] B@VKSR1MSNE)?3?KY
MXL8J98<U<F@U0=W-N&3@G)E>E\_V[@OMS#MB)FWL;_/YH/0LF!>6%_D3RZU,
M<R&LO*_,/*F9DY*MXY_5M60@IS;.,E*JI,02??0^Q[$(WO#!-NS$,F%Y@^I1
M8D^#D4;T)>M^GK3#"$@D?/CC%.HG_S6D2TN+5>IQ[".-?[#&?ZR(RXM:%"8_
M9S1YP4"W#QY"M5GKWH)V8!)F66((T\Z*Y+C7\YSJ,,Z527&+7_CP!X[OJQS/
MJL9>CM/4,?CV9\C0;1&UW_W!M=_]X52-IA_:2@7DX7$;?_D !4NB1-D@3]",
M5UUCF<W&"F=2?_$G=^MQXL4&J9<IVRSE"ZE332!PY3&ZYRV?H=AH,*^YIH0,
M+;\+$_9Z$Y-Y08[?*BO;YB\ODKO-Z.R !5GG"C! FL*U:)&V4^52RR=/3A\P
M8.W.$]>"I$D=53O#-E?\J[F P760+11:B>Y\F"ER1=SP_E%7?SO^%W1#"$.8
M /W,]Q2SWU#)]GPD.%=OT8&N@VLYV5#[<+'[A$58'VYE^CNK_C'PI5QICB +
MSH\6D]8I[D"@'QD,;=,0\X%0ZQ JIV*G8X5L@HUNTFF,8APLV*3-6Q/,WU:J
M2:BJL=1J*5;*&\#E(Q!P:=3Q2L!\ )_) $_8,?4DMJK3+WM.E_3T';Z8Q_)S
M?Z\>P/+:#Y0;'>X8K9!26!86'1A\OV#Y%$]@V?7*;:<?9Z#;W_?&QK!']=D!
MZ,)R'+&:#^IY!'AF4MMDON+W,>=V]-62/DRCI@VU B?6-G@B4L=3/F7MZ*_8
MT=OOK59/2,;=4./0ZU(T^_!NA8*4&MI0+]=F\2L<G^KV\>/*N!SX+O9*K^P;
M"+N\1L@_M.)Y:$K.9@<?+^WLSV"^6(;$9W) \CW/*UG/BQQ/'_G*4W3R-%'V
MCE]2$]_+H *,&2T-?  DL+"P'(\\A;!_3LC&E4,[0W<FDRO)I[5VR :-@7]^
MF_!GU:>BE,_,8:>EFQFC8[]L:0):#'-CHO+^>NAP^BEL_F%S"AUX]8$&PG-T
M-D*%7%LG_'7/.3Y_8M92.(?]56O>#E=DFIHI:P:[GL\PS91JCYS,MI=LT?H.
M\_@B8T&Z>'G,RZ?DG&7Q8W2%LW!CBM]4^#S_>K12(KV2IN,QCP&41%N).E:Q
M*J=G^\TS"6EN\/[FIK134FT*:CIC:Z!JVJ0*(<=S+(FQI-]4NYBK?NP=XI?7
M?4I6D0$YE56G/)>226HIK"['CER//\_V?['WGE%-1M^[8!"D"D%Z#U*5(HI2
ME!)$I8@(*H* $)'>05J D !*D2J@(*""@@+2.]("A-Z;($$@@("40$()@11N
M^-U9=\VL.[/6?)A9=V:M_X>=E7PX[_N>??;[[/WDG+WW+IB&GBN@K<,E+/_B
M6B197JU3*4ZH(_^M"V%K5G&LCZ59_/+V;_5$GT!R9T1]T$@.SC 4NI^3G%/S
M.=LM4OAB /,C]7<^/S(LXG+#Z%06$1RM5XA[*"3.U"315@M7W]%R>VDD5C%
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M=D59PTF0P2\E[//:FDE))_/:S)VX_-RB<ZR5[&_]>GCG3@"HYA. &^+XY@F
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MG,7?-J>%F+<[.(F22WJ?4QOO>K:J7Q92.J@X>G1-\Z4<>7G5I[_DY16UD!,
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M.P&YY9E] C# NN^+_<]'G?.^0H,,<4/5L_^.;3Z_]]I9O:ZJNLYZ[3E[YT7
M1\"UK8OT>WY4-JT3P 5(.(3 /0G>EY<CQ1"^$A60-6IM8$$8F'1OYID[7[C5
M'_4C^X:X.UE<"UM'*=]]AUG*3@!6N-;$);WZFZTI]C^$7UIQAWJD!=]9E@ZB
M3\#X[_,6Z8 R$)4([-AW>#^< \R <&$'6^#TRA>+\JV%U[>D,]F;?OH*E[@-
M^PQV.9CV]^HQM\W17!!\?!J,,\6ZHY ,VO3K5M&U^;7DH..Z%C\/W*VHLP\_
M7)D3N=1<?2W<,C***7&A@'J9Z+<(CN54T+Z(ZTY<,GARC_D@3%O^&VM(@D%!
M7.4BY"PTM*W1=X*L0K,4L0K%!O2ZN>_LW2:!X=^3YS"L "*)RLJ.,3H]S(<S
M]K1N/_95LL^=^=?H<1F5\;0,F^9[J/$R;"AD88OI]$]U7 ZUK8\6#K2$?B_-
M^^T^I6SI%FA^G/CQ@Y)W$-> \/-(Y1)F=7%01_[$/LE&9EA80]C% WO!IG)V
MMELRD>EKH0#]N@XH"X)[I'2D[3T31.T(!!_[1;=D4%E?D93=3P!BVMS_X%(X
MFY+#>16<\9^,NL# /P.^WN(F-^PA2V\%OM*(=#> J\UB.BLC:M_3Z7CJT'1<
MP;O<T\ ]-#[;(=7 X,99P0CY7J:D@[T"[!'>?6FA#1F%=DZD\OU&N_FXUL>0
M0J8V1K#B5E7D*@QG^Y.V<V8XD&RX 0 /BD'BGB[$^$+%F*GBQ-#.+/VDDCQ.
MR'J=ZB4IOS]*YUXH;%9+.11'H0T%/1S(:[B1'EMU(BTR.ON8&+P,%(9Z;79D
MA$QM#JG=;3H!6+H7L,E'A5]I$W^;L.;#D"X+. ^QAX9260-(2IMHK8*X T\[
M?V]NM@#E&1L7-:X%'9+)=OK314<O"[I7V/74G^5"E'?9UI0JL/>0-2$NYE;S
M6*L8-&3*2%0L= 7M!=JBQ4;@J&PN8_FS4A<<'QFVBX,*>/_/-CZ>'+!K3YM7
M9PT?HX4'##,\T@_/OY'T_=>OQWQ,8]U(G"'X2'D!> +X;6)Z AA;;>W_8:47
M7T"$]WGL-['9J(X9.M971[U(X.Z[8$8W9),+'(!$(G<SD;$Y!]VTVQG:E1U2
M6;UQ^MWHH.16,>H8B*/DLDJB=[LGCU545+.,Q=,+F=L2V2]VQZ*#']U_R3NY
M?TY_@9/X^$[M5/[4A;%]8JVKLAA%T?3!C,"-M^P]X1J$4BL ,0=%LT0+1/C-
MC$C)*14M(XNQ@TJ.(]A-M,.$R>KS%:XG$.EH_7/#/QFX^-]JAA*NXV(2P.Z(
M65D+2@'9^,LS%S&.2L,+N"U^G63-(YEY&A%M>71-4B-)LQO@S.2]<)S<AHC.
MZBYK+*610B2K[4:<$=MF(A?:L%WKP6YV%;SVC[Y0E]#7BW<>1CT1 (2P LB#
ME"_@E:L0)N26(,U <^<M:"/;'X.=$%RPET2+Q1U>J-P\S>]VM3(WIFZS:P^I
M&?MY*V6L'NF\')>\RQTEJML 2*4C"2UW'*NL5G*4:Z?8JY8RL_'NI_=.=#/Z
M\.FJ<11\V79_%*[-3;Q]R@")MXNAK*-D_99)3=%E=_4[0ND?CY_MY=<SGVFZ
M,R9Y]MS+P-;QYE<?S\ >M^U"8ZBLQB0OJ/N28WW,3@WBU?R9=)G:QDEN;[08
MB^;*_20A2^F+EF9O4PH9UH21AIJ&.(O%M83:"X705VUPP6DEU%'DYJ,Q[+8T
M.P6[_7IM0>77^G%869K]V?>)-:KF/N))\J'03M_NO*\_(L*9<O^3<_4=1*_I
M[+T,CEFH44)YJH9!.C\S0R=,*^L3^K'N/-]=OIU/LGSR^8F/<F OD,Z0:WT!
M9PF*:LQY+9Z^T &7:\#7]$HDHU0)?;*9_GH,[E>\3.L8L=D5\%5HV1H!1\F'
MR\$'M"5PL@F:X'Q4*5DQU;$.KP!VX#)FV;O5W_#<7DDPP-PCUU%P@ZY4C<PS
M2[ <]V]*YIG9;/5JNG[W\_ T:IJE\-YOANYQ@4CGS]^-"YC.N="O0(BRI8<)
M!R/$2VK)!R8@UW%7^.7FL?+R &&6J]FW%>K*4CB!= _'?((% +OL(?Q8_1/
M)2A1\+0I'(@""K/.P1E[,Q(+EC)ZDN,6:LIC:PQK1*]U15IK\;$EK#YU^"3E
M=#^BY;Q=E&8;P!XIR@S*K;?E'RNOC55Q_R31O?RDGLZN-7U&"-K61_<L$26H
M!?33 7U"U'M'D&U(ZM1?5 Y*$4PV;P[Z2K?^3CU>NK8F-+%1RHG)27([_ZWV
MZ%\[L2N&1^\LOA/3J*Q8G+ )[ARZ.['0#3T2F\4^116^Z3 Z["BY8BCMN&MV
M)M@Q$"/"B '52;^125Q.X3/XP^M@][;M@"'$0M >!UX<SB@KJW?$ -G0[G+M
MT7F,B1X9@(2WL+;L*N70PUQ@-A*3]9F76 U"(;F@RTO#M65_;*%U!U[[+?R6
MS9]O%:!?27HG"0H<2>B]?9L+3)'4VJPBLI.\71!B8!>@&$RN C?UY=N&&!?)
M.:?PV8-DGA. <Y.U$SHO)944'<IZ;-[J1)3%0;H>4G_E<+<J$K-1:._7)5X>
M/=$UBMH=#NE& V8-RGUA5W4 KL_D 7 /+@$?-D#8M=,2[#0^RCE-O041!&_6
MI9V^AN;E9.X@JDDVX>MIL99#ZL?5\G%V8$>6;-2479[+,?RM3/N[I^A\;:=K
MB;,ZP\HAQUDV:AW'JHEA :$%ZWRJ:O5W:KNZ:JOTI3H_IF[E\OU-&PD!X,&S
M>]3[LTL]E(B<$\#M>WLF1)GI:$]-5QKSPN,68LH/PV+,7UE6-,PDSC^KS[CX
M>P1VM;SB_QIC)T,>)-OE_NYQ_&YIO3[E^_=;2[X1CWNJ84<AP"$5(00@%U/>
MP36-:5>?P1<D:)^#>51,UNRPS;F9%/[[+%E?Z2J>$2$\>&;E\Z7S$I).2PFL
M%7WJ&TBW\MFX-4)A-@K)C' 27N!TLY6</&#VNDPV^OYM.$OQBZX/;Z_AP]N<
M(Y)GGSSI&6I8W@_MG >.PEQ?*#3?_NK:B/UP@^_X4W[0^<A0K,]=<QR"AH,P
MK=K4V8Y6@;'F:YXR:JB\=;R5I/WW.VYT78#@G*[DN#%JST*UB+8,'DC(2!1&
MJ5J%)?X9\FO<H)I#2]%.J;HO!X>:T_I6&Y5F4,MAR5A1G#UJX?SU.>5E_:HI
M^-C*C,W-YI0C->6VEQ:OTLZ#=>61OVI"V4.ZC10?]"\\K$X[B]U>LK3WX-1[
M$L'$0$]\M!YBG!1CQYN4[>A=,',WYS)Z2CKN>I_4HAE V1#\R(5^#1*^4$>(
MP2\3PO%K'<5 =C<AVR^+2G7!QU&=__ FA-#:.L\?-P25&IPKRK^YKWI'(LZ2
MGX"PEGB-I84WS5K?B?>Z5P>A[KH36S*&#LVU1J\4,B9X (SO.RJ85MLOQ #J
M)ZX#+)9CMNI)1E!W@B"E0!OLLL"UCWW1KF)CW,DX/C'D>.7/,TV'8N74*JG%
M]]&W!+2854B@9R.Q5 &B1K?0NYO1+8M:0&MDE&Y/0)%KQ9][<1PZY@%2@&#,
M*-,: GM+8H &]0%$GG_M8S5-9TH*Q).U#U,@WW^]]UTTYMI\4C>Y.K9_5"OO
MR'+V;WKAQ)T\==:_CCI]_T*S?IUFS1.E]<D?,[ J)P [FHP/]*.(79Y+"*)L
M,K:OA.P6KXO$,W7D" L^*/=UYK3WFN9BD8ZM["@I5E9XTQ"^T47O[ LJ:#2A
M!5",JQO+]\<5_#?C\QJ7W(T<WJS>D+UL=N9/:O"!2N!Q]^RCFO2IW7GY8LMW
M^6^'(\8F#\Z:,(2YT"]YOX'@+)0BCH'AWBI IHV@>07\X\X!QZ_LRDL+W)RZ
MP>,&<1'7$K:<//P%R]:H+#O!^)[.')8=S<?X>NO&YJ8I9TM_S\N[W6RNGHHZ
MLH.^(BXS*=E1+WT*7]O[EON,41G)ZCAJ/:7Z&QF,J\LN\>9"N%C^JQM[YB4J
M/&C&GK*9A?T'*$]%8KZ!JEH+2 ]@[%&P:YP-^)CH,NN'$Z7QGB0KGEF5!MG$
MP3/OA[4=Z,6YW#>M:)&^/(:?S-MT'P>.\=3DQ8]T4,7'FFV^?/W];,-\JFFP
M^PI_0*>R<I]( WT@_9F7\&>89Z<%9<]ZX9 )9.DBXC7,6I3FW243 ?>WK9^<
M?0,<BKBN_WCL[RM?D]I+I_'8+0&3ZG.+0H]'=)QVAM)%:SY>5 1V?C&CX9.'
M:\7<HHFI9I=FJ)DM.]$(@XBY/+((9H0B4.<&*K/UQC$UTB\? -/CNPW!B0 8
MBL1![3Y$LIP ["F(-NI5QA$(?I+_I1MAF4M8JJ%^EPND.P!2 #</*NLPMII2
M4A NQK>I+-7+)OPP,>+L5[>;WC$[WMD/)P[B-0+3P==<WGR_-?74T6"Y_7Z5
M\O,R(T\*M,2;FZB&HJI6\ME*C-;,A0QRW6TM<A4=A!T</3M/HRV0N@+LM\43
MP*P^"HUHAT3.L[7BJ:4_YE"^E** %V/9>GH,*HVI@M:I8I:J7[\\?RGPOI<2
MW7H!6DY@(E(*8>>(GQ8%4S1M@KP((>GO/;P<7).WEU($&==+?W-QT%VM\'XG
MNH0T:P;AECL@'-B_];CRJ'W(N789M:Z\=1Q:_C_ 4ZJQ '0-22\N< L*\?PT
M]>U[)OO[OZ/R0YXM@<CTOXYJ2DP,#CXN]'O\_ZGB*MM'NH&8=@=2;L11[I64
M/N[(DJD/\PPM_'<<1L'6G>/G-R^22GG^U].)H0RH&40+,T^/TLOO!1%6FXG9
MI"O47ZV<1$J^:OV2272X/E]YWNS<_:FI!(DK]X0T/RQSW7F2TMOSH7DO@9IB
M%L2'M[DEQ=V==EOB'?2O:3\-Y\4/& )S@7'-#VG6$D@\FT\4/4B4?/2K=LXW
M=X$_QN)^%DOGAT6I]]/]#],&Y%L!ZNQMFLED;B4,)*%<TWUY!RV[I/BZ43]6
MTVOB<H[===N'),T)A=VABMT?@RDESS%8W>!S^93, O)9HF/^YNVGE<2 10TM
M&P,[A/<7=(^ZY)<]AM!JXG20#B@37"N3L03^G4SX4T_)JT%RS+DO<#3K>REJ
MZM3)#Y4DO.&),[FK8!_MJ!CE?"Y3U+V*2*(]\7.B?0".1F8?$"U4"Y:0HNZ!
M0_;V3HW^N+ X2[/<8+;"^8&/4<F!RQ%OE?47IM-]W/BJ9FUNB0XU_S W<-+Y
MMQ$2"62PD%]<>-5*AXNNE:G,)8)0(3+E%Z1W]K$R\_.!O>V#L1%).CU6 !R$
M*+.S-5L$'T)6?RK-B"TUSHE7(17\.M!P$J^M6S&+.Z,?D,B3,C/7XW;T8L=Z
M$HG)1-0E)Y#U2__Q3R\PPB4&Q[\7V)VW<Y7LG3B[K\BM.;"2RJ;7'FTP"_FA
M8F(^5D.!=QC1".+LPZJTF+JF*,?$UA]MKW1 V3EU_&0>HPZ(2*O@'[(T49BQ
M:#F9%SIF<3_8KB+K;/V;WCU.A;B2;=2E-C2=DV(;TQ9RA@EC2?F(=$8P$85>
MIKJE!W:'W3/H=73_^6'@"COY7LDLSZ&9U3;Y JZ@'0STDLWIH#E8316M[COC
M+L<.?(DR#QXL"R7LC6AM%N6>02HB,/6@75XB^VF1R60*FTGYY(_^:<U+7Z&9
MI<.5>>O'E?5_[-2FBM0R/CI[87P_Y:GO\]#A+,A\**IQ?3N2H$IC1/E!3P@G
M@ [O(VDX[3(5BAG4V'OH*;)&/C%K1O$@\?+(DWK]/3[A3?],W@H]C  G!XO@
MH4J(P*-YJ3BIITMW60M?T>E@ !HT/C-$?$,+;TMP0,HK)FJV5_'W$T!D#DP0
M#X^A!?4G@!IG%(E_,B"9H=FP:/:V8* U]-NUKJL/#_/,76D<CN\NV/\J**QO
M,4S(TTO+R5BBZP#:/3DI-,/>D7 ^0D:-@T4TA-OJ'1V.1L9X]S#W3P <T]:I
M84Y@;H&7L(N-L'(?IYX_EH0CZ2#?A@;U-2]H^2=:R F7P*O%GP P7Q;X:/Y,
M8+WJW[SDKV:5T$(;UXD+^G5[Y1Y2!OV?]28=!#3Q(S?*)^1-(A8X%#3O:=YU
MQ]&4,C4O;CZOXN)O[=AT[H'?ZNNYCWL?#\K2IU$W[R95^A9;NYJK'I=V;&4=
MRSM8KMAR"+;]T>]O,;%;UP%]!-4[A\-<22K4*5L!2E&S:-X?:/R=1"[P>>M;
M@M[5/W05<P;%12O[O'1+7G,F96J9@2"--'7]A(^8$J4//@0DO@A[IBL*NWD]
M,WWKY[.M/=8C>J9(V*"/;Q9)UV#JZ8SH[;QSRA6]DJ/3;"< 5N!B,J'M%W+Q
M&=&$9&;/O_ [L!7:WGM$;ID+WM0!*=-HI295G!Q,7 Y=VGD#XJIEV=\!N*4B
MR9)PT:QAYK8%F64)\#N9JWH1]H^&8A36&!*F(V%0?'H1[26^2"FN&7FE?:XU
M2^DU_'R#FM5VN9N?Z(1>X, 5KYA4NYA"Z4]'MCE%.T*&PGK])0FJ[^W>ZG^7
M5]+%I<<L(C3_H2_GY L2CI!VM4F@:X+=V%QG0?61HES@$,T%3!!\6BD9,&/,
M"0 MCTG*$8N>Y^,CW.S.<!;DC/=_>.Y155)E#332]B^/5U-6RV8/"/?(A %J
M1'#&(;J-M(3V(!,!V%O^F35-1J\M]TE(&4.I.%W4#X'>?VJ,YB+G(5;S,]8;
MYGY6<^V\OTIZ[=,%W]Z\F1)94A )_%+^&>E>_OKF2!R584/[+-$> P'.08CI
M?UWW1GPNU+RZ%WW',9TD#'<R$V8<R5ECH$_@!+H3@Y:9X1(P,&XDKA3[MZ9^
M^GJ3S0.-8 ,EKB&N7LZ4=G%5]?VRZ IM$%$/%$.EQRU$8;^Y8O>-E6>-D\P%
M+I_6:];^J^@]2O=_2-GZ+_G_HS!ENB&J@>US[D\\34R)CS'9<[=^-_WY PT9
MF_O],?V%_5&RJ(G*OSI5/K3-1]5T\U&TE>X7B4@&%A&WFV<?MHEUE/R/)+@N
M<!T35@5/OPC"NN+8VEH%?SVOQBW$!\AK>%JAC=2_N:8:$;_XB+ZK<A1(?I=L
M!2!9_:>:%%&-4$'YV2IN"?.*QUBT 3EN+X%B 4JS!\*O+>UK7T0:IQ1?T7G"
MK"05X[;F=6TBVCL:C'L8IJTZQ;VD&H$(+%X] 3A&5P[&--M9_7K!5#]//YI4
M0W=L<1>F1>*ASL]+$,OQLF9$#3P"-0:U6()G2>TF7'R1A/\JF*Z:D%9EBE27
MN]<8+>G%N%-!#ELV5EM$1I!O+;78S5W_!#3)>=1X-1S2'Z<:R,HB^((G7.,C
M*V#^*U*Y58AL1*D$>Y;*6A)?X3:[J*)$"&8V=$9Q_Y-,J,M?]XP$YTPQ%LO&
M']57S10_RM#UU"#:M1$>(#YR8",^!X5\4V=J#=/'/>N6'XAWF5)IO)OR)2WD
M$KI**C[ZXIE/ ^$W<H%57HI+S?7I+$N&F/?W#$7B!&T,VAG$F"5K@_/!53OM
M36&6 >JMW$0)K5M/;_XICRFE+Z9_VW8$4T7$EP: >50&D.?(*GBORH)>">3$
M?GQ34[#@[;.IZC:3;Z'JXC[NNYN$($HNV N$CD$)I2,QWES0E\LF$SO:* V(
MI:5.ATT<$=#5BTIRH3_XKCYU\==Y78D$N<(V^M''Q7ONCUMH\)Y(= Y;CT%]
MOA YH[E:5YO\0-M%L/_LD4B.H_CG^?=;D(H"[*8L]FZ1._4<'A&SC,OI#&,1
M<H\7N%VB=KXX]J]<*A>^^25GJ3"7'N:69A2 Q!$G3[_$6.J72P1V9GU*B]U1
MJ)G-_F#S[HJ%0>8[#"Z8/@ZP\+7U"NW.=M3QSUJ4[]I"1-13/+6(L0A1X+;N
MZBG%EV(=E=!1=NM\(5-JL HA#,!CT0$1. &XE<=2@?]Y8K;%RQG%LRA,F)6&
M:E.E^\7/^LHL04N/FKH#E6ZC6['_H[S9F3CY)5#\0BU3IQ(SS>'H447(TA,J
M3R_@M*OM&0[3%9VY#;8ZUGRYWL^#?\G>GIT/UY[_VNQ'J*;D*2(<<R*/<Y(O
M7W>M/8QT*?7<>O'ACI@K"UM+KX:9?2J=]J\QF" Q"H&_A@&_:O8..]OR^5N9
M"Q^Z9!3]:D5?JD(ARNRJK(ML0IJ.V*N[L,<G  8DY7NK.'S"EAY?5[!,,6=_
MM&<T^:6N%JJP5,^<>/X%<Z*.YO$T>O*_;XI!+L%G(?71R20YZ]_0(/WQ$\"B
M C&M1 ]D,F::)B(W5"F=XSUX6U7W*WG8+*'<"A>FA@+A'@+C^6@N;&1I@9VL
M%OG<2WQT^T7]FSS1-#9OC8030* E"Z@K#D"1_HJ\WJQ&"H1Y4]Y1+[K"62E%
M_AK6+6QF?@0$_[J/7K[XA?NYN@PON_/+_C*G7O3 D'\@[BEZ?6FMC5Y%FS74
M9_(9K"2^DB\2/,>\P7QC"&#T/X'1<^)>-]H$Y7UV\[/<=)EV7Y[+U,L%FX')
MV.5'G71S25>87NKL0+)O K&2) AU-@C]O1AGCC(F!N".YU=*<R>]T\_LOE]S
M'Y S&":*YT@#;.FT<T&%[RQ6IA,TPTA!\+Z;UX@]W6J-LITY3)8I,GDBOK>4
M9R^(\]F+^ SF4;[\Y"\Z)-43["A?:T#H^$6.C.5/C++5>YFEY37KSS1F;,3%
M'*1CYD6*Y9\[6CY@] %HO8B[^+^SF%,YFB90B#U+.>'(:O[89D?,[.]]"GQX
M=5C=2Z;>\)>YT6O](Q'>&^9:Q164#^2P<I@)):N996G.R[\9SU'^M2?(][JO
M@MN>\F?=0M8;6XP7Z:<*R[.0+T3]EJD_%R%<R!X*>$NH,ZBR[$.K<4EH[LS>
M1QT#L%JYRG[I__(DO/^2__>$EWWEKU#8QT,+Y1*^4;WQ 848UK@\Z3?[ *&L
M'VZ'Z59>::%!14;LK9^\Z0?\%/O.2+TQRW"6#?]R2U:KD'XO'H6HE<5>)7E#
MESM=2>"A+S M8NA7F[!/L%NELU)5(W-!P2E&>U6)LUS@MU?._8D,/@'$@P21
M'CF_S6V$.Y&<Y+N+)X X6_J&)FO#^ZKX0G//H96:>(9'W5L_9I\>Q3(#UK8_
M%YPFRKPB9G?/BT]K@DF*\)'-)46)J<V X2I<6#K:U7J%J_GA:[,_A5<<WMXP
M5<X3$%,A!;I!:@OBD,ZSGRR6+V<L IF(JEKW?CUX\TW9T._ZW_KT_O:U-EL_
MTJ]C(1KTT'SX:=L9AQ, #\P4YSG]_@+N-?7"^&6G6-4_:,%%)ST&L1_W4K 0
M5A@KI92&^"/HG;801 Q50";Q^V;6HY]XV625;*A]A&-J\#E.%'_Z>N<%M?/<
ME3=Z;=DHO"< ]2\G@$;C$T!#_QJ-8"7?]% %5QZ/<"T9+7!"3"X=/)=(0"Q7
ME@*@7=-8.Y(QO O$WZSX%3Z:D05):&8ONR])G:FN3S171T6E&CC&77P#/93_
ML*)[[RVC,C.%GI*KK?8/4HWL,$;TM(K/*29E,E]%=[89!ESCK-3-W![4&;%+
MUZ2'G$.T>^N< **L<:/+.=CLE!S2<WD+*IM2H:TU=8!ZIC:V:N8/-)K^QN/P
M>S/##TT*5Y+)#*:,:BBP /P/HK8N;H&3++F4PT96PB4.5+O>=,3F.]A(I'Z)
M"'7]Z[C!=L/TWHJ%@ IF@5?[,NPN\17)ASHB)D*L7BS4!"\O,!-S[E6T9@U%
MU$^>/Q"0BEN]HDZ7,9KRQW/%XF "4Y9I_Y4LC).._L#I.H7F33"G6F$ABIZC
ME^C7XXC\5-;S7W_/(MIUP(XVCZ02 ]A:G(TC,3_"MU(VWGX8$"/W8L+8 ?",
MTZ+B1R"\?)?5#IE[C<HJN82,TY;&#1%:,"9"BAT]A5:Y?7&+>9E3,O;UPW$&
M@5M.CTR=P]NF9\'L"$P>LGJA<T=&WB16-81WZ\-006S*_FX^0=F X0YMW58;
M=Z)/ &)P#NIT.EP.MQ.S7:KI7;"N?3^D->>'JW(^N%F9@5UTT CY(4=3Y/RV
M?#]<!M$NAW!>B(7#IN"B+3C/_4RP"PZ[>2>70!G,7J:?,3-ERI^#]R/.-?OB
M=PR)>PS30;;RT1<32U=SX-^'35-J['!Y:_VJXT&<NG$'H#>?SU81/^$V.ZF<
MDY^^5DS7#'Q2#C8],Y8_=MUQ6JM[*]E'?C<;)01.1F(R3@"UTY'-@DQQ^7A]
ME)*PS6UAZ_[OUUU6/NANV_VYX]=I:1TB<A,C]LT"#<84@00UK8NARXL]6UC,
MD&&-=8ZH(6"R[!=!\$7#3])USG21V(&2!"*I76>]@1/X >P,FK7ORJDH)\LN
M,.:/^^_$/K+>4):)4LV&55E+[REW/]@?)CZSJSLCH"X7F/X"Z8]HUT(X+/"2
M1=.Z(=Q4F<&8)8ND-??B68'^%(=D^?N+_9^^&TIY=E[6C3+E\'NFUK5#E$H.
M=Z)\?(SZ?.9U%Y[_WN-@IE@ED3<JE@0 ;FAX,A&_&]'IS/3QIW=Z'@T./I"?
MX,!;.]ZXIIO1:?AXU/'DS1<;TWQOKH\X"OB\2+_!&_')QCYV^_'/!W"<5#B\
M">9U DA56MXA\1\ *3*IIRU)(Z5/ 'UG\-.4A)X3@.'S\E*5NWA=:I]0 5EF
M[]M(@G![!K"X3\1=B%(R4_E>M[P?\$)?[/V1&NDL;6ID+1($=@,/?*.2S.<&
M!^7<_X6L3F43AOZU@,C<4./ZLW99?U$'5)=U HBM*6==5Q/Z7E\T\^_8L3$C
M:Y<:$"DP^=)(@Q-PG$4NIB1Y*\*OGVYGMTK ;N$<O*@<M=:D@I8XY<K[57)M
M"8;_'-/\<\4,'OFV]WPY38 ^#P?U! C;PN[B%0AM9'R[IS=W!>%%"1-EUQVK
M-'-(\,"!MGHPA[B="/_O59%!7/.V?PQ7YVQ[&>D'+FQ&?+Q(I_< T)<+?%CV
M>&F$G(H41/SF.SP!W-$*".B'6=*49+&L1#HS?P+X%W-ZUH H#<::X,HQH(X=
M(5<X&!]5'[VS4_ON9UTT5/9MGT"$6<75/([<)/=M(#$8N#5[ KAK9'(":)-'
M4J]!3MMS7:+1I^0H! C.#YTPPY\ 7F&;#1'V)=]J:R9&-)W4!UF[=!(G Z3V
M(#X(5#W":>%8NA%!99P[ > W $3G[AQ^,@C?1&5MQQ5T?F::6IK>U_7P;)TY
M]U*O]87"; ;'#V@O=AZIAZ1!LLD=RGLJ<,-6Y=<B_^&]3??OZR\@BCME.1KV
M[*_" 4Y.[1UY/@_HR"OX@@X@$_G\:<MKV"7<0L2^00T[I[!P3B5**E7IPZ;J
MZD"UF(\&H6R RF:G^B6L&'9^;#%*:'PIS#!C.*S22'7S#FN/)(!Q,P7UV86^
M!,>^AMTDW8;:CO2$0.+(%W C^JTF=:Z-*BMQ3#_?M%WLLII?G%+.7PZ-UA1Y
M*1#"OU5,<H9N[RT_.6SS3K82_1Z%%YM7RS#YY8%+/_Y:N%!SL7_[:G2 _X6G
M\F=^H)@RD[L6<*:%]D^7<?RHOW?IGIB[Z #\ 6%ES0-/*9\1[LGQ.36''2-Q
M8MHX2'3)*JXL[X5TML&DXC*[L^ATUN*[P94D,=N/Y+F+]!O@V1["8!,E?1_$
M\6^>9VP1S]\)X7TP=6R<L#'"X\9:E#)FX"S]Z;SI^894O]VWL+!6/D3[K8.A
M"RJKQ/I%=OY'Z G]Q;^U]8/!D(/["R_\G9;I_:H2UJ#E3I0ZI-M.#*A:05LT
MNU.;IQX_DE2V,#RZ'Q I\UDY@770T=&>]0V M9^-CY2+?:$)GR"\IOR$7[KH
MS08[;5X86;-.Q4['YLMKBB\SE%3GB011^HY-F9Z0Z*@SMNK$@65O(;(LL?:[
MU6_875Q63;E6B:Y2C;[(5\'.V/Q<_Y1EU 7612*]EW4?PL7DZ+Y%^PZ)T8IF
MO&KO>Q'MX"TRI(!FA$:M<M;$8RKJ,?Y=B#3NE]=^+9NGU G M5K!E.&!1MA8
MK\HT=31G]T/YJP7"N=H3P*CW17H3*AM['MG,.QI;-.O>* <3?VS/.Y7T#U$#
M,=US[/PQ;Z[9\OUJ\I67P('-]04<S>8YR/X3\/,N_%1-O'[T 20Z0XRC[@3P
MVL]H0D(^U.W[Q4'MX%UN]7@Y>-#:=*DLF7>->G_VX0F@XE<,-?H7%E*53,Y<
MZ$"2N&E80)&Z!R 7T73C3S8C#KDO+O#"KA-!BYLL9.,2VZXB6V+V4SN"EL0O
M[H&^1\R7!Z&]]N$^B7V0(&(I?H(P2(DY8.?O O&HC+"3[^&,*;_K/BDH+AD\
MTF4+AK^P;I?R>O*LZ$+:RK\0403Q O43 P)(O00I>?YLZ(=EVZY]ZAN>A#R<
MLMJ:[=!I@;4H*4J"2K?_N;&-QM +DMLYZN>2VU*(HTQ3MDQX> Z>OCT$&'<]
MP_5ZBUL'N]ZO#X#N2_:6W)*5J'-3<]#Z+0M)0Y(465S!"$344V#2CN2EWR]W
MS07V W_'F"03WM%FF$RV('Y:$AC'PS2D!]$>CT27+FF.>;H%8[8B0""LIUVD
M_ $<*8? 9":> %AS"//$-=RL&0VN6K.Q$&<]=4OCVIDVR+.>J[[47AGDDT+Z
M/J0K>":C'5FK'X'55%R^%2;Z_MM^R&O^FPY%O)TO+SJ*:T@"2DKZ42*O?H?K
M=4Y [0F.1*%=$]\ _M?-_'D^AUR":WRC^KO?311^F^8&J?,J=>\DPODH.7#1
M!>ATM]HC]+_TERBV;&CSC&5^BKUIX0W[]+X>1WMT%8T+PV!J>/TVC>2X:QNF
M<S"UU&ZC/F\5MDOG':($\NC/%0J^"9#C]Q[TK;\A"" F+R*[E6:Y"?/UDS +
MW*PY;KK#) ;IFCXU;#3K_]D]O)E3=#'S4X8X_T.NOR(OF4L^^1&^40H0=@MQ
M<*X)N+9;B%(2F;YL6)SZNZ(^\?[#2[?DN_%=W$<I,>;R<J++%TSP["< 9NH\
M4D!;WG+(E:0*'^8$,:-'I/BFT1\XT4>O,SQ*/,]=K5O]TR_MW9(:7)Y%BX.X
MX.,AY9%DX6)80#Q*2/63ZA=EUT:^Z(??(B$*_$&.2N_E(ZBU/['SX6!:,.L-
MCI^7(?*3%(G5W:T<+4FH3B%8NI&WKP++S<+4;8&%OSYF*S8QDBVPQXM@M 9A
MC/*#K/:=&(\YJ&U]OXCEZV8SFCW"3"Q[VC\R,)WCY0<D!">TZY[5 ?3-M1W;
M4UE#3P RP&40*0JQ'M 2B, ]:)$1Y2?($RV\ 1V&!88OH3U#BIU5]53-U? ;
MR>A0 NH7T@$RL]=^^%FRIA(/[,*^'!=VV2^,2)HK9[CG)>/XR.1=4IOG(S8^
M4^8^^;]HM:C3K0ZQ*Z,8O#UTH9W*UY"JI*K$/&?9)HT.GI4]OAX!VL8(OKS!
M4-2K?7HB[&(#'IYW6H"%>-M^T9U-'@N?N#]1,%JJHL_F[AM$V(PQ/G(4N!S7
M(.7L(KHY"UY4IIEV-&+TS6EWUA, BA9H^-/]6ZA4PGXI@;V<;C;$32^9OP*]
M;E6$FB&^S_2\3SK@K=.,??VII.2QSSFS&//'D;H4/T@6F/X$X Q&V^X0MFA7
MZEYX ^<>K6G(3S+RM+61H-())F\I>26NO+%Y,_)^@O05:51(WWL"</>.:BSH
M+I]I6F**W-=G*W'+LE?,JC[+=3^A*M\A%<#1RRT;T22#U$;:(8@7U:(03J 8
M4[(@L25W4YM[$J85_/(-K$Z!=*>J9C#C/'"^.#JE0K?.PON^W[$AOF"Y(!+A
MC&0JB-,,+5%]\]70/]WP99W?GU4G<T>;BKR*7KV_X>KTFG%KS<:X&,P) &N'
M&0)VAM!@L":9?SVD+H=]-:?H&?K#=NN(')-Q56)5S]LV[)\K(0FC#+;G*5^U
MV:CC0J+;$8L[8BZV%Y(M:E.'/15LF+W^QMV16][:]4Q[_T(;:TQ2HP[,LU'>
MDY4*_VDS4\?YA*)ZFQNHXXU[,]^8N7TP=&^+/W)TM!H3!TX #*Y$OR7VFQM[
MB]^;?D"OV>C8HJ>._8*?/WWYPPAX0]E';<<C !UB7D#FRB,DX.L[/4'=)X!S
M5/&YH:+-STQ9%S'(QK3!!I?,OXF+[W>#/LQ?%D@U@#FO\- UD=BIDR#.5E7J
MZ((([-+2G#D;A;MC>OS6-Q3O1].:>Y=78\_TYM;WQVF_"+$8A=26=RIZ+^IO
M+2R? /BA7BL*!W.2QN[9AG_?.)KY]"L_B6 JVI!?,B'**,2#L%&D!QU_# (N
M]3[28-?%@%;E-R'$BPSQH"U7_/-*-+AR!L$M07><!0"_,(F?ER5.D"2)^CUP
M^>8D4F?C:ZM7SYYUG=$M>='2\.9*[)D$*1=UD6457,'6&LD?/@FJV<Z01>TP
M(!R?$;>-?GHK:=H56=YF_YQ6P/#&7IB7-4/YZ&/5C793GEV+S62B#(),,WH:
M0:?X_D+NKP3;\IZVS!HOD21:X&4?Z^2@_39-K>_/PKVEQ>= VMGY&<FE@%MX
M_N4@K!^);<-*_TVKG-LQJ&LDAC]#WCWH<HXG#Y?U-:[9V_E7E6^@/!6DDA.1
MER1:1XC?\)D.E#2R!=ZH+2M278S[Y[1_Z%3B,T:^(06/WAE!AG-%_VXQ_LPA
M7C3/<2R"=X-Y[9&L=L87[V=GJ+^73ESN:3VP.NHA>#<W-]->NQO$ JQCI@1N
M^HU$O=,-&?'#IV2Z/V!6P!+8^02 ;B*44*HTY0N(?HM#\XF+<_KZ^@@NXIYY
M]>L[X\WC L^C+W#G:AO<ZG1(99%F9/.W6*C5Q_*2@.0'N.T4TAV;=5MM8FCY
M/?'X3K1QHQZA/3!:SCY.V9*>T>6O[E-G^X]"!]Y$*>WW=@74[F/'H=Q;?F$E
M$!/H$Y_[D;<$^K9A#<ODJT].BXY8A;U?VPK3/+QEW%769*]8Y-C')?K/)Q26
ML$]738,9\\9H$D$8;]S57*35/&WED3(@S&CQ..#\Z7^;.[;))*[!J1- ):)C
MQG1Q N53E>/S>GH 4?-K9?4+;8&"<.^[CIQ^AG&C9IQN*'PU.),:=B\*G!AV
MF\2'Z'M'OD(;Z:1$ 8PRI=%"(]HOUQTQZG@.D.Q;3+[]"WL@G"C[,)HM^$5-
MW(Q]0J=E=:6.YEZ:;4 8Z3DYC%*F?06:U@&NUFJ-_P(%H[:G#L64IR0L'^E)
MOW<<R/M1_%[Z_(M <3XO=8CH:57>#;4LDRU1TB-;UW\CP1R? L>PFD74X0P%
M\)R@=T<5XKGH;4+1*)QY7JT=Q$K4-\=]FZK4K.</J1F+3_.7?"/X]/H_'>9*
MC'UKZ"A3 [%G^1!K0^)86+^YT.UZW20>S%Y68*WQR>1NE'A#K10YOPK%-RTN
MXJUGWCV'>>N.1<1":H#1FBPD\ :$WSZ;9(_B.[ZW,57JUFZ,-N#O>R*[G>%\
M=^V+E[Y >31<F6A!V"9B<2//<$IOR&<Q@:,'L>,:R55S;:F)J0IQ_=U_PV]+
M?([Y%D:/XR=83P6 ?TM,8Q!=UI"M%ETCHP'!H6^=0>S,:B^-/>6J4O._7*T0
MI * (0 <,OKF&K:=]!2J!XR=%\*OO=86@MH_<LZX-SX_K*8L=T.GL[9YIZ*J
M8@"I/CQXWN;TM)LMS&8<[!J:/'.XO)ICY[<4+!Y<@T48O;&W[.]T%.Z@$];#
M%_,ZFEV('O\)5DHD>B\R85M(Y]>Q>= S-N ED_"2O\&>^\0[00]_5/.)W[I@
M%-LGE?JVTJ;S8^K+L#3":=[:1V LB%<!+@A[BF/O02%$W;B^?;S&FR*1A5ES
M4+XM]\;.2=;M;X-T>.\0( S[_X$]Q/^2_X?EF7X/\,P<V81X;;F<V?70R!%1
M[I*1Y=F"NOK$4#IJS(B3939=L,=CVOLN *X/IWG$VDI*!$RV%':1V((;Z,JB
M&1&AN7[JT,HQ3N/!KEY\S1M1^H3;N[T)[='J *<"2IVV-,R1]GD>L@!]O&C;
MM&CRFBJ8J7+)<?K%U8V;G23RN]U<4\.GG65=9E7D$J._<M.;3WCH\.713DUX
M63)75NC3&E+7Y!>B7]"WVH3TX0PQ?[XJG<<#DH%&^CTBD<P;EQ9PAG/ A[20
M:"NF8&8C*VPJ.U E?O6*K>Z8 5U .[I-1(@D$0<@_Z,9^RC1^2E>#06*N>IR
M;$PHE;+J0AFDJXY<U;$#</&(L!Z[$YHI'RT(N93L -!9?87 ++0^.S7%%\PB
M^O=>().ZNODY?"JCSMN/(B]:"+1+-IX>23_+-7T"< 32_X9=HF'&1%<*]!6J
M,E'-N+FR7L^]P4*>]4K*V%/ F9*4ZN@G#&=NR?;#PDIAMD02R0/&3,Q;*@=L
MS//C?NV\\6^HT5(VD JJJ7AE&I4P <MS(J1D^YWM%6'_8DC)_M_: <A3K\)8
MB4,D-OBXU4XW.!(NEM9%9<33]UW^]M5J5JOG;14X4X'K-FCG#)/PN)F 2>,?
M!^TCVL0G9JW1I=]ZVFU<->]9@&>0Z C3MQP^W>Q$6EPVH/WKV)ZVN,_)HL3'
M> 1A@U+0? V?M[06E8\[[?K,>MW/!2T]:,(]/(;,Y))0Y]APF)4<[.?MB'J8
MW+1^ CAM;Z34G</W'1?3!8G:5!Q):A;1\W@N;G+]DNPGGK?..T8BV4DC2\ >
M<492*TUKLQ.G3H_?RB(:,TZC\9#./KRBW>ZL4=1]U8GA*\IJ1>]YT@X#KPIV
MFU@=C71!*D>P5_';("[JV/'W%/X8LBOA=X Q&.4S*^RIY[)$[_$6E9"GQZ7U
M1G9'"FTBZW4"F&6]2/]W(0(DJ@DA&5*[X/)XICBR9'"N.TI_TG]W5:MR(U6Z
MJ=B$ 1%V*ZS?+(&1X9+Z\@ 2DT 5_D6^AI/OQKD+V6R_U_PL=3EEP;I988#P
M5$_GN;(RD*:FLQ/?%/_[/LD ^7&T47*TME*<E*MTF!C^":=#Y15U ,=J8]Q%
M^KT!*G/78BD$!6:"A7%4?H.X/C8LUUL7/6CJ&$0ZWWHK<"YA^I\GCRG3J@66
M?M'&:X_*NHQ#6KS2GY0=_Q)CP@71=\.>>6[RL9=Q+"&IH"6,FV9EO)34'81;
M^2M5'-3_ KX\QDOHT##)DL'UI<#9K#,]40I?#&03QPJESA@<5]%T/$?THXTQ
MFJ2>)S[HZ4"*MO)#T2/=QVZ)6CL>)6\3]>[0/?E]'[\X*RC-%@EW7*S@QRCN
M]"!FY0D%$U0%MZ(E[R@$4\W=Y*TLN84_5C*%*94.L5_?<<>\W4[IWT)_U?:1
MWX^FW66<9EDI9!7\2"3"=81&HFK$HA;CRX6(WJBK5HH'43\T2]T(TX_NLYU]
M7"EBA,)$!4@=".Y(T 85K\^#:8.KJ7QD4?QA/,Q5;=M^8EM!,FF*Y2>#D<)+
M ]TB0; <CN.>7W*S2RZP;^1W1CN"6YOG=(/\X @NMWZM9TF)UY7?SP:"[ABW
M#/N*N1MBSWWQM^J1MQA=FR.:!9.C2SQ:#'/ZCV;3+%X9M&;?BS&NL_3.JPN,
M8.;//(?Q%-5__,=BG9V';O>0S).SZ!VK?1G>2Y4;UU3Z;E2RJ5IMM7'UJ779
M^G>#;X_%$Q%O(OF?YZ4E  S/_"=)F?3,!G8/9YN&\WN(NUS\Q<V6!U>MA^YJ
MMS_;,S-HVAUQ[TQ9_TJ%B9AEMU_/@IDITYH^^7PHZF9/-%R K!?_=-R[)E-Z
M2A%]O;4.:A3!PA#>YF!10IO<DQJ;VYV@ROD6YV^_;=PL/(N>*L^B=<=[=3YR
MZ1;*QAT?QP'PR-_H[C5CRCLJ-]K6>L ] !B]E?I45C<I0>)9].->[>Z6U%,+
MW"3L4I+(P;)=-I*$UT0^5K+.^*!GH6MZ?VO S-W?U=W"*RG-R+EFYYU<@;Y>
MS?EDFK5$(G%EG\0R\;*8\EC_9+Z.!>=T8>71'H49$>954WS:'NRG7\_CS^![
MIPOBS6=-IC&YR +H[.V)LF;94!P2TYH=*)/EGML&%AG(8"-DUJV82G@8KTDY
M5)*L"664[#*8(XE[$\G2"KI-"/;P'U"_7BR3YOVY+K5+HF-H[I-=]P.ZERR2
M:1##,1U0>DZ5,YD'9$#)U.;\AV"&2\*NX.NREW* -831V?40*PT;K\S\&TF6
MDHYIRGOA;0>]P_(#8._$Q\LY6+M%8^$EZ1X4NT4'F+TF%%FQ+G1WTN/XTV!:
MD7-3*F=3Y L>4P. E\VWW2%(]:0I4S>R_N\TXCP2\ZFQ=C6Y8-[VCUMZB.(?
M\[>S-W+8 SS^"N ;.*^]U=/C"+$H@G>$A$VED2Z0%:I;Z[*&MT5%^0PN2U[M
MC0GU,4MX=5 ._1JN?;J7D +O:U4B_CP!,".ZE***I7*X-/F5F\UQO44*.*G/
M_IY\V^<J[ZG)G0 X S=T7_6X('$6Q>Q,J K7>2WB[65C^276CH?[LT8JUL%K
MSZ+%^P<4W'Q3->OE4[4]'*BQ-/70P3NIPD0\/GMY.A9^@_R@"0^,;+[@7]((
MCG1L;8B<]^R5?),U6?%8Q/?O?V/O3<"A_O]^_X]4$IJR[R-KA607,FV62*@D
MZR1)$LJ2P3#V?9<4,4I"ELE>R-@5A<B^S4*R##.6\<F,<:;?_[K.=9_O??_/
MN<__G/_Y_N[[Y+H>+GS>8SX^WN_7Z_E\KU$^(K/NN$?PX&_Z@+\5Z0Q9P'2G
MH(D=C&^VB5BZLT4I?>K7H;GS=%&#B_?9IT^<IPS\;SA.8T\W<0</SD!1N-QZ
M8[H&F$-^NPMT!!\>O'-G4%WGAL_-_+N*M2(%B<2GNFDM(F[ER]S 09AM41[D
MBZ(WXR">:!97Z_T3OH_!<7^+(=E@$#7-<'$;])AE>6_;<833ZN%IEX-:TD<Z
M K?H/)E4HQ'8W5U@C]OV+I!D[PS&$CDR&KX3N6--2^_??'T9ES+ GV;X^%K"
M.U'2Y]]GO="S*?L+B)Z@G"&I@<+352?.-D2W(G=U5D[:?:2BA4Z4Z+;B")?Y
MK"53ZA^DE,^=[I,8KB/)T*XCUJG+H#(!Q4&7!=TP/QE[:RO2;XP@#<M;#T]>
M>/#&IR;4:9KC$Z4KI/0+8N^^R:'M''T 6?+[4"9F6X6-:C8_U<[(Z40'\FIC
MGGOZ\NA+NE@T2)UH/I)R;OL(/!M%OH)-@A_&WIV \8*#IN0K!41TE*;5J5&W
MX>VS,]Y.#]_V<;46:HE8?T^// U4IGS8:1OZ,+ *S/Y2V@7RLNC,+!IV;,$O
M"]ZZ"\3*^[N>R=>H\K!T24Q)G14WT <>P:L%2)>(R>"QVGAW<C(.U39S>($!
MQ38D;G[ULX^]E>B4N%;1_:VJB]?Q^^E?/14))\J]1)9FXN#L&ZNA:+(93 0!
M,49I]UT@R[YTF\\XZ)*^7*E6F3K:F+!B2+/<^.HO0 KBS(168CI^ODHLR* ?
M+W[[:H]U;&TZP/*]G^V'TC(K[2IB@FH&&F]'QS3N*T?4X58^H-2&M\O#!;/<
M-=;.%*M4IO'*GW@YOAPND2'W@[4._$#$Q,#(ELF"B&LMT_O(CVOPD AAY\69
M^\$2PU('I!^XKQ]B/[\@HI4D?5?ZD\GA1LP G'Q)7B0'1CTS^+*^[NDXG)1-
MG/L2*2(R\D*8IAVBI\U\1.F@6"G*4<RIE2$X4'Y28G#"N*JJHC*RP#=*/B;C
M^HDPHX/Y:QC3G20?6IDF51-T<_%S5R^;=1")E:[+4DF3>J#+)R5!LVJT. O-
MFB$;*45K>B,A8!U^E>]GYK"&=L>BC:EGD =9Z&7:6&KS)$NG8$(<H8EW:887
MA<M@G*&8139>P"6Z=:'V;V:/?!S<=.>'*;]R%KGAH'<]-?_FL-%K>4:I2IK
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M+@VF@7*&"R+%L@FU^116:LRP+^JPO:&7DN)&R]VM<(OZNPJ#]J=A*JS)4[O
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M6=HN< >]3<*@%M0LJ9;_!-+N7Y#0\*2X]T 7V_[?4Y%A8"CM/-)K)SU8'6E
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M5K$>7Z*IY8_GO)M')HX^-MNZ::#WA&4+V]$'GO!KAD4V!7W,C'&A]!8*2MB
M=R%Z*H&HU\HW8[9N."5-J5*BV_M A>@.J/B,F!0>%?Y ]Y2'2$_=TSONU\R]
M1U^1;K; II2QPTT1(+.^[W4&K?$PV?DN&VH%L:&C)?!F,M4W/2"LHN+)SL7\
M!;@+716$,D,6;BIY3/<(CB32IIQ:,SM(.B*3N?-+^6-? _<]5LJ/":KE3B7V
M@5O,"MU-K\[U]1=\>ZX:UDWD9K)=68I()H/U@)C\ B0"2]:'L"_HF8ZTHT3O
MBTN\./RU\*=Y60Z65B:UZB>.,W#;J(\#UN 1,Y6>K=!0A@FHVBRLD1$H,/F/
M7I9\QK2,HL3V_HZ H?]>+.9;0Y-^-V0QT)JF7O8C+1--?@X.BQ;UJ_E?CX$/
M$()O0'U_H0L_)]UC7;2=F C2Z'5K^$"HJ0GE3.M3C3#ZSOGTKB[ Y@T'@K^C
MR5:>S#A,NQM)+I^&BH.I[(DUESA.IGM,OPSE>GAN.?+Z_-$^8W#$!HRD74&U
M7-&UT$A^;=,'C;C]S#\K*-;-E+_=16+2&#7\7A0?KWDU1MMJ"E4Y0^=.QG>U
MH"J6<D^O-4F"M;I:MN\KWMA@X5/-J.$C.PM>D+V260!Y=93GZLY;/5U&O[9?
MAQD?(MHN'#\AC7W ^.:T/R>0YR@[5T'AP>"@PB_ZS>->[2\T%VLTM(:/#1TY
M+YEPHJB9M?]:T3_!I)__;_QU?;_O7[5!'NM?E^ P2_Q5'/P?GK6%R8&YKDZT
MX3V7/[BIE]>]17D@JCQNDX?3>F2&C3ZIO"!%!GC-2XN^K0&"!/21GVF<C+$N
MZB<R)M;W-/*H9N1)'YU/I$F.=&]/[4^E/97G8]>+X,\?=<[".D(WIH!@'>2M
MG0R8&VQ"A!HRXK,JW'4R%A\$,T^QL8=/^@>H%S01Y[)O]J>K"G[Z%:)@=J@[
M(.@C38DI$+2"^8*_HNX,F6;298/5HKEVL*47"S^C;!&G;P9E_WC4UY<DOUC_
MO^T_MZ>\\(WUDHW[,+K(IBW(T9?GW",W;\&TXTZW+D@5"SI+I)S#_<!*8=W[
M0-G>!K*533H!VXRI.YGJI#2QHA:D9TCS2%KT\Z=^.30?:]3+,OVL[\L'^>TM
M?2 8R6C&DJ^90!*A8PP ?.GM^1I<Y^!*>O>(K_9=P#['YB3OG9GZ^15<2N&&
M,%8-B\N#DR\C&F^-)[=CP[.\QA&)?G:+P8+5]K'(@.KA;BWKAF==D*&'=#TY
M.L\,XZ"UWZ-B5Q2[GHJ]Z<[KNZ8Z1A29?CVG2SFQ[OZY?BX'9<Z0H2]J@.#7
M?W]._Y>XP!'QQ@.;ICJFC=^72>IB%]]75N7BN=U>Q7]H-[H"OS=+8F--/RNL
M]@]][7"&DDUM "_08)\4Z8^(B3HFWP_!"+;[:27-D//]YX6^HZJ;(0$ 57@>
MZ4OA:8-R^K#78/F7MOVBU9XU;4X7>+U[@ZKG@#Y/=A:2>X<1V2G:!>ZYD-'+
MZ#+Z>="-8 9I*@XL-/3-@]^W2NG@7.S-GCZJ>J(QGD='P25MD;<8=IS."892
M+G2@!'3/;H\D-5Y[BTBVT G[&J1SY1-$QYR;C^=,)A!@SK;A2K:E1H%^M(OW
MMJ,*R>OM5(9T]> \_XB#G4J;]$D#@Y]S^@\/](J(V++MQ1'73*A/P$":!?TQ
MF$PXH"=_GXS@:>&OCXCGZXJIN;>!/=0B_&'MBT3=]KF)!)72--&$D?C@WEU
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M6A1*O,;[%+(3,OX>X+JI/#N$I*V/B\XDAJIL\K(@DI."8H3O3829%-L;?8K
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MKJR)NDB*&?P(U Y&SL'V[53 5 45*/UBL$XNK0KZ5$Y-#Y#(!S!X<)3R($=
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M_2@2QX-F(*RX0+!T5%4SX)IWA4 /<*TO6&QC.ABJ 75!)1R!("^/0&P."%E
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M=F23LF4IAF=>6]4-_ULZ4GY$N--RZ*+T 3I$$Y.$,'/)D;BL2HYH_-F0HV7
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MTFD9QFOR\(I$\2 5$,R-Q"-0VQP"@'<JV>O)EJ8G/)O@(^@X'7OY6_'F)Z+
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MP8+I 045V]# BVZ3WPW-T3O@(E;LK69VY #L-,HE$TQ1:G'@^S[T:TSV(+;
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MBI ^6$GA)*Y5DR[X: JC3Y9QGGUUNJM:+N@MZ?3[3OXH.^&OBE"&Q,Y;[-
M^OX^T/'&G%Q94:=[;<!@Q*>.^^*2F!BG=7;8H[)G!_T,1*-L?B5TE !IYJP"
M&_"*?8!-L(;B6AW^FBX VI#6DZ%W@E)F;@U/:V5;W]>HLF]J0-P HC.4]7C^
M)D;SRMOT)X@CR&_2Z:?.8J>?W\IBR))[2DFX9,*Q%F]?XIXMP:9^!*9?\:C9
M":;ZWL3J>LK2Y6GBTP,:%I^8;SH\UBKQZ1A!I)4%'"'F)@Z'F%?:J2]1M5:;
M13*-A[0JS9N$<]NV*LM@W#-X"/T*^6T>"<GI26U:B\%"GWF'N\EM^@WB+-IF
M!<Y*11T^>#="N^3_)"*X/,Q<>$$T+EXE0-'!W^S]]]7T_CRSV#6M]PGJA^;B
M)3ZKZWV26+X;P3$#ET6[D^7;?VFO3FE1@G#$>(ZU"R6_BAY<1BP^=U[S7\G/
MY4:9TX]I=.(E86;D2J,:D-\_Y%#!1*3HNT6KU G'NO<7A;YDC >5^'ZHBW[P
M(=JJ,X\;.YV"%V@]X8F<1 C 7%R(KQN]MP^_JR\K>=^K,WD_B7\D^.D^H/^3
M=4$U"4&VJ8R5Y/^S"F/)]VS5^6#_L.4YULU&LCTR4+WA+9?7UN;.]1M[#0BO
MRHEUBSQ3,+!XR?96;G]U/OEJ+B4^3L_YP]U^D?G*I]'RQ9?W %"7:>,MX!%R
MSL?&1O)HKO8WIW::6Z*LT,GF5N4V:[^\=6DHYOUNI>GP2JTNG)/[_->ICAZV
M<8&Z<E-QO\I_4#(6[+/R?[?D&[KV@?CL+.I\-UYD$O1[*];7&"MRM;34&/4Q
M1#O$TWP[^M/(*\Q+-"LH1,P;_T+$9$PCCU1\&BX/?I^[8:X>EN#0 $O18_63
MSP=X (!C\_R_?^3 ?^3VKQG5H)@,EE(>M6,/HE55X]%^)!THCX?)XW>_/OWY
MW.;F;)E4B\,1]<SK,/:,(0+9"B*,-AW-^1OA&&#:+RI6"N\7K%;&Y[V9XF\3
M)"O<$0P+WSYW\![,@GTA;I6?YDA7VWL:D.XW8X;1_":A/>FN)9QC\7YSDE?:
M\SGTQ>=*"?]NC#M8S.#0I!DPOD&/*3')EY%A(_E7K7]Y_6Y0ED]6\-&2.PDJ
M\ZD<2IA"CNBS=W^*?M][@9].Q^B S>40$7KP]_5-G; QVI4)CT::875H[_,!
M14'>^=9@A,5%2:\M1:)J._(@FI/<A,*VM8J](Z\]/>UL=Z,OO4H8\G\EK\X=
M91E90$Q(ZX_$OKUSOF&\D.8V_N[NGWJ<AJN>3K";>$#9__:.YPWMK,S=\/(L
M[>N]WK["/_]<(?(9E<I'ZO%;WJP(U-%9U55=?3O=6)T*&WV?:. ^KO:B/;)=
M>!W)0[_(Y ;=: @YXUO_ZS@/DJKP +^Z#%70@ZWLL=^+/^?K(7=Y!]E_!5C-
MCZT0F.!Y!T=]"-+RT7 <\<FN9DKM<#=/?G;EQ*N$8>WTL)[CEC6'+W2B/SP(
MM3)CWBP^AO#(X:P\_(/.5?OM:DRP>.'UID'E8;MJO\9[5G<YC22G]%4.!?O
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M?SC\7<<4B;'TV^3KSL%6"RN??4!C.K<":40_S[Q;A\Y-SLI0C7<9HWO?/Q>
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MWJ\'&&_-.(U%;S8.;/M$':?/:NXRH1<1B>=A")V ' ;%.AGB@<)_:G]I";O
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MW5.6'ZU[]##(.IA=K2>UX%2IR[4'1W:,SK!,[P/UJG2!J\CQ$5)/'7FY,_>
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MA6&.K;^R(^O1!?=?'A*Q<:Q'G2L(V#-1^2QJC3\77LZQ7D47)#9K:$+W,27
M[";AH4\;-6?:WKA^OY_&'5^@T^CTQ&<A*3:W6CD2)ZPNCP%EH,&P[M?PP8]6
M%PFOH5YPHXI)FA \W2I->3 V>8$%D"V,;NP-X "%C!^V]71$AC8K?]1STBZA
MSYI\KQ>;L0]:*6)S?C2&=_G 95Y,! NH*-X#.6SH_ES &=PJ"?#@6-^D'YYK
MTGZ803N&>V3TX$"JA.3(<L]DXI5]:2>&I>],('SV0&-?/]M0IU0M\3\)8,<*
M34;*]3*Y*N&&;VZ,^L$H[PGO(XPI:)TK-(<X O()JDFR0K\",O:S:_KLD>D.
MBX;@R]8?VQ*O0OWT(3-L9V]\U["?,WNC-:\>6M)[9]-PG'(PUVX]HFC\"G'X
M'3=1%UHU=)T=8YHRVZ" ,UPU8 PGYG=Y)H<Y2$8'T1T+IA:P.HU3KL<+W#TE
MU\9->&<['M=#9U32V[^<HQ;7H;"%U/@D0DYV#IV3G&&0T0:72S99SANBAVFD
M?/,]FAFLEV4,D;<^1@XG/HLB)]*HS4/*L)OY#MJ5H3-UC!L=)H/+@G+#LBF_
M'&2B?_!=Z)+FBJL]+C?RI8P0MX2:0?(&M&4<4C>R;]UN11R&>1(8)N:CBM,V
MD3K#;>5%XFJ)/.+<'*O>#Y...G#^Q!T,P)I#EBX2T=!Y:VY!*!],;J9(N]<L
MRCALOJ@R^1/LCZKKYYREAMZU):LUM[[FTH#KDQ$O_*[3;O@A^^N/977D@?Y^
M!I^FNN_=S[WC$;4O^W8B_D(&O/&PS):9'(_P.OIN#=NGL&3VG23HPR[:$[X@
M;I>D=9-^I9AG*ZK$V3S9I<)5PATJ<I8X4(\@R(4%2$WZ72&_@$(D9OWL\[=2
MM96IM^F.3S\U/#K[U6U60RIIUC\[GUOX@2SG/(:7?A44H@EYKYD-%,'%K/T>
M4):#_!5?8%E 9/&-;I/@F>,G2$X.?):!OYZL'J6[['9_264!+]A+T109DR$$
M/^-MUK)MTC*U9^V/AB&IRIK!\@F+UR[12@0K.O'DK;$:Y[9=T7R3'EO$.XPT
MC!,/\HBU=](M$(GZM%C,=&YC_ S)^_742*IC99_#CS5H38 %+"EM91T1 ZW"
MM#AIG9E"-$\KEP_:[#GO[$RF3KUODCOKL,0"BG4['E_CGL>0&.11(J(-\B+-
M)9EL89FA/SQZPVSH7MD0O$FGI[)=S-2_.U"X0#ZA&OH8VML+8:]F":8VN$KQ
MA(IZ5^D.'$MB.$TC>_.M(<5#6-3*['D6 -G%**,C1)5R"!,_555.C$[S>G=R
MBG ^?K27X?,>@_\,+4>$:[XS:T[G;]%H8KS/LKY<$?9TCY)01K'O->X%LR4D
M[:0%\RMROPM,1BBB&&;D^3P?GN/I(PN_=.%*#/_CZR[.'P75?R0:=!(#3[]G
M3ZDS\[L;F,X"K),(7XJ&9W^0GE LD58ZI6I'>TJAFMU !F$BJ,_&#;GWGXP_
M(^+Z' EWD*[V5%6%ZK,L1:R>S4A;].@%E6XW?[;2P_]XNHNH:@Y&YPZOK%84
M="Y.HLP!QBFR9E,OAY\*"TC0:PJ DEL>C]D->'QU?I?:_UJ 'TQW^HSN.:K,
MY/''=U:B'.@JH\X!CS7'/??:-V_'=+V&XXH\:\WH@EGX"EQ*:H,PY4M(R;E7
M=\T-1;>?*GFAB.4<VYR7_<QR4$W6"/N8B_98=1W4U<E]B$?]4Y7$DM7N#6J/
MYS:2+K!&=1C^TQE,/EI&FNR?<A2B'*%VAC@B+CAP_C*7;_' 3"3A]Q1/V( U
MA#O?\9@%\^")Z P?#<I*G]F];&8_8K_G3,A5\ V>=*GF%,9NE'2LDU.6MU1B
MB&/^EJE+THR1C#6PD):3\D'$*\3Q2>*L>S0]FY)XMNA_);_V7]%@P2C&.+A&
MX@X$G/ [#OJ3T0;DAO=HD+"Q>ZW^EA)O/>IAK";@HRIE&1Y@O!QH^P7P-[CL
MAV*4T3Q1?=QX%(,^]/LX$'0"467&  *X60"NQ^2?G,4Q ;,6W"'FR8 )Z(%Z
M[AFHD),H=]/#@7+Y?1OR.97:;[KN1_(T#*L!%ON?J,K_4@Y$'%:&*_D=)FO&
MJ(O=4:C@?:Y7,:2D2/+R,9!-"+-Y$RGUU)A#-FAR(_,@\[\?27%;43;#8$KB
MBW"9 8_ UU/4Q?G,B:"D=]]4V@#7Z]9J,Y )3;Q)V-T4VLQ<R.9[;#_V%WFR
M-O[)^3NO(\Z2K!UG(. IY-+X>WDNRE+MIX]JLX[;.L2Y:'(/'YJILY$)^>2
M#O)C6\[N3/!8;HJ1IBXEY3,>#WNF06[W:7^Z%K9)PR3[I+/CJ=WM@])F5OR$
MHU.=,CS'WQ=_TB(6W I:ZWT<5P0$9%U'QHINT@4'9YP'3_?#. DZ,/[5J)^U
MM9+VC-?2G>T(:-=G%D# ()R5(S-63SF81UO4HIK/X@<]MWP2#!DC+*#CBQ;
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M4>+E<*B/L#]'C273L\:6_2^-06),Z%S[N=<XQ,F0EJA#G)-B*3V ?ZH_[7E
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MF+*5I1A".^5YR',\CKOM>&Y=TU[G(D[8O3K27C,=BJ[$7;(%=6B$J<8<FT:
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M;U5L>&.DRC>863,MG_I<R%@F"BKPMU:.:SF3DBXLC:;%_7XU)D\X.RD[(;;
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M_+N[:BU.[E^R?9FS%OF$!MM>W.Z3"FK62T<93?V0*Q:JE,0F[0B="<RA',%
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M5?"REJ%R+@E'3]I>_PW8PH6=!D.P"S>X; 95&CX7R?UY<-((]!: G8-W'F$
MR\MM3%U__R7ZP,$;4HQNB-M**J)/H_GN__#;X4A9XM>T:QG]DZ;\;5=!.2ZE
MGZT'HX81>/QQ'M])1M*Y39@:\099F3C7>[0_%7JD/-3[:C-AON'% D3N>5C*
M9.US":6W'_L).K\9 %4DA&1/%,=?(#S^*L@Q[TM\$/-X6K=!'9QYG*IYTJ%0
MQ=RFG^NK4W*)@)X; ,TLI?> ZF%)A%4&@%U+I)^>\2S@J-OT<FNG'*?<>?"=
M)1T7<]52UH5K=R']C+6?("=SQ&Q'/5IH']KLRV+ [K6$RE%]>..)R891\O-
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M#_FRF?/K;W9__TXTA(>NYYECW6,=24(*_REKN\ ^<;YNFFZ<.#\_7][9>&^
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M=4F?L0QN2;-J?>,GVYSR"#GXFGU^*.^5^\U4TX"9_3@Z[UL&H&U-Q\$I]XQ
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M;DG0H%A0I:8Q'MAG^QZO2+"._92B,+R*P^S4R'A/\*-AO6K/TX5>B3+*7WI
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M@,*5(<' )Z*=+1'<[:MX6U1*.N'.A(:^@QC.,>S1K3SM2>>A5I!51@23O$!
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M]B=MS*Q ^DH[YSK11ZEFJ"4P&/ZG3[R_5[N=DVH\"8ZIW'Y0?T.A]42=LL
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M/T(_CKPXYELHT%'VL,F* KOP)_%9-0O'+PY=&89]ZS*Z.5H?I\K_DWRQ\FV
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MW/*SJ>:P\ /2^K-PN0B9(C6U(:%%1:=HZ$%_FPTM7U>L!#7 2.+5I6BZ8.A
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M.LB_OW@1\FB$8UXTO6K&$>OM>Q3KRW7:KSN"Z18/H!<J0MK93J8\0W=63!:
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MR\L2EV5BNR7??5AFNB<G)^*V\ILJK&U,*Z+S( :^0-E:E)<M ATGSSD,E9;
M'8I:<U*+_SR:ME3V]<T:L#.X*+AP5E89<*&E4-W0Q$. S@G%@-'F:=L'.M*J
MSBE3B#Y>X0^>:?(<U;;'VKGV54%Y-):FU'D(U/ E+"N;/YBV)>D=?/]V,,64
M3"U[J[)RZ?FV3?2QY\Q;Z)=3OE2AVB_I<&$8/HM,ATR\*4IL%:W]\'5#W<H]
MY]Z"7O=6DI^+'L/G3?(RQ"-E_, RK%VF3L_.*,*\+6?M,HDMX7W.U,:B\4*'
MW\#)NT/2@2&[Y<*51S@8!<8F#?H7KL/J#X&MUA4G9?N* V<W7,,<ZOVI.]>6
MN>>U(E]"@T(SC4X'?3$<X1K]?[0#+ZV@_<'F(3 706;T$-6J$/2W'J6+SR(:
MYGH,)S1-<=8/ Z'>=5Z?TS1>A89DF\";@OI.M7UGO&_=(9#"AH=3)*+I*<,&
MXFBB#81S#D$AOZ&]09XM47I[I^)AL<6G2Z;?I*8;_*IZ5Q_W%*$2-F2$1NLM
MN1<0/IO7ZC,,<D;+Y<>OF:]*/LGB<3J;T(SH*?IWOH"-(4I21VBO8%OW(PZ!
MZUJ:?Y4-H%EHHHG>DQ AL@/X%OG^%WMNY6UG$Q\SV9K92SA [UEB6@$C='[$
MUL:7NDPDZ')E6>,-4GK[LEGYKWI.E">R/O;DS+U=[K['7Q>;;^K]6Q%BM4RX
M3\NE!DN6//45K*FIPD=XLAL]@7)3'98M005?7)(D:-G5!IEN,2':N;1YWS2>
MWC<UPCJZ/I*Y?[5R.US^\=?"(,/7:CX&.I:@BA(V1.PF*$3 2$J:NI%$TRJZ
MBHOP@"FYUDCYW)4#5YESKA#+7"AB>A$.0:\:$H=I$2KM^];3JR9482]R,8EC
MVXA8;-)"G X[V.&CRH\%O,%E3K^4=0K2E#8BO+Y2;2Q.C1%_LWJ6LOGIY!QD
MLP=[<!*OREO&7'YNP-5P _:T#LCE;U\U)&G3(LZ@]V_:K:U1!6"$'UE>1'3W
MHE;P"4G[MFF^](Q'>?U5EUFMO3E 0\]Y63<=8_\P>![Z?_G/+CC1&/I'D]>7
MWCT_3%.HRX-(,8HF%?$=LMU(1'?^C8[25#T*6F*;[CDV(TRNOFAVZ1^_[FRK
MIG^G9E$6(??PT_H[BNB_ ]^RK5/GLK+/4,C.8'+0AX7.J3V'X2*-+OEK6J_=
MS_[;>OIPDJ%D=R+H%_^-I8)%0^L"L2&*O@*;^IS<WA_71=?;S$ZGK;XZ;[6G
MONPP2@XW2+;G4190Z:&*RN''$4K;Y(L>,6>HCJ3M."Q[SZ.$Q\:L]UVO>G_K
M)J3WZ&CLCG!P,#+<&M<E(S'2IHOPM29B8G25"2?EZ9,CIP/F3[[G+X^[:!J6
M;> QT_ %?PCP>8728@^![\*P.A@-M0G]^Z@&4XEV&[1<P<3I<X+M76@IU7NQ
M:PX.'T:?GMP'O1G >NF"SJ2<W9\X0/22_2EFU $R@2)R"/2?0#] _Z5-P?9G
MW0V@U]$="KJ<1>#_8.\]PYJ*MG;1(%60WCM21"FB]!XL=)'>A8B -!'IH0:I
M4D,14% BT@5$>B=T!*1W$$B"@/2$$J,DX<2]]_F^<[YS?]S[W.<^]][G[!_C
M5U;66G/.,=XQWKG&',,9JXPFMGMXL(7F)LKX^,@\MX2$W$C:L@\PBV!WXN*G
M0H5FP:1QF\5+. B1CAO]9-NHV9 WU5K+/G]'B)>^/U^!RU!3-8O/M$;C->TO
M'YS8$/X-K$_F//$"L#-]V&&.3?I'N@SYWW09R*F&590"$/')D06.%IOHG5CF
M[$O/J@9SVL;33;\+R:D1 O?!#B^3ZZ:1@F*%^G\0X L 'ZP.E' *HWZPT 8=
M\)!^=MH013SV4F$72R^?4(NYQRQXNM95BUM%MPUM@'J!'#A>TV7IQC%5^SLB
M*:]<16X;0BW21:"![+]USREPH &8 ,3#)X'(BVDLNI:-%C=N2T2\R4H>Z,@=
MMMKG=W'O)L<]&P $P-&FC+07@-YDG-*Y;#A]??2)V91(R+6Y!H(4_Y_W_=X
M'RD&VS7#Y$SJJN1U]L,V&3R;YU%?FW0!M(0X"F.1DJ]4YEA>&Z>7GK_^T7*Y
M_)-P-^#*D[8+ .X&9'\;-9'B2(;.32$*WI,^2@LG*V\J<W:Z%)^#4KS=$'TK
M\C1ILA\)>24)H&-G'P6;$^G(T=GA'-<PI;DH00;P^#CPY@6@#[,S>/<YFU..
MN!2 6_!XLI"[9R</<.*#$X^X +R2@CP[2N*T$F0(-T6?((>2&W[+(*8;C11M
MI \.IVW>ZJ!>4JF/?OC@3!9%GK05*8C+VE#"LY(/1"I-*\C$!0.9NG@\_Q1Y
MZJ.DY;\^NL%KN88T[7W_X:F*9>3C 7MJWS\^6#'<2\S)QF#S!DP0AS6$T>#5
M9G\-(8T9'BUJ9?6U1-<GW+[,SPX@>W<0]%3H,>TQ)!:&-C%F(XX+2&&,^]:7
M6P,#%Y[ /4[AK,L[>M+/O;]4-+*P:4WAV^>F[-46%:=;A/ASNTG ;XU]3*CI
MTL#Y# SI=TQJRGKDH-;UB2LYAM89%BHWF./-KVRSM-")C]]1?D3^"'[@>P&X
MH4/()Y%$(.%Z:XT<QK&SD+@*:_+I30U&^,3(!(PI]:J^"TU(5'^V[+<LNILU
M('LH<B3[ZKL0Y'U*L?=RZ^=M(JUAI0.>G5#518[WZ)JJ(855[A_L0<;.7$^J
MLM3>](A>#]*W*7^BY*V>P@*0OP @FF#'6AUT)#)TZP(P;;MWN$Z%5YO$<Z(W
M#-!&:>^]!5XZEUW+D\JF?CU%L=@-1:T.BQX;LH0H_"[[2YIPJ\CU91&L',YI
M8X).^D?HS2+4VZ(DC;L*:8&W=0-9GUL^)1>C8PB]-<Y(?F86!;Q->EZ2(]FT
M=X!@DL"-<RF_/;J*>\7:@<(QHD&[\3J6&C%R-Y3W:B,H?2*7Y],]@&@SF:5D
MBX9XM;#SX<+FEA9MLI(4!W8R:+A4FF;\WVIT)$4:EL+!_OGV4W2Z!V.D&;Q"
MR(;O804)4G: D[\*"X*F#AWTH)/[\FKBSXSYP2"MF2?SHNC2?.8<P]\%'DO=
M*>0=;,W)P=2;U@?O_A#_?XBOGD-X9IGN/ =XSSH_^)O=_>6YK8Z F !K62FF
ME;[K6F&7%BC>!79/W('Z$: *P+0N*9PXZ@+ CG_1F2GYWO5IOO9DV0RR(=>X
MD>;'D44J:$L*8'OY<?GE\[DMX'_=R) GFX#T&,OG:RAA"PBO&U<, YKF;W9H
MS9^ [BN.8 9"RAH,;/SCY QT2T\<FO$<AD0C@0D2"98AL/L^*L.S2Q(-C_8S
M_B8*#!&S/0)WUM%6C)=VB2J$]$#C?6_-" -O$8O&.?&D);JV[I?3NLLJ5^_G
M0S]0G+*1G6[W^OP6BR3%<%^D<XFO#';W-H\6#;%=:.C!;017@Q'5A,67^0[Q
MXIU)SXQ=9IV,AE3>H3>V#LGE[EP_XI S*9G4L_)DO^O/K=RQ,#X(H@)$0>3S
MPN37T.V$6F.3%Q_Q]<E_:K9^J%C _<A>*T4M3N@\,F4W]":LVH-3U9*0W7GX
MUI_.?L)-W0 ]S$I?PDW38Z8\9("S)M(RHG.'')EQP^AU;#;.OV@"96384RZM
M\%YX]9X>UN!8\\R$CLDL9,./3(*;BZ0$BB2601F+TQ6/CEM("("05$:N!>I:
M$V_77Y0?#: YCK9^OC&G), X.AVE L*)==3AU7#(<SV\:$-+G@\]#N(8/./D
M=C/]=[#<2NO$K_<L5RX "Q+Y6%+,];HH<AITMBE.?&UO'?Q_/8MC'_H/]"F&
M[XT8$ZXW?6 DL;EUDHU5#(M#->4CQ];I;FYFJ*O5[.WZH&QII4H-\\,"1=/B
MS/2_A(7$P_4D436X&[#],]1$8@$+VJW?)Z')IQRW@MSZ$'A=RLGH^+N6G0KO
M$PAO41\OQ6X?F%OT$AE6-))_N@B-F\PU:N 17HE(\5@S(,"^KM2/'&.:GZXI
M;G"AX.IP1*[CY7J<U[ENY)P VXSUT_PB+RNL8A(HQ$:D%6[3H_%5J_776&";
M,9Y]#UE:@EB$H]Y@Y&',[[5;T,\XM']DGAS^-KR^\9PHJX,7;"V0C"8-R6@,
MI09+ S5\(]YJY'"4@IDWY%LU43R1;&[I\LB*UF6P>6%L %@BO(=LW@(* O=M
M?0B,!J7$89*M_]U^ZKG3)4%B4P3./DVY9"(+(Z,.6*LOX*/RT(?4SR+B\*4X
MM?^:8=L,092O\<YV\7\/ER9\5%?PK/=RO#3_)/YWR"4O%3Y9J5C_^F_T@H(G
MI^[D# C!Y78B;2&?+D&R!TZUWRR :?I0Q8A (8>0;K8DU6DTW@?B)#D/^,MC
M3XQ@,=LM2X0#V)(W=+K3D'C9$OWYJ'<=X$,4\OHT#2Y"72NYV1CH*T38Z.;.
M(86:'0_JH!Z5XQ"W11&2*X_NC)QD^A:M5XQN+RH*<)4NN<2(U+I,4APO]";\
M50<C1@F5\XE$*@=YUA-%Z]IFG_XNO5ZK_0(GGM%EF"--0%7"VF[ T783":H/
M"]'6/41ECMJ;\-*]Q!)"N9/#P=-X-Q?QRB=Z)B]7_#<J/DLB:OK#:G!BT %C
MWG!U7%;A;GVX%(:JD%"$O "P[F")?N31'Y2 MV]7>>XR_' _9L_^9?T>TJ,/
M].HG?-+DV;F-H[XSQ]A+H+--6</EFC8?B[3/%G#',O66;?4.;6<5^/5=?5$2
MI5E &E8[;L\$7;,?\]'C7[E_3Z?_E?O'\NT_<O\@_^?S.$E&0.+G0R:$,J#K
M,%ZE\ #"XE%#55^B]>U3,^L ;T5L_>-+F%'A:#VRI!\O\S",T?"_U1ZH<8+=
M304LN*42<$S/!8 )K_:\B1.M7ZJ6W)QZ-P'@E+%X)?LQ52@+/2 DH1O& X;V
MKZ/-(@11C E=++A1Y$1<N+F' O25]!G]3?</F<X4"6-!-$Q4.6I!HAM27&?B
M&IR]P$L>D20/'CT<;MX^)RW<KBDXDV_=8)O[0K]?\9;DR\ELSBLZH4PT/\@=
M:\XEPD-Q<^>6D9-V\-2#QUUHR/Z)!QG4>"90C8:BK3C?H*BJ5/;'X36=VUT#
MO:4V/PID_JL*1VGX$VEK"CW^-._?V\@?'55^?K-A^'0O_T:QB=UE.R*-[23V
MFHH+J(CG&)*ZIC*+)]D)10AZ<^#]M^'@"K"S[O0:0N7[U=?]F3?]ISY>@>D,
MA 'Q[(+$!\8H'T(?\'3'PR:2"R<,=*_!75.*#:?('/*)J !K]NP_S;IJMBN6
M9F/(/&7XL4(SQ9V<Q+,?PQ.6=?O@2X+(N*8L+S9J\RGIP/Q6)OJ91PXZ]6JM
MASKH(HU+Y3\IPVLQ2LCQ+(0/3LJG-\)8KS'I&SC7 &;1J?>E\'-<-?[FN:[1
M*)M+P;[-V;5"PEL(HM!.?'\&O3:*Y!Q*I79$0Y+Q_(S8\(=-5.Z'!Y,9#(H%
M-"9LMT:4:7M^*Y\<T>!!&.JA&IR$#VE]^3T+>+O072\K/)IO("L=].]^-RPM
MJ?Y3=?@![9([\5B#IL<I7DC@[!P2SHVK<,.T(VN&UN/R*"(59M4%GWO?#-?\
M.J/B<'PKXRH%Y]>WL_MJ/<SI#++*1O9$6@=TPH9N0HTF-W'R D"'OX/8"YM/
M#*2SC<VZPRM2&?^DR[(?)!MS?%4D(^\,LG)OHVQ0<"EAPSJZ(\R-_E>B)OFK
M<!B3^[+W:VFQ!ER&G4[NTS->1R6C<:8.5_U',8ZFYQ:0'BU-RLC)=:I *"78
MN?=/33^09Z_)S]8=2U^8I9 ZFW3W057W%Q?EQ\+?]0$O+@N1GY(C^:&Q ?!X
M1YX&])7Y$]Q-7JZ-:=&&-J\W7=^HOW+H/'T*\!T6=>:O_%R3"73+!S%%#D#0
MQOF2ZSP>T^M[ EPS-\^\WG.[6;C'9@W+KASU ;KUY!:NZ/V4G >Z&B_SK&,_
MXM2<-O8<6$",]X+]-;[4YB$>CFZJ/#BB;1V7FX[2B$SZSX[2_UM*1ZX=X7V
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MW&L'HR0^IE"2?R"?AFG_0QD ELR%.Z,5[_4\L$6F(A[MQ]9C@[?_94:S_['
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MR?+?M@\O;Q<"!*9 ^1"T3J>4%ZQ>O'],'IXCH[!4_>L"$!SQ6A(V#]>7'+@
MN,+_WK3..%;!AP%\SW2^49+?X/S\KH="*S)'.VM4#UUZO8CL14RYN,I6E.8#
MDJ:IXW+6>R+Y<._188\RY(]X?A:(Y/SQ5O3CL+['9G7,1IU#@\4C?#N!G49_
M:WJ'&TP]B[P"-NR./KZLKEWNY;L;_XUI6MOKBMS5C 3+[\<?S"*Q"T/W'"\
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M4@;I8)PA82BEZ[1?F_=@CO=[9LEH?5M8I/Q.D'?LUUINQ=.H1,>R^<]H;G0
MFG\=5O?Y)75B("H&&]\(5MP*R. QV"W0U-AQ];)B.2SO:&L<X1Y7-%[O,]*A
MHY'1P,MR6S*8 S4VWX;OZU>[]Q%S:Z=FBWPG?I(/<V'XIX05!Y=7K@D8/9^
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M ,G>MLQ>09+MZ=_N _Y6G]($.0]%YW;H<]X3^U?"(.SX'^,1LY0A30$3WA^
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MJ@ S'^TC'3+H+M74&:DTHY;AM!#S.M9>:;_UG/B-<](E'MRFZ>7T,T )R6X
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MM04V:>=7@9OU6Z*)^$5'TN#K\H8S7U$27;=RSWNM\)R]M\4I!-R.V#"$OUM
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M6Q:D$S\TM[V:PO*Z.@]Z&ZBM-BN+O+/A*YW1&5!\E\AF=2Z)/*5H;(1GM!A
MRUGJPAQ\'UB)/=Y,!H.I5'6%3T(F0C;<4@3+4:D=/+)>.HFN&<$*^[?A6J92
M;($M!\XY0 W>49Z?XJ*WX<-3&G&;7];!W<H!\!7Y"3UN!*4',IH-9%5[;!/A
MG ;7%O2TRUV"D+U29Q]9.RG?='2,BGP"'#"7J'JW:"KYXY\Z+&2*NDZDLG\
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MQHP,3]W: [BE45JD3;?2[]VEWF:.GKR9ZK<<@E[/.G&>*)@7[0S<R)!NW$B
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MBUPP]Q]VUH\WDARYBC0.VHGF/[CA%0QQZHN8)]MO0.HR.P-5<3"+\1I'L:;
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M_VP><UV_%:6I!U,9*0V.!88IYA0B)L((<Q+X=F'BCO/.38UW;1^:2INLJ&H
M =DBV.1[:'Y@(>&Z6)MK,RE+H=A9R2- /;)VWVFN<04^=W@JLIMR)5=@F_(!
MNS6Y035HZR7+J:?MH^2&QXNF2(ZW]SDO-0Z*+ZOR7GNE6_]Z0*D?A3*!&*$
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M&KAU)>I\JRMS>OM'_B?%[=>,"_7'<R:6?*B0U8&>CM/%]B^<8\*R_,.@L5O
M?Z Q>Y4L*'\3M<GG-+/\DF?KJ.\X];F(F0]Y'!&(H@C!U \Q](6/DR3%<12Y
M%",X.M'<UNZ&U#8EO='KAEJG]//CL%JLG0.!-?*Z> RG/GND4X Y9>(/ MQD
M.?9] 73-FS^+RIF,^./W3YGK?I:+O2SV\]=?TI8Z^RJ:'GEWY+MN:*HST7*F
MUFOSU+PQC4YO\G<YT8MY>\TBBB3BIE@F3U.(:$ A#5("/98@ZOE1ZA'BWGVZ
M#REST[H-E;JO(Q=2E#I_M";?'3+*!Y".W0G2-)B/K+S73("&"U//W_2$WF7D
M"FP$TS*SOO3J;&&6GLV?+\%V^![/O:AYA5;.EZ!VN&/S12/V;YY"ECJ?]R>2
MY1^*JKK-E2DLU-;MS4IIA9P]OQ5E]I5HXJJ/2L$+J7Y6DR^H1#Y.?0\23G3Q
M+&.O"@DI2?PP1 'FU*H#W^6DS$VW;C@!]XH5\$>U)Z[^I&OU\#4#[LU2>HK)
M3LE. _[(2G8+]Y\,[A\ZW%M60,<+V&+&-/V\ M0PI)7ML)U3+D-UZ-XI/:F9
MO'O*9:@=ZI]RX8@]-OL_E6JB(ZU;%BQD.!#4@Y)B!I&G^]UCR: 7B2A-8I^S
MU/X@]-1,<U..AE:PVNYMI U/NNYM)+ZW;KRUW\UA8WL2<PM7P%!(CJSI&A"/
M-H@:"C '5\!0P$WD"_@LGG1'LUSM_K6WV30'.O50KGW+ZX?R2MU(:I!)L'73
MMV*UY+J1QVI9:Q.>J,\Z<EH7WJ\+,Y58[P2Z_=90GF,;$9QT/)P<8#K/@PT?
M.ZX'JQO<%#@7V>)=7F?U\Y='LEQVE7 6V,<)2KF$ :,A1'X0PQ1)#KV 2)3@
M5/UJY:0],O[<E'5#(C T@HY(.^UR#,'32G@ 7,;>R3M!8OT&GV%\8P=6G2%8
M"?;G^^+K#^K.Q@94'_9-OV.C3O(RGV&I>X7/7=:[ATY5+#-NUI$F865S6$M0
M$C&"4BBP/FKQD=JUHD398NHMQEB98)(&CCUTCDXVMU?Z4ZG6LNQIV51HWJ'<
MN8'.<83M=IU#X3;R*[]#YC2I:C;(#-Q+Y_A\4_?2.<OY@5XZY^_IFZ;6[0MO
M<AV2KFU3G7_[5\'OE3EXK4TY4^?N1<(["D.!68J@D'X"4>#[$.MF[801ZM%4
MILQ+W"H;]*1D;AIHPPC8XL2$5;2\@ TS0Y0OZ"M!.R4VB5Q&UG#CB:1'@MV%
M< Z;>]>7F(G3\B[$[&7&WJ4#]M.V>XG&UXR5*[)<-R37[8T[^W"[)7@L?9GX
M2GR1KB2#=$</DL04!M3#OI1*X\;,1=7V(V-N>G:=;:]?XW??:Y%S\3+U'K3<
M78%-WW?32WQ=C-BFJ?B0TK13N^/+:&2=.Z5XG+7P9>@.J8)[4C*I_KT,K7WE
M>^%H/4XJ-NG83:C\9VU(+V(4TCBF%-(XQ1!)%$+*,8-QK'N+QSQ1UJWU$<7!
M*>:F,;=*+K0Y Z8]IX,[_3"2%@</%^,SLK;:*J?00O-Y$&@<CA@NAFBBLP57
MJ-R\_"=1..G>/WSG='[]DY3O./1/7]G/M%P7G-_*#=Y4H?]KIB8JV<-S5SO"
MBP@2J=)]B J(DM2#!'D<TC -."$)BPERL2B=9I^;6MS*C5I3:JR6C]=_ZUE6
MPDT:=A;A:!B/K%HO@]?9M.L%TY 6G1L!DQIRO;#9M]_Z#=+7/4GKS1Y\XW_'
MD0S4TR8@)DD 48HX3+E/8((ICZ3:(/MVMMN9>>:FJ7XLRK+XEN7WC>]J/R7:
ML33?,7!M_8(70S:ZUX_66\X\\.LH1QEG<!C677=XJHF=<2?Y?>EJ.WUYSX*=
M.B?RL^@2)=66\KXDC^UR2BF):91&4 8L@HARJI1#FL*882G3E)& .QDWIR:;
MFX8PM((-L:"EMJ<=<Q)G.STQ%'ICNZMZ ^=>I],"D4'+=)Z:;]HJG1:<ORC2
M:7./>_33M5HPN5XTWR_)_0(CP5'" N@+1B%B:E-$$\&A0*F7)IS@@%G'/>V,
M/#?]L"8.:.KL0YUVX3K]YE\$PLBON27_3G%-!WF](*)I=[S)8ID.LK$=Q73X
M@@L6<)--^:9X?!)Y99Q6U]HE?-]4^W[>7/*)/.NOKK^1DJ\W&EO)[=<Y_UG4
M#P4OEL7]\S6M3+NG1<"2A$8T@'$42(BBF$!*I _3. D2]3VES*UN]_@TSTY=
M; C^2P_+860!.Q@@\Q';%'8,;+JG;_,+MA@&]!EL7]<R#0S7V\U3=PK4Z!WG
M%N_@UX[[H4VC:60UN(4U,MG3&VK3R.&@O3?1U/W6KJ[R5EMX:[>E_>VJKO3)
MMPXCZ?14[ 4D11Z!Q!-J0XIP"#&.4N@'(H@]A@3RK9*A^A(PMU5E7;J,M =(
MN>' %%5J*I,5&R8<UQUGX=@M(F-"/O**\*)0W,<UVFT=N"WZK\#;;+G25X^A
MWONB.*2N=J9A4L7;%Z%]+=I[G)ZGCUF>U>)#]O5E)^R?R?\IRC=+4E4?U4/:
MNHZ8LL:9%_DP"(G2B&KS#3%7LF)!$'HIYC1$5G6J>\X_-X78D \-_8?:V1L>
M@&$":"[ZGDHZ2LGR7'(\[,<^F1P<=O?3RG[@#7I>Z4C"M">6_?!Y<6;9<YCA
M8C'^GM4/O^0%K43Y54<2FQ:SU6X)%/WGJM2%(Y5QFU4?,D)-P48SUH)BYB62
M)Y $J0^1%%SIS$!I3\8]G)"(<HX63Z+,"OZE)F7=/W+C8EI=WO%]BD<\/17W
M69[K8']*U _,L4C).%+UL>02Q7HK[E&U$NJ>X3X5D/$H990D2<IE*]5WN64K
MJ)G(M*-W/(F^,S;,G,1IN62^MH#&7EC7'J2KG5X5WQ2/8)O)IO-Y]:)*V)I/
M8!B] FM6FV''#1<:3!1CAQ5=3NBKAQ\-AK5-F-)PDTU\ZK&[?[M>U0]%J2M!
M+!!!3" ?0X]&NF #]R"63$))$I]Z7LP"?YHSCF,4SFVKI=AZ+/*FT/95YVXB
M:W(G.N0X*L^1CS2&D-+\#S!>.+BNS\MWNJ.*<S*8Q<'$42)_'\<0YS >[-#A
M[$0]TI7:\=\7Y1WYKI<L]:VV<S^+I>[+>E?\353:M9=S]8W0%)EV<IDNF[FI
M3;S ?HQQY&'($T8@"I, 8D]M+RC7<7$>3PDF78O9.\LTIV%(L](VN\UH[Z8H
M'=)J$:4W'K,\>UP]FAI6WS9L5KK88B[J9MT E:CK91-Y:[HX_&.E#52BGPN7
M&F4#R?OTTC&U^*99+#J1Z>8IND+<%D^@90K<%:!A"RB^0,<8V'#6LRK_0&)S
MR!";7GQ3-5AY$.#IY=M7J7E7:A5^?OD>ZFISY+L6<VN[F<H-N@R=&HJ*![*4
MVXU5VJ1B_>.AUQ>LGM2M7W6'%C5BH6O>K1^.IB7+2B/W9W#WD%5K2M5'W82%
MY*;)2EZ95BYZ"KV&D/Q9_5KJ7XLGH?,L-:U-88'GH4KB#?M G,RN&VBJZ=+Q
MAL5F)W]OX*'[5@ KGPI=7_%CD7\1]]M-*+GO^Z%,(&4L@"@B/B0TC*$2*)91
MBD*4.'4%.#K3_/9V+:&NE;Z.(6FW&QL$GY$7RC6-:G=4Y+ E<\#6(-9@#%O6
MZ]AD$]?T.L/SRX)>YV[HIQ-NU>I3FH(*@G>.*[4N-D6@ZP7U..-Q2B$+E#I
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M_JT$+0- <=#V6&]Y "T3NK#$NZG0=S"9QY;"])V9V].HK5=C]W6H'TAMWA9
M\GQ%ELMG??FZ37/5G5(I(C/M8-F^NWF7MGL;#W4N=8D<3AKGO0:>SE:_A.\=
MT_VB@?I9\B8-2T=_?1%L59K5L=VS1C*-D PII"2E$!$D(68X@)2FG# IHL3.
M^W)VIKFM24V6I E=W-H_N5GFQV&U,\ ' 6ODU>,P3B/X;\^",:2]?'RR2<WB
MLSSO6[_G;^@5RM^4#+HCWYN3\LW14U%5;W0,A%)0WTC)JSNU)/T]6R[??7_*
M2O%+OJJSI8ZZ4+^+[#Y7IB]'?J)V_7$DE,%+,8$DE0@&:9RDD8A2DMBW"QZ.
MKKDIGY8LD*M-;+$^SC61+*)K0] <Y0K#$ >K-4M.$>N#"=;"3'X=<8VL_CJF
M@.*JC>3:/H#7$C.<@8XUH'D#FCG0< <V[(&6O]<1H5-&PFN(<K)TA2E%ZIK-
M,#3P9U(=!IMNRCR(H3':2Y(8?/A^1OO[59EG]:H4IO?S=_U)[0P4#0L91C01
M.(6Q%Q"(TE#9ZV' (>8>BX* Z<76Q6@_.M/LULV.4!-6T)%Z!0RQ;K;[<73M
M;/=!,!O[/+077,Z6^UDHAK3<CT\VJ>5^EN=]R_W\#7W#4DDE=!3L;H??!8X]
M) 4-(?91I"SQ",'4#SF,!?%]CTD<!%9I$&?FF9N&:$,B-:&NT::'<;33!@.@
M,[(NV *F+>(Q3GG],T@,&PMZ>*J)8SY/\OLRMO/TY3VV[UU)WTU:0I/AT[JB
M$J+@(WX $\9TJJ670H)3 2.FK 7D8<SM.G!;S#4W9;"NC/TR^ZE'$- 9G"UV
MR,.A-[*RF!0XAWWI< !.M->\!$BWG:,=-"=W@V>&F&Z'9\?+SJ[-\I8)4G]T
M-Z4%DY321%+($*(02>Q!RB2#.&0<A2P.$NP4-.],P=Q4L7K:PA'3?PSHMJ;:
MB%".;L3U20$ZV05OW"2@;?Q>+0W($#'?1*!MC"Y*!=H9Z(*#XL;M]5&QNBI+
M-<$BIBP)4AY"E@:);F#+(8T%A7&DM%O@122*J/,A\?XL<]-8S<%GGT[;AT'T
MXM!+0I)"R70I4J:C8D/"(6<^#A-$(LGEHBYJLIP*Q/5<OQ\0'<[5+X%FDC/U
MAL KL"%QX,/T8P@,?I#^8J+I#]&/\7KP /WHQ3VK<2KA?E3B-G4?E8;T$X]&
MD*,8J=><!C#%@=ISIRB-6<@"ZCDUNMP>?&XJ4M,&-'']JFANPV;W8O<%8^3W
MV1H']SJ8!Q@>M.#E]OC35K8\P-F+$I:'KNGE(6.Z?(>NPJMVAYR4O-:-LC*]
M]R?KVN777][$ZMU,1!#X"0LAC:(8ZMJ4,*5>"F,_46^O3R+=B"H7][J\^9VU
MV\R> *OG.FV>ZQ=DC.G)Z%@ '0]@PP38< $@4(P Q8F3B\A!0E:>MH$!G\KO
M-AN0G;QRXX ]F8]N.-!=?7;NP)WQX#D,.*4_SYW//>]>CP%Z+!1?LOO<=+50
M@ZVG--V/,U&U9?X#Y*,H"F D::KL.\0A%JF$C*0>]WQ)/-_*LV<YW]Q,OBV*
MP=:+T]'<HYN"!>86"G]8)$=6\Z\"HH-"'Q;,B=3XI:"ZJ6Y[B$XJ;(MAIE/3
M]CSM*&>'V_KMK]M2AY)+/TBD@"Q4ZA=Y<:(VU0&"@<"(AGX0>6'DXD#K4;9S
M H_9G9ZCE\>LJW^*>1K)R(>)T$=/(@C5_H4(J+@@22PD)I%3W;F95C?E2J.H
MIXYL3E1[H67G=YA=_=$S-46=_0P'ZT@.XF&8LJ+D86[VO0J#5(,\56CR)N="
M9GE6BZ7NE?+N>]O#4U>I_)8MEPO/HTJ7A1$4NN<E0@&%-(A#2&-/^-CS8XZ<
M6O-<0LSL7NSARQ8/(C,[13&5)$96+[M">%'+6/<P[GB!AAGPQS4[H./G3P-6
M8A\ UD$+M5]"S[1UW = [D69]R'&[+,[_TTLA;*._BK(LGYHH\<009BD+(0Q
M(1(B7U*8"E]"[K,82RH#9?;8[\</S# W!=G1"!HB73:)A_"SV5M?B,K8N^E=
M0/I$*!Y$QF7#?"%"4VV1.Z0>#)U#580XQ?WIW>^A&R?<[YZ@>W>'>^K"/HJ,
M/0B^6HJF<+E6BS\^?Q'W^@EHPL)W4Q"$3&D0>D0I-JY47)!22$+F0RH]SH/
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MZ''N$>GDH.E'QMRTVC;-37_>3/< :,@V77O=3.2>PK&S=\>'?&0MVC( 6@Z
M9N$*[,O L %:/IKR4']L6!DP?N,R+(>T)WM2,JEQ>!E:^Y;>A:/UK%VYU9ZJ
MJU>0B6JK8L&Z5Q%' 95IXD,_T%9=D B81I'.GTV()V2*?-^IN(#]U'-3CSO-
MU1RK6=KC;:?]QD%Q9(VW ^!.4926[BN@"!^E#90[7H,6Q;2??=HJF<ZHO"B;
MZ3Y"GP1A$[NFNZ!NIFA*K^R=0!,>4!]Y%%+!8HA\$<!4(@1IR@7& 4\HMZJJ
MZ33KW/146S/[6G?VW5"NWC=#NTM"JBWL%IO9,< <65V=QO&RR IK:%WR?$>
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MY%I/1K6IV8>M@J!KM[T00';U[M?+^I_/]^ &O\27^]I-_?VR]/<G(_"$EJ8
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MC7EV4IL]W]56;O!D!#?M#;3HQM;5LCOL&GA-CL4NS="0CQ#-L7?2!_;0_ZC
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M))E>7F0>0>VY2I@4@L9411@7HD7Q[4*,@6$WS+\*@@Y'[QZ8C'$^7MV!1K#
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MB*F(4I7%T6PA'[3/:+F.N0QO15:D(:M](88\W=>2576DL-FB95O9=^V\M?R
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M4V5)6B\P 4,3W-G26IU:H-%K]]=&LSM0JP&,6L!H67?O^-V$E-2_U>H&9,;
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M10J9P*E)#\9Q@JF,8_MTCHO#3(U,C&2@D787T.FPR7,93XM-LB H#<P=Q]B
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M70^:4E;Z;WI!%6TKP.9*_119_C!W5C.N&!9,4"BS)-<V><X@25 *)8HD$;+
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MS$4C@:DJ9$[M6QF<'V-JGV\C9;W? QHY73RF"SA:^)6WHS/P!WT*C$]5J L
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MJ"N-)S['BX_O8T*DL'^60CYVO7/*I7BGE\!V/X\15L0XX3".5:3M6B&@Z6\
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M3NI?6.G^VJ&PNZD?F7Q<?=</7F]>OM*_?M-?YR:GRV)!!$M%E&8P*I.[PRR
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M!C,:AAI/1AB)DR213E$W_<28&^E]R L3MJ]?JL2Y&5Z?6;"S-<?'=F3ZK!2
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MNEFW8\YYSN7('%QJ!)E1Z7(12?8"VM?5NH-2^1M@U >E_J %P UH(  U!N
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M-5QD21+P2!M 1&#M$$41@U2&"<PRC!FG(D)4N;5W\R29%0E,VO.M%6ZPDEM
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M9[FIG.Q%EJ4II8Q"2:6 F$ND7=\HAC)+,(U"FJ@0+[;K+5W:V:'V0SM1UEZ
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M,3L3'9O7JH&6;C?@H!UHJU='%X%&P7(F6RJ"6L>;LIGO6TZJRR'^&T[N5'$
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M&4&5%+A1P^/B0H?A:*?&"4 >_?S%X'NWQ_?V%;Z@$A[\7O_7:@%*-7RN0W>
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M/<R-$ZV, $4W]II*6J8^[3+-SV+IP(5]$1J9!D<$QX/^^H(T$?-U <N/]MJ
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M#.*,A#<_G-5X2 HX[F#267Y6M].)?/ZA_A';N^C*IFC=R7HG0Q8'0J20)R2
MF# -F28<IE@)) ."-/.:R1Y]SVV>G\09[Z3?%_SK'K5];1C<>&$D<$=FC<NX
M?LH*>]&NK*+8J#&J&=(!P+$BNZ]U_V;AW8ZXM,5XNS;1M>98%4%>[P46:4AD
M*E(*(QOAC6D40A9B 1/)<1C&BB0I7ZS4(]L8\\AIGIWTX#27TFHN'?8SWI3:
MW8%0E82^]<2. 70CGRZ@3!@ :M'X> 6-#G7"SNH\;&VPXRXFK@=V5K_7-<#.
M/];A<.\OV2K[L?WQP/)'M?EM:X.&FFH457F*NZHNT+W*R_N;1HW/*_,/82O#
MQV8R!Y2%,. Z@C@Q,SVU59_3@(9AB+52*78^]^LCR=Q,EUH7H)99E:WWJ9*3
M/9:)W'(EE*TEOREU!:M2V8.2/>9O8OWCB:U>_J.P?[/ULLH*/QY'8+T&UN%\
M<:KA&IFKFI&J] "5(N!.GU3KN:L+EH$#=<#G%:@5FFI</$XMIQJ?B0XTFW$Z
MGC('TVH_>S;?V0;\L=XN)> *9-4 <F,&2=#,(_"49Z*<E8WNOPYT%CH$[*W'
MI+TZF.X$=0@<C@Y7!VFPPP+Y06F5Y\JFWZG2>O^V7OUKRY:9SI1L?OG>L+59
MB<LY8*-O%U@C% D40BUB9%9&*B"CR%:ODZ%,%")!ZK2-[R["W);$0YF!K(4N
ME[E&:O!D7O!@TFXCX["TC8[WR&M:(V*9*J?2 !S!OWO@4(DRZGYT^#U6L-&'
M8:*EZ^%[F14.**V5V !6VG<;\T/.EJ4=47Q79DF3-MM1_1OVP^9VMO_2VXW-
M]V'?ETIN19G2!K \*ZSCM\QD8%]XOS,75V[S;*CUKM<@M2YTW5J>;H7KI?G1
MTM:OI:[I&M="*5G89..W0MC/S9ZTFVV)=0W5(>IU:8L%XDH2>Z<MD&:SA],X
MAC1,S=891UPE*A)1Y+3/Z]+YW-:Q1O9J[K%:^GI+5WI*BR/Y 7O,57DSVS<I
MI,< N7F,QH)]Y.7L&/%&<+"7'!R+/F3>27_ ALU+Z='_Q'DK_9%YG=>R0QM]
MXWTLC:Y7-D&9+=AS-HG<R5$0)QQ1'&*(>61OS20I9&%*($&(*D%B% :H6P"0
MMRPSY,)G8X@8DK/UB_?Y&;O' _D/CQOU303ZR$QX&#&TUZ,J#'8Y-^9$@42=
M@1TGLLA?G#<*->J,V^78H^Y-=J/7OZZ,^;-^7&7_+HW8NHOB7N796AH!<GL(
M^4%5_UUHG(9Q'%$H4&"+3@L$&=(1#!,NA8AX$B$O0O7J?6X4^OZ[^9>R<<Z/
MN:WYLCU0IMSU\5H=/T;U&Q$W#AT-YY%9\U#NDB$;R6] )3MHA >_-.(/6-"Z
M$VQ#<J*? ).R8"=L3GFO6R/^2>V,M6,=,'?Y-Y4_9T*5EWV18&F"0@UCA8R)
M&/$(,AX91HM9P+!.8N&69O-2!W/CJUK&,KMO+:9W=KNS0+9ST!#PC+]-]47&
M*\U=F_I]L]R=;7NR)'=MFAWFN&M];L#0S%TNO3M=_3YCR_MUD=F-J"W,MRKL
MF?Z7K-@L4F3,%\8H1)@CB+&FD(E$PI2BA(0AE2%S2ODTD#QS8XO+H88[G>SN
M9:<5:-0"O^\5 U8SSRCOON/J9A%-.%HCD]<4 S5,=*@_O*-'C'J(]/91I/[X
M.466=FBV&V/ORMZ5-P4WU8%)G1<MHIA$2AGK"U-M=I:&DCF1B?D;"KG $56:
M^+!Q2U]S8]I]A<E*UFOUX;VQ=6/$@1 ;F>TN@#5@RCD//(:DI[;N)J4>![U/
M:<7EE6Z4\?''TW+]HE1M-I9!0^]L/-CAF:KI^5D5&R5O_V"Y+,J*3H>_?[\N
M-K^M-_^M-E]WN\UJB_EIG=<_LL^A11!R%@::PS#6]L9PFAH60B%4BE(<4R9Q
MXN7?FE;\N1';WU7V^-V696?/*K>!?D^5S\98(T>^LC*N#U9A?H?1#C?@1;'<
MDP@G_F+<N'6^W\'8QQY6TWIHFR(3MWEN':?V[S=@IS0HM;;%P(J-^>G&C/T&
M[!7=.?SL<=6!LL/Q_=N,T9!+R,0:3+HJO<WHG"YT;R3%@ Z2>A(6'[;*WA7\
ME#VKA68BC4D<0F%]H%AR"1D*%(P3P61 N4A3KWK0KAW/;;TRTXH,X*LX!W$/
MIT1/X-[,^[!9VQC^>Y89[BZOI7YJR\TTC(>A!:O170GG^GY[GT$+(D[.@;;W
M.P;TG"7- Z/@W<O^D;K[DDD_L2S_&UMNE=E?;'\\E>&TC8EY6UF8]J!<F']^
MR)XSJ59R$44I)20R%KR0'.)8A9 2;L941*$,1:J)6WK+MQ!^;O38R 5>,K64
MGF%"4PZZ8US13(=R0HO\Z [!@>: OX"SEGMEHEL 0(D .(#@!NSV>S4*H($!
M-#@,&+ST!J,W:+33E/)/&Q[U!B/S*I[J+63HMAR^#I^U0;4G0>)$R$"B,($\
M313$"8Y@&IL%#45QPF2<XCCPBN)WZ71NR\_MF7C],JR\< LA[XZ^VWHR-*8C
MKP/G@O%+.,>*R/?!9TBF=>IW4H;T0>*4V;S>[<9(7]:KQP>5__B@^*;..I/9
M7)Y/]5;@3M_GV4ID3S91LMT4//RQ7C#*F3;_#UF<2H@E(X:K @*1#!$+$V-O
MH\"'H;H(,3?&LA?C_.BH$_1N]#0VH"/3E14?6OF!56"?1ZSV+1AAAV.J/E -
MR5R=Y)B4R?H@=<ILO=KJQG3OUZM-SL3F[]GF^_MML5G_4/G.\_%5/:O55NU]
MM(LT5H@0%D*4Z@1B9*/?J8R@IL8&2P(44NWE3/#K?F[L5@L(#H/>R_0=K+ E
M"Y;;.@FXJ+4$RT8U8)YZRK-U7I[O@;9]X1##YL:/XPW&R,S8" [^,)*#1O0C
M5VPS5'OYAR/+;K@-29.>$DQ*D-W0.:7&CJUT*AU=Q=IOUK^I377_R'RKVZ79
M[UKEF%R7>^*UOOWVUS! ,8H7* BIV80FD"%EXVB5L?P$Q9 B+B3A@A/./&I*
M^_8_-UK<74C9K&W5@^9Z7Z-%??>\UJ/,'_[MK[9T9@Q1[%5@V7N@VGEP OA'
M)L+Y(N]5\WK,$9BL&/8((^%;*KLKCE=J:'LW.V5Q[:XZGU3=[MQ,C[A@ZZC-
MU7<;;?RLJEYM>9'WK/C^:;G^X[^4?%1-S9%W2J]SN^(=%\M;V3MD"Q&(E(9(
M0L6X/?(3#+(HY1 A$;$HUB%'>/&L<K[VBB4>2CZ?Z7HHY=@AM4?Z-3.VJOES
M ^P]/;8L;?R36D"'I7]NZ]1&'\S>S?RGBFFY ;Q$PU[?[!#2/-AGX;8+>+.A
M'GEM=!ACJQZP^H%2P9O#D=X-XJFBY96YMI'M%G8]] @,'J@]F(#3AW8/C>W9
M8/#!.^F:W_SX"O'G5>,_OV<OUGF^0!%)$I3$4!-$(!8DLMD>*<1F2L4Z8 RS
MU,>G<[7'N>U7=N= 3Y5\OOG/KP'LQKN#PC;5/F.?<L#ZN79 WE\!LD/J=$=P
MADVF?JW3B=.K.V+P.N&ZZXL=:[@K;HSD8I.7&ZOR/GS(C96)HQ"2D&.(@XA
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MH. 1XRF2J0ABK].53F+,C:0^985-]F ^2>)YV-)M%!S/84;'=NPCFE(!6&H
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M+BK]^;U=SO6]2_.+[_+^:27K]=M</J^K@NP*23 E!$XBJ8UQJBWRF$>0)8I
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M@4:9+DU(J^-Z-'GK;-G1]8AS,#!/=YJ80(X6=78\!YJR6X5J [Q5:=!"CX$
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MZ_-A 5\:R<"JE;P.;1<[V1T,IC'?  L#=J+S.C#K=EJ#/;7OP$YQL*]YF]T
M.MWKR=_3'K3JFP>TKX=& .Q! ![JX'L#PD3?% <3?:)OS$BF_@3?'+?-PRM,
M7^\F9$QYQMO,O +*!YNBUQC?;W-U/Y\O_S1ME#XL5^^6&[96F_D]K\N"5WME
M]I;SN5JN3/74&4Z%BI6,H;9O<HA41"'F,8-2TEA$6'&DN(LWP5F"J1DH6P6
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MB9@#8^]&X7[H]?*[XR/'(W\_70]6!L]'>!;?WYBUYY/Z(E^6J[79A'^53W7
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M%-4L2Q2B"J4082H@BG,3<!MQF'*6,AE3;0T[U=P_/\S4;.!../!DI'-C^0M
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ML;\H4_OJ6TT<#8D;IL+R7&<4@(<^]FG#R/>*R'1M%7]I-?E+O9=JE3F(=AS
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M5DQ'E\LQBI8>E1NP&7K+;DI9:"M%OTG5O]5Y2NN?X/ZH1.(1=@_7L'-WF5P
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M#V.OR6&K .@TJ.MS?_W=%$W*89P[L)+;Q%B0_F!P#\S\$T/:81$8#/&15H+
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M)&510I5B5%#"LJP(.LU\C3!CXY2M+G9%W2H3QB1738\?X0P%>N_>@@W>>WJ
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MFO*"\33/L;>-=V:@L3'6B<80 9;+.50]++Q(6/7,1B=@ZF+IG<,KP-J+A-M
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M/!4PI1GA@I5:$S%9+59L-AS F]'^.P#L2\57P]8[$SMDC(C;9JN-E!%[K5[
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MYD;BYJ##S.47-&('F&@>4'O8N'$![#N*L<7.)LDX<5OD_.HU=H(QP-B-"^=
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M"%9G8#[?T?H&&+WM^V\T#X@[QYA_C\C^4-,Y#-WZ3Z&=N1_'.&<!V00#S]U
M^0:#SF%8?D)$P,]F,,089[@<AXBH[&5!Q+QOMXW%^^G<K/)OEDI.5V^9<"4:
M?V5?IT_KI\WFY0TSS['Y?")QKI.BI)#)#$%<H!02(5+;;P&)0I=(YD%=%D(&
M']OFPLIN7SWAI >\E1>(1N"PO430//CM)OI"M^<%K@6V%ARTDM^ 1O:M<P.\
MN01U\(:B"V8QMQ1!XP^ZJ>B"S.&VHM,].FPLS#VF*S:S^0W50J_^8DOUJW(5
M3],B1RRA"I*,F>U"A@I(E)F&/*."$Z&%UEY>U//#C(VK=@0%K:3@CUK6D(/%
MIW'U,,.CH-4S]_0/5(#M&P6P@2S:;L"%F:87\3AK<)Z^>C@S\J(&>\;AY6]W
M,_G<F:=[<^WMUVDU*426J1)+F"/;, ;EI6%$D<',F'=,H;0H5)"[>._N8R-"
M)QRPTH$_K'R!#M]]Y/RLL,YX]$QU_E $&U%'58YI)>T/,*@9=%2W0SOG^)<&
MKG9@6_.MONU4@W2;S?M'-F]BUA\6\SK5_E]J^O!H_GO[K);L0?W3W'KU,UNI
MMVRZ=)'N3XO9[.UB:>\ZX0G#G.$$9HDR>T!:)I 6(H<(%8)AD=H2.(,<C>]'
MO[$Q5BL[;(0'3GIHQ:^;65DE+IRG_BZ>*\\(V;BD'A&?1SB]7V.T5U>X]E2N
M#$S;L_T;I&Y BQ78>SJ!A0ML'\Q>:@^/]$D817F GE3\/BH)]#N_T8H.]"QF
MU_H$>CI7LCD18IO\WE;5^JD6Z#>K))N)]<Q5U_N@5G4RW%0TWW^SJ%:N(M]Z
MOOID!)QP0E11ZA26)>+62\P@5RF"(M$$H3PM,QR4NQM7O+$M]:UL8&F$"ZV%
M$'7>_-;BUYN-GI?21C'02.KZE]^ '>7 ;VZ5W:KGXG"M@IOKK(HW8#.MG\Y-
M:X<J#GV@'[< 1%0)!ZX=T0>Z+\M.]#)*Q[Y-2_6%3663N5BUQ?N:?FUURD_C
MQ-1<$DP*!@N&"[,'3#DDI-10BXRI#$M2\+ .3MY#CXVS&\G;S-NZ$4<3WJ^E
M;W+? OLY^<^%'U?W@W#//.P-;D1/<W? HK9^\A]]V"90P:B\: <5?H>Q^<U^
M=U;Y7I&PC2D^07FF99'E4/),&Y.WR"$ON39,F1;F#X2D(NA$\NNH,3::=;Z$
M30'13Y]_JT!(E9M7?B9>V[45:Z;_VWBP:D!V2U-Z>%%'Y*'RF=#OPQ%U5I/_
M)OXFG]D:SJWD)4VW);?M[&A$YM.YD_C3IM#(.VFDF>HIVYP?:/I!2F,#[/2>
M=SL@55L%'\S4[1H&DZ1,2L0D@5FF",1%1B"A/(&DQ!E/45E@BL.J<O<N<PC!
M#E.2NV9$UF%;TO\$^RV5HYJTGE?%5E>PHZQ+#V^K/^WJV^Z'6HW=CFE'9] H
M?=,LBUN]+VU3@U>_P>8HYD+7O]"#KFF#S<'A\C7<P!U]7>;M?#1+Y[;PB>O.
M]D%]7=W_I6;/ZM?%?/5HUAO.)<UX#EF"2HB51) 72$">2U[JI*0L54&.+K]Q
M1[?]FE:"S8!Y:5"@'\L39T\G5GST^O9@-1+O56E:+0!79N<R-31LVP&"NWG$
M74<@2%&]5IY##^NR"L/CA;\J\/)N?+2QP.^T_HG-;$VFSX]*K3Y-JS]W.O:^
MF[N*35:*]YN:YR4E-"^9@D6"E.4H#DF&,YCD,E5,92Q#04'6*V09'6]M=O7&
MX-$:\EH=X/0!3J&;W1[9.SI=49C^FLGT(\*!IJAG<NQ]=H*Y,P*N,?GT&G$&
MY=@(N!WR;HQ;=BU-NF(V*OL+6]HR>6V<+2\%1QP5D%'%(98EAU2E&A).<DUD
MCGE.PTJ-'AMF; QZ*\3Z:5WW<[31:C%=!9Z'N0"K'^%=#U;/7-8*"%H)>PA)
MG@<A;O',HR,-7 SSG+8OBUN>_7:G,X35HW6F/K.9=:/^RE;KY73UK7:;3M*4
M)$PA!%5NB  G AM>$!H*G=AS,X4@TNLD].6AQL8(5EBP(RUHQ6UB*4&GY,Y!
M?)X9X@+7,SL,AEG0Z<)(V UTPK I7+_08#5]4G5)C-6C M+FFIM/F?4AU<7)
M@;$)P&QJ?K<Q/ALHKD.!TSF0BJ] I835U?I#Z[VX85[UL%@Z=RJKS*]FNLR7
M[>T-6U6+V52Z%;"U4"MKB?P8[5BCQT1<.-IX[@Y#'F_TT.3@B*//%=>6S/N@
M5CLI<W7=JFTKY"(I1*ZT@I(3:?;/7$ N<0)+I3 S.^NDR+Q:,06..SI>7SQ]
M6<S=>V+>II/YK'L=OF_%:LV64S;;38[M6D/O_"QYYE#$Q[[OI(>=ZGD6]%VL
MVX)Y(&J_ZHY8]5,X[_S0KU0USPN/TR7S_"[O2&K3A[DKS39?-1V4;$UBLT )
MLYIMWY9,<VKLT!P62%"(=8DA+PL&D2@S2G%6$AU6 ]1KV+%1VN?UTQ-;?G-M
M$+8*@*T&H%4AD+/\)L&3LJ)#VS=CG8?2<%8O;!4$4U2R\AMY6*X*0N,%585=
MW8VI# M:Z^[C<O$\E4K^],V>9W@W?^?L<3.>L1VFS\X(GY2$ZQ07)=1:IQ!G
MHH24VY*>A!%2IC)+.9VL;*:2'UOY#QW$6!L!^GNWK 7@=A_KJLY/G+8R [81
M.HRL N;!C[#Z0;=GTK+ NEUX*[9-)/WAMQKEOX.-\.#V,LS!W!6.6$S^"AA]
M4 X+1^60QSK<8>"S!$W.Y:V4SC'!9MO(1=6>B9_@+$L$H0J6,E40,YQ"FN$2
MEFE29@H5>8;S08X,^$@[-AMO4Q]C4X)@VR;KS6+N9%ZS65TKX_U4*_"#H56;
M=E']?:## UX/@:>Q.):I[=O&O/XHP";9?ZOS3C"Y&E=-BI#I&45BOY? WT?^
M?@CVT=+T@P;M:=&J3@FW+5\UE_90\@?SIOZ\L*PZX9+RO,S-6D65@)A* KE*
MJ/D)LZR494I$6#>V'H0<VQ+5'$JJ"Z[]4<L8VFFDC[F,M.3T/$,]KS2[9? N
M34W\]> *[ 9=!KK(.2[VOP+I8-*_9JP.F0H_*Y&F*$EIDU)#,D%S05.8,T(@
MMB>EB+"%CC%#"9%$EZ77?N+8S<?&K48\D*8WP$K8I5#O(78>20=7(-(SE\4&
M(R";X I0!LH?V 4G4N3^A-)G8_6'UPP7G3\A[5X\_M1WKHW ?U+V/*I8N1::
MYA>U?%8_?;-,>*=MD&P;-)%Y(I$A*BA+@2 N*8&T) @BDBF.LUSPKM%X;QG&
MQG%OS%KR8':L]^Q/-=_$WE<+&WU9VD:T>YHY#^8587C_J0H-R?<R 0.&Y_=A
M;A2P7@AG/=J.%38_8IB0?3"6_83O_<5XI5!^,$ZGP_KAM[J6-=W)QYU>>]M7
M3R=E(G+$8"JY@IB4 A*E.51E6DJ<*H43U(TE3XXY-E;<?3/KP\Q="FWY@!W*
M<U$@')#7=M$;B+XN0M0/79T>]I7HZ2(.I^GH\J6O$^MJ.J%;D0X*U[8]TC\N
MIT)-)"(B21DSNU1A._'D!/(\0[!("$M*2M,<!QVM'DCNL=%@(SU06_$!6X'/
MYC%T)CQ N=WSH'388)?O4S!,V*N'N?V. F [VA^IV-XB !P$XXF%!<[9F*)B
MOJ*/RT,:=SYB1\I"A^_:#7/5G/+_O&*K==5$2G"!5*:H@!FR:Y7F%%*:4Y@P
M)7&>%+;U95C?RV/#C&UIV4H):C$[!J].@.I'_==#U3-3=T"I0U?*<R#$[3]Y
M=*2!.TV>T_9E3\FSW[ZR'L=/WW8/G_]SN5A_,;M_9W!/),>:%!A!BD4)L3"L
MP'!2PI1E.2<YE7F&.Q7>.#/HV#ABMX:#,4=^VBOAT$K>;"J[EM$X-P=^)!(;
MV9XI)0ZHW:M?>*#42YF+<^.^3CT+#R1.%J[PN;8;.]FDU\^N&IJYIBF285,;
MW\VK]=*..$D0DD4J%62")! CBLQ/J892F2G@%$DJ@@KT7QQQ;+SD,CVGK73V
M%*]+J0KT#EX&VH]_HL+7,_FX+/F-L$T#KX4&#M&-P/%8QQN;F)1S>=!!^<8;
M@T.R\;^P.].\G2W^^@\E']3/:CE]-I;6L]J6%V[J-ZZVQ<XE+23&O(!9GFN(
M,YI DN8E%"F2B..29RRH3DZX"&/C(O=&616 TP%LE=@I5-[ZW]G*IQ9YK,GR
MIZ_^IF (/HN+?B>.ZP9@;-(+E&)P%NR&TC%:['BG;CQYOU3,,.ZWSZN%^+-^
MM<HDD<;F*F&NM80XQ1KR).%0YD*6QCC392XG<_5@DSGN_>GPY4A>[QJMW[47
MX_7WWK6"@LI*>F-?+6'S(_[V[P2EZ3\ SFZ*/'/E)++RID@HJ*S_K[H!YI\O
MRA[=4K-O80QX9!K\&*XCJL,PV ;)SS62D<GIM.XQR>?(*(.2RVDM#\GCS#<[
M%IM6\VJZF-N$WVJ_XUN39\ERE%.AL3U*D4)<EAI279C-FS+6DR@+(EG0H8I+
M X[-0&KD=7T6 ^M+7X+6[_6/"5C/9+"+51]MSSR1B%HV^M*8P]:+]D3@1:%H
MW^LZ9/@?*:?_9F&&,Y>[7^[-7J_2RNP#Y<?%T@769G:N;5K(HCY^]*M:/2[D
MNTTUM$F*S7XLHQ)RC>SY+5N -V<"4JQI6>0L+XE7B9B^!!P=2=5R ]8*;C-P
M57VTZ\G)OE-K+B#IOH^Y/<]Z8YBQGEGR>-.4/07!CH8WH)W=C9+@?M%V$ZOU
M!._&,KL!QS)>>98'.MKQ2K,==EBDQZDX>^"DCW&'.[32(VI[!U_Z'"?.@G_W
MU]RL<H_3+Q^5>6W,._6@)D624HYI8O8,J##_Y GD*..VA)) /-.<:?^3?GYC
MCFU9WHAH8Q2+]:I:L;FTX=':FP!^8!5@X$LMOV?%CY IZ+;47@GLJZR>6Z2W
M0L?'\[K%[4I<7W6]"L+WZK7G#%*AR\FQ6[WJ"G%&MTND?^[2#CQN4Y+4^X49
M@BV7W_1BZ5IT?K7N327O%[_-UZOI;/I?:D*1$AKE'"I$<H@E,ONR4A/(2*H(
MR6F9IOY,[COJV+B\LG*#F1$<B!W)@6I$MSNN=2M\ /5XSX('F?>!;<]T_NJP
M!G!Z'_ .Q.IQ8 XC]E"XSE*[]\V&(_=0_?;H/?CBKCGCFXZ5;YH6E6U1-YWS
M1&640IK9O/&BD) 57$.5BK(LB$Y1&73&Z?108Z/R1CPPVTK\OT*SQD_"ZN?4
MCP-6S]R\(^0-:$'KHS3=933BII&?'&W@5/)+6K],)[]X13>:^$7K.JC];BX6
M3^J>??UDZ,EVQ9T+,V!]'&;U5EF/P\RELIL)_;;WY8E2DB&&*=04$XA5:?;[
MDDB88LY*1C16."BW*H),8R.>6CBP8E_!#[R.O_P=?+$58EW8C*V KM4!5:L/
M6!H]PL@IQF3ZL=C 4]0SW6VT <T\&1&!E1'L:^3211JEP$:KPXMNVIUR/)J,
M"'=,/HTAUJ#$&Q''0X:.>>L.6_K;)YML:U.HGMXOV!PE*6ER#03A*F5FTTY4
MAB#.T\38?=ILY DM2XY*R5CIO8<_.<S8"-=*!AII@1476'D#MI&G ?78CD>!
MJ6?2>P$.<)AU*-!V&JJ +784R ;:4W>%+FP7?1&1L]OFTU</MT^^J,'>QOCR
MMU^G=,COJK+'NN<[FW3[T=TVJG.VED0I6)D7.8*Z+##$HBC,;CO#L$AIQF3&
MJ$+%D!5%KE-G;#S?%AIY=EJYO-U=SY;]^'CA$?!#.G"E_2N?(S_#_/MY.GI>
MWF*6*OE]^W#]LO-PV8_-M[;0?$=U3.+,\YC*FURIT7=5]23.[,4NAA))JH[I
M[,N%4$I6;PW8[VW\]$Z_62HY74TD+XF@60ZQL@MP3FW-:9)#0@E-=9$S5)"@
M//93(XUM;6P%K;L2+]7S8O9L<U"$DQ:840/]2Z<Q]EN<HB#7\[JQ#YJ3TA51
M=7)&S&B_!$745/:3@PV;PWY)YQ?)ZQ<OZ,85O[JC-([2WLV_K%>VRXGM-VB=
M,,W.-2L$3<I20B11"G&J-&0ERJ&F&2^E,M21!9'&Y2''QAX[$@,G\@UHA79N
MSC#J\(#<CT/B MDSF5S"L(>C,O[XQ&08CU$'I1I_% XY)^#*CNX(&_^WM[_3
M;Z=S-A=3-ONXJ%S#I4TL.<4HR6B2P5(H8[-(1B$Q'T!"2JUIBAG*O)RV(8..
MC8 V,MOU=R,U:,7VB4=WGP#/W79D6/O>$U^/:/A&-0"BJ-M)GW&'W?0%(/%B
M:Q9R[2E>VIU48T[]^;__K?W$_&,](/_[W_X_4$L#!!0    ( )1$<%/?\>'"
M$%<! -3 #P 5    :&]L>"TR,#(Q,#DR-5]P<F4N>&UL[+U;<UNYDB;ZWK^B
M3LWKP2[<+QW=/2'+=K5C7&6%[>H]9UX8N"0D]J9(-TFY[/[U)[%(ZDI)%+G
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MRL48G33QJ30MB%EIK[52MK\+9[>?O!LD&LZ&'BC,)J!P=A4FX_AV,O/+$3[
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M_ 9=P2./S!D3-*%6VT*\(($;0ZS+G >10.0M18.';S1WJ!@<(H=J==:7B!O
MQUH.:^(%S4BG A),$DB\SB1D8XGR1H;@?-)B2R^.'AR1VU0,T_^O'C[V%W$+
M^-CLNA@YP#O\<C%2:%$QXJ.$\Q2)C-&0($PBWFD5E><>S)9+CSUZJ]>D#(.4
M'AV2GJ3< $X^PE>87L'BVF_7(%+FI5#!)@S:I348OF=&3 J@LPE2LBU7[P]'
MR7U"&G%:]U3LK$<IMX.2MRBGT]FT8^'OX^7%Z=5BB<'?'&/ R55)(9XL%H!_
MTF?_;62LXH*)C+%?:86(8D)144>T-CX:ZC.NLHI >@FMPV+M,'!L1UHU334
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MX60D'&QI65TZZACPQ%#'?'!:<56EX/0)FH8^9#H>Q [21ENV[(Y)%M9)P+5
M8C<[V1M#;'! E+1")QV\@"H7,!ZA9^@#I&,#:@\M- "F.\>P*T9&VMF4K W$
M\>(Q:H91B> 6@Y28#7?96T5K &D++4,?&E4&T:'2_P&&@EW+<#'+6]*8!Z:Y
MGOGTOE-=+V&F_W37$TE7R[RV$MTA2*HD$KPF(2$(&5@,\" +5:>IY4[4]39!
M>#4FUV#8(9/,)&<H4_-")!YPO80H?+!:.:!5VC/>):.9!%9/J'ATH/#+A=[
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M!C*5N\MO9(R5N"(820K0+]),$)MB*=5A')UQFG2=Z22[D[@;%O\JQSF55-=
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M3H1+5X9.9DX0DIH(#8IJES$^KG)QH9XAN[,%=Q_^_6:1""$9Q!!(,,Z4+@5
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M71=J^G;["[4%)&R"6F9<**WXM7>E(MEIXHVC1$4JE?;9LKQ+EZW=L3#D-G:
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M>G0TT,88>UYH3H0;BTQDL,0:[TAAP_$$,3SHJE-W4M,+\%AMQD-3>*RAR0:
M^<1HE5???_/_.9O?I!4X:&6*[>8Q(6L6EYNSS).0!(HP!<5HE5O$+Z!QF,;[
M1RJWKZ*HMC%XPUAQ)];+5U*FL\(U%6(9$5^FP]LB1F=T%BI)PUBM*QXOH7/P
M0OHZ>-D=EP<KKP%L/G!E<Y8Y)RZ)\25R9]J2@+]6<JM!6P%"T2JW6/<*.X9
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M)F<C> _'0% +VUI/FGX:/WN(?? +EB7876_-JTRQ"4BV2"@%F4J3*(;.HQ)
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M4HN2KY*$]Y;KP,PN$4"+XHJ7U]-_^F4ZBBTZ.+V^QTS@A!0A6P/!)UNGUB7
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MX)1Y$*7\-EO%?'V-\[RX65TIE8HJ=!TS8W5M^1"$=4'Q,&JK3$*N19,SYI!
M1Z'(O! 4C:K]OE#T^V(>-]<P'9*1>U$S95Z9.HPJY4H2[< $$^@_+ILV#M!>
M:8["CWVY^#E1[Z>#9['&ZXGS3*\_XOQ#7LWF&./-IYOK.IHBX'7U]E:+LF%
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M(?A8V^ 8Q5"Z6#)?K+&51RV."UA?2 _A*>8>17D]1"+/LD/789G>TRU*7YU
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M.>D#%W^YTU(+5V:TW(\)TT58ZQ5D(VWM&>;!I4B_S3XH:TR(9M!);KWNIKE
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M@:)3 )6X >>U %N<4-PF&:49%)D],]1(QO$TO#V'XC&5/_;&^UK-HK9%V%C
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MN[?R%!2P2&<+JYU*V7@SS-R+?L@?\5WV,+CJ6F@RG)+;A?;M[797KJ4G$9>
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M1+N7G&Y0?:LWU#VHJ(W4_./'O_G'F\5=T?YFEYG0%J&C$QR\2;;.ODXD,!7
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MK[]=O?H0\?Q$_I][<>X*>DOK$PMH3;3X]PK)K^;_WVGGQQ^GRW0U7]XL-NG
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MW<DX2)CWI98&,'6\X.[9GN7?K\+LMW"-/\YK?\))TBQ$%T@&S)$,K!'@>-+
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MD"C#( T:SL3?V_'TA^!\U].W"*8&,J/#BV5] 6:X,J$V./ LTI['::/V6F3
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M^+!!XZZ0\;U1UE@$%Z^Q3E\O>_0W^M5>#5?,OHA48[C'7-=S*G+[;+7H>"[
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MD7W[4-WZ7]3_";C,__EO_P)02P,$%     @ E$1P4V0@+5"L"   >[0  !0
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MH-0^NIUV>DM:ZZ3\L:#RFKX__9?/K)\%FE,.BMLZY149V?M&//QYQ>H"PC5
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M-ETVO',694F^@.K73[ROD-?Z<Q^-!7]];M%&(.G"_HO-+.G^!E!+ P04
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M?!3<F>01UK"\,<SK"\Y(H1]8L>^_Q2R<OPMV5FG\#[NS*A3?VZ>'-SYZ]T$
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M2F^*_,U]4_.L;[_L/=S>GU!+ P04    " "41'!3K<!J50T(  "N)0  %
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M0%J(_N V&=-\Q,DI..FZE)!H=VFCO;O#7_FN[5T6[L*M<.5D'A#J]!-'7$O
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M]6_06=\+M-Q[UQ_V1A<>],=75WX0*#?'$_##0,5R?@XWU_A&!>,%X>XYOLW
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M=&@N:'1M4$L! A0#%     @ E$1P4ZK&];C>#   %U0  !X
M ( !>4X  &5X-#,M:&]L>'@R,#(Y;F]T97-X9FER<W1S+FAT;5!+ 0(4 Q0
M   ( )1$<%-.F2">>@X  #5A   >              "  9-;  !E>#0X+6AO
M;'AX<V5C;VYD<W5P<&QE;65N="YH=&U02P$"% ,4    " "41'!3^=UD@H<-
M   )6   '@              @ %):@  97@T.2UH;VQX>'1H:7)D<W5P<&QE
M;65N=&$N:'1M4$L! A0#%     @ E$1P4Y*);5UJTP4 *EM  !$
M     ( !#'@  &AO;'@M,C R,3 Y,C4N:'1M4$L! A0#%     @ E$1P4PD+
ME5>R*0  '^P! !$              ( !I4L& &AO;'@M,C R,3 Y,C4N>'-D
M4$L! A0#%     @ E$1P4W<2_Q5C.P  N6L" !4              ( !AG4&
M &AO;'@M,C R,3 Y,C5?8V%L+GAM;%!+ 0(4 Q0    ( )1$<%-_O>A<>^T
M *)Q"@ 5              "  1RQ!@!H;VQX+3(P,C$P.3(U7V1E9BYX;6Q0
M2P$"% ,4    " "41'!3IW^1$SXJ P &8P0 %               @ '*G@<
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M              "  5D_#@!H;VQX<30M,C R,65X,S$Q+FAT;5!+ 0(4 Q0
M   ( )1$<%.1)?#M\@<  &DE   4              "  9A'#@!H;VQX<30M
M,C R,65X,S$R+FAT;5!+ 0(4 Q0    ( )1$<%/8!,F&6P4  ) 3   4
M          "  ;Q/#@!H;VQX<30M,C R,65X,S(Q+FAT;5!+ 0(4 Q0    (
M )1$<%,)%+67/04  $H3   4              "  4E5#@!H;VQX<30M,C R
@,65X,S(R+FAT;5!+!08     $P 3 " %  "X6@X    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
